PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	COLOMBATTI, A; MUCIGNAT, MT; BONALDO, P				COLOMBATTI, A; MUCIGNAT, MT; BONALDO, P			SECRETION AND MATRIX ASSEMBLY OF RECOMBINANT TYPE-VI COLLAGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOV-13 MOUSE CELLS; ALPHA-3 CHAIN; MESSENGER-RNA; VONWILLEBRAND-FACTOR; GLOBULAR DOMAINS; MOSAIC STRUCTURE; MAMMALIAN-CELLS; MULTIPLE FORMS; I COLLAGEN; EXPRESSION	A monomer of type VI collagen is composed of three different chains of 140 (alpha 1), 130 (alpha 2), and 250-350 kDa (alpha 3). Monomers assemble into dimers (6 chains) and tetramers (12 chains) that are stabilized by disulfide bonds and, once associated one to another, give rise to a microfilamentous network in close apposition with cell surfaces and banded collagen fibers. We have derived murine NIH/3T3 cell lines that were transfected with the cDNAs for the three chains and that constitutively expressed chicken type VI collagen. Cotransfection was efficient because, in three out of six isolated cell lines, all chicken chains were expressed. Southern blotting demonstrated that several copies of each cDNA were integrated approximately in equal number. Expression of the three polypeptide chains was consistent with the levels of the respective mRNAs. The three chicken chains assembled by disulfide bonding to form correctly folded triple helical aggregated composites with sizes corresponding to type VI collagen monomers, dimers, and tetramers. These functional recombinant assemblies were secreted and became incorporated into the extracellular matrix, where they formed an extensive fibrillar network.	UNIV UDINE,DIPARTIMENTO SCI & TECHNOL BIOMED,I-35100 UDINE,ITALY; UNIV PADUA,IST ISTOL & EMBRIOL,I-35100 PADUA,ITALY	University of Udine; University of Padua	COLOMBATTI, A (corresponding author), CTR RIFERIMENTO ONCOL,DIV ONCOL SPERIMENTALE 2,VIA PEDEMONTANA OCCIDENTALE 12,I-33081 AVIANO,ITALY.		Mucignat, Maria Teresa/AAY-3908-2020	Mucignat, Maria Teresa/0000-0002-9601-054X; Bonaldo, Paolo/0000-0002-9571-8140; colombatti, alfonso/0000-0002-3676-2379				AYAD S, 1989, BIOCHEM J, V262, P753, DOI 10.1042/bj2620753; BONALDO P, 1989, J BIOL CHEM, V264, P5575; BONALDO P, 1989, J BIOL CHEM, V264, P20235; BONALDO P, 1990, MATRIX, V10, P139, DOI 10.1016/S0934-8832(11)80162-9; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; BRUNS R, 1986, J CELL BIOL, V103, P394; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1989, EMBO J, P1937; COLOMBATTI A, 1988, COLLAGEN REL RES, V8, P331; COLOMBATTI A, 1987, J BIOL CHEM, V262, P14454; COLOMBATTI A, 1989, MATRIX, V9, P177, DOI 10.1016/S0934-8832(89)80048-4; COLOMBATTI A, 1992, EUR J BIOCHEM, V209, P785, DOI 10.1111/j.1432-1033.1992.tb17349.x; DEMARS M, 1990, J VIROL, V64, P5260, DOI 10.1128/JVI.64.11.5260-5269.1990; DOLIANA R, 1990, J CELL BIOL, V111, P2197, DOI 10.1083/jcb.111.5.2197; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FURTH JJ, 1991, EXP CELL RES, V192, P118, DOI 10.1016/0014-4827(91)90165-Q; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HUANG MTF, 1990, MOL CELL BIOL, V10, P1805, DOI 10.1128/MCB.10.4.1805; HUYLEBROECK D, 1983, GENE AMST, V66, P163; JANDER R, 1983, EUR J BIOCHEM, V133, P39, DOI 10.1111/j.1432-1033.1983.tb07427.x; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; KIELTY CM, 1991, J CELL SCI, V99, P797; KOLLER E, 1989, EMBO J, V8, P1037; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE ST, 1992, J BIOL CHEM, V267, P24126; LEE ST, 1988, J BIOL CHEM, V263, P13414; MAZZORANA M, 1992, J BIOL CHEM, V268, P3029; NELSON KK, 1990, P NATL ACAD SCI USA, V87, P6253, DOI 10.1073/pnas.87.16.6253; PERRIS R, 1993, EXP CELL RES, V209, P103, DOI 10.1006/excr.1993.1290; SAMBROOK J, 1989, MOL CLINING LABORATO; SCHNIEKE A, 1987, P NATL ACAD SCI USA, V84, P764, DOI 10.1073/pnas.84.3.764; SEGAT D, 1994, BLOOD, V83, P1586; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; TRUEB B, 1987, EUR J BIOCHEM, V166, P699, DOI 10.1111/j.1432-1033.1987.tb13568.x; TRUEB B, 1986, EMBO J, V5, P2815, DOI 10.1002/j.1460-2075.1986.tb04573.x; VANDERMARK K, 1984, EUR J BIOCHEM, V142, P493; WISE RJ, 1989, NUCLEIC ACIDS RES, V17, P3591; WU JJ, 1987, BIOCHEM J, V248, P373, DOI 10.1042/bj2480373; ZANUSSI S, 1992, J BIOL CHEM, V267, P24082	42	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13105	13111		10.1074/jbc.270.22.13105	http://dx.doi.org/10.1074/jbc.270.22.13105			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768905	hybrid			2022-12-27	WOS:A1995RB43900027
J	GOROVITS, BM; HOROWITZ, PM				GOROVITS, BM; HOROWITZ, PM			THE MOLECULAR CHAPERONIN CPN60 DISPLAYS LOCAL FLEXIBILITY THAT IS REDUCED AFTER BINDING WITH AN UNFOLDED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLASMA FIBRONECTIN; BOVINE LIVER RHODANESE; FLUORESCENCE POLARIZATION; ESCHERICHIA-COLI; STEADY-STATE; GROEL; RECONSTITUTION; SPECTROSCOPY; HYDROLYSIS; INVITRO	Steady-state fluorescence polarization was used to examine the chaperonin cpn60 that was covalently labeled with pyrene. Two compounds, 1-pyrenesulfonyl chloride or N-(1-pyrene)maleimide, were used to incorporate up to 8 mol of pyrene per mol of cpn80 14-mer. The fluorescence lifetime of the cpn60-pyrenesulfonyl chloride conjugate exhibited a double exponential decay: 5.36 ns, with a fractional contribution to the intensity of 7%, and 48.77 ns, with a fractional contribution to the intensity of 93%. These yield a second-order average lifetime of 45.58 ns at 20 degrees C. Analysis of the fluorescence polarization data for the pyrene probe by the Perrin-Weber treatment revealed the existence of two components that account for the depolarization. The fast component accounted for 24% of the depolarization at 20 degrees C. The rotational relaxation time for the cpn80 14-mer derived from the low viscosity part of the Perrin-Weber plot which accentuates the slow motion gave rho(h) = 1113 +/- 55 ns. When this value of rho(h) is compared with the rho(h) calculated based on the Stokes radius of cpn80 from ultracentrifugation, rho(Stokes), it leads to rho(h)/rho(Stokes) = 0.4 which is considerably smaller than the value expected (rho(h)/rho(Stokes) = 1) or actually found in the cpn60-rhodanese complex (rho(h)/rho(Stokes) = 0.93). These considerations and the observed presence of the fast motion suggest that cpn60 is not a rigid protein. Analysis of the polarization data as a function of temperature, which is weighted more toward the fast motion, showed that the rotational relaxation time assessed by temperature variation is greatly increased (from 552.5 to 2591 ns) for the complex of cpn80 with partially folded rhodanese (34-kDa monomeric protein). No change in rho(h) was observed upon formation of the cpn60 . ATP complex (rho(h) = 556.9 ns). These data indicate that there is local motion in the cpn80 14-mer molecule that can be frozen by formation of a binary complex with partially folded proteins. This conclusion is in keeping with results showing that the structure of cpn80 is generally stabilized when it forms complexes with passenger proteins (Mendoza, J. A., and Horowitz, P. M. (1994) J. Biol. Chem. 269, 25963-25965).	UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,SAN ANTONIO,TX 78284	University of Texas System; University of Texas Health San Antonio					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER; NIEHS NIH HHS [ESO5729] Funding Source: Medline; NIGMS NIH HHS [GM25177] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACUNA AU, 1987, BIOPHYS CHEM, V26, P63, DOI 10.1016/0301-4622(87)80008-X; AZUMI T, 1962, J CHEM PHYS, V37, P2413, DOI 10.1063/1.1733019; BENECKY MJ, 1990, BIOCHEMISTRY-US, V29, P3082, DOI 10.1021/bi00464a027; BENECKY MJ, 1991, BIOCHEMISTRY-US, V30, P4298, DOI 10.1021/bi00231a028; BERMAN HA, 1985, BIOCHEMISTRY-US, V24, P7140, DOI 10.1021/bi00346a018; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRANDSCH R, 1992, J BIOL CHEM, V267, P20844; Brent R. P., 1973, ALGORITHMS MINIMIZAT; BROCHON JC, 1972, EUR J BIOCHEM, V25, P20, DOI 10.1111/j.1432-1033.1972.tb01662.x; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V334, P44; HANTGAN RR, 1982, BIOCHEMISTRY-US, V21, P1821, DOI 10.1021/bi00537a018; HARTL FU, 1994, TRENDS BIOCHEM SCI, V217, P20; HAUGLAND RP, 1989, HDB FLUORESCENT PROB, P23; HOLLNEUGEBAUER B, 1991, BIOCHEMISTRY-US, V30, P11609; HOROVITZ A, 1993, J MOL BIOL, V231, P58, DOI 10.1006/jmbi.1993.1256; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; KIM DS, 1983, J BIOL CHEM, V258, P1768; KOPP JA, 1969, J BIOL CHEM, V244, P6309; Lakowicz J, 1983, PRINC FLUORESC SPECT, P51, DOI 10.1007/978-1-4615-7658-7; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P128; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MENDOZA JA, 1994, J BIOL CHEM, V269, P2447; MILLER DM, 1992, BIOCHIM BIOPHYS ACTA, V1121, P286, DOI 10.1016/0167-4838(92)90158-A; MIZOBATA T, 1992, J BIOL CHEM, V267, P17773; OHYASHIKI T, 1982, J BIOCHEM, V91, P1575, DOI 10.1093/oxfordjournals.jbchem.a133848; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; SOGAMI M, 1975, BIOCHIM BIOPHYS ACTA, V393, P446, DOI 10.1016/0005-2795(75)90073-2; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; STANIFORTH RA, 1994, BIOCHEM J, V300, P651, DOI 10.1042/bj3000651; STANIFORTH RA, 1994, FEBS LETT, V344, P129, DOI 10.1016/0014-5793(94)00348-3; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; WAHL P, 1967, J MOL BIOL, V30, P371, DOI 10.1016/S0022-2836(67)80045-7; WEBER G, 1953, ADV PROTEIN CHEM, V8, P415, DOI 10.1016/S0065-3233(08)60096-0; WEBER G, 1952, BIOCHEM J, V51, P145, DOI 10.1042/bj0510145; WEBER G, 1966, BIOCHEMISTRY-US, V5, P1900, DOI 10.1021/bi00870a017; WELTMAN JK, 1967, BIOCHEMISTRY-US, V6, P1437, DOI 10.1021/bi00857a028; ZAMYATNIN AA, 1984, ANNU REV BIOPHYS BIO, V13, P145, DOI 10.1146/annurev.bb.13.060184.001045; ZHENG XX, 1993, J BIOL CHEM, V268, P7489	44	25	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13057	13062		10.1074/jbc.270.22.13057	http://dx.doi.org/10.1074/jbc.270.22.13057			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768899	hybrid			2022-12-27	WOS:A1995RB43900020
J	RAYMOND, WW; TAM, EK; BLOUNT, JL; CAUGHEY, GH				RAYMOND, WW; TAM, EK; BLOUNT, JL; CAUGHEY, GH			PURIFICATION AND CHARACTERIZATION OF DOG MAST-CELL PROTEASE-3, AN OLIGOMERIC RELATIVE OF TRYPTASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LUNG TRYPTASE; GENE-RELATED PEPTIDE; HUMAN-SKIN TRYPTASE; SERINE PROTEASE; VASODILATOR ACTIVITY; COMPLEMENTARY-DNA; SUBSTANCE-P; CLONING; CHYMASE; TRYPSIN	The existence of a protein similar to 48% identical with mast cell tryptases was predicted previously from a dog mastocytoma cDNA Antibodies raised against a peptide based on the deduced sequence suggested that the protein (dog mast cell protease-3, dMCP-3) is expressed in mast cells. In this report, characterization of the protein purified from mastocytomas reveals an N-glycosylated, high molecular weight, tryptic serine protease, which appears to be a tetramer of catalytic subunits, approximately half of which are Linked by disulfide bonds. The oligomeric complex yields a single NH2-terminal sequence, which is identical with that predicted by dMCP-3 cDNA. This finding, and the lack of closely related genes on blots of genomic DNA, predict that each subunit is the product of one gene. Although dLMCP-3 binds to heparin, it is active and stable at low ionic strength in heparin's absence. It resists inactivation by inhibitors in plasma but is sensitive to small inhibitors, e.g. leupeptin and bis(5-amidino-2-benzimidazolyl)methane (BABIM). dMCP-3 hydrolyzes extended peptidyl p-nitroanilides ending in basic residues, with P1 arginine preferred to lysine; it hydrolyzes the Arg(18)-Ser(19) bond of calcitonin gene-related peptide but cleaves neither vasoactive intestinal peptide nor casein. These data suggest that dMCP-3 is a unique serine protease whose stability, formation of intersubunit disulfide bonds, inhibitor susceptibilities and substrate preferences differ from those of its closest relatives, the mast cell tryptases.	UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV HAWAII,JOHN A BURNS SCH MED,DEPT MED,HONOLULU,HI 96813; UNIV HAWAII,JOHN A BURNS SCH MED,DEPT PHARMACOL,HONOLULU,HI 96813	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Hawaii System; University of Hawaii System					NHLBI NIH HHS [HL-24136] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTER SC, 1990, ARCH BIOCHEM BIOPHYS, V276, P26, DOI 10.1016/0003-9861(90)90005-J; ALTER SC, 1989, IMMUNOL RES, V8, P130; BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2; BRAIN SD, 1988, NATURE, V335, P73, DOI 10.1038/335073a0; CAUGHEY GH, 1988, IMMUNOLOGY, V63, P339; CAUGHEY GH, 1988, J PHARMACOL EXP THER, V244, P133; CAUGHEY GH, 1987, ARCH BIOCHEM BIOPHYS, V258, P555, DOI 10.1016/0003-9861(87)90377-8; CAUGHEY GH, 1991, AM J RESP CELL MOL, V4, P387, DOI 10.1165/ajrcmb/4.5.387; CAUGHEY GH, 1993, J PHARMACOL EXP THER, V264, P676; CAUGHEY GH, 1994, AM J RESP CRIT CARE, V150, pS138, DOI 10.1164/ajrccm/150.6_Pt_2.S138; CAUGHEY GH, 1988, J HISTOCHEM CYTOCHEM, V251, pC935; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; HARTMANN T, 1992, AM J PHYSIOL, V262, pL528, DOI 10.1152/ajplung.1992.262.5.L528; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; JOHNSON DA, 1992, PROTEIN SCI, V1, P370; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; ORTIZ C, 1991, BIOCHEMISTRY-US, V30, P10026, DOI 10.1021/bi00105a030; REMINGTON SJ, 1988, BIOCHEMISTRY-US, V27, P8097, DOI 10.1021/bi00421a019; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; SALI A, 1993, J BIOL CHEM, V268, P9023; SAYAMA S, 1987, J BIOL CHEM, V263, P6808; SCHECHTER NM, 1993, BIOCHEMISTRY-US, V32, P2617, DOI 10.1021/bi00061a020; SCHWARTZ LB, 1981, J IMMUNOL, V126, P1290; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SCHWARTZ LB, 1990, NEUTRAL PROTEASES MA, V27, P90; SMITH TJ, 1984, J BIOL CHEM, V259, P1046; SMYTH MJ, 1992, J BIOL CHEM, V267, P24418; SOMMERHOFF CP, 1992, J IMMUNOL, V148, P2859; TAM EK, 1990, AM J RESP CELL MOL, V3, P27, DOI 10.1165/ajrcmb/3.1.27; TANAKA T, 1983, J BIOL CHEM, V258, P3552; VANDERSLICE P, 1989, BIOCHEMISTRY-US, V28, P4148, DOI 10.1021/bi00436a004; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; WALLS AF, 1992, BIOCHEM PHARMACOL, V43, P1243, DOI 10.1016/0006-2952(92)90498-8; YEZZI MJ, 1994, J IMMUNOL, V152, P3064	39	18	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13164	13170		10.1074/jbc.270.22.13164	http://dx.doi.org/10.1074/jbc.270.22.13164			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768912	hybrid			2022-12-27	WOS:A1995RB43900035
J	WEBER, J; SENIOR, AE				WEBER, J; SENIOR, AE			LOCATION AND PROPERTIES OF PYROPHOSPHATE-BINDING SITES IN ESCHERICHIA-COLI F1-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING; NONCATALYTIC SITES; ADENOSINE-TRIPHOSPHATASE; MITOCHONDRIAL F1-ATPASE; BETA-SUBUNIT; DIRECTED MUTAGENESIS; CATALYTIC SITES; ATP; ADENINE; F(1)-ATPASE	Binding of pyrophosphate (PPi) to the three catalytic (''C'') and three noncatalytic (''NC'') nucleotide sites of Escherichia coli F-1-ATPase was determined by fluorescence spectroscopy using mutant enzymes with tryptophan inserted specifically in either C sites (beta Y331W) or NC sites (alpha R365W). Fluorescence of the tryptophan is quenched on binding of nucleotide; PPi binding parameters were determined by competition with ATP or adenyl-5'-yl imidodiphosphate. It was found that MgPPi binds to each NC site with K-d = 20 mu M. In contrast, even at millimolar concentration, neither MgPPi nor free PPi showed significant binding to C sites. We confirmed that free PPi displaces nucleotide from C sites, but this was shown to be due to complexation of Mg2+ ions rather than to occupancy of the sites. MgPPi bound at NC sites was found not to affect ATP hydrolysis rates. From the data we propose a two-phase model for nucleotide binding at NC sites. In phase one, NC sites recognize the pyrophosphate ''end'' of the nucleotide, which binds initially with K-d similar to MgPPi; in phase two, a slow conformational change occurs which tightly sequesters adenine nucleotide. Phase two does not occur with guanine nucleotide. This model explains the preference of NC sites for adenine nucleotides. P-i (5 mM) did not bind to either C or NC sites.			WEBER, J (corresponding author), UNIV ROCHESTER,MED CTR,DEPT BIOCHEM,ROCHESTER,NY 14642, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025349, R37GM025349] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25349] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; CAPALDI RA, 1994, TRENDS BIOCHEM SCI, V19, P284, DOI 10.1016/0968-0004(94)90006-X; DAWSON RMC, 1984, DATA BIOCH RES, P399; DOWNIE JA, 1981, J BACTERIOL, V145, P200, DOI 10.1128/JB.145.1.200-210.1981; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; ISSARTEL JP, 1986, J BIOL CHEM, V261, P895; ISSARTEL JP, 1987, J BIOL CHEM, V262, P13538; JAULT JM, 1993, J BIOL CHEM, V268, P1558; KIRONDE FAS, 1986, J BIOL CHEM, V261, P2544; MILGROM YM, 1993, J BIOL CHEM, V268, P23179; O'Sullivan W J, 1979, Methods Enzymol, V63, P294; PAGAN J, 1990, FEBS LETT, V273, P147, DOI 10.1016/0014-5793(90)81071-U; PEINNEQUIN A, 1992, BIOCHEMISTRY-US, V31, P2088, DOI 10.1021/bi00122a028; PERLIN DS, 1984, BIOCHEMISTRY-US, V23, P4998, DOI 10.1021/bi00316a026; RAO R, 1988, J BIOL CHEM, V263, P5569; RAO R, 1988, J BIOL CHEM, V263, P15957; SENIOR AE, 1979, BIOCHEM J, V180, P111, DOI 10.1042/bj1800111; SENIOR AE, 1992, ARCH BIOCHEM BIOPHYS, V297, P340, DOI 10.1016/0003-9861(92)90682-M; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; WEBER J, 1994, J BIOL CHEM, V269, P20462; WEBER J, 1992, J BIOL CHEM, V267, P1712; WEBER J, 1994, J BIOL CHEM, V269, P11261; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER J, 1993, J BIOL CHEM, V268, P6241; WILKEMOUNTS S, 1994, ARCH BIOCHEM BIOPHYS, V309, P363, DOI 10.1006/abbi.1994.1125; WISE JG, 1981, J BIOL CHEM, V256, P383; WISE JG, 1983, BIOCHEM J, V215, P343, DOI 10.1042/bj2150343	28	47	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12653	12658		10.1074/jbc.270.21.12653	http://dx.doi.org/10.1074/jbc.270.21.12653			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759515	hybrid			2022-12-27	WOS:A1995QZ71100051
J	CHEN, RH; MOSES, HL; MARUOKA, EM; DERYNCK, R; KAWABATA, M				CHEN, RH; MOSES, HL; MARUOKA, EM; DERYNCK, R; KAWABATA, M			PHOSPHORYLATION-DEPENDENT INTERACTION OF THE CYTOPLASMIC DOMAINS OF THE TYPE-I AND TYPE-II TRANSFORMING GROWTH-FACTOR-BETA RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; SIGNAL TRANSDUCTION; PROTEIN PHOSPHATASE; EXPRESSION CLONING; XENOPUS EMBRYOS; KINASE; CELLS; ACTIVIN; LIGAND; BETAGLYCAN	Transforming growth factor-beta (TGF-beta) transduces signals through its type I and type II receptors. Both receptor types have previously been shown to interact in a heteromeric complex in the presence of TGF-beta. We have now characterized these interactions between both receptor types using a combination of yeast two-hybrid interaction assays and coimmunoprecipitation analyses. Our results indicate a direct association between the cytoplasmic domains of the two receptor types. Mutation analysis of these cytoplasmic domains reveals that this direct interaction requires kinase activity and, thus, depends on phosphorylation, probably via a transphosphorylation mechanism. Furthermore, the two receptor types already have an inherent affinity for each other in the absence of TGF-beta, and the heteromeric complex can be detected in coimmunoprecipitation under these conditions. Taken together, our results reveal a novel mechanism of receptor complex formation, whereby two different cytoplasmic domains directly associate with each other. This interaction may play a major role in activation of serine/threonine kinase receptors.	UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, CELL BIOL PROGRAM, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, PROGRAM DEV BIOL, SAN FRANCISCO, CA 94143 USA; VANDERBILT UNIV, SCH MED, DEPT CELL BIOL, NASHVILLE, TN 37232 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vanderbilt University	CHEN, RH (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT GROWTH & DEV, SAN FRANCISCO, CA 94143 USA.		Chen, Ruey-Hwa/G-6121-2019	Chen, Ruey-Hwa/0000-0001-8124-5832				AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; BRAND T, 1993, J BIOL CHEM, V268, P11500; CHEN RH, 1994, J BIOL CHEM, V269, P22868; CHEN RH, 1993, SCIENCE, V260, P1335, DOI 10.1126/science.8388126; DERYNCK R, 1994, TRENDS BIOCHEM SCI, V19, P548, DOI 10.1016/0968-0004(94)90059-0; Derynck R, 1994, CYTOKINE HDB, P319; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; GARBERS DL, 1994, MOL BIOL CELL, V5, P1; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HARPER JW, 1993, CELL, V75, P805; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; LAIHO M, 1990, J BIOL CHEM, V265, P18518; LAIHO M, 1991, J BIOL CHEM, V266, P9108; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; LUCAS C, 1991, METHOD ENZYMOL, V198, P303; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MASSAGUE J, 1985, J BIOL CHEM, V260, P2636; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHUM L, 1994, J CELL BIOL, V125, P903, DOI 10.1083/jcb.125.4.903; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WHITE MF, 1994, J BIOL CHEM, V269, P1; WIESER R, 1993, MOL CELL BIOL, V13, P7239, DOI 10.1128/MCB.13.12.7239; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172	46	79	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12235	12241		10.1074/jbc.270.20.12235	http://dx.doi.org/10.1074/jbc.270.20.12235			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744874	hybrid			2022-12-27	WOS:A1995QY73600079
J	HEYMACH, JV; SHOOTER, EM				HEYMACH, JV; SHOOTER, EM			THE BIOSYNTHESIS OF NEUROTROPHIN HETERODIMERS BY TRANSFECTED MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CRYSTAL-STRUCTURE; TRANSFORMING GROWTH-FACTOR-BETA-2; MONOCLONAL-ANTIBODIES; RECEPTOR-BINDING; SYSTEM; NGF; EXPRESSION; NEURONS; SUPERFAMILY	Prompted by the recent discovery that neurotrophins, which are known to be biologically active as noncovalently linked homodimers, can also be induced to form biologically active heterodimers in vitro, we have investigated the biosynthesis of neurotrophin heterodimers by transfected mammalian cells. When COS cells were cotransfected with expression plasmids for nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), or neurotrophin-3 (NT-3), the appropriate heterodimers were detected in the conditioned medium by immunoprecipitation and, in the case of NGF . NT-3, using a two-site enzyme-linked immunosorbent assay. Heterodimer formation occurred predominantly intracellularly and did not require precursor cleavage, because heterodimers containing pro-NGF and pro-BDNF were detected in the conditioned medium. When rat C6 glioma cells or mouse AtT-20 neuroendocrine cells were cotransfected with expression plasmids for NGF and NT-3, NGF . NT-3 heterodimer was detected at levels comparable with those of homodimeric NGF and NT-3, indicating that heterodimer formation can occur at significant levels in a variety of cell types. These data provide evidence that NGF, BDNF, and NT-3 are capable of forming heterodimers when coexpressed in mammalian cells and suggest that such heterodimers are likely to be formed in vivo when a single cell expresses multiple neurotrophins.	STANFORD UNIV,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305	Stanford University			Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942	NICHD NIH HHS [HD-07249] Funding Source: Medline; NINDS NIH HHS [NS 04270] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS004270] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSSON M, 1994, J BIOL CHEM, V269, P926; ARAKAWA T, 1994, J BIOL CHEM, V269, P27833; BOTHWELL MA, 1977, J BIOL CHEM, V252, P8532; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; EBENDAL T, 1989, J NEUROSCI RES, V22, P223, DOI 10.1002/jnr.490220302; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; HAMEL W, 1993, J NEUROSCI RES, V34, P147, DOI 10.1002/jnr.490340202; HARLOW E, 1988, ANTIBODIES LABORATOR, P490; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IBANEZ CF, 1991, J NEUROCHEM, V57, P1033, DOI 10.1111/j.1471-4159.1991.tb08254.x; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JUNGBLUTH S, 1994, EUR J BIOCHEM, V221, P677, DOI 10.1111/j.1432-1033.1994.tb18780.x; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; MURPHY RA, 1977, J CELL BIOL, V72, P769, DOI 10.1083/jcb.72.3.769; NARHI LO, 1993, J BIOL CHEM, V268, P13309; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; OSTMAN A, 1988, J BIOL CHEM, V263, P16202; PHILO J, 1994, J BIOL CHEM, V269, P27840; RADZIEJEWSKI C, 1992, BIOCHEMISTRY-US, V31, P4431, DOI 10.1021/bi00133a007; RADZIEWJEWSKI C, 1993, BIOCHEMISTRY-US, V32, P13350, DOI 10.1021/bi00211a049; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; SUTER U, 1992, J NEUROSCI, V2, P306; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; ZIMMERMANN A, 1981, P NATL ACAD SCI-BIOL, V78, P4611, DOI 10.1073/pnas.78.7.4611	39	52	58	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12297	12304		10.1074/jbc.270.20.12297	http://dx.doi.org/10.1074/jbc.270.20.12297			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744882	hybrid			2022-12-27	WOS:A1995QY73600087
J	LI, D; KOLATTUKUDY, PE				LI, D; KOLATTUKUDY, PE			CLONING AND EXPRESSION OF CDNA-ENCODING A PROTEIN THAT BINDS A PALINDROMIC PROMOTER ELEMENT ESSENTIAL FOR INDUCTION OF FUNGAL CUTINASE BY PLANT CUTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PUTATIVE ZINC FINGER; F-SP-PISI; ERYTHROID TRANSCRIPTION FACTOR; NITROGEN REGULATORY GENE; DNA-BINDING; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; MOLECULAR-CLONING; SEQUENCE; PROBES	Previous studies showed that a palindromic sequence located at -159 base pairs is essential for induction of cutinase gene in Fusarium solani f. sp. pisi (Nectria haematococca mating type VI) by the hydroxy fatty acids from plant cutin and that a 50-kDa nuclear protein binds to a promoter that contains this element. Screening of a phage lambda gt11 expression library with the concatenated palindromic sequence as the probe identified a cDNA encoding a palindrome-binding protein (PBP). Nucleotide sequence of this cDNA revealed an open reading frame that would code for PBP with a calculated molecular weight of 49,847. This PBP contains a putative nuclear localization signal and a zinc finger motif sharing homology with the zinc finger DNA binding domains of transcription factors from mammals, Saccharomyces cerevisiae, Neurospora crassa, and Ustilago maydis. A highly basic region immediately adjacent to the carboxyl side of the zinc finger was also observed. PBP expressed in Escherichia coli showed specific binding to the palindromic DNA fragment.	OHIO STATE UNIV,DEPT NEUROBIOTECHNOL,COLUMBUS,OH 43210	Ohio State University			kolattukudy, pappachan e/A-1350-2012					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAJAR A, 1989, P NATL ACAD SCI USA, V88, P8208; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; CORTON JC, 1989, J CELL BIOCH E, V13, P37; CUNNINGHAM TS, 1991, MOL CELL BIOL, V11, P6205, DOI 10.1128/MCB.11.12.6205; FU YH, 1990, MOL CELL BIOL, V10, P1056, DOI 10.1128/MCB.10.3.1056; HWANG CS, 1995, PLANT CELL, V7, P183, DOI 10.1105/tpc.7.2.183; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KADONAGA JT, 1991, METHOD ENZYMOL, V208, P10; KAMPER JT, 1994, J BIOL CHEM, V269, P9195; KEMP BE, 1991, METHOD ENZYMOL, V200, P63; KOLATTUKUDY PE, 1985, ANNU REV PHYTOPATHOL, V23, P223, DOI 10.1146/annurev.py.23.090185.001255; KOLLER W, 1982, PHYSIOL PLANT PATHOL, V20, P47, DOI 10.1016/0048-4059(82)90023-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; KUENZEL EA, 1987, J BIOL CHEM, V269, P9195; KULMBURG P, 1992, MOL CELL BIOL, V12, P1932, DOI 10.1128/MCB.12.5.1932; LAVALLIE ER, 1992, BIOTECHNOLOGY, V11, P187; LIN TS, 1978, J BACTERIOL, V133, P942, DOI 10.1128/JB.133.2.942-951.1978; MARMORSTEIN R, 1994, GENE DEV, V8, P2504, DOI 10.1101/gad.8.20.2504; MINEHART PL, 1991, MOL CELL BIOL, V11, P6216, DOI 10.1128/MCB.11.12.6216; MOORE JT, 1993, PROTEIN EXPRES PURIF, V4, P160, DOI 10.1006/prep.1993.1022; ORKIN SH, 1992, BLOOD, V80, P575; PODILA GK, 1988, SCIENCE, V242, P922, DOI 10.1126/science.242.4880.922; RIO SD, 1991, NUCLEIC ACIDS RES, V19, P6197; Sambrook J, 1989, MOL CLONING LABORATO; SINGH H, 1989, BIOTECHNIQUES, V7, P252; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TRAINOR CD, 1990, NATURE, V343, P92, DOI 10.1038/343092a0; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; VOISARD C, 1993, MOL CELL BIOL, V13, P7091, DOI 10.1128/MCB.13.11.7091; WITTE MM, 1988, MOL CELL BIOL, V8, P3726, DOI 10.1128/MCB.8.9.3726; WOLOSHUK CP, 1986, P NATL ACAD SCI USA, V83, P1704, DOI 10.1073/pnas.83.6.1704; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10642, DOI 10.1073/pnas.88.23.10642; 1992, QIAEXPRESSIONIST; 1986, FOCUS, V8, P2	41	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11753	11756		10.1074/jbc.270.20.11753	http://dx.doi.org/10.1074/jbc.270.20.11753			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744822	hybrid			2022-12-27	WOS:A1995QY73600014
J	WELHAM, MJ; LEARMONTH, L; BONE, H; SCHRADER, JW				WELHAM, MJ; LEARMONTH, L; BONE, H; SCHRADER, JW			INTERLEUKIN-13 SIGNAL-TRANSDUCTION IN LYMPHOHEMATOPOIETIC CELLS - SIMILARITIES AND DIFFERENCES IN SIGNAL-TRANSDUCTION WITH INTERLEUKIN-4 AND INSULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR GAMMA-CHAIN; TYROSINE PHOSPHORYLATION; GROWTH-FACTORS; IGE SYNTHESIS; B-CELLS; PROTEIN; ACTIVATION; KINASE; IL-4; GRB2	Interleukin-13 (IL-13) and interleukin-4 (IL-4) are related in structure and function and are thought to share a common receptor component. We have investigated the signal transduction pathways activated by these two growth factors, as well as insulin, in cell-lines and primary cells of lymphohemopoietic origin. All three factors induced the tyrosine phosphorylation of a protein of 170 kDa (p170), which coimmunoprecipitated with the p85 subunit of PI3'-kinase, via high affinity interactions mediated by the SH2 domains of p85. Antibodies raised against the entire insulin-receptor substrate-1 (IRS-1) protein immunoprecipitated p170 much less efficiently than they did IRS-1 from 3T3 cells. However, antibodies directed against the conserved pleckstrin homology domain of IRS-1 immunoprecipitated both p170 and IRS-1 with similar efficiency, suggesting they share structural similarities in this region. In lymphohemopoietic cells, IL-13, IL-4, and insulin failed to induce increased tyrosine phosphorylation of Shc, or its association with grb2, modification of Sos1, or activation of erk-1 and erk-2 mitogen-activated protein kinases, suggesting that p170 mediates downstream pathways distinct from those mediated by IRS-1. Both IL-13 and IL-4 induced low levels of tyrosine phosphorylation of Tyk-2 and Jak-1. IL-4 also activated the Jak-3-kinase, but, despite other similarities, IL-13 did not. Insulin failed to activate any of the known members of the Janus family of kinases. In that Jak-3 is reported to associate with the IL-2 gamma c chain, these data suggest that the IL-13 receptor does not utilize this subunit. However, both IL-13 and IL-4 induced tyrosine phosphorylation of the IL-4-140 kDa receptor chain, suggesting that this is a component of both receptors in these cells and accounts for the similarities in signaling pathways shared by IL-13 and IL-4.	UNIV BRITISH COLUMBIA, BIOMED RES CTR, VANCOUVER, BC V6T 1Z3, CANADA; UNIV BRITISH COLUMBIA, DEPT MED, VANCOUVER, BC V6T 1Z3, CANADA	University of British Columbia; University of British Columbia								ANDERSSON J, 1972, EUR J IMMUNOL, V2, P349, DOI 10.1002/eji.1830020410; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BACKER JM, 1993, J BIOL CHEM, V268, P8204; BALTENSPERGER K, 1993, SCIENCE, V260, P1950, DOI 10.1126/science.8391166; BECKMANN MP, 1992, CHEM IMMUNOL, V51, P107; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BROWN KD, 1989, J IMMUNOL, V142, P679; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; DEVRIES JE, 1991, CURR OPIN IMMUNOL, V3, P851, DOI 10.1016/S0952-7915(05)80003-2; DURONIO V, 1992, P NATL ACAD SCI USA, V89, P1587, DOI 10.1073/pnas.89.5.1587; GALIZZI JP, 1990, INT IMMUNOL, V2, P669, DOI 10.1093/intimm/2.7.669; GOLD MR, 1994, J BIOL CHEM, V269, P5403; HARADA N, 1992, J BIOL CHEM, V267, P22752; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; IZUHARA K, 1993, J BIOL CHEM, V268, P13097; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; JUSTEMENT L, 1986, J IMMUNOL, V137, P3664; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; KOETTNITZ K, 1993, EUR J IMMUNOL, V23, P988, DOI 10.1002/eji.1830230437; KOHLER I, 1994, FEBS LETT, V345, P187, DOI 10.1016/0014-5793(94)00438-2; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSDORP PM, 1986, CURR TOP MICROBIOL I, V132, P105; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MIZUGUCHI J, 1986, J IMMUNOL, V137, P2215; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SCHINDLER C, 1994, EMBO J, V13, P1350, DOI 10.1002/j.1460-2075.1994.tb06388.x; SELDIN DC, 1994, P NATL ACAD SCI USA, V91, P2140, DOI 10.1073/pnas.91.6.2140; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TURNER B, 1991, P NATL ACAD SCI USA, V88, P1227, DOI 10.1073/pnas.88.4.1227; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WANG LW, 1983, P NATL ACAD SCI USA, V90, P4032; WATTS JD, 1993, J IMMUNOL, V151, P6862; WELHAM MJ, 1994, J BIOL CHEM, V269, P23764; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; WELHAM MJ, 1994, J BIOL CHEM, V269, P5865; WELHAM MJ, 1992, J IMMUNOL, V149, P1683; WHITE MF, 1994, CURR OPIN GENET DEV, V4, P47, DOI 10.1016/0959-437X(94)90090-6; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; YIN TG, 1994, J BIOL CHEM, V269, P26614; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	65	144	155	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12286	12296		10.1074/jbc.270.20.12286	http://dx.doi.org/10.1074/jbc.270.20.12286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744881	hybrid			2022-12-27	WOS:A1995QY73600086
J	COHEN, T; GITAYGOREN, H; SHARON, R; SHIBUYA, M; HALABAN, R; LEVI, BZ; NEUFELD, G				COHEN, T; GITAYGOREN, H; SHARON, R; SHIBUYA, M; HALABAN, R; LEVI, BZ; NEUFELD, G			VEGF(121), A VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ISOFORM LACKING HEPARIN-BINDING ABILITY, REQUIRES CELL-SURFACE HEPARAN SULFATES FOR EFFICIENT BINDING TO THE VEGF RECEPTORS OF HUMAN-MELANOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; PERMEABILITY FACTOR; FACTOR FAMILY; IDENTIFICATION; MITOGEN; EXPRESSION; MOLECULES; CULTURE	Four vascular endothelial growth factor (VEGF) splice variants containing 121, 165, 189, and 206 amino acids are produced from a single human gene as a result of alternative splicing, VEGF(121) is not a heparin-binding protein, while the other VEGF species possess heparin binding ability, YU-ZAZ6 human melanoma cells expressed the mRNA encoding the VEGF receptor flt-1, but not the mRNA encoding the VEGF receptor KDR/flK-1. Both VEGF(121) and VEGF(165) bound to the VEGF receptors of these cells, Unexpectedly, heparin inhibited the binding of VEGF(121) as well as the binding of VEGF(165) to the VEGF receptors of the melanoma cells, Digestion of the cells with heparinase also inhibited the binding of both VEGF variants, The VEGF(165) binding ability of heparinase-digested cells could be partially restored by the addition of exogenous heparin to the binding reaction, In contrast, the addition of heparin to heparinase- digested cells did not restore VEGF(121) binding, These results suggest that cell surface heparan sulfates may regulate the binding ability of the VEGF receptors of the melanoma cells, They also indicate that heparin is not able to fully substitute for cell surface-associated heparan sulfates since VEGF(121) binding to the VEGF receptors of heparinase-treated cells is not restored by heparin. These data suggest that changes in the composition of cell-surface heparin-like molecules may differentially affect the interaction of various VEGF isoforms with VEGF receptors.	TECHNION ISRAEL INST TECHNOL,DEPT BIOL,IL-32000 HAIFA,ISRAEL; TECHNION ISRAEL INST TECHNOL,DEPT FOOD ENGN & BIOTECHNOL,IL-32000 HAIFA,ISRAEL; YALE UNIV,SCH MED,DEPT DERMATOL,NEW HAVEN,CT 06510; UNIV TOKYO,INST MED SCI,DEPT GENET,MINATO KU,TOKYO 108,JAPAN	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Yale University; University of Tokyo			Neufeld, Gera/F-1524-2019		NATIONAL CANCER INSTITUTE [R01CA044542, R29CA044542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041942] Funding Source: NIH RePORTER; NCI NIH HHS [CA44542] Funding Source: Medline; NIAMS NIH HHS [AR41942] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARZU T, 1985, BIOCHIM BIOPHYS ACTA, V845, P196, DOI 10.1016/0167-4889(85)90177-6; CAVARI S, 1993, FEBS LETT, V323, P155, DOI 10.1016/0014-5793(93)81469-G; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Cohen T, 1992, GROWTH FACTORS, V7, P131, DOI 10.3109/08977199209046402; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; GITAYGOREN H, 1993, BIOCHEM BIOPH RES CO, V190, P702, DOI 10.1006/bbrc.1993.1106; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311; HALABAN R, 1988, ONCOGENE RES, V3, P177; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; MOCZAR M, 1993, CLIN EXP METASTAS, V11, P462, DOI 10.1007/BF00054937; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NEUFELD G, 1988, J CELL PHYSIOL, V136, P537, DOI 10.1002/jcp.1041360321; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; OBERG C, 1994, GROWTH FACTORS, V10, P115, DOI 10.3109/08977199409010985; PARK JE, 1994, J BIOL CHEM, V269, P25646; PLOUET J, 1990, J BIOL CHEM, V265, P22071; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SEETHARAM L, 1995, ONCOGENE, V10, P135; SHEN H, 1993, BLOOD, V81, P2767; SHIBUYA M, 1990, ONCOGENE, V5, P519; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TERMAN BI, 1991, ONCOGENE, V6, P1677; TESSLER S, 1994, J BIOL CHEM, V269, P12456; TISCHER E, 1989, BIOCHEM BIOPH RES CO, V165, P1198, DOI 10.1016/0006-291X(89)92729-0; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988	36	223	229	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11322	11326		10.1074/jbc.270.19.11322	http://dx.doi.org/10.1074/jbc.270.19.11322			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744769	hybrid			2022-12-27	WOS:A1995QX86500046
J	EDWARDS, RA; HERRERASOSA, H; OTTO, J; BRYAN, J				EDWARDS, RA; HERRERASOSA, H; OTTO, J; BRYAN, J			CLONING AND EXPRESSION OF A MURINE FASCIN HOMOLOG FROM MOUSE-BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BUNDLING PROTEIN; URCHIN EGG EXTRACTS; GELATION; CELLS	The fascins are a widely distributed family of proteins that organize filamentous actin into bundles. We have cloned, sequenced, and expressed the murine homolog, Fascin is most abundant in brain and is found in other tissues including uterus and spleen. The deduced open reading frame encodes a protein of 493 amino acids with a molecular mass of 54,412 Ha. Previous solubility problems with bacterially expressed fascins were overcome by producing the mouse protein as a fusion with Escherichia coli thioredoxin, A method for cleaving the fusion protein and for purifying active recombinant fascin is described. The N-terminal sequence and molecular mass estimated on SDS gels indicate that recombinant fascin is full-length, Two-dimensional gel electrophoresis suggests that recombinant fascin is post-translationally modified in a manner similar to that observed in mouse brain, Recombinant fascin and the fusion protein are recognized by monoclonal anti-fascin antibodies and will bundle rabbit skeletal muscle F-actin in vitro at a stoichiometry of 4.1:1 actin to fascin. Electron cryomicroscopy images show that the reconstituted bundles are highly ordered, However, their fine structure differs from that of echinoid fascin-actin bundles, This structural difference can be attributed to fascin.	PURDUE UNIV, DEPT BIOL SCI, W LAFAYETTE, IN 47909 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	EDWARDS, RA (corresponding author), BAYLOR COLL MED, DEPT CELL BIOL, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.							ALLIS CD, 1979, P NATL ACAD SCI USA, V76, P4857, DOI 10.1073/pnas.76.10.4857; BRYAN J, 1982, METHOD CELL BIOL, V25, P175, DOI 10.1016/S0091-679X(08)61425-9; BRYAN J, 1993, P NATL ACAD SCI USA, V90, P9115, DOI 10.1073/pnas.90.19.9115; BRYAN J, 1978, J MOL BIOL, V125, P207, DOI 10.1016/0022-2836(78)90345-5; CANT K, 1994, J CELL BIOL, V125, P369, DOI 10.1083/jcb.125.2.369; DEROSIER D, 1977, J MOL BIOL, V113, P679, DOI 10.1016/0022-2836(77)90230-3; DEROSIER DJ, 1981, J MOL BIOL, V146, P77, DOI 10.1016/0022-2836(81)90367-3; DUH FM, 1994, DNA CELL BIOL, V13, P821, DOI 10.1089/dna.1994.13.821; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HOLTHUIS JCM, 1994, BBA-GENE STRUCT EXPR, V1219, P184, DOI 10.1016/0167-4781(94)90267-4; HUANG KP, 1986, J BIOL CHEM, V261, P2134; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KANE RE, 1975, J CELL BIOL, V66, P305, DOI 10.1083/jcb.66.2.305; KANE RE, 1976, J CELL BIOL, V71, P704, DOI 10.1083/jcb.71.3.704; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; MOSIALOS G, 1994, J VIROL, V68, P7320, DOI 10.1128/JVI.68.11.7320-7328.1994; OTTO JJ, 1981, CELL MOTIL CYTOSKEL, V1, P179, DOI 10.1002/cm.970010203; OTTO JJ, 1980, CELL MOTIL CYTOSKEL, V1, P31, DOI 10.1002/cm.970010104; OVERTON J, 1967, J MORPHOL, V122, P367, DOI 10.1002/jmor.1051220406; PATERSON J, 1991, GENETICS, V129, P1073; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIROYA Y, 1993, DEV GROWTH DIFFER, V35, P323; SPUDICH JA, 1971, J BIOL CHEM, V246, P4860; VIOLAND BN, 1994, PROTEIN SCI, V3, P1089, DOI 10.1002/pro.5560030712; YAMASHIROMATSUMURA S, 1986, J CELL BIOL, V103, P631, DOI 10.1083/jcb.103.2.631; YAMASHIROMATSUMURA S, 1985, J BIOL CHEM, V260, P5087	30	61	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10764	10770		10.1074/jbc.270.18.10764	http://dx.doi.org/10.1074/jbc.270.18.10764			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738015	hybrid			2022-12-27	WOS:A1995QW60100059
J	QI, Z; HUANG, QQ; LEE, KY; LEW, J; WANG, JH				QI, Z; HUANG, QQ; LEE, KY; LEW, J; WANG, JH			RECONSTITUTION OF NEURONAL CDC2-LIKE KINASE FROM BACTERIA-EXPRESSED CDK5 AND AN ACTIVE FRAGMENT OF THE BRAIN-SPECIFIC ACTIVATOR - KINASE ACTIVATION IN THE ABSENCE OF CDK5 PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-2; DIRECTED PROTEIN-KINASE; HUMAN CELL-CYCLE; TYROSINE PHOSPHORYLATION; CATALYTIC SUBUNIT; P34CDC2 KINASE; BOVINE BRAIN; YEAST; CDC2; GENE	Three truncated forms of p35 including the one corresponding to the 25-kDa subunit of the kinase have been expressed in Escherichia coli and shown to activate a bacteria-expressed Cdk5 with equal efficacy. The shortest truncated form of p35, p21, spanning amino acid residues 88 to 291, has been used to reconstitute active Cdk5 kinase and to characterize the activation reaction. The purified kinase displays similar specific enzyme activity and similar phosphorylation site specificity as the neuronal Cdc2-like kinase purified from bovine brain, Bovine brain extract contains Cdk5 uncomplexed with p35 or p25 which has also been found to be activated by p21 or p25. The results substantiate the previous suggestion that p35 is a specific Cdk5 activator, Several observations suggest that, unlike other well characterized Cdc2-like kinases whose activities depend on the phosphorylation of the catalytic subunits at a specific site by a distinct kinase, the reconstituted Cdk5/p21 does not depend on the phosphorylation of Cdk5 for activity. The reconstitution of the highly active Cdk5 kinase was achieved without requiring any other kinase in the reconstitution reaction. The possibility of autophosphorylation of Cdk5 on the putative activation site has been ruled out as no phosphorylation occurred on Cdk5 during the enzyme reaction. The rate and extent of the kinase reconstitution were not significantly affected by Mg2+ ATP.	UNIV CALGARY,FAC MED,DEPT MED BIOCHEM,MED RES COUNCIL GRP SIGNAL TRANSDUCT,CALGARY,AB T2N 4N1,CANADA	University of Calgary								BEAUDETTE KN, 1993, J BIOL CHEM, V268, P20825; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CONNELLCROWLEY L, 1993, MOL BIOL CELL, V4, P79, DOI 10.1091/mbc.4.1.79; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DESAI D, 1992, MOL BIOL CELL, V3, P571, DOI 10.1091/mbc.3.5.571; DRAETTA G, 1988, ONCOGENE, V2, P553; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; Fantes P, 1989, CURR OPIN CELL BIOL, V1, P250, DOI 10.1016/0955-0674(89)90096-3; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hunt T, 1989, CURR OPIN CELL BIOL, V1, P268, DOI 10.1016/0955-0674(89)90099-9; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; ISHIGURO K, 1994, FEBS LETT, V342, P203, DOI 10.1016/0014-5793(94)80501-6; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LEE TH, 1991, CELL, V64, P415, DOI 10.1016/0092-8674(91)90649-J; LEW J, 1992, J BIOL CHEM, V267, P25922; LEW J, 1992, J BIOL CHEM, V267, P13383; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Maller JL, 1991, CURR OPIN CELL BIOL, V3, P269; MATSUOKA M, 1994, MOL CELL BIOL, V14, P7265, DOI 10.1128/MCB.14.11.7265; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OKUDA T, 1992, ONCOGENE, V7, P2249; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PARKER LL, 1991, EMBO J, V10, P1255, DOI 10.1002/j.1460-2075.1991.tb08067.x; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; PINES J, 1990, New Biologist, V2, P389; POON RYC, 1993, EMBO J, V12, P3123, DOI 10.1002/j.1460-2075.1993.tb05981.x; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SHETTY KT, 1993, P NATL ACAD SCI USA, V90, P6844, DOI 10.1073/pnas.90.14.6844; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Solomon MJ, 1993, CURR OPIN CELL BIOL, V5, P180, DOI 10.1016/0955-0674(93)90100-5; SOLOMON MJ, 1993, EMBO J, V12, P3133, DOI 10.1002/j.1460-2075.1993.tb05982.x; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; TSAI LH, 1993, ONCOGENE, V8, P1593; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; XIONG Y, 1993, CELL, V71, P505	59	91	97	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10847	10854		10.1074/jbc.270.18.10847	http://dx.doi.org/10.1074/jbc.270.18.10847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738023	hybrid			2022-12-27	WOS:A1995QW60100071
J	ROHLFS, EM; DANIEL, KW; PREMONT, RT; KOZAK, LP; COLLINS, S				ROHLFS, EM; DANIEL, KW; PREMONT, RT; KOZAK, LP; COLLINS, S			REGULATION OF THE UNCOUPLING PROTEIN GENE (UCP) BY BETA(1), BETA(2), AND BETA(3)-ADRENERGIC RECEPTOR SUBTYPES IN IMMORTALIZED BROWN ADIPOSE CELL-LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; BETA-3-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; CYCLIC-AMP; NOREPINEPHRINE INFUSION; MOLECULAR-CLONING; ADENYLYL CYCLASES; PRIMARY CULTURE; EXON STRUCTURE; FAT-CELLS	Immortalized brown adipocyte cell lines derived from a mouse hibernoma express all three beta-adrenergic receptor subtypes, including beta(3)-adrenergic receptor (AR). In response to norepinephrine, cAMP production by plasma membranes from four clonal cell lines was stimulated to levels comparable with brown adipocytes isolated from interscapular brown adipose tissue (72.8-89.6 versus 97.8 pmol cAMP/min/mg of protein, respectively), Ah cell lines responded to the highly selective beta(3)-adrenergic receptor agonist CL316,243 by stimulating adenylyl cyclase activity (3-10-fold over basal), beta(1)-, beta(2)-, and beta(3)-adrenergic receptor mRNA was detected by Northern blotting and/or reverse transcriptase-polymerase chain reaction, Competition binding assays with the antagonists CGP20712A and I-125-cyanopindolol showed the proportions of beta(1)AR and beta(2)AR in immortalized cells to be similar to brown adipocytes from tissue (cells: 35% beta(1)AR, 65% beta(2)AR; brown adipocytes from tissue: beta(1)AR 41%, 59% beta(2)AR), Expression of brown fat-specific mitochondrial uncoupling protein (Ucp) was stimulated by beta-adrenergic agonists in two of the four cell lines, The ability of individual beta AR subtypes to regulate Ucp expression was examined with combinations of selective beta-adrenergic agonists and antagonists, Expression of Ucp could be induced by any of the beta-adrenergic receptor subtypes, However, the greatest response was obtained by stimulating all three beta-adrenergic receptor subtypes simultaneously (100 mu M: isoproterenol), Incubation of membranes from cultured cells or brown adipocytes from tissue with CL316,243 at an optimal concentration (5 mu M) did not prevent norepinephrine from further stimulating adenylyl cyclase activity, suggesting that the combined activation of beta(1)AR/beta(2)AR, plus beta(3)AR, together produced an additive cAMP response, Multiple forms of adenylyl cyclase were identified in brown and white adipocyte cell lines and tissues, Northern blot analysis detected adenylyl cyclase types 5, 6, and 10, Screening of reverse transcriptase-PCR products by DNA sequencing confirmed the identities of these forms and lower levels of additional isoforms, raising the possibility that beta-adrenergic receptor subtypes in adipocytes couple to distinct adenylyl cyclases, Because these cell lines display functional and phenotypic similarities to interscapular brown adipocytes, they will be a useful model to study the regulation of beta-adrenergic receptor expression and function, and the control of Ucp expression and activity.	DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710; JACKSON LAB,BAR HARBOR,ME 04609; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT PSYCHIAT,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BEHAV SCI,DURHAM,NC 27710; DUKE UNIV,MED CTR,SARAH W STEDMAN CTR NUTR STUDIES,DURHAM,NC 27710	Duke University; Howard Hughes Medical Institute; Jackson Laboratory; Duke University; Duke University; Duke University; Duke University				Premont, Richard/0000-0002-8053-5026	NICHD NIH HHS [HD08431] Funding Source: Medline; NIDDK NIH HHS [T32-DK07568, DK46793] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007568, R29DK046793] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0; BLOOM JD, 1992, J MED CHEM, V35, P3081, DOI 10.1021/jm00094a025; BOUILLAUD F, 1984, J BIOL CHEM, V259, P1583; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; CARPENE C, 1993, J PHARMACOL EXP THER, V265, P237; CASTEILLA L, 1991, EUR J BIOCHEM, V189, P195; CHAMPIGNY O, 1992, MOL CELL ENDOCRINOL, V86, P73, DOI 10.1016/0303-7207(92)90177-8; CHAMPIGNY O, 1991, P NATL ACAD SCI USA, V88, P10774, DOI 10.1073/pnas.88.23.10774; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLINS S, 1990, J BIOL CHEM, V265, P19330; COLLINS S, 1988, J BIOL CHEM, V263, P9067; COLLINS S, 1994, MOL ENDOCRINOL, V8, P518, DOI 10.1210/me.8.4.518; DOOLEY DJ, 1986, EUR J PHARMACOL, V130, P137, DOI 10.1016/0014-2999(86)90193-7; FEVE B, 1990, J BIOL CHEM, V265, P16343; FEVE B, 1992, J BIOL CHEM, V267, P15909; FOREST C, 1987, EXP CELL RES, V168, P233, DOI 10.1016/0014-4827(87)90431-9; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GELOEN A, 1988, AM J PHYSIOL, V254, pC175, DOI 10.1152/ajpcell.1988.254.1.C175; GETTYS TW, 1991, J BIOL CHEM, V266, P15949; GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HERRON D, 1990, FEBS LETT, V268, P196; HIMMSHAGEN J, 1983, NUTR REV, V41, P261, DOI 10.1111/j.1753-4887.1983.tb07196.x; HOLLENGA C, 1991, EUR J PHARMACOL, V200, P325, DOI 10.1016/0014-2999(91)90590-M; HOLLENGA C, 1991, BRIT J PHARMACOL, V102, P577, DOI 10.1111/j.1476-5381.1991.tb12215.x; IRELAND RC, 1986, J BIOL CHEM, V261, P1779; KLAUS S, 1994, J CELL SCI, V107, P313; KLAUS S, 1991, J CELL BIOL, V115, P1783, DOI 10.1083/jcb.115.6.1783; KOPECKY J, 1990, J BIOL CHEM, V265, P22204; KOZAK LP, 1988, J BIOL CHEM, V263, P12274; KOZAK UC, 1994, ENDOCRINOLOGY, V134, P906, DOI 10.1210/en.134.2.906; KOZAK UC, 1992, MOL ENDOCRINOL, V6, P763, DOI 10.1210/me.6.5.763; KUUSELA P, 1986, LIFE SCI, V38, P589, DOI 10.1016/0024-3205(86)90052-4; LAFONTAN M, 1993, J LIPID RES, V34, P1057; LAI E, 1982, J BIOL CHEM, V257, P6691; LANGIN D, 1991, EUR J PHARMACOL, V199, P281; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; MUZZIN P, 1991, J BIOL CHEM, V266, P24053; NAHMIAS C, 1991, EMBO J, V10, P3721, DOI 10.1002/j.1460-2075.1991.tb04940.x; NANTEL F, 1993, MOL PHARMACOL, V43, P548; Pieroni J P, 1993, Curr Opin Neurobiol, V3, P345, DOI 10.1016/0959-4388(93)90127-K; PREMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809, DOI 10.1073/pnas.89.20.9809; PREMONT RT, 1994, METHOD ENZYMOL, V238, P116; REHNMARK S, 1990, J BIOL CHEM, V265, P16464; RICQUIER D, 1986, J BIOL CHEM, V261, P13905; RODBELL M, 1964, J BIOL CHEM, V239, P375; ROSS SR, 1992, P NATL ACAD SCI USA, V89, P7561, DOI 10.1073/pnas.89.16.7561; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; SMITH U, 1984, J BIOL CHEM, V259, P8758; SMYTH MJ, 1993, J CELL SCI, V106, P1; TATE KM, 1991, EUR J BIOCHEM, V196, P357, DOI 10.1111/j.1432-1033.1991.tb15824.x; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; VANSPRONSEN A, 1993, EUR J BIOCHEM, V213, P1117, DOI 10.1111/j.1432-1033.1993.tb17861.x; WHITE JE, 1958, P SOC EXP BIOL MED, V99, P375; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716; ZHAO J, 1994, AM J PHYSIOL, V67, pC969	58	77	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10723	10732		10.1074/jbc.270.18.10723	http://dx.doi.org/10.1074/jbc.270.18.10723			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738011	hybrid			2022-12-27	WOS:A1995QW60100055
J	SONE, N; SAWA, G; SONE, T; NOGUCHI, S				SONE, N; SAWA, G; SONE, T; NOGUCHI, S			THERMOPHILIC BACILLI HAVE SPLIT CYTOCHROME-B GENES FOR CYTOCHROME-B(6) AND SUBUNIT-IV - FIRST CLONING OF CYTOCHROME-B FROM A GRAM-POSITIVE BACTERIUM (BACILLUS-STEAROTHERMOPHILUS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM SYNECHOCOCCUS-VULCANUS; C-OXIDASE; NUCLEOTIDE-SEQUENCE; TERMINAL OXIDASES; ELECTRON-TRANSFER; ESCHERICHIA-COLI; QUINOL OXIDASE; Q-CYCLE; COMPLEX; PS3	The genes of Bacillus stearothermophilus K1041 encoding cytochrome b((6)) (Bacillus cytochrome b is referred to as cytochrome b((6)) for its resemblance to plastid b(6)) and subunit IV of the quinol:cytochrome c oxidoreductase (bc(1) complex) were cloned and sequenced. For preparation of the probe for cloning, polymerase chain reaction was carried out using oligonucleotide mixtures targeting for N-terminal regions of cytochrome be and subunit IV of the thermophilic Bacillus PS3. The deduced amino acid sequences contained 224 residues of 25,425 daltons for cytochrome b((6)), and 173 residues of 19,371 daltons for subunit IV, and both open reading frames were separated by 67 base pairs. Cytochrome b and subunit IV contained 4 and 3 hydrophobic transmembrane segments, respectively, indicating that the fourth segment of subunit IV (eighth segment of cytochrome b) is lacking. Four histidine residues supposed to ligand two protohemes were conserved, but the two His in the fourth segment were separated by 14 amino acid residues like cytochrome b(6), not like mitochondrial cytochrome b. The residues that might have conferred the two quinol-binding sites were mostly conserved, but especially the third His residue in the fourth segment of mitochondrial cytochrome b was replaced by Arg in Bacillus cytochrome b(6) as in cytochrome b(6). These characteristics and quantitative comparison of the protein sequences indicate that this Bacillus sequence is unique and meanwhile rather close to the cyanobacteria-plastids type than the purple bacteria-mitochondria type.			SONE, N (corresponding author), KYUSHU INST TECHNOL,DEPT BIOCHEM ENGN & SCI,IIZUKA,FUKUOKA 820,JAPAN.		Sone, Takefumi/L-1348-2013; Sone, Takefumi/AAB-9423-2020	Sone, Takefumi/0000-0003-3467-679X; Sone, Takefumi/0000-0003-3467-679X				CAO J, 1992, J BIOL CHEM, V267, P24273; CROFTS A, 1987, CYTOCHROME SYSTEMS M, P617; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; ESPOSTIMD, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243; GARCIAHORSMAN JA, 1991, MOL MICROBIOL, V5, P197, DOI 10.1111/j.1365-2958.1991.tb01840.x; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P723, DOI 10.1021/bi00169a014; HAUSKA G, 1988, J BIOENERG BIOMEMBR, V20, P211, DOI 10.1007/BF00768395; HOWELL N, 1989, J MOL BIOL, V203, P307; ISHIZUKA M, 1990, J BIOCHEM-TOKYO, V108, P866, DOI 10.1093/oxfordjournals.jbchem.a123294; KALLAS T, 1988, J BIOL CHEM, V263, P14334; KUTOH E, 1988, J BIOL CHEM, V263, P9020; KYTE J, 1982, J MOL BIOL, V151, P389; LAEMMLI UK, 1970, NATURE, V277, P680; LAURAEUS M, 1991, EUR J BIOCHEM, V197, P699, DOI 10.1111/j.1432-1033.1991.tb15961.x; Maniatis T., 1982, MOL CLONING; MITCHELL P, 1975, J THEOR BIOL, V62, P327; NAKAYAMA N, 1992, BIOTECHNOL LETT, V14, P649, DOI 10.1007/BF01021636; Narumi I, 1992, BIOTECHNOL TECH, V6, P83, DOI 10.1007/BF02438695; NORBREGA FG, 1980, J BIOL CHEM, V255, P9828; OHTA S, 1988, BIOCHIM BIOPHYS ACTA, V933, P141, DOI 10.1016/0005-2728(88)90064-3; QUIRK PG, 1993, J BIOL CHEM, V268, P678; RAITIO M, 1987, EMBO J, V6, P2825, DOI 10.1002/j.1460-2075.1987.tb02579.x; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; ROBERTSON DE, 1990, BIOCHEMISTRY-US, V29, P11249, DOI 10.1021/bi00503a014; ROCK CD, 1987, CURR GENET, V12, P69, DOI 10.1007/BF00420729; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTANA M, 1992, J BIOL CHEM, V267, P10225; SARASTE M, 1991, EUR J BIOCHEM, V195, P517, DOI 10.1111/j.1432-1033.1991.tb15732.x; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; SONE N, 1987, J BIOL CHEM, V262, P15386; SONE N, 1991, J BIOCHEM-TOKYO, V110, P1016, DOI 10.1093/oxfordjournals.jbchem.a123671; SONE N, 1988, J BIOCHEM-TOKYO, V103, P606, DOI 10.1093/oxfordjournals.jbchem.a122314; SONE N, 1993, BIOCHIM BIOPHYS ACTA, V1183, P130, DOI 10.1016/0005-2728(93)90012-5; SONE N, 1991, SEIKAGAKU JAPANESE, V63, P873; TANO H, 1991, BIOCHEM BIOPH RES CO, V181, P437, DOI 10.1016/S0006-291X(05)81438-X; TOLNER B, 1992, MOL MICROBIOL, V6, P2845, DOI 10.1111/j.1365-2958.1992.tb01464.x; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; TRUMPOWER BL, 1990, MICROBIOL REV, V554, P101; VERBIST J, 1989, MOL GEN GENET, V219, P445, DOI 10.1007/BF00259618; VONWACHENFELDT C, 1990, FEMS MICROBIOL LETT, V100, P91; WIDGER WR, 1984, P NATL ACAD SCI-BIOL, V81, P674, DOI 10.1073/pnas.81.3.674; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; YANG X, 1988, J BIOL CHEM, P12282	44	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10612	10617		10.1074/jbc.270.18.10612	http://dx.doi.org/10.1074/jbc.270.18.10612			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737998	hybrid			2022-12-27	WOS:A1995QW60100040
J	SPERISEN, P; WANG, SM; SOLDAINI, E; PLA, M; RUSTERHOLZ, C; BUCHER, P; CORTHESY, P; REICHENBACH, P; NABHOLZ, M				SPERISEN, P; WANG, SM; SOLDAINI, E; PLA, M; RUSTERHOLZ, C; BUCHER, P; CORTHESY, P; REICHENBACH, P; NABHOLZ, M			MOUSE INTERLEUKIN-2 RECEPTOR-ALPHA GENE-EXPRESSION - INTERLEUKIN-1 AND INTERLEUKIN-2 CONTROL TRANSCRIPTION VIA DISTINCT CIS-ACTING ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; INDUCIBLE CYTOLYTIC ACTIVITY; POSITIVE REGULATORY ELEMENT; CELL GROWTH-FACTOR; CHAIN GENE; PROMOTER SEQUENCES; BINDING-PROTEIN; T-CELLS; IL-2	We have shown that interleukin-1 (IL-1) and IL-2 control IL-2 receptor alpha (IL-2R alpha) gene transcription in CD4(-)CD8(-) murine T lymphocyte precursors, Here we map the cis acting elements that mediate interleukin responsiveness of the mouse IL-2R alpha gene using a thymic lymphoma-derived hybridoma (PC60), The transcriptional response of the IL-2R alpha gene to stimulation by IL-1 + IL-2 is biphasic, IL-1 induces a rapid, protein synthesis-independent appearance of IL-2R alpha mRNA that is blocked by inhibitors of NF-kappa B activation, It also primes cells to become IL-2 responsive and thereby prepares the second phase, in which IL-2 induces a 100-fold further increase in IL-2R alpha transcripts. Transient transfection experiments show that several elements in the promoter-proximal region of the IL-2R alpha gene contribute to IL-1 responsiveness, most importantly an NF-kappa B site conserved in the human and mouse gene, IL-2 responsiveness, on the other hand, depends on a 78-nucleotide segment 1.3 kilobases upstream of the major transcription start site, This segment functions as an IL-2-inducible enhancer and lies within a region that becomes DNase I hypersensitive in normal T cells in which IL-2R alpha expression has been induced, IL-2 responsiveness requires three distinct elements within the enhancer. Two of these are potential binding sites for STAT proteins.	SWISS INST EXPTL CANC RES, CH-1066 EPALINGES, SWITZERLAND	Swiss Institute Experimental Cancer Research			Pla, Maria/K-5170-2017; , san ming wang/ABG-4910-2020	Pla, Maria/0000-0003-4382-5494; 				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASAO H, 1993, P NATL ACAD SCI USA, V90, P4127, DOI 10.1073/pnas.90.9.4127; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BALLARD D W, 1989, New Biologist, V1, P83; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; BISMUTH G, 1985, EUR J IMMUNOL, V15, P723, DOI 10.1002/eji.1830150716; BOSSELUT R, 1993, NUCLEIC ACIDS RES, V21, P5184, DOI 10.1093/nar/21.22.5184; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CONZELMANN A, 1982, NATURE, V298, P170, DOI 10.1038/298170a0; CROSS SL, 1989, SCIENCE, V244, P466, DOI 10.1126/science.2497520; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EILERS A, 1994, MOL CELL BIOL, V14, P1364, DOI 10.1128/MCB.14.2.1364; ERARD F, 1984, J EXP MED, V160, P584, DOI 10.1084/jem.160.2.584; ESPEL E, 1990, EMBO J, V9, P929, DOI 10.1002/j.1460-2075.1990.tb08191.x; FELDMAN MW, 1969, AM J HUM GENET, V21, P171; FREIMUTH WW, 1989, J IMMUNOL, V143, P3064; FROUSSARD P, 1991, MOL IMMUNOL, V28, P87, DOI 10.1016/0161-5890(91)90090-7; GARCIASANZ JA, 1993, EUR J IMMUNOL, V23, P1877, DOI 10.1002/eji.1830230822; GEERING G, 1966, J EXP MED, V124, P753, DOI 10.1084/jem.124.4.753; GILBOUR KC, 1994, P NATL ACAD SCI USA, V91, P6850; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; JOHN S, 1995, MOL CELL BIOL, V15, P1786; JOULIN V, 1991, EMBO J, V10, P1809, DOI 10.1002/j.1460-2075.1991.tb07706.x; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; KOST TA, 1983, NUCLEIC ACIDS RES, V11, P8287, DOI 10.1093/nar/11.23.8287; KRONKE M, 1985, J EXP MED, V161, P1593, DOI 10.1084/jem.161.6.1593; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LANSFORD RD, 1992, P NATL ACAD SCI USA, V89, P5966, DOI 10.1073/pnas.89.13.5966; LATTION AL, 1992, MOL CELL BIOL, V12, P5217, DOI 10.1128/MCB.12.11.5217; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LIN BB, 1990, MOL CELL BIOL, V10, P850, DOI 10.1128/MCB.10.2.850; LOWENTHAL JW, 1988, P NATL ACAD SCI USA, V85, P4468, DOI 10.1073/pnas.85.12.4468; LOWENTHAL JW, 1986, J IMMUNOL, V137, P2579; LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331; LOWENTHAL JW, 1985, J IMMUNOL, V134, P931; MALEK TR, 1985, J EXP MED, V161, P1575, DOI 10.1084/jem.161.6.1575; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; PIMENTELMUINOS FX, 1994, J IMMUNOL, V152, P5714; PLAETINCK G, 1989, EUR J IMMUNOL, V19, P897, DOI 10.1002/eji.1830190517; PLAETINCK G, 1990, J IMMUNOL, V145, P3340; POLLOCK R, 1990, NUCLEIC ACIDS RES, V18, P6197, DOI 10.1093/nar/18.21.6197; POMERANTZ JL, 1989, J IMMUNOL, V143, P4275; QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8; ROMAN D, 1990, New Biologist, V2, P642; SANZ JAG, 1990, J IMMUNOL, V145, P3111; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEEGERT D, 1994, J BIOL CHEM, V269, P8590; SEKALY RP, 1982, J IMMUNOL, V129, P1407; SILVA A, 1983, IMMUNOL REV, V76, P105, DOI 10.1111/j.1600-065X.1983.tb01099.x; SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864; SMITH MR, 1989, P NATL ACAD SCI USA, V86, P8526, DOI 10.1073/pnas.86.21.8526; SOLDAINI E, 1995, J BIOL CHEM, V270, P10733, DOI 10.1074/jbc.270.18.10733; Sperisen P, 1992, PCR Methods Appl, V1, P164; STREHLOW I, 1993, J BIOL CHEM, V268, P16590; SUZUKI N, 1987, J BIOL CHEM, V262, P5079; TIGGES MA, 1989, SCIENCE, V243, P781, DOI 10.1126/science.2492678; TOLEDANO MB, 1990, P NATL ACAD SCI USA, V87, P1830, DOI 10.1073/pnas.87.5.1830; VANDENBERG J, 1978, NATURE, V276, P37, DOI 10.1038/276037a0; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; WILSON A, 1994, EUR J IMMUNOL, V24, P1729, DOI 10.1002/eji.1830240802	66	63	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10743	10753		10.1074/jbc.270.18.10743	http://dx.doi.org/10.1074/jbc.270.18.10743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738013	hybrid			2022-12-27	WOS:A1995QW60100057
J	DONOHUE, PJ; ALBERTS, GF; GUO, Y; WINKLES, JA				DONOHUE, PJ; ALBERTS, GF; GUO, Y; WINKLES, JA			IDENTIFICATION BY TARGETED DIFFERENTIAL DISPLAY OF AN IMMEDIATE-EARLY GENE ENCODING A PUTATIVE SERINE/THREONINE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-I; THREONINE PROTEIN-KINASE; CULTURED MOUSE CELLS; MOLECULAR-CLONING; CONSERVED FEATURES; MULTIGENE FAMILY; G0/G1 TRANSITION; HEPARIN-BINDING; RESPONSE GENES; FIBROBLAST	Fibroblast growth factor (FGF)-1 mitogenic signal transduction is mediated in part by gene products that are specifically expressed in response to cell surface receptor binding and activation, We have used a targeted differential display method to identify PGF-1-inducible genes in murine NIH 3T3 fibroblasts, Here we report that one of these genes is predicted to encode a novel serine/threanine-specific protein kinase. This putative kinase has been named Fnk, for PGF-inducible kinase. The deduced Fnk amino acid sequence has 49, 36, 33, 32, and 22% overall identity to mouse serum-inducible kinase (Snk), mouse polo-like kinase (Plk), Drosophila polo, Saccharomyces Cdc5, and mouse Snk/Plk-akin kinase (Sak), respectively, These proteins are all members of the polo subfamily of structurally related serine/threonine binases, The Plk, polo, Cdc5, and Sak kinases are required for cell division. FGF-1 induction of Fnk mRNA expression is first detected at 30 min after mitogen addition, reflects transcriptional activation, and does not require de novo protein synthesis. FGF-2, platelet-derived growth factor-BE, calf serum, or phorbol myristate acetate treatment of quiescent cells also induces fnk gene expression. Fnk mRNA is expressed in vivo in a tissue-specific manner, with relatively high levels detected in newborn and adult mouse skin, These results indicate that Fnk may be a transiently expressed protein kinase involved in the early signaling events required for growth factor-stimulated cell cycle progression.	AMER RED CROSS, DEPT BIOL MOLEC, HOLLAND LAB, ROCKVILLE, MD 20855 USA	American Red Cross					NHLBI NIH HHS [HL-39727] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL039727, R01HL039727] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; BOTTARO DP, 1990, J BIOL CHEM, V265, P12767; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; BURGESS WH, 1990, MOL CELL BIOL, V10, P4770, DOI 10.1128/MCB.10.9.4770; BURGESS WH, 1995, REGULATION PROLIFERA; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHOWDHURY K, 1987, CELL, V48, P771, DOI 10.1016/0092-8674(87)90074-2; CLAY FJ, 1993, P NATL ACAD SCI USA, V90, P4882, DOI 10.1073/pnas.90.11.4882; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; DONOHUE PJ, 1994, J BIOL CHEM, V269, P8604; FENTON B, 1993, NATURE, V363, P637, DOI 10.1038/363637a0; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; GALLAGHER JT, 1994, J CLIN CHEM CLIN BIO, V32, P239; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; GOMPERTS M, 1990, ONCOGENE, V5, P1081; GRUNERT S, 1994, EMBO J, V13, P3618, DOI 10.1002/j.1460-2075.1994.tb06669.x; HAMANAKA R, 1994, CELL GROWTH DIFFER, V5, P249; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HATAI M, 1994, FEBS LETT, V350, P113, DOI 10.1016/0014-5793(94)00745-4; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOLTRICH U, 1994, P NATL ACAD SCI USA, V91, P1736, DOI 10.1073/pnas.91.5.1736; HSU DKW, 1993, BIOCHEM BIOPH RES CO, V197, P1483, DOI 10.1006/bbrc.1993.2644; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KITADA K, 1993, MOL CELL BIOL, V13, P4445, DOI 10.1128/MCB.13.7.4445; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; LAKE RJ, 1993, MOL CELL BIOL, V13, P7793, DOI 10.1128/MCB.13.12.7793; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; MATRISIAN LM, 1985, NUCLEIC ACIDS RES, V13, P711, DOI 10.1093/nar/13.3.711; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; NELKI D, 1990, NUCLEIC ACIDS RES, V18, P3655, DOI 10.1093/nar/18.12.3655; NIKAIDO T, 1991, EXP CELL RES, V192, P102, DOI 10.1016/0014-4827(91)90163-O; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; STONE B, 1994, NUCLEIC ACIDS RES, V22, P2612, DOI 10.1093/nar/22.13.2612; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0; TAVTIGIAN SV, 1994, MOL BIOL CELL, V5, P375, DOI 10.1091/mbc.5.3.375; VINCENT S, 1993, ONCOGENE, V8, P1603; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; WILLIAMS GT, 1992, MOL CELLULAR APPROAC, P115; ZHAN X, 1993, J BIOL CHEM, V268, P24427; ZUMSTEIN P, 1987, J BIOL CHEM, V262, P11252	52	183	191	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10351	10357		10.1074/jbc.270.17.10351	http://dx.doi.org/10.1074/jbc.270.17.10351			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730342	hybrid			2022-12-27	WOS:A1995QV41700091
J	GOODNIGHT, J; MISCHAK, H; KOLCH, W; MUSHINSKI, JF				GOODNIGHT, J; MISCHAK, H; KOLCH, W; MUSHINSKI, JF			IMMUNOCYTOCHEMICAL LOCALIZATION OF 8 PROTEIN-KINASE-C ISOZYMES OVEREXPRESSED IN NIH 3T3 FIBROBLASTS - ISOFORM-SPECIFIC ASSOCIATION WITH MICROFILAMENTS, GOLGI, ENDOPLASMIC-RETICULUM, AND NUCLEAR AND CELL-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER RECEPTOR; CYTOSKELETAL REARRANGEMENT; TRANSMEMBRANE PROTEINS; SUBSTRATE-SPECIFICITY; EMBRYO FIBROBLASTS; PLASMA-MEMBRANE; ACTIN FILAMENT; BETA-II; FAMILY; EXPRESSION	We have used immunocytochemical analyses to characterize the subcellular distribution of protein kinase C (PKC)-alpha; -beta I, -beta II, -gamma, -delta, -epsilon, -xi, and -eta in NIH 3T3 fibroblasts that overexpress these different PKC isozymes. Immunofluorescence studies and Western blotting with antibodies specific for individual isoforms revealed that before activation the majority of the PKCs are not membrane-bound and are diffusely distributed throughout the cytoplasm. In addition, a fraction of PKC-delta and -eta appears membrane-bound and concentrated in the Golgi apparatus, Activation of each isozyme's kinase activity (with the exception of PKC-xi) by treatment of these cells with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate results in isozyme specific alterations of cell morphology, as well as in a rapid, selective redistribution of the different PKC isozymes to distinct subcellular structures, Within minutes after 12-O-tetradecanoylphorbol-13-acetate treatment, PKC-alpha and -epsilon concentrate at cell margins. In addition, PKC-alpha accumulates in the endoplasmic reticulum, PKC-beta II associates with actin-rich microfilaments of the cytoskeleton, PKC-gamma accumulates in Golgi organelles, and PKC-epsilon associates with nuclear membranes. Our results demonstrate that each activated PKC isozyme specifically associates with a particular cellular structure, presumably containing the substrate for that isozyme. These findings support the hypothesis that PKC substrate specificity in vivo is mediated, at least in part, by the restricted subcellular locale for each PKC isozyme and its target protein.	NCI, GENET LAB, MOLEC GENET SECT, BETHESDA, MD 20892 USA; GSF MUNICH, FORSCHUNGSZENTRUM HAMATOL, INST CLIN MOLEC BIOL & TUMOR GENET, D-81377 MUNICH, GERMANY	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health			Kolch, Walter/ABF-2102-2021; Admin, SBI/HGB-2738-2022; Mischak, Harald/E-8685-2011	Kolch, Walter/0000-0001-5777-5016; Mischak, Harald/0000-0003-0323-0306				AKIMOTO K, 1994, J BIOL CHEM, V269, P12677; AZZI A, 1992, EUR J BIOCHEM, V208, P547, DOI 10.1111/j.1432-1033.1992.tb17219.x; BLUMBERG PM, 1976, NATURE, V264, P446, DOI 10.1038/264446a0; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CACACE AM, 1993, ONCOGENE, V8, P2095; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHIDA K, 1994, MOL CELL BIOL, V14, P3782, DOI 10.1128/MCB.14.6.3782; COUSSENS L, 1987, DNA-J MOLEC CELL BIO, V6, P389, DOI 10.1089/dna.1987.6.389; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DEMATTEIS MA, 1993, NATURE, V364, P818, DOI 10.1038/364818a0; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; DOWNEY GP, 1992, J CELL BIOL, V116, P695, DOI 10.1083/jcb.116.3.695; DRIEDGER PE, 1977, CANCER RES, V37, P3257; GOODNIGHT J, 1994, ADV CANCER RES, V64, P159, DOI 10.1016/S0065-230X(08)60838-6; GOPALAKRISHNA R, 1986, J BIOL CHEM, V261, P6438; GREGORIO CC, 1994, J CELL BIOL, V125, P345, DOI 10.1083/jcb.125.2.345; GREIF H, 1992, MOL CELL BIOL, V12, P1304, DOI 10.1128/MCB.12.3.1304; GUSOVSKY F, 1991, MOL PHARMACOL, V39, P124; HALSEY DL, 1987, J BIOL CHEM, V262, P2234; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HOCEVAR BA, 1991, J BIOL CHEM, V266, P28; ISHIZUKA T, 1992, BIOCHEM BIOPH RES CO, V183, P814, DOI 10.1016/0006-291X(92)90556-Z; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; JAMES G, 1992, J CELL BIOL, V116, P863, DOI 10.1083/jcb.116.4.863; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; KIRSCHMEIER PT, 1988, DNA-J MOLEC CELL BIO, V7, P219, DOI 10.1089/dna.1988.7.219; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; KONIG B, 1985, J CELL BIOCHEM, V29, P37, DOI 10.1002/jcb.240290105; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEACH KL, 1989, J CELL BIOL, V109, P685, DOI 10.1083/jcb.109.2.685; LEACH KL, 1992, J BIOL CHEM, V267, P21816; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LITCHFIELD DW, 1986, BIOCHEM BIOPH RES CO, V134, P1276, DOI 10.1016/0006-291X(86)90388-8; LOUVARD D, 1982, J CELL BIOL, V92, P92, DOI 10.1083/jcb.92.1.92; MCCAFFREY PG, 1987, BIOCHEM BIOPH RES CO, V146, P140, DOI 10.1016/0006-291X(87)90702-9; MCCLINTON D, 1990, MOL CELL BIOL, V10, P705, DOI 10.1128/MCB.10.2.705; MIKI M, 1987, EUR J BIOCHEM, V165, P125, DOI 10.1111/j.1432-1033.1987.tb11202.x; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; MISCHAK H, 1991, J IMMUNOL, V147, P3981; MISCHAK H, 1993, J BIOL CHEM, V268, P20110; MOCHLYROSEN D, 1990, CELL REGUL, V1, P693, DOI 10.1091/mbc.1.9.693; NAIRN AC, 1992, CIBA F SYMP, V164, P145; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OHNO S, 1991, ADV ENZYME REGUL, V31, P287, DOI 10.1016/0065-2571(91)90018-H; OLIVIER AR, 1994, J BIOL CHEM, V269, P2758; ONO Y, 1988, J BIOL CHEM, V263, P6927; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; OSADA S, 1990, J BIOL CHEM, V265, P22434; SCHAAP D, 1989, FEBS LETT, V243, P351, DOI 10.1016/0014-5793(89)80160-7; SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045; SELBIE LA, 1993, J BIOL CHEM, V268, P24296; TANG DG, 1993, EXP CELL RES, V207, P361, DOI 10.1006/excr.1993.1203; TIMAR J, 1993, CELL MOTIL CYTOSKEL, V26, P49, DOI 10.1002/cm.970260106; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; WERTH DK, 1984, J BIOL CHEM, V259, P5264; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121	62	291	291	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9991	10001		10.1074/jbc.270.17.9991	http://dx.doi.org/10.1074/jbc.270.17.9991			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730383	hybrid			2022-12-27	WOS:A1995QV41700045
J	TROTTI, D; VOLTERRA, A; LEHRE, KP; ROSSI, D; GJESDAL, O; RACAGNI, G; DANBOLT, NC				TROTTI, D; VOLTERRA, A; LEHRE, KP; ROSSI, D; GJESDAL, O; RACAGNI, G; DANBOLT, NC			ARACHIDONIC-ACID INHIBITS A PURIFIED AND RECONSTITUTED GLUTAMATE TRANSPORTER DIRECTLY FROM THE WATER PHASE AND NOT VIA THE PHOSPHOLIPID MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC ACID; RAT-BRAIN; PRIMARY CULTURES; FATTY-ACIDS; STRIATAL NEURONS; GLIAL-CELLS; ASTROCYTES; RECEPTORS; SYNAPTOSOMES; SENSITIVITY	Glutamate is believed to be the major excitatory transmitter in the mammalian central nervous system. Keeping the extracellular concentration of glutamate low, the glutamate transporters are required for normal brain function. Arachidonic acid (AA) inhibits glutamate uptake in relatively intact preparations (cells, tissue slices, and synaptosomes (Rhoads, D. E., Ockner, R. K., Peterson, N. A., and Raghupathy, E. (1983) Biochemistry 22, 1965-1970 and Volterra, A., Trotti, D., Cassutti, P., Tromba, C., Salvaggio, A., Melcangi, R. C., and Racagni, G. (1992b) J. Neurochem. 59, 600-606). The present study demonstrates that the effect of AA occurs also in a reconstituted system, consisting of a purified glutamate transporter protein incorporated into artificial cell membranes (liposomes). The characteristics of the AA effect in this system and in intact cells are similar with regard to specificity, sensitivity, time course, changes in V-max, and affinity. AA-ethyl ester is inactive, suggesting that the free carboxylic group is required for inhibitory activity. When incubated with proteoliposomes, AA (300 mu M, 15 min) mostly partitions to the lipid phase (lipid/water about 95:5). However, uptake inhibition is abolished by rapid dilution (6.5-fold) of the incubation medium (water phase), a procedure that does not modify the amount of AA associated with lipids. On the contrary, inhibition remains sustained if the same dilution volume contains as little as 5 mu M AA, a concentration inactive before saturation of liposome lipids with 300 mu M AA The same degree of inhibition (60%) is obtained by 5 mu M following preincubation with the inactive AA-ethyl ester (300 mu M) instead of AA. The Lipids apparently inactivate AA by extracting it from the mater phase. The results suggest that AA acts on the transporter from the water phase rather than via the membrane. This could be true for other proteins as well since gamma-aminobutyric acid uptake is similarly affected by AA.	UNIV OSLO, INST BASIC MED SCI, DEPT ANAT, N-0317 OSLO, NORWAY; UNIV MILAN, INST PHARMACOL SCI, CTR NEUROPHARMACOL, I-20133 MILAN, ITALY	University of Oslo; University of Milan			Danbolt, Niels Christian/A-1907-2014; Gjesdal, Ola/C-1941-2015; Rossi, Daniela Maria/AAA-3401-2021; Racagni, Giorgio A./B-5826-2011	Danbolt, Niels Christian/0000-0003-4227-4520; Rossi, Daniela Maria/0000-0002-3346-1327; Trotti, Davide/0000-0001-6338-6404; Gjesdal, Ola/0000-0003-1913-6445; Volterra, Andrea/0000-0003-1069-1602	Telethon [586] Funding Source: Medline	Telethon(Fondazione Telethon)		ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; CASPERS ML, 1993, BRAIN RES, V602, P215, DOI 10.1016/0006-8993(93)90685-G; CHAN PH, 1983, J NEUROCHEM, V40, P309, DOI 10.1111/j.1471-4159.1983.tb11284.x; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DANBOLT NC, 1994, PROG NEUROBIOL, V44, P377, DOI 10.1016/0301-0082(94)90033-7; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; DUMUIS A, 1993, MOL PHARMACOL, V43, P976; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; DURING MJ, 1993, LANCET, V341, P1607; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; HARDY SJ, 1994, J NEUROCHEM, V62, P1546; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; LAZAREWICZ JW, 1990, J NEUROCHEM, V55, P1875, DOI 10.1111/j.1471-4159.1990.tb05771.x; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LEVY LM, 1993, FEBS LETT, V317, P79, DOI 10.1016/0014-5793(93)81495-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNCH MA, 1994, NEUROSCI RES COMMUN, V14, P53; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; OKUN IM, 1992, GEN PHYSIOL BIOPHYS, V11, P589; OLNEY JW, 1990, ANNU REV PHARMACOL, V30, P47; ORDWAY RW, 1991, TRENDS NEUROSCI, V14, P96, DOI 10.1016/0166-2236(91)90069-7; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; RHOADS DE, 1983, BIOCHEMISTRY-US, V22, P1965, DOI 10.1021/bi00277a035; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; SANFELIU C, 1990, BRAIN RES, V526, P241, DOI 10.1016/0006-8993(90)91228-9; SIESJO BK, 1989, ANN NY ACAD SCI, V559, P323; STELLA N, 1994, J NEUROSCI, V14, P568; VOLTERRA A, 1992, J NEUROCHEM, V59, P600, DOI 10.1111/j.1471-4159.1992.tb09411.x; VOLTERRA A, 1992, ADV EXP MED BIOL, V318, P147; VOLTERRA A, 1994, MOL PHARMACOL, V46, P986; YU ACH, 1986, J NEUROCHEM, V47, P1181; ZAFRA F, 1990, BIOCHEM J, V271, P237, DOI 10.1042/bj2710237	38	101	102	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9890	9895		10.1074/jbc.270.17.9890	http://dx.doi.org/10.1074/jbc.270.17.9890			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730372				2022-12-27	WOS:A1995QV41700031
J	FUH, G; WELLS, JA				FUH, G; WELLS, JA			PROLACTIN RECEPTOR ANTAGONISTS THAT INHIBIT THE GROWTH OF BREAST-CANCER CELL-LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERM TISSUE-CULTURE; HORMONE RECEPTOR; BINDING-PROTEIN; RATIONAL DESIGN; LACTOGEN; SERUM	We investigated the mechanism of action of the human prolactin (hPRL) receptor on four different breast cancer cell lines, T-47D, MCF-7, BT-474, and SK-BR3, that express elevated levels of the receptor compared with normal cells. Cells treated with human growth hormone (hGH), which binds and activates the hPRL receptor, exhibited bell-shaped dose-response growth curves consistent with the sequential dimerization mechanism proposed for the hPRL receptor (Fuh, G., Colosi, P., Wood, W.I., and Wells, J.A. (1995) J. Biol. Chem. 268, 5376-5381). Growth stimulation was enhanced by Zn2+ which preferentially increases the affinity of hGH for the hPRL receptor. Furthermore, receptor-selective variants of hGH that bind the hPRL receptor but not the hGH receptor were agonistic, providing additional support that specific binding to the hPRL receptor can stimulate these breast cancer cells to grow. On this basis we produced variants of hGH and human placental lactogen (hPL) that were potential antagonists because they bind but do not dimerize the hPRL receptor. The hPL-based antagonist was less potent than the hGH-based antagonist toward the growth of MCF-7 cells, consistent with the lower affinity of hPL for hPRL receptor than for hGH. However, the hPL-based antagonist was more potent than the hGH antagonist for BT-474 cells. Antibodies to the hPRL receptor inhibited growth of FDC-P1 cells transfected with the hPRL receptor; these also inhibited MCF-7 cells and T47D cells but not BT-474 cells. A unique feature of BT-474 cells was found when screening its cDNA revealed the presence of a novel alternative splice of the hPRL receptor that codes for the soluble extracellular domain; this may explain these differential inhibitory effects. These studies provide further molecular insight into the potential role of the hPRL receptor in breast cancer and demonstrate that hPRL receptor antagonists can inhibit the growth of breast cancer cells.	GENENTECH INC,DEPT PROT ENGN,S SAN FRANCISCO,CA 94080; UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143	Roche Holding; Genentech; University of California System; University of California San Francisco			Wells, Jim A/O-9854-2016					ASHKENAZI A, 1987, FEBS LETT, V210, P51, DOI 10.1016/0014-5793(87)81296-6; BAUMANN G, 1986, J CLIN ENDOCR METAB, V62, P134, DOI 10.1210/jcem-62-1-134; BISWAS R, 1987, CANCER RES, V47, P3509; BONNETERRE J, 1987, CANCER RES, V47, P4724; BOUTIN JM, 1989, MOL ENDOCRINOL, V3, P1455, DOI 10.1210/mend-3-9-1455; CUNNINGHAM BC, 1991, P NATL ACAD SCI USA, V88, P3407, DOI 10.1073/pnas.88.8.3407; CUNNINGHAM BC, 1990, SCIENCE, V250, P1709, DOI 10.1126/science.2270485; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DJIANE J, 1985, J BIOL CHEM, V260, P1430; FUH G, 1993, J BIOL CHEM, V268, P5376; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; HUFF KK, 1988, MOL ENDOCRINOL, V2, P200, DOI 10.1210/mend-2-3-200; KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LOVE RR, 1991, CANCER, V68, P1401, DOI 10.1002/1097-0142(19910915)68:6<1401::AID-CNCR2820680637>3.0.CO;2-K; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; LOWMAN HB, 1991, J BIOL CHEM, V266, P10982; MADDOX PR, 1992, BRIT J CANCER, V65, P456, DOI 10.1038/bjc.1992.92; MANNI A, 1986, CANCER RES, V46, P1669; MURPHY LJ, 1984, CANCER RES, V44, P1963; PHARES CK, 1986, ANTICANCER RES, V6, P845; PLATICA M, 1991, INT J CANCER, V48, P109, DOI 10.1002/ijc.2910480120; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; SHIU RPC, 1979, CANCER RES, V39, P4381; SHIU RPC, 1985, J BIOL CHEM, V260, P1307; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; TORNELL J, 1991, INT J CANCER, V49, P114, DOI 10.1002/ijc.2910490121; WELLS JA, 1993, ANNU REV BIOPH BIOM, V22, P329, DOI 10.1146/annurev.bb.22.060193.001553	29	106	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13133	13137		10.1074/jbc.270.22.13133	http://dx.doi.org/10.1074/jbc.270.22.13133			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768908	hybrid			2022-12-27	WOS:A1995RB43900031
J	AMROLIA, PJ; CUNNINGHAM, JM; NEY, P; NIENHUIS, AW; JANE, SM				AMROLIA, PJ; CUNNINGHAM, JM; NEY, P; NIENHUIS, AW; JANE, SM			IDENTIFICATION OF 2 NOVEL REGULATORY ELEMENTS WITHIN THE 5'-UNTRANSLATED REGION OF THE HUMAN (A)GAMMA-GLOBIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN GENE; HUMAN GAMMA-GLOBIN; DOMINANT CONTROL REGION; STAGE SELECTOR ELEMENT; TRANSGENIC MICE; DEVELOPMENTAL EXPRESSION; DNA-SEQUENCES; MESSENGER-RNA; TRANSCRIPTION; PROMOTER	Interaction between the stage selector element (SSE) in the proximal gamma-globin promoter and hypersensitivity site 2 in the locus control region partly mediates the competitive silencing of the beta-globin promoter in the fetal developmental stage. We have now demonstrated that a second SSE-like element in the 5'-untranslated region of the gamma-gene also contributes to this competitive silencing of the beta-gene. Utilizing transient transfection assays in the fetal erythroid cell line, K562, we have shown that the core enhancer of hypersensitivity site 2 can preferentially interact with the proximal gamma-promoter in the absence of the SSE, completely silencing a linked beta-promoter. Mutation of a 20-base pair sequence of the gamma-gene 5'-untranslated region (UTR) led to derepression of beta-promoter activity. A marked activation of gamma-promoter activity was also observed with this mutation, suggesting the presence of a repressor. Fine mutagenesis dissected these activities to different regions of the 5'-UTR. The stage selector activity was localized to a region centered on nucleotides +13 to +15. Electromobility shift assays utilizing this sequence demonstrated binding of a fetal and erythroid-specific protein. The repressor activity of the 5'-UTR was localized to tandem GATA-like sites, which appear to bind a complex of two proteins, one of which is the erythroid transcription factor GATA-1. These results indicate that the 5'-UTR of the gamma-gene contains sequences that may be important for its transcriptional and developmental regulation.	ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38101 USA; UNIV TENNESSEE, DEPT PEDIAT, MEMPHIS, TN 38101 USA; ROYAL MELBOURNE HOSP, BONE MARROW RES LAB, PARKVILLE, VIC 3050, AUSTRALIA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Royal Melbourne Hospital	AMROLIA, PJ (corresponding author), ST JUDE CHILDRENS RES HOSP, DIV EXPTL HEMATOL, 332 N LAUDERDALE, MEMPHIS, TN 38101 USA.		Jane, Stephen/D-6659-2011	Jane, Stephen Marsden/0000-0002-1045-0481	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765] Funding Source: Medline; NHLBI NIH HHS [P01 HL53749-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; BERRY M, 1992, NATURE, V358, P499, DOI 10.1038/358499a0; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; CHADA K, 1986, NATURE, V319, P685, DOI 10.1038/319685a0; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; DILLON N, 1991, NATURE, V350, P252, DOI 10.1038/350252a0; DIX DJ, 1992, BIOCHEMISTRY-US, V31, P2818, DOI 10.1021/bi00125a024; ELLIS J, 1993, EMBO J, V12, P127, DOI 10.1002/j.1460-2075.1993.tb05638.x; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GALLARDA JL, 1989, GENE DEV, V3, P1845, DOI 10.1101/gad.3.12a.1845; GEBALLE AP, 1986, CELL, V46, P865, DOI 10.1016/0092-8674(86)90068-1; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GROSVELD GC, 1981, CELL, V25, P215, DOI 10.1016/0092-8674(81)90246-4; GROSVELD GC, 1982, NATURE, V295, P120, DOI 10.1038/295120a0; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; GUSTIN KE, 1993, BIOTECHNIQUES, V14, P22; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; JANE SM, 1995, EMBO J, V14, P97, DOI 10.1002/j.1460-2075.1995.tb06979.x; JANE SM, 1992, EMBO J, V11, P2961, DOI 10.1002/j.1460-2075.1992.tb05366.x; JANE SM, 1993, MOL CELL BIOL, V13, P3272, DOI 10.1128/MCB.13.6.3272; JONES KA, 1988, GENE DEV, V2, P1101, DOI 10.1101/gad.2.9.1101; KOLLIAS G, 1986, CELL, V46, P89, DOI 10.1016/0092-8674(86)90862-7; MANSOUR SL, 1986, MOL CELL BIOL, V6, P2684, DOI 10.1128/MCB.6.7.2684; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; PRATS AC, 1992, MOL CELL BIOL, V12, P4796, DOI 10.1128/MCB.12.10.4796; RAICH N, 1990, SCIENCE, V250, P1147, DOI 10.1126/science.2251502; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; SORRENTINO B, 1990, NUCLEIC ACIDS RES, V18, P2721, DOI 10.1093/nar/18.9.2721; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; THEILL LE, 1987, MOL CELL BIOL, V7, P4329, DOI 10.1128/MCB.7.12.4329; TOWNES TM, 1985, EMBO J, V4, P1715, DOI 10.1002/j.1460-2075.1985.tb03841.x	39	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12892	12898		10.1074/jbc.270.21.12892	http://dx.doi.org/10.1074/jbc.270.21.12892			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759548	hybrid			2022-12-27	WOS:A1995QZ71100085
J	IKEDA, Y; FUJII, J; TANIGUCHI, N; MEISTER, A				IKEDA, Y; FUJII, J; TANIGUCHI, N; MEISTER, A			HUMAN GAMMA-GLUTAMYL-TRANSPEPTIDASE MUTANTS INVOLVING CONSERVED ASPARTATE RESIDUES AND THE UNIQUE CYSTEINE RESIDUE OF THE LIGHT SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; TRANSFERASE TRANSPEPTIDASE; ACTIVE-SITE; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; SERINE PROTEASE; KIDNEY; CDNA; IDENTIFICATION; GLUTATHIONE	Mutant human gamma-glutamyl transpeptidases with amino acid substitutions on the light subunit at the Asp residues conserved among several species, and at the unique cysteine residue (Cys-454), were prepared and expressed in a baculovirus insect cell system. Replacement of Asp-423 by Ala or Glu led to major loss of enzyme activity, consistent with the conclusion that Asp-423 is essential for activity. A mutant in which Cys-454 was replaced by Ala was fully active, indicating that the unique light subunit thiol is not required for catalysis. Kinetic analysis of the hydrolysis reaction of L-gamma-glutamyl-p-nitroanilide indicated that the decreased activity of Asp-423 mutants is the consequence of an extremely high substrate K-m value, which is more than a 1000-fold greater than that for the wild-type enzyme, whereas the V-max is decreased only less than 90-fold. The results suggest that Asp-423, and to a lesser extent Asp-422, interact electrostatically with the alpha-amino group of the gamma-glutamyl donor substrate. Although further studies are required to evaluate the possibility that the reaction involves function of a charge (or proton) relay system, the present work suggests that the gamma-glutamyl moiety of the substrate binds electrostatically to specific groups on the enzyme; this facilitates gamma-glutamyl enzyme formation.	OSAKA UNIV,SCH MED,DEPT BIOCHEM,SUITA,OSAKA 565,JAPAN	Osaka University	IKEDA, Y (corresponding author), CORNELL UNIV,COLL MED,DEPT BIOCHEM,NEW YORK,NY 10021, USA.		Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968; Fujii, Junichi/0000-0003-2267-7357	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK012034] Funding Source: NIH RePORTER; NIDDK NIH HHS [2 R37 DK12034] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; COLOMA J, 1986, NUCLEIC ACIDS RES, V14, P1393, DOI 10.1093/nar/14.3.1393; COURTAY C, 1992, BIOCHEM PHARMACOL, V43, P2527, DOI 10.1016/0006-2952(92)90140-E; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; ELCE JS, 1980, BIOCHEM J, V185, P473, DOI 10.1042/bj1850473; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FUSHIKI T, 1983, J BIOCHEM-TOKYO, V93, P795, DOI 10.1093/jb/93.3.795; GARDELL SJ, 1979, J BIOL CHEM, V254, P4942; GOODSPEED DC, 1989, GENE, V76, P1, DOI 10.1016/0378-1119(89)90002-4; HEISTERKAMP N, 1991, P NATL ACAD SCI USA, V88, P6303, DOI 10.1073/pnas.88.14.6303; IKEDA Y, 1993, J BIOL CHEM, V268, P3980; IKEDA Y, 1994, FASEB J, V8, pA1357; INOUE M, 1977, EUR J BIOCHEM, V73, P335, DOI 10.1111/j.1432-1033.1977.tb11323.x; INOUE M, 1978, BIOCHEM BIOPH RES CO, V82, P1183, DOI 10.1016/0006-291X(78)90311-X; ISHIYE M, 1993, BIOTECHNOL PROGR, V9, P323, DOI 10.1021/bp00021a012; KUMAGAI H, 1993, J MOL BIOL, V234, P1259, DOI 10.1006/jmbi.1993.1677; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPERCHE Y, 1986, P NATL ACAD SCI USA, V83, P937, DOI 10.1073/pnas.83.4.937; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Meister A, 1976, ENZYMES BIOL MEMBR, Vv3, P315; Meister A, 1989, GLUTATHIONE CHEM BIO, P367; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; PAPANDRIKOPOULOU A, 1989, EUR J BIOCHEM, V183, P693, DOI 10.1111/j.1432-1033.1989.tb21100.x; PIWNICAWORMS H, 1987, CURRENT PROTOCOLS MO; RAJPERTDEMEYTS E, 1988, P NATL ACAD SCI USA, V85, P8840, DOI 10.1073/pnas.85.23.8840; SAKAMURO D, 1988, GENE, V73, P1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITH TK, 1995, J BIOL CHEM, V270, P12476, DOI 10.1074/jbc.270.21.12476; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; STOLE E, 1994, J BIOL CHEM, V269, P21435; STOLE E, 1990, P NATL ACAD SCI USA, V87, P1706, DOI 10.1073/pnas.87.5.1706; STOLE E, 1991, J BIOL CHEM, V266, P17850; SUZUKI H, 1989, J BACTERIOL, V171, P5169, DOI 10.1128/jb.171.9.5169-5172.1989; SZEWCZUK A, 1965, BIOCHIM BIOPHYS ACTA, V105, P352, DOI 10.1016/S0926-6593(65)80159-X; TANIGUCHI N, 1985, CANCER RES, V45, P5835; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; TATE SS, 1974, J BIOL CHEM, V249, P7593; TATE SS, 1977, P NATL ACAD SCI USA, V74, P931, DOI 10.1073/pnas.74.3.931; TATE SS, 1985, METHOD ENZYMOL, V113, P400; THOMPSON GA, 1976, BIOCHEM BIOPH RES CO, V71, P32, DOI 10.1016/0006-291X(76)90245-X	45	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12471	12475		10.1074/jbc.270.21.12471	http://dx.doi.org/10.1074/jbc.270.21.12471			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759490	hybrid			2022-12-27	WOS:A1995QZ71100023
J	VINCENT, O; GANCEDO, JM				VINCENT, O; GANCEDO, JM			ANALYSIS OF POSITIVE ELEMENTS SENSITIVE TO GLUCOSE IN THE PROMOTER OF THE FBP1 GENE FROM YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; SACCHAROMYCES-CEREVISIAE; DNA-BINDING; MIG1 REPRESSOR; FRUCTOSE-1,6-BISPHOSPHATASE; EXPRESSION; PROTEINS; DEREPRESSION; MECHANISMS; REGIONS	We have identified in the promoter of the FBP1 gene from Saccharomyces cerevisiae, which codes for fructose-1,6-bisphosphatase, two elements which can form specific DNA . protein complexes and which confer glucose-repressed expression to an heterologous reporter gene. Complex formation and activation of transcription by either element require a functional CAT1 gene and are not blocked by a hap2-1 mutation, although this mutation interferes with maximal expression of the FBP1 gene. A sequence from one of the elements acts as a weak upstream activating sequence, but its activity can be stimulated up to 10-fold by neighboring sequences. A further element of the promoter has been characterized, which forms a specific DNA . protein complex only when a nuclear extract from derepressed cells is used. This element does not activate transcription in a heterologous promoter. The DNA sequences of the three elements involved in protein binding, defined by DNase I footprinting, have no homology with consensus sequences for known activating factors.	CSIC,INST INVEST BIOMED,E-28029 MADRID,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)			vincent, Olivier/H-1620-2015	vincent, Olivier/0000-0003-4355-5367				Ausubel FM., 1988, CURRENT PROTOCOLS MO; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; DELAGUERRA R, 1988, FEBS LETT, V242, P149, DOI 10.1016/0014-5793(88)81004-4; ENTIAN KD, 1982, J BACTERIOL, V151, P1123, DOI 10.1128/JB.151.3.1123-1128.1982; FEDEROFF HJ, 1983, J BACTERIOL, V156, P301, DOI 10.1128/JB.156.1.301-307.1983; FLICK JS, 1992, GENETICS, V130, P295; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; Gancedo C., 1989, YEASTS, V3, P205; GANCEDO JM, 1992, EUR J BIOCHEM, V206, P297, DOI 10.1111/j.1432-1033.1992.tb16928.x; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Hanahan D., 1985, DNA CLONING PRACTICA, P109; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSTON M, 1993, MOL CELLULAR BIOL YE, P193; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; LAMPHIER MS, 1992, P NATL ACAD SCI USA, V89, P5922, DOI 10.1073/pnas.89.13.5922; LOMBARDO A, 1992, MOL CELL BIOL, V12, P2941, DOI 10.1128/MCB.12.7.2941; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; MERCADO JJ, 1994, EUR J BIOCHEM, V224, P473, DOI 10.1111/j.1432-1033.1994.00473.x; MERCADO JJ, 1991, FEBS LETT, V291, P97, DOI 10.1016/0014-5793(91)81112-L; MERCADO JJ, 1992, FEBS LETT, V311, P110, DOI 10.1016/0014-5793(92)81379-Z; Miller JH, 1972, EXPT MOL BIOL; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; NIEDERACHER D, 1992, CURR GENET, V22, P363, DOI 10.1007/BF00352437; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; ROGERS DT, 1988, J BIOL CHEM, V263, P6051; Sambrook J, 1989, MOL CLONING LABORATO; SCHNEIDER R, 1986, NUCLEIC ACIDS RES, V14, P1303, DOI 10.1093/nar/14.3.1303; SCHOLER A, 1994, MOL CELL BIOL, V14, P3616; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; VINCENT O, 1995, CURR GENET, V27, P387, DOI 10.1007/BF00352109; WANG HM, 1990, MOL CELL BIOL, V10, P1743, DOI 10.1128/MCB.10.4.1743; ZITOMER RS, 1978, J BACTERIOL, V135, P39, DOI 10.1128/JB.135.1.39-44.1978	38	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12832	12838		10.1074/jbc.270.21.12832	http://dx.doi.org/10.1074/jbc.270.21.12832			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759539	hybrid			2022-12-27	WOS:A1995QZ71100076
J	YOO, SH				YOO, SH			PH-INDUCED AND CA2+-INDUCED CONFORMATIONAL CHANGE AND AGGREGATION OF CHROMOGRANIN-B - COMPARISON WITH CHROMOGRANIN-A AND IMPLICATION IN SECRETORY VESICLE BIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMAFFIN GRANULES; SECRETOGRANIN-I; PROTEIN; BINDING; SEQUENCE; CA-2+; PHEOCHROMOCYTOMA; WIDESPREAD; ENDOCRINE; MEMBRANE	Chromogranins A and B have been known to undergo pH- and Ca2+-dependent aggregation, and this property is considered essential for the proper sorting of the vesicular matrix proteins. In the present study, purified native chromogranin B (CGB) from bovine adrenal medulla was used to study the pH- and Ca2+-dependent conformational changes and aggregation property. Similar to chromogranin A (CGA), which had been shown to undergo pH- and Ca2+-dependent conformational changes and to be composed of 60-65% random coil with 25-40% alpha-helicity, chromogranin B was also shown to consist of 65-70% random coil, 15-25% alpha-helix, and 10-15% beta-sheet structures. The high percentage of random coil suggests that CGB behaves hydrodynamically as an asymmetric molecule, thus explaining its anomalous migration on SDS-polyacrylamide gels. Further, CGB eluted from a gel filtration column in the volume indicative of a globular protein with molecular weight of similar to 200,000 at both the intravesicular pH of 5.5 and a near physiological pH of 7.5. Considering that dimeric CGA eluted from a gel filtration column in the position suggestive of a 300-kDa protein, this result indicated that CGB exists in a monomeric state at both pH levels. Like CGA, which exhibited greater aggregation at pH 5.5 than at pH 7.5 upon Ca2+ binding, CGB also aggregated much more readily at pH 5.5 than at pH 7.5. However, there was a marked difference in the aggregation properties of CGA and CGB with regard to their sensitivity to Ca2+: CGB was at least 2 orders of magnitude more sensitive to Ca2+ than CGA. This suggested that, in spite of the low concentration of CGB (approximately one-tenth that of CGA) in bovine adrenal chromaffin cells, CGB would start to aggregate well ahead of CGA in the trans-Golgi network. In view of the proposed importance of the pH- and Ca2+-induced chromogranin aggregation in vesicle biogenesis, the extreme sensitivity of CGB aggregation to Ca2+ appears to underline the potential importance of CGB aggregation in the early stages of vesicle biogenesis.			YOO, SH (corresponding author), NIDCD, NEUROCHEM LAB, 5 RES COURT, 2A37, BETHESDA, MD 20892 USA.							BAUER JW, 1991, BIOCHIM BIOPHYS ACTA, V1089, P124, DOI 10.1016/0167-4781(91)90094-3; BENEDUM UM, 1986, EMBO J, V5, P1495, DOI 10.1002/j.1460-2075.1986.tb04388.x; BENEDUM UM, 1987, EMBO J, V6, P1203, DOI 10.1002/j.1460-2075.1987.tb02355.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULENDA D, 1985, BIOCHEMISTRY-US, V24, P7760, DOI 10.1021/bi00347a039; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; DEDMAN JR, 1983, METHOD ENZYMOL, V102, P1; FARRIS FJ, 1978, J AM CHEM SOC, V100, P4469, DOI 10.1021/ja00482a026; FISCHERCOLBRIE R, 1987, J NEUROCHEM, V48, P262, DOI 10.1111/j.1471-4159.1987.tb13157.x; GERDES HH, 1989, J BIOL CHEM, V264, P12009; GILL BM, 1991, REGUL PEPTIDES, V33, P223, DOI 10.1016/0167-0115(91)90216-4; GORR SU, 1989, AM J PHYSIOL, V257, pE247, DOI 10.1152/ajpendo.1989.257.2.E247; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HUTTNER WB, 1988, INT CONGR SER, V799, P325; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; IACANGELO A, 1986, NATURE, V323, P82, DOI 10.1038/323082a0; REIFFEN FU, 1986, FEBS LETT, V195, P327, DOI 10.1016/0014-5793(86)80187-9; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; SIMON JP, 1989, BIOCHEM J, V262, P1; WINKLER H, 1986, NEUROSCIENCE, V18, P261, DOI 10.1016/0306-4522(86)90154-5; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; YOO SH, 1992, J BIOL CHEM, V267, P11236; YOO SH, 1994, J BIOL CHEM, V269, P12001; YOO SH, 1990, J BIOL CHEM, V265, P14414; YOO SH, 1991, J BIOL CHEM, V266, P7740; YOO SH, 1990, J BIOL CHEM, V265, P13446; YOO SH, 1993, BIOCHEMISTRY-US, V32, P8213, DOI 10.1021/bi00083a023; YOO SH, 1993, BIOCHIM BIOPHYS ACTA, V1179, P239, DOI 10.1016/0167-4889(93)90078-4; YOO SH, 1995, BIOPHYS J, V68, P116	29	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12578	12583		10.1074/jbc.270.21.12578	http://dx.doi.org/10.1074/jbc.270.21.12578			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759505	hybrid			2022-12-27	WOS:A1995QZ71100040
J	BENBARUCH, A; MICHIEL, DF; OPPENHEIM, JJ				BENBARUCH, A; MICHIEL, DF; OPPENHEIM, JJ			SIGNALS AND RECEPTORS INVOLVED IN RECRUITMENT OF INFLAMMATORY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TUMOR-NECROSIS-FACTOR; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; NEUTROPHIL CHEMOTACTIC FACTOR; HOST DEFENSE CYTOKINES; NF-KAPPA-B; INTERLEUKIN-8 GENE; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL-4-PHOSPHATE KINASE; TYROSINE PHOSPHORYLATION; COOPERATIVE INTERACTION		NCI,FREDERICK CANC RES & DEV CTR,PRI DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	BENBARUCH, A (corresponding author), NCI,FREDERICK CANC RES & DEV CTR,MOLEC IMMUNOREGULAT LAB,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21702, USA.		Huang, H/E-9490-2010					ABRUZZO LV, 1992, AM J PATHOL, V140, P365; ALAM R, 1994, J IMMUNOL, V153, P3155; ALI H, 1993, J BIOL CHEM, V268, P24247; AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; BERKOW RL, 1987, J LEUKOCYTE BIOL, V41, P441, DOI 10.1002/jlb.41.5.441; BRANDT E, 1992, J IMMUNOL, V149, P1356; BUHL AM, 1994, P NATL ACAD SCI USA, V91, P9190, DOI 10.1073/pnas.91.19.9190; BUHL AM, 1993, FEBS LETT, V323, P132, DOI 10.1016/0014-5793(93)81464-B; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; CHANG MS, 1994, J BIOL CHEM, V269, P25277; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; CHENG QC, 1992, J IMMUNOL, V148, P451; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; DENG WL, 1994, J IMMUNOL, V153, P2130; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; DEWALD B, 1988, J BIOL CHEM, V263, P16179; EXTON JH, 1990, J BIOL CHEM, V265, P1; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; GRINSTEIN S, 1988, J BIOL CHEM, V263, P1779; GRINSTEIN S, 1994, J BIOL CHEM, V269, P19313; GRINSTEIN S, 1992, J BIOL CHEM, V267, P18122; GRINSTEIN S, 1993, J BIOL CHEM, V268, P20223; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; HASKILL S, 1990, P NATL ACAD SCI USA, V87, P7732, DOI 10.1073/pnas.87.19.7732; HORUK R, 1994, IMMUNOL TODAY, V15, P169, DOI 10.1016/0167-5699(94)90314-X; INGLESE J, 1993, J BIOL CHEM, V268, P23735; JAFFE GJ, 1993, INVEST OPHTH VIS SCI, V34, P2776; KELNER GS, 1994, SCIENCE, V266, P139; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; KUNSCH C, 1994, J IMMUNOL, V153, P153; LUSTER AD, 1987, MOL CELL BIOL, V7, P3723, DOI 10.1128/MCB.7.10.3723; MAHE Y, 1991, J BIOL CHEM, V266, P13759; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; MCCOLL SR, 1993, J IMMUNOL, V150, P4550; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; MULLMANN TJ, 1993, J LEUKOCYTE BIOL, V53, P630, DOI 10.1002/jlb.53.6.630; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; OLIVEIRA IC, 1994, MOL CELL BIOL, V14, P5300, DOI 10.1128/MCB.14.8.5300; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; ORTMEYER J, 1993, AM J PHYSIOL, V264, pC402, DOI 10.1152/ajpcell.1993.264.2.C402; PEREZ HD, 1994, J BIOL CHEM, V269, P22485; PIKE MC, 1990, J BIOL CHEM, V265, P1866; PIKE MC, 1992, J IMMUNOL, V148, P3158; PITTET D, 1989, J BIOL CHEM, V264, P7251; QUALLIOTINEMANN D, 1993, J BIOL CHEM, V268, P23843; RICHARD S, 1994, J IMMUNOL, V152, P2479; ROBERTS TM, 1992, NATURE, V360, P534, DOI 10.1038/360534a0; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SCHRAUFSTATTER IU, 1993, J IMMUNOL, V151, P6418; SCHREIBER RE, 1994, J BIOL CHEM, V269, P326; SCHRODER JM, 1987, J IMMUNOL, V139, P3474; SHAAFI RI, 1986, J CELL BIOL, V102, P1459, DOI 10.1083/jcb.102.4.1459; SHAM RL, 1993, BLOOD, V82, P2546; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMITH RJ, 1992, J LEUKOCYTE BIOL, V52, P17, DOI 10.1002/jlb.52.1.17; SOZZANI S, 1994, J IMMUNOL, V152, P3615; SOZZANI S, 1993, J IMMUNOL, V150, P1544; SOZZANI S, 1995, BLOOD, V84, P3895; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; TAKANO T, 1994, J BIOL CHEM, V269, P22453; Taub D D, 1994, Ther Immunol, V1, P229; TEBO JM, 1992, J IMMUNOL, V149, P2352; THOMPSON HL, 1994, J BIOL CHEM, V269, P9486; TIMMERS HT, 1990, NUCLEIC ACIDS RES, V18, P23, DOI 10.1093/nar/18.1.23; VACHULA M, 1991, FASEB J, V5, pA1632; VERGHESE MW, 1987, J IMMUNOL, V138, P4374; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; XU LL, 1995, J LEUKOCYTE BIOL, V57, P335, DOI 10.1002/jlb.57.2.335; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233	77	351	357	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11703	11706		10.1074/jbc.270.20.11703	http://dx.doi.org/10.1074/jbc.270.20.11703			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744810	hybrid			2022-12-27	WOS:A1995QY73600001
J	MONLAUZEUR, L; RAJASEKARAN, A; CHAO, M; RODRIGUEZBOULAN, E; LEBIVIC, A				MONLAUZEUR, L; RAJASEKARAN, A; CHAO, M; RODRIGUEZBOULAN, E; LEBIVIC, A			A CYTOPLASMIC TYROSINE IS ESSENTIAL FOR THE BASOLATERAL LOCALIZATION OF MUTANTS OF THE HUMAN NERVE GROWTH-FACTOR RECEPTOR IN MADIN-DARBY CANINE KIDNEY-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; INFLUENZA-VIRUS HEMAGGLUTININ; PLASMA-MEMBRANE GLYCOPROTEIN; POLARIZED EPITHELIAL-CELLS; HUMAN NGF RECEPTOR; MDCK CELLS; VIRAL GLYCOPROTEINS; INTRACELLULAR-TRANSPORT; TRANSFERRIN RECEPTOR; GOLGI-APPARATUS	Deletion of 58 internal amino acids from the C-terminal cytoplasmic domain of p75 human nerve growth factor receptor (hNGFR) changes its localization from apical to basolateral in transfected Madin-Darby Canine Kidney (MDCK) cells (Le Bivic, A., Sambuy, Y., Patzak, A., Patil, N., Chao, M., and Rodriguez-Boulan, E. (1991) J. Cell Biol. 115, 607-618). The mutant protein, PS-NGFR, also shows a dramatic increase in its ability to endocytose NGF and to recycle through basolateral endosomes. We report here the site-directed mutagenesis analysis of PS-NGFR to localize and characterize its basolateral and endocytic sorting signals. Both signals reside in the proximal part of the PS cytoplasmic tail, between positions 306 and 314. Transferring the cytoplasmic tail (19 residues) and transmembrane domain of a truncated PS mutant to the ectodomain of the placental alkaline phosphatase, an apical glypiated ectoenzyme, redirected it to the basolateral membrane and the endocytic compartments. A tyrosine at position 308, present in this short cytoplasmic segment, was mutated into phenylalanine or alanine. The resulting mutants were expressed predominantly on the apical membrane of MDCK cells. Their ability to endocytose NGF was reduced with the alanine mutant showing the stronger diminution. The PS mutant contains a short cytoplasmic sequence necessary both for basolateral targeting and endocytosis, and the requirement for tyrosine at position 308 is crucial for basolateral targeting.	FAC SCI LUMINY, GENET & PHYSIOL DEV LAB, UMR 9943, F-13288 MARSEILLE 09, FRANCE; CORNELL UNIV, COLL MED, DEPT CELL BIOL & ANAT, NEW YORK, NY 10021 USA	UDICE-French Research Universities; Aix-Marseille Universite; Cornell University				Chao, Moses/0000-0002-6969-3744	NIGMS NIH HHS [R01 GM034107] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034107] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AROETI B, 1993, J CELL BIOL, V123, P1149, DOI 10.1083/jcb.123.5.1149; BERGER J, 1988, J BIOL CHEM, V263, P10016; BERND P, 1986, DEV BIOL, V115, P415, DOI 10.1016/0012-1606(86)90261-7; BREWER CB, 1991, J CELL BIOL, V114, P413, DOI 10.1083/jcb.114.3.413; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; DARGEMONT C, 1993, EMBO J, V12, P1713, DOI 10.1002/j.1460-2075.1993.tb05816.x; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; GOTTARDI C, 1993, J TISSUE CULTURE MET, V14, P173; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; MATLIN KS, 1984, J CELL BIOL, V99, P2131, DOI 10.1083/jcb.99.6.2131; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MISEK DE, 1984, CELL, V39, P537, DOI 10.1016/0092-8674(84)90460-4; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; MOSTOV KE, 1987, J CELL BIOL, V105, P2031, DOI 10.1083/jcb.105.5.2031; NABI IR, 1991, J CELL BIOL, V115, P1573, DOI 10.1083/jcb.115.6.1573; PRILL V, 1993, EMBO J, V12, P2181, DOI 10.1002/j.1460-2075.1993.tb05866.x; Riezman Howard, 1993, Trends in Cell Biology, V3, P273, DOI 10.1016/0962-8924(93)90056-7; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; RINDLER MJ, 1985, J CELL BIOL, V100, P136, DOI 10.1083/jcb.100.1.136; RODRIGUEZBOULAN E, 1984, J CELL BIOL, V98, P308, DOI 10.1083/jcb.98.1.308; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; RODRIGUEZBOULAN E, 1983, METHOD ENZYMOL, V98, P486; ROTH MG, 1987, J CELL BIOL, V104, P769, DOI 10.1083/jcb.104.3.769; SARGIACOMO M, 1989, J MEMBRANE BIOL, V107, P277, DOI 10.1007/BF01871942; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; STEPHENS EB, 1986, EMBO J, V5, P237, DOI 10.1002/j.1460-2075.1986.tb04204.x; THOMAS DC, 1993, J BIOL CHEM, V268, P3313; VAUX D, 1992, Trends in Cell Biology, V2, P189, DOI 10.1016/0962-8924(92)90232-C; WANDINGERNESS A, 1990, J CELL BIOL, V111, P987, DOI 10.1083/jcb.111.3.987	42	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12219	12225		10.1074/jbc.270.20.12219	http://dx.doi.org/10.1074/jbc.270.20.12219			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744872	hybrid			2022-12-27	WOS:A1995QY73600077
J	SHIOI, J; PANGALOS, MN; RIPELLINO, JA; VASSILACOPOULOU, D; MYTILINEOU, C; MARGOLIS, RU; ROBAKIS, NK				SHIOI, J; PANGALOS, MN; RIPELLINO, JA; VASSILACOPOULOU, D; MYTILINEOU, C; MARGOLIS, RU; ROBAKIS, NK			THE ALZHEIMER AMYLOID PRECURSOR PROTEOGLYCAN (APPICAN) IS PRESENT IN BRAIN AND IS PRODUCED BY ASTROCYTES BUT NOT BY NEURONS IN PRIMARY NEURAL CULTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; CEREBRAL HEMISPHERE; MOLECULAR-CLONING; BETA-PROTEIN; CNS INJURY; CELL; DISEASE; CDNA; RAT; PURIFICATION	Recent studies showed that the Alzheimer amyloid precursor (APP) occurs as the core protein of a chondroitin sulfate proteoglycan (appican) in C6 glioma cells, In the present study we show that appican is present ent in both human and rat brain tissue. Cortical rat brain cell cultures were used to identify appican-producing cells. Soluble secreted and cell associated appican was produced by mixed glial cultures but not by primary neuronal cultures. Among the three major glial cell types, astrocytes produced high levels of appican, while oligodendrocytes failed to produce any, Only low levels of this molecule were occasionally detected in microglial cultures. Expression of appican in astrocyte cultures was regulated by the composition of the growth media. N2a neuroblastoma cells also produced appican; however, treatment with dibutyryl cAMP which promotes neuronal differentiation in these cells inhibited its production without inhibiting synthesis of APP. In contrast to the restricted expression of appican, APP was present in all cultures, and its production was independent of appican synthesis. Neuronal cultures produced mainly APP(695) while glial cultures produced the Kunitz type protease inhibitor containing APP. The astrocyte specific expression of appican suggests a function distinct from the function of APP. Brain appicans may play a role in the development of Alzheimer disease neuropathology.	CUNY MT SINAI SCH MED, DEPT PSYCHIAT, NEW YORK, NY 10029 USA; CUNY MT SINAI SCH MED, FISHBERG RES CTR NEUROBIOL, NEW YORK, NY 10029 USA; CUNY MT SINAI SCH MED, DEPT NEUROL, NEW YORK, NY 10029 USA; NYU, MED CTR, DEPT PHARMACOL, NEW YORK, NY 10016 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; New York University			Robakis, Nikolaos/AAA-1838-2021; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NIA NIH HHS [AG08200, AG05138] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [RF1AG008200, P50AG005138, R01AG008200] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; ASCHNER M, 1993, J TOXICOL ENV HEALTH, V38, P329, DOI 10.1080/15287399309531721; BESNARD F, 1989, DISSECTION TISSUE CU, P136; BOTTENSTEIN JE, 1989, DISSECTION TISSUE CU, P109; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; CHAMAK B, 1994, J NEUROSCI RES, V38, P221, DOI 10.1002/jnr.490380213; Cole R., 1989, DISSECTION TISSUE CU, P121; DELOSMONTEROS AE, 1989, DISSECTION TISSUE CU, P140; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; DOU CL, 1994, J NEUROSCI, V14, P7616; ESTIN C, 1989, DISSECTION TISSUE CU, P112; FREDMAN P, 1984, ARCH BIOCHEM BIOPHYS, V233, P661, DOI 10.1016/0003-9861(84)90492-2; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; GEDDES JW, 1986, EXP NEUROL, V94, P767, DOI 10.1016/0014-4886(86)90254-2; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HARDY R, 1991, DEVELOPMENT, V111, P1061; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIANG WL, 1981, J BIOL CHEM, V256, P529; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KLINGER MM, 1985, J BIOL CHEM, V260, P4082; LABOURDETTE G, 1989, DISSECTION TISSUE CU, P134; LEVINE JM, 1994, J NEUROSCI, V14, P4716; MARGOLIS RK, 1993, EXPERIENTIA, V49, P429, DOI 10.1007/BF01923587; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P501, DOI 10.1098/rstb.1990.0122; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MILEV P, 1994, J CELL BIOL, V127, P1703, DOI 10.1083/jcb.127.6.1703; MORRISON RS, 1989, DISSECTION TISSUE CU, P187; OKAMOTO M, 1994, NEUROSCI LETT, V172, P51, DOI 10.1016/0304-3940(94)90660-2; PANGALOS MN, 1995, J BIOL CHEM, V270, P10388, DOI 10.1074/jbc.270.18.10388; PANGALOS MN, 1995, IN PRESS J NEUROCHEM; PARK TH, 1992, BRAIN RES, V599, P83, DOI 10.1016/0006-8993(92)90855-4; PARKER KK, 1980, SCIENCE, V208, P179, DOI 10.1126/science.6102413; PRASAD KN, 1975, BIOL REV, V50, P129, DOI 10.1111/j.1469-185X.1975.tb01055.x; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; REFOLO LM, 1989, BIOCHEM BIOPH RES CO, V164, P664, DOI 10.1016/0006-291X(89)91511-8; Robakis Nikolaos K., 1994, P317; ROBAKIS NK, 1990, INT CONGR SER, V884, P179; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROBAKIS NK, 1994, NEUROBIOL AGING, V15, P457, DOI 10.1016/0197-4580(94)90077-9; ROCH JM, 1992, J BIOL CHEM, V267, P2214; SAITOH T, 1994, NEUROBIOL AGING, V15, P461, DOI 10.1016/0197-4580(94)90078-7; SANETO RP, 1989, DISSECTION TISSUE CU, P148; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; SHIOI J, 1993, NEUROSCI LETT, V154, P121, DOI 10.1016/0304-3940(93)90186-O; SHIOI J, 1992, J BIOL CHEM, V267, P13819; SOLA C, 1993, NEUROSCIENCE, V53, P267, DOI 10.1016/0306-4522(93)90304-X; SPRECHER CA, 1993, BIOCHEMISTRY-US, V32, P4481, DOI 10.1021/bi00068a002; St George-Hyslop Peter H., 1994, P345; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Terry Robert D., 1994, P179; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; VANNOSTRAND WE, 1987, J BIOL CHEM, V262, P8508; WEIBEL M, 1989, DISSECTION TISSUE CU, P118; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	58	50	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11839	11844		10.1074/jbc.270.20.11839	http://dx.doi.org/10.1074/jbc.270.20.11839			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744833	hybrid			2022-12-27	WOS:A1995QY73600028
J	JI, Y; JONAS, A				JI, Y; JONAS, A			PROPERTIES OF AN N-TERMINAL PROTEOLYTIC FRAGMENT OF APOLIPOPROTEIN AI IN SOLUTION AND IN RECONSTITUTED HIGH-DENSITY-LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; RECEPTOR-BINDING DOMAIN; FUNCTIONAL-PROPERTIES; STRUCTURAL DOMAINS; MICELLAR COMPLEXES; PLASMA; ACTIVATION; PHOSPHATIDYLCHOLINES; PARTICLES; MEMBRANES	Limited proteolysis was used to study the domain structure and to produce a large N-terminal fragment of human apolipoprotein AI (apoAI), Digestion of reconstituted high density lipoprotein (rHDL) prepared with apoAI and dipalmitoyl phosphatidylcholine or palmitoyloleoyl phosphatidylcholine by chymotrypsin, trypsin, elastase, and subtilisin generated a major fragment of 22 kDa. Under milder conditions proteolysis of lipid-free apoAI produced a fragment of similar size, The fragments shared the same N terminus as intact apoAI, and the chymotryptic fragment had a molecular weight of 22,384 as determined by electrospray ionization mass spectrometry, Thus the fragment consists of the N-terminal 192 amino acid residues of apoAI, and the region around Tyr(192) seems to be especially accessible to proteases. In aqueous solution the fragment, apoAI-(1-192), had an alpha-helix content similar to that of apoAI (similar to 52%) but existed only as monomers and dimers, ApoAI-(1-192) lysed dimyristoyl phosphatidylcholine liposomes slowly compared with apoAI but did form rHDL complexes with palmitoyloleoyl phosphatidylcholine or dipalmitoyl phosphatidylcholine when prepared by the sodium cholate dialysis method, ApoAI-(1-192) rHDL exhibited sizes and size distributions distinct from apoAI: rHDL but displayed similar stability against denaturation, The isolated apoAI-(1-192) rHDLs retained a high ability to activate lecithin-cholesterol acyltransferase, comparable with the most effective apoAI rHDL, The results suggest that the C-terminal domain of apoAI is crucial for self-association and initial lipid binding but is not involved in specific lecithin-cholesterol acyltransferase activation.	UNIV ILLINOIS,COLL MED,DEPT BIOCHEM,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign					NHLBI NIH HHS [HL-16059] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016059] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAN CM, 1993, BIOCHEM J, V290, P449, DOI 10.1042/bj2900449; BANKA CL, 1991, J BIOL CHEM, V266, P23886; BOGUSKI MS, 1986, J LIPID RES, V27, P1011; BOLIN DJ, 1994, J BIOL CHEM, V269, P7429; BYRNE RE, 1983, BIOCHEMISTRY-US, V22, P2894, DOI 10.1021/bi00281a018; CAMEJO G, 1969, BIOCHIM BIOPHYS ACTA, V175, P290, DOI 10.1016/0005-2795(69)90007-5; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Cleland W W, 1979, Methods Enzymol, V63, P103; CREIGHTON TE, 1983, PROTEINS STRUCTURES, P316; DALTON MB, 1993, J BIOL CHEM, V268, P19274; GRAHAM DL, 1987, J BIOL CHEM, V262, P7439; JONAS A, 1986, BIOCHIM BIOPHYS ACTA, V876, P474, DOI 10.1016/0005-2760(86)90034-2; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1991, J LIPID RES, V32, P97; JONAS A, 1993, J BIOL CHEM, V268, P1596; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Jonas A., 1992, STRUCTURE FUNCTION A, P217; LINS L, 1993, BIOCHIM BIOPHYS ACTA, V1151, P137, DOI 10.1016/0005-2736(93)90096-I; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLEY RW, 1984, J LIPID RES, V25, P1277; MARCEL YL, 1991, J BIOL CHEM, V266, P3644; MATZ CE, 1982, J BIOL CHEM, V257, P4541; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MINNICH A, 1992, J BIOL CHEM, V267, P16553; MORRISON J, 1991, J BIOL CHEM, V266, P18780; MORRISON JR, 1992, J BIOL CHEM, V267, P13205; POWNALL HJ, 1978, BIOCHEMISTRY-US, V17, P1183, DOI 10.1021/bi00600a008; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SHORE VG, 1978, BIOCHIM BIOPHYS ACTA, V529, P319, DOI 10.1016/0005-2760(78)90075-9; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; STOKKE KT, 1971, SCAND J CLIN LAB INV, V27, P21, DOI 10.3109/00365517109080184; SWANEY JB, 1983, J LIPID RES, V24, P245; WALD JH, 1990, J BIOL CHEM, V265, P20037; WALD JH, 1990, J BIOL CHEM, V265, P20044; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194	39	120	126	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11290	11297		10.1074/jbc.270.19.11290	http://dx.doi.org/10.1074/jbc.270.19.11290			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744765	hybrid			2022-12-27	WOS:A1995QX86500042
J	KIM, TK; ZHAO, YM; GE, H; BERNSTEIN, R; ROEDER, RG				KIM, TK; ZHAO, YM; GE, H; BERNSTEIN, R; ROEDER, RG			TATA-BINDING PROTEIN RESIDUES IMPLICATED IN A FUNCTIONAL INTERPLAY BETWEEN NEGATIVE COFACTOR NC2 (DR1) AND GENERAL FACTORS TFIIA AND TFIIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; TRANSCRIPTION FACTOR; PREINITIATION COMPLEX; ACTIVATION DOMAIN; BASIC REPEAT; DNA-BINDING; INITIATION; INVITRO; TBP; MECHANISM	The TATA-binding protein (TBP) plays a key role in transcription initiation. Several negative cofactors (NC1, NC2, and Dr1) are known to interact with TBP in a manner that prevents productive interactions of transcription factors TFIIA and TFIIB with promoter-bound TBP. To gain insights into the regulatory interplay on the surface of TBP, we have employed mutant forms of TBP to identify amino acid residues important for interactions with the negative regulatory cofactor NC2 and the general factor TFIIB, The results show the involvement of distinct domains of TBP in these interactions. Residues (Lys-133, Lys-145, and Lys-151) in the basic repeat region are important for interactions with NC2, as well as with TFIIA (Buratowski, S., and Zhou, H. (1992) Science 255, 1130-1132; Lee, D. K,, DeJong, J., Hashimoto, S., Horikoshi, M., and Roeder, R. G. (1992) Mel. Cell. Biol. 12, 5189-5196), whereas a residue (Leu-189) in the second stirrup-like loop spanning S2' and S3' is required for interaction with TFIIB. In addition, we demonstrate that NC2 is identical to the previously cloned negative cofactor Drl. The implications of these results for TBP structure and function are discussed.			KIM, TK (corresponding author), ROCKEFELLER UNIV, BIOCHEM & MOLEC BIOL LAB, NEW YORK, NY 10021 USA.							ASO T, 1994, EMBO J, V13, P435, DOI 10.1002/j.1460-2075.1994.tb06278.x; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; BURATOWSKI S, 1992, SCIENCE, V255, P1130, DOI 10.1126/science.1546314; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; CHEN XB, 1993, GENE DEV, V7, P1837, DOI 10.1101/gad.7.10.1837; CHIANG CM, 1993, EMBO J, V12, P2749, DOI 10.1002/j.1460-2075.1993.tb05936.x; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; GE H, 1994, J BIOL CHEM, V269, P17136; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HOFFMANN A, 1991, NUCLEIC ACIDS RES, V19, P6337, DOI 10.1093/nar/19.22.6337; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; INOSTROZA JA, 1992, CELL, V70, P477; KIM K, 1994, J BIOL CHEM, V269, P4891; KIM TK, 1994, NATURE, V369, P252, DOI 10.1038/369252a0; KIM TK, 1994, NUCLEIC ACIDS RES, V22, P251, DOI 10.1093/nar/22.2.251; KIM TK, 1994, P NATL ACAD SCI USA, V91, P4170, DOI 10.1073/pnas.91.10.4170; KIM TK, 1993, J BIOL CHEM, V268, P20866; KRAUS VB, 1994, P NATL ACAD SCI USA, V91, P6279, DOI 10.1073/pnas.91.14.6279; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; NIKOLOV DB, 1994, NAT STRUCT BIOL, V1, P621, DOI 10.1038/nsb0994-621; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; WANG WD, 1992, GENE DEV, V6, P1716, DOI 10.1101/gad.6.9.1716; WORKMAN JL, 1988, CELL, V55, P211, DOI 10.1016/0092-8674(88)90044-X; YAMAMOTO T, 1992, P NATL ACAD SCI USA, V89, P2844, DOI 10.1073/pnas.89.7.2844; ZAWEL L, 1992, Current Opinion in Cell Biology, V4, P488, DOI 10.1016/0955-0674(92)90016-6	39	68	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10976	10981		10.1074/jbc.270.18.10976	http://dx.doi.org/10.1074/jbc.270.18.10976			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738039	hybrid			2022-12-27	WOS:A1995QW60100088
J	PELEG, S; SASTRY, M; COLLINS, ED; BISHOP, JE; NORMAN, AW				PELEG, S; SASTRY, M; COLLINS, ED; BISHOP, JE; NORMAN, AW			DISTINCT CONFORMATIONAL-CHANGES INDUCED BY 20-EPI ANALOGS OF 1-ALPHA,25-DIHYDROXYVITAMIN-D3 ARE ASSOCIATED WITH ENHANCED ACTIVATION OF THE VITAMIN-D-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,25-DIHYDROXYVITAMIN-D3 RECEPTOR; GENE; DIFFERENTIATION; BINDING; HORMONE; CELLS; METABOLISM; SEQUENCES; REQUIRES; GROWTH	The relative affinities of the 1 alpha,25-dihydroxyvitamin D-3 (1,25-D-3) analogues 20-epi-1 alpha,25-dihydroxyvitamin D-3 (IE) and 20-epi-22-oxa-24a,26a,27a-tri-homo-1 alpha,25-dihydroxyvitamin D-3 (ID) to the nuclear vitamin D receptor (VDR) are similar to that of 1,25 D-3, but their antiproliferative action is 1000-fold greater. We tested whether the greater antiproliferative effect of these analogues is due to a differential activation of the VDR. In ROS 17/2.8 cells, the effective doses required to produce 50% maximal stimulation (ED(50)) of transfected reporter genes driven by either the osteocalcin or the osteopontin vitamin D-response elements (VDRE) were 5 x 10(-9) M, 10(-10) M, and 10(-11) M for 1,25 D-3, ID, and IE, respectively. Similar results were obtained when recombinant human VDR was cotransfected into CV-1 cells with an osteocalcin VDRE-reporter plasmid. We found that in vitro the sensitivity of 1,25-D-3-induced and analogue-induced receptors to proteases was different. The ED(50) for binding to VDRE, as determined by electrophoretic mobility shift assays, was significantly higher for 1,25-D-3-induced than for analogue-induced VDR. The concentration of retinoid X receptor (RXR) was significantly lower in 1,25-D-3-induced than analogue-induced VDR complexes with VDRE. We therefore conclude that IE and ID augment transcriptional activity of VDR more than 1,25-D-3 does, by producing conformational changes that enhance dimerization of MDR with RXR. We suggest that these conformational changes are due to differences in the contact sites of the 20-epi analogues and 1,25-D-3 with the VDR.	UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MED SPECIALTIES,HOUSTON,TX 77030	University of California System; University of California Riverside; University of Texas System; UTMD Anderson Cancer Center					NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK009012, R01DK009012] Funding Source: NIH RePORTER; NCI NIH HHS [CA-16672] Funding Source: Medline; NIDDK NIH HHS [DK-09012] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLAN GF, 1992, J BIOL CHEM, V267, P19513; AMENTO E P, 1987, Steroids, V49, P55, DOI 10.1016/0039-128X(87)90079-1; BEEKMAN JM, 1993, MOL ENDOCRINOL, V7, P1266, DOI 10.1210/me.7.10.1266; BINDERUP L, 1991, BIOCHEM PHARMACOL, V42, P1565; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; CAFFREY JM, 1989, J BIOL CHEM, V264, P20265; DEMAY MB, 1992, P NATL ACAD SCI USA, V89, P8097, DOI 10.1073/pnas.89.17.8097; DILWORTH FJ, 1994, BIOCHEM PHARMACOL, V47, P987; FARACHCARSON MC, 1991, ENDOCRINOLOGY, V129, P1878; HAUSSLER MR, 1986, ANNU REV NUTR, V6, P527, DOI 10.1146/annurev.nu.06.070186.002523; KOEFFLER HP, 1984, CANCER RES, V44, P5624; KUIL CW, 1994, MOL CELL ENDOCRINOL, V102, pR1, DOI 10.1016/0303-7207(94)90112-0; LIEBERHERR M, 1989, J BIOL CHEM, V264, P20403; NEMERE I, 1984, ENDOCRINOLOGY, V115, P1467; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; NORMAN AW, 1993, J BIOL CHEM, V268, P13811; OZONO K, 1990, J BIOL CHEM, V265, P21881; PELEG S, 1993, MOL ENDOCRINOL, V7, P999, DOI 10.1210/me.7.8.999; Peleg S, 1989, Henry Ford Hosp Med J, V37, P194; PIKE JW, 1991, ANNU REV NUTR, V11, P189, DOI 10.1146/annurev.nu.11.070191.001201; SCHWARTZ Z, 1992, ENDOCRINOLOGY, V130, P2495, DOI 10.1210/en.130.5.2495; SCULE R, 1990, CELL, V61, P497; SIMBOLICAMPBELL M, 1992, CELL SIGNAL, V4, P99, DOI 10.1016/0898-6568(92)90011-V; SIMBOLICAMPBELL M, 1993, J BIOL CHEM, V269, P3257; SONE T, 1991, J BIOL CHEM, V266, P23296; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; Wecksler W R, 1980, Methods Enzymol, V67, P488; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHOU JY, 1989, BLOOD, V74, P82; ZHOU JY, 1991, BLOOD, V78, P75	30	185	188	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10551	10558		10.1074/jbc.270.18.10551	http://dx.doi.org/10.1074/jbc.270.18.10551			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737990	hybrid			2022-12-27	WOS:A1995QW60100031
J	SAITOH, H; DASSO, M				SAITOH, H; DASSO, M			THE RCC1 PROTEIN INTERACTS WITH RAN, RANBP1, HSC70, AND A 340-KDA PROTEIN IN XENOPUS EXTRACTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; CHROMOSOME CONDENSATION; KARYOPHILIC PROTEINS; CELL-CYCLE; REGULATOR; CLEAVAGE; NUCLEUS; MITOSIS	RCC1 is an abundant, highly conserved, chromatin-associated protein whose function is necessary for the preservation of a properly ordered cell cycle, RCC1 is also necessary for numerous nuclear processes, including nuclear transport and RNA metabolism; and it functions enzymatically as a guanine nucleotide exchange factor for a small, ras related GTPase called Ran. Studies in several organisms suggest that RCC1 may be part of a large complex containing multiple proteins. There is also evidence that RCC1 associates with chromatin through other proteins and that the binding of the complex to chromatin varies within the cell cycle. In order to characterize this putative complex, we have identified a number of other proteins as candidate compo nents of the complex by their association with a GST-RCC1 fusion protein. Three of these proteins have previously been identified (Ran, RanBP1, and hsc70). The fourth protein is novel and has a molecular mass of 340 kDa. In this report, we discuss a preliminary characterization of the interactions between these proteins.	NICHHD,MOLEC EMBRYOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)				Dasso, Mary/0000-0002-5410-1371				ANDERSON CW, 1973, J VIROL, V106, P1445; BEDDOW AL, 1995, IN PRESS P NATL ACAD; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; BISCHOFF RF, 1991, NATURE, V355, P80; BISCHOFF RF, 1995, EMBO J, V14, P705; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; DASSO M, 1993, TRENDS BIOCHEM SCI, V18, P96, DOI 10.1016/0968-0004(93)90161-F; DASSO M, 1994, EMBO J, V13, P5732, DOI 10.1002/j.1460-2075.1994.tb06911.x; DASSO M, 1992, MOL CELL BIOL, V12, P3337, DOI 10.1128/MCB.12.8.3337; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; GOLFARB DS, 1994, CURR BIOL, V4, P57; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Harlow E., 1988, ANTIBODIES LAB MANUA, V2nd, P479; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; IMAMOTO N, 1992, J CELL BIOL, V119, P1047, DOI 10.1083/jcb.119.5.1047; KORNBLUTH S, 1994, J CELL BIOL, V125, P705, DOI 10.1083/jcb.125.4.705; LEE A, 1993, J CELL SCI, V106, P287; LOUNSBURY KM, 1994, J BIOL CHEM, V269, P11285; MOORE MS, 1994, TRENDS BIOCHEM SCI, V19, P211, DOI 10.1016/0968-0004(94)90024-8; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; OKUNO Y, 1993, EXP CELL RES, V206, P134, DOI 10.1006/excr.1993.1129; POWERS MA, 1994, CELL, V79, P931, DOI 10.1016/0092-8674(94)90024-8; SEINO H, 1992, J CELL SCI, V102, P393; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8	26	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10658	10663		10.1074/jbc.270.18.10658	http://dx.doi.org/10.1074/jbc.270.18.10658			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738003	hybrid			2022-12-27	WOS:A1995QW60100046
J	BERGE, A; BJORCK, L				BERGE, A; BJORCK, L			STREPTOCOCCAL CYSTEINE PROTEINASE RELEASES BIOLOGICALLY-ACTIVE FRAGMENTS OF STREPTOCOCCAL SURFACE-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; CLOSELY LINKED GENES; BINDING PROTEIN; NUCLEOTIDE-SEQUENCE; IMMUNOGLOBULIN-G; CELL-SURFACE; RECEPTOR; PYOGENES; IDENTIFICATION; INFECTIONS	Streptococcus pyogenes are important pathogenic bacteria which produce an extracellular cysteine protein ase contributing to their virulence and pathogenicity. S. pyogenes also express surface molecules, M proteins, that are major virulence determinants due to their antiphagocytic property. In the present work live S. pyogenes bacteria of the M1 serotype were incubated with purified cysteine proteinase. Several peptides were solubilized, and analysis of their protein-binding properties and amino acid sequences revealed two internal fibrinogen-binding fragments of M1 protein (17 and 21 kDa, respectively), and a 36-kDa IgG-binding NH2-terminal fragment of protein H, an IgGFc-binding surface molecule, M protein also plays a role in streptococcal adherence, and removal of this and other surface proteins could promote bacterial dissemination, whereas the generation of soluble complexes between immunoglobulins and immunoglobulin-binding streptococcal surface proteins could be an etiological factor in the development of glomerulonephritis and rheumatic fever, Thus, in these serious complications to S. pyogenes infections immune complexes are found in affected organs. The cysteine proteinase also solubilized a 116-kDa internal fragment of C5a peptidase, another streptococcal surface protein, Activation of the complement system generates C5a, a peptide stimulating leukocyte chemotaxis, C5a-mediated granulocyte migration was blocked by the 116-kDa fragment. This mechanism, by which phagocytes could be prevented from reaching the site of infection, may also contribute to the pathogenicity and virulence of S. pyogenes.	LUND UNIV, DEPT CELL & MOLEC BIOL, MOLEC PATHOGENESIS SECT, S-22100 LUND, SWEDEN	Lund University								AKERSTROM B, 1992, J IMMUNOL, V148, P3238; AKESSON P, 1990, MOL IMMUNOL, V27, P523, DOI 10.1016/0161-5890(90)90071-7; AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BENNASR A, 1995, BIOCHEM J, V305, P173, DOI 10.1042/bj3050173; BERGE A, 1993, J BIOL CHEM, V268, P25417; BESSEN DE, 1992, INFECT IMMUN, V60, P124, DOI 10.1128/IAI.60.1.124-135.1992; BJORCK L, 1989, NATURE, V337, P385, DOI 10.1038/337385a0; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; CHEN CC, 1990, J BIOL CHEM, V265, P3161; CLEARY PP, 1992, INFECT IMMUN, V60, P5219, DOI 10.1128/IAI.60.12.5219-5223.1992; DAHLBOGE H, 1989, GENE, V79, P325; ELLEN RP, 1972, INFECT IMMUN, V5, P826, DOI 10.1128/IAI.5.5.826-830.1972; ELLIOTT SD, 1945, J EXP MED, V81, P573, DOI 10.1084/jem.81.6.573; ENGLARD S, 1990, METHOD ENZYMOL, V182, P285; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; GERLACH D, 1983, ZBL BAKT-INT J MED M, V255, P221, DOI 10.1016/S0174-3031(83)80161-9; GOMI H, 1990, J IMMUNOL, V144, P4046; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; GRUBB A, 1982, INT ARCH ALLER A IMM, V67, P369, DOI 10.1159/000233049; HAANES EJ, 1992, J BACTERIOL, V174, P4967, DOI 10.1128/JB.174.15.4967-4976.1992; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; HEATH DG, 1987, INFECT IMMUN, V55, P1233, DOI 10.1128/IAI.55.5.1233-1238.1987; HOLM SE, 1992, J INFECT DIS, V166, P31, DOI 10.1093/infdis/166.1.31; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; KANTOR FS, 1965, J EXP MED, V121, P849, DOI 10.1084/jem.121.5.849; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; KASTERN W, 1992, J BIOL CHEM, V267, P12820; KRONVALL G, 1973, J IMMUNOL, V111, P1401; LAPENTA D, 1994, MOL MICROBIOL, V12, P873, DOI 10.1111/j.1365-2958.1994.tb01075.x; LINDAHL G, 1989, MOL MICROBIOL, V3, P239, DOI 10.1111/j.1365-2958.1989.tb01813.x; LINDAHL G, 1989, MOL GEN GENET, V216, P372, DOI 10.1007/BF00334378; LINDAHL G, 1990, EPIDEMIOL INFECT, V105, P87, DOI 10.1017/S0950268800047683; Liu T. Y., 1971, ENZYMES, VIII, P609; LO SS, 1984, ANAL BIOCHEM, V136, P89, DOI 10.1016/0003-2697(84)90309-9; MARTIN DR, 1993, J INFECT DIS, V167, P1112, DOI 10.1093/infdis/167.5.1112; NELSON RD, 1975, J IMMUNOL, V115, P1650; NELSON RD, 1981, INVESTIGATION PHAGOC, P19; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; NILSON BHK, 1992, J BIOL CHEM, V267, P2234; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; Rentzsch G, 1970, Z Laryngol Rhinol Otol, V49, P391; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STENBERG L, 1992, MOL MICROBIOL, V6, P1185, DOI 10.1111/j.1365-2958.1992.tb01557.x; TAI JY, 1976, J BIOL CHEM, V251, P1955; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TYLEWSKA SK, 1988, CURR MICROBIOL, V16, P209, DOI 10.1007/BF01568531; WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144; WEXLER DE, 1983, INFECT IMMUN, V39, P239, DOI 10.1128/IAI.39.1.239-246.1983; WEXLER DE, 1985, INFECT IMMUN, V50, P757, DOI 10.1128/IAI.50.3.757-764.1985; YARNALL M, 1986, J IMMUNOL, V136, P2670	53	180	185	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9862	9867		10.1074/jbc.270.17.9862	http://dx.doi.org/10.1074/jbc.270.17.9862			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730368	hybrid			2022-12-27	WOS:A1995QV41700027
J	GAO, ZH; ZHI, G; HERRING, BP; MOOMAW, C; DEOGNY, L; SLAUGHTER, CA; STULL, JT				GAO, ZH; ZHI, G; HERRING, BP; MOOMAW, C; DEOGNY, L; SLAUGHTER, CA; STULL, JT			PHOTOAFFINITY-LABELING OF A PEPTIDE SUBSTRATE TO MYOSIN LIGHT-CHAIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RABBIT SKELETAL-MUSCLE; STEADY-STATE KINETICS; MGATP-BINDING SITE; INTRASTERIC REGULATION; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; SMOOTH-MUSCLE; CALMODULIN; ACTIVATION	The substrate binding properties of skeletal muscle myosin light chain kinase were investigated with a synthetic peptide containing the photoreactive amino acid p-benzoylphenylalanine (Bpa) incorporated amino-terminal of the phosphoacceptor serine (BpaKKRAAR-ATSNVFA), When photolyzed at 350 nm, the peptide was cross-linked stoichiometrically to myosin light chain kinase in a Ca2+/calmodulin-dependent manner, Peptide incorporation into kinase inhibited light chain phosphorylation, and the loss of kinase activity was proportional to the extent of peptide incorporated, After peptide I was incorporated into myosin light chain kinase, it was partially phosphorylated in the absence of Ca2+/calmodulin, The extent of phosphorylation increased in the presence of Ca2+/calmodulin. The cross-linked photoadduct was digested, labeled peptides were purified by high performance liquid chromatography, and sites of covalent modification were determined by amino acid sequencing and analysis, The covalent modification in the catalytic core occurred on Ile-373 (66%) and in a peptide containing residues Asn-422 to Met-437 (14%), respectively, Lys-572 in the autoinhibitory region accounted for 20% of the incorporated label, The coincident covalent modification of the autoinhibitory domain suggests that it is located near the catalytic site, Based upon a model of the catalytic core, the substrate peptide is predicted to bind in the cleft between the two lobes of the kinase, The orientation of the substrate peptide on myosin light chain kinase is similar to the orientation of the substrate recognition fragment, but not the high affinity binding fragment, of inhibitor peptide of cAMP-dependent protein kinase in the catalytic subunit of the cAMP-dependent protein kinase.	UNIV TEXAS,SW MED CTR,DEPT PHYSIOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL006296] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL06296] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAGCHI IC, 1992, MOL ENDOCRINOL, V6, P621, DOI 10.1210/me.6.4.621; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; BLUMENTHAL DK, 1982, BIOCHEMISTRY-US, V21, P2386, DOI 10.1021/bi00539a017; BOWMAN BF, 1992, J BIOL CHEM, V267, P5346; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; GALLAGHER PJ, 1993, J BIOL CHEM, V268, P26578; GAO ZH, 1992, BIOCHEMISTRY-US, V31, P6126, DOI 10.1021/bi00141a024; GEUSS U, 1985, EUR J BIOCHEM, V153, P327, DOI 10.1111/j.1432-1033.1985.tb09305.x; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HERRING BP, 1992, J BIOL CHEM, V267, P25945; HERRING BP, 1990, J BIOL CHEM, V265, P1724; HERRING BP, 1990, J BIOL CHEM, V265, P16588; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KAUER JC, 1986, J BIOL CHEM, V261, P695; KEMP BE, 1994, TRENDS BIOCHEM SCI, V19, P440, DOI 10.1016/0968-0004(94)90126-0; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KENNELLY PJ, 1991, FEBS LETT, V286, P217, DOI 10.1016/0014-5793(91)80977-B; KENNELLY PJ, 1992, BIOCHEMISTRY-US, V31, P5394, DOI 10.1021/bi00138a022; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MICHNOFF CH, 1986, J BIOL CHEM, V261, P8320; MILLER WT, 1988, P NATL ACAD SCI USA, V85, P5429, DOI 10.1073/pnas.85.15.5429; MITCHELL RD, 1995, IN PRESS BIOCHEMISTR; ONEIL KT, 1989, J BIOL CHEM, V264, P14571; STEWART JM, 1984, SOLID PHASE PEPTIDE, P63; STULL JT, 1991, HYPERTENSION, V17, P723, DOI 10.1161/01.HYP.17.6.723; STULL JT, 1986, ENZYMES, P113; SWEENEY HL, 1990, P NATL ACAD SCI USA, V87, P414, DOI 10.1073/pnas.87.1.414; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; WALSH D A, 1992, Current Opinion in Cell Biology, V4, P241, DOI 10.1016/0955-0674(92)90039-F; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; ZHI G, 1994, J BIOL CHEM, V269, P24723; ZOLLER MJ, 1987, METHOD ENZYMOL, V154, P329	40	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10125	10135		10.1074/jbc.270.17.10125	http://dx.doi.org/10.1074/jbc.270.17.10125			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730316	hybrid			2022-12-27	WOS:A1995QV41700063
J	MANDRIOTA, SJ; SEGHEZZI, G; VASSALLI, JD; FERRARA, N; WASI, S; MAZZIERI, R; MIGNATTI, P; PEPPER, MS				MANDRIOTA, SJ; SEGHEZZI, G; VASSALLI, JD; FERRARA, N; WASI, S; MAZZIERI, R; MIGNATTI, P; PEPPER, MS			VASCULAR ENDOTHELIAL GROWTH-FACTOR INCREASES UROKINASE RECEPTOR EXPRESSION IN VASCULAR ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR-BINDING SITE; PLASMINOGEN-ACTIVATOR; INHIBITOR PAI-1; U937 MONOCYTES; HUMAN-TUMOR; ANGIOGENESIS; CLONING; CHAIN; DEGRADATION; ANTIBODIES	Vascular endothelial growth factor (VEGF) is a potent angiogenic factor and endothelial cell-specific mitogen that stimulates urokinase-type plasminogen activator (uPA) activity in vascular endothelial cells. Here, we report that VEGP increases the high affinity binding of uPA to the same cells and that this binding is prevented by a peptide corresponding to the uPA receptor (uPAR) binding growth factor-like domain of uPA. Ligand crosslinking, ligand blotting, and uPA-Sepharose affinity chromatography revealed an increase in a cell surface uPA binding protein that corresponds to the uPAR on the basis of its affinity for uPA, M(r) of 50,000-55,000, and phosphatidylinositol-specific phospholipase C sensitivity. By Scatchard analysis, VEGF increased the number of uPAR molecules by 2.83.5 fold and concomitantly decreased their affinity for uPA By northern blotting uPAR mRNA was increased in a dose- and time dependent manner in response to VEGF. Taken together, these findings demonstrate that VEGF-induced angiogenesis is accompanied by increased uPAR expression and uPA activity on the endothelial cell surface. These observations are consistent with the notion that the uPA-uPAR interaction facilitates cellular invasion.	UNIV GENEVA, MED CTR, DEPT MORPHOL, CH-1211 GENEVA 4, SWITZERLAND; UNIV PAVIA, DIPARTIMENTO GENET & MICROBIOL, I-27100 PAVIA, ITALY; GENENTECH INC, DEPT CARDIOVASC RES, San Francisco, CA 94080 USA; HEART & STROKE FDN CANADA, OTTAWA, ON K1N 9M2, CANADA	University of Geneva; University of Pavia; Roche Holding; Genentech			Mazzieri, Roberta/C-9773-2015; Pepper, Michael S./M-6143-2014	Mazzieri, Roberta/0000-0002-5172-0927; Pepper, Michael S./0000-0001-6406-2380; Mignatti, Paolo/0000-0002-8157-457X				APPELLA E, 1987, J BIOL CHEM, V262, P4437; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; BACHARACH E, 1992, P NATL ACAD SCI USA, V89, P10686, DOI 10.1073/pnas.89.22.10686; BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; BUSSO N, 1986, J BIOL CHEM, V261, P9309; BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clark ER, 1932, AM J ANAT, V51, P49, DOI 10.1002/aja.1000510104; CROWLEY CW, 1993, P NATL ACAD SCI USA, V90, P5021, DOI 10.1073/pnas.90.11.5021; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; DUMLER I, 1994, FEBS LETT, V343, P103, DOI 10.1016/0014-5793(94)80298-X; ELLIS V, 1989, J BIOL CHEM, V264, P2185; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; FERRARA N, 1991, METHOD ENZYMOL, V198, P391; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; FIBBI G, 1990, EXP CELL RES, V187, P33, DOI 10.1016/0014-4827(90)90112-N; FISHER R, 1985, J BIOL CHEM, V260, P1223; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FURIE MB, 1984, J CELL BIOL, V98, P1033, DOI 10.1083/jcb.98.3.1033; GROSS JL, 1982, J CELL BIOL, V95, P974, DOI 10.1083/jcb.95.3.974; HADDOCK RC, 1991, J BIOL CHEM, V266, P21466; HOLLAS W, 1991, CANCER RES, V51, P3690; HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224; KLAGSBRUN M, 1993, CURR BIOL, V3, P699, DOI 10.1016/0960-9822(93)90073-W; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; KOBAYASHI H, 1991, J BIOL CHEM, V266, P5147; KRATZSCHMAR J, 1993, GENE, V125, P177, DOI 10.1016/0378-1119(93)90325-W; KRISTENSEN P, 1984, FEBS LETT, V168, P33, DOI 10.1016/0014-5793(84)80201-X; LARSSON LI, 1984, J CELL BIOL, V98, P894, DOI 10.1083/jcb.98.3.894; MIGNATTI P, 1991, J CELL BIOL, V113, P1193, DOI 10.1083/jcb.113.5.1193; MIGNATTI P, 1989, J CELL BIOL, V108, P671, DOI 10.1083/jcb.108.2.671; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Neufeld Gera, 1994, Progress in Growth Factor Research, V5, P89, DOI 10.1016/0955-2235(94)90019-1; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; OSSOWSKI L, 1991, CANCER RES, V51, P274; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; OSSOWSKI L, 1991, J CELL BIOL, V115, P1107, DOI 10.1083/jcb.115.4.1107; PEPPER MS, 1993, J CELL BIOL, V122, P673, DOI 10.1083/jcb.122.3.673; PEPPER MS, 1990, CELL DIFFER DEV, V32, P319, DOI 10.1016/0922-3371(90)90046-Y; PEPPER MS, 1994, EXP CELL RES, V210, P298, DOI 10.1006/excr.1994.1042; PEPPER MS, 1987, J CELL BIOL, V105, P2535, DOI 10.1083/jcb.105.6.2535; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5; PEPPER MS, 1990, J CELL BIOL, V111, P743, DOI 10.1083/jcb.111.2.743; PETERSEN LC, 1988, J BIOL CHEM, V263, P11189; PLOUG M, 1991, J BIOL CHEM, V266, P1926; PYKE C, 1991, AM J PATHOL, V138, P1059; QUAX PHA, 1991, CELL REGUL, V2, P793, DOI 10.1091/mbc.2.10.793; RABBANI SA, 1992, J BIOL CHEM, V267, P14151; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; SAKSELA O, 1987, J CELL BIOL, V105, P957, DOI 10.1083/jcb.105.2.957; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; TSAFRIRI A, 1989, ENDOCRINOLOGY, V124, P415, DOI 10.1210/endo-124-1-415; VASSALLI JD, 1984, J EXP MED, V159, P1653, DOI 10.1084/jem.159.6.1653; VASSALLI JD, 1994, FIBRINOLYSIS, V8, P172, DOI 10.1016/0268-9499(94)90715-3; VASSALLI JD, 1987, FEBS LETT, V214, P187, DOI 10.1016/0014-5793(87)80039-X; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; WALTZ DA, 1993, J CLIN INVEST, V91, P1541, DOI 10.1172/JCI116360; WEI Y, 1994, J BIOL CHEM, V269, P32380	65	235	243	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9709	9716		10.1074/jbc.270.17.9709	http://dx.doi.org/10.1074/jbc.270.17.9709			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730348	Green Published, hybrid			2022-12-27	WOS:A1995QV41700006
J	ROSIERS, CD; DIDONATO, L; COMTE, B; LAPLANTE, A; MARCOUX, C; DAVID, F; FERNANDEZ, CA; BRUNENGRABER, H				ROSIERS, CD; DIDONATO, L; COMTE, B; LAPLANTE, A; MARCOUX, C; DAVID, F; FERNANDEZ, CA; BRUNENGRABER, H			ISOTOPOMER ANALYSIS OF CITRIC-ACID CYCLE AND GLUCONEOGENESIS IN RAT-LIVER - REVERSIBILITY OF ISOCITRATE DEHYDROGENASE AND INVOLVEMENT OF ATP-CITRATE LYASE IN GLUCONEOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KREBS CYCLE; HEPATOCYTE HETEROGENEITY; HEPATIC GLUCONEOGENESIS; QUANTITATIVE-ANALYSIS; GLYCOGEN REPLETION; PERFUSED LIVERS; C-14 TRACER; METABOLISM; GLUCOSE; PYRUVATE	We conducted an extensive mass isotopomer analysis of citric acid cycle and gluconeogenic metabolites isolated from livers of overnight fasted rats perfused with 4 mM glucose, 0.2 mM octanoate, 1 mM [U-C-13(3)]lactate, and 0.2 mM [U-C-13(3)]pyruvate, in the anterograde or retrograde mode, In both perfusion modes, two distinct isotopomer patterns were observed: (i) those of phosphoenolpyruvate, glucose, malate, and aspartate and (ii) those of citrate, alpha-ketoglutarate, glutamate, and glutamine. Key citric acid cycle parameters and, hence, rates of gluconeogenesis, calculated (Lee. W.-N. P. (1989) J. Biol. Chem. 264, 13002-13004 and Lee, W.-N. P. (1993) J. Biol. Chem. 268, 25522-25526) from our mass isotopomer data did not only vary, but lead to conclusions inconsistent with Lee's citric acid cycle model, Compared to lactate and pyruvate uptake, which sets an upper limit to glucose production, rates of gluconeogenesis calculated (i) with the phosphoenolpyruvate and citrate data were similar, but those calculated (ii) with the glutamate data amounted to only 60%, which is unlikely, All these conclusions are independent of the perfusion modes, We provide evidence that the following processes contribute to the observed labeling discrepancy: (i) the reversibility of the isocitrate dehydrogenase reaction and (ii) an active citrate cleavage pathway for the transfer of the oxaloacetate carbon skeleton from mitochondria to the cytosol. Also, a good fit of our labeling data was obtained with a model of citric acid cycle and gluconeogenesis which we developed to incorporate the above reactions (Fernandez, C. A., and Des Rosiers, C. (1995) J. Biol. Chem. 270, 10037-10042), The following conclusions can be drawn from the calculated reaction rates: (i) about half of the lactate conversion to glucose occurs via the citrate cleavage pathway, (ii) the flux through the reversal of the isocitrate dehydrogenase reaction is almost as fast as that through the citrate synthase reaction, and (iii) the Bur through citrate synthase and alpha-ketoglutarate dehydrogenase is 1.6 and 3.2-fold that through pyruvate carboxylase, respectively.	UNIV MONTREAL, DEPT NUTR, MONTREAL, PQ H3C 3J7, CANADA; UNIV MONTREAL, DEPT BIOCHEM, MONTREAL, PQ H3C 3J7, CANADA; CASE WESTERN RESERVE UNIV, DEPT NUTR, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, DEPT BIOMED ENGN, CLEVELAND, OH 44106 USA	Universite de Montreal; Universite de Montreal; Case Western Reserve University; Case Western Reserve University			Rosiers, Christine Des/O-6285-2014		NIDDK NIH HHS [DK35543] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035543] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARANYAI JM, 1989, BIOCHEM J, V258, P121, DOI 10.1042/bj2580121; BARTELS H, 1987, FEBS LETT, V221, P277, DOI 10.1016/0014-5793(87)80940-7; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, V4, P1696; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, P1836; Bernt E., 1974, METHODS ENZYMATIC AN, P1704, DOI DOI 10.1016/B978-0-12-091304-6.50017-3; BEYLOT M, 1993, ANAL BIOCHEM, V212, P526, DOI 10.1006/abio.1993.1363; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; COHEN SM, 1983, J BIOL CHEM, V258, P4294; DADAMO AF, 1965, J BIOL CHEM, V240, P613; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; DESROSIERS C, 1994, P INT FEDERATION AUT, P354; DIDONATO L, 1993, J BIOL CHEM, V268, P4170; DIDONATO L, 1993, FASEB J, V7, pA866; DIDONATO L, 1992, FASEB J, V6, pA1520; DUSZYNSKI J, 1978, J BIOL CHEM, V253, P6149; ESENMO E, 1992, AM J PHYSIOL, V263, pE36, DOI 10.1152/ajpendo.1992.263.1.E36; FERNANDEZ C, 1994, P INT FEDERATION AUT, P367; FERNANDEZ CA, 1995, J BIOL CHEM, V270, P10037, DOI 10.1074/jbc.270.17.10037; GUTMANN I, 1974, METHOD ENZYMAT AN, V4, P1464; HAUSSINGER D, 1983, EUR J BIOCHEM, V133, P269, DOI 10.1111/j.1432-1033.1983.tb07458.x; HEATH DF, 1985, BIOCHEM J, V227, P851, DOI 10.1042/bj2270851; HEATH DF, 1972, BIOCHEM J, V127, P453, DOI 10.1042/bj1270453; HETENYI G, 1979, CAN J PHYSIOL PHARM, V57, P767, DOI 10.1139/y79-119; HETENYI G, 1982, FED PROC, V41, P104; HETENYI G, 1982, QUANTITATION PHYSL M, P201; JUNGERMANN K, 1992, ENZYME, V46, P33, DOI 10.1159/000468777; KALDERON B, 1986, FEBS LETT, V204, P29, DOI 10.1016/0014-5793(86)81381-3; KATZ J, 1993, J BIOL CHEM, V268, P25509; Katz J, 1976, Curr Top Cell Regul, V10, P237; KATZ J, 1985, AM J PHYSIOL, V248, pR391, DOI 10.1152/ajpregu.1985.248.4.R391; KATZ J, 1989, J BIOL CHEM, V264, P12994; KELLEHER JK, 1985, AM J PHYSIOL, V248, pE252, DOI 10.1152/ajpendo.1985.248.2.E252; KELLEHER JK, 1986, AM J PHYSIOL, V250, pE296, DOI 10.1152/ajpendo.1986.250.3.E296; KORNACKER MS, 1965, BIOCHEM J, V94, P209, DOI 10.1042/bj0940209; KREBS HA, 1966, BIOCHEM J, V101, P242, DOI 10.1042/bj1010242; LANDAU BR, 1993, AM J PHYSIOL, V265, pE636, DOI 10.1152/ajpendo.1993.265.4.E636; LEE WNP, 1991, BIOCHEM MED METAB B, V45, P298, DOI 10.1016/0885-4505(91)90034-I; LEE WNP, 1993, J BIOL CHEM, V268, P25522; Lund P., 1974, METHODS ENZYMATIC AN, V4, P1719; MAGNUSSON I, 1991, J BIOL CHEM, V266, P6975; MULLHOFER G, 1977, EUR J BIOCHEM, V75, P331, DOI 10.1111/j.1432-1033.1977.tb11533.x; MULLHOFER G, 1977, EUR J BIOCHEM, V75, P319, DOI 10.1111/j.1432-1033.1977.tb11532.x; MULLHOFER G, 1972, H-S Z PHYSIOL CHEM, V353, P1461, DOI 10.1515/bchm2.1972.353.2.1461; ROGNSTAD R, 1977, J BIOL CHEM, V252, P1831; ROGNSTAD R, 1988, Medical Science Research, V16, P293; ROGNSTAD R, 1993, BIOCHEM ARCH, V9, P15; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; ROSIERS CD, 1991, J BIOL CHEM, V266, P1574; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; SCHUMANN WC, 1991, J BIOL CHEM, V266, P6985; SHULMAN GI, 1987, J CLIN INVEST, V80, P387, DOI 10.1172/JCI113084; SOKELL S, 1976, USE ISOLATED LINEAR, P29; SRERE PA, 1993, BIOL CHEM H-S, V374, P833; SRERE PA, 1967, BIOCHEM BIOPH RES CO, V26, P556, DOI 10.1016/0006-291X(67)90101-5; STERNICZUK A, 1991, EUR J BIOCHEM, V196, P151, DOI 10.1111/j.1432-1033.1991.tb15798.x; STRISOWER EH, 1952, J BIOL CHEM, V198, P115; Takeda Y., 1969, METHOD ENZYMOL, V13, P153, DOI [DOI 10.1016/0076-6879(69)13032-3, 10.1016/0076-6879(69)13032-3]; TISSOT S, 1990, DIABETOLOGIA, V33, P449, DOI 10.1007/BF00405104; TSERNG KY, 1983, AM J PHYSIOL, V245, pE476, DOI 10.1152/ajpendo.1983.245.5.E476; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4617	61	100	100	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10027	10036		10.1074/jbc.270.17.10027	http://dx.doi.org/10.1074/jbc.270.17.10027			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730304	hybrid			2022-12-27	WOS:A1995QV41700049
J	MATSUMOTO, K; OKUWAKI, M; KAWASE, H; HANDA, H; HANAOKA, F; NAGATA, K				MATSUMOTO, K; OKUWAKI, M; KAWASE, H; HANDA, H; HANAOKA, F; NAGATA, K			STIMULATION OF DNA-TRANSCRIPTION BY THE REPLICATION FACTOR FROM THE ADENOVIRUS GENOME IN A CHROMATIN-LIKE STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-ORIENTED TRANSCRIPTION; MAJOR LATE PROMOTER; RNA POLYMERASE-II; CORE PROTEIN; VIRAL-DNA; INVITRO; INITIATION; BINDING; ACTIVATION; INFECTION	Adenovirus (Ad) genome DNA is complexed with viral core proteins in the virus particle and in host cells during the early stages of infection. This DNA protein complex, called Ad core, is thought to be the template for transcription and DNA replication in infected cells. The Ad core functioned as template for DNA replication in the cell-free system consisting of viral replication proteins, uninfected HeLa nuclear extracts, and a novel factor, template activating factor-I (TAF-I) that we have isolated from uninfected HeLa cytoplasmic fractions. The Ad core did not function as an efficient template in the cell-free transcription system with nuclear extracts of uninfected HeLa cells. The addition of TAF-I resulted in the stimulation of transcription from E1A and ML promoters on the Ad core, TAF-I was required, at least, for the formation of preinitiation complexes. These observations suggest that, in addition to factors essential for transcription on naked DNA template, the factor such as TAF-I needed for replication of the Ad core is also required for transcription from the Ad genome in a chromatin-like structure.	TOKYO INST TECHNOL,FAC BIOSCI & BIOTECHNOL,DEPT BIOMOLEC ENGN,YOKOHAMA,KANAGAWA 227,JAPAN; MITSUBISHI KASEI INST LIFE SCI,MACHIDA,TOKYO 194,JAPAN; INST PHYS & CHEM RES,CELLULAR PHYSIOL LAB,SAITAMA 35101,JAPAN	Tokyo Institute of Technology; RIKEN			Matsumoto, Ken/F-9083-2013; Okuwaki, Mitsuru/R-3038-2019	Matsumoto, Ken/0000-0002-7864-3394; Okuwaki, Mitsuru/0000-0003-2118-442X				ADAMS CC, 1993, CELL, V72, P305, DOI 10.1016/0092-8674(93)90109-4; BROWN DT, 1975, J VIROL, V16, P366, DOI 10.1128/JVI.16.2.366-387.1975; BURATOWSKI S, 1993, SCIENCE, V260, P37, DOI 10.1126/science.8465198; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; CONTRERAS R, 1982, NATURE, V300, P500, DOI 10.1038/300500a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GODING CR, 1983, EMBO J, V2, P339, DOI 10.1002/j.1460-2075.1983.tb01428.x; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; JANSENDURR P, 1989, J VIROL, V63, P5124, DOI 10.1128/JVI.63.12.5124-5132.1989; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KAPLAN LM, 1979, P NATL ACAD SCI USA, V76, P5534, DOI 10.1073/pnas.76.11.5534; KOIKEDA S, 1990, BIOCHIM BIOPHYS ACTA, V1048, P85, DOI 10.1016/0167-4781(90)90026-X; KORN R, 1986, VIROLOGY, V150, P342, DOI 10.1016/0042-6822(86)90299-0; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LEITH IR, 1989, J GEN VIROL, V70, P3235, DOI 10.1099/0022-1317-70-12-3235; MATSUMOTO K, 1989, BIOCHEM BIOPH RES CO, V164, P1212, DOI 10.1016/0006-291X(89)91798-1; MATSUMOTO K, 1993, J BIOL CHEM, V268, P10582; MATSUMOTO K, 1991, FEBS LETT, V280, P53, DOI 10.1016/0014-5793(91)80202-E; MAVROMARANAZOS P, 1987, VIROLOGY, V161, P593, DOI 10.1016/0042-6822(87)90156-5; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; NAKANISHI Y, 1986, BIOCHEM BIOPH RES CO, V136, P86, DOI 10.1016/0006-291X(86)90880-6; RUSSELL WC, 1971, J GEN VIROL, V11, P35, DOI 10.1099/0022-1317-11-1-35; Sambrook J, 1989, MOL CLONING LABORATO; SCHMID A, 1992, CELL, V71, P853, DOI 10.1016/0092-8674(92)90560-Y; TAMANOI F, 1982, P NATL ACAD SCI-BIOL, V79, P2221, DOI 10.1073/pnas.79.7.2221; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; THOMAS GP, 1980, CELL, V22, P523; TOTH M, 1992, NUCLEIC ACIDS RES, V20, P5143, DOI 10.1093/nar/20.19.5143; WEIL PA, 1979, CELL, V18, P469; WOLFFE AP, 1991, J CELL SCI, V99, P201; WORKMAN JL, 1988, CELL, V55, P211, DOI 10.1016/0092-8674(88)90044-X; WORKMAN JL, 1990, EMBO J, V9, P1299, DOI 10.1002/j.1460-2075.1990.tb08239.x	32	55	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9645	9650		10.1074/jbc.270.16.9645	http://dx.doi.org/10.1074/jbc.270.16.9645			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721897	hybrid			2022-12-27	WOS:A1995QU08900086
J	LAGROST, L; DENGREMONT, C; ATHIAS, A; DEGEITERE, C; FRUCHART, JC; LALLEMANT, C; GAMBERT, P; CASTRO, G				LAGROST, L; DENGREMONT, C; ATHIAS, A; DEGEITERE, C; FRUCHART, JC; LALLEMANT, C; GAMBERT, P; CASTRO, G			MODULATION OF CHOLESTEROL EFFLUX FROM FU5AH HEPATOMA-CELLS BY THE APOLIPOPROTEIN CONTENT OF HIGH-DENSITY-LIPOPROTEIN PARTICLES - PARTICLES CONTAINING VARIOUS PROPORTIONS OF APOLIPOPROTEINS A-I AND A-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; CELLULAR LIPID EFFLUX; HUMAN-PLASMA; ADIPOSE-CELLS; HUMAN-FIBROBLASTS; LPA-I; MONOCLONAL-ANTIBODIES; BINDING DOMAIN; HEPG2 CELLS; RAT-LIVER	The influence of apolipoproteins (ape) A-I and A-II on the ability of high density lipoproteins (HDL) to remove cholesterol from cultured Fu5AH rat hepatoma cells was studied independently on alterations in the overall structure and lipid composition of the lipoprotein particles. To this end, apoA-I was progressively replaced by apoA-II in ultracentrifugally isolated HDL(3) without inducing changes in other remaining Lipoprotein components. As apoA-II was progressively substituted for apoA-I in HDL(3) (A-II:A-I+A-II percentage mass: 29.5, 47.6, 71.5, 97.4, and 98.9%), the rate of cholesterol efflux from Fu5AH hepatoma gradually and significantly decreased after 2 or 4 h of incubation at 37 degrees C (cholesterol efflux: 30.4 +/- 0.8, 24.1 +/- 1.0, 19.8 +/- 1.2, 15.7 +/- 1.4, and 13.4 +/- 1.3%/2 h, respectively; 38.4 +/- 1.5, 29.2 +/- 0.9, 27.0 +/- 0.2, 20.4 +/- 0.4, and 17.5 +/- 1.0%/4 h, respectively) (p < 0.01 with all A-II-enriched HDL(3) fractions as compared with non-enriched homologues). In agreement with data obtained with total HDL(3), increasing the A-II:A-I+A-II percentage mass in HDL(3) particles containing initially only apoA-I (HDL(3)-A-I) progressively reduced cellular cholesterol efflux. After 2 h of incubation, cholesterol efflux correlated negatively with A-II:A-I+A-II percentage mass (r = -0.86; p < 0.0001; n = 20), but not with either free cholesterol:phospholipid ratio, A-I+A-II:total lipid ratio or mean size of HDL(3). As determined by using Spearman rank correlation analysis, the A-II:A-I+A-II% mass ratio correlated negatively with the apparent maximal efflux (V-max(efflux)) (rho = -0.68; p < 0.05, n = 10), but not with the HDL(3) concentration required to obtain 50% of maximal efflux (K-m(efflux)) (rho = -0.08; not significant, n = 10). It was concluded that the apoA-I and apoA-II content of HDL(3) is one determinant of its ability to promote cholesterol efflux from Fu5AH rat hepatoma cells.	FAC MED DIJON,INSERM,BIOCHIM LIPOPROT LAB,CJF 9310,F-21033 DIJON,FRANCE; INST PASTEUR,INSERM,SERV ETUDE RECH LIPOPROT & ATHEROSCLEROSE,U325,F-59019 LILLE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille								AGNANI G, 1993, BIOCHEMISTRY-US, V32, P2643, DOI 10.1021/bi00061a024; ALLAN CM, 1993, BIOCHEM J, V290, P449, DOI 10.1042/bj2900449; ALLAN CM, 1992, J BIOL CHEM, V267, P13257; BARBARAS R, 1986, BIOCHIM BIOPHYS ACTA, V888, P143, DOI 10.1016/0167-4889(86)90015-7; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V142, P63, DOI 10.1016/0006-291X(87)90451-7; BARKIA A, 1991, ATHEROSCLEROSIS, V87, P135, DOI 10.1016/0021-9150(91)90016-V; BEKAERT ED, 1991, J LIPID RES, V32, P1587; BEKAERT ED, 1992, BIOCHIM BIOPHYS ACTA, V1126, P105, DOI 10.1016/0005-2760(92)90223-I; BIESBROECK R, 1983, J CLIN INVEST, V71, P525, DOI 10.1172/JCI110797; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V1085, P209; BRINTON EA, 1987, BIOCHIM BIOPHYS ACTA, V920, P68, DOI 10.1016/0005-2760(87)90312-2; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CASTRO GR, 1994, CIRCULATION, V90, P240; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; CHEUNG MC, 1993, J CLIN INVEST, V91, P522, DOI 10.1172/JCI116231; CHUNG J, 1979, J BIOL CHEM, V254, P7456; COLLET X, 1991, J BIOL CHEM, V266, P9145; CURTISS LK, 1985, J BIOL CHEM, V260, P2982; DAVIDSON WS, 1994, J BIOL CHEM, V269, P8959; DELAMATRE J, 1986, BIOCHIM BIOPHYS ACTA, V875, P419, DOI 10.1016/0005-2760(86)90061-5; DUVERGER N, 1993, BIOCHEMISTRY-US, V32, P12372, DOI 10.1021/bi00097a014; FIDGE NH, 1985, J BIOL CHEM, V260, P3570; FIELDING C J, 1981, Proceedings of the National Academy of Sciences of the United States of America, V78, P3911, DOI 10.1073/pnas.78.6.3911; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; FIELDING PE, 1994, BIOCHEMISTRY-US, V33, P6981, DOI 10.1021/bi00188a030; FRUCHART JC, 1992, CLIN CHEM, V38, P793; HARA H, 1992, LIPIDS, V27, P302, DOI 10.1007/BF02536480; HARA H, 1991, J BIOL CHEM, V266, P3080; JACKSON RL, 1975, J BIOL CHEM, V250, P7204; JAMES RW, 1988, J LIPID RES, V29, P1557; JOHNSON WJ, 1986, J BIOL CHEM, V261, P5766; JOHNSON WJ, 1988, J BIOL CHEM, V263, P14099; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JOHNSON WJ, 1993, J LIPID RES, V32, P1993; JONAS A, 1994, J LIPID RES, V35, P860; KILSDONK EPC, 1990, BIOCHIM BIOPHYS ACTA, V1045, P205, DOI 10.1016/0005-2760(90)90121-D; LAGOCKI PA, 1980, J BIOL CHEM, V255, P3701; LAGROST L, 1994, J BIOL CHEM, V269, P3189; LEBLOND L, 1991, J BIOL CHEM, V266, P6058; LETIZIA JY, 1991, BIOCHEMISTRY-US, V30, P866, DOI 10.1021/bi00217a041; LI QQ, 1993, BIOCHEMISTRY-US, V32, P4597, DOI 10.1021/bi00068a016; LUCHOOMUN J, 1994, BBA-LIPID LIPID MET, V1212, P319, DOI 10.1016/0005-2760(94)90206-2; MAHLBERG FH, 1991, J BIOL CHEM, V266, P19930; MAHLBERG FH, 1992, J BIOL CHEM, V267, P4541; MARZ W, 1988, BIOCHIM BIOPHYS ACTA, V962, P155, DOI 10.1016/0005-2760(88)90107-5; MILLER GJ, 1975, LANCET, V1, P16; MORRISON JR, 1992, J BIOL CHEM, V267, P13205; MOYA MD, 1994, ARTERIOSCLER THROMB, V14, P1056; NAKAMURA R, 1993, ARTERIOSCLER THROMB, V13, P1307, DOI 10.1161/01.ATV.13.9.1307; OHTA T, 1992, BIOCHIM BIOPHYS ACTA, V1165, P119, DOI 10.1016/0005-2760(92)90083-8; OIKAWA S, 1993, BIOCHIM BIOPHYS ACTA, V1165, P327, DOI 10.1016/0005-2760(93)90144-X; ORAM JF, 1983, ARTERIOSCLEROSIS, V3, P420, DOI 10.1161/01.ATV.3.5.420; ORAM JF, 1981, J BIOL CHEM, V256, P8348; PHILLIPS MC, 1980, ATHEROSCLEROSIS, V36, P409, DOI 10.1016/0021-9150(80)90220-8; PIETERS MN, 1993, BIOCHEM J, V292, P819, DOI 10.1042/bj2920819; RADER DJ, 1991, J LIPID RES, V32, P1849; RIFAI N, 1986, CLIN CHEM, V32, P957; ROSSENEU M, 1981, EUR J BIOCHEM, V117, P347, DOI 10.1111/j.1432-1033.1981.tb06344.x; ROTHBLAT GH, 1982, J BIOL CHEM, V257, P4775; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; SCHULTZ JR, 1993, NATURE, V365, P762, DOI 10.1038/365762a0; SEGREST JP, 1992, J LIPID RES, V33, P141; SOLA R, 1993, ARTERIOSCLER THROMB, V13, P958, DOI 10.1161/01.ATV.13.7.958; STEINMETZ A, 1990, J BIOL CHEM, V265, P7859; VADIVELOO PK, 1990, BIOCHIM BIOPHYS ACTA, V1045, P135, DOI 10.1016/0005-2760(90)90142-K; VADIVELOO PK, 1992, BIOCHEM J, V284, P145, DOI 10.1042/bj2840145; VANTORNOUT P, 1983, BIOCHIM BIOPHYS ACTA, V751, P175; VONECKARDSTEIN A, 1993, J BIOL CHEM, V268, P2616; VONHODENBERG E, 1991, BIOCHIM BIOPHYS ACTA, V1086, P173, DOI 10.1016/0005-2760(91)90005-3	69	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13004	13009		10.1074/jbc.270.22.13004	http://dx.doi.org/10.1074/jbc.270.22.13004			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768892	hybrid			2022-12-27	WOS:A1995RB43900013
J	DENNIG, J; HAGEN, G; BEATO, M; SUSKE, G				DENNIG, J; HAGEN, G; BEATO, M; SUSKE, G			MEMBERS OF THE SP TRANSCRIPTION FACTOR FAMILY CONTROL TRANSCRIPTION FROM THE UTEROGLOBIN PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT ACTIVATION DOMAINS; BETA-GLOBIN PROMOTER; BOX-BINDING-PROTEINS; GLUCOCORTICOID RECEPTOR; GEL-ELECTROPHORESIS; MAMMALIAN-CELLS; SV40 ENHANCER; CC10 GENE; EXPRESSION; ELEMENTS	Previous analyses of the uteroglobin promoter revealed seven distinct regions, which contribute to its overall activity in epithelial cells from endometrium and lung, Most significantly, a mutation of the promoter sequence around 65 base pairs upstream of the transcriptional start site severely impairs promoter activity. The transcription factor acting through this sequence has not been identified yet, Here, we report that members of the Sp transcription factor family specifically recognize this non-classical GC box, in addition to another functional motif located 230 base pairs upstream of the transcriptional start site. We have characterized in detail the interaction of recombinant Sp3 with both motifs by DNase I footprinting and methylation protection using the wild-type uteroglobin promoter and various linker scanning mutants as templates, Electrophoretic mobility shift analyses show that Sp1 and Sp3 both bind with similar affinity to these elements, We demonstrate that the DNA-binding proteins in the endometrial cell line Ishikawa which recognize these motifs are also Sp1 and Sp3. Gene transfer experiments into Drosophila Schneider cells that do not contain endogenous Sp factors revealed that both DNA motifs respond to transiently expressed Sp1 and Sp3. Our results show thus that the level of transcription from the uteroglobin promoter is controlled by members of the Sp transcription factor family through unusual Sp binding sites.			DENNIG, J (corresponding author), UNIV MARBURG,INST MOLEK BIOL & TUMORFORSCH,EMIL MANNKOPFF STR 2,D-35037 MARBURG,GERMANY.		Beato, Miguel/B-5564-2015	Beato, Miguel/0000-0002-2878-2222; Suske, Guntram/0000-0002-4807-0513				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BEATO M, 1983, REGULATION GENE EXPR, P151; BECKER PB, 1986, NATURE, V324, P686, DOI 10.1038/324686a0; CATO ACB, 1986, EMBO J, V5, P2237, DOI 10.1002/j.1460-2075.1986.tb04490.x; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DANESCH U, 1987, EMBO J, V6, P625, DOI 10.1002/j.1460-2075.1987.tb04800.x; DEBOER E, 1988, EMBO J, V7, P4203, DOI 10.1002/j.1460-2075.1988.tb03317.x; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1986, TRENDS BIOCHEM SCI, V11, P395, DOI 10.1016/0968-0004(86)90149-0; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; JANTZEN K, 1987, NUCLEIC ACIDS RES, V15, P4535, DOI 10.1093/nar/15.11.4535; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KLUG J, 1994, MOL CELL BIOL, V14, P6208, DOI 10.1128/MCB.14.9.6208; Maniatis T, 1989, DECONTAMINATION DILU; Maxam A M, 1980, Methods Enzymol, V65, P499; MISSEYANNI A, 1991, NUCLEIC ACIDS RES, V19, P2849, DOI 10.1093/nar/19.11.2849; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PHILIPSEN S, 1990, EMBO J, V9, P2159, DOI 10.1002/j.1460-2075.1990.tb07385.x; PITLUK ZW, 1991, J VIROL, V65, P6661, DOI 10.1128/JVI.65.12.6661-6670.1991; SAFFER JD, 1990, GENE DEV, V4, P659, DOI 10.1101/gad.4.4.659; SANDMOLLER A, 1991, MECH DEVELOP, V34, P57, DOI 10.1016/0925-4773(91)90091-J; SAWAYA PL, 1993, MOL CELL BIOL, V13, P3860, DOI 10.1128/MCB.13.7.3860; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SCHULE R, 1988, NATURE, V332, P87, DOI 10.1038/332087a0; SEIPEL K, 1992, EMBO J, V11, P4961, DOI 10.1002/j.1460-2075.1992.tb05603.x; SLATER EP, 1990, MOL ENDOCRINOL, V4, P604, DOI 10.1210/mend-4-4-604; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; STRIPP BR, 1992, J BIOL CHEM, V267, P14703; Suske Guntram, 1992, Gene Expression, V2, P339; THIESEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3203, DOI 10.1093/nar/18.11.3203; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; XIAO JH, 1987, GENE DEV, V1, P794, DOI 10.1101/gad.1.8.794; ZENKE M, 1986, EMBO J, V5, P387, DOI 10.1002/j.1460-2075.1986.tb04224.x	43	107	108	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12737	12744		10.1074/jbc.270.21.12737	http://dx.doi.org/10.1074/jbc.270.21.12737			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759528	hybrid			2022-12-27	WOS:A1995QZ71100064
J	LIU, WC; YOON, J; BURG, M; CHEN, L; PAK, WL				LIU, WC; YOON, J; BURG, M; CHEN, L; PAK, WL			MOLECULAR CHARACTERIZATION OF 2 DROSOPHILA GUANYLATE CYCLASES EXPRESSED IN THE NERVOUS-SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC PEPTIDE RECEPTOR; LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; PHOSPHOLIPASE-C GENE; NITRIC-OXIDE; CYCLIC-GMP; ACTIVITY REQUIRES; ENZYME SUBUNITS; CARBON-MONOXIDE; MEMBRANE FORM	We have isolated, by interspecies hybridization, two classes of Drosophila cDNA each encoding a different guanylate cyclase (GC). One of them encodes an alpha subunit homolog of soluble GC, designated DGC alpha 1, and the other encodes a receptor-type GC, designated DrGC. The dgc alpha 1 cDNA encodes a protein of 676 amino acids and maps to 99B. In situ hybridization to adult tissue sections showed that dgc alpha 1 mRNA is found mainly in the cell bodies of the optic lobe, central brain, and thoracic ganglia. The DGC alpha 1 protein was also localized primarily to the nervous system by immunocytochemical staining, consistent with results of in situ hybridization. However, no detectable expression of this protein was found in the retina. The other class of cDNA, drgc, maps to 76C and encodes a 1525-amino acid protein displaying structural features similar to other known receptor-type guanylate cyclases. However, it has a C-terminal 430 amino acid region that has no homology 60 any known proteins. drgc RNA is expressed at low levels throughout development and in adult heads and bodies. In situ hybridizations to adult tissue sections showed that drgc mRNA is expressed in a wide range of tissues, including the optic lobe, central brain, thoracic ganglia, digestive tract, and the oocyte.	PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907; KYUNG HEE UNIV,DEPT GENET ENGN,KYONGGI DO,SOUTH KOREA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kyung Hee University					NATIONAL EYE INSTITUTE [R37EY000033, R56EY000033, R01EY000033] Funding Source: NIH RePORTER; NEI NIH HHS [EY00033] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANGERER LM, 1987, IN SITU HYBRIDIZATIO, P42; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; BACIGALUPO J, 1991, P NATL ACAD SCI USA, V88, P7938, DOI 10.1073/pnas.88.18.7938; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; BUECHLER WA, 1991, BIOCHEM BIOPH RES CO, V174, P351, DOI 10.1016/0006-291X(91)90527-E; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CORNWELL TL, 1989, J BIOL CHEM, V264, P1146; CRAVEN PA, 1978, J BIOL CHEM, V253, P8433; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; DESAUVAGE FJ, 1992, P NATL ACAD SCI USA, V89, P9089, DOI 10.1073/pnas.89.19.9089; DEVEREUX J, 1992, GCG SEQUENCE ANAL SO; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; ENGELS WR, 1986, FOCUS, V8, P6; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FESENKO EE, 1985, NATURE, V313, P311; Gall JG, 1971, METHOD ENZYMOL, V21, P470; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GIGLIOTTI S, 1993, DEV BIOL, V159, P450, DOI 10.1006/dbio.1993.1255; GOY MF, 1991, TRENDS NEUROSCI, V14, P293, DOI 10.1016/0166-2236(91)90140-P; GUAN KL, 1988, ANAL BIOCHEM, V192, P262; HAFEN E, 1986, DROSOPHILA PRACTICAL, P139; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARTENECK C, 1990, FEBS LETT, V272, P221, DOI 10.1016/0014-5793(90)80489-6; HUMBERT P, 1990, EUR J BIOCHEM, V190, P273, DOI 10.1111/j.1432-1033.1990.tb15572.x; ITOH N, 1985, DROS INF SERVICE, V61, P89; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; KOESLING D, 1991, FASEB J, V5, P2785, DOI 10.1096/fasebj.5.13.1680765; KOESLING D, 1990, FEBS LETT, V266, P128, DOI 10.1016/0014-5793(90)81523-Q; KOESLING D, 1988, FEBS LETT, V239, P29, DOI 10.1016/0014-5793(88)80539-8; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; MAHMOUDI M, 1989, BIOTECHNIQUES, V7, P331; MCNEIL L, 1995, J BIOL CHEM, V270, P7189, DOI 10.1074/jbc.270.13.7189; MILLER K, 1987, BRL FOCUS, V9, P14; MINKE B, 1991, PROG RETIN RES, V11, P99, DOI 10.1016/0278-4327(91)90026-X; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; NAKANE M, 1990, J BIOL CHEM, V265, P16841; NAKANE M, 1988, BIOCHEM BIOPH RES CO, V156, P1000; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PALMER RMJ, 1987, NATURE, V333, P664; PAUPARDINTRITSC.D, 1986, NATURE, V323, P812; PAUPARDINTRITSC.D, 1986, J NEUROSCI, V6, P2715; PAYNE R, 1986, PHOTOBIOCH PHOTOBIOP, V13, P373; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REGULSKI M, 1993, ABSTRACT NEUROBIOLOG, P126; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULZ S, 1992, J BIOL CHEM, V267, P16019; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHORTRIDGE RD, 1991, J BIOL CHEM, V266, P12474; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; THORPE DS, 1989, J BIOL CHEM, V264, P6545; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VINCENT SR, 1992, TRENDS NEUROSCI, V15, P108, DOI 10.1016/0166-2236(92)90021-Y; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WILCOX JN, 1991, MOL CELL BIOL, V11, P3454, DOI 10.1128/MCB.11.7.3454; YOON JS, 1989, J BIOL CHEM, V264, P18536; YOSHIKAWA S, 1993, J NEUROCHEM, V60, P1570, DOI 10.1111/j.1471-4159.1993.tb03324.x; YUEN PST, 1992, ANNU REV NEUROSCI, V15, P193; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	76	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12418	12427		10.1074/jbc.270.21.12418	http://dx.doi.org/10.1074/jbc.270.21.12418			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759483	hybrid			2022-12-27	WOS:A1995QZ71100016
J	MARSHALL, NF; PRICE, DH				MARSHALL, NF; PRICE, DH			PURIFICATION OF P-TEFB, A TRANSCRIPTION FACTOR REQUIRED FOR THE TRANSITION INTO PRODUCTIVE ELONGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RNA POLYMERASE-II; ADENOSINE-DEAMINASE GENE; C-FOS GENE; MESSENGER-RNA; SEQUENCE REQUIREMENTS; MAMMALIAN-CELLS; FACTOR-SIII; HELA-CELLS; 5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE; TERMINATION	Production of full-length runoff transcripts in vitro and functional mRNA in vivo is sensitive to the drug 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB). We previously proposed the existence of an activity, P-TEF (positive transcription elongation factor) that functions in a DRB-sensitive manner to allow RNA polymerase II elongation complexes to efficiently synthesize long transcripts (Marshall, N. F. and Price, D. H. (1992) Mol. Cell. Biol. 12, 2078-2090). We have fractionated nuclear extracts of Drosophila melanogaster K-c cells and identified three activities, P-TEFa, factor 2, and P-TEFb, that are directly involved in reconstructing DRB-sensitive transcription. P-TEFb is essential for the production of DRB-sensitive long transcripts in vitro, while P-TEFa and factor 2 are stimulatory. P-TEFb activity is associated with a protein comprising two polypeptide subunits with apparent molecular masses of 124 and 43 kDa. Using a P-TEFb-dependent transcription system, we show that P-TEFb acts after initiation and is the limiting factor in the production of long run-off transcripts.	UNIV IOWA,DEPT BIOCHEM,IOWA CITY,IA 52242	University of Iowa			Price, David H/F-6173-2010	Price, David/0000-0002-5597-385X	NIGMS NIH HHS [R01-GM35500] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; CHEN Z, 1991, MOL CELL BIOL, V11, P6248, DOI 10.1128/MCB.11.12.6248; CHINSKY JM, 1989, J BIOL CHEM, V264, P14561; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; FLORES O, 1992, J BIOL CHEM, V267, P2786; FRASER NW, 1979, P NATL ACAD SCI USA, V76, P2571, DOI 10.1073/pnas.76.6.2571; KEPHART DD, 1992, MOL CELL BIOL, V12, P2067, DOI 10.1128/MCB.12.5.2067; KERPPOLA TK, 1991, FASEB J, V5, P2833, DOI 10.1096/fasebj.5.13.1916107; KESSLER M, 1989, J BIOL CHEM, V264, P9785; KESSLER M, 1991, J BIOL CHEM, V266, P13019; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; LAUB O, 1980, P NATL ACAD SCI-BIOL, V77, P3297, DOI 10.1073/pnas.77.6.3297; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; MEULIA T, 1993, MOL CELL BIOL, V13, P5647, DOI 10.1128/MCB.13.9.5647; PRICE DH, 1987, J BIOL CHEM, V262, P3244; RESNEKOV O, 1989, P NATL ACAD SCI USA, V86, P12, DOI 10.1073/pnas.86.1.12; ROBERTS S, 1992, EMBO J, V11, P1085, DOI 10.1002/j.1460-2075.1992.tb05147.x; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; SCHNEIDERSCHAUL.J, 1987, EUR J IMMUNOL, V17, P713; SEHGAL PB, 1976, CELL, V9, P473, DOI 10.1016/0092-8674(76)90092-1; SPENCER CA, 1990, ONCOGENE, V5, P777; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; TAMM I, 1980, BIOCHEMISTRY-US, V19, P2743, DOI 10.1021/bi00553a032; TAMM I, 1979, P NATL ACAD SCI USA, V76, P5750, DOI 10.1073/pnas.76.11.5750; YUE X, 1993, MOL CELL BIOL, V13, P3191, DOI 10.1128/MCB.13.6.3191; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x	31	417	430	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12335	12338		10.1074/jbc.270.21.12335	http://dx.doi.org/10.1074/jbc.270.21.12335			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759473	hybrid			2022-12-27	WOS:A1995QZ71100003
J	ROWLEY, RB; BOLEN, JB; FARGNOLI, J				ROWLEY, RB; BOLEN, JB; FARGNOLI, J			MOLECULAR-CLONING OF RODENT P72(SYK) - EVIDENCE OF ALTERNATIVE MESSENGER-RNA SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOPHILIC LEUKEMIA-CELLS; PROTEIN-TYROSINE KINASE; HIGH-AFFINITY RECEPTOR; IMMUNOGLOBULIN-E; IGE RECEPTOR; SIGNAL TRANSDUCTION; HISTAMINE-RELEASE; CROSS-LINKING; BETA-SUBUNIT; PHOSPHORYLATION	Northern blot analysis of polyadenylated RNA prepared from RBL-2H3 cells revealed the presence of three distinct mRNAs encoding p72(Syk), a protein-tyrosine kinase previously shown to be associated with the high affinity IgE receptor present on the surface of these cells (Hutchcroft, J. E., Geahlen, R. L., Deanin, G. G., and Oliver, J. M. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 9107-9111), Here we report the full-length nucleotide sequence of two of these messages, as well as the complete predicted amino acid sequence of the rodent p72(Syk) protein-tyrosine kinase. In addition, we report evidence indicating alternative splicing of p72(Syk) mRNAs within RBL-2H3 cells. This splicing event results in the expression of two distinct protein isoforms that differ with respect to the presence of a 23-amino acid insert located within the region of the protein that separates the two SH2 domains from the catalytic domain. Both mRNAs arising from this splicing event appear to encode functional protein-tyrosine kinases, as expression of the corresponding cDNAs in COS cells results in the production of proteins of the expected sizes that possess intrinsic tyrosine specific kinase activity.			ROWLEY, RB (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC BIOL,POB 4000,H4114,PRINCETON,NJ 08543, USA.							ALBER G, 1991, J BIOL CHEM, V266, P22613; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CONNELLY PA, 1991, BIOCHEM BIOPH RES CO, V177, P192, DOI 10.1016/0006-291X(91)91967-H; COOKE M P, 1989, New Biologist, V1, P66; EISEMAN E, 1992, NATURE, V355, P78; HUTCHCROFT JE, 1992, P NATL ACAD SCI USA, V89, P9107, DOI 10.1073/pnas.89.19.9107; KAWAKAMI T, 1992, J IMMUNOL, V148, P3513; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; KUSTER H, 1990, J BIOL CHEM, V265, P6448; LAW CL, 1994, J BIOL CHEM, V269, P12310; LEVY JB, 1987, MOL CELL BIOL, V7, P4142, DOI 10.1128/MCB.7.11.4142; LI W, 1992, MOL CELL BIOL, V12, P3176, DOI 10.1128/MCB.12.7.3176; Maniatis T., 1984, MOL CLONING; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; PYPER JM, 1990, MOL CELL BIOL, V10, P2035, DOI 10.1128/MCB.10.5.2035; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMIZU A, 1988, P NATL ACAD SCI USA, V85, P1907, DOI 10.1073/pnas.85.6.1907; STANLEY E, 1991, MOL CELL BIOL, V11, P3399, DOI 10.1128/MCB.11.7.3399; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; YAGI S, 1994, BIOCHEM BIOPH RES CO, V200, P28, DOI 10.1006/bbrc.1994.1409; YI TL, 1991, MOL CELL BIOL, V11, P2391, DOI 10.1128/MCB.11.5.2391; YU KT, 1991, J BIOL CHEM, V266, P22564	29	32	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12659	12664		10.1074/jbc.270.21.12659	http://dx.doi.org/10.1074/jbc.270.21.12659			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759516	hybrid			2022-12-27	WOS:A1995QZ71100052
J	ZHAO, H; BANERJEE, AK				ZHAO, H; BANERJEE, AK			INTERACTION BETWEEN THE NUCLEOCAPSID PROTEIN AND THE PHOSPHOPROTEIN OF HUMAN PARAINFLUENZA VIRUS-3 - MAPPING OF THE INTERACTING DOMAINS USING A 2-HYBRID SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; REGULATES TRANSCRIPTION INVITRO; PARA-INFLUENZA VIRUS-3; P-PROTEIN; SEPARATE DOMAINS; GENE-EXPRESSION; VIRAL-PROTEINS; MESSENGER-RNA; ACIDIC DOMAIN; GENOME RNA	A two-hybrid system was used to study interaction in vivo between the nucleocapsid protein (NP) and the phosphoprotein (P) of human parainfluenza virus type 3 (HPIV-3). Two plasmids, one containing the amino terminus of P fused to the DNA-binding domain of the yeast transactivator, GAL4, and the other containing the amino terminus of NP fused to the herpesvirus transactivator, VP16, were transfected in COS-1 cells along with a chloramphenicol acetyltransferase (CAT) reporter plasmid containing GAL4 DNA-binding sites. A specific and high-affinity interaction between NP and P was observed as measured by the activation of the CAT gene. Mapping of the domains in P (603 amino acids) involved in the association with NP revealed that NH2-terminal 40 and COOH-terminal 20 amino acids are important for such association. Interestingly, a stretch of NH2-terminal amino acids as short as 63-403 interacted with NP more than the wild type, reaching greater than 2.5-fold as measured by the CAT assay. These results suggest that a domain is present in P that negatively regulates its interaction with NP. Deletion of NH2-terminal 40 and COOH-terminal 160 amino acids of NP reduced the CAT activity by more than 95%. These results underscore the important differences between negative strand RNA viruses with respect to interactions between these two viral proteins involved in gene expression.	CLEVELAND CLIN FDN, RES INST, DEPT MOLEC BIOL, CLEVELAND, OH 44195 USA; CASE WESTERN RESERVE UNIV, DEPT BIOL, CLEVELAND, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032027] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-32027] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BANERJEE AK, 1991, PHARMACOL THERAPEUT, V51, P47, DOI 10.1016/0163-7258(91)90041-J; BANERJEE AK, 1992, VIROLOGY, V188, P417, DOI 10.1016/0042-6822(92)90495-B; BARIK S, 1992, J VIROL, V66, P1109, DOI 10.1128/JVI.66.2.1109-1118.1992; BARIK S, 1992, P NATL ACAD SCI USA, V89, P6570, DOI 10.1073/pnas.89.14.6570; CHATTOPADHYAY D, 1987, P NATL ACAD SCI USA, V84, P8932, DOI 10.1073/pnas.84.24.8932; CHATTOPADHYAY D, 1987, CELL, V49, P407, DOI 10.1016/0092-8674(87)90293-5; CURRAN J, 1993, J VIROL, V67, P4358, DOI 10.1128/JVI.67.7.4358-4364.1993; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; CURRAN J, 1994, VIROLOGY, V202, P875, DOI 10.1006/viro.1994.1409; DE BP, 1990, J VIROL, V64, P1135, DOI 10.1128/JVI.64.3.1135-1142.1990; EMERSON SU, 1987, P NATL ACAD SCI USA, V84, P5655, DOI 10.1073/pnas.84.16.5655; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FU ZF, 1994, VIROLOGY, V200, P590, DOI 10.1006/viro.1994.1222; GALINSKI MS, 1991, ADV VIRUS RES, V39, P129; GALINSKI MS, 1992, VIROLOGY, V186, P543, DOI 10.1016/0042-6822(92)90020-P; HOMANN HE, 1991, J VIROL, V65, P1304, DOI 10.1128/JVI.65.3.1304-1309.1991; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; LUK D, 1986, VIROLOGY, V153, P318, DOI 10.1016/0042-6822(86)90036-X; MARTIN KJ, 1990, NATURE, V346, P147, DOI 10.1038/346147a0; PATTNAIK AK, 1990, J VIROL, V64, P2948, DOI 10.1128/JVI.64.6.2948-2957.1990; PELUSO RW, 1988, VIROLOGY, V162, P369, DOI 10.1016/0042-6822(88)90477-1; RYAN KW, 1990, VIROLOGY, V174, P515, DOI 10.1016/0042-6822(90)90105-Z; RYAN KW, 1991, VIROLOGY, V180, P126, DOI 10.1016/0042-6822(91)90016-5; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Sambrook J, 1989, MOL CLONING LABORATO; SANCHEZ A, 1985, VIROLOGY, V143, P45, DOI 10.1016/0042-6822(85)90095-9; SMALLWOOD S, 1994, VIROLOGY, V202, P154, DOI 10.1006/viro.1994.1331; TAKACS AM, 1993, P NATL ACAD SCI USA, V90, P10375, DOI 10.1073/pnas.90.21.10375; TAKACS AM, 1992, J VIROL, V66, P5842, DOI 10.1128/JVI.66.10.5842-5848.1992; TAKACS AM, 1991, NEW BIOL, V3, P581; VASAVADA HA, 1991, P NATL ACAD SCI USA, V88, P10686, DOI 10.1073/pnas.88.23.10686	32	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12485	12490		10.1074/jbc.270.21.12485	http://dx.doi.org/10.1074/jbc.270.21.12485			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759493	hybrid			2022-12-27	WOS:A1995QZ71100026
J	COLEMAN, ME; DEMAYO, F; YIN, KC; LEE, HM; GESKE, R; MONTGOMERY, C; SCHWARTZ, RJ				COLEMAN, ME; DEMAYO, F; YIN, KC; LEE, HM; GESKE, R; MONTGOMERY, C; SCHWARTZ, RJ			MYOGENIC VECTOR EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR-I STIMULATES MUSCLE-CELL DIFFERENTIATION AND MYOFIBER HYPERTROPHY IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTIN GENE; SKELETAL-MUSCLE; IGF-I; MYOBLAST DIFFERENTIATION; TISSUE CONCENTRATIONS; REGULATED EXPRESSION; BINDING-PROTEIN; SEQUENCE; ACID; RAT	The avian skeletal alpha-actin gene was used as a template for construction of a myogenic expression vector that was utilized to direct expression of a human IGF-I cDNA in cultured muscle cells and in striated muscle of transgenic mice. The proximal promoter region, together with the first intron and 1.8 kilobases of 3'-noncoding flanking sequence of the avian skeletal alpha-actin gene directed high level expression of human insulin-like growth factor I (IGF-I) in stably transfected C2C12 myoblasts and transgenic mice. Expression of the actin/IGF-I hybrid gene in C2C12 muscle cells increased levels of myogenic basic helix-loop-helix factor and contractile protein mRNAs and enhanced myotube formation, Expression of the actin/IGF-I hybrid gene in mice elevated IGF-I concentrations in skeletal muscle 47-fold resulting in myofiber hypertrophy, IGF-I concentrations in serum and body weight were not increased by transgene expression, suggesting that the effects of transgene expression were localized, These results indicate that sustained overexpression of IGF-I in skeletal muscle elicits myofiber hypertrophy and provides the basis for manipulation of muscle physiology utilizing skeletal alpha-actin-based vectors.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT COMPARAT PATHOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine			DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336	NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER; NIA NIH HHS [T32AG00183] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ASANTE EA, 1994, TRANSGENIC RES, V3, P59, DOI 10.1007/BF01976028; AYLING CM, 1989, J ENDOCRINOL, V123, P429, DOI 10.1677/joe.0.1230429; BEHRINGER RR, 1990, ENDOCRINOLOGY, V127, P1033, DOI 10.1210/endo-127-3-1033; BERGSMA DJ, 1986, MOL CELL BIOL, V6, P2462, DOI 10.1128/MCB.6.7.2462; BISCHOFF R, 1990, J CELL BIOL, V111, P201, DOI 10.1083/jcb.111.1.201; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; CARSON JA, 1995, IN PRESS AM J PHYSL; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOW KL, 1990, MOL CELL BIOL, V10, P528, DOI 10.1128/MCB.10.2.528; COHICK WS, 1993, ANNU REV PHYSIOL, V55, P131, DOI 10.1146/annurev.ph.55.030193.001023; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DERCOLE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P935, DOI 10.1073/pnas.81.3.935; DEVOL DL, 1990, AM J PHYSIOL, V259, pE89, DOI 10.1152/ajpendo.1990.259.1.E89; DUNWOODIE SL, 1994, J BIOL CHEM, V269, P12212; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; FLORINI JR, 1987, MUSCLE NERVE, V10, P577, DOI 10.1002/mus.880100702; FLORINI JR, 1989, AM J PHYSIOL, V256, pC701, DOI 10.1152/ajpcell.1989.256.4.C701; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718; FORNWALD JA, 1982, NUCLEIC ACIDS RES, V10, P3861, DOI 10.1093/nar/10.13.3861; FRENCH BA, 1990, GENE, V88, P173, DOI 10.1016/0378-1119(90)90029-Q; GRICHNIK JM, 1986, NUCLEIC ACIDS RES, V14, P1682; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HAN VKM, 1987, SCIENCE, V236, P193, DOI 10.1126/science.3563497; HAYWARD LJ, 1986, J CELL BIOL, V102, P1485, DOI 10.1083/jcb.102.4.1485; HOGAN B, 1986, MANIPULATING MOUSE E; HU MCT, 1986, MOL CELL BIOL, V6, P15, DOI 10.1128/MCB.6.1.15; JAMES PL, 1993, J BIOL CHEM, V268, P22305; JANSEN M, 1983, NATURE, V306, P609, DOI 10.1038/306609a0; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEVINOVITZ A, 1992, MOL ENDOCRINOL, V6, P1227, DOI 10.1210/me.6.8.1227; LI H, 1994, J CELL BIOL, V124, P827, DOI 10.1083/jcb.124.5.827; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; PARKER TG, 1990, P NATL ACAD SCI USA, V87, P7066, DOI 10.1073/pnas.87.18.7066; PEARSE AGE, 1972, HISTOCHEMISTRY THEOR, V1; PETROPOULOS CJ, 1989, MOL CELL BIOL, V9, P3785, DOI 10.1128/MCB.9.9.3785; POWELL DR, 1986, J CLIN ENDOCR METAB, V63, P1186; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; SCHWARTZ RJ, 1973, J BIOL CHEM, V248, P6426; SHANI M, 1986, MOL CELL BIOL, V6, P2624, DOI 10.1128/MCB.6.7.2624; SOUTHERN EM, 1979, J MOL BIOL, V98, P503; TOLLEFSEN SE, 1989, J BIOL CHEM, V264, P13810; VANDEKERCKHOVE J, 1984, J MOL BIOL, V179, P391, DOI 10.1016/0022-2836(84)90072-X; VANDENBURGH HH, 1991, AM J PHYSIOL, V260, pC475, DOI 10.1152/ajpcell.1991.260.3.C475; WADE R, 1989, ANNU REV PHYSIOL, V51, P179, DOI 10.1146/annurev.physiol.51.1.179; ZHU YY, 1991, J CELL BIOL, V115, P745, DOI 10.1083/jcb.115.3.745	54	497	522	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12109	12116		10.1074/jbc.270.20.12109	http://dx.doi.org/10.1074/jbc.270.20.12109			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744859	hybrid			2022-12-27	WOS:A1995QY73600062
J	HANADA, M; AIMESEMPE, C; SATO, T; REED, JC				HANADA, M; AIMESEMPE, C; SATO, T; REED, JC			STRUCTURE-FUNCTION ANALYSIS OF BCL-2 PROTEIN IDENTIFICATION OF CONSERVED DOMAINS IMPORTANT FOR HOMODIMERIZATION WITH BCL-2 AND HETERODIMERIZATION WITH BAX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FOLLICULAR LYMPHOMA; PROGRAMMED CELL-DEATH; TRANSGENIC MICE; GENE-TRANSFER; APOPTOSIS; ONCOPROTEIN; CHEMOTHERAPY; EXPRESSION; REGULATOR; SURVIVAL	The Bcl-2 protein is a suppressor of programmed cell death that homodimerizes with itself and forms heterodimers with a homologous protein Bax, a promoter of cell death. Expression of Bax in Saccharomyces cerevisiae as a membrane-bound fusion protein results in a lethal phenotype that is suppressible by co-expression of Bcl-2. Functional analysis of deletion mutants of human Bcl-2 in yeast demonstrated the presence of at least three conserved domains that are required to suppress Bar-mediated cytotoxicity, termed domains A (amino acids 11-33), B (amino acids 138-154), and C (amino acids 188-196). In vitro binding experiments using GST-Bcl-2 fusion proteins demonstrated that Bcl-2(Delta B) and Bcl-2(Delta C) deletion mutants had a markedly impaired ability to heterodimerize with Bax but retained the ability to homodimerize with wild-type Bcl-2. In contrast, Bcl-a(Delta A) and an NH2-terminal deletion mutant Bcl-2(Delta 1-82) retained Bax binding activity in vitro but failed to suppress Bar-mediated cytotoxicity in yeast. Sequences downstream of domain C in the region 197-218 also were shown to be required for Bax-binding in vitro and anti-death function in yeast. Analysis of Bcl-2/Bcl-2 homodimerization using both in vitro binding assays as well as a yeast two-hybrid method provided evidence in support of a head-to-tail model for Bcl-2/Bcl-2 homodimerization and revealed that sequences within the NH2-terminal A domain interact with a structure that requires the presence of both the carboxyl B and C domains in combination. In addition to further delineating structural features within Bcl-2 that are required for homo-dimerization, the findings reported here support the hypothesis that Bcl-2 promotes cell survival by binding directly to Bax but suggest that ability to bind Bax can be insufficient for anti-cell death function.	LA JOLLA CANC RES FDN, ONCOGENE & TUMOR SUPPRESSOR GENE PROGRAM, LA JOLLA, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute				Sempe, Christine/0000-0001-6903-1575				BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BORNER C, 1994, J CELL BIOL, V126, P1059, DOI 10.1083/jcb.126.4.1059; BREDESEN DE, 1994, APOPTOSIS, V2, P397; CAMPOS L, 1993, BLOOD, V81, P3091; CAMPOS L, 1994, BLOOD, V84, P595; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; GOLEMIS EA, 1994, CURRENT PROTOCOLS MO; GOUGEON ML, 1993, SCIENCE, V260, P1269, DOI 10.1126/science.8098552; Green D R, 1992, Semin Immunol, V4, P379; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; KATSUMATA M, 1992, P NATL ACAD SCI USA, V89, P11376, DOI 10.1073/pnas.89.23.11376; KITADA S, 1994, ANTISENSE RES DEV, V4, P71, DOI 10.1089/ard.1994.4.71; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MIYASHITA T, 1993, BLOOD, V81, P151; MIYASHITA T, 1992, CANCER RES, V52, P5407; MIYASHITA T, 1994, ONCOGENE, V9, P1799; NGUYEN M, 1994, J BIOL CHEM, V269, P16521; OFFIT K, 1989, BRIT J HAEMATOL, V72, P178, DOI 10.1111/j.1365-2141.1989.tb07680.x; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; REED JC, 1988, NATURE, V336, P259, DOI 10.1038/336259a0; REED JC, 1994, IN PRESS HEMATOL ONC; SATO T, 1994, GENE, V140, P291, DOI 10.1016/0378-1119(94)90561-4; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; TANAKA S, 1993, J BIOL CHEM, V268, P10920; TSUJIMOTO Y, 1987, ONCOGENE, V2, P3; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; YUNIS JJ, 1989, NEW ENGL J MED, V320, P1047, DOI 10.1056/NEJM198904203201605; ZEHAVA CL, 1990, J BIOL CHEM, V265, P4929; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	40	366	383	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11962	11969		10.1074/jbc.270.20.11962	http://dx.doi.org/10.1074/jbc.270.20.11962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744846	hybrid			2022-12-27	WOS:A1995QY73600045
J	HOPKINS, PCR; CROWTHER, DC; CARRELL, RW; STONE, SR				HOPKINS, PCR; CROWTHER, DC; CARRELL, RW; STONE, SR			DEVELOPMENT OF A NOVEL RECOMBINANT SERPIN WITH POTENTIAL ANTITHROMBOTIC PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE HUMAN ALPHA-1-ANTITRYPSIN; PRO-ARG CHLOROMETHYLKETONE; OVOMUCOID 3RD DOMAINS; HUMAN ALPHA-THROMBIN; PROTEIN-C; SERINE PROTEINASES; REACTIVE SITE; ALPHA-1-PROTEINASE INHIBITOR; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	Recombinant alpha(1)-antitrypsin with a P-1 arginine residue (Arg-alpha(1)-antitrypsin) is a rapid inhibitor of both thrombin and activated protein C (APC). A series of mutants were made in an attempt to increase the specificity of this serpin for thrombin over APC. Initially, P-2 and P'(1) residues of Arg-alpha(1)-antitrypsin were replaced in single and double mutations by the corresponding residues in antithrombin and C1 inhibitor which are very poor inhibitors of APC. No improvement in selectivity was achieved by these mutations. In fact, all P-2/P'(1) substitutions led to a decrease in selectivity for thrombin over APC. For example, replacement of the P-2 proline of Arg-alpha(1)-antitrypsin by glycine decreased the association rate constant (k(ass)) with thrombin by 37-fold while the k(ass) value with APC was reduced by only 16-fold. Co operative effects were observed with the double P-2 and P'(1) substitutions; the mutational effects were not additive, The decrease in the k(ass) for thrombin caused by the mutation of the P-2 proline to alanine or glycine was 3 fold greater when threonine was present in the P'(1) position instead of the normal serine. In contrast to the disappointing results with the P-2/P'(1) mutations, replacement of the P-7 to P'(3) residues of alpha(1)-antitrypsin by those of antithrombin led to a dramatic increase in selectivity. Although this substitution only affected the k(ass) value with thrombin by 10-fold, a 12,500-fold decrease in this value with APC was observed. Substitution of proline for the P-2 glycine of this chimeric serpin increased the k(ass) values with thrombin and APC by 7- and 90-fold, respectively. The effect of the P-2 substitution was again found to depend on the sequence surrounding the residue; the change in the k(ass) for APC caused by the P-2 Pro --> Gly replacement was 6-fold larger in the chimeric serpin. Evaluation of the k(ass) values of the chimeric serpin with a P-2 proline in light of the likely rates of inhibition of thrombin and APC during antithrombotic therapy with heparin suggested that this serpin may have kinetic parameters suitable for an antithrombotic agent.			HOPKINS, PCR (corresponding author), UNIV CAMBRIDGE, CTR MRC, DEPT HAEMATOL, HILLS RD, CAMBRIDGE CB2 2QH, ENGLAND.		Hopkins, Paul/E-5215-2010		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARDELT W, 1991, J MOL BIOL, V220, P1041, DOI 10.1016/0022-2836(91)90370-L; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1992, PROTEIN SCI, V1, P426; CARRELL RW, 1986, BIOTECHNOL GENET ENG, V4, P291; CHASE T, 1970, METHOD ENZYMOL, V19, P20; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FOX I, 1993, THROMB HAEMOSTASIS, V69, P157; HARKER LA, 1994, J CLIN PHARMACOL, V34, P3, DOI 10.1002/j.1552-4604.1994.tb03960.x; HARPER PL, 1993, THROMB HAEMOSTASIS, V69, P729; HEEB MJ, 1990, J BIOL CHEM, V265, P2365; HERMANS JM, 1993, BIOCHEM J, V295, P239, DOI 10.1042/bj2950239; HIRSH J, 1992, BLOOD, V79, P1; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; HOROVITZ A, 1987, J MOL BIOL, V196, P733, DOI 10.1016/0022-2836(87)90045-3; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; JEPPSSON JO, 1978, CLIN SCI MOL MED, V55, P103, DOI 10.1042/cs0550103; JOHANSEN H, 1987, MOL BIOL MED, V4, P291; KETTNER C, 1990, J BIOL CHEM, V265, P18289; LASKOWSKI M, 1987, BIOCHEMISTRY-US, V26, P202, DOI 10.1021/bi00375a028; LAURELL M, 1992, J CLIN INVEST, V89, P1094, DOI 10.1172/JCI115689; LOSCALZO J, 1985, ARCH BIOCHEM BIOPHYS, V240, P446, DOI 10.1016/0003-9861(85)90049-9; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; MADISON EL, 1990, J BIOL CHEM, V265, P21423; MARBET GA, 1993, J CARDIOVASC PHARM, V22, P364, DOI 10.1097/00005344-199309000-00004; MAST AE, 1990, BIOL CHEM H-S, V371, P101; OLSON ST, 1992, THROMBIN STRUCTURE F, P159; PATSTON PA, 1990, J BIOL CHEM, V265, P10786; PHILLIPS JE, 1994, J BIOL CHEM, V269, P16696; SCHAPIRA M, 1987, J CLIN INVEST, V80, P582, DOI 10.1172/JCI113108; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; STONE SR, 1985, BIOCHEM J, V230, P497, DOI 10.1042/bj2300497; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; THEUNISSEN HJM, 1993, J BIOL CHEM, V268, P9035; TRAVIS J, 1986, BIOL CHEM H-S, V367, P853, DOI 10.1515/bchm3.1986.367.2.853; TYAGI SC, 1991, J BIOL CHEM, V266, P5279; WALLACE A, 1989, BIOCHEM J, V257, P191, DOI 10.1042/bj2570191; WEITZ J, 1993, J LAB CLIN MED, V122, P364; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WRIGHT G, 1991, BIO-TECHNOL, V9, P830, DOI 10.1038/nbt0991-830; YORK JD, 1991, J BIOL CHEM, V266, P8495; YU SD, 1977, ARCH BIOCHEM BIOPHYS, V179, P477, DOI 10.1016/0003-9861(77)90136-9	45	51	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11866	11871		10.1074/jbc.270.20.11866	http://dx.doi.org/10.1074/jbc.270.20.11866			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744836	hybrid			2022-12-27	WOS:A1995QY73600032
J	SEKLER, I; LO, RS; MASTROCOLA, T; KOPITO, RR				SEKLER, I; LO, RS; MASTROCOLA, T; KOPITO, RR			SULFATE TRANSPORT MEDIATED BY THE MAMMALIAN ANION-EXCHANGERS IN RECONSTITUTED PROTEOLIPOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; BICARBONATE TRANSPORT; ERYTHROCYTE-MEMBRANE; INTRACELLULAR PH; CYTOSOLIC PH; CHLORIDE; BINDING; PROTON; PROTEIN; LINE	The kinetic properties of sulfate transport mediated by the anion exchangers AE1 and AE2 have been examined, Microsomes isolated from HEK cells transiently overexpressing either protein were reconstituted in unilamellar, 200-600-nm diameter proteoliposomes. Transport mediated by the exchangers was monitored by loading the reconstituted proteoliposomes with the slowly transportable anion SO42- using [S-35]SO42- as a tracer and performing [S-35]SO42-/SO42- exchange. The following data suggest that AE1 and AE2 have been functionally reconstituted: (i) the rate of SO42- transport in AE1 and AE2 containing proteoliposomes was 10-20 times higher than in proteoliposomes derived from control microsomes; (ii) the transport of SO42- was strongly dependent on the presence of a trans anion; and (iii) the anion exchanger inhibitors, 4,4'-diisothiocyanostilbene-2,2'-disulfonate (DIDS) and 4,4'-dinitrostilbene-2,2'-disulfonate (DNDS) totally abolished SO42- transport, Furthermore, DIDS inhibits SO42- transport only when occluded inside the vesicles, indicating a uniform, asymmetrical, inside out orientation of the reconstituted exchangers, The K-i values of the stilbene disulfonate compound DNDS were 2.5 and 4 mu M for AE1 and AE2, respectively, suggesting that the two exchangers pos sess similar high affinity sites for stilbene compounds. Both AE1 and AE2 showed the same steep pH dependence of sulfate transport, which was maximal at pH 5.5 and reduced to less than 10% (of the value at pH 5.5) at pH 8.5, suggesting that an acidic residue shared by AE1 and AE2 participates in the pH regulation of sulfate transport.	STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305	Stanford University					NIGMS NIH HHS [GM38543] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALPER SL, 1988, J BIOL CHEM, V263, P17092; ARONSON PS, 1989, ANNU REV PHYSIOL, V51, P419; BARZILAY M, 1979, MEMBRANE BIOCHEM, V2, P227, DOI 10.3109/09687687909063866; CABANTCHIK ZI, 1992, AM J PHYSIOL, V31, pC803; DARNELL J, 1990, MOL CELL BIOL, P489; FROHLICH O, 1982, J MEMBRANE BIOL, V65, P111, DOI 10.1007/BF01870474; GASKO OD, 1976, ANAL BIOCHEM, V72, P57, DOI 10.1016/0003-2697(76)90506-6; GREEN J, 1990, J GEN PHYSIOL, V95, P121, DOI 10.1085/jgp.95.1.121; GUNN RB, 1973, ERYTHROCYTES THROMBO, P77; HE XJ, 1993, AM J PHYSIOL, V264, pC1075, DOI 10.1152/ajpcell.1993.264.4.C1075; HOPFER U, 1987, ANNU REV PHYSIOL, V49, P51, DOI 10.1146/annurev.ph.49.030187.000411; HUMPHREYS BD, 1994, AM J PHYSIOL, V36, pC1295; JENNINGS ML, 1976, J MEMBRANE BIOL, V28, P187, DOI 10.1007/BF01869697; JENNINGS ML, 1989, ANNU REV BIOPHYS BIO, V18, P397, DOI 10.1146/annurev.bb.18.060189.002145; KAPLAN JH, 1976, FEBS LETT, V62, P182, DOI 10.1016/0014-5793(76)80048-8; KARNISKI LP, 1987, AM J PHYSIOL, V253, pF513, DOI 10.1152/ajprenal.1987.253.3.F513; KNAUF PA, 1986, MEMBRANE TRANSPORT D, P191; KOHNE W, 1981, BIOCHIM BIOPHYS ACTA, V229, P547; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; KRUPKA RM, 1989, J MEMBRANE BIOL, V109, P159, DOI 10.1007/BF01870855; KUDRYCKI KE, 1990, J BIOL CHEM, V265, P462; LEE BS, 1991, J BIOL CHEM, V266, P11448; LUKACOVIC MF, 1981, BIOCHEMISTRY-US, V20, P3145, DOI 10.1021/bi00514a025; MILANICK MA, 1982, J GEN PHYSIOL, V79, P87, DOI 10.1085/jgp.79.1.87; MILANICK MA, 1984, AM J PHYSIOL, V247, pC247, DOI 10.1152/ajpcell.1984.247.3.C247; MUALLEM S, 1985, J BIOL CHEM, V260, P6641; PASSOW H, 1986, REV PHYSL BIOCH PHAR, V103, P62; REINERTSEN KV, 1988, J BIOL CHEM, V263, P11117; RUETZ S, 1993, J CELL BIOL, V121, P37, DOI 10.1083/jcb.121.1.37; SAITO Y, 1983, J PHYSIOL-LONDON, V336, P635, DOI 10.1113/jphysiol.1983.sp014602; SCHNELL KF, 1977, J MEMBRANE BIOL, V30, P319; SEE H, 1990, BIOCHEM J, V271, P147, DOI 10.1042/bj2710147; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; VAUGHANJONES RD, 1979, J PHYSIOL-LONDON, V295, P111, DOI 10.1113/jphysiol.1979.sp012957; WOOD PG, 1992, J MEMBRANE BIOL, V127, P139	35	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11251	11256		10.1074/jbc.270.19.11251	http://dx.doi.org/10.1074/jbc.270.19.11251			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744759	hybrid			2022-12-27	WOS:A1995QX86500036
J	STRINGER, HAR; PANNEKOEK, H				STRINGER, HAR; PANNEKOEK, H			THE SIGNIFICANCE OF FIBRIN BINDING BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 FOR THE MECHANISM OF TISSUE-TYPE PLASMINOGEN ACTIVATOR-MEDIATED FIBRINOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLATELETS; UROKINASE-TYPE; VITRONECTIN; SITES; IDENTIFICATION; THROMBOLYSIS; THROMBUS; RELEASE; PAI-1; LYSIS	The specific, reversible interaction between plasminogen activator inhibitor 1 (PAI-1) and intact fibrin polymers was studied using both purified components and isolated activated platelets as a source of PAI-1. A key reagent in these experiments is a PAI-1 mutant, having its P-1 reactive center residue arginine replaced by methionine (PAI-1 R346M), The second-order association rate of PAI-1 R346M with tissue-type plasminogen activator is over 10,000 fold lower than that of wild-type PAI-1, whereas the ability of the variant to bind to fibrin is unaltered, Competition experiments demonstrated that PAI-1 R346M is equally effective as wild-type PAI-1 in displacing I-125-labeled PAI-1 from fibrin, Fibrinolysis, mediated by tissue-type plasminogen activator, is inhibited in a dose dependent manner by purified PAI-1. The inhibition can be relieved in a dose dependent manner by PAI-1 R346M, presumably due to displacement of wild-type PAI-1 by PAI-1 R346M. Perfusion studies, using platelet-rich clots, revealed that the incorporation of PAI-1 R346M dose dependently decreased the 50% clot lysis time. These data indicate that PAI-1 R346M displaces fibrin-bound, endogenous PAI-1 released from activated platelets. Implications to manipulate PAI-1 activity for the management of clinical complications, in particular reocclusion after thrombolytic therapy, are discussed.	UNIV AMSTERDAM,ACAD MED CTR,DEPT BIOCHEM K1159,1105 AZ AMSTERDAM,NETHERLANDS	University of Amsterdam; Academic Medical Center Amsterdam								BIEMOND BJ, 1995, CIRCULATION, V91, P1175, DOI 10.1161/01.CIR.91.4.1175; BLINC A, 1994, THROMB HAEMOSTASIS, V71, P230; BRAATEN JV, 1993, BLOOD, V81, P1290; COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; COLLER BS, 1990, NEW ENGL J MED, V322, P33, DOI 10.1056/NEJM199001043220107; DEVRIES C, 1989, J BIOL CHEM, V264, P12604; DEVRIES C, 1990, J BIOL CHEM, V265, P13547; EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029; ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HIGGINS DL, 1987, BIOCHEMISTRY-US, V26, P7786, DOI 10.1021/bi00398a038; HORREVOETS AJG, 1994, J BIOL CHEM, V269, P12639; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; KEIJER J, 1991, BLOOD, V78, P401; KEIJER J, 1991, J BIOL CHEM, V266, P10700; KRUITHOF EKO, 1986, THROMB HAEMOSTASIS, V55, P201; LEGRAND C, 1985, BIOCHIM BIOPHYS ACTA, V812, P802, DOI 10.1016/0005-2736(85)90275-5; LEVI M, 1992, CIRCULATION, V85, P305, DOI 10.1161/01.CIR.85.1.305; LIJNEN HR, 1990, J BIOL CHEM, V266, P4041; MANN KG, 1992, SEMIN HEMATOL, V29, P213; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; PANNEKOEK H, 1988, Fibrinolysis, V2, P123, DOI 10.1016/0268-9499(88)90025-2; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; PREISSNER KT, 1989, BLOOD, V74, P1989; REILLY CF, 1992, J BIOL CHEM, V267, P17128; ROBBIE LA, 1993, THROMB HAEMOSTASIS, V70, P301; SANCHO E, 1994, EUR J BIOCHEM, V224, P125, DOI 10.1111/j.1432-1033.1994.tb20003.x; STRINGER HAR, 1994, ARTERIOSCLER THROMB, V14, P1452, DOI 10.1161/01.ATV.14.9.1452; TORRBROWN SR, 1993, THROMB RES, V72, P413, DOI 10.1016/0049-3848(93)90241-F; TRANTHANG C, 1986, EUR J BIOCHEM, V160, P599, DOI 10.1111/j.1432-1033.1986.tb10080.x; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WAGNER OF, 1989, J CLIN INVEST, V84, P647, DOI 10.1172/JCI114211	32	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11205	11208		10.1074/jbc.270.19.11205	http://dx.doi.org/10.1074/jbc.270.19.11205			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744752	hybrid			2022-12-27	WOS:A1995QX86500029
J	TCHOU, J; GROLLMAN, AP				TCHOU, J; GROLLMAN, AP			THE CATALYTIC MECHANISM OF FPG PROTEIN - EVIDENCE FOR A SCHIFF-BASE INTERMEDIATE AND AMINO-TERMINUS LOCALIZATION OF THE CATALYTIC SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APURINIC APYRIMIDINIC SITES; FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; IMIDAZOLE RINGS; DAMAGED DNA; ZINC-FINGER; REPAIR; EXCISION; ENDONUCLEASE	Our recent structure-activity analysis of Fpg protein of Escherichia coli, using oligodeoxynucleotides containing various 8-oxopurine derivatives, has allowed us to postulate an enzyme mechanism involving protonation of 8-oxoguanine at O-6 and nucleophilic attack of the deoxyribose moiety at C-1' leading to the formation of an enzyme-substrate Schiff base intermediate (Tchou, J., Bodepudi, V., Shibutani, S., Antoshechkin, I., Miller, J., Grollman, A. P., and Johnson, F. (1994) J. Biol. Chem. 269, 15318-15324). In this paper, sodium cyanoborohydride has been used to convert the transient intermediate to a covalent enzyme-DNA complex. The location of the active site of Fpg protein is further delineated using two approaches. 1) A radiolabeled DNA substrate is used to tag the active site of Fpg protein, using sodium cyanoborohydride. The active site is mapped to the first 73 amino acid residue fragment by cyanogen bromide cleavage analysis. 2) A maltose-binding protein fusion system is used to generate amino terminal modifications of Fpg protein to explore the role of the aminoterminal region in DNA binding and catalysis. Results support the conclusion that the active site of Fpg protein is located at or near the amino terminus. Thus, Fpg protein may act in a similar fashion as T4 endonuclease V, a DNA repair enzyme that uses its amino-terminal alpha-amino group of threonine to carry out catalysis via Schiff base formation (Dodson ct al., 1993).	SUNY STONY BROOK,DEPT PHARMACOL SCI,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL CANCER INSTITUTE [R01CA017395, R37CA017395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES004068] Funding Source: NIH RePORTER; NCI NIH HHS [CA-17395] Funding Source: Medline; NIEHS NIH HHS [ES04068] Funding Source: Medline; NIGMS NIH HHS [GM07518] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILLY V, 1989, BIOCHEM J, V262, P581, DOI 10.1042/bj2620581; BODEPUDI V, 1992, CHEM RES TOXICOL, V5, P608, DOI 10.1021/tx00029a004; BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; BOITEUX S, 1990, J BIOL CHEM, V265, P3916; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; BREIMER LH, 1984, NUCLEIC ACIDS RES, V12, P6359, DOI 10.1093/nar/12.16.6359; CHETSANGA CJ, 1983, CARCINOGENESIS, V4, P997, DOI 10.1093/carcin/4.8.997; CHETSANGA CJ, 1979, NUCLEIC ACIDS RES, V6, P3673, DOI 10.1093/nar/6.11.3673; DODSON ML, 1993, BIOCHEMISTRY-US, V32, P8284, DOI 10.1021/bi00083a032; FERSHT A, 1985, ENZYME STRUCTURE MEC, P69; GRAVES RJ, 1992, J BIOL CHEM, V267, P14429; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; KOW YW, 1987, BIOCHEMISTRY-US, V26, P8200, DOI 10.1021/bi00399a027; LAEMMLI UK, 1970, NATURE, V27, P680; LAVAL J, 1990, MUTAT RES, V233, P73, DOI 10.1016/0027-5107(90)90152-T; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; OCONNOR TR, 1993, J BIOL CHEM, V268, P9063; OCONNOR TR, 1989, P NATL ACAD SCI USA, V86, P5222, DOI 10.1073/pnas.86.14.5222; OLEYKOWSKI CA, 1993, J BIOL CHEM, V268, P7990; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHROCK RD, 1991, J BIOL CHEM, V266, P17631; SCHROCK RD, 1993, J BIOL CHEM, V268, P880; TAKESHITA M, 1987, J BIOL CHEM, V262, P10171; TCHOU J, 1993, MUTAT RES, V299, P277, DOI 10.1016/0165-1218(93)90104-L; TCHOU J, 1994, J BIOL CHEM, V269, P15318; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TCHOU J, 1993, J BIOL CHEM, V268, P26738; WEISS B, 1987, ADV ENZYMOL RAMB, V60, P1	31	127	130	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11671	11677		10.1074/jbc.270.19.11671	http://dx.doi.org/10.1074/jbc.270.19.11671			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744806	hybrid			2022-12-27	WOS:A1995QX86500090
J	KIM, HY; THOMAS, D; HANLEY, MR				KIM, HY; THOMAS, D; HANLEY, MR			CHROMATOGRAPHIC RESOLUTION OF AN INTRACELLULAR CALCIUM INFLUX FACTOR FROM THAPSIGARGIN-ACTIVATED JURKAT CELLS - EVIDENCE FOR MULTIPLE ACTIVITIES INFLUENCING CALCIUM ELEVATION IN XENOPUS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MESSENGER; CA2+	Acid extracts of thapsigargin-stimulated Jurkat cells revealed both intracellular and extracellular activities stimulating Ca2+-dependent Cl- currents on Xenopus laevis oocytes. Chromatographic fractionation of these extracts on gel filtration separated two active fractions of M(r) approximately 600 and 400. Moreover, the M(r) 600 fraction exhibited both intracellular and extracellular activities. However, the intracellular activity was absent from extracts of unstimulated Jurkat cells, suggesting its production was stimulated by thapsigargin. The further purification of this fraction by high performance thin layer chromatography resolved a single fraction which was active only on microinjection and which required calcium entry for activation of current responses. These results suggest that a single authentic calcium influx factor can be resolved by purification from confounding activities detected in crude acid extracts.	UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616	University of California System; University of California Davis								BERRIDGE MJ, 1993, NATURE, V361, P314; FERGUSON JE, 1992, ARCH BIOCHEM BIOPHYS, V297, P388, DOI 10.1016/0003-9861(92)90689-T; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PETERSEN CCH, 1994, J BIOL CHEM, V269, P32246; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; THOMAS D, 1995, J BIOL CHEM, V270, P6429, DOI 10.1074/jbc.270.12.6429	7	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9706	9708		10.1074/jbc.270.17.9706	http://dx.doi.org/10.1074/jbc.270.17.9706			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730347	hybrid			2022-12-27	WOS:A1995QV41700005
J	MATSUO, M; YOKOGAWA, T; NISHIKAWA, K; WATANABE, K; OKADA, N				MATSUO, M; YOKOGAWA, T; NISHIKAWA, K; WATANABE, K; OKADA, N			HIGHLY SPECIFIC AND EFFICIENT CLEAVAGE OF SQUID TRNA(LYS) CATALYZED BY MAGNESIUM-IONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENYLALANINE TRANSFER-RNA; YEAST TRANSFER-RNAPHE; DIVALENT METAL-IONS; SELF-CLEAVAGE; BINDING-SITES; ACCEPTOR STEM; MITOCHONDRIA; REFINEMENT; MECHANISM; RIBOZYME	Two lysine isoacceptor tRNAs corresponding to the codons AAA and AAG, respectively, were isolated from squid (Loligo bleekeri), and their nucleotide sequences were determined. During this analysis, we discovered that the tRNA with the anticodon CUU was efficiently cleaved at a specific site in the presence of magnesium ions, whereas the tRNA with the anticodon UUU was not. Cleavage occurred almost exclusively at the phosphodiester linkage between G(15) and D-16 (p16). The most remarkable feature of this cleavage reaction is that the end product was not a 2',3'-cyclic phosphate but was mainly a 3'-phosphate. Thus, this reaction was distinct from the well characterized cleavage of yeast tRNA(Phe) by lead and from reactions catalyzed by various other metalloribozymes. The presence of a cytidine residue at position 60 was required for efficient cleavage but was not crucial for the reaction, and the entire tRNA molecule had to be intact for this specific and efficient cleavage reaction. The present study provides evidence that there exists a new catalytic mechanism for cleavage of tRNA that exploits biologically ubiquitous ions rather than toxic, nonessential ions such as lead.	TOKYO INST TECHNOL, FAC BIOSCI & BIOTECHNOL, MIDORI KU, YOKOHAMA, KANAGAWA 226, JAPAN; UNIV TOKYO, FAC ENGN, DEPT CHEM & BIOTECHNOL, BUNKYO KU, TOKYO 113, JAPAN	Tokyo Institute of Technology; University of Tokyo								ALTMAN S, 1989, ADV ENZYMOL RAMB, V62, P1; BEHLEN LS, 1990, BIOCHEMISTRY-US, V29, P2515, DOI 10.1021/bi00462a013; BROWN RS, 1983, NATURE, V303, P543, DOI 10.1038/303543a0; BROWN RS, 1985, BIOCHEMISTRY-US, V24, P4785, DOI 10.1021/bi00339a012; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CIESIOLKA J, 1989, EUR J BIOCHEM, V186, P71, DOI 10.1111/j.1432-1033.1989.tb15179.x; CIESIOLKA J, 1986, BIOPHOSPHATES THEIR, P409; DAHM SC, 1991, BIOCHEMISTRY-US, V30, P9464, DOI 10.1021/bi00103a011; DENG HY, 1992, BIOCHEMISTRY-US, V31, P10518, DOI 10.1021/bi00158a015; DONISKELLER H, 1980, NUCLEIC ACIDS RES, V8, P3133, DOI 10.1093/nar/8.14.3133; FORSTER AC, 1987, CELL, V49, P211, DOI 10.1016/0092-8674(87)90562-9; FUJIMOTO M, 1974, AGR BIOL CHEM TOKYO, V38, P1555, DOI 10.1080/00021369.1974.10861384; HIMENO H, 1989, NUCLEIC ACIDS RES, V17, P7855, DOI 10.1093/nar/17.19.7855; HINGERTY B, 1978, J MOL BIOL, V124, P523, DOI 10.1016/0022-2836(78)90185-7; HOLBROOK SR, 1977, NUCLEIC ACIDS RES, V4, P2811, DOI 10.1093/nar/4.8.2811; JACK A, 1977, J MOL BIOL, V111, P315, DOI 10.1016/S0022-2836(77)80054-5; KOIZUMI M, 1991, BIOCHEMISTRY-US, V30, P5145, DOI 10.1021/bi00235a005; KRZYZOSIAK WJ, 1988, BIOCHEMISTRY-US, V27, P5771, DOI 10.1021/bi00415a056; KUCHINO Y, 1987, METHOD ENZYMOL, V155, P379; LIMMER S, 1993, P NATL ACAD SCI USA, V90, P6199, DOI 10.1073/pnas.90.13.6199; MARCINIEC T, 1989, FEBS LETT, V243, P293, DOI 10.1016/0014-5793(89)80148-6; NILSEN TW, 1994, CELL, V78, P1, DOI 10.1016/0092-8674(94)90563-0; NISHIMURA S, 1969, BIOCHEMISTRY-US, V8, P832, DOI 10.1021/bi00831a011; PAN T, 1992, NATURE, V358, P560, DOI 10.1038/358560a0; PAN T, 1992, BIOCHEMISTRY-US, V31, P3887, DOI 10.1021/bi00131a001; PERROTTA AT, 1991, NATURE, V350, P434, DOI 10.1038/350434a0; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; QUIGLEY GJ, 1978, P NATL ACAD SCI USA, V75, P64, DOI 10.1073/pnas.75.1.64; RORDORF BF, 1976, BIOPOLYMERS, V15, P1491, DOI 10.1002/bip.1976.360150805; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAMPSON JR, 1987, COLD SPRING HARB SYM, V52, P267, DOI 10.1101/SQB.1987.052.01.032; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; STOUT CD, 1978, ACTA CRYSTALLOGR B, V34, P1529, DOI 10.1107/S0567740878006056; SUH YA, 1993, NUCLEIC ACIDS RES, V21, P3277, DOI 10.1093/nar/21.14.3277; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; WATSON JD, 1987, MOL BIOL GENE, P1097; WERNER C, 1976, BIOCHIM BIOPHYS ACTA, V432, P161, DOI 10.1016/0005-2787(76)90158-1; WINTERMEYER W, 1973, BIOCHIM BIOPHYS ACTA, V299, P82, DOI 10.1016/0005-2787(73)90399-7; YOKOGAWA T, 1989, NUCLEIC ACIDS RES, V17, P2623, DOI 10.1093/nar/17.7.2623	40	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10097	10104		10.1074/jbc.270.17.10097	http://dx.doi.org/10.1074/jbc.270.17.10097			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730314	hybrid			2022-12-27	WOS:A1995QV41700059
J	PONGUBALA, JMR; ATCHISON, ML				PONGUBALA, JMR; ATCHISON, ML			ACTIVATING TRANSCRIPTION FACTOR-1 AND CYCLIC-AMP RESPONSE ELEMENT MODULATOR CAN MODULATE THE ACTIVITY OF THE IMMUNOGLOBULIN-KAPPA 3' ENHANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-REGULATED ENHANCER; LIGHT-CHAIN EXPRESSION; DNA-BINDING; CDNA CLONES; GENE; PROTEIN; SITE; CREM; INDUCIBILITY; PROMOTER	Previously we determined that the immunoglobulin kappa 3' enhancer (kappa E3') contains at least two functional DNA sequences (PU.1/NF-EM5 and E2A) within its 132-base pair active core. We have determined that the activities of these two sequences are insufficient to account for the entire activity of the 132-base pair core. Using site-directed linker scan mutagenesis across the core fragment we identified several additional functional sequences. We used one of these functional sequences to screen a lambda gt11 cDNA expression library resulting in the isolation of cDNA clones encoding the transcription factors ATF-1 (activating transcription factor) and CREM. (cyclic AMP response element modulator). Because ATF-1 and CREM are known to bind to cAMP response elements (CRE), this functional sequence was named the kappa E3'-CRE. We show that dibutyryl cAMP can increase kappa E3' enhancer activity, and in transient expression assays ATF-1 caused a 4-5-fold increase in the activity of the core enhancer while CREM-alpha expression resulted in repression of enhancer activity. RNA analyses showed increased levels of ATF-1 mRNA during B cell development and some changes in CREIM transcript processing. By joining various fragments of the kappa E3' enhancer to the kappa E3'-CRE, we observed that the kappa E3'-CRE can synergistically increase transcription in association with the PU.1/NF-EM5 binding sites, suggesting a functional interaction between the proteins that bind to these DNA sequences. Consistent with this possibility, we found that ATF-1 and CREM can physically interact with PU.1. The isolation of activator and repressor proteins that bind to the kappa E3'-CRE may relate to previous conflicting results concerning the role of the cAMP signal transduction pathway in kappa gene transcription.	UNIV PENN,SCH VET MED,DEPT ANIM BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania					NIGMS NIH HHS [R01 GM42415] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042415] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATCHISON ML, 1987, CELL, V48, P121, DOI 10.1016/0092-8674(87)90362-X; ATCHISON ML, 1990, EMBO J, V9, P3109, DOI 10.1002/j.1460-2075.1990.tb07508.x; ATCHISON ML, 1988, EMBO J, V7, P4213, DOI 10.1002/j.1460-2075.1988.tb03318.x; BOMSZTYK K, 1990, J BIOL CHEM, V265, P9413; BRISKIN M, 1988, SCIENCE, V242, P1036, DOI 10.1126/science.3143155; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FOULKES NS, 1991, P NATL ACAD SCI USA, V88, P5448, DOI 10.1073/pnas.88.12.5448; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GIRI JG, 1984, J IMMUNOL, V132, P223; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAGMAN J, 1990, GENE DEV, V4, P978, DOI 10.1101/gad.4.6.978; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HURST HC, 1991, NUCLEIC ACIDS RES, V19, P4601, DOI 10.1093/nar/19.17.4601; JUDDE JG, 1992, MOL CELL BIOL, V12, P5206, DOI 10.1128/MCB.12.11.5206; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; MCGILLIS JP, 1993, CELL IMMUNOL, V150, P405, DOI 10.1006/cimm.1993.1208; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; NAKAJIMA K, 1993, MOL CELL BIOL, V13, P3027, DOI 10.1128/MCB.13.5.3027; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; PONGUBALA JMR, 1992, MOL CELL BIOL, V11, P1041; REHFUSS RP, 1991, J BIOL CHEM, V266, P18431; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P959, DOI 10.1128/MCB.9.3.959; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WAGNER S, 1993, SCIENCE, V262, P395, DOI 10.1126/science.8211160; WEEKS RS, 1988, J IMMUNOL, V140, P1312; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x; ZARET KS, 1990, P NATL ACAD SCI USA, V87, P5469, DOI 10.1073/pnas.87.14.5469; ZIFF EB, 1990, TRENDS GENET, V6, P69, DOI 10.1016/0168-9525(90)90081-G	42	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10304	10313		10.1074/jbc.270.17.10304	http://dx.doi.org/10.1074/jbc.270.17.10304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730336	hybrid			2022-12-27	WOS:A1995QV41700085
J	SZABO, P; MOITRA, J; RENCENDORJ, A; RAKHELY, G; RAUCH, T; KISS, I				SZABO, P; MOITRA, J; RENCENDORJ, A; RAKHELY, G; RAUCH, T; KISS, I			IDENTIFICATION OF A NUCLEAR FACTOR-I FAMILY PROTEIN-BINDING SITE IN THE SILENCER REGION OF THE CARTILAGE MATRIX PROTEIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; TRANSCRIPTION FACTORS; DNA-REPLICATION; DEVELOPING LIMB; PROMOTER; SEQUENCE; CELLS; ENHANCER; CLONING; GROWTH	Cartilage matrix protein (CMP) is synthesized by chondrocytes in a developmentally regulated manner, Here we have dissected promoter upstream elements involved in its transcriptional regulation We show that although the 79-base pair CMP minimal promoter is promiscuous, 1137 base pairs of 5'-flanking region are capable of directing tissue and developmental stage specific transcription when fused to a reporter gene, This results from two positive control regions which, in proliferating chondrocytes, relieve the repression mediated by two non-tissue-specific negative control regions. Characterization of the promoter proximal silencer by DNase I footprinting and gel shifts revealed the presence of two elements, SI and SII, which bound mesenchymal cell proteins, Methylation interference analysis indicated a gapped palindromic binding site similar to nuclear factor I (NF-I) family proteins within SI, but only a half-site within SII. Gel shift assays with specific NF-I and mutated SI competitors, binding of recombinant NF-I, as well as supershift analysis with NF-I-specific antiserum verified the binding of NF-I family proteins to the SI element, Double-stranded SI and SII oligonucleotides inserted in single copy in either orientation were found to repress both homologous and heterologous promoters upon transfection into mesenchymal cells, Transcriptional repression also occurred when a consensus NF-I site itself was fused to the CMP minimal promoter, We conclude that NF-I-related protein(s) can mediate transcriptional repression in cells of mesenchymal origin.	HUNGARIAN ACAD SCI, BIOL RES CTR, INST BIOCHEM, H-6701 SZEGED, HUNGARY	Hungarian Academy of Sciences; Hungarian Biological Research Center			Rakhely, Gabor/K-3696-2014	Rakhely, Gabor/0000-0003-2557-3641; Szabo, Piroska/0000-0001-9314-7009				ABKEN H, 1992, NUCLEIC ACIDS RES, V20, P3527, DOI 10.1093/nar/20.13.3527; ADOLPHE M, 1992, BIOL REGULATION CHON, P1; ARGRAVES WS, 1987, P NATL ACAD SCI USA, V84, P464, DOI 10.1073/pnas.84.2.464; ASZODI A, 1994, MATRIX BIOL, V14, P181, DOI 10.1016/0945-053X(94)90007-8; AUSUBEL FM, 1988, CURRENT PROTOCOLS MO, P201; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CEREGHINI S, 1987, CELL, V50, P627, DOI 10.1016/0092-8674(87)90036-5; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; CLARK AR, 1993, BIOCHEM J, V296, P521, DOI 10.1042/bj2960521; CORTHESY B, 1990, MOL CELL BIOL, V10, P3926, DOI 10.1128/MCB.10.8.3926; COWELL IG, 1994, TRENDS BIOCHEM SCI, V19, P38, DOI 10.1016/0968-0004(94)90172-4; DUSSERRE Y, 1992, MOL CELL BIOL, V12, P5228, DOI 10.1128/MCB.12.11.5228; FRANZEN A, 1987, DIFFERENTIATION, V36, P199, DOI 10.1111/j.1432-0436.1987.tb00194.x; GHOSH D, 1990, NUCLEIC ACIDS RES, V18, P1749, DOI 10.1093/nar/18.7.1749; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GUERIN SL, 1993, EUR J BIOCHEM, V213, P399, DOI 10.1111/j.1432-1033.1993.tb17774.x; HALL B, 1991, CARTILAGE MOL ASPECT, V1, P153; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAUSER N, 1994, J BIOL CHEM, V269, P25747; HORTON W, 1987, P NATL ACAD SCI USA, V84, P8864, DOI 10.1073/pnas.84.24.8864; HUNTER E, 1979, METHOD ENZYMOL, V58, P381; JACKSON DA, 1993, MOL CELL BIOL, V13, P2401, DOI 10.1128/MCB.13.4.2401; JETT M, 1977, J BIOL CHEM, V252, P2134; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KARSENTY G, 1990, J BIOL CHEM, V265, P9934; KISS I, 1989, J BIOL CHEM, V264, P8126; KISS I, 1990, MOL CELL BIOL, V10, P2432, DOI 10.1128/MCB.10.5.2432; KRUSE U, 1994, FEBS LETT, V348, P46, DOI 10.1016/0014-5793(94)00585-0; KRUSE U, 1994, J MOL BIOL, V238, P860, DOI 10.1006/jmbi.1994.1343; KUJAWA MJ, 1989, EXP CELL RES, V183, P45, DOI 10.1016/0014-4827(89)90417-5; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; LEVITT D, 1975, DEV BIOL, V43, P75, DOI 10.1016/0012-1606(75)90132-3; MAINI PK, 1991, INT REV CYTOL, V129, P91; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MUNDLOS S, 1994, DEV DYNAM, V199, P241, DOI 10.1002/aja.1001990308; NEHLS MC, 1991, MOL CELL BIOL, V11, P4065, DOI 10.1128/MCB.11.8.4065; PAONESSA G, 1988, EMBO J, V7, P3115, DOI 10.1002/j.1460-2075.1988.tb03178.x; PAULSSON M, 1979, BIOCHEM J, V183, P539, DOI 10.1042/bj1830539; PERKINS SJ, 1994, J MOL BIOL, V238, P104, DOI 10.1006/jmbi.1994.1271; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; ROY RJ, 1992, NUCLEIC ACIDS RES, V20, P401, DOI 10.1093/nar/20.3.401; RUPP RAW, 1990, NUCLEIC ACIDS RES, V18, P2607, DOI 10.1093/nar/18.9.2607; Sambrook J, 1989, MOL CLONING LABORATO; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; SEALEY L, 1987, MOL CELL BIOL, V7, P787, DOI 10.1128/MCB.7.2.787; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; STIRPE NS, 1989, DEVELOPMENT, V107, P23; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2; [No title captured]	57	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10212	10221		10.1074/jbc.270.17.10212	http://dx.doi.org/10.1074/jbc.270.17.10212			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730325				2022-12-27	WOS:A1995QV41700073
J	SOKOLOV, BP; ALAKOKKO, L; DHULIPALA, R; ARITA, M; KHILLAN, JS; PROCKOP, DJ				SOKOLOV, BP; ALAKOKKO, L; DHULIPALA, R; ARITA, M; KHILLAN, JS; PROCKOP, DJ			TISSUE-SPECIFIC EXPRESSION OF THE GENE FOR TYPE-I PROCOLLAGEN (COL1A1) IN TRANSGENIC MICE - ONLY 476 BASE-PAIRS OF THE PROMOTER ARE REQUIRED IF COLLAGEN GENES ARE USED AS REPORTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-BETA; PUTATIVE REGULATORY SEQUENCES; PARTIALLY DELETED GENE; MESSENGER-RNA LEVELS; 1ST INTRON; OSTEOGENESIS IMPERFECTA; TRANSCRIPTIONAL CONTROL; LUNG FIBROBLASTS; DNA-SEQUENCES; PHENOTYPE	Inconsistent data have been reported on the size of the promoter that is necessary for high levels of tissue-specific expression of the COL1A1 gene for type I procollagen. Some of the inconsistencies may be traced to the use of reporter gene constructs. Therefore, we prepared transgenic mice with modifications of the intact gene engineered so that the level of expression of the transgene could be assayed both as mRNA and protein that were similar to the products from the endogenous COL1A1 gene. The results with a mini-COL1A1 gene lacking 41 internal exons and introns indicated that the first intron and 90% of the 3'-untranslated region were not essential for tissue-specific expression. In a hybrid COL1A1/COL2A1 construct, a 1,9-kilobase 5'-fragment from the COL1A1 gene that contained only 476 of the promoter was linked to a promoterless 29.5 kilobase fragment of the human COL2A1 gene for type II procollagen. The hybrid COL1A1/COL2A1 construct was expressed as both mRNA and protein in tissues that normally synthesize type I procollagen but not type II procollagen. Apparently, 476 base pairs of the promoter are sufficient to drive tissue-specific expression of the COL1A1 gene and totally inappropriate expression of the COL2A1 gene.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, JEFFERSON INST MOLEC MED, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA	Jefferson University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039740, P01AR038188] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-38188, AR-39740] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1991, J BIOL CHEM, V266, P14175; BALDWIN CT, 1989, BIOCHEM J, V262, P521, DOI 10.1042/bj2620521; BEDALOV A, 1994, J BIOL CHEM, V269, P4903; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; BOAST S, 1990, J BIOL CHEM, V265, P13351; BOGDANOVIC Z, 1994, J BONE MINER RES, V9, P285; BORNSTEIN P, 1988, J BIOL CHEM, V263, P1603; BORNSTEIN P, 1989, PROG NUCLEIC ACID RE, V37, P67; CHOE I, 1987, J BIOL CHEM, V262, P5408; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONSTANTINOU CD, 1989, J CLIN INVEST, V83, P574, DOI 10.1172/JCI113920; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; DECROMBRUGGHE B, 1991, ANN RHEUM DIS, V50, P872, DOI 10.1136/ard.50.Suppl_4.872; FINE A, 1987, J BIOL CHEM, V262, P3897; FINE A, 1989, J BIOL CHEM, V264, P16988; GANGULY A, 1994, P NATL ACAD SCI USA, V91, P7365, DOI 10.1073/pnas.91.15.7365; HELMINEN HJ, 1993, J CLIN INVEST, V92, P582, DOI 10.1172/JCI116625; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; KHILLAN JS, 1991, J BIOL CHEM, V266, P23373; KHILLAN JS, 1994, P NATL ACAD SCI USA, V91, P6298, DOI 10.1073/pnas.91.14.6298; KING SL, 1994, J BIOL CHEM, V269, P13156; LISKA DJ, 1994, J CELL BIOL, V125, P695, DOI 10.1083/jcb.125.3.695; LISKA DJ, 1990, CELL REGUL, V1, P487, DOI 10.1091/mbc.1.6.487; MAATTA A, 1993, BIOCHEM J, V294, P365, DOI 10.1042/bj2940365; MATHEWS MB, 1980, BIOL COLLAGEN, P193; MOREIRA J L, 1992, Methods in Molecular and Cellular Biology, V3, P23; OLSEN AS, 1991, J BIOL CHEM, V266, P1117; PAVLIN D, 1992, J CELL BIOL, V116, P227, DOI 10.1083/jcb.116.1.227; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; PEREIRA R, 1994, J CLIN INVEST, V93, P1765, DOI 10.1172/JCI117161; PEREIRA R, 1993, J CLIN INVEST, V91, P709, DOI 10.1172/JCI116252; PIERCE RA, 1987, J BIOL CHEM, V262, P1652; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; PROCKOP DJ, 1994, IN PRESS ANN REV BIO; RAGHOW R, 1989, MOL CELL BIOCHEM, V86, P5; RIPPE RA, 1989, MOL CELL BIOL, V9, P2224, DOI 10.1128/MCB.9.5.2224; RITZENTHALER JD, 1991, BIOCHEM J, V280, P157, DOI 10.1042/bj2800157; Rossert J., 1994, Matrix Biology, V14, P370, DOI 10.1016/0945-053X(94)90073-6; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; ROSSOUW CMS, 1987, J BIOL CHEM, V262, P15151; SLACK JL, 1991, MOL CELL BIOL, V11, P2066, DOI 10.1128/MCB.11.4.2066; SOKOLOV BP, 1993, BIOCHEMISTRY-US, V32, P9242, DOI 10.1021/bi00086a033; SOLISHERRUZO JA, 1988, J BIOL CHEM, V263, P5841; THOREY IS, 1993, MOL CELL BIOL, V13, P6742, DOI 10.1128/MCB.13.11.6742; TROMP G, 1988, BIOCHEM J, V253, P919, DOI 10.1042/bj2530919; VANDENBERG P, 1991, P NATL ACAD SCI USA, V88, P7640, DOI 10.1073/pnas.88.17.7640; WALSH MJ, 1987, J BIOL CHEM, V262, P10814	47	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9622	9629		10.1074/jbc.270.16.9622	http://dx.doi.org/10.1074/jbc.270.16.9622			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721894	hybrid			2022-12-27	WOS:A1995QU08900083
J	WANG, WY; POLAND, BW; HONZATKO, RB; FROMM, HJ				WANG, WY; POLAND, BW; HONZATKO, RB; FROMM, HJ			IDENTIFICATION OF ARGININE RESIDUES IN THE PUTATIVE L-ASPARTATE BINDING-SITE OF ESCHERICHIA-COLI ADENYLOSUCCINATE SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLONING; SEQUENCE; PURA	Three arginine residues in the putative aspartate binding site of Escherichia coli adenylosuccinate synthetase were changed to leucines by site-directed mutagenesis. The mutant enzymes R303L, R304L, and R305L were purified to homogeneity on the basis of sodium dodecyl sulfate polyacrylamide gel electrophoresis and characterized by CD spectrometry and initial rate kinetics. CD spectral analysis indicated no differences in secondary structure between the mutants and the wild-type enzyme in the absence of substrates. The K-m values for GTP and IMP for the mutants and the mild-type enzyme were comparable. However, the mutant enzymes exhibited 50-200-fold increases in their values of K-m for the substrate aspartate relative to the wild-type enzyme. Although the K-m values for the mutant enzymes decreased, the changes were not as dramatic as those observed for the K-m of aspartate. The modeling of aspartate in the crystal structure of the complex of adenylosuccinate synthetase with IMP and MgGDP(-1) is consistent with the results of mutagenesis, placing the alpha- and beta- carboxylates of aspartate near the side chains of Arg-131, -303, and -305.	IOWA STATE UNIV SCI & TECHNOL, DEPT BIOCHEM & BIOPHYS, AMES, IA 50011 USA	Iowa State University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS010546, R56NS010546] Funding Source: NIH RePORTER; NINDS NIH HHS [NS10546] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASS MB, 1987, ARCH BIOCHEM BIOPHYS, V256, P335, DOI 10.1016/0003-9861(87)90454-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COOPER BF, 1986, BIOCHEMISTRY-US, V25, P7323, DOI 10.1021/bi00371a013; FROMM HJ, 1958, BIOCHIM BIOPHYS ACTA, V29, P255, DOI 10.1016/0006-3002(58)90182-3; GUICHERIT OM, 1994, J BIOL CHEM, V269, P4488; GUICHERIT OM, 1991, J BIOL CHEM, V266, P22582; HAMPTON A, 1970, BIOCHIM BIOPHYS ACTA, V198, P594, DOI 10.1016/0005-2744(70)90136-1; KANG C, 1994, J BIOL CHEM, V269, P24046; KANG CH, 1994, ARCH BIOCHEM BIOPHYS, V310, P475, DOI 10.1006/abbi.1994.1195; KUSANO T, 1992, J BIOL CHEM, V267, P11242; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEBERMAN I, 1956, J BIOL CHEM, V223, P327; MANTSALA P, 1992, J BACTERIOL, V174, P1883; POLAND BW, 1993, J BIOL CHEM, V268, P25334; POWELL SM, 1992, FEBS LETT, V303, P4, DOI 10.1016/0014-5793(92)80465-S; RUDOLPH FB, 1969, J BIOL CHEM, V244, P3832; RUDOLPH FB, 1971, THESIS IOWA STATE U; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPEISER DM, 1992, MOL CELL BIOL, V12, P5301, DOI 10.1128/MCB.12.12.5301; STAYTON MM, 1983, CURR TOP CELL REGUL, V22, P103; STAYTON MM, 1976, 172ND ANN M AM CHEM, P155; WIESMULLER L, 1991, J BIOL CHEM, V266, P2480; WOLFE SA, 1988, J BIOL CHEM, V263, P19147	24	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13160	13163		10.1074/jbc.270.22.13160	http://dx.doi.org/10.1074/jbc.270.22.13160			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768911	hybrid			2022-12-27	WOS:A1995RB43900034
J	CIPPITELLI, M; SICA, A; VIGGIANO, V; YE, JP; GHOSH, P; BIRRER, MJ; YOUNG, HA				CIPPITELLI, M; SICA, A; VIGGIANO, V; YE, JP; GHOSH, P; BIRRER, MJ; YOUNG, HA			NEGATIVE TRANSCRIPTIONAL REGULATION OF THE INTERFERON-GAMMA PROMOTER BY GLUCOCORTICOIDS AND DOMINANT-NEGATIVE MUTANTS OF C-JUN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; DNA-BINDING; GENE-EXPRESSION; NUCLEAR FACTOR; LYMPHOCYTE-T; HUMAN INTERLEUKIN-2; SIGNALING PATHWAY; MAMMALIAN-CELLS; FAMILY MEMBERS; TATA BOX	Interferon-gamma (IFN-gamma) is an immunoregulatory cytokine expressed in large granular lymphocytes and T cells. However, the molecular mechanisms underlying IFN-gamma gene transcription have not been fully defined. Here, we analyze the mechanisms responsible for the inhibition of IFN-gamma promoter activity by the glucocorticoid hormone dexamethasone. Cotransfection assays performed in Jurkat T cells demonstrated that the activity of the initial 108 base pairs of the IFN-gamma promoter was down-regulated in the presence of dexamethasone. Furthermore, utilizing electrophoretic mobility shift analysis, we identified activator protein 1 AP-1-cAMP response element binding protein-activating transcription factor (CREB-ATF) binding elements situated in positions of the IFN-gamma promoter previously identified as essential for promoter activity. Moreover, dominant negative mutants of the c-Jun proto-oncogene were able to mimic the same down-regulatory effect exerted by dexamethasone, and mutations that abolished the binding of the AP-1 . CREB-ATF factors were able to block the glucocorticoid effect. These results suggest a model involving the inhibition of IFN-gamma AP-1 CREB-ATF DNA binding complexes as one of the mechanisms involved in the negative regulatory action of glucocorticoids on IFN-gamma gene expression and support the relevance of AP-1 . CREB-ATF binding factors during the transcriptional activation of the IFN-gamma promoter in T cells.	NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,EXPTL IMMUNOL LAB,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702; NCI,DIV CANC PREVENT & CONTROL,BIOMARKERS & PREVENT RES BRANCH,ROCKVILLE,MD 20850	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Sica, Antonio/AAB-9546-2020; Ye, Jianping/N-1998-2017; Young, Howard/A-6350-2008	Ye, Jianping/0000-0003-3875-365X; CIPPITELLI, Marco/0000-0002-9620-538X; Young, Howard/0000-0002-3118-5111				ABE E, 1992, P NATL ACAD SCI USA, V89, P2864, DOI 10.1073/pnas.89.7.2864; ALANI R, 1991, MOL CELL BIOL, V11, P6286, DOI 10.1128/MCB.11.12.6286; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ARYA SK, 1984, J IMMUNOL, V133, P273; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOUMPAS DT, 1991, J CLIN INVEST, V87, P1739, DOI 10.1172/JCI115192; BOUMPAS DT, 1991, CLIN EXP RHEUMATOL, V9, P413; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BROWN DA, 1992, EUR J IMMUNOL, V22, P2419, DOI 10.1002/eji.1830220935; BROWN DA, 1991, EUR J IMMUNOL, V21, P1879, DOI 10.1002/eji.1830210815; BROWN PH, 1994, ONCOGENE, V9, P791; BROWN PH, 1993, ONCOGENE, V8, P877; CHANG TJ, 1993, MOL ENDOCRINOL, V7, P528, DOI 10.1210/me.7.4.528; CHRIVIA JC, 1990, J EXP MED, V172, P661, DOI 10.1084/jem.172.2.661; CICCARONE VC, 1990, J IMMUNOL, V144, P725; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CULPEPPER J, 1987, LYMPHOKINES, V13, P275; DEGRAZIA U, 1994, J EXP MED, V180, P1485, DOI 10.1084/jem.180.4.1485; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GHOSH P, 1993, P NATL ACAD SCI USA, V90, P1696, DOI 10.1073/pnas.90.5.1696; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HADMAN M, 1993, ONCOGENE, V8, P1895; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P3782, DOI 10.1128/MCB.13.6.3782; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; MARINE J, 1991, P NATL ACAD SCI USA, V88, P7284, DOI 10.1073/pnas.88.16.7284; MARODER M, 1993, MOL ENDOCRINOL, V7, P570, DOI 10.1210/me.7.4.570; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; MUKAIDA N, 1992, IMMUNOLOGY, V75, P674; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NORTHROP JP, 1992, J EXP MED, V175, P1235, DOI 10.1084/jem.175.5.1235; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; OEHLER T, 1992, MOL CELL BIOL, V12, P5508, DOI 10.1128/MCB.12.12.5508; PALIOGIANNI F, 1993, J CLIN INVEST, V91, P1481, DOI 10.1172/JCI116353; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; PETRAK D, 1994, J IMMUNOL, V153, P2046; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8; RAY A, 1990, MOL CELL BIOL, V10, P5736, DOI 10.1128/MCB.10.11.5736; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; STAUBER C, 1992, NEW BIOL, V4, P527; STROMSTEDT PE, 1991, MOL CELL BIOL, V11, P3379, DOI 10.1128/MCB.11.6.3379; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; ULLMAN KS, 1993, GENE DEV, V7, P188, DOI 10.1101/gad.7.2.188; VACCA A, 1992, J EXP MED, V175, P637, DOI 10.1084/jem.175.3.637; VACCA A, 1990, J BIOL CHEM, V265, P8075; WIELAND S, 1991, EMBO J, V10, P2513, DOI 10.1002/j.1460-2075.1991.tb07791.x; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YE JP, 1994, J BIOL CHEM, V269, P25728; YOUNG HA, 1990, PHARMACOL THERAPEUT, V45, P137, DOI 10.1016/0163-7258(90)90012-Q; YOUNG HA, 1994, J IMMUNOL, V153, P3603; ZHANG XK, 1991, J BIOL CHEM, V266, P8248	65	114	115	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12548	12556		10.1074/jbc.270.21.12548	http://dx.doi.org/10.1074/jbc.270.21.12548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759501	hybrid			2022-12-27	WOS:A1995QZ71100036
J	KONRAD, RJ; YOUNG, RA; RECORD, RD; SMITH, RM; BUTKERAIT, P; MANNING, D; JARETT, L; WOLF, BA				KONRAD, RJ; YOUNG, RA; RECORD, RD; SMITH, RM; BUTKERAIT, P; MANNING, D; JARETT, L; WOLF, BA			THE HETEROTRIMERIC G-PROTEIN G(I) IS LOCALIZED TO THE INSULIN SECRETORY GRANULES OF BETA-CELLS AND IS INVOLVED IN INSULIN EXOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING REGULATORY PROTEINS; PERMEABILIZED RINM5F CELLS; ACYL-COA ESTERS; PANCREATIC-ISLETS; KINASE-C; HUMAN PLATELETS; GLUCOSE SENSOR; COMPOUND 48/80; ION CHANNELS; MALONYL-COA	Mastoparan, a tetradecapeptide found in wasp venom that stimulates G-proteins, increases insulin secretion from beta-cells. In this study, we have examined the role of heterotrimeric G-proteins in mastoparan-induced insulin secretion from the insulin-secreting beta-cell line beta-TC3. Mastoparan stimulated insulin secretion in a dose-dependent manner from digitonin-permeabilized beta-TC3 cells, Active mastoparan analogues mastoparan 7, mastoparan 8, and mastoparan X also stimulated secretion, Mastoparan 17, an inactive analogue of mastoparan, did not increase insulin secretion from permeabilized beta-TC3 cells, Mastoparan-induced insulin secretion from permeabilized beta-TC3 cells was inhibited by pretreatment of the cells with pertussis toxin, suggesting that mastoparan-induced insulin secretion is mediated through a pertussis toxin sensitive G-protein present distally in exocytosis. Enriched insulin secretory granules (ISG) were prepared by sucrose/nycodenz ultracentrifugation, Western immunoblotting performed on beta-TC3 ho mogenate and ISG demonstrated that G alpha(i) was dramatically enriched in ISG. Levels of G alpha(o) and G alpha(q) were comparable in homogenate and ISG. Mastoparan stimulated ISG GTPase activity in a pertussis toxin sensitive manner. Mastoparan 7 and mastoparan 8 also stimulated GTPase activity in the ISG, while the inactive analogue mastoparan 17 had no effect. Selective localization of G alpha(1) to ISG was confirmed with electron microscopic immunocytochemistry in beta-TC3 cells and beta-cells from rat pancreas, In contrast to G alpha(o) and G alpha(q), G alpha(i) was clearly localized to the ISG, Together, these data suggest that mastoparan may act through the heterotrimeric G-protein G alpha(i) located in the ISG of beta-cells to stimulate insulin secretion.	UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania				Ritchie, Rae/0000-0002-0693-0693	NIDDK NIH HHS [R01 DK28143, R01 DK43354] Funding Source: Medline; NIGMS NIH HHS [R01 GM34781] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028143, R01DK043354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM034781] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHCROFT SJH, 1980, DIABETOLOGIA, V18, P5, DOI 10.1007/BF01228295; BAFFY G, 1993, DIABETES, V42, P1878, DOI 10.2337/diabetes.42.12.1878; COLCA JR, 1985, BIOCHEM J, V228, P529, DOI 10.1042/bj2280529; COOK DL, 1988, DIABETES, V37, P495, DOI 10.2337/diabetes.37.5.495; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; DANILENKO M, 1993, BIOCHEM BIOPH RES CO, V196, P1296, DOI 10.1006/bbrc.1993.2393; DEENEY JT, 1992, J BIOL CHEM, V267, P19840; DUNNE MJ, 1991, BIOCHIM BIOPHYS ACTA, V1071, P67, DOI 10.1016/0304-4157(91)90012-L; EASOM RA, 1990, J BIOL CHEM, V265, P14938; HEDESKOV CJ, 1980, PHYSIOL REV, V60, P442, DOI 10.1152/physrev.1980.60.2.442; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HILLAIREBUYS D, 1992, MOL CELL BIOCHEM, V109, P133; HORISBERGER M, 1994, HISTOCHEMISTRY, V82, P219; HSU WH, 1991, J BIOL CHEM, V266, P837; HUTTON JC, 1982, DIABETOLOGIA, V23, P365; JONES PM, 1993, MOL CELL ENDOCRINOL, V94, P97, DOI 10.1016/0303-7207(93)90056-P; JOYCEBRADY M, 1991, J BIOL CHEM, V266, P6859; KOMATSU M, 1993, J BIOL CHEM, V268, P23297; KONRAD RJ, 1992, BIOCHEM J, V287, P283, DOI 10.1042/bj2870283; KOWLURU A, 1994, BBA-MOL CELL RES, V1222, P360, DOI 10.1016/0167-4889(94)90041-8; KOWLURU A, 1994, BBA-MOL CELL RES, V1222, P348, DOI 10.1016/0167-4889(94)90040-X; LAW SF, 1992, MOL PHARMACOL, V42, P398; LEWIS JM, 1991, CELL REGUL, V2, P1097, DOI 10.1091/mbc.2.12.1097; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LOUNSBURY KM, 1993, J BIOL CHEM, V268, P3494; MACDONALD MJ, 1990, DIABETES, V39, P1461, DOI 10.2337/diabetes.39.12.1461; MALAISSE WJ, 1979, METABOLISM, V28, P373, DOI 10.1016/0026-0495(79)90111-2; MATSCHINSKY F, 1993, J CLIN INVEST, V92, P2092, DOI 10.1172/JCI116809; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; MAYORGA LS, 1993, P NATL ACAD SCI USA, V90, P10255, DOI 10.1073/pnas.90.21.10255; MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; MONTMAYEUR JP, 1994, SCIENCE, V263, P95, DOI 10.1126/science.8272874; MOUSLI M, 1990, FEBS LETT, V259, P260, DOI 10.1016/0014-5793(90)80023-C; MOUSLI M, 1990, TRENDS PHARMACOL SCI, V11, P358, DOI 10.1016/0165-6147(90)90179-C; NILSSON T, 1989, J BIOL CHEM, V264, P973; NORGAUER J, 1992, BIOCHEM J, V282, P393, DOI 10.1042/bj2820393; OLSZEWSKI S, 1994, J BIOL CHEM, V269, P27987; OZAKI Y, 1990, BIOCHEM BIOPH RES CO, V170, P779, DOI 10.1016/0006-291X(90)92159-W; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; RAJAN AS, 1990, DIABETES CARE, V13, P340, DOI 10.2337/diacare.13.3.340; ROBERTSON RP, 1991, DIABETES, V40, P1, DOI 10.2337/diabetes.40.1.1; ROSS EM, 1994, METHOD ENZYMOL, V297, P26; SEAQUIST ER, 1992, DIABETES, V41, P1390, DOI 10.2337/diabetes.41.11.1390; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOLER AP, 1989, P NATL ACAD SCI USA, V86, P6640, DOI 10.1073/pnas.86.17.6640; SUKUMAR M, 1992, J BIOL CHEM, V267, P21421; TANIMURA A, 1991, BIOCHEM BIOPH RES CO, V177, P802, DOI 10.1016/0006-291X(91)91860-F; TOMITA U, 1991, J BIOCHEM-TOKYO, V109, P184, DOI 10.1093/oxfordjournals.jbchem.a123342; TRAN D, 1993, CELL SIGNAL, V5, P565, DOI 10.1016/0898-6568(93)90052-N; TURK J, 1987, PROG LIPID RES, V26, P125, DOI 10.1016/0163-7827(87)90010-5; ULLRICH S, 1988, J BIOL CHEM, V263, P8615; ULLRICH S, 1990, BIOCHEM J, V270, P273, DOI 10.1042/bj2700273; VALLAR L, 1987, J BIOL CHEM, V262, P5049; VITALE N, 1993, J BIOL CHEM, V268, P14715; WEINGARTEN R, 1990, J BIOL CHEM, V265, P11044; WENHAM RM, 1994, J BIOL CHEM, V269, P4947; WHEELERJONES CPD, 1991, BIOCHEM SOC T, V19, pS114, DOI 10.1042/bst019114s; WHEELERJONES CPD, 1992, BIOCHEM J, V281, P465, DOI 10.1042/bj2810465; WILLIAMS AG, 1990, BLOOD, V76, P721; WOLF BA, 1988, J BIOL CHEM, V263, P3565; WOLLHEIM CB, 1990, FEBS LETT, V268, P376, DOI 10.1016/0014-5793(90)81289-Z; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914	66	97	98	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12869	12876		10.1074/jbc.270.21.12869	http://dx.doi.org/10.1074/jbc.270.21.12869			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759545	hybrid			2022-12-27	WOS:A1995QZ71100082
J	LEE, SH; KIM, DK				LEE, SH; KIM, DK			THE ROLE OF THE 34-KDA SUBUNIT OF HUMAN REPLICATION PROTEIN-A IN SIMIAN-VIRUS-40 DNA-REPLICATION IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; POLYMERASE-ALPHA-PRIMASE; SV40 T-ANTIGEN; CELL-CYCLE; INVITRO REPLICATION; BINDING-PROTEIN; FACTOR-A; SACCHAROMYCES-CEREVISIAE; CDC2 KINASE; ORIGIN	Human replication protein A (RPA) is a three subunit protein complex involved in DNA replication, repair, and recombination. We investigated the role of the 34-kDa subunit (p34) of RPA in DNA replication by generating a series of p34 mutants. While deletion of the N-terminal domain of p34 prevented its phosphorylation by both cyclin dependent kinase (Cdk) and DNA-dependent kinase, a double point mutant that lacks the major phosphorylation sites for Cdk could be phosphorylated by DNA-dependent kinase. In simian virus 40 (SV40) DNA replication, RPA containing either of these mutants functioned as efficiently as wild-type RPA. However, mutant RPA containing C-terminally deleted p34 was only marginally active. This indicates that the C-terminal region, but not the phosphorylation domain of p34, is necessary for RPA function in DNA replication. Furthermore, RPA containing the C-terminally deleted p34 mutant could stimulate DNA polymerase alpha, and bind to single-stranded DNAs but was limited in its ability to unwind DNA or interact with SV40 large T antigen (T Ag). These results suggest that RPA p34 interacts with SV40 T Ag during the initiation of SV40 DNA replication and may be necessary for DNA unwinding.	UNIV TENNESSEE, COLL MED, DEPT PATHOL, MEMPHIS, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	LEE, SH (corresponding author), ST JUDE CHILDRENS RES HOSP, DEPT VIROL & MOLEC BIOL, MEMPHIS, TN 38101 USA.				NCI NIH HHS [5P30 CA 21765-16] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; BLOW JJ, 1990, CELL, V62, P855, DOI 10.1016/0092-8674(90)90261-C; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; BROWN GW, 1993, MOL BIOCHEM PARASIT, V59, P323, DOI 10.1016/0166-6851(93)90230-U; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; DUTTA A, 1991, COLD SH Q B, V56, P315; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; ELLEDGE SJ, 1992, P NATL ACAD SCI USA, V89, P2907, DOI 10.1073/pnas.89.7.2907; ERDILE LF, 1991, J BIOL CHEM, V266, P12090; ERDILE LF, 1990, J BIOL CHEM, V265, P3177; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; KENNY MK, 1990, J BIOL CHEM, V265, P769; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LEE SH, 1991, J BIOL CHEM, V266, P594; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; MELENDY T, 1993, J BIOL CHEM, V268, P3389; MITSIS PG, 1993, BIOCHEMISTRY-US, V32, P5257, DOI 10.1021/bi00070a038; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; PAN ZQ, 1993, J BIOL CHEM, V268, P20443; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; PAN ZQ, 1993, J BIOL CHEM, V268, P20438; ROBERTS JM, 1988, SCIENCE, V241, P1486, DOI 10.1126/science.2843984; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; STIGGER E, 1994, P NATL ACAD SCI USA, V91, P579, DOI 10.1073/pnas.91.2.579; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; UMBRICHT CB, 1993, J BIOL CHEM, V268, P6131; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523	53	83	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12801	12807		10.1074/jbc.270.21.12801	http://dx.doi.org/10.1074/jbc.270.21.12801			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759535	hybrid			2022-12-27	WOS:A1995QZ71100072
J	TAN, JC; BRAUN, S; RONG, H; DIGIACOMO, R; DOLPHIN, E; BALDWIN, S; NARULA, SK; ZAVODNY, PJ; CHOU, CC				TAN, JC; BRAUN, S; RONG, H; DIGIACOMO, R; DOLPHIN, E; BALDWIN, S; NARULA, SK; ZAVODNY, PJ; CHOU, CC			CHARACTERIZATION OF RECOMBINANT EXTRACELLULAR DOMAIN OF HUMAN INTERLEUKIN-10 RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; BIOLOGICAL PROPERTIES; MOLECULAR-CLONING; LYMPHOCYTES-B; CELLS; GROWTH; IL-10; DIMERIZATION; BINDING; STOICHIOMETRY	The extracellular region of the human interleukin-10 (hIL-10) receptor was expressed using a myeloma cell line and was purified to homogeneity by Ligand-affinity chromatography. SDS-polyacrylamide gel electrophoresis analysis indicated that the soluble receptor is glycosylated and has an apparent molecular mass of 35,000-45,000. Under native conditions, soluble hIL-10 receptor was determined by gel filtration to be a monomeric protein. Soluble hIL-10 receptor was able to inhibit the binding of I-125-hTL-10 to the full-length receptor and was able to antagonize the effect of human IL-10 in cell proliferation and cytokine synthesis inhibition. The apparent dissociation constant (K-d) of soluble hIL-10 receptor was determined to be 563 +/- 59 pM, approximately 2- to 10-fold higher than that found on intact cells (Tan, J. C., Idelicato, S. R., Narula, S. IL, Zavodny, P. J., and Chou, C.-C. (1993) J. Biol. Chem. 268, 21053-21059; Liu, Y., Wei, S. H.-Y., Ho, A S.-Y., de Waal Malefyt, R., and Moore, IL m. (1994) J. Immunol. 152, 1821-1829). When hIL-10 binds soluble hIL-10 receptor in solution, a single complex was detected by gel filtration, and the complex was found to consist of two hIL-10 dimers and four soluble receptor monomers, suggesting that hIL-10 may induce a novel mode of oligomerization of the receptor upon binding.	SCHERING PLOUGH CORP,RES INST,DEPT IMMUNOL,KENILWORTH,NJ 07033	Merck & Company; Schering Plough Corporation								ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; BAIOCCHI RA, 1995, BLOOD, V84, P1063; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BEBBINGTON CR, 1992, BIO-TECHNOL, V10, P169, DOI 10.1038/nbt0292-169; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; BURDIN N, 1993, J EXP MED, V177, P295, DOI 10.1084/jem.177.2.295; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; DEVOS R, 1993, J BIOL CHEM, V268, P6581; DING L, 1993, J IMMUNOL, V151, P1224; FERNANDEZBOTRAN R, 1991, J EXP MED, V174, P673, DOI 10.1084/jem.174.3.673; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FOUNTOULAKIS M, 1992, EUR J BIOCHEM, V208, P781, DOI 10.1111/j.1432-1033.1992.tb17248.x; Galfre G, 1981, Methods Enzymol, V73, P3; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GREENLUND AC, 1993, J BIOL CHEM, V268, P18103; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; HOWARD M, 1992, J CLIN IMMUNOL, V12, P239, DOI 10.1007/BF00918147; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; LEV S, 1992, J BIOL CHEM, V267, P15970; LIU Y, 1994, J IMMUNOL, V152, P1821; MACNEIL IA, 1990, J IMMUNOL, V145, P4167; MALEFYT RD, 1991, J EXP MED, V174, P1209; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; MOSMANN TR, 1991, IMMUNOL TODAY, V12, pA49; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; OZMEN L, 1993, J IMMUNOL, V150, P2698; PENG B, 1995, IN PRESS LEUKEMIA RE, V19; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SUDA T, 1990, CELL IMMUNOL, V129, P228, DOI 10.1016/0008-8749(90)90200-B; TAN JC, 1993, J BIOL CHEM, V268, P21053; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; WANG P, 1994, BLOOD, V83, P2678, DOI 10.1182/blood.V83.9.2678.bloodjournal8392678; WARD LD, 1994, J BIOL CHEM, V269, P23286; YET MG, 1993, BLOOD, V82, P1713, DOI 10.1182/blood.V82.6.1713.bloodjournal8261713	41	53	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12906	12911		10.1074/jbc.270.21.12906	http://dx.doi.org/10.1074/jbc.270.21.12906			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759550	hybrid			2022-12-27	WOS:A1995QZ71100087
J	VAISMAN, BL; KLEIN, HG; ROUIS, M; BERARD, AM; KINDT, MR; TALLEY, GD; MEYN, SM; HOYT, RF; MARCOVINA, SM; ALBERS, JJ; HOEG, JM; BREWER, HB; SANTAMARINAFOJO, S				VAISMAN, BL; KLEIN, HG; ROUIS, M; BERARD, AM; KINDT, MR; TALLEY, GD; MEYN, SM; HOYT, RF; MARCOVINA, SM; ALBERS, JJ; HOEG, JM; BREWER, HB; SANTAMARINAFOJO, S			OVEREXPRESSION OF HUMAN LECITHIN-CHOLESTEROL ACYLTRANSFERASE LEADS TO HYPERALPHALIPOPROTEINEMIA IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEIN-A-I; HEPATIC LIPASE DEFICIENCY; ESTER TRANSFER PROTEIN; GENE; PLASMA; RECEPTOR; SEQUENCE; LIVER; ATHEROGENESIS	Lecithin cholesterol acyltransferase (LCAT) is a key enzyme which catalyzes the esterification of free cholesterol present in plasma lipoproteins. In order to evaluate the role of LCAT in HDL metabolism, a 6.2-kilobase (kb) fragment consisting of 0.851 and 1.134 kb of the 5'- and 3'-flanking regions, as well as the entire human LCAT gene, was utilized to develop transgenic mice. Three different transgenic mouse lines overexpressing human LCAT at plasma levels 11-, 14-, and 109-fold higher than non-transgenic mice were established, Northern blot hybridization analysis demonstrated that the injected 6.2-kb fragment contained the necessary DNA sequences to direct tissue specific expression of the human LCAT gene in mouse liver. Compared to age- and sex-matched controls, total cholesterol and HDL cholesterol levels were increased in all 3 transgenic mice lines by 124-218 and 123-194%, respectively, while plasma triglyceride concentrations remained similar to that of control animals. Fast protein liquid chromatography analysis of transgenic mouse plasma revealed marked increases in high density lipo-sportin (HDL)-cholesteryl ester and phospholipid as well as the formation of larger size HDL. Thus, the majority of the increase in transgenic plasma cholesterol concentrations was due to accumulation of cholesteryl ester in HDL consistent with enhanced esterification of free cholesterol in mouse HDL by human LCAT. Plasma concentrations of apoA-I, apoA-II, and apoE were increased in high expressor homozygote mice who also demonstrated an accumulation of an apoE-rich HDL(1). Like the mouse enzyme, human LCAT was found to be primarily associated with mouse HDL. Our studies demonstrate a high correlation between plasma LCAT activity and total as well as HDL cholesterol levels establishing that in mice LCAT modulates plasma HDL concentrations. Overexpression of LCAT in mice leads to HDL elevation as well as increased heterogeneity of the HDL lipoprotein particles, indicating that high levels of plasma LCAT activity may be associated with hyperalphalipoproteinemia and enhanced reverse cholesterol transport.	NHLBI,MOLEC DIS BRANCH,BETHESDA,MD 20892; NHLBI,ANIM MED & SURG LAB,BETHESDA,MD 20892; UNIV WASHINGTON,SCH MED,DEPT MED,NW LIPID RES CTR,SEATTLE,WA 98103	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle			Vaisman, Boris L/B-3453-2008; Rouis, Mustapha/E-4993-2016	Meyn, Susan/0000-0002-0894-0721; Rouis, Mustapha/0000-0003-4197-6555	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30086] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1981, J CLIN INVEST, V67, P141, DOI 10.1172/JCI110006; AUWERX JH, 1989, ARTERIOSCLEROSIS, V9, P319, DOI 10.1161/01.ATV.9.3.319; BOYLE TP, 1992, GENE, V117, P243; BRECKENRIDGE WC, 1982, ATHEROSCLEROSIS, V45, P161, DOI 10.1016/0021-9150(82)90136-8; BROWN ML, 1989, NATURE, V342, P48; BURSTEIN M, 1970, J LIPID RES, V11, P583; CARLSON LA, 1986, ACTA MED SCAND, V219, P435; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CONNELLY PW, 1990, AM J HUM GENET, V46, P470; CONNELLY PW, 1980, ATHEROSCLEROSIS, V36, P40; DEMANT T, 1988, J LIPID RES, V29, P1603; DESILVA HV, 1994, J LIPID RES, V35, P1297; DUVERGER N, 1993, BIOCHEMISTRY-US, V32, P12373; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; FIELDING CJ, 1984, J LIPID RES, V25, P1624; FIELDING PE, 1994, BIOCHEMISTRY-US, V33, P6981, DOI 10.1021/bi00188a030; FOJO SS, 1984, BIOCHEM BIOPH RES CO, V124, P308, DOI 10.1016/0006-291X(84)90953-7; FORTE T, 1971, J CLIN INVEST, V50, P1141, DOI 10.1172/JCI106586; FORTE TM, 1984, ARTERIOSCLEROSIS, V4, P130, DOI 10.1161/01.ATV.4.2.130; GLOMSET JA, 1966, J LIPID RES, V7, P638; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GORDON V, 1983, J BIOL CHEM, V258, P6202; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HOGAN B, 1986, MANIPULATING MOUSE E, P91; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; KARATHANASIS SK, 1983, P NATL ACAD SCI-BIOL, V80, P6147, DOI 10.1073/pnas.80.20.6147; KLEIN HG, 1993, J LIPID RES, V34, P49; KLEIN HG, 1993, J CLIN INVEST, V92, P479, DOI 10.1172/JCI116591; KOO C, 1985, J BIOL CHEM, V260, P1934; MCLEAN J, 1986, NUCLEIC ACIDS RES, V14, P9397, DOI 10.1093/nar/14.23.9397; MERONI G, 1991, BIOCHEM BIOPH RES CO, V180, P1469, DOI 10.1016/S0006-291X(05)81361-0; Norum K, 1989, METABOLIC BASIS INHE, P1181; RADER DJ, 1994, J CLIN INVEST, V93, P321, DOI 10.1172/JCI116962; RAMJI DP, 1991, NUCLEIC ACIDS RES, V19, P1139, DOI 10.1093/nar/19.5.1139; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sambrook J, 1989, MOL CLONING LABORATO; STOFFEL W, 1992, BIOL CHEM H-S, V373, P187, DOI 10.1515/bchm3.1992.373.1.187; STOKKE KT, 1971, SCAND J CLIN LAB INV, V27, P21, DOI 10.3109/00365517109080184; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; TAKEGOSHI T, 1988, JPN J MED, V27, P295, DOI 10.2169/internalmedicine1962.27.295; TALL AR, 1993, J LIPID RES, V34, P1255; TALL AR, 1977, J BIOL CHEM, V252, P7288; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WARDEN CH, 1989, J BIOL CHEM, V264, P21573; YAMASHITA S, 1991, METAB CLIN EXP, V7, P756	47	111	112	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12269	12275		10.1074/jbc.270.20.12269	http://dx.doi.org/10.1074/jbc.270.20.12269			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744879	hybrid			2022-12-27	WOS:A1995QY73600084
J	BERNARDO, K; HURWITZ, R; ZENK, T; DESNICK, RJ; FERLINZ, K; SCHUCHMAN, EH; SANDHOFF, K				BERNARDO, K; HURWITZ, R; ZENK, T; DESNICK, RJ; FERLINZ, K; SCHUCHMAN, EH; SANDHOFF, K			PURIFICATION, CHARACTERIZATION, AND BIOSYNTHESIS OF HUMAN ACID CERAMIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; LONG-CHAIN BASES; AMINO-ACIDS; INHIBITION; SPHINGOMYELINASE; DIFFERENTIATION; CHROMATOGRAPHY; SPHINGOSINE; SPHINGANINE; DERIVATIVES	Acid ceramidase (N-acylsphingosine deacylase, EC 3.5.1.23) is the lysosomal enzyme catalyzing the hydrolysis of ceramide to sphingosine and free fatty acid, Its inherited deficiency causes ceramide accumulation in Farber's disease. The enzyme was purified to apparent homogeneity from human urine by sequential chromatography on octyl-Sepharose, concanavalin A-Sepharose, blue-Sepharose, and DEAE-cellulose. The final preparation, which was enriched similar to 4450-fold over the starting material, resulted in a polypeptide of similar to 50 kDa and could be reduced into two subunits of similar to 13 (alpha) and similar to 40 (beta) kDa. Treatment of the purified enzyme with endoglycosidase H or peptide-N-glycanase F reduced the molecular mass of the beta subunit to similar to 30-35 and similar to 27 kDa, respectively. In contrast, the molecular mass of the alpha subunit was unchanged, The purified enzyme had an apparent K-m of 149 mu M and a V-max of 136 nmol/mg/h using N-lauroylsphingosine as substrate. Polyclonal antibodies were raised against the purified urinary enzyme and used to investigate the biosynthesis of acid ceramidase. Immunoprecipitation studies on metabolically labeled skin fibroblasts indicated that both subunits arose from a single precursor of similar to 55 kDa. A minor portion of newly synthesized acid ceramidase was secreted into the me dium as a monomeric 47-kDa protein, indicating that generation of the mature heterodimeric enzyme occurred in endosomal and/or lysosomal compartments.	UNIV BONN,INST ORGAN CHEM & BIOCHEM,D-53121 BONN,GERMANY; CUNY MT SINAI SCH MED,DEPT HUMAN GENET,NEW YORK,NY 10029	University of Bonn; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai								ARORA RC, 1972, J LIPID RES, V13, P86; CHEN WW, 1981, ARCH BIOCHEM BIOPHYS, V208, P444, DOI 10.1016/0003-9861(81)90531-2; CHEN WW, 1979, FED PROC, V38, P405; Freund J, 1942, P SOC EXP BIOL MED, V49, P548; FREUND J, 1952, ADV TUBERC RES, V7, P130; GATT S, 1963, J BIOL CHEM, V238, P3131; GATT S, 1966, J BIOL CHEM, V241, P3724; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HERBERT WJ, 1986, HDB EXPT IMMUNOLOGY; JARRETT HW, 1986, ANAL BIOCHEM, V153, P189, DOI 10.1016/0003-2697(86)90079-5; KAN CC, 1993, TRENDS GLYCOSCI GLYC, V5, P99; KLEIN A, 1994, BIOCHEM BIOPH RES CO, V200, P1440, DOI 10.1006/bbrc.1994.1612; Kolesnick Richard, 1992, Trends in Cell Biology, V2, P232, DOI 10.1016/0962-8924(92)90310-J; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MERRILL AH, 1986, J BIOL CHEM, V261, P2610; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; MORELL P, 1972, J LIPID RES, V13, P203; MOSER HW, 1983, METABOLIC BASIS INHE, P820; NIELSON A, 1969, BIOCHIM BIOPHYS ACTA, V176, P339; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; PENTCHEV PG, 1973, J BIOL CHEM, V248, P5256; POOLE TB, 1987, UFAW HDB CARE MANAGE, P56; QUINTERN LE, 1987, BIOCHIM BIOPHYS ACTA, V922, P323, DOI 10.1016/0005-2760(87)90055-5; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; ROTHER J, 1992, BIOCHEM BIOPH RES CO, V189, P14, DOI 10.1016/0006-291X(92)91518-U; SCHAGGER H, 1987, ANAL BIOCHEM, V106, P368; SCHNABEL D, 1992, J BIOL CHEM, V267, P3312; SHAPIRO D, 1961, J AM CHEM SOC, V83, P3327, DOI 10.1021/ja01476a033; SUGITA M, 1975, BIOCHIM BIOPHYS ACTA, V398, P125, DOI 10.1016/0005-2760(75)90176-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG E, 1991, J BIOL CHEM, V266, P14486; WEITZ G, 1986, ENZYMES LIPID METABO, V2, P261; WILSON E, 1986, J BIOL CHEM, V261, P2616; YAMANAKA T, 1982, J NEUROCHEM, V38, P1753, DOI 10.1111/j.1471-4159.1982.tb06659.x; YAVIN E, 1969, BIOCHEMISTRY-US, V8, P1692, DOI 10.1021/bi00832a052; ZIMMERMANN P, 1988, LIEBIGS ANN CHEM, P663	38	161	174	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11098	11102		10.1074/jbc.270.19.11098	http://dx.doi.org/10.1074/jbc.270.19.11098			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744740	hybrid			2022-12-27	WOS:A1995QX86500015
J	CHEN, X; PENG, JM; PEDRAM, M; SWENSON, CA; RUBENSTEIN, PA				CHEN, X; PENG, JM; PEDRAM, M; SWENSON, CA; RUBENSTEIN, PA			THE EFFECT OF THE S14A MUTATION ON THE CONFORMATION AND THERMOSTABILITY OF SACCHAROMYCES-CEREVISIAE G-ACTIN AND ITS INTERACTION WITH ADENINE-NUCLEOTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND ADENOSINE 5'-TRIPHOSPHATE; LOW-AFFINITY SITES; MUSCLE G-ACTIN; DIVALENT-CATION; MYOSIN SUBFRAGMENT-1; ACANTHAMOEBA PROFILIN; YEAST ACTIN; F-ACTIN; BINDING; ATP	The actin Ser(14) hydroxyl is one of a number of ligands that binds to the gamma-phosphate of ATP thereby stabilizing the actin ATP complex. In yeast actin, conversion of Ser(14) to Ala (S14A), causes a temperature-sensitive phenotype in vivo and temperature-sensitive polymerization defects in vitro (Chen, X., and Rubenstein, P. A. (1995) J. Biol. Chem. 270, 11406-11414). Here, using a new luciferase-based procedure, we show that the mutation results in a 40-60-fold decrease in actin's affinity for ATP. The mutation causes a decrease in the intrinsic ATPase activity of both Ca- and Mg-G-actin at 30 degrees C and alters the protease susceptibility of sites on subdomain 2. Ca-S14A-actin but not Mg-S14A-actin binds etheno-ATP at 37 degrees C, Intrinsic tryptophan fluorescence measurements show that at 37 degrees C, Mg-S14A-actin but not the calcium form unfolds, CD measurements show the mutation causes a decrease in the apparent denaturation temperature for Ca-actin from 57 to 45 degrees C and for the magnesium form a decrease from 52 to 40 degrees C. Based on a re-examination of actin's crystal structure coordinates, we propose that the Ser(14) hydroxyl forms a polar bridge between the ATP gamma-phosphate and the amide nitrogen of Gly(74), thus conferring additional stability on the actin small domain.	UNIV IOWA,COLL MED,DEPT BIOCHEM,IOWA CITY,IA 52242	University of Iowa			Chen, Xin/D-2073-2010; Pedram, Mehrdad/L-4072-2016	Pedram, Mehrdad/0000-0002-7348-3475; Rubenstein, Peter/0000-0003-1225-4414	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-33689] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAKURA S, 1961, ARCH BIOCHEM BIOPHYS, V92, P140, DOI 10.1016/0003-9861(61)90228-4; BERTAZZON A, 1990, BIOCHEMISTRY-US, V29, P291, DOI 10.1021/bi00453a040; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BRYAN J, 1985, J CELL BIOL, V101, P1236, DOI 10.1083/jcb.101.4.1236; CARLIER MF, 1986, J BIOL CHEM, V261, P785; CARLIER MF, 1993, P NATL ACAD SCI USA, V90, P5034, DOI 10.1073/pnas.90.11.5034; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; CHEN X, 1995, J BIOL CHEM, V270, P11406, DOI 10.1074/jbc.270.19.11406; COOK RK, 1992, J BIOL CHEM, V267, P9430; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; ESTES JE, 1987, J BIOL CHEM, V362, P4952; FIEVEZ S, 1993, FEBS LETT, V316, P186, DOI 10.1016/0014-5793(93)81212-I; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V89, P7290; FRIEDEN C, 1980, J BIOL CHEM, V255, P8991; FRIEDEN C, 1982, J BIOL CHEM, V257, P2882; GERGELY J, 1960, 1960 C CONTR JAN PIT; GERSHMAN LC, 1986, BIOCHEM BIOPH RES CO, V135, P607, DOI 10.1016/0006-291X(86)90036-7; GOLDSCHMIDTCLER.PJ, 1991, J CELL BIOL, V113, P1081; HAARER BK, 1990, J CELL BIOL, V110, P105, DOI 10.1083/jcb.110.1.105; HASTINGS JW, 1963, J OPT SOC AM, V53, P1401; HOLMES K, 1992, TRENDS CELL BIL, V2, P53; JACOBSON GR, 1976, P NATL ACAD SCI USA, V73, P2742, DOI 10.1073/pnas.73.8.2742; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KITAZAWA T, 1982, J MUSCLE RES CELL M, V3, P437, DOI 10.1007/BF00712093; KONNO K, 1985, P NATL ACAD SCI USA, V82, P7904, DOI 10.1073/pnas.82.23.7904; KONNO K, 1987, BIOCHEMISTRY-US, V26, P3582, DOI 10.1021/bi00386a050; LAHAM LE, 1993, J BIOL CHEM, V268, P14202; LEACH FR, 1981, J APPL BIOCHEM, V3, P473; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; MORNET D, 1984, P NATL ACAD SCI-BIOL, V81, P3680, DOI 10.1073/pnas.81.12.3680; NEIDL C, 1979, EUR J BIOCHEM, V101, P163; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; NOWAK E, 1988, BIOCHEMISTRY-US, V24, P1538; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; SALHANY JM, 1975, P NATL ACAD SCI USA, V72, P4966, DOI 10.1073/pnas.72.12.4966; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SPUDICH JA, 1974, J BIOL CHEM, V249, P6013; STRZELECKAGOLAS.H, 1993, EUR J BIOCHEM, V211, P731; TELLAM RL, 1986, BIOCHEMISTRY-US, V25, P5799, DOI 10.1021/bi00367a068; TIRION MM, 1993, J MOL BIOL, V230, P186, DOI 10.1006/jmbi.1993.1135; TOBACMAN LS, 1982, J BIOL CHEM, V257, P4166; VALENTINRANC C, 1989, J BIOL CHEM, V264, P20871; WAECHTER F, 1977, EUR J BIOCHEM, V74, P227, DOI 10.1111/j.1432-1033.1977.tb11385.x; WAECHTER F, 1975, EUR J BIOCHEM, V57, P543; WEBER A, 1969, BIOCHEMISTRY-US, V8, P2266, DOI 10.1021/bi00834a005; ZIMMERLE CT, 1987, BIOCHEMISTRY-US, V26, P6545, DOI 10.1021/bi00394a039	49	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11415	11423		10.1074/jbc.270.19.11415	http://dx.doi.org/10.1074/jbc.270.19.11415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744778	hybrid			2022-12-27	WOS:A1995QX86500057
J	JANSSEN, JJM; BOVEEGEURTS, PHM; MERKX, M; DEGRIP, WJ				JANSSEN, JJM; BOVEEGEURTS, PHM; MERKX, M; DEGRIP, WJ			HISTIDINE TAGGING BOTH ALLOWS CONVENIENT SINGLE-STEP PURIFICATION OF BOVINE RHODOPSIN AND EXERTS IONIC STRENGTH-DEPENDENT EFFECTS ON ITS PHOTOCHEMISTRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							META-II; DIFFERENCE SPECTROSCOPY; RECOMBINANT PROTEINS; INSECT CELLS; EXPRESSION; BACULOVIRUS; GENE; PROTONATION; MEMBRANE; INVITRO	For rapid single-step purification of recombinant rhodopsin, a baculovirus expression vector was constructed containing the bovine opsin coding sequence extended at the 3'-end by a short sequence encoding six histidine residues, Recombinant baculovirus-infected Spodoptera frugiperda cells produce bovine opsin carrying a C terminal histidine tag (v-opshis(6x)). The presence of this tag was confirmed by immunoblot analysis. Incubation with 11-cis-retinal produced a photosensitive pigment (v-Rhohis(6x)) at a level of 15-20 pmol/10(6) cells. The histidine tag was exploited to purify v-rthohis(6x) via immobilized metal affinity chromatography. Optimized immobilized metal affinity chromatography yielded a binding capacity of greater than or equal to 35 nmol of v-Rhohis(6x) per ml of resin and purification factors up to 500. Best samples were at least 85% pure, with an average age purity of 70% (A(280) nm/A(500) nm = 2.5 +/- 0.4, n = 7). Remaining contamination was largely removed upon reconstitution into lipids, yielding rhodopsin proteoliposomes with a purity over 95%. Spectral analysis of v-Rhohis(6x) showed a small but significant red shift (501 +/- 1 nm) compared to wild type rhodopsin (498 +/- 1 nm). The pK(a) of the Meta I <-> Meta II equilibrium in v-Rhohis(6x) is down-shifted from 7.3 to 6.4 resulting in a significant shift at pH 6.5 toward the Meta I photointermediate. Both effects are reversed upon increasing the ionic strength. FT-IR analysis of the Rho --> Meta II transition shows that the corresponding structural changes are identical in wild type and v-Rhohis(6x).			JANSSEN, JJM (corresponding author), UNIV NIJMEGEN,CTR EYE RES,DEPT BIOCHEM,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.		Merkx, Maarten/E-7009-2011; Merkx, Matthias AW/H-8074-2014; DeGrip, Willem/L-4335-2015	Merkx, Matthias AW/0000-0002-0687-9760; DeGrip, Willem/0000-0001-7637-4920				BORJIGIN J, 1994, J BIOL CHEM, V269, P14715; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; CHEN XS, 1993, EUR J BIOCHEM, V214, P845, DOI 10.1111/j.1432-1033.1993.tb17988.x; COTTON RGH, 1993, MUTAT RES, V285, P125, DOI 10.1016/0027-5107(93)90060-S; de Grip W. J., 1985, PROG RETIN RES, V4, P137; DeCaluwe G. L. J., 1993, METHODS NEUROSCI, V15, P307; DEGRIP WJ, 1988, PHOTOCHEM PHOTOBIOL, V48, P497, DOI 10.1111/j.1751-1097.1988.tb02852.x; DEGRIP WJ, 1983, BIOCHIM BIOPHYS ACTA, V734, P168, DOI 10.1016/0005-2736(83)90115-3; DEGRIP WJ, 1985, BIOCHIM BIOPHYS ACTA, V809, P97, DOI 10.1016/0005-2728(85)90172-0; DEGRIP WJ, 1979, CHEM PHYS LIPIDS, V23, P321, DOI 10.1016/0009-3084(79)90010-0; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; GENTZ R, 1988, EMBO J, V7, P225, DOI 10.1002/j.1460-2075.1988.tb02803.x; HENDRIKS T, 1976, BIOCHIM BIOPHYS ACTA, V433, P271, DOI 10.1016/0005-2736(76)90093-6; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; JANSEN JJM, 1991, BIOCHIM BIOPHYS ACTA, V1089, P68, DOI 10.1016/0167-4781(91)90086-2; JANSSEN JJM, 1988, MOL BIOL REP, V13, P65, DOI 10.1007/BF00539052; JANSSEN JJM, 1990, FEBS LETT, V260, P113, DOI 10.1016/0014-5793(90)80080-3; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Molday RS, 1989, PROG RET RES, V8, P173; NATHANS J, 1989, VISION RES, V29, P907, DOI 10.1016/0042-6989(89)90105-3; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; RATH P, 1993, BIOCHEMISTRY-US, V32, P10277, DOI 10.1021/bi00090a001; REDDY RG, 1994, ARCH BIOCHEM BIOPHYS, V312, P219, DOI 10.1006/abbi.1994.1302; ROTHSCHILD KJ, 1987, BIOPHYS J, V51, P345, DOI 10.1016/S0006-3495(87)83341-6; ROTHSCHILD KJ, 1980, BIOCHIM BIOPHYS ACTA, V596, P338, DOI 10.1016/0005-2736(80)90121-2; SMITH MC, 1988, J BIOL CHEM, V263, P7211; SUMMERS MD, 1987, TEX AGR EXP STN B, P1555; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; WANG MY, 1994, BIOTECHNOL BIOENG, V43, P349, DOI 10.1002/bit.260430502; ZOZULYA SA, 1990, PROTEIN ENG, V3, P453, DOI 10.1093/protein/3.5.453; ZUIDEMA D, 1990, J GEN VIROL, V71, P2201, DOI 10.1099/0022-1317-71-10-2201	36	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11222	11229		10.1074/jbc.270.19.11222	http://dx.doi.org/10.1074/jbc.270.19.11222			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744755	Green Published, Green Submitted, hybrid			2022-12-27	WOS:A1995QX86500032
J	KOVACSOVICS, TJ; BACHELOT, C; TOKER, A; VLAHOS, CJ; DUCKWORTH, B; CANTLEY, LC; HARTWIG, JH				KOVACSOVICS, TJ; BACHELOT, C; TOKER, A; VLAHOS, CJ; DUCKWORTH, B; CANTLEY, LC; HARTWIG, JH			PHOSPHOINOSITIDE 3-KINASE INHIBITION SPARES ACTIN ASSEMBLY IN ACTIVATING PLATELETS BUT REVERSES PLATELET-AGGREGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; PROTEIN-KINASE-C; THROMBIN-STIMULATED PLATELETS; HUMAN BLOOD-PLATELETS; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; 3-PHOSPHORYLATED PHOSPHOINOSITIDES; MONOCLONAL-ANTIBODIES	Platelet stimulation by thrombin leads to the activation of phosphoinositide 3-kinase (PI 3-K) and to the production of the D3 phosphoinositides, phosphatidylinositol 3,4-bisphosphate (PdtIns-3,4-P-2) and 3,4,5-trisphosphate (PdtIns-3,4,5-P-3). Because changes in the levels of these phosphoinositides correlate with the kinetics of actin assembly, they have been proposed to mediate actin assembly, causing cell shape changes, Wortmannin and LY294002, two unrelated inhibitors of PI 3-K, were used to investigate the role of PI 3-K in platelet actin assembly and aggregation. Both PI 3-K inhibitors abrogated the production of PdtIns-3,4-P-2 and PdtIns-3,4,5-P-3 in thrombin receptor-activating peptide (TRAP)-stimulated cells. However, neither wortmannin nor LY294002 altered the kinetics of actin assembly or the exposure of nucleation sites in TRAP-stimulated cells. In contrast, PI 3-K inhibitors showed a specific inhibitory pattern of cell aggregation, characterized by a primary phase of aggregation followed by progressive disaggregation. Flow cytometry analysis with the PAC1 monoclonal antibody or with FITC-labeled fibrinogen indicated that wortmannin inhibited the maintenance of the platelet integrin GPIIb-IIIa in its active state. Wortmannin also inhibited, in a dose-dependent manner, platelet aggregation induced by the binding of the monoclonal antibodies P256 and LIBS-6 to GPIIb-IIIa. LIBS Fab-induced aggregation also led to the production of PdtIns 3,4 P-2. Platelet secretion, as evidenced by the release of preloaded C-14-5-hydroxytryptamine secretion or P-selectin up-regulation, was not affected by PI 3-K inhibition. These results demonstrate that the generation of D3 phosphoinositides is not required for actin assembly in TRAP-activated platelets, However, PI 3-K stimulation is necessary for prolonged GPIIb-IIIa activation and irreversible platelet aggregation, PI 3-K stimulation downstream of GPIIb-IIIa engagement may provide positive feedback required to sustain active GPIIb-IIIa.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV EXPTL MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV HEMATOL ONCOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT ANAT & CELL BIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115; ELI LILLY & CO,LILLY RES LABS,CARDIOVASC RES,INDIANAPOLIS,IN 46285; BETH ISRAEL HOSP,DEPT MED,DIV SIGNAL TRANSDUCT,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Eli Lilly; Harvard University; Beth Israel Deaconess Medical Center			Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Bachelot-Loza, Christilla/0000-0002-6264-902X	NHLBI NIH HHS [HL47874] Funding Source: Medline; NIGMS NIH HHS [GM41890, R01 GM041890] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041890, R01GM041890] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRANOFF BW, 1983, J BIOL CHEM, V258, P2076; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BACHELOT C, 1990, EUR J BIOCHEM, V190, P177, DOI 10.1111/j.1432-1033.1990.tb15562.x; BACHELOT C, 1991, BIOCHEM J, V284, P923; BACHELOT C, 1991, CELL SIGNAL, V3, P539; BALDASSARE JJ, 1992, J BIOL CHEM, V267, P15585; BENGTSSON T, 1989, J BIOL CHEM, V263, P17385; BILLAH MM, 1982, J BIOL CHEM, V257, P2705; CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; CHANG JD, 1993, J BIOL CHEM, V268, P14208; CRABOS M, 1992, BIOCHEM J, V288, P891, DOI 10.1042/bj2880891; DADABAY CY, 1991, J CELL BIOL, V112, P1151, DOI 10.1083/jcb.112.6.1151; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; EBERLE M, 1990, J BIOL CHEM, V265, P16725; FARADAY N, 1994, J LAB CLIN MED, V123, P728; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; FOX JEB, 1993, J BIOL CHEM, V268, P25973; FOX JEB, 1981, NATURE, V292, P650, DOI 10.1038/292650a0; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117; GRABER SE, 1982, J BIOL CHEM, V257, P4606; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; HANNUN YA, 1987, J BIOL CHEM, V262, P13620; HARTWIG JH, 1989, BIOCHIM BIOPHYS ACTA, V1010, P64, DOI 10.1016/0167-4889(89)90185-7; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P17078; HORVATH AR, 1992, EMBO J, V11, P855, DOI 10.1002/j.1460-2075.1992.tb05123.x; HUANG MM, 1993, J CELL BIOL, V122, P473, DOI 10.1083/jcb.122.2.473; HUANG RS, 1991, J BIOL CHEM, V266, P18435; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; KIMURA K, 1994, J BIOL CHEM, V269, P18961; KING WG, 1991, BIOCHEM J, V278, P475, DOI 10.1042/bj2780475; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MICHELSON AD, 1991, BLOOD, V77, P770; MORII N, 1992, J BIOL CHEM, V267, P20921; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; NAKASHIMA S, 1991, BIOCHEM J, V275, P355, DOI 10.1042/bj2750355; NOLAN RD, 1990, J BIOL CHEM, V265, P2441; OKADA T, 1994, J BIOL CHEM, V269, P3563; POWIS G, 1994, CANCER RES, V54, P2419; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; RIDLEY AJ, 1992, CELL, V70, P410; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; SHATTIL SJ, 1992, J BIOL CHEM, V267, P18424; SHATTIL SJ, 1994, J BIOL CHEM, V269, P14738; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHATTIL SJ, 1987, BLOOD, V70, P307; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; SORISKY A, 1992, BIOCHEM J, V286, P581, DOI 10.1042/bj2860581; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; SULTAN C, 1991, J BIOL CHEM, V266, P23554; SULTAN C, 1990, BIOCHEM J, V269, P831, DOI 10.1042/bj2690831; THOMAS KM, 1990, J BIOL CHEM, V265, P20061; THOMASON PA, 1994, J BIOL CHEM, V269, P16525; TOKER A, 1994, J BIOL CHEM, V269, P32358; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; VANWILLIGEN G, 1991, BIOCHEM J, V273, P115, DOI 10.1042/bj2730115; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; VLAHOS CJ, 1995, IN PRESS DRUGS FUTUR; VOURETCRAVIARI V, 1992, MOL BIOL CELL, V3, P95, DOI 10.1091/mbc.3.1.95; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WATSON SP, 1988, BIOCHEM J, V246, P345; WENNSTROM S, 1994, ONCOGENE, V9, P651; WYMANN M, 1994, BIOCHEM J, V298, P517, DOI 10.1042/bj2980517; YANO H, 1993, J BIOL CHEM, V268, P25846; YATOMI Y, 1992, BIOCHEM J, V285, P745, DOI 10.1042/bj2850745; ZHANG J, 1992, J BIOL CHEM, V267, P4686; ZHANG J, 1993, J BIOL CHEM, V268, P22251	79	190	191	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11358	11366		10.1074/jbc.270.19.11358	http://dx.doi.org/10.1074/jbc.270.19.11358			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744773	hybrid			2022-12-27	WOS:A1995QX86500050
J	MOLINO, M; BLANCHARD, N; BELMONTE, E; TARVER, AP; ABRAMS, C; HOXIE, JA; CERLETTI, C; BRASS, LF				MOLINO, M; BLANCHARD, N; BELMONTE, E; TARVER, AP; ABRAMS, C; HOXIE, JA; CERLETTI, C; BRASS, LF			PROTEOLYSIS OF THE HUMAN PLATELET AND ENDOTHELIAL-CELL THROMBIN RECEPTOR BY NEUTROPHIL-DERIVED CATHEPSIN-G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; ACTIVATION; PEPTIDES; ANTIPROTEINASES; MECHANISM; RESPONSES; ELASTASE; CLONING; RELEASE; BINDING	Cathepsin G is a neutrophil-derived protease that has been shown to inhibit the effects of thrombin on some cells expressing thrombin receptors while acting as an agonist on others, The present studies examine whether cleavage of the thrombin receptor by cathepsin G can account for these diverse effects, When added to cells that normally respond to thrombin, cathepsin G prevented a subsequent cytosolic Ca2+ increase caused by thrombin, but had no effect on responses to the thrombin receptor agonist peptide, SFLLRN. These effects were observed in cells in which cathepsin G had little or no agonist effect (human umbilical vein endothelial cells and HEL cells), as well as in cells in which cathepsin G acted as an agonist (platelets and CHRF-288 cells), Binding studies using monoclonal antibodies with defined epitopes within the first 60 residues of the thrombin receptor N-terminus showed that incubation of platelets and endothelial cells with cathepsin G abolished the binding of all of the antibodies, while thrombin abolished only the binding of antibodies whose epitopes were N-terminal to the known thrombin cleavage site between Arg(41) and Ser(42). Analysis of peptide proteolytic fragments identified three potential cleavage sites for cathepsin G: Arg(41)-Ser(42), Phe(43)-Leu(44), and phe(55)-Trp(56). Cleavage at phe(55)-Trp(56) would account for both the observed loss of all of the antibody binding sites and the inhibition of receptor activation by thrombin. Two approaches were used to determine whether a solitary cleavage at Arg(41)-Ser(42) could result in receptor activation, In the first, HEL cells were exposed to cathepsin G or thrombin in the presence of an antibody whose epitope includes Phe(55), The antibody inhibited responses to thrombin, but augmented the response to cathepsin G. In the second, COS-1 cells were transfected with variant thrombin receptors in which Phe(65) and Trp(56) were mutated to alanine, Transfected wild-type receptors responded to thrombin, but not cathepsin G, while the variant receptors responded to both proteases, These results 1) suggest that the ability of cathepsin G to inhibit responses to thrombin, but not SFLLRN, is due to cleavage of the receptor at Phe(55) Trp(56), deleting the tethered ligand domain, and 2) show that cathepsin G can activate thrombin receptors, but only if the cleavage site at phe(55)-Trp(56) is mutated or otherwise protected, This defines one mechanism by which neutrophil activation can prevent cellular responses to thrombin, while suggesting that the agonist effects of cathepsin G are less likely to be due to activation of the one known form of the human thrombin receptor unless post-translational modifications or local structural constraints prevent access of the enzyme to the phe(55)-Trp(58) site.	UNIV PENN,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PATHOL,PHILADELPHIA,PA 19104; IST RIC FARMACOL MARIO NEGRI,CONSORZIO MARIO NEGRI SUD,I-66030 SANTA MARIA IMBAR,ITALY	University of Pennsylvania; University of Pennsylvania; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS			Cerletti, Chiara/K-6447-2016	Cerletti, Chiara/0000-0002-4759-3179	NCI NIH HHS [CA-16520] Funding Source: Medline; NHLBI NIH HHS [HL40387] Funding Source: Medline; NIDDK NIH HHS [DK-19525] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAHOU WF, 1993, J CLIN INVEST, V91, P1405, DOI 10.1172/JCI116344; BRASS LF, 1991, J BIOL CHEM, V266, P958; BRASS LF, 1992, J BIOL CHEM, V267, P6044; BRASS LF, 1994, J BIOL CHEM, V269, P2943; BRASS LF, 1992, J BIOL CHEM, V267, P13795; BRASS LF, 1994, ANN NY ACAD SCI, V714, P1, DOI 10.1111/j.1749-6632.1994.tb12025.x; DEAN NM, 1989, ANAL BIOCHEM, V183, P199, DOI 10.1016/0003-2697(89)90468-5; ERNST E, 1987, JAMA-J AM MED ASSOC, V257, P2318, DOI 10.1001/jama.257.17.2318; EVANGELISTA V, 1993, BLOOD, V81, P2947; EVANGELISTA V, 1991, BLOOD, V77, P2379; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; JAFFE EA, 1994, J CLIN INVEST, V52, P2745; LAROSA CA, 1994, BLOOD, V84, P158; LAROSA CA, 1994, J VASC SURG, V19, P306, DOI 10.1016/S0741-5214(94)70106-7; LEROY EC, 1984, J CLIN INVEST, V74, P1003, DOI 10.1172/JCI111467; MAISON CM, 1991, J IMMUNOL, V147, P921; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; MEHTA J, 1989, CIRCULATION, V79, P546; MOLINO M, 1993, BLOOD, V82, P2442; MOLINO M, 1992, BIOCHEM J, V288, P741, DOI 10.1042/bj2880741; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; PIDARD D, 1994, BIOCHEM J, V303, P489, DOI 10.1042/bj3030489; PINTUCCI G, 1993, J LAB CLIN MED, V122, P69; PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; SELAK MA, 1990, BIOCHEM J, V266, P55, DOI 10.1042/bj2660055; SELAK MA, 1994, BIOCHEM J, V297, P269, DOI 10.1042/bj2970269; SELAK MA, 1988, BIOCHEM J, V251, P293, DOI 10.1042/bj2510293; SUIDAN HS, 1994, P NATL ACAD SCI USA, V91, P8112, DOI 10.1073/pnas.91.17.8112; TOTANI L, 1994, ARTERIOSCLER THROMB, V14, P125, DOI 10.1161/01.ATV.14.1.125; TURKINGTON PT, 1992, THROMB RES, V67, P147, DOI 10.1016/0049-3848(92)90134-V; TURKINGTON PT, 1991, THROMB RES, V63, P399, DOI 10.1016/0049-3848(91)90226-M; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; WEKSLER BB, 1989, BLOOD, V74, P1627; WOOLKALIS MJ, 1995, J BIOL CHEM, V270, P9868, DOI 10.1074/jbc.270.17.9868	41	139	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11168	11175		10.1074/jbc.270.19.11168	http://dx.doi.org/10.1074/jbc.270.19.11168			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744748	hybrid			2022-12-27	WOS:A1995QX86500024
J	BUCALA, R; MITCHELL, R; ARNOLD, K; INNERARITY, T; VLASSARA, H; CERAMI, A				BUCALA, R; MITCHELL, R; ARNOLD, K; INNERARITY, T; VLASSARA, H; CERAMI, A			IDENTIFICATION OF THE MAJOR SITE OF APOLIPOPROTEIN-B MODIFICATION BY ADVANCED GLYCOSYLATION END-PRODUCTS BLOCKING UPTAKE BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYVINYLIDENE DIFLUORIDE; LYSINE RESIDUES; BINDING; INVIVO; APOPROTEINS; COMPONENT; MEMBRANES; SEQUENCE; B-100; RICH	Advanced glycosylation end products (AGEs) arise from glucose-derived Amadori products and have been implicated in the pathogenesis of diabetic vascular disease, We recently reported the presence of an AGE-modified form of low density lipoprotein (LDL) that circulates in high amounts in patients with diabetes or renal insufficiency and that exhibits impaired plasma clearance kinetics, We utilized AGE-specific antibodies to identify the major sites of AGE modification within protease-digested preparations of apolipoprotein B that impair the binding of the AGE-modified form of LDL by human fibroblast LDL receptors, The predominant site of AGE immunoreactivity was found to lie within a single, 67-amino acid region located 1791 residues NH2-terminal of the putative LDL receptor binding domain, These data point to the high reactivity and specificity of this site for AGE formation and provide further evidence for important structural interactions between the LDL receptor binding domain and remote regions of the apolipoprotein B polypeptide.	UNIV CALIF SAN FRANCISCO,GLADSTONE INST CARDIOVASC DIS,SAN FRANCISCO,CA 94141	University of California System; University of California San Francisco; The J David Gladstone Institutes	BUCALA, R (corresponding author), PICOWER INST MED RES,350 COMMUNITY DR,MANHASSET,NY 11030, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019655] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19655-15] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BROWN WV, 1994, MED CLIN N AM, V78, P143, DOI 10.1016/S0025-7125(16)30180-8; BUCALA R, 1994, DRUG DEVELOP RES, V32, P77, DOI 10.1002/ddr.430320204; BUCALA R, 1993, P NATL ACAD SCI USA, V90, P6434, DOI 10.1073/pnas.90.14.6434; BUCALA R, 1994, P NATL ACAD SCI USA, V91, P9441, DOI 10.1073/pnas.91.20.9441; CHAN L, 1992, J BIOL CHEM, V267, P25621; CHEN GC, 1989, BIOCHEMISTRY-US, V28, P2477, DOI 10.1021/bi00432a019; FERNANDEZ J, 1992, ANAL BIOCHEM, V201, P255, DOI 10.1016/0003-2697(92)90336-6; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; IBERG N, 1986, J BIOL CHEM, V261, P3542; Innerarity T L, 1986, Methods Enzymol, V129, P542; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; JENSEN T, 1988, DIABETOLOGIA, V31, P142, DOI 10.1007/BF00276846; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653; LUNDKATZ S, 1988, J BIOL CHEM, V263, P13831; LUNDKATZ S, 1989, ARTERIOSCLEROSIS, V9, P715; MAHLEY RW, 1979, J CLIN INVEST, V64, P743, DOI 10.1172/JCI109518; MAHLEY RW, 1977, J BIOL CHEM, V252, P7279; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; MAKITA Z, 1992, SCIENCE, V258, P651, DOI 10.1126/science.1411574; MAKITA Z, 1994, LANCET, V343, P1519, DOI 10.1016/S0140-6736(94)92935-1; MARCEL YL, 1987, ARTERIOSCLEROSIS, V7, P166, DOI 10.1161/01.ATV.7.2.166; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MILNE R, 1989, J BIOL CHEM, V264, P19754; MIYATA T, 1993, J CLIN INVEST, V92, P1243, DOI 10.1172/JCI116696; Njoroge F G, 1989, Prog Clin Biol Res, V304, P85; RUDERMAN NB, 1984, PROG CARDIOVASC DIS, V26, P373, DOI 10.1016/0033-0620(84)90011-2; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; STONE KL, 1991, HPLC PEPTIDES PROTEI; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; WITZTUM JL, 1982, DIABETES, V31, P283, DOI 10.2337/diabetes.31.4.283; 1992, ANN DATA REPORT	33	112	119	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10828	10832		10.1074/jbc.270.18.10828	http://dx.doi.org/10.1074/jbc.270.18.10828			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738020	hybrid			2022-12-27	WOS:A1995QW60100068
J	CORCORAN, ML; KIBBEY, MC; KLEINMAN, HK; WAHL, LM				CORCORAN, ML; KIBBEY, MC; KLEINMAN, HK; WAHL, LM			LAMININ SIKVAV PEPTIDE INDUCTION OF MONOCYTE-MACROPHAGE PROSTAGLANDIN E(2) AND MATRIX METALLOPROTEINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							IV COLLAGENASE; BASEMENT-MEMBRANE; TUMOR-GROWTH; A-CHAIN; INHIBITION; ACTIVATION; RECEPTOR; INVIVO; CELLS	The laminin-derived synthetic peptide containing the SIKVAV (Ser-Ile-Lys-Val-Ala-Val) amino acid sequence has been previously shown to regulate tumor invasion, metastasis, and angiogenesis. Here, we demonstate that this peptide also modulates human monocyte responses. Moreover, the monocytic responses elicited by this peptide are influenced by the culture conditions. When elutriated monocytes were cultured on SIKVAV substrate or in suspension with this peptide, the synthesis of prostaglandin E(2), interstitial collagenase, and gelatinase B was induced and was further enhanced in the presence of concanavalin A (ConA). However, when monocytes were adhered before adding soluble SIKVAV, the peptide alone failed to induce the production of prostaglandin E(2) or matrix metalloproteinases. If adherent monocytes were exposed to SIKVAV in the presence of ConA, this peptide enhanced the ConA induced production of these mediators. In contrast to SIKVAV, the intact laminin molecule failed to influence these monocyte responses. This is the first demonstration that a laminin derived peptide is capable of inducing or enhancing monocyte inflammatory responses that may influence a number of biological activities such as wound healing or excessive connective tissue destruction associated with chronic inflammation.	NIDR,IMMUNOL LAB,CELLULAR IMMUNOL SECT,BETHESDA,MD 20892; NIDR,DEV BIOL LAB,CELL BIOL SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)								BEEZHOLD DH, 1992, J LEUKOCYTE BIOL, V51, P59, DOI 10.1002/jlb.51.1.59; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; CHANG ZL, 1993, J LEUKOCYTE BIOL, V53, P79, DOI 10.1002/jlb.53.1.79; CORCORAN ML, 1992, J BIOL CHEM, V267, P515; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324; GUDEWICZ PW, 1994, J LEUKOCYTE BIOL, V55, P423, DOI 10.1002/jlb.55.4.423; KANEMOTO T, 1991, INVAS METAST, V11, P84; KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633; KIBBEY MC, 1994, J CELL PHYSIOL, V160, P185, DOI 10.1002/jcp.1041600121; KLEINMAN HK, 1993, VITAM HORM, V47, P161, DOI 10.1016/S0083-6729(08)60446-X; KOHN FR, 1991, EXP HEMATOL, V19, P653; LASKIN DL, 1994, AM J RESP CELL MOL, V10, P58, DOI 10.1165/ajrcmb.10.1.8292381; MERTZ PM, 1994, J BIOL CHEM, V269, P21322; SHAPIRO SD, 1993, J BIOL CHEM, V268, P8170; STACK S, 1991, BIOCHEMISTRY-US, V30, P2073, DOI 10.1021/bi00222a011; SWEENEY TM, 1991, CANCER METAST REV, V10, P245, DOI 10.1007/BF00050795; TASHIRO K, 1991, J CELL PHYSIOL, V146, P451, DOI 10.1002/jcp.1041460316; WAHL LM, 1984, CELL IMMUNOL, V85, P373, DOI 10.1016/0008-8749(84)90251-X; WAHL LM, 1990, J IMMUNOL, V144, P3518; WAHL LM, 1987, CELL IMMUNOL, V105, P411, DOI 10.1016/0008-8749(87)90088-8; WAHL LM, 1981, MANUAL MACROPHAGE ME, P423; WATANABE H, 1993, J CELL SCI, V104, P991	24	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10365	10368		10.1074/jbc.270.18.10365	http://dx.doi.org/10.1074/jbc.270.18.10365			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737965	hybrid			2022-12-27	WOS:A1995QW60100002
J	ERNST, OP; HOFMANN, KP; SAKMAR, TP				ERNST, OP; HOFMANN, KP; SAKMAR, TP			CHARACTERIZATION OF RHODOPSIN MUTANTS THAT BIND TRANSDUCIN BUT FAIL TO INDUCE GTP NUCLEOTIDE UPTAKE - CLASSIFICATION OF MUTANT PIGMENTS BY FLUORESCENCE, NUCLEOTIDE RELEASE, AND FLASH-INDUCED LIGHT-SCATTERING ASSAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PHOTORECEPTOR-MEMBRANES; SCHIFF-BASE COUNTERION; G-PROTEIN; METARHODOPSIN-II; OUTER SEGMENTS; AMINO-ACID; ACTIVATION; EQUILIBRIUM; RECEPTOR; COMPLEX	The photoreceptor rhodopsin is a seven-transmembrane helix receptor that activates the G protein transducin in response to light. Several site-directed rhodopsin mutants have been reported to be defective in transducin activation. Two of these mutants bound transducin in response to light, but failed to release the bound transducin in the presence of GTP (Franke, R. R., Konig, B., Sakmar, T. P., Khorana, H. G., and Hofmann, K. P. (1990) Science 250, 123-125). The present study was carried out to determine the nucleotide-binding state of transducin as it interacts with rhodopsin mutants. Five mutant bovine opsin genes were prepared by site-specific mutagenesis. Three mutant genes had deletions from one cytoplasmic loop each: AB Delta 70-71; CD Delta 143-150; and EF Delta 237-249. Two additional loop CD mutant genes were prepared: E134R/R135E had a reversal of a conserved charge pair, and CD r140-152 had a 13-amino acid sequence replaced by a sequence derived from the amino terminal tail. Three types of assays were carried out: 1) a fluorescence assay of photoactivated rhodopsin (R*) dependent guanosine 5'-O-(3-thiotriphosphate) uptake by transducin, 2) an assay of R*-dependent release of labeled GDP from the alpha-subunit of transducin holoenzyme (G(t alpha)). GDP, and 3) a light-scattering assay of R* G(t) complex formation and dissociation. We show that the mutant pigments, which are able to bind transducin in a light-dependent manner but lack the ability to activate transducin, most likely form R*. G(t alpha beta gamma). GDP complexes that are impaired in GDP release.	ROCKEFELLER UNIV,HOWARD HUGHES MED INST,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021; UNIV FREIBURG,INST BIOPHYS & STRAHLENBIOL,D-79104 FREIBURG,GERMANY	Howard Hughes Medical Institute; Rockefeller University; University of Freiburg			Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953				ARNIS S, 1994, J BIOL CHEM, V269, P23879; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BENNETT N, 1985, J BIOL CHEM, V260, P4156; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P9165, DOI 10.1021/bi00086a023; FAHMY K, 1994, BIOCHEMISTRY-US, V33, P13700, DOI 10.1021/bi00250a021; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; HECK M, 1993, BIOCHEMISTRY-US, V32, P8220, DOI 10.1021/bi00083a024; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; HOFMANN KP, 1976, BIOPHYS STRUCT MECH, V2, P61, DOI 10.1007/BF00535653; HOFMANN KP, 1983, BIOCHIM BIOPHYS ACTA, V725, P60, DOI 10.1016/0005-2728(83)90224-4; HOFMANN KP, 1992, SIGNAL TRANSDUCTION, P71; KAHLERT M, 1990, J BIOL CHEM, V265, P18928; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KUHN H, 1981, BIOCHEMISTRY-US, V20, P2410; KUHN H, 1981, P NATL ACAD SCI-BIOL, V78, P6873, DOI 10.1073/pnas.78.11.6873; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; MIN KC, 1993, J BIOL CHEM, V268, P9400; MORO O, 1993, J BIOL CHEM, V268, P22273; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; PANICO J, 1990, J BIOL CHEM, V265, P18922; PULVERMULLER A, 1993, BIOCHEMISTRY-US, V32, P14082, DOI 10.1021/bi00214a002; SAKMAR TP, 1991, P NATL ACAD SCI USA, V88, P3079, DOI 10.1073/pnas.88.8.3079; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SCHLEICHER A, 1987, J MEMBRANE BIOL, V95, P271, DOI 10.1007/BF01869489; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; STRYER L, 1991, J BIOL CHEM, V266, P10711; WEISS ER, 1987, J BIOL CHEM, V262, P4319; ZVYAGA TA, 1994, BIOCHEMISTRY-US, V33, P9753, DOI 10.1021/bi00198a046; ZVYAGA TA, 1993, J BIOL CHEM, V268, P4661; ZVYAGA TA, 1993, J BIOL CHEM, V269, P13056	42	77	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10580	10586		10.1074/jbc.270.18.10580	http://dx.doi.org/10.1074/jbc.270.18.10580			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737995	hybrid			2022-12-27	WOS:A1995QW60100036
J	KUDLICKI, W; ODOM, OW; KRAMER, G; HARDESTY, B; MERRILL, GA; HOROWITZ, PM				KUDLICKI, W; ODOM, OW; KRAMER, G; HARDESTY, B; MERRILL, GA; HOROWITZ, PM			THE IMPORTANCE OF THE N-TERMINAL SEGMENT FOR DNAJ-MEDIATED FOLDING OF RHODANESE WHILE BOUND TO RIBOSOMES AS PEPTIDYL-TRANSFER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LIVER RHODANESE; TRANSCRIPTION TRANSLATION; BINDING	Two lines of evidence indicate the importance of the N-terminal portion of rhodanese for correct folding of the nascent ribosome-bound polypeptide. A mutant gene lacking the codons for amino acids 1-23 of the wild-type protein is expressed very efficiently by coupled transcription/translation on Escherichia coli ribosomes; however, the mutant protein that is released from the ribosomes is enzymatically inactive. The mutant protein does not undergo the reaction that is promoted by the bacterial chaperone, DnaJ, which appears to be essential for folding of ribosome-bound rhodanese into the native conformation, The effect of DnaJ is monitored by fluorescence from coumarin cotranslationally incorporated at the N terminus of nascent rhodanese. Secondly, a synthetic peptide corresponding to the N-terminal 17 amino acids of the wild-type protein interferes with the synthesis of wild-type rhodanese but has much less effect on the synthesis of the N-terminal deletion mutant. The N-terminal peptide inhibits the effect of DnaJ on the nascent wild-type rhodanese and blocks the chaperone-mediated release and activation of ribosome-bound full-length rhodanese polypeptides that accumulate during in, vitro synthesis. The results lead to the hypothesis that the N-terminal segment of rhodanese is required for its chaperone-dependent folding on the ribosome.	UNIV TEXAS, DEPT CHEM & BIOCHEM, AUSTIN, TX 78712 USA; BROOKE ARMY MED CTR, DEPT CLIN INVEST, FT SAM HOUSTON, TX 78234 USA; UNIV TEXAS, HLTH SCI CTR, DEPT BIOCHEM, SAN ANTONIO, TX 78284 USA	University of Texas System; University of Texas Austin; San Antonio Military Medical Center; United States Department of Defense; United States Army; University of Texas System; University of Texas Health San Antonio					NIEHS NIH HHS [ES05729] Funding Source: Medline; NIGMS NIH HHS [GM25177] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Cundliffe E., 1980, RIBOSOMES STRUCTURE, P555; EISENSTEIN M, 1994, SUPRAMOLECULAR STRUC, P231; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GU ZP, 1994, P NATL ACAD SCI USA, V91, P5612, DOI 10.1073/pnas.91.12.5612; GU ZP, 1994, J BACTERIOL, V176, P6238, DOI 10.1128/jb.176.20.6238-6244.1994; HARDESTY B, 1993, TRANSLATIONAL APPARA, P847; HENDRICK JP, 1993, P NATL ACAD SCI USA, V90, P10216, DOI 10.1073/pnas.90.21.10216; HOL WGJ, 1983, FUND APPL TOXICOL, V3, P370, DOI 10.1016/S0272-0590(83)80007-4; HOROWITZ PM, 1993, ACS SYM SER, V516, P167; JARABAK R, 1974, BIOCHEMISTRY-US, V13, P3233, DOI 10.1021/bi00713a006; KUDLICKI W, 1994, J BIOL CHEM, V269, P16549; KUDLICKI W, 1994, J MOL BIOL, V244, P319, DOI 10.1006/jmbi.1994.1732; KUDLICKI W, 1992, ANAL BIOCHEM, V206, P389, DOI 10.1016/0003-2697(92)90383-I; KUDLICKI W, 1994, ANAL BIOCHEM, V217, P12, DOI 10.1006/abio.1994.1077; MENDOZA JA, 1994, J PROTEIN CHEM, V13, P15, DOI 10.1007/BF01891988; MERRILL GA, 1992, J PROTEIN CHEM, V11, P193, DOI 10.1007/BF01025225; MOFFAT JG, 1994, J BACTERIOL, V176, P7115, DOI 10.1128/JB.176.22.7115-7117.1994; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; ODOM OW, 1984, BIOCHEMISTRY-US, V23, P5069, DOI 10.1021/bi00316a037; PICKING WD, 1992, BIOCHEMISTRY-US, V31, P2368, DOI 10.1021/bi00123a023; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; Stewart JM, 1984, SOLID PHASE PEPTIDE; TSALKOVA T, 1993, BIOCHEMISTRY-US, V32, P3377, DOI 10.1021/bi00064a022; WESTLEY J, 1973, ADV ENZYMOL RAMB, V39, P327; [No title captured]	27	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10650	10657		10.1074/jbc.270.18.10650	http://dx.doi.org/10.1074/jbc.270.18.10650			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738002	hybrid			2022-12-27	WOS:A1995QW60100045
J	PANGALOS, MN; EFTHIMIOPOULOS, S; SHIOI, J; ROBAKIS, NK				PANGALOS, MN; EFTHIMIOPOULOS, S; SHIOI, J; ROBAKIS, NK			THE CHONDROITIN SULFATE ATTACHMENT SITE OF APPICAN IS FORMED BY SPLICING OUT EXON-15 OF THE AMYLOID PRECURSOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ALZHEIMERS-DISEASE; PROTEOGLYCAN FORM; MESSENGER-RNA; PROTEIN GENE; MUTATION; BRAIN; CDNA; GLYCOSAMINOGLYCANS; LOCALIZATION; PEPTIDES	Appicans are secreted and cell-associated chondroitin sulfate proteoglycans containing Alzheimer amyloid precursor (APP) as their core protein, Appicans are found in brain tissue, and in cell cultures their expression depends on both cell type and growth conditions. Here we report that the core protein of appicans derives from an APP mRNA lacking exon 15. Splicing out of this exon creates a new consensus sequence for the attachment of a chondroitin sulfate chain in the resulting APP product. Transfection of C6 glioma or 293 kidney fibroblast cells with APP cDNAs containing exon 15 produced no appican, while transfection with an APP cDNA lacking this exon induced high levels of appican production. Polymerase chain reactions indicated that appican-producing cells contained an APP mRNA species without exon 15, whereas cells without this mRNA produced no appican. Site directed mutagenesis combined with immunoreactivity experiments showed that the chondroitin sulfate chain is attached to a serine residue 16 amino acids upstream of the amino terminus of the A beta sequence of APP. The attachment of a glycosaminoglycan chain close to the A beta sequence of APP may affect the proteolytic processing of APP and production of A beta. The proteoglycan nature of APP suggests that addition of the chondroitin sulfate glycosaminoglycan is important for the implementation of the biological function of these proteins.	CUNY MT SINAI SCH MED, DEPT PSYCHIAT, NEW YORK, NY 10029 USA; CUNY MT SINAI SCH MED, FISHBERG RES CTR NEUROBIOL, NEW YORK, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai			Robakis, Nikolaos/AAA-1838-2021; Efthimiopoulos, Spiros/H-3956-2013	Efthimiopoulos, Spiros/0000-0001-9244-4570	NIA NIH HHS [AG05138, AG08200] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [RF1AG008200, R01AG008200, P50AG005138] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x; BUEE L, 1993, BRAIN RES, V601, P154, DOI 10.1016/0006-8993(93)91706-X; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; EFTHIMIOPOULOS S, 1994, J NEUROSCI RES, V38, P81, DOI 10.1002/jnr.490380111; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KONIG G, 1992, J BIOL CHEM, V267, P10804; LEVINE JM, 1994, J NEUROSCI, V14, P4716; MARGOLIS RK, 1993, EXPERIENTIA, V49, P429, DOI 10.1007/BF01923587; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; OKAMOTO M, 1994, NEUROSCI LETT, V172, P51, DOI 10.1016/0304-3940(94)90660-2; PANGALOS MN, 1995, IN PRESS J NEUROCHEM; REFOLO LM, 1989, BIOCHEM BIOPH RES CO, V164, P664, DOI 10.1016/0006-291X(89)91511-8; Robakis Nikolaos K., 1994, P317; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; SHIOI J, 1993, NEUROSCI LETT, V154, P121, DOI 10.1016/0304-3940(93)90186-O; SHIOI J, 1992, J BIOL CHEM, V267, P13819; SHIOI J, 1995, IN PRESS J BIOL CHEM, V270; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367	30	61	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10388	10391		10.1074/jbc.270.18.10388	http://dx.doi.org/10.1074/jbc.270.18.10388			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737970	hybrid			2022-12-27	WOS:A1995QW60100008
J	PRIES, F; KINGMA, J; KROOSHOF, GH; JERONIMUSSTRATINGH, CM; BRUINS, AP; JANSSEN, DB				PRIES, F; KINGMA, J; KROOSHOF, GH; JERONIMUSSTRATINGH, CM; BRUINS, AP; JANSSEN, DB			HISTIDINE-289 IS ESSENTIAL FOR HYDROLYSIS OF THE ALKYL-ENZYME INTERMEDIATE OF HALOALKANE DEHALOGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL EPOXIDE HYDROLASE; CATALYTIC MECHANISM; ESCHERICHIA-COLI; MUTAGENESIS; EXPRESSION; SITE; RESIDUE	Haloalkane dehalogenase (DhIA) from Xanthobacter autotrophicus GJ10 catalyzes the hydrolytic cleavage of carbon-halogen bonds in a broad range of halogenated aliphatic compounds, Previous work has shown that Asp(124), which is located close to the internal substrate-binding cavity, carries out a nucleophilic attack on the C-alpha of the alkylhalide, displacing the halogen, The resulting alkyl-enzyme intermediate is subsequently hydrolyzed, In order to study the role of His(289) in the hydrolysis of the intermediate, a His(289) --> Gln mutant was constructed by site-directed mutagenesis. The purified mutant enzyme was not catalytically active with haloalkanes, but a halide burst stoichiometric to the amount of enzyme was observed with 1,2-dibromoethane. Using ion spray mass spectrometry, accumulation of the covalent alkyl-enzyme and binding of the alkyl moiety of the substrate to an Asp(124)-containing tryptic peptide were shown, Fluorescence-quenching experiments indicated that halide ions are strongly bound by the alkyl-enzyme but not by the substrate-free enzyme, The results show that His(289) is the base catalyst for the dealkylation of the covalent intermediate, but that it is not essential for the initial nucleophilic attack of Asp(124) on the C-1 atom of the haloalkane. Furthermore, the halide ion that is released in the first step probably leaves the active site only after hydrolysis of the alkyl-enzyme.	UNIV GRONINGEN,DEPT BIOCHEM,9747 AG GRONINGEN,NETHERLANDS; UNIV GRONINGEN,DEPT PHARM,9747 AG GRONINGEN,NETHERLANDS	University of Groningen; University of Groningen								ARAND M, 1994, FEBS LETT, V338, P251, DOI 10.1016/0014-5793(94)80278-5; BELL PA, 1993, J BIOL CHEM, V268, P14011; BRUINS AP, 1987, ANAL CHEM, V59, P2642, DOI 10.1021/ac00149a003; BRUINS AP, 1988, 36TH P ASMS C MASS S, P1242; CHANG JY, 1983, METHOD ENZYMOL, V91, P455; CHEAH E, 1993, PROTEINS, V16, P64, DOI 10.1002/prot.340160108; Covey T R, 1988, Rapid Commun Mass Spectrom, V2, P249, DOI 10.1002/rcm.1290021111; DIPERSIO LP, 1991, J BIOL CHEM, V266, P4033; FRANKEN SM, 1991, EMBO J, V10, P1297, DOI 10.1002/j.1460-2075.1991.tb07647.x; GIBNEY G, 1990, P NATL ACAD SCI USA, V87, P7546, DOI 10.1073/pnas.87.19.7546; JANSSEN DB, 1989, J BACTERIOL, V171, P6791, DOI 10.1128/jb.171.12.6791-6799.1989; LACOURCIERE GM, 1993, J AM CHEM SOC, V115, P10466, DOI 10.1021/ja00075a115; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; LIAO DI, 1992, BIOCHEMISTRY-US, V31, P9796, DOI 10.1021/bi00155a037; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PRIES F, 1994, BIOCHEMISTRY-US, V33, P1242, DOI 10.1021/bi00171a026; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHANSTRA JP, 1993, PROTEIN EXPRES PURIF, V4, P479, DOI 10.1006/prep.1993.1063; SCHRAG JD, 1993, J MOL BIOL, V230, P575, DOI 10.1006/jmbi.1993.1171; VERSCHUEREN KHG, 1993, BIOCHEMISTRY-US, V32, P9031, DOI 10.1021/bi00086a008; VERSCHUEREN KHG, 1993, J MOL BIOL, V232, P856, DOI 10.1006/jmbi.1993.1436; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0	22	78	86	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10405	10411		10.1074/jbc.270.18.10405	http://dx.doi.org/10.1074/jbc.270.18.10405			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737973	Green Submitted, hybrid			2022-12-27	WOS:A1995QW60100011
J	REYNOLDS, WF				REYNOLDS, WF			DEVELOPMENTAL STAGE-SPECIFIC REGULATION OF XENOPUS TRANSFER-RNA GENES BY AN UPSTREAM PROMOTER ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-III; TRANSCRIPTION FACTOR-IIIB; STABLE COMPLEX-FORMATION; YEAST TRANSFER-RNA; DIFFERENTIAL EXPRESSION; 5'-FLANKING SEQUENCES; 5-S RNA; OOCYTE; BINDING; REGION	Typically the internal promoter elements of tRNA genes are necessary and sufficient to support transcription. Here a sequence element preceding a Xenopus tRNA gene is shown to be required for transcription in late stage, but not early stage oocyte extracts. The constitutive tyro gene is expressed in both early and late oocyte extracts, whereas the early oocyte specific tyr-Cooc gene is only expressed in early extracts. An upstream promoter element (URR), between positions -42 and -14 of the tyro gene, mediates this differential expression. The URR is required for tyro transcription in late oocyte extracts. Placing the URR upstream of the tyrCooc gene allows this gene to be transcribed in late extracts. The URR is irrelevant to transcription in early extracts; transcription of tyro or tyrCooc requires only the internal promoter sequences. This indicates the polymerase III transcriptional machinery changes during oogenesis, resulting in a stringent upstream sequence requirement. Mutations within the URR are shown to alter the preferred site of initiation by RNA polymerase III. Shifting the position of the URR upstream by one half helical turn also repositioned the site of initiation, suggesting the URR directs the placement of the initiation factor complex or polymerase itself.			REYNOLDS, WF (corresponding author), SAN DIEGO REG CANC CTR,SAN DIEGO,CA 92121, USA.				NCRR NIH HHS [RR09118-09] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR009118] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDREWS MT, 1991, DEV BIOL, V146, P250, DOI 10.1016/0012-1606(91)90466-G; BARTHOLOMEW B, 1991, MOL CELL BIOL, V11, P5181, DOI 10.1128/MCB.11.10.5181; BOGENHAGEN DF, 1982, CELL, V28, P413, DOI 10.1016/0092-8674(82)90359-2; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GLIKIN GC, 1984, CELL, V37, P33, DOI 10.1016/0092-8674(84)90298-8; GOTTESFELD JM, 1994, SCIENCE, V263, P81, DOI 10.1126/science.8272869; GOUILLOUD E, 1986, J BIOL CHEM, V261, P486; HUIBREGTSE JM, 1989, MOL CELL BIOL, V9, P3244, DOI 10.1128/MCB.9.8.3244; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KASSAVETIS GA, 1992, CELL, V71, P1055, DOI 10.1016/0092-8674(92)90399-W; LASSAR AB, 1983, SCIENCE, V222, P740, DOI 10.1126/science.6356356; LEVEILLARD T, 1991, J BIOL CHEM, V266, P5162; LOFQUIST A, 1986, J BIOL CHEM, V261, P4600; MORRY MJ, 1986, MOL CELL BIOL, V6, P105, DOI 10.1128/MCB.6.1.105; MULLER F, 1987, NUCLEIC ACIDS RES, V15, P7191, DOI 10.1093/nar/15.17.7191; OEI SL, 1990, J BIOL CHEM, V265, P7485; PALIDA FA, 1993, NUCLEIC ACIDS RES, V21, P5875, DOI 10.1093/nar/21.25.5875; PALMER JM, 1990, TRENDS BIOCHEM SCI, V15, P300, DOI 10.1016/0968-0004(90)90018-7; RAMEAU G, 1994, MOL CELL BIOL, V14, P822, DOI 10.1128/MCB.14.1.822; RAYMOND GJ, 1983, NUCLEIC ACIDS RES, V11, P5969, DOI 10.1093/nar/11.17.5969; REYNOLDS WF, 1989, NUCLEIC ACIDS RES, V17, P9381; REYNOLDS WF, 1988, MOL CELL BIOL, V8, P5056, DOI 10.1128/MCB.8.11.5056; REYNOLDS WF, 1988, NUCLEIC ACIDS RES, V16, P3391, DOI 10.1093/nar/16.8.3391; REYNOLDS WF, 1992, MOL CELL BIOL, V12, P946, DOI 10.1128/MCB.12.3.946; REYNOLDS WF, 1993, NUCLEIC ACIDS RES, V21, P4372, DOI 10.1093/nar/21.18.4372; ROONEY RJ, 1988, NUCLEIC ACIDS RES, V16, P2509, DOI 10.1093/nar/16.6.2509; SCHAACK J, 1984, J BIOL CHEM, V259, P1461; SEGALL J, 1980, J BIOL CHEM, V255, P1986; SEIDEL CW, 1992, J MOL BIOL, V227, P1009, DOI 10.1016/0022-2836(92)90517-N; SETZER DR, 1985, J BIOL CHEM, V260, P2483; SHAW KJ, 1984, MOL CELL BIOL, V4, P657, DOI 10.1128/MCB.4.4.657; STUTZ F, 1989, GENE DEV, V3, P1190, DOI 10.1101/gad.3.8.1190; SULLIVAN HS, 1994, MOL CELL BIOL, V14, P1806, DOI 10.1128/MCB.14.3.1806; TAPPING RI, 1994, J BIOL CHEM, V269, P21812; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; WOLFFE AP, 1988, SCIENCE, V241, P1626, DOI 10.1126/science.3420414; YOUNG LS, 1986, P NATL ACAD SCI USA, V83, P374, DOI 10.1073/pnas.83.2.374	37	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10703	10710		10.1074/jbc.270.18.10703	http://dx.doi.org/10.1074/jbc.270.18.10703			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738008	hybrid			2022-12-27	WOS:A1995QW60100052
J	FRY, AM; SCHULTZ, SJ; BARTEK, J; NIGG, EA				FRY, AM; SCHULTZ, SJ; BARTEK, J; NIGG, EA			SUBSTRATE-SPECIFICITY AND CELL-CYCLE REGULATION OF THE NEK2 PROTEIN-KINASE, A POTENTIAL HUMAN HOMOLOG OF THE MITOTIC REGULATOR NIMA OF ASPERGILLUS-NIDULANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; IDENTIFICATION; ACTIVATION; INTERPHASE; DIVISION; MUTATION; MITOSIS; MEMBERS; GENE	The human Nek2 protein kinase is the closest known mammalian relative of the mitotic regulator NIMA of Aspergillus nidulans, The two kinases share 47% sequence identity over their catalytic domains and display a similar cell cycle-dependent expression peaking at the G(2) to M phase transition. Hence, it is attractive to speculate that human Nek2 and fungal NIMA may carry out similar functions at the onset of mitosis, To study the biochemical properties and substrate specificity of human Nek2 and compare them to those reported previously for other NIMA-related protein kinases, we have expressed Nek2 in insect cells. We show that recombinant Nek2 is active as a serine/threonine-specific protein kinase and may undergo autophosphorylation. Both human Nek2 and fungal NIMA phosphorylate a similar, albeit not identical, set of proteins and synthetic peptides, and beta-casein was found to be a suitable substrate for assaying Nek2 in vitro. By exploiting these findings, we have studied the cell cycle regulation of Nek2 activity in HeLa cells. We show that Nek2 activity parallels its abundance, being low during M and G(1) but high during S and G(2) phase. Taken together, our results suggest that human Nek2 resembles fungal NIMA in its primary structure, cell cycle regulation of expression, and substrate specificity, but that Nek2 may function earlier in the cell cycle than NIMA.	SWISS INST EXPTL CANC RES, CH-1066 EPALINGES, SWITZERLAND; DANISH CANC SOC, DIV CANC BIOL, DK-2100 COPENHAGEN, DENMARK	Swiss Institute Experimental Cancer Research; Danish Cancer Society			Bartek, Jiri/G-5870-2014	nigg, erich/0000-0003-4835-5719				BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; BERGEN LG, 1984, J BACTERIOL, V159, P114, DOI 10.1128/JB.159.1.114-119.1984; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; DOONAN JH, 1992, J CELL SCI, V103, P599; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HARLOW E, 1988, ANTIBODIES LABORATOR; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KEMP BE, 1977, J BIOL CHEM, V252, P4888; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LETWIN K, 1992, EMBO J, V11, P3521, DOI 10.1002/j.1460-2075.1992.tb05435.x; LU KP, 1994, EMBO J, V13, P2103, DOI 10.1002/j.1460-2075.1994.tb06486.x; LU KP, 1993, J BIOL CHEM, V268, P8769; LU KP, 1994, J BIOL CHEM, V269, P6603; LUKAS J, 1992, EUR J BIOCHEM, V207, P169, DOI 10.1111/j.1432-1033.1992.tb17034.x; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; OAKLEY BR, 1983, J CELL BIOL, V96, P1155, DOI 10.1083/jcb.96.4.1155; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; OSMANI AH, 1991, EMBO J, V10, P2669, DOI 10.1002/j.1460-2075.1991.tb07810.x; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; PEARSON RB, 1993, PROTEIN PHOSPHORYLAT, P265; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; SCHULTZ SJ, 1993, CELL GROWTH DIFFER, V4, P821; SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P625; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543	27	130	133	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12899	12905		10.1074/jbc.270.21.12899	http://dx.doi.org/10.1074/jbc.270.21.12899			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759549	hybrid			2022-12-27	WOS:A1995QZ71100086
J	JUNG, LJ; CHAN, CF; GLAZER, AN				JUNG, LJ; CHAN, CF; GLAZER, AN			CANDIDATE GENES FOR THE PHYCOERYTHROCYANIN ALPHA-SUBUNIT LYASE - BIOCHEMICAL-ANALYSIS OF PECE AND PECF INTERPOSON MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM MASTIGOCLADUS-LAMINOSUS; CRYSTAL-STRUCTURE ANALYSIS; INVITRO ATTACHMENT; SYNECHOCOCCUS-SPP; ENERGY-TRANSFER; C-PHYCOCYANIN; ANABAENA; PHYCOBILIPROTEINS; PHYCOBILISOMES; CRYSTALLIZATION	The rod substructures of the Anabaena sp, PCC 7120 phycobilisome contain the light harvesting proteins C-phycocyanin and phycoerythrocyanin (PEG), Even at low light intensities, PEC represents no more than 5% of the phycobilisome protein, The beta subunits of both proteins carry thioether-linked phycocyanobilin (PCB) at beta-Cys-82 and beta-Cys-155; however, C-phycocyanin has PCB at alpha-Cys-84 whereas PEC alpha subunit carries phycobiliviolin at this position. The Anabaena sp, PCC 7120 pec operon is made up of five genes, PecB and pecA encode the beta and alpha subunits of PEC, pecC encodes a linker polypeptide associated with PEC in the rod substructure, and pecE and pecF are genes of unknown function that show a high degree of homology to cpcE and cpcF, that encode a C-phycocyanin alpha subunit PCB lyase (Fairchild, C, D., Zhao, J., Zhou, J., Colson, S, E., Bryant, D. A., and Glazer, A. N. (1992) Proc. Natl. Acad. Sci. U.S. A. 89, 7017-7021), Insertional mutants in pecE and pecF, and an interposon mutant in which a portion of both pecE and pecF was deleted, were constructed. All three types of mutants grew 1.3 times slower than wild-type under limiting light conditions and showed a 20% reduction in the PCB content of whole cells relative to chlorophyll alpha. Holo-PEC was missing from the phycobilisomes of all three types of mutants and the level of the PEC linker polypeptide was reduced relative to the wild-type. However, similar to 30% of the wild-type level of the PEC beta subunit was present in all of these phycobilisomes, In contrast, the PEC alpha subunit was barely detectable in the pecE and pecF mutants, but was present in the pecEF deletion mutant as a PCB-adduct in a 1:1 ratio with the PEC beta subunit. The identity of this ''unnatural'' adduct was confirmed by isolation of the subunit and amino-terminal sequencing, These biochemical results support the inference that pecE and pecF encode a PEC a subunit phycobiliviolin lyase, and, in conjunction with earlier findings, demonstrate that phycobiliprotein bilin lyases show high selectivity (rather than absolute specificity) for both the bilin and the polypeptide substrate.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley					NIGMS NIH HHS [GM28994] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028994] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; ARCIERO DM, 1988, J BIOL CHEM, V263, P18350; BANCROFT I, 1989, J BACTERIOL, V171, P5949, DOI 10.1128/jb.171.11.5949-5954.1989; BELKNAP WR, 1987, EMBO J, V6, P871, DOI 10.1002/j.1460-2075.1987.tb04833.x; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; BRYANT DA, 1976, ARCH MICROBIOL, V9, P77; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; CORNEJO J, 1992, J BIOL CHEM, V267, P14790; DELORIMIER R, 1993, PLANT MOL BIOL, V21, P225, DOI 10.1007/BF00019939; DEMARSAC NT, 1988, METHOD ENZYMOL, V167, P318; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; DUERRING M, 1990, J MOL BIOL, V211, P633, DOI 10.1016/0022-2836(90)90270-V; EBERLEIN M, 1990, GENE, V94, P133, DOI 10.1016/0378-1119(90)90480-F; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P28988; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; FUGLISTALLER P, 1986, BIOL CHEM H-S, V367, P601, DOI 10.1515/bchm3.1986.367.2.601; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1973, J BIOL CHEM, V248, P663; GLAZER AN, 1973, J BIOL CHEM, V248, P659; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI LM, 1992, J BIOL CHEM, V267, P19204; MATHIES RA, 1994, REV SCI INSTRUM, V65, P807, DOI 10.1063/1.1144905; ONG LJ, 1991, J BIOL CHEM, V266, P9515; Sambrook J, 1989, MOL CLONING LABORATO; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; SWANSON RV, 1992, J BACTERIOL, V174, P2640, DOI 10.1128/jb.174.8.2640-2647.1992; SWANSON RV, 1990, ANAL BIOCHEM, V188, P295, DOI 10.1016/0003-2697(90)90609-D; SWANSON RV, 1992, J BACTERIOL, V174, P5488; YAMANAKA G, 1978, J BIOL CHEM, V253, P8303; YU MH, 1981, J BIOL CHEM, V256, P3130; ZHAO JD, 1989, ARCH MICROBIOL, V152, P447, DOI 10.1007/BF00446927; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	38	34	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12877	12884		10.1074/jbc.270.21.12877	http://dx.doi.org/10.1074/jbc.270.21.12877			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759546	hybrid			2022-12-27	WOS:A1995QZ71100083
J	SILLMAN, AL; MONROE, JG				SILLMAN, AL; MONROE, JG			ASSOCIATION OF P72(SYK) WITH THE SRC HOMOLOGY-G (SH2) DOMAINS OF PLC-GAMMA-1 IN B-LYMPHOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; CELL ANTIGEN RECEPTOR; PHOSPHOLIPASE-C; PHOSPHORYLATION SITES; ACTIVATION; BINDING; IG; C-GAMMA-1; EXPRESSION	Phospholipase C gamma-catalyzed inositol phospholipid hydrolysis, a critical step in B cell antigen receptor signaling leading to second messenger generation and proliferation, depends upon tyrosine kinase activation. The B cell antigen receptor-associated tyrosine kinases p53/ 56(lyn), p59(fyn), p55(blk), and p72(syk) are assumed to participate in receptor-initiated signaling. It is unknown, however, which of these kinases is involved in the tyrosine phosphorylation and resulting activation of phospholipase C gamma in response to antigen receptor cross-linking. We have used a fusion protein containing the tandem src homology-2 (SH2) domains of phospholipase C gamma 1 (PLC gamma 1) to identify B cell kinases which associate with PLC gamma 1. Using an in vitro kinase assay, we demonstrate SH2-dependent association of tyrosine kinase activity from anti-mu-stimulated B cells. The PLC gamma 1 SH2 domains associate with a prominent 70-72-kDa tyrosine phosphoprotein from anti-mu-stimulated, but not resting, B cells. Immunoblotting and secondary immunoprecipitation studies definitively identify this protein as p72(syk). These results imply a physical interaction between PLC gamma 1 and p72(syk) in antigen receptor-stimulated B cells. This conclusion is confirmed by our ability to co-immunoprecipitate p72(syk) and PLC gamma 1 from lysates of anti-mu-stimulated B cells. These results implicate p72(syk) in the activation of phospholipase C gamma 1 during B cell antigen receptor signaling.	UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104	University of Pennsylvania				Sillman, Amy/0000-0001-6970-3765	NIAID NIH HHS [AI23568, AI23592] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R23AI023568, R01AI023592, R01AI023568] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V888, P7410; CARTER RH, 1991, P NATL ACAD SCI USA, V88, P2745, DOI 10.1073/pnas.88.7.2745; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; COGGESHALL KM, 1984, J IMMUNOL, V133, P3382; COOPER JA, 1981, MOL CELL BIOL, V1, P165, DOI 10.1128/MCB.1.2.165; GOLDSCHMIDTCLER.PJ, 1991, SCIENCE, V251, P1231; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HEMPEL WM, 1992, J IMMUNOL, V148, P3021; HEMPEL WM, 1991, J IMMUNOL, V146, P3713; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; HUTCHCROFT JE, 1991, J BIOL CHEM, V266, P14846; KASHISHIAN A, 1993, MOL BIOL CELL, V4, P49, DOI 10.1091/mbc.4.1.49; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; LANE PJL, 1991, J IMMUNOL, V146, P715; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; MONROE JG, 1985, J IMMUNOL, V135, P1674; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; PADEH S, 1991, J CLIN INVEST, V87, P1114, DOI 10.1172/JCI115074; RANSOM JT, 1986, J IMMUNOL, V137, P708; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; ROIFMAN CM, 1992, BIOCHEM BIOPH RES CO, V183, P411, DOI 10.1016/0006-291X(92)90496-8; SIDORENKO SP, 1995, P NATL ACAD SCI USA, V92, P359, DOI 10.1073/pnas.92.2.359; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; ZHU GC, 1992, P NATL ACAD SCI USA, V89, P9559, DOI 10.1073/pnas.89.20.9559	29	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11806	11811		10.1074/jbc.270.20.11806	http://dx.doi.org/10.1074/jbc.270.20.11806			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744830	hybrid			2022-12-27	WOS:A1995QY73600024
J	DEROUICHE, R; BENEDETTI, H; LAZZARONI, JC; LAZDUNSKI, C; LLOUBES, R				DEROUICHE, R; BENEDETTI, H; LAZZARONI, JC; LAZDUNSKI, C; LLOUBES, R			PROTEIN COMPLEX WITHIN ESCHERICHIA-COLI INNER MEMBRANE - TOLA N-TERMINAL DOMAIN INTERACTS WITH TOLQ AND TOLR PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATION SYSTEM; NUCLEOTIDE-SEQUENCES; ENERGY TRANSDUCTION; OUTER-MEMBRANE; TONB; IMPORT; TOPOLOGY; GENES; EXBD; LOCALIZATION	The TolA, TolB, TolQ, and TolR proteins are involved in maintaining the integrity of the Escherichia coli outer membrane and in the import of group A colicins and filamentous phage DNA. TolA, TolQ, and TolR are localized in the inner membrane while TolB is periplasmic, although a small amount of membrane-associated TolB is always found. In vivo cross-linking experiments with formaldehyde were performed in order to determine the proteins interacting with TolA In wild-type strains, two specific complexes of 65 and 71 kDa, com prising TolA, were identified. These complexes were absent in a tolQ strain, while only the 65-kDa complex was absent in a tolR strain. When the tol strains were transformed with plasmids encoding TolR or TolQ, the specific complexes were restored. Moreover, immunoprecipitation experiments with the antiserum directed against TolA indicated that TolQ and TolR were co-immunoprecipitated with TolA after cross-linking. These data demonstrate that TolA interacts directly with TolR and TolQ. Two truncated TolA proteins devoid of either the C-terminal or the central domains of the protein were subjected to in vivo cross-linking. Since these two TolA derivatives still formed specific complexes with TolR and TolQ, we concluded that the TolA N-terminal domain interacted with these proteins.	CNRS, INGN & DYNAM SYST MEMBRANAIRES LAB, F-13402 MARSEILLE 20, FRANCE; UNIV LYON 1, CNRS, UMR 106, MICROBIOL & GENET MOLEC LAB, F-69622 VILLEURBANNE, FRANCE	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1				LLOUBES, Roland/0000-0002-9520-1053				Bachmann B.J., 1987, E COLI S TYPHIMURIUM, V2, P1192; BENEDETTI H, 1991, EMBO J, V10, P1989, DOI 10.1002/j.1460-2075.1991.tb07728.x; BOURDINEAUD JP, 1989, J BACTERIOL, V171, P2458, DOI 10.1128/jb.171.5.2458-2465.1989; BOUVERET E, 1995, J BIOL CHEM, V270, P11071, DOI 10.1074/jbc.270.19.11071; BRAUN V, 1993, MOL MICROBIOL, V8, P261, DOI 10.1111/j.1365-2958.1993.tb01570.x; DAVIES JK, 1975, J BACTERIOL, V123, P96, DOI 10.1128/JB.123.1.96-101.1975; EICKHELMERICH K, 1989, J BACTERIOL, V171, P5117, DOI 10.1128/jb.171.9.5117-5126.1989; ESPESSET D, 1994, MOL MICROBIOL, V13, P1121, DOI 10.1111/j.1365-2958.1994.tb00503.x; FISCHER E, 1989, J BACTERIOL, V171, P5129; FOGNINILEFEBVRE N, 1987, MOL GEN GENET, V209, P391, DOI 10.1007/BF00329670; GELI V, 1993, FEMS MICROBIOL LETT, V109, P335; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; ISNARD M, 1994, J BACTERIOL, V176, P6392, DOI 10.1128/jb.176.20.6392-6396.1994; JASKULA JC, 1994, J BACTERIOL, V176, P2326, DOI 10.1128/JB.176.8.2326-2338.1994; KAMPFENKEL K, 1993, J BACTERIOL, V175, P4485, DOI 10.1128/JB.175.14.4485-4491.1993; KAMPFENKEL K, 1992, J BACTERIOL, V174, P5485, DOI 10.1128/JB.174.16.5485-5487.1992; KAMPFENKEL K, 1993, J BIOL CHEM, V268, P6050; KARLSSON M, 1993, MOL MICROBIOL, V8, P379, DOI 10.1111/j.1365-2958.1993.tb01581.x; LARSEN RA, 1994, MOL MICROBIOL, V13, P627, DOI 10.1111/j.1365-2958.1994.tb00457.x; LARSEN RA, 1993, MOL MICROBIOL, V10, P943, DOI 10.1111/j.1365-2958.1993.tb00966.x; LAZZARONI JC, 1995, J MOL BIOL, V246, P1, DOI 10.1006/jmbi.1994.0058; LEVENGOOD SK, 1991, P NATL ACAD SCI USA, V88, P5939, DOI 10.1073/pnas.88.14.5939; LEVENGOOD SK, 1989, J BACTERIOL, V171, P6600, DOI 10.1128/jb.171.12.6600-6609.1989; LEVENGOODFREYERMUTH SK, 1993, J BACTERIOL, V175, P222, DOI 10.1128/JB.175.1.222-228.1993; MULLER MM, 1993, J BACTERIOL, V175, P6059, DOI 10.1128/JB.175.18.6059-6061.1993; POSTLE K, 1993, J BIOENERG BIOMEMBR, V25, P591; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; ROOF SK, 1991, J BACTERIOL, V173, P5554, DOI 10.1128/jb.173.17.5554-5557.1991; SKARE JT, 1991, MOL MICROBIOL, V5, P2883, DOI 10.1111/j.1365-2958.1991.tb01848.x; SKARE JT, 1993, J BIOL CHEM, V268, P16302; SUN TP, 1986, J BACTERIOL, V165, P107, DOI 10.1128/jb.165.1.107-115.1986; SUN TP, 1987, J BACTERIOL, V169, P2667, DOI 10.1128/jb.169.6.2667-2674.1987; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIANNEY A, 1994, J BACTERIOL, V176, P822, DOI 10.1128/jb.176.3.822-829.1994; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x	36	108	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11078	11084		10.1074/jbc.270.19.11078	http://dx.doi.org/10.1074/jbc.270.19.11078			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744737	hybrid			2022-12-27	WOS:A1995QX86500012
J	HAHN, FM; POULTER, CD				HAHN, FM; POULTER, CD			ISOLATION OF SCHIZOSACCHAROMYCES-POMBE ISOPENTENYL DIPHOSPHATE ISOMERASE CDNA CLONES BY COMPLEMENTATION AND SYNTHESIS OF THE ENZYME IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; GENE; PYROPHOSPHATE; BIOSYNTHESIS; MUTAGENESIS; INHIBITION; MUTANTS; PLASMID	Isopentenyl diphosphate (IPP) isomerase catalyzes an essential activation step in the isoprene biosynthetic pathway. The Saccharomyces cerevisiae gene for IPP isomerase, IDI1, was recently isolated and characterized (Anderson, M. S., Muehlbacher, M., Street, I. P., Proffitt, J., and Poulter, C. D, (1989) J. Biol. Chem. 264, 19169-19175), and the wild-type gene, IDI1, was disrupted with a LEU2 marker to create a diploid yeast strain heterozygous for the idi1::leu2 disruption, which revealed that IDI1 was an essential single-copy gene (Mayer, M. P., Hahn, F. M., Stillman, D. J., and Poulter, C. D. (1992) Yeast 8, 743-748). We now report the isolation of a cDNA clone from Schizosaccharomyces pombe by a plasmid shuffle-mediated complementation of the LEU2 disrupted yeast gene. The S. pombe clone encoded a 26,864-dalton polypeptide of 227 amino acids with a high degree of similarity to the S. cerevisiae IDI1 enzyme. S. pombe IPP isomerase contained the essential Cys and Glu catalytic residues identified in yeast isomerase (Street, I. P., Coffman, H. R., Baker, J., and Poulter, C. (1994) Biochemistry 33, 4212-4217) but was significantly smaller than the S. cerevisiae enzyme. The plasmid shuffle technique is an excellent procedure for screening expression libraries for IPP isomerase activity by complementation of the idi1 mutation.	UNIV UTAH, DEPT CHEM, SALT LAKE CITY, UT 84112 USA	Utah System of Higher Education; University of Utah					NIGMS NIH HHS [GM125521] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON MS, 1989, J BIOL CHEM, V264, P326; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Elbe R, 1992, BIOTECHNIQUES, V13, P18; FIKES JD, 1990, NATURE, V346, P291, DOI 10.1038/346291a0; GOODWIN TW, 1971, BIOCHEM J, V123, P293, DOI 10.1042/bj1230293; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUOKA S, 1991, J BIOL CHEM, V266, P3464; MAYER MP, 1992, YEAST, V8, P743, DOI 10.1002/yea.320080907; MUEHLBACHER M, 1985, J AM CHEM SOC, V107, P8307, DOI 10.1021/ja00312a107; MUEHLBACHER M, 1988, BIOCHEMISTRY-US, V27, P7315, DOI 10.1021/bi00419a021; POPJAK G, 1970, NATURAL SUBSTANCES F, P17; POULTER CD, 1990, ACCOUNTS CHEM RES, V23, P70, DOI 10.1021/ar00171a003; POULTER CD, 1981, BIOSYNTHESIS ISOPREN, V1, P162; REARDON JE, 1985, J AM CHEM SOC, V107, P4078, DOI 10.1021/ja00299a054; REARDON JE, 1986, BIOCHEMISTRY-US, V25, P7315; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATTERWHITE DM, 1985, METHOD ENZYMOL, V110, P92; SCOPES R, 1982, PROTEIN PURIFICATION, P266; SHERMAN F, 1991, METHOD ENZYMOL, V194, P21; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Spurgeon S.L., 1981, BIOSYNTHESIS ISOPREN, V1, P1; STREET IP, 1990, BIOCHEMISTRY-US, V29, P7531, DOI 10.1021/bi00484a023; STREET IP, 1994, BIOCHEMISTRY-US, V33, P4212, DOI 10.1021/bi00180a014; STREET IP, 1991, TETRAHEDRON, V47, P5919, DOI 10.1016/S0040-4020(01)86484-X; XUAN J, 1994, GENOMICS, V20, P128; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZARET KS, 1985, J BACTERIOL, V162, P579, DOI 10.1128/JB.162.2.579-583.1985; [No title captured]	35	27	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11298	11303		10.1074/jbc.270.19.11298	http://dx.doi.org/10.1074/jbc.270.19.11298			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744766	hybrid			2022-12-27	WOS:A1995QX86500043
J	HESSELGESSER, J; CHITNIS, CE; MILLER, LH; YANSURA, DG; SIMMONS, LC; FAIRBROTHER, WJ; KOTTS, C; WIRTH, C; GILLECECASTRO, BL; HORUK, R				HESSELGESSER, J; CHITNIS, CE; MILLER, LH; YANSURA, DG; SIMMONS, LC; FAIRBROTHER, WJ; KOTTS, C; WIRTH, C; GILLECECASTRO, BL; HORUK, R			A MUTANT OF MELANOMA GROWTH-STIMULATING ACTIVITY DOES NOT ACTIVATE NEUTROPHILS BUT BLOCKS ERYTHROCYTE INVASION BY MALARIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; INTERLEUKIN-8 RECEPTORS; 3-DIMENSIONAL STRUCTURE; SCANNING MUTAGENESIS; CHEMOKINE RECEPTOR; PLASMODIUM-VIVAX; CYTOKINE FAMILY; DETERMINANTS; RESOLUTION; PARASITE	Alanine scanning mutagenesis of the charged amino acids of melanoma growth stimulating activity (MGSA) was used to identify specific residues that are involved in binding to the human erythrocyte Duffy antigen/chemokine receptor (DARC) and to the type B interleukin-8 receptor (IL-8RB) on neutrophils, Receptor binding and biological studies with the alanine scan mutants of MGSA demonstrate that MGSA binds to DARC and the IL-8RB through distinct binding regions, One of the MGSA mutants, E6A, binds to human erythrocytes and is able to inhibit malaria invasion as efficiently as wild type MGSA but has a severely reduced ability to bind to or signal through the IL-8RB, Mutant chemokines like E6A could prove to be useful therapeutically for the design of receptor blocking drugs that inhibit erythrocyte invasion by Plasmodium vivax malaria.	GENENTECH INC,S SAN FRANCISCO,CA 94080; NIH,MALARIA RES LAB,BETHESDA,MD 20205	Roche Holding; Genentech; National Institutes of Health (NIH) - USA				Chitnis, Chetan/0000-0002-8773-9865				BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; CHANG CN, 1987, GENE, V55, P189, DOI 10.1016/0378-1119(87)90279-4; CHAUDHURI A, 1993, P NATL ACAD SCI USA, V90, P10793, DOI 10.1073/pnas.90.22.10793; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HORUK R, 1993, BIOCHEMISTRY-US, V32, P5733, DOI 10.1021/bi00073a002; HORUK R, 1994, IMMUNOL TODAY, V15, P169, DOI 10.1016/0167-5699(94)90314-X; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; HORUK R, 1993, J BIOL CHEM, V268, P541; LEE J, 1992, J BIOL CHEM, V267, P16283; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; MILLER JH, 1972, EXPT MOL GENETICS, P37; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1986, NEW ENGL J MED, V295, P302; MOSER B, 1993, J BIOL CHEM, V268, P7125; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NEOTE K, 1993, J BIOL CHEM, V268, P12247; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; PEVERI P, 1988, J EXP MED, V167, P1547, DOI 10.1084/jem.167.5.1547; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; STCHARLES R, 1989, J BIOL CHEM, V264, P2092	29	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11472	11476		10.1074/jbc.270.19.11472	http://dx.doi.org/10.1074/jbc.270.19.11472			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744785	hybrid			2022-12-27	WOS:A1995QX86500064
J	PHILIPS, MR; FEOKTISTOV, A; PILLINGER, MH; ABRAMSON, SB				PHILIPS, MR; FEOKTISTOV, A; PILLINGER, MH; ABRAMSON, SB			TRANSLOCATION OF P21(RAC2) FROM CYTOSOL TO PLASMA-MEMBRANE IS NEITHER NECESSARY NOR SUFFICIENT FOR NEUTROPHIL NADPH OXIDASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; CELL-FREE SYSTEM; GTP-BINDING PROTEIN; DEPENDENT SUPEROXIDE PRODUCTION; ADENINE-DINUCLEOTIDE PHOSPHATE; CHRONIC GRANULOMATOUS-DISEASE; GDP DISSOCIATION INHIBITOR; REGULATORY PROTEIN; SUBCELLULAR-LOCALIZATION; GUANINE-NUCLEOTIDES	Activation of the membrane-associated NADPH oxidase of neutrophils requires several cytosolic factors including p47(phox), p67(phox) and p21(rac2), We compared NADPH oxidase activity with the membrane translocation of p47(phox), p67(phox), and p21(rac2), In a cell-free system, GTP gamma S stimulated translocation of p47(phox) and p67(phox) to the plasma membrane only in the presence of arachidonate, and this translocation correlated with NADPH oxidase activity of the reisolated plasma membranes (R = 0.94 and 0.97, respectively), In contrast, GTP gamma S-stimulated p21(rac2) translocation with or without arachidonate, and the extent of translocation did not correlate with oxidase activity (R = 0.17), Neutrophil cytoplasts were used to relate membrane translocation of p47(phox), p67(phox) and p21(rac2) to membrane oxidase activity in response to the inflammatory agonists, Whereas N-formyl-methionyl-leucyl-phenylalanine stimulated equimolar, transient membrane translocation of p47(phox) and p67(phox) which kinetically paralleled NADPH oxidase activity, relatively little p21(rac2) translocated (moles of p47(phox)/p21(rac2) = 16.6), Moreover, although phorbol 12-myristate 13-acetate stimulated both the stable translocation of p47(phox) and p67(phox) and sustained NADPH oxidase activity, it did not stimulate p21(rac2) translocation, From these data we conclude that membrane translocation of p21(rac2) does not regulate NADPH oxidase activity stoichiometrically.			PHILIPS, MR (corresponding author), NYU,SCH MED,DEPT MED,550 1ST AVE,NEW YORK,NY 10016, USA.			Abramson, Steven/0000-0002-0668-6344; Pillinger, Michael/0000-0003-3168-1542; Mark, Philips/0000-0002-1179-8156	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036224, R29AI036224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR011949, R37AR011949] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL19721] Funding Source: Medline; NIAID NIH HHS [AI-36224] Funding Source: Medline; NIAMS NIH HHS [AR11949] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABO A, 1994, BIOCHEM J, V298, P585, DOI 10.1042/bj2980585; ABO A, 1992, NATURE, V353, P668; ARAKI S, 1990, J BIOL CHEM, V265, P13007; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; DEWALD B, 1979, J CLIN INVEST, V63, P21, DOI 10.1172/JCI109273; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; DORSEUIL O, 1992, J BIOL CHEM, V267, P20540; ELBENNA J, 1994, J BIOL CHEM, V269, P6729; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HEYWORTH PG, 1986, BIOCHEM J, V239, P723, DOI 10.1042/bj2390723; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P1217, DOI 10.1091/mbc.4.11.1217; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; ISOMURA M, 1991, ONCOGENE, V6, P119; IYER SS, 1994, J BIOL CHEM, V269, P22405; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KORCHAK HM, 1983, P NATL ACAD SCI-BIOL, V80, P4968, DOI 10.1073/pnas.80.16.4968; KWONG CH, 1993, BIOCHEMISTRY-US, V32, P5711, DOI 10.1021/bi00072a029; LANG P, 1993, BIOCHEM BIOPH RES CO, V196, P1522, DOI 10.1006/bbrc.1993.2424; LECABEC V, 1994, BIOCHEM BIOPH RES CO, V198, P1216, DOI 10.1006/bbrc.1994.1172; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; PARK JW, 1992, J BIOL CHEM, V267, P19901; PARK JW, 1992, J BIOL CHEM, V267, P17327; PEVERI P, 1992, P NATL ACAD SCI USA, V89, P2494, DOI 10.1073/pnas.89.6.2494; PHILIPS MR, 1991, J BIOL CHEM, V266, P1289; PHILIPS MR, 1993, SCIENCE, V259, P977, DOI 10.1126/science.8438158; PHILIPS MR, 1994, CLIN RES, V42, pA150; PHILIPS MR, 1993, CLIN RES, V41, pA322; PILLINGER MH, 1994, J BIOL CHEM, V269, P1486; QUINN MT, 1993, J BIOL CHEM, V268, P20983; QUINN MT, 1989, NATURE, V342, P198, DOI 10.1038/342198a0; REIBMAN J, 1988, J BIOL CHEM, V263, P6322; ROOS D, 1983, J CELL BIOL, V97, P368, DOI 10.1083/jcb.97.2.368; ROTROSEN D, 1993, J BIOL CHEM, V268, P14256; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; SEGAL AW, 1978, LANCET, V2, P446; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; TYAGI SR, 1992, BIOCHEMISTRY-US, V31, P2765, DOI 10.1021/bi00125a017; UEDA T, 1990, J BIOL CHEM, V265, P9373; UHLINGER DJ, 1993, J BIOL CHEM, V268, P8624; VOLKER C, 1990, Methods (Orlando), V1, P283, DOI 10.1016/S1046-2023(05)80329-9; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; WOODMAN RC, 1991, J CLIN INVEST, V87, P1345, DOI 10.1172/JCI115138	58	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11514	11521		10.1074/jbc.270.19.11514	http://dx.doi.org/10.1074/jbc.270.19.11514			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744791	hybrid			2022-12-27	WOS:A1995QX86500070
J	BANEYX, F; BERTSCH, U; KALBACH, CE; VANDERVIES, SM; SOLL, J; GATENBY, AA				BANEYX, F; BERTSCH, U; KALBACH, CE; VANDERVIES, SM; SOLL, J; GATENBY, AA			SPINACH CHLOROPLAST CPN21 CO-CHAPERONIN POSSESSES 2 FUNCTIONAL DOMAINS FUSED TOGETHER IN A TOROIDAL STRUCTURE AND EXHIBITS NUCLEOTIDE-DEPENDENT BINDING TO PLASTID CHAPERONIN-60	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; GROES-LIKE CHAPERONIN; HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; LARGE SUBUNITS; PEA-CHLOROPLASTS; GENE DUPLICATION; IDENTIFICATION; ATP	Chloroplasts contain a 21-kDa co-chaperonin polypeptide (cpn21) formed by two GroES-like domains fused together in tandem. Expression of a double-domain spinach cpn21 in Escherichia coli groES mutant strains supports growth of bacteriophages lambda and T5, and will also suppress a temperature-sensitive growth phenotype of a groES619 strain. Each domain of cpn21 expressed separately can function independently to support bacteriophage lambda growth, and the N-terminal domain will additionally suppress the temperature-sensitive growth phenotype. These results indicate that chloroplast cpn21 has two functional domains, either of which can interact with GroEL in vivo to facilitate bacteriophage morphogenesis. Purified spinach cpn21 has a ring-like toroidal structure and forms a stable complex with E. coli GroEL in the presence of ADP and is functionally interchangeable with bacterial GroES in the chaperonin-facilitated refolding of denatured ribulose-1,5-bisphosphate carboxylase. Cpn21 also inhibits the ATPase activity of GroEL. Cpn21 binds with similar efficiency to both the alpha and beta subunits of spinach cpn60 in the presence of adenine nucleotides, with ATP being more effective than ADP. The tandemly fused domains of cpn21 evolved early and are present in a wide range of photosynthetic eukaryotes examined, indicating a high degree of conservation of this structure in chloroplasts.	DUPONT CO INC,CENT RES & DEV,DIV MOLEC BIOL,EXPTL STN,WILMINGTON,DE 19880; INST BOT,D-24098 KIEL,GERMANY; UNIV GENEVA,DEPT BIOCHIM MED,CH-1211 GENEVA 4,SWITZERLAND	DuPont; University of Geneva								ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; BANEYX F, 1992, J BIOL CHEM, V267, P11637; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; BERTSCH U, 1992, P NATL ACAD SCI USA, V89, P8696, DOI 10.1073/pnas.89.18.8696; BLOOM MV, 1983, P NATL ACAD SCI-BIOL, V80, P1013, DOI 10.1073/pnas.80.4.1013; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; BURT WJE, 1994, FEBS LETT, V339, P139, DOI 10.1016/0014-5793(94)80401-X; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; ELLIS RJ, 1988, PHOTOSYNTH RES, V16, P101, DOI 10.1007/BF00039488; FAYET O, 1986, MOL GEN GENET, V202, P435, DOI 10.1007/BF00333274; GATENBY AA, 1994, ANNU REV PLANT PHYS, V45, P469; GATENBY AA, 1981, NATURE, V291, P117, DOI 10.1038/291117a0; GATENBY AA, 1988, EMBO J, V7, P1307, DOI 10.1002/j.1460-2075.1988.tb02945.x; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HARTMAN DJ, 1992, P NATL ACAD SCI USA, V89, P3394, DOI 10.1073/pnas.89.8.3394; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; LIANG H, 1993, P NATL ACAD SCI USA, V90, P7010, DOI 10.1073/pnas.90.15.7010; LISSIN NM, 1990, NATURE, V348, P339, DOI 10.1038/348339a0; LUBBEN TH, 1990, P NATL ACAD SCI USA, V87, P7683, DOI 10.1073/pnas.87.19.7683; LUBBEN TH, 1989, PLANT CELL, V1, P1223, DOI 10.1105/tpc.1.12.1223; MARTEL R, 1990, GENE, V94, P181, DOI 10.1016/0378-1119(90)90385-5; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MAYR EM, 1994, J MOL BIOL, V235, P84, DOI 10.1016/S0022-2836(05)80017-8; MCLACHLAN AD, 1987, COLD SPRING HARB SYM, V52, P411, DOI 10.1101/SQB.1987.052.01.048; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; MUSGROVE JE, 1987, EUR J BIOCHEM, V163, P529, DOI 10.1111/j.1432-1033.1987.tb10900.x; PUSHKIN AV, 1982, BIOCHIM BIOPHYS ACTA, V704, P379, DOI 10.1016/0167-4838(82)90169-8; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; ROSPERT S, 1993, P NATL ACAD SCI USA, V90, P10967, DOI 10.1073/pnas.90.23.10967; ROY H, 1982, J CELL BIOL, V94, P20, DOI 10.1083/jcb.94.1.20; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; TANG J, 1978, NATURE, V271, P618, DOI 10.1038/271618a0; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; ZEILSTRARYALLS J, 1993, J BACTERIOL, V175, P1134, DOI 10.1128/JB.175.4.1134-1143.1993; ZWEIG M, 1973, J MOL BIOL, V80, P505, DOI 10.1016/0022-2836(73)90418-X	44	52	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10695	10702		10.1074/jbc.270.18.10695	http://dx.doi.org/10.1074/jbc.270.18.10695			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738007	hybrid			2022-12-27	WOS:A1995QW60100051
J	DEYASHIKI, Y; OHSHIMA, K; NAKANISHI, M; SATO, K; MATSUURA, K; HARA, A				DEYASHIKI, Y; OHSHIMA, K; NAKANISHI, M; SATO, K; MATSUURA, K; HARA, A			MOLECULAR-CLONING AND CHARACTERIZATION OF MOUSE ESTRADIOL 17-BETA-DEHYDROGENASE (A-SPECIFIC), A MEMBER OF THE ALDOKETOREDUCTASE FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TESTICULAR 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; CHAIN ALCOHOL DEHYDROGENASES; HUMAN ALDOSE REDUCTASE; FEMALE RABBIT LIVER; 17-BETA-HYDROXYSTEROID DEHYDROGENASE; 20-BETA-HYDROXYSTEROID DEHYDROGENASE; DIHYDRODIOL DEHYDROGENASES; HYDROGEN TRANSFER; MULTIPLE FORMS; 3-BETA-HYDROXYSTEROID DEHYDROGENASE	Several mammalian livers contain monomeric 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) with A-stereospecificity in hydrogen transfer, which differs from the B-specific dimeric enzyme of human placenta in its ability to catalyze the oxidoreduction of xenobiotic trans-dihydrodiols of aromatic hydrocarbons and carbonyl compounds, Here, we report the isolation and characterization of a mouse cDNA clone encoding monomeric 17 beta-HSD of the liver, This clone had an entire coding region for a protein of 323 amino acid residues with a molecular weight of 37,055, The deduced sequence of the protein aligned with a high degree of identity with rat and rabbit 20 alpha-HSDs, rat and human 3 alpha-HSD/dihydrodiol dehydrogenases, and bovine prostaglandin F synthase, which are members of the aldoketoreductase family, but was distinct from human 17 beta-HSD and carbonyl reductase, members of the short chain dehydrogenases. The expression of the cDNA in Escherichia coli resulted in synthesis of a protein that was active toward androgens, estrogens, and xenobiotic substrates. The recombinant and mouse liver 17 beta-HSDs also exhibited low 20 alpha-HSD activity toward progestins, which is similar to bifunctional activity of human placental 17 beta-HSD. Therefore, the mouse enzyme was given the designation of estradiol 17 beta-dehydrogenase (A-specific). Northern analysis of mouse tissues revealed the existence of a single 1.7-kilobase 17 beta-HSD mRNA species in the liver, kidney, testis, and stomach, The liver mRNA content was considerably more abundant than those found in the other tissues, as 17 beta-HSD protein was mainly detected in the liver by Western analysis.	GIFU PHARMACEUT UNIV,BIOCHEM LAB,GIFU 502,JAPAN	Gifu Pharmaceutical University								ANTOUN GR, 1985, BIOCHEM J, V225, P391, DOI 10.1042/bj2250391; ANTOUN GR, 1985, BIOCHEM J, V225, P383, DOI 10.1042/bj2250383; BAKER ME, 1992, FEBS LETT, V301, P89, DOI 10.1016/0014-5793(92)80216-4; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BOHREN KM, 1992, J BIOL CHEM, V267, P20965; BORHANI DW, 1992, J BIOL CHEM, V267, P24841; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEYASHIKI Y, 1994, BIOCHEM J, V299, P545, DOI 10.1042/bj2990545; Engel L L, 1974, Recent Prog Horm Res, V30, P139; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; HARA A, 1986, ARCH BIOCHEM BIOPHYS, V249, P225, DOI 10.1016/0003-9861(86)90578-3; HARA A, 1986, BIOCHEM PHARMACOL, V35, P4005; HARA A, 1987, J BIOCHEM-TOKYO, V102, P1585, DOI 10.1093/oxfordjournals.jbchem.a122208; HARA A, 1982, J BIOCHEM, V92, P1753, DOI 10.1093/oxfordjournals.jbchem.a134105; HARA A, 1988, BIOCHEMISTRY LIFE SC, V7, P121; HOOG SS, 1994, P NATL ACAD SCI USA, V91, P2517, DOI 10.1073/pnas.91.7.2517; HUNYH TV, 1985, DNA CLONING PRACTICA, V1, P49; KOBAYASHI K, 1978, J BIOL CHEM, V253, P3635; KROZOWSKI Z, 1992, MOL CELL ENDOCRINOL, V84, P25; LACY WR, 1993, MOL ENDOCRINOL, V7, P58, DOI 10.1210/me.7.1.58; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEENDERS F, 1994, EUR J BIOCHEM, V222, P221, DOI 10.1111/j.1432-1033.1994.tb18860.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAREKOV L, 1990, FEBS LETT, V266, P51, DOI 10.1016/0014-5793(90)81504-H; MIURA R, 1994, BIOCHEM J, V299, P561, DOI 10.1042/bj2990561; NAKAGAWA M, 1989, J BIOCHEM-TOKYO, V106, P633, DOI 10.1093/oxfordjournals.jbchem.a122908; NAKAJIN S, 1989, CHEM PHARM BULL, V37, P148; NAKAYAMA T, 1985, J BIOCHEM-TOKYO, V98, P1131, DOI 10.1093/oxfordjournals.jbchem.a135362; NAKAYAMA T, 1987, ENZYMOLOGY MOL BIOL, P415; NEIDLE E, 1992, EUR J BIOCHEM, V204, P113, DOI 10.1111/j.1432-1033.1992.tb16612.x; PAWLOWSKI JE, 1991, J BIOL CHEM, V266, P8820; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; PINEDA JA, 1989, J STEROID BIOCHEM, V33, P1223, DOI 10.1016/0022-4731(89)90433-0; Platt K, 1977, SYNTHESIS-STUTTGART, V7, P449; QIN KN, 1993, J STEROID BIOCHEM, V46, P673, DOI 10.1016/0960-0760(93)90308-J; Sambrook J, 1989, MOL CLONING LABORATO; SAWADA H, 1988, BIOCHEM PHARMACOL, V37, P453, DOI 10.1016/0006-2952(88)90214-6; SHEN CC, 1979, J STEROID BIOCHEM, V10, P187, DOI 10.1016/0022-4731(79)90234-6; SHEN CC, 1978, ENDOCRINOLOGY, V103, P2040, DOI 10.1210/endo-103-6-2040; SIMON H, 1975, ISOTOPES ORGANIC CHE, V2, P153; STOLZ A, 1993, J BIOL CHEM, V268, P10448; TANAKA M, 1992, J BIOL CHEM, V267, P13451; TOBIAS B, 1982, J BIOL CHEM, V257, P2783; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TUBOI S, 1992, POSTTRANSLATIONAL MO, P3; WARREN JC, 1993, BIOCHEMISTRY-US, V32, P1401, DOI 10.1021/bi00057a003; WATANABE K, 1988, P NATL ACAD SCI USA, V85, P11, DOI 10.1073/pnas.85.1.11; WERMUTH B, 1992, PROSTAGLANDINS, V44, P5, DOI 10.1016/0090-6980(92)90102-Y; WILLIAMSON DG, 1979, STEROID BIOCH, V1, P83; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; WU L, 1993, J BIOL CHEM, V268, P12964; YIN SJ, 1991, EUR J BIOCHEM, V197, P359, DOI 10.1111/j.1432-1033.1991.tb15919.x; 1992, ENZYME NOMENCLATURE, P24	53	108	110	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10461	10467		10.1074/jbc.270.18.10461	http://dx.doi.org/10.1074/jbc.270.18.10461			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737980	hybrid			2022-12-27	WOS:A1995QW60100018
J	QUAN, LT; CAPUTO, A; BLEACKLEY, RC; PICKUP, DJ; SALVESEN, GS				QUAN, LT; CAPUTO, A; BLEACKLEY, RC; PICKUP, DJ; SALVESEN, GS			GRANZYME-B IS INHIBITED BY THE COWPOX VIRUS SERPIN CYTOKINE RESPONSE MODIFIER-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DEATH GENE CED-3; SERINE PROTEASES; PROTEIN; ENZYME; PURIFICATION; APOPTOSIS; CYTOLYSIS; SUBSTRATE; ENCODES	The ability of cytolytic cells to cause apoptosis in target cells is in part due to the action of the serine proteinase granzyme B, We demonstrate that granzyme B is inhibited, with an association rate constant of 2.9 x 10(5) M(-1) S-1, by the cowpox viral serpin cytokine response modifier A (CrmA). Previously we have shown CrmA to be an inhibitor of the cysteine proteinase interleukin-1 beta-converting enzyme (ICE), Thus the mechanism of CrmA involves the unusual ability to efficiently inhibit proteinases from two distinct catalytic classes, in this case serine and cysteine proteinases. Granzyme B and ICE are both used to combat viral infection, and we propose that cowpox virus uses CrmA to evade the contribution of these two proteinases, Thus, through CrmA, the virus may influence two of the pathways normally used to kill virus-infected cells: acting on endogenous proteinases such as ICE and on exogenous proteinases delivered by cytotoxic lymphocytes to infected cells.	DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MICROBIOL,DURHAM,NC 27710; UNIV ALBERTA,DEPT BIOCHEM,EDMONTON,AB T6G 2H7,CANADA	Duke University; Duke University; University of Alberta					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI032982, R01AI032982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038860] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32982] Funding Source: Medline; NIGMS NIH HHS [GM38860] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERKE G, 1994, ANNU REV IMMUNOL, V12, P735, DOI 10.1146/annurev.immunol.12.1.735; BLACK RA, 1989, J BIOL CHEM, V264, P5323; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; FERNANDESALNEMR.T, 1994, J BIOL CHEM, V269, P30761; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; HANNA WL, 1993, PROTEIN EXPRES PURIF, V4, P398, DOI 10.1006/prep.1993.1052; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; KOMIYAMA T, 1994, TECHNIQUES IN PROTEIN CHEMISTRY V, P305; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; PALUMBO GJ, 1989, VIROLOGY, V172, P262, DOI 10.1016/0042-6822(89)90128-1; PICKUP DJ, 1986, P NATL ACAD SCI USA, V83, P7698, DOI 10.1073/pnas.83.20.7698; POE M, 1991, J BIOL CHEM, V266, P98; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; SMYTH MJ, 1994, CLIN EXP PHARMACOL P, V21, P67, DOI 10.1111/j.1440-1681.1994.tb02438.x; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P2641, DOI 10.1021/bi00408a001; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	26	230	233	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10377	10379		10.1074/jbc.270.18.10377	http://dx.doi.org/10.1074/jbc.270.18.10377			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737968	hybrid			2022-12-27	WOS:A1995QW60100005
J	CASTAING, B; ZELWER, C; LAVAL, J; BOITEUX, S				CASTAING, B; ZELWER, C; LAVAL, J; BOITEUX, S			HU PROTEIN OF ESCHERICHIA-COLI BINDS SPECIFICALLY TO DNA THAT CONTAINS SINGLE-STRAND BREAKS OR GAPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-LIKE PROTEIN; POLY(ADP-RIBOSE) POLYMERASE; FPG PROTEINS; REPAIR; EXCISION; REPLICATION; GLYCOSYLASE; SITE; IHF; OVERPRODUCTION	In this study, we have identified a protein in Escherichia coli that specifically binds to double-stranded DNA containing a single-stranded gap of one nucleotide. The gap-DNA binding (GDB) protein was purified to apparent homogeneity, The analysis of the amino-terminal sequencing of the GDB protein shows two closely related sequences we identify as the alpha and beta subunits of the HU protein, Furthermore, the GDB protein is not detected in the crude extract of an E. coli double mutant strain hupA hupB that has no functional HU protein. These results led us to identify the GDB protein as the HU protein. HU binds strongly to double stranded 30-mer oligonucleotides containing a nick or a single-stranded gap of one or two nucleotides, Apparent dissociation constants were measured for these various DNA duplexes using a gel retardation assay, The K-D(app) values were 8 nM for the 30-mer duplex that contains a nick and 4 and 2 nM for those that contain a 1- or a 2-nucleotide gap, respectively, The affinity of HU for these ligands is at least 100-fold higher than for the same 30-mer DNA duplex without nick or gap. Other single-stranded breaks or gaps, which are intermediate products in the repair of abasic sites after incision by the Fpg, Nth, or Nfo proteins, are also preferentially bound by the HU protein, Due to specific: binding to DNA strand breaks, HU may play a role in replication, recombination, and repair.	INST GUSTAVE ROUSSY,CNRS,URA 147,REPARAT LES RADIO & CHIMIOIND GRP,F-94805 VILLEJUIF,FRANCE; CTR BIOPHYS MOLEC,CNRS,UPR 4301,EQUIPE CRISTALLOG BIOL,F-45071 ORLEANS 2,FRANCE	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)				Castaing, Bertrand/0000-0001-5077-8978				BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; BOITEUX S, 1993, J PHOTOCH PHOTOBIO B, V19, P87, DOI 10.1016/1011-1344(93)87101-R; BOITEUX S, 1989, MOL GEN GENET, V215, P300, DOI 10.1007/BF00339732; BONNEFOY E, 1994, J MOL BIOL, V242, P116, DOI 10.1006/jmbi.1994.1563; BONNEFOY E, 1992, EMBO J, V11, P4489, DOI 10.1002/j.1460-2075.1992.tb05550.x; BONNEFOY E, 1991, EMBO J, V10, P687, DOI 10.1002/j.1460-2075.1991.tb07998.x; BONNEFOY E, 1989, P NATL ACAD SCI USA, V86, P7691, DOI 10.1073/pnas.86.20.7691; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BROYLES SS, 1986, J MOL BIOL, V187, P47, DOI 10.1016/0022-2836(86)90405-5; CASTAING B, 1993, NUCLEIC ACIDS RES, V21, P2899, DOI 10.1093/nar/21.12.2899; CASTAING B, 1992, NUCLEIC ACIDS RES, V20, P389, DOI 10.1093/nar/20.3.389; CHARNEAU P, 1991, J VIROL, V65, P2415, DOI 10.1128/JVI.65.5.2415-2421.1991; DIANOV G, 1994, NUCLEIC ACIDS RES, V22, P993, DOI 10.1093/nar/22.6.993; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DING RC, 1992, J BIOL CHEM, V267, P12804; DIXON NE, 1984, P NATL ACAD SCI-BIOL, V81, P424, DOI 10.1073/pnas.81.2.424; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; FLASHNER Y, 1988, CELL, V54, P713, DOI 10.1016/S0092-8674(88)80016-3; GRAVES RJ, 1992, J BIOL CHEM, V267, P14429; HARTKE A, 1991, MUTAT RES, V255, P39, DOI 10.1016/0921-8777(91)90016-I; HAYS JB, 1970, J MOL BIOL, V48, P297, DOI 10.1016/0022-2836(70)90162-2; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; HWANG DS, 1992, J BIOL CHEM, V267, P23083; JOHNSON RC, 1986, CELL, V46, P531, DOI 10.1016/0092-8674(86)90878-0; KIM J, 1988, NUCLEIC ACIDS RES, V16, P1135, DOI 10.1093/nar/16.3.1135; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LAVOIE BD, 1990, J BIOL CHEM, V265, P1623; LECAER JP, 1988, ANAL BIOCHEM, V169, P246, DOI 10.1016/0003-2697(88)90281-3; LECAM E, 1994, J MOL BIOL, V235, P1062, DOI 10.1006/jmbi.1994.1057; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; MILLS JB, 1994, BIOCHEMISTRY-US, V33, P1797, DOI 10.1021/bi00173a024; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; MORISATO D, 1987, CELL, V51, P101, DOI 10.1016/0092-8674(87)90014-6; PONTIGGIA A, 1993, MOL MICROBIOL, V7, P343, DOI 10.1111/j.1365-2958.1993.tb01126.x; PREOBRAJENSKAYA O, 1994, IN PRESS MOL MICROBI; ROUVIEREYANIV J, 1975, P NATL ACAD SCI USA, V72, P3428, DOI 10.1073/pnas.72.9.3428; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; SANCAR A, 1993, PHOTOCHEM PHOTOBIOL, V57, P905, DOI 10.1111/j.1751-1097.1993.tb09233.x; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; THRAVES PJ, 1985, CANCER RES, V45, P386; TRAVERS AA, 1994, CELL, V77, P167, DOI 10.1016/0092-8674(94)90306-9; WADA M, 1989, GENE, V76, P345, DOI 10.1016/0378-1119(89)90174-1	46	127	129	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10291	10296		10.1074/jbc.270.17.10291	http://dx.doi.org/10.1074/jbc.270.17.10291			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730334	hybrid			2022-12-27	WOS:A1995QV41700083
J	GAO, F; LIPSCOMB, B; WU, IM; RICHTER, ML				GAO, F; LIPSCOMB, B; WU, IM; RICHTER, ML			IN-VITRO ASSEMBLY OF THE CORE CATALYTIC COMPLEX OF THE CHLOROPLAST ATP SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING FACTOR-I; NUCLEOTIDE-BINDING-SITES; ISOLATED BETA-SUBUNIT; ADENOSINE-TRIPHOSPHATASE; ESCHERICHIA-COLI; ALPHA-3-BETA-3 COMPLEX; RHODOSPIRILLUM-RUBRUM; ISOLATED ALPHA; RECONSTITUTION; F1-ATPASE	The regulatory gamma subunit and an alpha beta complex were isolated from the catalytic F-1 portion of the chloroplast ATP synthase, The isolated gamma subunit was devoid of catalytic activity, whereas the alpha beta complex exhibited a very low ATPase activity (similar to 200 nmol/min/mg of protein), The alpha beta complex migrated as a hexameric alpha(3) beta(3) complex during ultracentrifugation and gel filtration but reversibly dissociated into alpha and beta monomers after freezing and thawing in the presence of ethylenediamine tetraacetic acid and in the absence of nucleotides, Conditions are described in which the gamma and alpha beta preparations were combined to rapidly and efficiently reconstitute a fully functional catalytic core enzyme complex, The reconstituted enzyme exhibited normal tight binding and sensitivity to the inhibitory epsilon subunit and to the allosteric inhibitor tentoxin, However, neither the alpha beta complex nor the isolated gamma subunit alone could bind the epsilon subunit or tentoxin with high affinity, Similarly, high affinity binding sites for ATP and ADP, which are characteristic of the core alpha(3) beta(3) gamma enzyme, were absent from the alpha beta complex, The results indicate that when the gamma subunit binds to the alpha beta complex, it induces a three-dimensional conformation in the enzyme, which is necessary for tight binding of the inhibitors and for high-affinity, asymmetric nucleotide binding.	UNIV KANSAS,DEPT BIOCHEM,LAWRENCE,KS 66045	University of Kansas								ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ADMON A, 1987, BIOCHEMISTRY-US, V26, P3193, DOI 10.1021/bi00385a038; ALOISE P, 1990, J BIOL CHEM, V266, P10368; ANDRALOJC PJ, 1992, FEBS LETT, V310, P187, DOI 10.1016/0014-5793(92)81326-H; AVITAL S, 1991, J BIOL CHEM, V266, P7067; AVNI A, 1992, SCIENCE, V257, P1245, DOI 10.1126/science.1387730; BOEKEMA EJ, 1992, BIOCHIM BIOPHYS ACTA, V1098, P131, DOI 10.1016/S0005-2728(05)80328-7; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN GG, 1994, P NATL ACAD SCI USA, V91, P11497, DOI 10.1073/pnas.91.24.11497; CHEN ZG, 1992, FEBS LETT, V298, P69, DOI 10.1016/0014-5793(92)80024-B; COLVERT KK, 1992, BIOCHEMISTRY-US, V31, P3130; DUNN SD, 1980, J BIOL CHEM, V255, P113; FUTAI M, 1977, BIOCHEM BIOPH RES CO, V79, P1231, DOI 10.1016/0006-291X(77)91138-X; GIRAULT G, 1988, J BIOL CHEM, V263, P14690; GROMETELHANAN Z, 1984, BIOCHEMISTRY-US, V23, P1022, DOI 10.1021/bi00300a034; HARADA M, 1991, BIOCHIM BIOPHYS ACTA, V1056, P279, DOI 10.1016/S0005-2728(05)80059-3; HISABORI T, 1986, J BIOCHEM-TOKYO, V100, P663, DOI 10.1093/oxfordjournals.jbchem.a121758; HSU SY, 1984, BIOCHEMISTRY-US, V23, P988, DOI 10.1021/bi00300a029; HU NM, 1993, J BIOL CHEM, V268, P8536; ISSARTEL JP, 1984, BIOCHEMISTRY-US, V23, P6591, DOI 10.1021/bi00321a048; KAGAWA Y, 1989, FEBS LETT, V249, P67, DOI 10.1016/0014-5793(89)80017-1; KANANSHVILI D, 1983, J BIOL CHEM, V258, P3714; LARSON EM, 1989, BIOCHIM BIOPHYS ACTA, V973, P67, DOI 10.1016/S0005-2728(89)80404-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCARTY RE, 1985, ENZYMES BIOL MEMBR, P383; MILLS DA, 1991, J BIOL CHEM, V266, P7440; MILLS DA, 1990, CURRENT PROGR PHOTOS, V3, P6; MIWA K, 1989, P NATL ACAD SCI USA, V86, P6484, DOI 10.1073/pnas.86.17.6484; NALIN CM, 1988, CURR TOP BIOENERG, V15, P273; OHTA S, 1980, J BIOCHEM-TOKYO, V87, P1609, DOI 10.1093/oxfordjournals.jbchem.a132904; PATRIE WJ, 1984, J BIOL CHEM, V259, P1121; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PENEFSKY HS, 1990, ADV ENZYMOL, V64, P173; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; RICHTER ML, 1986, J BIOL CHEM, V261, P2109; RICHTER ML, 1985, BIOCHEMISTRY-US, V24, P5755, DOI 10.1021/bi00342a011; SHAPIRO AB, 1990, J BIOL CHEM, V265, P4340; SHAPIRO AB, 1991, J BIOL CHEM, V266, P4194; SHAPIRO AB, 1991, J BIOL CHEM, V266, P17276; SHAPIRO AB, 1988, J BIOL CHEM, V263, P14160; SHOSHAN V, 1980, J BIOL CHEM, V255, P384; STEELE JA, 1976, P NATL ACAD SCI USA, V73, P2245, DOI 10.1073/pnas.73.7.2245; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; XUE ZX, 1987, BIOCHEMISTRY-US, V26, P3749, DOI 10.1021/bi00387a001; YOSHIDA M, 1977, J BIOL CHEM, V252, P3480; YOSHIDA M, 1982, J BIOL CHEM, V265, P2483	48	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9763	9769		10.1074/jbc.270.17.9763	http://dx.doi.org/10.1074/jbc.270.17.9763			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730354	hybrid			2022-12-27	WOS:A1995QV41700013
J	GENOT, EM; PARKER, PJ; CANTRELL, DA				GENOT, EM; PARKER, PJ; CANTRELL, DA			ANALYSIS OF THE ROLE OF PROTEIN-KINASE-C-ALPHA, PROTEIN-KINASE-EPSILON, AND PROTEIN-KINASE-ZETA IN T-CELL ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER; SIGNAL-TRANSDUCTION; RECEPTOR; DOMAIN; GENE; DIACYLGLYCEROL; TRANSCRIPTION; P21(RAS); BINDING	T cells express multiple isotypes of protein kinase C (PKC) and although it is well accepted that PKCs have an important role in T cell activation, little is known about the function of individual PRC isotypes. To address this issue, mutationally active PKC-alpha, -epsilon, or -zeta have been transfected into T cells and the consequences for T cell activation determined, p21(ras) plays an essential role in T cell activation, Accordingly, the effects of the constitutively active PKCs were compared to the effects of mutationally activated p21(ras), The data indicate that PKC-epsilon and, to a lesser extent PKC-alpha but not -zeta can regulate the transcription factors AP-1 and nuclear factor of activated T cells (NF-AT-1), The ability of PKC-epsilon to induce transactivation of NF-AT-1 and AP-I was similar to the stimulatory effect of a constitutively activated p21(ras), PKC-epsilon, but not PKC-alpha nor activated p21(ras), was able to induce NF-KB activity, Phorbol esters induce expression of CD69 whereas none of the activated PKC isotypes tested were able to have this effect. Activated Src and p21(ras) were able to induce CD69 expression. These results indicate selective functions for different PKC isotypes in T cells. Moreover, the data comparing the effects of activated has and PKC mutants suggest that PKC-alpha, p21(ras), and PKC-epsilon are not positioned linearly on a single signal transduction pathway.	IMPERIAL CANC RES FUND,LYMPHOCYTE ACTIVAT LAB,LONDON WC2A 3PX,ENGLAND; IMPERIAL CANC RES FUND,PROT PHOSPHORYLAT LAB,LONDON WC2A 3PX,ENGLAND	Cancer Research UK; Cancer Research UK			Genot, Elisabeth/G-8031-2014; Parker, Peter j/D-5192-2013	parker, peter/0000-0002-6218-2933				AHMED S, 1991, BIOCHEM J, V280, P233, DOI 10.1042/bj2800233; BAIER G, 1993, J BIOL CHEM, V268, P4997; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; BERRY N, 1990, EUR J BIOCHEM, V189, P205, DOI 10.1111/j.1432-1033.1990.tb15478.x; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; DAUM G, 1994, TRENDS BIOCHEM SCI, V227, P474; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V227, P470; DECOCK JBJ, 1994, FEBS LETT, V356, P275, DOI 10.1016/0014-5793(94)01283-0; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; GOODE NT, 1994, FEBS LETT, V340, P145, DOI 10.1016/0014-5793(94)80190-8; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; MURAMATSU MA, 1989, MOL CELL BIOL, V9, P831, DOI 10.1128/MCB.9.2.831; NUNES J, 1993, INT IMMUNOL, V5, P311, DOI 10.1093/intimm/5.3.311; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; ORR JW, 1992, J BIOL CHEM, V267, P15263; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PEARS CJ, 1990, EUR J BIOCHEM, V194, P89, DOI 10.1111/j.1432-1033.1990.tb19431.x; PULVERER BJ, 1993, ONCOGENE, V8, P407; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; SCHAAP D, 1989, FEBS LETT, V243, P352; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; TSUTSUMI A, 1993, J IMMUNOL, V150, P1754; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILLIAMS DH, 1992, BIOCHIM BIOPHYS ACTA, V1180, P9, DOI 10.1016/0925-4439(92)90020-N; WOODROW M, 1993, J EXP MED, V178, P1517, DOI 10.1084/jem.178.5.1517; WOTTON D, 1993, J BIOL CHEM, V268, P17975	35	177	179	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9833	9839		10.1074/jbc.270.17.9833	http://dx.doi.org/10.1074/jbc.270.17.9833			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730364	hybrid			2022-12-27	WOS:A1995QV41700023
J	HUA, SB; LI, XQ; COFFINO, P; WANG, CC				HUA, SB; LI, XQ; COFFINO, P; WANG, CC			RAT ANTIZYME INHIBITS THE ACTIVITY BUT DOES NOT PROMOTE THE DEGRADATION OF MOUSE ORNITHINE DECARBOXYLASE IN TRYPANOSOMA-BRUCEI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULOCYTE LYSATE; INTRACELLULAR DEGRADATION; NEUROSPORA-CRASSA; POLYAMINE; PROTEIN; EXPRESSION; PUTRESCINE; DIFLUOROMETHYLORNITHINE; TARGET; ENZYME	Ornithine decarboxylase (ODC) of African kypanosomes is an important target for anti-trypanosomal chemotherapy because of its remarkable stability in vivo, The in vivo activity and stability of mammalian ODC are regulated by polyamines, Polyamines induce antizyme, which inactivates ODC by tight association and promotes degradation of ODC by the mammalian 26 S proteasome, Here we found, in contrast to mammalian cells, that polyamines caused no reduction of ODC activity in Trypanosoma brucei, Mouse ODC expressed in T. brucei was also unaffected by exogenous polyamines, suggesting that a mammalian antizyme equivalent may be absent in T. brucei, The rat antizyme expressed in T. brucei was found capable of inhibiting mouse ODC activity by the formation of rat antizyme-mouse ODC complex, However, complex formation did not lead to degradation of mouse ODC in T. brucei, Further in vitro experiments suggested the presence of an inhibitory factor(s) in trypanosome, which interferes with the degradation of mouse ODC, We also demonstrated the presence of proteasomes in T. brucei, But the mobility of the trypanosomal proteasome on native gel is different from that of the mammalian proteasome, Thus, the absence of antizyme, the presence of inhibitory factor(s), and the differences between trypanosomal and mammalian proteasome may account for the stability of mouse ODC in T. brucei cells,	UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco				Coffino, Philip/0000-0003-0344-5083	NIAID NIH HHS [AI21786] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI021786, R01AI021786, R56AI021786] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AFFRANCHINO JL, 1993, GENE, V132, P75, DOI 10.1016/0378-1119(93)90516-6; BABY TG, 1991, BIOCHIM BIOPHYS ACTA, V1092, P161, DOI 10.1016/0167-4889(91)90150-V; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1983, MOL BIOCHEM PARASIT, V7, P209, DOI 10.1016/0166-6851(83)90022-1; BARNETT GR, 1988, J BIOL CHEM, V263, P10005; BASS KE, 1992, J BIOL CHEM, V267, P11034; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; DAVIS RH, 1985, P NATL ACAD SCI USA, V82, P4105, DOI 10.1073/pnas.82.12.4105; FONG WF, 1976, BIOCHIM BIOPHYS ACTA, V428, P456, DOI 10.1016/0304-4165(76)90054-4; FONZI WA, 1989, J BIOL CHEM, V264, P18110; FRIEDMAN H, 1994, P NATL ACAD SCI USA, V91, P2031, DOI 10.1073/pnas.91.6.2031; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GHODA L, 1990, J BIOL CHEM, V265, P11823; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GUPTA M, 1985, J BIOL CHEM, V260, P2941; HARLOW E, 1988, ANTIBODIES LABORATOR, P421; HELLER JS, 1976, P NATL ACAD SCI USA, V73, P1858, DOI 10.1073/pnas.73.6.1858; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; HUA SB, 1994, J CELL BIOCHEM, V54, P20, DOI 10.1002/jcb.240540104; JANNE J, 1989, ORNITHINE DECARBOXYL, P59; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; LI XQ, 1994, MOL CELL BIOL, V14, P87, DOI 10.1128/MCB.14.1.87; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; MAMROUDKIDRON E, 1994, FEBS LETT, V337, P239, DOI 10.1016/0014-5793(94)80199-1; MATSUFUJI S, 1990, J BIOCHEM-TOKYO, V108, P365, DOI 10.1093/oxfordjournals.jbchem.a123207; MITCHELL JLA, 1983, BIOCHEM J, V214, P345, DOI 10.1042/bj2140345; MIYAZAKI Y, 1992, GENE, V113, P191, DOI 10.1016/0378-1119(92)90395-6; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MURAKAMI Y, 1985, BIOCHEM J, V226, P893, DOI 10.1042/bj2260893; MURAKAMI Y, 1992, J BIOL CHEM, V267, P13138; MURAKAMI Y, 1993, BIOCHEM J, V295, P305, DOI 10.1042/bj2950305; NATHAN HC, 1981, BIOCHEM PHARMACOL, V30, P3010, DOI 10.1016/0006-2952(81)90270-7; OKA T, 1989, ORNITHINE DECARBOXYL, P7; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; PHILLIPS MA, 1987, J BIOL CHEM, V262, P8721; PHILLIPS MA, 1988, J BIOL CHEM, V263, P17933; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; RIVETT AJ, 1993, BIOCHEM J, V291, P1; ROSENBERGHASSON Y, 1989, EUR J BIOCHEM, V185, P469, DOI 10.1111/j.1432-1033.1989.tb15138.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SJOERDSMA A, 1984, CLIN PHARMACOL THER, V35, P287, DOI 10.1038/clpt.1984.33; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TEKWANI BL, 1992, MOL CELL BIOCHEM, V117, P53, DOI 10.1007/BF00230410; TOKUNAGA F, 1994, J BIOL CHEM, V269, P17382; TORRI AF, 1993, MOL BIOCHEM PARASIT, V57, P305, DOI 10.1016/0166-6851(93)90206-D	49	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10264	10271		10.1074/jbc.270.17.10264	http://dx.doi.org/10.1074/jbc.270.17.10264			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730330	hybrid			2022-12-27	WOS:A1995QV41700079
J	SCHWEIZER, A; ROHRER, J; KORNFELD, S				SCHWEIZER, A; ROHRER, J; KORNFELD, S			DETERMINATION OF THE STRUCTURAL REQUIREMENTS FOR PALMITOYLATION OF P63	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STOMATITIS-VIRUS GLYCOPROTEIN; SITE-SPECIFIC MUTAGENESIS; DIPEPTIDYL PEPTIDASE-IV; GROWTH CONE PROTEIN; ACYL-COENZYME-A; FATTY-ACID; TRANSFERRIN RECEPTOR; MEMBRANE ATTACHMENT; TRANSPORT VESICLES; CYSTEINE RESIDUES	Palmitoylation of p63, a type II membrane protein localized in the endoplasmic reticulum, is induced in a reversible manner by the drug brefeldin A. To study the requirements for palmitoylation, mutant forms of p63 were expressed in COS cells and analyzed by metabolic labeling with [H-3]palmitate, immunoprecipitation, and SDS-polyacrylamide gel electrophoresis. By investigating deletion and point mutations, Cys(100) in the 106-amino acid cytoplasmic tail of p63 has been identified as the site of acylation. Site directed mutagenesis of residues 99-105 together with cytoplasmic tail truncation mutants showed that the amino acids surrounding Cys(100) are not critical for palmitoylation of this residue. Analysis of a chimeric construct between p63 and the plasma membrane protein dipeptidylpeptidase IV further revealed that p63 palmitoylation is not dependent on its transmembrane domain. In contrast, the six-amino acid distance between the end of the predicted transmembrane domain and the palmitoylation site was found to be essential for proper acylation of p63.			SCHWEIZER, A (corresponding author), WASHINGTON UNIV, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA.			Rohrer, Jack/0000-0002-2058-490X	NCI NIH HHS [CA08759] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BONATTI S, 1989, J BIOL CHEM, V264, P12590; CRISE B, 1992, J BIOL CHEM, V267, P13593; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; GALBIATI F, 1994, BIOCHEM J, V303, P697, DOI 10.1042/bj3030697; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GUTIERREZ L, 1991, BIOCHIM BIOPHYS ACTA, V1078, P147, DOI 10.1016/0167-4838(91)99003-B; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HONG WJ, 1990, J CELL BIOL, V111, P323, DOI 10.1083/jcb.111.2.323; HONG WJ, 1987, P NATL ACAD SCI USA, V84, P7962, DOI 10.1073/pnas.84.22.7962; JAMES G, 1989, J BIOL CHEM, V264, P20998; JING S, 1987, EMBO J, V6, P327, DOI 10.1002/j.1460-2075.1987.tb04758.x; JING SQ, 1990, J BIOL CHEM, V265, P11555; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; KAUFMAN JF, 1984, J BIOL CHEM, V259, P7230; KINET JP, 1985, BIOCHEMISTRY-US, V24, P7342, DOI 10.1021/bi00346a048; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOCH N, 1986, J BIOL CHEM, V261, P3434; KOEGL M, 1994, BIOCHEM J, V303, P749, DOI 10.1042/bj3030749; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; MAGEE AI, 1985, EMBO J, V4, P1137, DOI 10.1002/j.1460-2075.1985.tb03751.x; MUNDY DI, 1992, J CELL BIOL, V116, P135, DOI 10.1083/jcb.116.1.135; OBRIEN PJ, 1987, J BIOL CHEM, V262, P5210; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; OGATA S, 1989, J BIOL CHEM, V264, P3596; OMARY MB, 1981, J BIOL CHEM, V256, P4715; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; PAPAC DI, 1992, J BIOL CHEM, V267, P16889; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; PFANNER N, 1990, J CELL BIOL, V110, P955, DOI 10.1083/jcb.110.4.955; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; ROSE JK, 1984, P NATL ACAD SCI-BIOL, V81, P2050, DOI 10.1073/pnas.81.7.2050; Sambrook J, 1989, MOL CLONING LABORATO; SCHLESINGER MJ, 1980, J BIOL CHEM, V255, P21; SCHLESINGER MJ, 1994, LIPID MODIFICATION P; SCHMIDT MFG, 1979, P NATL ACAD SCI USA, V76, P1687, DOI 10.1073/pnas.76.4.1687; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; SCHMIDT MFG, 1982, VIROLOGY, V116, P327, DOI 10.1016/0042-6822(82)90424-X; SCHWEIZER A, 1994, J CELL BIOL, V126, P25, DOI 10.1083/jcb.126.1.25; SCHWEIZER A, 1993, J CELL SCI, V104, P671; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SCHWEIZER A, 1993, J CELL SCI, V104, P685; SEFTON BM, 1987, J CELL BIOL, V104, P1449, DOI 10.1083/jcb.104.6.1449; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; STAUFENBIEL M, 1987, MOL CELL BIOL, V7, P2981, DOI 10.1128/MCB.7.8.2981; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; VEIT M, 1991, J VIROL, V65, P2491, DOI 10.1128/JVI.65.5.2491-2500.1991; VEIT M, 1993, FEBS LETT, V336, P243, DOI 10.1016/0014-5793(93)80812-9; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	55	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9638	9644		10.1074/jbc.270.16.9638	http://dx.doi.org/10.1074/jbc.270.16.9638			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721896				2022-12-27	WOS:A1995QU08900085
J	OHNISHI, K; NIIMURA, Y; HIDAKA, M; MASAKI, H; SUZUKI, H; UOZUMI, T; NISHINO, T				OHNISHI, K; NIIMURA, Y; HIDAKA, M; MASAKI, H; SUZUKI, H; UOZUMI, T; NISHINO, T			ROLE OF CYSTEINE-337 AND CYSTEINE-340 IN FLAVOPROTEIN THAT FUNCTIONS AS NADH OXIDASE FROM AMPHIBACILLUS-XYLANUS STUDIED BY SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; COLI THIOREDOXIN REDUCTASE; ESCHERICHIA-COLI; ACTIVE-SITE; DISULFIDE OXIDOREDUCTASES; SALMONELLA-TYPHIMURIUM; LACKING CYTOCHROME; MERCURIC REDUCTASE; PURIFICATION; CATALASE	A flavoprotein from Amphibacillus xylanus catalyzes the reduction of oxygen to hydrogen peroxide, Each polypeptide chain in the tetrameric enzyme contains 5 cysteine residues, The complete reduction of enzyme by dithionite requires 6 electrons, Such behavior indicates the presence of redox centers in addition to the FAD, and these could be disulfides, In order to assess the catalytic role of disulfide in the enzyme, 2 of the cysteines (Cys-337 and Cys-340), which show a high degree of homology with alkyl hydroperoxide reductase F52a protein and thioredoxin reductase, have been changed to serines by site-directed mutagenesis of the cloned flavoprotein gene (individually and in a double mutant), Titration of the three mutant enzymes, lacking Cys-337, Cys-340, or both cysteines, requires only 2 electron eq to reach the reduced flavin state, These results indicate the absence of a redox-active disulfide and demonstrate the involvement of Cys-337 and Cys-340 in the redox-active disulfide, The catalytic activity of the three enzymes was examined by steady-state analysis, The K-m for NADH and oxygen and the k(cat) value of these mutant enzymes were essentially the same as those of wild type, The NADH oxidase activities were also accelerated markedly in the presence of free FAD, which is the case for wild-type enzyme, The NADH:5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) oxidoreductase activities of all mutant enzymes were less than 3% of the activity of wild-type enzyme, The weak DTNB reductase activities in the mutant enzymes lacking Cys-337 or Cys-340 may occur through direct reduction of the mixed disulfide Cys-337-thiol or Cys-340-thiol and nitrothiobenzoate by FADH(2). However, the weak DTNB reductase activity in the mutant enzyme lacking both cysteines indicates that FADH(2) can reduce either DTNB or another disulfide directly, albeit inefficiently, These results suggest intramolecular dithiol-disulfide interchange reactions in the flavoprotein.	TOKYO UNIV AGR, DEPT FOOD SCI & TECHNOL, ABASHIRI, HOKKAIDO 09924, JAPAN; TOKYO UNIV AGR & TECHNOL, DEPT AGR CHEM, TOKYO, JAPAN; UNIV TOKYO, DEPT BIOTECHNOL, TOKYO 113, JAPAN; NIPPON MED COLL, DEPT BIOCHEM & MOLEC BIOL, TOKYO 113, JAPAN	Tokyo University of Agriculture; Tokyo University of Agriculture & Technology; University of Tokyo; Nippon Medical School								AHMED SA, 1989, J BIOL CHEM, V264, P19856; AHMED SA, 1989, J BIOL CHEM, V264, P19864; CHEN CW, 1980, ANAL BIOCHEM, V101, P339, DOI 10.1016/0003-2697(80)90197-9; COCCO D, 1988, EUR J BIOCHEM, V174, P267, DOI 10.1111/j.1432-1033.1988.tb14093.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; FOX B, 1982, J BIOL CHEM, V257, P2498; HARBURY HA, 1959, P NATL ACAD SCI USA, V45, P1708, DOI 10.1073/pnas.45.12.1708; HIGUCHI M, 1993, J GEN MICROBIOL, V139, P2343, DOI 10.1099/00221287-139-10-2343; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; KOIKE K, 1985, J BIOCHEM, V97, P1279, DOI 10.1093/oxfordjournals.jbchem.a135179; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MASSEY V, 1962, J BIOL CHEM, V237, P2347; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MILLER SM, 1989, BIOCHEMISTRY-US, V28, P1194, DOI 10.1021/bi00429a037; NIIMURA Y, 1993, J BACTERIOL, V175, P7945, DOI 10.1128/JB.175.24.7945-7950.1993; NIIMURA Y, 1987, AGR BIOL CHEM TOKYO, V51, P2271; NIIMURA Y, 1990, INT J SYST BACTERIOL, V40, P297, DOI 10.1099/00207713-40-3-297; NIIMURA Y, 1989, FEMS MICROBIOL LETT, V61, P79, DOI 10.1016/S0378-1097(98)00072-X; OHNISHI K, 1994, J BIOL CHEM, V269, P31418; PARK HJ, 1992, EUR J BIOCHEM, V205, P881, DOI 10.1111/j.1432-1033.1992.tb16853.x; PRONGAY AJ, 1989, J BIOL CHEM, V264, P2656; PRONGAY AJ, 1992, J BIOL CHEM, V267, P25181; PRONGAY AJ, 1990, J BIOL CHEM, V265, P18968; REINARDS R, 1981, EUR J BIOCHEM, V120, P329, DOI 10.1111/j.1432-1033.1981.tb05708.x; RONCHI S, 1972, J BIOL CHEM, V247, P2083; RUSSEL M, 1988, J BIOL CHEM, V263, P9015; SAEKI Y, 1985, J BIOCHEM-TOKYO, V98, P1433, DOI 10.1093/oxfordjournals.jbchem.a135411; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT HL, 1986, EUR J BIOCHEM, V156, P149, DOI 10.1111/j.1432-1033.1986.tb09560.x; SCHULTZ PG, 1985, BIOCHEMISTRY-US, V24, P6840, DOI 10.1021/bi00345a016; TARTAGLIA LA, 1990, J BIOL CHEM, V265, P10535; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WAKSMAN G, 1994, J MOL BIOL, V236, P800, DOI 10.1006/jmbi.1994.1190; Williams C H Jr, 1979, Methods Enzymol, V62, P185; WILLIAMS CH, 1965, J BIOL CHEM, V240, P4793; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; XUEMIN X, 1991, J BIOCHEM-TOKYO, V109, P678; ZANETTI G, 1968, J BIOL CHEM, V243, P4013	41	24	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5812	5817		10.1074/jbc.270.11.5812	http://dx.doi.org/10.1074/jbc.270.11.5812			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7726998				2022-12-27	WOS:A1995QM94500021
J	LO, ACY; THINAKARAN, G; SLUNT, HH; SISODIA, SS				LO, ACY; THINAKARAN, G; SLUNT, HH; SISODIA, SS			METABOLISM OF THE AMYLOID PRECURSOR-LIKE PROTEIN-2 IN MDCK CELLS - POLARIZED TRAFFICKING OCCURS INDEPENDENT OF THE CHONDROITIN SULFATE GLYCOSAMINOGLYCAN CHAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOGLYCAN CORE PROTEIN; ALZHEIMERS-DISEASE; INVARIANT-CHAIN; INTRACELLULAR-TRANSPORT; EPITHELIAL-CELLS; IDENTIFICATION; ANGIOPATHY; HOMOLOG; BRAIN; CDNA	Deposition of beta-amyloid peptide in senile plaques is a principal neuropathological hallmark of Alzheimer's disease. beta-Amyloid peptide is derived from larger amyloid precursor proteins. Amyloid precursor protein is a member of a family of integral membrane glycoproteins that includes amyloid precursor-like protein (APLP) 1 and 2. Alternatively spliced pre mRNAs encode several APLP2 isoforms; the APLP2-751 isoform is a substrate for modifications by a chondroitin sulfate glycosaminoglycan (CS GAG) chain, whereas the APLP2-763 isoform does not undergo CS GAG modification. In this report, we have examined the sorting and metabolism of APLP2-751 and APLP2-763 in polarized epithelial Madin-Darby canine kidney (MDCK) cells. We demonstrate that, despite differences in post-translational modifications, both the APLP2-751 proteoglycan and APLP2-763 isoform were targeted and secreted to the basolateral compartment of MDCK cells. We document that the kinetics of intracellular maturation of full-length forms and secretion of soluble derivatives generated from each isoform were indistinguishable. Our results are consistent with the view that, in MDCK cells, the CS GAG chain of APLP2 has little influence on intracellular trafficking and that the principal basolateral targeting determinants are likely to reside in the APLP2 core protein.	JOHNS HOPKINS UNIV, SCH MED, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Lo, Amy C. Y./C-1195-2009	Lo, Amy C. Y./0000-0003-4239-6851	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020471, P01NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER; NIA NIH HHS [AG 05146] Funding Source: Medline; NINDS NIH HHS [NS 20471] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x; CAPLAN MJ, 1987, NATURE, V329, P632, DOI 10.1038/329632a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; Gupta-Bansal Rekha, 1994, Society for Neuroscience Abstracts, V20, P1055; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LO ACY, 1994, J BIOL CHEM, V269, P30966; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MILLER J, 1988, P NATL ACAD SCI USA, V85, P1359, DOI 10.1073/pnas.85.5.1359; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; SANDBRINK R, 1994, J BIOL CHEM, V269, P14227; SANT AJ, 1985, J IMMUNOL, V135, P416; Shaffer L. M., 1994, Society for Neuroscience Abstracts, V20, P1242; SIEMERS KA, 1993, SCIENCE, V260, P554, DOI 10.1126/science.260.5107.554; SIMONIS S, 1990, MOL IMMUNOL, V27, P413, DOI 10.1016/0161-5890(90)90165-V; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; SNOW AD, 1988, AM J PATHOL, V133, P456; SNOW AD, 1990, AM J PATHOL, V137, P1353; SPRECHER CA, 1993, BIOCHEMISTRY-US, V32, P4481, DOI 10.1021/bi00068a002; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; YAMAGUCHI H, 1992, AM J PATHOL, V141, P249	29	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12641	12645		10.1074/jbc.270.21.12641	http://dx.doi.org/10.1074/jbc.270.21.12641			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759513	hybrid			2022-12-27	WOS:A1995QZ71100049
J	LOPEZ, LA; SHEETZ, MP				LOPEZ, LA; SHEETZ, MP			A MICROTUBULE-ASSOCIATED PROTEIN (MAP2) KINASE RESTORES MICROTUBULE MOTILITY IN EMBRYONIC BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; SOLUBLE FACTORS; CELL-DIVISION; PHOSPHORYLATION; TUBULIN; LOCALIZATION; SEPARATION; BINDING; AXON; IDENTIFICATION	Motility driven by the microtubule motors, kinesin and cytoplasmic dynein, is inhibited by MAP2 (Lopez, L. A., and Sheetz, M. P. (1993) Cell Motil. Cytoskeleton 24, 1-16). The MAP2 inhibition is reversed by a kinase that is co-purified with chicken embryonic MAP2, completely releasing MAP2 from the microtubules. We have identified this activity with a kinase, embryonic MAP2 kinase (M(r) = 100,000), which phosphorylates MAP2 at serine amino acid residues. This kinase is c-AMP independent and inhibited by potassium fluoride and glycerol 2-phosphate. Only the phosphorylation produced by embryonic MAP2 kinase can change the affinity of MAP2 by microtubules. Bovine MAPS kinase, Cdc2 kinase, mitogenic activated protein kinase, and the NIMA kinase are able to phosphorylate MAP2 but do not change the affinity for microtubules. In vivo, embryonic MAP2 kinase could play a major role in the regulation of motility and positioning of membranous organelles within the cells even at substoichiometric levels.	DUKE UNIV, MED CTR, DEPT CELL BIOL, DURHAM, NC 27710 USA	Duke University					NIGMS NIH HHS [GM-34775] Funding Source: Medline; NINDS NIH HHS [NS-23345] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023345] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BERKOWITZ SA, 1977, BIOCHEMISTRY-US, V16, P5610, DOI 10.1021/bi00644a035; BORISY GG, 1975, ANN NY ACAD SCI, V253, P107, DOI 10.1111/j.1749-6632.1975.tb19196.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; BURNS RG, 1984, EUR J BIOCHEM, V141, P609, DOI 10.1111/j.1432-1033.1984.tb08236.x; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CACERES A, 1984, J NEUROSCI, V4, P394; CACERES A, 1986, J NEUROSCI, V6, P714; CHENG HC, 1986, J BIOL CHEM, V261, P989; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9143; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HOSHI M, 1992, EUR J BIOCHEM, V203, P43, DOI 10.1111/j.1432-1033.1992.tb19825.x; HUTCHCROFT JE, 1991, METHOD ENZYMOL, V200, P417; JAMESON L, 1981, P NATL ACAD SCI-BIOL, V78, P3413, DOI 10.1073/pnas.78.6.3413; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KOSIK KS, 1987, J NEUROSCI, V7, P3142; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; LOCKWOOD AH, 1978, CELL, V13, P613, DOI 10.1016/0092-8674(78)90212-X; LOPEZ LA, 1993, CELL MOTIL CYTOSKEL, V24, P1, DOI 10.1002/cm.970240102; LOPEZ LA, 1991, J CELL BIOL, V115; LU KP, 1993, J BIOL CHEM, V268, P8769; MABUCHI I, 1990, DEV GROWTH DIFFER, V32, P549; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; OKABE S, 1989, P NATL ACAD SCI USA, V86, P4127, DOI 10.1073/pnas.86.11.4127; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; RAPPAPORT L, 1976, EUR J BIOCHEM, V62, P539, DOI 10.1111/j.1432-1033.1976.tb10188.x; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; RAY LB, 1988, J BIOL CHEM, V263, P12721; SCHROER TA, 1988, J CELL BIOL, V107, P1785, DOI 10.1083/jcb.107.5.1785; SCHROER TA, 1991, ANNU REV PHYSIOL, V53, P629, DOI 10.1146/annurev.ph.53.030191.003213; SEVERIN FF, 1991, FEBS LETT, V282, P65, DOI 10.1016/0014-5793(91)80445-9; SHERLINE P, 1977, J CELL BIOL, V72, P380, DOI 10.1083/jcb.72.2.380; SILLIMAN CC, 1989, BIOCHEM BIOPH RES CO, V160, P993, DOI 10.1016/S0006-291X(89)80099-3; SLOBODA RD, 1982, METHOD ENZYMOL, V85, P409; SLOBODA RD, 1975, P NATL ACAD SCI USA, V72, P177, DOI 10.1073/pnas.72.1.177; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; VALLANO ML, 1986, ANN NY ACAD SCI, V466, P453, DOI 10.1111/j.1749-6632.1986.tb38422.x; VALLEE RB, 1981, J CELL BIOL, V90, P568, DOI 10.1083/jcb.90.3.568; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376	53	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12511	12517		10.1074/jbc.270.21.12511	http://dx.doi.org/10.1074/jbc.270.21.12511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759496	hybrid			2022-12-27	WOS:A1995QZ71100030
J	RAUSSENS, V; NARAYANASWAMI, V; GOORMAGHTIGH, E; RYAN, RO; RUYSSCHAERT, JM				RAUSSENS, V; NARAYANASWAMI, V; GOORMAGHTIGH, E; RYAN, RO; RUYSSCHAERT, JM			ALIGNMENT OF THE APOLIPOPHORIN-III ALPHA-HELICES IN COMPLEX WITH DIMYRISTOYLPHOSPHATIDYLCHOLINE - A UNIQUE SPATIAL ORIENTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; HIGH-DENSITY-LIPOPROTEINS; SECONDARY STRUCTURE; MANDUCA-SEXTA; APOLIPOPROTEIN; PROTEINS; PEPTIDES	Apolipophorin-III (apoLp-III) from Manduca sexta can exist in two alternate states: as a globular, lipid-free helix bundle or a Lipid surface-associated apolipoprotein. Previous papers (Ryan R. O., Oikawa K., and Kay C. M. (1993) J. Biol. Chem. 268, 1525-1530; Wientzek M., Hay C. M., Oikawa H., and Ryan R. O. (1994) J. Biol. Chem. 269, 4605-4612) have investigated the structures and properties of apolipophorin-III from M. sexta in the lipid-free state and associated to lipids. Association of apoLp-III with dimyristoylphosphatidylcholine vesicles leads to the formation of uniform lipid discs with an average diameter and thickness of 18.5 +/- 2.0 and 4.8 +/- 0.8 nm, respectively. These discs contain six molecules of apoLp-III. Geometrical calculations based on these data, together with x-ray crystallographic data from the homologous L. migratoria apoLp-III (Breiter D. R., Kanost M. R., Benning M. M., Wesenberg G., Law J. H., Wells M. A., Rayment I., and Holden H. M, (1991) Biochemistry 30, 603-608), have allowed the presentation of a model of lipid-protein interaction, in which the alpha-helices of the apoLp-III orient perpendicular to the phospholipid chains and surround the lipid disc. Here, using polarized Fourier transform-attenuated total reflection infrared spectroscopy, we provide the first experimental evidence of a unique perpendicular orientation of the alpha-helices with respect to the fatty acyl chains of the phospholipids in the disc.	UNIV ALBERTA, DEPT BIOCHEM, LIPID & LIPOPROT RES GRP, EDMONTON, AB T6G 2S2, CANADA	University of Alberta	RAUSSENS, V (corresponding author), FREE UNIV BRUSSELS, CHIM PHYS MACROMOLEC INTERFACES LAB, CP206-2, CAMPUS PLAINE, B-1050 BRUSSELS, BELGIUM.			Narayanaswami, Vasanthy/0000-0001-7088-4057; Goormaghtigh, Erik/0000-0002-2071-2262				BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; BREITER DR, 1991, BIOCHEMISTRY-US, V30, P603, DOI 10.1021/bi00217a002; CHALLOU N, 1994, BIOCHEMISTRY-US, V33, P6902, DOI 10.1021/bi00188a020; COLE KD, 1987, J BIOL CHEM, V262, P11794; FRINGELI UP, 1981, MEMBRANE SPECTROSCOP, P270; GOORMAGHTIGH E, 1994, J BIOL CHEM, V269, P27409; GOORMAGHTIGH E, 1991, EUR J BIOCHEM, V202, P1299, DOI 10.1111/j.1432-1033.1991.tb16503.x; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; GOORMAGHTIGH E, 1991, EUR J BIOCHEM, V195, P421, DOI 10.1111/j.1432-1033.1991.tb15721.x; GOORMAGHTIGH E, 1990, MOL DESCRIPTION BIOL, P285; HOLDEN HM, 1988, J BIOL CHEM, V263, P3960; KAWOOYA JK, 1986, J BIOL CHEM, V261, P3588; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; RIFICI VA, 1985, BIOCHIM BIOPHYS ACTA, V834, P205, DOI 10.1016/0005-2760(85)90157-2; ROTHSCHILD KJ, 1979, BIOPHYS J, V25, P473, DOI 10.1016/S0006-3495(79)85317-5; RYAN RO, 1993, J BIOL CHEM, V268, P1525; SHAPIRO JP, 1983, BIOCHEM BIOPH RES CO, V115, P924, DOI 10.1016/S0006-291X(83)80023-0; SONVEAUX N, 1994, J BIOL CHEM, V269, P25687; SWANEY JB, 1980, J BIOL CHEM, V255, P877; TSUBOI M, 1962, J POLYM SCI, V59, P139, DOI 10.1002/pol.1962.1205916712; VANDENBUSSCHE G, 1992, BIOCHEMISTRY-US, V31, P9169, DOI 10.1021/bi00153a008; VANDERHORST DJ, 1988, J BIOL CHEM, V263, P2027; WALD JH, 1990, J BIOL CHEM, V265, P20044; WELLS MA, 1985, INSECT BIOCHEM, V15, P565, DOI 10.1016/0020-1790(85)90116-7; WIENTZEK M, 1994, J BIOL CHEM, V269, P4605; ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042	27	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12542	12547		10.1074/jbc.270.21.12542	http://dx.doi.org/10.1074/jbc.270.21.12542			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759500	hybrid			2022-12-27	WOS:A1995QZ71100035
J	SKURAT, AV; ROACH, PJ				SKURAT, AV; ROACH, PJ			PHOSPHORYLATION OF SITES 3A AND 3B (SER(640) ANS SER(644)) IN THE CONTROL OF RABBIT MUSCLE GLYCOGEN-SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SKELETAL-MUSCLE; MULTISITE PHOSPHORYLATION; MOLECULAR MECHANISM; HORMONAL-CONTROL; IDENTIFICATION; INACTIVATION; SEPARATION; INSULIN; CLONING	Glycogen synthase kinase-3 inactivates rabbit muscle glycogen synthase by sequential phosphorylation of four COOH-terminal residues Ser(652) (site 4), Ser(648) (site 3c), Ser(644) (site 3b), and Ser(640) (site 3a). Effective recognition of glycogen synthase by glycogen synthase kinase-3 occurs only after the phosphorylation of Ser(656) (site 5) catalyzed by casein kinase II. The present study addresses specifically the role of sites 3a and 3b in the regulation of glycogen synthase expressed in COS cells, Simultaneous Ser --> Ala substitutions at sites 3 a, b and c, 4, and 5 in the same protein molecule eliminated P-32 labeling in the proteolytic fragment Arg(634)-Lys(682), which contains these sites, This mutant enzyme (which also had a Ser --> Ala substitution at site 2 in the NH2 terminus) had a -/+ glucose-6-P activity ratio of similar to 0.8, similar to that of totally dephosphorylated enzyme, Reinstating serine residues at either site 3a or site 3b restored labeling in the Arg(634)-Lys(682) peptide and caused a decrease in the activity ratio to 0.4-0.6, When both sites 3a and 3b were reintroduced, there was complete inactivation of the enzyme. Thus, sites 3a and 3b are sufficient for the inactivation of glycogen synthase and act synergistically to control activity. This investigation demonstrates the existence of an alternate mechanism for the phosphorylation of sites 3a and 3b that does not depend on prior phosphorylation of site 5.			SKURAT, AV (corresponding author), INDIANA UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, INDIANAPOLIS, IN 46202 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027221, R56DK027221, R01DK027221] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK27221] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAI G, 1990, J BIOL CHEM, V265, P7843; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNER MF, 1989, P NATL ACAD SCI USA, V86, P1443, DOI 10.1073/pnas.86.5.1443; COHEN P, 1982, EUR J BIOCHEM, V124, P21, DOI 10.1111/j.1432-1033.1982.tb05902.x; COHEN P, 1982, NATURE, V296, P613, DOI 10.1038/296613a0; Cohen P., 1986, ENZYMES, VXVII, P461; DEPAOLIROACH AA, 1983, J BIOL CHEM, V258, P702; DEPAOLIROACH AA, 1981, J BIOL CHEM, V256, P8955; EMBI N, 1981, EUR J BIOCHEM, V115, P405, DOI 10.1111/j.1432-1033.1981.tb05252.x; FARKAS I, 1991, J BIOL CHEM, V266, P15602; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; KASLOW HR, 1984, FEBS LETT, V172, P294, DOI 10.1016/0014-5793(84)81144-8; KURET J, 1985, EUR J BIOCHEM, V151, P39, DOI 10.1111/j.1432-1033.1985.tb09066.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARNER J, 1990, ADV ENZYMOL RAMB, V63, P173; LAWRENCE JC, 1983, J BIOL CHEM, V258, P710; Maniatis T., 1982, MOL CLONING; NAKIELNY S, 1991, EUR J BIOCHEM, V199, P713, DOI 10.1111/j.1432-1033.1991.tb16175.x; NUTTALL FQ, 1994, ARCH BIOCHEM BIOPHYS, V311, P443, DOI 10.1006/abbi.1994.1260; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; PICTON C, 1982, EUR J BIOCHEM, V124, P37, DOI 10.1111/j.1432-1033.1982.tb05903.x; POULTER L, 1988, EUR J BIOCHEM, V175, P497, DOI 10.1111/j.1432-1033.1988.tb14222.x; ROACH PJ, 1976, J BIOL CHEM, V251, P1913; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; SKURAT AV, 1993, J BIOL CHEM, V268, P14701; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; WANG YH, 1993, J BIOL CHEM, V268, P23876; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; ZHANG WM, 1989, FASEB J, V3, P2532, DOI 10.1096/fasebj.3.13.2509275; ZHANG WM, 1993, ARCH BIOCHEM BIOPHYS, V304, P219, DOI 10.1006/abbi.1993.1342	33	82	87	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12491	12497		10.1074/jbc.270.21.12491	http://dx.doi.org/10.1074/jbc.270.21.12491			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759494	hybrid			2022-12-27	WOS:A1995QZ71100027
J	ZHAI, LM; GRAVES, PR; ROBINSON, LC; ITALIANO, M; CULBERTSON, MR; ROWLES, J; COBB, MH; DEPAOLIROACH, AA; ROACH, PJ				ZHAI, LM; GRAVES, PR; ROBINSON, LC; ITALIANO, M; CULBERTSON, MR; ROWLES, J; COBB, MH; DEPAOLIROACH, AA; ROACH, PJ			CASEIN KINASE I-GAMMA SUBFAMILY - MOLECULAR-CLONING, EXPRESSION, AND CHARACTERIZATION OF 3 MAMMALIAN ISOFORMS AND COMPLEMENTATION OF DEFECTS IN THE SACCHAROMYCES-CEREVISIAE YCK GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; SUBSTRATE DETERMINANTS; GLYCOGEN-SYNTHASE; CELL-CYCLE; PURIFICATION; YEAST; DNA; PHOSPHORYLATION; FRAGMENTS; TESTIS	Casein kinase I, one of the first protein kinases identified biochemically, is known to exist in multiple isoforms in mammals. Using a partial cDNA fragment corresponding to an isoform termed CK1 gamma, three full-length rat testis cDNAs were cloned that defined three separate members of this subfamily. The isoforms, designated CK1 gamma 1, CK1 gamma 2, and CK1 gamma 3, have predicted molecular masses of 43,000, 45,500, and 49,700. CK1 gamma 3 may also exist in an alternatively spliced form. The proteins are more than 90% identical to each other within the protein kinase domain but only 51-59% identical to other casein kinase I isoforms within this region. Messages for CK1 gamma 1 (2 kilobases (kb)), CK1 gamma 2 (1.5 and 2.4 kb), and CK1 gamma 3 (2.8 kb) were detected by Northern hybridization of testis RNA. Message for CK1 gamma 3 was also observed in brain, heart, kidney, lung, liver, and muscle whereas CK1 gamma 1 and CK1 gamma 2 messages were restricted to testis. All three CK1 gamma isoforms were expressed as active enzymes in Escherichia coli and partially purified. The enzymes phosphorylated typical in vitro casein kinase I substrates such as casein, phosvitin, and a synthetic peptide, D4. Phosphorylation of the D4 peptide was activated by heparin whereas phosphorylation of the protein substrates was inhibited. The known casein kinase I inhibitor CK1-7 also inhibited the CK1 gamma s although less effectively than the CK1 alpha or CK1 delta isoforms. All three CK1 gamma s underwent autophosphorylation when incubated with ATP and Mg2+. The YCK1 and YCK2 genes in Saccharomyces cerevisiae encode casein kinase I homologs, defects in which lead to aberrant morphology and growth arrest. Expression of mammalian CK1 gamma 1 or CK1 gamma 3 restored growth and normal morphology to a yeast mutant carrying a disruption of YCK1 and a temperature-sensitive allele of YCK2, suggesting overlap of function between the yeast Yck proteins and these CK1 isoforms.	LOUISIANA STATE UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, SHREVEPORT, LA 71130 USA; UNIV WISCONSIN, MOLEC BIOL LAB, MADISON, WI 53706 USA; UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	ZHAI, LM (corresponding author), INDIANA UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, INDIANAPOLIS, IN 46202 USA.		Robinson, Lucy C/M-6865-2019	Cobb, Melanie/0000-0003-0833-5473; Robinson, Lucy/0000-0001-6454-040X	NIDDK NIH HHS [DK27221] Funding Source: Medline; NIGMS NIH HHS [GM44140, GM26217] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027221, R56DK027221, R01DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026217, R01GM044140] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD Z, 1982, J BIOL CHEM, V257, P8348; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; CASPERSON GF, 1983, J BIOL CHEM, V258, P7911; CEGIELSKA A, 1994, J VIROL, V68, P269, DOI 10.1128/JVI.68.1.269-275.1994; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELPECH M, 1986, EUR J BIOCHEM, V160, P333, DOI 10.1111/j.1432-1033.1986.tb09976.x; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; GARRETT S, 1991, MOL CELL BIOL, V11, P4045, DOI 10.1128/MCB.11.8.4045; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; GRAVES PR, 1993, J BIOL CHEM, V268, P6394; HADFIELD C, 1986, GENE, V45, P149, DOI 10.1016/0378-1119(86)90249-0; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HOEKSTRA MF, 1994, MOL BIOL CELL, V5, P877, DOI 10.1091/mbc.5.8.877; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; KEARNEY PH, 1994, BIOCHEM BIOPH RES CO, V203, P231, DOI 10.1006/bbrc.1994.2172; MILNE DM, 1992, ONCOGENE, V7, P1351; PINNA LA, 1991, NATO ASI SERIES CELL, V56, P197; PINNA LA, 1989, PEPTIDES PROTEIN PHO, P145; POULTER L, 1988, EUR J BIOCHEM, V175, P497, DOI 10.1111/j.1432-1033.1988.tb14222.x; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; ROSSI G, 1991, NATURE, V351, P158, DOI 10.1038/351158a0; ROWLES J, 1991, P NATL ACAD SCI USA, V88, P9548, DOI 10.1073/pnas.88.21.9548; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sherman F., 1986, METHODS YEAST GENETI; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; VANCURA A, 1994, J BIOL CHEM, V269, P19271; WANG PC, 1992, MOL BIOL CELL, V3, P275, DOI 10.1091/mbc.3.3.275; WANG PC, 1994, J BIOL CHEM, V269, P12014; ZHAI LM, 1992, BIOCHEM BIOPH RES CO, V189, P944, DOI 10.1016/0006-291X(92)92295-9	37	88	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12717	12724		10.1074/jbc.270.21.12717	http://dx.doi.org/10.1074/jbc.270.21.12717			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759525	hybrid			2022-12-27	WOS:A1995QZ71100061
J	LEI, KJ; PAN, CJ; LIU, JL; SHELLY, LL; CHOU, JY				LEI, KJ; PAN, CJ; LIU, JL; SHELLY, LL; CHOU, JY			STRUCTURE-FUNCTION ANALYSIS OF HUMAN GLUCOSE-6-PHOSPHATASE, THE ENZYME-DEFICIENT IN GLYCOGEN-STORAGE-DISEASE TYPE 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL GLUCOSE-6-PHOSPHATASE; 6-PHOSPHOFRUCTO-2-KINASE FRUCTOSE-2,6-BISPHOSPHATASE; ALKALINE-PHOSPHATASE; PROTEINS; SYSTEM; MUTAGENESIS; MUTATIONS; MECHANISM; CATALYSIS; GENE	Glucose-6-phosphatase (G6Pase) is the enzyme deficient in glycogen storage disease type 1a, an autosomal recessive disorder. We have previously identified six mutations in the G6Pase gene of glycogen storage disease type 1a patients and demonstrated that these mutations abolished or greatly reduced enzymatic activity of G6Pase, a hydrophobic protein of 357 amino acids. Of these, four mutations (R83C, R295C, G222R, and Q347X) are missense and one (Q347X) generates a truncated G6Pase of 346 residues. To further understand the roles and structural requirements of amino acids 83, 222, 295, and those at the carboxyl terminus in G6Pase catalysis, we characterized mutant G6Pases generated by near-saturation mutagenesis of the aforementioned amino acids. Substitution of Arg-83 with amino acids of diverse structures including Lys, a conservative change, yielded mutant G6Pase with no enzymatic activity. On the other hand, substitution of Arg-295 with Lys (R295K) retained high activity, and R295N, R295S, and R295Q exhibited moderate activity. All other substitutions of Arg-295 had no G6Pase activity, suggesting that the role of Arg-295 is to stabilize the protein either by salt bridge or hydrogen-bond formation. Substitution of Gly-222, however, remained functional unless a basic (Arg or Lys), acidic (Asp), or large polar (Gin) residue was introduced, consistent with the hydrophobic requirement of codon 222, which is predicted to be in the fourth membrane-spanning domain. It is possible that Arg-83 is involved in stabilizing the enzyme (His)-phosphate intermediate formed during G6Pase catalysis. There exist 9 conserved His residues in human G6Pase. His-9, His-119, His-252, and His-353 reside on the same side of the endoplasmic reticulum membrane as Arg-83. Whereas H119A mutant G6Pase had no enzymatic activity, H9A, H252A, and H353A mutant G6Pases retained significant activity. Substitution of His-119 with amino acids of diverse structures also yielded mutant G6Pase with no activity, suggesting that His-119 is the phosphate acceptor in G6Pase catalysis. We also present data demonstrating that the carboxyl-terminal 8 residues in human G6Pase are not essential for G6Pase catalysis.	NICHHD, HUMAN GENET BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								ARION WJ, 1980, J BIOL CHEM, V255, P396; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BAZAN JF, 1989, P NATL ACAD SCI USA, V86, P9642, DOI 10.1073/pnas.86.24.9642; BEAUDET AL, 1991, HARRISONS PRINCIPLES, P1854; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COUNTAWAY JL, 1988, J BIOL CHEM, V263, P2673; FELDMAN F, 1972, BIOCHIM BIOPHYS ACTA, V268, P698, DOI 10.1016/0005-2744(72)90274-4; Hers HG, 1989, METABOLIC BASIS INHE, P425; HOYLAERTS MF, 1992, BIOCHEM J, V286, P23, DOI 10.1042/bj2860023; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; LANGE AJ, 1994, BIOCHEM BIOPH RES CO, V201, P302, DOI 10.1006/bbrc.1994.1702; LEI KJ, 1994, J CLIN INVEST, V93, P1994, DOI 10.1172/JCI117192; LEI KJ, 1995, J CLIN INVEST, V95, P234, DOI 10.1172/JCI117645; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; NANDI CL, 1993, PROTEIN ENG, V6, P247, DOI 10.1093/protein/6.3.247; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, P349; ROBERTS VA, 1994, J MOL BIOL, V235, P1098, DOI 10.1006/jmbi.1994.1060; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SUKALSKI KA, 1989, ADV ENZYMOL RAMB, V62, P93; TAULER A, 1990, J BIOL CHEM, V265, P15617; WELLS JA, 1985, GENE, V34, P315, DOI 10.1016/0378-1119(85)90140-4	25	62	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11882	11886		10.1074/jbc.270.20.11882	http://dx.doi.org/10.1074/jbc.270.20.11882			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744838	hybrid			2022-12-27	WOS:A1995QY73600034
J	ASAI, T; MIURA, S; SIBLEY, LD; OKABAYASHI, H; TAKEUCHI, T				ASAI, T; MIURA, S; SIBLEY, LD; OKABAYASHI, H; TAKEUCHI, T			BIOCHEMICAL AND MOLECULAR CHARACTERIZATION OF NUCLEOSIDE TRIPHOSPHATE HYDROLASE ISOZYMES FROM THE PARASITIC PROTOZOAN TOXOPLASMA-GONDII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; VIRULENT; FRAGMENT; STRAINS; BINDING	We have previously reported the presence of a novel nucleoside triphosphate hydrolase (NTPase) in the rapidly multiplying tachyzoite form of a virulent strain (RH) of Toxoplasma gondii. On further examination, it was found that the purified enzyme was not a single enzyme but was a mixture of two isozymes termed NTPase-I and NTPase-II. The two isozymes had similar molecular masses of approximately 240-270 kDa by gel filtration and contained four identical subunits of molecular mass 66-67 kDa by SDS polyacrylamide gel electrophoresis. Both forms of the NTPase were activated by dithiothreitol, and NTPase-I had a specific activity 4.5-fold higher than NTPase II in hydrolysis of ATP, The primary difference between these isozymes lies in their ability to hydrolyze nucleoside triphosphate versus diphosphate substrates. While NTPase-II hydrolyzed ATP to ADP and ADP to AMP at almost the same rate, NTPase-I hydrolyzed ADP to AMP at a much slower rate (0.7% of the rate for ATP). The complete cDNAs for NTPase-I and NTPase-II were sequenced and found to encode the same size predicted open reading frame of which only 16 of 628 amino acids differed between the two isozymes, Both forms of the NTPase contained an NH2-terminal hydrophobic signal peptide, consistent with our previous findings that these enzymes are secreted into the host cell vacuole occupied by the parasite. The gene encoding NTPase-II was found in all strains of Toxoplasma, while the NTPase-I was confined only to virulent strains, Expression of this highly active ATPase (NTPase-I) may contribute to intracellular survival and virulence of T. gondii.	YOKOHAMA CITY UNIV,SCH MED,RADIOISOTOPE RES CTR,YOKOHAMA,KANAGAWA 236,JAPAN; WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110	Yokohama City University; Washington University (WUSTL)	ASAI, T (corresponding author), KEIO UNIV,SCH MED,DEPT TROP MED & PARASITOL,SHINJUKU KU,35 SHINANOMACHI,TOKYO 160,JAPAN.		Sibley, L. David/C-4616-2008		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034036] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI034036, AI34036] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASAI T, 1986, COMP BIOCHEM PHYS B, V85, P365, DOI 10.1016/0305-0491(86)90013-1; ASAI T, 1983, J BIOL CHEM, V258, P6816; ASAI T, 1992, J CLIN MICROBIOL, V30, P1291, DOI 10.1128/JCM.30.5.1291-1293.1992; ASAI T, 1987, INFECT IMMUN, V55, P1332, DOI 10.1128/IAI.55.5.1332-1335.1987; ASAI T, 1987, ZBL BAKT-INT J MED M, V264, P464; ASAI T, 1990, FEMS MICROBIOL LETT, V72, P89, DOI 10.1111/j.1574-6968.1990.tb03867.x; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BERMUDES D, 1994, J BIOL CHEM, V269, P29252; BERNINSONE P, 1994, J BIOL CHEM, V269, P207; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleland W W, 1979, Methods Enzymol, V63, P103; DESMONTS G, 1974, NEW ENGL J MED, V290, P1110, DOI 10.1056/NEJM197405162902003; Dubey J. P., 1977, PARASITIC PROTOZOA, V3, P101; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; GROVER CM, 1990, J CLIN MICROBIOL, V28, P2297, DOI 10.1128/JCM.28.10.2297-2301.1990; JOHNSON AM, GENE AMST, V85, P215; LUFT BJ, 1988, J INFECT DIS, V157, P1, DOI 10.1093/infdis/157.1.1; O'Sullivan W J, 1979, Methods Enzymol, V63, P294; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PENEFSKY HS, 1960, J BIOL CHEM, V235, P3330; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHWARTZMAN JD, 1982, EXP PARASITOL, V53, P77, DOI 10.1016/0014-4894(82)90094-7; SIBLEY LD, 1994, EXP PARASITOL, V79, P301, DOI 10.1006/expr.1994.1093; SIBLEY LD, 1992, GENETICS, V132, P1003; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; WALTON KM, 1993, ANNU REV BIOCHEM, V62, P101	28	148	159	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11391	11397		10.1074/jbc.270.19.11391	http://dx.doi.org/10.1074/jbc.270.19.11391			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744775	hybrid			2022-12-27	WOS:A1995QX86500054
J	HORIUCHI, H; GINER, A; HOFLACK, B; ZERIAL, M				HORIUCHI, H; GINER, A; HOFLACK, B; ZERIAL, M			A GDP/GTP EXCHANGE-STIMULATORY ACTIVITY FOR THE RAB5-RABGDI COMPLEX ON CLATHRIN-COATED VESICLES FROM BOVINE BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEINS; GDP DISSOCIATION INHIBITOR; RAB GERANYLGERANYL TRANSFERASE; SMG P25A; COMPONENT-A; YEAST; SECRETION; MEMBRANE; SEC4; PURIFICATION	Small GTPases of the Rab family are key regulators of intracellular transport, They are associated with the cytoplasmic surface of distinct exocytic and endocytic organelles and with transport vesicles connecting these compartments, Rab proteins are also present in the cytosol in the GDP-bound conformation complexed to Rab GDP dissociation inhibitor (RabGDI), Upon membrane association, RabGDI is released, and the Rab protein is converted into the GTP-bound form, In this paper we have investigated whether Rab5, which regulates the clathrin-coated vesicle-mediated pathway of endocytosis, can directly associate with the membrane of clathrin-coated vesicles (CCV) purified from bovine brain in vitro. We found that RabGDI can specifically deliver Rab5 but not Rab7, which is localized to late endosomes, to CCV, Furthermore, CCV contain a heat- and trypsin-sensitive activity that stimulates the dissociation of GDP from Rab5, but not from Rab7, and the subsequent binding of GTP, The activity was found to be associated with the CCV membrane but not with the coat components. CCV weakly stimulated GDP release from either post-translationally modified or unmodified Rab5 alone, However, maximal GDP dissociation stimulation required the presence of RabGDI, suggesting that the factor(s) responsible for the membrane association and GDP/GTP exchange of Rab5 recognize the protein complexed to RabGDI, These data demonstrate that CCV are competent for acquiring Rab5 and for converting the molecule into the GTP-bound active form.	EUROPEAN MOLEC BIOL LAB,D-69012 HEIDELBERG,GERMANY	European Molecular Biology Laboratory (EMBL)			HOFLACK, Bernard/AAZ-6668-2020					ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARAKI S, 1991, MOL CELL BIOL, V11, P1438, DOI 10.1128/MCB.11.3.1438; ARAKI S, 1990, J BIOL CHEM, V265, P13007; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BRENNWALD P, 1993, NATURE, V362, P560, DOI 10.1038/362560a0; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1994, P NATL ACAD SCI USA, V91, P5061, DOI 10.1073/pnas.91.11.5061; BURSTEIN ES, 1993, J BIOL CHEM, V268, P22247; BURSTEIN ES, 1992, P NATL ACAD SCI USA, V89, P1154, DOI 10.1073/pnas.89.4.1154; BURTON J, 1993, NATURE, V361, P464, DOI 10.1038/361464a0; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; DIRACSVEJSTRUP AB, 1994, J BIOL CHEM, V269, P15427; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOUD B, 1991, Current Opinion in Cell Biology, V3, P626, DOI 10.1016/0955-0674(91)90033-U; HORIUCHI H, 1995, IN PRESS METHODS ENZ; LI GP, 1993, J BIOL CHEM, V268, P24475; LIAN JP, 1993, CELL, V73, P735, DOI 10.1016/0092-8674(93)90253-M; MERESSE S, 1990, J BIOL CHEM, V265, P18833; MOYA M, 1993, NATURE, V361, P460, DOI 10.1038/361460a0; NISHIMURA N, 1994, J BIOL CHEM, V269, P14191; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; PETER F, 1994, J CELL BIOL, V126, P1393, DOI 10.1083/jcb.126.6.1393; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; SAHAGIAN G, 1985, J BIOL CHEM, V260, P9338; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SASAKI T, 1991, MOL CELL BIOL, V11, P2909, DOI 10.1128/MCB.11.5.2909; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; SIMONS K, 1993, NEURON, V11, P789, DOI 10.1016/0896-6273(93)90109-5; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; STAHL B, 1994, J BIOL CHEM, V269, P24770; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; STENMARK H, 1994, EMBO J, V13, P128; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; ULLRICH O, 1995, IN PRESS METHODS ENZ; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I	49	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11257	11262		10.1074/jbc.270.19.11257	http://dx.doi.org/10.1074/jbc.270.19.11257			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744760	hybrid			2022-12-27	WOS:A1995QX86500037
J	KUPKE, T; KEMPTER, C; JUNG, G; GOTZ, F				KUPKE, T; KEMPTER, C; JUNG, G; GOTZ, F			OXIDATIVE DECARBOXYLATION OF PEPTIDES CATALYZED BY FLAVOPROTEIN EPID - DETERMINATION OF SUBSTRATE-SPECIFICITY USING PEPTIDE LIBRARIES AND NEUTRAL LOSS MASS-SPECTROMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLISION-INDUCED DISSOCIATION; EPIDERMIN BIOSYNTHETIC GENES; LANTIBIOTIC EPIDERMIN; PROTEINS; PURIFICATION; BINDING	flavoprotein EpiD catalyzes the COOH-terminal oxidative decarboxylation of the lantibiotic precursor peptide EpiA. Variations of the COOH-terminal heptapeptide (SFNSYCC7)-F-1 of EpiA were used for determining the substrate specificity of EpiD, When Cys(7) was replaced by serine, cysteine-amide, homocysteine, or a thioether amino acid residue, no reaction with EpiD was observed, Heptapeptide libraries with one variable amino acid residue at positions 1-7 of the peptide substrate (SFNSYCC7)-F-1 were incubated with EpiD, and the reaction products were identified by neutral loss mass spectrometry, When the penultimate cysteine residue Cys(6) of the substrate peptide was replaced with Ser, Thr, Ala, or Val, the reaction still occurred, Tyr(5) could be replaced with other hydrophobic amino acid residues, Mass spectrometry was used to compare the kinetics of the reaction of EpiD with various peptides, Peptide sequencing of the reaction products was performed by tandem mass spectrometry, confirming that the last cysteine residue was modified, The removal of the acid COOH-terminal carboxyl group was confirmed by determination of the isoelectric points of the reaction products, To study the interaction between EpiA and EpiD, EpiA was coupled to N-hydroxysuccinimide-activated Sepharose HiTrap material; EpiD was only retarded under reducing conditions.	UNIV TUBINGEN,INST ORGAN CHEM,D-72076 TUBINGEN,GERMANY	Eberhard Karls University of Tubingen	KUPKE, T (corresponding author), UNIV TUBINGEN,WALDHAUSERSTR 70-8,D-72076 TUBINGEN,GERMANY.			Kupke, Thomas/0000-0003-2341-1710				ALLGAIER H, 1985, ANGEW CHEM INT EDIT, V24, P1051, DOI 10.1002/anie.198510511; AUGUSTIN J, 1992, EUR J BIOCHEM, V204, P1149, DOI 10.1111/j.1432-1033.1992.tb16740.x; AUGUSTIN J, 1991, NISIN NOVEL LANTIBIO, P277; BIEMANN K, 1990, METHOD ENZYMOL, V193, P455, DOI 10.1016/0076-6879(90)93433-L; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUINS AP, 1987, ANAL CHEM, V59, P2642, DOI 10.1021/ac00149a003; CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; Covey T R, 1988, Rapid Commun Mass Spectrom, V2, P249, DOI 10.1002/rcm.1290021111; HAYES RN, 1990, METHOD ENZYMOL, V193, P237, DOI 10.1016/0076-6879(90)93418-K; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; JANSON JC, 1989, PROTEIN PURIFICATION; JARDINE I, 1990, METHOD ENZYMOL, V193, P441, DOI 10.1016/0076-6879(90)93432-K; JUNG G, 1991, ANGEW CHEM INT EDIT, V30, P1051, DOI 10.1002/anie.199110513; JUNG G, 1992, ANGEW CHEM INT EDIT, V31, P367, DOI 10.1002/anie.199203673; KOGLER H, 1991, NISIN NOVEL LANTIBIO, P159; KUPKE T, 1993, FEMS MICROBIOL LETT, V112, P43, DOI 10.1016/0378-1097(93)90535-A; KUPKE T, 1992, J BACTERIOL, V174, P5354, DOI 10.1128/JB.174.16.5354-5361.1992; KUPKE T, 1994, J BIOL CHEM, V269, P5653; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; MARKLEY JL, 1993, NMR MACROMOLECULES, P101; METZGER JW, 1994, ANAL BIOCHEM, V219, P261, DOI 10.1006/abio.1994.1266; OJCIUS DM, 1991, TRENDS BIOCHEM SCI, V16, P225, DOI 10.1016/0968-0004(91)90090-I; PESCHEL A, 1993, MOL MICROBIOL, V9, P31, DOI 10.1111/j.1365-2958.1993.tb01666.x; REISS Y, 1990, Methods (Orlando), V1, P241, DOI 10.1016/S1046-2023(05)80323-8; RIGGS P, 1990, CURRENT PROTOCOLS MO; Sahl H. G., 1991, NISIN NOVEL LANTIBIO, P347; SCHNELL N, 1992, EUR J BIOCHEM, V204, P57, DOI 10.1111/j.1432-1033.1992.tb16605.x; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; SKAUGEN M, 1994, J BIOL CHEM, V269, P27183; WUTHRICH K, 1989, SCIENCE, V243, P45, DOI 10.1126/science.2911719; YAN SCB, 1989, TRENDS BIOCHEM SCI, V14, P264, DOI 10.1016/0968-0004(89)90060-1; YOST RA, 1990, METHOD ENZYMOL, V193, P154, DOI 10.1016/0076-6879(90)93415-H	32	96	98	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11282	11289		10.1074/jbc.270.19.11282	http://dx.doi.org/10.1074/jbc.270.19.11282			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744764	hybrid			2022-12-27	WOS:A1995QX86500041
J	MORIYAMA, Y; YAMAMOTO, A; YAMADA, H; TASHIRO, Y; TOMOCHIKA, KI; TAKAHASHI, M; MAEDA, M; FUTAI, M				MORIYAMA, Y; YAMAMOTO, A; YAMADA, H; TASHIRO, Y; TOMOCHIKA, KI; TAKAHASHI, M; MAEDA, M; FUTAI, M			MICROVESICLES ISOLATED FROM BOVINE POSTERIOR PITUITARY ACCUMULATE NOREPINEPHRINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMAFFIN GRANULE MEMBRANES; SYNAPTIC-LIKE MICROVESICLES; PANCREATIC BETA-CELLS; VACUOLAR H+-ATPASE; SENSITIVE ATPASE; HORMONE-RELEASE; PROTON PUMP; VESICLES; TRANSPORT; NEUROHYPOPHYSIS	Histochemical study indicated that the posterior pituitary possesses numerous microvesicles (MVs) containing synaptophysin, a marker protein specific for brain synaptic vesicles (Navone, F., Di Gioia, G., Jahn, R., Browning, M., Greengard, P., and De Carnilli, P. (1989) J. Cell Biol. 109, 3425-2433). By monitoring cross-reactivity with anti synaptophysin antibody, the MVs were highly purified from bovine posterior pituitaries by a combination of differential and sucrose density gradient centrifugations. The purified MVs had an average diameter of about 60 nm and were associated with synaptophysin as revealed by immunoelectron microscopy. The vesicles contained ATPase activity partially sensitive to bafilomycin A(1) and to vanadate. The membrane fraction immunoisolated with anti-synaptophysin antibody also exhibited similar ATPase activity. The two ATPases could be purified separately; the vanadate-sensitive enzyme was identified as a 115-kDa polypeptide immunochemically similar to chromaffin granule P-ATPase (forming phosphoenzyme intermediate), and the bafilomycin A(1) sensitive ATPase showed essentially the same properties as those of vacuolar type H+-ATPases. Upon addition of ATP, the MVs formed an electrochemical gradient of protons and took up norepinephrine in a reserpine-sensitive manner, indicating the presence of secondary monoamine transporter coupled with vacuolar type H+-ATPase. No uptake of L-glutamate, gamma-aminobutyrate, glycine, or acetylcholine was observed, The identification of MVs as organelles responsible for storage of monoamines is important for understanding the physiological function of the posterior pituitary.	OSAKA UNIV,INST SCI & IND RES,DEPT BIOCHEM & ORGAN CHEM,IBARAKI,OSAKA 567,JAPAN; KANSAI MED UNIV,DEPT PHYSIOL,MORIGUCHI,OSAKA 570,JAPAN; OKAYAMA UNIV,FAC PHARMACEUT SCI,OKAYAMA 700,JAPAN; MITSUBISHI LIFE SCI INST,MACHIDA,TOKYO 194,JAPAN	Osaka University; Kansai Medical University; Okayama University			YAMADA, Hiroshi/B-2251-2011; Yamada, Hiroshi/AGZ-4497-2022	YAMADA, Hiroshi/0000-0002-9328-3446; Yamada, Hiroshi/0000-0002-9328-3446				ANNAERT WG, 1993, J NEUROCHEM, V60, P1746, DOI 10.1111/j.1471-4159.1993.tb13399.x; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BROADWELL RD, 1984, J COMP NEUROL, V228, P155, DOI 10.1002/cne.902280203; CRUBER KA, 1976, P NATL ACAD SCI USA, V73, P1314; Douglas WW, 1970, MEM SOC ENDOCR, V19, P353; FORGAC M, 1992, PHYSIOL REV, V69, P765; GERSCHENFELD HM, 1960, ENDOCRINOLOGY, V66, P741, DOI 10.1210/endo-66-5-741; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MORIYAMA Y, 1989, J BIOL CHEM, V264, P18445; MORIYAMA Y, 1990, J BIOL CHEM, V265, P9165; MORIYAMA Y, 1990, J BIOCHEM, V108, P689, DOI 10.1093/oxfordjournals.jbchem.a123264; MORIYAMA Y, 1987, J BIOL CHEM, V262, P9175; MORIYAMA Y, 1991, ARCH BIOCHEM BIOPHYS, V286, P252, DOI 10.1016/0003-9861(91)90037-J; MORIYAMA Y, 1988, J BIOL CHEM, V263, P8521; MORRIS JF, 1980, NEUROSCIENCE, V5, P639, DOI 10.1016/0306-4522(80)90061-5; NAVONE F, 1989, J CELL BIOL, V109, P3425, DOI 10.1083/jcb.109.6.3425; NELSON N, 1989, J BIOENERG BIOMEMBR, V21, P553, DOI 10.1007/BF00808113; NORDMANN JJ, 1976, NATURE, V261, P723, DOI 10.1038/261723a0; OBATA K, 1986, BRAIN RES, V375, P37, DOI 10.1016/0006-8993(86)90956-X; ONEAL SG, 1979, BIOCHEM BIOPH RES CO, V89, P845, DOI 10.1016/0006-291X(79)91855-2; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; REGIERVIGOUROUX A, 1993, NEUROCHEM RES, V18, P59; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; RUSSELL JT, 1987, CURR TOP MEMBR TRANS, V31, P277; RUSSELL JT, 1984, J BIOL CHEM, V259, P9496; SCHERMAN D, 1982, BIOCHEMISTRY-US, V21, P687, DOI 10.1021/bi00533a016; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; THOMASREETZ A, 1993, P NATL ACAD SCI USA, V90, P5317, DOI 10.1073/pnas.90.11.5317; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; TWEEDLE CD, 1983, PROG BRAIN RES, V60, P259; WALCHSOLIMENA C, 1993, J NEUROSCI, V13, P3895	33	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11424	11429		10.1074/jbc.270.19.11424	http://dx.doi.org/10.1074/jbc.270.19.11424			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744779	hybrid			2022-12-27	WOS:A1995QX86500058
J	SKORKOGLONEK, J; KRZEWSKI, K; LIPINSKA, B; BERTOLI, E; TANFANI, F				SKORKOGLONEK, J; KRZEWSKI, K; LIPINSKA, B; BERTOLI, E; TANFANI, F			COMPARISON OF THE STRUCTURE OF WILD-TYPE HTRA HEAT-SHOCK PROTEASE AND MUTANT HTRA PROTEINS - A FOURIER-TRANSFORM INFRARED SPECTROSCOPIC STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CLP PROTEASE; ESCHERICHIA-COLI; SECONDARY STRUCTURE; SERINE PROTEASES; SPECTRA; RESOLUTION; COMPONENT; GENE; TEMPERATURES; PROTEOLYSIS	The HtrA protease of Escherichia coli, identical with the DegP protease, is a 48-kDa heat shock protein, indispensable for bacterial survival only at temperatures above 42 degrees C. Proteolytic activity of HtrA is inhibited by diisopropyl fluorophosphate, suggesting that HtrA is a serine protease. We have recently found that mutational alteration of serine in position 210 of the mature HtrA or of histidine in position 105 totally eliminated proteolytic activity of HtrA. However, little was known about the consequences of the mutations on HtrA conformation, In this work, Fourier transform infrared spectroscopy has been used to examine the conformation in aqueous solution of wild-type HtrA and mutant HtrAS210 and HtrAH105 proteins, The spectra were collected at different temperatures in order to gain information also on the thermal stability of the three proteins, The analysis of HtrA protein spectrum, by resolution-enhancement methods, revealed that beta-sheet is the major structural element of the conformation of HtrA, Deconvoluted as well as second derivative spectra of wild-type HtrA and mutant HtrAS210 and HtrAH105 collected at 20 degrees C were identical, indicating no differences in the secondary structure of these proteins, The analysis of spectra obtained at different temperatures revealed a maximum of protein denaturation within 65-70 degrees C for wild-type HtrA as well as for the HtrAS210 and HtrAH105 mutant proteins, However, the thermal denaturation pattern of wild-type HtrA revealed a lower cooperativity in the denaturation process as compared to the mutant proteins which instead behaved similarly, These data suggest that the mutations in HtrA protein induced minor changes in the tertiary structure of the protein (most likely located at the mutation sites), Our results strongly support the idea that Ser(210) and His(105) may represent two elements of the active-site triad (Ser, His, and Asp), found in most serine proteases. We have also found that in vitro, in the range from 37 to 55 degrees C, the proteolytic activity of HtrA rapidly increased with temperature and that HtrA activity remained unchanged for at least 4 h at 45 degrees C.	UNIV GDANSK, DEPT BIOCHEM, PL-80822 GDANSK, POLAND; UNIV ANCONA, SCH MED, INST BIOCHEM, I-60131 ANCONA, ITALY	Fahrenheit Universities; University of Gdansk; Marche Polytechnic University			Skorko-Glonek, Joanna/AAF-5516-2020; Tanfani, Fabio/F-1441-2010	Skorko-Glonek, Joanna/0000-0002-8084-5251; Lipinska, Barbara/0000-0001-9510-4811; Tanfani, Fabio/0000-0001-7685-4692				BANECKI B, 1992, J BIOL CHEM, V267, P25051; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CASAL HL, 1988, BIOCHIM BIOPHYS ACTA, V957, P11, DOI 10.1016/0167-4838(88)90152-5; CAVARD D, 1989, J BACTERIOL, V171, P6316, DOI 10.1128/jb.171.11.6316-6322.1989; CHIRGADZE YN, 1975, BIOPOLYMERS, V14, P679, DOI 10.1002/bip.1975.360140402; CHUANG SE, 1993, J BACTERIOL, V175, P2026, DOI 10.1128/JB.175.7.2026-2036.1993; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; FABIAN H, 1993, J MOL BIOL, V232, P967, DOI 10.1006/jmbi.1993.1442; FERNANDEZBALLESTER G, 1992, BIOCHEM J, V288, P421, DOI 10.1042/bj2880421; GEORGOPOULOS C, 1990, STRESS PROTEINS BIOL, P191; GOERGOPOULOS C, 1994, BIOL HEAT SHOCK PROT, P209; GOTTESMAN S, 1989, ANNU REV GENET, V23, P163, DOI 10.1146/annurev.ge.23.120189.001115; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; GROSS CA, 1990, STRESS PROTEINS BIOL, P167; HARIS PI, 1986, BIOCHIM BIOPHYS ACTA, V874, P255, DOI 10.1016/0167-4838(86)90024-5; JACKSON M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P231, DOI 10.1016/0167-4838(91)90563-F; JACKSON M, 1992, BIOCHIM BIOPHYS ACTA, V1118, P139, DOI 10.1016/0167-4838(92)90141-Y; JAMES MNG, 1980, J MOL BIOL, V144, P43, DOI 10.1016/0022-2836(80)90214-4; JOHNSON K, 1991, MOL MICROBIOL, V5, P401, DOI 10.1111/j.1365-2958.1991.tb02122.x; KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; KROH HE, 1990, J BACTERIOL, V172, P6026, DOI 10.1128/jb.172.10.6026-6034.1990; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; Morimoto R.I., 1990, STRESS PROTEINS BIOL, P450, DOI [10.1126/science.249.4968.572-a, DOI 10.1126/SCIENCE.249.4968.572-A]; MUGA A, 1993, BIOCHIM BIOPHYS ACTA, V1162, P291, DOI 10.1016/0167-4838(93)90293-Z; NEIDHARDT FC, 1987, ESCHERICHIA COLI SAL, P1334; OSBORNE HB, 1982, METHOD ENZYMOL, V88, P676; READ RJ, 1988, J MOL BIOL, V200, P523, DOI 10.1016/0022-2836(88)90541-4; ROOP RM, 1994, INFECT IMMUN, V62, P1000, DOI 10.1128/IAI.62.3.1000-1007.1994; SALOMAA P, 1964, J AM CHEM SOC, V86, P1, DOI 10.1021/ja01055a001; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; YU A, 1991, FEBS LETT, V287, P211	45	50	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11140	11146		10.1074/jbc.270.19.11140	http://dx.doi.org/10.1074/jbc.270.19.11140			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744744	hybrid			2022-12-27	WOS:A1995QX86500020
J	CRUZ, MA; YUAN, HB; LEE, JR; WISE, RJ; HANDIN, RI				CRUZ, MA; YUAN, HB; LEE, JR; WISE, RJ; HANDIN, RI			INTERACTION OF THE VON-WILLEBRAND-FACTOR (VWF) WITH COLLAGEN - LOCALIZATION OF THE PRIMARY COLLAGEN-BINDING SITE BY ANALYSIS OF RECOMBINANT VWF A DOMAIN POLYPEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN VONWILLEBRAND-FACTOR; PLATELET GLYCOPROTEIN-IB; FACTOR-VIII; FIBRINOGEN BINDING; FIBRILLAR COLLAGEN; IIB/IIIA COMPLEX; ESCHERICHIA-COLI; CROSS-LINKING; IX COMPLEX; AGGREGATION	The von Willebrand factor (vWF) mediates platelet adhesion to the vascular subendothelium by binding to collagen, other matrix constituents, and the platelet receptor glycoproteins Ib/IX and IIb/IIIa, Although substantial progress has been made in defining vWF structure-function relationships, there are conflicting data regarding the location of its collagen-binding site(s), Possible collagen-binding sites have been localized in the A1 and A3 domains of vWF, To study the proposed binding sites, we have expressed cDNA sequences encoding the A1 and A3 domains of vWF in Escherichia coli and purified the resulting proteins from bacterial inclusion bodies. In addition, a chimeric molecule containing residues 465-598 of the vWF A1 domain polypeptide (vWF-A1) fused in frame to residues 1018-1114 of the vWF A3 domain polypeptide (vWF-A3) was also expressed, Each of the three recombinant proteins purified as a monomer and contained a single disulfide bond, As previously reported (Cruz, M. A., Handin, R. I., and Wise, R. J, (1993) J. Biol. Chem, 268, 21238-21245), recombinant vWF-A1 inhibited ristocetin-induced platelet agglutination, but did not compete with vWF multimers for collagen binding, In contrast, vWF-A3 inhibited the binding of multimeric vWF to immobilized collagen, but did not inhibit ristocetin-induced platelet agglutination, Metabolically labeled vWF-A3 bound to immobilized collagen in a saturable and reversible manner with a K-d of 1.8 x 10(-6) M. The vWF-A1/A3 chimera was bifunctional, It inhibited vWF binding to platelet glycoprotein Ib/IX with an IC50 of 0.6 x 10(-6) M and inhibited vWF binding to collagen with an IC50 of 0.5-1.0 x 10(-6) M. These results, taken together, provide firm evidence that the major collagen-binding site in vWF resides in the A3 domain.	HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV HEMATOL ONCOL,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard Medical School								ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8326, DOI 10.1021/bi00447a010; AZUMA H, 1991, J BIOL CHEM, V266, P12342; BERNDT MC, 1992, BIOCHEMISTRY-US, V31, P11144, DOI 10.1021/bi00160a027; BOCKENSTEDT P, 1986, J CLIN INVEST, V78, P551, DOI 10.1172/JCI112608; BONTHRON D, 1986, NUCLEIC ACIDS RES, V14, P7125, DOI 10.1093/nar/14.17.7125; BONTHRON DT, 1986, NATURE, V324, P270, DOI 10.1038/324270a0; CHRISTOPHE O, 1991, BLOOD, V78, P2310; CRUZ MA, 1992, J BIOL CHEM, V267, P1303; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; DEMARCO L, 1985, P NATL ACAD SCI USA, V82, P7424; DEMARCO L, 1985, J CLIN INVEST, V75, P1198, DOI 10.1172/JCI111816; DENIS C, 1993, ARTERIOSCLER THROMB, V13, P398, DOI 10.1161/01.ATV.13.3.398; DONG ZY, 1994, BLOOD, V84, pA388; FUJIMURA Y, 1991, BLOOD, V77, P113; FUJIMURA Y, 1987, J BIOL CHEM, V262, P1734; GIRMA JP, 1987, BLOOD, V70, P605; GRALNICK HR, 1992, P NATL ACAD SCI USA, V89, P7880, DOI 10.1073/pnas.89.17.7880; GRALNICK HR, 1985, J CLIN INVEST, V75, P19; Jorieux S, 1990, Blood Coagul Fibrinolysis, V1, P375, DOI 10.1097/00001721-199010000-00004; KALAFATIS M, 1987, BLOOD, V5, P1577; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MOHRI H, 1989, J BIOL CHEM, V264, P17361; MOHRI H, 1988, J BIOL CHEM, V263, P17901; MORTON LF, 1983, THROMB RES, V32, P545, DOI 10.1016/0049-3848(83)90056-7; NYMAN D, 1980, THROMB RES, V17, P209, DOI 10.1016/0049-3848(80)90307-2; PARETI FI, 1987, J BIOL CHEM, V262, P13835; PARETI FI, 1986, J BIOL CHEM, V261, P15310; PIETU G, 1989, BIOCHEM BIOPH RES CO, V164, P1339; RAND JH, 1991, J CLIN INVEST, V88, P253, DOI 10.1172/JCI115285; ROTH GJ, 1986, BIOCHEMISTRY-US, V25, P8357, DOI 10.1021/bi00374a004; SANTORO SA, 1982, COLLAGEN REL RES, V2, P31; SANTORO SA, 1981, THROMB RES, V21, P689, DOI 10.1016/0049-3848(81)90272-3; SHELTONINLOES BB, 1986, BIOCHEMISTRY-US, V25, P3164, DOI 10.1021/bi00359a014; SIXMA JJ, 1984, J CLIN INVEST, V74, P736, DOI 10.1172/JCI111489; SIXMA JJ, 1991, EUR J BIOCHEM, V688, P1; SUGIMOTO M, 1991, BIOCHEMISTRY-US, V30, P5202, DOI 10.1021/bi00235a013; TAKAGI J, 1989, J BIOL CHEM, V264, P6017; TURITTO VT, 1984, J CLIN INVEST, V74, P1730, DOI 10.1172/JCI111591; VERWEIJ CL, 1986, EMBO J, V5, P1839, DOI 10.1002/j.1460-2075.1986.tb04435.x; WEISS HJ, 1978, J LAB CLIN MED, V92, P750; WISE RJ, 1991, J BIOL CHEM, V266, P21948; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9	43	123	130	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10822	10827		10.1074/jbc.270.18.10822	http://dx.doi.org/10.1074/jbc.270.18.10822			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738019	hybrid			2022-12-27	WOS:A1995QW60100067
J	LIU, HI; SONO, M; KADKHODAYAN, S; HAGER, LP; HEDMAN, B; HODGSON, KO; DAWSON, JH				LIU, HI; SONO, M; KADKHODAYAN, S; HAGER, LP; HEDMAN, B; HODGSON, KO; DAWSON, JH			X-RAY-ABSORPTION NEAR-EDGE STUDIES OF CYTOCHROME P-450-CAM, CHLOROPEROXIDASE, AND MYOGLOBIN - DIRECT EVIDENCE FOR THE ELECTRON RELEASING CHARACTER OF A CYSTEINE THIOLATE PROXIMAL LIGAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; CO BOND ANGLE; ACTIVE-SITE; STRUCTURAL CHARACTERIZATION; PARAMAGNETIC RESONANCE; EXAFS SPECTROSCOPY; XANES SPECTROSCOPY; CRYSTAL-STRUCTURE; COMPOUND-II; LIGATION	The low spin ferric and low and high spin ferrous forms of myoglobin, bacterial cytochrome P-450-CAM, and chloroperoxidase have been examined by Fe-K x-ray absorption edge spectroscopy. The positions of the absorption edge and the shapes of preedge and edge regions of imidazole adducts of ferric P-450-CAM and chloroperoxidase are essentially the same when compared with thiolate-ligated ferric myoglobin. As these three protein derivatives all have six-coordinate, low spin, ferric hemes with axial imidazole and thiolate ligands, the superposition of x-ray absorption edge spectral properties demonstrates that the protein environment does not effect the spectra, provided one compares heme iron centers with identical coordination numbers, spin and oxidation states, and ligand sets. In contrast, a 0.96 eV difference is observed in the energy of the absorption edge for imidazole- and thiolate-ligated ferric myoglobin with the latter shifted to lower energy as observed for ferrous myoglobin states. Similarly, in the low spin ferric-imidazole and ferrous-CO states, the energies of the absorption edge for chloroperoxidase and P-450-CAM are shifted in the direction of the ferrous state (to lower energy) when compared with those for analogous myoglobin derivatives. In the deoxyferrous high spin state, comparison of the edge spectra of chloroperoxidase with analogous data for cytochrome P-450-CAM suggests that the electron density at the iron is similar for these two protein states. The shifts observed in the energies of the x-ray absorption edge for the thiolate ligated states of these proteins relative to derivatives lacking a thiolate ligand provide a direct measure of the electron releasing character of a thiolate axial ligand. These results therefore support the suggested role of the cysteinate proximal ligand of P-450 as a strong internal electron donor to promote O-O bond cleavage in the putative ferric-peroxide intermediate to generate the proposed ferryl oxo ''active oxygen'' state of the reaction cycle.	STANFORD UNIV,STANFORD SYNCHROTRON RADIAT LAB,STANFORD,CA 94305; UNIV S CAROLINA,DEPT CHEM & BIOCHEM,COLUMBIA,SC 29208; UNIV S CAROLINA,SCH MED,COLUMBIA,SC 29208; UNIV ILLINOIS,DEPT BIOCHEM,URBANA,IL 61801	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Illinois System; University of Illinois Urbana-Champaign	LIU, HI (corresponding author), STANFORD UNIV,DEPT CHEM,STANFORD,CA 94305, USA.		Dawson, John/HDM-6702-2022	Dawson, John H/0000-0002-4902-4295	NCRR NIH HHS [RR-01209] Funding Source: Medline; NIGMS NIH HHS [GM-07768] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Anderson LA, 1990, STRUCT BOND, V74, P1; BIANCONI A, 1985, NATURE, V318, P685, DOI 10.1038/318685a0; BUCHLER JW, 1978, ANGEW CHEM INT EDIT, V17, P407, DOI 10.1002/anie.197804071; CARTIER C, 1982, BIOCHIM BIOPHYS ACTA, V1119, P169; CHANCE B, 1983, BIOCHEMISTRY-US, V22, P3820, DOI 10.1021/bi00285a017; CHANG CS, 1993, BIOCHEMISTRY-US, V32, P923, DOI 10.1021/bi00054a025; CONGIUCASTELLAN.A, 1987, BIOCHEM BIOPH RES CO, V147, P31; Cramer S. P., 1979, PROG INORG CHEM, V25, P1, DOI [DOI 10.1002/9780470166260.CH1, 10.1002/9780470166260.ch1]; CRAMER SP, 1978, J AM CHEM SOC, V100, P7282, DOI 10.1021/ja00491a027; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; DAWSON JH, 1986, J AM CHEM SOC, V108, P8114, DOI 10.1021/ja00285a052; DAWSON JH, 1992, J INORG BIOCHEM, V45, P179, DOI 10.1016/0162-0134(92)80043-U; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; DAWSON JH, 1976, J AM CHEM SOC, V98, P3707, DOI 10.1021/ja00428a054; ECCLES TK, 1977, THESIS STANFORD U; EISENBERGER P, 1976, P NATL ACAD SCI USA, V73, P491, DOI 10.1073/pnas.73.2.491; EISENBERGER P, 1978, NATURE, V294, P30; HAHN JE, 1982, J BIOL CHEM, V257, P934; HEWSON DW, 1978, PORPHYRINS, V7, P295; HOLLENBERG PF, 1980, J BIOL CHEM, V255, P4801; KADHKODAYAN S, 1992, MECHANISTIC STUDIES; MORRIS DR, 1966, J BIOL CHEM, V241, P1763; MORRIS DR, 1966, J BIOL CHEM, V241, P7495; O'Keeffe D H, 1978, Methods Enzymol, V52, P151; Penner-Hahn J. E., 1989, IRON PORPHYRINS 3, P235; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; PERUTZ MF, 1982, NATURE, V295, P535, DOI 10.1038/295535a0; PICKARD MA, 1982, CAN J MICROBIOL, V27, P1298; PORTER TD, 1991, J BIOL CHEM, V266, P13469; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POWERS L, 1984, BIOCHEMISTRY-US, V23, P5519, DOI 10.1021/bi00318a021; RAAG R, 1992, FRONTIERS BIOTRANSFO, V7, P1; SCOTT RA, 1985, METHOD ENZYMOL, V117, P414; SHIRO Y, 1991, BIOCHIM BIOPHYS ACTA, V1115, P101, DOI 10.1016/0304-4165(91)90018-C; SHIRO Y, 1990, J AM CHEM SOC, V112, P2921, DOI 10.1021/ja00164a012; SONO M, 1982, J BIOL CHEM, V257, P8308; UNGER BP, 1986, BACTERIA, V10, P558; WANG S, 1989, PHYSICA B, V158, P119, DOI 10.1016/0921-4526(89)90222-6; WATANABE Y, 1992, ENZYMES, V20, P405; ZHANG K, 1991, PROTEINS, V10, P279, DOI 10.1002/prot.340100402	41	38	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10544	10550		10.1074/jbc.270.18.10544	http://dx.doi.org/10.1074/jbc.270.18.10544			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737989	hybrid			2022-12-27	WOS:A1995QW60100030
J	FERNANDEZ, CA; ROSIERS, CD				FERNANDEZ, CA; ROSIERS, CD			MODELING OF LIVER CITRIC-ACID CYCLE AND GLUCONEOGENESIS BASED ON C-13 MASS ISOTOPOMER DISTRIBUTION ANALYSIS OF INTERMEDIATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KREBS CYCLE; RAT-LIVER; QUANTITATIVE-ANALYSIS; METABOLISM; INVIVO; CARBON; <U-C-13>GLUCOSE; GLUCOSE; LACTATE; ATOMS	We have developed and implemented a model that can predict the positional isotopomer distribution of various hepatic metabolites labeled with [U-C-13(3)]lactate and/or [U-C-13(3)]pyruvate for given relative flux rates through the citric acid cycle and gluconeogenesis reactions, Our model includes (i) isotopic exchange between alpha-ketoglutarate and glutamate, (ii) a reversible isocitrate dehydrogenase reaction, (iii) an active ATP-citrate lyase, and (iv) aspartate and malate shuttles with separate cytosolic and mitochondrial pools for oxaloacetate, malate, and fumarate. A parameter estimation routine fit the mass isotopomer distribution of selected metabolites measured by gas chromatography-mass spectrometry to the model predicted distributions, We fit measured mass isotopomer distributions of phosphoenolpyruvate, citrate, alpha-ketoglutarate, glutamate, and pyruvate isolated fi om fasted rat livers perfused with [U-C-13(3)]lactate + [U-C-13(3)]pyruvate. This fitting yielded rates which we express relative to that of pyruvate carboxylase: citric acid cycle represented by the irreversible alpha-ketoglutarate dehydrogenase = 0.32; citrate synthase = 0.64; reversal of isocitrate dehydrogenase = 0.52; citrate lyase = 0.33, aspartate shuttle = 0.24, and malate shuttle = 0.44, Rates calculated for the cytosolic and mitochondrial fumarate and malate dehydrogenase reactions are subject to uncertainties as indicated by identifiability analyses. Previous forms of our model that did not include pyruvate kinase, exchange of cu ketoglutarate with glutamate, reversibility of isocitrate dehydrogenase, and/or ATP-citrate lyase activity were not as successful at predicting our measured values, This model offers a general tool for studying the regulation of the citric acid cycle and gluconeogenesis and can be readily modified for any C-13-labeled lactate or pyruvate substrate.	CASE WESTERN RESERVE UNIV, DEPT BIOMED ENGN, CLEVELAND, OH 44106 USA; UNIV MONTREAL, DEPT NUTR, MONTREAL, PQ H3C 3J7, CANADA	Case Western Reserve University; Universite de Montreal			Rosiers, Christine Des/O-6285-2014					BARANYAI JM, 1989, BIOCHEM J, V258, P121, DOI 10.1042/bj2580121; Bunch James R., 1979, LINPACK USERS GUIDE; COHEN SM, 1983, J BIOL CHEM, V258, P4294; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; DIDONATO L, 1993, J BIOL CHEM, V268, P4170; DUSZYNSKI J, 1978, J BIOL CHEM, V253, P6149; FERNANDEZ C, 1994, P INT FEDERATION AUT, P365; GOEBEL R, 1982, FED PROC, V41, P96; HEATH DF, 1985, BIOCHEM J, V227, P851, DOI 10.1042/bj2270851; HETENYI G, 1982, FED PROC, V41, P104; JUNGERMANN K, 1992, ENZYME, V46, P33, DOI 10.1159/000468777; KATZ J, 1993, J BIOL CHEM, V268, P25509; KATZ J, 1985, AM J PHYSIOL, V248, pR391, DOI 10.1152/ajpregu.1985.248.4.R391; KATZ J, 1989, J BIOL CHEM, V264, P12994; KELLEHER JK, 1985, AM J PHYSIOL, V248, pE252, DOI 10.1152/ajpendo.1985.248.2.E252; KELLEHER JK, 1986, AM J PHYSIOL, V250, pE296, DOI 10.1152/ajpendo.1986.250.3.E296; LANDAU BR, 1993, AM J PHYSIOL, V265, pE636, DOI 10.1152/ajpendo.1993.265.4.E636; LASDON LS, 1989, GRG 2 USERS GUIDE; Lee W. N. P., 1989, J BIOL CHEM, V264, P13002; LEE WNP, 1991, BIOCHEM MED METAB B, V45, P298, DOI 10.1016/0885-4505(91)90034-I; LEE WNP, 1993, J BIOL CHEM, V268, P25522; LEE WNP, 1991, STABLE ISOTOPES PEDI, P179; MAGNUSSON I, 1991, J BIOL CHEM, V266, P6975; MULLHOFER G, 1977, EUR J BIOCHEM, V75, P319, DOI 10.1111/j.1432-1033.1977.tb11532.x; ROGNSTAD R, 1993, BIOCHEM ARCH, V9, P15; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; ROSIERS CD, 1991, J BIOL CHEM, V266, P1574; Rothery P, 1993, MODELS BIOL MATH STA; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; SHULMAN GI, 1987, J CLIN INVEST, V80, P387, DOI 10.1172/JCI113084; SRERE PA, 1993, BIOL CHEM H-S, V374, P833; Stoer J., 2013, INTRO NUMERICAL ANAL, VVolume 12, DOI [10.1007/978-0-387-21738-3, DOI 10.1007/978-0-387-21738-3]; STRISOWER EH, 1952, J BIOL CHEM, V198, P115; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; VOGT JA, 1994, AM J PHYSIOL, V266, pE1012, DOI 10.1152/ajpendo.1994.266.6.E1012; ZUPKE C, 1994, P INT FEDERATION AUT, P394	36	44	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10037	10042		10.1074/jbc.270.17.10037	http://dx.doi.org/10.1074/jbc.270.17.10037			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730305	hybrid			2022-12-27	WOS:A1995QV41700050
J	FUJIHARA, S; ABE, H; YONEYAMA, T				FUJIHARA, S; ABE, H; YONEYAMA, T			A NEW POLYAMINE 4-AMINOBUTYLCADAVERINE - OCCURRENCE AND ITS BIOSYNTHESIS IN ROOT-NODULES OF ADZUKI BEAN PLANT VIGNA-ANGULARIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; EXTREME THERMOPHILE; DIAMINE OXIDASE; HOMOSPERMIDINE SYNTHASE; CHEMOTAXONOMIC MARKER; GAS-CHROMATOGRAPHY; PURIFICATION; BRADYRHIZOBIUM; RHIZOBIUM; SEEDLINGS	Root nodules of adzuki bean plant (Vigna angularis) contained a novel polyamine. The chemical structure of the new polyamine was determined to be NH2(CH2)(5)-NH(CH2)(4)NH2 (4-aminobutylcadaverine) based on gas chromatography-mass spectrometry. The occurrence of 4-aminobutylcadaverine was specific to the root nodules, since the unusual triamine was not detected in other organs of the adzuki bean plant. Bacteroids, isolated from root nodules, contained both sym-homospermidine and 4-aminobutylcadaverine, whereas the plant cytosol fraction contained large quantities of putrescine and cadaverine. A cell-free extract of bacteroids showed the ability to form this triamine from putrescine and cadaverine under the presence of NAD(+) and K+. 1,3-Diaminopropane and NADH were inhibitory for the synthesis of both sym-homospermidine and 4 aminobutylcadaverine. [1,4-N-15]Putrescine was incorporated not only into sym-homospermidine but also into 4-aminobutylcadaverine by the cell-free extract of bacteroids when incubated with excess cadaverine. Analysis of the frag ment ion peaks in the N-15-enriched 4-aminobutylcadaverine indicated the transfer of a aminobutyl moiety to the amino terminus of cadaverine. These results suggest that, in adzuki bean, 4-aminobutylcadaverine is formed through the action of homospermidine synthase in nodule bacteroids under a cadaverine-rich environment.	NATL AGR RES CTR,PLANT NUTR & DIAG LAB,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,INST APPL BIOCHEM,TSUKUBA,IBARAKI 305,JAPAN	National Agriculture & Food Research Organization - Japan; University of Tsukuba								ALHONENHONGISTO L, 1980, BIOCHEM BIOPH RES CO, V93, P1005, DOI 10.1016/0006-291X(80)90589-6; ANGELINI R, 1985, PHYTOCHEMISTRY, V24, P2511, DOI 10.1016/S0031-9422(00)80657-3; Bergersen FJ, 1974, BIOL NITROGEN FIXATI, P473; BOTTCHER F, 1993, PHYTOCHEMISTRY, V32, P679, DOI 10.1016/S0031-9422(00)95154-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSSE J, 1988, SYST APPL MICROBIOL, V11, P1; DELHAIZE E, 1987, PHYTOCHEMISTRY, V26, P641, DOI 10.1016/S0031-9422(00)84757-3; DEROSA M, 1976, BIOCHEM BIOPH RES CO, V69, P253, DOI 10.1016/S0006-291X(76)80300-2; FLORES HE, 1982, PLANT PHYSIOL, V69, P701, DOI 10.1104/pp.69.3.701; FLORIS G, 1983, PHYTOCHEMISTRY, V22, P1871, DOI 10.1016/0031-9422(83)80004-1; FUJIHARA S, 1982, BIOCHEM BIOPH RES CO, V107, P403, DOI 10.1016/0006-291X(82)91718-1; FUJIHARA S, 1994, PLANT CELL PHYSIOL, V35, P1127, DOI 10.1093/oxfordjournals.pcp.a078705; FUJIHARA S, 1986, J CHROMATOGR, V383, P271, DOI 10.1016/S0378-4347(00)83473-8; FUJIHARA S, 1989, BIOCHEM BIOPH RES CO, V165, P659, DOI 10.1016/S0006-291X(89)80016-6; FUJIHARA S, 1993, APPL ENVIRON MICROB, V59, P1104, DOI 10.1128/AEM.59.4.1104-1109.1993; HAMANA K, 1992, CRIT REV MICROBIOL, V18, P261, DOI 10.3109/10408419209113518; HAMANA K, 1990, FEMS MICROBIOL LETT, V71, P71, DOI 10.1111/j.1574-6968.1990.tb03800.x; HOLTTA E, 1983, BIOCHEM J, V210, P945; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; MATSUDA H, 1981, PLANT CELL PHYSIOL, V22, P737; NIITSU M, 1993, J CHROMATOGR, V641, P115, DOI 10.1016/0021-9673(93)83465-5; OKADA M, 1979, J BIOCHEM, V85, P1235; OSHIMA T, 1982, J BIOL CHEM, V257, P9913; OSHIMA T, 1975, BIOCHEM BIOPH RES CO, V63, P1093, DOI 10.1016/0006-291X(75)90681-6; OSHIMA T, 1979, J BIOL CHEM, V254, P8720; PAULUS TJ, 1982, J BACTERIOL, V152, P291; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Phillips G. C., 1991, BIOCH PHYSL POLYAMIN, P121; SABO DL, 1974, BIOCHEMISTRY-US, V13, P662, DOI 10.1021/bi00701a005; SANCHEZ F, 1991, ANNU REV PLANT PHYS, V42, P507, DOI 10.1146/annurev.pp.42.060191.002451; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; SMITH TA, 1985, BIOCHEM SOC T, V13, P319, DOI 10.1042/bst0130319; SMITH TA, 1985, ANNU REV PLANT PHYS, V36, P117, DOI 10.1146/annurev.pp.36.060185.001001; SRIVENUGOPAL KS, 1980, BIOCHEM J, V190, P461, DOI 10.1042/bj1900461; Suresh M. R., 1976, Phytochemistry, V15, P483, DOI 10.1016/S0031-9422(00)88952-9; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR CW, 1964, J BIOL CHEM, V239, P2194; Tait GH, 1979, BIOCHEM SOC T, V7, P199, DOI 10.1042/bst0070199; TAIT GH, 1985, BIOCHEM SOC T, V13, P316, DOI 10.1042/bst0130316; TAJIMA S, 1982, PLANT PHYSIOL, V70, P388, DOI 10.1104/pp.70.2.388; YAMAMOTO S, 1993, J BIOCHEM-TOKYO, V114, P45, DOI 10.1093/oxfordjournals.jbchem.a124137	41	27	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9932	9938		10.1074/jbc.270.17.9932	http://dx.doi.org/10.1074/jbc.270.17.9932			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730376	hybrid			2022-12-27	WOS:A1995QV41700037
J	YIN, WS; SMILEY, E; GERMILLER, J; MECHAM, RP; FLORER, JB; WENSTRUP, RJ; BONADIO, J				YIN, WS; SMILEY, E; GERMILLER, J; MECHAM, RP; FLORER, JB; WENSTRUP, RJ; BONADIO, J			ISOLATION OF A NOVEL LATENT TRANSFORMING GROWTH-FACTOR-BETA BINDING-PROTEIN GENE (LTBP-3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT COMPLEX; SMOOTH-MUSCLE CELLS; EGF-LIKE DOMAIN; HUMAN FACTOR-IX; TGF-BETA; EXTRACELLULAR-MATRIX; PROCESSING ENDOPROTEASES; OSTEOBLAST PHENOTYPE; EXPRESSION PATTERN; ENDOTHELIAL-CELLS	This paper reports the molecular cloning of a novel gene in the mouse that shows structural similarities to the microfibril protein fibrillin and to the latent trans forming growth factor-beta (TGF-beta) binding protein (LTBP), a component of the latent TGF-beta complex. The gene was initially isolated during a low stringency polymerase chain reaction screen of a NIH 3T3 cell cDNA library using primers that amplify a human fibrillin-1 epidermal growth factor-like repeat, Three lines of evidence suggest that the mouse gene is a third member of the LTBP gene family, which we designate LTBP-3. First, the deduced polypeptide, which consists of 15 epidermal growth factor-like repeats, 3 TGF binding protein repeats, and 2 proline- and glycine-rich sequences, shows 38.4% identity with LTBP-1 but only 27% identity with fibrillin-1. Second, the gene appears to be co-expressed in developing mouse tissues with TGF-beta. Third, immunoprecipitation studies using mouse preosteoblast MC3T3-E1 cells and a specific anti-peptide polyclonal antiserum reveal that the mouse polypeptide forms a complex with the TGF-beta 1 precursor. Finally, we note that the LTBP-3 gene was recently localized to a distinct genetic locus (Li, X., Yin, W., Perez-Jurado, L., Bonadio, J., and Francke, U. (1995) Mamm. Genome 6, 42-45). Identification of a third binding protein provides further insight into a mechanism by which latent TGF-beta complexes can be targeted to connective tissue matrices and cells.	UNIV MICHIGAN,DEPT PATHOL,ANN ARBOR,MI 48109; WASHINGTON UNIV,SCH MED,DEPT CELL BIOL & PHYSIOL,ST LOUIS,MO 63110; CHILDRENS HOSP RES FDN,DEPT PEDIAT,DIV HUMAN GENET,CINCINNATI,OH 45229	University of Michigan System; University of Michigan; Washington University (WUSTL); Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation					NHLBI NIH HHS [HL-41926] Funding Source: Medline; NIAMS NIH HHS [AR-40586] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040586] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMARNANI S, 1993, J BONE MINER RES, V8, P157; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BENEZRA M, 1993, BLOOD, V81, P3324; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BONEWALD LF, 1991, MOL ENDOCRINOL, V5, P741, DOI 10.1210/mend-5-6-741; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; CHEN YP, 1993, J BIOL CHEM, V268, P27381; COLOSETTI P, 1993, FEBS LETT, V320, P140, DOI 10.1016/0014-5793(93)80079-A; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DALLAS SL, 1994, J BIOL CHEM, V269, P6815; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; FALCONE DJ, 1993, J BIOL CHEM, V268, P11951; FLAUMENHAFT R, 1993, J CELL BIOL, V120, P995, DOI 10.1083/jcb.120.4.995; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9; GRONKE RS, 1989, P NATL ACAD SCI USA, V86, P3609, DOI 10.1073/pnas.86.10.3609; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LEHNERT SA, 1988, DEVELOPMENT, V104, P263; LI X, 1995, MAMM GENOME, V6, P42, DOI 10.1007/BF00350892; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MIYAZONO K, 1989, NATURE, V338, P158, DOI 10.1038/338158a0; MIYAZONO K, 1992, J BIOL CHEM, V267, P5668; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; MIYAZONO K, 1993, GASTROENTEROL JPN, V28, P81; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; MOREN A, 1994, J BIOL CHEM, V269, P32469; OGAWA Y, 1992, J BIOL CHEM, V267, P2325; OLOFSSON A, 1992, J BIOL CHEM, V267, P19482; PELTON RW, 1989, DEVELOPMENT, V106, P759; PELTON RW, 1990, DEVELOPMENT, V110, P609; PELTON RW, 1990, DEV BIOL, V141, P456, DOI 10.1016/0012-1606(90)90401-4; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PIRCHER R, 1986, BIOCHEM BIOPH RES CO, V136, P30, DOI 10.1016/0006-291X(86)90872-7; PIRCHER R, 1984, CANCER RES, V44, P5538; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; Sambrook J, 1989, MOL CLONING LABORATO; SATO Y, 1993, J CELL BIOL, V123, P1249, DOI 10.1083/jcb.123.5.1249; SELANDERSUNNERH.M, 1992, J BIOL CHEM, V0267; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; SEYEDIN SM, 1987, J BIOL CHEM, V262, P1946; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STENFLO J, 1987, P NATL ACAD SCI USA, V84, P368, DOI 10.1073/pnas.84.2.368; STENMAN G, 1994, CYTOGENET CELL GENET, V66, P117, DOI 10.1159/000133680; STREULI CH, 1993, J CELL BIOL, V120, P253, DOI 10.1083/jcb.120.1.253; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; TAKETAZU F, 1994, LAB INVEST, V70, P620; TSUJI T, 1990, P NATL ACAD SCI USA, V87, P8835, DOI 10.1073/pnas.87.22.8835; TWARDZIK DR, 1990, ANN NY ACAD SCI, V593, P276, DOI 10.1111/j.1749-6632.1990.tb16119.x; VANVLASSELAER P, 1994, J CELL BIOL, V124, P569, DOI 10.1083/jcb.124.4.569; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; YIN WS, 1995, J BIOL CHEM, V270, P1798, DOI 10.1074/jbc.270.4.1798; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	62	124	129	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10147	10160		10.1074/jbc.270.17.10147	http://dx.doi.org/10.1074/jbc.270.17.10147			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730318	hybrid			2022-12-27	WOS:A1995QV41700065
J	SUZUKI, H; WATANABE, M; FUJINO, T; YAMAMOTO, T				SUZUKI, H; WATANABE, M; FUJINO, T; YAMAMOTO, T			MULTIPLE PROMOTERS IN RAT ACYL-COA SYNTHETASE GENE MEDIATE DIFFERENTIAL EXPRESSION OF MULTIPLE TRANSCRIPTS WITH 5'-END HETEROGENEITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; CANDIDA-LIPOLYTICA; SACCHAROMYCES-CEREVISIAE; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; MAMMALIAN-CELLS; MESSENGER-RNA; CLONING; DNA; LIVER	Nucleotide sequence analysis of six independently isolated cDNAs for rat acyl-CoA synthetase (ACS) revealed three forms of ACS mRNA, designated form-A, -B, and -C mRNAs, which differ in their 5'-untranslated regions. Form-A mRNA was preferentially detected in normal and peroxisome-induced livers, whereas form-B mRNA was found in peroxisome-induced livers but not in normal livers and hearts, and form-C mRNA was preferentially found in normal hearts and peroxisome-induced livers. Analysis of two overlapping genomic clones for the rat ACS gene revealed that the three 5'-untranslated regions of the mRNAs are individually encoded by three different exons located within a 20-kilobase genomic fragment. The transcription start sites of the three forms of ACS mRNA were determined and nucleotide sequences of 5'-upstream regions of the three 5'-end exons were determined. The 5'-upstream regions were fused to the chloramphenicol acetyltransferase gene and transcription units of the three forms of ACS mRNAs were determined. These data indicate that the three forms of ACS mRNA with 5'-end heterogeneity are generated by alternative transcription from three promoters in the rat ACS gene.	TOHOKU UNIV,CTR GENE RES,AOBA KU,SENDAI,MIYAGI 981,JAPAN	Tohoku University								ABE T, 1992, J BIOCHEM-TOKYO, V111, P123, DOI 10.1093/oxfordjournals.jbchem.a123707; BLACK PN, 1992, J BIOL CHEM, V267, P25513; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CONNERTON IF, 1990, MOL MICROBIOL, V4, P451, DOI 10.1111/j.1365-2958.1990.tb00611.x; DEVIRGILIO C, 1992, YEAST, V8, P1043, DOI 10.1002/yea.320081207; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; DURONIO RJ, 1992, J CELL BIOL, V117, P515, DOI 10.1083/jcb.117.3.515; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FUJINO T, 1992, J BIOCHEM-TOKYO, V111, P197, DOI 10.1093/oxfordjournals.jbchem.a123737; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENE JJ, 1988, CURRENT PROTOCOLS MO; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HIJIKATA M, 1990, J BIOL CHEM, V265, P4600; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; ISHII N, 1987, J BIOL CHEM, V262, P8144; KAMIRYO T, 1979, P NATL ACAD SCI USA, V76, P4390, DOI 10.1073/pnas.76.9.4390; KAMIRYO T, 1977, P NATL ACAD SCI USA, V74, P4947, DOI 10.1073/pnas.74.11.4947; LEE F, 1984, NUCLEIC ACIDS RES, V12, P4191, DOI 10.1093/nar/12.10.4191; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LOZOYA E, 1988, EUR J BIOCHEM, V176, P661, DOI 10.1111/j.1432-1033.1988.tb14328.x; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MACONOCHIE MK, 1992, MOL GEN GENET, V234, P211, DOI 10.1007/BF00283841; MARTINEZBLANCO H, 1993, GENE, V130, P265, DOI 10.1016/0378-1119(93)90429-7; MASUDA T, 1989, GENE, V77, P265; MISHINA M, 1978, EUR J BIOCHEM, V89, P321, DOI 10.1111/j.1432-1033.1978.tb12533.x; MISHINA M, 1978, EUR J BIOCHEM, V82, P347, DOI 10.1111/j.1432-1033.1978.tb12029.x; MIYAZAWA S, 1985, J BIOCHEM, V98, P723, DOI 10.1093/oxfordjournals.jbchem.a135330; OSUMI T, 1987, J BIOL CHEM, V262, P8138; PHILLIPS M, 1986, J BIOL CHEM, V261, P821; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOONJANS K, 1993, EUR J BIOCHEM, V216, P615, DOI 10.1111/j.1432-1033.1993.tb18181.x; SHIMOMURA I, 1992, BIOCHIM BIOPHYS ACTA, V1124, P112, DOI 10.1016/0005-2760(92)90086-B; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; TANAKA T, 1979, EUR J BIOCHEM, V98, P165, DOI 10.1111/j.1432-1033.1979.tb13173.x; TOMODA H, 1991, J BIOL CHEM, V266, P4214; WEINER FR, 1991, J BIOL CHEM, V266, P23525; WOOD KV, 1989, SCIENCE, V244, P700, DOI 10.1126/science.2655091	41	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9676	9682		10.1074/jbc.270.16.9676	http://dx.doi.org/10.1074/jbc.270.16.9676			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721900	hybrid			2022-12-27	WOS:A1995QU08900091
J	HUGHES, PE; OTOOLE, TE; YLANNE, J; SHATTIL, SJ; GINSBERG, MH				HUGHES, PE; OTOOLE, TE; YLANNE, J; SHATTIL, SJ; GINSBERG, MH			THE CONSERVED MEMBRANE-PROXIMAL REGION OF AN INTEGRIN CYTOPLASMIC DOMAIN SPECIFIES LIGAND-BINDING AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; PLATELET GPIIB-IIIA; BETA-SUBUNIT; MONOCLONAL-ANTIBODIES; FIBRINOGEN BINDING; SURFACE EXPRESSION; RECEPTOR FUNCTION; LAMININ RECEPTOR; ALPHA-ACTININ; ADHESION	Integrin affinities for ligands can change markedly via a process termed inside-out signaling. We expressed several truncations of the beta(3) cytoplasmic domain in conjunction with an ''activating'' alpha subunit chimera, alpha(IIb)alpha(6B). Deletion of the 4 C-terminal residues of the beta(3) tail blocked inside-out signaling as assessed by the binding of an activation specific antibody, PAC1. Several additional truncations remained in the low affinity state, but complete truncation (beta(3) Delta 717) caused PAC1 binding, Activation by this truncation mutant did not depend on the cr subunit cytoplasmic domain and was resistant to inhibitors of cellular metabolism and the over-expression of an isolated beta(3) cytoplasmic domain. Since deletion of beta 3(Leu(717)-Asp(723)) results in a constitutively activated integrin, this membrane-proximal seven amino acids of the beta(3) cytoplasmic domain is required to maintain alpha(IIb)beta(3) in a default low affinity state. The amino acid sequence of this region is conserved among integrins. Moreover, the conserved membrane-proximal sequence in alpha subunit tails seems to serve a similar function. Consequently, the conserved membrane-proximal regions of both integrin cytoplasmic domains control the ligand binding affinity of the extracellular domain.	SCRIPPS RES INST, DEPT VASC BIOL, LA JOLLA, CA 92037 USA; UNIV HELSINKI, DEPT BIOCHEM, SF-00170 HELSINKI, FINLAND; UNIV PENN, SCH MED, DEPT CELL & DEV BIOL, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT MED, PHILADELPHIA, PA 19104 USA	Scripps Research Institute; Finland National Institute for Health & Welfare; University of Helsinki; University of Pennsylvania; University of Pennsylvania			O'Toole, Timothy/I-4172-2013	Ylanne, Jari/0000-0003-4627-021X	NHLBI NIH HHS [HL48728, HL 40387] Funding Source: Medline; NIAMS NIH HHS [AR 27214] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P01HL048728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214, R37AR027214] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALIG L, 1992, J MED CHEM, V35, P4393, DOI 10.1021/jm00101a017; ALTIERI DC, 1988, J BIOL CHEM, V263, P7007; BAJT ML, 1994, J BIOL CHEM, V269, P20913; BENNETT JS, 1993, J BIOL CHEM, V268, P3580; BENNETT JS, 1983, P NATL ACAD SCI-BIOL, V80, P2417, DOI 10.1073/pnas.80.9.2417; BENNETT JS, 1988, J BIOL CHEM, V263, P12948; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; BUCK CA, 1986, J CELL BIOL, V103, P2421, DOI 10.1083/jcb.103.6.2421; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; CHEN YP, 1994, J BIOL CHEM, V269, P18307; CROWE DT, 1994, J BIOL CHEM, V269, P14411; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; DELWEL GO, 1993, J BIOL CHEM, V268, P25865; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DU XP, 1993, J BIOL CHEM, V268, P23087; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; FILARDO EJ, 1994, J BIOL CHEM, V269, P4641; FRACHET P, 1992, BIOCHEMISTRY-US, V31, P2408, DOI 10.1021/bi00123a028; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GINSBERG MH, 1992, COLD SPRING HARB SYM, V57, P221, DOI 10.1101/SQB.1992.057.01.027; GINSBERG MH, 1990, BLOOD, V76, P2017; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; Hemler M.E, 1994, INTEGRINS BIOL PROBL, P1; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; HOGERVORST F, 1993, J BIOL CHEM, V268, P18427; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JULIANO R, 1994, CANCER METAST REV, V13, P25, DOI 10.1007/BF00690416; KADOWAKI H, 1989, GENE, V76, P161, DOI 10.1016/0378-1119(89)90018-8; KASSNER PD, 1994, J BIOL CHEM, V269, P19859; KAWAGUCHI S, 1994, MOL BIOL CELL, V5, P977, DOI 10.1091/mbc.5.9.977; KAWAGUCHI S, 1993, J BIOL CHEM, V268, P16279; KISHIMOTO TK, 1987, CELL, V50, P193, DOI 10.1016/0092-8674(87)90215-7; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; MUIR TW, 1994, BIOCHEMISTRY-US, V33, P7701, DOI 10.1021/bi00190a025; NELSON C, 1992, J BIOL CHEM, V267, P3351; NEMOTO Y, 1992, J BIOL CHEM, V267, P20916; Otey C. A., 1994, Molecular Biology of the Cell, V5, p66A; OTEY CA, 1993, J BIOL CHEM, V268, P21193; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1989, BLOOD, V74, P14; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PEERSCHKE EI, 1980, BLOOD, V55, P841; RABB H, 1993, J IMMUNOL, V151, P990; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; SCHWARTZ M A, 1992, Trends in Cell Biology, V2, P304, DOI 10.1016/0962-8924(92)90120-C; Shattil SJ, 1991, CURR OPIN CELL BIOL, V3, P869, DOI 10.1016/0955-0674(91)90062-4; SHATTIL SJ, 1992, J BIOL CHEM, V267, P18424; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHAW LM, 1993, J CELL BIOL, V123, P1017, DOI 10.1083/jcb.123.4.1017; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; TAUB R, 1989, J BIOL CHEM, V264, P259; WILCOX DA, 1994, J BIOL CHEM, V269, P4450; Williams Michael J., 1994, Trends in Cell Biology, V4, P109, DOI 10.1016/0962-8924(94)90059-0; WIPPLER J, 1994, J BIOL CHEM, V269, P8754; WOODS VL, 1984, BLOOD, V63, P368	62	166	173	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12411	12417		10.1074/jbc.270.21.12411	http://dx.doi.org/10.1074/jbc.270.21.12411			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759482	hybrid			2022-12-27	WOS:A1995QZ71100015
J	IWAMI, G; KAWABE, J; EBINA, T; CANNON, PJ; HOMCY, CJ; ISHIKAWA, Y				IWAMI, G; KAWABE, J; EBINA, T; CANNON, PJ; HOMCY, CJ; ISHIKAWA, Y			REGULATION OF ADENYLYL-CYCLASE BY PROTEIN-KINASE-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; HETEROLOGOUS DESENSITIZATION; PHOSPHORYLATION SITES; PHOSPHOLIPASE-C; IDENTIFICATION; ATTENUATION; CELLS	The changing relationship between stimuli and responses after prolonged receptor stimulation is a general feature of hormonal signaling systems, termed desensitization. This phenomenon has been best exemplified in the covalent modification of the G protein-linked catecholamine receptors. However, other components within this signaling pathway can be involved in desensitization. Here we present evidence that desensitization occurs at the level of the effector enzyme itself through phosphorylation. Type V adenylyl cyclase (AC) is the major isoform expressed in the heart. Using purified enzymes, we demonstrate that protein kinase A (PKA) directly phosphorylates and thereby inhibits type V AC catalytic activity, This inhibition was negated in the presence of PKA inhibitor. Analysis of enzyme kinetics revealed that this inhibition was due to a decrease in the catalytic rate, not to a decrease in the affinity for the substrate ATP. Our results indicate that AC catalytic activity can be regulated through PKA-mediated phosphorylation, suggesting another mechanism of desensitization for receptor pathways which signal via increases in intracellular cAMP.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PHARMACOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,PEARL RIVER,NY 10965	Columbia University; Columbia University					NHLBI NIH HHS [HL-21006, HL-38070] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038070, P50HL021006] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BREDT DS, 1992, J BIOL CHEM, V267, P10976; CHEN Y, 1994, J BIOL CHEM, V269, P7839; CLARK RB, 1989, MOL PHARMACOL, V36, P343; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HOMCY CJ, 1991, ANNU REV PHYSIOL, V53, P137, DOI 10.1146/annurev.physiol.53.1.137; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; IYENGAR R, 1993, FASEB J, V7, P768, DOI 10.1096/fasebj.7.9.8330684; KASSIS S, 1982, J BIOL CHEM, V257, P5312; KAWABE J, 1994, J BIOL CHEM, V269, P16554; KIRCHICK HJ, 1983, ENDOCRINOLOGY, V113, P1638, DOI 10.1210/endo-113-5-1638; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; LIGGETT SB, 1989, MOL PHARMACOL, V36, P641; OZAWA K, 1993, J BIOL CHEM, V268, P2280; PREMONT RT, 1992, ENDOCRINOLOGY, V131, P2774, DOI 10.1210/en.131.6.2774; PREMONT RT, 1989, ENDOCRINOLOGY, V125, P1151, DOI 10.1210/endo-125-3-1151; RYU SH, 1990, J BIOL CHEM, V265, P17941; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SIBLEY DR, 1984, J BIOL CHEM, V259, P9742; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TOBISE K, 1994, CIRC RES, V74, P596, DOI 10.1161/01.RES.74.4.596; WANG WH, 1991, P NATL ACAD SCI USA, V88, P9722, DOI 10.1073/pnas.88.21.9722; WEST MHP, 1984, ELECTROPHORESIS, V5, P133, DOI 10.1002/elps.1150050302	24	175	178	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12481	12484		10.1074/jbc.270.21.12481	http://dx.doi.org/10.1074/jbc.270.21.12481			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759492	hybrid			2022-12-27	WOS:A1995QZ71100025
J	ZHANG, L; ESKO, JD				ZHANG, L; ESKO, JD			ACCUMULATION OF A PENTASACCHARIDE TERMINATING IN ALPHA-N-ACETYLGLUCOSALMINE IN AN ANIMAL-CELL MUTANT DEFECTIVE IN HEPARAN-SULFATE BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-LINKAGE REGION; SWARM RAT CHONDROSARCOMA; CHONDROITIN SULFATE; FLAVOBACTERIUM-HEPARINUM; GALACTOSYLTRANSFERASE-I; CARTILAGE PROTEOGLYCAN; STRUCTURAL-ANALYSIS; LYSOSOMAL-ENZYMES; DERMATAN SULFATE; OLIGOSACCHARIDES	Heparan sulfate biosynthesis initiates by the transfer of alpha-D-GlcNAc from UDP-GlcNAc to the D-GlcA moiety of the linkage tetrasaccharide, GlcA beta 1-3Gal beta 1-3Gal beta 1-4Xyl beta 1-core protein. The enzyme catalyzing this reaction differs from the alpha-GlcNAc transferase involved in chain polymerization based on genetic and enzymatic studies of an animal cell mutant defective in chain polymerization (Fritz, T. A., Gabb, M. M., Wei, G., and Esko, J. D. (1994) J. Biol. Chem. 269, 28809-28814), In this report we show that this mutant also accumulates a pentasaccharide intermediate containing alpha-GlcNAc, A fusion protein was made from the IgG-binding domain of protein A and a segment of the proteoglycan, betaglycan. This segment contained one glycosaminoglycan attachment site that primes only chondroitin sulfate and another that primes both heparan sulfate and chondroitin sulfate (Zhang, L., and Esko, J. D. (1994) J. Biol. Chem. 264, 19295-19299). Expression of the chimera in the mutant resulted in the accumulation of an oligosaccharide that labeled with [6-H-3]GlcN. The oligosaccharide comigrated with a pentasaccharide standard derived from chondroitin sulfate, but acid hydrolysis gave 98% [H-3]GlcN, Heparin lyase III digestion yielded [H-3]GlcNAc, suggesting that the GlcNAc residue was alpha-linked to the nonreducing terminus, Enzymatic treatment of [6-H-3]Gal-labeled material yielded the tetrasaccharide, Delta GlcA-[H-3]Gal-[H-3]Gal-xylitol. These findings suggest that pentasaccharide had the structure, GlcNAc alpha 1-4GlcA beta 1-3Gal beta 1-3Gal beta 1-4Xyl. Its accumulation in a Chinese hamster ovary cell mutant defective in the polymerizing alpha-GlcNAc transferase provides in vivo evidence that two alpha-GlcNAc transferases catalyze the formation of heparan sulfate.	UNIV ALABAMA,SCH MED,DEPT BIOCHEM & MOLEC GENET,BIRMINGHAM,AL 35294; UNIV ALABAMA,SCH DENT,DEPT BIOCHEM & MOLEC GENET,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham								DEWAARD P, 1992, J BIOL CHEM, V267, P6036; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 1991, CURR OPIN CELL BIOL, V3, P805, DOI 10.1016/0955-0674(91)90054-3; FRANSSON LA, 1990, BIOCHEM J, V269, P381, DOI 10.1042/bj2690381; FRANSSON LA, 1985, J BIOL CHEM, V260, P4722; FREEZE HH, 1993, J BIOL CHEM, V268, P1618; FRITZ TA, 1994, J BIOL CHEM, V269, P28809; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; HASCALL VC, 1972, J BIOL CHEM, V247, P4521; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; KINGSLEY DM, 1986, CELL, V67, P785; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LUDWIGS U, 1987, BIOCHEM J, V245, P795, DOI 10.1042/bj2450795; MANZI A, 1995, J BIOL CHEM, V270, P9154, DOI 10.1074/jbc.270.16.9154; NADER HB, 1990, J BIOL CHEM, V265, P16807; NILSSON B, 1985, EMBO J, V4, P1075, DOI 10.1002/j.1460-2075.1985.tb03741.x; OEGEMA TR, 1984, J BIOL CHEM, V259, P1720; OIKE Y, 1980, BIOCHEM J, V191, P193, DOI 10.1042/bj1910193; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; REITMAN ML, 1981, J BIOL CHEM, V256, P4275; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; ROHRMANN K, 1985, EUR J BIOCHEM, V148, P463, DOI 10.1111/j.1432-1033.1985.tb08862.x; SALIMATH PV, 1995, J BIOL CHEM, V270, P9164, DOI 10.1074/jbc.270.16.9164; SHIBATA S, 1992, J BIOL CHEM, V267, P6548; SPIRO RC, 1991, J CELL BIOL, V115, P1463, DOI 10.1083/jcb.115.5.1463; SU K, 1993, J BIOL CHEM, V268, P14301; SUGAHARA K, 1992, EUR J BIOCHEM, V204, P401, DOI 10.1111/j.1432-1033.1992.tb16649.x; SUGAHARA K, 1988, J BIOL CHEM, V263, P10168; SUGAHARA K, 1992, J BIOL CHEM, V267, P1528; TAKAGAKI K, 1991, J BIOCHEM-TOKYO, V109, P514, DOI 10.1093/oxfordjournals.jbchem.a123413; VARKI A, 1980, J BIOL CHEM, V255, P8398; VERTEL BM, 1994, BIOCHEM J, V301, P211, DOI 10.1042/bj3010211; VILLERS C, 1994, BIOCHEM J, V298, P135, DOI 10.1042/bj2980135; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295	39	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12557	12562		10.1074/jbc.270.21.12557	http://dx.doi.org/10.1074/jbc.270.21.12557			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759502	hybrid			2022-12-27	WOS:A1995QZ71100037
J	EPSTEIN, JA; LAM, P; JEPEAL, L; MAAS, RL; SHAPIRO, DN				EPSTEIN, JA; LAM, P; JEPEAL, L; MAAS, RL; SHAPIRO, DN			PAX3 INHIBITS MYOGENIC DIFFERENTIATION OF CULTURED MYOBLAST CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TUMOR ALVEOLAR RHABDOMYOSARCOMA; PAIRED BOX GENE; WAARDENBURG SYNDROME; DOMAIN GENE; DNA; MUTATION; PROTEIN; HOMEODOMAIN; FIBROBLASTS; RECOGNITION	Pax3 is an evolutionarily conserved transcription factor expressed in the lateral dermomyotome, a region that gives rise to limb muscle progenitors. Mutations in Pax-3 account for the mouse mutant Splotch which develops without limb musculature. We demonstrate that Pax3 can inhibit myogenic differentiation of C2C12 myoblasts normally induced by exposure to low serum. Specific missense mutations that affect the DNA binding characteristics of the two distinct DNA binding domains of Pax3 abolish this effect. Furthermore, we show that Pax3 can inhibit myogenic differentiation of 10T1/2 fibroblasts transfected with MyoD, but not of 10T1/2 cells transfected with myogenin. This anti-myogenic property is shared by a PAX3-forkhead fusion protein resulting from a t(2;13) chromosomal translocation found in pediatric alveolar rhabdomyosarcomas. These results suggest that Pax3 may suppress the terminal differentiation of migrating limb myoblasts and that the PAX3-forkhead fusion may contribute to the phenotype of alveolar rhabdomyosarcoma by preventing terminal differentiation.	BRIGHAM & WOMENS HOSP, DEPT GENET, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; ST JUDE CHILDRENS RES HOSP, DEPT EXPTL ONCOL, MEMPHIS, TN 38101 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; St Jude Children's Research Hospital	EPSTEIN, JA (corresponding author), BRIGHAM & WOMENS HOSP, HOWARD HUGHES MED INST, DIV CARDIOL, THORN 910, 20 SHATTUCK ST, BOSTON, MA 02115 USA.			Epstein, Jonathan/0000-0001-8637-4465	NCI NIH HHS [CA-23099, CA-21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA023099] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BOBER E, 1994, DEVELOPMENT, V120, P603; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P3685, DOI 10.1073/pnas.91.9.3685; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; FRANZ T, 1993, ANAT EMBRYOL, V187, P371; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; GOULDING M, 1994, DEVELOPMENT, V120, P957; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOTH CF, 1993, AM J HUM GENET, V52, P455; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; KRIEG PA, 1987, METHOD ENZYMOL, V155, P313; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; SHAFER BW, 1994, NUCLEIC ACIDS RES, V22, P4574; SHAPIRO DN, 1993, CANCER RES, V53, P5108; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; TREISMAN J, 1989, CELL, V59, P553; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9	39	177	181	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11719	11722		10.1074/jbc.270.20.11719	http://dx.doi.org/10.1074/jbc.270.20.11719			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744814	hybrid			2022-12-27	WOS:A1995QY73600005
J	LEE, SF; COTE, GP				LEE, SF; COTE, GP			PURIFICATION AND CHARACTERIZATION OF A DICTYOSTELIUM PROTEIN-KINASE REQUIRED FOR ACTIN ACTIVATION OF THE MG2+ ATPASE ACTIVITY OF DICTYOSTELIUM MYOSIN ID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN KINASE; ACANTHAMOEBA MYOSIN; SENSITIVE METHOD; CASTELLANII; ISOFORM; BINDING; LOCALIZATION; DISCOIDEUM; AUTOPHOSPHORYLATION; PHOSPHORYLATION	We have isolated a protein from Dictyostelium with a molecular mass of 110 kDa as judged by SDS-gel electrophoresis that can stimulate the actin-activated MgATPase activity of Dictyostelium myosin ID (MyoD). In the presence of MgATP the 110-kDa protein incorporated phosphate into itself and into the heavy chain, but not the light chain, of MyoD. Phosphorylation to 0.5 mol of P-i/mol increased the MyoD actin-activated MgATPase rate from 0.2 to 3 mu mol/min/mg. Renaturation following SDS-gel electrophoresis demonstrated that the 110-kDa protein contained intrinsic protein kinase and autophosphorylation activity. Autophosphorylation to 1 mol of P-i/mol enhanced the rate at which the 110-kDa protein kinase phosphorylated MyoD by 40-fold. The rate of autophosphorylation was strongly dependent on the 110-kDa protein kinase concentration, indicating an intermolecular reaction. Synthetic peptides of 9-11 residues corresponding to the heavy chain phosphorylation site of Acanthamoeba myosin IC and the homologous sites in Dictyostelium myosin IB (MyoB) and MyoD were poor substrates for the 110-kDa protein kinase. The 110-kDa protein kinase was unable to phosphorylate the MyoB isozyme suggesting that it may be specific for MyoD.	QUEENS UNIV, DEPT BIOCHEM, KINGSTON, ON K7L 3N6, CANADA	Queens University - Canada								ALBANESI JP, 1985, J BIOL CHEM, V260, P8649; ALBANESI JP, 1985, J BIOL CHEM, V260, P1174; BEMENT WM, 1993, NATURE, V365, P785, DOI 10.1038/365785a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRZESKA H, 1989, J BIOL CHEM, V264, P19340; BRZESKA H, 1990, J BIOL CHEM, V265, P16138; BRZESKA H, 1990, J BIOL CHEM, V265, P3591; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; COTE GP, 1985, J BIOL CHEM, V260, P4543; COTE GP, 1987, J BIOL CHEM, V262, P1065; COUDRIER E, 1992, FEBS LETT, V307, P87, DOI 10.1016/0014-5793(92)80907-X; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; DOBERSTEIN SK, 1993, NATURE, V365, P841, DOI 10.1038/365841a0; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; FATH KR, 1994, CURR OPIN CELL BIOL, V6, P131, DOI 10.1016/0955-0674(94)90126-0; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; Hammer J A, 1991, Trends Cell Biol, V1, P50, DOI 10.1016/0962-8924(91)90089-R; HAMMER JA, 1994, J MUSCLE RES CELL M, V15, P1, DOI 10.1007/BF00123827; HAMMER JA, 1983, J BIOL CHEM, V258, P168; JUNG G, 1990, J CELL BIOL, V110, P1955, DOI 10.1083/jcb.110.6.1955; JUNG G, 1989, P NATL ACAD SCI USA, V86, P6186, DOI 10.1073/pnas.86.16.6186; JUNG G, 1994, FEBS LETT, V342, P197, DOI 10.1016/0014-5793(94)80500-8; JUNG G, 1993, J BIOL CHEM, V268, P14981; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KING MM, 1983, J BIOL CHEM, V258, P9925; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SF, 1993, J BIOL CHEM, V268, P20923; LYNCH TJ, 1989, J BIOL CHEM, V264, P19333; MARUTA H, 1977, J BIOL CHEM, V252, P8329; MEDLEY QG, 1991, METHOD ENZYMOL, V196, P23; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; ROSENFELD SS, 1994, BIOCHEMISTRY-US, V33, P2322, DOI 10.1021/bi00174a045; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TITUS MA, 1989, CELL REGUL, V1, P55, DOI 10.1091/mbc.1.1.55; TITUS MA, 1994, P NATL ACAD SCI USA, V91, P9446, DOI 10.1073/pnas.91.20.9446; TITUS MA, 1993, MOL BIOL CELL, V4, P233, DOI 10.1091/mbc.4.2.233; Titus MA, 1993, CURR OPIN CELL BIOL, V5, P77, DOI 10.1016/S0955-0674(05)80011-0; TODHUNTER JA, 1977, BIOCHIM BIOPHYS ACTA, V485, P87, DOI 10.1016/0005-2744(77)90195-4; URRUTIA RA, 1993, BIOCHIM BIOPHYS ACTA, V1173, P225, DOI 10.1016/0167-4781(93)90185-G; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; ZOT HG, 1992, J CELL BIOL, V116, P367, DOI 10.1083/jcb.116.2.367	45	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11776	11782		10.1074/jbc.270.20.11776	http://dx.doi.org/10.1074/jbc.270.20.11776			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744826	hybrid			2022-12-27	WOS:A1995QY73600019
J	EVANS, RJ; BRAY, J; CHILDS, JD; VIGERS, GPA; BRANDHUBER, BJ; SKALICKY, JJ; THOMPSON, RC; EISENBERG, SP				EVANS, RJ; BRAY, J; CHILDS, JD; VIGERS, GPA; BRANDHUBER, BJ; SKALICKY, JJ; THOMPSON, RC; EISENBERG, SP			MAPPING RECEPTOR-BINDING SITES IN INTERLEUKIN (IL)-1 RECEPTOR ANTAGONIST AND IL-1-BETA BY SITE-DIRECTED MUTAGENESIS - IDENTIFICATION OF A SINGLE-SITE IN IL-1RA AND 2 SITES IN IL-1-BETA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN IL-1-ALPHA; REFINEMENT; EXPRESSION; RESOLUTION; INHIBITOR; PROTEIN; 1-ALPHA	Interleukin-l receptor antagonist (IL-1ra), an IL-1 family member, binds with high affinity to the type I IL-1 receptor (IL-1RI), blocking IL-1 binding but not inducing an IL-l-like response. Extensive site-directed mutagenesis has been used to identify residues in IL-1ra and IL-1 beta involved in binding to IL-1RI. These analyses have revealed the presence of two discrete receptor binding sites on IL-1 beta. Only one of these sites is present on IL-1ra, consisting of residues Trp-16, Gln-20, Tyr-34, Gln-36, and Tyr-147. Interestingly, the absent second site is at the location of the major structural difference between IL-1 beta and IL-1 beta, which are otherwise structurally similar. The two receptor binding sites on IL-1 beta are also present on IL-1 alpha. Thus, it appears that the two IL-1 agonist molecules have two sites for IL-1RI binding, and the homologous antagonist molecule, IL-1ra, has only one. Based on these observations, a hypothesis is presented to account for the difference in activity between the agonist and antagonist proteins. It is proposed that the presence of the two receptor binding sites may be necessary for agonist activity.	UNIV COLORADO,DEPT CHEM & BIOCHEM,BOULDER,CO 80309	University of Colorado System; University of Colorado Boulder	EVANS, RJ (corresponding author), SYNERGEN INC,BOULDER,CO 80301, USA.			Vigers, Guy/0000-0003-4451-8453				BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DINARELLO CA, 1991, BLOOD, V77, P1627; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; DRIPPS DJ, 1991, J BIOL CHEM, V266, P10331; EISENBERG SP, 1991, P NATL ACAD SCI USA, V88, P5232, DOI 10.1073/pnas.88.12.5232; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; FERRETTI M, 1994, J CLIN INVEST, V94, P449, DOI 10.1172/JCI117345; GAYLE RB, 1993, J BIOL CHEM, V268, P22105; GEHRKE L, 1990, J BIOL CHEM, V265, P5922; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; GREENFEDER S, 1994, J CELL BIOCH S, V18, P217; GRUTTER MG, 1994, PROTEIN ENG, V7, P663, DOI 10.1093/protein/7.5.663; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; JU G, 1991, P NATL ACAD SCI USA, V88, P2658, DOI 10.1073/pnas.88.7.2658; KAWASHIMA H, 1991, PROTEIN ENG, V5, P171; LABRIOLATOMPKINS E, 1993, PROTEIN ENG, V6, P535, DOI 10.1093/protein/6.5.535; LABRIOLATOMPKINS E, 1991, P NATL ACAD SCI USA, V88, P11182, DOI 10.1073/pnas.88.24.11182; MACDONALD HR, 1986, FEBS LETT, V209, P295, DOI 10.1016/0014-5793(86)81130-9; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; PRIESTLE JP, 1989, P NATL ACAD SCI USA, V86, P9667, DOI 10.1073/pnas.86.24.9667; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SLACK J, 1993, J BIOL CHEM, V268, P2513; STOCKMAN BJ, 1992, BIOCHEMISTRY-US, V31, P5237, DOI 10.1021/bi00138a001; SVENSON M, 1993, CYTOKINE, V5, P427, DOI 10.1016/1043-4666(93)90032-Z; VIGERS GPK, 1994, J BIOL CHEM, V269, P12874; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; YAMAYOSHI M, 1990, LYMPHOKINE RES, V9, P405	29	85	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11477	11483		10.1074/jbc.270.19.11477	http://dx.doi.org/10.1074/jbc.270.19.11477			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744786	hybrid			2022-12-27	WOS:A1995QX86500065
J	MACLEOD, AR; ROULEAU, J; SZYF, M				MACLEOD, AR; ROULEAU, J; SZYF, M			REGULATION OF DNA METHYLATION BY THE RAS SIGNALING PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; DENOVO METHYLATION; MOUSE CELLS; HA-RAS; METHYLTRANSFERASE; PROTEIN; TRANSCRIPTION; PROMOTER; SEQUENCE; TRANSFORMATION	We demonstrate that DNA methylation in an adrenocortical tumor cell line, Y1, is controlled by the Ras signaling pathway. Forced expression of a cDNA encoding human GAP(120) (hGAP), a down-modulator of Ras activity or partial derivative 9-Jun a transdominant negative mutant of Jun, in Y1 cells reverts the transformed morphology of the cells and results in a reduction in the level of DNA methylation, DNA methyltransferase (MeTase) mRNA, and enzymatic activity, Introduction of an oncogenic Ha-ras into the GAP transfectants results in reversion to a transformed morphology and an increase in the levels of DNA methylation and DNA MeTase activity. Transient transfection CAT assays demonstrate that the expression of DNA MeTase promoter in Y1 cells is regulated by Ras and AP-1. These results establish a molecular link between a major signaling pathway involved in tumorigenesis and DNA methylation.	MCGILL UNIV, DEPT PHARMACOL & THERAPEUT, MONTREAL, PQ H3G 1Y6, CANADA	McGill University								ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; KAUTIAINEN TL, 1986, J BIOL CHEM, V261, P1594; KESHET E, 1983, NUCLEIC ACIDS RES, V11, P3571, DOI 10.1093/nar/11.11.3571; LAZARISKARATZAS A, 1992, GENE DEV, V6, P1631, DOI 10.1101/gad.6.9.1631; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; MICHALOWSKY LA, 1989, MOL CELL BIOL, V9, P885, DOI 10.1128/MCB.9.3.885; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1985, BIOCH BIOL DNA METHY, P239; ROULEAU J, 1995, J BIOL CHEM, V270, P1595, DOI 10.1074/jbc.270.4.1595; ROULEAU J, 1992, J BIOL CHEM, V267, P7368; SCHWAB M, 1983, NATURE, V303, P497, DOI 10.1038/303497a0; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SISTONEN L, 1989, EMBO J, V8, P815, DOI 10.1002/j.1460-2075.1989.tb03442.x; SZYF M, 1992, J BIOL CHEM, V267, P12831; SZYF M, 1985, J BIOL CHEM, V260, P8653; SZYF M, 1989, P NATL ACAD SCI USA, V86, P6853, DOI 10.1073/pnas.86.18.6853; SZYF M, 1991, J BIOL CHEM, V266, P10027; SZYF M, 1991, BIOCHEM CELL BIOL, V69, P764, DOI 10.1139/o91-117; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; SZYF M, 1984, P NATL ACAD SCI-BIOL, V81, P3278, DOI 10.1073/pnas.81.11.3278; SZYF M, 1990, MOL ENDOCRINOL, V4, P1144, DOI 10.1210/mend-4-8-1144; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; UHLER MD, 1987, J BIOL CHEM, V262, P15202; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; YASUMURA Y, 1966, CANCER RES, V26, P529	43	170	176	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11327	11337		10.1074/jbc.270.19.11327	http://dx.doi.org/10.1074/jbc.270.19.11327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744770	hybrid			2022-12-27	WOS:A1995QX86500047
J	WOJCIKIEWICZ, RJH				WOJCIKIEWICZ, RJH			TYPE-I, TYPE-II, AND TYPE-III INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS ARE UNEQUALLY SUSCEPTIBLE TO DOWN-REGULATION AND ARE EXPRESSED IN MARKEDLY DIFFERENT PROPORTIONS IN DIFFERENT CELL-TYPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRISPHOSPHATE RECEPTOR; NEUROBLASTOMA-CELLS; MOLECULAR-CLONING; DIFFERENT MODES; CHOLECYSTOKININ; MOBILIZATION; TISSUES; BINDING; KIDNEY; BRAIN	The type I inositol 1,4,5-trisphosphate (InsP(3)) receptor can be rapidly depleted from cells during stimulation of phosphoinositide hydrolysis because its degradation is accelerated (Wojcikiewicz, R. J. H., Furuichi, T., Nakade, S., Mikoshiba, K., and Nahorski, S. R. (1994) J. Biol. Chem. 269, 7963-7969). The present study examines the regulatory properties of type II and III InsP(3) receptors. Initially, the relative abundance of InsP(3) receptors was defined in a range of cell types by quantitative immunoblotting. These studies showed that the proportions in which type I, II, and III InsP, receptors are expressed differs greatly and that some cells (for example, AR4-2J rat pancreatoma cells) express all three receptors. Analysis of the effects of cholecystokinin and bombesin on AR4-2J cells showed that each of the InsP(3) receptors could be down-regulated during activation of phosphoinositide hydrolysis, but that depletion of the type II receptor was limited. Such a discrepancy was also seen in rat cerebellar granule cells and was found to result from the type II receptor being relatively resistant to degradation. In conclusion, type I, II, and III receptors can all be down-regulated, but with different characteristics. As the relative abundance of InsP, receptors is extremely variable, the extent to which activation of the down-regulatory process alters intracellular signaling will vary depending on which InsP(3) receptors are expressed.			WOJCIKIEWICZ, RJH (corresponding author), SUNY HLTH SCI CTR, COLL MED, DEPT PHARMACOL, 750 E ADAMS ST, SYRACUSE, NY 13210 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049194] Funding Source: NIH RePORTER; NIDDK NIH HHS [R29 DK49194] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DESMEDT H, 1994, J BIOL CHEM, V269, P21691; ENYEDI P, 1994, ENDOCRINOLOGY, V134, P2354, DOI 10.1210/en.134.6.2354; FISCHER GA, 1994, J BIOL CHEM, V269, P19216; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; JOSEPH SK, 1993, J BIOL CHEM, V268, P23059; Levi G., 1989, DISSECTION TISSUE CU, P211; LOGSDON CD, 1989, HDB PHYSL 6, V3, P515; LYTTON J, 1988, J BIOL CHEM, V263, P15024; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; MATOZAKI T, 1990, J BIOL CHEM, V265, P6247; MENNITI FS, 1991, MOL PHARMACOL, V40, P727; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; PENDLETON RG, 1987, J PHARMACOL EXP THER, V241, P110; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Rehfeld JF., 1989, HDB PHYSL, VII; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; Sambrook J, 1989, MOL CLONING LABORATO; SEVA C, 1994, REGUL PEPTIDES, V52, P31, DOI 10.1016/0167-0115(94)90018-3; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; WHITHAM EM, 1991, EUR J PHARM-MOLEC PH, V206, P181, DOI 10.1016/S0922-4106(05)80017-3; WOJCIKIEWICZ RJH, 1992, J NEUROCHEM, V59, P383, DOI 10.1111/j.1471-4159.1992.tb08916.x; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; WOJCIKIEWICZ RJH, 1991, J BIOL CHEM, V266, P22234; WOJCIKIEWICZ RJH, 1993, TRENDS PHARMACOL SCI, V14, P279, DOI 10.1016/0165-6147(93)90131-3; YAMAMOTOHINO M, 1994, RECEPTOR CHANNEL, V2, P9	31	364	366	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11678	11683		10.1074/jbc.270.19.11678	http://dx.doi.org/10.1074/jbc.270.19.11678			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744807	hybrid			2022-12-27	WOS:A1995QX86500091
J	MARKS, MS; GERMAIN, RN; BONIFACINO, JS				MARKS, MS; GERMAIN, RN; BONIFACINO, JS			TRANSIENT AGGREGATION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II CHAINS DURING ASSEMBLY IN NORMAL SPLEEN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HLA-DR MOLECULES; INVARIANT CHAIN; ENDOPLASMIC-RETICULUM; INTRACELLULAR-TRANSPORT; BINDING-PROTEIN; PEPTIDE BINDING; MICE LACKING; ASSOCIATION; EXPRESSION; ANTIGENS	Many cell surface proteins exist as complexes of multiple subunits. It is well established that most such complexes are assembled within the endoplasmic reticulum (ER). However, the mechanistic details of the assembly process are largely unknown. We show here that alpha and beta subunits of major histocompatibility complex class II antigens in spleen cells of normal mice pass through a transiently aggregated phase in the ER prior to assembly with the invariant chain (Ii). Aggregates form immediately after synthesis and disappear concomitantly with assembly of mature alpha beta Ii complexes. In spleen cells lacking Ii, aggregates fail to be efficiently dissociated over time, implicating subunit assembly as a requirement for disaggregation. Two ER chaperones, BiP and calnexin, bind to newly synthesized class II MHC chains but do not contribute appreciably to the large size of the aggregates. Our observations suggest that some subunits of multisubunit complexes pass through a transient, dynamic high molecular weight aggregate phase during the physiological process of assembly. The results further suggest a novel role for Ii in promoting stable dissociation of preformed aggregates containing alpha and beta subunits rather than in preventing their formation.	NICHHD,CELL BIOL & METAB BRANCH,BETHESDA,MD 20892; NIAID,IMMUNOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Marks, Michael S/Q-7223-2019; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Marks, Michael S/0000-0001-7435-7262; Bonifacino, Juan S./0000-0002-5673-6370				ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; CLAESSONWELSH L, 1985, J IMMUNOL, V135, P3551; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DESILVA A, 1993, J CELL BIOL, V120, P647, DOI 10.1083/jcb.120.3.647; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; KOCH N, 1987, EMBO J, V6, P1677, DOI 10.1002/j.1460-2075.1987.tb02417.x; KOCH N, 1982, NATURE, V299, P644, DOI 10.1038/299644a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAMB CA, 1992, J IMMUNOL, V148, P3478; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; LE AQ, 1994, J BIOL CHEM, V269, P7514; LOKEN MR, 1982, J IMMUNOL METHODS, V50, P85; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MEHRINGER JH, 1991, J IMMUNOL, V146, P920; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NGUYEN QV, 1989, J BIOL CHEM, V264, P1631; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; ROTHENHAUSLER B, 1990, P NATL ACAD SCI USA, V87, P352, DOI 10.1073/pnas.87.1.352; SANT AJ, 1991, J EXP MED, V174, P799, DOI 10.1084/jem.174.4.799; SCHAIFF WT, 1991, J IMMUNOL, V147, P603; SCHAIFF WT, 1992, J EXP MED, V176, P657, DOI 10.1084/jem.176.3.657; SCHREIBER KL, 1994, INT IMMUNOL, V6, P101, DOI 10.1093/intimm/6.1.101; SPRINGER T, 1978, EUR J IMMUNOL, V8, P539, DOI 10.1002/eji.1830080802; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; WADA I, 1994, J BIOL CHEM, V269, P7464; YILLA M, 1992, J CELL BIOL, V118, P245, DOI 10.1083/jcb.118.2.245	51	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10475	10481		10.1074/jbc.270.18.10475	http://dx.doi.org/10.1074/jbc.270.18.10475			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737982	hybrid			2022-12-27	WOS:A1995QW60100020
J	OLIVEIRA, PL; KAWOOYA, JK; RIBEIRO, JMC; MEYER, T; POORMAN, R; ALVES, EW; WALKER, FA; MACHADO, EA; NUSSENZVEIG, RH; PADOVAN, GJ; MASUDA, H				OLIVEIRA, PL; KAWOOYA, JK; RIBEIRO, JMC; MEYER, T; POORMAN, R; ALVES, EW; WALKER, FA; MACHADO, EA; NUSSENZVEIG, RH; PADOVAN, GJ; MASUDA, H			A HEME-BINDING PROTEIN FROM HEMOLYMPH AND OOCYTES OF THE BLOODSUCKING INSECT, RHODNIUS-PROLIXUS - ISOLATION AND CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBIN GENE-CLUSTER; NUCLEOTIDE-SEQUENCE; HEMOPEXIN; RABBIT; DEGRADATION	A heme-binding protein has been isolated and characterized from both the hemolymph and oocytes of the blood sucking insect, Rhodnius prolixus, The protein from both sources is identical in most aspects studied. The Rhodnius heme binding protein (RHBP) is com posed of a single 15-kDa polypeptide chain coiled in a highly alpha-helical structure which binds non-covalently one heme/polypeptide chain, This RHBP is not produced by limited degradation of hemoglobin from the vertebrate host, since specific polyclonal antibodies against it do not cross-react with rabbit hemoglobin, and since it differs from hemoglobin in having a distinct amino-acid composition and NH2-terminal sequence, The spectrum of the dithionite-reduced protein has peaks at 426, 530, and 559 nm and resembles that of a b-type cytochrome. RHBP from hemolymph is not saturated with heme and promptly binds heme added to the solution, The oocyte protein, on the other hand, is fully saturated and is not capable of binding additional heme.	UNIV SAO PAULO,FAC MED RIBEIRAO PRETO,DEPT CLIN MED,BR-14049900 RIBEIRAO PRET,BRAZIL; UNIV SAO PAULO,FAC MED RIBEIRAO PRETO,CTR INTERDEPT QUIM PROT,BR-14049900 RIBEIRAO PRET,BRAZIL; CEPHALON INC,W CHESTER,PA 19380; UNIV ARIZONA,DEPT ENTOMOL,TUCSON,AZ 85721; UNIV ARIZONA,DEPT BIOCHEM,TUCSON,AZ 85721; UNIV ARIZONA,DEPT CHEM,TUCSON,AZ 85721	Universidade de Sao Paulo; Universidade de Sao Paulo; Teva Pharmaceutical Industries; Cephalon Inc.; University of Arizona; University of Arizona; University of Arizona	OLIVEIRA, PL (corresponding author), UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,POB 68041,BR-21941590 RIO JANEIRO,BRAZIL.		Walker, Frances A/O-4395-2016; Machado, Ednildo A/G-9725-2013; L. Oliveira, Pedro/A-9438-2010	L. Oliveira, Pedro/0000-0003-0307-354X; Machado, Ednildo/0000-0002-4428-3829; Ribeiro, Jose/0000-0002-9107-0818	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018694, R37AI018694] Funding Source: NIH RePORTER; NIAID NIH HHS [NIAID 18694] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AFT RL, 1984, J BIOL CHEM, V259, P301; ALONZO N, 1968, ANAL BIOCHEM, V23, P272, DOI 10.1016/0003-2697(68)90359-X; [Anonymous], 1991, BIOL BLOOD SUCKING I; Ascoli F, 1981, Methods Enzymol, V76, P72; CHANG CT, 1978, ANAL BIOCHEM, V19, P13; CHENG JF, 1986, J BIOL CHEM, V261, P839; DANSAPETRETSKI M, 1994, J BIOL CHEM, V279, P10893; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FRIEND WG, 1965, CAN J ZOOL, V43, P892; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Hagihara B, 1975, ENZYMES, P549; HRKAL Z, 1971, BIOCHEMISTRY-US, V10, P1746, DOI 10.1021/bi00786a002; KUNKEL JG, 1985, COMPREHENSIVE INSECT, V1, P83; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCAS B, 1980, ANAL BIOCHEM, V109, P192, DOI 10.1016/0003-2697(80)90028-7; MARGOT JB, 1989, J MOL BIOL, V205, P15, DOI 10.1016/0022-2836(89)90362-8; MORGAN WT, 1972, J BIOL CHEM, V247, P7181; MORGAN WT, 1976, ANN CLIN RES, V8, P223; MORGAN WT, 1984, J BIOL CHEM, V19, P12001; Nomenclature Committee of the International Union of Biochemistry (NC-IUB), 1989, J BIOL CHEM, V267, P665; OLIVEIRA PL, 1989, INSECT BIOCHEM, V19, P489; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; TAKETANI S, 1987, J BIOL CHEM, V262, P4639; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; WALKER FA, 1988, J AM CHEM SOC, V110, P6234, DOI 10.1021/ja00226a045; Wigglesworth VB, 1943, PROC R SOC SER B-BIO, V131, P313, DOI 10.1098/rspb.1943.0010	28	77	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10897	10901		10.1074/jbc.270.18.10897	http://dx.doi.org/10.1074/jbc.270.18.10897			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738030				2022-12-27	WOS:A1995QW60100078
J	IZQUIERDO, JM; RICART, J; OSTRONOFF, LK; EGEA, G; CUEZVA, JM				IZQUIERDO, JM; RICART, J; OSTRONOFF, LK; EGEA, G; CUEZVA, JM			CHANGING PATTERNS OF TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL CONTROL OF BETA-F-1-ATPASE GENE-EXPRESSION DURING MITOCHONDRIAL BIOGENESIS IN LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE BETA-SUBUNIT; MUSCLE ADP/ATP TRANSLOCATOR; TISSUE-SPECIFIC ISOFORMS; CYTOCHROME-C-OXIDASE; RNA-BINDING PROTEIN; ATP SYNTHASE; RAT-LIVER; MESSENGER-RNA; ALPHA-SUBUNIT; GAMMA-SUBUNIT	To elucidate the mechanisms that regulate the expression of nuclear genes during biogenesis of mammalian mitochondria, the expression pattern of the beta-subunit of the ATP synthase gene has been characterized in rat liver between day 20 in utero and 12 weeks postnatal. The parallelism existing between transcriptional activity of the gene and the amount of beta-F-1-ATPase protein in liver indicates that proliferation of mitochondria is controlled at the transcriptional level. On the other hand, an increased stability (4-5-fold) of beta-F-1-ATPase mRNA during early neonataI life as well as a rapid postnatal activation of translation rates affecting mitochondrial proteins appear to control mitochondrial differentiation. Immunoelectron microscopy of the F-1-ATPase complex during liver development revealed that the rapid postnatal increase in the in vivo rate of F-1-ATPase synthesis was mostly used for functional differentiation of pre-existing organelles (VaIcarce, C., Navarrete, it. M., Encabo, P., Loeehes, E., Satrustegui, J., and Cuezva, J. M. (1988) J. Biol Chem. 263, 7767-7775). The findings support that beta-F-1-ATPase mRNA decay is developmentally regulated in liver, indicating that gene expression is also controlled at this level during physiological transitions that affect biogenesis of mitochondria.	UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOLEC SEVERO OCHOA, DEPT BIOL MOLEC, E-28049 MADRID, SPAIN; UNIV BARCELONA, FAC MED, DEPT BIOL CELULAR & ANAT PATOL, E-08036 BARCELONA, SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona			Egea, Gustavo/I-2394-2014; Cuezva, Jose M/F-8381-2011; Cuezva, Jose M/AAR-5392-2020	Egea, Gustavo/0000-0001-5242-150X; Cuezva Marcos, Jose Manuel/0000-0003-1118-248X				ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; ATTARDI G, 1990, BIOCHEM SOC T, V18, P509, DOI 10.1042/bst0180509; BABISS LE, 1986, P NATL ACAD SCI USA, V83, P6504, DOI 10.1073/pnas.83.17.6504; BACHVAROVA RF, 1992, CELL, V69, P895, DOI 10.1016/0092-8674(92)90606-D; BARATGUERIDE M, 1987, MITOCHONDRIA PRACTIC, P245; BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329; Belasco J. G., 1993, CONTROL MESSENGER RN, P475; BOUVET P, 1994, CELL, V77, P931, DOI 10.1016/0092-8674(94)90141-4; BREEN GAM, 1988, BIOCHEM BIOPH RES CO, V152, P264, DOI 10.1016/S0006-291X(88)80709-5; BREEN GAM, 1988, BIOCHEMISTRY-US, V27, P3955, DOI 10.1021/bi00411a010; CANTATORE P, 1986, CELL DIFFER DEV, V19, P125, DOI 10.1016/0045-6039(86)90069-2; CHAU CMA, 1992, J BIOL CHEM, V267, P6999; CHRZANOWSKALIGHTOWLERS ZMA, 1994, J BIOL CHEM, V269, P27322; CHUNG AB, 1992, J BIOL CHEM, V267, P21154; CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; CUEZVA JM, 1990, REPROD BIOL, P113; CUEZVA JM, 1993, PHYSL BASIS PERINATA, P47; ENDO H, 1994, J BIOL CHEM, V269, P12488; GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x; GARBOCZI DN, 1988, BIOCHEMISTRY-US, V27, P553, DOI 10.1021/bi00402a008; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; GOPALAKRISHNAN L, 1994, J BIOL CHEM, V269, P105; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; Greenberg ME, 1993, CONTROL MESSENGER RN, P199, DOI 10.1016/B978-0-08-091652-1.50013-X; GRIFFITHS G, 1986, J HISTOCHEM CYTOCHEM, V34, P1389, DOI 10.1177/34.11.3534077; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HARAGUCHI Y, 1994, J BIOL CHEM, V269, P9330; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOMMES FA, 1975, NORMAL PATHOLOGICAL, P1; IZQUIERDO JM, 1990, J BIOL CHEM, V265, P9090; IZQUIERDO JM, 1993, FEBS LETT, V323, P109, DOI 10.1016/0014-5793(93)81459-D; IZQUIERDO JM, 1993, BIOCHEM BIOPH RES CO, V196, P55, DOI 10.1006/bbrc.1993.2215; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; KIKUCHI K, 1992, J BIOL CHEM, V267, P21505; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LI K, 1990, J BIOL CHEM, V265, P20585; LUIS AM, 1989, BIOCHEM BIOPH RES CO, V159, P216, DOI 10.1016/0006-291X(89)92425-X; LUIS AM, 1993, J BIOL CHEM, V268, P1868; LYONNET S, 1988, J CLIN INVEST, V81, P1682, DOI 10.1172/JCI113506; Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89; MATSUDA C, 1993, J BIOL CHEM, V268, P24950; MATSUDA C, 1993, FEBS LETT, V325, P281, DOI 10.1016/0014-5793(93)81089-I; MAYOR F, 1985, BIOL NEONATE, V48, P185, DOI 10.1159/000242171; NAGLEY P, 1991, TRENDS GENET, V7, P1, DOI 10.1016/0168-9525(91)90002-8; NECKELMANN N, 1989, GENOMICS, V5, P829, DOI 10.1016/0888-7543(89)90125-0; OHTA S, 1988, J BIOL CHEM, V263, P11257; PATEL MS, 1982, BIOCH DEV FETUS NEON, P553; PIERCE DJ, 1992, BIOCHIM BIOPHYS ACTA, V1132, P265, DOI 10.1016/0167-4781(92)90160-2; POLLAK JK, 1980, TRENDS BIOCHEM SCI, V5, P23, DOI 10.1016/S0968-0004(80)80073-9; POLOSA PL, 1991, J BIOL CHEM, V266, P10011; PREISS T, 1993, J BIOL CHEM, V268, P10659; PREISS T, 1993, J BIOL CHEM, V268, P24523; ROHR HP, 1971, LAB INVEST, V24, P128; RUIZ J P G, 1978, Proceedings of the National Academy of Sciences of the United States of America, V75, P4189, DOI 10.1073/pnas.75.9.4189; SANTAREN JF, 1993, J BIOCHEM, V113, P129, DOI 10.1093/oxfordjournals.jbchem.a124014; SCARPULLA RC, 1986, J BIOL CHEM, V261, P4660; Schimke R T, 1975, Methods Enzymol, V40, P241; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; SUZUKI H, 1991, J BIOL CHEM, V266, P2333; TOMURA H, 1990, J BIOL CHEM, V265, P6525; TORRONI A, 1990, J BIOL CHEM, V265, P20589; VALCARCE C, 1991, FEBS LETT, V294, P225, DOI 10.1016/0014-5793(91)81435-B; VALCARCE C, 1990, J BIOCHEM, V108, P642; VALCARCE C, 1988, J BIOL CHEM, V263, P7767; VALCARCE C, 1994, BIOCHEM J, V303, P855, DOI 10.1042/bj3030855; VANDERZEE CA, 1994, J BIOL CHEM, V269, P6972; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; WALKER JE, 1989, BIOCHEMISTRY-US, V28, P4702, DOI 10.1021/bi00437a029; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WEBSTER KA, 1990, J CELL PHYSIOL, V142, P566, DOI 10.1002/jcp.1041420316; WICKENS M, 1990, TRENDS BIOCHEM SCI, V15, P320, DOI 10.1016/0968-0004(90)90022-4; WILLIAMS RS, 1987, J BIOL CHEM, V262, P2764; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOOWARREN H, 1981, J BIOL CHEM, V256, P224	76	83	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10342	10350		10.1074/jbc.270.17.10342	http://dx.doi.org/10.1074/jbc.270.17.10342			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730341	hybrid			2022-12-27	WOS:A1995QV41700090
J	KARUNAGARAN, D; TZAHAR, E; LIU, NL; WEN, DZ; YARDEN, Y				KARUNAGARAN, D; TZAHAR, E; LIU, NL; WEN, DZ; YARDEN, Y			NEU DIFFERENTIATION FACTOR INHIBITS EGF BINDING - A MODEL FOR TRANSREGULATION WITHIN THE ERBB FAMILY OF RECEPTOR TYROSINE KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; AMINO-ACID SUBSTITUTION; HIGH-AFFINITY RECEPTORS; SIGNAL TRANSDUCTION; MONOCLONAL-ANTIBODY; PHORBOL ESTERS; PHOSPHORYLATION; PROTEIN; CELLS; FIBROBLASTS	Neu differentiation factor (NDF, or heregulin) and epidermal growth factor (EGF) are structurally related proteins that bind to distinct members of the ErbB family of receptor tyrosine kinases. Here we show that NDF inhibits EGF binding in a cell type-specific manner. The inhibitory effect is distinct from previously characterized mechanisms that involve protein kinase C and receptor internalization because it occurred at 4 degrees C and displayed reversibility. The extent of inhibition correlated with both receptor saturation and affinity of different NDF isoforms, and it was abolished upon overexpression of either EGF receptor or ErbB-2. Binding kinetics and equilibrium analyses indicated that NDF reduced the affinity, rather than the number, of EGF receptors, through an acceleration of the rate of ligand dissociation and deceleration of the association rate, On the basis of co-immunoprecipitation of EGF and NDF receptors, we attribute the inhibitory effect to the formation of receptor heterodimers. According to this model, EGF binding to NDF-occupied heterodimers is partially blocked. This model of negative trans-regulation within the ErbB family is relevant to other subgroups of receptor tyrosine kinases and may have physiological implications.	AMGEN INC, AMGEN CTR, THOUSAND OAKS, CA 91320 USA	Amgen	KARUNAGARAN, D (corresponding author), WEIZMANN INST SCI, DEPT CHEM IMMUNOL, IL-76100 REHOVOT, ISRAEL.		Karunagaran, Devarajan/A-8148-2010; YARDEN, YOSEF/K-1467-2012	Karunagaran, Devarajan/0000-0001-9331-8947; 	NCI NIH HHS [CA51712] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051712] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRD TA, 1990, J BIOL CHEM, V265, P235; BOEYNAEMS JM, 1980, OUTLINES RECEPTOR TH; BOWENPOPE DF, 1983, J CELL BIOL, V96, P679, DOI 10.1083/jcb.96.3.679; BRANDTRAUF PW, 1989, J PROTEIN CHEM, V8, P749, DOI 10.1007/BF01024899; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; COCHET C, 1988, J BIOL CHEM, V263, P3290; COLLINS MKL, 1984, J CELL PHYSIOL, V118, P133, DOI 10.1002/jcp.1041180205; DAVIS RJ, 1987, J BIOL CHEM, V262, P6832; DAVIS RJ, 1985, CANCER CELL, V3, P101; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; DIFIORE PP, 1992, EMBO J, V11, P3927, DOI 10.1002/j.1460-2075.1992.tb05486.x; DOUGALL WC, 1993, J CELL BIOCHEM, V53, P61, DOI 10.1002/jcb.240530108; GOLDMAN R, 1990, BIOCHEMISTRY-US, V29, P11024, DOI 10.1021/bi00502a002; GULLICK WJ, 1990, INT J CANCER, P55; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; LEE LS, 1978, SCIENCE, V202, P313, DOI 10.1126/science.308698; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MASSAGUE J, 1990, J BIOL CHEM, V265, P21393; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; PELES E, 1991, EMBO J, V10, P2077, DOI 10.1002/j.1460-2075.1991.tb07739.x; PELES E, 1993, EMBO J, V12, P961, DOI 10.1002/j.1460-2075.1993.tb05737.x; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; QIAN XL, 1992, P NATL ACAD SCI USA, V89, P1330, DOI 10.1073/pnas.89.4.1330; SAMANTA A, 1994, P NATL ACAD SCI USA, V91, P1711, DOI 10.1073/pnas.91.5.1711; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SPIVAKKROIZMAN T, 1992, J BIOL CHEM, V267, P8056; STANCOVSKI I, 1991, P NATL ACAD SCI USA, V88, P8691, DOI 10.1073/pnas.88.19.8691; STANCOVSKI I, 1994, REGULATORY MECHANISM; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; WATERFIELD MD, 1982, J CELL BIOCHEM, V20, P149, DOI 10.1002/jcb.240200207; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; WOFSY C, 1992, BIOPHYS J, V63, P98, DOI 10.1016/S0006-3495(92)81572-2; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YARDEN Y, 1981, BIOCHIM BIOPHYS ACTA, V674, P188, DOI 10.1016/0304-4165(81)90377-9; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	48	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9982	9990		10.1074/jbc.270.17.9982	http://dx.doi.org/10.1074/jbc.270.17.9982			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730382	hybrid			2022-12-27	WOS:A1995QV41700044
J	MORIGUCHI, T; KAWASAKI, H; MATSUDA, S; GOTOH, Y; NISHIDA, E				MORIGUCHI, T; KAWASAKI, H; MATSUDA, S; GOTOH, Y; NISHIDA, E			EVIDENCE FOR MULTIPLE ACTIVATORS FOR STRESS-ACTIVATED PROTEIN-KINASES C-JUN AMINO-TERMINAL KINASES - EXISTENCE OF NOVEL ACTIVATORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MAP KINASE; PHOSPHORYLATION; PATHWAYS; IDENTIFICATION; CASCADE	Stress-activated protein kinases (SAPRs) or c-Jun amino-terminal kinases (JNKs), which belong to a subgroup of the mitogen-activated protein kinase (MAPK) superfamily, are activated in response to a variety of stresses in mammalian cells. An activity to activate a recombinant rat SAPK alpha was detected in extracts obtained from rat fibroblastic 3Y1 cells exposed to hyperosmolar media and was resolved into unadsorbed and adsorbed fractions on Q Sepharose chromatography. The adsorbed activity was identified as XMEK2/SEK1/MKK4 by using several anti-XMEK2 antibodies. Thus, a 45-kDa protein that was recognized specifically by these anti-XMEK2 antibodies co-eluted with the SAPK alpha activating activity during chromatography on Q-Sepharose and Superose 6, and the activity could be immunoprecipitated by the antibodies from these fractions. The unadsorbed activity, whose level was much greater than that of the adsorbed activity, did not contain XMEK2/SEK1/MKK4 and was also activated in a time-dependent manner by osmotic shock. This activity was further resolved into several peaks during chromatography on heparin-Sepharose and hydroxylapatite. Most of these peaks eluted separately from major peaks of a kinase activity toward p38/MPK2, another subgroup of the MAPK superfamily, whereas the activated XMEK2/SEK1/MKK4 could phosphorylate p38/MPK2 efficiently. These results indicate the existence of multiple activators for SAPR/JNK; one is XMEK2/SEK1/MKK4, and the others are previously undescribed factors.	KYOTO UNIV,INST VIRUS RES,DEPT MOLEC BIOL & GENET,SAKYO KU,KYOTO 60601,JAPAN	Kyoto University			Kawasaki, Hiroshi/C-4404-2015; Moriguchi, Tetsuo/D-7061-2012	Moriguchi, Tetsuo/0000-0002-9598-4991; Kawasaki, Hiroshi/0000-0002-2514-1497				Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; FUKUDA M, 1994, J BIOL CHEM, V269, P33097; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HATTORI K, 1988, P NATL ACAD SCI USA, V85, P9148, DOI 10.1073/pnas.85.23.9148; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; KOSAKO H, 1993, EMBO J, V12, P787, DOI 10.1002/j.1460-2075.1993.tb05713.x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; KYRIAKIS JM, 1991, J BIOL CHEM, V266, P10043; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEEVERS S J, 1992, Trends in Cell Biology, V2, P283, DOI 10.1016/0962-8924(92)90105-V; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SEGER R, 1994, J BIOL CHEM, V269, P25699; YASHAR BM, 1993, MOL CELL BIOL, V13, P5738, DOI 10.1128/MCB.13.9.5738	28	119	124	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12969	12972		10.1074/jbc.270.22.12969	http://dx.doi.org/10.1074/jbc.270.22.12969			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768885	hybrid			2022-12-27	WOS:A1995RB43900006
J	KHOO, KH; DELL, A; MORRIS, HR; BRENNAN, PJ; CHATTERJEE, D				KHOO, KH; DELL, A; MORRIS, HR; BRENNAN, PJ; CHATTERJEE, D			INOSITOL PHOSPHATE CAPPING OF THE NONREDUCING TERMINI OF LIPOARABINOMANNAN FROM RAPIDLY GROWING STRAINS OF MYCOBACTERIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOMBARDMENT MASS-SPECTROMETRY; TUMOR-NECROSIS-FACTOR; STRUCTURAL FEATURES; CELL-WALLS; BOVIS BCG; TUBERCULOSIS; ANTIGENICITY; VIRULENT	Previous studies have demonstrated that the nonreducing termini of the lipoarabinomannan (LAM) from Mycobacterium tuberculosis are extensively capped with mannose residues, whereas those from a fast growing Mycobacterium sp., once thought to be an attenuated strain of M. tuberculosis, are not. The noncapped LAM, termed AraLAM, is known to be more potent than the mannose capped LAM (ManLAM) in inducing functions associated with macrophage activation. Using a combination of chemical and enzymatic approaches coupled with fast atom bombardment-mass spectrometry analysis, we demonstrated that LAMs from all M. tuberculosis strains examined (Erdman, H37Ra, and H37Rv), as well as the attenuated Mycobacterium bovis BCG strain, are mannose-capped with the extent of capping varying between 40 and 70%. The nonreducing termini of LAM from Mycobacterium leprae were also found to be capped with mannoses but at a significantly lower level. A novel inositol phosphate capping motif was identified on a minor portion of the otherwise uncapped arabinan termini of LAMs from the fast growing Mycobacterium sp. and Mycobacterium smegmatis ATCC 14468 and mc(2)155. In addition, an inositol phosphate tetra-arabinoside was isolated from among endoarabinase digestion products of AraLAM and was shown to induce tumor necrosis factor-a production. Accordingly, we concluded that AraLAM is characteristic of some rapidly growing Mycobacterium spp. It is distinct from ManLAMs of M. tuberculosis, M. bovis BCG, and Mycobacterium leprae not only in the absence of mannose-capping but also in containing some terminal inositol phosphate substituents which may account for its particular potency in inducing macrophage activation.	UNIV LONDON IMPERIAL COLL SCI & TECHNOL,DEPT BIOCHEM,LONDON SW7 2AZ,ENGLAND	Imperial College London	KHOO, KH (corresponding author), COLORADO STATE UNIV,DEPT MICROBIOL,FT COLLINS,CO 80523, USA.		Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X	NIAID NIH HHS [AI-05074, AI 18357] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018357, R01AI018357, R22AI018357] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; BRENNAN PJ, 1990, MICROBIAL DETERMINANTS OF VIRULENCE AND HOST RESPONSE, P55; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652; CHATTERJEE D, 1993, GLYCOBIOLOGY, V3, P497, DOI 10.1093/glycob/3.5.497; CHATTERJEE D, 1992, INFECT IMMUN, V60, P1249, DOI 10.1128/IAI.60.3.1249-1253.1992; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; DELL A, 1994, METHOD ENZYMOL, V230, P108; DELL A, 1990, CARBOHYD RES, V200, P59, DOI 10.1016/0008-6215(90)84182-T; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; MCCONVILLE MJ, 1991, J BIOL CHEM, V266, P15170; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; MCNEIL M, 1991, J BIOL CHEM, V266, P13217; MCNEIL MR, 1994, GLYCOBIOLOGY, V4, P165, DOI 10.1093/glycob/4.2.165; PRINZIS S, 1993, J GEN MICROBIOL, V139, P2649, DOI 10.1099/00221287-139-11-2649; ROACH TIA, 1994, INFECT IMMUN, V62, P1176, DOI 10.1128/IAI.62.4.1176-1184.1994; ROACH TIA, 1993, J IMMUNOL, V150, P1886; ROACH TIA, 1995, IN PRESS J IMMUNOL; ROSENFELD L, 1974, CARBOHYD RES, V32, P287, DOI 10.1016/S0008-6215(00)82106-0; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; TSAI PK, 1986, P NATL ACAD SCI USA, V82, P4119; VENISSE A, 1993, J BIOL CHEM, V268, P12401; WYNN TA, 1993, J IMMUNOL, V151, P1430	28	154	157	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12380	12389		10.1074/jbc.270.21.12380	http://dx.doi.org/10.1074/jbc.270.21.12380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759478	hybrid			2022-12-27	WOS:A1995QZ71100011
J	NIEDERGANG, F; HEMAR, A; HEWITT, CRA; OWEN, MJ; DAUTRYVARSAT, A; ALCOVER, A				NIEDERGANG, F; HEMAR, A; HEWITT, CRA; OWEN, MJ; DAUTRYVARSAT, A; ALCOVER, A			THE STAPHYLOCOCCUS-AUREUS ENTEROTOXIN-B SUPERANTIGEN INDUCES SPECIFIC T-CELL RECEPTOR DOWN-REGULATION BY INCREASING ITS INTERNALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR VIRUS SUPERANTIGENS; CYTOTOXIC LYMPHOCYTES-T; CLASS-II MOLECULES; ANTIGEN RECEPTOR; HLA-DR; TRANSGENIC MICE; CLONAL ANERGY; BINDING; MODULATION; COMPLEX	Superantigens are able to stimulate T lymphocyte populations expressing T cell antigen receptors (TCR) belonging to particular V beta families. Moreover, the presence of these superantigens may induce long term unresponsiveness (anergy) of these sensitive cells, Some bacterial toxins are potent superantigens, We have analyzed in vitro the capacity of some Staphylococcus aureus enterotoxin superantigens to modulate T cell antigen receptor expression and the cellular mechanisms involved, Staphylococcus enterotoxin B (SEB) induced rapid down regulation of surface T cell antigen receptors in V beta 3-expressing T lymphocytes, as assessed by flow cytometry, This phenomenon was a consequence of the direct interaction between the toxin and the TCR since it was observed in the absence of cells expressing major histocompatibility complex class II molecules. The cellular mechanism involved in SEE-induced downregulation of TCR was further investigated, Immunofluorescence and confocal microscopy experiments showed that toxin B induced intracellular accumulation of TCR . CD3 in endocytic vesicles, Moreover, SEE induced an increase in T cell receptor endocytosis as measured using radiolabeled Fab fragments of an anti-CD3 monoclonal antibody. Taken together, our observations indicate that Staphylococcus enterotoxin B superantigen induced changes in the dynamics of surface T cell receptors, which resulted in the fast reduction of membrane receptor numbers,	INST PASTEUR,UNITE BIOL INTERACT CELLULAIRES,CNRS,URA 1960,F-75724 PARIS 15,FRANCE; IMPERIAL CANC RES FUND,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Cancer Research UK			Hewitt, Colin/GXH-7289-2022	Hewitt, Colin/0000-0001-5826-8577; Niedergang, Florence/0000-0002-7064-830X; Alcover, Andres/0000-0002-9507-3450				ACHAORBEA H, 1993, IMMUNOL REV, V131, P5, DOI 10.1111/j.1600-065X.1993.tb01527.x; ACRES RB, 1986, J BIOL CHEM, V261, P6210; ARNOLD B, 1993, IMMUNOL TODAY, V14, P12, DOI 10.1016/0167-5699(93)90317-E; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; BORST J, 1993, IMMUNOL REV, V132, P49, DOI 10.1111/j.1600-065X.1993.tb00837.x; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DELLABONA P, 1990, CELL, V62, P1115, DOI 10.1016/0092-8674(90)90388-U; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; DISANTO JP, 1989, IMMUNOGENETICS, V30, P494, DOI 10.1007/BF02421181; DUPREZ V, 1991, J BIOL CHEM, V266, P1497; FISCHER H, 1989, J IMMUNOL, V142, P3151; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; HERMAN A, 1990, J EXP MED, V172, P709, DOI 10.1084/jem.172.3.709; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; HOMMELBERREY GA, 1991, J IMMUNOL, V147, P3237; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KRANGEL MS, 1987, J EXP MED, V165, P1141, DOI 10.1084/jem.165.4.1141; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MARRACK P, 1993, IMMUNOL REV, V131, P79, DOI 10.1111/j.1600-065X.1993.tb01531.x; MINAMI Y, 1987, J BIOL CHEM, V262, P13342; MOLLICK JA, 1988, SCIENCE, V244, P817; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; OHEHIR RE, 1990, P NATL ACAD SCI USA, V87, P8884, DOI 10.1073/pnas.87.22.8884; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; ROBBINS PA, 1991, J EXP MED, V173, P221, DOI 10.1084/jem.173.1.221; RUSSELL JK, 1990, BIOCHEM BIOPH RES CO, V168, P696, DOI 10.1016/0006-291X(90)92377-C; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; TAKADA S, 1987, J IMMUNOL, V139, P3231; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; UCHIYAMA T, 1989, J IMMUNOL, V143, P3175; VINEY JL, 1992, HYBRIDOMA, V11, P701, DOI 10.1089/hyb.1992.11.701; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WEYAND CM, 1987, J IMMUNOL, V138, P1351; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; ZANDERS ED, 1983, NATURE, V303, P625, DOI 10.1038/303625a0; ZUMLA A, 1992, CLIN INFECT DIS, V15, P313, DOI 10.1093/clinids/15.2.313	43	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12839	12845		10.1074/jbc.270.21.12839	http://dx.doi.org/10.1074/jbc.270.21.12839			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759540	hybrid			2022-12-27	WOS:A1995QZ71100077
J	BENKIRANE, N; GUICHARD, G; VANREGENMORTEL, MHV; BRIAND, JP; MULLER, S				BENKIRANE, N; GUICHARD, G; VANREGENMORTEL, MHV; BRIAND, JP; MULLER, S			CROSS-REACTIVITY OF ANTIBODIES TO RETRO-INVERSO PEPTIDOMIMETICS WITH THE PARENT PROTEIN HISTONE H3 AND CHROMATIN CORE PARTICLE - SPECIFICITY AND KINETIC RATE-CONSTANT MEASUREMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; HEXAPEPTIDE; PEPTIDES; ANALOGS; BOND	A series of monoclonal antibodies has been generated against an hexapeptide of sequence IRGERA corresponding to the C-terminal residues 130-135 of histone H3 and three analogues of this model peptide. The analogues correspond to the D-enantiomer, containing only D-residues, and two retro-peptides containing NH-CO bonds instead of natural amide peptide bonds. The chirality of each residue was maintained in the retropeptide and inverted in the retro-inverso-peptide. Monoclonal antibodies were generated from mice immunized with the analogues coupled to neutral small unilamellar liposomes containing monophosphoryl lipid A as adjuvant. The reactivity of antibodies with the four analogues and with the parent protein H3 was studied in enzyme-linked immunosorbent assay and in a biosensor system. The equilibrium affinity constant (K(a)lpha) toward the retro-inverso-peptide of two out of three antibodies of IgG1 isotype induced against the L-hexapeptide was 7-75-fold higher than toward the homologous L-peptide. The range of K-alpha, values of four antibodies of IgG1 and IgG2a isotypes generated against the retro inverso-peptide was 0.6-1.9 x 10(9) M(-1) for both the retro-inverso- and L-peptides. Furthermore, antibodies to the L- and retroinverso-peptides cross reacted strongly (in some cases better than with the homologous peptide) with the parent histone H3 and with chromatin subunits containing H3. The results are thus promising in respect to the potential use of retro inverso-analogues, which are particularly stable, in the design of much more potent synthetic vaccines or to generate antibody probes.	INST BIOL MOLEC & CELLULAIRE, CNRS, UPR 9021, F-67084 STRASBOURG, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			GUICHARD, Gilles/I-3858-2016; Muller, Sylviane/J-5319-2014; Benkirane-Jessel, Nadia/H-6438-2016	GUICHARD, Gilles/0000-0002-2584-7502; Benkirane-Jessel, Nadia/0000-0003-3059-3559				ALTSCHUH D, 1992, BIOCHEMISTRY-US, V31, P6298, DOI 10.1021/bi00142a019; BENKIRANE N, 1993, J BIOL CHEM, V268, P26279; BRIAND J-P, 1989, Peptide Research, V2, P381; CHOREV M, 1983, J MED CHEM, V26, P129, DOI 10.1021/jm00356a003; FAUCHERE JL, 1992, ADV DRUG RES, V23, P128; FRIEDE M, 1993, MOL IMMUNOL, V30, P539, DOI 10.1016/0161-5890(93)90028-A; GOODMAN M, 1979, ACCOUNTS CHEM RES, V12, P1, DOI 10.1021/ar50133a001; GUICHARD G, 1994, PEPTIDE RES, V7, P308; GUICHARD G, 1994, P NATL ACAD SCI USA, V91, P9765, DOI 10.1073/pnas.91.21.9765; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KARLSSON R, 1992, STRUCTURE ANTIGENS, V1, P127; KAZMIERSKI WM, 1992, INT J PEPT PROT RES, V39, P401; LEBAN JJ, 1993, P NATL ACAD SCI USA, V90, P1922, DOI 10.1073/pnas.90.5.1922; MARRAUD M, 1993, BIOPOLYMERS, V33, P1135, DOI 10.1002/bip.360330715; Miggiano V., 1982, RES DISCL, V217, P155; MULLER S, 1982, EMBO J, V1, P421, DOI 10.1002/j.1460-2075.1982.tb01185.x; MULLER S, 1987, MOL IMMUNOL, V24, P779, DOI 10.1016/0161-5890(87)90062-9; MULLER S, 1989, METHOD ENZYMOL, V170, P251; MULLER S, 1988, SYNTHETIC POLYPEPTID, P95; NEIMARK J, 1993, PEPTIDE RES, V6, P219; SHEMYAKIN MM, 1969, ANGEW CHEM INT EDIT, V8, P492, DOI 10.1002/anie.196904921; Zeder Lutz Gabrielle, 1993, Journal of Molecular Recognition, V6, P71, DOI 10.1002/jmr.300060205	23	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11921	11926		10.1074/jbc.270.20.11921	http://dx.doi.org/10.1074/jbc.270.20.11921			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744843	hybrid			2022-12-27	WOS:A1995QY73600039
J	LO, YYC; CRUZ, TF				LO, YYC; CRUZ, TF			INVOLVEMENT OF REACTIVE OXYGEN SPECIES IN CYTOKINE AND GROWTH-FACTOR INDUCTION OF C-FOS EXPRESSION IN CHONDROCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TUMOR-NECROSIS-FACTOR; ARACHIDONIC-ACID METABOLITES; COLONY-STIMULATING FACTOR; FACTOR-ALPHA; MAP KINASE; PHOSPHOLIPASE ACTIVATION; TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; CELLS-INVITRO; PHORBOL ESTER	The cytokine tumor necrosis factor alpha (TNF alpha) and the growth factor basic fibroblast growth factor (bFGF) are known to induce early response genes such as c-fos and c-jun in various cell types. Activation of AP-1, a heterodimeric complex of Fos and Jun proteins, is required for matrix metalloproteinase production and cell proliferation. However, the signaling pathways by which these two factors influence the expression and activities of AP-1 remain currently poorly characterized. Several studies have shown that cytokines induce reactive oxygen species (ROS) production, but growth factor induction of ROS has not been reported. In the present study we demonstrate that both TNF alpha and bFGF induce ROS production, and that this is a common signaling event involved in the stimulation of c-fos gene expression in chondrocytes. To our knowledge, this is the first report directly demonstrating ROS production upon stimulation with a growth factor. TNF alpha and bFGF induction of ROS production is mediated through flavonoid-containing enzymes such as NADPH oxidase. Moreover, the ROS nitric oxide is not responsible for the induction of c-fos expression by TNF alpha and bFGF. In addition, the inhibitory effects of antioxidants on c-fos expression may account for their protective roles against proliferative and inflammatory diseases such as cancer, cardiovascular diseases, and arthritis.	MT SINAI HOSP, SAMUEL LUNENFELD RES INST, CONNECT TISSURE RES GRP, TORONTO, ON M5G 1X5, CANADA; UNIV TORONTO, DEPT CELLULAR & MOLEC PATHOL, TORONTO, ON M5S 1A8, CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto								AGNEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BLAKE DR, 1987, BRIT MED BULL, V43, P371, DOI 10.1093/oxfordjournals.bmb.a072188; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CAMUSSI G, 1991, EUR J BIOCHEM, V202, P3, DOI 10.1111/j.1432-1033.1991.tb16337.x; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARK MA, 1988, BIOCHEM J, V250, P125, DOI 10.1042/bj2500125; CONQUER JA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P1, DOI 10.1016/0167-4889(92)90021-3; COUGHLIN SR, 1988, J BIOL CHEM, V263, P988; CRUZ TF, 1990, BIOCHEM J, V269, P717, DOI 10.1042/bj2690717; DAMOULIS PD, 1994, BIOCHEM BIOPH RES CO, V201, P924, DOI 10.1006/bbrc.1994.1790; DEUCHER GP, 1992, FREE RADICALS AGING, P428; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; ESCH F, 1985, P NATL ACAD SCI USA, V82, P6507, DOI 10.1073/pnas.82.19.6507; FIALKOW L, 1994, J BIOL CHEM, V269, P31234; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; FREESWICK PD, 1994, J SURG RES, V57, P205, DOI 10.1006/jsre.1994.1132; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HALIDAY EM, 1991, EMBO J, V10, P109, DOI 10.1002/j.1460-2075.1991.tb07926.x; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HENDERSON LM, 1993, EUR J BIOCHEM, V211, P157, DOI 10.1111/j.1432-1033.1993.tb19882.x; IMAMURA K, 1988, J BIOL CHEM, V263, P10247; ISACCHI A, 1992, ANGIOGENESIS KEY PRI, P101; KNAUER MF, 1990, J CELL PHYSIOL, V142, P469, DOI 10.1002/jcp.1041420305; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LOBB RR, 1986, ANAL BIOCHEM, V154, P1, DOI 10.1016/0003-2697(86)90487-2; LUNDJOHANSEN F, 1992, CYTOMETRY, V13, P693, DOI 10.1002/cyto.990130705; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; NOSE K, 1991, EUR J BIOCHEM, V201, P99, DOI 10.1111/j.1432-1033.1991.tb16261.x; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PATTE C, 1992, CELL MOL BIOL, V38, P429; PUCHACZ E, 1993, BRAIN RES, V610, P39, DOI 10.1016/0006-8993(93)91214-D; RAO GN, 1992, CIRC RES, V70, P593, DOI 10.1161/01.RES.70.3.593; RICHTER J, 1989, J IMMUNOL, V142, P3199; RICHTER J, 1990, P NATL ACAD SCI USA, V87, P9472, DOI 10.1073/pnas.87.23.9472; ROSE RC, 1993, FASEB J, V7, P1135, DOI 10.1096/fasebj.7.12.8375611; RUBINEK T, 1993, BIOCHIM BIOPHYS ACTA, V1176, P51, DOI 10.1016/0167-4889(93)90176-P; SA G, 1994, J BIOL CHEM, V269, P3219; SAKLATVALA J, 1993, FEBS LETT, V334, P189, DOI 10.1016/0014-5793(93)81709-9; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SHERMAN ML, 1990, J CLIN INVEST, V85, P442, DOI 10.1172/JCI114457; SPORN MB, 1990, HDB EXPT PHARM PEPTI, V95, P3; STEFANOVICRACIC M, 1993, ARTHRITIS RHEUM, V36, P1036, DOI 10.1002/art.1780360803; STEVENSON MA, 1994, CANCER RES, V54, P12; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; TIKU ML, 1990, J IMMUNOL, V145, P690; VERGHESE MW, 1987, J IMMUNOL, V138, P4374; VILCEK J, 1986, J EXP MED, V163, P632, DOI 10.1084/jem.163.3.632; ZAFARULLAH M, 1992, FEBS LETT, V306, P169, DOI 10.1016/0014-5793(92)80992-P	57	452	462	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11727	11730		10.1074/jbc.270.20.11727	http://dx.doi.org/10.1074/jbc.270.20.11727			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744816	hybrid			2022-12-27	WOS:A1995QY73600007
J	MCMAHON, RJ; FROST, SC				MCMAHON, RJ; FROST, SC			NUTRIENT CONTROL OF GLUT1 PROCESSING AND TURNOVER IN 3T3-L1 ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICKEN-EMBRYO FIBROBLASTS; GLUCOSE-TRANSPORT ACTIVITY; HAMSTER OVARY CELLS; HEXOSE TRANSPORTER; SUGAR-TRANSPORT; INSULIN; STARVATION; PROTEIN; BIOSYNTHESIS; DEPRIVATION	Metabolic labeling and immunoprecipitation were used to analyze the glucose-dependent regulation of GLUT1 synthesis, processing, and turnover in a murine adipocyte cell line, Metabolically labeled GLUT1 from control cells migrated as a 46-kDa protein, while GLUT1 from cells deprived of glucose for more than 12 h migrated as a 37-kDa protein, On the basis of tunicamycin sensitivity, both GLUT1 species arose from a common protein migrating at 36 kDa, In addition, the rate of synthesis of GLUT1 in control and glucose-deprived cells was similar, In short pulse-chase experiments, we distinguished two species arising from the core GLUT1 protein in control cells; an intermediate and the mature 46-kDa species, In contrast, only one glycoform, the 37-kDa species, arose from the core protein in glucose-deprived cells, which was not further processed in either the presence or absence of glucose. Although 12-18 h of glucose deprivation were required to affect GLUT1 glycosylation, glucose-deprived cells quickly recovered the ability to correctly glycosylate GLUT1 upon the readdition of glucose (t(1/2) < 1 h), GLUT1 in control adipocytes exhibited a half-life of approximately 14 h, while that in glucose-deprived adipocytes was greater than 50 h. This effect was readily reversed upon the readdition of glucose, In total, these data show that glucose deprivation alters both the processing (glycosylation) and turnover (degradation) of GLUT1, These results are discussed in light of transport function.	UNIV FLORIDA,DEPT BIOCHEM & MOLEC BIOL,GAINESVILLE,FL 32610	State University System of Florida; University of Florida					NIDDK NIH HHS [DK45035] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASANO T, 1991, J BIOL CHEM, V266, P24632; CHANEY W, 1986, J BIOL CHEM, V261, P551; DANKERT JR, 1985, BIOCHEMISTRY-US, V24, P2754, DOI 10.1021/bi00332a024; FEUGEAS JP, 1991, BIOCHIM BIOPHYS ACTA, V1066, P59, DOI 10.1016/0005-2736(91)90250-C; FROST SC, 1985, J BIOL CHEM, V260, P2646; GERMINARIO RJ, 1982, J CELL PHYSIOL, V112, P367, DOI 10.1002/jcp.1041120309; GOULD GW, 1990, TRENDS BIOCHEM SCI, V15, P17; HASPEL HC, 1988, J CELL PHYSIOL, V136, P361, DOI 10.1002/jcp.1041360221; HASPEL HC, 1985, J BIOL CHEM, V260, P7219; HASPEL HC, 1991, MOL ENDOCRINOL, V5, P61, DOI 10.1210/mend-5-1-61; KITZMAN HH, 1993, J BIOL CHEM, V268, P1320; KLETZIEN RF, 1975, J BIOL CHEM, V250, P593; KLIP A, 1994, FASEB J, V8, P43, DOI 10.1096/fasebj.8.1.8299889; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; MUECKLER M, 1986, CELL, V44, P629, DOI 10.1016/0092-8674(86)90272-2; REARICK JI, 1981, J BIOL CHEM, V256, P6255; REED BC, 1990, ARCH BIOCHEM BIOPHYS, V279, P261, DOI 10.1016/0003-9861(90)90490-P; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; SHAWVER LK, 1987, MOL CELL BIOL, V7, P2112, DOI 10.1128/MCB.7.6.2112; SIGEL MB, 1983, METHOD ENZYMOL, V93, P3; TORDJMAN KM, 1990, BIOCHEM J, V271, P201, DOI 10.1042/bj2710201; VANPUTTEN JPM, 1985, J BIOL CHEM, V260, P7996; WALKER PS, 1989, J BIOL CHEM, V264, P6587; YAMADA K, 1983, J BIOL CHEM, V258, P9786	24	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12094	12099		10.1074/jbc.270.20.12094	http://dx.doi.org/10.1074/jbc.270.20.12094			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744857	hybrid			2022-12-27	WOS:A1995QY73600060
J	FINCH, PW; LENGEL, C; CHEDID, M				FINCH, PW; LENGEL, C; CHEDID, M			CLONING AND CHARACTERIZATION OF THE PROMOTER REGION OF THE HUMAN KERATINOCYTE GROWTH-FACTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY REGIONS; FACTOR RECEPTORS; OVALBUMIN GENE; EXPRESSION; SEQUENCE; IDENTIFICATION; TRANSCRIPTION; PROTEIN; FAMILY; INTERLEUKIN-6	Keratinocyte growth factor (KGF), a member of the fibroblast growth factor family of related proteins, is expressed by stromal fibroblasts and acts on epithelial cells in a paracrine fashion. To understand the mechanisms responsible for regulating normal KGF expression and how these might be altered in disease, the 5'-flanking region of this gene was cloned. The presence of two KGF transcription initiation sites was suggested by ribonuclease protection assay and confirmed by primer extension analysis. Examination of the genomic DNA sequence revealed the presence of the putative promoter sequences TATTTA and CCAAT, located 31 and 50 base pairs upstream, respectively, from the first of the two mRNA start points, and putative initiator sequences surrounding each transcription start site, Transient transfection into murine NIH/3T3 fibroblasts demonstrated that the region required for basal level KGF promoter activity was located between bases -225 and +190. Inclusion of sequences between -1503 and -775 markedly reduced promoter activation, indicating the presence of negative regulatory element(s) in this region. A similar pattern of promoter activation was detected in human fibroblasts and in murine C2C12 myoblasts. In contrast, no chloramphenicol acetyltransferase activity was observed in macrophages and epithelial and lymphoid cells transfected with the same constructs. Northern blot analysis revealed a strong correlation between KGF RNA expression and promoter activation in all cells tested. Activation of the KGF promoter could be induced by the proinflammatory cytokines interleukin 1 and interleukin 6 and by the adenylate cyclase activator forskolin. Taken together, these results indicate the existence of cis-acting element(s) responsible for selective activation of the KGF promoter only in cells that express KGF mRNA and may provide a mechanistic basis for KGF gene expression during inflammation.	NCI,CELLULAR & MOLEC BIOL LAB,BETHESDA,MD 20892; BROWN UNIV,RHODE ISL HOSP,DEPT CLIN NEUROSCI,PROVIDENCE,RI 02903	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Brown University; Lifespan Health Rhode Island; Rhode Island Hospital								ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; ALARID ET, 1994, P NATL ACAD SCI USA, V91, P1074, DOI 10.1073/pnas.91.3.1074; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BOTTARO DP, 1990, J BIOL CHEM, V265, P12767; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHEDID M, 1994, J BIOL CHEM, V269, P10753; DAS HK, 1988, J BIOL CHEM, V263, P11452; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884; DRESCENZI M, 1994, J CELL BIOL, V125, P1137; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; GOLDFARB M, 1990, CELL GROWTH DIFFER, V1, P439; HEBST RS, 1989, P NATL ACAD SCI USA, V83, P7653; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HIRANO T, 1992, CLIN IMMUNOL IMMUNOP, V62, pS60, DOI 10.1016/0090-1229(92)90042-M; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KELLEY MJ, 1992, P NATL ACAD SCI USA, V89, P9287, DOI 10.1073/pnas.89.19.9287; KEMLER I, 1989, EMBO J, V8, P2001, DOI 10.1002/j.1460-2075.1989.tb03607.x; LE JM, 1989, LAB INVEST, V61, P588; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MASON JJ, 1994, MECH DEVELOP, V45, P15; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MELTON DW, 1986, CELL, V44, P319, DOI 10.1016/0092-8674(86)90766-X; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; RIGGS KJ, 1991, MOL CELL BIOL, V11, P1765, DOI 10.1128/MCB.11.3.1765; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SLEIGH MJ, 1986, ANAL BIOCHEM, V156, P251, DOI 10.1016/0003-2697(86)90180-6; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; TAYLOR KA, 1994, J VIROL, V68, P6421, DOI 10.1128/JVI.68.10.6421-6431.1994; TORA L, 1988, EMBO J, V7, P3771, DOI 10.1002/j.1460-2075.1988.tb03261.x; WANG WP, 1989, MOL CELL BIOL, V9, P2387, DOI 10.1128/MCB.9.6.2387; WEISSMAN JD, 1991, MOL CELL BIOL, V11, P4228, DOI 10.1128/MCB.11.8.4228; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; YAN GC, 1992, MOL ENDOCRINOL, V6, P2123, DOI 10.1210/me.6.12.2123; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	50	37	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11230	11237		10.1074/jbc.270.19.11230	http://dx.doi.org/10.1074/jbc.270.19.11230			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744756	hybrid			2022-12-27	WOS:A1995QX86500033
J	HANIEL, A; WELGELUSSEN, U; KUHN, K; POSCHL, E				HANIEL, A; WELGELUSSEN, U; KUHN, K; POSCHL, E			IDENTIFICATION AND CHARACTERIZATION OF A NOVEL TRANSCRIPTIONAL SILENCER IN THE HUMAN COLLAGEN TYPE-IV GENE COL4A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; F9 TERATOCARCINOMA CELLS; COMMON PROMOTER REGION; GROWTH-FACTOR-BETA; RNA POLYMERASE-II; HEAD-TO-HEAD; DIVERGENT TRANSCRIPTION; EUKARYOTIC TRANSCRIPTION; BIDIRECTIONAL PROMOTER; BINDING PROTEIN	Collagen type IV [alpha 1(IV)(2) alpha 2(IV)] is the basic structural component of all basement membranes. The two subunit genes COL4A1 and COL4A2 are found closely linked in the human and murine genomes and are transcribed divergently from a common promoter, Previously, activating elements had been detected within both genes which are indispensable for efficient transcription. An additional negative regulatory element has now been identified within the third intron of the COL4A2 gene which is able to inhibit transcription of both COL4 genes from their shared promoter, as well as the nonrelated herpes simplex virus thymidine kinase promoter. The element exerts its inhibitory effect largely independently from its relative orientation and distance from the initiation site of transcription. Therefore, the element represents a silencer, which is named the ''COL4 silencer.'' The minimal functional silencer could be narrowed down by deletion mapping to a sequence element located within intron 3 of the COL4A2 gene. This motif is specifically recognized by a nuclear protein, named ''SILBF,'' and the binding site of which was determined by footprinting assays. Mutation studies and deletion analysis proved that the presence of this sequence element and its interaction with SILBF is not only essential but also sufficient for the silencing function. We assume that the COL4 silencer plays an important role in the control of overall expression and the balance of divergent transcription of both COL4 genes.	UNIV ERLANGEN NURNBERG,INST EXPTL MED,D-91054 ERLANGEN,GERMANY; MAX PLANCK INST BIOCHEM,BINDEGEWEBSFORSCH ABT,D-82152 MARTINSRIED,GERMANY	University of Erlangen Nuremberg; Max Planck Society								BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BURBELO PD, 1990, J BIOL CHEM, V265, P4839; BURBELO PD, 1988, P NATL ACAD SCI USA, V85, P9679, DOI 10.1073/pnas.85.24.9679; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; CHIANG PK, 1992, J BIOL CHEM, V267, P4988; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; FISCHER G, 1993, BIOCHEM J, V292, P687, DOI 10.1042/bj2920687; GARABEDIAN MJ, 1985, P NATL ACAD SCI USA, V82, P1396, DOI 10.1073/pnas.82.5.1396; GENERSCH E, 1994, EMBO J, V14, P791; GIDONI D, 1985, SCIENCE, V230, P511, DOI 10.1126/science.2996137; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; GUO XD, 1991, NATURE, V349, P707, DOI 10.1038/349707a0; HEIKKILA P, 1993, J BIOL CHEM, V268, P24677; HENNIGHAUSEN L, 1987, METHOD ENZYMOL, V152, P721; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HERSCHBACH BM, 1993, ANNU REV CELL BIOL, V9, P479, DOI 10.1146/annurev.cellbio.9.1.479; HORTON W, 1987, P NATL ACAD SCI USA, V84, P8864, DOI 10.1073/pnas.84.24.8864; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; JACKSON ME, 1991, J CELL SCI, V100, P1; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; KALLURI R, 1991, J BIOL CHEM, V266, P24018; KARSENTY G, 1988, J BIOL CHEM, V263, P13909; KARSENTY G, 1991, J BIOL CHEM, V266, P24842; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; KAYTES P, 1988, J BIOL CHEM, V263, P19274; KHOURY G, 1983, CELL, V33, P313, DOI 10.1016/0092-8674(83)90410-5; KOHNO K, 1985, J BIOL CHEM, V260, P4441; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MARIYAMA M, 1992, GENOMICS, V13, P809, DOI 10.1016/0888-7543(92)90157-N; NATARAJAN V, 1984, P NATL ACAD SCI-BIOL, V81, P6290, DOI 10.1073/pnas.81.20.6290; OSLEY MA, 1986, CELL, V45, P537, DOI 10.1016/0092-8674(86)90285-0; POLLNER R, 1990, ANN NY ACAD SCI, V580, P44, DOI 10.1111/j.1749-6632.1990.tb17916.x; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; RAVAZZOLO R, 1991, J BIOL CHEM, V266, P7382; RENKAWITZ R, 1990, TRENDS GENET, V6, P192, DOI 10.1016/0168-9525(90)90176-7; RITZENTHALER JD, 1991, BIOCHEM J, V280, P157, DOI 10.1042/bj2800157; ROGERS MB, 1990, J CELL BIOL, V110, P1767, DOI 10.1083/jcb.110.5.1767; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; SCHMIDT C, 1993, BIOCHIM BIOPHYS ACTA, V1174, P1, DOI 10.1016/0167-4781(93)90085-R; SOININEN R, 1988, J BIOL CHEM, V263, P17217; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; WILLIAMS TJ, 1986, MOL CELL BIOL, V6, P4558, DOI 10.1128/MCB.6.12.4558; YAMADA Y, 1990, ANN NY ACAD SCI, V580, P81, DOI 10.1111/j.1749-6632.1990.tb17920.x; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	54	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11209	11215		10.1074/jbc.270.19.11209	http://dx.doi.org/10.1074/jbc.270.19.11209			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744753	hybrid			2022-12-27	WOS:A1995QX86500030
J	SHAPIRO, AD; PFEFFER, SR				SHAPIRO, AD; PFEFFER, SR			QUANTITATIVE-ANALYSIS OF THE INTERACTIONS BETWEEN PRENYL RAB9, GDP DISSOCIATION INHIBITOR-ALPHA, AND GUANINE-NUCLEOTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; TRANS GOLGI NETWORK; SMG P25A; REGULATORY PROTEIN; EXCHANGE PROTEIN; LATE ENDOSOMES; BOVINE BRAIN; RAS; MEMBRANE; KINETICS	Rab9 is a Ras-like GTPase required for the transport of mannose 6-phosphate receptors between late endosomes and the trans Golgi network. Rab9 occurs in the cytosol as a complex with GDP dissociation inhibitor (GDI), which we have shown delivers prenyl Rab9 to late endosomes in a functional form. We report here basal rate constants for guanine nucleotide dissociation and GTP hydrolysis for prenyl Rab9. Both rate constants were influenced in part by the hydrophobic environment of the prenyl group. Guanine nucleotide dissociation and GTP hydrolysis rates were lower in the presence of lipid; detergent stimulated intrinsic nucleotide exchange. GDI-alpha inhibited GDP dissociation from prenyl Rab9 by 2.4-fold. GDI-alpha associated with prenyl Rab9 with a K-D of 60 nM in 0.1% Lubrol and 23 nM in 0.02% Lubrol. In 0.1% Lubrol, GDI-alpha inhibited GDP dissociation half maximally at 72 +/- 18 nM, consistent with the K-D determinations. These data suggest that GDI-alpha associates with prenyl Rab9 with a K-D of less than or equal to 23 nM under physiological conditions. Finally, a previously uncharacterized minor form of GDI-alpha inhibited GDP dissociation from prenyl Babe by 1.9-fold and bound prenyl Rab9 with a K-D of 67 nM in 0.1% Lubrol.			SHAPIRO, AD (corresponding author), STANFORD UNIV,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305, USA.				NIDDK NIH HHS [DK37332] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037332, R56DK037332, R01DK037332] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARAKI S, 1990, J BIOL CHEM, V265, P13007; BERANGER F, 1994, J BIOL CHEM, V269, P13637; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; DIRACSVEJSTRUP AB, 1994, J BIOL CHEM, V269, P15427; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; GARRETT MD, 1993, FEBS LETT, V331, P233, DOI 10.1016/0014-5793(93)80343-S; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; GRIFFITHS G, 1989, J CELL BIOL, V109, P2703, DOI 10.1083/jcb.109.6.2703; KABCENELL AK, 1990, J BIOL CHEM, V265, P9366; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; MATSUI Y, 1990, MOL CELL BIOL, V10, P4116, DOI 10.1128/MCB.10.8.4116; MUSHA T, 1992, J BIOL CHEM, V267, P9821; NISHIMURA N, 1994, J BIOL CHEM, V269, P14191; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SASAKI T, 1991, MOL CELL BIOL, V11, P2909, DOI 10.1128/MCB.11.5.2909; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SHAPIRO AD, 1993, J BIOL CHEM, V268, P6925; SHISHEVA A, 1994, J BIOL CHEM, V269, P23865; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; SOLDATI T, 1995, IN PRESS METHODS ENZ; STEELEMORTIMER O, 1993, FEBS LETT, V329, P313, DOI 10.1016/0014-5793(93)80244-O; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; ZAHNER JE, 1993, MOL CELL BIOL, V13, P217, DOI 10.1128/MCB.13.1.217; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I	36	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11085	11090		10.1074/jbc.270.19.11085	http://dx.doi.org/10.1074/jbc.270.19.11085			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744738	hybrid			2022-12-27	WOS:A1995QX86500013
J	GARRED, O; VANDEURS, B; SANDVIG, K				GARRED, O; VANDEURS, B; SANDVIG, K			FURIN-INDUCED CLEAVAGE AND ACTIVATION OF SHIGA TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREFELDIN-A; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; PROTECTIVE ANTIGEN; SECRETORY PROTEINS; GOLGI-COMPLEX; CELL-SURFACE; ENDOPROTEASE; ENDOCYTOSIS	Shiga toxin has a single A subunit non-covalently associated with a pentamer of B subunits. The toxin has a trypsin-sensitive region near the COOH-terminal end of the A-chain, and upon cleavage, two disulfide bonded fragments, A(1) and A(2), are generated. These fragments are also formed upon incubation with cells. The disulfide loop contains the sequence (Arg-X-X-Arg), which is a consensus motif for cleavage by the membrane-anchored protease furin. We found that a soluble form of furin cleaves intact A-chain producing A(1) and A(2) fragments, and furin also seems to be responsible for rapid cellular cleavage of Shiga toxin. LoVo cells, which normally do not produce functional furin, cleave intact A-chain very efficiently when transfected with furin (LoVo/fur), whereas a control cell (LoVo/neo) cleaves the toxin very slowly. To investigate the role of this cleavage for intoxication of cells, we studied the ability of unnicked and furin-nicked toxin to inhibit protein synthesis in LoVo/fur and LoVo/neo cells. LoVo/fur cells were intoxicated equally well with unnicked and nicked toxin, whereas in LoVo/neo cells nicked toxin was about 20 times more active than unnicked toxin. The results suggest that cleavage of Shiga toxin is important for intoxication of cells, and they indicate that furin can cleave and thereby activate Shiga toxin in cells.	NORWEGIAN RADIUM HOSP, INST CANC RES, N-0310 OSLO, NORWAY; UNIV COPENHAGEN, PANUM INST, DEPT ANAT, STRUCT CELL BIOL UNIT, DK-2200 COPENHAGEN, DENMARK	University of Oslo; University of Copenhagen								BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; BURGESS BJ, 1993, MOL MICROBIOL, V10, P171, DOI 10.1111/j.1365-2958.1993.tb00913.x; CHIRON MF, 1994, J BIOL CHEM, V269, P18167; COHEN A, 1987, J BIOL CHEM, V262, P17088; DAMKE H, 1991, J BIOL CHEM, V266, P24829; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; FUJIWARA T, 1989, CELL STRUCT FUNCT, V14, P605, DOI 10.1247/csf.14.605; HALBAN PA, 1994, BIOCHEM J, V299, P1; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; KIRSCHKE H, 1977, EUR J BIOCHEM, V74, P293, DOI 10.1111/j.1432-1033.1977.tb11393.x; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; KONGMUANG U, 1988, FEMS MICROBIOL LETT, V56, P105, DOI 10.1016/0378-1097(88)90135-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; OBRIEN AD, 1992, PATHOGENESIS SHIGELL, P65; OLSNES S, 1981, J BIOL CHEM, V256, P8732; PELHAM H R B, 1992, Trends in Cell Biology, V2, P183, DOI 10.1016/0962-8924(92)90230-K; SAMUEL JE, 1994, J BIOL CHEM, V269, P4853; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; SANDVIG K, 1991, J CELL BIOL, V113, P553, DOI 10.1083/jcb.113.3.553; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SANDVIG K, 1994, J CELL BIOL, V126, P53, DOI 10.1083/jcb.126.1.53; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; SAXENA SK, 1989, J BIOL CHEM, V264, P596; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; TSUNEOKA M, 1993, J BIOL CHEM, V268, P26461; ULMER JB, 1989, P NATL ACAD SCI USA, V86, P6992, DOI 10.1073/pnas.86.18.6992; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; VANDEURS B, 1989, INT REV CYTOL, V117, P131; YAMASHINA S, 1990, CELL STRUCT FUNCT, V15, P31, DOI 10.1247/csf.15.31	44	167	177	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10817	10821						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738018				2022-12-27	WOS:A1995QW60100066
J	RAY, P; ZHANG, DH; ELIAS, JA; RAY, A				RAY, P; ZHANG, DH; ELIAS, JA; RAY, A			CLONING OF A DIFFERENTIALLY EXPRESSED I-KAPPA-B-RELATED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; TUMOR-NECROSIS-FACTOR; ANKYRIN-LIKE REPEATS; TRANSCRIPTION FACTORS; PROTOONCOGENE BCL-3; INTERLEUKIN-6 GENE; REL FAMILY; DROSOPHILA; DNA; ACTIVATION	We have cloned a cDNA corresponding to a novel gene from a human epithelial cell line by subtractive hybridization and polymerase chain reaction techniques, This gene is expressed at the message level and at the protein level in a lung alveolar type II-like epithelial cell line but not in lung fibroblasts. In adult human tissues, the mRNA for this gene was detected only in the heart and the skeletal muscle, but not in the brain, placenta, whole lung, liver, or kidney. We have named this gene I kappa BR (for I kappa B-related) since its 52-kDa protein product has significant homology to the I kappa B family of proteins which function as inhibitory cytoplasmic retention proteins for the vertebrate rel/NF-kappa B transcription factors. Although the important role of NF-kappa B in gene activation in cells of the immune system is now well established, a similar role in other cell types or in vertebrate development is less clear. The deduced amino acid sequence of I kappa BR has the most significant homology to the Drosophila protein Cactus which inhibits the function of the NF KB-like protein Dorsal. In electrophoretic mobility shift experiments, I kappa BR inhibited the ability of the p50: p65 NF-kappa B heterodimer to bind DNA. The DNA binding ability of the p50 homodimer but not the p65 homodimer was drastically inhibited by I kappa BR. In transfection experiments, overexpression of I kappa BR significantly inhibited NF-kappa B-dependent transcription from the Ig kappa enhancer. This new member of the I kappa B family of proteins, I kappa BR, may play an important role in regulation of NF-kappa B function in epithelial cells.			RAY, P (corresponding author), YALE UNIV,SCH MED,DEPT INTERNAL MED,PULM & CRIT CARE SECT,333 CEDAR ST,NEW HAVEN,CT 06520, USA.				NHLBI NIH HHS [HL 52014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL052014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMSON IYR, 1974, LAB INVEST, V30, P35; ALBERTELLA MR, 1994, HUM MOL GENET, V3, P793, DOI 10.1093/hmg/3.5.793; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baeuerle P. A., 1991, MOL ASPECTS CELLULAR, P409; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BENNETT V, 1992, J BIOL CHEM, V267, P8703; Bernfield M., 1984, ROLE EXTRACELLULAR M, P545; BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y; DAVIS LH, 1991, J BIOL CHEM, V266, P11163; DAVIS N, 1991, SCIENCE, V253, P1268, DOI 10.1126/science.1891714; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; FORSTER AC, 1985, NUCLEIC ACIDS RES, V13, P745, DOI 10.1093/nar/13.3.745; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GRILLI M, 1993, INT REV CYTOL, V143, P1; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LIOU HC, 1992, EMBO J, V11, P3003, DOI 10.1002/j.1460-2075.1992.tb05370.x; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MILNER CM, 1993, BIOCHEM J, V290, P811, DOI 10.1042/bj2900811; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; NORRIS JL, 1992, GENE DEV, V6, P1654, DOI 10.1101/gad.6.9.1654; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PRICE GJ, 1987, BIOCHEM J, V245, P595, DOI 10.1042/bj2450595; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; RAY A, 1994, J BIOL CHEM, V269, P12940; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; ROEHL H, 1993, NATURE, V364, P632, DOI 10.1038/364632a0; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818	44	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10680	10685		10.1074/jbc.270.18.10680	http://dx.doi.org/10.1074/jbc.270.18.10680			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738005	hybrid			2022-12-27	WOS:A1995QW60100049
J	SOLDAINI, E; PLA, M; BEERMANN, F; ESPEL, E; CORTHESY, P; BARANGE, S; WAANDERS, GA; MACDONALD, HR; NABHOLZ, M				SOLDAINI, E; PLA, M; BEERMANN, F; ESPEL, E; CORTHESY, P; BARANGE, S; WAANDERS, GA; MACDONALD, HR; NABHOLZ, M			MOUSE INTERLEUKIN-2 RECEPTOR-ALPHA GENE-EXPRESSION - DELIMITATION OF CIS-ACTING REGULATORY ELEMENTS IN TRANSGENIC MICE AND BY MAPPING OF DNASE-I HYPERSENSITIVE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMATURE LYT-2-/L3T4 THYMOCYTES; GROWTH-FACTOR RECEPTORS; MONOCLONAL-ANTIBODIES; CHAIN GENE; LYMPHOCYTE-T; STEM-CELLS; IL-2; ACTIVATION; CHROMATIN; MURINE	The alpha chain of the interleukin-2 receptor (IL-2R alpha) is a key regulator of lymphocyte proliferation, To analyze the mechanisms controlling its expression in normal cells, we used the 5'-flanking region (base pairs -2539/+93) of the mouse gene to drive chloramphenicol acetyltransferase expression in four transgenic mouse lines, Constitutive transgene activity was restricted to lymphoid organs, In mature T lymphocytes, transgene and endogenous IL-2R alpha gene expression was stimulated by concanavalin A and up regulated by IL-2 with very similar kinetics, In thymic T cell precursors, IL-1 and IL-2 cooperatively induced transgene and IL-2R alpha gene expression, These results show that regulation of the endogenous IL-2R alpha gene occurs mainly at the transcrip tional level, They demonstrate that cis-acting elements in the 5'-flanking region present in the transgene confer correct tissue specificity and inducible expression in mature T cells and their precursors in response to antigen, IL-1, and IL-2, In a complementary approach, we screened the 5' end of the endogenous IL-2R alpha gene for DNase-I hypersensitive sites, We found three lymphocyte specific DNase-I hypersensitive sites. Two, at -0.05 and -5.3 kilobase pairs, are present in resting T cells, A third site appears at -1.35 kilobase pairs in activated T cells, It co-localizes with IL-2-responsive elements identified by transient transfection experiments.	SWISS INST EXPTL CANC RES,CH-1066 EPALINGES,SWITZERLAND; LUDWIG INST CANC RES,CH-1066 EPALINGES,SWITZERLAND	Swiss Institute Experimental Cancer Research; Ludwig Institute for Cancer Research			Espel, Enric/ABD-3481-2020; Pla, Maria/K-5170-2017	Espel, Enric/0000-0003-1666-3821; Pla, Maria/0000-0003-4382-5494				ARDAVIN C, 1992, EUR J IMMUNOL, V22, P859, DOI 10.1002/eji.1830220334; BALLARD D W, 1989, New Biologist, V1, P83; BEERMANN F, 1993, MECH DEVELOP, V42, P59, DOI 10.1016/0925-4773(93)90098-I; BISMUTH G, 1985, EUR J IMMUNOL, V15, P723, DOI 10.1002/eji.1830150716; BRAUN MY, 1993, EUR J IMMUNOL, V23, P1462, DOI 10.1002/eji.1830230710; BROMBACHER F, 1994, INT IMMUNOL, V6, P189, DOI 10.1093/intimm/6.2.189; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CAO XQ, 1993, P NATL ACAD SCI USA, V90, P8464, DOI 10.1073/pnas.90.18.8464; CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0; CHEN JZ, 1994, INT IMMUNOL, V6, P1265, DOI 10.1093/intimm/6.8.1265; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CROSS SL, 1989, SCIENCE, V244, P466, DOI 10.1126/science.2497520; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; ERARD F, 1984, J EXP MED, V160, P584, DOI 10.1084/jem.160.2.584; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FREIMUTH WW, 1989, J IMMUNOL, V143, P3064; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; GEPPERT TD, 1987, J IMMUNOL, V138, P1660; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0; HOGAN B, 1986, MANIPULATING MOUSE E; HOWE RC, 1988, J IMMUNOL, V140, P1047; HYDE JE, 1979, NUCLEIC ACIDS RES, V7, P31, DOI 10.1093/nar/7.1.31; IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759; KIMURA A, 1981, EUR J IMMUNOL, V11, P475, DOI 10.1002/eji.1830110607; KRONKE M, 1985, J EXP MED, V161, P1593, DOI 10.1084/jem.161.6.1593; Laemmli UK, 1992, CURR OPIN GENET DEV, V2, P275, DOI 10.1016/S0959-437X(05)80285-0; LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LIN BB, 1990, MOL CELL BIOL, V10, P850, DOI 10.1128/MCB.10.2.850; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; LOUGHNAN MS, 1987, P NATL ACAD SCI USA, V84, P5399, DOI 10.1073/pnas.84.15.5399; LOWENTHAL JW, 1988, P NATL ACAD SCI USA, V85, P4468, DOI 10.1073/pnas.85.12.4468; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; LOWENTHAL JW, 1986, J IMMUNOL, V137, P2579; MALEK TR, 1985, J EXP MED, V161, P1575, DOI 10.1084/jem.161.6.1575; MILLER AE, 1992, IMMUNOGENETICS, V35, P24, DOI 10.1007/BF00216623; MILLER MR, 1978, BIOCHEMISTRY-US, V17, P1073, DOI 10.1021/bi00599a021; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; MOREAU JL, 1987, EUR J IMMUNOL, V17, P929, DOI 10.1002/eji.1830170706; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; PHILIP R, 1993, J BIOL CHEM, V268, P16087; PIMENTELMUINOS FX, 1994, J IMMUNOL, V152, P5714; PLAETINCK G, 1990, J IMMUNOL, V145, P3340; POMERANTZ JL, 1989, J IMMUNOL, V143, P4275; RAULET DH, 1985, NATURE, V314, P101, DOI 10.1038/314101a0; ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455; ROCHA B, 1993, J IMMUNOL, V140, P1076; ROEDERER M, 1991, Methods (Orlando), V2, P248, DOI 10.1016/S1046-2023(05)80067-2; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; ROMAN D, 1990, New Biologist, V2, P642; ROTHENBERG EV, 1994, EUR J IMMUNOL, V24, P24, DOI 10.1002/eji.1830240105; SOLDAINI E, 1992, EUR J IMMUNOL, V22, P1707, DOI 10.1002/eji.1830220707; SPERISEN P, 1995, J BIOL CHEM, V270, P10743, DOI 10.1074/jbc.270.18.10743; STEWART AF, 1991, NUCLEIC ACIDS RES, V19, P3157, DOI 10.1093/nar/19.11.3157; TAKACS L, 1985, CLIN EXP IMMUNOL, V59, P37; TANAKA T, 1991, J IMMUNOL, V147, P2222; TOLEDANO MB, 1990, P NATL ACAD SCI USA, V87, P1830, DOI 10.1073/pnas.87.5.1830; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; WAGA S, 1993, J BIOL CHEM, V268, P6429; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; WILSON A, 1994, EUR J IMMUNOL, V24, P1729, DOI 10.1002/eji.1830240802; ZHANG L, 1990, NUCLEIC ACIDS RES, V18, P1797, DOI 10.1093/nar/18.7.1797; ZURAWSKI SM, 1986, J IMMUNOL, V137, P3354	69	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10733	10742		10.1074/jbc.270.18.10733	http://dx.doi.org/10.1074/jbc.270.18.10733			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738012				2022-12-27	WOS:A1995QW60100056
J	AQVIST, J; MOWBRAY, SL				AQVIST, J; MOWBRAY, SL			SUGAR RECOGNITION BY A GLUCOSE/GALACTOSE RECEPTOR - EVALUATION OF BINDING ENERGETICS FROM MOLECULAR-DYNAMICS SIMULATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; HYDROGEN-BONDS; PROTEIN; GALACTOSE; SIMULATIONS; CHEMOTAXIS; TRANSPORT; ENERGY	A new theoretical method for free energy calculations is used to compute the absolute binding constants for beta-D-glucose and methyl-beta-D-galactoside to the periplasmic glucose/galactose receptor from Salmonella typhimurium. The computer simulation results agree well with available experimental data and make it possible to assess the sources of both the high affinity as well as the specificity for glucose. It was found that the major contribution to the binding energy comes from electrostatic interactions and particularly hydrogen bonds of the charge-dipole type. We also predict the structure of the complex with methyl-galactoside as this has not yet been experimentally determined.			AQVIST, J (corresponding author), SWEDISH UNIV AGR SCI,UPPSALA BIOMED CTR,DEPT MOLEC BIOL,BOX 590,S-75124 UPPSALA,SWEDEN.		Mowbray, Sherry L/D-2141-2013					ANRAKU Y, 1968, J BIOL CHEM, V243, P3116; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; AQVIST J, 1994, J PHYS CHEM-US, V98, P8253, DOI 10.1021/j100084a049; AQVIST J, 1993, J AM CHEM SOC, V115, P631; BOOS W, 1969, EUR J BIOCHEM, V10, P66; FLOCCO MM, 1994, J BIOL CHEM, V269, P8931; HAZELBAUER GL, 1971, NATURE-NEW BIOL, V230, P101, DOI 10.1038/newbio230101a0; LEE FS, 1992, J CHEM PHYS, V97, P3100, DOI 10.1063/1.462997; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; MILLER DM, 1980, J BIOL CHEM, V255, P2465; MIYAMOTO S, 1993, P NATL ACAD SCI USA, V90, P8402, DOI 10.1073/pnas.90.18.8402; Mowbray S L, 1990, Receptor, V1, P41; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V742, P16, DOI 10.1016/0167-4838(83)90353-9; ROTMAN B, 1972, Journal of Bacteriology, V111, P791; STRAATSMA TP, 1992, ANNU REV PHYS CHEM, V43, P407; van Gunsteren W. F., 1987, GRONINGEN MOL SIMULA; VERMERSCH PS, 1992, J MOL BIOL, V226, P923, DOI 10.1016/0022-2836(92)91041-M; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267; Warshel A, 1989, COMPUTER SIMULATIONS, P120; ZOU JY, 1993, J MOL BIOL, V233, P739, DOI 10.1006/jmbi.1993.1549; ZUKIN RS, 1977, BIOCHEMISTRY-US, V16, P381, DOI 10.1021/bi00622a007	23	69	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9978	9981						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730381				2022-12-27	WOS:A1995QV41700043
J	ENGLANDER, EW; HOWARD, BH				ENGLANDER, EW; HOWARD, BH			NUCLEOSOME POSITIONING BY HUMAN ALU ELEMENTS IN CHROMATIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-III; REPEATED DNA-SEQUENCES; TUMOR VIRUS PROMOTER; MAMMALIAN GENOMES; TRANSGENIC MICE; XENOPUS-LAEVIS; GLOBIN GENES; TRANSCRIPTION; FAMILY; ORGANIZATION	Alu sequences are interspersed throughout the genomes of primate cells, occurring singly and in clusters around RNA polymerase II-transcribed genes, Because these repeat elements are capable of positioning nucleosomes in in vitro reconstitutes (Englander, E. W., Wolffe, A. P., and Howard, B. H. (1993) J. Biol. Chem. 268, 19565-19573), we investigated whether they also influence in vivo chromatin structure. When assayed collectively using consensus sequence probes and native chromatin as template, Alu family members were found to confer rotational positioning on nucleosomes or nucleosome-like particles. In particular, a 10-base pair pattern of DNase I nicking that spanned the RNA polymerase III box A promoter motif extended upstream to cover diverse 5'-flanking sequences, suggesting that Alu repeats may in fluence patterns of nucleosome formation over neighboring regions. Computational analysis of a set of naturally occurring Alu sequences indicated that nucleosome positioning information is intrinsic to these elements, Inasmuch as local chromatin organization influences gene expression, the capacity of Alu sequences to affect chromatin structure as demonstrated here may help to clarify some features of these elements.	NICHHD, MOLEC GROWTH REGULAT LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								ARONOW BJ, 1992, MOL CELL BIOL, V12, P4170, DOI 10.1128/MCB.12.9.4170; ARVEILER B, 1992, MAMM GENOME, V3, P661, DOI 10.1007/BF00444360; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P865, DOI 10.1093/nar/20.4.865; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; BUTTINELLI M, 1993, P NATL ACAD SCI USA, V90, P9315, DOI 10.1073/pnas.90.20.9315; CALLADINE CR, 1986, J MOL BIOL, V192, P907, DOI 10.1016/0022-2836(86)90036-7; CHEN EY, 1991, GENOMICS, V10, P792, DOI 10.1016/0888-7543(91)90465-Q; CHIPEV CC, 1992, MOL CELL BIOL, V12, P45, DOI 10.1128/MCB.12.1.45; COSTANZO G, 1990, J MOL BIOL, V216, P363, DOI 10.1016/S0022-2836(05)80327-4; DANIELS GR, 1985, NATURE, V317, P819, DOI 10.1038/317819a0; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; DUNCAN C, 1979, P NATL ACAD SCI USA, V76, P5095, DOI 10.1073/pnas.76.10.5095; DUNCAN CH, 1981, GENE, V13, P185, DOI 10.1016/0378-1119(81)90007-X; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; ELDER JT, 1981, NUCLEIC ACIDS RES, V9, P1171, DOI 10.1093/nar/9.5.1171; ENGLANDER EW, 1993, J BIOL CHEM, V268, P19565; FITZGERALD PC, 1985, J BIOL CHEM, V260, P5318; FUHRMAN SA, 1981, NUCLEIC ACIDS RES, V9, P6439, DOI 10.1093/nar/9.23.6439; GIBBS PEM, 1987, BIOCHEMISTRY-US, V26, P1332, DOI 10.1021/bi00379a020; GOTTESFELD JM, 1987, MOL CELL BIOL, V7, P1612, DOI 10.1128/MCB.7.5.1612; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; HAYES JJ, 1993, P NATL ACAD SCI USA, V90, P6415, DOI 10.1073/pnas.90.14.6415; HELLMANNBLUMBERG U, 1993, MOL CELL BIOL, V13, P4523, DOI 10.1128/MCB.13.8.4523; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; HOWARD B H, 1990, New Biologist, V2, P759; HWU HR, 1986, P NATL ACAD SCI USA, V83, P3875, DOI 10.1073/pnas.83.11.3875; IRIS FJM, 1993, NAT GENET, V3, P137, DOI 10.1038/ng0293-137; JELINEK WR, 1982, ANNU REV BIOCHEM, V51, P813, DOI 10.1146/annurev.bi.51.070182.004121; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; KARIYA Y, 1987, GENE, V53, P1, DOI 10.1016/0378-1119(87)90087-4; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; MATERA AG, 1990, MOL CELL BIOL, V10, P5424, DOI 10.1128/MCB.10.10.5424; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; MOYZIS RK, 1989, GENOMICS, V4, P273, DOI 10.1016/0888-7543(89)90331-5; NEZNANOV NS, 1993, MOL CELL BIOL, V13, P1815, DOI 10.1128/MCB.13.3.1815; Okada N, 1991, CURR OPIN GENET DEV, V1, P498, DOI 10.1016/S0959-437X(05)80198-4; PAN J, 1981, NUCLEIC ACIDS RES, V9, P1151; PANNING B, 1993, MOL CELL BIOL, V13, P3231, DOI 10.1128/MCB.13.6.3231; PANNING B, 1994, VIROLOGY, V202, P408, DOI 10.1006/viro.1994.1357; PEREZSTABLE C, 1984, P NATL ACAD SCI-BIOL, V81, P5291, DOI 10.1073/pnas.81.17.5291; PINA B, 1990, J MOL BIOL, V216, P975, DOI 10.1016/S0022-2836(99)80015-1; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; PRUNELL A, 1982, EMBO J, V1, P173, DOI 10.1002/j.1460-2075.1982.tb01143.x; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; SCHLISSEL MS, 1984, CELL, V37, P903, DOI 10.1016/0092-8674(84)90425-2; Schmid C, 1992, CURR OPIN GENET DEV, V2, P874, DOI 10.1016/S0959-437X(05)80110-8; SCHMID CW, 1991, NUCLEIC ACIDS RES, V19, P5613, DOI 10.1093/nar/19.20.5613; SHEN C-K J, 1982, Journal of Molecular and Applied Genetics, V1, P343; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1; SINGER MF, 1982, CELL, V28, P433, DOI 10.1016/0092-8674(82)90194-5; TANAKA S, 1992, EMBO J, V11, P1187, DOI 10.1002/j.1460-2075.1992.tb05159.x; THOREY IS, 1993, MOL CELL BIOL, V13, P6742, DOI 10.1128/MCB.13.11.6742; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WILLARD C, 1987, J MOL EVOL, V26, P180, DOI 10.1007/BF02099850; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0	63	87	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10091	10096		10.1074/jbc.270.17.10091	http://dx.doi.org/10.1074/jbc.270.17.10091			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730313	hybrid			2022-12-27	WOS:A1995QV41700058
J	RODRIGUEZ, PL; CARRASCO, L				RODRIGUEZ, PL; CARRASCO, L			POLIOVIRUS PROTEIN 2C CONTAINS 2 REGIONS INVOLVED IN RNA-BINDING ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOVEMENT PROTEIN; ESCHERICHIA-COLI; BREFELDIN-A; REPLICATION; RECOGNITION; MUTANTS; DOMAIN; MOTIFS; CDNA; BOX	Poliovirus protein 2C is involved in poliovirus RNA replication, although the exact function of 2C is still unknown. Recently, it was shown that 2C can be purified to high levels when expressed as a fusion protein with maltose binding protein (MBP), Evidence was pre presented that 2C has ATPase and GTPase activities; preliminary results also indicated that 2C interacts with RNA (Rodriguez, P. L., and Carrasco, L. (1993) J. Biol. Chem. 268, 8105-8110), In the present study, 20 variants of 2C have been generated, and their NTPase and RNA binding activities were analyzed. Moreover, an easy procedure to obtain genuine 2C after factor Xa cleavage of an MBP(2)-2C fusion protein is described. This work has determined that 2C has two regions involved in RNA binding: a NH2-terminal region located between amino acids 21 and 45 and a COOH-terminal region involving an Arg-rich region located between amino acids 312 and 319. Deletion of either the NH2- or COOH-terminal RNA-binding region abolishes RNA binding. Deletion of an internal region of protein 2C that includes the nucleotide-binding motif does not affect RNA binding, whereas this deletion destroys ATPase and GTPase activities. Therefore, the NTPase activity and the RNA binding capacity of protein 2C are located in different regions of the molecule.	UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOLEC, E-28049 MADRID, SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)			Rodriguez, Pedro L./K-4605-2014; Carrasco, Luis/E-2435-2012; Carrasco, Luis/H-3001-2017	Rodriguez, Pedro L./0000-0002-5886-9425; Carrasco, Luis/0000-0003-3833-8835				Atabekov J G, 1990, Adv Virus Res, V38, P201, DOI 10.1016/S0065-3527(08)60863-5; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BERNSTEIN HD, 1986, J VIROL, V60, P1040, DOI 10.1128/JVI.60.3.1040-1049.1986; BIAMONTI G, 1994, FEBS LETT, V340, P1, DOI 10.1016/0014-5793(94)80162-2; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; CITOVSKY V, 1992, PLANT CELL, V4, P397, DOI 10.1105/tpc.4.4.397; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DOMIER LL, 1987, VIROLOGY, V158, P20, DOI 10.1016/0042-6822(87)90233-9; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUINEA R, 1990, EMBO J, V9, P2011, DOI 10.1002/j.1460-2075.1990.tb08329.x; HARLOW E, 1988, ANTIBODIES LABORATOR; HELLEN CUT, 1992, VIROLOGY, V187, P391, DOI 10.1016/0042-6822(92)90440-Z; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HULL R, 1989, ANNU REV PHYTOPATHOL, V27, P213; IRURZUN A, 1992, VIROLOGY, V191, P166, DOI 10.1016/0042-6822(92)90178-R; JOHNSON KL, 1991, J VIROL, V65, P4341, DOI 10.1128/JVI.65.8.4341-4349.1991; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; LEE CZ, 1993, J VIROL, V67, P2221, DOI 10.1128/JVI.67.4.2221-2227.1993; LI JP, 1988, J VIROL, V62, P4016, DOI 10.1128/JVI.62.11.4016-4021.1988; MATTAJ IW, 1993, CELL, V73, P837, DOI 10.1016/0092-8674(93)90265-R; MAYNELL LA, 1992, J VIROL, V66, P1985, DOI 10.1128/JVI.66.4.1985-1994.1992; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; MIRZAYAN C, 1994, VIROLOGY, V199, P176, DOI 10.1006/viro.1994.1110; MOLLA A, 1993, J VIROL, V67, P5932, DOI 10.1128/JVI.67.10.5932-5938.1993; MOLLA A, 1992, NATURE, V356, P255, DOI 10.1038/356255a0; NAGAI K, 1984, NATURE, V309, P810, DOI 10.1038/309810a0; OSMAN TAM, 1993, J GEN VIROL, V74, P2453, DOI 10.1099/0022-1317-74-11-2453; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; PAUL AV, 1994, VIROLOGY, V199, P188, DOI 10.1006/viro.1994.1111; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; PINCUS SE, 1986, J VIROL, V60, P793, DOI 10.1128/JVI.60.2.793-796.1986; RODRIGUEZ PL, 1994, BIOTECHNIQUES, V17, P702; RODRIGUEZ PL, 1995, BIOTECHNIQUES, V18, P238; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; Sambrook J, 1989, MOL CLONING LABORATO; SARNOW P, 1990, CURR TOP MICROBIOL, V161, P155; SEMLER BL, 1988, RNA GENETICS, V1, P23; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; TETERINA NL, 1992, J GEN VIROL, V73, P1977, DOI 10.1099/0022-1317-73-8-1977; TOLSKAYA EA, 1994, J MOL BIOL, V236, P1310, DOI 10.1016/0022-2836(94)90060-4; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033	49	95	99	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10105	10112		10.1074/jbc.270.17.10105	http://dx.doi.org/10.1074/jbc.270.17.10105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730315	hybrid			2022-12-27	WOS:A1995QV41700060
J	WU, J; DUNHAM, WR; WEISS, B				WU, J; DUNHAM, WR; WEISS, B			OVERPRODUCTION AND PHYSICAL CHARACTERIZATION OF SOXR, A [2FE-2S] PROTEIN THAT GOVERNS AN OXIDATIVE RESPONSE REGULON IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAMAGNETIC-RESONANCE SPECTROSCOPY; DISTRIBUTED SYSTEMS; STRESS REGULON; GENES; EXPRESSION; IRON; DEHYDROGENASE; CLUSTER; RES	SoxR protein governs the soxRS (superoxide response) regulon of Escherichia coli by becoming a transcriptional activator when the cells are exposed to compounds that mediate univalent redox reactions, many of which produce superoxide as a by-product, SoxR was overproduced and purified to near homogeneity from a strain bearing an expression vector, It could bind specifically to the soxS operator even in the absence of RNA polymerase, The aerobically purified protein, which is readily autooxidized, could activate the transcription of soxS DNA even without exposure to known inducing agents, SoxR is a globular homodimer, It contains one [2Fe-2S] cluster per polypeptide chain, as demonstrated by optical and EPR spectroscopy combined with stoichiometric analysis of iron content, unpaired electron-spin density, and reduction by dithionite. The protein is active in its oxidized ([2Fe-2S](2+)) state. The presence of a prosthetic group capable of univalent redox reactions may help to explain the activation of the regulon in vivo by compounds that can mediate such reactions.	UNIV MICHIGAN, SCH MED, DEPT PATHOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DIV BIOPHYS RES, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00042] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMABILECUEVAS CF, 1991, NUCLEIC ACIDS RES, V19, P4479, DOI 10.1093/nar/19.16.4479; Ausubel FM, 1988, MOL REPROD DEV; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2019, DOI 10.1093/nar/20.suppl.2019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULL C, 1981, J BIOL CHEM, V256, P2673; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; CAMMACK R, 1985, BIOCHEM SOC T, V13, P572, DOI 10.1042/bst0130572; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; CHAN E, 1987, P NATL ACAD SCI USA, V84, P3189, DOI 10.1073/pnas.84.10.3189; DEMPLE B, 1991, ANNU REV GENET, V25, P315, DOI 10.1146/annurev.ge.25.120191.001531; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; GURBIEL RJ, 1989, BIOCHEMISTRY-US, V28, P4861, DOI 10.1021/bi00437a051; HAGEN WR, 1985, J MAGN RESON, V61, P233, DOI 10.1016/0022-2364(85)90078-2; HAGEN WR, 1985, J MAGN RESON, V61, P220, DOI 10.1016/0022-2364(85)90077-0; HIDALGO E, 1994, EMBO J, V13, P138, DOI 10.1002/j.1460-2075.1994.tb06243.x; HOLMQUIST B, 1988, METHOD ENZYMOL, V158, P6, DOI 10.1016/0076-6879(88)58042-4; HUNT J, 1993, J BIOL CHEM, V268, P18685; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; MAYHEW SG, 1969, J BIOL CHEM, V244, P2830; MILMAN G, 1987, METHOD ENZYMOL, V153, P482; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; ORMEJOHNSON WH, 1982, IRON SULFUR PROTEINS, P67; Rogers S G, 1980, Methods Enzymol, V65, P201; Sambrook J., 1989, MOLECULAR CLONING LA, V2 nd; Smith M. H., 1968, CRC HDB BIOCH, pC3; Steczko J, 1991, Protein Expr Purif, V2, P221, DOI 10.1016/1046-5928(91)90075-T; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TSANEVA IR, 1990, J BACTERIOL, V172, P4197, DOI 10.1128/jb.172.8.4197-4205.1990; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEISS B, 1994, INT CONGR SER, V1058, P241; WERTH MT, 1992, FEBS LETT, V299, P1, DOI 10.1016/0014-5793(92)80086-V; WU J, 1992, J BACTERIOL, V174, P3915, DOI 10.1128/jb.174.12.3915-3920.1992; WU J, 1991, J BACTERIOL, V173, P2864, DOI 10.1128/JB.173.9.2864-2871.1991; YOON PS, 1980, BIOCHEMISTRY-US, V19, P2172, DOI 10.1021/bi00551a027	36	90	97	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10323	10327		10.1074/jbc.270.17.10323	http://dx.doi.org/10.1074/jbc.270.17.10323			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730338	hybrid			2022-12-27	WOS:A1995QV41700087
J	GILBERT, DM; NEILSON, A; MIYAZAWA, H; DEPAMPHILIS, ML; BURHANS, WC				GILBERT, DM; NEILSON, A; MIYAZAWA, H; DEPAMPHILIS, ML; BURHANS, WC			MIMOSINE ARRESTS DNA-SYNTHESIS AT REPLICATION FORKS BY INHIBITING DEOXYRIBONUCLEOTIDE METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE DOMAIN; CHINESE-HAMSTER CELLS; AMINO-ACID MIMOSINE; SIMIAN VIRUS-40; XENOPUS EGGS; PLASMID DNA; RIBONUCLEOTIDE REDUCTASE; GENE AMPLIFICATION; PURIFIED DNA; CHO CELLS	Mimosine has been reported to specifically prevent initiation of DNA replication in the chromosomes of mammalian nuclei. To test this hypothesis, the effects of mimosine were examined in several DNA replication systems and compared with the effects of aphidicolin, a specific inhibitor of replicative DNA polymerases. Our results demonstrated that mimosine inhibits DNA synthesis in mitochondrial, nuclear, and simian virus 40 (SV40) genomes to a similar extent. Furthermore, mimosine and aphidicolin were indistinguishable in their ability to arrest SV40 replication forks and mammalian nuclear chromosomal replication forks. In contrast to aphidicolin, mimosine did not inhibit DNA replication in lysates of mammalian cells supplied with exogenous deoxyribonucleotide triphosphate precursors for DNA synthesis. Mimosine also had no effect on initiation or elongation of DNA replication in Xenopus eggs or egg extracts containing high levels of deoxyribonucleotide triphosphates. In parallel with its inhibitory effect on DNA synthesis in mammalian cells, mimosine altered deoxyribonucleotide triphosphate pools in a manner similar to that reported for another DNA replication inhibitor that affects deoxyribonucleotide metabolism, hydroxyurea. Taken together, these results show that mimosine inhibits DNA synthesis at the level of elongation of nascent chains by altering deoxyribonucleotide metabolism.	ROSWELL PK CANC INST, DEPT MOLEC & CELLULAR BIOL, BUFFALO, NY 14263 USA; ROCHE INST MOLEC BIOL, ROCHE RES CTR, NUTLEY, NJ 07110 USA	Roswell Park Cancer Institute; Roche Holding					NCI NIH HHS [CA16056] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANACHKOVA B, 1989, MOL CELL BIOL, V9, P532, DOI 10.1128/MCB.9.2.532; ANDREASSEN PR, 1992, P NATL ACAD SCI USA, V89, P2272, DOI 10.1073/pnas.89.6.2272; BESTWICK RK, 1982, J BIOL CHEM, V257, P9305; BESTWICK RK, 1982, J BIOL CHEM, V257, P9300; BLOW JJ, 1990, J CELL SCI, V95, P383; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BURHANS WC, 1990, CELL, V62, P955, DOI 10.1016/0092-8674(90)90270-O; BURHANS WC, 1986, P NATL ACAD SCI USA, V83, P7790, DOI 10.1073/pnas.83.20.7790; CARBONAROHALL D, 1993, ONCOGENE, V8, P1649; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; DAI YM, 1994, VIROLOGY, V205, P210, DOI 10.1006/viro.1994.1636; DECKER RS, 1986, MOL CELL BIOL, V6, P3815, DOI 10.1128/MCB.6.11.3815; DEPAMPHILIS ML, 1993, J BIOL CHEM, V268, P1; DEPAMPHILIS ML, 1986, PAPOVAVIRIDAE, V1, P99; DIJKWEL PA, 1992, MOL CELL BIOL, V12, P3715, DOI 10.1128/MCB.12.9.3715; DINTERGOTTLIEB G, 1983, J BIOL CHEM, V258, P3809; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; FELDMAN ST, 1994, CANCER RES, V54, P494; GILBERT DM, 1993, COLD SPRING HARB SYM, V58, P475, DOI 10.1101/SQB.1993.058.01.054; GILBERT DM, 1992, NUCLEIC ACIDS RES, V20, P4525, DOI 10.1093/nar/20.17.4525; GILBERT DM, 1987, CELL, V50, P59, DOI 10.1016/0092-8674(87)90662-3; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; HANAUSKEABEL HM, 1994, BBA-MOL CELL RES, V1221, P115, DOI 10.1016/0167-4889(94)90003-5; HARLAND RM, 1980, CELL, V21, P761, DOI 10.1016/0092-8674(80)90439-0; HEINTZ NH, 1982, P NATL ACAD SCI-BIOL, V79, P4083, DOI 10.1073/pnas.79.13.4083; HEINTZ NH, 1988, MOL CELL BIOL, V8, P1923, DOI 10.1128/MCB.8.5.1923; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HUI EKW, 1993, FEBS LETT, V318, P193, DOI 10.1016/0014-5793(93)80020-U; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; Kornberg A., 1992, DNA REPLICATION; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LEVENSON V, 1993, NUCLEIC ACIDS RES, V21, P3997, DOI 10.1093/nar/21.17.3997; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; MARRACINO RL, 1990, MOL BIOL CELL, V3, P389; MOSCA PJ, 1992, MOL CELL BIOL, V12, P4375, DOI 10.1128/MCB.12.10.4375; MUDZINSKI SP, 1993, TOXICOL APPL PHARM, V119, P166, DOI 10.1006/taap.1993.1057; NETHANEL T, 1990, J VIROL, V64, P5912, DOI 10.1128/JVI.64.12.5912-5918.1990; NEWPORT J, 1989, J CELL SCI, P149; REICHARD P, 1983, SCIENCE, V221, P514, DOI 10.1126/science.6306767; REICHARD P, 1978, FED PROC, V37, P9; RYAN JJ, 1993, MOL CELL BIOL, V13, P711, DOI 10.1128/MCB.13.1.711; Sambrook J, 1989, MOL CLONING LABORATO; SANCHEZ JA, 1992, J CELL SCI, V103, P907; SKOOG L, 1971, EUR J BIOCHEM, V19, P81, DOI 10.1111/j.1432-1033.1971.tb01290.x; SNAPKA RM, 1991, NUCLEIC ACIDS RES, V19, P5065, DOI 10.1093/nar/19.18.5065; TAPPER DP, 1978, J MOL BIOL, V120, P401, DOI 10.1016/0022-2836(78)90427-8; TELFER JF, 1993, FEBS LETT, V329, P238, DOI 10.1016/0014-5793(93)80229-N; THOMPSON JF, 1969, ANNU REV BIOCHEM, V38, P137, DOI 10.1146/annurev.bi.38.070169.001033; TIMSON J, 1975, MUTAT RES, V32, P115, DOI 10.1016/0165-1110(75)90002-0; TOBEY RA, 1970, J CELL BIOL, V46, P151, DOI 10.1083/jcb.46.1.151; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; WANGH LJ, 1989, J CELL SCI, V93, P1; WATSON PA, 1991, CYTOMETRY, V12, P242, DOI 10.1002/cyto.990120306; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; WOODLAND HR, 1972, BIOCHEM J, V127, P597, DOI 10.1042/bj1270597; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; YOSHIDA M, 1992, CANCER RES, V52, P6676	60	109	112	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9597	9606		10.1074/jbc.270.16.9597	http://dx.doi.org/10.1074/jbc.270.16.9597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721891	hybrid			2022-12-27	WOS:A1995QU08900080
J	WATSON, A; LATCHMAN, D				WATSON, A; LATCHMAN, D			THE CYCLIC-AMP RESPONSE ELEMENT IN THE CALCITONIN CALCITONIN-GENE-RELATED PEPTIDE GENE PROMOTER IS NECESSARY BUT NOT SUFFICIENT FOR ITS ACTIVATION BY NERVE GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT SENSORY NEURONS; FACTOR REGULATES EXPRESSION; CAT-REPORTER GENE; PC12 CELLS; C-FOS; TRANSCRIPTION; PROTEIN; BINDING; CREB; PHOSPHORYLATION	The gene encoding calcitonin gene related peptide (CGRP) is inducible by nerve growth factor (NGF) in primary dorsal root ganglion neurons. By transfecting these primary neurons, we have defined a region of the CGRP promoter from -140 to -72 relative to the transcriptional start site which is essential for its inducibility by NGF as well as by cyclic AMP and which can confer these responses on a heterologous promoter. A cyclic AMP response element (CRE) within this region is essential for both these responses which are abolished by site directed mutagenesis of this element. In contrast to the intact fragment the isolated CRE can confer responsiveness to cyclic AMP but not NGF on a heterologous promoter. The reasons for the different role of the CRE in the response of the CGRP promoter to cyclic AMP and NGF are discussed.	UCL, SCH MED, DEPT MOLEC PATHOL, LONDON W1P 6DB, ENGLAND	University of London; University College London; UCL Medical School								ABKEN H, 1992, NUCLEIC ACIDS RES, V20, P3527, DOI 10.1093/nar/20.13.3527; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DONG YH, 1993, NUCLEIC ACIDS RES, V21, P771, DOI 10.1093/nar/21.3.771; FREBOURG T, 1988, GENE, V65, P315, DOI 10.1016/0378-1119(88)90468-4; GABELLINI N, 1992, J CELL BIOL, V118, P131, DOI 10.1083/jcb.118.1.131; GALLI E, 1994, J BIOL CHEM, V269, P17359; GILCHRIST CA, 1992, BIOCHEM BIOPH RES CO, V187, P1395, DOI 10.1016/0006-291X(92)90457-V; GILCHRIST CA, 1991, DNA CELL BIOL, V10, P743, DOI 10.1089/dna.1991.10.743; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; KENDALL G, 1994, MOL BRAIN RES, V25, P73, DOI 10.1016/0169-328X(94)90280-1; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; Levi-Montalcini R, 1976, Prog Brain Res, V45, P235, DOI 10.1016/S0079-6123(08)60993-0; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; LINDSAY RM, 1990, EUR J NEUROSCI, V2, P389, DOI 10.1111/j.1460-9568.1990.tb00431.x; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Lo D C, 1992, Curr Opin Neurobiol, V2, P336, DOI 10.1016/0959-4388(92)90125-5; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MILLBRANDT J, 1987, SCIENCE, V238, P797; MILLBRANDT J, 1986, P NATL ACAD SCI USA, V83, P4789; MILLBRANDT J, 1988, NEURON, V1, P183; SAKAMOTO KM, 1994, MOL CELL BIOL, V14, P5975, DOI 10.1128/MCB.14.9.5975; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; SYMES AJ, 1992, FEBS LETT, V306, P229, DOI 10.1016/0014-5793(92)81006-8; WATSON A, 1995, INP RESS EUR J NERUO; WINTER J, 1988, NEURON, V1, P973, DOI 10.1016/0896-6273(88)90154-7; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	38	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9655	9660		10.1074/jbc.270.16.9655	http://dx.doi.org/10.1074/jbc.270.16.9655			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721899	hybrid			2022-12-27	WOS:A1995QU08900088
J	DIEUAIDENOUBHANI, M; RAFFARD, G; CANIONI, P; PRADET, A; RAYMOND, P				DIEUAIDENOUBHANI, M; RAFFARD, G; CANIONI, P; PRADET, A; RAYMOND, P			QUANTIFICATION OF COMPARTMENTED METABOLIC FLUXES IN MAIZE ROOT-TIPS USING ISOTOPE DISTRIBUTION FROM C-13-LABELED OR C-14-LABELED GLUCOSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; ACID BETA-OXIDATION; PISUM-SATIVUM-L; CARBOHYDRATE-METABOLISM; STARCH BIOSYNTHESIS; HYPOXIC ACCLIMATION; TRIOSE PHOSPHATES; NITRITE REDUCTION; SOLUBLE SUGARS; POTATO-TUBERS	Metabolic pathways of the intermediate metabolism of maize root tips were identified and quantified after labeling to isotopic and metabolic steady state using glucose labeled on carbon-1, -2, or 6 with C-14 or C-13. The specific radioactivity of amino acids and the C-13-specific enrichment of specific carbons of free glucose, sucrose, alanine and glutamate were measured and used to calculate metabolic fluxes. The non-triose pathways, including synthesis of polysaccharides, accumulation of free hexoses, and to a lesser extent starch synthesis, were found to consume 75% of the glucose entering the root tips. The cycle of synthesis and hydrolysis of sucrose was found to consume about 70% of the ATP produced by respiration. The comparison of the specific radioactivities of amino acids and phospholipid glycerol phosphate after labeling with [1-C-14] or [6-C-14]glucose revealed the operation of the pentose phosphate pathway. The transfer of label from [2-C-14]glucose to carbon-1 of starch glucosyl units confirmed the operation of this pathway and indicated that it is located in plastids. It was found to consume 32% of the hexose phosphates entering the triose pathways. The remaining 68% were consumed by glycolysis. The determination of the specific enrichment of carbohydrate carbons -1 and -6 after labeling with [1-C-13]glucose indicated that both the conversion of triose phosphates back to hexose phosphates and the transaldolase exchange contributed to this randomization. Of the triose phosphates produced by glycolysis and the pentose phosphate pathway, about 60% were found to be recycled to hexose phosphates, and 28% were directed to the tricarboxylic acid cycle. Of this 28%, two-thirds were found to be directed through the pyruvate kinase branch and one-third through the phosphoenolpyruvate branch. The latter essentially has an anaplerotic function since little malate was found to be converted to pyruvate (malic enzyme reaction).	INRA, CTR RECH BORDEAUX, PHYSIOL VEGETALE STN, F-33883 VILLENAVE DORNON, FRANCE; UNIV BORDEAUX 2, CNRS, UMR 9551, F-33076 BORDEAUX, FRANCE	INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux								BORCHERT S, 1993, PLANT PHYSIOL, V101, P303, DOI 10.1104/pp.101.1.303; BOWSHER CG, 1989, PLANTA, V177, P359, DOI 10.1007/BF00403594; BRETHARTE MS, 1994, PLANT PHYSIOL, V105, P19, DOI 10.1104/pp.105.1.19; BROUQUISSE R, 1992, PLANTA, V188, P384, DOI 10.1007/BF00192806; BROUQUISSE R, 1991, PLANT PHYSIOL, V96, P619, DOI 10.1104/pp.96.2.619; CHANCE EM, 1983, J BIOL CHEM, V258, P3785; COHEN SM, 1981, P NATL ACAD SCI-BIOL, V78, P60, DOI 10.1073/pnas.78.1.60; DAVIES KM, 1993, PLANT PHYSIOL, V102, P1337, DOI 10.1104/pp.102.4.1337; DAWSON RMC, 1974, BIOCHEM J, V144, P169, DOI 10.1042/bj1440169; DIEUAIDE M, 1993, BIOCHEM J, V296, P199, DOI 10.1042/bj2960199; DIEUAIDE M, 1992, PLANT PHYSIOL, V99, P595, DOI 10.1104/pp.99.2.595; DOUCE R, 1989, ANNU REV PLANT PHYS, V40, P371, DOI 10.1146/annurev.pp.40.060189.002103; EMES MJ, 1983, PLANTA, V158, P97, DOI 10.1007/BF00397700; ENTWISTLE G, 1990, BIOCHEM J, V271, P467, DOI 10.1042/bj2710467; FREHNER M, 1990, PLANT PHYSIOL, V94, P538, DOI 10.1104/pp.94.2.538; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; GIAQUINTA RT, 1983, PLANT PHYSIOL, V72, P362, DOI 10.1104/pp.72.2.362; GIBBS M, 1955, PLANT PHYSIOL, V30, P343, DOI 10.1104/pp.30.4.343; GRAHAM IA, 1994, PLANT CELL, V6, P761, DOI 10.1105/tpc.6.5.761; HARGREAVES JA, 1988, PHYTOCHEMISTRY, V27, P1627, DOI 10.1016/0031-9422(88)80416-3; HATZFELD WD, 1990, PLANTA, V180, P198, DOI 10.1007/BF00193996; HILL SA, 1994, PLANTA, V192, P52, DOI 10.1007/BF00198692; HOLE DJ, 1992, PLANT PHYSIOL, V99, P213, DOI 10.1104/pp.99.1.213; JAMES F, 1993, PLANT PHYSIOL BIOCH, V31, P845; JOURNET EP, 1986, J BIOL CHEM, V261, P3193; JOURNET EP, 1985, PLANT PHYSIOL, V79, P458, DOI 10.1104/pp.79.2.458; KATZ J, 1967, BIOCHEMISTRY-US, V6, P2227, DOI 10.1021/bi00859a046; KATZ J, 1979, TECHNIQUES METABOL B, V208, P1; KEELING PL, 1988, PLANT PHYSIOL, V87, P311, DOI 10.1104/pp.87.2.311; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; LJUNGDAHL L, 1961, J BIOL CHEM, V236, P1622; MALLOY CR, 1988, J BIOL CHEM, V263, P6964; MCDERMITT DK, 1981, ANN BOT-LONDON, V48, P275, DOI 10.1093/oxfordjournals.aob.a086125; MOING A, 1992, PLANT PHYSIOL, V100, P1878, DOI 10.1104/pp.100.4.1878; MORRIS GA, 1982, CAN J CHEM, V60, P2431, DOI 10.1139/v82-352; NEUHAUS HE, 1993, BIOCHEM J, V296, P395, DOI 10.1042/bj2960395; PORTAIS JC, 1993, EUR J BIOCHEM, V149, P1; REES T, 1988, BIOCH PLANTS, P1; Rees T.A.P., 1990, PLANT PHYSIOL, P106; REES TA, 1980, BIOCH PLANTS, V2, P1; ROBERTS JKM, 1992, PLANT PHYSIOL, V98, P480, DOI 10.1104/pp.98.2.480; SAGLIO PH, 1980, PLANT PHYSIOL, V66, P516, DOI 10.1104/pp.66.3.516; SAGLIO PH, 1980, PLANT PHYSIOL, V66, P1053, DOI 10.1104/pp.66.6.1053; SALON C, 1988, J BIOL CHEM, V263, P12278; STITT M, 1980, PHYTOCHEMISTRY, V19, P1583, DOI 10.1016/S0031-9422(00)83774-7; SUMEGI B, 1993, BIOCHEMISTRY-US, V32, P12725, DOI 10.1021/bi00210a022; VIOLA R, 1991, PLANTA, V183, P202, DOI 10.1007/BF00197789; WENDLER R, 1991, PLANTA, V183, P31, DOI 10.1007/BF00197564; XIA JH, 1988, PLANT PHYSIOL, V88, P1015, DOI 10.1104/pp.88.4.1015; XIA JH, 1992, PLANT PHYSIOL, V100, P40, DOI 10.1104/pp.100.1.40	50	140	141	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13147	13159		10.1074/jbc.270.22.13147	http://dx.doi.org/10.1074/jbc.270.22.13147			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768910	Green Submitted, hybrid			2022-12-27	WOS:A1995RB43900033
J	TRONCHERE, H; PLANAT, V; RECORD, M; TERCE, F; RIBBES, G; CHAP, H				TRONCHERE, H; PLANAT, V; RECORD, M; TERCE, F; RIBBES, G; CHAP, H			PHOSPHATIDYLCHOLINE TURNOVER IN ACTIVATED HUMAN NEUTROPHILS - AGONIST-INDUCED CYTIDYLYLTRANSFERASE TRANSLOCATION IS SUBSEQUENT TO PHOSPHOLIPASE-D ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHORBOL 12-MYRISTATE 13-ACETATE; STIMULATED HUMAN-NEUTROPHILS; II ASCITE CELLS; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; PHOSPHATIDATE PHOSPHOHYDROLASE; POLYMORPHONUCLEAR LEUKOCYTES; DIACYLGLYCEROL FORMATION; SIGNAL TRANSDUCTION	Phosphatidylcholine synthesis and degradation are tightly regulated to assure a constant amount of the phospholipid in cellular membranes. The chemotactic peptide fMLP and the phorbol ester, phorbol 12-myristate 13-acetate, are known to stimulate phosphatidylcholine degradation by phospholipase D in human neutrophils. fMLP alone triggered phosphatidylcholine breakdown into phosphatidic acid, but did not stimulate phosphatidylcholine synthesis or activation of the rate-limiting enzyme CTP:phosphocholine cytidylyltransferase. Adding cytochalasin B to fMLP led to some conversion of phosphatidic acid into diglyceride, and fMLP was then able to trigger choline incorporation into phosphatidylcholine, and cytidylyltransferase translocation from cytosol to membranes. Inhibition of phosphatidylcholine-phospholipase D activation with tyrphostin led to inhibition of choline incorporation. Therefore, phosphatidic acid-derived diglyceride but not phosphatidic acid alone was effective to promote cytidylyltransferase translocation. With phorbol 12-myristate 13-acetate as agonist, and by selective labeling of phosphatidylinositol and phosphatidylcholine, we demonstrated that only phosphatidylcholine-derived diglyceride participated in cytidylyltransferase translocation. Oleic acid stimulated phosphatidylcholine synthesis, but induced a weak increase in diglyceride and a slight cytidylyltransferase translocation, and did not stimulate phospholipase D activity. Our data established that only diglyceride derived from phosphatidylcholine degradation by the phospholipase D/phosphatidate phosphatase pathway are required for agonist-induced cytidylyltransferase translocation and subsequent choline incorporation into phosphatidylcholine.	HOP PURPAN, INSERM, U326, F-31059 TOULOUSE, FRANCE	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)			RECORD, Michel/G-3493-2017; TRONCHERE, Helene/M-5631-2014; Tercé, François/M-5863-2018	RECORD, Michel/0000-0003-1893-0022; Tercé, François/0000-0003-4488-2167; Planat-Benard, Valerie/0000-0002-0712-4220				AGWU DE, 1989, J BIOL CHEM, V264, P1405; BENTLEY JK, 1981, BIOCHIM BIOPHYS ACTA, V678, P238; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOMALASKI JS, 1990, J LEUKOCYTE BIOL, V47, P1; CABOT MC, 1988, BIOCHIM BIOPHYS ACTA, V959, P46, DOI 10.1016/0005-2760(88)90148-8; CHALIFOUR R, 1982, J NEUROCHEM, V39, P299, DOI 10.1111/j.1471-4159.1982.tb03946.x; COOK HW, 1989, J BIOL CHEM, V264, P2746; CORNELL R, 1987, BIOCHIM BIOPHYS ACTA, V919, P37, DOI 10.1016/0005-2760(87)90215-3; DANIEL LW, 1986, J BIOL CHEM, V261, P9128; Garcia Gil M, 1982, Biochem J, V206, P67; GELAS P, 1992, BIOCHEM J, V287, P67, DOI 10.1042/bj2870067; GELAS P, 1989, FEBS LETT, V251, P213, DOI 10.1016/0014-5793(89)81457-7; GEORGE TP, 1991, J BIOL CHEM, V266, P12419; GIL MG, 1981, BIOCHEM BIOPH RES CO, V101, P740, DOI 10.1016/0006-291X(81)91813-1; GUY GR, 1982, CANCER RES, V42, P1980; HONEYCUTT PJ, 1986, J BIOL CHEM, V261, P5900; HOUWELING M, 1994, J BIOL CHEM, V269, P7544; JAMIL H, 1992, J BIOL CHEM, V267, P1752; KISS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P457, DOI 10.1016/0003-9861(92)90597-P; KOLESNICK RN, 1987, J BIOL CHEM, V262, P14525; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MATO JM, 1983, P NATL ACAD SCI-BIOL, V80, P1929, DOI 10.1073/pnas.80.7.1929; OHTA H, 1985, J BIOL CHEM, V260, P5771; OLSON SC, 1991, J BIOL CHEM, V266, P17236; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P447, DOI 10.1016/0005-2760(84)90171-1; PELECH SL, 1983, J BIOL CHEM, V258, P6782; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; PIKE MC, 1980, CELL, V20, P373, DOI 10.1016/0092-8674(80)90623-6; PREISS J, 1986, J BIOL CHEM, V261, P8597; RECORD M, 1985, BIOCHIM BIOPHYS ACTA, V819, P1, DOI 10.1016/0005-2736(85)90188-9; RECORD M, 1982, BIOCHIM BIOPHYS ACTA, V688, P57, DOI 10.1016/0005-2736(82)90578-8; REINHOLD SL, 1989, J BIOL CHEM, V264, P21652; SIDDIQUI RA, 1992, EUR J BIOCHEM, V210, P601, DOI 10.1111/j.1432-1033.1992.tb17460.x; STRUM JC, 1993, BIOCHIM BIOPHYS ACTA, V1169, P25, DOI 10.1016/0005-2760(93)90077-M; TERCE F, 1988, J BIOL CHEM, V263, P3142; TERCE F, 1991, BIOCHIM BIOPHYS ACTA, V1084, P69, DOI 10.1016/0005-2760(91)90057-O; THOMPSON NT, 1991, TRENDS PHARMACOL SCI, V12, P404, DOI 10.1016/0165-6147(91)90617-2; TORRES M, 1993, J IMMUNOL, V150, P1563; TREVES S, 1987, EXP CELL RES, V168, P285, DOI 10.1016/0014-4827(87)90001-2; TRONCHERE H, 1993, BIOCHEM J, V293, P739, DOI 10.1042/bj2930739; TRONCHERE H, 1994, BBA-LIPID LIPID MET, V1212, P137, DOI 10.1016/0005-2760(94)90248-8; TRONCHERE H, 1991, BIOCHEM BIOPH RES CO, V176, P157, DOI 10.1016/0006-291X(91)90903-K; TYAGI SR, 1988, J BIOL CHEM, V263, P13191; UTAL AK, 1991, J BIOL CHEM, V266, P24084; VANCE DE, 1989, PHOSPHATIDYLCHOLINE, P225; VANCE DE, 1981, METHOD ENZYMOL, V71, P579; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WRIGHT TM, 1988, J BIOL CHEM, V263, P9374; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210	52	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13138	13146		10.1074/jbc.270.22.13138	http://dx.doi.org/10.1074/jbc.270.22.13138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768909	hybrid			2022-12-27	WOS:A1995RB43900032
J	JUANG, HH; COSTELLO, LC; FRANKLIN, RB				JUANG, HH; COSTELLO, LC; FRANKLIN, RB			ANDROGEN MODULATION OF MULTIPLE TRANSCRIPTION START SITES OF THE MITOCHONDRIAL ASPARTATE-AMINOTRANSFERASE GENE IN RAT PROSTATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR VIRUS; CITRATE PRODUCTION; RESPONSE ELEMENT; VENTRAL PROSTATE; TESTOSTERONE; EXPRESSION; PROMOTER; RECEPTOR; INTRON	Mitochondrial aspartate aminotransferase (mAAT) is one of two key enzymes in the pathway of citrate production in prostate. Expression of mAAT is modulated by testosterone and prolactin in prostate. We cloned the promoter and 5'-flanking region of the rat mAAT gene and sequenced 2.0 kilobases of the DNA. This fragment contains the 5'-regulatory promoter region that lacks a TATA and a CCAAT box but is G+C rich. The 5'-upstream flanking region contains sequences that have high homology with the consensus glucocorticoid response element/androgen response element (ARE) and a reported ARE sequence that is different from the consensus sequence. Functional transcription studies showed that a 481-base region containing the two ARE sequences was sufficient for androgen-regulated gene expression. There are multiple transcription start sites that are regulated by testosterone in prostate. In liver, on the other hand, castration did not affect transcription from any of the start sites. Therefore, these data provide evidence that transcriptional regulation of the rat pmAAT gene occurs through an ARE located in the 5'-region. In addition, not only is gene expression modulated by testosterone, but the effect of testosterone on transcription is cell specific.	UNIV MARYLAND,SCH DENT,DEPT PHYSIOL,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore			Juang, Horng-Heng/AAG-7683-2020; Juang, Horng-Heng/G-2313-2012	Juang, Horng-Heng/0000-0002-8524-8253	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028015, R01DK042839] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42839, DK28015] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALDER AJ, 1991, MOL ENDOCRINOL, V5, P1587; CATO ACB, 1987, EMBO J, V6, P363, DOI 10.1002/j.1460-2075.1987.tb04763.x; CATO ACB, 1988, EMBO J, V7, P1403, DOI 10.1002/j.1460-2075.1988.tb02957.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAESSENS F, 1989, BIOCHEM BIOPH RES CO, V164, P833, DOI 10.1016/0006-291X(89)91534-9; COSTELLO LC, 1991, PROSTATE, V19, P181, DOI 10.1002/pros.2990190302; DENISON SH, 1989, ENDOCRINOLOGY, V124, P1091, DOI 10.1210/endo-124-2-1091; FRANKLIN RB, 1990, J STEROID BIOCHEM, V35, P569, DOI 10.1016/0022-4731(90)90200-C; FRANKLIN RB, 1987, J STEROID BIOCHEM, V28, P247, DOI 10.1016/0022-4731(87)91015-6; FRANKLIN RB, 1982, J UROLOGY, V127, P798, DOI 10.1016/S0022-5347(17)54052-5; FRANKLIN RB, 1992, MOL CELL ENDOCRINOL, V90, P27, DOI 10.1016/0303-7207(92)90097-P; FRANKLIN RB, 1986, HORM METAB RES, V18, P177, DOI 10.1055/s-2007-1012264; HAM J, 1988, NUCLEIC ACIDS RES, V16, P5263, DOI 10.1093/nar/16.12.5263; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; Maniatis T., 1982, MOL CLONING; MATTINGLY JR, 1987, BIOCHEM BIOPH RES CO, V149, P859, DOI 10.1016/0006-291X(87)90487-6; MODARESSI S, 1993, BIOL CHEM H-S, V374, P327, DOI 10.1515/bchm3.1993.374.1-6.327; OTTEN AD, 1988, MOL ENDOCRINOL, V2, P143, DOI 10.1210/mend-2-2-143; PAVEPREUX M, 1990, J BIOL CHEM, V265, P4444; QIAN K, 1993, J STEROID BIOCHEM, V44, P13, DOI 10.1016/0960-0760(93)90146-N; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHATT MD, 1990, EMBO J, V9, P481, DOI 10.1002/j.1460-2075.1990.tb08134.x; SETOYAMA C, 1990, J BIOL CHEM, V265, P1293; TAN JA, 1992, J BIOL CHEM, V267, P4456; TOUSSAINT C, 1994, J BIOL CHEM, V269, P13318; TSUZUKI T, 1987, J MOL BIOL, V198, P21, DOI 10.1016/0022-2836(87)90454-2; WEISINGER G, 1992, J BIOL CHEM, V267, P4508	29	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12629	12634		10.1074/jbc.270.21.12629	http://dx.doi.org/10.1074/jbc.270.21.12629			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759512	hybrid			2022-12-27	WOS:A1995QZ71100047
J	SCHALLER, GE; LADD, AN; LANAHAN, MB; SPANBAUER, JM; BLEECKER, AB				SCHALLER, GE; LADD, AN; LANAHAN, MB; SPANBAUER, JM; BLEECKER, AB			THE ETHYLENE RESPONSE MEDIATOR ETR1 FROM ARABIDOPSIS FORMS A DISULFIDE-LINKED DIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; 2-COMPONENT REGULATORS; PROTEIN; RESISTANCE; EXPRESSION; RECEPTOR; IDENTIFY; MUTANTS	Mutations in the ETR1 gene of the higher plant Arabidopsis confer insensitivity to ethylene, indicating a role for the gene product in ethylene signal perception and transduction. The ETR1 gene product has an aminoterminal hydrophobic domain and a carboxyl-terminal domain showing homology to the two-component signal transduction proteins of bacteria. me report here that in both its native Arabidopsis and when transgenically expressed in yeast, the ETR1 protein is isolated from membranes as a dimer of 147 kDa. Treatment with the reducing agent dithiothreitol converted the dimer to a monomer of 79 kDa, indicative of a disulfide linkage between monomers. Expression of truncated versions of ETR1 in yeast confirmed that the high molecular mass form is a homodimer and demonstrated that the aminoterminal region of ETR1 is necessary and sufficient for this dimerization. Site-directed mutagenesis of two cysteines near the amino terminus of ETR1 prevented formation of the covalently linked dimer in yeast, consistent with a role in disulfide bond formation. These data indicate that ETR1 may use a dimeric mechanism of signal transduction in a manner similar to its bacterial counterparts but with the additional feature of a disulfide bond between monomers.	UNIV WISCONSIN,DEPT BOT,MADISON,WI 53706; MONSANTO CO,AGR GRP,CHESTERFIELD,MO 63198	University of Wisconsin System; University of Wisconsin Madison; Monsanto								Abeles F, 1992, ETHYLENE PLANT BIOL; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; CHANG C, 1992, PLANT CELL, V4, P1263, DOI 10.1105/tpc.4.10.1263; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; CHANG C, 1995, IN PRESS P NATL ACAD; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; HADFIELD C, 1986, GENE, V45, P149, DOI 10.1016/0378-1119(86)90249-0; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; KUMAR MA, 1992, BIOTECHNIQUES, V12, P198; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORD JM, 1987, METHOD ENZYMOL, V148, P542; MONK BC, 1991, J BIOL CHEM, V266, P18097; NOIVA R, 1994, PROTEIN EXPRES PURIF, V5, P1, DOI 10.1006/prep.1994.1001; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; PAKULA AA, 1992, P NATL ACAD SCI USA, V89, P4144, DOI 10.1073/pnas.89.9.4144; PAN SQ, 1993, P NATL ACAD SCI USA, V90, P9939, DOI 10.1073/pnas.90.21.9939; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; PAZOUR GJ, 1991, P NATL ACAD SCI USA, V88, P6941, DOI 10.1073/pnas.88.16.6941; Sambrook J, 1989, MOL CLONING LABORATO; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; VAN DER STRAETEN D, 1993, PLANT PHYSIOL, V102, P401, DOI 10.1104/pp.102.2.401; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341	27	193	206	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12526	12530		10.1074/jbc.270.21.12526	http://dx.doi.org/10.1074/jbc.270.21.12526			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759498	hybrid			2022-12-27	WOS:A1995QZ71100032
J	SANYAL, A; GETZ, GS				SANYAL, A; GETZ, GS			IMPORT OF TRANSCRIPTION FACTOR MTF1 INTO THE YEAST MITOCHONDRIA TAKES PLACE THROUGH AN UNUSUAL PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFIED PRECURSOR PROTEIN; ADP ATP CARRIER; CYTOCHROME-C; SACCHAROMYCES-CEREVISIAE; RNA-POLYMERASE; INNER MEMBRANE; RECEPTOR; STEPS	We report studies of the import into mitochondria of MTF1, a nucleus-encoded factor that markedly stimulates the specific transcription of mitochondrial DNA. Unlike most of the mitochondrial precursor proteins studied so far, import of MTF1 does not appear to require a receptor on the outer membrane, membrane potential across the inner membrane, or ATP hydrolysis. Its import is not affected by low temperature. It lacks a cleavable presequence but translocates across the inner membrane through its amino terminus; its sorting is independent of hsp60. Our results indicate an unusual and distinct import pathway for MTF1 into the yeast mitochondria.	UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; UNIV CHICAGO,DEPT PATHOL,CHICAGO,IL 60637; UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637	University of Chicago; University of Chicago; University of Chicago					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL004442] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL04442] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Cryer D R, 1975, Methods Cell Biol, V12, P39; DAUM G, 1982, J BIOL CHEM, V257, P3028; DEZAMAROCZY M, 1985, GENE, V37, P1, DOI 10.1016/0378-1119(85)90252-5; EILERS M, 1987, EMBO J, V6, P1073, DOI 10.1002/j.1460-2075.1987.tb04860.x; EILERS M, 1988, EMBO J, V7, P1139, DOI 10.1002/j.1460-2075.1988.tb02923.x; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HINES V, 1993, J BIOL CHEM, V268, P449; HWANG S, 1989, J CELL BIOL, V109, P487, DOI 10.1083/jcb.109.2.487; HWANG ST, 1991, J BIOL CHEM, V266, P21083; JANG SH, 1991, J BIOL CHEM, V266, P22671; LISOWSKY T, 1988, MOL GEN GENET, V214, P218, DOI 10.1007/BF00337714; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; MILLER BR, 1991, J CELL BIOL, V112, P833, DOI 10.1083/jcb.112.5.833; NICHOLSON DW, 1988, J BIOL CHEM, V263, P19034; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; PFANNER N, 1987, J BIOL CHEM, V262, P7528; PFANNER N, 1990, J BIOL CHEM, V265, P16321; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; SANYAL A, 1995, MOL GEN GENET, V246, P56, DOI 10.1007/BF00290133; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; STUART RA, 1990, CELL, V60, P31, DOI 10.1016/0092-8674(90)90713-O	27	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11970	11976		10.1074/jbc.270.20.11970	http://dx.doi.org/10.1074/jbc.270.20.11970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744847	hybrid			2022-12-27	WOS:A1995QY73600046
J	HU, P; YIN, C; ZHANG, KM; WRIGHT, LD; NIXON, TE; WECHSLER, AS; SPRATT, JA; BRIGGS, FN				HU, P; YIN, C; ZHANG, KM; WRIGHT, LD; NIXON, TE; WECHSLER, AS; SPRATT, JA; BRIGGS, FN			TRANSCRIPTIONAL REGULATION OF PHOSPHOLAMBAN GENE AND TRANSLATIONAL REGULATION OF SERCA2 GENE PRODUCES COORDINATE EXPRESSION OF THESE 2 SARCOPLASMIC-RETICULUM PROTEINS DURING SKELETAL-MUSCLE PHENOTYPE SWITCHING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW; CA-2+-ATPASE; SEQUENCE; ATPASE; TWITCH; KINASE; FIBERS	Chronic 1 Hz stimulation of the canine latissimus dorsi muscle produced a time-dependent switch from the fast-twitch to the slow-twitch phenotype, This included changes in the proteins of the sarcoplasmic reticulum, After 3 days of muscle stimulation, there was down-regulation of fast-twitch Ca-ATPase (SERCA1a) mRNA and induction of slow-twitch Ca-ATPase (SERCA2a) mRNA; most changes in both mRNAs were nearly complete after 14 days of stimulation, Although the induction of phospholamban mRNA began after 3 days of muscle stimulation, its up-regulation was not completed until the muscle had been stimulated for 42 days, The time course of expression of SERCA2a protein was very different from that of SERCA2a mRNA, suggesting that SERCA2 gene expression is regulated at the translational as well as the transcriptional level, The time course of expression of phospholamban protein closely followed that of phospholamban mRNA, suggesting that this gene is under transcriptional control, Thus coordinated expression of SERCA2a and phospholamban proteins is achieved via translational control of the SERCA2 gene and transcriptional control of the phospholamban gene.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHYSIOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,RICHMOND,VA 23298	Virginia Commonwealth University; Virginia Commonwealth University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045957, R55HL045957] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45957] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARAI M, 1992, AM J PHYSIOL, V262, pC614, DOI 10.1152/ajpcell.1992.262.3.C614; BRIGGS FN, 1990, FEBS LETT, V259, P269, DOI 10.1016/0014-5793(90)80025-E; BRIGGS FN, 1992, J BIOL CHEM, V267, P26056; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; JORGENSEN AO, 1988, CELL MOTIL CYTOSKEL, V9, P164, DOI 10.1002/cm.970090208; JORGENSEN AO, 1986, J BIOL CHEM, V261, P3775; KANDARIAN SC, 1994, AM J PHYSIOL, V266, pC1190, DOI 10.1152/ajpcell.1994.266.5.C1190; KIRCHBERGER MA, 1976, J BIOL CHEM, V251, P725; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBERER E, 1989, EUR J BIOCHEM, V185, P51, DOI 10.1111/j.1432-1033.1989.tb15080.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; NAGAI R, 1989, P NATL ACAD SCI USA, V86, P2966, DOI 10.1073/pnas.86.8.2966; OHLENDIECK K, 1991, EUR J BIOCHEM, V202, P739, DOI 10.1111/j.1432-1033.1991.tb16428.x; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; PETTE D, 1984, MED SCI SPORT EXER, V16, P517; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHULTE LM, 1993, AM J PHYSIOL, V264, pC1308, DOI 10.1152/ajpcell.1993.264.5.C1308; SHAM JSK, 1991, AM J PHYSIOL, V261, pH1344, DOI 10.1152/ajpheart.1991.261.4.H1344	21	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11619	11622		10.1074/jbc.270.19.11619	http://dx.doi.org/10.1074/jbc.270.19.11619			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744801	hybrid			2022-12-27	WOS:A1995QX86500083
J	LEUSEN, JHW; FLUITER, K; HILARIUS, PM; ROOS, D; VERHOEVEN, AJ; BOLSCHER, BGJM				LEUSEN, JHW; FLUITER, K; HILARIUS, PM; ROOS, D; VERHOEVEN, AJ; BOLSCHER, BGJM			INTERACTIONS BETWEEN THE CYTOSOLIC COMPONENTS P47(PHOX) AND P67(PHOX) OF THE HUMAN NEUTROPHIL NADPH OXIDASE THAT ARE NOT REQUIRED FOR ACTIVATION IN THE CELL-FREE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; CHRONIC GRANULOMATOUS-DISEASE; GTP-BINDING PROTEIN; PLASMA-MEMBRANE; CYTOCHROME-B558; OXIDOREDUCTASE; RECONSTITUTION; PURIFICATION; EXPRESSION; P47-PHOX	Activation of the human NADPH oxidase requires the interaction of at least four cytosolic proteins and one membrane bound heterodimeric protein. Src homology 3 (SH3) domains and their proline rich counterstructures have been shown to play an important role in protein-protein interactions. Because it was found that the cytosolic oxidase components p67(phox), p47(phox), and p40(phox) reside in a complex in resting neutrophils, we studied the role of SH3 domains in their interaction by use of an overlay technique. Wild-type and mutated labeled p67(phox) and p47(phox) were used to detect immobilized cytosolic proteins on a protein blot. A specific association of native p67(phox) to blotted p47(phox) and blotted p40(phox) was found. These interactions were not disturbed by deleting the only proline-rich region (amino acids 227-231) in p67(phox). We also found a specific association of native p47(phox) with blotted p67(phox). Deletions in a putative SH3-binding region of p47(phox) completely abrogated the interaction with p67(phox). Other results suggest that the C terminus of p47(phox) exposes this SH3-binding domain for interaction with p67(phox). Similar results were obtained when the binding of cytosolic p67(phox) to wild-type or mutated p47(phox) were studied in solution. Interestingly, mutants of p47(phox) unable to bind to p67(phox) were fully capable of supporting superoxide production under cell-free activation conditions, We conclude that an interaction between the C-terminal proline-rich region of p47(phox) and the second SH3 domain of p67(phox) is not required for oxidase activity in the cell-free assay.	NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,1066 CX AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,EXPTL & CLIN IMMUNOL LAB,1066 CX AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,EMMA CHILDRENS HOSP,ACAD MED CTR,DEPT PEDIAT,1105 AZ AMSTERDAM,NETHERLANDS	University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam			Fluiter, Kees/H-2828-2015; Leusen, Jeanette/I-9010-2014; , Jeanette/AAG-3736-2019	Fluiter, Kees/0000-0003-0898-7260; Leusen, Jeanette/0000-0003-4982-6914				ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; AMBRUSO DR, 1990, J BIOL CHEM, V265, P924; AMBRUSO DR, 1990, J BIOL CHEM, V265, P19370; BOLSCHER BGJM, 1989, J CLIN INVEST, V83, P757, DOI 10.1172/JCI113954; BOLSCHER BGJM, 1990, J BIOL CHEM, V265, P15782; CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; DEMENDEZ I, 1994, J BIOL CHEM, V269, P16326; FINAN P, 1994, J BIOL CHEM, V269, P13752; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; LEUSEN JHW, 1994, J CLIN INVEST, V95, P2120; MUSACCHIO A, 1992, FEBS LETT, V307, P55, DOI 10.1016/0014-5793(92)80901-R; PARK JW, 1994, BIOCHEMISTRY-US, V33, P2907, DOI 10.1021/bi00176a021; PARK JW, 1992, J BIOL CHEM, V267, P17327; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Roos D, 1986, Methods Enzymol, V132, P225; ROTROSEN D, 1993, J BIOL CHEM, V268, P14256; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH RM, 1991, BLOOD, V77, P673; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; TSUNAWAKI S, 1994, BIOCHEM BIOPH RES CO, V199, P1378, DOI 10.1006/bbrc.1994.1383; UHLINGER DJ, 1992, BIOCHEM BIOPH RES CO, V186, P509, DOI 10.1016/S0006-291X(05)80837-X; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557	31	67	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11216	11221		10.1074/jbc.270.19.11216	http://dx.doi.org/10.1074/jbc.270.19.11216			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744754	hybrid			2022-12-27	WOS:A1995QX86500031
J	SCHLEMMER, SR; YANG, CH; SIROTNAK, FM				SCHLEMMER, SR; YANG, CH; SIROTNAK, FM			FUNCTIONAL MODULATION OF MULTIDRUG RESISTANCE-RELATED P-GLYCOPROTEIN BY CA2+-CALMODULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PLASMA-MEMBRANE VESICLES; HAMSTER OVARY CELLS; GENE-PRODUCT; TRANSPORT; LEUKEMIA; CHANNEL; EFFLUX; DNA	Studies with inside-out plasma membrane vesicles from multidrug-resistant (MDR 3) murine erythroleukemia (MEL/VCR-6) cells have provided evidence for down-modulation of P-glycoprotein (P-gp) function by Ca-2+-calmodulin (CLM). These studies showed that CLM in the presence or absence of Ca2+ had no effect on binding of [H-3]vinblastine (VBL) by P-gp in inside out plasma membrane vesicles. However, profound inhibition of ATP-dependent [H-3]VBL efflux by these vesicles was demonstrated by the addition of subnanomolar concentrations of CLM (IC50 = 0.15 +/- 0.02 nM). The addition of 1 mM Ca2+ reduced the inhibition of [H-3]VBL efflux by CLM, shifting the concentration required for inhibition to the nM range (IC50 = 2.55 +/- 0.35 nM). The inhibition of [H-3]VBL efflux by 0.6 nM CLM was reduced with as little as 0.01 mM Ca2+, and no inhibition occurred with concentrations greater than 0.2 mM Ca2+. Binding of CLM, itself, to P-gp was demonstrated in two ways, The P-gp content of detergent-solubilized plasma membrane from MEL/VCR-6 cells could be appreciably depleted by treating this material with CLM-Sepharose beads as shown by SDS-polyacrylamide gel electrophoresis (PAGE) and Western blotting with anti-P-gp antibody (C219) before and after CLM-Sepharose treatment. Also, depletion of P-gp from solution by CLM was less in the presence of 1 mM Ca2+. Blotting of P-gp after SDS-PAGE of plasma membrane from MEL/VCR-6 cells was also obtained using I-125-CLM as a probe. These results strongly suggest that the MDR 3 homolog of P-gp is a CLM-binding protein and that direct interaction of Ca2+-CLM with P-gp, while not affecting its binding of [H-3]VBL, down-modulates the translocation of this agent in the presence of ATP.	MEM SLOAN KETTERING CANC CTR,PROGRAM MOLEC PHARMACOL & EXPTL THERAPEUT,NEW YORK,NY 10021; CORNELL UNIV,GRAD SCH MED SCI,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Cornell University					NCI NIH HHS [CA 18856, CA 08748, CA 56517] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA056517, P30CA008748, P01CA018856] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; ALTENBERG GA, 1993, P NATL ACAD SCI USA, V90, P9735, DOI 10.1073/pnas.90.20.9735; BECK WT, 1987, BIOCHEM PHARMACOL, V26, P2879; BIEDLER JL, 1970, CANCER RES, V30, P1174; CHEUNG WY, 1979, SCIENCE, V207, P19; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P161, DOI 10.1016/0005-2736(92)90079-2; FORD JM, 1990, PHARMACOL REV, V42, P155; GILL DR, 1992, CELL, V71, P23, DOI 10.1016/0092-8674(92)90263-C; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; HISSIN PJ, 1978, BIOCHIM BIOPHYS ACTA, V508, P401, DOI 10.1016/0005-2736(78)90342-5; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; JAYANTHI LD, 1994, J BIOL CHEM, V269, P14424; KAMIMOTO Y, 1989, J BIOL CHEM, V264, P11693; KLEE CB, 1988, ANN REV BIOCH, V49, P489; KUNTEBOMMANAHAL.NT, 1985, CANCER RES, V45, P5382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; REUTZ S, 1993, P NATL ACAD SCI USA, V90, P11588; REUTZ S, 1994, J BIOL CHEM, V269, P12277; RIORDAN JR, 1985, PHARMACOL THERAPEUT, V28, P51, DOI 10.1016/0163-7258(85)90082-8; ROEPE PD, 1992, BIOCHEMISTRY-US, V31, P12555, DOI 10.1021/bi00165a003; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; SCHLEMMER SR, 1992, J BIOL CHEM, V267, P14746; SCHLEMMER SR, 1994, J BIOL CHEM, V269, P31059; SIMON S, 1994, P NATL ACAD SCI USA, V91, P1128, DOI 10.1073/pnas.91.3.1128; TOWBIN H, 1979, P NATL ACAD SCI USA, V70, P4350; TSURUO T, 1984, CANCER RES, V44, P5095; TUPPER JT, 1977, J CELL BIOL, V75, P12, DOI 10.1083/jcb.75.1.12; VANDERBLIEK AM, 1986, MOL CELL BIOL, V6, P1671, DOI 10.1128/MCB.6.5.1671	32	17	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11040	11042		10.1074/jbc.270.19.11040	http://dx.doi.org/10.1074/jbc.270.19.11040			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744732	hybrid			2022-12-27	WOS:A1995QX86500005
J	AIZAWA, H; SUTOH, K; TSUBUKI, S; KAWASHIMA, S; ISHII, A; YAHARA, I				AIZAWA, H; SUTOH, K; TSUBUKI, S; KAWASHIMA, S; ISHII, A; YAHARA, I			IDENTIFICATION, CHARACTERIZATION, AND INTRACELLULAR-DISTRIBUTION OF COFILIN IN DICTYOSTELIUM-DISCOIDEUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN DEPOLYMERIZING FACTOR; BINDING PROTEINS; PORCINE BRAIN; NUCLEOTIDE-SEQUENCE; SKELETAL-MUSCLE; F-ACTIN; PURIFICATION; TROPOMYOSIN; DESTRIN; CDNA	We identified and purified an actin monomer-binding protein of apparent molecular weight of 15,000 from Dictyostelium discoideum. The 15-kDa protein depolymerized actin filaments in a pH-dependent manner. The protein also had an activity to decrease apparent viscosity of actin solutions in a dose dependent manner. This activity was inhibited by phosphatidyl inositides. Molecular cloning of genes encoding this protein revealed that the protein is 42% identical in its primary sequence to yeast cofilin. We concluded that the 15-kDa protein is cofilin of this organism. D. discoideum cells contain two cofilin genes (DCOF1 and DCOF2) whose nucleotide sequences were entirely identical in their exsons while the promoter and intron regions were different. Promoter assay experiments revealed that DCOF1 is expressed both in vegetative and differentiating cells and that DCOF2 is not expressed under any conditions examined. Gene disruption experiments suggested that DCOF1 might be essential for the proliferation of D. discoideum cells whereas the disruption of DCOF2 was proven not to alter any phenotypes. Indirect immunofluorescence microscopic observations showed that cofilin is distributed diffusely throughout cytoplasm in vegetative cells. In flattened cells under starvation stress, cofilin localized at dramatically reorganizing actin cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques. These results suggest that cofilin may be involved in dynamic reorganization of membranous actin cytoskeletons.	TOKYO METROPOLITAN INST MED SCI, DEPT CELL BIOL, BUNKYO KU, TOKYO 113, JAPAN; TOKYO METROPOLITAN INST MED SCI, DEPT MOLEC BIOL, BUNKYO KU, TOKYO 113, JAPAN; UNIV TOKYO, COLL ARTS & SCI, DEPT PURE & APPL SCI, TOKYO 153, JAPAN	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; University of Tokyo								ABE H, 1990, BIOCHEMISTRY-US, V29, P7420, DOI 10.1021/bi00484a010; ADAMS ME, 1990, BIOCHEMISTRY-US, V29, P7414, DOI 10.1021/bi00484a009; AIZAWA H, 1989, J BIOL CHEM, V264, P5885; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; BRENNER SL, 1983, J BIOL CHEM, V258, P5013; COOPER JA, 1986, J BIOL CHEM, V261, P477; DHARMAWARDHANE S, 1991, CELL MOTIL CYTOSKEL, V20, P279, DOI 10.1002/cm.970200404; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; FUKUI Y, 1978, J CELL BIOL, V76, P146, DOI 10.1083/jcb.76.1.146; HALL AL, 1988, J CELL BIOCHEM, V37, P285, DOI 10.1002/jcb.240370304; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; IIDA K, 1993, GENE, V124, P115; IIDA K, 1992, CELL STRUCT FUNCT, V17, P39, DOI 10.1247/csf.17.39; KATSUMARU H, 1982, EXP CELL RES, V137, P353, DOI 10.1016/0014-4827(82)90036-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MG, 1983, CELL, V33, P477; Loomis W., 2012, DEV DICTYOSTELIUM DI; MABUCHI I, 1983, J CELL BIOL, V97, P1612, DOI 10.1083/jcb.97.5.1612; MAEKAWA S, 1984, J BIOCHEM-TOKYO, V95, P377, DOI 10.1093/oxfordjournals.jbchem.a134618; Maniatis T., 1982, MOL CLONING; MATSUZAKI F, 1988, J BIOL CHEM, V263, P11564; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; MORIYAMA K, 1992, J BIOL CHEM, V267, P7240; MORIYAMA K, 1990, NUCLEIC ACIDS RES, V18, P3053, DOI 10.1093/nar/18.10.3053; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P6624, DOI 10.1021/bi00344a049; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; QUIRK S, 1993, BIOCHEMISTRY-US, V32, P8525, DOI 10.1021/bi00084a019; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UYEDA TQ, 1994, SCIENCE, V368, P567; VANDEKERCKHOVE J, 1992, Current Opinion in Cell Biology, V4, P36, DOI 10.1016/0955-0674(92)90056-I; YONEZAWA N, 1991, J BIOL CHEM, V266, P17218; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382; YONEZAWA N, 1987, CELL STRUCT FUNCT, V12, P443, DOI 10.1247/csf.12.443	45	95	102	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10923	10932		10.1074/jbc.270.18.10923	http://dx.doi.org/10.1074/jbc.270.18.10923			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738034	hybrid			2022-12-27	WOS:A1995QW60100082
J	DUGAN, JM; DEWIT, C; MCCONLOGUE, L; MALTESE, WA				DUGAN, JM; DEWIT, C; MCCONLOGUE, L; MALTESE, WA			THE RAS-RELATED GTP-BINDING PROTEIN, RAB1B, REGULATES EARLY STEPS IN EXOCYTIC TRANSPORT AND PROCESSING OF BETA-AMYLOID PRECURSOR PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; ALZHEIMERS-DISEASE; INTRACELLULAR-TRANSPORT; ENDOCYTIC PATHWAY; CRYSTAL-STRUCTURE; GOLGI-COMPLEX; BREFELDIN-A; PEPTIDE; CLEAVAGE	The role of the Ras-related GTP-binding protein, Rab1B, in intracellular trafficking of beta-amyloid precursor protein (beta APP) was studied in cultured 293 cells, beta APP is processed via one of two alternative routes. In the major secretory pathway, beta APP is cleaved by alpha-secretase within the region comprising the beta-amyloid peptide (A beta), resulting in release of a soluble NH2-terminal exodomain (APP(alpha)) and a 3-kDa peptide (p3) derived from the carboxyl-terminal tail. In the alternative amyloidogenic pathway, beta APP is cleaved by beta-secretase, with the release of a truncated exodomain (APP(beta)) and an intact A beta peptide. When beta APP(751) was coexpressed with Rab1B(wt) or dominant negative Rab1B mutants (Rab1B(N121I) or Rab1B(S22N)) there was a marked decrease in conversion of the immature Endo-H sensitive form of beta APP(751) (108 kDa) to the mature O-glycosylated form of beta APP(751) (130 kDa) in cells expressing the mutant forms of Rab1B. The block in Golgi-dependent processing of beta APP was accompanied by inhibition of secretion of APP(S) (APP(alpha)). A similar decrease in secretion of APP(S) (APP, + APP(beta)) was observed in cells that were coexpressing Rab1B(N121I) with the ''Swedish'' variant of beta APP(751) (i.e. beta APPSW(751)), which undergoes increased amyloidogenic processing. Coincident with the decline in APP(8) secretion, the cells coexpressing beta APPSW(751) with Rab1B(N121I) showed a 90% decrease in AP secretion. The data indicate that Rab1B plays a key role in endoplasmic reticulum --> Golgi transport of beta APP, and that beta APP must pass through a late Golgi compartment before entering either the alpha-secretase or the amyloidogenic beta-secretase pathway. The results also suggest that mutant versions of other Rab proteins that function in different parts of the exocytic and endocytic pathways may be useful in defining the specific routes of beta APP transport involved in the biogenesis of A beta.	WEIS CTR RES, GEISINGER CLIN, DANVILLE, PA 17822 USA; ATHENA NEUROSCI, S SAN FRANCISCO, CA 94080 USA						NATIONAL CANCER INSTITUTE [R01CA034569] Funding Source: NIH RePORTER; NCI NIH HHS [CA34569] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BERANGER F, 1994, J BIOL CHEM, V269, P13637; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; BRUNGER AT, 1990, P NATL ACAD SCI USA, V87, P4849, DOI 10.1073/pnas.87.12.4849; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHEN YT, 1993, P NATL ACAD SCI USA, V90, P6508, DOI 10.1073/pnas.90.14.6508; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; FERRONOVICK S, 1993, ANNU REV CELL BIOL, V9, P575; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GANDY S, 1994, INT REV NEUROBIOL, V36, P29, DOI 10.1016/S0074-7742(08)60302-5; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1994, J BIOL CHEM, V269, P17741; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Higuchi R., 1989, PCR TECHNOLOGY, P61; HO DY, 1993, P NATL ACAD SCI USA, V90, P3655, DOI 10.1073/pnas.90.8.3655; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; KNOPS J, 1991, J BIOL CHEM, V266, P7285; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRUPINSKI J, 1992, J BIOL CHEM, V267, P24858; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI GP, 1993, J BIOL CHEM, V268, P24475; LO ACY, 1994, J BIOL CHEM, V269, P30966; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; MALTESE WA, 1990, J BIOL CHEM, V265, P2148; MANLEY TF, 1990, NUCLEIC ACIDS RES, V18, P937; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; OVERMEYER JH, 1992, J BIOL CHEM, V267, P22686; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; PIND SN, 1994, J CELL BIOL, V125, P239, DOI 10.1083/jcb.125.2.239; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; PRICE DL, 1993, P NATL ACAD SCI USA, V90, P6381, DOI 10.1073/pnas.90.14.6381; ROBERTS SB, 1994, J BIOL CHEM, V269, P3111; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; SCHWANINGER R, 1992, J CELL BIOL, V119, P1077, DOI 10.1083/jcb.119.5.1077; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SIMAN R, 1993, J BIOL CHEM, V268, P16602; SIMONS K, 1993, NEURON, V11, P789, DOI 10.1016/0896-6273(93)90109-5; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; ULMER JB, 1991, J BIOL CHEM, V266, P9173; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WILSON AL, 1993, J BIOL CHEM, V268, P14561; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; ZHONG ZY, 1994, J BIOL CHEM, V269, P627	73	57	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10982	10989		10.1074/jbc.270.18.10982	http://dx.doi.org/10.1074/jbc.270.18.10982			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738040	hybrid			2022-12-27	WOS:A1995QW60100089
J	DEISSLER, H; LOTTSPEICH, F; RAJEWSKY, MF				DEISSLER, H; LOTTSPEICH, F; RAJEWSKY, MF			AFFINITY PURIFICATION AND CDNA CLONING OF RAT NEURAL DIFFERENTIATION AND TUMOR-CELL SURFACE-ANTIGEN GP130(RB13-6) REVEALS RELATIONSHIP TO HUMAN AND MURINE PC-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; MEMBRANE GLYCOPROTEIN PC-1; FIBROBLAST GROWTH-FACTOR; 5'-NUCLEOTIDE PHOSPHODIESTERASE; NUCLEOTIDE PYROPHOSPHATASE; MONOCLONAL-ANTIBODY; PROTEIN-KINASE; IDENTIFICATION; EXPRESSION; PHOSPHORYLATION	Monoclonal antibody RB13-6 recognizes a subset of rat brain glial precursor cells that are highly susceptible to malignant conversion by the carcinogen N-ethyl-N-nitrosourea. The corresponding cell surface antigen was identified as a membrane glycoprotein (gp130(RB13-6)) and purified by immunoaffinity chromatography from the tumorigenic neuroectodermal rat cell line BT4Ca, Sequencing of 5 endoproteinase generated peptides of the purified antigen permitted the specific amplification of a cDNA fragment by reverse transcription-polymerase chain reaction and subsequent isolation of the complete coding sequence from a fetal rat brain cDNA library, The derived amino acid sequence indicates that the RB13-6 antigen is related to the human and murine plasma cell membrane protein PC-1, a nucleotide pyrophosphatase/alkaline phosphodiesterase and ectoprotein kinase. Similarly, purified gp130(RB13-6) possesses 5'-nucleotidase activity that can be inhibited with EDTA. Different from PC-1, gp130(RB13-6) isolated from BT4Ca cells is not a disulfide-linked dimer and contains an RGD-tripeptide sequence which, together with other structural features, suggests a possible function in cell adhesion and its subversion in malignant phenotypes.	UNIV ESSEN GESAMTHSCH,SCH MED,INST CELL BIOL CANC RES,D-45122 ESSEN,GERMANY; MAX PLANCK INST BIOCHEM,D-82152 MARTINSRIED,GERMANY	University of Duisburg Essen; Max Planck Society								Arch J R, 1978, Essays Biochem, V14, P82; AURIVILLIUS M, 1990, FEBS LETT, V264, P267, DOI 10.1016/0014-5793(90)80264-J; BAUGHMAN G, 1992, J IMMUNOL, V149, P1488; BELLI SI, 1993, EUR J BIOCHEM, V217, P421, DOI 10.1111/j.1432-1033.1993.tb18261.x; BUCKLEY MF, 1990, J BIOL CHEM, V265, P17506; CLEEVES V, 1991, BIOCH CHARAKTERISIER; CULP JS, 1985, J BIOL CHEM, V260, P8320; DRUCKREY H, 1966, NATURE, V210, P1378, DOI 10.1038/2101378a0; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; DUX R, 1991, J IMMUNOL METHODS, V144, P175, DOI 10.1016/0022-1759(91)90084-S; DUX R, 1991, CYTOMETRY, V12, P422, DOI 10.1002/cyto.990120507; DZHANDZHUGAZYAN K, 1993, FEBS LETT, V336, P279, DOI 10.1016/0014-5793(93)80820-K; EBERLE GM, 1989, THESIS U ESSEN ESSEN; ECKERSKORN C, 1989, CHROMATOGRAPHIA, V28, P92, DOI 10.1007/BF02290390; FRANK W, 1972, EXP CELL RES, V70, P390, DOI 10.1016/0014-4827(72)90151-6; GODING JW, 1982, J IMMUNOL, V129, P2636; GRUNDMANN U, 1990, DNA CELL BIOL, V9, P243, DOI 10.1089/dna.1990.9.243; HARAHAP AR, 1988, J IMMUNOL, V141, P2317; JENNE D, 1991, BIOCH BIOPHSY RES CO, V176, P10000; KINDLERROHRBORN A, 1985, DIFFERENTIATION, V30, P53, DOI 10.1111/j.1432-0436.1985.tb00513.x; KINDLERROHRBORN A, 1994, DIFFERENTIATION, V57, P215, DOI 10.1007/s002580050057; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRETSINGER RH, 1987, COLD SPRING HARB SYM, V52, P499, DOI 10.1101/SQB.1987.052.01.057; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAERUM OD, 1977, Z KREBSFORSCH KLIN O, V89, P273, DOI 10.1007/BF00283783; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MURATA J, 1994, J BIOL CHEM, V269, P30479; NIKITIN AY, 1991, P NATL ACAD SCI USA, V88, P9939, DOI 10.1073/pnas.88.22.9939; ODA Y, 1991, J BIOL CHEM, V266, P16791; ODA Y, 1993, J BIOL CHEM, V268, P27318; PATTHY L, 1988, J MOL BIOL, V202, P689, DOI 10.1016/0022-2836(88)90550-5; RAJEWSKY MF, 1985, THEORIES MODELS CELL, P155; RAJEWSKY MF, 1977, ORIGINS HUMAN CANCER, P709; REBBE NF, 1991, P NATL ACAD SCI USA, V88, P5192, DOI 10.1073/pnas.88.12.5192; REBBE NF, 1993, MOL IMMUNOL, V30, P87, DOI 10.1016/0161-5890(93)90429-F; ROJIANI MV, 1991, BIOCHEMISTRY-US, V30, P9859, DOI 10.1021/bi00105a008; Sambrook J, 1989, MOL CLONING LABORATO; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; TAKAHASHI T, 1970, J EXP MED, V131, P1325, DOI 10.1084/jem.131.6.1325; URIARTE M, 1993, BIOCHEM J, V293, P93, DOI 10.1042/bj2930093; VANDRIEL IR, 1987, J BIOL CHEM, V262, P4882	42	68	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9849	9855		10.1074/jbc.270.17.9849	http://dx.doi.org/10.1074/jbc.270.17.9849			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730366	hybrid			2022-12-27	WOS:A1995QV41700025
J	KNIGHT, JB; YAMAUCHI, K; PESSIN, JE				KNIGHT, JB; YAMAUCHI, K; PESSIN, JE			DIVERGENT INSULIN AND PLATELET-DERIVED GROWTH-FACTOR REGULATION OF FOCAL ADHESION KINASE (PP125(FAK)) TYROSINE PHOSPHORYLATION, AND REARRANGEMENT OF ACTIN STRESS FIBERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; EXTRACELLULAR-MATRIX; SIGNAL TRANSDUCTION; PAXILLIN; IDENTIFICATION; CYTOSKELETON; STIMULATION; ACTIVATION; PP125FAK; BOMBESIN	Insulin treatment of Chinese hamster ovary cells expressing high levels of the human insulin receptor resulted in the tyrosine dephosphorylation of the 125-kDa focal adhesion kinase (pp125(FAK)). The decrease in pp125(FAK) tyrosine phosphorylation paralleled a decrease in the cellular content of actin stress fibers, and these changes were independent of the extracellular matrix on which the cells were grown. The reduction in both pp125(FAK) tyrosine phosphorylation and actin stress fibers occurred in an insulin concentration-dependent manner, with significant effects at approximately 0.3 nM and a maximal effect at 3 nM. However, in the continuous presence of insulin, the decreases in the tyrosine phosphorylation state of pp125(FAK) and actin stress fiber content were transient, Maximal reduction of pp125(FAK) tyrosine phosphorylation was observed following 15 min of insulin treatment, with a return to unstimulated control levels by 60 min. Similarly, actin stress fiber content was maximally reduced by 15 min of insulin treatment and fully recovered by 60 min. In contrast to insulin, platelet-derived growth factor stimulation increased actin stress fiber content and enhanced pp125(FAK) tyrosine phosphorylation, These data demonstrate a novel signaling role for insulin in inducing the tyrosine dephosphorylation of pp125(FAK) and a concomitant reorganization of actin stress fibers, which underlies at least one aspect of signaling divergence between the insulin and platelet-derived growth factor receptor tyrosine kinases.	UNIV IOWA,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	University of Iowa					NIDDK NIH HHS [DK25295, DK33823] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033823, R01DK033823, P30DK025295] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CHEN HC, 1994, J BIOL CHEM, V269, P31229; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; FRATTALI AL, 1991, J BIOL CHEM, V266, P9829; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; HERMAN B, 1985, J CELL BIOL, V100, P1031, DOI 10.1083/jcb.100.4.1031; HITT AL, 1994, CURR OPIN CELL BIOL, V6, P120, DOI 10.1016/0955-0674(94)90125-2; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; KUMAGAI N, 1993, FEBS LETT, V329, P273, DOI 10.1016/0014-5793(93)80236-N; LI SL, 1993, EXP CELL RES, V205, P353, DOI 10.1006/excr.1993.1097; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Otey C A, 1990, Semin Cell Biol, V1, P391; RANKIN S, 1994, J BIOL CHEM, V269, P704; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SABA H, 1994, P NATL ACAD SCI USA, V91, P3984; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHWARTZ M A, 1992, Trends in Cell Biology, V2, P304, DOI 10.1016/0962-8924(92)90120-C; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; SHATTIL SJ, 1994, J BIOL CHEM, V269, P14738; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; TSAKIRIDIS T, 1994, J BIOL CHEM, V269, P29934; TURNER CE, 1993, J CELL SCI, V105, P637; WENG ZG, 1993, J BIOL CHEM, V268, P14956; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; ZACHARY I, 1992, J BIOL CHEM, V267, P19031	33	70	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10199	10203		10.1074/jbc.270.17.10199	http://dx.doi.org/10.1074/jbc.270.17.10199			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730324	hybrid			2022-12-27	WOS:A1995QV41700071
J	SHINOMURA, T; ZAKO, M; ITO, K; UJITA, M; KIMATA, K				SHINOMURA, T; ZAKO, M; ITO, K; UJITA, M; KIMATA, K			THE GENE STRUCTURE AND ORGANIZATION OF MOUSE PG-M, A LARGE CHONDROITIN SULFATE PROTEOGLYCAN - GENOMIC BACKGROUND FOR THE GENERATION OF MULTIPLE PG-M TRANSCRIPTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERSICAN; CHONDROGENESIS; AMPLIFICATION; SEQUENCE; CLONING; CDNAS; BUD	We previously showed not only the presence of multiple RNA transcripts of different sizes encoding the core protein of mouse PG-M, but also their tissue-dependent expression, Major causes for the multiple forms were found to be due to alternative usage of the two different chondroitin sulfate attachment domains (alpha and beta). In this study, genomic DNA analysis has revealed that these domains are encoded by two large exons, exon VII (2880 base pairs) and exon VIII (5229 base pairs), The splice sites of these two exons were consistent with the occurrence of alternative splicing without frameshift. Furthermore, the mouse PG-M gene was shown to have four distinct polyadenylation signals and three candidates for the transcription initiation site as well. These genomic structural variations may contribute to the multiplicity of PG-M transcripts. Northern hybridization analysis showed that at least three different transcripts were generated by different usage of the distinct polyadenylation signals.	AICHI MED UNIV,INST MOLEC SCI MED,NAGAKUTE,AICHI 48011,JAPAN	Aichi Medical University								DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GREENE JM, 1994, CURRENT PROTOCOLS MO; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; KIMATA K, 1986, J BIOL CHEM, V261, P3517; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHINOMURA T, 1990, ANAT EMBRYOL, V181, P227; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; SHINOMURA T, 1990, DEV GROWTH DIFFER, V32, P243; UJITA M, 1994, J BIOL CHEM, V269, P27603; VIHINEN T, 1993, J BIOL CHEM, V268, P17261; ZAKO M, 1995, J BIOL CHEM, V270, P3914, DOI 10.1074/jbc.270.8.3914; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	16	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10328	10333		10.1074/jbc.270.17.10328	http://dx.doi.org/10.1074/jbc.270.17.10328			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730339	hybrid			2022-12-27	WOS:A1995QV41700088
J	WANG, F; KAN, M; YAN, GC; XU, JM; MCKEEHAN, WL				WANG, F; KAN, M; YAN, GC; XU, JM; MCKEEHAN, WL			ALTERNATELY SPLICED NH2-TERMINAL IMMUNOGLOBULIN-LIKE LOOP-I IN THE ECTODOMAIN OF THE FIBROBLAST GROWTH-FACTOR (FGF) RECEPTOR-1 LOWERS AFFINITY FOR BOTH HEPARIN AND FGF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE EPITHELIAL-CELLS; SIGNAL-TRANSDUCTION; EXPRESSION; KINASE; RAT	Alternate splicing of a single exon encoding an NH2-terminal immunoglobulin (Ig) disulfide loop in the ectodomain of the fibroblast growth factor receptor (FGFR) types 1 and 2 results in alpha and beta isoforms that exhibit 3- and 2-Ig loops, respectively, Previously we demonstrated that alternately spliced Loop I has no independent ligand binding activity but is sufficiently interactive with the ligand- and heparin-binding site formed by Loops II and III to lower affinity for the same fibroblast growth factor (FGF) ligand. Here we show that a lower affinity of FGFR1 alpha for heparin parallels the lower affinity for FGF-1. A mutant of FGFR1 alpha in which the sequence between Loops I and II was deleted exhibits high affinity for both FGF-1 and heparin and other properties of the FGPR1 beta isoform, which include resistance to degradation by trypsin and display of specific antibody epitopes, This suggests that the interloop sequence facilitates the interaction of Loop I with Loops II and III, Lack of expression of both exons coding for Loop I and the sequence between Loops I and II in the FGFR2 gene characterizes rat prostate tumor cells, which exhibit a loss of the low affinity class of FGF receptors, Although the exon coding for the sequence between Loops I and II is alternately spliced in the FGFR2 beta isoform, coordinate expression with the exon coding for Loop I results in the functional differences between the FGFR alpha and FGPR beta variants.	TEXAS A&M UNIV,ALBERT B ALKEK INST BIOSCI & TECHNOL,DEPT BIOCHEM & BIOPHYS,HOUSTON,TX 77030	Texas A&M University System					NCI NIH HHS [CA59971] Funding Source: Medline; NIDDK NIH HHS [DK35310, DK38639] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA059971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035310, P01DK038639] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		HOU JZ, 1991, SCIENCE, V251, P665, DOI 10.1126/science.1846977; HOU JZ, 1992, J BIOL CHEM, V267, P17804; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KOBRIN MS, 1993, CANCER RES, V53, P4741; MANSSON PE, 1989, CANCER RES, V49, P2485; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; SHI E, 1993, MOL CELL BIOL, V13, P3907, DOI 10.1128/MCB.13.7.3907; WANG F, 1995, J BIOL CHEM, V270, P10222, DOI 10.1074/jbc.270.17.10222; XU JM, 1992, J BIOL CHEM, V267, P17792; YAMAGUCHI F, 1994, P NATL ACAD SCI USA, V91, P484, DOI 10.1073/pnas.91.2.484; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; YAN GC, 1993, BIOCHEM BIOPH RES CO, V194, P512, DOI 10.1006/bbrc.1993.1849	13	117	130	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10231	10235		10.1074/jbc.270.17.10231	http://dx.doi.org/10.1074/jbc.270.17.10231			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730327	hybrid			2022-12-27	WOS:A1995QV41700075
J	WU, DQ; JIANG, HP; SIMON, MI				WU, DQ; JIANG, HP; SIMON, MI			DIFFERENT ALPHA-1-ADRENERGIC RECEPTOR SEQUENCES REQUIRED FOR ACTIVATING DIFFERENT G-ALPHA SUBUNITS OF GQ CLASS OF G-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE HYDROLYSIS; SIGNAL-TRANSDUCTION PATHWAYS; PHOSPHOLIPASE-C; ADRENERGIC-RECEPTORS; GAMMA; CELLS; SELECTIVITY; SPECIFICITY; SUBTYPES; FAMILY	In order to understand the specific interactions between receptors and guanine nucleotide-binding regulatory protein (G proteins), we attempted to delineate the alpha 1B-adrenergic receptor sequences involved in activation of the alpha subunits of the Gq class of G proteins. A number of specific mutations were introduced into the third inner loop of the receptor, and the mutants were tested for their abilities to activate different G alpha subunits of the Gq class. Our results indicate that the receptor sequences required for activating G alpha q/11, G alpha 14, or G alpha 16 are different. The sequence extending from residues Lys(240) to His(252) is required for activation of G alpha q/11, but not for activation of G alpha 14 or G alpha 16. Two segments in the third loop of the receptor are required for activation of G alpha 14: one is located at the N terminus of the loop ending at residue Asn(226), and the other is located at the C terminus of the loop starting from residue Ser(278). The fatter contains a BBXXB motif, which is apparently critical for G alpha 14 coupling, but not for G alpha 16 or G alpha q/11 conpling. Furthermore, the three amino acids stretch (Tyr(217) to Val(219)) included in the N-terminal segment is not only required for G alpha 14 coupling, but also for G alpha q/11 coupling. It may be involved to some extent in G alpha 16 coupling as well.	CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology	WU, DQ (corresponding author), UNIV ROCHESTER,DEPT PHARMACOL,601 ELMWOOD AVE,ROCHESTER,NY 14642, USA.							AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; ARAGAY AM, 1992, J BIOL CHEM, V267, P24983; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V90, P163; CHABRE O, 1994, J BIOL CHEM, V269, P5730; CHAZENBALK GD, 1990, J BIOL CHEM, V265, P20970; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HEDIN KE, 1993, CELL SIGNAL, V5, P505, DOI 10.1016/0898-6568(93)90046-O; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KOSUGI S, 1992, J BIOL CHEM, V267, P24153; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; RONDA ES, 1994, J BIOL CHEM, V269, P326; RUBENSTEIN RC, 1991, BIOCHEMISTRY-US, V30, P10769, DOI 10.1021/bi00108a023; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; UEDA N, 1994, J BIOL CHEM, V269, P4388; WANGE RL, 1991, J BIOL CHEM, V266, P11409; WONG SKF, 1994, J BIOL CHEM, V269, P18968; WONG SKF, 1990, J BIOL CHEM, V265, P6219; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; WU DQ, 1992, J BIOL CHEM, V267, P25798; WU DQ, 1992, J BIOL CHEM, V267, P1811	32	63	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9828	9832		10.1074/jbc.270.17.9828	http://dx.doi.org/10.1074/jbc.270.17.9828			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730363	hybrid			2022-12-27	WOS:A1995QV41700022
J	XU, LZ; HARRISON, RW; WEBER, IT; PILKIS, SJ				XU, LZ; HARRISON, RW; WEBER, IT; PILKIS, SJ			HUMAN BETA-CELL GLUCOKINASE - DUAL ROLE OF SER-151 IN CATALYSIS AND HEXOSE AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN HEXOKINASE; AMINO-ACID SEQUENCE; C-TERMINAL HALVES; YEAST HEXOKINASE; LIVER GLUCOKINASE; CLONED CDNA; EXPRESSION; MUTAGENESIS; INSULIN; ENZYME	Glucokinase is distinguished from yeast hexokinase and low K-m mammalian hexokinases by its low affinity for glucose and its cooperative behavior, even though glucose binding residues and catalytic residues are highly conserved in all of these forms of hexokinase, The roles of Ser-151 and Asn-166 as determinants of hexose affinity and cooperative behavior of human glucokinase have been evaluated by site-directed mutagenesis, expression and purification of the wild-type and mutant enzymes, and steady-state kinetic analysis. Mutation of Asn-166 to arginine increased apparent affinity for both glucose and ATP by a factor of 3, Mutation of Ser-151 to cysteine, aIanine, or glycine lowered the K-m for glucose by factors of 2, 26-, and 40-fold, respectively, decreased V-max abolished cooperativity for glucose, and also decreased K-m for mannose and fructose. The Ser-151 mutants had hexose R, values similar to those of yeast hexokinase, hexokinase I, and the recombinantly expressed COOH-terminal half of hexokinase I. However, the K-i values for the competitive inhibitors, N-acetylglucosamine and glucose-6-P, were unchanged, suggesting that Ser-151 is not important for inhibitor binding, Mutation of Ser-151 also increased the K-m for ATP about 5-fold and abolished the enzyme's low ATPase activity, which indicates it is essential for ATP hydrolysis. The substrate-induced change in intrinsic fluorescence of S151A occurred at a much lower glucose concentration than that for wild-type enzyme. The results implicate a dual role for Ser-151 as a determinant of hexose affinity and catalysis, exclusive of the glucose-induced conformational change, and suggest that the low hexose affinity of glucokinase is dependent on interaction of Ser-151 with other regions of the protein.	UNIV MINNESOTA,DEPT BIOCHEM,MINNEAPOLIS,MN 55455; THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,DEPT PHARMACOL,PHILADELPHIA,PA 19107; SUNY STONY BROOK,DEPT PHYSIOL & BIOPHYS,STONY BROOK,NY 11794	University of Minnesota System; University of Minnesota Twin Cities; Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook				Harrison, Robert/0000-0003-2449-1214	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046562] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK46562] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON CM, 1979, SCIENCE, V204, P375, DOI 10.1126/science.220706; ANDREONE TL, 1989, J BIOL CHEM, V264, P363; ARORA KK, 1990, J BIOL CHEM, V265, P6481; ARORA KK, 1993, J BIOL CHEM, V268, P18259; ARORA KK, 1993, J BIOL CHEM, V266, P5359; BAIJAL M, 1992, ARCH BIOCHEM BIOPHYS, V298, P271, DOI 10.1016/0003-9861(92)90123-E; CARDENAS ML, 1984, EUR J BIOCHEM, V145, P163, DOI 10.1111/j.1432-1033.1984.tb08536.x; CHARLES RS, 1994, DIABETES, V43, P784, DOI 10.2337/diab.43.6.784; DELAFUEN.G, 1970, EUR J BIOCHEM, V16, P226; FROHLICH KU, 1985, GENE, V36, P105, DOI 10.1016/0378-1119(85)90074-5; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; GRANNER DK, 1990, J BIOL CHEM, V265, P10171; HARRISON RW, 1985, THESIS YALE U NEW HA; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KOPETZKI E, 1985, GENE, V39, P95, DOI 10.1016/0378-1119(85)90113-1; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUROMIZU K, 1979, FED PROC, V35, P302; LANGE AJ, 1991, BIOCHEM J, V277, P159, DOI 10.1042/bj2770159; LIN SX, 1990, J BIOL CHEM, V265, P9670; LIU F, 1991, BIOCHEM BIOPH RES CO, V177, P305, DOI 10.1016/0006-291X(91)91983-J; MAGNANI M, 1992, BIOCHEM J, V285, P193, DOI 10.1042/bj2850193; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; MENEZES LC, 1976, EUR J BIOCHEM, V65, P41, DOI 10.1111/j.1432-1033.1976.tb10387.x; NISHI S, 1988, BIOCHEM BIOPH RES CO, V157, P937, DOI 10.1016/S0006-291X(88)80964-1; PILKIS SJ, 1994, J BIOL CHEM, V269, P21925; PRINTZ RL, 1993, J BIOL CHEM, V268, P5209; ROSE IA, 1967, J BIOL CHEM, V242, P1635; SCHWAB DA, 1989, P NATL ACAD SCI USA, V86, P2563, DOI 10.1073/pnas.86.8.2563; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; URETA T, 1982, COMP BIOCHEM PHYS B, V71, P549, DOI 10.1016/0305-0491(82)90461-8; VIOLA RE, 1982, BIOCHEMISTRY-US, V21, P1295, DOI 10.1021/bi00535a029; WEINHOUSE S, 1976, CURR TOP CELL REGUL, V11, P1; WHITE TK, 1989, ARCH BIOCHEM BIOPHYS, V274, P375, DOI 10.1016/0003-9861(89)90451-7; XU LZ, 1994, J BIOL CHEM, V269, P27458; XU LZ, 1995, IN PRESS BIOCHEMISTR	35	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9939	9946		10.1074/jbc.270.17.9939	http://dx.doi.org/10.1074/jbc.270.17.9939			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730377	hybrid			2022-12-27	WOS:A1995QV41700038
J	CASTUMA, CE; HUANG, RP; KORNBERG, A; REUSCH, RN				CASTUMA, CE; HUANG, RP; KORNBERG, A; REUSCH, RN			INORGANIC POLYPHOSPHATES IN THE ACQUISITION OF COMPETENCE IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY-BETA-HYDROXYBUTYRATE; MEMBRANE-STRUCTURE; PLASMA-MEMBRANES; TRANSFORMATION; COMPLEXES; PROTEIN; KINASE; GENE	A complex of polyhydroxybutyrate (PHB), Ca2+, and inorganic polysulphate (polyP) was proposed as the membrane component responsible for competence for DNA entry in Escherichia coli (Reusch, R.N., ans Sadoff, H.L. (1988) Proc. Natl. Acad. Sci. USA 85, 4176-4180). While chemical and immunological assays and 1H NMR have unequivocally established the identity and content of PHB in the complex, comparable methods were not available for polyP. With specific enzyme assays developed for polyP, we have identified, in chloroform extracts of competent cell membranes, a novel form of polyP of about 60 to 70 residues in a stoichiometric ratio of PHB to polyP of 2:1. In E-coli mutants, incapable of synthesizing the predominant, thousand-long polyP chains, appearance of this short polyP and its inclusion in membranes can account for their capacity to develop competence and indicates an auxiliary pathway for polyP synthesis. A variety of fluorescent lipid probes demonstrate the appearance of extensive rigid domains in membranes of competent cell. We propose that the PHB.Ca2+.polyP complex perturbs the conformation of the lipid matrix, making it more permeable to charged molecules and thus allowing the entry of DNA.	STANFORD UNIV,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305; MICHIGAN STATE UNIV,DEPT MICROBIOL,E LANSING,MI 48824	Stanford University; Michigan State University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033375, R01GM007581, R37GM007581] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-33375, GM-07581] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN KH, 1990, J BIOL CHEM, V265, P11734; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; AKIYAMA M, 1992, J BIOL CHEM, V267, P22556; CALVIN NM, 1988, J BACTERIOL, V170, P2796, DOI 10.1128/jb.170.6.2796-2801.1988; CASTUMA CE, 1993, J BIOL CHEM, V268, P24665; CLARK JE, 1987, ANAL BIOCHEM, V161, P280, DOI 10.1016/0003-2697(87)90452-0; CORNIBERT J, 1971, MACROMOLECULES, V3, P741; CROOKE E, 1994, J BIOL CHEM, V269, P6290; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; KORNBERG A, 1994, PHOSPHATE IN MICROORGANISMS, P204; KULAEV IS, 1983, ADV MICROB PHYSIOL, V24, P83, DOI 10.1016/S0065-2911(08)60385-9; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; REUSCH R, 1987, CAN J MICROBIOL, V33, P435, DOI 10.1139/m87-073; REUSCH RN, 1992, BIOCHIM BIOPHYS ACTA, V1123, P33, DOI 10.1016/0005-2760(92)90168-U; REUSCH RN, 1989, P SOC EXP BIOL MED, V191, P377; REUSCH RN, 1983, J BACTERIOL, V156, P778, DOI 10.1128/JB.156.2.778-788.1983; REUSCH RN, 1988, P NATL ACAD SCI USA, V85, P4176, DOI 10.1073/pnas.85.12.4176; REUSCH RN, 1986, J BACTERIOL, V168, P553, DOI 10.1128/jb.168.2.553-562.1986; REUSCH RN, 1992, FEMS MICROBIOL LETT, V103, P119, DOI 10.1016/0378-1097(92)90301-4; SEEBACH D, 1994, EUR J BIOCHEM, V224, P317, DOI 10.1111/j.1432-1033.1994.00317.x; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; SKLAR LA, 1980, MOL CELL BIOCHEM, V32, P169; SMITH M, 1990, FOCUS, V12, P38; WOOD HG, 1988, ANNU REV BIOCHEM, V57, P235, DOI 10.1146/annurev.bi.57.070188.001315; WURST H, 1994, J BIOL CHEM, V269, P10996	26	82	93	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12980	12983		10.1074/jbc.270.22.12980	http://dx.doi.org/10.1074/jbc.270.22.12980			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768888	hybrid			2022-12-27	WOS:A1995RB43900009
J	MOOLENAAR, WH				MOOLENAAR, WH			LYSOPHOSPHATIDIC ACID, A MULTIFUNCTIONAL PHOSPHOLIPID MESSENGER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PHOSPHATIDIC-ACID; 3T3 CELLS; FIBROBLASTS; ACTIVATION; IDENTIFICATION; PLATELETS; RECEPTOR; PHOSPHORYLATION; PROLIFERATION; THROMBIN				MOOLENAAR, WH (corresponding author), NETHERLANDS CANC INST,DIV CELLULAR BIOCHEM,PLESMANLAAN 121,1066 CX AMSTERDAM,NETHERLANDS.							BARRY ST, 1994, J CELL SCI, V107, P2033; BILLAH MM, 1981, J BIOL CHEM, V256, P5399; CHRZANOWSKAWODN.M, 1994, J CELL SCI, V107, P3643; COOK S, 1994, NATURE, V369, P361, DOI 10.1038/369361a0; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; GERRARD JM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P282, DOI 10.1016/0005-2760(89)90112-4; HA KS, 1994, BIOCHEM J, V302, P55; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HII CST, 1994, BIOCHEM J, V303, P475, DOI 10.1042/bj3030475; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; HOWE LR, 1993, J BIOL CHEM, V268, P20717; IMAMURA F, 1993, BIOCHEM BIOPH RES CO, V193, P497, DOI 10.1006/bbrc.1993.1651; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; JALINK K, 1993, P NATL ACAD SCI USA, V90, P1857, DOI 10.1073/pnas.90.5.1857; JALINK K, 1994, BBA-REV CANCER, V1198, P185, DOI 10.1016/0304-419X(94)90013-2; JALINK K, 1995, BIOCHEM J, V307, P609, DOI 10.1042/bj3070609; JALINK K, 1990, J BIOL CHEM, V265, P12232; KOBAYASHI T, 1994, FEBS LETT, V351, P38, DOI 10.1016/0014-5793(94)00815-9; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; KOLODNEY MS, 1993, J BIOL CHEM, V268, P23850; KUMAGAI N, 1993, J BIOL CHEM, V268, P24535; Moolenaar Wouter H., 1994, Trends in Cell Biology, V4, P213, DOI 10.1016/0962-8924(94)90144-9; NOBES CD, 1995, J CELL SCI, V108, P225; PIAZZA GA, 1995, EXP CELL RES, V216, P51, DOI 10.1006/excr.1995.1007; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; SHIONO S, 1993, BIOCHEM BIOPH RES CO, V193, P667, DOI 10.1006/bbrc.1993.1676; SIMON MF, 1995, BIOCHEM BIOPH RES CO, V108, P1743; STOLL LL, 1994, J BIOL CHEM, V269, P4254; SUGIURA T, 1994, ARCH BIOCHEM BIOPHYS, V311, P358, DOI 10.1006/abbi.1994.1249; THOMPSON FJ, 1994, BIOCHEM J, V300, P457, DOI 10.1042/bj3000457; THOMSON FJ, 1994, MOL PHARMACOL, V45, P718; THOMSON FJ, 1995, BIOCHEM J, V306, P305, DOI 10.1042/bj3060305; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; TIGYI G, 1992, J BIOL CHEM, V267, P21360; TIGYI G, 1994, P NATL ACAD SCI USA, V91, P1908, DOI 10.1073/pnas.91.5.1908; TOKUMURA A, 1994, AM J PHYSIOL, V267, pC204, DOI 10.1152/ajpcell.1994.267.1.C204; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; VANDERBEND RL, 1992, BIOCHEM J, V285, P235, DOI 10.1042/bj2850235; VANDERBEND RL, 1992, BIOCHIM BIOPHYS ACTA, V1125, P110, DOI 10.1016/0005-2760(92)90163-P; VANDERBEND RL, 1992, EMBO J, V11, P2495, DOI 10.1002/j.1460-2075.1992.tb05314.x; VEMURI GS, 1994, BIOCHEM BIOPH RES CO, V202, P1619, DOI 10.1006/bbrc.1994.2118; XIE MS, 1994, ARCH BIOCHEM BIOPHYS, V312, P254, DOI 10.1006/abbi.1994.1307; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; ZHANG QH, 1994, J CELL BIOL, V127, P1447, DOI 10.1083/jcb.127.5.1447	55	544	586	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12949	12952		10.1074/jbc.270.22.12949	http://dx.doi.org/10.1074/jbc.270.22.12949			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768880	hybrid			2022-12-27	WOS:A1995RB43900001
J	FUJII, H; JOHNSON, MK; FINNEGAN, MG; MIKI, T; YOSHIDA, LS; KAKINUMA, K				FUJII, H; JOHNSON, MK; FINNEGAN, MG; MIKI, T; YOSHIDA, LS; KAKINUMA, K			ELECTRON-SPIN-RESONANCE STUDIES ON NEUTROPHIL CYTOCHROME B(558) - EVIDENCE THAT LOW-SPIN HEME IRON IS ESSENTIAL FOR O-2-RADICAL-ANION GENERATING ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; PHAGOCYTE NADPH OXIDASE; PARAMAGNETIC RESONANCE; RESPIRATORY BURST; PORCINE NEUTROPHILS; C REDUCTASE; SUPEROXIDE; PURIFICATION; FLAVIN; PARTICIPATION	Cytochrome b(558) purified from pig neutrophils was studied to characterize the spin state of the heme iron in relation to its O-2-radical-anion generating activity. ESR spectra of cytochrome b(558) either from resting or stimulated neutrophils showed a low-spin hemoprotein with g(1,2,3) of 3.2, 2.1, and 1.3 (estimated), At physiological pH, the oxidized cytochrome b(558) is in a purely low-spin state, On lowering or raising pH from 7, the spin state changes to high-spin. The ESR spectrum of high-spin cytochrome b(558) was identical to that of methemoglobin, suggesting that the axial-ligand type in both hemoproteins may be the same, i.e. histidine is the fifth ligand. The ratio of the low-spin to high-spin heme in cytochrome b(558) was evaluated by magnetic circular dichroism spectroscopy. The pH of cytochrome b(558) was varied to form different ratios of the low-spin to high-spin states of the heme, and its O-2-radical-anion generating activity was examined in cell-free systems, O-2-radical-anion farming activity decreased concomitant with loss of the low-spin heme, which provides direct evidence that the low-spin state of cytochrome b(558) is essential to generate O-2-radical-anion and the heme retains the low-spin state through the redox cycle.	UNIV GEORGIA,DEPT CHEM,ATHENS,GA 30602; UNIV GEORGIA,CTR METALLOENZYME STUDIES,ATHENS,GA 30602	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	FUJII, H (corresponding author), TOKYO METROPOLITAN INST MED SCI,DEPT INFLAMMAT RES,BUNKYO KU,18-22 HONKOMAGOME 3-CHOME,TOKYO 113,JAPAN.				NIGMS NIH HHS [GM51962] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051962] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABIOR BM, 1976, J CLIN INVEST, V58, P989, DOI 10.1172/JCI108553; BABIOR BM, 1984, BLOOD, V64, P959; CROSS AR, 1981, BIOCHEM J, V194, P599, DOI 10.1042/bj1940599; CROSS AR, 1985, BIOCHEM J, V226, P881, DOI 10.1042/bj2260881; CROSS AR, 1982, BIOCHEM J, V204, P479, DOI 10.1042/bj2040479; CURNUTTE JT, 1993, CLIN IMMUNOL IMMUNOP, V67, pS2, DOI 10.1006/clin.1993.1078; FOROOZAN R, 1992, J BIOL CHEM, V267, P24400; FUJII H, 1992, BIOCHIM BIOPHYS ACTA, V1136, P239, DOI 10.1016/0167-4889(92)90112-O; FUJII H, 1991, BIOCHIM BIOPHYS ACTA, V1095, P201, DOI 10.1016/0167-4889(91)90100-C; FUJII H, 1995, J BIOL CHEM, V270, P3193, DOI 10.1074/jbc.270.7.3193; HASHIMOTO Y, 1962, J BIOL CHEM, V237, P3843; HURST JK, 1991, J BIOL CHEM, V266, P1627; ISOGAI Y, 1993, J BIOL CHEM, V268, P4025; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; LAPORTE F, 1991, EUR J BIOCHEM, V196, P59, DOI 10.1111/j.1432-1033.1991.tb15785.x; MCCURLEY JP, 1990, BIOCHIM BIOPHYS ACTA, V1020, P176, DOI 10.1016/0005-2728(90)90049-A; MIKI T, 1992, J BIOL CHEM, V267, P18695; MIKI T, 1992, J BIOL CHEM, V267, P19673; NAKAMURA M, 1985, FEBS LETT, V186, P215, DOI 10.1016/0014-5793(85)80711-0; OMURA T, 1962, J BIOL CHEM, V237, P1375; ORKIN SH, 1989, ANNU REV IMMUNOL, V7, P277; PALMER G, 1985, BIOCHEM SOC T, V13, P548, DOI 10.1042/bst0130548; PEMBER SO, 1984, J BIOL CHEM, V259, P590; RAVAL P, 1993, BIOCHEM BIOPH RES CO, V196, P543; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SALERNO JC, 1984, J BIOL CHEM, V259, P2331; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SIEDOW JN, 1978, J BIOL CHEM, V253, P2392; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; VICKERY L, 1976, J AM CHEM SOC, V98, P351, DOI 10.1021/ja00418a006; YAMAGUCHI T, 1989, J BIOL CHEM, V264, P112	33	19	19	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12685	12689		10.1074/jbc.270.21.12685	http://dx.doi.org/10.1074/jbc.270.21.12685			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759520	hybrid			2022-12-27	WOS:A1995QZ71100056
J	MARINCS, F; WHITE, DWR				MARINCS, F; WHITE, DWR			DIVERGENT TRANSCRIPTION AND A REMOTE OPERATOR PLAY A ROLE IN CONTROL OF EXPRESSION OF A NOPALINE CATABOLISM PROMOTER IN AGROBACTERIUM-TUMEFACIENS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ESCHERICHIA-COLI; DNA-TEMPLATE; TI PLASMIDS; GENE; PROTEIN; OPERON; INVIVO; FUSION	The nocP-nocR divergent gene arrangement of the nopaline catabolism (noc) operon of the Agrobacterium tumefaciens Ti plasmid pTiT37 was examined with respect to the expression of the nocP promoter. Under repressive conditions, i.e. in the absence of nopaline, four distinct levels of P-nocP expression were observed. The lowest level of expression, i.e. full repression, was detected in the presence of the NocR repressor, together with the remote noc operator and productive transcription from the divergent nocR promoter. The next level was observed in the absence of either the NocR protein or of the operator or of both. The third level was detected when abortive transcription from the nocR promoter occurred, irrespective of the presence or absence of the NocR protein. The highest level of P-nocP expression was observed in the absence of both productive transcription from P-nocR and the operator sequence, whether or not the NocR protein was present. Under inductive conditions, i.e. in the presence of nopaline, expression of P-nocP was activated if both the NocR protein and the operator were present. Absence of either NocR or the operator resulted in lack of inducibility of the nocP promoter. Transcription from the divergent nocR promoter had no influence on the activation of P-nocP. It was also found that the absence of the operator affected plasmid supercoiling in vivo. The results suggest that DNA topology has a role in the regulation of the nocP promoter.			MARINCS, F (corresponding author), AGRES,GRASSLANDS RES CTR,PLANT MOLEC GENET LAB,TENNENT DR,PRIVATE BAG 11008,PALMERSTON NORTH 5320,NEW ZEALAND.		Marincs, Ferenc/A-8562-2011	Marincs, Ferenc/0000-0002-5388-8344				AMOUYAL M, 1989, CELL, V58, P545, DOI 10.1016/0092-8674(89)90435-2; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BOWATER RP, 1994, EMBO J, V13, P5647, DOI 10.1002/j.1460-2075.1994.tb06903.x; BRILL SJ, 1988, CELL, V54, P403, DOI 10.1016/0092-8674(88)90203-6; CHEN DR, 1992, P NATL ACAD SCI USA, V89, P8784, DOI 10.1073/pnas.89.18.8784; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; CONDEE CW, 1992, J BACTERIOL, V174, P8094, DOI 10.1128/JB.174.24.8094-8101.1992; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; DRLICA K, 1988, BIOCHEMISTRY-US, V27, P2253, DOI 10.1021/bi00407a001; FIGUEROA N, 1988, P NATL ACAD SCI USA, V85, P9416, DOI 10.1073/pnas.85.24.9416; GIAEVER GN, 1988, BIOPHYS CHEM, V29, P7, DOI 10.1016/0301-4622(88)87020-0; GOODRICH JA, 1991, TRENDS BIOCHEM SCI, V16, P394, DOI 10.1016/0968-0004(91)90162-O; IRANI MH, 1983, CELL, V32, P783, DOI 10.1016/0092-8674(83)90064-8; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; LEWIN B, 1990, GENES, V4, P257; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LOBELL RB, 1990, SCIENCE, V250, P528, DOI 10.1126/science.2237403; MARINCS F, 1993, MOL GEN GENET, V241, P65, DOI 10.1007/BF00280202; MARINCS F, 1994, MOL GEN GENET, V244, P367, DOI 10.1007/BF00286688; NORDHEIM A, 1982, COLD SPRING HARB SYM, V47, P93; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; ROSENBERG M, 1983, SCIENCE, V222, P734, DOI 10.1126/science.6356355; Sambrook J, 1989, MOL CLONING LABORATO; SAUNDERS SE, 1990, NUCLEIC ACIDS RES, V18, P4948, DOI 10.1093/nar/18.16.4948; SCIAKY D, 1978, PLASMID, V1, P238, DOI 10.1016/0147-619X(78)90042-2; TAN JY, 1994, J BACTERIOL, V176, P1077, DOI 10.1128/JB.176.4.1077-1086.1994; THOMPSON RJ, 1990, BACTERIAL CHROMOSOME, P227; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; VANLAREBEKE N, 1977, MOL GEN GENET, V152, P119, DOI 10.1007/BF00268807; WANG JC, 1988, SCIENCE, V240, P300, DOI 10.1126/science.3281259	31	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12339	12342		10.1074/jbc.270.21.12339	http://dx.doi.org/10.1074/jbc.270.21.12339			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759474	hybrid			2022-12-27	WOS:A1995QZ71100004
J	NICKERSON, KG; TAO, MH; CHEN, HT; LARRICK, J; KABAT, EA				NICKERSON, KG; TAO, MH; CHEN, HT; LARRICK, J; KABAT, EA			HUMAN AND MOUSE MONOCLONAL-ANTIBODIES TO BLOOD-GROUP A SUBSTANCE, WHICH ARE NEARLY IDENTICAL IMMUNOCHEMICALLY, USE RADICALLY DIFFERENT PRIMARY SEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFUCOSYL TYPE-1 CHAIN; AMINO-ACID-SEQUENCES; GROUP-A; HYBRIDOMA ANTIBODIES; VARIABLE REGIONS; COMBINING SITES; ANTIGEN-BINDING; VL GENES; IMMUNOGLOBULIN GENES; ABH ANTIGENS	A human monoclonal antibody (HuA) specific for blood group A substance with two fucose groups was found to be immunochemically almost identical with that of a previously characterized mouse monoclonal anti-A, AC-1001. The V-H and V-L chain cDNAs of HuA were sequenced and compared with those of AC-1001. The human and mouse antibodies used V-H and V-k genes that came from different families and shared minimal nucleotide and amino acid sequence identity. Thus, two antibodies from two different species can use evolutionarily unrelated sequences to bind the same carbohydrate epitope. The cloned HuA V-H and V-L genes were then transfected into a mouse myeloma cell line and re-expressed, together, and each separately with an irrelevant V-H or V-L. Only the original HuA V-H and V-k had anti-A activity, demonstrating that both the heavy and light chains contributed to specificity.	COLUMBIA UNIV, COLL PHYS & SURG, DEPT MED, NEW YORK, NY 10032 USA; COLUMBIA UNIV, COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA; COLUMBIA UNIV, COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; COLUMBIA UNIV, COLL PHYS & SURG, CTR CANC, NEW YORK, NY 10032 USA; STANFORD UNIV, DIV ONCOL, PALO ALTO, CA 94304 USA; GENELABS INC, REDWOOD CITY, CA 94063 USA	Columbia University; Columbia University; Columbia University; Columbia University; Stanford University	NICKERSON, KG (corresponding author), COLUMBIA UNIV, COLL PHYS & SURG, DEPT MICROBIOL, NEW YORK, NY 10032 USA.			Tao, Mi-Hua/0000-0002-4307-5729	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027508, R01AI019042] Funding Source: NIH RePORTER; NIAID NIH HHS [2RO1 AI/GM19042-07, 5RO1 AI27508-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABE K, 1984, J IMMUNOL, V132, P1951; AKOLKAR PN, 1987, J IMMUNOL, V139, P3911; AKOLKAR PN, 1987, J IMMUNOL, V138, P4472; ANDRIA ML, 1990, J IMMUNOL, V144, P2614; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BORDEN P, 1987, P NATL ACAD SCI USA, V84, P2440, DOI 10.1073/pnas.84.8.2440; BORREBACK CAK, 1990, THERAPEUTIC MONOCLON; BRODEUR PH, 1988, J EXP MED, V168, P2261, DOI 10.1084/jem.168.6.2261; CATON AJ, 1990, J IMMUNOL, V144, P1965; CHEN HT, 1985, J BIOL CHEM, V260, P3208; CHEN HT, 1987, J BIOL CHEM, V262, P13579; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CLAFLIN JL, 1981, J EXP MED, V153, P352, DOI 10.1084/jem.153.2.352; CLAUSEN H, 1985, BIOCHEMISTRY-US, V24, P6190, DOI 10.1021/bi00343a024; CLAUSEN H, 1987, TRANSPL P, V19, P4408; CLAUSEN H, 1985, BIOCHEMISTRY-US, V24, P3578, DOI 10.1021/bi00335a028; DABELSTEEN E, 1988, CANCER RES, V48, P181; DICKERSON RE, 1983, HEMOGLOBIN STRUCTURE, P66; DILDROP R, 1984, IMMUNOL TODAY, V5, P85, DOI 10.1016/0167-5699(84)90034-3; ERLANGER BF, 1989, IMMUNOL TODAY, V10, P151, DOI 10.1016/0167-5699(89)90170-9; FOUNG SKH, 1984, J IMMUNOL METHODS, V70, P83, DOI 10.1016/0022-1759(84)90392-2; FURUKAWA K, 1985, BIOCHEMISTRY-US, V24, P7820, DOI 10.1021/bi00347a047; GOOI HC, 1985, J BIOL CHEM, V260, P3218; HAKOMORI SI, 1987, BIOCHEM SOC T, V15, P593, DOI 10.1042/bst0150593; HIETER PA, 1982, J BIOL CHEM, V257, P1516; KABAT EA, 1991, J IMMUNOL, V147, P1709; KABAT EA, 1990, PHYS CHEM BIOL, V34, P11; Kabat EA, 1991, SEQUENCES PROTEINS I; KIRKHAM PM, 1992, EMBO J, V11, P603, DOI 10.1002/j.1460-2075.1992.tb05092.x; KISAILUS EC, 1978, J EXP MED, V147, P830, DOI 10.1084/jem.147.3.830; LARRICK JW, 1989, BIOCHEM BIOPH RES CO, V160, P1250, DOI 10.1016/S0006-291X(89)80138-X; LEAHY DJ, 1988, P NATL ACAD SCI USA, V85, P3661, DOI 10.1073/pnas.85.11.3661; LLOYD KO, 1987, AM J CLIN PATHOL, V87, P129, DOI 10.1093/ajcp/87.1.129; LLOYD KO, 1966, BIOCHEMISTRY-US, V5, P1489, DOI 10.1021/bi00869a007; LOMBES M, 1989, J BIOL CHEM, V264, P2528; LUBENKO A, 1986, VOX SANG, V51, P136, DOI 10.1111/j.1423-0410.1986.tb00230.x; MATSUDA T, 1989, J IMMUNOL, V142, P863; METOKI R, 1989, JNCI-J NATL CANCER I, V81, P1151, DOI 10.1093/jnci/81.15.1151; NAHMIAS C, 1988, J IMMUNOL, V140, P1304; Nyholm P G, 1989, J Mol Recognit, V2, P103, DOI 10.1002/jmr.300020302; OLEE TW, 1992, J EXP MED, V175, P831, DOI 10.1084/jem.175.3.831; PADLAN EA, 1991, METHOD ENZYMOL, V203, P3; PANKA DJ, 1987, J IMMUNOL, V139, P2385; PECH M, 1984, NUCLEIC ACIDS RES, V12, P9229, DOI 10.1093/nar/12.24.9229; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; SAMUELSSON BE, 1987, TRANSPLANT P, V19, P4401; SCHIFFMAN G, 1962, J AM CHEM SOC, V84, P463, DOI 10.1021/ja00862a028; SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41; SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; SHIN SU, 1989, METHOD ENZYMOL, V178, P459; SIKDER SK, 1989, J IMMUNOL, V142, P888; SIKDER SK, 1985, J IMMUNOL, V135, P4215; SILBERSTEIN LE, 1989, J EXP MED, V169, P1631, DOI 10.1084/jem.169.5.1631; SPATZ LA, 1990, J IMMUNOL, V144, P2821; TO ACW, 1986, CANCER-AM CANCER SOC, V58, P2435, DOI 10.1002/1097-0142(19861201)58:11<2435::AID-CNCR2820581114>3.0.CO;2-N; TULLIEZ M, 1987, LEUKEMIA, V1, P44; VANAK J, 1989, NEOPLASMA, V36, P479; WANG D, 1991, MOL IMMUNOL, V28, P1387, DOI 10.1016/0161-5890(91)90041-H; WANG DN, 1990, J IMMUNOL, V145, P3002; Watkins W M, 1980, Adv Hum Genet, V10, P1; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0	63	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12457	12465		10.1074/jbc.270.21.12457	http://dx.doi.org/10.1074/jbc.270.21.12457			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759488	hybrid			2022-12-27	WOS:A1995QZ71100021
J	ENGLE, MJ; MAHMOOD, A; ALPERS, DH				ENGLE, MJ; MAHMOOD, A; ALPERS, DH			2 RAT INTESTINAL ALKALINE-PHOSPHATASE ISOFORMS WITH DIFFERENT CARBOXYL-TERMINAL PEPTIDES ARE BOTH MEMBRANE-BOUND BY A GLYCAN PHOSPHATIDYLINOSITOL LINKAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT-LIKE PARTICLES; CLEAVAGE ATTACHMENT SITE; ANCHOR ATTACHMENT; PROTEINS; SIGNAL; RNA	Two cDNAs encode rat intestinal alkaline phosphatases having completely different carboxyl-terminal peptides; one is hydrophobic and fulfills the consensus requirements for glycan phosphatidylinositol linkage, and the other is neither hydrophobic nor hydrophilic, but contains a small amino acid domain (-NSASS-) just distal to a region of 17 threonine residues, Constructs were created using 80% of the amino terminal portion of one alkaline phosphatase and the carboxyl terminal portions of each of the isoforms. Both of the carboxyl-terminal peptides supported glycan phosphatidylinositol linkage as demonstrated by the following criteria: 1) plasma membrane targeting in transfected COS-1 cells, 2) release of transfected alkaline phosphatase by phosphatidylinositol-specific phospholipase C, 3) appearance of the trypanosome variable glycoprotein crossreacting determinant after phospholipase C treatment, 4) ethanolamine incorporation into newly synthesized enzyme, 5) loss of phospholipase C release after mutation of the omega and omega + 2 positions in the putative linkage site, -NSA-, and 6) evidence of surface membrane localization by immunofluorescence using antibody against rat intestinal alkaline phosphatase. These data demonstrate that a predicted hydrophobic carboxyl-terminal sequence is not essential for glycan phosphatidylinositol linkage, Moreover, because both isomers are membrane bound, the origin of soluble enzyme in the serum is likely to arise from the action of serum phosphatidylinositol-specific phospholipase D.	WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,DIV GASTROENTEROL,ST LOUIS,MO 63110	Washington University (WUSTL)								ELIAKIM R, 1990, AM J PHYSIOL, V259, pG93, DOI 10.1152/ajpgi.1990.259.1.G93; ELIAKIM R, 1989, J BIOL CHEM, V264, P20614; ENGLE MJ, 1992, CLIN CHEM, V38, P2506; GERBER LD, 1992, J BIOL CHEM, V267, P12168; KLEEREKOPER M, 1970, CLIN SCI, V38, P339, DOI 10.1042/cs0380339; LOWE M, 1990, BIOCHIM BIOPHYS ACTA, V1037, P170, DOI 10.1016/0167-4838(90)90164-B; MAHMOOD A, 1993, ARCH BIOCHEM BIOPHYS, V300, P280, DOI 10.1006/abbi.1993.1039; MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P157, DOI 10.1073/pnas.87.1.157; MORAN P, 1991, J BIOL CHEM, V266, P1250; MORAN P, 1991, J CELL BIOL, V115, P329, DOI 10.1083/jcb.115.2.329; ORCHANSKY PL, 1988, J BIOL CHEM, V263, P15159; STROM M, 1991, BIOCHIM BIOPHYS ACTA, V1090, P299, DOI 10.1016/0167-4781(91)90193-P; SUSSMAN NL, 1986, BIOCHEM J, V234, P563, DOI 10.1042/bj2340563; TIETZE CC, 1992, AM J PHYSIOL, V263, pG756, DOI 10.1152/ajpgi.1992.263.5.G756; YEDLIN ST, 1981, J BIOL CHEM, V256, P5620; YEH KY, 1994, BIOCHEM J, V301, P893, DOI 10.1042/bj3010893; YOUNG GP, 1981, AM J PHYSIOL, V241, pG461, DOI 10.1152/ajpgi.1981.241.6.G461	17	29	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11935	11940		10.1074/jbc.270.20.11935	http://dx.doi.org/10.1074/jbc.270.20.11935			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744844	hybrid			2022-12-27	WOS:A1995QY73600041
J	FIGUEIREDO, MS; BROWNLEE, GG				FIGUEIREDO, MS; BROWNLEE, GG			CIS-ACTING ELEMENTS AND TRANSCRIPTION FACTORS INVOLVED IN THE PROMOTER ACTIVITY OF THE HUMAN FACTOR-VIII GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-SPECIFIC TRANSCRIPTION; FACTOR-IX PROMOTER; HEMOPHILIA-A; HEPATIC TRANSCRIPTION; ANTIHEMOPHILIC-FACTOR; BINDING PROTEIN; C/EBP ISOFORMS; ALBUMIN GENE; EXPRESSION; SITE	Factor VIII is a glycoprotein that is essential for blood coagulation. Although factor VIII mRNA has been detected in a variety of human tissues, hepatocytes are considered to be the major source of plasma factor VIII. In this report we demonstrate that the 5'-flanking region of the factor VIII gene is able to transcribe a luciferase reporter gene in three human liver-derived cell lines: PLC/PRF/5, Chang, and HepG2. DNase I footprinting showed the presence of 19 protein binding sites (labeled A to S, proximal to distal) distributed along the region from nucleotide -1175 to -9 of the factor VIII promoter (+1 refers to the translation initiation codon, ATG). Functional analysis of 5' and 3' deletion mutants of the promoter region in PLC/PRF/5 cells revealed that the region from -279 to -64, including sites B to D, contains all the necessary elements for maximal promoter activity. By using electrophoretic mobility shift assays with nuclear extracts and purified transcription factors, and antibody supershift assays we were able to characterize four liver-enriched factors and one ubiquitous transcription factor interacting with the proximal promoter binding sites (sites A to E): hepatocyte nuclear factor (HNF) 1 (site A), NF kappa B (site B), C/EBP alpha and C/EBP beta (proximal and distal regions of site C, and site D), and HNF4 (site E). Additionally, mutation of the putative TATA box GATAAA (positions -201 to -196) to GACCGA resulted in less than 2-fold decrease in promoter activity, suggesting that the putative TATA box is not essential for factor VIII promoter activity. These results significantly contribute to the understanding of the control of the hepatic transcription of the factor MII gene.	UNIV OXFORD,SIR WILLIAM DUNN SCH PATHOL,CHEM PATHOL UNIT,OXFORD OX1 3RE,ENGLAND	University of Oxford	FIGUEIREDO, MS (corresponding author), UNIV SAO PAULO,SCH MED RIBEIRAO PRETO,DEPT CLIN MED,BR-14048900 RIBEIRAO PRET,BRAZIL.							Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BONTEMPO FA, 1987, BLOOD, V69, P1721; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHAMBAZ J, 1991, J BIOL CHEM, V266, P11676; COSTA RH, 1988, MOL CELL BIOL, V8, P81, DOI 10.1128/MCB.8.1.81; CRABTREE GR, 1992, TRANSCRIPTIONAL REGU, P1063; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; CROSSLEY M, 1992, SCIENCE, V257, P377, DOI 10.1126/science.1631558; DESIMONE V, 1987, EMBO J, V6, P2759, DOI 10.1002/j.1460-2075.1987.tb02570.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; LEE ME, 1991, J BIOL CHEM, V266, P16188; LENARDO MJ, 1988, P NATL ACAD SCI USA, V85, P8825, DOI 10.1073/pnas.85.23.8825; LEVINE PH, 1987, HEMOSTASIS THROMBOSI, P97; LEWIS JH, 1985, NEW ENGL J MED, V312, P1189; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; MAIRE P, 1989, SCIENCE, V244, P343, DOI 10.1126/science.2711183; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; RALL LB, 1985, LANCET, V1, P44; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; RAY A, 1994, MOL CELL BIOL, V14, P4324, DOI 10.1128/MCB.14.6.4324; RYDEN TA, 1989, MOL CELL BIOL, V9, P1155, DOI 10.1128/MCB.9.3.1155; Sambrook J, 1989, MOL CLONING LABORATO; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902; TUDDENHAM EGD, 1994, NUCLEIC ACIDS RES, V22, P3511, DOI 10.1093/nar/22.17.3511; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WHITE GC, 1989, BLOOD, V73, P1; WIELAND K, 1990, THROMB RES, V59, P871, DOI 10.1016/0049-3848(90)90400-7; WION KL, 1985, NATURE, V317, P726, DOI 10.1038/317726a0; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	42	65	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11828	11838		10.1074/jbc.270.20.11828	http://dx.doi.org/10.1074/jbc.270.20.11828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744832	hybrid			2022-12-27	WOS:A1995QY73600027
J	RAMAMOORTHY, R; SWIHART, KG; MCCOY, JJ; WILSON, ME; DONELSON, JE				RAMAMOORTHY, R; SWIHART, KG; MCCOY, JJ; WILSON, ME; DONELSON, JE			INTERGENIC REGIONS BETWEEN TANDEM GP63 GENES INFLUENCE THE DIFFERENTIAL EXPRESSION OF GP63 RNAS IN LEISHMANIA-CHAGASI PROMASTIGOTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' UNTRANSLATED REGION; MESSENGER-RNA; TRYPANOSOMA-BRUCEI; DONOVANI-CHAGASI; SURFACE GLYCOPROTEIN; MAJOR PROMASTIGOTES; DNA TRANSFECTION; SITE SELECTION; PARP PROMOTER; HEAT-SHOCK	The major surface protease, gp63, of Leishmania chagasi is encoded by 18 or more tandem msp genes that can be grouped into three classes on the basis of their unique 3'-untranslated sequences (3'-UTRs) and their differential expression, RNAs from the mspLs occur predominantly during the logarithmic phase of promastigote growth in vitro, RNAs from the mspSs are present mainly in stationary phase, and RNAs from mspCs occur throughout growth in culture, All three classes of gp63 genes are constitutively transcribed during all growth phases, indicating that their expression is post-transcriptionally regulated, Chimeric plasmids containing the three different 3'-UTRs and downstream intergenic regions (IRs) fused downstream of the beta-galactosidase (beta-gal) coding region were transfected into L. chagasi, and their effects on beta-gal RNA processing and enzymatic activity were examined, The presence of the 3'-UTRs by themselves had no substantive effect on beta-gal expression, However, the 3'-UTR from a mspS plus its IR resulted in about 20-fold more beta-gal activity and RNA in stationary phase relative to logarithmic phase cells, In contrast, the 3'-UTRs plus IRs of mspL and mspC had either no or little effect, respectively, on beta-gal expression, Thus, differential expression of the mspLs and mspSs is post-transcriptionally controlled by different mechanisms.	UNIV IOWA,DEPT BIOCHEM,IOWA CITY,IA 52242; UNIV IOWA,DEPT INTERNAL MED,IOWA CITY,IA 52242; UNIV IOWA,DEPT MICROBIOL,IOWA CITY,IA 52242; VET ADM MED CTR,IOWA CITY,IA; HOWARD HUGHES MED INST,IOWA CITY,IA 52242	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Howard Hughes Medical Institute			Donelson, John E/F-5795-2010	Wilson, Mary/0000-0001-8680-7275	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI032135, R01AI032135, R29AI030126] Funding Source: NIH RePORTER; NIAID NIH HHS [AI30126, AI32135] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BORDIER C, 1986, P NATL ACAD SCI USA, V83, P5988, DOI 10.1073/pnas.83.16.5988; BORDIER C, 1987, PARASITOL TODAY, V3, P151, DOI 10.1016/0169-4758(87)90199-2; BRODIN TN, 1992, MOL BIOCHEM PARASIT, V52, P241, DOI 10.1016/0166-6851(92)90056-P; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CHANG KP, 1990, ANNU REV MICROBIOL, V44, P499, DOI 10.1146/annurev.mi.44.100190.002435; CHUNG SH, 1990, NUCLEIC ACIDS RES, V18, P4561, DOI 10.1093/nar/18.15.4561; Cleveland DW, 1989, CURR OPIN CELL BIOL, V1, P1148, DOI 10.1016/S0955-0674(89)80065-1; COBURN CM, 1991, MOL BIOCHEM PARASIT, V46, P169, DOI 10.1016/0166-6851(91)90210-W; COULSON RMR, 1990, MOL BIOCHEM PARASIT, V40, P63, DOI 10.1016/0166-6851(90)90080-6; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; ERONDU NE, 1991, MOL BIOCHEM PARASIT, V49, P303, DOI 10.1016/0166-6851(91)90074-G; FRANKE ED, 1985, J IMMUNOL, V134, P2713; GILLIS P, 1991, J BIOL CHEM, V266, P3172; GONZALEZ A, 1985, NUCLEIC ACIDS RES, V13, P5789, DOI 10.1093/nar/13.16.5789; GOTTLIEB E, 1992, P NATL ACAD SCI USA, V89, P7164, DOI 10.1073/pnas.89.15.7164; HUANG J, 1991, MOL CELL BIOL, V11, P3180, DOI 10.1128/MCB.11.6.3180; HUANG J, 1991, EMBO J, V10, P3877, DOI 10.1002/j.1460-2075.1991.tb04957.x; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; KAPOTAS N, 1993, NUCLEIC ACIDS RES, V21, P4067, DOI 10.1093/nar/21.17.4067; KOOTER JM, 1984, NUCLEIC ACIDS RES, V12, P9457, DOI 10.1093/nar/12.24.9457; LAYDEN RE, 1988, MOL CELL BIOL, V8, P1352, DOI 10.1128/MCB.8.3.1352; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; MALLINSON DJ, 1989, PARASITOLOGY, V98, P7, DOI 10.1017/S0031182000059631; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; PEARSON RD, 1980, J IMMUNOL, V125, P2195; RAMAMOORTHY R, 1992, J BIOL CHEM, V267, P1888; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; ROBERTS SC, 1993, MOL BIOCHEM PARASIT, V62, P157, DOI 10.1016/0166-6851(93)90106-8; RUDENKO G, 1990, MOL CELL BIOL, V10, P3492, DOI 10.1128/MCB.10.7.3492; RUSSELL DG, 1989, IMMUNOL TODAY, V10, P328, DOI 10.1016/0167-5699(89)90188-6; SACKS DL, 1990, MOL BIOCHEM PARASIT, V42, P225, DOI 10.1016/0166-6851(90)90165-I; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; WALDER JA, 1986, SCIENCE, V233, P569, DOI 10.1126/science.3523758; WILSON ME, 1988, J IMMUNOL, V141, P265; WILSON ME, 1989, J IMMUNOL, V143, P678; WILSON ME, 1993, J BIOL CHEM, V268, P15731; WONG S, 1993, MOL CELL BIOL, V13, P207, DOI 10.1128/MCB.13.1.207; ZARLEY JH, 1991, J CLIN INVEST, V88, P1511, DOI 10.1172/JCI115461	41	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12133	12139		10.1074/jbc.270.20.12133	http://dx.doi.org/10.1074/jbc.270.20.12133			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744862	hybrid			2022-12-27	WOS:A1995QY73600065
J	WATANABE, SI; HINO, A; WADA, K; ELIASON, JF; UCHIDA, T				WATANABE, SI; HINO, A; WADA, K; ELIASON, JF; UCHIDA, T			PURIFICATION, CLONING, AND EXPRESSION OF MURINE URIDINE PHOSPHORYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL GROWTH-FACTOR; THYMIDINE PHOSPHORYLASE; TUMOR-CELLS; 5'-DEOXY-5-FLUOROURIDINE; ACTIVATION; 5-FLUOROURACIL; FLUOROURACIL; INHIBITORS; CARCINOMA	Uridine phosphorylase was purified 10,300-fold from tumors of the murine colorectal adenocarcinoma cell line, Colon-26. Degenerate DNA probes were synthesized corresponding to partial amino acid sequences and used to screen a Colon-26 cDNA library. A cDNA clone of 1327 base pairs that contains a 5' untranslated region, a coding region of 933 base pairs, and a 3' nontranslated region with a polyadenylated tail was identified. The cDNA was confirmed to be uridine phosphorylase by 1) sequence comparison to uridine phosphorylase of Escherichia coli, 2) substrate specificity studies with recombinant protein expressed in COS-7 cells that demonstrated relatively high enzyme activity with uridine as substrate compared low levels when thymidine was used, and 3) inhibition of enzyme activity by the competitive inhibitor 2,2'-anhydro-5-ethyluridine. Northern blot analysis using the cDNA as a probe, demonstrated high levels of mRNA expression in Colon-26. Expression was low in NIH3T3 cells, but high in DMBA-3 and PH-1 cells, which are NIH3T3 derived cells that have been transformed with mutated murine Ha-ras and viral Ha-ras, respectively. Expression of uridine phosphorylase mRNA in these cell lines was further enhanced by treating the cells with the inflammatory cytokines, tumor necrosis factor-alpha, interleukin 1 alpha, and interferon gamma.	NIPPON ROCHE RES CTR,DEPT MOLEC GENET,KAMAKURA,KANAGAWA 247,JAPAN	Roche Holding	WATANABE, SI (corresponding author), NIPPON ROCHE RES CTR,DEPT ONCOL,200 KAJIWARA,KAMAKURA,KANAGAWA 247,JAPAN.			Uchida, Takafumi/0000-0003-3665-4906				ARMSTRONG RD, 1980, CANCER RES, V40, P3333; ARMSTRONG RD, 1981, CANCER RES, V41, P4891; ASAI K, 1992, J BIOL CHEM, V267, P20311; BIZUB D, 1986, P NATL ACAD SCI USA, V83, P6048, DOI 10.1073/pnas.83.16.6048; BOLLAG W, 1980, EUR J CANCER, V16, P427, DOI 10.1016/0014-2964(80)90221-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P1156; EDA H, 1993, JPN J CANCER RES, V84, P341, DOI 10.1111/j.1349-7006.1993.tb02876.x; EDA H, 1993, CANCER CHEMOTH PHARM, V32, P333, DOI 10.1007/BF00735915; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; ELIASON JF, 1990, INT J CANCER, V46, P113, DOI 10.1002/ijc.2910460121; ELKOUNI MH, 1993, CANCER RES, V53, P3687; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FURUKAWA T, 1992, NATURE, V356, P668, DOI 10.1038/356668a0; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HARAGUCHI M, 1994, NATURE, V368, P198, DOI 10.1038/368198a0; ISHITSUKA H, 1980, GANN, V71, P112; KONO A, 1983, CHEM PHARM BULL, V31, P175; LAURENT PL, 1994, EUR J CANCER, V30A, P1859, DOI 10.1016/0959-8049(94)00341-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIWA M, 1986, CHEM PHARM BULL, V34, P4225; MOGHADDAM A, 1992, BIOCHEMISTRY-US, V31, P12141, DOI 10.1021/bi00163a024; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ EL, 1992, BIOCHEM BIOPH RES CO, V182, P1232, DOI 10.1016/0006-291X(92)91863-L; TEVAEARAI HT, 1992, EUR J CANCER, V28A, P368, DOI 10.1016/S0959-8049(05)80055-3; USUKI K, 1992, BIOCHEM BIOPH RES CO, V184, P1311, DOI 10.1016/S0006-291X(05)80025-7; VERES Z, 1985, BIOCHEM PHARMACOL, V34, P1737, DOI 10.1016/0006-2952(85)90643-4; WADLER S, 1991, J CLIN ONCOL, V9, P1806, DOI 10.1200/JCO.1991.9.10.1806	28	29	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12191	12196		10.1074/jbc.270.20.12191	http://dx.doi.org/10.1074/jbc.270.20.12191			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744869	hybrid			2022-12-27	WOS:A1995QY73600073
J	BHATTACHARYYA, KK; BRAKE, PB; ELTOM, SE; OTTO, SA; JEFCOATE, CR				BHATTACHARYYA, KK; BRAKE, PB; ELTOM, SE; OTTO, SA; JEFCOATE, CR			IDENTIFICATION OF A RAT ADRENAL CYTOCHROME-P450 ACTIVE IN POLYCYCLIC-HYDROCARBON METABOLISM AS RAT CYP1B1 - DEMONSTRATION OF A UNIQUE TISSUE-SPECIFIC PATTERN OF HORMONAL AND ARYL-HYDROCARBON RECEPTOR-LINKED REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSLOCATOR PROTEIN; DIOXIN-RESPONSIVE ENHANCER; LIGANDED AH RECEPTOR; INDUCIBLE CYTOCHROME-P450; CRYSTAL-STRUCTURE; DNA INTERACTIONS; SEQUENCE; BINDING; 7,12-DIMETHYLBENZ<A>ANTHRACENE; EXPRESSION	Antibodies against a novel adrenocorticotropic hormone-inducible cytochrome P450 (P450RAP), responsible for polycyclic aromatic hydrocarbon metabolism in rat adrenal microsomes (Otto, S., Bhattacharyya, K. K., and Jefcoate, C. R. (1992) Endocrinology 131, 3067-3076), identified a cDNA clone encoding a partial cytochrome P450 sequence from a rat adrenal cDNA library. Rescreening a second cDNA library yielded several clones up to 5.0 kilobases (kb) encoding a 1629-base pair open reading frame, The deduced amino acid sequence (543 residues) matched completely with five peptides cleaved from P450RAP, The amino acid sequence of P450RAP is 92% identical to a 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible CYP1B1, cloned from mouse C3H10T1/2 (10T1/2) embryo fibroblast cells (Savas, U., Bhattacharyya, K, K,, Christou, M., Alexander, D. L., and Jefcoate, C. R. (1994) J. Biol. Chem. 269, 14905-14911), which shows nearly the same characteristics in polycyclic aromatic hydrocarbon metabolism. The available 5'- and 3'-noncoding regions show, respectively, 93 and 83% sequence identity. We conclude that P450RAP protein is encoded by a rat CYP1B1 gene orthologous to the mouse CYP1B1 gene. Alignment of rat CYP1B1 amino acid sequences with rat CYP1A1 (39% identical) indicated eight regions of high identity for each (60-78%), interspersed by extensive regions of less than 30% similarity, The CYP1B1 cDNAs hybridize a 5.2-kb mRNA in rat adrenals, consistent with the length of the longest clones and the mRNA recognized in 10T1/2 cells. CYP1B1 mRNA was elevated by a 2-day adrenocorticotropic hormone treatment but much less than CYP11A1 (cytochrome P450 side chain cleavage) mRNA (2-fold versus 4-fold). The lower levels of the 5,2-kb mRNA in other steroidogenic cells (ovary) was consistent with the amount of immunodetectable CYP1B1 protein and, unlike the adrenal, expression in the ovary was stimulated B-fold by beta-naphthhoflavone, an aryl hydrocarbon receptor agonist, in parallel with CYP1A1 induction, In several other tissues (liver > lung > uterus much greater than kidney), CYP1B1 mRNA and protein were constitutively undetectable but highly induced by beta-naphthoflavone, although at much lower levels than CYP1A1. Rat CYP1B1, therefore, exhibits regulation through hormonal signaling and the aryl hydrocarbon receptor in a cell-specific manner.	UNIV WISCONSIN,SCH MED,DEPT PHARMACOL,MADISON,WI 53706; UNIV WISCONSIN,SCH MED,CTR ENVIRONM TOXICOL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NCI NIH HHS [CA16265] Funding Source: Medline; NIEHS NIH HHS [2 T32 ES07015] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; AKELLA R, 1993, BIOTECHNIQUES, V14, P726; BENGTSSON M, 1988, XENOBIOTICA, V18, P1255, DOI 10.3109/00498258809042249; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CHARBONNEAU H, 1989, PRACTICAL GUIDE PROT, P29; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRISTOU M, 1994, CARCINOGENESIS, V15, P725, DOI 10.1093/carcin/15.4.725; EDWARDS RJ, 1989, BIOCHEMISTRY-US, V28, P3762, DOI 10.1021/bi00435a021; FUJIIKURIYAMA Y, 1992, FASEB J, V6, P706, DOI 10.1096/fasebj.6.2.1537460; GEORGELLIS A, 1989, CHEM-BIOL INTERACT, V72, P65, DOI 10.1016/0009-2797(89)90018-5; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; LUSSKA A, 1993, J BIOL CHEM, V268, P6575; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; OMIECINSKI CJ, 1990, CANCER RES, V50, P4315; OTTO S, 1992, ENDOCRINOLOGY, V131, P3067, DOI 10.1210/en.131.6.3067; OTTO S, 1991, ENDOCRINOLOGY, V129, P970, DOI 10.1210/endo-129-2-970; PELKONEN O, 1982, PHARMACOL REV, V34, P189; POTTENGER LH, 1991, ARCH BIOCHEM BIOPHYS, V286, P488, DOI 10.1016/0003-9861(91)90070-Y; POULOS TL, 1985, J BIOL CHEM, V260, P6122; PROBST MR, 1993, MOL PHARMACOL, V44, P511; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVAS U, 1993, CARCINOGENESIS, V14, P2013, DOI 10.1093/carcin/14.10.2013; SAVAS U, 1994, J BIOL CHEM, V269, P14905; SHEN ES, 1992, J BIOL CHEM, V267, P6815; SHEN ZY, 1993, P NATL ACAD SCI USA, V90, P11483, DOI 10.1073/pnas.90.24.11483; Sims P., 1981, POLYCYCLIC HYDROCARB, V3, P117; SOGAWA K, 1985, J BIOL CHEM, V260, P5026; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; WHITLOCK JP, 1993, CHEM RES TOXICOL, V6, P754, DOI 10.1021/tx00036a003; WILSON NM, 1984, CARCINOGENESIS, V5, P1475, DOI 10.1093/carcin/5.11.1475; YAMAZAKI S, 1993, J BIOCHEM-TOKYO, V114, P652, DOI 10.1093/oxfordjournals.jbchem.a124232	35	159	164	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11595	11602		10.1074/jbc.270.19.11595	http://dx.doi.org/10.1074/jbc.270.19.11595			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744798	hybrid			2022-12-27	WOS:A1995QX86500080
J	GU, WG; REINES, D				GU, WG; REINES, D			IDENTIFICATION OF A DECAY IN TRANSCRIPTION POTENTIAL THAT RESULTS IN ELONGATION-FACTOR DEPENDENCE OF RNA-POLYMERASE-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-S-II; INITIATION FACTOR-ALPHA; ESCHERICHIA-COLI; TERNARY COMPLEXES; MESSENGER-RNA; EUKARYOTIC TRANSCRIPTION; FACTOR-SII; STRUCTURAL-ANALYSIS; CHAIN ELONGATION; KINETOPLAST DNA	The rate of RNA elongation by RNA polymerase II (pol II) is affected by DNA sequences called intrinsic arrest sites. Efficient transcription through these sites requires elongation factor SII. In addition to the sequence-specific features of the DNA, we show that the acquisition of SII-dependence is a function of its ''dwell-time'' at an arrest site. This temperature-dependent decay in elongation potential appears irreversible, implying that factor-dependent and factor-independent elongation complexes are not mutually interconvertible at this position. TFIIF and NH4Cl are known to increase the elongation rate of pol II. Both agents preempt arrest, consistent with the idea that elongation dwell time influences the process. TFIIF and SII act upon different steps in a complementary way to prevent or resolve arrest, respectively. They are probably instrumental in facilitating the efficient transcription of large eukaryotic genes in vivo.	EMORY UNIV,SCH MED,GRAD PROGRAM BIOCHEM & MOLEC BIOL,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322	Emory University; Emory University			excellency, Your/R-2357-2019	excellency, Your/0000-0003-0832-6243	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046331] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046331] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; Chamberlin M.J., 1994, HARVEY LECT, V88, P1; CHAN CL, 1994, TRANSCRIPTION MECHAN, P297; CHEN HC, 1992, GENE, V116, P253, DOI 10.1016/0378-1119(92)90522-Q; CHRISTIE KR, 1994, J BIOL CHEM, V269, P936; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; EILAT D, 1982, P NATL ACAD SCI-BIOL, V79, P3818, DOI 10.1073/pnas.79.12.3818; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; ERIE DA, 1992, ANNU REV BIOPH BIOM, V21, P379, DOI 10.1146/annurev.bb.21.060192.002115; FLORES O, 1989, J BIOL CHEM, V264, P8913; GRIFFITH J, 1986, CELL, V46, P717, DOI 10.1016/0092-8674(86)90347-8; GU WG, 1993, J BIOL CHEM, V268, P25604; GUO HL, 1993, J BIOL CHEM, V268, P18762; HAGLER J, 1992, SCIENCE, V255, P983, DOI 10.1126/science.1546295; HIRASHIMA S, 1988, J BIOL CHEM, V263, P3858; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; KANAI A, 1991, J BIOCHEM-TOKYO, V109, P674, DOI 10.1093/oxfordjournals.jbchem.a123439; Kane C. M., 1994, TRANSCRIPTION MECH R, P279; KERPPOLA TK, 1990, BIOCHEMISTRY-US, V29, P269, DOI 10.1021/bi00453a037; KRUMMEL B, 1992, J MOL BIOL, V225, P221, DOI 10.1016/0022-2836(92)90917-9; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; KRUMMEL B, 1992, J MOL BIOL, V225, P239, DOI 10.1016/0022-2836(92)90918-A; LANG WH, 1994, CELL, V79, P527, DOI 10.1016/0092-8674(94)90261-5; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; MARINI JC, 1984, J BIOL CHEM, V259, P8974; MARSHALL TK, 1990, NUCLEIC ACIDS RES, V18, P6293, DOI 10.1093/nar/18.21.6293; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; METZGER W, 1989, EMBO J, V8, P2745, DOI 10.1002/j.1460-2075.1989.tb08416.x; MOTE J, 1994, J MOL BIOL, V236, P725, DOI 10.1006/jmbi.1994.1185; NAKANISHI T, 1992, J BIOL CHEM, V267, P13200; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; REINES D, 1992, J BIOL CHEM, V267, P15516; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1989, J BIOL CHEM, V264, P10799; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; REINES D, 1991, J BIOL CHEM, V266, P10510; REINES D, 1994, TRANSCRIPTION MECHAN, P263; ROBERTS J, 1992, TRANSCRIPTIONAL REGU, P389; SLUDER AE, 1988, J BIOL CHEM, V263, P9917; TAN SY, 1994, BIOTECHNIQUES, V16, P824; THUMMEL CS, 1992, SCIENCE, V255, P39, DOI 10.1126/science.1553530; TSUBOI A, 1992, NUCLEIC ACIDS RES, V20, P3250, DOI 10.1093/nar/20.12.3250; VONHIPPEL PH, 1991, P NATL ACAD SCI USA, V88, P2307, DOI 10.1073/pnas.88.6.2307; VONHIPPEL PH, 1992, SCIENCE, V255, P809, DOI 10.1126/science.1536005; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; WIEST DK, 1992, J BIOL CHEM, V267, P7733; WIEST DK, 1990, MOL CELL BIOL, V10, P5782, DOI 10.1128/MCB.10.11.5782; XU QH, 1994, J BIOL CHEM, V269, P3100; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; YOO OJ, 1991, NUCLEIC ACIDS RES, V19, P1073, DOI 10.1093/nar/19.5.1073	63	64	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11238	11244		10.1074/jbc.270.19.11238	http://dx.doi.org/10.1074/jbc.270.19.11238			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744757	Green Accepted, hybrid			2022-12-27	WOS:A1995QX86500034
J	RAZI, N; LINDAHL, U				RAZI, N; LINDAHL, U			BIOSYNTHESIS OF HEPARIN HEPARAN-SULFATE - THE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE REACTIONS - TARGET AND INHIBITOR SACCHARIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITHROMBIN-BINDING SEQUENCE; HIGH-AFFINITY; SUBSTRATE-SPECIFICITY; NITROUS-ACID; DEPOLYMERIZATION; FRAGMENTS; RESIDUES; REGION; CELLS	O-Sulfation at C-3 of N-sulfated GlcN units concludes polymer modification and the formation of antithrombin binding regions in the biosynthesis of heparin/heparan sulfate, The resulting GlcNSO(3)(3-OSO3) units are largely restricted to heparin chains with high affinity for antithrombin (H-A heparin). Low affinity (L(A)) heparin fails to serve as a substrate in the 3-O-sulfotransferase reaction yet contains potential 3-O-sulfate acceptor sites (Kusche, M., Torri, G., Casu, B., and Lindahl, U. (1990) J. Biol, Chem, 265, 7292-7300), as verified in the present study using a novel sequencing procedure, O-Desulfated, re-N-sulfated L(A) heparin, as well as an octasaccharide fraction isolated after heparinase I digestion of L(A) heparin, both yielded labeled H-A components following incubation with solubilized mouse mastocytoma microsomal enzymes and [S-35]adenosine 3'-phosphate 5'phosphosulfate (PAPS), suggesting that the 3-O-sulfotransferase may be inhibited by sulfated saccharide sequences outside the 3-O-sulfate acceptor region, Indeed, the addition of L(A) heparin precluded enzymatic 3-O-sulfation of a synthetic pentasaccharide substrate, The K-m for the pentasaccharide was determined to similar to be 6 mu M. Incubations of mixed pentasaccharide substrate and saccharide inhibitors revealed K-i values for intact L(A) heparin and for a heparin octasaccharide fraction of similar to 1.3 and similar to 0.7 mu M, respectively, Inhibition experiments with selectively desulfated heparin indicated that both IdoA 2-O-sulfate and GlcN 6-O-sulfate groups contributed to the inhibition of the 3-O-sulfotransferase. By contrast, chondroitin sulfate or dermatan sulfate showed no significant inhibitory activity, It is proposed that the regulation of GlcN 3-O-sulfation during biosynthesis of heparin/heparan sulfate depends on the topological organization of the membrane-bound enzyme machinery in the intact cell.			RAZI, N (corresponding author), UNIV UPPSALA,CTR BIOMED,DEPT MED & PHYSIOL CHEM,BOX 575,S-75123 UPPSALA,SWEDEN.							ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; ATHA DH, 1987, BIOCHEMISTRY-US, V26, P6454, DOI 10.1021/bi00394a024; BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BOURIN MC, 1993, BIOCHEM J, V289, P313, DOI 10.1042/bj2890313; CASU B, 1981, BIOCHEM J, V197, P599, DOI 10.1042/bj1970599; CHOAY J, 1983, BIOCHEM BIOPH RES CO, V116, P492, DOI 10.1016/0006-291X(83)90550-8; CONRAD HE, 1992, ADV EXP MED BIOL, V313, P31; FURTH J, 1957, P SOC EXP BIOL MED, V95, P824; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; HOOK M, 1976, FEBS LETT, V66, P90, DOI 10.1016/0014-5793(76)80592-3; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; JACOBSSON I, 1979, J BIOL CHEM, V254, P2975; KUSCHE M, 1988, J BIOL CHEM, V263, P15474; KUSCHE M, 1991, J BIOL CHEM, V266, P7400; KUSCHE M, 1990, J BIOL CHEM, V265, P7292; LANE DA, 1986, J BIOL CHEM, V261, P3980; LAURENT TC, 1978, BIOCHEM J, V175, P691, DOI 10.1042/bj1750691; LEVY L, 1962, P SOC EXP BIOL MED, V190, P901; LIDHOLT K, 1992, BIOCHEM J, V287, P21, DOI 10.1042/bj2870021; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; LINDAHL U, 1983, J BIOL CHEM, V258, P9826; LINDAHL U, 1984, J BIOL CHEM, V259, P2368; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; LINHARDT RJ, 1992, J BIOL CHEM, V267, P2380; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; LOGANATHAN D, 1990, BIOCHEMISTRY-US, V29, P4362, DOI 10.1021/bi00470a015; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; PEJLER G, 1987, BIOCHEM J, V248, P69, DOI 10.1042/bj2480069; PEJLER G, 1988, J BIOL CHEM, V263, P5197; PEJLER G, 1987, J BIOL CHEM, V262, P5036; PETITOU M, 1988, CARBOHYD RES, V179, P163, DOI 10.1016/0008-6215(88)84116-8; PETITOU M, 1987, CARBOHYD RES, V167, P67, DOI 10.1016/0008-6215(87)80268-9; RENOSTO F, 1977, ARCH BIOCHEM BIOPHYS, V180, P416, DOI 10.1016/0003-9861(77)90056-X; RIESENFELD J, 1981, J BIOL CHEM, V256, P2389; ROBBINS PW, 1962, METHOD ENZYMOL, V5, P964, DOI 10.1016/S0076-6879(62)05343-4; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SHWORAK NW, 1994, J BIOL CHEM, V269, P24941; TEIEN AN, 1976, THROMB RES, V8, P859, DOI 10.1016/0049-3848(76)90014-1; THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2; VANBOECKEL CAA, 1993, ANGEW CHEM INT EDIT, V32, P1671, DOI 10.1002/anie.199316713	43	27	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11267	11275		10.1074/jbc.270.19.11267	http://dx.doi.org/10.1074/jbc.270.19.11267			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744762	hybrid			2022-12-27	WOS:A1995QX86500039
J	WU, J; SPIEGEL, S; STURGILL, TW				WU, J; SPIEGEL, S; STURGILL, TW			SPHINGOSINE 1-PHOSPHATE RAPIDLY ACTIVATES THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY BY A G-PROTEIN-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; NECROSIS-FACTOR-ALPHA; MAP KINASE; CELL-PROLIFERATION; 3T3 CELLS; CERAMIDE; IDENTIFICATION; SPHINGOSINE-1-PHOSPHATE; SPHINGOMYELINASE; DIFFERENTIATION	Addition of sphingosine 1-phosphate induces proliferation of quiescent Swiss 3T3 fibroblasts by unknown mechanisms. To identify the pathways involved, the ability of sphingosine 1-phosphate to activate mitogen-activated protein (MAP) kinase was studied. Sphingosine 1-phosphate rapidly activated the Raf/MAP kinase kinase (MKK)/MAP kinase pathway, and the concentration dependence for MAP kinase activation correlated with that for induction of DNA synthesis. Both MKK1 and MKK2 were activated by sphingosine 1-phosphate, assessed by specific immune complex kinase assays. Prior treatment of the Swiss 3T3 cells with pertussis toxin inhibited 70-80% of the sphingosine 1-phosphate-stimulated MAP kinase activity, Thus, one of the direct or indirect targets of exogenous sphingosine 1-phosphate appears to be a G(i)/G(o) protein.	UNIV VIRGINIA,HLTH SCI CTR,HOWARD HUGHES MED INST,DEPT MED,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,DEPT PHARMACOL,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,MARKEY CTR CELL SIGNALING,CHARLOTTESVILLE,VA 22908; GEORGETOWN UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOL,WASHINGTON,DC 20007	Howard Hughes Medical Institute; University of Virginia; University of Virginia; University of Virginia; Georgetown University			Wu, Jie/R-2404-2019	Wu, Jie/0000-0002-2864-1606	NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041077] Funding Source: NIH RePORTER; NCI NIH HHS [CA61774] Funding Source: Medline; NIDDK NIH HHS [NIDK41077] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BIELAWSKA A, 1992, FEBS LETT, V307, P211, DOI 10.1016/0014-5793(92)80769-D; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P236, DOI 10.1016/0968-0004(94)90147-3; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DESAI NN, 1993, J CELL BIOL, V121, P385; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; DURIEUX ME, 1993, TRENDS PHARMACOL SCI, V14, P249, DOI 10.1016/0165-6147(93)90021-B; GARDNER AM, 1994, METHOD ENZYMOL, V238, P258; GHOSH TK, 1994, J BIOL CHEM, V269, P22628; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HAUSER JML, 1994, J BIOL CHEM, V269, P6803; HIPSKIND RA, 1994, MOL CELL BIOL, V14, P6219, DOI 10.1128/MCB.14.9.6219; JALINK K, 1994, IN PRESS BIOCH J; JARVIS WD, 1994, J BIOL CHEM, V269, P31685; KIM MY, 1991, J BIOL CHEM, V266, P484; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; LOZANO J, 1994, J BIOL CHEM, V269, P19200; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MATTIE M, 1994, J BIOL CHEM, V269, P3181; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; OLIVERA A, 1992, J BIOL CHEM, V267, P26121; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; RAINES MA, 1993, J BIOL CHEM, V268, P14572; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; SPIEGEL S, 1993, ADV LIPID RES, V25, P105; SU Y, 1994, J BIOL CHEM, V269, P16512; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; WU J, 1993, P NATL ACAD SCI USA, V90, P173, DOI 10.1073/pnas.90.1.173; WU J, 1993, MOL CELL BIOL, V13, P4539, DOI 10.1128/MCB.13.8.4539; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; ZHANG H, 1990, J BIOL CHEM, V265, P21309	46	181	183	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11484	11488		10.1074/jbc.270.19.11484	http://dx.doi.org/10.1074/jbc.270.19.11484			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744787	hybrid			2022-12-27	WOS:A1995QX86500066
J	FEVE, B; PIETRIROUXEL, F; ELHADRI, K; DRUMARE, MF; STROSBERG, AD				FEVE, B; PIETRIROUXEL, F; ELHADRI, K; DRUMARE, MF; STROSBERG, AD			LONG-TERM PHORBOL ESTER TREATMENT DOWN-REGULATES THE BETA(3)-ADRENERGIC RECEPTOR IN 3T3-F442A ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BETA-ADRENERGIC-RECEPTOR; HUMAN BETA-3-ADRENERGIC RECEPTOR; 3T3-L1 FIBROBLASTS; ADENYLATE-CYCLASE; RAT ADIPOCYTES; MOLECULAR CHARACTERIZATION; INSULIN; PHOSPHORYLATION; DESENSITIZATION	The role of protein kinase C (PKC) in the regulation of the beta(3)-adrenergic receptor (beta(3)-AR) gene was examined in murine 3T3-F442A adipocytes, which express this receptor subtype at a high level, We also investigated the involvement of this kinase in the modulation of beta(3)-AR gene expression by insulin, Long term exposure of 3T3-F442A adipocytes to phorbol 12-myristate 13-acetate (PMA) decreased beta(3)-AR mRNA content in a time- and concentration dependent manner, with maximal changes observed at 6 h (6.5-fold decrease) and at 100 nM PMA. This inhibition was selective for beta(3)-AR transcripts, since beta(1)- and beta(2)-AR mRNA content remained unchanged, Also, (-)-[I-125] cyanopindolol saturation and competition binding experiments on adipocyte membranes indicated that PMA induced an similar to 2-fold decrease in beta(3)-AR expression, while that of the two other subtypes was not affected, This correlated with a lower efficacy of beta(3)-AR agonists to stimulate adenylyl cyclase, Conversely, long term exposure to PMA did not alter adenylyl cyclase activity in response to guanosine 5'-O-(3-thiotriphosphate) or forskolin, The inactive phorbol ester 4 alpha-phorbol 12,13-didecanoate did not repress beta(3)-AR mRNA levels. Inhibition of beta(3)-AR mRNA by PMA was suppressed by the PKC-selective inhibitor bisindolylmaleimide, and was not observed in PKC-depleted cells, indicating that PKC was involved in this response, mRNA turnover experiments showed that the half-life of beta(3)-AR transcripts was not affected by long term PMA exposure. When 3T3-F442A adipocytes were pretreated with PMA for 24 h to downregulate PKC, or with bisindolylmaleimide, the insulin-induced inhibition of beta(3)-AR mRNA levels was reduced by 44-67%, These findings demonstrate that sustained PKC activation exerts a specific control of beta(3)-AR gene expression and is involved, at least in part, in the modulation by insulin of this adrenergic receptor subtype.	CNRS,UPR 0415,F-75014 PARIS,FRANCE; UNIV PARIS 07,INST COCHIN GENET MOLEC,F-75014 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	FEVE, B (corresponding author), HOP HENRI MONDOR,INSERM,U82,F-94010 CRETEIL,FRANCE.			EL HADRI, KHADIJA/0000-0002-1275-9861; Feve, Bruno/0000-0001-6577-9009; Pietri-Rouxel, France/0000-0002-6258-7594				ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; ARCH JRS, 1993, MED RES REV, V13, P663, DOI 10.1002/med.2610130604; BLACKSHEAR PJ, 1991, J BIOL CHEM, V266, P10946; BLIN N, 1993, MOL PHARMACOL, V44, P1094; BOUVIER M, 1991, FEBS LETT, V279, P243, DOI 10.1016/0014-5793(91)80159-Z; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BROWN JA, 1994, DNA SEQUENCE, V4, P319, DOI 10.3109/10425179409020858; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHAMBAUTGUERIN AM, 1987, EUR J BIOCHEM, V170, P381, DOI 10.1111/j.1432-1033.1987.tb13711.x; CHERQUI G, 1986, ENDOCRINOLOGY, V118, P1759, DOI 10.1210/endo-118-5-1759; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLINS S, 1991, ANNU REV PHYSIOL, V53, P497, DOI 10.1146/annurev.physiol.53.1.497; EDWARDS DR, 1994, TRENDS PHARMACOL SCI, V15, P239, DOI 10.1016/0165-6147(94)90318-2; EGAN JJ, 1990, P NATL ACAD SCI USA, V87, P1052, DOI 10.1073/pnas.87.3.1052; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FEVE B, 1991, J BIOL CHEM, V266, P20329; FEVE B, 1990, J BIOL CHEM, V265, P16343; FEVE B, 1992, J BIOL CHEM, V267, P15909; FEVE B, 1994, P NATL ACAD SCI USA, V91, P5677, DOI 10.1073/pnas.91.12.5677; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GRANNEMAN JG, 1994, ENDOCRINOLOGY, V135, P1025, DOI 10.1210/en.135.3.1025; GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895; HEIDENREICH KA, 1990, J BIOL CHEM, V265, P15076; HEIDENREICH KA, 1993, J BIOL CHEM, V268, P1463; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; JOHNSON JA, 1990, MOL PHARMACOL, V38, P289; KELLEHER DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4316, DOI 10.1073/pnas.81.14.4316; KRIEF S, 1994, J BIOL CHEM, V269, P6664; LAI E, 1982, J BIOL CHEM, V257, P6691; LIGGETT SB, 1993, P NATL ACAD SCI USA, V90, P3665, DOI 10.1073/pnas.90.8.3665; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MESSINA JL, 1994, ENDOCRINOLOGY, V135, P2327, DOI 10.1210/en.135.6.2327; MESSINA JL, 1992, J BIOL CHEM, V267, P9223; MUZZIN P, 1991, J BIOL CHEM, V266, P24053; NAHMIAS C, 1991, EMBO J, V10, P3721, DOI 10.1002/j.1460-2075.1991.tb04940.x; NAKADA MT, 1990, J PHARMACOL EXP THER, V253, P221; NAKADA MT, 1987, MOL PHARMACOL, V31, P377; NAKADA MT, 1989, BIOCHEM J, V260, P53, DOI 10.1042/bj2600053; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NANTEL F, 1994, J BIOL CHEM, V269, P13148; NANTEL F, 1993, MOL PHARMACOL, V43, P548; OBRIEN RM, 1991, P NATL ACAD SCI USA, V88, P6580, DOI 10.1073/pnas.88.15.6580; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SIBLEY DR, 1984, BIOCHEM BIOPH RES CO, V121, P973, DOI 10.1016/0006-291X(84)90772-1; SMAL J, 1989, P NATL ACAD SCI USA, V86, P4705, DOI 10.1073/pnas.86.12.4705; SRINIVASAN M, 1994, J BIOL CHEM, V269, P16662; STANDAERT ML, 1993, ENDOCRINOLOGY, V132, P689, DOI 10.1210/en.132.2.689; STEIN B, 1993, EMBO J, V10, P3879; STRULOVICI B, 1991, J BIOL CHEM, V266, P168; STUMPO DJ, 1994, J BIOL CHEM, V269, P21184; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VANSPRONSEN A, 1993, EUR J BIOCHEM, V213, P1117, DOI 10.1111/j.1432-1033.1993.tb17861.x; WAYS DK, 1992, J BIOL CHEM, V267, P4799; WELSH GI, 1993, FEBS LETT, V316, P241, DOI 10.1016/0014-5793(93)81300-O; YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0; YUAN NY, 1994, J BIOL CHEM, V269, P23032; ZHAO L, 1994, ENDOCRINOLOGY, V135, P2504, DOI 10.1210/en.135.6.2504	60	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10952	10959		10.1074/jbc.270.18.10952	http://dx.doi.org/10.1074/jbc.270.18.10952			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738037	hybrid			2022-12-27	WOS:A1995QW60100085
J	REDDY, JC; MORRIS, JC; WANG, J; ENGLISH, MA; HABER, DA; SHI, Y; LICHT, JD				REDDY, JC; MORRIS, JC; WANG, J; ENGLISH, MA; HABER, DA; SHI, Y; LICHT, JD			WT1-MEDIATED TRANSCRIPTIONAL ACTIVATION IS INHIBITED BY DOMINANT-NEGATIVE MUTANT PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR GENE-PRODUCT; ZINC FINGER PROTEIN; DNA-BINDING SITE; WILMS-TUMOR; KIDNEY DEVELOPMENT; PROMOTER ACTIVITY; POINT MUTATIONS; WT1 GENE; LOCUS; EXPRESSION	The WT1 tumor suppressor gene encodes four isoforms of a zinc finger transcription factor with both activation and repression functions which are dependent upon promoter architecture, Using a simple HSV-tk promoter containing 5'-Egr-1/WT1-binding sites, we found that WT1 isoforms (A) and (B) strongly activated transcription, WT1(A) and (B) bound equally well to the Egr-1/WT1 binding site, but WT1(B), which contains a 17 amino acid insertion compared to WT1(A), was a consistently stronger activator of transcription than WT1(A), Transcriptional activation by wild-type WT1 was inhibited by coexpression of WT(PM) or WT(AR), genetically defined dominant negative alleles of WT1, In vitro, as well as in the yeast two-hybrid system, WT1 protein associated with itself and with dominant negative mutant proteins, The major domain required for self-association and inhibition of transcriptional activation mapped to the first 182 amino acids of WT1, Dominant negative WT1 alleles may play a role in tumorigenesis by associating with wild-type WT1 proteins and decreasing their transcriptional activity.	CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT MED,DIV MOLEC MED,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DERALD H RUTTENBERG CANC CTR,DIV NEOPLAST DIS,NEW YORK,NY 10029; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CELLULAR & MOLEC BIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,CTR CANC,BOSTON,MA 02129	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital			Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369	NATIONAL CANCER INSTITUTE [R01CA058596, R37CA058596, R01CA058997, R01CA059998] Funding Source: NIH RePORTER; NCI NIH HHS [CA59998, CA58997, CA58596] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ausubel FM, 1988, MOL REPROD DEV; Baird Paul N., 1992, Human Molecular Genetics, V1, P301, DOI 10.1093/hmg/1.5.301; BARDEESY N, 1994, GENOMICS, V21, P663, DOI 10.1006/geno.1994.1333; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BUCKLER AJ, 1991, MOL CELL BIOL, V11, P1707, DOI 10.1128/MCB.11.3.1707; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; COPPES MJ, 1993, P NATL ACAD SCI USA, V90, P1416, DOI 10.1073/pnas.90.4.1416; DELUCA NA, 1987, NUCLEIC ACIDS RES, V15, P4491, DOI 10.1093/nar/15.11.4491; DEY BR, 1994, MOL ENDOCRINOL, V8, P595, DOI 10.1210/me.8.5.595; DRUMMOND IA, 1994, MOL CELL BIOL, V14, P3800, DOI 10.1128/MCB.14.6.3800; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HABER DA, 1992, P NATL ACAD SCI USA, V89, P6010, DOI 10.1073/pnas.89.13.6010; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HARRINGTON MA, 1993, J BIOL CHEM, V268, P21271; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LEVINE M, 1989, CELL, V59, P105; LICHT JD, 1993, P NATL ACAD SCI USA, V90, P11361, DOI 10.1073/pnas.90.23.11361; LITTLE MH, 1992, P NATL ACAD SCI USA, V89, P4791, DOI 10.1073/pnas.89.11.4791; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; MAHESWARAN S, 1993, P NATL ACAD SCI USA, V90, P5100, DOI 10.1073/pnas.90.11.5100; MORRIS JF, 1991, ONCOGENE, V6, P2339; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; PELLETIER J, 1991, NATURE, V353, P431, DOI 10.1038/353431a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; RUPPRECHT HD, 1994, J BIOL CHEM, V269, P6198; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; WANG ZY, 1993, P NATL ACAD SCI USA, V90, P8896, DOI 10.1073/pnas.90.19.8896; WANG ZY, 1993, J BIOL CHEM, V268, P9172; WANG ZY, 1992, J BIOL CHEM, V267, P21999; WERNER H, 1994, J BIOL CHEM, V269, P12577; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	43	148	154	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10878	10884		10.1074/jbc.270.18.10878	http://dx.doi.org/10.1074/jbc.270.18.10878			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738027	hybrid			2022-12-27	WOS:A1995QW60100075
J	SCHWARZ, A; RAPAPORT, E; HIRSCHBERG, K; FUTERMAN, AH				SCHWARZ, A; RAPAPORT, E; HIRSCHBERG, K; FUTERMAN, AH			A REGULATORY ROLE FOR SPHINGOLIPIDS IN NEURONAL GROWTH - INHIBITION OF SPHINGOLIPID SYNTHESIS AND DEGRADATION HAVE OPPOSITE EFFECTS ON AXONAL BRANCHING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; CULTURED HIPPOCAMPAL-NEURONS; CERAMIDE ANALOG; CELL-SURFACE; GLYCOSPHINGOLIPID SYNTHESIS; ANTISENSE OLIGONUCLEOTIDES; GLUCOSYLCERAMIDE SYNTHESIS; INOSITOL TRISPHOSPHATE; NEURITE OUTGROWTH; SECRETORY PATHWAY	Sphingolipids, particularly gangliosides, are enriched in neuronal membranes where they have been implicated as mediators of various regulatory events, We recently provided evidence that sphingolipid synthesis is necessary to maintain neuronal growth by demonstrating that in hippocampal neurons, inhibition of ceramide synthesis by Fumonisin B-1 (FB1) disrupted axonal outgrowth (Harel, R, and Futerman, A, H, (1993) J, Biol, Chem, 268, 14476-14481), We now analyze further the relationship between neuronal growth and sphingolipid metabolism by examining the effect of an inhibitor of glucosylceramide synthesis, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and by examining the effects of both FB1 and PDMP at various stages of neuronal development, No effects of FB1 or PDMP were observed during the first 2 days in culture, but by day 3 axonal morphology was significantly altered, irrespective of the time of addition of the inhibitors to the cultures, Cells incubated with FB1 or PDMP had a shorter axon plexus and less axonal branches, FB1 appeared to cause a retraction of axonal branches between days 2 and 3, although long term incubation had no apparent effect on neuronal morphology or on the segregation of axonal or dendritic proteins, In contrast, incubation of neurons with conduritol B-epoxide, an inhibitor of glucosylceramide degradation, caused an increase in the number of axonal branches and a corresponding increase in the length of the axon plexus, A direct correlation was observed between the number of axonal branch points per cell and the extent of inhibition of either sphingolipid synthesis or degradation, These results suggest that sphingolipids play an important role in the formation or stabilization of axonal branches.	UNIV BATH,DEPT BIOCHEM,BATH BA2 7AY,AVON,ENGLAND	University of Bath	SCHWARZ, A (corresponding author), WEIZMANN INST SCI,DEPT MEMBRANE RES & BIOPHYS,IL-76100 REHOVOT,ISRAEL.			Futerman, Anthony/0000-0003-0013-0115				BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; BLACKBURN CC, 1986, J BIOL CHEM, V261, P2873; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CACERES A, 1986, J NEUROSCI, V6, P714; DOHERTY P, 1992, J CELL BIOL, V117, P1093, DOI 10.1083/jcb.117.5.1093; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; FELDINGHABERMANN B, 1990, BIOCHEMISTRY-US, V29, P6314, DOI 10.1021/bi00478a028; FENTIE IH, 1993, J NEUROCYTOL, V22, P498, DOI 10.1007/BF01181569; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1994, TRENDS GLYCOSCI GLYC, V6, P143; Futerman Anthony H., 1994, V40, P93; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Goslin K., 1991, CULTURING NERVE CELL, P251; HAKAMORI S, 1990, J BIOL CHEM, V265, P18713; HANADA K, 1992, J BIOL CHEM, V267, P23527; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HAREL R, 1993, J BIOL CHEM, V268, P14476; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; INOKUCHI J, 1990, CANCER RES, V50, P6731; INOKUCHI JI, 1989, J CELL PHYSIOL, V141, P573, DOI 10.1002/jcp.1041410316; JAREB M I, 1991, Society for Neuroscience Abstracts, V17, P739; JOSHI HC, 1993, J CELL BIOL, V121, P1191, DOI 10.1083/jcb.121.6.1191; KAN CC, 1992, J BIOL CHEM, V267, P9663; KIRSCH J, 1990, J NEUROCHEM, V55, P1031, DOI 10.1111/j.1471-4159.1990.tb04593.x; LEDEEN RW, 1989, NEUROBIOLOGY GLYCOCO, P43; Legler G, 1977, Methods Enzymol, V46, P368; LEIN PJ, 1991, DEV BRAIN RES, V60, P187, DOI 10.1016/0165-3806(91)90047-M; LISANTI MP, 1993, J CELL BIOL, V123, P595, DOI 10.1083/jcb.123.3.595; LISANTI MP, 1990, P NATL ACAD SCI USA, V87, P7419, DOI 10.1073/pnas.87.19.7419; MAHDIYOUN S, 1992, ARCH BIOCHEM BIOPHYS, V292, P506, DOI 10.1016/0003-9861(92)90023-P; MEIVARLEVY I, 1994, BIOCHEM J, V303, P377, DOI 10.1042/bj3030377; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; OKADA Y, 1988, FEBS LETT, V235, P25, DOI 10.1016/0014-5793(88)81227-4; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Radin N S, 1981, Methods Enzymol, V72, P673; RADIN NS, 1993, ADV LIPID RES, V26, P183; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; ROSENWALD AG, 1993, J BIOL CHEM, V268, P4577; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; SHAYMAN JA, 1990, J BIOL CHEM, V265, P12135; SHUKLA GS, 1991, BIOCHIM BIOPHYS ACTA, V1083, P101, DOI 10.1016/0005-2760(91)90130-A; SIEGEL DA, 1994, J NEUROCHEM, V62, P1852; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SOFER A, 1995, IN PRESS J BIOL CHEM, V270; SPIEGEL S, 1986, J CELL BIOL, V102, P1898, DOI 10.1083/jcb.102.5.1898; UEMURA K, 1990, J BIOCHEM-TOKYO, V108, P525; UEMURA K, 1991, J BIOCHEM-TOKYO, V110, P96, DOI 10.1093/oxfordjournals.jbchem.a123549; VANECHTEN G, 1990, EUR J CELL BIOL, V51, P135; WALSH FS, 1992, GPI MEMBRANE ANCHORS, P294; WANG E, 1991, J BIOL CHEM, V266, P14486; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x; WU GS, 1990, J NEUROCHEM, V55, P484, DOI 10.1111/j.1471-4159.1990.tb04161.x; Yu R.K., 1989, NEUROBIOLOGY GLYCOCO, P1; YU WQ, 1994, J NEUROSCI, V14, P5872; ZELLER CB, 1992, AM J PHYSIOL, V262, pC1341, DOI 10.1152/ajpcell.1992.262.6.C1341	62	145	147	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10990	10998		10.1074/jbc.270.18.10990	http://dx.doi.org/10.1074/jbc.270.18.10990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738041	hybrid			2022-12-27	WOS:A1995QW60100090
J	GOOD, DW				GOOD, DW			HYPEROSMOLALITY INHIBITS BICARBONATE ABSORPTION IN RAT MEDULLARY THICK ASCENDING LIMB VIA A PROTEIN-TYROSINE KINASE-DEPENDENT PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-VOLUME REGULATION; NA+/H+ EXCHANGER; PHOSPHATASE-ACTIVITY; SIGNAL TRANSDUCTION; HERBIMYCIN-A; PHOSPHORYLATION; ACTIVATION; LYMPHOCYTES; MECHANISMS; SHRINKAGE	In the rat medullary thick ascending limb (MTAL), hyperosmolality inhibits transepithelial HCO, absorption (JHCO(3)(-)) by inhibiting apical membrane Na+/H+ exchange, To examine signaling mechanisms involved in this regulatory response, MTALs were isolated and perfused in vitro with 25 mM HCO3- solutions (290 mosmol/kg H2O). Osmolality was increased in lumen and bath solutions by addition of 300 mM mannitol or 75 mM NaCl. Addition of mannitol reduced JHCO(3)(-) by 60% and addition of NaCl reduced JHCO(3)(-) by 50%. With the protein tyrosine kinase (PTK) inhibitor genistein (7 mu M) or herbimycin A (1 mu M) in the bath, addition of mannitol reduced JHCO(3)(-) only by 11% and addition of NaCl reduced JHCO(3)(-) only by 15%. Staurosporine (10(-7) M) or forskolin (10(-6) M) in the bath had no effect on inhibition of JHCO(3)(-) by hypertonic NaCl. Genistein had no effect on inhibition of JHCO(3)(-) by vasopressin (a cyclic AMP-dependent process) or stimulation of JHCO(3)(-) by prostaglandin E(2) (a protein kinase C-dependent process). Under isosmotic conditions, addition of genistein or herbimycin A to the bath increased JHCO(3)(-) by 30% through stimulation of apical membrane Na+/H+ exchange, Addition of the tyrosine phosphatase inhibitor molybdate (50 mu M) to the bath reproduced the inhibition of JHCO(3)(-) observed with hyperosmolality. These data indicate that 1) the effect of hyperosmolality to inhibit MTAL HCO3- absorption through inhibition of apical membrane Na+/H+ exchange is mediated via a PTK-dependent pathway that functions independent of regulation by cyclic AMP and protein kinase C, and 2) a constitutive PTR activity inhibits apical membrane Na+/H+ exchange and HCO3- absorption under isosmotic conditions, Our results suggest that tyrosine phosphorylation is a critical step in inhibition of the apical Na+/H+ exchanger isoform NHE-3 by hyperosmolality.	UNIV TEXAS, MED BRANCH, DEPT PHYSIOL & BIOPHYS, GALVESTON, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	GOOD, DW (corresponding author), UNIV TEXAS, MED BRANCH, DEPT INTERNAL MED, 301 UNIV BLVD, 4 200 JOHN SEALY HOSP E-62, GALVESTON, TX 77555 USA.				NIDDK NIH HHS [DK38217] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038217] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIYAMA T, 1991, METHOD ENZYMOL, V201, P362; BIANCHINI L, 1991, J BIOL CHEM, V266, P15406; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; BOOKSTEIN C, 1994, J CLIN INVEST, V93, P106, DOI 10.1172/JCI116933; BORENSZTEIN P, 1994, J AM SOC NEPHROL, V5, P248; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; CHAMBERLIN ME, 1989, AM J PHYSIOL, V257, pC159, DOI 10.1152/ajpcell.1989.257.2.C159; DAVIS BA, 1992, AM J PHYSIOL, V262, pC533, DOI 10.1152/ajpcell.1992.262.2.C533; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; Good David W., 1992, Journal of the American Society of Nephrology, V3, P777; GOOD DW, 1984, AM J PHYSIOL, V247, pF35, DOI 10.1152/ajprenal.1984.247.1.F35; GOOD DW, 1992, J CLIN INVEST, V89, P184, DOI 10.1172/JCI115560; GOOD DW, 1993, SEMIN NEPHROL, V13, P225; GOOD DW, 1990, J CLIN INVEST, V85, P1006, DOI 10.1172/JCI114530; GOOD DW, 1994, J AM SOC NEPHROL, V5, P679; GREEN J, 1988, J BIOL CHEM, V263, P5012; GRINSTEIN S, 1985, J GEN PHYSIOL, V85, P765, DOI 10.1085/jgp.85.5.765; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; GRINSTEIN S, 1992, J BIOL CHEM, V267, P23823; GRINSTEIN S, 1986, J BIOL CHEM, V261, P8009; GRINSTEIN S, 1985, J CELL BIOL, V101, P269, DOI 10.1083/jcb.101.1.269; Grinstein Sergio, 1992, News in Physiological Sciences, V7, P232; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HEBERT SC, 1986, AM J PHYSIOL, V250, pC920, DOI 10.1152/ajpcell.1986.250.6.C920; HEBERT SC, 1986, AM J PHYSIOL, V250, pC907, DOI 10.1152/ajpcell.1986.250.6.C907; HOFFMANN EK, 1989, PHYSIOL REV, V69, P315, DOI 10.1152/physrev.1989.69.2.315; ITOH T, 1994, J CLIN INVEST, V93, P2387, DOI 10.1172/JCI117245; JENNINGS ML, 1990, J GEN PHYSIOL, V95, P1021, DOI 10.1085/jgp.95.6.1021; KAPUS A, 1994, J BIOL CHEM, V269, P23544; KIRK KL, 1984, J MEMBRANE BIOL, V79, P53, DOI 10.1007/BF01868526; KNOX KA, 1994, CELL IMMUNOL, V155, P62, DOI 10.1006/cimm.1994.1102; LANE PJL, 1991, J IMMUNOL, V146, P715; MAHER PA, 1993, P NATL ACAD SCI USA, V90, P11177, DOI 10.1073/pnas.90.23.11177; PARKER JC, 1990, J GEN PHYSIOL, V96, P1141, DOI 10.1085/jgp.96.6.1141; SOLEIMANI M, 1994, J BIOL CHEM, V269, P15613; SUN AM, 1994, J AM SOC NEPHROL, V5, P263; TILLY BC, 1993, J BIOL CHEM, V268, P19919; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TSE M, 1993, J AM SOC NEPHROL, V4, P969; TSUNODA Y, 1993, AM J PHYSIOL, V264, pG351, DOI 10.1152/ajpgi.1993.264.2.G351; UEHARA Y, 1991, METHOD ENZYMOL, V201, P370; WALTON KM, 1993, ANNU REV BIOCHEM, V62, P101; WATTS B A III, 1991, Journal of the American Society of Nephrology, V2, P715; WATTS BA, 1994, J BIOL CHEM, V269, P20250; YAO XR, 1993, CELL IMMUNOL, V149, P364, DOI 10.1006/cimm.1993.1162	46	37	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9883	9889		10.1074/jbc.270.17.9883	http://dx.doi.org/10.1074/jbc.270.17.9883			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730371	hybrid			2022-12-27	WOS:A1995QV41700030
J	FRANK, S; HUBNER, G; BREIER, G; LONGAKER, MT; GREENHALGH, DG; WERNER, S				FRANK, S; HUBNER, G; BREIER, G; LONGAKER, MT; GREENHALGH, DG; WERNER, S			REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IN CULTURED KERATINOCYTES - IMPLICATIONS FOR NORMAL AND IMPAIRED WOUND-HEALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR NECROSIS FACTOR; FACTOR-ALPHA; PERMEABILITY FACTOR; CELL GROWTH; FACTOR-BETA; PROLIFERATION; ANGIOGENESIS; DIFFERENTIATION; INHIBITION; INDUCTION	Recent in situ hybridization studies had demonstrated a strong increase in vascular endothelial growth factor (VEGF) mRNA expression in the hyperproliferative epithelium during wound healing. To determine potential mediators of VEGF induction during this process, we analyzed the regulation of VEGF expression in cultured human keratinocytes, We found a large induction of VEGF expression upon treatment of quiescent cells with serum, epidermal growth factor, transforming growth factor-beta 1, keratinocyte growth factor, or the proinflammatory cytokine tumor necrosis factor alpha, respectively, Since all these factors are present at the wound site during the early phase of wound healing, they might also be responsible for VEGF induction after cutaneous injury. To determine the importance of increased VEGF production for wound repair, we compared the time course of VEGF mRNA expression during wound healing of healthy control mice with the kinetics of VEGF expression during skin repair of genetically diabetic db/db mice which are characterized by impaired wound healing, In normal mice we found elevated VEGF mRNA levels during the period when granulation tissue formation occurs. In contrast, VEGF mRNA levels even declined during this period in db/db mice, suggesting that a defect in VEGF regulation might be associated with wound healing disorders.	MAX PLANCK INST BIOCHEM,D-82152 MARTINSRIED,GERMANY; MAX PLANCK INST PHYSIOL & CLIN RES,D-61231 BAD NAUHEIM,GERMANY; NYU,SCH MED,INST RECONSTRUCT PLAST SURG,NEW YORK,NY 10016; SHRINERS BURNS INST,DEPT SURG,CINCINNATI,OH 45229; UNIV CINCINNATI,CINCINNATI,OH 45229	Max Planck Society; Max Planck Society; New York University; University System of Ohio; University of Cincinnati			Breier, Georg/E-3580-2016	Breier, Georg/0000-0002-9467-780X; Werner, Sabine/0000-0001-7397-8710				BAIRD A, 1986, BIOCHEM BIOPH RES CO, V138, P476, DOI 10.1016/0006-291X(86)90305-0; BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; BREIER G, 1992, DEVELOPMENT, V114, P521; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; BROWN LF, 1988, AM J PATHOL, V130, P455; CHEDID M, 1994, J BIOL CHEM, V269, P10753; CICCO NA, 1990, BLOOD, V75, P2049; Clark RAF, 1991, PHYSL BIOCH MOL BIOL, P576; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; COLEMAN DL, 1982, DIABETES, V31, P1; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DINARELLO CA, 1991, CYTOKINE HDB, P47; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; FRATERSCHRODER M, 1986, BIOCHEM BIOPH RES CO, V137, P295, DOI 10.1016/0006-291X(86)91209-X; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121, DOI 10.1091/mbc.4.1.121; GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; KOPAN R, 1987, J CELL BIOL, V105, P427, DOI 10.1083/jcb.105.1.427; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LINDEMANN A, 1989, J CLIN INVEST, V83, P1313; LORD PCW, 1991, J CLIN INVEST, V87, P1312, DOI 10.1172/JCI115134; MADTES DK, 1988, CELL, V53, P285, DOI 10.1016/0092-8674(88)90390-X; MARTINET Y, 1986, NATURE, V319, P158, DOI 10.1038/319158a0; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; RAPPOLEE DA, 1988, SCIENCE, V241, P7087; Rheinwald J G, 1980, Methods Cell Biol, V21A, P229, DOI 10.1016/S0091-679X(08)60769-4; RISAU W, 1990, Progress in Growth Factor Research, V2, P71, DOI 10.1016/0955-2235(90)90010-H; Risau W, 1992, GROWTH FACTORS, V7, P261, DOI 10.3109/08977199209046408; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; SAUDER DN, 1988, ARCH DERMATOL RES, V80, P71; SCHREIBER AB, 1986, SCIENCE, V232, P1250, DOI 10.1126/science.2422759; SHIPLEY GD, 1986, CANCER RES, V46, P2068; SYMINGTON FW, 1989, J INVEST DERMATOL, V92, P798, DOI 10.1111/1523-1747.ep12696816; TOSATO G, 1988, SCIENCE, V239, P502, DOI 10.1126/science.2829354; WEINDEL K, 1992, BIOCHEM BIOPH RES CO, V183, P1167, DOI 10.1016/S0006-291X(05)80313-4; WERNER S, 1994, J INVEST DERMATOL, V103, P469, DOI 10.1111/1523-1747.ep12395564; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Wong H. L., 1989, HUMAN MONOCYTES, P383	49	621	654	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12607	12613		10.1074/jbc.270.21.12607	http://dx.doi.org/10.1074/jbc.270.21.12607			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759509	hybrid			2022-12-27	WOS:A1995QZ71100044
J	LINSEMAN, DA; BENJAMIN, CW; JONES, DA				LINSEMAN, DA; BENJAMIN, CW; JONES, DA			CONVERGENCE OF ANGIOTENSIN-II AND PLATELET-DERIVED GROWTH-FACTOR RECEPTOR SIGNALING CASCADES IN VASCULAR SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; NUCLEOTIDE EXCHANGE; MESSENGER-RNA; GRB2; KINASES; RAS; ACTIVATION; PDGF; SH2; DIACYLGLYCEROL	Signaling cascades elicited by ansotensin II resemble those characteristic of growth factor stimulation. In this report, we demonstrate that angiotensin II converges with platelet-derived growth factor (PDGF) beta-receptor signaling cascades, independent of PDGF. Stimulation of smooth muscle cells with angiotensin II resulted in tyrosine phosphorylation on She proteins and subsequent complex formation between She and growth factor receptor binding protein a (GRB2). A 180-kDa protein co-precipitating with Shc . GRB2 complexes also demonstrated increased phosphorylation in response to ansotensin II. Immunoblot analyses and proteolytic digests failed to distinguish this 180-kDa protein from authentic PDGF beta-receptors. Corresponding with Shc and PDGF receptor phosphorylation induced by angiotensin II was the recruitment and phosphorylation of c-Src. Autocrine release of platelet-derived growth factor failed to account for Shc complex formation at the PDGF receptor following angiotensin II treatment, and a specific ansotensin II type I receptor antagonist, losartan, abolished the response. These results support a novel model for cross-talk between the G-protein-linked ansotensin II receptor and the PDGF receptor tyrosine kinase in vascular smooth muscle cells, Communication with the PDGF receptor may account for the ability of angiotensin II to elicit responses typical of growth factor signal transduction.	UPJOHN CO,KALAMAZOO,MI 49001	Pfizer			Linseman, Daniel/L-3846-2019					BENJAMIN CW, 1994, J BIOL CHEM, V269, P30911; BERK BC, 1993, J CELL PHYSIOL, V154, P368, DOI 10.1002/jcp.1041540221; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; DUFF JL, 1992, BIOCHEM BIOPH RES CO, V188, P257, DOI 10.1016/0006-291X(92)92378-B; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GRIENDLING KK, 1986, J BIOL CHEM, V261, P5901; HOLLENBERG MD, 1994, TRENDS PHARMACOL SCI, V15, P108, DOI 10.1016/0165-6147(94)90046-9; HUCKLE WR, 1992, P NATL ACAD SCI USA, V89, P8837, DOI 10.1073/pnas.89.18.8837; ITOH H, 1993, J CLIN INVEST, V91, P2268, DOI 10.1172/JCI116454; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASSEGUE B, 1993, BIOCHEM J, V292, P509, DOI 10.1042/bj2920509; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARRERO MB, 1994, J BIOL CHEM, V269, P10935; MCGLADE J, 1992, P NATL ACAD SCI USA, V89, P8869, DOI 10.1073/pnas.89.19.8869; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; OWENS GK, 1986, J CELL BIOL, V105, P343; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PRONK GJ, 1994, MOL CELL BIOL, V14, P1575, DOI 10.1128/MCB.14.3.1575; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SALEINI AE, 1994, ONCOGENE, V9, P2827; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SASAOKA T, 1994, J BIOL CHEM, V269, P32621; SCHORB W, 1994, J BIOL CHEM, V269, P19626; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SJOLUND M, 1988, J CELL BIOL, V106, P403, DOI 10.1083/jcb.106.2.403; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; TSUDA T, 1991, FEBS LETT, V285, P44, DOI 10.1016/0014-5793(91)80721-E; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; YOKOTE K, 1994, J BIOL CHEM, V269, P15337	36	270	275	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12563	12568		10.1074/jbc.270.21.12563	http://dx.doi.org/10.1074/jbc.270.21.12563			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759503	hybrid			2022-12-27	WOS:A1995QZ71100038
J	SU, W; LIU, W; SCHAFFHAUSEN, BS; ROBERTS, TM				SU, W; LIU, W; SCHAFFHAUSEN, BS; ROBERTS, TM			ASSOCIATION OF POLYOMAVIRUS MIDDLE TUMOR-ANTIGEN WITH PHOSPHOLIPASE-C-GAMMA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN-KINASE-C; T-ANTIGEN; TYROSINE PHOSPHORYLATION; VIRUS; TRANSFORMATION; PP60C-SRC; ACTIVATION; COMPLEX; INVITRO; SITES	Middle tumor antigen (MT) is the primary transforming protein of murine Polyomavirus. MT transforms by associating with and modulating the activities of cellular proteins involved in control of cell proliferation. MT binds to and is phosphorylated by cellular tyrosine kinases. The phosphorylated tyrosines become docking sites for SH2 (Src homology 2) domain-containing molecules. Tyrosine 322 of MT is known to be phosphorylated but has no known binding protein. We have found that phospholipase C-gamma 1 (PLC-gamma 1), a SH2 domain containing protein, coimmunoprecipitates with MT. Tyrosine phosphorylation of PLC-gamma 1 is elevated in cells expressing MT, suggesting activation of this enzyme by MT. A Tyr-322 --> Phe mutation in MT renders it defective in MT-PLC-gamma 1 interaction and in transformation. From the correlation between transformation and MT-PLC-gamma 1 interaction, we suggest that PLC-gamma 1 may play a role in transformation.	HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; TUFTS UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02111	Harvard University; Harvard Medical School; Tufts University	SU, W (corresponding author), HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CELLULAR & MOLEC BIOL,M857,44 BINNEY ST,BOSTON,MA 02115, USA.				NATIONAL CANCER INSTITUTE [R01CA030002, R37CA030002, R01CA034722] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA034722, CA30002] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOLEN JB, 1984, CELL, V38, P767, DOI 10.1016/0092-8674(84)90272-1; CAMPBELL KS, 1994, P NATL ACAD SCI USA, V91, P6344, DOI 10.1073/pnas.91.14.6344; CARMICHAEL G, 1984, P NATL ACAD SCI-BIOL, V81, P679, DOI 10.1073/pnas.81.3.679; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CHENG SH, 1990, MOL CELL BIOL, V10, P5569, DOI 10.1128/MCB.10.10.5569; CHERINGTON V, 1986, P NATL ACAD SCI USA, V83, P4307, DOI 10.1073/pnas.83.12.4307; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; COURTNEIDGE SA, 1984, EMBO J, V3, P585, DOI 10.1002/j.1460-2075.1984.tb01852.x; DELAGE S, 1993, CANCER RES, V53, P2762; DILWORTH SM, 1993, J VIROL, V67, P2235, DOI 10.1128/JVI.67.4.2235-2244.1993; DILWORTH SM, 1994, NATURE, V367, P87, DOI 10.1038/367087a0; GOLDSCHMIDTCLER.PJ, 1991, SCIENCE, V251, P1231; GORGA FR, 1990, J VIROL, V64, P105, DOI 10.1128/JVI.64.1.105-112.1990; HARVEY R, 1984, MOL CELL BIOL, V4, P1334, DOI 10.1128/MCB.4.7.1334; HUNTER T, 1984, EMBO J, V3, P73, DOI 10.1002/j.1460-2075.1984.tb01763.x; KAPLAN DR, 1989, BIOCHIM BIOPHYS ACTA, V948, P345, DOI 10.1016/0304-419X(89)90006-1; KAPLAN DR, 1986, P NATL ACAD SCI USA, V83, P3624, DOI 10.1073/pnas.83.11.3624; KINGSTON RE, 1994, CURRENT PROTOCALS MO; KORMAN AJ, 1987, P NATL ACAD SCI USA, V84, P2150, DOI 10.1073/pnas.84.8.2150; KORNBLUTH S, 1987, NATURE, V325, P171, DOI 10.1038/325171a0; MARCELLUS R, 1991, ONCOGENE, V6, P1037; MARKLAND W, 1986, J VIROL, V59, P384, DOI 10.1128/JVI.59.2.384-391.1986; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; SCHAFFHAUSEN B, 1981, J VIROL, V40, P184, DOI 10.1128/JVI.40.1.184-196.1981; SHMUELI E, 1993, J INTERN MED, V234, P397, DOI 10.1111/j.1365-2796.1993.tb00761.x; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0	33	77	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12331	12334		10.1074/jbc.270.21.12331	http://dx.doi.org/10.1074/jbc.270.21.12331			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759472				2022-12-27	WOS:A1995QZ71100002
J	XU, XL; WILLIAMS, JW; BREMER, EG; FINNEGAN, A; CHONG, ASF				XU, XL; WILLIAMS, JW; BREMER, EG; FINNEGAN, A; CHONG, ASF			INHIBITION OF PROTEIN-TYROSINE PHOSPHORYLATION IN T-CELLS BY A NOVEL IMMUNOSUPPRESSIVE AGENT, LEFLUNOMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; PHOSPHOLIPASE C-GAMMA-1; KINASE-ACTIVITY; CROSS-LINKING; GENE-PRODUCT; ACTIVATION; STIMULATION; EVENTS	Leflunomide, a novel immunosuppressive drug, is able to prevent and reverse allograft and xenograft rejection in rodents, dogs, and monkeys. It is also effective in the treatment of several rodent models of arthritis and autoimmune disease. In vitro studies indicate that leflunomide is capable of inhibiting anti-CD3- and interleukin-2 (IL-2)-stimulated T cell proliferation. However, the biochemical mechanism for the inhibitory activity of leflunomide has not been elucidated. In this study, we characterized the inhibitory effects of leflunomide on Src family (p56(lck) and p59(fyn))-mediated protein tyrosine phosphorylation. Leflunomide was able to inhibit p59(fyn) and p56(lck) activity in in vitro tyrosine kinase assays. The IC50 values for p59(fyn) (immunoprecipitated from either Jurkat or CTLL-4 cell lysate) autophosphorylation and phosphorylation of the exogenous substrate, histone 2B, mere 125-175 and 22-40 mu M respectively, while the IC50 no values for p56(lck) (immunoprecipitated from Jurkat cell lysates) autophosphorylation and phosphorylation of histone 2B were 160 and 65 mu M respectively. We also demonstrated the ability of leflunomide to inhibit protein tyrosine phosphorylation induced by anti-CD3 monoclonal antibody in Jurkat cells. The IC50 values for total intracellular tyrosine phosphorylation ranged from 5 to 45 mu M, with the IC50 values for the zeta chain and phospholipase C isoform gamma 1 being 35 and 44 mu M respectively. Leflunomide also inhibited Ca2+ mobilization in Jurkat cells stimulated by anti-CD3 antibody but not in those stimulated by ionomycin. Distal events of anti-CD3 monoclonal antibody stimulation, namely, IL-2 production and IL-2 receptor expression on human T lymphocytes, were also inhibited by leflunomide. Finally, tyrosine phosphorylation in CTLL-4 cells stimulated by IL-2 was also inhibited by leflunomide. These data collectively demonstrate the ability of leflunomide to inhibit tyrosine kinase activity in vitro, and suggest that inhibition of tyrosine phosphorylation events may be the mechanism by which leflunomide functions as an immunosuppressive agent.	RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT MICROBIOL IMMUNOL, CHICAGO, IL 60612 USA; RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT INTERNAL MED, RHEUMATOL SECT, CHICAGO, IL 60612 USA; CHICAGO INST NEUROSURG & NEURORES, CHICAGO, IL 60614 USA	Rush University; Rush University	XU, XL (corresponding author), RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT GEN SURG, CHICAGO, IL 60612 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI034061, R01AI034061] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34061] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM RT, 1992, TRENDS BIOCHEM SCI, V17, P434, DOI 10.1016/0968-0004(92)90015-2; ALESSANDRINI A, 1992, P NATL ACAD SCI USA, V89, P8200, DOI 10.1073/pnas.89.17.8200; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BARTLETT RR, 1991, AGENTS ACTIONS, V32, P10, DOI 10.1007/BF01983301; CASSATELLA MA, 1989, J EXP MED, V169, P549, DOI 10.1084/jem.169.2.549; CHONG ASF, 1993, TRANSPLANTATION, V55, P1361, DOI 10.1097/00007890-199306000-00028; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DASILVA AJ, 1992, MOL IMMUNOL, V29, P1417, DOI 10.1016/0161-5890(92)90215-J; DESAI DM, 1990, NATURE, V348, P66, DOI 10.1038/348066a0; FRASER JD, 1993, IMMUNOL TODAY, V14, P357, DOI 10.1016/0167-5699(93)90236-E; GRABER M, 1992, INT IMMUNOL, V4, P1201, DOI 10.1093/intimm/4.11.1201; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HSI ED, 1989, J BIOL CHEM, V264, P10836; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; LIAO F, 1993, J IMMUNOL, V150, P2668; MATTAR T, 1993, FEBS LETT, V334, P161, DOI 10.1016/0014-5793(93)81704-4; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; NAIR R, 1995, J HEART LUNG TRANS S, P554; NEL AE, 1991, J IMMUNOL, V147, P1933; NEL AE, 1990, J IMMUNOL, V144, P2683; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; TREVILLYAN JM, 1990, J IMMUNOL, V145, P3223; TSGANKOV AY, 1994, J BIOL CHEM, V269, P7792; TSYGANKOV AY, 1992, J BIOL CHEM, V267, P18259; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; WILLIAMS JW, 1993, TRANSPLANTATION, V57, P1233; XIAO F, 1994, TRANSPLANTATION, V58, P828; ZIELINSKI T, 1994, AGENTS ACTIONS, V38, P80; ZIELINSKI T, 1995, IN PRESS INFLAMMATIO	32	189	201	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12398	12403		10.1074/jbc.270.21.12398	http://dx.doi.org/10.1074/jbc.270.21.12398			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759480	hybrid			2022-12-27	WOS:A1995QZ71100013
J	CHEN, YR; SHENOY, SK; YU, CA; YU, L				CHEN, YR; SHENOY, SK; YU, CA; YU, L			IDENTIFICATION OF AMINO-ACID-RESIDUES INVOLVED IN STRUCTURAL AND UBIQUINONE-BINDING FUNCTIONS OF SUBUNIT-IV OF THE CYTOCHROME BC(1) COMPLEX FROM RHODOBACTER-SPHAEROIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; PURIFICATION; R-26	Previous studies established that subunit IV of the cytochrome bc(1) complex from Rhodobacter sphaeroides is involved in structural and ubiquinone-binding functions of the complex, To identify regions or amino acid residues responsible for these functions, deletion, insertion, and substitution mutations at various regions of subunit IV were generated and characterized, Mutational effects on the structural role of subunit IV are indicated by a delay in photosynthetic growth and by a decrease in the cytochrome bc(1) complex activity in chromatophores upon detergent treatment, An effect on the ubiquinone-binding function of subunit IV is suggested by an increase in the apparent K-m for 2,3-dimethoxy-5-methyl-6-geranyl-1,4-benzoquinol (Q(2)H(2)) of the complex, RSIV Delta(2-5), in which residues 2-5 are deleted, had photosynthetic growth behavior, tolerance to detergent treatment, and an apparent K-m for Q(2)H(2) of its cytochrome be, complex similar to those of wild-type or complement cells, indicating that amino acid residues 2-5 are not essential for subunit IV function, RSIV Delta(2-11), with residues 2-11 missing, showed a 24-h delay in pho tosynthetic growth and a 65% inactivation of the cytochrome bc(1) complex upon dodecyl maltoside solubilization, However, its apparent K-m for Q(2)H(2) was the same as in wild-type cells, indicating that deletion of amino acid residues 6-11 results in loss of the structural but not the ubiquinone-binding function of subunit IV. RSIV Delta(113-124), which has 13 amino acid residues deleted from the C terminus, had photosynthetic growth behavior, tolerance to detergent treatment, and ubiquinone-binding kinetics similar to those of wild-type or complement cells, indicating that residues 113-124 are not essential, Point mutants RSIV(W79L) and RSIV(W79F), in which tryptophan 79 was replaced with leucine or phenylalanine, showed a 24-h delay in photosynthetic growth, a decrease of 75% of the cytochrome bc(1) complex activity in chromatophores upon detergent solubilization, and a 4-fold increase in the apparent K-m for Q(2)H(2), indicating that Trp-79 is essential for the structural and ubiquinone-binding functions of subunit IV.			CHEN, YR (corresponding author), OKLAHOMA STATE UNIV,DEPT BIOCHEM & MOLEC BIOL,STILLWATER,OK 74078, USA.		Shenoy, Sudha/AAN-4075-2021	Shenoy, Sudha/0000-0002-2565-4663				ANDREWS KM, 1990, BIOCHEMISTRY-US, V29, P2645, DOI 10.1021/bi00463a004; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; CHEN YR, 1994, BIOCHEMISTRY-US, V33, P10207, DOI 10.1021/bi00199a050; Cramer W.A., 1990, ENERGY TRANSDUCTION; DEISENHOFER J, 1989, SCIENCE, V245, P1463, DOI 10.1126/science.245.4925.1463; DONOHUE TJ, 1988, BIOCHEMISTRY-US, V27, P1918, DOI 10.1021/bi00406a018; GENNIS RB, 1993, J BIOENERG BIOMEMBR, V25, P195, DOI 10.1007/BF00762582; KIRAUCIUNAS A, 1989, BIOCHIM BIOPHYS ACTA, V976, P70; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LJUNGDAHL O, 1987, BIOCHIM BIOPHYS ACTA, V891, P227; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PURVIS DJ, 1990, J BIOL CHEM, V265, P1208; Sambrook J, 1989, MOL CLONING LABORATO; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; USUI S, 1991, J BIOL CHEM, V266, P15644; WU J, 1995, BIOCHEM J, V305, P823, DOI 10.1042/bj3050823; YANG X, 1988, J BIOL CHEM, V261, P12282; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; YU L, 1984, J BIOL CHEM, V259, P5752; YU L, 1991, BIOCHEMISTRY-US, V30, P4934, DOI 10.1021/bi00234a014; YU L, 1987, BIOCHEMISTRY-US, V26, P3658, DOI 10.1021/bi00386a060; YU L, 1986, BIOCHIM BIOPHYS ACTA, V852, P203, DOI 10.1016/0005-2728(86)90225-2; ZHU Y S, 1985, Journal of Bacteriology, V162, P925	23	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11496	11501		10.1074/jbc.270.19.11496	http://dx.doi.org/10.1074/jbc.270.19.11496			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744789	hybrid			2022-12-27	WOS:A1995QX86500068
J	ISAMBERT, H; VENIER, P; MAGGS, AC; FATTOUM, A; KASSAB, R; PANTALONI, D; CARLIER, MF				ISAMBERT, H; VENIER, P; MAGGS, AC; FATTOUM, A; KASSAB, R; PANTALONI, D; CARLIER, MF			FLEXIBILITY OF ACTIN-FILAMENTS DERIVED FROM THERMAL FLUCTUATIONS - EFFECT OF BOUND NUCLEOTIDE, PHALLOIDIN, AND MUSCLE REGULATORY PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; F-ACTIN; ATP-ACTIN; THIN-FILAMENTS; SKELETAL-MUSCLE; ADP-ACTIN; MYOSIN SUBFRAGMENT-1; STRUCTURAL BASIS; CROSS-LINKING; POLYMERIZATION	Single actin filaments undergoing brownian movement in two dimensions were observed at 20 degrees C in fluorescence optical video microscopy, The persistence length (L(p)) was derived from the analysis of either the cosine correlation function or the average transverse fluctuations of a series of recorded shapes of filaments assembled from rhodamine actin. Phalloidin-stabilized filaments had a persistence length of 18 +/- 1 mu m, in agreement with recent observations, In the absence of phalloidin, rhodamine-labeled filaments could be observed under a variety of solution conditions once diluted in free unlabeled G-actin at the appropriate critical concentration. Such nonstabilized F-ADP-actin filaments had the same L(p) of 9 +/- 0.5 mu m, whether they had been assembled from ATP-G-actin or from ADP-G-actin, and independently of the tightly bound divalent metal ion, In the presence of BeF3-, which mimics the gamma-phosphate of ATP, F-ADP-BeF3-actin was appreciably more rigid, with L(p) = 13.5 mu m. Hence, newly formed F-ADP-P-i-actin filaments are more rigid than ''old'' F-ADP-actin filaments, a fact which has implications in actin-based motility processes. In the presence of skeletal tropomyosin and troponin, filaments were rigid (L(p) = 20 +/- 1 mu m) in the off state (-Ca2+), and flexible (L(p) = 12 mu m) in the on state (+Ca2+), consistent with the steric blocking model, In agreement with x-ray diffraction data, no appreciable difference was recorded between the off and on states using smooth muscle tropomyosin and caldesmon (L(p) 20 +/- 1 mu m). In conclusion, this method allows accurate measurement of small (less than or equal to 15%) changes in mechanical properties of actin filaments in correlation with their biological functions.	CNRS,ENZYMOL LAB,F-91198 GIF SUR YVETTE,FRANCE; CTR RECH BIOCHIM MACROMOLEC,F-34033 MONTPELLIER,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	ISAMBERT, H (corresponding author), ECOLE SUPER PHYS & CHIM IND VILLE PARIS,PHYSICOCHIM THEOR GRP,10 RUE VAUQUELIN,F-75005 PARIS,FRANCE.							BAILEY K, 1948, BIOCHEM J, V43, P271, DOI 10.1042/bj0430271; BARLACU S, 1992, AM J PHYSIOL, V262, pC569; BARTEGI A, 1990, J BIOL CHEM, V265, P2231; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; BREMER A, 1991, J CELL BIOL, V115, P689, DOI 10.1083/jcb.115.3.689; BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617; BRETSCHER A, 1984, J BIOL CHEM, V259, P2873; Carlier Marie-France, 1994, Seminars in Cell Biology, V5, P183, DOI 10.1006/scel.1994.1023; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1985, J BIOL CHEM, V260, P6565; CARLIER MF, 1988, J BIOL CHEM, V263, P817; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; COMBEAU C, 1989, J BIOL CHEM, V264, P19017; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8; Doi M., 1988, THEORY POLYM DYNAMIC; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; EGELMAN EH, 1991, J MOL BIOL, V217, P405, DOI 10.1016/0022-2836(91)90743-P; EISENBERG E, 1974, J BIOL CHEM, V249, P4742; ELSON EL, 1988, ANNU REV BIOPHYS BIO, V17, P397; FARGE E, 1993, MACROMOLECULES, V26, P5041, DOI 10.1021/ma00071a009; Fujime S, 1972, Adv Biophys, V3, P1; GERSHMAN LC, 1987, ANN NY ACAD SCI, V438, P264; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; HANSON J, 1973, PROC R SOC SER B-BIO, V183, P39, DOI 10.1098/rspb.1973.0003; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; HIBBERD MG, 1986, ANNU REV BIOPHYS BIO, V15, P119; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; ISHIWATA S, 1972, J MOL BIOL, V68, P511, DOI 10.1016/0022-2836(72)90103-9; JANMEY PA, 1990, NATURE, V347, P95, DOI 10.1038/347095a0; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JANMEY PA, 1988, BIOCHEMISTRY-US, V27, P8218, DOI 10.1021/bi00421a035; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KAES J, 1993, EUROPHYS LETT, V21, P865; KELLOGG DR, 1988, DEVELOPMENT, V103, P675; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; KRESS M, 1986, J MOL BIOL, V188, P325, DOI 10.1016/0022-2836(86)90158-0; LANDAU LD, 1980, STATISTICAL PHYSIC 1; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; LEPAULT J, 1994, J STRUCT BIOL, V112, P79, DOI 10.1006/jsbi.1994.1009; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MARSTON SB, 1993, J BIOL CHEM, V268, P12317; MARTONOSI A, 1960, J BIOL CHEM, V235, P1700; MCLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18; MENETRET JF, 1991, J MOL BIOL, V219, P139, DOI 10.1016/0022-2836(91)90554-J; MOOS C, 1967, BIOCHIM BIOPHYS ACTA, V147, P536, DOI 10.1016/0005-2795(67)90013-X; NEWMAN J, 1993, BIOPHYS J, V64, P1559, DOI 10.1016/S0006-3495(93)81525-X; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; OTT A, 1994, PHYS REV, V48, P1642; PANTALONI D, 1984, J BIOL CHEM, V259, P6274; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; PICKENBROCK T, 1992, BIOPOLYMERS, V32, P1471; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; POPP D, 1992, J MOL BIOL, V224, P65, DOI 10.1016/0022-2836(92)90576-6; Popp D., 1991, Advances in Biophysics, V27, P89, DOI 10.1016/0065-227X(91)90010-B; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; ROGERS DF, MATH ELEMENTS COMPUT, pCH5; SAFER D, 1994, BIOESSAYS, V7, P473; SCHMIDT CF, 1989, MACROMOLECULES, V22, P3638, DOI 10.1021/ma00199a023; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TAKEBAYASHI T, 1977, BIOCHIM BIOPHYS ACTA, V492, P357, DOI 10.1016/0005-2795(77)90086-1; TIRION MM, 1993, J MOL BIOL, V230, P186, DOI 10.1006/jmbi.1993.1135; VALENTINRANC C, 1991, J BIOL CHEM, V266, P7668; VALENTINRANC C, 1991, J BIOL CHEM, V266, P17872; VENIER P, 1994, J BIOL CHEM, V269, P13353; VIBERT P, 1993, J CELL BIOL, V123, P313, DOI 10.1083/jcb.123.2.313; WAKABAYASHI K, 1985, BIOPHYS J, V47, P847, DOI 10.1016/S0006-3495(85)83989-8; YANAGIDA T, 1978, J MOL BIOL, V126, P507, DOI 10.1016/0022-2836(78)90056-6	77	453	458	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11437	11444		10.1074/jbc.270.19.11437	http://dx.doi.org/10.1074/jbc.270.19.11437			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744781	hybrid			2022-12-27	WOS:A1995QX86500060
J	FUTTER, CE; CONNOLLY, CN; CUTLER, DF; HOPKINS, CR				FUTTER, CE; CONNOLLY, CN; CUTLER, DF; HOPKINS, CR			NEWLY SYNTHESIZED TRANSFERRIN RECEPTORS CAN BE DETECTED IN THE ENDOSOME BEFORE THEY APPEAR ON THE CELL-SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC-LIKE MICROVESICLES; CYTOPLASMIC DOMAIN; GOLGI-COMPLEX; MDCK CELLS; INTERNALIZATION; EFFICIENT; SIGNAL; ENDOCYTOSIS; MOTIF; SITE	It is well established that a proportion of newly synthesized lysosomal enzymes and class II major histocompatibility complex antigens are delivered directly to the endocytic pathway from the Golgi complex. Here we show that a significant proportion of newly synthesized transferrin receptors can be detected in endosomes before reaching the cell surface. These newly synthesized transferrin receptors are delivered to the endosome more efficiently than either constitutively secreted soluble proteins or glycophosphatidylinositol-anchored plasma membrane proteins suggesting that their transfer to the endosome is signal-dependent. Identification of a signal-dependent transfer step for proteins like the transferrin receptor operating on the exocytic pathway has important implications for membrane biogenesis, especially in the establishment of cell surface polarity.	UCL, MRC, MOLEC CELL BIOL LAB, LONDON WC1E 6BQ, ENGLAND; UCL, DEPT BIOL, LONDON WC1E 6BQ, ENGLAND	University of London; University College London; University of London; University College London				Cutler, Daniel/0000-0002-4288-7530; Connolly, Christopher/0000-0002-0445-8874; Futter, Clare/0000-0001-5559-9389				BAUERFEIND R, 1993, NEURON, V11, P105, DOI 10.1016/0896-6273(93)90275-V; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; CHANG ACY, 1988, FOCUS, V10, P66; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; DARGEMONT C, 1993, EMBO J, V12, P1713, DOI 10.1002/j.1460-2075.1993.tb05816.x; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FUTTER CE, 1989, J CELL SCI, V94, P685; GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HALL J, 1990, J BIOL CHEM, V265, P19996; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MCGRAW TE, 1991, J CELL BIOL, V112, P853, DOI 10.1083/jcb.112.5.853; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; STOORVOGEL W, 1988, J CELL BIOL, V106, P1821, DOI 10.1083/jcb.106.6.1821; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TROWBRIDGE IS, 1981, P NATL ACAD SCI-BIOL, V78, P3039, DOI 10.1073/pnas.78.5.3039; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021	26	151	156	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10999	11003		10.1074/jbc.270.18.10999	http://dx.doi.org/10.1074/jbc.270.18.10999			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738042	hybrid			2022-12-27	WOS:A1995QW60100091
J	RUMSEY, SC; GALEANO, NF; LIPSCHITZ, B; DECKELBAUM, RJ				RUMSEY, SC; GALEANO, NF; LIPSCHITZ, B; DECKELBAUM, RJ			OLEATE AND OTHER LONG-CHAIN FATTY-ACIDS STIMULATE LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVITY BY ENHANCING ACYL-COENZYME A-CHOLESTEROL ACYLTRANSFERASE ACTIVITY AND ALTERING INTRACELLULAR REGULATORY CHOLESTEROL POOLS IN CULTURED-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEP G2 CELLS; MOUSE PERITONEAL-MACROPHAGES; RAT-LIVER MICROSOMES; HMG-COA REDUCTASE; DIETARY-FAT; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; ESTER ACCUMULATION; MONONUCLEAR-CELLS; HUMAN-FIBROBLASTS; J774 MACROPHAGES	Modification of dietary fatty acid composition results in changes in plasma cholesterol levels in man. We examined the effect of in vitro fatty acid supplementation on low density lipoprotein (LDL) receptor activity in cultured cells and questioned whether changes were related to fatty acid-induced alterations in acyl-CoA: cholesterol acyltransferase (ACAT) activity, Preincubation of cultured cells (i.e, human skin fibroblasts, J774 macrophages, and HepG2 cells) with oleic acid (oleic acid:bovine serum albumin molar ratio 2:1) at 37 degrees C for longer than 2 h resulted in a 1.2- to 1.5-fold increase in LDL cell binding at 4 degrees C and LDL cell degradation at 37 degrees C, Scatchard analysis showed that oleic acid increased LDL receptor number but not LDL affinity (K-d). Fatty acid supplementation of J774 macrophages increased both LDL receptor activity and cholesteryl ester accumulation, The ACAT inhibitor, 58-035, eliminated both effects, and increased ACAT activity preceded stimulation of LDL receptor activity by 1-2 h, Supplementation of macrophages with triolein emulsion particles also increased LDL cell binding and degradation, and addition of cholesterol to the emulsions abolished this effect. Among fatty acids tested, oleate (18:1), arachidonate (20:4), and eicosapentanoate (20:5) demonstrated the greatest effects, We hypothesize that certain fatty acids delivered to cells either in free form, or as triglyceride, first increase cellular ACAT activity, which then causes a decrease in an intracellular free cholesterol pool, signaling a need for increased LDL receptor activity. This mechanism may play a role in the effect of certain dietary fatty acids on LDL metabolism in vivo.	COLUMBIA UNIV,DEPT PEDIAT,NEW YORK,NY 10032; COLUMBIA UNIV,INST HUMAN NUTR,NEW YORK,NY 10032	Columbia University; Columbia University					NHLBI NIH HHS [HL 21006, HL 40404] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL021006, R01HL040404] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUWERX JH, 1989, P NATL ACAD SCI USA, V86, P1133, DOI 10.1073/pnas.86.4.1133; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BERRY EM, 1991, AM J CLIN NUTR, V53, P899, DOI 10.1093/ajcn/53.4.899; BIHAIN BE, 1989, J BIOL CHEM, V264, P17316; BIHAIN BE, 1992, BIOCHEMISTRY-US, V13, P4628; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHATTERJEE S, 1993, J BIOL CHEM, V268, P3401; DAUMERIE CM, 1992, P NATL ACAD SCI USA, V89, P10797, DOI 10.1073/pnas.89.22.10797; DIXON JL, 1991, J BIOL CHEM, V266, P5080; FIELD FJ, 1987, J LIPID RES, V28, P50; FREEMAN DA, 1992, J LIPID RES, V33, P1139; FURUKAWA S, 1992, J BIOL CHEM, V267, P22630; GAVIGAN SJP, 1981, BIOCHIM BIOPHYS ACTA, V665, P632, DOI 10.1016/0005-2760(81)90283-6; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOODMAN DS, 1964, J BIOL CHEM, V239, P1335; GRUNDY SM, 1990, J LIPID RES, V31, P1149; HAMANAKA R, 1992, J BIOL CHEM, V267, P13160; HASHIMOTO S, 1978, BIOCHEM BIOPH RES CO, V82, P1111, DOI 10.1016/0006-291X(78)90302-9; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HAYES KC, 1992, FASEB J, V6, P2600, DOI 10.1096/fasebj.6.8.1592210; HEGSTED DM, 1993, AM J CLIN NUTR, V57, P875, DOI 10.1093/ajcn/57.6.875; HEGSTED DM, 1965, AM J CLIN NUTR, V17, P281; JOHNSON MR, 1983, ARTERIOSCLEROSIS, V8, P242; KEYS A, 1957, LANCET, V1, P66; KUO P, 1990, ARTERIOSCLEROSIS, V10, P111, DOI 10.1161/01.ATV.10.1.111; KUO P, 1990, BIOCHEMISTRY-US, V29, P6626, DOI 10.1021/bi00480a011; KUO PC, 1989, ARTERIOSCLEROSIS, V9, P919, DOI 10.1161/01.ATV.9.6.919; LOSCALZO J, 1987, ARTERIOSCLEROSIS, V7, P450, DOI 10.1161/01.ATV.7.5.450; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATHUR SN, 1983, BIOCHIM BIOPHYS ACTA, V751, P401, DOI 10.1016/0005-2760(83)90299-0; MATTSON FH, 1985, J LIPID RES, V26, P194; MCCLOSKEY HM, 1988, BIOCHIM BIOPHYS ACTA, V963, P456, DOI 10.1016/0005-2760(88)90314-1; MENSINK RP, 1989, NEW ENGL J MED, V321, P436, DOI 10.1056/NEJM198908173210705; MITROPOULOS KA, 1980, BIOCHIM BIOPHYS ACTA, V619, P247, DOI 10.1016/0005-2760(80)90073-9; ONTKO JA, 1972, J BIOL CHEM, V247, P1788; ROTH M, 1991, P NATL ACAD SCI USA, V88, P1888, DOI 10.1073/pnas.88.5.1888; RUDLING M, 1992, J LIPID RES, V33, P493; RUSTAN AC, 1988, J BIOL CHEM, V263, P8126; SCHWIEGELSHOHN B, 1995, J BIOL CHEM, V270, P1761, DOI 10.1074/jbc.270.4.1761; SHARKEY MF, 1990, J LIPID RES, V31, P2167; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI [10.1146/annurev.nutr.13.1.355, 10.1146/annurev.nu.13.070193.002035]; SPADY DK, 1990, J LIPID RES, V31, P1809; SPECTOR AA, 1979, J LIPID RES, V20, P536; SPECTOR AA, 1980, J LIPID RES, V21, P169; TABAS I, 1991, J CELL BIOL, V115, P1547, DOI 10.1083/jcb.115.6.1547; TABAS I, 1988, J BIOL CHEM, V263, P1266; TABAS I, 1987, J CLIN INVEST, V79, P418, DOI 10.1172/JCI112828; TABAS I, 1985, P NATL ACAD SCI USA, V82, P416, DOI 10.1073/pnas.82.2.416; TAM SP, 1991, J BIOL CHEM, V266, P16764; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; WONG S, 1987, ATHEROSCLEROSIS, V64, P139, DOI 10.1016/0021-9150(87)90239-5; WOOLLETT LA, 1992, J LIPID RES, V33, P77; WOOLLETT LA, 1992, J CLIN INVEST, V89, P1133, DOI 10.1172/JCI115694; XU XX, 1991, J BIOL CHEM, V266, P24849	56	73	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10008	10016		10.1074/jbc.270.17.10008	http://dx.doi.org/10.1074/jbc.270.17.10008			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730302	hybrid			2022-12-27	WOS:A1995QV41700047
J	TAKAGI, Y; NINOMIYA, H; SAKAMOTO, A; MIWA, S; MASAKI, T				TAKAGI, Y; NINOMIYA, H; SAKAMOTO, A; MIWA, S; MASAKI, T			STRUCTURAL BASIS OF G-PROTEIN SPECIFICITY OF HUMAN ENDOTHELIN RECEPTORS - A STUDY WITH ENDOTHELIN(A/B) CHIMERAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING PROTEINS; SIGNAL-TRANSDUCTION; LIGAND-BINDING; SUBTYPES; DOMAINS; CLONING; CELLS; CDNA; EXPRESSION; DELINEATION	The endothelin (ET) family of peptides acts via two subtypes of guanine nucleotide-binding regulatory protein (G protein) coupled receptors termed ET(A) and ET(B). ET-1 stimulated cAMP formation in Chinese hamster ovary (CHO) cells stably expressing human wild-type ET(A) (CHO/hET(A) cells) while it inhibited cAMP formation in CHO cells expressing human wild-type ET(B) (CHO/hET(B) cells), and pharmacological evidence indicated that the opposite effects were due to the selective coupling of each receptor subtype with G alpha s/G alpha i. To find out a receptor domain(s) that determined the selective coupling, a series of chimeric receptors between hET(A) and hET(B) was expressed on CHO cells, and the effect of ET-1 on cAMP formation in each cell line was tested. hET(A) with the replacement of second and/or third intracellular loop (ICLII and/or -III) to the corresponding region(s) of hET(B) failed to transmit the stimulatory effect of ET-1. hET(B) with the replacement of ICLIII to the corresponding region of hET(A) failed to transmit the inhibitory effect of ET-1. A chimeric receptor with ICLII of hET(B) and with ICLIII of hET(A) failed to transmit both effects. In cells expressing chimeric receptors with ICLII of hET(A) and with ICLIII of hET(B), ET-1 inhibited cAMP formation while it stimulated cAMP formation when cells were pretreated with pertussis toxin. These results indicated the roles of ICLII and -III of hETR as a major determinant of the selective coupling of hET(A) and hET(B) with G alpha s/G alpha i, respectively. We also demonstrated that each receptor subtype expressed on the same cell could work independently, i.e. for hET(A) to activate G alpha s and for hET(B) to activate G alpha i, resulting in dose dependent dual effects of ET-1 on cAMP formation.	KYOTO UNIV,FAC MED,DEPT PHARMACOL,KYOTO 606,JAPAN	Kyoto University			Miwa, Soichi/D-8468-2012	Takagi, Yasutaka/0000-0002-5787-0379				ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; ARAMORI I, 1992, J BIOL CHEM, V267, P12468; BONNER TI, 1992, TRENDS PHARMACOL SCI, V13, P48, DOI 10.1016/0165-6147(92)90021-W; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; EGUCHI S, 1993, ENDOCRINOLOGY, V132, P524, DOI 10.1210/en.132.2.524; HASHIDO K, 1993, CELL MOL BIOL RES, V39, P3; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; JAMES AF, 1994, NATURE, V370, P297, DOI 10.1038/370297a0; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; LIN WW, 1993, MOL PHARMACOL, V44, P158; MIHARA S, 1993, J PHARMACOL EXP THER, V268, P1122; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; ODA K, 1992, FEBS LETT, V299, P187, DOI 10.1016/0014-5793(92)80244-B; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; ONO K, 1994, NATURE, V370, P301, DOI 10.1038/370301a0; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SAKAMOTO A, 1991, BIOCHEM BIOPH RES CO, V178, P656, DOI 10.1016/0006-291X(91)90158-4; SAKAMOTO A, 1993, J BIOL CHEM, V268, P8547; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; STRADER CD, 1987, J BIOL CHEM, V262, P16439; TAKUWA N, 1989, J BIOL CHEM, V264, P7856; WESS J, 1990, MOL PHARMACOL, V38, P517; WONG SKF, 1990, J BIOL CHEM, V265, P6219; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	32	79	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10072	10078		10.1074/jbc.270.17.10072	http://dx.doi.org/10.1074/jbc.270.17.10072			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730310				2022-12-27	WOS:A1995QV41700055
J	KOUNNAS, MZ; LOUKINOVA, EB; STEFANSSON, S; HARMONY, JAK; BREWER, BH; STRICKLAND, DK; ARGRAVES, WS				KOUNNAS, MZ; LOUKINOVA, EB; STEFANSSON, S; HARMONY, JAK; BREWER, BH; STRICKLAND, DK; ARGRAVES, WS			IDENTIFICATION OF GLYCOPROTEIN-330 AS AN ENDOCYTIC RECEPTOR FOR APOLIPOPROTEIN-J/CLUSTERIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ATTACK-COMPLEX; ALPHA-2-MACROGLOBULIN RECEPTOR; SULFATED GLYCOPROTEIN-2; HEYMANN NEPHRITIS; DENSITY LIPOPROTEINS; MOLECULAR-CLONING; GENE-EXPRESSION; LDL RECEPTOR; TESTIS FLUID; PROTEIN	Glycoprotein 330 (gp330) is a member of a family of endocytic receptors related to the low density lipoprotein receptor. gp330 has previously been shown to bind a number of ligands in common with its family member, the low density Lipoprotein receptor-related protein (LRP). To identify ligands specific for gp330 and relevant to its localization on epithelia such as in the mammary gland, gp330-Sepharose affinity chromatography was performed. As a result, a 70-kDa protein was selected from human milk and identified by protein sequencing to be apolipoprotein J/clusterin (apoJ). Solid-phase binding assays confirmed that gp330 bound to aporJ with high affinity (K-d = 14.2 nM). Similarly, gp330 bound to apoJ transferred to nitrocellulose after SDS-polyacrylamide gel electrophoresis. LRP, however, showed no binding to apoJ in either type of assay. The binding of gp330 to apoJ could be competitively inhibited with excess apoJ as well as with the gp330 ligands apolipoprotein E, lipoprotein Lipase, and the receptor-associated protein, a 39-kDa protein that acts to antagonize binding of all known ligands for gp330 and LRP. Several cultured cell Lines that express gp330 and ones that do not express the receptor were examined for their ability to bind and internalize I-125-apoJ. Only cells that expressed gp330 endocytosed and degraded radiolabeled apoJ. Furthermore, F9 cells treated with retinoic acid and dibutyryl cyclic AMP to increase expression levels of gp330 displayed an increased capacity to internalize and degrade apoJ. Cellular internalization and degradation of radiolabeled apoJ could be inhibited with unlabeled apoJ, receptor-associated protein, and gp330 antibodies. The results indicate that gp330 but not LRP can bind to apoJ in vitro and that gp330 expressed by cells can mediate apoJ endocytosis leading to lysosomal degradation.	AMER RED CROSS,DEPT BIOCHEM,JH HOLLAND LAB,ROCKVILLE,MD 20855; UNIV CINCINNATI,COLL MED,DEPT PHARMACOL & CELL BIOPHYS,CINCINNATI,OH 45267; NHLBI,MOLEC DIS BRANCH,BETHESDA,MD 20892	American Red Cross; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042581] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41496] Funding Source: Medline; NIDDK NIH HHS [DK45598] Funding Source: Medline; NIGMS NIH HHS [GM42581] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BLASCHUK O, 1983, J BIOL CHEM, V258, P7714; BUTTYAN R, 1989, MOL CELL BIOL, V9, P3473, DOI 10.1128/MCB.9.8.3473; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; CHRISTENSEN EI, 1992, J HISTOCHEM CYTOCHEM, V40, P1481, DOI 10.1177/40.10.1382088; DESILVA HV, 1990, J BIOL CHEM, V265, P14292; DESILVA HV, 1990, J BIOL CHEM, V265, P13240; FRENCH LE, 1993, J CELL BIOL, V122, P1119, DOI 10.1083/jcb.122.5.1119; FRENCH LE, 1992, J CLIN INVEST, V90, P1919, DOI 10.1172/JCI116069; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; JAMES RW, 1991, ARTERIOSCLER THROMB, V11, P645, DOI 10.1161/01.ATV.11.3.645; JENNE DE, 1992, TRENDS BIOCHEM SCI, V17, P154, DOI 10.1016/0968-0004(92)90325-4; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; JOMARY C, 1993, MOL BRAIN RES, V20, P279, DOI 10.1016/0169-328X(93)90053-R; JONES SE, 1992, FEBS LETT, V6, P279; KELLY ME, 1994, CELL IMMUNOL, V159, P124, DOI 10.1006/cimm.1994.1302; KERJASCHKI D, 1987, J EXP MED, V166, P109, DOI 10.1084/jem.166.1.109; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; KIRSZBAUM L, 1989, EMBO J, V8, P711, DOI 10.1002/j.1460-2075.1989.tb03430.x; KORENBERG JR, 1994, GENOMICS, V22, P88, DOI 10.1006/geno.1994.1348; Kounnas M Z, 1994, In Vivo, V8, P343; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P21862; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; LASLOP A, 1993, J NEUROCHEM, V61, P1498, DOI 10.1111/j.1471-4159.1993.tb13645.x; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MOESTRUP SK, 1993, J BIOL CHEM, V268, P16564; MOESTRUP SK, 1993, J BIOL CHEM, V268, P13691; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murphy B F, 1989, Int Immunol, V1, P551, DOI 10.1093/intimm/1.5.551; ORLANDO RA, 1992, P NATL ACAD SCI USA, V89, P6698, DOI 10.1073/pnas.89.15.6698; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; SENSIBAR JA, 1993, BIOL REPROD, V49, P233, DOI 10.1095/biolreprod49.2.233; SITO A, 1994, P NATL ACAD SCI USA, V91, P9725; STRICKLAND DK, 1994, FIBRINOLYSIS, V8, P204, DOI 10.1016/0268-9499(94)90718-8; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; STUART WD, 1992, BIOCHEMISTRY-US, V31, P8553; SYLVESTER SR, 1991, BIOL REPROD, V45, P195, DOI 10.1095/biolreprod45.1.195; VAKEVA A, 1993, IMMUNOLOGY, V80, P177; WATTS MJ, 1990, BIOCHEM J, V265, P471, DOI 10.1042/bj2650471; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321	48	201	205	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13070	13075		10.1074/jbc.270.22.13070	http://dx.doi.org/10.1074/jbc.270.22.13070			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768901	hybrid			2022-12-27	WOS:A1995RB43900022
J	CULOUSCOU, JM; CARLTON, GW; ARUFFO, A				CULOUSCOU, JM; CARLTON, GW; ARUFFO, A			HER4 RECEPTOR ACTIVATION AND PHOSPHORYLATION OF SHC PROTEINS BY RECOMBINANT HEREGULIN-FC FUSION PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCTION; DIFFERENTIATION FACTOR; MAMMARY-TUMORS; EGF RECEPTOR; GRB2; RAS; MEMBER; ASSOCIATION	Heregulins (HRGs) are mosaic glycoproteins that bind to and induce the tyrosine phosphorylation of the HER4/p180(erbB4) receptor. This work was aimed at studying the biological effects induced by recombinant epidermal growth factor (EGF)-like domains of KRGs as well as identifying intracellular molecules involved in HERA signaling. To this end, we cloned the EGF-like domains of HRG-alpha, -beta 2, and -beta 3 into a eukaryotic expression vector in frame with sequences encoding a thrombin cleavage site followed by the Fc portion of a human IgG1. These chimeric genes directed the expression of recombinant fusion proteins, rHRGs-T-Fc, which specifically stimulated the phosphorylation of HER4/p180(erbB4). We also show that rHRG-alpha-T-Fc bound to human breast cancer cells that express HER4 receptors and induced the expression of intercellular adhesion molecule-1. After thrombin protease cleavage of rHRGs-T-Fc, their EGF-like domains were purified and shown to stimulate protein phosphorylation in HER4-expressing cells. Moreover, the rHRG-beta 2 EGF-like domain markedly induced the phosphorylation of She proteins on tyrosine, suggesting a role for these adaptor molecules in HRG-mediated signaling.			CULOUSCOU, JM (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST, 3005 1ST AVE, SEATTLE, WA 98121 USA.							BACUS SS, 1993, CANCER RES, V53, P5251; BLOMQUIST MC, 1984, P NATL ACAD SCI-BIOL, V81, P7363, DOI 10.1073/pnas.81.23.7363; BURNS LA, 1993, J BIOL CHEM, V268, P17659; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; CULOUSCOU JM, 1993, J BIOL CHEM, V268, P18407; CUTLER RL, 1993, J BIOL CHEM, V268, P21463; DAMEN JE, 1993, BLOOD, V82, P2296; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DUMONT DJ, 1993, ONCOGENE, V8, P1293; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SCHORB W, 1994, J BIOL CHEM, V269, P19626; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SEGATTO O, 1993, ONCOGENE, V8, P2105; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; WHITE MF, 1994, J BIOL CHEM, V269, P1; YOKOTE K, 1994, J BIOL CHEM, V269, P15337; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	41	27	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12857	12863		10.1074/jbc.270.21.12857	http://dx.doi.org/10.1074/jbc.270.21.12857			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759543	hybrid			2022-12-27	WOS:A1995QZ71100080
J	FENG, YH; NODA, K; SAAD, Y; LIU, XP; HUSAIN, A; KARNIK, SS				FENG, YH; NODA, K; SAAD, Y; LIU, XP; HUSAIN, A; KARNIK, SS			THE DOCKING OF ARG(2) OF ANGIOTENSIN-II WITH ASP(2) RECEPTOR IS ESSENTIAL FOR FULL AGONISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLONING; EXPRESSION; INHIBITION	The structural model of AT(1) angiotensin receptor contains seven-transmembrane alpha-helices with three interhelical loops on either side of the membrane. The angiotensin II binding pocket within the receptor is not clearly defined. We showed earlier that Lys(199) in transmembrane-helix-5 of the AT(1) receptor binds the COOH-terminal alpha-carboxyl group of angiotensin II (Node, Y., Saad, Y., Kinoshita, A., Boyle, T. P., Graham, R. M., Husain, A., and Karnik, S. S. (1995) J. Biol. Chem. 270, 2284-2289), We now show that His(183) Asp(281), both located in the extracellular domain of the AT(1) receptor, are involved in binding the NH2-terminal Asp(1) and Arg(2) residues of angiotensin II, respectively. The Asp(1)/His(183) interaction appears to be weak and is unlikely to be important for agonism, But the loss of Arg(2)/Asp(281) interaction leads to partial agonism of the receptor, The action of non-peptide agonists is not affected by Asp(281) mutations. These results suggest that several independent interactions between angiotensin II and AT(1) receptor are necessary for full agonism. Since L-162,313 the non-peptide agonist of the AT(1) receptor is a partial agonist that does not make contact with Asp(281), we speculate that the degree of agonism may be increased if it is redesigned to make contacts with Asp(281).			FENG, YH (corresponding author), CLEVELAND CLIN FDN,RES INST,DEPT MOLEC CARDIOL,9500 EUCLID AVE,CLEVELAND,OH 44195, USA.		Husain, Ahsan/J-6861-2012; Karnik, Sadashiva/Y-2477-2019	Husain, Ahsan/0000-0003-3426-3469; Karnik, Sadashiva/0000-0003-0746-2753	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL033713] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL33713, R01 HL057470] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BIHAREAU C, 1993, P NATL ACAD SCI USA, V90, P5133; BORDERS CL, 1994, PROTEIN SCI, V3, P541; BUMPUS FM, 1977, HYPERTENSION PHYSIOP, P183; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; HUCKLE WR, 1989, J BIOL CHEM, V264, P8619; HUSAIN A, 1986, J PHARMACOL EXP THER, V2339, P71; JO H, 1994, J BIOL CHEM, V269, P16533; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; KIVLIGHN SD, 1995, IN PRESS AM J PHARM; MARIE J, 1994, J BIOL CHEM, V269, P20815; MARSHALL GR, 1974, RECENT ADV RENAL PHY, P215; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; NODA K, 1994, J BIOL CHEM, V269, P6743; PERELMAN S, 1995, J BIOL CHEM, V270, P1493; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SCHAMBYE HT, 1994, P NATL ACAD SCI USA, V91, P7046, DOI 10.1073/pnas.91.15.7046; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Underwood D J, 1994, Chem Biol, V1, P211, DOI 10.1016/1074-5521(94)90013-2; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S	24	131	132	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12846	12850		10.1074/jbc.270.21.12846	http://dx.doi.org/10.1074/jbc.270.21.12846			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759541	hybrid			2022-12-27	WOS:A1995QZ71100078
J	JUZUMIENE, DI; SHAPKINA, TG; WOLLENZIEN, P				JUZUMIENE, DI; SHAPKINA, TG; WOLLENZIEN, P			DISTRIBUTION OF CROSS-LINKS BETWEEN MESSENGER-RNA ANALOGS AND 16-S RIBOSOMAL-RNA IN ESCHERICHIA-COLI 70-S RIBOSOMES MADE UNDER EQUILIBRIUM CONDITIONS AND THEIR RESPONSE TO TRANSFER-RNA BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA ANALOGS; DECODING SITE; CONSERVED LOOP; IDENTIFICATION; SUBUNIT; POSITIONS; COMPLEX; CROSSLINKING; STREPTOMYCIN; DERIVATIVES	The interaction between mRNA and Escherichia coli ribosomes has been studied by photochemical crosslinking using mRNA analogues that contain 4-thiouridine (s(4)U) or s(4)U modified with azidophenylacyl bromide (APAB), either two nucleotides upstream or eight nucleotides downstream from the nucleotide sequence ACC, the codon for tRNA(Thr). The sequences of the mRNA analogues were described earlier (Stade, K, Rinke-Appel, J., and Brimacombe, R (1989) Nucleic Acids Res. 17, 9889-9908; Rinke-Appel, J., Stade, K., and Brimacombe, R. (1991) EMBO J, 10, 2195-2202), Under equilibrium conditions, both of these mRNA analogues bind and cross-link to 70 S ribosomes without the presence of tRNA(Thr); however, there are significant increases both in binding and particularly in cross-linking in the presence of the tRNA(Thr). Four regions contain cross-linking sites that increase in the presence of tRNA, C-1395, A(532) A(1196) (and minor sites around these three positions), and C-1539/U-1532. Three other cross-linking sites, U-723, A(845), and U-1381, show very little change in extent of crosslinking when tRNA is present. A conformational change in the 30 S subunit allowing additional accessibility to the 16 S rRNA by the mRNA analogues upon tRNA binding best explains the behavior of the tRNA-dependent and tRNA-independent mRNA-16 S rRNA cross-linking sites.	N CAROLINA STATE UNIV, DEPT BIOCHEM, RALEIGH, NC 27695 USA	University of North Carolina; North Carolina State University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043237] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43237] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER RW, 1994, BIOCHEMISTRY-US, V33, P12109, DOI 10.1021/bi00206a014; BARTA A, 1984, P NATL ACAD SCI-BIOL, V81, P3607, DOI 10.1073/pnas.81.12.3607; BHANGU R, 1992, BIOCHEMISTRY-US, V31, P5937, DOI 10.1021/bi00140a033; BHANGU R, 1994, BIOCHEMISTRY-US, V33, P3063, DOI 10.1021/bi00176a040; CAPEL MS, 1988, J MOL BIOL, V200, P65, DOI 10.1016/0022-2836(88)90334-8; COOPERMAN BS, 1980, RIBOSOMES STRUCTURE, P531; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; DONTSOVA O, 1992, EMBO J, V11, P3105, DOI 10.1002/j.1460-2075.1992.tb05383.x; DONTSOVA O, 1991, EMBO J, V10, P2613, DOI 10.1002/j.1460-2075.1991.tb07803.x; DRAGON F, 1993, NUCLEIC ACIDS RES, V21, P1199, DOI 10.1093/nar/21.5.1199; England T E, 1980, Methods Enzymol, V65, P65; GAUTHIER A, 1988, MOL GEN GENET, V214, P192, DOI 10.1007/BF00337710; GORNICKI P, 1984, J BIOL CHEM, V259, P493; GREUER B, 1987, NUCLEIC ACIDS RES, V15, P3241, DOI 10.1093/nar/15.8.3241; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3051, DOI 10.1093/nar/21.13.3051; HUTTENHOFER A, 1994, EMBO J, V13, P3892, DOI 10.1002/j.1460-2075.1994.tb06700.x; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; INOUE H, 1987, FEBS LETT, V215, P327, DOI 10.1016/0014-5793(87)80171-0; ISAACS ST, 1977, BIOCHEMISTRY-US, V16, P1058, DOI 10.1021/bi00625a005; KATUNIN VI, 1980, NUCLEIC ACIDS RES, V8, P403, DOI 10.1093/nar/8.2.403; KRZYZOSIAK W, 1987, BIOCHEMISTRY-US, V26, P2353, DOI 10.1021/bi00382a042; LAEMAIGREDUBREU.Y, 1991, NUCLEIC ACIDS RES, V19, P3653; LIM V, 1992, NUCLEIC ACIDS RES, V20, P2627, DOI 10.1093/nar/20.11.2627; LIN FL, 1984, J MOL BIOL, V172, P77, DOI 10.1016/0022-2836(84)90415-7; MELANCON P, 1988, NUCLEIC ACIDS RES, V16, P9631, DOI 10.1093/nar/16.20.9631; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; Ofengand J, 1977, Methods Enzymol, V46, P683; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; POWERS T, 1993, P NATL ACAD SCI USA, V90, P1364, DOI 10.1073/pnas.90.4.1364; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; POWERS T, 1994, J MOL BIOL, V235, P156, DOI 10.1016/S0022-2836(05)80023-3; PRINCE JB, 1982, P NATL ACAD SCI-BIOL, V79, P5450, DOI 10.1073/pnas.79.18.5450; RAMAKRISHNAN V, 1992, NATURE, V358, P768, DOI 10.1038/358768a0; RINKEAPPEL J, 1993, NUCLEIC ACIDS RES, V21, P2853, DOI 10.1093/nar/21.12.2853; RINKEAPPEL J, 1991, EMBO J, V10, P2195, DOI 10.1002/j.1460-2075.1991.tb07755.x; SANTER M, 1993, BIOCHEMISTRY-US, V32, P5539, DOI 10.1021/bi00072a007; SHATSKY IN, 1991, BIOCHIMIE, V73, P937, DOI 10.1016/0300-9084(91)90135-N; STADE K, 1989, NUCLEIC ACIDS RES, V17, P9889, DOI 10.1093/nar/17.23.9889; STERN S, 1988, METHOD ENZYMOL, V164, P481; STERN S, 1988, J MOL BIOL, V204, P447, DOI 10.1016/0022-2836(88)90588-8; STOEFFLER G, 1984, STRUCTURE FUNCTION G, P28; SYLVERS LA, 1992, BIOCHIMIE, V74, P381, DOI 10.1016/0300-9084(92)90116-V; TANNER NK, 1988, BIOCHEMISTRY-US, V27, P8852, DOI 10.1021/bi00424a025; VARTIKAR JV, 1989, J MOL BIOL, V209, P221, DOI 10.1016/0022-2836(89)90274-X; VLADIMIROV SN, 1990, BIOCHIM BIOPHYS ACTA, V1048, P245, DOI 10.1016/0167-4781(90)90063-8; WELLER J, 1994, J BIOL CHEM, V269, P19369; WOLLENZIEN PL, 1988, METHOD ENZYMOL, V164, P319; WOWER J, 1989, P NATL ACAD SCI USA, V86, P5232, DOI 10.1073/pnas.86.14.5232	48	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12794	12800		10.1074/jbc.270.21.12794	http://dx.doi.org/10.1074/jbc.270.21.12794			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759534	hybrid			2022-12-27	WOS:A1995QZ71100071
J	VATER, CA; BARTLE, LM; LESZYK, JD; LAMBERT, JM; GOLDMACHER, VS				VATER, CA; BARTLE, LM; LESZYK, JD; LAMBERT, JM; GOLDMACHER, VS			RICIN-A CHAIN CAN BE CHEMICALLY CROSS-LINKED TO THE MAMMALIAN RIBOSOMAL-PROTEINS L9 AND L10E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSIDASE ACTIVITY; ESCHERICHIA-COLI RIBOSOME; RNA IDENTITY ELEMENTS; A-CHAIN; EUKARYOTIC RIBOSOMES; TOXIC LECTINS; RAT-LIVER; MECHANISM; SEQUENCE; SITE	Indirect immunofluorescence studies revealed that when fixed, permeabilized cultured human cells were incubated with ricin A chain, the toxin molecule localized in a staining pattern indicative of binding to the endoplasmic reticulum and to nucleoli. Chemical crosslinking experiments were performed to identify the cellular components that mediated the binding of ricin A chain. Conjugates were formed between I-125-labeled ricin A chain and two proteins present in preparations of total cell membranes and in samples of purified mammalian ribosomes, Specificity of the ricin A chain-ribosome interaction was demonstrated by inhibition of formation of the complexes by excess unlabeled ricin A chain, but not by excess unlabeled gelonin, another ribosome-inactivating protein. Complexes of ricin A chain cross-linked to the ribosomal proteins were purified and subjected to proteolytic digestion with trypsin. Amino acid sequencing of internal tryptic peptides enabled identification of the ricin A chain-binding proteins as L9 and L10e of the mammalian large ribosomal subunit.	WORCESTER FDN EXPTL BIOL INC, CORE LAB PROT CHEM, SHREWSBURY, MA 01545 USA	Worcester Foundation for Biomedical Research	VATER, CA (corresponding author), IMMUNOGEN INC, CAMBRIDGE, MA 02139 USA.							BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; CAWLEY DB, 1979, BIOCHEMISTRY-US, V18, P2648, DOI 10.1021/bi00579a034; ENDO Y, 1988, BIOCHEM BIOPH RES CO, V150, P1032, DOI 10.1016/0006-291X(88)90733-4; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; ENDO Y, 1991, J MOL BIOL, V221, P193, DOI 10.1016/0022-2836(91)90814-M; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; FERNANDEZPUENTES C, 1976, EUR J BIOCHEM, V64, P437, DOI 10.1111/j.1432-1033.1976.tb10320.x; FOXWELL BMJ, 1985, BIOCHIM BIOPHYS ACTA, V840, P193, DOI 10.1016/0304-4165(85)90119-9; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUKUI Y, 1987, METHOD CELL BIOL, V28, P347; GLUCK A, 1992, J MOL BIOL, V226, P411, DOI 10.1016/0022-2836(92)90956-K; GOLDEN BL, 1993, EMBO J, V12, P4901, DOI 10.1002/j.1460-2075.1993.tb06184.x; HAMEL E, 1972, J BIOL CHEM, V247, P805; HARDESTY B, 1971, METHOD ENZYMOL, V20, P316; HEDBLOM ML, 1978, J SUPRAMOL STR CELL, V9, P253, DOI 10.1002/jss.400090210; HOLMBERG L, 1994, BIOCHEMISTRY-US, V33, P15159, DOI 10.1021/bi00254a027; HORI N, 1993, NUCLEIC ACIDS RES, V21, P4395, DOI 10.1093/nar/21.18.4395; IPPOLITI R, 1992, FEBS LETT, V298, P145, DOI 10.1016/0014-5793(92)80042-F; JOHNSON VG, 1991, INTRACELLULAR TRAFFI, P183; JONES DGL, 1991, NUCLEIC ACIDS RES, V19, P5785, DOI 10.1093/nar/19.20.5785; KAETZEL CS, 1987, BIOCHEM J, V241, P39, DOI 10.1042/bj2410039; KISCHA K, 1971, NATURE-NEW BIOL, V233, P62, DOI 10.1038/newbio233062a0; KROWCZYNSKA AM, 1989, NUCLEIC ACIDS RES, V17, P6408, DOI 10.1093/nar/17.15.6408; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB FI, 1985, EUR J BIOCHEM, V148, P265, DOI 10.1111/j.1432-1033.1985.tb08834.x; LAMBERT JM, 1981, J MOL BIOL, V149, P451, DOI 10.1016/0022-2836(81)90481-2; LARSON DE, 1991, BIOCHEM CELL BIOL, V69, P5, DOI 10.1139/o91-002; MARTIN TE, 1969, J MOL BIOL, V43, P135, DOI 10.1016/0022-2836(69)90084-9; MARTIN TE, 1971, METHOD ENZYMOL, V20, P417; MITSUI K, 1988, NUCLEIC ACIDS RES, V16, P3573, DOI 10.1093/nar/16.8.3573; MONTANARO L, 1975, BIOCHEM J, V146, P127, DOI 10.1042/bj1460127; MONTANARO L, 1973, BIOCHEM J, V136, P677, DOI 10.1042/bj1360677; MONZINGO AF, 1992, J MOL BIOL, V227, P1136, DOI 10.1016/0022-2836(92)90526-P; NEWTON CH, 1990, J BACTERIOL, V172, P579, DOI 10.1128/jb.172.2.579-588.1990; NOLAN PA, 1993, GENE, V134, P223, DOI 10.1016/0378-1119(93)90097-M; NOLAN RD, 1976, EUR J BIOCHEM, V64, P69, DOI 10.1111/j.1432-1033.1976.tb10275.x; OLSNES S, 1973, MOL BIOL REP, V1, P15, DOI 10.1007/BF00357400; OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0; READY MP, 1991, PROTEINS, V10, P270, DOI 10.1002/prot.340100311; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; SANTOS C, 1994, J BIOL CHEM, V269, P15689; SCHRIER PI, 1973, BIOCHEM BIOPH RES CO, V53, P90, DOI 10.1016/0006-291X(73)91405-8; SHIMMIN LC, 1989, J MOL EVOL, V29, P448, DOI 10.1007/BF02602915; SKOLD SE, 1982, EUR J BIOCHEM, V127, P225, DOI 10.1111/j.1432-1033.1982.tb06859.x; SMITH A, 1989, BRIT J CANCER, V59, P174, DOI 10.1038/bjc.1989.36; Spedding G., 1990, RIBOSOMES PROTEIN SY; STOFFLER G, 1986, STRUCTURE FUNCTION G, P28; SUZUKI K, 1990, GENE, V93, P297, DOI 10.1016/0378-1119(90)90239-N; Traut R. R., 1986, STRUCTURE FUNCTION G, P286; TRAUT RR, 1983, J BIOL CHEM, V258, P4592; UCHIUMI T, 1986, EUR J BIOCHEM, V156, P37, DOI 10.1111/j.1432-1033.1986.tb09545.x; UCHIUMI T, 1992, J BIOL CHEM, V267, P19179; WALLECZEK J, 1988, EMBO J, V7, P3571, DOI 10.1002/j.1460-2075.1988.tb03234.x; WITTMANNLIEBOLD B, 1984, ADV PROTEIN CHEM, V36, P56; WOOL IG, 1991, BIOCHIMIE, V73, P861, DOI 10.1016/0300-9084(91)90127-M	57	50	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12933	12940		10.1074/jbc.270.21.12933	http://dx.doi.org/10.1074/jbc.270.21.12933			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759553				2022-12-27	WOS:A1995QZ71100091
J	WANG, J; AUGER, KR; JARVIS, L; SHI, Y; ROBERTS, TM				WANG, J; AUGER, KR; JARVIS, L; SHI, Y; ROBERTS, TM			DIRECT ASSOCIATION OF GRB2 WITH THE P85 SUBUNIT OF PHOSPHATIDYLINOSITOL 3-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; MIDDLE T-ANTIGEN; PHOSPHOINOSITIDE 3-KINASE; SIGNAL TRANSDUCTION; INTACT-CELLS; PROTEIN; TRANSFORMATION; POLYOMAVIRUS; ACTIVATION; BIND	Phosphatidylinositol 3-kinase (PI 3-kinase) has been shown to play a key role in growth factor signaling pathways, although its signaling mechanism has not been fully elucidated. Using the yeast interaction trap system, we have identified Grb2 as a PI 3-kinase interacting protein. Our experiments demonstrate that p85, the regulatory subunit of PI 3-kinase, interacts with Grb2 in vivo, and this interaction is independent of growth factor stimulation. The direct association between Grb2 and p85 was reconstituted in vitro with glutathione S-transferase fusion proteins. Domain analyses and peptide competition indicate that the association is mediated by the SH3 domains of Grb2 and the proline-rich motifs of p85 and that only one SH3 domain is required for minimal binding. The interaction does not displace the catalytic subunit of PI 3-kinase but is exclusive of Sos. Signaling through PI 3-kinase, therefore, may involve the ubiquitous adapter Grb2, which serves as a convergence point for multiple pathways.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT PATHOL,DIV CELL & MOLEC BIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School					NCI NIH HHS [CA30002] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA030002, R01CA030002] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUGER KR, 1989, J BIOL CHEM, V264, P20181; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; COUGHLIN SR, 1989, SCIENCE, V243, P1191; COURTNEIDGE SA, 1987, CELL, V50, P1031, DOI 10.1016/0092-8674(87)90169-3; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; EBERLE M, 1990, J BIOL CHEM, V265, P16725; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FUKUI Y, 1991, ONCOGENE, V6, P407; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; KAPLAN DR, 1986, P NATL ACAD SCI USA, V83, P3624, DOI 10.1073/pnas.83.11.3624; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; LING LE, 1992, J VIROL, V66, P1702, DOI 10.1128/JVI.66.3.1702-1708.1992; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MONFAR M, 1995, MOL CELL BIOL, V15, P326, DOI 10.1128/MCB.15.1.326; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PALLAS DC, 1988, J VIROL, V62, P3934, DOI 10.1128/JVI.62.11.3934-3940.1988; PARKER PJ, 1992, CELL GROWTH DIFFER, V3, P747; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; RODRIGUEZ VP, 1994, NATURE, V370, P527; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SCHLAEPFER DD, 1994, NATURE, V372, P786; SERUNIAN LA, 1990, J VIROL, V64, P4718, DOI 10.1128/JVI.64.10.4718-4725.1990; SEVERINSSON L, 1990, MOL CELL BIOL, V10, P801, DOI 10.1128/MCB.10.2.801; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; VEMURI GS, 1994, BIOCHEM BIOPH RES CO, V202, P1619, DOI 10.1006/bbrc.1994.2118; WELHAM MJ, 1994, J BIOL CHEM, V269, P23764; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; ZHANG J, 1993, J BIOL CHEM, V268, P22251; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	48	100	102	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12774	12780		10.1074/jbc.270.21.12774	http://dx.doi.org/10.1074/jbc.270.21.12774			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759531	hybrid			2022-12-27	WOS:A1995QZ71100068
J	ZHAO, ZZ; TAN, Z; WRIGHT, JH; DILTZ, CD; SHEN, SH; KREBS, EG; FISCHER, EH				ZHAO, ZZ; TAN, Z; WRIGHT, JH; DILTZ, CD; SHEN, SH; KREBS, EG; FISCHER, EH			ALTERED EXPRESSION OF PROTEIN-TYROSINE-PHOSPHATASE 2C IN 293 CELLS AFFECTS PROTEIN-TYROSINE PHOSPHORYLATION AND MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE; SRC HOMOLOGY-2 DOMAINS; CORKSCREW; SIGNAL; SYP	PTP2C, an SH2 domain-containing protein-tyrosine phosphatase, is recruited to the growth factor receptors upon stimulation of cells. To investigate its role in growth factor signaling, we have overexpressed by approximately 6-fold the native PTP2C and a catalytically inactive mutant of the enzyme in 293 human embryonic kidney cells. The native PTP2C was located entirely in the cytosol, while the inactive mutant was nearly equally distributed in cytosolic and membrane fractions. Expression of the latter caused hyperphosphorylation on tyrosine of a 43-kDa protein, which was coimmunoprecipitated and co-partitioned in the plasma membrane fraction with the inactive PTP2C mutant. This protein may represent a physiological substrate of PTP2C. Overexpression of the native PTP2C enhanced epidermal growth factor (EGF)-stimulated mitogen-activated protein (MAP) kinase kinase activity by 30%, whereas expression of the inactive mutant reduced the stimulated activity by 50%. Similar effects were observed for the activation of MAP kinase as determined by activity assay, gel mobility shift, and tyrosine phosphorylation. The data suggest that the phosphatase activity of PTP2C is partly required for MAP kinase activation by EGF and that PTP2C may function by dephosphorylating the 43-kDa membrane protein.	UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195; NATL RES COUNCIL CANADA,BIOTECHNOL RES INST,MONTREAL,PQ H4P 2R2,CANADA	University of Washington; University of Washington Seattle; National Research Council Canada	ZHAO, ZZ (corresponding author), UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM042508] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07902] Funding Source: Medline; NIGMS NIH HHS [GM42508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI M, 1992, FEBS LETT, V314, P335, DOI 10.1016/0014-5793(92)81500-L; AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BOUCHARD P, 1994, J BIOL CHEM, V269, P19585; CASE RD, 1994, J BIOL CHEM, V269, P10467; CRIMAUDO C, 1987, EMBO J, V6, P75, DOI 10.1002/j.1460-2075.1987.tb04721.x; DAUM G, 1993, ANAL BIOCHEM, V211, P50, DOI 10.1006/abio.1993.1231; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; PERALDI P, 1994, P NATL ACAD SCI USA, V91, P5002, DOI 10.1073/pnas.91.11.5002; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; SEGER R, 1994, J BIOL CHEM, V269, P25699; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664, DOI 10.1073/pnas.92.3.664; ZHAO ZH, 1993, P NATL ACAD SCI USA, V90, P4251, DOI 10.1073/pnas.90.9.4251; ZHAO ZZ, 1994, J BIOL CHEM, V269, P8780	28	83	85	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11765	11769		10.1074/jbc.270.20.11765	http://dx.doi.org/10.1074/jbc.270.20.11765			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744825	hybrid			2022-12-27	WOS:A1995QY73600017
J	ALTSCHULER, DL; PETERSON, SN; OSTROWSKI, MC; LAPETINA, EG				ALTSCHULER, DL; PETERSON, SN; OSTROWSKI, MC; LAPETINA, EG			CYCLIC-AMP-DEPENDENT ACTIVATION OF RAP1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GTP-BINDING PROTEINS; GDP/GTP EXCHANGE PROTEIN; BOVINE BRAIN CYTOSOL; SMG P21; SIGNAL TRANSDUCTION; MUTATIONAL ANALYSIS; MOLECULAR-CLONING; EFFECTOR DOMAIN; HUMAN-PLATELETS; KREV-1 PROTEIN	Rap1 proteins belong to the Ras superfamily of small molecular weight GTP-binding proteins. Although Rap1 and Pas share approximately 50% overall amino acid sequence identity, the effector domains of the two proteins are identical, suggesting either similar or antagonistic signaling roles. Several pathways leading to Ras activation have been defined, including those initiated by agonist binding to tyrosine kinase or G(i)-coupled receptors, Nothing is known about such events for Rap1 proteins. The cAMP-mediated inhibition of Ras-dependent MAP kinase activation is well documented and resembles that caused by expression of GTPase-deficient Rap1. We have developed a system whereby signals leading to Rap1b activation, i.e. an increase in Rap1b-bound GTP/GDP ratio, can be measured. We report here that treatment of cells with agents that elevate intracellular cAMP levels result in Rap1b activation, These results demonstrate for the first time agonist-dependent activation of Rap1 proteins.	BURROUGHS WELLCOME CO,DIV CELL BIOL,RES TRIANGLE PK,NC 27709; DUKE UNIV,MED CTR,DEPT MICROBIOL,DURHAM,NC 27710	Burroughs Wellcome Fund; Duke University			Ostrowski, Michael/H-3108-2011	Ostrowski, Michael/0000-0003-2948-6297	NCI NIH HHS [CA53271] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053271] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; BAIM SB, 1991, P NATL ACAD SCI USA, V88, P5072, DOI 10.1073/pnas.88.12.5072; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOKOCH GM, 1993, BIOCHEM J, V289, P17, DOI 10.1042/bj2890017; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; BUSS JE, 1991, MOL CELL BIOL, V11, P1523, DOI 10.1128/MCB.11.3.1523; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CAMPA MJ, 1991, BIOCHEM BIOPH RES CO, V174, P1, DOI 10.1016/0006-291X(91)90475-M; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; HARIHARAN IK, 1991, CELL, V67, P717, DOI 10.1016/0092-8674(91)90066-8; HATA Y, 1991, J BIOL CHEM, V266, P6571; HATA Y, 1990, J BIOL CHEM, V265, P7104; JELINEK MA, 1992, ONCOGENE, V7, P1687; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; KALEKO M, 1990, MOL CELL BIOL, V10, P464, DOI 10.1128/MCB.10.2.464; KAWATA M, 1990, P NATL ACAD SCI USA, V87, P8960, DOI 10.1073/pnas.87.22.8960; KAWATA M, 1989, J BIOL CHEM, V264, P15688; KIKUCHI A, 1989, J BIOL CHEM, V264, P9133; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; LAPETINA EG, 1989, P NATL ACAD SCI USA, V86, P3131, DOI 10.1073/pnas.86.9.3131; LEROSEY I, 1991, BIOCHEM BIOPH RES CO, V175, P430, DOI 10.1016/0006-291X(91)91582-W; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; NODA M, 1993, BIOCHIM BIOPHYS ACTA, V1155, P97, DOI 10.1016/0304-419X(93)90024-7; PASTAN IH, 1975, ANNU REV BIOCHEM, V44, P491, DOI 10.1146/annurev.bi.44.070175.002423; POLAKIS P, 1992, J BIOL CHEM, V267, P10780; POLAKIS PG, 1990, P NATL ACAD SCI USA, V88, P239; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; RUBINFELD B, 1992, MOL CELL BIOL, V12, P4634, DOI 10.1128/MCB.12.10.4634; SAKODA T, 1992, ONCOGENE, V7, P1705; SATOH T, 1992, J BIOL CHEM, V267, P24149; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; YATANI A, 1991, J BIOL CHEM, V266, P22222; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	45	118	119	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10373	10376		10.1074/jbc.270.18.10373	http://dx.doi.org/10.1074/jbc.270.18.10373			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737967	hybrid			2022-12-27	WOS:A1995QW60100004
J	MHAOUTY, S; COHEN-TANNOUDJI, J; BOUETALARD, R; LIMONBOULEZ, I; MALTIER, JP; LEGRAND, C				MHAOUTY, S; COHEN-TANNOUDJI, J; BOUETALARD, R; LIMONBOULEZ, I; MALTIER, JP; LEGRAND, C			CHARACTERISTICS OF THE ALPHA(2)/BETA(2)-ADRENERGIC RECEPTOR-COUPLED ADENYLYL-CYCLASE SYSTEM IN RAT MYOMETRIUM DURING PREGNANCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-2-ADRENERGIC RECEPTOR; HAMSTER OVARY CELLS; BETA-GAMMA-SUBUNITS; ADRENERGIC-RECEPTOR; ALPHA-2B-ADRENERGIC RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; MOLECULAR-CLONING; G-PROTEINS; EXPRESSION; SUBTYPES	alpha(2A)- and alpha(2B)-adrenoreceptors (AR), identified by Northern blotting in rat myometrium, showed a differential expression during the course of pregnancy, Indeed, the alpha(2A)-AR transcript was present at mid-pregnancy, whereas high levels of alpha(2B)-AR mRNA could be detected at term, The role of these subtypes in modulating beta(2)-AR-stimulated adenylyl cyclase activity was investigated on myometrial membranes from mid-pregnancy and term, At nanomolar concentrations of clonidine (full alpha(2)-AR agonist) or oxymetazoline (partial alpha(2A)-AR agonist), adenylyl cyclase activity was inhibited by up to 50 +/- 7% at mid-pregnancy or 75 +/- 7% at term, whereas at micromolar concentrations, alpha(2)-AR agonists potentiate adenylyl cyclase activity by 140-170% at midpregnancy, Both inhibitory and stimulatory components of this biphasic response were blocked by yohimbine, a selective alpha(2)-AR antagonist, Preincubation of myometrial membranes with G(i2) and/or G(i3) antisera eliminated alpha(2)-AR mediated attenuation or potentiation of isoproterenol stimulated adenylyl cyclase, thus indicating that both the inhibitory and stimulatory components are mediated via G(i2) and G(i3). In addition, type II and IV adenylyl cyclases were identified by Northern blotting in the pregnant rat myometrium, Altogether these data strongly suggest that the alpha(2A)-AR at mid-pregnancy potentiates adenylyl cyclase types II and IV through beta gamma released from G(i2) and G(i3) proteins, whereas the alpha(2B)-AR expression at term may be related to persistent inhibition.	UNIV PARIS 06, REPROD PHYSIOL LAB, CNRS, URA 1449, F-75230 PARIS 05, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite			Limon, Isabelle/AAJ-6169-2020; Limon, Isabelle/P-2750-2017	Limon, Isabelle/0000-0002-8773-6971; Limon, Isabelle/0000-0002-8773-6971; Mhaouty-Kodja, Sakina/0000-0001-9743-5243				BYLUND DB, 1992, MOL PHARMACOL, V42, P1; BYLUND DB, 1988, J PHARMACOL EXP THER, V245, P600; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COHEN-TANNOUDJI J, 1991, J MOL ENDOCRINOL, V6, P137, DOI 10.1677/jme.0.0060137; COHENTANNOUDJI J, 1995, IN PRESS BIOL REPROD, V182; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; COTECCHIA S, 1990, J BIOL CHEM, V265, P63; DUZIC E, 1992, J BIOL CHEM, V267, P24045; EASON MG, 1992, J BIOL CHEM, V267, P15795; ELWARDYMEREZAK J, 1994, J MOL ENDOCRINOL, V13, P23, DOI 10.1677/jme.0.0130023; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; FLORDELLIS CS, 1990, HYPERTENSION, V15, P881, DOI 10.1161/01.HYP.15.6.881; FLORDELLIS CS, 1991, P NATL ACAD SCI USA, V88, P1019, DOI 10.1073/pnas.88.3.1019; FRASER CM, 1989, J BIOL CHEM, V264, P11754; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; HANDY DE, 1993, HYPERTENSION, V21, P861, DOI 10.1161/01.HYP.21.6.861; HARRISON JK, 1991, MOL PHARMACOL, V40, P407; JONES SB, 1991, MOL PHARMACOL, V39, P239; JONES SB, 1988, J BIOL CHEM, V263, P14236; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; LANIER SM, 1991, J BIOL CHEM, V266, P10470; LEGRAND C, 1993, J PHARMACOL EXP THER, V266, P439; LEGRAND C, 1991, J PHARMACOL EXP THER, V256, P767; LEHBARCH H, 1977, BIOCHEMISTRY-US, V16, P473; LOMASNEY JW, 1991, BIOCHIM BIOPHYS ACTA, V1095, P127, DOI 10.1016/0167-4889(91)90075-9; LOMASNEY JW, 1990, P NATL ACAD SCI USA, V87, P5094, DOI 10.1073/pnas.87.13.5094; LORENZ W, 1990, MOL PHARMACOL, V38, P599; LUSTIG KD, 1993, J BIOL CHEM, V268, P13900; MALTIER JP, 1989, BIOL REPROD, V40, P531, DOI 10.1095/biolreprod40.3.531; Maniatis T., 1989, MOL CLONING LABORATO, P21; MARSHALL JM, 1981, AM J PHYSIOL, V240, pC165, DOI 10.1152/ajpcell.1981.240.5.C165; MORIMOTO BH, 1994, J BIOL CHEM, V269, P4065; OKAYAMA H, 1987, METHOD ENZYMOL, V154, P3; PAPKA RE, 1985, CELL TISSUE RES, V242, P475; PEPPERL DJ, 1993, MOL PHARMACOL, V44, P802; REGAN JW, 1988, P NATL ACAD SCI USA, V85, P6301, DOI 10.1073/pnas.85.17.6301; RUFFOLO RR, 1988, ALPHA 2 ADRENERGIC R, P187; TANFIN Z, 1991, FEBS LETT, V278, P4, DOI 10.1016/0014-5793(91)80070-J; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; VIVAT V, 1992, J BIOL CHEM, V267, P7975; VOIGT MM, 1991, FEBS LETT, V278, P45, DOI 10.1016/0014-5793(91)80080-M; WEINSHANK RL, 1990, MOL PHARMACOL, V38, P681; ZENG DW, 1990, P NATL ACAD SCI USA, V87, P3102, DOI 10.1073/pnas.87.8.3102	44	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					11012	11016		10.1074/jbc.270.18.11012	http://dx.doi.org/10.1074/jbc.270.18.11012			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738044	hybrid			2022-12-27	WOS:A1995QW60100093
J	PARDON, E; HAEZEBROUCK, P; DEBAETSELIER, A; HOOKE, SD; FANCOURT, KT; DESMET, J; DOBSON, CM; VANDAEL, H; JONIAU, M				PARDON, E; HAEZEBROUCK, P; DEBAETSELIER, A; HOOKE, SD; FANCOURT, KT; DESMET, J; DOBSON, CM; VANDAEL, H; JONIAU, M			A CA2+-BINDING CHIMERA OF HUMAN LYSOZYME AND BOVINE ALPHA-LACTALBUMIN THAT CAN FORM A MOLTEN GLOBULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION BINDING; NMR-SPECTROSCOPY; CHICKEN LYSOZYME; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL UNITS; STRUCTURAL UNITS; EXONS; EXCHANGE; STATE; SITE	In contrast to lysozymes, which undergo two-state thermal denaturation, the Ca2+-free form of the homologous alpha-lactalbumins forms an intermediate ''molten globule'' state, To understand this difference, we have produced a chimera of human lysozyme and bovine alpha-lactalbumin, In the synthetic gene of the former the sequence coding for amino acid residues 76-102 was replaced by that for bovine alpha-lactalbumin 72-97, which represents the Ca2+-binding loop and the central helix C, The chimeric protein, LYLA1, expressed in Saccharomyces cerevisiae was homogeneous on electrophoresis and mass spectrometry, Its Ca2+ binding constant was 2.50 (+/-0.04) x 10(8) M(-1), and its muramidase activity 10% of that of human lysozyme, One dimensional NMR spectroscopy indicated the presence of a compact, well structured protein, From two-dimensional NMR spectra, main chain resonances for 118 of a total of 129 residues could be readily assigned, Nuclear Overhauser effect analysis and hydrogen-deuterium exchange measurements indicated the presence and persistence of all expected secondary structure elements, Thermal denaturation, measured by circular dichroism, showed a single transition temperature for the Ca2+ form at 90 degrees C, whereas unfolding of the apo form occurred at 73 degrees C in the near-UV and 81 degrees C in the far-UV range. These observations illustrate that by transplanting the central part of bovine alpha-lactalbumin, we have introduced into human lysozyme two important properties of alpha-lactalbumins, i.e. stabilization through Ca2+ binding and molten globule behavior.	KATHOLIEKE UNIV LEUVEN,INTERDISCIPLINARY RES CTR,B-8500 KORTRIJK,BELGIUM; UNIV OXFORD,OXFORD CTR MOLEC SCI,NEW CHEM LAB,OXFORD OX1 3QT,ENGLAND; INNOGENET,B-9052 GHENT,BELGIUM	KU Leuven; University of Oxford; Innogenetics NV								ACHARYA KR, 1989, J MOL BIOL, V208, P99, DOI 10.1016/0022-2836(89)90091-0; ALEXANDRESCU AT, 1993, BIOCHEMISTRY-US, V32, P1707, DOI 10.1021/bi00058a003; ARTYMIUK PJ, 1981, J MOL BIOL, V152, P737, DOI 10.1016/0022-2836(81)90125-X; BARR PJ, 1987, J EXP MED, V165, P1160, DOI 10.1084/jem.165.4.1160; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLAKE CCF, 1979, NATURE, V277, P598, DOI 10.1038/277598a0; BREW K, 1967, J BIOL CHEM, V242, P3747; CANFIELD RE, 1971, NATURE-NEW BIOL, V232, P16, DOI 10.1038/newbio232016a0; CHIPMAN DM, 1967, J BIOL CHEM, V242, P4388; DEBAETSELIER A, 1989, Patent No. 89870140; DELHAISE P, 1984, J MOL GRAPHICS, V2, P103, DOI 10.1016/0263-7855(84)80002-8; DESMET J, 1987, BIOCHIM BIOPHYS ACTA, V912, P211, DOI 10.1016/0167-4838(87)90091-4; DESMET J, 1991, EUR BIOPHYS J BIOPHY, V20, P263, DOI 10.1007/BF00450561; DOBSON CM, 1991, CIBA F SYMP, V161, P167; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; ERHART E, 1983, J BACTERIOL, V156, P625, DOI 10.1128/JB.156.2.625-635.1983; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GO M, 1983, P NATL ACAD SCI-BIOL, V80, P1964, DOI 10.1073/pnas.80.7.1964; HAEZEBROUCK P, 1995, J MOL BIOL, V246, P382, DOI 10.1006/jmbi.1994.0093; HAEZEBROUCK P, 1993, PROTEIN ENG, V6, P643, DOI 10.1093/protein/6.6.643; HAEZEBROUCK P, 1992, BIOCHIM BIOPHYS ACTA, V1122, P305, DOI 10.1016/0167-4838(92)90409-7; HAYNIE DT, 1983, PROTEIN-STRUCT FUNCT, V16, P115; HOOKE SD, 1994, BIOCHEMISTRY-US, V33, P5867, DOI 10.1021/bi00185a026; IKEGUCHI M, 1986, BIOCHEMISTRY-US, V25, P6965, DOI 10.1021/bi00370a034; IKEGUCHI M, 1986, J BIOCHEM-TOKYO, V99, P1191, DOI 10.1093/oxfordjournals.jbchem.a135582; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JUNG A, 1980, P NATL ACAD SCI-BIOL, V77, P5759, DOI 10.1073/pnas.77.10.5759; KIKUCHI M, 1982, P NATL ACAD SCI USA, V85, P9411; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRONMAN MJ, 1989, CRIT REV BIOCHEM MOL, V24, P565, DOI 10.3109/10409238909080054; KUCHINKE W, 1989, BIOCHEM BIOPH RES CO, V159, P927, DOI 10.1016/0006-291X(89)92197-9; KUMAGAI I, 1992, P NATL ACAD SCI USA, V89, P5887, DOI 10.1073/pnas.89.13.5887; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; KUNKEL TA, 1985, P NATL ACAD SCI USA, V81, P4642; KUROKI R, 1989, P NATL ACAD SCI USA, V86, P6903, DOI 10.1073/pnas.86.18.6903; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; KUWAJIMA K, 1985, BIOCHEMISTRY-US, V24, P874, DOI 10.1021/bi00325a010; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; MURAKAMI K, 1982, BIOCHEMISTRY-US, V21, P5488, DOI 10.1021/bi00265a017; NITTA K, 1988, BIOL CHEM H-S, V369, P671, DOI 10.1515/bchm3.1988.369.2.671; NITTA K, 1989, EUR J BIOCHEM, V182, P111, DOI 10.1111/j.1432-1033.1989.tb14806.x; PENG ZY, 1994, BIOCHEMISTRY-US, V33, P2136, DOI 10.1021/bi00174a021; REDFIELD C, 1990, BIOCHEMISTRY-US, V29, P7201, DOI 10.1021/bi00483a007; SEGAWA T, 1983, J BIOCHEM-TOKYO, V93, P1321, DOI 10.1093/oxfordjournals.jbchem.a134266; SHEWALE JG, 1984, J BIOL CHEM, V259, P4947; SMITH SG, 1987, BIOCHEM J, V342, P353; STOLTZFUS A, 1994, SCIENCE, V265, P202, DOI 10.1126/science.8023140; STUART DI, 1986, NATURE, V324, P84, DOI 10.1038/324084a0; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; VANDAEL H, 1993, BIOCHEMISTRY-US, V32, P11886, DOI 10.1021/bi00095a018; VIAENE A, 1991, EUR J BIOCHEM, V202, P471, DOI 10.1111/j.1432-1033.1991.tb16396.x; VILOTTE JL, 1987, BIOCHIMIE, V69, P609, DOI 10.1016/0300-9084(87)90180-5; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K., 1986, NMR PROTEINS NUCL AC	56	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10514	10524		10.1074/jbc.270.18.10514	http://dx.doi.org/10.1074/jbc.270.18.10514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737986	hybrid			2022-12-27	WOS:A1995QW60100026
J	PENNICA, D; SHAW, KJ; SWANSON, TA; MOORE, MW; SHELTON, DL; ZIONCHECK, KA; ROSENTHAL, A; TAGA, T; PAONI, NF; WOOD, WI				PENNICA, D; SHAW, KJ; SWANSON, TA; MOORE, MW; SHELTON, DL; ZIONCHECK, KA; ROSENTHAL, A; TAGA, T; PAONI, NF; WOOD, WI			CARDIOTROPHIN-1 - BIOLOGICAL-ACTIVITIES AND BINDING TO THE LEUKEMIA INHIBITORY FACTOR-RECEPTOR GP130 SIGNALING COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; ADAPTIVE PHYSIOLOGICAL-RESPONSE; CARDIAC GENE-EXPRESSION; EMBRYONIC STEM-CELLS; CYTOKINE RECEPTORS; STIMULATING FACTOR; MOLECULAR-CLONING; FACTOR MAINTAINS; CNTF RECEPTOR; GROWTH-FACTOR	Cardiotrophin-1 (CT-1) is a newly isolated cytokine that was identified based on its ability to induce cardiac myocyte hypertrophy, It is a member of the family of cytokines that includes interleukins-6 and -11, leukemia inhibitory factor (LIF), ciliary neurotrophic factor, and oncostatin M, These cytokines induce a pleiotropic set of growth and differentiation activities via receptors that use a common signaling subunit, gp130. In this work we determine the activity of CT-1 in six in vitro biological assays and examine the composition of its cell surface receptor, We find that CT-1 is inactive in stimulating the growth of the hybridoma cell line, B9 and inhibits the growth of the mouse myeloid leukemia cell line, M1. CT-1 induces a phenotypic switch in rat sympathetic neurons and promotes the survival of rat dopaminergic and chick ciliary neurons. CT-1 also inhibits the differentiation of mouse embryonic stem cells. CT-1 and LIF cross-compete for binding to M1 cells, K-d [CT-1] similar to 0.7 nM, and this binding is inhibited by an anti-gp130 monoclonal antibody, Both ligands can be specifically crosslinked to a protein on M1 cells with the mobility of the LIF receptor (similar to 200 kDa), In addition, CT-1 binds directly to a purified, soluble form of the LIF receptor in solution K-d, similar to 211 nM). These data show that CT-1 has a wide range of hematopoietic, neuronal, and developmental activities and that it can act via the LIF receptor and the gp130 signaling subunit.	GENENTECH INC, DEPT BIOL MOLEC, San Francisco, CA 94080 USA; GENENTECH INC, DEPT CELL GENET, San Francisco, CA 94080 USA; GENENTECH INC, DEPT NEUROBIOL, San Francisco, CA 94080 USA; GENENTECH INC, DEPT IMMUNOL, San Francisco, CA 94080 USA; GENENTECH INC, DEPT CARDIOVASC BIOL, San Francisco, CA 94080 USA; OSAKA UNIV, INST MOLEC & CELLULAR BIOL, OSAKA 565, JAPAN	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Osaka University								AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; BAUMANN G, 1994, J CLIN ENDOCR METAB, V78, P1113, DOI 10.1210/jc.78.5.1113; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BRAUNWALD E, 1994, HEART DISEASE, P393; Bruce A. Gregory, 1992, Progress in Growth Factor Research, V4, P157, DOI 10.1016/0955-2235(92)90029-H; CHIEN KR, 1993, ANNU REV PHYSIOL, V55, P77, DOI 10.1146/annurev.ph.55.030193.000453; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; CHIEN KR, 1993, SCIENCE, V260, P916, DOI 10.1126/science.8493528; CONOVER JC, 1993, DEVELOPMENT, V119, P559; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; Davis S, 1993, CURR OPIN CELL BIOL, V5, P281, DOI 10.1016/0955-0674(93)90117-9; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; FONNUM F, 1969, BIOCHEM J, V115, P465, DOI 10.1042/bj1150465; GEARING DP, 1992, NEW BIOL, V4, P61; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GLADEK A, 1983, ARCH IMMUNOL THER EX, V31, P541; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; GREENLUND AC, 1993, J BIOL CHEM, V268, P18103; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; Hawrot E, 1979, Methods Enzymol, V58, P574; HILTON DJ, 1988, P NATL ACAD SCI USA, V85, P5971, DOI 10.1073/pnas.85.16.5971; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Ip Nancy Y., 1992, Progress in Growth Factor Research, V4, P139, DOI 10.1016/0955-2235(92)90028-G; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; KITAMURA T, 1994, TRENDS ENDOCRIN MET, V5, P8, DOI 10.1016/1043-2760(94)90115-5; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; LAYTON MJ, 1992, P NATL ACAD SCI USA, V89, P8616, DOI 10.1073/pnas.89.18.8616; LAYTON MJ, 1994, J BIOL CHEM, V269, P17048; LEUNG DW, 1992, NEURON, V8, P1045, DOI 10.1016/0896-6273(92)90126-X; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LIU JW, 1992, J BIOL CHEM, V267, P16763; LOWE DG, 1989, DNA-J MOLEC CELL BIO, V8, P351, DOI 10.1089/dna.1.1989.8.351; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MANTHORPE M, 1989, NERVE GROWTH FACTORS, V12, P31; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; METCALF D, 1989, P NATL ACAD SCI USA, V86, P5948, DOI 10.1073/pnas.86.15.5948; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MOSLEY B, 1994, CYTOKINE, V6, P554; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; PATTERSON PH, 1994, P NATL ACAD SCI USA, V91, P7833, DOI 10.1073/pnas.91.17.7833; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; RAO MS, 1993, J NEUROBIOL, V24, P215, DOI 10.1002/neu.480240208; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; RICHARDSON PM, 1994, PHARMACOL THERAPEUT, V63, P187, DOI 10.1016/0163-7258(94)90045-0; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; ROCKMAN HA, 1993, CIRCULATION, V87, P14; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; ROSE TM, 1994, CYTOKINE, V6, P48, DOI 10.1016/1043-4666(94)90007-8; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SAITO M, 1992, J IMMUNOL, V148, P4066; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SPORENO E, 1994, J BIOL CHEM, V269, P10991; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; TAGA T, 1992, FASEB J, V6, P3387, DOI 10.1096/fasebj.6.15.1334470; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79; TOMIDA M, 1994, J BIOCHEM-TOKYO, V115, P557, DOI 10.1093/oxfordjournals.jbchem.a124375; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WARD LD, 1994, J BIOL CHEM, V269, P23286; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; YIN TG, 1994, EXP HEMATOL, V22, P467; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	84	411	428	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10915	10922		10.1074/jbc.270.18.10915	http://dx.doi.org/10.1074/jbc.270.18.10915			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738033	hybrid			2022-12-27	WOS:A1995QW60100081
J	BROSS, P; JESPERSEN, C; JENSEN, TG; ANDRESEN, BS; KRISTENSEN, MJ; WINTER, V; NANDY, A; KRAUTLE, F; GHISLA, S; BOLUND, L; KIM, JJP; GREGERSEN, N				BROSS, P; JESPERSEN, C; JENSEN, TG; ANDRESEN, BS; KRISTENSEN, MJ; WINTER, V; NANDY, A; KRAUTLE, F; GHISLA, S; BOLUND, L; KIM, JJP; GREGERSEN, N			EFFECTS OF 2 MUTATIONS DETECTED IN MEDIUM-CHAIN ACYL-COA DEHYDROGENASE (MCAD)-DEFICIENT PATIENTS ON FOLDING, OLIGOMER ASSEMBLY, AND STABILITY OF MCAD ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A DEHYDROGENASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; ESCHERICHIA-COLI; ISOVALERYL-COENZYME; LIVER MITOCHONDRIA; MESSENGER-RNA; PROTEIN; DEFICIENCY	We have used expression of human medium chain acyl-CoA dehydrogenase (MCAD) in Escherichia coli as a model system for dissecting the molecular effects of two mutations detected in patients with MCAD deficiency, We demonstrate that the R28C mutation predominantly affects polypeptide folding. The amounts of active R28C mutant enzyme produced could be modulated between undetectable to 100% of the wild-type control by manipulating the level of available chaperonins and the growth temperature, For the prevalent K304E mutation, however, the amounts of active mutant enzyme could be modulated only in a range from undetectable to approximately 50% of the wild-type, and the as sembled mutant enzyme displayed a decreased thermal stability. Two artificially constructed mutants (R304Q and K304E/D346K) yielded clearly higher amounts of active MCAD enzyme than the K304E mutant but were also responsive to chaperonin co-overexpression and growth at low temperature. The thermal stability profile of the H304E/D346K double mutant was shifted to even lower temperatures than that of the K304E mutant, whereas that of the K804Q mutant was closely similar to the wild-type, Taken together, the results show that the K304E mutation affects (i) polypeptide folding due to elimination of the positively charged lysine and (ii) oligomer assembly and stability due to replacement of lysine 304 with the negatively charged glutamic acid.	AARHUS UNIV,INST HUMAN GENET,DK-8000 AARHUS C,DENMARK; MED COLL WISCONSIN,DEPT BIOCHEM,MILWAUKEE,WI 53226; UNIV KONSTANZ,FAC BIOL,W-7750 CONSTANCE,GERMANY	Aarhus University; Medical College of Wisconsin; University of Konstanz	BROSS, P (corresponding author), AARHUS UNIV HOSP,SKEJBY SYGEHUS,FAC HLTH SCI,CTR MED MOLEC BIOL,BRENDSTRUPGARDSVEJ,DK-8200 AARHUS N,DENMARK.		Bross, Peter/B-7219-2013; Andresen, Brage/D-2515-2012	Bross, Peter/0000-0001-9526-8525; Andresen, Brage/0000-0001-7488-3035				ANDRESEN BS, 1994, AM J HUM GENET, V54, P975; ANDRESEN BS, 1993, AM J HUM GENET, V53, P730; Beinert H., 1963, ENZYMES, P447; BROSS P, 1994, BIOCHEM MED METAB B, V52, P36, DOI 10.1006/bmmb.1994.1031; BROSS P, 1993, BIOCHIM BIOPHYS ACTA, V1182, P264, DOI 10.1016/0925-4439(93)90068-C; BROSS P, 1990, J BIOL CHEM, V265, P7116; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DURAN M, 1985, J PEDIATR-US, V107, P397, DOI 10.1016/S0022-3476(85)80514-X; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GORDON CL, 1994, J BIOL CHEM, V269, P27941; GORDON CL, 1994, GENETICS, V136, P427; GREGERSEN N, 1993, HUM HERED, V43, P342, DOI 10.1159/000154157; GREGERSEN N, 1991, HUM GENET, V86, P545; HALE DE, 1992, J PEDIATR-US, V121, P1, DOI 10.1016/S0022-3476(05)82532-6; HARTL FU, 1994, TRENDS BIOCHEM SCI, V19, P20, DOI 10.1016/0968-0004(94)90169-4; IAFOLLA AK, 1994, J PEDIATR-US, V124, P409, DOI 10.1016/S0022-3476(94)70363-9; INDO Y, 1991, GENOMICS, V111, P609; IZAI K, 1992, J BIOL CHEM, V267, P1027; JENSEN TG, 1995, IN PRESS HUM MUTAT; KELLY DP, 1987, P NATL ACAD SCI USA, V84, P4068, DOI 10.1073/pnas.84.12.4068; KELLY DP, 1990, P NATL ACAD SCI USA, V97, P9326; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; KOLVRAA S, 1982, CLIN CHIM ACTA, V126, P53, DOI 10.1016/0009-8981(82)90361-8; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUIPERS OP, 1991, NUCLEIC ACIDS RES, V19, P4558, DOI 10.1093/nar/19.16.4558; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; MATSUBARA Y, 1990, J CLIN INVEST, V85, P1058, DOI 10.1172/JCI114536; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; MATSUBARA Y, 1990, BIOCHEM BIOPH RES CO, V171, P498, DOI 10.1016/0006-291X(90)91421-N; MATSUBARA Y, 1987, J BIOL CHEM, V262, P10104; MATTHEWS BW, 1993, CURR OPIN STRUC BIOL, V3, P589, DOI 10.1016/0959-440X(93)90088-3; MITRAKI A, 1993, J BIOL CHEM, V268, P20071; NAITO E, 1990, J CLIN INVEST, V85, P1575, DOI 10.1172/JCI114607; NAITO E, 1989, J CLIN INVEST, V83, P1605, DOI 10.1172/JCI114058; SAIJO T, 1994, J BIOL CHEM, V269, P4401; Tanaka K., 1992, Human Mutation, V1, P271, DOI 10.1002/humu.1380010402; VANDYCK L, 1994, J BIOL CHEM, V269, P238; WILCKEN B, 1994, ARCH DIS CHILD, V70, P410, DOI 10.1136/adc.70.5.410; YOKOTA I, 1992, J BIOL CHEM, V267, P26004; YOKOTA I, 1990, J CLIN INVEST, V86, P100	42	75	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10284	10290		10.1074/jbc.270.17.10284	http://dx.doi.org/10.1074/jbc.270.17.10284			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730333	Green Published			2022-12-27	WOS:A1995QV41700082
J	CHU, W; BURNS, DK; SWERLICK, RA; PRESKY, DH				CHU, W; BURNS, DK; SWERLICK, RA; PRESKY, DH			IDENTIFICATION AND CHARACTERIZATION OF A NOVEL CYTOKINE-INDUCIBLE NUCLEAR-PROTEIN FROM HUMAN ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; DNA-BINDING ACTIVITY; PLASMINOGEN-ACTIVATOR INHIBITOR; FACTOR-ALPHA; GROWTH-FACTOR; TRANSCRIPTION FACTORS; LEUKOCYTE ADHESION; GENE-EXPRESSION; MESSENGER-RNA	Vascular endothelial cells undergo profound changes upon cellular activation including expression of a spectrum of cell activation-associated genes. These changes play important roles in many physiological and pathological events, By differential screening of a cDNA library prepared from interleukin-1 alpha and tumor necrosis factor-alpha-stimulated human dermal microvascular endothelial cells, we have identified a novel cytokine-inducible gene, designated as C-193, The compiled cDNA sequence of C-193 is 1901 base pairs long and shows no significant homology with any known gene sequence, Genomic DNA analysis revealed that C-193 is encoded by a single gene, which is conserved in different mammalian species. The C-193 gene was localized to human chromosome 10 by Southern blot analysis of somatic cell hybrids, Multiple AT-rich mRNA decay elements were identified in the 3'-untranslated region, C-193 mRNA expression was rapidly and transiently induced by treatment with interleukin-1 alpha or tumor necrosis factor-alpha, reached a peak of expression about 16 h post tumor necrosis factor-alpha stimulation, and the induction of C-193 was protein synthesis independent, Lipopolysaccharide and cycloheximide were also potent inducers of C-193 mRNA Therefore, C-193 represents a new addition to the primary response gene family, In vitro translation of C-193 yielded a 36-kDa protein product, consistent with the predicted open reading frame of 818 amino acids and a calculated molecular mass of 36 kDa for C-193 protein, The predicted protein sequence contains a basic amino acid cluster similar to a nuclear localization signal, four tandem repeats of ankyrin-like se quence, and multiple consensus protein phosphorylation sites, C-193 was engineered with a FLAG tag at its carboxyl terminus and transiently expressed in COS cells, Consistent with the presence of a putative nuclear localization signal, the C-193-FLAG protein was localized to the nucleus of transfected COS cells by indirect immunofluorescence microscopy, C-193-FLAG prepared in vitro was capable of binding DNA cellulose, These results indicate that C-193 protein may play an important role in endothelial cell activation.	HOFFMANN LA ROCHE INC,ROCHE RES CTR,DEPT INFLAMMAT AUTOIMMUNE DIS,NUTLEY,NJ 07110; EMORY UNIV,SCH MED,DEPT DERMATOL,ATLANTA,GA 30322	Roche Holding; Emory University			Swerlick, Robert/AAY-1998-2020	Swerlick, Robert/0000-0002-9802-4144				AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1990, SCIENCE, V242, P540; BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y; BLANK V, 1991, EMBO J, V13, P4159; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; CHU W, 1994, J IMMUNOL, V153, P4179; CHU W, 1994, EUR J BIOCHEM, V225, P695, DOI 10.1111/j.1432-1033.1994.00695.x; DAVIS N, 1991, SCIENCE, V253, P1268, DOI 10.1126/science.1891714; DEMARTIN E, 1993, EMBO J, V12, P2733; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GHERSA P, 1992, J BIOL CHEM, V267, P19226; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOPP TP, 1988, BIOTECHNOLOGY, V6, P1205; HUANG RP, 1994, BIOCHEM BIOPH RES CO, V200, P1271, DOI 10.1006/bbrc.1994.1588; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LARRICK JW, 1990, FASEB J, V4, P3215, DOI 10.1096/fasebj.4.14.2172061; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; MCMAHON SB, 1992, FASEB J, V6, P2707, DOI 10.1096/fasebj.6.9.1612295; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C; POLYANOVSKY OL, 1990, BIOESSAYS, V12, P205, DOI 10.1002/bies.950120503; PONGRATZ I, 1991, J BIOL CHEM, V266, P16813; RINGOLD GM, 1984, P NATL ACAD SCI-BIOL, V81, P3964, DOI 10.1073/pnas.81.13.3964; ROBINSON EA, 1989, P NATL ACAD SCI USA, V86, P1850, DOI 10.1073/pnas.86.6.1850; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sambrook J, 1989, MOL CLONING LABORATO; SAWDEY M, 1989, J BIOL CHEM, V264, P10396; SCARPATI EM, 1989, J BIOL CHEM, V264, P20705; SCHLEEF RR, 1988, J BIOL CHEM, V263, P5797; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; SWERLICK RA, 1993, J INVEST DERMATOL, V100, pS111, DOI 10.1111/1523-1747.ep12356595; SWERLICK RA, 1992, J IMMUNOL, V148, P78; TEWARI M, 1992, MOL CELL BIOL, V12, P2898, DOI 10.1128/MCB.12.6.2898; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WOLF FW, 1992, J BIOL CHEM, V267, P1317	57	94	104	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10236	10245		10.1074/jbc.270.17.10236	http://dx.doi.org/10.1074/jbc.270.17.10236			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730328	hybrid			2022-12-27	WOS:A1995QV41700076
J	ROTHENBERG, ME; EILERTSON, CD; KLEIN, K; ZHOU, Y; LINDBERG, I; MCDONALD, JK; MACKIN, RB; NOE, BD				ROTHENBERG, ME; EILERTSON, CD; KLEIN, K; ZHOU, Y; LINDBERG, I; MCDONALD, JK; MACKIN, RB; NOE, BD			PROCESSING OF MOUSE PROGLUCAGON BY RECOMBINANT PROHORMONE CONVERTASE-1 AND IMMUNOPURIFIED PROHORMONE CONVERTASE-2 IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; PROPROTEIN CONVERTASE; ENDOPROTEASE FAMILY; ESCHERICHIA-COLI; MESSENGER-RNAS; YEAST KEX2; PC2; FURIN; RAT; IDENTIFICATION	The mouse tumor cell line alpha TC1-6 was used as a model system to examine the post-translational processing of proglucagon. Determination of the mouse preproglucagon cDNA sequence and comparison with the published sequences of rat and human preproglucagons revealed nucleic acid homologies of 89.1 and 84%, respectively, and amino acid homologies of 94 and 89.4%, respectively. Immunohistochemical analyses with antibodies directed against PC2 and glucagon colocalized both the enzyme and substrate within the same secretory granules. PC1 was also immunolocalized in secretory gran granules. Cells were metabolically labeled with [H-3]tryptophan, and extracts were analyzed by reverse-phase high pressure liquid chromatography. Radioactive peptides with retention times identical to those of synthetic peptide standards were recovered and subjected to peptide mapping to verify their identities. To determine the potential role of PC1 and PC2 in proglucagon processing, H-3-labeled proglucagon was incubated in vitro with recombinant PC1 and/or immunopurified PC2. Both enzymes cleaved proglucagon to yield the major proglucagon fragment, glicentin, and oxyntomodulin, whereas only PC1 released glucagon-like peptide-I from the major proglucagon fragment. Neither PCI nor PC2 processed glucagon from proglucagon in vitro. These results suggest a potential role for PC1 and/or PC2 in cleaving several of the normal products, excluding glucagon, from the mouse proglucagon precursor.	EMORY UNIV, DEPT ANAT & CELL BIOL, ATLANTA, GA 30322 USA; LOUISIANA STATE UNIV, MED CTR, DEPT BIOCHEM & MOLEC BIOL, NEW ORLEANS, LA 70112 USA; CREIGHTON UNIV, DEPT BIOMED SCI, OMAHA, NE 68178 USA	Emory University; Louisiana State University System; Creighton University			Lindberg, Iris/Q-3825-2019		NIDA NIH HHS [R01 DA005084, R56 DA005084] Funding Source: Medline; NIDDK NIH HHS [DK 44986] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005084, R56DA005084] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDREWS PC, 1987, EXPERIENTIA, V43, P784, DOI 10.1007/BF01945356; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENNETT DL, 1992, J BIOL CHEM, V267, P15229; BLACHE P, 1994, FEBS LETT, V344, P65, DOI 10.1016/0014-5793(94)00371-8; BLOOMQUIST BT, 1991, MOL ENDOCRINOL, V5, P2014, DOI 10.1210/mend-5-12-2014; BRESLIN MB, 1993, J BIOL CHEM, V268, P27084; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; BRUBAKER PL, 1991, ADV EXP MED BIOL, V291, P143; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; DOCHERTY K, 1982, ANNU REV PHYSIOL, V44, P625, DOI 10.1146/annurev.ph.44.030182.003205; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; HAKES DJ, 1991, ENDOCRINOLOGY, V129, P3053, DOI 10.1210/endo-129-6-3053; HAN VKM, 1986, J NEUROSCI RES, V16, P97, DOI 10.1002/jnr.490160110; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; HOLST JJ, 1994, J BIOL CHEM, V269, P18827; HORIMOTO T, 1994, J VIROL, V68, P6074, DOI 10.1128/JVI.68.9.6074-6078.1994; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; KORNER J, 1991, P NATL ACAD SCI USA, V88, P6834, DOI 10.1073/pnas.88.15.6834; LIN KH, 1991, BIOTECHNIQUES, V11, P748; LINDBERG I, 1992, BIOCHEM BIOPH RES CO, V183, P1, DOI 10.1016/0006-291X(92)91599-L; LUI EY, 1990, ENDOCRINOLOGY, V126, P110, DOI 10.1210/endo-126-1-110; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; MACKIN RB, 1987, J BIOL CHEM, V262, P6453; MARCINKIEWICZ M, 1994, ENDOCRINOLOGY, V135, P1651, DOI 10.1210/en.135.4.1651; MARCINKIEWICZ M, 1993, P NATL ACAD SCI USA, V90, P4922, DOI 10.1073/pnas.90.11.4922; MARTENS GJM, 1994, P NATL ACAD SCI USA, V91, P5784, DOI 10.1073/pnas.91.13.5784; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MILGRAM SL, 1989, PEPTIDES, V10, P1013, DOI 10.1016/0196-9781(89)90184-8; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; NAGAMUNE H, 1995, ENDOCRINOLOGY, V136, P357, DOI 10.1210/en.136.1.357; NAKAGAWA T, 1993, J BIOCHEM-TOKYO, V113, P132, DOI 10.1093/oxfordjournals.jbchem.a124015; NAKAYAMA K, 1991, J BIOCHEM, V109, P803, DOI 10.1093/oxfordjournals.jbchem.a123461; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; NEERMANARBEZ M, 1994, BIOCHEM J, V300, P57, DOI 10.1042/bj3000057; NOE BD, 1986, PEPTIDES, V7, P331, DOI 10.1016/0196-9781(86)90232-9; ORCI L, 1994, J CELL BIOL, V126, P1149, DOI 10.1083/jcb.126.5.1149; ORSKOV C, 1992, DIABETOLOGIA, V35, P701; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; RINDLER M J, 1992, Current Opinion in Cell Biology, V4, P616, DOI 10.1016/0955-0674(92)90080-V; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; Sambrook J, 1989, MOL CLONING LABORATO; SEIDAH NG, 1992, MOL ENDOCRINOL, V6, P1559, DOI 10.1210/me.6.10.1559; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SHEN FS, 1993, J BIOL CHEM, V268, P24910; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TSUJI A, 1994, BIOCHEM BIOPH RES CO, V200, P943, DOI 10.1006/bbrc.1994.1541; TSUJI A, 1994, BIOCHEM BIOPH RES CO, V202, P1452, DOI 10.1006/bbrc.1994.2094; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378; YI Z, 1993, J BIOL CHEM, V268, P5615	59	57	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10136	10146		10.1074/jbc.270.17.10136	http://dx.doi.org/10.1074/jbc.270.17.10136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730317	hybrid			2022-12-27	WOS:A1995QV41700064
J	LAN, Y; LU, TF; LOVETT, PS; CREIGHTON, DJ				LAN, Y; LU, TF; LOVETT, PS; CREIGHTON, DJ			EVIDENCE FOR A (TRIOSEPHOSPHATE ISOMERASE-LIKE) CATALYTIC-LOOP NEAR THE ACTIVE-SITE OF GLYOXALASE-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TRIOSE-PHOSPHATE ISOMERASE; LIMITED PROTEOLYSIS; PSEUDOMONAS-PUTIDA; CLONING; INHIBITION; SEPARATION; PROTEINS; RESIDUE; GENE	The conformational mobility of glyoxalase I (Glx I) during catalysis has been probed using stable analogs of the enediol intermediate that forms along the reaction pathway: GSC(O)N(OH)R, where GS = glutathionyl and R = CH3 (1), C6H5 (2), C6H4Cl (3), or C6H4Br (4). For human erythrocyte Glx I, catalysis is unlikely to be coupled to major changes in protein secondary structure, as the circular dichroism spectrum of the enzyme (190-260 nm) is insensitive to saturating concentrations of either enediol analog or S-D-lactoylglutathione, the product of the Glx I reaction. However, a small conformational change is indicated by the fact that binding of enediol analog to the active site decreases intrinsic protein fluorescence by 11%, and protects the enzyme from proteolytic cleavage by Pronase E at the C-side of Ala-92 and Leu-93. In contrast, binding of S-D-lactoylglutathione does not affect protein fluorescence, and increases the rate of proteolytic cleavage by 1.5-fold. These observations are consistent with a model of catalysis in which a flexible peptide loop folds over and stabilizes the enediol intermediate bound to the active site. Indeed, a highly conserved sequence of amino acid residues is found near the proteolytic cleavage sites, for human Glx I (100-111) and Pseudomonas putida Glx I (93-105), that shows significant sequence homology to the ''catalytic loop'' of chicken muscle triosephosphate isomerase (TIM) (165-176). The active site base (Glu-165) of TIM, which catalyzes the proton transfer reaction during isomerization, corresponds in position to Glu-93 of P. putida Glx I, Consistent with a functional role for Glu-93, a mutant enzyme in which Glu-93 is replaced by Asp shows no detectable catalytic activity.	UNIV MARYLAND,DEPT CHEM & BIOCHEM,CHEM DYNAM LAB,BALTIMORE,MD 21228; UNIV MARYLAND,DEPT SCI BIOL,CHEM DYNAM LAB,BALTIMORE,MD 21228	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore								ARONSSON AC, 1979, ANAL BIOCHEM, V92, P390, DOI 10.1016/0003-2697(79)90676-6; CLARKE AR, 1986, NATURE, V324, P699, DOI 10.1038/324699a0; CREIGHTON DJ, 1988, MOL STRUCTURE ENERGE, V9, P353; DELAMARE S, 1972, BIOCHEM J, V129, P321, DOI 10.1042/bj1290321; DOOLITTLE RF, 1985, SCI AM, V253, P88, DOI 10.1038/scientificamerican1085-88; DUVALL EJ, 1987, J BACTERIOL, V169, P4235, DOI 10.1128/jb.169.9.4235-4241.1987; FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001; HAMILTON DS, 1992, J BIOL CHEM, V267, P24933; HARTMAN FC, 1971, BIOCHEMISTRY-US, V10, P146, DOI 10.1021/bi00777a021; KIM NS, 1993, J BIOL CHEM, V268, P11217; LO TWC, 1992, BIOCHEM PHARMACOL, V44, P2357, DOI 10.1016/0006-2952(92)90680-H; LU TF, 1994, GENE, V150, P93, DOI 10.1016/0378-1119(94)90864-8; Maniatis T., 1982, MOL CLONING; MILLER JC, 1971, BIOCHEM J, V123, P163, DOI 10.1042/bj1230163; MURTHY NSRK, 1994, J MED CHEM, V37, P2161, DOI 10.1021/jm00040a007; OTTESEN M, 1967, ANNU REV BIOCHEM, V36, P55, DOI 10.1146/annurev.bi.36.070167.000415; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; RAINES RT, 1986, BIOCHEMISTRY-US, V25, P7142, DOI 10.1021/bi00370a057; RANGANATHAN S, 1993, J BIOL CHEM, V268, P5661; RHEE H, 1987, BIOCHEM BIOPH RES CO, V147, P831, DOI 10.1016/0006-291X(87)91005-9; RICHARD JP, 1991, BIOCHEMISTRY-US, V30, P4581, DOI 10.1021/bi00232a031; ROSE IA, 1961, J BIOL CHEM, V236, P3086; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SELLIN S, 1982, BIOCHEMISTRY-US, V21, P4850, DOI 10.1021/bi00263a004; SUN AQ, 1993, J BIOL CHEM, V268, P26872; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; Vander Jagt D.L., 1989, GLUTATHIONE CHEM, P597; WINN SI, 1981, PHILOS T ROY SOC B, V293, P121, DOI 10.1098/rstb.1981.0066	28	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12957	12960		10.1074/jbc.270.22.12957	http://dx.doi.org/10.1074/jbc.270.22.12957			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768882	hybrid			2022-12-27	WOS:A1995RB43900003
J	DELEZAY, O; BAGHDIGUIAN, S; FANTINI, J				DELEZAY, O; BAGHDIGUIAN, S; FANTINI, J			THE DEVELOPMENT OF NA+-DEPENDENT GLUCOSE-TRANSPORT DURING DIFFERENTIATION OF AN INTESTINAL EPITHELIAL-CELL CLONE IS REGULATED BY PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HT29-D4 CELLS; LLC-PK1 CELLS; LINE; EXPRESSION; MONOLAYERS; MESSENGER	The sodium-dependent glucose transporter SGLT1 is expressed on the apical plasma membrane of fully differentiated enterocytes. Recently, we have found that the cotransport function appears gradually during the process of differentiation of the human intestinal epithelial cell clone HT-29-D4. However, the SGLT1 protein was detected in both undifferentiated and differentiated HT-29-D4 cells suggesting that sodium-glucose cotransport was dependent on post-translational events controlling the efficient targeting of the protein in the plasma membrane, In the present study, we have analyzed the molecular mechanisms controlling the functional expression of the SGLT1 protein during the course of HT-29-D4 differentiation. We show that the appearance of the cotransport function in the apical membrane is blocked by 1-5-isoquinolinesulfonyl)-2-methylpiperazine-HCl (H-7), a potent inhibitor of protein kinase C activity, Moreover, H-7 treatment was associated with an unability of HT-29-D4 cells to organize into a polarized monolayer of differentiated cells. Reciprocally, short term treatment (15 min) of undifferentiated cells by 0.1 mu M phorbol myristyl acetate resulted in the appearance of the cotransport function. In contrast, inhibition of cAMP and cGMP-dependent protein kinases by N-(2-guanidinoethyl)-5-isoquinolinesulfonamide-HCl did not prevent the development of sodium-glucose cotransport during the differentiation of HT-29-D4 cells. In addition, stimulation of cAMP dependent protein kinases by 8-Cl-cAMP did not induce the cotransport function in undifferentiated HT-29-D4 cells. By using immunogold labeling at the electron microscopy level, we demonstrated that phorbol myristyl acetate induced the redistribution of SGLT1 protein from intracellular sites to the plasma membrane. In conclusion, our data show that the appearance of a functional sodium-glucose cotransporter in HT-29-D4 cells is controlled, at least in part, by intracellular pathways regulated by the activity of protein kinase C.	FAC MED NORD,CNRS,URA 1455,F-13916 MARSEILLE 20,FRANCE; FAC MED NORD,INSERM,U270,F-13916 MARSEILLE 20,FRANCE; UNIV MONTPELLIER 3,CNRS,INRA,URA 1186,F-34032 MONTPELLIER,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Paul-Valery				Baghdiguian, Stephen/0000-0002-2992-9708; Fantini, Jacques/0000-0001-8653-5521				AMSLER K, 1982, AM J PHYSIOL, V242, pC94, DOI 10.1152/ajpcell.1982.242.1.C94; BRIGNONI M, 1993, EXP CELL RES, V205, P171, DOI 10.1006/excr.1993.1072; CITI S, 1992, J CELL BIOL, V117, P169, DOI 10.1083/jcb.117.1.169; COREY JL, 1994, J BIOL CHEM, V269, P14759; CUTZ E, 1989, NEW ENGL J MED, V230, P646; DELEZAY O, 1995, IN PRESS J CELL PHYS; FANTINI J, 1988, EUR J CELL BIOL, V46, P458; FANTINI J, 1989, J CELL PHYSIOL, V141, P126, DOI 10.1002/jcp.1041410119; FANTINI J, 1989, BIOL CELL, V65, P163, DOI 10.1016/0248-4900(89)90024-5; FANTINI J, 1990, EUR J CELL BIOL, V51, P110; FANTINI J, 1986, J CELL SCI, V83, P235; FANTINI J, 1992, CANCER J - FRANCE, V5, P78; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HIRAYAMA BA, 1992, BIOCHIM BIOPHYS ACTA, V1103, P37, DOI 10.1016/0005-2736(92)90054-P; KIMMICH GA, 1981, AM J PHYSIOL, V241, pC227, DOI 10.1152/ajpcell.1981.241.5.C227; LEE WS, 1994, J BIOL CHEM, V269, P12032; MCROBERTS JA, 1989, FUNCTIONAL EPITHELIA, P235; MOLITORIS BA, 1990, J CLIN INVEST, V85, P3, DOI 10.1172/JCI114427; PENG H, 1993, J CELL PHYSIOL, V154, P238, DOI 10.1002/jcp.1041540205; REMY L, 1984, VIRCHOWS ARCH B, V46, P297, DOI 10.1007/BF02890318; SMITH MW, 1992, EXP PHYSIOL, V77, P525, DOI 10.1113/expphysiol.1992.sp003616; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDENBOSCH L, 1991, BIOCHIM BIOPHYS ACTA, V1092, P244, DOI 10.1016/0167-4889(91)90163-R	23	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12536	12541		10.1074/jbc.270.21.12536	http://dx.doi.org/10.1074/jbc.270.21.12536			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759499				2022-12-27	WOS:A1995QZ71100034
J	TOLLET, P; HAMBERG, M; GUSTAFSSON, JA; MODE, A				TOLLET, P; HAMBERG, M; GUSTAFSSON, JA; MODE, A			GROWTH-HORMONE SIGNALING LEADING TO CYP2C12 GENE-EXPRESSION IN RAT HEPATOCYTES INVOLVES PHOSPHOLIPASE A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-SENSITIVE CYTOSOLIC PHOSPHOLIPASE-A2; ARACHIDONIC-ACID METABOLISM; MESSENGER-RNA EXPRESSION; TYROSINE KINASE-ACTIVITY; DNA-BINDING PROTEINS; MESANGIAL CELLS; NONCYCLOOXYGENASE METABOLITES; 3T3-F442A FIBROBLASTS; PRIMARY CULTURES; MAP KINASE	The expression of CYP2C12 is liver-specific and regulated at the transcriptional level by growth hormone (GH). In attempts to elucidate the nature of signaling molecules mediating the GH regulation of this gene in rat hepatocytes, a role for phospholipase A(2) (PLA(2)) as a transducer of GH-induced levels of P4502C12 mRNA was investigated. GH was shown to induce tyrosyl-phosphorylation of p42 and p44 microtubule-associated protein (MAP) kinases and to reduce the electrophoretic mobility of a 100-kDa protein, immunologically related to cPLA(2). These events were observed in parallel with GH-stimulated release of [H-3]arachidonic acid ([H-3]AA) from cellular phospholipids of rat hepatocytes labeled with [H-3]AA. These rapid effects of GH action, as well as the GH-induced expression of CYP2C12, were inhibited in cells treated with the tyrosine kinase inhibitor herbimycin A. Similarly, when the GH-induced liberation of [H-3]AA was blocked by the PLA(2) inhibitor mepacrine or the Ca2+ channel blocker verapamil, GH-induced accumulation of P4502C12 mRNA was absent. These results suggest a correlation between PLA(2) activity and GH regulation of the CYP2C12 gene. The inhibitory effect of mepacrine on GH induction of P4502C12 mRNA was reversed by AA addition, further supporting a role for eicosanoids in the regulation of CYP2C12. Finally, inhibitors of P45O-mediated AA metabolism, SKF-525A and ketoconazole as well as eicosatetraynoic acid, blocked the GH-mediated induction of P4502C12 mRNA, whereas more specific inhibitors of cyclooxygenase or lipoxygenase metabolism did not. Based on these results, we suggest that GH signaling in rat hepatocytes, leading to increased expression of CYP2C12, involves PLA(2) activation and subsequent P450-catalyzed formation of an active AA metabolite.	KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,S-17177 STOCKHOLM,SWEDEN; KAROLINSKA INST,DIV PHYSIOL CHEM 2,S-17177 STOCKHOLM,SWEDEN	Karolinska Institutet; Karolinska Institutet	TOLLET, P (corresponding author), HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT MED NUTR,F 60 NOVUM,S-14186 HUDDINGE,SWEDEN.			Hamberg, Mats/0000-0002-8910-7810				ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; AXELROD J, 1988, TRENDS NEUROSCI, V11, P117, DOI 10.1016/0166-2236(88)90157-9; BLACKWELL GJ, 1983, BRIT MED BULL, V39, P260, DOI 10.1093/oxfordjournals.bmb.a071830; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; BURCH RM, 1983, J PHARMACOL EXP THER, V227, P84; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; CAMPBELL GS, 1993, J BIOL CHEM, V268, P7427; CAPDEVILA JH, 1990, J BIOL CHEM, V265, P10865; CAPDEVILA JH, 1992, FASEB J, V6, P731, DOI 10.1096/fasebj.6.2.1537463; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FINBLOOM DS, 1994, MOL CELL BIOL, V14, P2113, DOI 10.1128/MCB.14.3.2113; FITZPATRICK FA, 1989, PHARMACOL REV, V40, P229; FORCE T, 1991, J BIOL CHEM, V266, P4295; FOSTER CM, 1988, BIOCHEMISTRY-US, V27, P326, DOI 10.1021/bi00401a049; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; GRASDALEN H, 1975, FEBS LETT, V60, P294, DOI 10.1016/0014-5793(75)80734-4; GRONICH JH, 1990, BIOCHEM J, V271, P37, DOI 10.1042/bj2710037; GRONICH JH, 1988, J BIOL CHEM, V263, P16645; GRONOWSKI AM, 1994, J BIOL CHEM, V269, P7874; HALIDAY EM, 1991, EMBO J, V10, P109, DOI 10.1002/j.1460-2075.1991.tb07926.x; HAMMARSTROM S, 1977, BIOCHIM BIOPHYS ACTA, V487, P517, DOI 10.1016/0005-2760(77)90221-1; HANDLER JA, 1990, J BIOL CHEM, V265, P3669; HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475; JURIVICH DA, 1994, P NATL ACAD SCI USA, V91, P2280, DOI 10.1073/pnas.91.6.2280; KAST R, 1993, J BIOL CHEM, V268, P16795; KOCAREK TA, 1993, MOL PHARMACOL, V43, P328; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEGRAVEREND C, 1992, MOL ENDOCRINOL, V6, P259, DOI 10.1210/me.6.2.259; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LIN LL, 1992, J BIOL CHEM, V267, P23451; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MATHEWS LS, 1989, J BIOL CHEM, V264, P9905; MCGIFF JC, 1981, ANNU REV PHARMACOL, V21, P479, DOI 10.1146/annurev.pa.21.040181.002403; MEYER DJ, 1994, J BIOL CHEM, V269, P4701; MODE A, 1989, J ENDOCRINOL, V120, P311, DOI 10.1677/joe.0.1200311; MOLLER C, 1992, J BIOL CHEM, V267, P23403; NAKAMURA T, 1992, EMBO J, V11, P4917, DOI 10.1002/j.1460-2075.1992.tb05598.x; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; NORSTEDT G, 1987, J ENDOCRINOL, V115, P135, DOI 10.1677/joe.0.1150135; PREISS J, 1986, J BIOL CHEM, V261, P8597; RAO GN, 1993, ONCOGENE, V8, P2759; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; RUI H, 1994, J BIOL CHEM, V269, P5364; SALARI H, 1984, PROSTA LEUKOTR MED, V13, P53, DOI 10.1016/0262-1746(84)90102-1; SATO N, 1994, CURR OPIN CELL BIOL, V6, P174, DOI 10.1016/0955-0674(94)90133-3; SATOH T, 1992, J BIOL CHEM, V267, P24149; SCHUETZ EG, 1988, J CELL PHYSIOL, V134, P309, DOI 10.1002/jcp.1041340302; SCHWARTZ Y, 1992, ENDOCRINOLOGY, V131, P772, DOI 10.1210/en.131.2.772; SCHWARTZ Y, 1990, ENDOCRINOLOGY, V127, P170, DOI 10.1210/endo-127-1-170; SCHWARTZ Y, 1991, P NATL ACAD SCI USA, V88, P6790, DOI 10.1073/pnas.88.15.6790; SCHWARTZMAN M, 1985, NATURE, V314, P620, DOI 10.1038/314620a0; SELLMAYER A, 1991, J BIOL CHEM, V266, P3800; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; SHUAI K, 1994, CURR OPIN CELL BIOL, V6, P253, DOI 10.1016/0955-0674(94)90144-9; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STRED SE, 1990, ENDOCRINOLOGY, V127, P2506, DOI 10.1210/endo-127-5-2506; STRED SE, 1992, ENDOCRINOLOGY, V130, P1626, DOI 10.1210/en.130.3.1626; TEBBEY PW, 1992, BIOCHIM BIOPHYS ACTA, V1171, P27, DOI 10.1016/0167-4781(92)90136-N; TOLLET P, 1991, MOL ENDOCRINOL, V5, P1351; TOLLET P, 1990, MOL ENDOCRINOL, V4, P1934, DOI 10.1210/mend-4-12-1934; TOLLET P, 1994, J LIPID RES, V35, P248; VANSCHAIK RHN, 1993, BIOCHIM BIOPHYS ACTA, V1169, P1, DOI 10.1016/0005-2760(93)90075-K; WANG XY, 1993, J BIOL CHEM, V268, P3573; WINSTON LA, 1992, J BIOL CHEM, V267, P4747; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; YOSHIDA S, 1990, ARCH BIOCHEM BIOPHYS, V280, P346, DOI 10.1016/0003-9861(90)90340-5	80	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12569	12577		10.1074/jbc.270.21.12569	http://dx.doi.org/10.1074/jbc.270.21.12569			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759504	hybrid			2022-12-27	WOS:A1995QZ71100039
J	OSTERMAN, AL; KINCH, LN; GRISHIN, NV; PHILLIPS, MA				OSTERMAN, AL; KINCH, LN; GRISHIN, NV; PHILLIPS, MA			ACIDIC RESIDUES IMPORTANT FOR SUBSTRATE-BINDING AND COFACTOR REACTIVITY IN EUKARYOTIC ORNITHINE DECARBOXYLASE IDENTIFIED BY ALANINE SCANNING MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; PYRIDOXAL 5'-PHOSPHATE; LACTATE-DEHYDROGENASE; ESCHERICHIA-COLI; ACTIVE-SITE; TRYPSIN; ENZYME; SPECIFICITY; RESOLUTION; MUTANTS	Ornithine decarboxylases from Trypanosoma brucei, mouse, and Leishmania donovani share strict specificity for three basic amino acids, ornithine, lysine, and arginine. To identify residues involved in this substrate specificity and/or in the reaction chemistry, six conserved acidic resides (Asp-88, Glu-94, Asp-233, Glu-274, Asp-361, and Asp-364) were mutated to alanine in the T. brucei enzyme. Each mutation causes a substantial loss in enzyme efficiency. Most notably, mutation of Asp-361 increases the K-m for ornithine by 2000-fold, with little effect on k(cat), suggesting that this residue is an important substrate binding determinant. Mutation of the only strictly conserved acidic residue, Glu-274, decreases k(cat) 50-fold; however, substitution of N-methylpyridoxyl-5'-phosphate for pyridoxal-5'-phosphate as the cofactor in the reaction restores the k(cat) of E274A to wild-type levels. These data demonstrate that Glu-274 interacts with the protonated pyridine nitrogen of the cofactor to enhance the electron withdrawing capability of the ring, analogous to Asp-222 in aspartate aminotransferase (Onuffer, J. J., and Kirsch, J. F. (1994) Protein Eng. 7, 413-424). Eukaryotic ornithine decarboxylase is a homodimer with two shared active sites. Residues 88, 94, 233, and 274 are contributed to each active site from the same subunit as Lys 69, while residues 361 and 364 are part of the Cys-360 subunit.			OSTERMAN, AL (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235, USA.			Kinch, Lisa/0000-0003-3041-2615	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034432] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI34432-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAIROCH A, 1993, NUCLEIC ACIDS RES, V21, P3097, DOI 10.1093/nar/21.13.3097; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; COLEMAN CS, 1994, J BIOL CHEM, V269, P3155; COLL M, 1991, EMBO J, V10, P1; DOWHAN W, 1970, J BIOL CHEM, V245, P4629; ELLERBY LM, 1990, BIOCHEMISTRY-US, V29, P5797, DOI 10.1021/bi00476a022; GRAF L, 1988, P NATL ACAD SCI USA, V85, P4961, DOI 10.1073/pnas.85.14.4961; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; KHOURI HE, 1991, BIOCHEMISTRY-US, V30, P8929, DOI 10.1021/bi00101a003; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LUYTEN MA, 1989, BIOCHEMISTRY-US, V28, P6605, DOI 10.1021/bi00442a011; MCCANN PP, 1992, PHARMACOL THERAPEUT, V54, P195, DOI 10.1016/0163-7258(92)90032-U; OH BH, 1993, J BIOL CHEM, V268, P11348; ONUFFER JJ, 1994, PROTEIN ENG, V7, P413, DOI 10.1093/protein/7.3.413; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; PEGG AE, 1979, BIOCHIM BIOPHYS ACTA, V568, P416, DOI 10.1016/0005-2744(79)90310-3; PFEUFFER T, 1972, BIOCHEMISTRY-US, V11, P2125, DOI 10.1021/bi00761a020; PHILLIPS MA, 1990, J BIOL CHEM, V265, P20692; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SEELY JE, 1983, METHOD ENZYMOL, P158; Segel IH, 1975, ENZYME KINETICS, P113; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; STROUD RM, 1974, J MOL BIOL, V83, P185, DOI 10.1016/0022-2836(74)90387-8; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TOBIAS KE, 1993, BIOCHEMISTRY-US, V32, P5842, DOI 10.1021/bi00073a017; WENTE SR, 1987, P NATL ACAD SCI USA, V84, P31, DOI 10.1073/pnas.84.1.31; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242; YANO T, 1992, BIOCHEMISTRY-US, V31, P5878, DOI 10.1021/bi00140a025	29	73	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11797	11802		10.1074/jbc.270.20.11797	http://dx.doi.org/10.1074/jbc.270.20.11797			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744828	hybrid			2022-12-27	WOS:A1995QY73600022
J	YANG, B; JUNG, D; MOTTO, D; MEYER, J; KORETZKY, G; CAMPBELL, KP				YANG, B; JUNG, D; MOTTO, D; MEYER, J; KORETZKY, G; CAMPBELL, KP			SH3 DOMAIN-MEDIATED INTERACTION OF DYSTROGLYCAN AND GRB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DYSTROPHIN-GLYCOPROTEIN COMPLEX; RECEPTOR TYROSINE KINASES; SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; MUSCULAR-DYSTROPHY; PROTEIN; DEFICIENCY; SARCOLEMMA; INTEGRINS; ACTIN	Dystroglycan is a novel laminin receptor that links the extracellular matrix and sarcolemma in skeletal muscle. The dystroglycan complex containing alpha- and beta-dystroglycan also serves as an agrin receptor in muscle, where it may regulate agrin-induced acetylcholine receptor clustering at the neuromuscular junction. beta-Dystroglycan has now been expressed in vitro and shown to directly interact with Grb2, an adapter protein involved in signal transduction and cytoskeletal organization. Protein binding assays with two Grb2 mutants, Grb2/P49L and Grb2/G203R, which correspond to the loss of-function mutants in the Caenorhabditis elegans sem-5, demonstrated that the dystroglycan-Grb2 association is through beta-dystroglycan C-terminal proline-rich domains and Grb2 Src homology 3 domains. Affinity chromatography has also shown endogenous skeletal muscle Grb2 interacts with beta-dystroglycan. Immunoprecipitation experiments have demonstrated that Grb2 associates with alpha/beta-dystroglycan in vivo in both skeletal muscle and brain. The specific dystroglycan-Grb2 interaction may play an important role in extracellular matrix-mediated signal transduction and/or cytoskeleton organization in skeletal muscle that may be essential for muscle cell viability.	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA 52242	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa			Koretzky, Gary/AAU-5381-2021	Campbell, Kevin/0000-0003-2066-5889				BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IBRAGHIMOVBESKR.O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHINOVBESKR, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KIM WH, 1994, CANCER RES, V54, P5005; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MATUOKA K, 1993, EMBO J, V12, P3467, DOI 10.1002/j.1460-2075.1993.tb06021.x; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; OHLENDIECK K, 1991, FEBS LETT, V283, P230, DOI 10.1016/0014-5793(91)80595-T; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; SCHLAEPFER DD, 1994, NATURE, V372, P786; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	33	233	240	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11711	11714		10.1074/jbc.270.20.11711	http://dx.doi.org/10.1074/jbc.270.20.11711			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744812	hybrid			2022-12-27	WOS:A1995QY73600003
J	HELLER, B; WANG, ZQ; WAGNER, EF; RADONS, J; BURKLE, A; FEHSEL, K; BURKART, V; KOLB, H				HELLER, B; WANG, ZQ; WAGNER, EF; RADONS, J; BURKLE, A; FEHSEL, K; BURKART, V; KOLB, H			INACTIVATION OF THE POLY(ADP-RIBOSE) POLYMERASE GENE AFFECTS OXYGEN RADICAL AND NITRIC-OXIDE TOXICITY IN ISLET CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND BREAKS; PANCREATIC-ISLETS; ADP-RIBOSYLATION; BB RATS; NICOTINAMIDE; MACROPHAGES; METABOLISM; INHIBITORS; GENERATION; ALLOXAN	Activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) is an early response of cells exposed to DNA-damaging compounds such as nitric oxide (NO) or reactive oxygen intermediates (ROI). Excessive poly(ADP ribose) formation by PARP has been assumed to deplete cellular NAD(+) pools and to induce the death of several cell types, including the loss of insulin-producing islet cells in type I diabetes. In the present study we used cells from mice with a disrupted and thus inactivated PARP gene to provide direct evidence for a causal relationship between PARP activation, NAD(+) depletion, and cell death. We found that mutant islet cells do not show NAD(+) depletion after exposure to DNA damaging radicals and are more resistant to the toxicity of both NO and ROI. These findings directly prove that PARP activation is responsible for most of the loss of NAD(+) following such treatment. The ADP-ribosylation inhibitor 3-aminobenzamide partially protected islet cells with intact PARP gene but not mutant cells from lysis following either NO or ROI treatment. Hence the protective action of 3-aminobenzamide must be due to inhibition of PARP and does not result from its other pharmacological properties such as oxygen radical scavenging. Finally, by the use of mutant cells an alternative pathway of cell death was discovered which does not require PARR activation and NAD(+) depletion, In conclusion, the data prove the causal relationship of PARP activation and subsequent islet cell death and demonstrate the existence of an alternative pathway of cell death pendent of PARP activation and NAD(+) depletion.	UNIV DUSSELDORF, DIABET RES INST, D-40225 DUSSELDORF, GERMANY; RES INST MOLEC PATHOL, A-1030 VIENNA, AUSTRIA; GERMAN CANC RES CTR, D-69120 HEIDELBERG, GERMANY; UNIV DUSSELDORF, INST IMMUNOBIOL, D-40225 DUSSELDORF, GERMANY	Heinrich Heine University Dusseldorf; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf				Wagner, Erwin F/0000-0001-7872-0196				Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; APPELS B, 1989, J IMMUNOL, V142, P3803; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BURKART V, 1992, DIABETOLOGIA, V35, P1028, DOI 10.1007/BF02221677; BURKLE A, 1993, CARCINOGENESIS, V14, P559, DOI 10.1093/carcin/14.4.559; BUSCEMA M, 1992, METABOLISM, V41, P296, DOI 10.1016/0026-0495(92)90274-E; CARSON DA, 1986, EXP CELL RES, V164, P273, DOI 10.1016/0014-4827(86)90028-5; CARSON DA, 1986, J EXP MED, V163, P746, DOI 10.1084/jem.163.3.746; CLEAVER JE, 1991, MUTAT RES, V257, P1, DOI 10.1016/0165-1110(91)90016-O; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; FEHSEL K, 1993, DIABETES, V42, P496, DOI 10.2337/diabetes.42.3.496; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; HELLER B, 1994, BIOL CHEM H-S, V375, P597, DOI 10.1515/bchm3.1994.375.9.597; HINZ M, 1973, FEBS LETT, V30, P225, DOI 10.1016/0014-5793(73)80656-8; JOHNSON GS, 1981, BIOCHEM INT, V2, P611; KALLMANN B, 1992, LIFE SCI, V51, P671, DOI 10.1016/0024-3205(92)90240-P; KAWAMITSU H, 1984, BIOCHEMISTRY-US, V23, P3771, DOI 10.1021/bi00311a032; KLEEMANN R, 1993, FEBS LETT, V328, P9, DOI 10.1016/0014-5793(93)80954-S; KRONCKE KD, 1993, BIOCHIM BIOPHYS ACTA, V1182, P221, DOI 10.1016/0925-4439(93)90144-P; KRONCKE KD, 1991, BIOCHEM BIOPH RES CO, V175, P752, DOI 10.1016/0006-291X(91)91630-U; MALAISSE WJ, 1982, P NATL ACAD SCI-BIOL, V79, P927, DOI 10.1073/pnas.79.3.927; NISSELBA.JS, 1969, ANAL BIOCHEM, V27, P212, DOI 10.1016/0003-2697(69)90025-6; NOWICKI M, 1991, CELL IMMUNOL, V132, P115, DOI 10.1016/0008-8749(91)90011-Y; PARKS DA, 1986, ACTA PHYSIOL SCAND, V126, P87; PIPELEERS D, 1986, P NATL ACAD SCI USA, V83, P5267, DOI 10.1073/pnas.83.14.5267; RABINOVITCH A, 1992, J LAB CLIN MED, V119, P455; RADONS J, 1994, BIOCHEM BIOPH RES CO, V199, P1270, DOI 10.1006/bbrc.1994.1368; RANKIN PW, 1989, J BIOL CHEM, V264, P4312; RICHTER C, 1993, TOXICOL LETT, V67, P119, DOI 10.1016/0378-4274(93)90050-8; SIMS JL, 1983, BIOCHEMISTRY-US, V22, P5188, DOI 10.1021/bi00291a019; VEDIA LM, 1992, J BIOL CHEM, V267, P24929; WANG ZQ, 1995, IN PRESS GENES DEV; WELSH N, 1992, BIOCHEM BIOPH RES CO, V182, P333, DOI 10.1016/S0006-291X(05)80149-4; WU GY, 1993, DIABETES, V42, P520, DOI 10.2337/diabetes.42.4.520; YAMADA K, 1982, DIABETES, V31, P749, DOI 10.2337/diabetes.31.9.749; YAMAMOTO H, 1981, NATURE, V294, P284, DOI 10.1038/294284a0; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	39	269	288	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11176	11180		10.1074/jbc.270.19.11176	http://dx.doi.org/10.1074/jbc.270.19.11176			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744749	hybrid			2022-12-27	WOS:A1995QX86500025
J	INOUE, I; ROHRWASSER, A; HELIN, C; JEUNEMAITRE, X; CRAIN, P; BOHLENDER, J; LIFTON, RP; CORVOL, P; WARD, K; LALOUEL, JM				INOUE, I; ROHRWASSER, A; HELIN, C; JEUNEMAITRE, X; CRAIN, P; BOHLENDER, J; LIFTON, RP; CORVOL, P; WARD, K; LALOUEL, JM			A MUTATION OF ANGIOTENSINOGEN IN A PATIENT WITH PREECLAMPSIA LEADS TO ALTERED KINETICS OF THE RENIN-ANGIOTENSIN SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORS; RADIOIMMUNOASSAY; SUBSTRATE; HYPERTENSION; SPECIFICITY; PLASMA; IDENTIFICATION; GENE; SITE	Angiotensinogen exhibits genetic linkage to and association with essential hypertension and preeclampsia, a common hypertensive disorder of pregnancy; however, the polymorphisms detected thus far provide no functional clues, In a preeclamptic patient, we have identified a mutation leading to the replacement of leucine by phenylalanine at position 10 of mature angiotensinogen (L10F), the site of renin cleavage. Kinetic analyses of the enzymes of the renin-angiotensin system, using either model peptides or full-length substrates, show that this mutation significantly alters the reactions with both renin and angiotensin-converting enzyme. For the renin reaction on a full-length substrate, this substitution leads to a 10-fold decrease in K-m (from 1.1 to 0.09 mu M) and a 5-fold decrease in k(cat) (from 1.0 to 0.22 s(-1)); as a result, catalytic efficiency (k(cat)/K-m) is increased by a factor of 2 (1.1 versus 2.4 mu M(-1) s(-1)). In the reaction of angiotensin converting enzyme on angiotensin decapeptides, the substitution has no effect on K-m (38.0 versus 30.0 mu M), but increases k(cat) and catalytic efficiency >2-fold (k(cat) = 15.0 versus 37.0 s(-1); k(cat)/K-m = 0.41 versus 1.23). The renin-angiotensin system, challenged by the profound physiological adaptations of pregnancy, is perturbed in preeclampsia; consequently, the L10F mutation may promote this condition in carrier subjects.	UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,HLTH SCI CTR,DEPT OBSTET & GYNECOL,SALT LAKE CITY,UT 84112; UNIV UTAH,HLTH SCI CTR,ECCLES INST HUMAN GENET,PROGRAM HUMAN MOLEC BIOL & GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,HLTH SCI CTR,DEPT MED CHEM,SALT LAKE CITY,UT 84112; COLL FRANCE,INSERM,U36,F-75005 PARIS,FRANCE; INSERM,U367,PARIS,FRANCE; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536; YALE UNIV,SCH MED,BAYER CTR MOLEC MED,DEPT GENET,NEW HAVEN,CT 06536; YALE UNIV,SCH MED,DEPT MED,NEW HAVEN,CT 06536	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Howard Hughes Medical Institute; Yale University; Yale University; Yale University	INOUE, I (corresponding author), UNIV UTAH,HLTH SCI CTR,ECCLES INST HUMAN GENET,HOWARD HUGHES MED INST,6TH FLOOR,SALT LAKE CITY,UT 84112, USA.		JEUNEMAITRE, Xavier/AAQ-4853-2021	JEUNEMAITRE, Xavier/0000-0001-5925-381X				ARNGRIMSSON R, 1993, NAT GENET, V4, P114, DOI 10.1038/ng0693-114; August PA, 1990, HYPERTENSION PATHOPH, P1761; BOGER J, 1985, J MED CHEM, V28, P1779, DOI 10.1021/jm00150a007; BURTON J, 1988, BIOCHIM BIOPHYS ACTA, V952, P8, DOI 10.1016/0167-4838(88)90095-7; CAMPBELL DJ, 1993, RENIN ANGIOTENSIN SY; CORVOL P, 1989, CLIN EXP HYPERTENS A, V11, P463; CUMIN F, 1987, BIOCHIM BIOPHYS ACTA, V913, P10, DOI 10.1016/0167-4838(87)90226-3; CUNNINGHAM FG, 1992, NEW ENGL J MED, V326, P927; DELORME A, 1976, AM J MED, V61, P725, DOI 10.1016/0002-9343(76)90153-4; DHANARAJ V, 1992, NATURE, V357, P466, DOI 10.1038/357466a0; GENAIN C, 1984, J CLIN ENDOCR METAB, V59, P478, DOI 10.1210/jcem-59-3-478; GOMEZ RA, 1993, HYPERTENSION, V21, P470, DOI 10.1161/01.HYP.21.4.470; GOULD AB, 1971, CARDIOVASC RES, V5, P86, DOI 10.1093/cvr/5.1.86; HAAS E, 1967, CIRC RES, V20, P45, DOI 10.1161/01.RES.20.1.45; HABER E, 1989, J HYPERTENS, V7, pS81, DOI 10.1097/00004872-198904002-00017; HATA A, 1990, NUCLEIC ACIDS RES, V18, P5407, DOI 10.1093/nar/18.18.5407; HATA A, 1994, J CLIN INVEST, V93, P1285, DOI 10.1172/JCI117083; HERMANN K, 1984, J CHROMATOGR, V312, P273, DOI 10.1016/S0021-9673(01)92781-5; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUTCHINS C, 1991, CRIT REV BIOCHEM MOL, V26, P77, DOI 10.3109/10409239109081721; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KLEINERT HD, 1989, AM J HYPERTENS, V2, P800, DOI 10.1093/ajh/2.10.800; LUTHER RR, 1991, CLIN NEPHROL, V36, P181; MENARD J, 1972, ENDOCRINOLOGY, V90, P422, DOI 10.1210/endo-90-2-422; MENARD J, 1985, J HYPERTENS       S3, V5, pS275; MORRIS BJ, 1989, J HYPERTENS, V7, pS9, DOI 10.1097/00004872-198904002-00003; ONDETTI MA, 1982, ANNU REV BIOCHEM, V51, P283, DOI 10.1146/annurev.bi.51.070182.001435; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PICKENS PT, 1965, CIRC RES, V17, P438, DOI 10.1161/01.RES.17.5.438; PLOUIN PF, 1989, PRESSE MED, V18, P917; Poulsen K, 1976, Prog Biochem Pharmacol, V12, P135; POULSEN K, 1986, J HYPERTENS, V4, P65, DOI 10.1097/00004872-198602000-00011; ROHRBACH MS, 1981, J BIOL CHEM, V256, P225; SEALEY JE, 1972, KIDNEY INT, V1, P240, DOI 10.1038/ki.1972.34; SIELECKI AR, 1989, SCIENCE, V243, P1346, DOI 10.1126/science.2493678; SKEGGS LT, 1968, J EXP MED, V128, P13, DOI 10.1084/jem.128.1.13; SKEGGS LT, 1957, J EXP MED, V106, P439, DOI 10.1084/jem.106.3.439; SLATER EE, 1981, J BIOL CHEM, V256, P8164; TEWKSBURY DA, 1990, HYPERTENSION PATHOPH, P1196; TRYON ES, 1984, FED PROC, V43, P1854; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59	41	60	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11430	11436		10.1074/jbc.270.19.11430	http://dx.doi.org/10.1074/jbc.270.19.11430			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744780	hybrid			2022-12-27	WOS:A1995QX86500059
J	SASAOKA, T; LANGLOIS, WJ; ROSE, DW; OLEFSKY, JM				SASAOKA, T; LANGLOIS, WJ; ROSE, DW; OLEFSKY, JM			MECHANISMS OF ENHANCED TRANSMEMBRANE SIGNALING BY AN INSULIN-RECEPTOR LACKING A CYTOPLASMIC BETA-SUBUNIT DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; GROWTH FACTOR-I; PROTEIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; SUBSTRATE-1; FIBROBLASTS; ANTIBODIES; ADIPOCYTES; EXPRESSION	We have recently characterized a mutant insulin receptor (HIR Delta 978) in which the insulin receptor beta-subunit was truncated at amino acid residue 978, Compared with parental Rat1 cells, the cells expressing the truncated receptor exhibited enhanced sensitivity to insulin's biologic actions, All of these effects are now extended to transcriptional events, since we now show enhanced sensitivity to insulin stimulation of c-fos mRNA expression, These effects were insulin-specific, since insulin-like growth factor-1 stimulation of glucose incorporation into glycogen, cy-aminoisobutyric acid uptake, and thymidine incorporation into DNA were normal, In addition, the truncated receptor exhibited enhanced sensitivity only in vivo, but not in vitro, since the kinase activity of wheat germ agglutinin-purified recep tor preparations was comparable between HIR Delta 978 and parental Rat1 insulin receptors, Parental rat endogenous insulin like growth factor-1 receptors and transfected human insulin receptors form hybrid receptors as well as homologous tetrameric receptors, The normal heterotetrameric receptors possess kinase activity in vivo leading to tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) and its association with the p85 regulatory subunit of phosphatidyl inositol 3-kinase, Interestingly, preincubation with human-specific anti-insulin receptor antibody abolished the increased insulin sensitivity in glucose incorporation into glycogen in HIR Delta 978 cells, Furthermore, microinjection of anti-IRS-1 antibody into HIR Delta 978 cells inhibited insulin stimulation of DNA synthesis, In summary: 1) truncated receptors on the cell surface confer enhanced insulin sensitivity in vivo; 2) the normal heterotetrameric receptors are functionally active and couple to IRS-1 efficiently; and 3) IRS-1 is an important molecule transmitting insulin's biological signals in HIR Delta 978 cells.	UNIV CALIF SAN DIEGO,DEPT MED 0673,DIV ENDOCRINOL & METAB,LA JOLLA,CA 92093; VET ADM MED CTR,MED RES SERV,SAN DIEGO,CA 92161	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)					NIDDK NIH HHS [DK33651] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, R01DK033651] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BELYAVSKY A, 1989, NUCLEIC ACIDS RES, V17, P2919, DOI 10.1093/nar/17.8.2919; CHOU CK, 1987, J BIOL CHEM, V262, P1842; HEIDENREICH KA, 1984, J BIOL CHEM, V259, P6511; MAEGAWA H, 1988, J BIOL CHEM, V263, P1629; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; ROSE DW, 1994, P NATL ACAD SCI USA, V91, P797, DOI 10.1073/pnas.91.2.797; SASAOKA T, 1988, DIABETES, V37, P1515, DOI 10.2337/diabetes.37.11.1515; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; SASAOKA T, P NATL ACAD SCI USA, V90, P4379; SIDDLE K, 1987, BIOCHEM SOC T, V15, P47, DOI 10.1042/bst0150047; STUMPO DJ, 1991, J BIOL CHEM, V266, P455; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAKATA Y, 1992, J BIOL CHEM, V267, P9065; TAKATA Y, 1991, J BIOL CHEM, V266, P9135; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WILDEN PA, 1992, J BIOL CHEM, V267, P13719; YAMAMOTOHONDA R, 1993, J BIOL CHEM, V268, P16859; YONEZAWA K, 1992, J BIOL CHEM, V267, P25958	22	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10885	10892		10.1074/jbc.270.18.10885	http://dx.doi.org/10.1074/jbc.270.18.10885			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738028	hybrid			2022-12-27	WOS:A1995QW60100076
J	TAGUCHI, F; YAMAMOTO, Y; SATOH, K				TAGUCHI, F; YAMAMOTO, Y; SATOH, K			RECOGNITION OF THE STRUCTURE AROUND THE SITE OF CLEAVAGE BY THE CARBOXYL-TERMINAL PROCESSING PROTEASE FOR D1 PRECURSOR PROTEIN OF THE PHOTOSYSTEM-II REACTION-CENTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCENEDESMUS-OBLIQUUS; PARTIAL-PURIFICATION; SPINACH; SIGNAL; POLYPEPTIDE; ENZYME; PHOTOACTIVATION; TRANSLATION; SUBUNITS; COMPLEX	In order to analyze the structural requirement(s) for proteolytic cleavage, synthetic oligopeptides corresponding to the carboxyl-terminal (COOH-terminal) sequence of the precursor to the D1 protein (pD1) of the photosystem II reaction center, with or without substituted side chain(s) around the cleavage site, were subjected to enzymatic analysis with partially purified processing protease from spinach. The efficiency of action as a competitive inhibitor of the enzymatic cleavage of the COOH-terminal extension, as well as the capacity to serve as a substrate, was used as an indication of effective binding to the protease. Neither a COOH-terminal fragment consisting of the 9 amino acids that are cleaved from pD1 by the protease nor a COOH-terminal fragment of the mature protein consisting of 15 amino acids inhibited the enzymatic processing of pD1. By contrast, a COOH-terminal fragment of pD1 consisting of 24 amino acids, which included the sequences of both the COOH-terminal extension and the COOH-terminal 15 amino acids of the mature protein, was effective both as a competitive inhibitor and as a substrate. This result suggests that the structure formed by linkage between these two parts of the protein moiety is important in the substrate-enzyme interaction. Among substitutions around the cleavage site, the replacement of Leu-343 by Ala (L343A) specifically destroyed the ability of the oligopeptide to serve as either a substrate or an inhibitor, suggesting that the presence of the hydrophobic Leu residue is crucial for the formation of the recognition site. A series of six substitutions at Ala-345 had marked effects on the value of V-max, without affecting the binding affinity, as represented by K-m; the order of substitutions at residue 345 in terms of their effects on V-max was Ala, Ser, Phe, Cys > Gly > Val much greater than Pro. With a Pro residue at position 345, the oligopeptide was practically inactive as a substrate.	OKAYAMA UNIV, FAC SCI, DEPT BIOL, OKAYAMA 700, JAPAN; NATL INST BASIC BIOL, DIV BIOL REGULAT & PHOTOBIOL, OKAZAKI, AICHI 444, JAPAN	Okayama University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)								ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; BORCHERT TV, 1991, J BACTERIOL, V173, P276, DOI 10.1128/jb.173.1.276-282.1991; BOWYER JR, 1992, J BIOL CHEM, V267, P5424; DEBUS RJ, 1988, P NATL ACAD SCI USA, V85, P427, DOI 10.1073/pnas.85.2.427; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DINER BA, 1988, J BIOL CHEM, V263, P8972; ELLIS RJ, 1981, ANNU REV PLANT PHYS, V32, P111, DOI 10.1146/annurev.pp.32.060181.000551; FIKES JD, 1990, J BIOL CHEM, V265, P3417; FUJITA S, 1989, FEBS LETT, V255, P1, DOI 10.1016/0014-5793(89)81049-X; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GERWIN BI, 1966, J BIOL CHEM, V241, P3331; INAGAKI N, 1989, FEBS LETT, V246, P218, DOI 10.1016/0014-5793(89)80286-8; INAGAKI N, 1990, CURRENT RES PHOTOSYN, V3, P763; KELLER M, 1984, FEBS LETT, V175, P173, DOI 10.1016/0014-5793(84)80593-1; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERS A, 1992, J BIOL CHEM, V267, P17494; MATTOO AK, 1989, CELL, V56, P241, DOI 10.1016/0092-8674(89)90897-0; MINAMI E, 1985, PLANT CELL PHYSIOL, V26, P839; MOHAMED A, 1993, MOL GEN GENET, V238, P161, DOI 10.1007/BF00279543; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; REISFELD A, 1982, EUR J BIOCHEM, V124, P125, DOI 10.1111/j.1432-1033.1982.tb05914.x; SASAKI T, 1984, J BIOL CHEM, V259, P2489; SATOH K, 1988, PHYSIOL PLANTARUM, V72, P209, DOI 10.1111/j.1399-3054.1988.tb06645.x; SATOH K, 1992, NATO ADV SCI I A-LIF, V226, P375; SATOH K, 1993, PHOTOSYNTHETIC REACT, V1, P289; SATOH K, 1992, RES PHOTOSYNTHESIS, V2, P3; SHESTAKOV SV, 1994, J BIOL CHEM, V269, P19354; SVENSSON B, 1991, Z NATURFORSCH C, V46, P765; TAGUCHI F, 1993, FEBS LETT, V326, P227, DOI 10.1016/0014-5793(93)81796-3; TAKAHASHI M, 1988, FEBS LETT, V240, P6, DOI 10.1016/0014-5793(88)80330-2; TAKAHASHI Y, 1990, PLANT CELL PHYSIOL, V31, P273; TAYLOR MA, 1988, FEBS LETT, V237, P229, DOI 10.1016/0014-5793(88)80207-2; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WATANABE A, 1982, P NATL ACAD SCI-BIOL, V79, P6304, DOI 10.1073/pnas.79.20.6304; ZURAWSKI G, 1982, P NATL ACAD SCI-BIOL, V79, P6260, DOI 10.1073/pnas.79.20.6260	37	28	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10711	10716		10.1074/jbc.270.18.10711	http://dx.doi.org/10.1074/jbc.270.18.10711			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738009	hybrid			2022-12-27	WOS:A1995QW60100053
J	TSAI, AL; KULMACZ, RJ; PALMER, G				TSAI, AL; KULMACZ, RJ; PALMER, G			SPECTROSCOPIC EVIDENCE FOR REACTION OF PROSTAGLANDIN-H SYNTHASE-1 TYROSYL RADICAL WITH ARACHIDONIC-ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-SPIN-RESONANCE; HIGHER OXIDATION-STATES; CYCLOOXYGENASE CATALYSIS; ENDOPEROXIDE SYNTHASE; PEROXIDASE REACTION; PHOTOSYSTEM-II; PENTADIENYL; ENZYME; POTENTIALS	The coupling between the peroxidase and cyclooxygenase activities of prostaglandin H synthase (PGHS) has been proposed to be mediated by a critical tyrosyl radical through a branched chain mechanism (Dietz, R,, Nastainczyk, W,, and Ruf, H. H, (1988) fur. J, Biochem, 171, 321-328), In this study, we have examined the ability of PGHS isoform-1 (PGHS-1) tyrosyl radicals to react with arachidonate, Anaerobic addition of arachidonate following formation of the peroxide-induced wide doublet or wide singlet tyrosyl radical led to disappearance of the tyrosyl radicals and emergence of a new EPR signal, which is distinct from known PGHS-1 tyrosyl radicals, The new radical was clearly derived from arachidonate because its EPR line shape changed when 5,6,8,9,11,12,14,15-octadeuterated arachidonate was used, Subsequent addition of oxygen to samples containing the fatty acyl radical resulted in regeneration of tyrosyl radical EPR, In contrast, the peroxide-generated tyrosyl radical in indomethacin-treated PGHS-1 (a narrow singlet) failed to react with arachidonate, consistent with the cyclooxygenase inhibition by indomethacin, These results indicate that the peroxide-generated wide doublet and wide singlet tyrosyl radicals serve as immediate oxidants of arachidonate bound at the cyclooxygenase active site to form a carbon-centered fatty acyl radical, which reacts with oxygen to form a hydroperoxide, These observations represent the first direct evidence of chemical coupling between the peroxidase reaction and arachidonate oxygenation in PGHS-1 and support the proposed role for a tyrosyl radical in cyclooxygenase catalysis.	RICE UNIV,DEPT BIOCHEM & CELL BIOL,HOUSTON,TX 77251	Rice University	TSAI, AL (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT INTERNAL MED,DIV HEMATOL,6431 FANNIN ST,HOUSTON,TX 77030, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021337, R01GM021337] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44911, GM21337] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARRY BA, 1990, J BIOL CHEM, V265, P20139; BASCETTA E, 1982, J CHEM SOC CHEM COMM, P110, DOI 10.1039/c39820000110; DAVIES AG, 1981, J CHEM SOC PERK T 2, P633, DOI 10.1039/p29810000633; DEFELIPPIS MR, 1989, BIOCHEMISTRY-US, V28, P4847, DOI 10.1021/bi00437a049; DEGRAY JA, 1992, J BIOL CHEM, V267, P23583; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; DUTTON PL, 1971, BIOCHIM BIOPHYS ACTA, V226, P63, DOI 10.1016/0005-2728(71)90178-2; HINCHLIFFE A, 1974, J MOL STRUCT, V23, P273, DOI 10.1016/0022-2860(74)85041-6; HOGANSON CW, 1992, BIOCHEMISTRY-US, V31, P11874, DOI 10.1021/bi00162a028; KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x; KOPPENOL WH, 1990, FEBS LETT, V264, P165, DOI 10.1016/0014-5793(90)80239-F; KULMACZ RJ, 1990, BIOCHEMISTRY-US, V29, P8760, DOI 10.1021/bi00489a037; Kulmacz RJ, 1987, PROSTAGLANDINS RELAT, P209; LASSMANN G, 1991, J BIOL CHEM, V266, P20045; MIYAMOTO T, 1976, J BIOL CHEM, V251, P2629; MIZUNO K, 1982, PROSTAGLANDINS, V23, P743; NELSON MJ, 1990, BIOCHEMISTRY-US, V29, P6897, DOI 10.1021/bi00481a020; NELSON MJ, 1994, BIOCHEMISTRY-US, V33, P4966, DOI 10.1021/bi00182a027; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SCHREIBER J, 1986, ARCH BIOCHEM BIOPHYS, V249, P126, DOI 10.1016/0003-9861(86)90567-9; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; SMITH WL, 1992, BIOCHEMISTRY-US, V31, P3, DOI 10.1021/bi00116a001; SUSTMANN R, 1979, CHEM BER-RECL, V112, P1440, DOI 10.1002/cber.19791120437; TSAI AL, 1994, J BIOL CHEM, V269, P5085; TSAI AL, 1992, J BIOL CHEM, V267, P17753; TSAI AL, 1983, BIOCHIM BIOPHYS ACTA, V722, P349, DOI 10.1016/0005-2728(83)90083-X; WERTZ JE, 1986, ELECTRON SPIN RESON, P462	28	113	114	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10503	10508		10.1074/jbc.270.18.10503	http://dx.doi.org/10.1074/jbc.270.18.10503			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737984	hybrid			2022-12-27	WOS:A1995QW60100024
J	ALONSO, G; KOEGL, M; MAZURENKO, N; COURTNEIDGE, SA				ALONSO, G; KOEGL, M; MAZURENKO, N; COURTNEIDGE, SA			SEQUENCE REQUIREMENTS FOR BINDING OF SRC FAMILY TYROSINE KINASES TO ACTIVATED GROWTH-FACTOR RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATING FACTOR-I; PDGF BETA-RECEPTOR; SIGNAL-TRANSDUCTION; SH2 DOMAIN; C-SRC; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; ASSOCIATION; MOLECULES	Activation of growth factor receptor protein tyrosine kinases frequently results in the binding of numerous proteins to their tyrosine-phosphorylated cytoplasmic domains, These interactions involve the SH2 domains of the binding proteins and phosphorylated tyrosines on the receptor molecules, with the specificity of interaction dictated by the amino acid composition surrounding the phosphorylated tyrosine, In the case of the platelet derived growth factor (PDGF) receptor, the major binding site for Src family tyrosine kinases is in the juxtamembrane domain and includes tyrosine 579 (Mori, S,, Ronnstrand, L., Yokote, K., Engstrom, Angstrom, Courtneidge, S, A, Claesson Welsh, L,, and Heldin, C-H. (1993) EMBO J. 12, 2257-2264), To analyze in more detail which amino acids surrounding the phosphorylated tyrosine at position 579 were important for high affinity interaction with Src family kinases, we synthesized a series of phosphopeptides corresponding to this binding site in which single amino acids were individually changed and tested their ability to compete with the PDGF receptor for binding of Fyn, We found that not only the three residues carboxyl-terminal to the phosphorylated tyrosine were important but that also residues at positions -1 and +4 relative to the tyrosine were required, Phosphorylation of both tyrosines 579 and 581 significantly increased competition efficiency, The activated colony stimulating factor-1 (CSF-1) receptor, which is known to associate with Src family kinases, has a sequence in its juxtamembrane region similar to that surrounding Tyr 579 of the PDGF receptor, and a phosphopeptide modeled on this sequence competed the association of Fyn with the receptor in vitro, Furthermore, mutational analysis demonstrated that these sequences were required for the efficient association of Src family kinases with the activated CSF-1 receptor in vivo, Phosphopeptides corresponding to the Src family binding sites of both PDGF and CSF-1 receptors activated Src kinase activity in vitro, These observations support a model in which the enzymatic activity of Src family tyrosine kinases is controlled by intra- and intermolecular interactions of tyrosine phosphorylated peptides with the SH2 domain of the kinases.	EUROPEAN MOLEC BIOL LAB, DIFFERENTIAT PROGRAMME, D-69012 HEIDELBERG, GERMANY	European Molecular Biology Laboratory (EMBL)				Ronnstrand, Lars/0000-0003-1275-5809				ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; CAMPBELL KS, 1994, P NATL ACAD SCI USA, V91, P6344, DOI 10.1073/pnas.91.14.6344; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; COURTNEIDGE SA, 1993, EMBO J, V12, P943, DOI 10.1002/j.1460-2075.1993.tb05735.x; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; GOULD KL, 1988, MOL CELL BIOL, V8, P3345, DOI 10.1128/MCB.8.8.3345; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOEGL M, 1994, BIOCHEM J, V302, P737, DOI 10.1042/bj3020737; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LAROSE L, 1993, ONCOGENE, V8, P2493; LIU XQ, 1993, ONCOGENE, V8, P1119; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; RALSTON R, 1985, P NATL ACAD SCI USA, V82, P7845, DOI 10.1073/pnas.82.23.7845; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; ROCHE S, 1995, MOL CELL BIOL, V15, P1102; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; TWAMLEY GM, 1992, ONCOGENE, V7, P1893; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	38	171	174	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9840	9848		10.1074/jbc.270.17.9840	http://dx.doi.org/10.1074/jbc.270.17.9840			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730365	hybrid			2022-12-27	WOS:A1995QV41700024
J	LAMBERG, A; PIHLAJANIEMI, T; KIVIRIKKO, KI				LAMBERG, A; PIHLAJANIEMI, T; KIVIRIKKO, KI			SITE-DIRECTED MUTAGENESIS OF THE ALPHA-SUBUNIT OF HUMAN PROLYL 4-HYDROXYLASE - IDENTIFICATION OF 3 HISTIDINE-RESIDUES CRITICAL FOR CATALYTIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; ISOPENICILLIN-N-SYNTHASE; BETA-SUBUNIT; MOLECULAR-CLONING; ENDOPLASMIC-RETICULUM; LYSYL HYDROXYLASE; ENZYME; SEQUENCE; 2-OXOGLUTARATE; INHIBITORS	Prolyl 4-hydroxylase (EC 1.14.11.2) catalyzes the formation of hydroxyproline in collagens, The vertebrate enzyme is an alpha(2) beta(2) tetramer in which the alpha subunits contribute to most parts of the two catalytic sites, To study the roles of histidine and cysteine residues in this catalytic activity we converted all 5 histidines that are conserved between species, 4 nonconserved histidines, and 3 conserved cysteines of the human a subunit individually to serine and expressed the mutant a subunits together with the mild-type beta subunit in insect cells by means of baculovirus vectors, Mutation of any of the 3 conserved histidines, residues 412, 485, and 501, inactivated the enzyme completely or essentially completely, with no effect on tetramer assembly or binding of the tetramer to poly(L-proline), These histidines are likely to provide the three ligands needed for the binding of Fe2+ to a catalytic site, Mutation of either of the other 2 conserved histidines reduced the amount of enzyme tetramer by 20-25% and the activity of the tetramer by 30-60%, Mutation of the nonconserved histidine 324 to tally prevented tetramer assembly, whereas mutation of the 3 other nonconserved histidines had no effects, Two of the 3 cysteine to serine mutations, those involving residues 486 and 511, totally prevented tetramer assembly under the present conditions, whereas the third, involving residue 150, had only a minor effect in reducing tetramer assembly and activity, The data do not support previous suggestions that cysteine residues are involved in Fe2+ binding sites, Additional mutagenesis experiments demonstrated that the two glycosylated asparagines have no role in tetramer assembly or catalytic activity.	UNIV OULU, DEPT MED BIOCHEM, SF-90220 OULU, FINLAND; UNIV OULU, COLLAGEN RES UNIT, SF-90220 OULU, FINLAND	University of Oulu; University of Oulu				Pihlajaniemi, Taina/0000-0002-1664-9045				BASSUK JA, 1989, P NATL ACAD SCI USA, V86, P7382, DOI 10.1073/pnas.86.19.7382; BRITSCH L, 1993, EUR J BIOCHEM, V217, P745, DOI 10.1111/j.1432-1033.1993.tb18301.x; DEJONG L, 1984, BIOCHIM BIOPHYS ACTA, V787, P105; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; GRUENWALD S, 1993, BACULOVIRUS EXPRESSI; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; HELAAKOSKI T, 1989, P NATL ACAD SCI USA, V86, P4392, DOI 10.1073/pnas.86.12.4392; HELAAKOSKI T, 1994, J BIOL CHEM, V269, P27847; HELAAKOSKI T, 1995, IN PRESS P NATL ACAD; JIA S, 1994, P NATL ACAD SCI USA, V91, P7227, DOI 10.1073/pnas.91.15.7227; JIANG F, 1991, BIOCHEMISTRY-US, V30, P11437, DOI 10.1021/bi00112a010; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; JOHN DCA, 1994, BIOCHEMISTRY-US, V33, P14018, DOI 10.1021/bi00251a009; KAO WWY, 1988, CONNECT TISSUE RES, V18, P157, DOI 10.3109/03008208809016805; KEDERSHA NL, 1985, BIOCHEMISTRY-US, V24, P5952, DOI 10.1021/bi00342a040; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; KIVIRIKKO KI, 1987, METHOD ENZYMOL, V144, P96; KIVIRIKKO KI, 1990, ANN NY ACAD SCI, V580, P132, DOI 10.1111/j.1749-6632.1990.tb17925.x; KOIVU J, 1987, J BIOL CHEM, V262, P6447; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; MAJAMAA K, 1986, J BIOL CHEM, V261, P7819; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; MING LJ, 1991, BIOCHEMISTRY-US, V30, P11653, DOI 10.1021/bi00114a007; MYLLYLA R, 1992, BIOCHEM J, V286, P923, DOI 10.1042/bj2860923; MYLLYLA R, 1977, EUR J BIOCHEM, V80, P349, DOI 10.1111/j.1432-1033.1977.tb11889.x; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; NOIVA R, 1992, J BIOL CHEM, V267, P3553; PARKKONEN T, 1988, BIOCHEM J, V256, P1005, DOI 10.1042/bj2561005; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; RANDALL CR, 1993, BIOCHEMISTRY-US, V32, P6664, DOI 10.1021/bi00077a020; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TUDERMAN L, 1975, EUR J BIOCHEM, V52, P9, DOI 10.1111/j.1432-1033.1975.tb03967.x; VEIJOLA J, 1994, J BIOL CHEM, V269, P26746; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x	37	61	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9926	9931		10.1074/jbc.270.17.9926	http://dx.doi.org/10.1074/jbc.270.17.9926			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730375	hybrid			2022-12-27	WOS:A1995QV41700036
J	SATO, T; XIAO, DM; LI, H; HUANG, FL; HUANG, KP				SATO, T; XIAO, DM; LI, H; HUANG, FL; HUANG, KP			STRUCTURE AND REGULATION OF THE GENE ENCODING THE NEURON-SPECIFIC PROTEIN-KINASE-C SUBSTRATE NEUROGRANIN (RC3 PROTEIN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPSIN-I GENE; CALMODULIN-BINDING DOMAIN; TYROSINE-HYDROXYLASE GENE; TRANSCRIPTION FACTOR AP-2; INTESTINAL-PEPTIDE GENE; BRAIN-SPECIFIC GENE; CYCLIC-AMP; PHOSPHORYLATION SITE; 5'-FLANKING REGION; ENHANCER ACTIVITY	A 13-kilobase pair genomic DNA encoding a 78-amino acid brain-specific calmodulin-binding protein kinase C (PKC) substrate, neurogranin (Ng/RC3; also known as RC3 or p17), has been sequenced, The Ng/RC3 gene is composed of four exons and three introns, with the protein-coding region located in the first and second exons. This gene was found to have multiple transcriptional start sites clustered within 20 base pairs (bp); it lacks the TATA, GC, and CCAAT boxes in the proximal up stream region of the start sites. The promoter activity was characterized by transfection of 293 cells with nested deletion mutants of the 5'-flanking region fused to the luciferase reporter gene. A minimal construct containing bp +11 to +256 was nearly as active as that covering bp -1508 to +256, whereas a shorter one covering bp +40 to +256 had a greatly reduced activity. Between bp +11 and +40 lies a 12-nucleotide sequence (CCCCGCCCGACCC) containing overlapping binding sites for AP2 (CCGCCCACCC) and SP1 (CCCGCC); this region may be important for conferring the basal transcriptional activity of the Ng/BC3 gene. The expression of a Ng/RC3-luciferase fusion construct (-1508/+256) in transfected 293 cells was stimulated by phorbol 12-myristate 13-acetate (PMA), but not by cAMP, arachidonic acid, vitamin D, retinoic acid, or thyroxines T-3 and T-4. PMA caused a 2-4-fold stimulation of all the reporter gene constructs ranging from +11/+256 to -1508/+256. The stimulatory effects of PMA could be magnified by cotransfection with both Ca2+-dependent and -independent phorbol ester-binding PKC-alpha, -beta(I), -beta(II), -gamma, -delta, and -epsilon cDNAs, but not by non-phorbol ester-binding PHC-xi cDNA. The Ng/RC3 and PKC-gamma genes have a similar expression pattern in the brain during development. These two genes share at least four conserved sequence segments 1.5 kiIobase pair upstream from their transcriptional start sites and a gross similarity in that they possess several AT-rich segments within bp -550 to -950, A near homogeneous 20-kDa DNA-binding protein purified from rat brain was able to bind to these AT-rich regions of both Ng/RC3 and PKC-gamma genes with footprints containing ATTA, ATAA, and AATA sequences.	NICHHD, ENDOCRINOL & REPROD RES BRANCH, METAB REGULAT SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; APEL ED, 1990, BIOCHEMISTRY-US, V29, P2330, DOI 10.1021/bi00461a017; BAUDIER J, 1991, J BIOL CHEM, V266, P229; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN SY, 1986, J NEUROSCI, V6, P3618; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; CHEN KH, 1990, J BIOL CHEM, V265, P19961; CHEN KH, 1993, FEBS LETT, V325, P210, DOI 10.1016/0014-5793(93)81075-B; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FINK JS, 1991, J BIOL CHEM, V266, P3882; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; GRABCZYK E, 1990, EUR J NEUROSCI, V2, P822, DOI 10.1111/j.1460-9568.1990.tb00393.x; HE X, 1991, NEURON, V7, P183, DOI 10.1016/0896-6273(91)90257-Z; HOWLAND DS, 1991, MOL BRAIN RES, V11, P345, DOI 10.1016/0169-328X(91)90044-X; HUANG FL, 1993, METHODS NEUROSCI, V18, P127; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; INGRAHAM HA, 1986, MOL CELL BIOL, V6, P2923, DOI 10.1128/MCB.6.8.2923; INIGUEZ MA, 1993, ENDOCRINOLOGY, V133, P467, DOI 10.1210/en.133.2.467; IZUMI R, 1992, GENE, V112, P189, DOI 10.1016/0378-1119(92)90375-Y; KARNS LR, 1987, SCIENCE, V236, P597, DOI 10.1126/science.2437653; KLANN E, 1992, J NEUROCHEM, V58, P1576, DOI 10.1111/j.1471-4159.1992.tb11382.x; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LANDIS SC, 1990, TRENDS NEUROSCI, V13, P344, DOI 10.1016/0166-2236(90)90147-3; LEDOUARIN NM, 1990, ANN NY ACAD SCI, V599, P131; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; LIU YC, 1990, TRENDS PHARMACOL SCI, V11, P107; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; MAHONEY CW, 1994, PROTEIN KINASE C, P16; Maxam A M, 1980, Methods Enzymol, V65, P499; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; MONCOLLIN V, 1994, TRANSCRIPTION MECHAN, P45; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; NEDIVI E, 1992, J NEUROSCI, V12, P691; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OLIVA D, 1991, GENOMICS, V10, P157, DOI 10.1016/0888-7543(91)90496-2; PETTERSSON M, 1987, GENE DEV, V1, P962, DOI 10.1101/gad.1.9.962; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; SAKIMURA K, 1987, GENE, V60, P103, DOI 10.1016/0378-1119(87)90218-6; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SANGAMESWARAN L, 1993, MOL BRAIN RES, V19, P62, DOI 10.1016/0169-328X(93)90149-J; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; SHASKUS J, 1992, J BIOL CHEM, V267, P18821; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SMALE S.T., 1994, TRANSCRIPTION MECHAN, P63; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; VANDERHOORN FA, 1987, J MOL BIOL, V193, P255, DOI 10.1016/0022-2836(87)90217-8; VANHOOFF COM, 1988, J NEUROSCI, V8, P1789; VIBERT M, 1989, EUR J BIOCHEM, V181, P33, DOI 10.1111/j.1432-1033.1989.tb14690.x; VYAS S, 1990, EMBO J, V9, P3707, DOI 10.1002/j.1460-2075.1990.tb07583.x; WATSON JB, 1992, P NATL ACAD SCI USA, V89, P8581, DOI 10.1073/pnas.89.18.8581; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859; YOSHIDA Y, 1988, J BIOL CHEM, V263, P9868	62	38	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10314	10322		10.1074/jbc.270.17.10314	http://dx.doi.org/10.1074/jbc.270.17.10314			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730337	hybrid			2022-12-27	WOS:A1995QV41700086
J	WANG, LH; SUDHOF, TC; ANDERSON, RGW				WANG, LH; SUDHOF, TC; ANDERSON, RGW			THE APPENDAGE DOMAIN OF ALPHA-ADAPTIN IS A HIGH-AFFINITY BINDING-SITE FOR DYNAMIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-COATED PITS; DROSOPHILA-MELANOGASTER; INVITRO BINDING; AP-2 SUBUNIT; PROTEIN; SHIBIRE; VESICLES; ENDOCYTOSIS; MUTATIONS; RECEPTOR	Dynamin is a GTPase that appears to be required for endocytosis. Even though this molecule is known to be in surface-coated pits, the identity of the resident coat proteins that account for this localization is not known, Here we show that dynamin is one of three synaptic terminal proteins that bind with specificity to the ap pendage domain of alpha-adaptin. Binding is sensitive to both salt and pH levels but is not affected by nucleotides. Using recombinant dynamin expressed in SF9 cells, we estimate that the binding affinity is similar to 200 nM. Binding does not require GTP, and the GTPase activity of dynamin is not stimulated by this interaction. These results suggest that the COOH terminus of alpha-adaptin may be a domain within AP2 that mediates the initial interactions between dynamin and surface-coated pits, This may be an essential step in the regulation of coated pit budding.	UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								BELTZER JP, 1991, EMBO J, V10, P3735, DOI 10.1002/j.1460-2075.1991.tb04942.x; BOOKER GW, 1993, CELL, V73, P813, DOI 10.1016/0092-8674(93)90259-S; CARPENTER G, 1992, FASEB J, V6, P3283, DOI 10.1096/fasebj.6.14.1385243; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; CROWTHER RA, 1981, J CELL BIOL, V91, P790, DOI 10.1083/jcb.91.3.790; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAVID C, 1994, MOL BIOL CELL, V5, P194; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KIRCHHAUSEN T, 1989, P NATL ACAD SCI USA, V86, P2612, DOI 10.1073/pnas.86.8.2612; LICHTE B, 1992, EMBO J, V11, P2521, DOI 10.1002/j.1460-2075.1992.tb05317.x; LIU JP, 1994, J BIOL CHEM, V269, P21043; MAHAFFEY DT, 1990, J BIOL CHEM, V265, P16514; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; PATHAK RK, 1989, J HISTOCHEM CYTOCHEM, V37, P69, DOI 10.1177/37.1.2491753; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PEELER JS, 1993, J CELL BIOL, V120, P47, DOI 10.1083/jcb.120.1.47; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; SEEDORF K, 1994, J BIOL CHEM, V269, P16009; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; SOSA MA, 1993, J BIOL CHEM, V268, P12537; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; VIGERS GPA, 1986, EMBO J, V5, P2079, DOI 10.1002/j.1460-2075.1986.tb04469.x; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; ZHOU SB, 1993, J BIOL CHEM, V268, P12655	32	171	172	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10079	10083		10.1074/jbc.270.17.10079	http://dx.doi.org/10.1074/jbc.270.17.10079			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730311	hybrid			2022-12-27	WOS:A1995QV41700056
J	LUTTRELL, LM; HAWES, BE; TOUHARA, K; VANBIESEN, T; KOCH, WJ; LEFKOWITZ, RJ				LUTTRELL, LM; HAWES, BE; TOUHARA, K; VANBIESEN, T; KOCH, WJ; LEFKOWITZ, RJ			EFFECT OF CELLULAR EXPRESSION OF PLECKSTRIN HOMOLOGY DOMAINS ON G(I)-COUPLED RECEPTOR SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BETA-GAMMA-SUBUNITS; PH DOMAIN; IDENTIFICATION; TRANSDUCTION; FIBROBLASTS; SEQUENCE; P21(RAS); PATHWAY; DIMERS	Pleckstrin homology (PH) domains are 90-110 amino acid regions of protein sequence homology that are found in a variety of proteins involved in signal transduction and growth control. We have previously reported that the PH domains of several proteins, including beta ARK1, PLC gamma, IRS-1, Ras-GRF, and Ras-GAP, expressed as glutathione S-transferase fusion proteins, can reversibly bind purified bovine brain GP gamma subunits in vitro with varying affinity. To determine whether PH domain peptides would behave as antagonists of GP gamma subunit-mediated signal transduction in intact cells, plasmid minigene constructs encoding these PH domains were prepared, which permit transient cellular expression of the peptides. Pertussis toxin-sensitive, GP gamma subunit-mediated inositol phosphate (IF) product ion was significantly inhibited in COS-7 cells transiently coexpressing the alpha 2-C10 adrenergic receptor (AR) and each of the PH domain peptides. Pertussis toxin-insensitive, G(q) alpha subunit-mediated IP production via coexpressed M1 muscarinic acetylcholine receptor (Mi AChR) was attenuated only by the PLC gamma PH domain peptide, suggesting that the inhibitory effect of most of the PH domain peptides was G beta gamma subunit-specific. Stimulation of the mitogen-activated protein (MAP) kinase pathway by G(i)-coupled receptors in COS-7 cells has been reported to require activation of p21(ras) and to be independent of protein kinase C. Since several proteins involved in activation contain PH domains, the effect of PH domain peptide expression on alpha 2-C10 AR-mediated p21(ras)-GTP exchange and MAP kinase activation as well as direct G beta gamma subunit-mediated activation of MAP kinase was determined. In each assay, coexpression of the PH domain peptides resulted in significant inhibition. Increasing G beta gamma subunit expression surmounted PH domain peptide-mediated inhibition of MAP kinase activation. These data suggest that the PH domain peptides behave as specific antagonists of G beta gamma-mediated signaling in intact cells and that interactions between PH domains and G beta gamma subunits or structurally related proteins may play a role in the activation of mitogenic signaling pathways by G protein-coupled receptors.	DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Duke University; Howard Hughes Medical Institute; Duke University; Duke University			Lefkowitz, Robert/AAW-2649-2021	Luttrell, Louis/0000-0003-2805-6949	NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBLAS J, 1993, J BIOL CHEM, V268, P22235; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DAVIS LH, 1994, J BIOL CHEM, V269, P4409; DURONIO RJ, 1992, PROTEINS, V13, P41, DOI 10.1002/prot.340130105; FAURE M, 1994, J BIOL CHEM, V269, P7851; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; GRABER SG, 1992, J BIOL CHEM, V267, P13123; HALSMA RJ, 1993, NATURE, V363, P310; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HAWES BE, 1994, J BIOL CHEM, V269, P15776; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; HOWE LR, 1993, J BIOL CHEM, V268, P20717; INGLESE J, 1994, P NATL ACAD SCI USA, V91, P3637, DOI 10.1073/pnas.91.9.3637; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NEER EJ, 1994, PROTEIN SCI, V3, P3; PEITSCH MC, 1993, TRENDS BIOCHEM SCI, V18, P292, DOI 10.1016/0968-0004(93)90038-O; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; WINITZ S, 1994, J BIOL CHEM, V269, P1889; WINITZ S, 1993, J BIOL CHEM, V268, P19196; WU DQ, 1992, J BIOL CHEM, V267, P1811; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; YATSUNAMI K, 1985, P NATL ACAD SCI USA, V82, P1936, DOI 10.1073/pnas.82.7.1936; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0	44	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12984	12989		10.1074/jbc.270.22.12984	http://dx.doi.org/10.1074/jbc.270.22.12984			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768889	hybrid			2022-12-27	WOS:A1995RB43900010
J	BARR, DP; MASON, RP				BARR, DP; MASON, RP			MECHANISM OF RADICAL PRODUCTION FROM THE REACTION OF CYTOCHROME-C WITH ORGANIC HYDROPEROXIDES - AN ESR SPIN-TRAPPING INVESTIGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; OXIDATION; RESONANCE; PEROXYL; ALKOXYL; PROTEINS; CATALASE; HEMATIN; HEART	The mechanism for the reaction of cytochrome c with t-butyl hydroperoxide and cumene hydroperoxide was investigated, ESR spin trapping studies using 5,5-dimethyl-1-pyrroline N-oxide were performed to demonstrate the presence of hydroperoxide-derived peroxyl, alkoxyl, and methyl radicals. Computer simulation of the experimental data obtained at various 5,5-dimethyl-1-pyrroline N-oxide concentrations was used to determine the relative contributions of each radical adduct to each composite ESR spectrum, From these analyses, it was concluded that the alkoxyl radical of the hydroperoxide was the initial radical produced, presumably by homolytic scission of the O-O bond by ferric cytochrome c. This was in contrast to a previous ESR study that proposed a heterolytic peroxidase-type mechanism for the reaction of cytochrome c with organic hydroperoxides, Methyl radicals were produced from the beta-scission of the alkoxyl radical, The peroxyl radicals are shown to be secondary products formed from the reaction of oxygen with the methyl radical to produce the methyl peroxyl radical, In separate experiments, visible absorption spectroscopy revealed that the heme center was destroyed during the reaction, Both the heme destruction and production of radical adducts were inhibited by cyanide, presumably due to the formation of a cyanoheme complex.			BARR, DP (corresponding author), NIEHS, MOLEC BIOPHYS LAB, RES TRIANGLE PK, NC 27709 USA.		Mason, Ronald P/G-5967-2019	Mason, Ronald P/0000-0002-1859-9109				BARTOLI GM, 1994, ARCH BIOCHEM BIOPHYS, V312, P81, DOI 10.1006/abbi.1994.1283; BLUMENTHAL DC, 1980, J BIOL CHEM, V255, P5859; CADENAS E, 1980, BIOCHEM J, V187, P131, DOI 10.1042/bj1870131; CHAMULITRAT W, 1989, J BIOL CHEM, V264, P7889; CHOO KY, 1981, INT J CHEM KINET, V13, P833, DOI 10.1002/kin.550130907; DAVIES MJ, 1988, BIOCHIM BIOPHYS ACTA, V964, P28, DOI 10.1016/0304-4165(88)90063-3; DICKERSON RE, 1971, J BIOL CHEM, V246, P1511; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; DYER C, 1979, BIOCHIM BIOPHYS ACTA, V579, P253, DOI 10.1016/0005-2795(79)90053-9; HANNA PM, 1992, ARCH BIOCHEM BIOPHYS, V296, P640, DOI 10.1016/0003-9861(92)90620-C; HAREL S, 1988, FREE RADICAL RES COM, V5, P11, DOI 10.3109/10715768809068554; HAREL S, 1988, FREE RADICAL RES COM, V5, P21, DOI 10.3109/10715768809068555; INGOLD KU, 1969, ACCOUNTS CHEM RES, V2, P1, DOI 10.1021/ar50013a001; KALYANARAMAN B, 1983, J BIOL CHEM, V258, P3855; KOPPENOL WH, 1984, ISR J CHEM, V24, P11; LEDWITH A, 1973, PROC R SOC LON SER-A, V332, P151, DOI 10.1098/rspa.1973.0018; MAIR RD, 1971, ORGANIC PEROXIDES, V2, P542; MARGOLIASH E., 1966, ADVANCE PROTEIN CHEM, V21, P113, DOI 10.1016/S0065-3233(08)60128-X; MASON RP, 1984, METHOD ENZYMOL, V105, P416; MOREHOUSE KM, 1987, FEBS LETT, V222, P246, DOI 10.1016/0014-5793(87)80379-4; ODONNELL V, 1994, BIOCHEM J, V304, P707, DOI 10.1042/bj3040707; OSHEROFF N, 1980, J BIOL CHEM, V255, P1689; RADI R, 1993, FREE RADICAL BIO MED, V15, P653, DOI 10.1016/0891-5849(93)90169-U; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P112, DOI 10.1016/0003-9861(91)90171-E; RADI R, 1993, ARCH BIOCHEM BIOPHYS, V300, P409, DOI 10.1006/abbi.1993.1055; ROSEN GM, 1980, MOL PHARMACOL, V17, P233; ROUBAL WT, 1966, ARCH BIOCHEM BIOPHYS, V113, P150, DOI 10.1016/0003-9861(66)90168-8; RUSSELL GA, 1957, J AM CHEM SOC, V79, P3871, DOI 10.1021/ja01571a068; SMALL RD, 1979, PHOTOCHEM PHOTOBIOL, V29, P49, DOI 10.1111/j.1751-1097.1979.tb09258.x; TAPPEL AL, 1953, ARCH BIOCHEM BIOPHYS, V44, P378, DOI 10.1016/0003-9861(53)90056-3; TAPPEL AL, 1961, AUTOXIDAT ANTITOX, V1, P325; TERAO J, 1990, MEMBRANE LIPID OXIDA, V1, P219; THORNALLEY PJ, 1983, BIOCHIM BIOPHYS ACTA, V759, P16, DOI 10.1016/0304-4165(83)90183-6; VANDERZEE J, 1989, BIOCHIM BIOPHYS ACTA, V980, P175, DOI 10.1016/0005-2736(89)90397-0; WUTHRICH K, 1971, BIOCHIM BIOPHYS ACTA, V253, P98, DOI 10.1016/0005-2728(71)90237-4	35	92	95	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12709	12716		10.1074/jbc.270.21.12709	http://dx.doi.org/10.1074/jbc.270.21.12709			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759524	hybrid			2022-12-27	WOS:A1995QZ71100060
J	MAYER, A; NEUPERT, W; LILL, R				MAYER, A; NEUPERT, W; LILL, R			TRANSLOCATION OF APOCYTOCHROME-C ACROSS THE OUTER-MEMBRANE OF MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; HEME LYASE; PRECURSOR PROTEINS; YEAST APOISO-1-CYTOCHROME-C; NEUROSPORA-CRASSA; RECEPTOR-SITES; IMPORT; TRANSPORT; REQUIREMENTS; BIOGENESIS	Apocytochrome c follows a unique pathway into mitochondria, Import does not require the general protein translocation machinery, protease-sensitive components of the outer membrane, or a membrane potential across the inner membrane. We investigated the membrane binding and translocation steps of the import reaction using purified outer membrane vesicles (OMV) from Neurospora crassa mitochondria, OMV specifically bound, but did not import apocytochrome c. If, however, specific antibodies were enclosed inside OMV, apocytochrome c was accumulated in soluble form in the lumen. Import was reversible, since apocytochrome c became accessible to external protease after release from the antibodies. Thus, OMV are competent of translocating apocytochrome c into their lumen, but lack a binding partner which traps the apoprotein. In intact mitochondria, cytochrome c heme lyase (CCHL), a peripheral protein of the inner membrane, serves such a function by stably associating with apocytochrome c in a complex which is detectable by co-immunoprecipitation. We suggest a model for the import mechanism of apocytochrome c in which the apoprotein specifically associates with and reversibly passes across the outer membrane. Translocation is rendered unidirectional by stable association with CCHL which serves as a ''trans side receptor.'' Finally, heme is attached by CCHL and the holoprotein folds into its native structure.	UNIV MUNICH, INST PHYSIOL CHEM PHYS BIOCHEM & ZELLBIOL, D-80336 MUNICH, GERMANY	University of Munich				Lill, Roland/0000-0002-8345-6518				BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; DEKRUIJFF B, 1992, MEMBRANE BIOGENESIS, P85; DUMONT ME, 1991, MOL CELL BIOL, V11, P5487, DOI 10.1128/MCB.11.11.5487; DUMONT ME, 1993, MOL CELL BIOL, V13, P6442, DOI 10.1128/MCB.13.10.6442; DUMONT ME, 1988, J BIOL CHEM, V263, P15928; DUMONT ME, 1995, IN PRESS ADV MOL CEL, V43; GONZALES DH, 1990, J BIOENERG BIOMEMBR, V22, P753; HAKVOORT TBM, 1990, P NATL ACAD SCI USA, V87, P4996, DOI 10.1073/pnas.87.13.4996; HALLERMAYER G, 1974, H-S Z PHYSIOL CHEM, V355, P279, DOI 10.1515/bchm2.1974.355.1.279; Hannavy K, 1993, CURR OPIN CELL BIOL, V5, P694, DOI 10.1016/0955-0674(93)90142-D; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; HENNIG B, 1983, METHOD ENZYMOL, V97, P261; HENNIG B, 1983, P NATL ACAD SCI-BIOL, V80, P4963, DOI 10.1073/pnas.80.16.4963; JORDI W, 1989, J BIOL CHEM, V264, P2292; KIEBLER M, 1993, J MEMBRANE BIOL, V135, P191; MATHEWS FS, 1985, PROG BIOPHYS MOL BIO, V45, P1, DOI 10.1016/0079-6107(85)90004-5; MAYER A, 1995, CELL, V80, P127, DOI 10.1016/0092-8674(95)90457-3; MAYER A, 1993, J CELL BIOL, V121, P1233, DOI 10.1083/jcb.121.6.1233; MAYER A, 1995, IN PRESS METHODS ENZ; NARGANG FE, 1988, J BIOL CHEM, V263, P9388; NICHOLSON DW, 1987, EUR J BIOCHEM, V164, P147, DOI 10.1111/j.1432-1033.1987.tb11006.x; NICHOLSON DW, 1989, P NATL ACAD SCI USA, V86, P4340, DOI 10.1073/pnas.86.12.4340; NICHOLSON DW, 1988, J BIOL CHEM, V263, P19034; NYE SH, 1990, MOL CELL BIOL, V10, P5763, DOI 10.1128/MCB.10.11.5763; NYE SH, 1990, MOL CELL BIOL, V10, P5753, DOI 10.1128/MCB.10.11.5753; OOI CE, 1992, CELL, V71, P87, DOI 10.1016/0092-8674(92)90268-H; PFALLER R, 1988, J CELL BIOL, V107, P2483, DOI 10.1083/jcb.107.6.2483; PFANNER N, 1985, EMBO J, V4, P2819, DOI 10.1002/j.1460-2075.1985.tb04009.x; RIETVELD A, 1984, J BIOL CHEM, V259, P6704; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1991, METHOD CELL BIOL, V34, P345; SPRINKLE JR, 1990, P NATL ACAD SCI USA, V87, P5729, DOI 10.1073/pnas.87.15.5729; STUART RA, 1990, BIOCHIMIE, V72, P115, DOI 10.1016/0300-9084(90)90136-5; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; ZIMMERMANN R, 1981, EUR J BIOCHEM, V116, P455, DOI 10.1111/j.1432-1033.1981.tb05357.x	38	100	102	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12390	12397		10.1074/jbc.270.21.12390	http://dx.doi.org/10.1074/jbc.270.21.12390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759479	hybrid			2022-12-27	WOS:A1995QZ71100012
J	REYMOND, CD; BEGHDADIRAIS, C; ROGGERO, M; DUARTE, EA; DESPONDS, C; BERNARD, M; GROUX, D; MATILE, H; BRON, C; CORRADIN, G; FASEL, NJ				REYMOND, CD; BEGHDADIRAIS, C; ROGGERO, M; DUARTE, EA; DESPONDS, C; BERNARD, M; GROUX, D; MATILE, H; BRON, C; CORRADIN, G; FASEL, NJ			ANCHORING OF AN IMMUNOGENIC PLASMODIUM-FALCIPARUM CIRCUMSPOROZOITE PROTEIN ON THE SURFACE OF DICTYOSTELIUM-DISCOIDEUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL ALKALINE-PHOSPHATASE; HUMAN MALARIA PARASITE; T-CELL EPITOPES; MEMBRANE ANCHOR; ORAL SALMONELLA; VACCINE; EXPRESSION; GENE; SPOROZOITE; SEQUENCE	The circumsporozoite protein (CSP), a major antigen of Plasmodium falciparum, was expressed in the slime mold Dictyostelium discoideum. Fusion of the parasite protein to a leader peptide derived from Dictyostelium contact site A was essential for expression. The natural parasite surface antigen, however, was not detected at the slime mold cell surface as expected but retained intracellularly. Removal of the last 23 amino acids re suited in secretion of CSP, suggesting that the C-terminal segment of the CSP, rather than an ectoplasmic domain, was responsible for retention, Cell surface expression was obtained when the CSP C-terminal segment was replaced by the D. discoideum contact site A glycosyl phosphatidylinositol anchor signal sequence. Mice were immunized with Dictyostelium cells harboring CSP at their surface, The raised antibodies recognized two different regions of the CSP, Anti-sporozoite titers of these sera were equivalent to anti-peptide titers detected by enzyme-linked immunosorbent assay, Thus, cell surface targeting of antigens can be obtained in Dictyostelium, generating sporozoite-like cells having potentials for vaccination, diagnostic tests, or basic studies involving parasite cell surface proteins.	UNIV LAUSANNE, INST BIOCHEM, CH-1066 EPALINGES, SWITZERLAND; UNIV LAUSANNE, INST HISTOL & EMBRYOL, CH-1005 LAUSANNE, SWITZERLAND; F HOFFMANN LA ROCHE & CO LTD, PHARMA RES DEPT, CH-4002 BASEL, SWITZERLAND	University of Lausanne; University of Lausanne; Roche Holding			Fasel, Nicolas/O-4253-2016	Fasel, Nicolas/0000-0003-0136-7245				AGGARWAL A, 1990, J EXP MED, V172, P1083, DOI 10.1084/jem.172.4.1083; BALLOU WR, 1987, LANCET, V1, P1277; BARTH A, 1994, J CELL BIOL, V124, P205, DOI 10.1083/jcb.124.1.205; BEGHDADIRAIS C, 1993, J CELL SCI, V105, P831; BLUMTIROUVANZIAM U, 1994, J IMMUNOL, V153, P4134; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BORDIER C, 1986, P NATL ACAD SCI USA, V83, P5988, DOI 10.1073/pnas.83.16.5988; BOULANGER N, 1988, ACTA TROP, V45, P55; CALVOCALLE JM, 1993, J IMMUNOL, V150, P1403; CARAS IW, 1994, BRAZ J MED BIOL RES, V27, P185; CARDELLI JA, 1989, J BIOL CHEM, V264, P3454; CASPERS P, 1989, MOL BIOCHEM PARASIT, V35, P185, DOI 10.1016/0166-6851(89)90121-7; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; CONZELMANN A, 1986, EMBO J, V5, P3291, DOI 10.1002/j.1460-2075.1986.tb04642.x; CORRADIN G, 1994, CLIN IMMUNOTHER, V1, P191, DOI 10.1007/BF03258505; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; DELAHUNTY MD, 1993, J BIOL CHEM, V268, P12017; DONTFRAID F, 1988, MOL BIOL MED, V5, P185; ENEA V, 1984, SCIENCE, V225, P628, DOI 10.1126/science.6204384; ETLINGER HM, 1988, J IMMUNOL, V140, P626; FASEL N, 1991, CELL BIOL INT REP, V15, P1051; FASEL N, 1992, GENE, V111, P157, DOI 10.1016/0378-1119(92)90683-G; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; Glenn D., 1988, Australian Journal of Biotechnology, V1, P48; GOOD MF, 1987, SCIENCE, V235, P1059, DOI 10.1126/science.2434994; HAYNES PA, 1993, EUR J BIOCHEM, V216, P729, DOI 10.1111/j.1432-1033.1993.tb18192.x; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; HOFFMAN SL, 1991, SCIENCE, V252, P520, DOI 10.1126/science.2020852; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; KAISER CA, 1987, SCIENCE, V235, P312, DOI 10.1126/science.3541205; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; LEW AM, 1989, J IMMUNOL, V142, P4012; Loomis W., 2012, DEV DICTYOSTELIUM DI; LOUVION JF, 1991, NUCLEIC ACIDS RES, V19, P6133, DOI 10.1093/nar/19.22.6133; LOWE ME, 1992, J CELL BIOL, V116, P799, DOI 10.1083/jcb.116.3.799; LUNA EJ, 1984, J CELL BIOL, V99, P58, DOI 10.1083/jcb.99.1.58; MANIAK M, 1990, NUCLEIC ACIDS RES, V18, P3211, DOI 10.1093/nar/18.11.3211; MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P157, DOI 10.1073/pnas.87.1.157; MORAN P, 1992, J CELL BIOL, V119, P763, DOI 10.1083/jcb.119.4.763; MORAN P, 1991, J CELL BIOL, V115, P329, DOI 10.1083/jcb.115.2.329; NARDIN EH, 1993, ANNU REV IMMUNOL, V11, P687, DOI 10.1146/annurev.iy.11.040193.003351; NELLEN W, 1985, GENE, V39, P155, DOI 10.1016/0378-1119(85)90309-9; NOEGEL A, 1986, EMBO J, V5, P1473, DOI 10.1002/j.1460-2075.1986.tb04384.x; NUSSENZWEIG RS, 1994, SCIENCE, V265, P1381, DOI 10.1126/science.8073276; NUSSENZWEIG V, 1989, ADV IMMUNOL, V45, P283, DOI 10.1016/S0065-2776(08)60695-1; POOLE S, 1981, J MOL BIOL, V153, P273, DOI 10.1016/0022-2836(81)90278-3; REYMOND CD, 1984, CELL, V39, P141, DOI 10.1016/0092-8674(84)90199-5; ROMERO PJ, 1988, EUR J IMMUNOL, V18, P1951, DOI 10.1002/eji.1830181213; SADOFF JC, 1988, SCIENCE, V240, P336, DOI 10.1126/science.3281260; Sambrook J, 1989, MOL CLONING LABORATO; SHARMA S, 1985, SCIENCE, V228, P879, DOI 10.1126/science.3890178; SIU CH, 1988, BIOCHEM CELL BIOL, V66, P1089, DOI 10.1139/o88-126; STADLER J, 1989, EMBO J, V8, P371, DOI 10.1002/j.1460-2075.1989.tb03387.x; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; VAUTI F, 1990, MOL CELL BIOL, V10, P4080, DOI 10.1128/MCB.10.8.4080; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WARRICK HM, 1988, NUCLEIC ACIDS RES, V16, P6617, DOI 10.1093/nar/16.14.6617; YOUNG JF, 1985, SCIENCE, V228, P958, DOI 10.1126/science.2988125	59	31	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12941	12947		10.1074/jbc.270.21.12941	http://dx.doi.org/10.1074/jbc.270.21.12941			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759554	hybrid			2022-12-27	WOS:A1995QZ71100092
J	WELTER, JF; CRISH, JF; AGARWAL, C; ECKERT, RL				WELTER, JF; CRISH, JF; AGARWAL, C; ECKERT, RL			FOS-RELATED ANTIGEN (FRA-1), JUNB, AND JUND ACTIVATE HUMAN INVOLUCRIN PROMOTER TRANSCRIPTION BY BINDING TO PROXIMAL AND DISTAL AP1 SITES TO MEDIATE PHORBOL ESTER EFFECTS OIL PROMOTER ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL KERATINOCYTES; CROSS-LINKED ENVELOPE; HUMAN KERATIN-1 GENE; C-FOS; MESSENGER-RNA; ULTRASTRUCTURAL-LOCALIZATION; TERMINAL DIFFERENTIATION; CORNIFIED ENVELOPE; PROTEIN COMPLEXES; TRANSGENIC MICE	Human involucrin (hINV) is a cornified envelope precursor that is specifically expressed in the suprabasal epidermal layers. We previously demonstrated that 2500 base pairs of the hINV gene upstream regulatory region confers differentiation appropriate regulation in transgenic mice. An analysis of the hINV gene sequence upstream of the transcription start site reveals five potential AP1 binding sites (AP1-1 to 5). Using reporter gene constructs in human keratinocytes, we show that the most distal (AP1-5) and most proximal (AP1-1) AP1 sites are essential for high level transcriptional activity. Simultaneous mutation of these sites reduces transcription by 80%. Gel supershift experiments indicate the interaction of these sites with Fra-1, junB, and junD. Involucrin mRNA levels increase 10-fold and promoter activity 5-11-fold when differentiation is induced by phorbol ester. Functional studies implicate AP1-1 and AP1-5 in mediating the phorbol ester-dependent increase in promoter activity. No involucrin promoter activity or involucrin mRNA was detected in 3T3 fibroblasts. We conclude that (i) two AP1 sites in the hINV promoter are important elements required for keratinocyte specific expression, (ii) these AP1-1 sites mediate the phorbol ester-dependent increase in promoter activity, and (iii) Fra-1, junB, and junD may be important regulators of hINV expression in epidermis.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHYSIOL BIOPHYS,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT DERMATOL,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT REPROD BIOL,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT ONCOL,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007678] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07678] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; BASSETSEGUIN N, 1994, ONCOGENE, V9, P765; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; BRASELMANN S, 1993, P NATL ACAD SCI USA, V90, P1657, DOI 10.1073/pnas.90.5.1657; CANDELIERE GA, 1991, MOL ENDOCRINOL, V5, P1780, DOI 10.1210/mend-5-12-1780; CASTELLAZZI M, 1991, P NATL ACAD SCI USA, V88, P8890, DOI 10.1073/pnas.88.20.8890; COHEN D R, 1989, Critical Reviews in Oncogenesis, V1, P65; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; CRISH JF, 1993, DIFFERENTIATION, V53, P191, DOI 10.1111/j.1432-0436.1993.tb00708.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DJIAN P, 1993, MOL BIOL EVOL, V10, P1136; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; ECKERT RL, 1989, PHYSIOL REV, V69, P1316, DOI 10.1152/physrev.1989.69.4.1316; ECKERT RL, 1986, CELL, V46, P83; FISHER C, 1991, DEVELOPMENT, V111, P253; GILFIX BM, 1985, J BIOL CHEM, V260, P1406; HANNAN RD, 1993, J MOL CELL CARDIOL, V25, P1137, DOI 10.1006/jmcc.1993.1127; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HUFF CA, 1993, J BIOL CHEM, V268, P377; KAY R, 1987, NUCLEIC ACIDS RES, V15, P2778, DOI 10.1093/nar/15.6.2778; KOVARY K, 1992, MOL CELL BIOL, V12, P5015, DOI 10.1128/MCB.12.11.5015; LEE E, 1991, CARCINOGENESIS, V12, P1651, DOI 10.1093/carcin/12.9.1651; LEE SC, 1993, J BIOL CHEM, V268, P12164; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LONGLEY J, 1991, J INVEST DERMATOL, V97, P974, DOI 10.1111/1523-1747.ep12491890; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; MIANO JM, 1993, AM J PATHOL, V142, P715; MULLER R, 1983, NATURE, V304, P454, DOI 10.1038/304454a0; MURTHY S, 1993, J STRUCT BIOL, V111, P68, DOI 10.1006/jsbi.1993.1037; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; PARK K, 1992, J BIOL CHEM, V267, P10810; PERSICO AM, 1993, MOL BRAIN RES, V20, P91, DOI 10.1016/0169-328X(93)90113-4; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; REDNER RL, 1992, ONCOGENE, V7, P43; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; ROTHNAGEL JA, 1993, J INVEST DERMATOL, V101, P506, DOI 10.1111/1523-1747.ep12365886; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; STEPHENS JM, 1993, MOL CELL BIOCHEM, V123, P63, DOI 10.1007/BF01076476; STEVEN AC, 1990, J STRUCT BIOL, V104, P150, DOI 10.1016/1047-8477(90)90071-J; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; TAKAHASHI H, 1993, J INVEST DERMATOL, V100, P10, DOI 10.1111/1523-1747.ep12349867; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; THIERRY F, 1992, J VIROL, V66, P3740, DOI 10.1128/JVI.66.6.3740-3748.1992; WANG ZQ, 1993, J BONE MINER RES, V8, P839; WARHOL MJ, 1982, HUM PATHOL, V13, P1095, DOI 10.1016/S0046-8177(82)80245-1; WATT FM, 1981, J CELL BIOL, V90, P738, DOI 10.1083/jcb.90.3.738; WIRTH PJ, 1987, CANCER RES, V47, P2831; YAFFE MB, 1993, J INVEST DERMATOL, V100, P3, DOI 10.1111/1523-1747.ep12349857; YAFFE MB, 1992, J BIOL CHEM, V267, P12233; Yoneda Kozo, 1992, Journal of Dermatology (Tokyo), V19, P761; YOUNUS J, 1992, J CELL PHYSIOL, V152, P232, DOI 10.1002/jcp.1041520203; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	63	179	183	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12614	12622		10.1074/jbc.270.21.12614	http://dx.doi.org/10.1074/jbc.270.21.12614			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759510	hybrid			2022-12-27	WOS:A1995QZ71100045
J	CHANG, JY; SCHINDLER, P; CHATRENET, B				CHANG, JY; SCHINDLER, P; CHATRENET, B			THE DISULFIDE STRUCTURES OF SCRAMBLED HIRUDINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; RECOMBINANT HIRUDIN; THROMBIN; DOMAIN	Scrambled hirudins consist of a collection of equilibrated isomers and serve as essential folding intermediates during the in vitro renaturation of hirudin (Chatrenet, B., and Chang, J.-Y. (1993) J. Biol. Chem, 268, 20988-20996). Ten fractions of scrambled hirudins have been isolated. Their disulfide structures were deduced from the analysis of thermolysin digested peptides by amino acid sequencing and mass spectrometry. The results reveal 9 fractions of pure scrambled species, and, together, 11 species of scrambled structures have been identified, About all possible disulfide isomers of hirudin have been found to exist, The three native disulfides, Cys(6)-Cys(14), Cys(16)-Cys(28), Cys(22)-Cys(39), detected in five different scrambled species and constitute 18% of the total disulfide bonds found in scrambled hirudins.			CHANG, JY (corresponding author), CIBA GEIGY LTD,PHARMACEUT RES LABS,K-121,104,CH-4002 BASEL,SWITZERLAND.							ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BOERNSEN KO, 1990, CHIMIA, V44, P412; CHANG JY, 1994, J BIOL CHEM, V269, P22087; CHANG JY, 1990, J BIOL CHEM, V265, P22159; CHANG JY, 1994, BIOCHEM J, V300, P643, DOI 10.1042/bj3000643; CHANG JY, 1983, FEBS LETT, V164, P307, DOI 10.1016/0014-5793(83)80307-X; CHATRENET B, 1993, J BIOL CHEM, V268, P20988; CREIGHTON TE, 1979, J MOL BIOL, V129, P411, DOI 10.1016/0022-2836(79)90504-7; DODT J, 1986, BIOL CHEM H-S, V367, P803, DOI 10.1515/bchm3.1986.367.2.803; Fenton J W 2nd, 1981, Ann N Y Acad Sci, V370, P468, DOI 10.1111/j.1749-6632.1981.tb29757.x; FOLKERS PJM, 1989, BIOCHEMISTRY-US, V28, P2601, DOI 10.1021/bi00432a038; GRUETTER M, 1990, EMBO J, V9, P2361; HABER E, 1962, J BIOL CHEM, V237, P1839; HANIU M, 1994, INT J PEPT PROT RES, V43, P81; HARUYAMA H, 1989, BIOCHEMISTRY-US, V28, P4301, DOI 10.1021/bi00436a027; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KRSTENANSKY JL, 1987, FEBS LETT, V211, P10, DOI 10.1016/0014-5793(87)81264-4; MAO SJT, 1988, BIOCHEMISTRY-US, V27, P8170, DOI 10.1021/bi00421a027; MARKWARDT F, 1985, BIOMED BIOCHIM ACTA, V44, P1007; MARKWARDT F, 1958, H-S Z PHYSIOL CHEM, V312, P85, DOI 10.1515/bchm2.1958.312.1.85; Markwardt F., 1970, METHOD ENZYMOL, V19, P924, DOI [10.1016/0076-6879(70)19082-3, DOI 10.1016/0076-6879(70)19082-3]; RAMSEIER U, 1994, ANAL BIOCHEM, V221, P231, DOI 10.1006/abio.1994.1406; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; ZHANG RM, 1991, BIOCHEMISTRY-US, V30, P11343, DOI 10.1021/bi00111a021	26	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11992	11997		10.1074/jbc.270.20.11992	http://dx.doi.org/10.1074/jbc.270.20.11992			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744849	hybrid			2022-12-27	WOS:A1995QY73600049
J	LIAO, K; LANE, MD				LIAO, K; LANE, MD			THE BLOCKADE OF PREADIPOCYTE DIFFERENTIATION BY PROTEIN-TYROSINE-PHOSPHATASE HA2 IS REVERSED BY VANADATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; INDUCED GENE-EXPRESSION; STEAROYL-COA DESATURASE; 3T3-L1 PREADIPOCYTES; MAMMALIAN-CELLS; MESSENGER-RNAS; HUMAN-PLACENTA; FATTY-ACID; DNA; ADIPOCYTES	A tyrosine phosphatase, i.e, PTPase HA2, was previously isolated from 3T3-L1 cells and characterized using O-phospho Tyrosine(19)-422/aP2 protein (a target of the insulin receptor tyrosine kinase) as substrate. The nucleotide sequence of a PTPase HA2 cDNA showed it to be a homologue of PTPase 1B. When induced to differentiate into adipocytes, confluent 3T3-L1 preadipocytes undergo mitotic clonal expansion followed by growth arrest and then coordinate expression of adipocyte genes, During clonal expansion, expression of PTPase HA2 increases abruptly and then decreases concomitant with the transcriptional activation of adipocyte genes, Constitutive expression of the PTPase by 3T3-L1 preadipocytes using a PTPase HA2 expression vector prevents adipocyte gene expression and differentiation into adipocytes, Appropriately timed exposure of transfected preadipocytes to vanadate (a PTPase inhibitor), just as clonal expansion ceases restores their capacity to differentiate, Treatment of transfected preadipocytes with vanadate prior to or during clonal expansion fails to reverse PTPase HA2-blocked differentiation, whereas treatment of untransfected preadipocytes during mitotic clonal expansion blocks differentiation. Vanadate added following clonal expansion has no effect on differentiation. Thus, a critical tyrosine phosphorylation event(s) occurs between termination of clonal expansion and initiation of adipocyte gene expression while a critical tyrosine dephosphorylation event(s) occurs during clonal expansion.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205	Johns Hopkins University								BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BERNIER M, 1988, J BIOL CHEM, V263, P13626; BERNIER M, 1987, P NATL ACAD SCI USA, V84, P844; BERNLOHR DA, 1984, P NATL ACAD SCI-BIOL, V81, P5468, DOI 10.1073/pnas.81.17.5468; BERNLOHR DA, 1985, J BIOL CHEM, V260, P5563; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V24, P5294; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROST SC, 1987, J BIOL CHEM, V262, P9872; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HOFFMAN RD, 1992, J BIOL CHEM, V267, P14005; HRESKO RC, 1990, J BIOL CHEM, V265, P21075; HRESKO RC, 1988, P NATL ACAD SCI USA, V88, P8835; KAESTNER KH, 1989, J BIOL CHEM, V264, P14755; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; KARASUYAMA H, 1989, J EXP MED, V169, P13, DOI 10.1084/jem.169.1.13; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO K, 1991, J BIOL CHEM, V266, P6544; LIAO K, 1994, FASEB J, V82; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; MACDOUGALD OA, 1994, ANN REV BIOCH, V64, P345; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; MCMASTER GK, 1977, P NATL ACAD SCI USA, V77, P5201; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293; THOMAS PS, 1980, P NATL ACAD SCI USA, V77, P4835; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; VASSEURCOGNET M, 1993, CURR OPIN GENET DEV, V3, P238, DOI 10.1016/0959-437X(93)90029-O; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; YANG VW, 1989, P NATL ACAD SCI USA, V86, P3629, DOI 10.1073/pnas.86.10.3629	42	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12123	12132		10.1074/jbc.270.20.12123	http://dx.doi.org/10.1074/jbc.270.20.12123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744861	hybrid			2022-12-27	WOS:A1995QY73600064
J	MYERS, MG; GRAMMER, TC; BROOKS, J; GLASHEEN, EM; WANG, LM; SUN, XJ; BLENIS, J; PIERCE, JH; WHITE, MF				MYERS, MG; GRAMMER, TC; BROOKS, J; GLASHEEN, EM; WANG, LM; SUN, XJ; BLENIS, J; PIERCE, JH; WHITE, MF			THE PLECKSTRIN HOMOLOGY DOMAIN IN INSULIN-RECEPTOR SUBSTRATE-1 SENSITIZES INSULIN SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PHOSPHATIDYLINOSITOL 3-KINASE; IRS-1; ACTIVATION; PROTEIN; TRANSMISSION; MUSCLE; CELLS	The NH2 terminus of insulin receptor substrate-1 (IRS-1) contains a pleckstrin homology (PH) domain. We deleted the PH domain in IRS-1 (IRS-1(Delta PH)) and expressed the mutant in Chinese hamster ovary and 32D cells. During insulin stimulation, IRS-1(Delta PH) is poorly tyrosine-phosphorylated in CHO cells, but undergoes serine/threonine phosphorylation. Similarly, IRS-1(Delta PH) fails to undergo insulin-stimulated tyrosine phosphorylation in 32D cells, which uncouples the activation of phosphatidylinositol 3'-kinase and p70(s6k) from the endogenous insulin receptors. Overexpression of the insulin receptor in 32D(IR) cells, however, restores tyrosine phosphorylation of IRS-1(Delta PH) and rescues insulin responses including mitogenesis. Thus, while the PH domain is not required for the engagement of downstream signals, it is one of the elements in the NH2 terminus of IRS-1 that is needed for a sensitive coupling to insulin receptors, especially at ordinary receptor levels found in most cells and tissues.	DIV RES, BOSTON, MA 02215 USA						NCI NIH HHS [CA 46595] Funding Source: Medline; NIDDK NIH HHS [DK 38712, DK 43808] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA046595, R01CA046595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R55DK038712, R01DK043808, R29DK038712] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARAKI E, 1993, DIABETES, V42, P1041, DOI 10.2337/diabetes.42.7.1041; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; GUSTAFSON TA, 1995, IN PRESS MOL CELL BI; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; KARANAUGH WM, 1994, SCIENCE, V266, P1862; KELLER SR, 1993, BIOCHIM BIOPHYS ACTA, V1172, P323, DOI 10.1016/0167-4781(93)90222-Y; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; MYERS MG, 1994, J BIOL CHEM, V269, P28783; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WHITE MF, 1991, METHOD ENZYMOL, V201, P65; YONEZAWA K, 1994, J BIOL CHEM, V269, P4634; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0	27	116	117	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11715	11718		10.1074/jbc.270.20.11715	http://dx.doi.org/10.1074/jbc.270.20.11715			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744813	hybrid			2022-12-27	WOS:A1995QY73600004
J	WALDMANN, R; CHAMPIGNY, G; LAZDUNSKI, M				WALDMANN, R; CHAMPIGNY, G; LAZDUNSKI, M			FUNCTIONAL DEGENERIN-CONTAINING CHIMERAS IDENTIFY RESIDUES ESSENTIAL FOR AMILORIDE-SENSITIVE NA+ CHANNEL FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CAENORHABDITIS-ELEGANS; NEURODEGENERATION; EXPRESSION; CELLS	The highly selective, amiloride-sensitive Na+ channel is formed of three homologous subunits termed alpha, beta, and gamma. The three subunits exhibit similarities with Caenorhabditis elegans proteins called degenerins involved in sensory touch transduction and, when mutated, in neurodegeneration. Swelling of neurons observed in neurodegeneration suggests an involvement of ion transport, but the channel function of degenerins has not yet been demonstrated. We used chimeras to study the functional relationship between the epithelial sodium channel and the degenerin Mec-4. Exchange of the hydrophobic domains of the Na+ channel alpha subunit by those of Mec-4 results in a functional ion channel with changed pharmacology for amiloride and benzamil and changed selectivity, conductance, gating, and voltage dependence. All of these differences were also obtained by exchanging Ser-589 and Ser-593 in the second transmembrane region by the corresponding residues of Mec-4, suggesting that these two residues are essential for the ionic pore function of the channel.	INST PHARMACOL MOLEC & CELLULAIRE,F-06560 VALBONNE,FRANCE				Waldmann, Rainer/Q-2108-2016	Waldmann, Rainer/0000-0002-4599-2926				CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; GARTY H, 1994, FASEB J, V8, P523; GUILLEMARE E, 1992, BIOCHEMISTRY-US, V31, P12463, DOI 10.1021/bi00164a024; HAMILL OP, 1992, TRENDS PHARMACOL SCI, V13, P373, DOI 10.1016/0165-6147(92)90115-M; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; JENTSCH TJ, 1994, NATURE, V367, P412, DOI 10.1038/367412a0; LI XJ, 1994, P NATL ACAD SCI USA, V91, P1814, DOI 10.1073/pnas.91.5.1814; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; LINGUEGLIA E, 1994, J BIOL CHEM, V269, P13736; PALMER LG, 1992, ANNU REV PHYSIOL, V54, P51, DOI 10.1146/annurev.ph.54.030192.000411; RENARD S, 1994, J BIOL CHEM, V269, P12981; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; VANDEYAR MA, 1988, GENE, V65, P129, DOI 10.1016/0378-1119(88)90425-8; VANRENTERGHEM C, 1991, PFLUG ARCH EUR J PHY, V419, P401, DOI 10.1007/BF00371123; VIGNE P, 1989, J BIOL CHEM, V264, P7663; VOILLEY N, 1994, P NATL ACAD SCI USA, V91, P247, DOI 10.1073/pnas.91.1.247	21	100	104	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11735	11737		10.1074/jbc.270.20.11735	http://dx.doi.org/10.1074/jbc.270.20.11735			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744818	hybrid			2022-12-27	WOS:A1995QY73600009
J	BHATTACHARJEE, H; LI, JX; KSENZENKO, MY; ROSEN, BP				BHATTACHARJEE, H; LI, JX; KSENZENKO, MY; ROSEN, BP			ROLE OF CYSTEINYL RESIDUES IN METALLOACTIVATION OF THE OXYANION-TRANSLOCATING ARSA ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION PUMP; MOLECULAR CHARACTERIZATION; CATALYTIC SUBUNIT; ESCHERICHIA-COLI; PROTEIN; BINDING; RESISTANCE	The ArsA protein, the catalytic subunit of the oxyan ion-translocating ATPase responsible for resistance to arsenicals and antimonials in Escherichia coli, is activated by arsenite or antimonite. Activation is associated with dimerization of the ArsA protein. Enzymatic activity was rapidly but reversibly inhibited by the sulfhydryl reagent methyl methanethiosulfonate, suggesting that at least one cysteinyl residue is required for catalytic activity. Each of the four cysteinyl residues in the ArsA protein, Cys(26), Cys(113), Cys(172), and Cys(422), were individually changed to seryl residues. The C26S protein had normal properties. Cells expressing the other three mutations lost resistance to arsenite and antimonite. The C113S, C172S, and C422S enzymes each had relatively normal K-m values for ATP but reduced affinity for antimonite and arsenite. The V-max of the activated enzymes ranged from very low for the C113S and C422S enzymes to near normal for the C172S enzyme, These results suggest a mechanism of activation by formation of a tricoordinate complex between Sb(III) or As(LII) and the cysteine thiolates 113, 172, and 422.	WAYNE STATE UNIV,SCH MED,DEPT BIOCHEM,DETROIT,MI 48201	Wayne State University				Rosen, Barry P./0000-0002-5230-4271	NIAID NIH HHS [AI19793] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019793] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHAKRABORTI PK, 1992, J BIOL CHEM, V267, P11366; CHEN CM, 1986, J BIOL CHEM, V261, P5030; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; CRUSE WBT, 1972, ACTA CRYSTALL B-STRU, VB 28, P1325, DOI 10.1107/S0567740872004236; FREEMAN HC, 1975, INORGANIC BIOCH, P153; HELMANN JD, 1990, SCIENCE, V247, P946, DOI 10.1126/science.2305262; HSU CM, 1989, J BIOL CHEM, V264, P17349; HSU CM, 1991, J BIOL CHEM, V266, P2327; KARKARIA CE, 1991, ARCH BIOCHEM BIOPHYS, V288, P107, DOI 10.1016/0003-9861(91)90170-N; KAVOUNIS CA, 1982, ACTA CRYSTALLOGR B, V38, P2686, DOI 10.1107/S0567740882009613; KENNEDY MC, 1988, J BIOL CHEM, V263, P8190; KSENZENKO MY, 1993, BIOCHEMISTRY-US, V32, P13362, DOI 10.1021/bi00211a051; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOBLEY HLT, 1983, MOL GEN GENET, V191, P421, DOI 10.1007/BF00425757; MODARRESS KJ, 1994, J BIOL CHEM, V269, P25621; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; QUIOCHO FA, 1987, NATURE, V329, P561, DOI 10.1038/329561a0; ROSEN BP, 1988, J BIOL CHEM, V263, P3067; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHI WP, 1994, J BIOL CHEM, V269, P19826; SMITH DJ, 1975, BIOCHEMISTRY-US, V14, P766, DOI 10.1021/bi00675a019; TISA LS, 1990, J BIOL CHEM, V265, P190; VOGEL G, 1976, BIOCHEMISTRY-US, V16, P208	25	53	54	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11245	11250		10.1074/jbc.270.19.11245	http://dx.doi.org/10.1074/jbc.270.19.11245			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744758	hybrid			2022-12-27	WOS:A1995QX86500035
J	BRAUN, KP; CODY, RB; JONES, DR; PETERSON, CM				BRAUN, KP; CODY, RB; JONES, DR; PETERSON, CM			A STRUCTURAL ASSIGNMENT FOR A STABLE ACETALDEHYDE-LYSINE ADDUCT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT BINDING; SERUM-ALBUMIN; HEMOGLOBIN; PROTEINS; BACTERIORHODOPSIN; TEETOTALERS; ALDEHYDES; INVIVO; PLASMA	Acetaldehyde is the first oxidation product of ethanol in vivo. Lysine residues in proteins such as hemoglobin have been implicated as target structures for acetaldehyde adducts resulting from ethanol consumption. Although the presence of both stable and unstable acetaldehyde-hemoglobin adducts has been established, the structural characterization of the adducts has received relatively little attention, As a model for such adduct formation, we studied the peptide pentalysine in vitro. Pentalysine has several potential sites for adduct formation, The amino-terminal amine group as well as the E-amine groups of each lysine side chain can serve as potential sites for modification by acetaldehyde, Mass spectrometry, nuclear magnetic resonance, and Raman spectroscopy were employed to demonstrate that acetaldehyde forms a stable linkage to lysine amine groups via a Schiff base.	CALIF POLYTECH STATE UNIV SAN LUIS OBISPO,SAN LUIS OBISPO,CA 93407; JEOL USA,PEABODY,MA 01960	California State University System; California Polytechnic State University San Luis Obispo; Jeol Ltd; JEOL USA	BRAUN, KP (corresponding author), SANSUM MED RES FDN,2219 BATH ST,SANTA BARBARA,CA 93105, USA.		Peterson, Karen/E-8084-2015	Peterson, Karen/0000-0001-6737-8698	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007614] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA07614] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AUSTIN JE, 1992, P NATL ACAD SCI USA, V89, P8439, DOI 10.1073/pnas.89.18.8439; BARRY RE, 1987, LIVER, V7, P364; BEHRENS UJ, 1988, BIOCHEM BIOPH RES CO, V154, P584, DOI 10.1016/0006-291X(88)90180-5; DING A, 1993, P NATL ACAD SCI USA, V90, P3797, DOI 10.1073/pnas.90.9.3797; DONOHUE TM, 1983, ARCH BIOCHEM BIOPHYS, V220, P239, DOI 10.1016/0003-9861(83)90406-X; FRAENKELCONRAT H, 1988, P NATL ACAD SCI USA, V85, P3759; GROSS MD, 1994, ALCOHOL ALCOHOLISM, V29, P31; HALVORSON MR, 1993, ALCOHOL, V10, P409, DOI 10.1016/0741-8329(93)90029-N; HAZELETT SE, 1993, ALCOHOL CLIN EXP RES, V17, P1107, DOI 10.1111/j.1530-0277.1993.tb05672.x; HOBERMAN HD, 1981, ALCOHOL CLIN EXP RES, V6, P260; HOFFMANN T, 1993, ALCOHOL CLIN EXP RES, V17, P69, DOI 10.1111/j.1530-0277.1993.tb00728.x; JAFFE EK, 1990, BIOCHEMISTRY-US, V29, P8345, DOI 10.1021/bi00488a021; JENNETT RB, 1987, ARCH BIOCHEM BIOPHYS, V256, P10, DOI 10.1016/0003-9861(87)90420-6; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; LIVNAH N, 1993, BIOCHEMISTRY-US, V32, P7223, DOI 10.1021/bi00079a019; LORD RC, 1970, J MOL BIOL, V50, P509, DOI 10.1016/0022-2836(70)90208-1; MAUCH TJ, 1987, ALCOHOL ALCOHOLISM, V2, P103; MCKINNON G, 1987, NEUROSCI LETT, V79, P163, DOI 10.1016/0304-3940(87)90690-2; MONNIER VM, 1989, MAILLARD REACTION AG, P1; NGUYEN LB, 1985, ALDEHYDE ADDUCTS ALC; PETERSON CM, 1987, ALCOHOL, V4, P477, DOI 10.1016/0741-8329(87)90089-9; PETERSON CM, 1974, ANN INTERN MED, V81, P152, DOI 10.7326/0003-4819-81-2-152; PETERSON CM, 1993, ALCOHOL, V10, P327, DOI 10.1016/0741-8329(93)90015-G; SANDORFY C, 1970, CHEM CARBON NITROGEN; SANGEORGE RC, 1986, J BIOL CHEM, V261, P6811; SAVOLAINEN MJ, 1987, LIFE SCI, V40, P841, DOI 10.1016/0024-3205(87)90032-4; SILLANAUKEE P, 1992, J LAB CLIN MED, V120, P42; STAHOVEC WL, 1984, J CHROMATOGR, V298, P399; STEVENS VJ, 1981, J CLIN INVEST, V67, P361, DOI 10.1172/JCI110043; THOMPSON LK, 1992, BIOCHEMISTRY-US, V31, P7931, DOI 10.1021/bi00149a026; TUMA DJ, 1987, ALCOHOL CLIN EXP RES, V11, P579, DOI 10.1111/j.1530-0277.1987.tb00178.x; TUMA DJ, 1985, ALDEHYDE ADDUCTS ALC, P3	32	43	45	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11263	11266		10.1074/jbc.270.19.11263	http://dx.doi.org/10.1074/jbc.270.19.11263			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744761	hybrid			2022-12-27	WOS:A1995QX86500038
J	STROM, A; WESTIN, S; EGUCHI, H; GUSTAFSSON, JA; MODE, A				STROM, A; WESTIN, S; EGUCHI, H; GUSTAFSSON, JA; MODE, A			CHARACTERIZATION OF ORPHAN NUCLEAR RECEPTOR-BINDING ELEMENTS IN SEX-DIFFERENTIATED MEMBERS OF THE CYP2C GENE FAMILY EXPRESSED IN RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; INVITRO TRANSCRIPTION; SUPERFAMILY; PROMOTER; HNF-4; ACTIVATION; APOCIII; CELLS	The HepG2-specific P450 2C factor motif (HPF1-motif) is conserved in many hepatic cytochrome P450 genes (CYP). Its functional importance for rabbit CYP2C genes has led to the proposal that the HPF1 motif acts as a common regulator for the liver-specific expression of CYP2 genes with hepatic nuclear factor (HNF)-4 being the corresponding trans-activator, The HPF1-like elements in the rat CYP2C genes 2C7, 2C11, 2C12, and 2C13 have been studied with regard to functional importance and binding of the orphan receptors HNF-4, apoAI reglatory protein-1 (ARP-1), and v-erbA-related receptors (EAR) 3 and 2. Binding activity in rat liver nuclear extracts includes these orphan receptors as judged from electromobility supershift experiments and from results obtained with expressed receptors, although the element in (CYP2C11 did not bind HNF-4, Mutations of the HPF1-like elements in the CYP2C7, CYP2C11, and CYP2C12 promoters had marginal effects on the expression of luciferase reporter gene constructs transiently transfected into HepG2 cells, whereas for CYP2C13 the activity was reduced to 60% of the wild type construct, Coexpression of HNF-4 in COS-7 cells had limited effect on the luciferase activity generated from the 2C promoters, maximally 3 fold. Our data indicate that the HPF1 elements in the rat CYP2C genes have limited functional importance and that HNF-4 is not a major trans-activator for any of these genes.	HUDDINGE UNIV HOSP,KAROLINSKA INST,NOVUM,DEPT MED NUTR,S-14186 HUDDINGE,SWEDEN	Karolinska Institutet			Eguchi, Hiromi/GWC-5633-2022					BERKENSTAM A, 1992, CELL, V69, P401, DOI 10.1016/0092-8674(92)90443-G; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARDOT P, 1993, BIOCHEMISTRY-US, V32, P9080, DOI 10.1021/bi00086a013; CHEN D, 1994, J BIOL CHEM, V269, P5420; GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HARNISH DC, 1994, J BIOL CHEM, V269, P28220; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KIMURA A, 1993, J BIOL CHEM, V268, P11125; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KTISTAKI E, 1994, NUCLEIC ACIDS RES, V22, P4689, DOI 10.1093/nar/22.22.4689; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LEGRAVEREND C, 1994, BIOCHEMISTRY-US, V33, P9889, DOI 10.1021/bi00199a010; LEGRAVEREND C, 1992, MOL ENDOCRINOL, V6, P259, DOI 10.1210/me.6.2.259; MARTINEZ E, 1991, EMBO J, V10, P263, DOI 10.1002/j.1460-2075.1991.tb07946.x; MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; NISHIYORI A, 1994, J BIOL CHEM, V269, P1323; OGAMI K, 1990, J BIOL CHEM, V265, P9808; PAULWEBER B, 1993, MOL CELL BIOL, V13, P1534, DOI 10.1128/MCB.13.3.1534; POWER RF, 1991, SCIENCE, V252, P1546, DOI 10.1126/science.2047861; Sambrook J, 1989, MOL CLONING LABORATO; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SUNDSETH SS, 1992, J BIOL CHEM, V267, P3907; VENEPALLY P, 1992, J BIOL CHEM, V267, P17333; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0	28	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11276	11281		10.1074/jbc.270.19.11276	http://dx.doi.org/10.1074/jbc.270.19.11276			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744763	hybrid			2022-12-27	WOS:A1995QX86500040
J	KNOLL, LJ; JOHNSON, DR; GORDON, JI				KNOLL, LJ; JOHNSON, DR; GORDON, JI			COMPLEMENTATION OF SACCHAROMYCES-CEREVISIAE STRAINS CONTAINING FATTY-ACID ACTIVATION GENE (FAA) DELETIONS WITH A MAMMALIAN ACYL-COA SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A CARBOXYLASE; ESCHERICHIA-COLI; RECOMBINANT THIOESTERASE; OLE1 GENE; EXPRESSION; INHIBITION; TRIACSINS; PROLIFERATION; DESATURASE; TRANSPORT	Four unlinked fatty acid activation (FAA) genes encoding acyl-CoA synthetases have been identified in Saccharomyces cerevisiae and characterized by noting the phenotypes of isogenic strains containing all possible combinations of faa null alleles, None of these genes is required for vegetative growth when acyl-CoA production by the fatty acid synthetase (Fas) complex is active. When Fas is inhibited by cerulenin, exponentially growing cells are not viable on media containing a fermentable carbon source unless supplemented with fatty acids such as myristate, palmitate, or oleate, The functionally interchangeable FAA1 and FAA4 genes are responsible for activation of these imported fatty acids. Analysis of lysates prepared from isogenic FAA1FAA4 and faa1 Delta faa4 Delta strains indicated that Faa1p and Faa4p together account for 99% of total cellular myristoyl-CoA and palmitoyl-CoA synthetase activities. Genetic complementation studies revealed that rat liver acyl-CoA synthetase (RLACS) rescues the viability of faa1 Delta faa4 Delta cells in media containing a fermentable carbon source, myristate or palmitate, plus cerulenin. Rescue is greater at 37 degrees C compared with 24 degrees C, paralleling the temperature-dependent changes in RLACS activity in vitro as well as the enzyme's ability to direct incorporation of tritiated myristate and palmitate into cellular phospholipids in vivo. Complementation by RLACS is blocked by treatment of cells with triacsin C (1-hydroxy-3-(E,E,E,2',4',7'-undecatrienylidine) triazene), Even though Faa1p, Faa4p, and RLACS are all able to activate imported myristate and palmitate in S. cerevisiae, the sensitivity of Faa4p and RLACS, but not Faa1p, to inhibition by triacsin C suggests that the rat liver enzyme is functionally more analogous to Faa4p than to Faa1p, Finally, an assessment of myristate and palmitate import into FAA1FAA4 and faa1 Delta faa4 Delta strains, with or without episomes that direct overexpression of Faa1p, Faa4p or RLACS, indicated that fatty acid uptake is not coupled to activation in S. cerevisiae.	WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL)					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027179, U01AI030188] Funding Source: NIH RePORTER; NIAID NIH HHS [AI30188, AI27179] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABE T, 1992, J BIOCHEM-TOKYO, V111, P123, DOI 10.1093/oxfordjournals.jbchem.a123707; BARTANA J, 1973, BIOCHEM J, V135, P411, DOI 10.1042/bj1350411; BARTANA J, 1973, BIOCHEM J, V131, P199, DOI 10.1042/bj1310199; BERG P, 1956, J BIOL CHEM, V222, P991; BERG P, 1958, SCIENCE, V129, P895; BLACK PN, 1991, J BACTERIOL, V173, P435, DOI 10.1128/jb.173.2.435-442.1991; BLACK PN, 1992, J BIOL CHEM, V267, P25513; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; CAUSERET C, 1993, BIOL CELL, V77, P89, DOI 10.1016/S0248-4900(05)80178-9; DURONIO RJ, 1992, J CELL BIOL, V117, P515, DOI 10.1083/jcb.117.3.515; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; FUJINO T, 1992, J BIOCHEM-TOKYO, V111, P197, DOI 10.1093/oxfordjournals.jbchem.a123737; FUNABASHI H, 1989, J BIOCHEM-TOKYO, V105, P751, DOI 10.1093/oxfordjournals.jbchem.a122739; HORI T, 1987, J BIOCHEM-TOKYO, V101, P949, DOI 10.1093/oxfordjournals.jbchem.a121964; JOHNSON DR, 1994, J BIOL CHEM, V269, P18037; JOHNSON DR, 1994, J CELL BIOL, V127, P751, DOI 10.1083/jcb.127.3.751; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; KNOLL LJ, 1994, J BIOL CHEM, V269, P16348; KNOLL LJ, 1993, J BIOL CHEM, V268, P4281; KOHLWEIN SD, 1983, BIOCHIM BIOPHYS ACTA, V792, P310; LAI K, 1994, J BIOL CHEM, V269, P2245; MCDONOUGH VM, 1992, J BIOL CHEM, V267, P5931; MISHINA M, 1980, EUR J BIOCHEM, V111, P79; NOMURA S, 1972, J BIOCHEM-TOKYO, V71, P783, DOI 10.1093/oxfordjournals.jbchem.a129827; NUNN WD, 1986, J BIOL CHEM, V261, P167; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; PALTAUF F, 1992, MOL CELLULAR BIOL YE, V2, P415; PAZIRANDEH M, 1991, J BIOL CHEM, V266, P20946; PAZIRANDEH M, 1989, J BIOL CHEM, V264, P18195; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SCHOONJANS K, 1993, EUR J BIOCHEM, V216, P615, DOI 10.1111/j.1432-1033.1993.tb18181.x; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; TANAKA H, 1982, J ANTIBIOT, V35, P157, DOI 10.7164/antibiotics.35.157; TOMODA H, 1991, J BIOL CHEM, V266, P4214; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; TRIGATTI BL, 1992, BIOCHEM CELL BIOL, V70, P76, DOI 10.1139/o92-011; VANCE D, 1972, BIOCHEM BIOPH RES CO, V48, P649, DOI 10.1016/0006-291X(72)90397-X; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993	42	50	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10861	10867		10.1074/jbc.270.18.10861	http://dx.doi.org/10.1074/jbc.270.18.10861			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738025				2022-12-27	WOS:A1995QW60100073
J	SCHIAVO, G; SHONE, CC; BENNETT, MK; SCHELLER, RH; MONTECUCCO, C				SCHIAVO, G; SHONE, CC; BENNETT, MK; SCHELLER, RH; MONTECUCCO, C			BOTULINUM NEUROTOXIN TYPE-C CLEAVES A SINGLE LYS-ALA BOND WITHIN THE CARBOXYL-TERMINAL REGION OF SYNTAXINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETANUS TOXIN; NEUROTRANSMITTER RELEASE; SYNAPTIC VESICLES; PROTEIN; ZINC; IDENTIFICATION; RECEPTORS; SEQUENCE; SNAP-25; FUSION	Botulinum neurotoxin serotype C (BoNT/C) is a 150-kDa protein produced by Clostridium botulinum, which causes animal botulism. In contrast to the other botulinum neurotoxins that contain one atom of zinc, highly purified preparations of BoNT/C bind two atoms of zinc per toxin molecule. BoNT/C is a zinc endopeptidase that cleaves syntaxin 1A at the Lys(253)-Ala(254) and syntaxin 1B at the Lys(252)-Ala(253) peptide bonds, only when they are inserted into a lipid bilayer. The other Lys-Ala bond present within the carboxyl-terminal region is not hydrolyzed. Syntaxin isoforms 2 and 3 are also cleaved by BoNT/C, while syntaxin 4 is resistant. These data suggest that BoNT/C recognizes a specific spatial organization of syntaxin, adopted upon membrane insertion, which brings a selected Lys-Ala peptide bond of its carboxyl-terminal region to the active site of this novel metalloproteinase.	UNIV PADUA,DIPARTIMENTO SCI BIOMED,I-35121 PADUA,ITALY; PUBL HLTH LAB SERV,CTR APPL MICROBIOL & RES,PROT TOXINS SECT,SALISBURY SP4 0JG,WILTS,ENGLAND; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720; STANFORD UNIV,HOWARD HUGHES MED INST,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305	University of Padua; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Stanford University	SCHIAVO, G (corresponding author), UNIV PADUA,CTR CONSIGLIO NAZL RIC BIOMEMBRANE,VIA TRIESTE 75,I-35121 PADUA,ITALY.			Schiavo, Giampietro/0000-0002-4319-8745	Telethon [473] Funding Source: Medline	Telethon(Fondazione Telethon)		BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAUSER D, 1990, NUCLEIC ACIDS RES, V18, P4924, DOI 10.1093/nar/18.16.4924; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; INOUE A, 1992, J BIOL CHEM, V267, P10613; JANKOVIC J, 1994, THERAPY BOTULINUM TO; LOVEJOY B, 1994, SCIENCE, V263, P375, DOI 10.1126/science.8278810; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; OGUMA K, 1990, LANCET, V336, P1449, DOI 10.1016/0140-6736(90)93157-K; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PATARNELLO T, 1993, NATURE, V364, P581, DOI 10.1038/364581b0; Powers J.C., 1986, PROTEINASE INHIBITOR, P219; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; ROSSETTO O, 1992, BIOCHEM J, V285, P9, DOI 10.1042/bj2850009; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1992, EMBO J, V11, P3577, DOI 10.1002/j.1460-2075.1992.tb05441.x; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; Schiavo G, 1993, Trends Microbiol, V1, P170, DOI 10.1016/0966-842X(93)90086-7; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SCHIAVO G, 1991, EUR J BIOCHEM, V199, P705, DOI 10.1111/j.1432-1033.1991.tb16174.x; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; Simpson L.L., 1989, BOTULINUM NEUROTOXIN; Smith L. D. S., 1988, BOTULISM ORGANISM IT; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; WRIGHT JF, 1992, J BIOL CHEM, V267, P9053; YAMASAKI S, 1994, P NATL ACAD SCI USA, V91, P4688, DOI 10.1073/pnas.91.11.4688; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764; YAMASAKI S, 1994, BIOCHEM BIOPH RES CO, V200, P829, DOI 10.1006/bbrc.1994.1526	42	232	239	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10566	10570		10.1074/jbc.270.18.10566	http://dx.doi.org/10.1074/jbc.270.18.10566			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737992				2022-12-27	WOS:A1995QW60100033
J	VOSSEBELD, PJM; KESSLER, J; VONDEMBORNE, AEGK; ROOS, D; VERHOEVEN, AJ				VOSSEBELD, PJM; KESSLER, J; VONDEMBORNE, AEGK; ROOS, D; VERHOEVEN, AJ			HETEROTYPIC FC-GAMMA-R CLUSTERS EVOKE A SYNERGISTIC CA2+ RESPONSE IN HUMAN NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED RESPIRATORY BURST; IMMUNE-COMPLEXES; CROSS-LINKING; TUMOR-CELLS; RECEPTOR; RII; PHAGOCYTOSIS; GRANULOCYTES; MECHANISMS; DISTINCT	Both Fc gamma receptors on human neutrophils (Fc gamma RIIa and Fc gamma RIIIb) are capable of initiating signal transduction after multivalent cross-linking. However, immune complexes most likely activate neutrophils by a combined homotypic and heterotypic cross-linking of Fc gamma Rs. We have investigated the effect of homotypic and heterotypic Fc gamma R cluster formation on changes in the intracellular free Ca2+ concentration. Combined heterotypic and homotypic cluster formation resulted in a Ca2+ response that was strongly enhanced as compared to the sum of both individual Fc gamma R responses. This synergistic response was caused by the formation of heterotypic clusters of Fc gamma Rs and not by the simultaneous formation of homotypic clusters. This conclusion was supported by experiments with a bispecific antibody binding to both Fc gamma RIIa and Fc gamma RIIb. The heterotypic Fc gamma R cross-linking results in efficient activation of Ca2+ influx, probably caused by a more pronounced depletion of intracellular Ca2+ stores. Stimulation with immune complexes also induced Ca2+ influx in normal neutrophils, but not in Fc gamma RIIIb-deficient neutrophils. The synergism between both Fc gamma Rs was also apparent in other responses of neutrophils, such as the activation of the respiratory burst. This study shows that the two different Fc gamma Rs on neutrophils complement each other in mediating an important cellular response.	UNIV AMSTERDAM,EXPTL & CLIN IMMUNOL LAB,1066 CX AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT HEMATOL,1105 AZ AMSTERDAM,NETHERLANDS	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	VOSSEBELD, PJM (corresponding author), NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,PUBLICAT SECRETARIAT,PLESMANLAAN 125,1066 CX AMSTERDAM,NETHERLANDS.		Kessler, Jan/C-5559-2009					ANDERSON CL, 1990, J EXP MED, V171, P1333, DOI 10.1084/jem.171.4.1333; BIJSTERBOSCH MK, 1986, BIOCHEM BIOPH RES CO, V137, P500, DOI 10.1016/0006-291X(86)91238-6; BOROS P, 1991, J EXP MED, V173, P1473, DOI 10.1084/jem.173.6.1473; BRUNKHORST BA, 1992, J BIOL CHEM, V267, P20659; CROCKETTTORABI E, 1990, J IMMUNOL, V145, P3026; DEMAUREX N, 1994, BIOCHEM J, V297, P595, DOI 10.1042/bj2970595; EDBERG JC, 1992, IMMUNOL RES, V11, P239, DOI 10.1007/BF02919130; EDBERG JC, 1994, J IMMUNOL, V152, P2826; EMMENDORFFER A, 1990, J IMMUNOL METHODS, V131, P269, DOI 10.1016/0022-1759(90)90198-5; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLAM TJ, 1988, BIOCHEM J, V255, P179, DOI 10.1042/bj2550179; HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2365; HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2359; HUIZINGA TWJ, 1990, J IMMUNOL, V144, P1432; HUIZINGA TWJ, 1988, NATURE, V333, P667, DOI 10.1038/333667a0; HUIZINGA TWJ, 1990, BLOOD, V76, P1927; HUNDT M, 1992, EUR J IMMUNOL, V22, P811, DOI 10.1002/eji.1830220327; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; KIMBERLY RP, 1990, J EXP MED, V171, P1239, DOI 10.1084/jem.171.4.1239; KOENDERMAN L, 1989, J IMMUNOL, V142, P623; LANIER LL, 1988, J IMMUNOL, V141, P3478; NAZIRUDDIN B, 1992, J IMMUNOL, V149, P3702; ORY PA, 1991, BLOOD, V77, P2682; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; ROSALES C, 1991, J IMMUNOL, V146, P3937; ROSENFELD SI, 1985, J CLIN INVEST, V76, P2317, DOI 10.1172/JCI112242; ROTHE G, 1991, J IMMUNOL METHODS, V138, P133, DOI 10.1016/0022-1759(91)90074-P; SALMON JE, 1987, J EXP MED, V166, P1798, DOI 10.1084/jem.166.6.1798; SALMON JE, 1991, J IMMUNOL, V146, P997; SHEN L, 1989, MOL IMMUNOL, V26, P959, DOI 10.1016/0161-5890(89)90114-4; STENDAHL O, 1994, SCIENCE, V265, P1439, DOI 10.1126/science.8073285; TOSI MF, 1988, J IMMUNOL, V141, P2097; WALKER BAM, 1991, J IMMUNOL, V146, P735; WILLIS HE, 1988, J IMMUNOL, V140, P234; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	37	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10671	10679		10.1074/jbc.270.18.10671	http://dx.doi.org/10.1074/jbc.270.18.10671			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738004	hybrid			2022-12-27	WOS:A1995QW60100048
J	NWAKA, S; KOPP, M; HOLZER, H				NWAKA, S; KOPP, M; HOLZER, H			EXPRESSION AND FUNCTION OF THE TREHALASE GENES NTH1 AND YBR0106 IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; CATABOLITE INACTIVATION; INDUCED ACCUMULATION; NEUTRAL TREHALASE; ACID TREHALASE; YEAST; STRESS; PURIFICATION; DISRUPTION; PROTEINS	The biological function of the trehalose-degrading yeast enzyme neutral trehalase consists of the control of the concentration of trehalose, which is assumed to play a role in thermotolerance, in germination of spores, and in other life functions of yeast, Resequencing of the neutral trehalase gene NTH1 on chromosome IV resulted in the observation of two possible start codons (Kopp, M., Nwaka, S., and Holzer, H. (1994) Gene (Amst.) 150, 403-404). We show here that only the most upstream start codon which initiates translation of the longest possible ORF is used for expression of NTH1 in vivo. A gene with 77% identity with NTH1, YBR0106, which was discovered during sequencing of chromosome II (Wolfe, K. H., and Lohan, A. J. E. (1994) Yeast 10, S41-S46), is shown here to be expressed into mRNA. Experiments with a mutant disrupted in the YBR0106 ORF showed, in contrast to a NTH1 deletion mutant, no changes in trehalase activity and in trehalose concentration, However, similar to the NTH1 gene a requirement of the intact YBR0106 gene for thermotolerance is demonstrated in experiments with the respective mutants. This indicates that the products of the likely duplicated YBR0106 gene and the NTH1 gene serve a heat shock protein function, In case of the YBR0106 gene, this is the only phenotypic feature found at present.	UNIV FREIBURG,INST BIOCHEM,D-79104 FREIBURG,GERMANY	University of Freiburg								APP H, 1989, J BIOL CHEM, V264, P17583; ATTFIELD PV, 1987, FEBS LETT, V225, P259, DOI 10.1016/0014-5793(87)81170-5; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fischer E, 1895, BERICHTE DTSCH CHEM, V28, P1429, DOI [10.1002/CBER.18950280243, DOI 10.1002/CBER.18950280243]; GOUNALAKI N, 1994, EMBO J, V13, P4036, DOI 10.1002/j.1460-2075.1994.tb06720.x; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; HIRSCH HH, 1992, EUR J BIOCHEM, V207, P867, DOI 10.1111/j.1432-1033.1992.tb17118.x; HOLZER H, 1989, RBC-CELL BIOL REV, V21, P305; HOLZER H, 1976, TRENDS BIOCHEM SCI, V1, P178, DOI 10.1016/S0968-0004(76)80018-7; HOTTIGER T, 1987, J BACTERIOL, V169, P5518, DOI 10.1128/jb.169.12.5518-5522.1987; HOTTIGER T, 1992, EUR J BIOCHEM, V210, P125, DOI 10.1111/j.1432-1033.1992.tb17399.x; IGLOI GL, 1993, BIOTECHNIQUES, V15, P486; IT H, 1984, AGR BIOL CHEM TOKYO, V48, P175; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; KIENLE I, 1993, YEAST, V9, P607, DOI 10.1002/yea.320090607; KOBAYASHI N, 1993, MOL CELL BIOL, V13, P248, DOI 10.1128/MCB.13.1.248; KOPP M, 1993, J BIOL CHEM, V268, P4766; KOPP M, 1994, GENE, V150, P403, DOI 10.1016/0378-1119(94)90462-6; LONDESBOROUGH J, 1984, BIOCHEM J, V219, P511, DOI 10.1042/bj2190511; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAGASANIK B, 1961, COLD SPRING HARB SYM, V26, P249, DOI 10.1101/SQB.1961.026.01.031; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x; MITTENBUHLER K, 1988, J BIOL CHEM, V263, P8537; MONOD J, 1947, GROWTH, V11, P223; NORTHEMANN W, 1988, BIOCHEMISTRY-US, V27, P9194, DOI 10.1021/bi00426a018; NORTHEMANN W, 1989, J BIOL CHEM, V264, P16072; NWAKA S, 1995, FEBS LETT, V360, P286, DOI 10.1016/0014-5793(95)00105-I; NWAKA S, 1994, FEBS LETT, V344, P225, DOI 10.1016/0014-5793(94)00385-8; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J, 1989, MOL CLONING LABORATO; Sherman F., 1986, METHODS YEAST GENETI; THEVELEIN JM, 1988, EXP MYCOL, V12, P1, DOI 10.1016/0147-5975(88)90011-4; THEVELEIN JM, 1984, MICROBIOL REV, V48, P42, DOI 10.1128/MMBR.48.1.42-59.1984; TOHE A, 1993, YEAST, V9, P481, DOI 10.1002/yea.320090504; WINKLER K, 1991, FEBS LETT, V291, P261; WOLFE KH, 1994, YEAST, V10, pS41, DOI 10.1002/yea.320100006; WOLSKAMITASZKO B, 1981, ANAL BIOCHEM, V116, P241, DOI 10.1016/0003-2697(81)90351-1	41	90	93	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10193	10198		10.1074/jbc.270.17.10193	http://dx.doi.org/10.1074/jbc.270.17.10193			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730323	hybrid			2022-12-27	WOS:A1995QV41700070
J	PRATICO, D; LAWSON, JA; FITZGERALD, GA				PRATICO, D; LAWSON, JA; FITZGERALD, GA			CYLOOXYGENASE-DEPENDENT FORMATION OF THE ISOPROSTANE, 8-EPI PROSTAGLANDIN FA(2-ALPHA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITES; PLATELET; THROMBOXANE; RECEPTOR; SYNTHASE; SERIES; 8-EPI-PROSTAGLANDIN-F2-ALPHA; NONCYCLOOXYGENASE; DISCRIMINATION; PHOSPHOLIPIDS	Isoprostanes are a family of prostaglandin (PG) isomers formed in an enzyme-independent manner. They circulate in plasma and are excreted in urine. One of them, 8-epi PGF(2 alpha) is a vasoconstrictor and mitogen, effects which are prevented by thromboxane antagonists. Given that 8-epi PGF(2 alpha) may be formed by cyclooxygenase (COX) (Corey, E. J., Shih, C., Shig, N-Y., and Shimoji, K. (1984) Tetrahedron Letts. 44, 5013-5016; Hecker, M., Ullrich, V., Fischer, C., and Meese, C. O. (1987) fur J. Biochem. 169, 113-123) and that this might confound its use as an index of free radical generation, we sought to characterize the mechanism of its formation by human platelets. Activation of platelets by threshold concentrations of collagen, thrombin, and arachidonic acid resulted in formation of 8-epi PGF(2 alpha) coincident with that of the COX product, thromboxane, and the 12 lipoxygenase product, 12-hydroxyeicosatetraenoic acid, as detected by selected ion monitoring assays using gas chromatography-mass spectrometry. The effect appeared selective for 8 epi PGF(2 alpha) among the F-2 isoprostanes. Pretreatment of platelets with aspirin or indomethacin abolished 8-epi PGF(2 alpha) formation. COX-independent activation of platelets by high doses of collagen or thrombin, by the phorbol ester, phorbol 12-myristate IS-acetate, or the prostaglandin endoperoxide analog U 46619 was not associated with 8-epi PGF(2 alpha) formation. Confirmation of the nature of the material formed by platelet COX as 8-epi PGF(2 alpha) included its cochromatography over three highly resolving high performance liquid chromatography systems, identification by electron impact mass spectrometry, and its formation by partially purified COX. Inhibition of platelet thromboxane formation was associated with augmented 8-epi PGF(2 alpha) formation. A major component of 8 epi PGF(2 alpha) formed in serum by healthy volunteers was shown to be sensitive to inhibition by aspirin err vivo. In addition to its generation by free radical catalyzed mechanisms, 8 epi PGF(2 alpha) may be formed as a PG by human platelets. Given that activation of platelet COX characterizes many of the human syndromes which are putatively associated with free radical generation, assessment of the contribution of this pathway is relevant to the use of 8 epi PGF(2 alpha) as an index of lipid peroxidation in vivo.	UNIV PENN,CTR EXPTL THERAPEUT,PHILADELPHIA,PA 19104	University of Pennsylvania			FitzGerald, Garret A/A-4222-2010					BANERJEE M, 1992, AM J PHYSIOL, V263, pH660, DOI 10.1152/ajpheart.1992.263.3.H660; COREY EJ, 1984, TETRAHEDRON LETT, V44, P5013; DABBAGH AJ, 1994, BIOCHEM J, V330, P799; FITZGERALD DJ, 1988, CIRCULATION, V77, P142, DOI 10.1161/01.CIR.77.1.142; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; FITZGERALD GA, 1985, CIRCULATION, V72, P1194, DOI 10.1161/01.CIR.72.6.1194; FUNK CD, 1993, MOL PHARMACOL, V44, P934; FUNKAGA M, 1993, AM J PHYSIOL, V264, P1619; FURCI L, 1991, J PHARMACOL EXP THER, V258, P74; GOPAUL NK, 1994, BIOCHEM BIOPH RES CO, V200, P338, DOI 10.1006/bbrc.1994.1453; GOPAUL NK, 1994, FEBS LETT, V348, P297, DOI 10.1016/0014-5793(94)00628-8; GORMAN RR, 1983, PROSTAGLANDINS, V26, P325, DOI 10.1016/0090-6980(83)90099-0; HECKER M, 1987, EUR J BIOCHEM, V169, P113, DOI 10.1111/j.1432-1033.1987.tb13587.x; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; KAYAMA N, 1981, PROSTAGLANDINS, V21, P543, DOI 10.1016/0090-6980(81)90003-4; KAYGANICHHARRIS.KA, 1993, J LIPID RES, V34, P1229; KINGSLEY Y, 1994, J PHARMACOL EXP THER, V270, P1192; KINSELLA BT, 1994, ANN NY ACAD SCI, V714, P270, DOI 10.1111/j.1749-6632.1994.tb12054.x; LAWSON JA, 1994, ANN NY ACAD SCI, V744, P139; LYNCH SM, 1994, J CLIN INVEST, V93, P998, DOI 10.1172/JCI117107; MIDDLEDITCH BS, 1973, ANAL BIOCHEM, V55, P509, DOI 10.1016/0003-2697(73)90140-1; MORROW JD, 1994, BBA-LIPID LIPID MET, V1210, P244, DOI 10.1016/0005-2760(94)90128-7; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1994, J BIOL CHEM, V269, P4317; MORROW JD, 1992, PROSTAGLANDINS, V44, P155, DOI 10.1016/0090-6980(92)90077-7; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; MORROW JD, 1992, J CLIN INVEST, V90, P250; NOWAK J, 1987, CIRCULATION, V76, P6, DOI 10.1161/01.CIR.76.1.6; NUSING RM, 1993, J BIOL CHEM, V268, P25253; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; RIM EB, 1993, NEW ENGL J MED, V328, P1450; ROBERTS LJ, 1979, BIOCHIM BIOPHYS ACTA, V575, P185, DOI 10.1016/0005-2760(79)90020-1; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; TAKAHARA K, 1990, J BIOL CHEM, V265, P6836; TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826; ZWEIER JL, 1994, J BIOL CHEM, V269, P24156	37	241	244	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9800	9808		10.1074/jbc.270.17.9800	http://dx.doi.org/10.1074/jbc.270.17.9800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730359	hybrid			2022-12-27	WOS:A1995QV41700018
J	RODD, D; HERSH, LB				RODD, D; HERSH, LB			ENDOPEPTIDASE-24.16B-A NEW VARIANT OF ENDOPEPTIDASE-24.16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; RAT-BRAIN; METALLOENDOPEPTIDASE ENKEPHALINASE; NEUTRAL ENDOPEPTIDASE; DEGRADING PEPTIDASE; LEUKEMIA ANTIGEN; NEUROTENSIN; PURIFICATION; IDENTIFICATION; SPECIFICITY	A peptidase, isolated from rat testes, is inhibited by 1 mM o-phenanthroline, 1 mu M N-(1-(R,S)-carboxyl-3-phenyl-propyl)-Ala-Ala-Phe-p-aminobenzoate, and 6 mM Pro-ILe, properties similar to those ascribed to endopeptidase 24.16. The enzyme hydrolyzes dynorphin A-8, neurotensin 1-13, angiotensin I, and substance P. Kinetic analysis of a series of angiotensin I analogs showed that substitutions at P-1, P-1', or P-2' had little effect on K-m or k(cat). Variation of peptide size with a series of dynorphin A peptides showed chain length to be significant. The peptidase cleaved dynorphin A-8 at both Leu(5)-Arg(6) and Arg(6)-Arg(7), and neurotensin 1-13 at Pro(10)-Tyr(11) and Arg(8)-Arg(9). In contrast, rat endopeptidase 24.16 cleaves dynorphin A-8 at Gly(4)-Leu(5) and Leu(5)-Arg(6), and neurotensin 1-13 only at Pro(10)-Tyr(11). These findings, as well as the observation that endopeptidase 24.16 exhibits a considerably higher affinity for Pro-Ile, K-i = 90 mu M, indicates the peptidase isolated in this study is related to, but distinct from, rat endopeptidase 24.16. We propose that this new endopeptidase be referred to as endopeptidase 24.16B, while the originally described enzyme be referred to as endopeptidase 24.16A	UNIV KENTUCKY, ALBERT B CHANDLER MED CTR,DEPT BIOCHEM, LEXINGTON, KY 40536 USA	University of Kentucky					NIDA NIH HHS [DA 02243] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARELLI H, 1993, EUR J BIOCHEM, V211, P79, DOI 10.1111/j.1432-1033.1993.tb19872.x; BARKER JL, 1978, SCIENCE, V199, P1451, DOI 10.1126/science.204016; BENSON JR, 1975, P NATL ACAD SCI USA, V72, P619, DOI 10.1073/pnas.72.2.619; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASEY ML, 1991, J BIOL CHEM, V266, P23041; CHABRY J, 1990, J NEUROSCI, V10, P3916, DOI 10.1523/JNEUROSCI.10-12-03916.1990; CHECLER F, 1986, J BIOL CHEM, V261, P1274; CHECLER F, 1983, J NEUROCHEM, V41, P375, DOI 10.1111/j.1471-4159.1983.tb04753.x; CHECLER F, 1993, BIOCHEM SOC T, V21, P692, DOI 10.1042/bst0210692; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; DAHMS P, 1992, EUR J BIOCHEM, V208, P145, DOI 10.1111/j.1432-1033.1992.tb17168.x; DAUCH P, 1991, EUR J BIOCHEM, V202, P269, DOI 10.1111/j.1432-1033.1991.tb16372.x; DAUCH P, 1991, BIOCHEM J, V280, P421, DOI 10.1042/bj2800421; DIXON DM, 1990, BRIT J PHARMACOL, V101, P674, DOI 10.1111/j.1476-5381.1990.tb14139.x; FERRARIO CM, 1991, HYPERTENSION, V18, pS126, DOI 10.1161/01.HYP.18.5_Suppl.III126; GAFFORD JT, 1983, BIOCHEMISTRY-US, V22, P3265, DOI 10.1021/bi00282a035; KERR MA, 1974, BIOCHEM J, V137, P489, DOI 10.1042/bj1370489; KOBAYASHI R, 1991, GASTROENTEROLOGY, V100, P25, DOI 10.1016/0016-5085(91)90578-9; LETARTE M, 1988, J EXP MED, V168, P1247, DOI 10.1084/jem.168.4.1247; LOTVALL JO, 1990, BRIT J PHARMACOL, V100, P69; LYRENAS S, 1988, OBSTET GYNECOL, V72, P54; MALFROY B, 1978, NATURE, V276, P523, DOI 10.1038/276523a0; MILLICAN PE, 1991, BIOCHEM J, V276, P583, DOI 10.1042/bj2760583; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; OSEI SY, 1993, EUR J PHARMACOL, V234, P35, DOI 10.1016/0014-2999(93)90703-K; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; WAKSMAN G, 1986, P NATL ACAD SCI USA, V83, P1523, DOI 10.1073/pnas.83.5.1523; WELCHES WR, 1991, J HYPERTENS, V9, P631, DOI 10.1097/00004872-199107000-00008	29	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10056	10061		10.1074/jbc.270.17.10056	http://dx.doi.org/10.1074/jbc.270.17.10056			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730308	hybrid			2022-12-27	WOS:A1995QV41700053
J	GMACHL, M; KREIL, G				GMACHL, M; KREIL, G			THE PRECURSORS OF THE BEE VENOM CONSTITUENTS APAMIN AND MCD PEPTIDE ARE ENCODED BY 2 GENES IN TANDEM WHICH SHARE THE SAME 3'-EXON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEGRANULATING PEPTIDE; HONEYBEE PREPROMELITTIN; K+ CHANNELS; SEQUENCE; AMPLIFICATION; RECEPTOR; CLEAVAGE; PROTEIN; BLOCKS; IMPORT	From a cDNA Library prepared fi om venom glands of worker bees, clones encoding the precursors of apamin and MCD peptide have been isolated. The cDNAs are similar at the 5'-ends and identical in their 3'-regions, Analysis of the corresponding genes has revealed the existence of six exons separated by introns rich in A + T. Starting from the 5'-end, these exons are arranged in the following order: three exons of the mast cell degranulating (MCD) peptide precursor, two exons of the gene for the apamin precursor, and finally a 3'-exon present in both cDNAs. This suggests that the bulk of the apamin gene resides in the third intron of the MCD peptide gene. Using inverse polymerase chain reaction, a segment of genomic DNA upstream of the first exon of the MCD precursor gene was obtained. The sequence of this segment shows 81% identity to the DNA sequence preceding the first exon of the apamin gene and both contain a putative TATA box. We thus propose that the mRNA encoding the apamin precursor originates from a primary transcript which starts in the third intron of the MCD peptide gene. Both cDNAs encode unusually small precursors comprising only 46 amino acids in case of apamin and 50 in the case of the MCD peptide.	AUSTRIAN ACAD SCI,INST MOLEC BIOL,A-5020 SALZBURG,AUSTRIA	Austrian Academy of Sciences								Banks B. E. C., 1978, Journal of Physiology, V284, P160; BANKS BEC, 1979, NATURE, V282, P415, DOI 10.1038/282415a0; BILLINGHAM ME, 1973, NATURE, V245, P163, DOI 10.1038/245163a0; Blake Derek J., 1994, Trends in Cell Biology, V4, P19, DOI 10.1016/0962-8924(94)90034-5; BOMAN HG, 1989, J BIOL CHEM, V264, P5852; CHERUBINI E, 1987, NATURE, V328, P70, DOI 10.1038/328070a0; DARMER D, 1991, P NATL ACAD SCI USA, V88, P2555, DOI 10.1073/pnas.88.6.2555; FOSSET M, 1984, P NATL ACAD SCI-BIOL, V81, P7228, DOI 10.1073/pnas.81.22.7228; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GAULDIE J, 1976, EUR J BIOCHEM, V61, P369, DOI 10.1111/j.1432-1033.1976.tb10030.x; GMACHL M, 1993, P NATL ACAD SCI USA, V90, P3569, DOI 10.1073/pnas.90.8.3569; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HENIKOFF S, 1986, CELL, V44, P33, DOI 10.1016/0092-8674(86)90482-4; HUGUES M, 1982, P NATL ACAD SCI-BIOL, V79, P1308, DOI 10.1073/pnas.79.4.1308; JACOBSON RS, 1991, J ALLERGY CLIN IMMUN, V89, P292; JOHN SWM, 1991, NUCLEIC ACIDS RES, V19, P408, DOI 10.1093/nar/19.2.408; KREIL G, 1980, EUR J BIOCHEM, V111, P49, DOI 10.1111/j.1432-1033.1980.tb06073.x; KREIL G, 1990, TRENDS BIOCHEM SCI, V15, P23, DOI 10.1016/0968-0004(90)90126-V; KUCHLER K, 1989, EUR J BIOCHEM, V184, P249, DOI 10.1111/j.1432-1033.1989.tb15014.x; MARQUEZE B, 1987, EUR J BIOCHEM, V169, P295, DOI 10.1111/j.1432-1033.1987.tb13611.x; REHM H, 1988, BIOCHEMISTRY-US, V27, P1827, DOI 10.1021/bi00406a005; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHLENSTEDT G, 1987, EMBO J, V6, P699, DOI 10.1002/j.1460-2075.1987.tb04810.x; SHIPOLINI RA, 1971, FEBS LETT, V17, P39, DOI 10.1016/0014-5793(71)80558-6; TAYLOR JW, 1984, J BIOL CHEM, V259, P3957; TERWILLIGER TC, 1982, BIOPHYS J, V37, P353, DOI 10.1016/S0006-3495(82)84683-3; VLASAK R, 1983, EUR J BIOCHEM, V135, P123, DOI 10.1111/j.1432-1033.1983.tb07626.x; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; ZIMMERMANN R, 1986, J BIOL CHEM, V261, P2889	29	22	32	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12704	12708		10.1074/jbc.270.21.12704	http://dx.doi.org/10.1074/jbc.270.21.12704			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759523	hybrid			2022-12-27	WOS:A1995QZ71100059
J	BAKER, RT; VARSHAVSKY, A				BAKER, RT; VARSHAVSKY, A			YEAST N-TERMINAL AMIDASE - A NEW ENZYME AND COMPONENT OF THE N-END RULE PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-PROTEIN TRANSFERASE; SHORT-LIVED PROTEIN; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; DEGRADATION SIGNAL; HIGH-TEMPERATURES; SHUTTLE VECTORS; UBIQUITIN; GENE	The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue. Tertiary destabilizing N-terminal residues asparagine and glutamine function through their conversion, by enzymatic deamidation, into the secondary destabilizing residues aspartate and glutamate, whose activity requires their enzymatic conjugation to arginine, one of the primary destabilizing residues. We isolated a Saccharomyces cerevisiae gene, termed NTA1, that encodes an amidase (Nt-amidase) specific for N-terminal asparagine and glutamine. Alterations at the putative active-site cysteine of the 52-kDa Nt-amidase inactivate the enzyme. Null nta1 mutants are viable but unable to degrade N-end rule substrates that bear N-terminal asparagine or glutamine. The effects of overexpressing Nt-amidase and other components of the N-end rule pathway suggest interactions between these components and the existence of a multienzyme targeting complex.	CALTECH, DIV BIOL, PASADENA, CA 91125 USA	California Institute of Technology					NIDDK NIH HHS [DK39520] Funding Source: Medline; NIGMS NIH HHS [GM31530] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039520, R01DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; AMBLER RP, 1987, FEBS LETT, V215, P285, DOI 10.1016/0014-5793(87)80163-1; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER R, 1991, NUCLEIC ACIDS RES, V19, P1945, DOI 10.1093/nar/19.8.1945; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; BAKER RT, 1992, J BIOL CHEM, V267, P23364; BALZI E, 1990, J BIOL CHEM, V265, P7464; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1988, J BIOL CHEM, V263, P11155; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; ELLISON KS, 1991, J BIOL CHEM, V266, P24116; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; Guthrie C, 1991, GUIDE YEAST GENETICS; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HILL CP, 1993, P NATL ACAD SCI USA, V90, P4136, DOI 10.1073/pnas.90.9.4136; HINNEBUSCH AG, 1991, MOL CELLULAR BIOL YE, V1, P627; Hochstrasser Mark, 1992, Current Opinion in Cell Biology, V4, P1024, DOI 10.1016/0955-0674(92)90135-Y; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; KNIGHTON DR, 1994, NAT STRUCT BIOL, V1, P186, DOI 10.1038/nsb0394-186; KNOWLES JR, 1991, J THEOR BIOL, V152, P53, DOI 10.1016/S0022-5193(05)80509-0; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; MADURA K, 1993, J BIOL CHEM, V268, P12046; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; NOGI Y, 1993, MOL CELL BIOL, V13, P114, DOI 10.1128/MCB.13.1.114; NYUNOYA H, 1984, J BIOL CHEM, V259, P9790; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; REISS Y, 1988, J BIOL CHEM, V263, P2693; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SHARON G, 1991, J BIOL CHEM, V266, P15890; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sherman F., 1986, METHODS YEAST GENETI; SHRADER TE, 1993, J BACTERIOL, V175, P4364, DOI 10.1128/JB.175.14.4364-4374.1993; SIKORSKI RS, 1989, GENETICS, V122, P19; SPENCER J, 1995, IN PRESS MOL CELL BI; SPRAGUE GF, 1983, CELL, V32, P409, DOI 10.1016/0092-8674(83)90460-9; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; STEWART AE, 1994, J BIOL CHEM, V269, P23509; STEWART AE, 1995, IN PRESS J BIOL CHEM; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; TEEM JL, 1983, P NATL ACAD SCI-BIOL, V80, P4403, DOI 10.1073/pnas.80.14.4403; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0	65	79	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12065	12074		10.1074/jbc.270.20.12065	http://dx.doi.org/10.1074/jbc.270.20.12065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744855	Green Accepted, hybrid			2022-12-27	WOS:A1995QY73600057
J	FLASPOHLER, JA; BOCZKOWSKI, D; HALL, BL; MILCAREK, C				FLASPOHLER, JA; BOCZKOWSKI, D; HALL, BL; MILCAREK, C			THE 3'-UNTRANSLATED REGION OF MEMBRANE EXON-2 FROM THE GAMMA-2A IMMUNOGLOBULIN GENE CONTRIBUTES TO EFFICIENT TRANSCRIPTION TERMINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; H-CHAIN GENE; 3' UNTRANSLATED REGION; POLY(A) SITE; MESSENGER-RNA; POLYADENYLATION SIGNAL; GLOBIN GENE; LYMPHOCYTES-B; EXPRESSION; SEQUENCES	Elements of the mouse Immunoglobulin gamma 2a gene, near the membrane specific poly(A) addition site, were inserted into a heterologous location in either a synthetic mouse gamma 2b gene or a gpt/SV40 chimeric gene and then assayed for their ability to terminate RNA polymerase II transcription in isolated nuclei of transfected myeloma cells, The intact gamma 2a membrane specific 3'-untranslated region, with its potential stem loop forming sequences and poly(A) site, is able to efficiently terminate transcription in the absence of the downstream region in which transcription normally terminates (term). Termination efficiency in the presence of the termination fragment decreases either when sequences specifying a potential stem/loop, upstream of the poly(A) region, are interrupted or when the stronger membrane poly(A) site is substituted with a weaker, secretory specific poly(A) site. We therefore conclude that the gamma 2a membrane-specific untranslated region plays a major role in specifying downstream termination. We further conclude that the immunoglobulin gamma 2a, membrane-specific, 3'-untranslated region can function in the context of the gpt gene, driven by an SV40 promoter, to terminate transcription in a poly(A) site dependent fashion.	UNIV PITTSBURGH,SCH MED,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050145] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 50145] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CITRON B, 1984, NUCLEIC ACIDS RES, V12, P8723, DOI 10.1093/nar/12.22.8723; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; DAS A, 1993, ANNU REV BIOCHEM, V62, P893; EDWALDSGILBERT G, 1993, MOL CELL BIOL, V13, P3472, DOI 10.1128/MCB.13.6.3472; FALCKPEDERSEN E, 1985, CELL, V40, P897, DOI 10.1016/0092-8674(85)90349-6; FLASPOHLER JA, 1990, J IMMUNOL, V144, P2802; FLASPOHLER JA, 1992, BIOTECHNIQUES, V13, P68; FRAYNE EG, 1984, MOL CELL BIOL, V4, P2921, DOI 10.1128/MCB.4.12.2921; GALLI G, 1987, GENE DEV, V1, P471, DOI 10.1101/gad.1.5.471; GILMARTIN GM, 1992, EMBO J, V11, P4419, DOI 10.1002/j.1460-2075.1992.tb05542.x; GUISE JW, 1988, J IMMUNOL, V140, P3988; HAGENBUCHLE O, 1984, CELL, V38, P737, DOI 10.1016/0092-8674(84)90269-1; HALL B, 1989, MOL IMMUNOL, V26, P819, DOI 10.1016/0161-5890(89)90137-5; HALL BL, 1989, THESIS U PITTSBURGH; KOBRIN BJ, 1986, MOL CELL BIOL, V6, P1687, DOI 10.1128/MCB.6.5.1687; LANG RB, 1982, NUCLEIC ACIDS RES, V10, P611, DOI 10.1093/nar/10.2.611; LANOIX J, 1988, EMBO J, V7, P2515, DOI 10.1002/j.1460-2075.1988.tb03099.x; LASSMAN CR, 1992, J IMMUNOL, V148, P2578; LASSMAN CR, 1992, J IMMUNOL, V148, P1251; LAW A, 1987, P NATL ACAD SCI USA, V4, P9160; LEMEUR MA, 1984, EMBO J, V3, P2779, DOI 10.1002/j.1460-2075.1984.tb02209.x; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; MAA MC, 1990, J BIOL CHEM, V265, P12513; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MINTY AJ, 1983, J MOL BIOL, V167, P77, DOI 10.1016/S0022-2836(83)80035-7; MIRALLES VJ, 1991, NUCLEIC ACIDS RES, V19, P3593, DOI 10.1093/nar/19.13.3593; MORRISON SL, 1984, ANNU REV IMMUNOL, V2, P239, DOI 10.1146/annurev.immunol.2.1.239; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; NATSUUMESAKAI S, 1977, IMMUNOLOGY, V32, P861; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; PRIBYL TM, 1988, MOL CELL BIOL, V8, P5369, DOI 10.1128/MCB.8.12.5369; RICHARDS JE, 1983, NATURE, V306, P483, DOI 10.1038/306483a0; ROHRBAUGH ML, 1985, MOL CELL BIOL, V8, P5369; RUSSNAK R, 1990, GENE DEV, V4, P764, DOI 10.1101/gad.4.5.764; TISCH R, 1990, MOL CELL BIOL, V10, P5340, DOI 10.1128/MCB.10.10.5340; WARD SB, 1992, MOL IMMUNOL, V29, P279, DOI 10.1016/0161-5890(92)90110-J; WEISS EA, 1989, J IMMUNOL, V143, P1046; WELS JA, 1984, EMBO J, V3, P2041, DOI 10.1002/j.1460-2075.1984.tb02089.x; WHITELAW E, 1986, EMBO J, V5, P2915, DOI 10.1002/j.1460-2075.1986.tb04587.x; YUAN D, 1990, J IMMUNOL, V145, P3491; YUAN D, 1984, J EXP MED, V160, P564, DOI 10.1084/jem.160.2.564	41	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11903	11911		10.1074/jbc.270.20.11903	http://dx.doi.org/10.1074/jbc.270.20.11903			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744841	hybrid			2022-12-27	WOS:A1995QY73600037
J	RUSSELL, M; LANGECARTER, C; JOHNSON, GL				RUSSELL, M; LANGECARTER, C; JOHNSON, GL			DIRECT INTERACTION BETWEEN RAS AND THE KINASE DOMAIN OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE KINASE (MEKK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							P21(RAS); GTPASE	Mitogen-activated protein kinase kinase kinase (MEKK1) is a serine-threonine kinase that regulates sequential protein kinase pathways involving stress-activated protein kinases and mitogen-activated protein kinases. MEKK1 is activated in response to growth factor stimulation of cells and by expression of activated Ras. We demonstrate that the kinase domain of MEKK1 (MEKK(COOH)) binds to GST-Ras(V12) in a GTP-dependent manner. Purified bacterially expressed MEKK(COOH) binds to GST Ras(V12)(GTP gamma S) (GTP gamma S is guanosine 5'-3-O-(thio)triphosphate), demonstrating a direct interaction of the two proteins. A Ras effector domain peptide blocks the binding of MEKK(COOH) to GST-Ras(V12)(GTP gamma S). MEKK(COOH) complexed with GST-Ras(V12)(GTP gamma S) is capable of phosphorylating MEK1. These findings indicate that MEKK1 directly binds Ras . GTP. Thus, Ras interacts with protein kinases of both the Raf and MEKK families.	NATL JEWISH CTR IMMUNOL & RESP MED,DIV BASIC SCI,DENVER,CO 80206; UNIV COLORADO,SCH MED,DEPT PHARMACOL,DENVER,CO 80262	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Lange, Carol/0000-0003-2751-3976	NCI NIH HHS [CA09313] Funding Source: Medline; NIDDK NIH HHS [DK37871] Funding Source: Medline; NIGMS NIH HHS [GM30324] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030324, R01GM030324] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSEBEL FM, 1987, CURRENT PROTOCOLS MO; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P236, DOI 10.1016/0968-0004(94)90147-3; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOWNWARD J, 1991, J CURR BIOL, V1, P353; GARDNER AM, 1994, METHOD ENZYMOL, V238, P258; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; JOHNSON GL, 1994, J CELL BIOCHEM, V54, P415, DOI 10.1002/jcb.240540408; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LANGECARTER C, 1994, SCIENCE, V260, P315; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LANGECARTER CA, 1995, METHOD ENZYMOL, V255, P290; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VICIANA PR, 1994, NATURE, V370, P527; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WOLL PJ, 1988, P NATL ACAD SCI USA, V85, P1859, DOI 10.1073/pnas.85.6.1859; YAN MH, 1994, NATURE, V372, P798; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	26	171	173	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11757	11760		10.1074/jbc.270.20.11757	http://dx.doi.org/10.1074/jbc.270.20.11757			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744823	hybrid			2022-12-27	WOS:A1995QY73600015
J	SZEDLACSEK, SE; WASOWICZ, E; HULEA, SA; NISHIDA, HI; KUMMEROW, FA; NISHIDA, T				SZEDLACSEK, SE; WASOWICZ, E; HULEA, SA; NISHIDA, HI; KUMMEROW, FA; NISHIDA, T			ESTERIFICATION OF OXYSTEROLS BY HUMAN PLASMA LECITHIN-CHOLESTEROL ACYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL-METABOLISM; HUMAN-SERUM; PHOSPHOLIPASE-ACTIVITY; SUBSTRATE-SPECIFICITY; MASS-SPECTROMETRY; HUMAN ATHEROMA; HUMAN AORTA; ESTERS; 26-HYDROXYCHOLESTEROL; PHOSPHATIDYLCHOLINE	In the present study, lecithin-cholesterol acyltransferase (LCAT) catalyzed esterification of oxysterols was investigated by using discoidal bilayer particles (DBP) containing various oxysterols, phosphatidylcholines, and apolipoprotein A-I. The esterified oxysterols were analyzed by high pressure liquid chromatography, gas chromatography, and mass spectrometry. LCAT esterified all oxysterols tested that are known to be present in human plasma. The esterification yields in almost all cases were relatively high, often as high as the yield of cholesterol esterification. When DBP preparations containing 27-hydroxycholesterol and various phosphatidylcholines were used for the LCAT reaction, both monoesters and diesters were produced. The mass spectrometry analysis showed that the monoester was produced by the esterification of the 3 beta-hydroxyl group and not the 27-hydroxyl group. The diesters were apparently produced by the esterification of the 27-hydroxyl group only after the esterification of the 3 beta-hydroxyl group. Phosphatidylcholine containing a saturated acyl group at sn-1 position and an unsaturated acyl group at sn-2 position gave generally high esterification yield. The esterification of various oxysterols was compared by using DBP containing dioleoyl-phosphatidylcholine and individual oxysterols. All oxysterols produced 3 beta-oleoyl monoesters, Unlike 27-hydroxycholesterol, 25-hydroxycholesterol, 7 alpha-hydroxycholesterol, 7 beta-hydroxycholesterol, or cholestanetriol did not produce diesters. Various factors influencing the formation of the monoesters and diesters from 27-hydroxycholesterol were investigated. When dioleoyl-phosphatidylcholine was used as the acyl donor, prolonged dialysis of DBP preparations and increase in the ratio of the enzyme concentration to substrate particle concentration increased the diester formation. Significant amounts of diesters were also produced by using 1-palmitoyl-2-oleoyl-phosphatidylcholine and other phosphatidylcholines as the acyl donors. By analyzing the conditions of monoester and diester formation, a scheme for the LCAT reaction pathway was proposed.	UNIV ILLINOIS, BURNSIDES RES LAB, DEPT FOOD SCI, URBANA, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign			Szedlacsek, Stefan Eugen/F-1830-2010	Szedlacsek, Stefan Eugen/0000-0002-3416-5036	NHLBI NIH HHS [HL-17597] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL017597, F31HL117597, R37HL017597] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARON L, 1978, J BIOL CHEM, V253, P7220; ASSMANN G, 1978, SCAND J CLIN LAB INV, V38, P16, DOI 10.3109/00365517809104894; BJORKHEM I, 1986, ANAL BIOCHEM, V154, P497, DOI 10.1016/0003-2697(86)90021-7; BROOKS CJW, 1966, BIOCHIM BIOPHYS ACTA, V125, P620, DOI 10.1016/0005-2760(66)90055-5; BROOKS CJW, 1971, ATHEROSCLEROSIS, V13, P223, DOI 10.1016/0021-9150(71)90025-6; BROOKS CJW, 1972, PROTIDES BIOL FLUIDS, V19, P101; CARPENTER KLH, 1993, BIOCHIM BIOPHYS ACTA, V1167, P121, DOI 10.1016/0005-2760(93)90151-X; Doi Y, 1981, Methods Enzymol, V71 Pt C, P753; DOLPHIN PJ, 1992, STRUCTURE FUNCTION A, P295; FIELDING CJ, 1991, METHOD ENZYMOL, V197, P426; FIELDING CJ, 1990, ADV CHOLESTEROL RES, P271; FUMAGALLI R, 1971, LIFE SCI 2-BIOCH GEN, V10, P25, DOI 10.1016/0024-3205(71)90221-9; GLOMSET JA, 1968, J LIPID RES, V9, P155; HAMILTON RL, 1976, J CLIN INVEST, V58, P667, DOI 10.1172/JCI108513; JAVITT NB, 1981, J BIOL CHEM, V256, P2644; JONAS A, 1987, J BIOL CHEM, V262, P3969; KATO H, 1989, J BIOL CHEM, V264, P4082; KITABATAKE K, 1979, BIOCHIM BIOPHYS ACTA, V573, P145, DOI 10.1016/0005-2760(79)90181-4; KNIGHTS BA, 1967, J GAS CHROMATOGR, V5, P273, DOI 10.1093/chromsci/5.6.273; LUSBY WR, 1984, LIPIDS, V19, P888, DOI 10.1007/BF02534520; MAERKER G, 1986, J AM OIL CHEM SOC, V63, P767, DOI 10.1007/BF02541961; MORRISON WR, 1961, J LIPID RES, V2, P600; NAQVI SHM, 1973, STEROIDS, V22, P285, DOI 10.1016/0039-128X(73)90092-5; NICHOLS AV, 1971, BIOCHIM BIOPHYS ACTA, V231, P175, DOI 10.1016/0005-2760(71)90266-9; NISHIDA HI, 1986, J BIOL CHEM, V261, P2028; ODA H, 1990, J LIPID RES, V31, P2209; PENG SK, 1992, BIOL EFFECTS CHOLEST; PIRAN U, 1979, LIPIDS, V14, P478, DOI 10.1007/BF02533465; POWNALL HJ, 1985, J BIOL CHEM, V260, P2146; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SMITH LL, 1970, ATHEROSCLEROSIS, V12, P1; SMITH LL, 1981, J STEROID BIOCHEM, V14, P889, DOI 10.1016/0022-4731(81)90238-7; SMITH LL, 1989, FREE RADICAL BIO MED, V7, P285, DOI 10.1016/0891-5849(89)90136-6; SMITH LL, 1987, CHEM PHYS LIPIDS, V44, P87, DOI 10.1016/0009-3084(87)90046-6; SUBBAIAH PV, 1994, BIOCHEMISTRY-US, V33, P13259, DOI 10.1021/bi00249a012; SUBBAIAH PV, 1988, BIOCHIM BIOPHYS ACTA, V963, P445, DOI 10.1016/0005-2760(88)90313-X; SZEDLACSEK SE, 1991, BIOCHEM J, V279, P855, DOI 10.1042/bj2790855; TENG JI, 1981, J STEROID BIOCHEM, V14, P569, DOI 10.1016/0022-4731(81)90032-7; VANLIER JE, 1967, BIOCHEMISTRY-US, V6, P3269, DOI 10.1021/bi00862a037	39	46	46	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11812	11819		10.1074/jbc.270.20.11812	http://dx.doi.org/10.1074/jbc.270.20.11812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744831	hybrid			2022-12-27	WOS:A1995QY73600025
J	WANG, CI; YANG, Q; CRAIK, CS				WANG, CI; YANG, Q; CRAIK, CS			ISOLATION OF A HIGH-AFFINITY INHIBITOR OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BY PHAGE DISPLAY OF ECOTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BOUND UROKINASE; AMINO-ACID-SEQUENCE; MOLECULAR MASS UROKINASE; PROTEIN INHIBITORS; ESCHERICHIA-COLI; HUMAN-MONOCYTES; POOR PROGNOSIS; REACTIVE SITE; BREAST-CANCER; FUSION PHAGE	Ecotin, a serine protease inhibitor found in the periplasm of Escherichia coli, is unique in its ability and mechanism of inhibiting serine proteases of a broad range of substrate specificity. However, although the catalytic domain of human urokinase-type plasminogen activator (uPA) has 40% identity to bovine trypsin and the substrate specificities of these two proteases are virtually identical, ecotin inhibits uPA almost 10,000-fold less efficiently than trypsin. Ecotin was expressed on the surface of filamentous bacteriophage (ecotin phage) to allow the isolation of more potent inhibitors of uPA from a library of ecotin variants. The 142-amino acid inhibitor was fused to the C-terminal domain of the M13 minor coat protein, pIII, through a Gly-Gly-Gly linker and assembled into phage particles. The ecotin phage were shown to react with anti-ecotin antibodies, revealing a stoichiometry of approximately one ecotin per bacteriophage. The ecotin displayed on the surface of phage inhibited trypsin with an equilibrium dissociation constant of 6.7 nM, in close approximation to that of free ecotin, indicating that phage-associated ecotin is correctly folded and functionally active. Reactive-site amino acids 84 and 85 of ecotin were then randomized and a library of 400 unique ecotin phage was created. Three hundred thousand members of the library were screened with immobilized uPA and subjected to three rounds of binding and in vitro selection. DNA sequence analysis of the selected ecotin phage showed that ecotin M84R/M85R predominated while ecotin M84R, M84K, and M84R/M85K were present at a lower frequency. The four ecotin variants were overexpressed and purified and their affinities toward uPA were determined. Each of the selected ecotin variants exhibited increased affinity for uPA when compared to wild-type ecotin with ecotin M84R/M85R showing a 2800-fold increase in binding affinity.	UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco					NIGMS NIH HHS [GM07175] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPELLA E, 1987, J BIOL CHEM, V262, P4437; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; COREY DR, 1993, GENE, V128, P129; CRISSMAN JW, 1984, VIROLOGY, V132, P445, DOI 10.1016/0042-6822(84)90049-7; CROWLEY CW, 1993, P NATL ACAD SCI USA, V90, P5021, DOI 10.1073/pnas.90.11.5021; CUBELLIS MV, 1989, P NATL ACAD SCI USA, V86, P4828, DOI 10.1073/pnas.86.13.4828; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; ELLIS V, 1991, J BIOL CHEM, V266, P12752; ELLIS V, 1990, J BIOL CHEM, V265, P9904; FOEKENS JA, 1994, J CLIN ONCOL, V12, P1648, DOI 10.1200/JCO.1994.12.8.1648; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOODSON RJ, 1994, P NATL ACAD SCI USA, V91, P7129, DOI 10.1073/pnas.91.15.7129; GRONDAHLHANSEN J, 1993, CANCER RES, V53, P2513; GUNZLER WA, 1982, H-S Z PHYSIOL CHEM, V363, P1155, DOI 10.1515/bchm2.1982.363.2.1155; HABER E, 1989, SCIENCE, V243, P51, DOI 10.1126/science.2492113; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; JAMIESON AC, 1994, BIOCHEMISTRY-US, V33, P5689, DOI 10.1021/bi00185a004; JANICKE F, 1993, BREAST CANCER RES TR, V24, P195, DOI 10.1007/BF01833260; KESKIOJA J, 1982, BIOCHIM BIOPHYS ACTA, V720, P141, DOI 10.1016/0167-4889(82)90005-2; KIRCHHEIMER JC, 1987, FASEB J, V1, P125, DOI 10.1096/fasebj.1.2.3038646; KIRCHHEIMER JC, 1988, J IMMUNOL, V141, P4229; KIRCHHEIMER JC, 1989, BLOOD, V74, P1396; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; MASUCCI MT, 1991, J BIOL CHEM, V266, P8655; MAYER M, 1990, CLIN BIOCHEM, V23, P197, DOI 10.1016/0009-9120(90)90601-P; MCGRATH ME, 1991, J BIOL CHEM, V266, P6620; MCGRATH ME, 1994, EMBO J, V13, P1502, DOI 10.1002/j.1460-2075.1994.tb06411.x; MCGRATH ME, 1991, J MOL BIOL, V222, P139, DOI 10.1016/0022-2836(91)90199-G; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; NIELSEN LS, 1988, J BIOL CHEM, V263, P2358; PANNEKOEK H, 1993, GENE, V128, P135, DOI 10.1016/0378-1119(93)90164-X; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; PEDERSEN H, 1994, CANCER RES, V54, P120; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; POLLANEN J, 1990, P NATL ACAD SCI USA, V87, P2230, DOI 10.1073/pnas.87.6.2230; QUIGLEY JP, 1987, P NATL ACAD SCI USA, V84, P2776, DOI 10.1073/pnas.84.9.2776; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; ROBERTS BL, 1992, P NATL ACAD SCI USA, V89, P2429, DOI 10.1073/pnas.89.6.2429; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHULZE AJ, 1994, FEBS LETT, V344, P117, DOI 10.1016/0014-5793(94)00369-6; SEYMOUR JL, 1994, BIOCHEMISTRY-US, V33, P3949, DOI 10.1021/bi00179a022; SHERMAN PM, 1992, J BIOL CHEM, V267, P7588; SLOANE BF, 1981, SCIENCE, V212, P1151, DOI 10.1126/science.7233209; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; STEFFENS GJ, 1982, H-S Z PHYSIOL CHEM, V363, P1043, DOI 10.1515/bchm2.1982.363.2.1043; TESTA JE, 1990, CANCER METAST REV, V9, P353, DOI 10.1007/BF00049524; THORPE SM, 1989, CANCER RES, V49, P6008; TOWLE MJ, 1993, CANCER RES, V53, P2553; VANMOURIK JA, 1984, J BIOL CHEM, V259, P14914; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; WILHELM O, 1994, FEBS LETT, V337, P131, DOI 10.1016/0014-5793(94)80259-9; Williams J W, 1979, Methods Enzymol, V63, P437; YORK JD, 1991, J BIOL CHEM, V266, P8495	60	74	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12250	12256		10.1074/jbc.270.20.12250	http://dx.doi.org/10.1074/jbc.270.20.12250			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744876	hybrid			2022-12-27	WOS:A1995QY73600081
J	YANG, JX; BROWN, MS; HO, YK; GOLDSTEIN, JL				YANG, JX; BROWN, MS; HO, YK; GOLDSTEIN, JL			3 DIFFERENT REARRANGEMENTS IN A SINGLE INTRON TRUNCATE STEROL REGULATORY ELEMENT-BINDING PROTEIN-2 AND PRODUCE STEROL-RESISTANT PHENOTYPE IN 3 CELL-LINES - ROLE OF INTRONS IN PROTEIN EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; LEUCINE ZIPPER PROTEIN; FAMILIAL HYPERCHOLESTEROLEMIA; CULTURED-CELLS; RECEPTOR GENE; TRANSCRIPTION; CHOLESTEROL; ENDOCYTOSIS; PIECES	The cholesterol analogue 25-hydroxycholesterol kills animal cells by blocking the proteolytic activation of two sterol-regulated transcription factors designated sterol regulatory element binding protein-1 and -2 (SREBP-1 and SREBP-2), These proteins, each similar to 1150 amino acids in length, are embedded in the membranes of the nucleus and endoplasmic reticulum by virtue of hydrophobic COOH-terminal segments, In cholesterol-depleted cells the proteins are cleaved to release soluble NH2-terminal fragments of similar to 480 amino acids that enter the nucleus and activate genes encoding the low density lipoprotein receptor and enzymes of cholesterol synthesis, 25-Hydroxycholesterol blocks this cleavage, and cells die of cholesterol deprivation, We previously described a mutant 25-hydroxycholesterol-resistant hamster cell line (SRD-1 cells) in which the SREBP-2 gene had undergone a recombination between the intron following codon 460 and an intron in an unrelated gene, The SREBP-2 sequence terminated at residue 460, eliminating the membrane attachment domain and producing a constitutively active factor that no longer required proteolysis and thus was not inhibited by 25-hydroxycholesterol. Here, we report that two additional sterol-resistant cell lines (SRD-2 and SRD-3) have also undergone genomic rearrangements in the intron following codon 460 of the SREBP-2 gene, Although the molecular rearrangements differ in the three mutant lines, each leads to the production of a constitutively active transcription factor whose SREBP-2 sequence terminates at residue 460, These findings provide a dramatic illustration of the advantage that introns provide in allowing proteins to gain new functions in response to new environmental challenges.			YANG, JX (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.				NHLBI NIH HHS [HL20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; CHANG TY, 1982, BIOCHEMISTRY-US, V21, P5316, DOI 10.1021/bi00264a030; DAWSON PA, 1991, J BIOL CHEM, V266, P9128; GILBERT W, 1985, SCIENCE, V228, P823, DOI 10.1126/science.4001923; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HERZ J, 1990, J BIOL CHEM, V265, P21355; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LEONARD S, 1988, BIOCHIM BIOPHYS ACTA, V947, P101, DOI 10.1016/0304-4157(88)90021-4; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Patthy L, 1991, CURR OPIN STRUC BIOL, V1, P351, DOI 10.1016/0959-440X(91)90033-P; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SATO R, 1994, J BIOL CHEM, V269, P17267; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; YANG JX, 1994, GENE DEV, V8, P1910, DOI 10.1101/gad.8.16.1910; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	23	88	91	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12152	12161		10.1074/jbc.270.20.12152	http://dx.doi.org/10.1074/jbc.270.20.12152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744865	hybrid			2022-12-27	WOS:A1995QY73600068
J	BRUCE, C; DAVIDSON, WS; KUSSIE, P; LUNDKATZ, S; PHILLIPS, MC; GHOSH, R; TALL, AR				BRUCE, C; DAVIDSON, WS; KUSSIE, P; LUNDKATZ, S; PHILLIPS, MC; GHOSH, R; TALL, AR			MOLECULAR DETERMINANTS OF PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN-BINDING TO HIGH-DENSITY-LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; LIPID TRANSFER PROTEIN; CELL-DERIVED CHOLESTEROL; PARTICLES; ACYLTRANSFERASE; LECITHIN; CHARGE; CONFORMATION; PURIFICATION; METABOLISM	The plasma cholesteryl ester transfer protein (CETP) mediates the transfer of neutral lipids between lipoproteins and is associated with high density lipoproteins (HDL), To understand the mechanism of interaction of CETP with HDL, we studied the binding of pure recombinant CETP to 1-palmitoyl-2-oleoylphosphatidylcholine (POPC)/apoA-I discoidal particles, Separating bound from free CETP using native gradient gel electrophoresis, complexes of CETP with 10-nm hydrodynamic diameter discoidal particles migrated with a diameter of 12-16 nm, compared with similar to 7.5 nm for CETP, At lower ratios of CETP to discs, CETP bound to discs without displacement of apoA-I. CETP alone was unable to generate discoidal complexes, Cross-linking and fluorescence resonance energy transfer experiments indicated that CETP bound to discs as monomers, Cross-linking of CETP to apoA-I in discs suggested proximity of apoA-I and CETP, By negative-stain electron microscopy, discoidal complexes containing CETP and CETP monoclonal antibody showed localization of antibody molecules to the disc edge, suggesting that CETP was bound to the disc edge, The binding of CETP to discs of different composition or size was studied, Discs (10-nm Stokes diameter) prepared with either apoA-I or apoA-II had a similar K-d (120 nM), Inclusion of 1 mol % cholesteryl oleate, 5 mol % cholesterol, or 6 mol % phosphatidylinositol increased the binding affinity of CETP 3-10 times (20-30 nar), In comparison, plasma HDL(3) had a K-d of similar to 450 nM, For POPC/apoA-I discs, 10-nm discs bound CETP with much higher affinity than smaller 7.8-nm discs (K-d = 1-2 mu M), 7.7-nm hydrodynamic diameter POPC/apoA-I spherical particles containing either triolein or cholesteryl oleate in their core bound CETP with higher affinity (K-d = 50-100 mu M) than 7.8-nm POPC/apoA-I discs, Thus, CETP appears to bind to the perimeter of discoidal particles, possibly in a process in which flexible segments in apoA-I or apoA-II accommodate CETP at the disc edge, The binding of CETP to HDL is markedly influenced by overall particle size and shape and by lipid composition, and the increased binding affinity for cholesterol- and cholesteryl ester containing discs suggests a higher affinity of CETP for nascent than mature HDL.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,DIV MOLEC MED,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; MED COLL PENN,DEPT BIOCHEM,PHILADELPHIA,PA 19129	Columbia University; Columbia University; Drexel University			Tall, Alan/AAT-8528-2021	Phillips, Michael/0000-0002-7147-8007; Bruce, Can/0000-0002-3101-1250; Davidson, William/0000-0003-2756-2989				BANKA CL, 1994, J BIOL CHEM, V269, P10288; BANKA CL, 1991, J BIOL CHEM, V266, P23886; CALABRESI L, 1993, BIOCHEMISTRY-US, V32, P6477, DOI 10.1021/bi00076a023; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CLAY MA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P52, DOI 10.1016/0005-2760(92)90125-F; DAVIDSON WS, 1994, J BIOL CHEM, V269, P8859; DRAYNA D, 1987, NATURE, V327, P632, DOI 10.1038/327632a0; EISENBERG S, 1984, J LIPID RES, V25, P1017; FRANCONE OL, 1989, J BIOL CHEM, V264, P7066; GREEN PHR, 1978, J CLIN INVEST, V61, P528, DOI 10.1172/JCI108963; GUYARDDANGREMON.V, 1994, J LIPID RES, V35, P982; HAMILTON RL, 1976, J CLIN INVEST, V58, P667, DOI 10.1172/JCI108513; HAYEK T, 1992, J CLIN INVEST, V90, P505, DOI 10.1172/JCI115887; HESLER CB, 1989, J BIOL CHEM, V264, P11317; HESLER CB, 1987, J BIOL CHEM, V262, P2275; JOHNSON DA, 1984, J BIOL CHEM, V259, P5717; JOHNSON FL, 1986, J LIPID RES, V27, P537; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; KATO H, 1989, J BIOL CHEM, V264, P4082; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; MARCEL YL, 1990, J CLIN INVEST, V85, P10, DOI 10.1172/JCI114397; MENG QH, 1993, J BIOL CHEM, V268, P16966; MORTON RE, 1990, J LIPID RES, V31, P1559; MORTON RE, 1981, J BIOL CHEM, V256, P1992; MORTON RE, 1988, J BIOL CHEM, V263, P12235; MOULIN P, 1994, J LIPID RES, V35, P793; MUSLINER TA, 1991, J LIPID RES, V32, P917; NISHIDA HI, 1993, J BIOL CHEM, V268, P16352; OHNISHI T, 1994, BIOCHEMISTRY-US, V33, P6093, DOI 10.1021/bi00186a008; PATTNAIK NM, 1979, J BIOL CHEM, V254, P2782; QUINET E, 1993, J BIOL CHEM, V268, P16891; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; RYE KA, 1989, J LIPID RES, V30, P335; SAMMETT D, 1985, J BIOL CHEM, V260, P6687; SEGREST JP, 1992, J LIPID RES, V33, P141; SPARKS DL, 1993, J BIOL CHEM, V268, P23250; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SWENSON TL, 1989, J BIOL CHEM, V264, P14318; TAKAHASHI K, 1993, J CLIN INVEST, V92, P2060, DOI 10.1172/JCI116802; TALL A, 1987, J CLIN INVEST, V79, P1217, DOI 10.1172/JCI112940; TALL AR, 1977, J BIOL CHEM, V252, P4701; TALL AR, 1993, J LIPID RES, V34, P1255; TALL AR, 1977, NATURE, V265, P163, DOI 10.1038/265163a0; WALD JH, 1990, J BIOL CHEM, V265, P20037; WANG SK, 1995, J BIOL CHEM, V270, P612, DOI 10.1074/jbc.270.2.612; WEINBERG RB, 1994, J BIOL CHEM, V269, P29588	47	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11532	11542		10.1074/jbc.270.19.11532	http://dx.doi.org/10.1074/jbc.270.19.11532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744792	hybrid			2022-12-27	WOS:A1995QX86500072
J	DING, JB; VLAHOS, CJ; LIU, RC; BROWN, RF; BADWEY, JA				DING, JB; VLAHOS, CJ; LIU, RC; BROWN, RF; BADWEY, JA			ANTAGONISTS OF PHOSPHATIDYLINOSITOL 3-KINASE BLOCK ACTIVATION OF SEVERAL NOVEL PROTEIN-KINASES IN NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT CHAIN KINASE; RESPIRATORY BURST; CHEMOTACTIC FACTORS; STIMULATION; CALCIUM; PHOSPHORYLATION; SUBSTRATE; TRANSDUCTION; LEUKOCYTES; WORTMANNIN	Several novel protein kinases are known to be rapidly activated in neutrophils stimulated with the chemoattractant fMet-Leu-Phe (fMLP), These kinases include a histone H4 protein kinase and several renaturable kinases with molecular masses of about 69, 63, 49, and 40 kDa, The renaturable kinases can catalyze the phosphorylation of a peptide that corresponds to residues 297-331 of the 47-kDa subunit of the NADPH-oxidase system (p47-phox). Previous studies have indicated that the activation of all of these protein kinases involves an uncharacterized stimulatory pathway and/or novel second messenger, The studies reported herein were undertaken to determine if phosphatidylinositol 3-kinase (PI3-K) is a component of this pathway, We report that certain chromone derivatives (e.g. 2-(4-morpholinyl)-8-phenylchromone (LY294002)) and wortmannin, which inhibit PIS-K by distinct mechanisms, blocked activation of all of these novel kinases, These antagonists also inhibited the phosphorylation of p47-phox (about 50%) and O-2(radical anion) release (about 80%) in cells stimulated with fMLP, but not with 4 beta-phorbol 12-myristate 13-acetate. A strong correlation exists between the amounts of these antagonists required to produce 50% inhibition of PB-K in vitro and O-2(radical anion) release in vivo. In contrast, a single atom substitution of LY294002 produced a compound (LY303511) that did not inhibit PI3-K, Compound LY303511 did not appreciably inhibit the activation of the novel protein kinases or O-2(radical anion) generation, These data strongly suggest that PI3-K is involved in the activation of several novel protein kinases in neutrophils, one or more of which may be involved in O-2(radical anion) release.	BOSTON BIOMED RES INST,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115; ELI LILLY & CO,LILLY RES LABS,INDIANAPOLIS,IN 46285	Boston Biomedical Research Institute; Harvard University; Harvard Medical School; Eli Lilly					NIAID NIH HHS [AI23323] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023323] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Badwey J A, 1986, Methods Enzymol, V132, P365; BAGGIOLINI M, 1993, FASEB J, V7, P1004, DOI 10.1096/fasebj.7.11.8396540; BAGGIOLINI M, 1987, EXP CELL RES, V169, P408, DOI 10.1016/0014-4827(87)90201-1; BRUMELL JH, 1994, AM J PHYSIOL, pC1574; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; DEWALD B, 1988, J BIOL CHEM, V263, P16179; DHAND R, 1994, CELL, V13, P522; DING JB, 1993, J BIOL CHEM, V268, P5234; DING JB, 1994, FEBS LETT, V348, P149, DOI 10.1016/0014-5793(94)00593-1; DING JB, 1993, J BIOL CHEM, V268, P17326; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; GRINSTEIN S, 1993, J BIOL CHEM, V268, P20223; HEYWORTH PG, 1989, J BIOL CHEM, V264, P14935; HEYWORTH PG, 1990, J BIOENERG BIOMEMBR, V22, P1, DOI 10.1007/BF00762842; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HUANG CK, 1988, J BIOL CHEM, V263, P13144; HUANG CK, 1990, J CELL BIOCHEM, V44, P221, DOI 10.1002/jcb.240440404; LAM K, 1994, J BIOL CHEM, V269, P20648; MAJUMDAR S, 1993, BIOCHIM BIOPHYS ACTA, V1176, P276, DOI 10.1016/0167-4889(93)90056-U; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; OKADA T, 1994, J BIOL CHEM, V269, P3563; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; POWIS G, 1994, CANCER RES, V54, P2419; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SHAAFI RI, 1988, PROG ALLERGY, V42, P1; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; THELEN M, 1994, P NATL ACAD SCI USA, V91, P4960, DOI 10.1073/pnas.91.11.4960; TOKER A, 1994, J BIOL CHEM, V269, P32358; TRAYNORKAPLAN AE, 1989, J BIOL CHEM, V264, P15668; TRAYNORKAPLAN AE, 1988, NATURE, V344, P353; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P9563; WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0	48	110	113	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11684	11691		10.1074/jbc.270.19.11684	http://dx.doi.org/10.1074/jbc.270.19.11684			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744808	hybrid			2022-12-27	WOS:A1995QX86500092
J	SAKAUE, H; HARA, K; NOGUCHI, T; MATOZAKI, T; KOTANI, K; OGAWA, W; YONEZAWA, K; WATERFIELD, MD; KASUGA, M				SAKAUE, H; HARA, K; NOGUCHI, T; MATOZAKI, T; KOTANI, K; OGAWA, W; YONEZAWA, K; WATERFIELD, MD; KASUGA, M			RAS-INDEPENDENT AND WORTMANNIN-SENSITIVE ACTIVATION OF GLYCOGEN-SYNTHASE BY INSULIN IN CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR SUBSTRATE-1; VACCINIA VIRUS; 70K-S6 KINASE; PHOSPHORYLATION; STIMULATION; INHIBITION; IRS-1; SHC	Activation of glycogen synthase is one of the major metabolic events triggered by exposure of cells to insulin. The molecular mechanism by which insulin activates glycogen synthase was investigated. The possible role of Ras and mitogen-activated protein kinase cascade was investigated with a stable cell line, CHO-IR-C/S 46, that overexpresses insulin receptors and a catalytically inactive SH-PTP 2 protein phosphatase and in which insulin does not induce the formation of the Ras-GTP complex or the subsequently activation of the mitogen-activated protein kinase cascade. Insulin activated glycogen synthase in this cell line to a similar extent as in parental CHO-IR cells, The importance of heteromeric phosphoinositide (PI) 3-kinase in insulin activation of glycogen synthase was examined in a stable cell line, CHO-IR/Delta p85, that overexpresses insulin receptors and a dominant negative mutant (Delta p85) of the 85-kDa subunit of PI-3 kinase that lacks the binding site for the catalytic 110-kDa subunit. Insulin-dependent activation of PI-3 kinase and glucose transport, but not the formation of the Ras-GTP complex, are markedly attenuated in this cell line. In CHO-IR/Delta p85 cells, insulin activated glycogen synthase to a similar extent as in parental CRO-IR cells. The failure of overproduction of the mutant (Delta p85) protein to inhibit insulin activation of glycogen synthase was also confirmed by transient expression in Rat 1 cells with the use of a recombinant vaccinia virus. However, wortmannin abolished insulin activation of glycogen synthase in all cell lines. These data suggest the existence of a Ras-independent and wortmannin-sensitive pathway for activation of glycogen synthase by insulin,	KOBE UNIV, SCH MED, DEPT INTERNAL MED 2, CHUO KU, KOBE 650, JAPAN; LUDWIG INST CANC RES, LONDON W1P 8BT, ENGLAND; UNIV LONDON UNIV COLL, DEPT BIOCHEM & MOLEC BIOL, LONDON WC1E 6BT, ENGLAND	Kobe University; Ludwig Institute for Cancer Research; University of London; University College London			Sakaue, Hiroshi/ABE-2337-2021; OGAWA, Wataru/AAQ-9586-2020	Sakaue, Hiroshi/0000-0002-2468-2363; 				AHN NG, 1990, J BIOL CHEM, V265, P11495; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CALVO V, 1992, P NATL ACAD SCI USA, V89, P75741; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; EAGAN SE, 1993, NATURE, V365, P781; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HARA K, 1995, BIOCHEM BIOPH RES CO, V208, P735, DOI 10.1006/bbrc.1995.1399; HOSHIKAWA N, 1991, J GEN VIROL, V72, P2509, DOI 10.1099/0022-1317-72-10-2509; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LAVAN BE, 1992, J BIOL CHEM, V267, P11631; LEE CH, 1993, P NATL ACAD SCI USA, V90, P11713, DOI 10.1073/pnas.90.24.11713; LIN FA, 1994, J BIOL CHEM, V269, P1255; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; OKADA T, 1994, J BIOL CHEM, V269, P3568; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; ROBINSON LJ, 1993, J BIOL CHEM, V268, P26422; SAKAUE M, 1995, MOL CELL BIOL, V15, P379, DOI 10.1128/MCB.15.1.379; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; STEPHENS L, 1994, CURR BIOL, V4, P203, DOI 10.1016/S0960-9822(00)00049-X; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SUGIMOTO M, 1985, MICROBIOL IMMUNOL, V29, P421, DOI 10.1111/j.1348-0421.1985.tb00843.x; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015; YANO H, 1993, J BIOL CHEM, V268, P25846; YONEZAWA K, 1992, J BIOL CHEM, V267, P25958; YONEZAWA K, 1994, J BIOL CHEM, V269, P4634	42	77	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11304	11309		10.1074/jbc.270.19.11304	http://dx.doi.org/10.1074/jbc.270.19.11304			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744767	hybrid			2022-12-27	WOS:A1995QX86500044
J	DYCK, JRB; FLIEGEL, L				DYCK, JRB; FLIEGEL, L			SPECIFIC ACTIVATION OF THE NA+/H+ EXCHANGER GENE DURING NEURONAL DIFFERENTIATION OF EMBRYONAL CARCINOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR PH; RETINOIC ACID; TRANSCRIPTION FACTOR; HL-60 CELLS; PHORBOL ESTER; AP-2; ACIDIFICATION; PROLIFERATION; LYMPHOCYTES; FIBROBLASTS	We examined the regulation of the Na+/H+ exchanger gene during differentiation of the pig mouse embryonal carcinoma cells, Treatment of P19 cells with retinoic acid induces the development of neurons, astroglia, and microglia cells, Upon retinoic acid induced differentiation of P19 cells, there was an early and rapid 10-fold increase in NHE1 transcription, A proximal cis-acting AP-2 site of the NHE1 promoter was sufficient for stimulation of transcription of the gene by differentiation. Bandshift experiments demonstrated that in retinoic acid-treated cells there was an elevated level of AP-2 transcription factor binding to the AP-2 consensus site of the Na+/H+ exchanger gene, In the differentiation defective mutant RAC65, the effect of differentiation on Na+/H+ exchanger gene expression was reduced by 60%. Examination of Na+/H+ exchanger activity showed that retinoic acid treated P19 cells recovered from an acid load at a rate approximately three times greater than untreated cells. The increases in gene expression and protein activity preceded major changes in cell morphology, suggesting that the initiation of differentiation is linked to NHE1 gene expression, Our findings show for the first time that the NHE1 gene is activated early in cell differentiation and that this activation may play an important role in the process of neuronal cell differentiation.	UNIV ALBERTA,FAC MED,DEPT PEDIAT,MRC,MOLEC BIOL MEMBRANES GRP,EDMONTON,AB T6G 2S2,CANADA	University of Alberta				Dyck, Jason/0000-0002-7045-2884				ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685; ALVAREZ J, 1989, EUR J BIOCHEM, V183, P709, DOI 10.1111/j.1432-1033.1989.tb21102.x; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; BIERMAN AJ, 1987, J BIOL CHEM, V262, P9621; BISHOP JF, 1990, FEBS LETT, V264, P125, DOI 10.1016/0014-5793(90)80781-D; BORON WF, 1983, J GEN PHYSIOL, V81, P29, DOI 10.1085/jgp.81.1.29; CHAILLET JR, 1985, J GEN PHYSIOL, V86, P765, DOI 10.1085/jgp.86.6.765; CHAMBARD JC, 1986, EXP CELL RES, V164, P282, DOI 10.1016/0014-4827(86)90029-7; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; DYCK JRB, 1995, J BIOL CHEM, V270, P1375, DOI 10.1074/jbc.270.3.1375; FLIEGEL L, 1993, BIOCHEM J, V296, P273, DOI 10.1042/bj2960273; FLIEGEL L, 1993, BIOCHEM J, V289, P101, DOI 10.1042/bj2890101; GRINSTEIN S, 1983, J GEN PHYSIOL, V82, P619, DOI 10.1085/jgp.82.5.619; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HAZAV P, 1989, CANCER RES, V49, P72; JONESVILLENEUVE EV, 1993, MOL CELL BIOL, V3, P2271; KOLYADA AY, 1994, BBA-GENE STRUCT EXPR, V1217, P54; LADOUX A, 1987, J BIOL CHEM, V262, P811; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; MAIDORN RP, 1993, BRIT J CANCER, V67, P297, DOI 10.1038/bjc.1993.56; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; PHILIPP J, 1994, DEV BIOL, V165, P602, DOI 10.1006/dbio.1994.1279; PIPKIN J L, 1991, Applied and Theoretical Electrophoresis, V2, P17; POUYSSEGUR J, 1985, TRENDS BIOCHEM SCI, V10, P453, DOI 10.1016/0968-0004(85)90030-1; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; PRATT CMA, 1990, MOL CELL BIOL, V10, P6446; RAC GN, 1992, J CELL PHYSL, V151, P361; RAO GN, 1993, AM J PHYSIOL, V264, pC1278, DOI 10.1152/ajpcell.1993.264.5.C1278; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SMITH LL, 1988, J BIOL CHEM, V263, P7359; SPECTOR NL, 1994, FEBS LETT, V337, P184, DOI 10.1016/0014-5793(94)80270-X; STARNAUD R, 1993, MOL CELL BIOL, V13, P1590, DOI 10.1128/MCB.13.3.1590; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; VAIRO G, 1993, CELL GROWTH DIFFER, V4, P461; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557	37	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10420	10427		10.1074/jbc.270.18.10420	http://dx.doi.org/10.1074/jbc.270.18.10420			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737975	hybrid			2022-12-27	WOS:A1995QW60100013
J	KIM, JS; SOUCEK, J; MATOUSEK, J; RAINES, RT				KIM, JS; SOUCEK, J; MATOUSEK, J; RAINES, RT			STRUCTURAL BASIS FOR THE BIOLOGICAL-ACTIVITIES OF BOVINE SEMINAL RIBONUCLEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; CRYSTAL-STRUCTURE; RNASE; INVITRO; PLASMA; GROWTH; FLUID; CELLS; TUMOR	Bovine seminal ribonuclease (BS-RNase) is a homolog of RNase A with special biological properties that include specific antitumor, aspermatogenic, and immunosuppressive activities. Unlike RNase A, BS-RNase is a dimer cross-linked by disulfide bonds between Cys(31) of one subunit and Cys(32) Of the other. At equilibrium, this dimer is a mixture of two distinct quaternary forms, M=M and MxM. The conversion of M=M to MxM entails the exchange of NH2-terminal alpha-helices between subunits. Here, the cytotoxic activities of purified MxM were shown to be greater than those of purified M=M, despite extensive equilibration of M=M and MxM during the time course of the assays. Replacing Cys(31) or Cys(32) with a serine residue did not compromise the enzymatic activity of dimeric BS-RNase, but reduced both the fraction of MxM at equilibrium and the cytotoxicity. We conclude that the MxM form is responsible for the special biological properties of BS-RNase. Since cytosolic ribonuclease inhibitor binds tightly to monomeric but not dimeric BS-RNase and only the MxM form can remain dimeric in the reducing environment of the cytosol, we propose that BS-RNase has evolved its MxM form to retain its lethal enzymatic activity in vivo.	UNIV WISCONSIN,DEPT BIOCHEM,MADISON,WI 53706; INST HEMATOL & BLOOD TRANSFUS,DEPT CELL PHYSIOL,CR-12820 PRAGUE 2,CZECH REPUBLIC; INST ANIM PHYSIOL & GENET,CR-27721 LIBECHOV,CZECH REPUBLIC	University of Wisconsin System; University of Wisconsin Madison; Institute of Hematology Prague; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences			Raines, Ronald T./A-5009-2013; KIM, Jin-Soo/M-6918-2013	Raines, Ronald T./0000-0001-7164-1719; KIM, Jin-Soo/0000-0003-4847-1306	NIGMS NIH HHS [GM-44783] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044783] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM, 1988, MOL REPROD DEV; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; BARTHOLEYNS J, 1976, P NATL ACAD SCI USA, V73, P573, DOI 10.1073/pnas.73.2.573; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Berger S L, 1979, Methods Enzymol, V58, P486; BORCHERT TV, 1994, P NATL ACAD SCI USA, V91, P1515, DOI 10.1073/pnas.91.4.1515; BREITMAN TR, 1980, P NATL ACAD SCI USA, V71, P2936; BREUKELMAN HJ, 1993, RIBONUCLEASES CHEM B; CRESTFIELD A M, 1962, Arch Biochem Biophys, VSuppl 1, P217; D'Alessio Giuseppe, 1993, Trends in Cell Biology, V3, P106, DOI 10.1016/0962-8924(93)90166-X; DALESSIO G, 1975, BIOCHEMISTRY-US, V14, P1116, DOI 10.1021/bi00677a004; DALESSIO G, 1991, TRENDS BIOCHEM SCI, V16, P104, DOI 10.1016/0968-0004(91)90042-T; DALESSIO G, 1972, EUR J BIOCHEM, V26, P153, DOI 10.1111/j.1432-1033.1972.tb01751.x; DENIGRIS M, 1993, BIOCHEM BIOPH RES CO, V193, P155, DOI 10.1006/bbrc.1993.1603; DIDONATO A, 1994, J BIOL CHEM, V269, P17394; DOSTAL J, 1973, J REPROD FERTIL, V33, P263, DOI 10.1530/jrf.0.0330263; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; JAMES K, 1984, IMMUNOL TODAY, V5, P357, DOI 10.1016/0167-5699(84)90079-3; KIM EE, 1992, BIOCHEMISTRY-US, V31, P12304, DOI 10.1021/bi00164a004; KIM JS, 1993, J BIOL CHEM, V268, P17392; KIM JS, 1994, EUR J BIOCHEM, V224, P109, DOI 10.1111/j.1432-1033.1994.tb20001.x; KIM JS, 1993, PROTEIN SCI, V2, P348; KIM JS, 1995, IN PRESS BIOCH J; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KUNITZ M, 1946, J BIOL CHEM, V164, P563; LACCETTI P, 1992, CANCER RES, V52, P4582; LIBONATI M, 1976, EUR J BIOCHEM, V69, P445, DOI 10.1111/j.1432-1033.1976.tb10929.x; LIBONATI M, 1969, EUR J BIOCHEM, V8, P81, DOI 10.1111/j.1432-1033.1969.tb00498.x; MANCHENO JM, 1994, BIOCHEM BIOPH RES CO, V199, P119, DOI 10.1006/bbrc.1994.1202; MATOUSEK J, 1994, ANIM GENET, V25, P45, DOI 10.1111/j.1365-2052.1994.tb00402.x; MATOUSEK J, 1973, EXPERIENTIA, V29, P858, DOI 10.1007/BF01946329; MATOUSEK J, 1992, ANIMAL GENET S1, V23, P46; MAZZARELLA L, 1987, GAZZ CHIM ITAL, V117, P91; MURTHY BS, 1992, BIOCHEM J, V281, P343, DOI 10.1042/bj2810343; NEWTON DL, 1994, J NEUROSCI, V14, P538; PICCOLI R, 1992, P NATL ACAD SCI USA, V89, P1870, DOI 10.1073/pnas.89.5.1870; PICCOLI R, 1988, BIOCHEM J, V253, P329, DOI 10.1042/bj2530329; PICCOLI R, 1993, RIBONUCLEASES CHEM B; PICCOLI R, 1983, J BIOL CHEM, V259, P693; SAXENA SK, 1991, J BIOL CHEM, V266, P21208; SELA M, 1957, BIOCHIM BIOPHYS ACTA, V26, P502, DOI 10.1016/0006-3002(57)90096-3; SINHA ND, 1984, NUCLEIC ACIDS RES, V12, P4539, DOI 10.1093/nar/12.11.4539; SMITH GK, 1978, BIOCHEMISTRY-US, V17, P2633, DOI 10.1021/bi00606a027; SOUCEK J, 1983, FOLIA BIOL-PRAGUE, V29, P250; SOUCEK J, 1986, NAT IMMUN CELL GROW, V5, P250; SOUCEK J, 1993, RIBONUCLEASES CHEM B; SUZUKI H, 1987, BIOL CHEM H-S, V368, P1305, DOI 10.1515/bchm3.1987.368.2.1305; TAMBURRINI M, 1989, J PROTEIN CHEM, V8, P719, DOI 10.1007/BF01024897; TAMBURRINI M, 1990, EUR J BIOCHEM, V190, P145, DOI 10.1111/j.1432-1033.1990.tb15557.x; VESCIA S, 1980, CANCER RES, V40, P3740; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; YOULE RJ, 1993, CRIT REV THER DRUG, V10, P1	52	81	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10525	10530		10.1074/jbc.270.18.10525	http://dx.doi.org/10.1074/jbc.270.18.10525			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737987	hybrid			2022-12-27	WOS:A1995QW60100027
J	SCHRAUFSTATTER, IU; MA, M; OADES, ZG; BARRITT, DS; COCHRANE, CG				SCHRAUFSTATTER, IU; MA, M; OADES, ZG; BARRITT, DS; COCHRANE, CG			THE ROLE OF TYR(13) AND LYS(15) OF INTERLEUKIN-8 IN THE HIGH-AFFINITY INTERACTION WITH THE INTERLEUKIN-8-RECEPTOR TYPE-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYL PEPTIDE RECEPTOR; AMINO TERMINUS; LIGAND-BINDING; NEUTROPHILS; MUTAGENESIS; EXPRESSION; RESIDUES; DOMAIN	Interleukin-8 (IL-8) has at least two binding regions for both the A and the B type IL-8 receptors. This study defines an important region between Cys(7) and Cys(50) that, together with the Glu(4)-Leu(5)-Arg(6) sequence of the NH2 terminus, accounts for the high affinity binding of IL-8 to the IL-8 A receptor on leukocytes, Utilizing rabbit IL-8 that shares 82% sequence identity with human IL-8, but has 200-fold lower binding affinity for the IL-8 A receptor, residues of the human homologue were sequentially exchanged into the rabbit molecule, Replacement of rabbit His(13) and Thr(15) with Tyr(13) and Lys(15) Of the human molecule converted the low affinity binding of the rabbit IL-8 to the high affinity binding of human IL-8 as shown by both competitive binding and by Ca2+ mobilization, As a corollary, replacement of the Tyr(13) and Lys(15) Of the human IL-8 with His(13) and Thr(15) Of the rabbit IL-8 reduced binding activity of this mutated human IL-8 200-fold, The site of interaction on the IL-8 receptor type A for the Tyr(13) and Lys(15) sequence was found to be in the NH2-terminal region of this receptor, A structural pattern of the binding between IL-8 and the A type IL-8 receptor is proposed.			SCHRAUFSTATTER, IU (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL023584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI027506] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 23584] Funding Source: Medline; NIAID NIH HHS [AI27506] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ausubel FM., 2006, ENZYMATIC MANIPULATI; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; DEFORGE LE, 1991, IMMUNOL INVEST, V20, P89, DOI 10.3109/08820139109054928; DIXON RAF, 1988, COLD SPRING HARB SYM, V53, P487, DOI 10.1101/SQB.1988.053.01.056; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; GAYLE RB, 1993, J BIOL CHEM, V268, P7283; HEBERT CA, 1993, J BIOL CHEM, V268, P18549; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; LEE J, 1992, J BIOL CHEM, V267, P16283; LEONG SR, 1994, J BIOL CHEM, V269, P19343; MOSER B, 1991, J BIOL CHEM, V266, P10666; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; PAOLINI JF, 1994, J IMMUNOL, V153, P2704; PROSSNITZ ER, 1993, J IMMUNOL, V151, P5704; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; SCHRAUFSTATTER IU, 1993, J IMMUNOL, V151, P6418; Sekido Nobuaki, 1993, Nature (London), V365, P655; SUZUKI H, 1994, J BIOL CHEM, V269, P18263	27	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10428	10431		10.1074/jbc.270.18.10428	http://dx.doi.org/10.1074/jbc.270.18.10428			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737976	hybrid			2022-12-27	WOS:A1995QW60100014
J	OLSON, ST; STEPHENS, AW; HIRS, CHW; BOCK, PE; BJORK, I				OLSON, ST; STEPHENS, AW; HIRS, CHW; BOCK, PE; BJORK, I			KINETIC CHARACTERIZATION OF THE PROTEINASE BINDING DEFECT IN A REACTIVE-SITE VARIANT OF THE SERPIN, ANTITHROMBIN - ROLE OF THE P1' RESIDUE IN TRANSITION-STATE STABILIZATION OF ANTITHROMBIN-PROTEINASE COMPLEX-FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTION; CATALYZED PROTEASE INACTIVATION; FACTOR-XA; ALPHA-THROMBIN; ANTI-THROMBIN; BOND LOOP; HEPARIN ACCELERATION; SUBSTRATE PROPERTIES; TARGET PROTEINASES; TRANSIENT KINETICS	To elucidate the role of the P1' residue of the serpin, antithrombin (AT), in proteinase inhibition, the source of the functional defect in a natural Ser-394 --> Leu variant, AT-Denver, was investigated. AT-Denver inhibited thrombin, Factor Ma, plasmin, and Factor Xa with second order rate constants that were 430-, 120-, 40-, and 7-fold slower, respectively, than those of native AT, consistent with an altered specificity of the variant inhibitor for its target proteinases. AT-Denver inhibited thrombin and Factor Xa with nearly equimolar stoichiometries and formed SDS-stable complexes with these proteinases, indicating that the diminished inhibitor activity was not due to an enhanced turnover of the inhibitor as a substrate, Binding and kinetic studies showed that heparin binding to AT-Denver as well as heparin accelerations of AT-Denver-proteinase reactions were normal, consistent with the P1' mutation not affecting the heparin activation mechanism. Resolution of the two-step reaction of AT-Denver with thrombin revealed that the majority of the defective function was localized in the second reaction step and resulted from a 190-fold decreased rate constant for conversion of a noncovalent proteinase-inhibitor encounter complex to a stable, covalent complex, Little or no effects of the mutation on the binding constant for encounter complex formation or on the rate constant for stable complex dissociation were evident, These results support a role for the P1' residue of antithrombin in transition-state stabilization of a substrate-like attack of the proteinase on the inhibitor-reactive bond following the formation of a proteinase-inhibitor encounter complex but prior to the conformational change leading to the trapping of proteinase in a stable, covalent complex. Such a role indicates that the P1' residue does not contribute to thermodynamic stabilization of AT-proteinase complexes and instead favors a kinetic stabilization of these complexes by a suicide substrate reaction mechanism.	UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262; VANDERBILT UNIV,DEPT PATHOL,NASHVILLE,TN 37232; SWEDISH UNIV AGR SCI,DEPT VET MED CHEM,S-75123 UPPSALA,SWEDEN	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Vanderbilt University; Swedish University of Agricultural Sciences	OLSON, ST (corresponding author), UNIV ILLINOIS,CTR MOLEC BIOL ORAL DIS,RM 530E,DENT M-C 860,801 S PAULINA ST,CHICAGO,IL 60612, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039888, R37HL039888, R29HL039888] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-02832, HL-39888] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUSTIN RC, 1991, BLOOD, V77, P2185; BARLOW GH, 1969, J BIOL CHEM, V244, P1138; BJORK I, 1992, J BIOL CHEM, V267, P1976; BJORK I, 1982, J BIOL CHEM, V257, P2406; BJORK I, 1992, J BIOL CHEM, V267, P19047; BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501; BJORK I, 1981, FEBS LETT, V126, P257, DOI 10.1016/0014-5793(81)80255-4; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1992, EUR J BIOCHEM, V204, P423; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; CASO R, 1991, BRIT J HAEMATOL, V77, P87, DOI 10.1111/j.1365-2141.1991.tb07953.x; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DANIELSSON A, 1983, BIOCHEM J, V213, P345, DOI 10.1042/bj2130345; DERECHIN VM, 1990, J BIOL CHEM, V265, P5623; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; ENGH RA, 1990, PROTEIN ENG, V3, P469, DOI 10.1093/protein/3.6.469; ERDJUMENT H, 1989, THROMB RES, V54, P613, DOI 10.1016/0049-3848(89)90127-8; ERDJUMENT H, 1988, J BIOL CHEM, V263, P5589; ERDJUMENT H, 1988, THROMB HAEMOSTASIS, V60, P471; FENTON JW, 1977, J BIOL CHEM, V252, P3587; FISH WW, 1979, EUR J BIOCHEM, V101, P31, DOI 10.1111/j.1432-1033.1979.tb04212.x; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; JESTY J, 1979, J BIOL CHEM, V254, P44; JORDAN RE, 1980, J BIOL CHEM, V255, P81; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DA, 1989, BRIT J HAEMATOL, V71, P91, DOI 10.1111/j.1365-2141.1989.tb06280.x; LANE DA, 1989, J BIOL CHEM, V264, P10200; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LAWRENCE DA, 1994, J BIOL CHEM, V269, P27657; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1982, J BIOL CHEM, V257, P4891; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1988, J BIOL CHEM, V263, P1698; OLSON ST, 1981, J BIOL CHEM, V256, P1065; OLSON ST, 1985, J BIOL CHEM, V260, P153; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; OLSON ST, 1994, SEMIN THROMB HEMOST, V20, P373, DOI 10.1055/s-2007-1001928; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; OWEN MC, 1988, FEBS LETT, V231, P317, DOI 10.1016/0014-5793(88)80841-X; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; READ RJ, 1986, PROTEINASE INHIBITOR, P301; RUBIN H, 1990, J BIOL CHEM, V265, P1199; SAMBRANO JE, 1986, J CLIN INVEST, V77, P887, DOI 10.1172/JCI112386; SCHECHTER NM, 1993, J BIOL CHEM, V268, P23626; SHERMAN PM, 1992, J BIOL CHEM, V267, P7588; SKRIVER K, 1991, J BIOL CHEM, V266, P9216; STEPHENS AW, 1988, J BIOL CHEM, V263, P15849; STEPHENS AW, 1987, J BIOL CHEM, V262, P1044; THEUNISSEN HJM, 1993, J BIOL CHEM, V268, P9035	56	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9717	9724		10.1074/jbc.270.17.9717	http://dx.doi.org/10.1074/jbc.270.17.9717			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730349	hybrid			2022-12-27	WOS:A1995QV41700007
J	MALABARBA, MG; KIRKEN, RA; RUI, H; KOETTNITZ, K; KAWAMURA, M; OSHEA, JJ; KALTHOFF, FS; FARRAR, WL				MALABARBA, MG; KIRKEN, RA; RUI, H; KOETTNITZ, K; KAWAMURA, M; OSHEA, JJ; KALTHOFF, FS; FARRAR, WL			ACTIVATION OF JAR3, BUT NOT JAK1, IS CRITICAL TO INTERLEUKIN-4 (IL4) STIMULATED PROLIFERATION AND REQUIRES A MEMBRANE-PROXIMAL REGION OF IL4 RECEPTOR-ALPHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA SIGNAL-TRANSDUCTION; NATURAL-KILLER-CELLS; TYROSINE KINASE; FUNCTIONAL COMPONENT; CHAIN; IL-2; LINE; IDENTIFICATION	The tyrosine kinases JAK1 and JARS have been shown to undergo tyrosine phosphorylation in response to interleukin-2 (IL), IL4, IL7, and IL9, cytokines which share the common IL2 receptor gamma-chain (IL2R gamma), and evidence has been found for a preferential coupling of JAK3 to IL2R gamma and JAK1 to IL2R beta. Here we show, using human premyeloid TF-1 cells, that IL4 stimulates JAK3 to a larger extent than JAK1, based upon three different evaluation criteria. These include a more vigorous tyrosine phosphorylation of JAK3 as measured by anti-phosphotyrosine immunoblotting, a more marked activation of JAK3 as determined by in vitro tyrosine kinase assays and a more manifest presence of JAK3 in activated IL4-receptor complexes. These observations suggest that IL4 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL4-induced heterodimerization of IL4R alpha and IL2R gamma. Indeed, when human IL4R alpha was stably expressed in mouse BA/F3 cells, robust IL4-induced proliferation and JAK3 activation occurred without detectable involvement of JAK1, JAK2, or TYK2. The present study suggests that JAK1 plays a subordinate role in IL4 receptor signaling, and that in certain cells exclusive JARS activation may mediate IL4-induced cell growth. Moreover, mutational analysis of human IL4R alpha showed that a membrane-proximal cytoplasmic region was critical for JARS activation, while the I4R motif was not, which is compatible with a role of JARS upstream of the recruitment of the insulin receptor substrate-1/4PS signaling proteins by IL4 receptors.	NCI,FREDERICK CANC RES & DEV CTR,BIOL RESPONSE MODIFIERS PROGRAM,MOLEC IMMUNOREGULAT LAB,FREDERICK,MD 21702; SANDOZ GMBH,RES INST,A-1235 VIENNA,AUSTRIA; NCI,FREDERICK CANC RES & DEV CTR,BIOL RESPONSE MODIFIERS PROGRAM,EXPTL IMMUNOL LAB,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Novartis; Sandoz; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	MALABARBA, MG (corresponding author), NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702, USA.		Malabarba, Maria Grazia/L-4805-2015	Malabarba, Maria Grazia/0000-0002-9457-2047	FIC NIH HHS [5FO5 TWO4300-02] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F05TW004300] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; ASAO H, 1994, FEBS LETT, V351, P201, DOI 10.1016/0014-5793(94)00831-0; DASILVA L, 1994, J BIOL CHEM, V269, P18267; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; HAN X, 1988, LYMPHOKINE RES, V141, P227; HARADA N, 1992, J BIOL CHEM, V267, P22752; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KARRAY S, 1988, J EXP MED, V168, P85, DOI 10.1084/jem.168.1.85; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KIRKEN RA, 1993, J BIOL CHEM, V268, P22765; KIRKEN RA, 1994, J BIOL CHEM, V269, P19136; KITAMURA T, 1991, INT IMMUNOL, V3, P571, DOI 10.1093/intimm/3.6.571; KOETTNITZ K, 1993, EUR J IMMUNOL, V23, P988, DOI 10.1002/eji.1830230437; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NAGLER A, 1988, J IMMUNOL, V141, P2349; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; PAUL WE, 1991, BLOOD, V77, P1859; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; RUI H, 1994, J BIOL CHEM, V269, P5364; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SELDIN DC, 1994, P NATL ACAD SCI USA, V91, P2140, DOI 10.1073/pnas.91.6.2140; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; TANAKA N, 1994, P NATL ACAD SCI USA, V91, P7271, DOI 10.1073/pnas.91.15.7271; TORIGOE T, 1992, CYTOKINE, V4, P369, DOI 10.1016/1043-4666(92)90080-B; VOSS SD, 1992, J EXP MED, V176, P531, DOI 10.1084/jem.176.2.531; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L	37	59	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9630	9637		10.1074/jbc.270.16.9630	http://dx.doi.org/10.1074/jbc.270.16.9630			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721895	hybrid			2022-12-27	WOS:A1995QU08900084
J	SHARF, R; AZRIEL, A; LEJBKOWICZ, F; WINOGRAD, SS; EHRLICH, R; LEVI, BZ				SHARF, R; AZRIEL, A; LEJBKOWICZ, F; WINOGRAD, SS; EHRLICH, R; LEVI, BZ			FUNCTIONAL DOMAIN ANALYSIS OF INTERFERON CONSENSUS SEQUENCE BINDING-PROTEIN (ICSBP) AND ITS ASSOCIATION WITH INTERFERON REGULATORY FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR; HUMAN ADENOVIRUSES; INDUCIBLE GENES; FACTOR-I; ELEMENTS; ALPHA; IRF-1; SYSTEM; FAMILY; ISGF-3	Interferon consensus sequence binding protein (ICSBP) is a member of the interferon regulatory factor (IRF) family of proteins that include IRF-1, IRF-2, and ISGF3 gamma which share sequence similarity at the putative DNA binding domain (DBD). ICSBP is expressed exclusively in cells of the immune system and acts as a repressor of interferon consensus sequence (ICS) containing promoters that can be alleviated by interferons. In this communication, we have searched for functional domains of ICSBP by dissecting the DBD from the repression activity. The putative DBD of ICSBP (amino acids 1-121) when fused in frame to the transcriptional activation domain of the herpes simplex VP16 (ICSEP-VP16) is a very strong activator of ICS-containing promoters. In addition, ICSBP-VP16 fusion construct transfected into adenovirus (Ad) 12 transformed cells enabled cell surface expression of major histocompatibility complex class I antigens as did treatment with interferon. On the other hand, the DBD of the yeast transcriptional activator GAL4 was fused in frame to a truncated ICSBP in which the DBD was impaired resulting in a chimeric construct GAIA-ICSBP. This construct is capable of repressing promoters containing GAL4 binding sites. Thus, ICSBP contains at least two independent domains: a DBD and a transcriptional repressor domain. Furthermore, we have tested possible interactions between ICSBP and IRFs. The chimeric construct GAL4-ICSBP inhibited the stimulated effect of IRF I on a reporter gene, implying for a possible interaction between IRF-1 and ICSBP. Electromobility shift assays, demonstrated that ICSBP can associate with IRF-2 or IRF-1 in vitro as well as in vivo. Thus, ICSBP contains a third functional domain that enables the association with IRFs. These associations are probably important for the fine balance between positive and negative regulators involved in the interferon-mediated signal transduction pathways in cells of the immune system.	TECHNION ISRAEL INST TECHNOL,DEPT FOOD ENGN & BIOTECHNOL,IL-32000 HAIFA,ISRAEL; TEL AVIV UNIV,GEORGE S WISE FAC LIFE SCI,DEPT CELL RES & IMMUNOL,TEL AVIV,ISRAEL	Technion Israel Institute of Technology; Tel Aviv University								BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; FAN CM, 1989, EMBO J, V8, P101, DOI 10.1002/j.1460-2075.1989.tb03353.x; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; HAHN S, 1993, NATURE, V363, P672, DOI 10.1038/363672a0; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HISATAKE K, 1993, NATURE, V363, P744, DOI 10.1038/363744a0; KIRCHHOFF S, 1993, NUCLEIC ACIDS RES, V21, P2881, DOI 10.1093/nar/21.12.2881; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIN RT, 1994, J BIOL CHEM, V269, P17542; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; PELLEGRINI S, 1993, TRENDS BIOCHEM SCI, V18, P338, DOI 10.1016/0968-0004(93)90070-4; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; ROTEMYEHUDAR R, 1994, GENE, V144, P265, DOI 10.1016/0378-1119(94)90388-3; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V18, P7539; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SHEMESH J, 1993, J BIOL CHEM, V268, P15704; SHEMESH J, 1991, J VIROL, V65, P5544, DOI 10.1128/JVI.65.10.5544-5548.1991; STARK GR, 1992, J INTERFERON RES, V12, P147, DOI 10.1089/jir.1992.12.147; TANAKA N, 1992, ADV IMMUNOL, V52, P263, DOI 10.1016/S0065-2776(08)60877-9; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; WEISZ A, 1992, J BIOL CHEM, V267, P25589; WEISZ A, 1994, INT IMMUNOL, V6, P1125; WILLIAMS BRG, 1991, EUR J BIOCHEM, V200, P1, DOI 10.1111/j.1432-1033.1991.tb21041.x	29	96	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13063	13069		10.1074/jbc.270.22.13063	http://dx.doi.org/10.1074/jbc.270.22.13063			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768900	hybrid			2022-12-27	WOS:A1995RB43900021
J	HUGUET, EL; SMITH, K; BICKNELL, R; HARRIS, AL				HUGUET, EL; SMITH, K; BICKNELL, R; HARRIS, AL			REGULATION OF WNT5A MESSENGER-RNA EXPRESSION IN HUMAN MAMMARY EPITHELIAL-CELLS BY CELL-SHAPE, CONFLUENCE, AND HEPATOCYTE GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; XENOPUS EMBRYOS; GENE FAMILY; ECTOPIC EXPRESSION; MET PROTOONCOGENE; ONCOGENE INT-1; DIFFERENTIATION; INVOLVEMENT; INDUCTION; INVITRO	The Wnts are a family of genes with a role in cell fate and morphological development in numerous embryonic and adult tissues, In mouse mammary tissue a subset of the Wnts have a function in the normal development of the gland, and abberant expression of Wnts normally silent in this tissue causes mammary carcinomas. We have previously shown that Wnt5a expression is elevated in the epithelial component of proliferative lesions of human breast and have therefore examined the regulation of Wnt5a mRNA expression in the human mammary epithelial cell line HB2, which has a luminal phenotype and thus represents the most commonly transformed cell type in human breast cancer, Wnt5a was up-regulated 30-fold at confluence, This up-regulation was induced specifically by confluence and not by the growth arrest that accompanied it, In addition, Wnt5a was down-regulated 3-fold by changes in cell shape associated with the transition from growth on a two-dimensional surface (flat cell morphology) to growth in three-dimensional gels (spherical cell morphology), Cytoskeletal disruption with non-toxic doses of colchicine also induced a spherical morphology and brought about a dose dependent down-regulation of Wnt5a. Wnt5a was also down-regulated 10-fold during the hepatocyte growth factor-induced branching of HB2 cell aggregates in collagen gels, The down-regulation of Wnt5a preceded the branching process, A similar result was obtained with primary human breast epithelial populations and the breast cancer cell line MDA468. We conclude that regulation of Wnt5a expression is a downstream effect of signaling by hepatocyte growth factor, These results are consistent with a role for Wnt5a in mammary epithelial cell motility and are in accord with Xwnt5a's function in embryonal cell migration, If Wnt5a's function in human mammary epithelial cells is similar to that of Xwnt5a, its up-regulation at confluence may be a mechanism for inhibition of cell migration beyond confluence.			HUGUET, EL (corresponding author), UNIV OXFORD, JOHN RADCLIFFE HOSP, INST MOLEC MED, IMPERIAL CANC RES FUND, GROWTH FACTORS GRP, OXFORD OX3 9DU, ENGLAND.		Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409				Ausubel FM, 1991, CURRENT PROTOCOLS MO; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BENZEEV A, 1987, J BIOL CHEM, V262, P5366; BENZEEV A, 1991, BIOESSAYS, V13, P207, DOI 10.1002/bies.950130502; BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557; BRADLEY RS, 1993, J CELL BIOL, V123, P1857, DOI 10.1083/jcb.123.6.1857; CLARK CC, 1993, GENOMICS, V18, P249, DOI 10.1006/geno.1993.1463; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; FAWCETT J, 1994, THESIS U OXFORD; FURLONG RA, 1992, BIOESSAYS, V14, P613, DOI 10.1002/bies.950140908; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; HAEUPTLE MT, 1983, J CELL BIOL, V96, P1425, DOI 10.1083/jcb.96.5.1425; HOLLIDAY R, 1972, NATURE, V238, P26, DOI 10.1038/238026a0; HUGUET EL, 1994, CANCER RES, V54, P2615; INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579; Johnson R. T., 1993, CELL CYCLE PRACTICAL, P1; LEJEUNE S, 1995, CLIN CANCER RES, V1, P215; MALEK AM, 1994, J HYPERTENS, V12, P989; MCCARTHY SA, 1992, J BIOL CHEM, V267, P21617; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; MOON RT, 1993, DEVELOPMENT, V119, P97; MOON RT, 1993, J CELL SCI, P183; MORIMOTO A, 1991, BIOCHEM BIOPH RES CO, V179, P1042, DOI 10.1016/0006-291X(91)91924-2; Nigg E A, 1990, Adv Cancer Res, V55, P271, DOI 10.1016/S0065-230X(08)60471-6; NUSSE R, 1992, J STEROID BIOCHEM, V43, P9, DOI 10.1016/0960-0760(92)90181-H; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; OLSON DJ, 1992, DEV BIOL, V151, P204, DOI 10.1016/0012-1606(92)90227-8; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; SCHLAEPFER DD, 1994, NATURE, V372, P786; SEVELY JL, 1987, CELL BIOL, V59, P121; SHANNON JM, 1987, BIOCHIM BIOPHYS ACTA, V931, P143, DOI 10.1016/0167-4889(87)90200-X; SIDOW A, 1992, P NATL ACAD SCI USA, V89, P5098, DOI 10.1073/pnas.89.11.5098; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; STREULI CH, 1990, J CELL BIOL, V110, P1405; TSARFATY I, 1992, SCIENCE, V257, P1258, DOI 10.1126/science.1387731; UNEMORI EN, 1986, J CELL BIOL, V103, P1021, DOI 10.1083/jcb.103.3.1021; VANNLEEUVEN F, 1994, NATURE, V368, P342; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; YAMASHITA J, 1994, CANCER RES, V54, P1630; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; ZAKANY J, 1993, NATURE, V362, P546, DOI 10.1038/362546a0; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115	52	62	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12851	12856		10.1074/jbc.270.21.12851	http://dx.doi.org/10.1074/jbc.270.21.12851			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759542	hybrid			2022-12-27	WOS:A1995QZ71100079
J	WANG, M; DRUCKER, DJ				WANG, M; DRUCKER, DJ			THE LIM DOMAIN HOMEOBOX GENE ISL-1 IS A POSITIVE REGULATOR OF ISLET CELL-SPECIFIC PROGLUCAGON GENE-TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ALPHA-CELLS; GLUCAGON GENE; BINDING-PROTEINS; DNA-BINDING; SOMATOSTATIN EXPRESSION; INSULIN GENE; HOMEODOMAIN; PROMOTER; ELEMENT; INTESTINE	The LIM domain homeobox gene islet 1 (isl-1) is expressed in the embryonic nervous system and may be an early marker of motor neuron specification. isl-1 is expressed in all 4 islet cell types, but a role for isl-1 in the regulation of insulin gene expression has not been demonstrated, and the genetic targets for isl-1 in the pancreas remain unknown. We show here that the proximal rat proglucagon gene promoter binds an amino-terminally truncated Trp-E-isl-1 fusion protein that lacks the LIM domains. The proglucagon gene promoter also binds full-length in vitro translated isl-1 containing the intact LIM domains. isl-1 antisera detects binding of proglucagon gene sequences to isl-1 present in a slowly-migrating complex in nuclear extracts from InR1-G9 islet cells. The transcriptional properties of the proglucagon gene promoter sequences that bind isl-1 (designated Ga, Gb, and Gc) were assessed after transfection of reporter genes into wild type and isl-1-antisense (isl-1(AS)) InR1-G9 islet cells, The proximal proglucagon gene (Ga) promoter sequence reduced TK-CAT activity by similar to 50%, but no change in the activity of the Ga-TK-CAT plasmid was seen after transfection of isl-1(AS) InR1-G9 cells. In contrast, the Gb/Gc sites activated transcription 2-3-fold in wild type InR1-G9 cells, and the isl-1-dependent activation of gene transcription through the Gb/Gc element was eliminated following transfection of isl-1(AS) InR1-G9 cells. These data demonstrate that the LIM domain homeobox gene isl-1 1) is not constrained from DNA binding by its LIM domains and 2) functions as a positive regulator of proglucagon gene transcription in the endocrine pancreas.	UNIV TORONTO,TORONTO GEN HOSP,BANTING & BEST DIABET CTR,TORONTO,ON M5G 2C4,CANADA; UNIV TORONTO,TORONTO GEN HOSP,DEPT CLIN BIOCHEM,TORONTO,ON M5G 2C4,CANADA; UNIV TORONTO,TORONTO GEN HOSP,DEPT MED GENET,TORONTO,ON M5G 2C4,CANADA; UNIV TORONTO,TORONTO GEN HOSP,DEPT MED,TORONTO,ON M5G 2C4,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital			Drucker, Daniel J/A-4092-2010					DONG JL, 1991, MOL ENDOCRINOL, V5, P1633, DOI 10.1210/mend-5-11-1633; DRUCKER DJ, 1987, J BIOL CHEM, V262, P15659; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; GAJIC D, 1993, ENDOCRINOLOGY, V132, P1055, DOI 10.1210/en.132.3.1055; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KNEPEL W, 1990, J BIOL CHEM, V265, P8725; KNEPEL W, 1991, MOL ENDOCRINOL, V5, P1457, DOI 10.1210/mend-5-10-1457; LEE YC, 1990, ENDOCRINOLOGY, V127, P2217, DOI 10.1210/endo-127-5-2217; LEE YC, 1992, J BIOL CHEM, V267, P10705; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; OHLSSON H, 1991, MOL ENDOCRINOL, V5, P897, DOI 10.1210/mend-5-7-897; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; PHILIPPE J, 1994, MOL CELL BIOL, V14, P3514, DOI 10.1128/MCB.14.5.3514; PROST E, 1986, GENE, V45, P107, DOI 10.1016/0378-1119(86)90138-1; RUDNICK A, 1994, P NATL ACAD SCI USA, V91, P12203, DOI 10.1073/pnas.91.25.12203; SANCHEZGARCIA I, 1993, J MOL BIOL, V231, P945, DOI 10.1006/jmbi.1993.1343; SANCHEZGARCIA I, 1993, EMBO J, V12, P4243, DOI 10.1002/j.1460-2075.1993.tb06108.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; THORENS B, 1993, DIABETES, V42, P1219, DOI 10.2337/diabetes.42.9.1219; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8917; Varshavsky A, 1987, Methods Enzymol, V151, P551, DOI 10.1016/S0076-6879(87)51044-8; WADMAN L, 1994, EMBO J, V13, P4831; WANG M, 1994, ENDOCRINOLOGY, V134, P1416, DOI 10.1210/en.134.3.1416; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239	33	90	97	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12646	12652		10.1074/jbc.270.21.12646	http://dx.doi.org/10.1074/jbc.270.21.12646			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759514				2022-12-27	WOS:A1995QZ71100050
J	BJORNSTEDT, M; HAMBERG, M; KUMAR, S; XUE, J; HOLMGREN, A				BJORNSTEDT, M; HAMBERG, M; KUMAR, S; XUE, J; HOLMGREN, A			HUMAN THIOREDOXIN REDUCTASE DIRECTLY REDUCES LIPID HYDROPEROXIDES BY NADPH AND SELENOCYSTINE STRONGLY STIMULATES THE REACTION VIA CATALYTICALLY GENERATED SELENOLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							T-CELL LEUKEMIA; GLUTATHIONE-PEROXIDASE; PURIFICATION; SUBSTRATE; OXYGEN; LIVER; ACID; SELENODIGLUTATHIONE; 15-LIPOXYGENASE; MECHANISM	Human placenta thioredoxin reductase (HP-TR) in the presence of NADPH-catalyzed reduction of (15S)-hydroperoxy-(5Z),(8Z),11(Z),13(E)-eicosatetraenoic acid ((15S)-HPETE) into the corresponding alcohol ((15S)-HETE). Incubation of 50 nM HP-TR and 0.5 mM NADPH with 300 mu M 18-HPETE for 5 min resulted in formation of 16.5 mu M 15-HETE. After 60 min, 74.7 mu M 15-HPETE was reduced. The rate of the reduction of 15-HPETE by the HP-TR/NADPH peroxidase system was increased 8-fold by the presence of 2.5 mu M selenocystine, a diselenide amino acid. In this case, 15-HPETE was catalytically reduced by the selenol amino acid, selenocysteine, generated from the diselenide by the HP-TR/NADPH system. To a smaller extent, selenodiglutathione or human thioredoxin also potentiated the reduction of 15-HPETE by HP-TR. Hydrogen peroxide and 15-HPETE were reduced at approximately the same rate by HP-TR, thioredoxin, and selenocystine. In contrast, t-butyl hydroperoxide was reduced at a 10-fold lower rate. Our data suggest two novel pathways for the reduction and detoxification of lipid hydroperoxides, hydrogen peroxide, and organic hydroperoxides, i.e. the human thioredoxin reductase-dependent pathway and a coupled reduction in the presence of selenols or selenide resulting from the reduction of selenocystine or selenodiglutathione.	KAROLINSKA INST, MED NOBEL INST BIOCHEM, S-17177 STOCKHOLM, SWEDEN; KAROLINSKA INST, DEPT MED BIOCHEM & BIOPHYS, S-17177 STOCKHOLM, SWEDEN	Karolinska Institutet; Karolinska Institutet				Hamberg, Mats/0000-0002-8910-7810				BJORNSTEDT M, 1992, J BIOL CHEM, V267, P8030; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; BRYANT R W, 1981, Progress in Lipid Research, V20, P279, DOI 10.1016/0163-7827(81)90055-2; BURK RF, 1991, FASEB J, V5, P2274, DOI 10.1096/fasebj.5.9.1830557; ESAKI N, 1982, J BIOL CHEM, V257, P4386; Flohe L., 1989, GLUTATHIONE CHEM BIO, P644; FORDHUTCHINSON AW, 1991, EICOSANOIDS, V4, P65; GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; HAMBERG M, 1989, LIPIDS, V24, P249, DOI 10.1007/BF02535158; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1980, P NATL ACAD SCI-BIOL, V77, P5149, DOI 10.1073/pnas.77.9.5149; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LEE BJ, 1989, J BIOL CHEM, V264, P9724; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; MAIORINO M, 1988, BIOCHEM PHARMACOL, V37, P2267, DOI 10.1016/0006-2952(88)90591-6; MITSUI A, 1992, BIOCHEM BIOPH RES CO, V186, P1220, DOI 10.1016/S0006-291X(05)81536-0; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; TANAKA H, 1987, METHOD ENZYMOL, V143, P240; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; WENDEL A, 1980, FEBS LETT, V120, P209, DOI 10.1016/0014-5793(80)80299-7; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; YASUDA K, 1980, BIOCHEM BIOPH RES CO, V96, P243, DOI 10.1016/0006-291X(80)91206-1; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; YODOI J, 1991, ADV CANCER RES, V57, P381; ZHANG LY, 1994, CHEM PHYS LIPIDS, V74, P151, DOI 10.1016/0009-3084(94)90056-6	33	258	260	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11761	11764		10.1074/jbc.270.20.11761	http://dx.doi.org/10.1074/jbc.270.20.11761			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744824	hybrid			2022-12-27	WOS:A1995QY73600016
J	SELBIE, LA; DARBY, K; SCHMITZPEIFFER, C; BROWNE, CL; HERZOG, H; SHINE, J; BIDEN, TJ				SELBIE, LA; DARBY, K; SCHMITZPEIFFER, C; BROWNE, CL; HERZOG, H; SHINE, J; BIDEN, TJ			SYNERGISTIC INTERACTION OF Y1-NEUROPEPTIDE-Y AND ALPHA(1B)-ADRENERGIC RECEPTORS IN THE REGULATION OF PHOSPHOLIPASE-C, PROTEIN-KINASE-C, AND ARACHIDONIC-ACID PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; INTRACELLULAR CALCIUM RELEASE; HUMAN ERYTHROLEUKEMIA-CELLS; BETA-GAMMA-SUBUNITS; NEUROPEPTIDE-Y; ADENYLATE-CYCLASE; 2ND MESSENGER; CA-2+; INHIBITION; MECHANISMS	Neuropeptide Y (NPY) and norepinephrine, found colocalized in sympathetic neurons innervating blood vessels, exert synergistic responses on vasoconstriction. To examine the signaling mechanisms involved, free of complications associated with mixed receptor populations, we have established a stable Chinese hamster ovary cell line expressing both Y1-NPY and alpha(1b)-adrenergic receptors. Occupation of either receptor species, with 100 nM peptide YY (PYY) or 10 mu M phenylephrine (PE), respectively, resulted in a rapid increase in the cytoplasmic free calcium concentration ([Ca2+](i)) as assessed with Fura-2/AM. The rise due to PYY, but not that due to PE, was abolished by pretreatment with pertussis toxin, Both responses were largely maintained in the absence of extracellular Ca2+, but abolished by prior depletion of intracellular Ca2+ pools with either thapsigargin or 2,5-di-(t-butyl)-1,4-benzohydroquinone. Using cells prelabeled with myo-[H-3]inositol, PE promoted a rapid (5 s) rise in inositol 1,4,5-trisphosphate (Ins(1,4,5)P-3) as analyzed by anion-exchange high pressure liquid chromatography, whereas the response to PYY (first significant at >15 s post-stimulation) was too slow to play a causative role in Ca2+ mobilization. Combination of PE and PYY resulted in increases in [Ca2+](i) which were at best additive, whereas they promoted a clearly synergistic rise in Ins(1,4,5)P-3 at both 15 and 60 s, Co-stimulation also resulted in a synergistic activation of both protein kinase C (PKC) and [H-3]arachidonic acid release. In either instance PYY alone was without effect. The potentiation of arachidonic acid release was abolished by depletion of cellular PKC following chronic treatment with phorbol esters. It is suggested that the ability of PYY to mobilize Ca2+ in an Ins(1,4,5)P-3-independent fashion minimizes the functional importance of the capacity to potentiate PE-stimulated Ins(1,4,5)P-3 generation. Instead the major consequences of the synergistic activation of phospholipase C are mediated via PKC, the other route of the signaling pathway.	ST VINCENTS HOSP,GARVAN INST MED RES,DARLINGHURST,NSW 2010,AUSTRALIA	Garvan Institute of Medical Research; St Vincents Hospital Sydney			Schmitz-Peiffer, Carsten/J-6918-2012; Biden, Trevor/AAW-2829-2021; Herzog, Herbert/B-8294-2008	Schmitz-Peiffer, Carsten/0000-0001-7330-7255; Biden, Trevor/0000-0001-5211-0234				AAKERLUND L, 1990, FEBS LETT, V260, P73, DOI 10.1016/0014-5793(90)80069-U; ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; ANDRIANTSITOHAI.R, 1988, BRIT J PHARMACOL, V95, P219; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIDEN TJ, 1993, BIOCHEM J, V293, P721, DOI 10.1042/bj2930721; COTECCHIA S, 1988, P NATL ACAD SCI USA, V85, P7159, DOI 10.1073/pnas.85.19.7159; DANIELS AJ, 1989, BIOCHEM BIOPH RES CO, V165, P1138, DOI 10.1016/0006-291X(89)92721-6; DANIELS AJ, 1992, MOL PHARMACOL, V41, P767; DUCKLES SP, 1994, LIFE SCI, V55, P103; EDVINSSON L, 1984, BRIT J PHARMACOL, V83, P519, DOI 10.1111/j.1476-5381.1984.tb16516.x; FALLGREN B, 1994, J AUTONOM NERV SYST, V44, P151; FELDER CC, 1991, P NATL ACAD SCI USA, V88, P6477, DOI 10.1073/pnas.88.15.6477; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUPTA SK, 1990, SCIENCE, V249, P662, DOI 10.1126/science.2166341; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; IMAGAWA T, 1992, J BIOCHEM-TOKYO, V112, P508, DOI 10.1093/oxfordjournals.jbchem.a123930; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; KAMAMURA K, 1991, BIOCHEM BIOPH RES CO, V179, P309; KASS GEN, 1989, J BIOL CHEM, V264, P15192; KASSIS S, 1987, J BIOL CHEM, V262, P3429; KOLESNICK RN, 1985, J BIOL CHEM, V260, P707; LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE MW, 1994, AM J PHYSIOL, V267, pC659, DOI 10.1152/ajpcell.1994.267.3.C659; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LOBAUGH LA, 1990, J BIOL CHEM, V265, P18393; LOBAUGH LA, 1990, AM J PHYSIOL, V258, pC913, DOI 10.1152/ajpcell.1990.258.5.C913; LUNDBERG JM, 1988, EUR J PHARMACOL, V145, P21, DOI 10.1016/0014-2999(88)90344-5; MATTIE M, 1994, J BIOL CHEM, V269, P3181; MCDERMOTT BJ, 1993, CARDIOVASC RES, V27, P893, DOI 10.1093/cvr/27.6.893; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; MICHEL MC, 1991, TRENDS PHARMACOL SCI, V12, P389, DOI 10.1016/0165-6147(91)90610-5; MICHEL MC, 1994, BRIT J PHARMACOL, V112, P499, DOI 10.1111/j.1476-5381.1994.tb13101.x; MIHARA S, 1989, FEBS LETT, V259, P79, DOI 10.1016/0014-5793(89)81499-1; MOTULSKY HJ, 1988, AM J PHYSIOL, V255, pE880, DOI 10.1152/ajpendo.1988.255.6.E880; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; PARK DG, 1993, J BIOL CHEM, V268, P4573; PEREZ DM, 1993, MOL PHARMACOL, V44, P784; PERNOW J, 1986, ACTA PHYSIOL SCAND, V126, P239, DOI 10.1111/j.1748-1716.1986.tb07811.x; POTTER EK, 1988, PHARMACOL THERAPEUT, V37, P251, DOI 10.1016/0163-7258(88)90028-9; REYNOLDS EE, 1988, BIOCHEM BIOPH RES CO, V151, P919, DOI 10.1016/S0006-291X(88)80369-3; SHO K, 1991, J BIOL CHEM, V266, P12180; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; SUZUKI E, 1990, MOL PHARMACOL, V38, P725; WAEBER B, 1988, AM J HYPERTENS, V1, P193, DOI 10.1093/ajh/1.2.193; WAHLESTEDT C, 1985, J PHARMACOL EXP THER, V234, P735; WAHLESTEDT C, 1990, AM J PHYSIOL, V258, pR736, DOI 10.1152/ajpregu.1990.258.3.R736; WAHLESTEDT C, 1993, ANN REV PHARM TOXICO, V32, P309	52	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11789	11796		10.1074/jbc.270.20.11789	http://dx.doi.org/10.1074/jbc.270.20.11789			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744827	hybrid			2022-12-27	WOS:A1995QY73600021
J	PRASAD, KSS; JORDAN, JE; KOURY, MJ; BONDURANT, MC; BRANDT, SJ				PRASAD, KSS; JORDAN, JE; KOURY, MJ; BONDURANT, MC; BRANDT, SJ			ERYTHROPOIETIN STIMULATES TRANSCRIPTION OF THE TAL1/SCL GENE AND PHOSPHORYLATION OF ITS PROTEIN PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; T-CELL LEUKEMIA; ERYTHROID PROGENITOR CELLS; DNA-BINDING; ENHANCER-BINDING; MESSENGER-RNA; TAL-1 GENE; SCL GENE; EXPRESSION; MYOD	Activation of the TAL1 (or SCL) gene, originally identified through its involvement by a recurrent chromosomal translocation, is the most frequent molecular lesion recognized in T-cell acute lymphoblastic leukemia. The protein products of this gene contain the basic-helix-loop-helix motif characteristic of a large family of transcription factors that bind to the canonical DNA sequence CANNTG as protein heterodimers. TAL1 expression by erythroid cells in vivo and in chemical-induced erythroleukemia cell lines in vitro suggested the gene might regulate aspects of erythroid differentiation. Since the terminal events of erythropoiesis are controlled by the glycoprotein hormone erythropoietin (Epo), we investigated whether the expression or activity of the TAL1 gene and its protein products were affected by Epo in splenic erythroblasts from mice infected with an anemia-inducing strain of Friend virus (FVA cells), Epo elicited a rapid, dose-related increase in TALI mRNA by increasing transcription of the gene and stabilizing one of its mRNAs, An Epo-inducible TAL1 DNA binding activity was identified in FVA cell nuclear extracts that subsequently decayed despite accumulating mRNA and protein. Induction of DNA binding activity was associated temporally with Epo-induced phosphorylation of nuclear TAL1 protein. These results indicate that Epo acts at both transcriptional and posttranscriptional levels on the TAL1 locus in Friend virus-induced erythroblasts and establish a link between Epo signaling mechanisms and a member of a family of transcription factors involved in the differentiation of diverse cell lineages.	VANDERBILT UNIV,MED CTR,DEPT MED,DIV HEMATOL,NASHVILLE,TN 37232; VANDERBILT UNIV,MED CTR,DEPT CELL BIOL,DIV HEMATOL,NASHVILLE,TN 37232; DEPT VET AFFAIRS MED CTR,NASHVILLE,TN 37232	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System					NHLBI NIH HHS [R29HL49118] Funding Source: Medline; NIDDK NIH HHS [R01 DK31513] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031513] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BAER R, 1993, SEMIN CANCER BIOL, V4, P341; BEGLEY CG, 1991, P NATL ACAD SCI USA, V88, P869, DOI 10.1073/pnas.88.3.869; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BEGLEY CG, 1994, GENE, V138, P93, DOI 10.1016/0378-1119(94)90787-0; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BERNARD O, 1991, ONCOGENE, V6, P1477; BONDURANT MC, 1985, MOL CELL BIOL, V5, P675, DOI 10.1128/MCB.5.4.675; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; CARROLL MP, 1991, J BIOL CHEM, V266, P14964; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; CHENG JT, 1993, MOL CELL BIOL, V13, P801, DOI 10.1128/MCB.13.2.801; CHENG JT, 1993, ONCOGENE, V8, P677; CHIBA T, 1993, P NATL ACAD SCI USA, V90, P11593, DOI 10.1073/pnas.90.24.11593; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CROSS MA, 1994, ONCOGENE, V9, P3013; DANDREA AD, 1992, BIOCHIM BIOPHYS ACTA, V1114, P31, DOI 10.1016/0304-419X(92)90004-I; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELWOOD NJ, 1994, LEUKEMIA, V8, P106; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRO FE, 1993, J BIOL CHEM, V268, P5741; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; FITZGERALD TJ, 1991, BLOOD, V78, P2686; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; GARRELL J, 1991, BIOESSAYS, V13, P493, DOI 10.1002/bies.950131002; GOLDFARB AN, 1994, LEUKEMIA LYMPHOMA, V12, P157, DOI 10.3109/10428199409059586; GOLDFARB AN, 1992, BLOOD, V80, P2858; GREEN AR, 1991, ONCOGENE, V6, P475; GREEN AR, 1992, ONCOGENE, V7, P653; HARLOW E, 1988, ANTIBODIES LABORATOR; HSU HL, 1991, MOL CELL BIOL, V11, P3037, DOI 10.1128/MCB.11.6.3037; HSU HL, 1994, MOL CELL BIOL, V14, P1256, DOI 10.1128/MCB.14.2.1256; HSU HL, 1994, MOL CELL BIOL, V91, P3181; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; HWANG LY, 1993, ONCOGENE, V8, P3043; KADESCH T, 1993, CELL GROWTH DIFFER, V4, P49; KALLIANPUR AR, 1994, BLOOD, V83, P1200; KELLEY LL, 1993, BLOOD, V82, P2340; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; KOURY MJ, 1982, J CELL PHYSL, V121, P526; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LECOINTE N, 1994, ONCOGENE, V9, P2623; LEONARD M, 1993, BLOOD, V82, P1071; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MOUTHON MA, 1993, BLOOD, V81, P647; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; QUERTERMOUS EE, 1994, P NATL ACAD SCI USA, V91, P7066, DOI 10.1073/pnas.91.15.7066; QUINN CO, 1990, J BIOL CHEM, V265, P22342; SANCHEZGARCIA I, 1994, P NATL ACAD SCI USA, V91, P7869, DOI 10.1073/pnas.91.17.7869; SHOJI W, 1994, J BIOL CHEM, V269, P5078; SPIVAK JL, 1991, BLOOD, V77, P1228; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; VISVADER J, 1991, ONCOGENE, V6, P187; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; VORONOVA AF, 1994, P NATL ACAD SCI USA, V91, P5952, DOI 10.1073/pnas.91.13.5952; WADMAN IA, 1994, ONCOGENE, V9, P3713; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WICKREMA A, 1991, BLOOD, V78, P2269, DOI 10.1182/blood.V78.9.2269.bloodjournal7892269	68	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11603	11611		10.1074/jbc.270.19.11603	http://dx.doi.org/10.1074/jbc.270.19.11603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744799	hybrid			2022-12-27	WOS:A1995QX86500081
J	TERRY, MJ; MCDOWELL, MT; LAGARIAS, JC				TERRY, MJ; MCDOWELL, MT; LAGARIAS, JC			(3Z)-PHYTOCHROMOBILIN AND (3E)-PHYTOCHROMOBILIN ARE INTERMEDIATES IN THE BIOSYNTHESIS OF THE PHYTOCHROME CHROMOPHORE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIVERDIN-IX-ALPHA; DIMETHYL ESTER; BILE-PIGMENTS; PHYCOBILINS; EXPRESSION; FORM	Using a high performance liquid chromatography (HPLC)-based assay, we have demonstrated that isolated oat etioplasts convert the linear tetrapyrrole biliverdin IX alpha to (3E)-phytochromobilin, the proposed precursor of the chromophore of the plant photoreceptor phytochrome. In addition to (3E)-phytochromobilin, the synthesis of a second phytochromobilin was detected by its ability to functionally assemble with recombinant oat apophytochrome A. The structure of this new pigment has been determined to be the 3Z isomer of phytochromobilin by absorption and H-1 NMR spectroscopy. Like (3E)-phytochromobilin, assembly of HPLC-purified (3Z)-phytochromobilin with apophytochrome yielded a holoprotein that is spectrally indistinguishable from native oat phytochrome A. However, the postchromato-graphic conversion of (3Z)- to (3E)-phytochromobilin appears to be responsible for this result. Kinetic HPLC analyses have demonstrated that (3Z) -phytochromobilin is synthesized prior to the 3E isomer by oat etioplasts. We therefore propose that (3Z)-phytochromobilin is the immediate product of biliverdin IX alpha reduction by the enzyme phytochromobilin synthase. This implicates the presence of an isomerase that catalyzes the conversion of (3Z)- to (3E)-phytochromobilin, the immediate precursor of the phytochrome A chromophore.	UNIV CALIF DAVIS,MOLEC & CELLULAR BIOL SECT,DAVIS,CA 95616	University of California System; University of California Davis			Lagarias, John Clark/L-3139-2013; Terry, Matthew/ABE-6419-2020; Terry, Matthew/B-3000-2012	Lagarias, John Clark/0000-0002-2093-0403; Terry, Matthew/0000-0001-5002-2708; Terry, Matthew/0000-0001-5002-2708				BEALE SI, 1991, J BIOL CHEM, V266, P22328; BEALE SI, 1991, J BIOL CHEM, V266, P22333; BEALE SI, 1991, J BIOL CHEM, V266, P22341; CHAPMAN DJ, 1967, J AM CHEM SOC, V89, P976; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; COLE WJ, 1967, J AM CHEM SOC, V89, P3643, DOI 10.1021/ja00990a055; CORNEJO J, 1992, J BIOL CHEM, V267, P14790; CRESPI HL, 1967, J AM CHEM SOC, V89, P3642, DOI 10.1021/ja00990a054; CRESPI HL, 1969, PHYTOCHEMISTRY, V8, P759, DOI 10.1016/S0031-9422(00)85848-3; ELICH TD, 1989, J BIOL CHEM, V264, P183; FURUYA M, 1993, ANNU REV PLANT PHYS, V44, P617, DOI 10.1146/annurev.pp.44.060193.003153; GOSSAUER A, 1978, J AM CHEM SOC, V100, P5928, DOI 10.1021/ja00486a053; GOSSAUER A, 1983, TETRAHEDRON, V39, P1933, DOI 10.1016/S0040-4020(01)88708-1; GROSSAUER A, 1974, LIEBIGS ANN CHEM, P1496; Kendrick RE, 1994, PHOTOMORPHOGENESIS P; KUNKEL T, 1993, EUR J BIOCHEM, V215, P587, DOI 10.1111/j.1432-1033.1993.tb18069.x; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; LAGARIAS JC, 1987, PHOTOCHEM PHOTOBIOL, V46, P5, DOI 10.1111/j.1751-1097.1987.tb04729.x; LI L, 1982, J BIOL CHEM, V267, P19204; MCDONAGH AF, 1980, BIOCHEM J, V189, P193, DOI 10.1042/bj1890193; QUAIL PH, 1991, ANNU REV GENET, V25, P389, DOI 10.1146/annurev.ge.25.120191.002133; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Sage LC., 1992, PIGMENT IMAGINATION; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TERRY MJ, 1993, J BIOL CHEM, V268, P26099; TERRY MJ, 1991, J BIOL CHEM, V266, P22215; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; WELLER JP, 1980, CHEM BER-RECL, V113, P1603, DOI 10.1002/cber.19801130439	29	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11111	11118		10.1074/jbc.270.19.11111	http://dx.doi.org/10.1074/jbc.270.19.11111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744741	Green Accepted, hybrid			2022-12-27	WOS:A1995QX86500017
J	CHUN, MY; LIN, HY; HENIS, YI; LODISH, HF				CHUN, MY; LIN, HY; HENIS, YI; LODISH, HF			ENDOTHELIN-INDUCED ENDOCYTOSIS OF CELL-SURFACE ET(A) RECEPTORS - ENDOTHELIN REMAINS INTACT AND BOUND TO THE ET(A) RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; HETEROTRIMERIC G-PROTEIN; FUNCTIONAL EXPRESSION; MEDIATED ENDOCYTOSIS; EPITHELIAL-CELLS; PLASMA-MEMBRANE; CLONING; CDNA; FAMILY; DESENSITIZATION	We demonstrate unusual features of the intracellular processing of endothelin-1 (ET-1) and its receptor ET(A), the receptor subtype that mediates contraction of vascular smooth muscle cells. First, we show that in stably transfected CHO cells expressing ET(A), binding of an ET-1 ligand induces rapid endocytosis of cell surface ET(A). Receptor endocytosis was measured both by immunofluorescence and by radioiodinated antibodies specific for ET(A). Second, we demonstrate that ET-1 remains intact for up to 2 h after endocytosis and, as judged by co-immunoprecipitation, internalized I-125-ET-1 remains bound to ET(A) receptors. We hypothesize that internalized ET-1, bound to ET(A) receptors, continues to activate a signal-transducing G protein, thus accounting for the prolonged period of contraction induced in smooth muscle cells by a single administration of ET-1.	WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; TEL AVIV UNIV, GEORGE S WISE FAC LIFE SCI, DEPT BIOCHEM, IL-69978 TEL AVIV, ISRAEL	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Tel Aviv University				Henis, Yoav/0000-0002-1408-3877	NHLBI NIH HHS [HL-41484] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; ASCOLI M, 1978, J BIOL CHEM, V253, P4892; BATTISTINI B, 1993, LAB INVEST, V68, P600; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BOMSEL M, 1993, J BIOL CHEM, V268, P25824; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; BRIDGES K, 1982, P NATL ACAD SCI-BIOL, V79, P350, DOI 10.1073/pnas.79.2.350; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DAVENPORT AP, 1989, J CARDIOVASC PHARM, V13, pS166, DOI 10.1097/00005344-198900135-00045; DEALMEIDA JB, 1994, J CELL SCI, V107, P507; DEGOUVILLE ACL, 1989, LIFE SCI, V45, P1499, DOI 10.1016/0024-3205(89)90415-3; FEHLMANN M, 1982, P NATL ACAD SCI-BIOL, V79, P5921, DOI 10.1073/pnas.79.19.5921; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; GRIENDLING KK, 1989, J BIOL CHEM, V264, P8237; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; HUGGINS JP, 1993, PHARMACOL THERAPEUT, V59, P55, DOI 10.1016/0163-7258(93)90041-B; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; INOUE Y, 1990, J PHYSIOL-LONDON, V423, P171, DOI 10.1113/jphysiol.1990.sp018017; JAMES AF, 1994, NATURE, V370, P297, DOI 10.1038/370297a0; KARNE S, 1993, J BIOL CHEM, V268, P19126; KIRCHHAUSEN T, 1993, CURR OPIN STRUC BIOL, V3, P182, DOI 10.1016/S0959-440X(05)80150-2; KLOOG Y, 1989, FEBS LETT, V253, P199, DOI 10.1016/0014-5793(89)80958-5; LEFKOWITZ RJ, 1993, ADV SEC MESS PHOSPH, V28, P1; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; MARSDEN PA, 1989, BIOCHEM BIOPH RES CO, V158, P86, DOI 10.1016/S0006-291X(89)80180-9; MASUDA Y, 1989, FEBS LETT, V257, P208, DOI 10.1016/0014-5793(89)81535-2; MELLMAN I, 1992, J EXP BIOL, V172, P39; MORELAND S, 1992, BIOCHEM BIOPH RES CO, V184, P100, DOI 10.1016/0006-291X(92)91163-K; NAKAMUTA M, 1991, BIOCHEM BIOPH RES CO, V177, P34, DOI 10.1016/0006-291X(91)91944-8; OGAWA Y, 1991, BIOCHEM BIOPH RES CO, V178, P248, DOI 10.1016/0006-291X(91)91806-N; ONO K, 1994, NATURE, V370, P301, DOI 10.1038/370301a0; PIMPLIKAR SW, 1993, NATURE, V362, P456, DOI 10.1038/362456a0; RESINK TJ, 1989, BIOCHEM BIOPH RES CO, V158, P279, DOI 10.1016/S0006-291X(89)80209-8; SAKAMOTO A, 1991, BIOCHEM BIOPH RES CO, V178, P656, DOI 10.1016/0006-291X(91)90158-4; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SCHMID SL, 1992, BIOESSAYS, V14, P589, DOI 10.1002/bies.950140903; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; STAHL P, 1980, CELL, V19, P207, DOI 10.1016/0092-8674(80)90402-X; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; STOW JL, 1993, J CELL SCI, P33; SUMNER MJ, 1992, BRIT J PHARMACOL, V107, P858, DOI 10.1111/j.1476-5381.1992.tb14537.x; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; TSAI JS, 1981, BIOCHIM BIOPHYS ACTA, V673, P259, DOI 10.1016/0304-4165(81)90334-2; VAN LF, 1980, CELL, V20, P37; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	57	94	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10855	10860		10.1074/jbc.270.18.10855	http://dx.doi.org/10.1074/jbc.270.18.10855			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738024	hybrid			2022-12-27	WOS:A1995QW60100072
J	SHEARS, SB; ALI, N; CRAXTON, A; BEMBENEK, ME				SHEARS, SB; ALI, N; CRAXTON, A; BEMBENEK, ME			SYNTHESIS AND METABOLISM OF BIS-DIPHOSPHOINOSITOL TETRAKISPHOSPHATE IN-VITRO AND IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; 3-PHOSPHATASE; PURIFICATION; TURNOVER	The pathway of synthesis and metabolism of bis-diphosphoinositol tetrakisphosphate (PP-InsP(4)-PP) was elucidated by high performance liquid chromatography using newly available H-3- and P-32-labeled substrates. Metabolites were also identified by using two purified phosphatases in a structurally diagnostic manner: tobacco ''pyrophosphatase'' (Shinshi, Ii,, Miwa, M., Kato, K., Noguchi, M. Matsushima, T., and Sugimura, T. (1976) Biochemistry 15, 2185-2190) and rat hepatic multiple inositol polyphosphate phosphatase (MIPP; Craxton, A., All, N., and Shears, S. B. (1995) Biochem. J. 305, 491-498). The demonstration that diphosphoinositol polyphosphates were hydrolyzed by MIPP provides new information on its substrate specificity, although MIPP did not metabolize significant amounts of these polyphosphates in either rat liver homogenates or intact AR4-2J cells. In liver homogenates, inositol hexakisphosphate (InsP(6)) was phosphorylated first to a diphosphoinositol pentakisphosphate (PP-InsP(5)) and then to PP-InsP(4)-PP. These kinase reactions were reversed by phosphatases, establishing two coupled substrate cycles. The two dephosphorylations were probably performed by distinct phosphatases that were distinguished by their separate positional specificities, and their different sensitivities to inhibition by F- (IC50 values of 0.03 mM and 1.4 mM against PP-InsP(5) and PP-InsP(5)-PP, respectively). In [H-3]inositol-labeled AR4-2J cells, the steady-state levels of PP-[H-3]InsP(5) and PP-[H-3]InsP(4)-PP were, respectively, 2-3 and 0.6% of the level of [H-3]InsP(6). The ongoing turnover of these polyphosphates was revealed by treatment of cells with 0.8 mM NaF for 40 min, which reduced levels of [H-3]InsP(6) by 50%, increased the levels of PP-[H-3]InsP(5) 16-fold, and increased levels of PP-[H-3]InsP(4)-PP 5-fold. A large increase in levels of PP-[H-3]InsP(5) also occurred in cells treated with 10 mM NaF, but then no significant change to levels of PP-[H-3]InsP(4)-PP were observed; there may be important differences in the control of the turnover of these two compounds.	DUPONT CO INC,DEPT MED PROD,NEN,BOSTON,MA 02118	DuPont	SHEARS, SB (corresponding author), NIEHS,CELLULAR & MOLEC PHARMACOL LAB,INOSITOL LIPID SECT,RES TRIANGLE PK,NC 27709, USA.		Shears, Stephen B/C-6335-2019	Shears, Stephen B/0000-0001-7309-8916				ALI N, 1993, J BIOL CHEM, V268, P6161; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRAXTON A, 1995, BIOCHEM J, V305, P491, DOI 10.1042/bj3050491; CUNHAMELO JR, 1988, J BIOL CHEM, V263, P14245; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; Irvine Robin F., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P161; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; JOHNSON M T, 1986, Biotechniques, V4, P64; Kirk CJ., 1990, PEPTIDE HORMONE ACTI, P151; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; NOGIMORI K, 1991, J BIOL CHEM, V266, P16499; OLIVER KG, 1992, J BIOL CHEM, V267, P21528; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Shears Stephen B., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P63; SHINSHI H, 1976, BIOCHEMISTRY-US, V15, P2185, DOI 10.1021/bi00655a024; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564	19	58	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10489	10497		10.1074/jbc.270.18.10489	http://dx.doi.org/10.1074/jbc.270.18.10489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737983	hybrid			2022-12-27	WOS:A1995QW60100022
J	GOODEMOTE, KA; MATTIE, ME; BERGER, A; SPIEGEL, S				GOODEMOTE, KA; MATTIE, ME; BERGER, A; SPIEGEL, S			INVOLVEMENT OF A PERTUSSIS-TOXIN-SENSITIVE G-PROTEIN IN THE MITOGENIC SIGNALING PATHWAYS OF SPHINGOSINE 1-PHOSPHATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID LEVELS; SWISS 3T3 CELLS; CELLULAR PROLIFERATION; ENDOGENOUS GANGLIOSIDE; TRANSDUCTION PATHWAYS; DNA-SYNTHESIS; KINASE-C; FIBROBLASTS; SPHINGOSINE-1-PHOSPHATE; CALCIUM	Sphingosine 1-phosphate, a sphingolipid metabolite, was previously reported to increase DNA synthesis in quiescent Swiss 3T3 fibroblasts and to induce transient increases in intracellular free calcium (Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G., and Spiegel, S. (1991) J. Cell Biol. 114, 155-167). Tn the present study, pretreatment of Swiss 3T3 fibroblasts with pertussis toxin reduced sphingosine l-phosphate-induced DNA synthesis. Sphingosine l-phosphate decreased cellular cAMP levels and also caused a drastic decrease in isoproterenol- and forskolin-stimulated cAMP accumulation. Pertussis toxin treatment prevented the inhibitory effect of sphingosine 1-phosphate on cAMP accumulation, suggesting that a pertussis toxin-sensitive G(i) or G(i)-like protein may be involved in sphingosine 1-phosphate-mediated inhibition of cAMP accumulation. Mitogenic concentrations of sphingosine 1-phosphate stimulated production of inositol phosphates which was inhibited by pertussis toxin, while the response to bradykinin was not affected. Furthermore, calcium release induced by sphingosine 1-phosphate, but not by bradykinin, was also attenuated by pertussis toxin treatment. However, sphingosine 1-phosphate induced phosphatidic acid accumulation was unaffected by pertussis toxin. The increase in specific DNA binding activity of activator protein-1, which was induced by treatment of quiescent Swiss 3T3 fibroblasts with sphingosine 1-phosphate, was also inhibited by pertussis toxin. These results suggest that some of the sphingosine 1-phosphate-induced signaling pathways are mediated by G proteins that are substrates for pertussis toxin.	GEORGETOWN UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOL,WASHINGTON,DC 20007	Georgetown University					NCI NIH HHS [F32CA09249] Funding Source: Medline; NIGMS NIH HHS [1RO1 GM43880] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA009249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BREITTMAYER JP, 1991, IMMUNOLOGY, V73, P134; BUEHRER BM, 1992, J BIOL CHEM, V267, P3154; CHAMBARD JC, 1987, NATURE, V326, P800, DOI 10.1038/326800a0; CHAO CP, 1994, J BIOL CHEM, V269, P5849; CUI Z, 1991, J BIOL CHEM, V266, P20276; DESAI NN, 1992, J BIOL CHEM, V267, P23122; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; GHOSH TK, 1994, J BIOL CHEM, V269, P22628; GOMEZMUNOZ A, 1994, J BIOL CHEM, V269, P8937; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HERMOUET S, 1993, CELL SIGNAL, V5, P215, DOI 10.1016/0898-6568(93)90072-T; HILDEBRANDT JD, 1986, FEBS LETT, V203, P87, DOI 10.1016/0014-5793(86)81442-9; JOHNSON GL, 1994, J CELL BIOCHEM, V54, P415, DOI 10.1002/jcb.240540408; JOHNSON JA, 1990, J BIOL CHEM, V265, P9333; KAHAN C, 1992, J BIOL CHEM, V267, P13369; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; LAMORTE VJ, 1993, J CELL BIOL, V121, P91, DOI 10.1083/jcb.121.1.91; LETTERIO JJ, 1986, SCIENCE, V234, P1117, DOI 10.1126/science.3465038; MATTIE M, 1994, J BIOL CHEM, V269, P3181; MERRILL AH, 1991, J BIOENERG BIOMEMBR, V23, P83; NEER EJ, 1988, NATURE, V33, P129; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; OLIVERA A, 1994, J BIOL CHEM, V269, P17924; POUYSSEGUR J, 1992, ANNU REV PHYSIOL, V54, P195, DOI 10.1146/annurev.ph.54.030192.001211; RITCHIE T, 1992, BIOCHEM BIOPH RES CO, V186, P790, DOI 10.1016/0006-291X(92)90815-3; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; SPIEGEL S, 1989, J BIOL CHEM, V264, P6766; SPIEGEL S, 1988, EXP CELL RES, V177, P414, DOI 10.1016/0014-4827(88)90474-0; Spiegel Sarah, 1993, V25, P105; STOFFEL W, 1973, H-S Z PHYSIOL CHEM, V354, P1311, DOI 10.1515/bchm2.1973.354.2.1311; SU Y, 1994, J BIOL CHEM, V269, P16512; UI M, 1986, P163; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; VANVELDHOVEN PP, 1991, J BIOL CHEM, V266, P12502; ZHANG H, 1990, J BIOL CHEM, V265, P76; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; ZHANG H, 1990, J BIOL CHEM, V265, P21309	43	155	157	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10272	10277		10.1074/jbc.270.17.10272	http://dx.doi.org/10.1074/jbc.270.17.10272			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730331	hybrid			2022-12-27	WOS:A1995QV41700080
J	HUNYADY, L; BOR, M; BALLA, T; CATT, KJ				HUNYADY, L; BOR, M; BALLA, T; CATT, KJ			CRITICAL ROLE OF A CONSERVED INTRAMEMBRANE TYROSINE RESIDUE IN ANGIOTENSIN-II RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ADRENAL GLOMERULOSA CELLS; PROTEIN-COUPLED RECEPTORS; BETA-ADRENERGIC-RECEPTOR; MUTAGENESIS; SIGNAL; SEQUESTRATION; GENERATION; LIGAND; GS	The rat type 1a (AT(1a)) angiotensin II (Ang II) receptor contains a highly conserved tyrosine residue in the fifth transmembrane region that is present in most G protein-coupled receptors. The role of this amino acid in AT(1) receptor activation was analyzed in a mutant receptor (Y215F) created by replacing Tyr(215) with phenylalanine, The mutant receptor was highly expressed in transfected COS-7 cells, and its binding affinity for the peptide antagonist [Sar(1),Ile(8)]Ang II was similar to that of the wild type receptor. Although the structural integrity of the peptide ligand binding domain was preserved in the Y215F mutant receptor, its affinity for the native agonist, Ang II, was significantly reduced. Also, whereas guanosine 5'-3-O-(thio)triphosphate markedly reduced Ang II binding to the wild type receptor, it had little effect on agonist binding to the mutant receptor. Agonist-induced internalization of the mutant receptor was also impaired, and its ability to mediate inositoI phosphate responses to Ang II stimulation was abolished. The concomitant decreases in receptor internalization and G protein-mediated signaling of the Y215F mutant receptor indicate that Tyr(215) has a critical role in AT(1) receptor activation. In view of its conservation among members of the seven transmembrane domain receptor superfamily, this residue is likely to be of general importance in signal transduction from G protein-coupled receptors.	SEMMELWEIS UNIV MED,SCH MED,DEPT PHYSIOL,H-1444 BUDAPEST,HUNGARY	Semmelweis University	HUNYADY, L (corresponding author), NICHHD,ERRB,BLDG 49,RM 6A36,BETHESDA,MD 20892, USA.			Balla, Tamas/0000-0002-9077-3335				ANDERSON KM, 1993, AM J PHYSIOL, V264, pC179, DOI 10.1152/ajpcell.1993.264.1.C179; BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BALLA T, 1991, J BIOL CHEM, V266, P24719; BERNSTEIN KE, 1993, AM J KIDNEY DIS, V22, P745, DOI 10.1016/S0272-6386(12)80441-0; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; BLUML K, 1994, J BIOL CHEM, V269, P11537; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; Catt KJ, 1993, CELLULAR MOL BIOL RE, P307; CHEUNG AH, 1992, MOL PHARMACOL, V41, P1061; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; FINDLAY JBC, 1993, BIOCHEM SOC T, V21, P869, DOI 10.1042/bst0210869; HAUSDORFF WP, 1992, ASIA PAC J PHARMACOL, V7, P149; HEDIN KE, 1993, CELL SIGNAL, V5, P505, DOI 10.1016/0898-6568(93)90046-O; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; HUNYADY L, 1991, J BIOL CHEM, V266, P2783; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MARIE J, 1994, J BIOL CHEM, V269, P20815; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; OHYAMA K, 1992, BIOCHEM BIOPH RES CO, V189, P677, DOI 10.1016/0006-291X(92)92254-U; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SPAT A, 1991, EXP PHYSIOL, V76, P859, DOI 10.1113/expphysiol.1991.sp003550; VINSON GP, 1994, J ENDOCRINOL, V141, pR5, DOI 10.1677/joe.0.141R005; WESS J, 1993, LIFE SCI, V53, P1447, DOI 10.1016/0024-3205(93)90618-D	27	59	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9702	9705		10.1074/jbc.270.17.9702	http://dx.doi.org/10.1074/jbc.270.17.9702			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730346	hybrid			2022-12-27	WOS:A1995QV41700004
J	JOST, JP; SIEGMANN, M; SUN, LJ; LEUNG, R				JOST, JP; SIEGMANN, M; SUN, LJ; LEUNG, R			MECHANISMS OF DNA DEMETHYLATION IN CHICKEN EMBRYOS - PURIFICATION AND PROPERTIES OF A 5-METHYLCYTOSINE-DNA GLYCOSYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REMOVAL; CELLS	We have previously shown that in developing chicken embryos and differentiating mouse myoblasts, the demethylation of 5-metCpGs occurs through the replacement of 5-methylcytosine by cytosine (Jest, J, P, (1993) Proc, Natl. Acad. Sci, U.S.A. 90, 4685-4688; Jest, J. P, and Jest, Y. C, (1994) J. Biol, Chem, 269, 10040-10043), We have now purified over 30,000-fold a 5-methylcytosine-DNA glycosylase from Ig-day-old chicken embryos, The enzyme copurifies with a mismatch specific thymine-DNA glycosylase and an apyrimidic-endonuclease. The reaction product of the highly purified 8-methylcytosine-DNA glycosylase is 5-methylcytosine. The copurified apyrimidic-endonuclease activity cleaves 3' from the apyrimidic sugar. A 52.5-kDa peptide, isolated as a single band from preparative SDS-polyacrylamide gels, has both the 5-methylcytosine-DNA glycosylase and the mismatch-specific thymine-DNA glycosylase activities, 5 Methylcytosine-DNA glycosylase has an apparent pi of 5.5-7.5 and maximal activity between pH 6.5 and 7.5, The K-m for hemimethylated oligonucleotide substrate is 8 x 10(-8) M with a V-max of 4 x 10(-11) mol/h/mu g protein, B-Methylcytosine-DNA glycosylase binds equally well to methylated and non-methylated DNA, The enzyme reacts six times faster with the hemimethylated DNA than with the same bifilarly methylated DNA sequence, and single-stranded methylated DNA is not a substrate, The action of the enzyme is distributive.			JOST, JP (corresponding author), FRIEDRICH MIESCHER INST,POB 2543,CH-4002 BASEL,SWITZERLAND.							Adams R. L. P., 1985, MOL BIOL DNA METHYLA; ADAMS RLP, 1990, FEBS LETT, V269, P29, DOI 10.1016/0014-5793(90)81111-Z; BESTOR TH, 1984, MOL CELL BIOL, V4, P1800, DOI 10.1128/MCB.4.9.1800; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; CEDAR H, 1979, NUCLEIC ACIDS RES, V6, P2125, DOI 10.1093/nar/6.6.2125; EGAN NB, 1988, ANAL BIOCHEM, V172, P488; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HARLOW E, 1988, ANTIBODIES LABORATOR; HUGHES MJ, 1991, LABORATORY GUIDE IN, P79; JOST JP, 1994, J BIOL CHEM, V269, P10040; JOST JP, 1993, DNA METHYLATION MOL; JOST JP, 1995, IN PRESS GENE AMST; JOST JP, 1993, P NATL ACAD SCI USA, V90, P4685; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; RAZIN A, 1984, DNA METHYLATION BIOC; VAIRAPANDI M, 1993, NUCLEIC ACIDS RES, V21, P5323, DOI 10.1093/nar/21.23.5323	18	122	125	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9734	9739		10.1074/jbc.270.17.9734	http://dx.doi.org/10.1074/jbc.270.17.9734			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730351				2022-12-27	WOS:A1995QV41700009
J	WADE, M; BLAKE, MC; JAMBOU, RC; HELIN, K; HARLOW, E; AZIZKHAN, JC				WADE, M; BLAKE, MC; JAMBOU, RC; HELIN, K; HARLOW, E; AZIZKHAN, JC			AN INVERTED REPEAT MOTIF STABILIZES BINDING OF E2F AND ENHANCES TRANSCRIPTION OF THE DIHYDROFOLATE-REDUCTASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS-INFECTED CELLS; HUMAN MYC PROMOTER; DNA-BINDING; TRANS-ACTIVATION; E4 GENE; COOPERATIVE BINDING; COMPLEX-FORMATION; GROWTH-REGULATION; CELLULAR GENES; MESSENGER-RNA	An overlapping inverted repeat sequence that binds the eukaryotic transcription factor E2F is 100% conserved near the major transcription start sites in the promoters of three mammalian genes encoding dihydrofolate reductase, and is also found in the promoters of several other important cellular and viral genes. This element, 5' TTTCGCGCCAAA-3', is comprised of two overlapping, oppositely oriented sites which match the consensus E2F site (5'-TTT(C/G) (C/G)CGC-3'). Recent work has shown that E2F binding activity is composed of at least six related cellular polypeptides which are capable of forming DNA-binding home- and heterodimers. We have investigated the binding of cellular E2F activity and of home- and heterodimers of cloned E2F proteins to the inverted repeat E2F element. We have demonstrated that mutations in this element that abolish its inverted repeat nature, while preserving a single consensus E2F site, significantly decrease the binding stability of all of the forms of E2F tested. The rate of association of E2F-1/DP-1 heterodimers with the inverted repeat wild type site was not significantly different from those with the two single site mutated probes, Furthermore, the mutations decrease in vitro transcription and transient reporter gene expression 2-5-fold, an effect equivalent to that of abolishing E2F binding altogether. These data suggest a functional role that may explain the conservation of inverted repeat E2F elements among the DHFR promoters and several other cellular and viral promoters.	ROSWELL PK CANC INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263; UNIV N CAROLINA,LINEBERGER CANC RES CTR,CHAPEL HILL,NC 27599; UNIV N CAROLINA,CURRICULUM GENET & MOLEC BIOL,CHAPEL HILL,NC 27599; MASSACHUSETTS GEN HOSP,CTR CANC,BOSTON,MA	Roswell Park Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts General Hospital			Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Helin, Kristian/0000-0003-1975-6097				Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; AZIZKHAN JC, 1986, BIOCHEMISTRY-US, V25, P6228, DOI 10.1021/bi00368a059; BABISS LE, 1989, J VIROL, V63, P2709, DOI 10.1128/JVI.63.6.2709-2717.1989; BAGCHI S, 1990, CELL, V62, P659, DOI 10.1016/0092-8674(90)90112-R; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; CHEN MJ, 1984, J BIOL CHEM, V259, P3933; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DYSON N, 1993, J VIROL, V67, P7641, DOI 10.1128/JVI.67.12.7641-7647.1993; FARNHAM PJ, 1993, BIOCHIM BIOPHYS ACTA, V1156, P125; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; HARDY S, 1989, MOL CELL BIOL, V9, P4495, DOI 10.1128/MCB.9.10.4495; HARDY S, 1989, GENE DEV, V3, P1062, DOI 10.1101/gad.3.7.1062; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; Helin Kristian, 1993, Trends in Cell Biology, V3, P43, DOI 10.1016/0962-8924(93)90150-Y; HIEBERT SW, 1991, J VIROL, V65, P3547, DOI 10.1128/JVI.65.7.3547-3552.1991; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; HSIAO KM, 1994, GENE DEV, V8, P1526, DOI 10.1101/gad.8.13.1526; HUANG MM, 1989, GENE DEV, V3, P1699, DOI 10.1101/gad.3.11.1699; HUANG S, 1992, DNA CELL BIOL, V11, P539, DOI 10.1089/dna.1992.11.539; HUBER HE, 1993, P NATL ACAD SCI USA, V90, P3525, DOI 10.1073/pnas.90.8.3525; HUBER HE, 1994, J BIOL CHEM, V269, P6999; IVEYHOYLE M, 1993, MOL CELL BIOL, V13, P7802, DOI 10.1128/MCB.13.12.7802; JANSENDURR P, 1989, EMBO J, V8, P3365, DOI 10.1002/j.1460-2075.1989.tb08499.x; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; LATHANGUE NB, 1994, TRENDS BIOCHEM SCI, V19, P108, DOI 10.1016/0968-0004(94)90202-X; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; LOEKEN MR, 1989, J BIOL CHEM, V264, P6572; MARTON MJ, 1990, J VIROL, V64, P2345, DOI 10.1128/JVI.64.5.2345-2359.1990; MCGROGAN M, 1985, J BIOL CHEM, V260, P2307; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; MEANS AL, 1990, MOL CELL BIOL, V10, P653, DOI 10.1128/MCB.10.2.653; MITCHELL PJ, 1986, MOL CELL BIOL, V6, P425, DOI 10.1128/MCB.6.2.425; MUDRYJ M, 1990, EMBO J, V9, P2179, DOI 10.1002/j.1460-2075.1990.tb07387.x; NEILL SD, 1990, P NATL ACAD SCI USA, V87, P2008, DOI 10.1073/pnas.87.5.2008; NEILL SD, 1991, J VIROL, V65, P5364, DOI 10.1128/JVI.65.10.5364-5373.1991; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; NEVINS JR, 1992, SCIENCE, V258, P424; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; OUELLETTE MM, 1992, ONCOGENE, V7, P1075; RAYCHAUDHURI P, 1990, J VIROL, V64, P2702, DOI 10.1128/JVI.64.6.2702-2710.1990; REICHEL R, 1989, J VIROL, V63, P3643, DOI 10.1128/JVI.63.9.3643-3650.1989; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; WADE M, 1992, MOL CELL BIOL, V12, P4364, DOI 10.1128/MCB.12.10.4364; YEE AS, 1987, EMBO J, V6, P2061, DOI 10.1002/j.1460-2075.1987.tb02471.x; YEE AS, 1989, MOL CELL BIOL, V9, P578, DOI 10.1128/MCB.9.2.578	59	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9783	9791		10.1074/jbc.270.17.9783	http://dx.doi.org/10.1074/jbc.270.17.9783			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730357	hybrid			2022-12-27	WOS:A1995QV41700016
J	SERRE, L; VERBREE, EC; DAUTER, Z; STUITJE, AR; DEREWENDA, ZS				SERRE, L; VERBREE, EC; DAUTER, Z; STUITJE, AR; DEREWENDA, ZS			THE ESCHERICHIA-COLI MALONYL-COA-ACYL CARRIER PROTEIN TRANSACYLASE AT 1.5-ANGSTROM RESOLUTION - CRYSTAL-STRUCTURE OF A FATTY-ACID SYNTHASE COMPONENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MOLECULAR-CLONING; COENZYME-A; COMPLEX; GENE; BIOSYNTHESIS; SYNTHETASE; EXPRESSION; CDNA	Endogenous fatty acids are synthesized in all organisms in a pathway catalyzed by the fatty acid synthase complex. In bacteria, where the fatty acids are used primarily for incorporation into components of cell membranes, fatty acid synthase is made up of several independent cytoplasmic enzymes, each catalyzing one specific reaction. The initiation of the elongation step, which extends the length of the growing acyl chain by two carbons, requires the transfer of the malonyl moiety from malonyl-CoA onto the acyl carrier protein. We report here the crystal structure (refined at 1.5-Angstrom resolution to an R factor of 0.19) of the malonyl-CoA specific transferase from Escherichia coli. The protein has an alpha/beta type architecture, but its fold is unique. The active site inferred from the location of the catalytic Ser-92 contains a typical nucleophilic elbow as observed in alpha/beta hydrolases. Serine 92 is hydrogen bonded to His-201 in a fashion similar to various serine hydrolases. However, instead of a carboxyl acid typically found in catalytic triads, the main chain carbonyl of Gln-250 serves as a hydrogen bond acceptor in an interaction with His-201. Two other residues, Arg-117 and Glu-11, are also located in the active site, although their function is not clear.	FREE UNIV AMSTERDAM,INST MOLEC BIOL SCI,DEPT GENET,BIOCTR,1081 HV AMSTERDAM,NETHERLANDS; EMBL OUTSTN,D-22603 HAMBURG,GERMANY	Vrije Universiteit Amsterdam; European Molecular Biology Laboratory (EMBL)	SERRE, L (corresponding author), UNIV ALBERTA,DEPT BIOCHEM,MRC,PROT STRUCT & FUNCT GRP,4-74 MED SCI BLDG,EDMONTON,AB T6G 2H7,CANADA.			SERRE, laurence/0000-0002-6794-1492				AMY CM, 1989, P NATL ACAD SCI USA, V86, P3114, DOI 10.1073/pnas.86.9.3114; BAKER PJ, 1990, ACTA CRYSTALLOGR A, V46, P721, DOI 10.1107/S0108767390005153; BLANCHARD H, 1994, J MOL BIOL, V241, P574, DOI 10.1006/jmbi.1994.1532; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; BOURNE Y, 1994, J MOL BIOL, V238, P709, DOI 10.1006/jmbi.1994.1331; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; Brunger A. T., 1993, X PLOR MANUAL VERSIO; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; BUCKNER JS, 1978, ARCH BIOCHEM BIOPHYS, V186, P152, DOI 10.1016/0003-9861(78)90474-5; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; DEREWENDA U, 1994, NAT STRUCT BIOL, V1, P36, DOI 10.1038/nsb0194-36; DEREWENDA ZS, 1991, BIOCHEM CELL BIOL, V69, P842, DOI 10.1139/o91-125; DIXON MM, 1989, BIOCHEMISTRY-US, V28, P7034; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P6135, DOI 10.1021/bi00416a046; HOLZER KP, 1989, P NATL ACAD SCI USA, V86, P4387, DOI 10.1073/pnas.86.12.4387; JONES TA, 1991, ACTA CRYSTALLOGR A, V97, P110; JOSHI AK, 1993, BIOCHEM J, V296, P143, DOI 10.1042/bj2960143; JOSHI VC, 1971, ARCH BIOCHEM BIOPHYS, V143, P493, DOI 10.1016/0003-9861(71)90234-7; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPUSAS M, 1991, BIOCHEMISTRY-US, V30, P6029; KATZ L, 1993, ANNU REV MICROBIOL, V47, P875, DOI 10.1146/annurev.mi.47.100193.004303; LAMZIN VS, 1990, ACTA CRYSTALLOGR D, V49, P129; LASKOWSKI RA, 1992, PROCHECK VERSION 2 P; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; MARSDEN AFA, 1994, SCIENCE, V263, P378, DOI 10.1126/science.8278811; MATHUR M, 1992, J BIOL CHEM, V267, P19388; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PETROVICS G, 1993, MOL MICROBIOL, V8, P1083, DOI 10.1111/j.1365-2958.1993.tb01653.x; RANGAN VS, 1991, J BIOL CHEM, V266, P19180; RUCH FE, 1973, J BIOL CHEM, V248, P8080; SERRE L, 1994, J MOL BIOL, V242, P99, DOI 10.1006/jmbi.1994.1559; SHEN B, 1994, SCIENCE, V262, P1535; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; SMITH S, 1985, EUR J BIOCHEM, V152, P547, DOI 10.1111/j.1432-1033.1985.tb09230.x; VERWOERT IIGS, 1992, J BACTERIOL, V174, P2851, DOI 10.1128/JB.174.9.2851-2857.1992; WEI YY, 1995, NAT STRUCT BIOL, V2, P218, DOI 10.1038/nsb0395-218; WILLIAMS.IP, 1966, J BIOL CHEM, V241, P2326; ZHANG KYJ, 1993, ACTA CRYSTALLOGR D, V49, P213, DOI 10.1107/S0907444992007911; 1988, CCP4 SUITE PROGRAMS	42	156	163	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12961	12964		10.1074/jbc.270.22.12961	http://dx.doi.org/10.1074/jbc.270.22.12961			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768883	hybrid			2022-12-27	WOS:A1995RB43900004
J	WHITE, CB; CHEN, Q; KENYON, GL; BABBITT, PC				WHITE, CB; CHEN, Q; KENYON, GL; BABBITT, PC			A NOVEL ACTIVITY OF OMPT - PROTEOLYSIS UNDER EXTREME DENATURING CONDITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI OUTER-MEMBRANE; AMINO-ACID-SEQUENCE; ESCHERICHIA-COLI; FUSION PROTEINS; CREATINE-KINASE; CLEAVAGE SITE; PROTEASE; GENE; PURIFICATION; TRANSPORT	A novel property of the bacterial outer membrane protein T, OmpT, has been discovered. It is active under extreme denaturing conditions. This finding emerged during characterization of a protease associated with the degradation of recombinant proteins expressed as inclusion bodies in Escherichia coli. These inclusion body proteins are stable to proteolytic degradation until they are solubilized by denaturation. The protease that degrades them under denaturing conditions was identified as OmpT on the basis of substrate specificity, inhibitor profile, and confirmation that its N-terminal sequence is identical with that of OmpT. A previously unknown property of this enzyme, OmpT's preference for denatured substrates, may provide a clue to its physiological function. To facilitate further characterization of this proteolytic activity, we have optimized a system to extract and assay OmpT under denaturing conditions using a soluble substrate, rabbit muscle creatine.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; UNIV CALIF DAVIS,DEPT FOOD SCI,DAVIS,CA 95616	University of California System; University of California San Francisco; University of California System; University of California Davis					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR017323, R01AR017323] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR17323] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BABBITT PC, 1990, BIO-TECHNOL, V8, P945, DOI 10.1038/nbt1090-945; BABBITT PC, 1992, FASEB J, V6, pA325; BABBITT PC, 1991, PROTEIN REFOLDING, P154; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; BELEW M, 1970, METHODS ENZYMOLOGY P, P576; CERRITELLI SM, 1993, BIOCHIMIE, V75, P107, DOI 10.1016/0300-9084(93)90031-M; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; GRODBERG J, 1988, NUCLEIC ACIDS RES, V16, P1209, DOI 10.1093/nar/16.3.1209; HANKE C, 1992, MOL GEN GENET, V233, P42, DOI 10.1007/BF00587559; HARRIS JI, 1956, NATURE, V177, P471, DOI 10.1038/177471a0; HATZFELD M, 1992, FEBS LETT, V302, P239, DOI 10.1016/0014-5793(92)80450-U; INOKUCHI K, 1982, NUCLEIC ACIDS RES, V10, P6957, DOI 10.1093/nar/10.21.6957; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KLAUSER T, 1992, EMBO J, V11, P2327, DOI 10.1002/j.1460-2075.1992.tb05292.x; LASSEN SF, 1992, BIOCHEM INT, V27, P601; LEYTUS SP, 1981, P NATL ACAD SCI-BIOL, V78, P1485, DOI 10.1073/pnas.78.3.1485; LUNDRIGAN MD, 1992, FEMS MICROBIOL LETT, V97, P51; MANNING PA, 1977, FEMS MICROBIOL LETT, V1, P275, DOI 10.1111/j.1574-6968.1977.tb00631.x; MATSUBARA H, 1970, METHOD ENZYMOL, P642; MIZUNO T, 1983, J BIOL CHEM, V258, P6932; MUTOH N, 1982, FEBS LETT, V137, P171, DOI 10.1016/0014-5793(82)80341-4; OTTENSEN M, 1970, METHODS ENZYMOLOGY P, P199; PRESCOTT JM, 1970, METHODS ENZYMOLOGY P, P530; QIZHI Y, 1985, SCI SIN B, V28, P484; QIZHI Y, 1982, SCI SINICA, V25, P1296; RONCARI G, 1976, METHODS ENZYMOLOGY P, P522; SHAPIRA E, 1969, J BIOL CHEM, V244, P1026; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; SUGIMURA K, 1988, J BACTERIOL, V170, P3650, DOI 10.1128/jb.170.8.3650-3654.1988; TANZER ML, 1959, J BIOL CHEM, V234, P3201; ZHAO GP, 1993, J BIOL CHEM, V268, P14912; ZHOU HM, 1986, BIOCHIM BIOPHYS ACTA, V869, P69, DOI 10.1016/0167-4838(86)90311-0	32	44	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12990	12994		10.1074/jbc.270.22.12990	http://dx.doi.org/10.1074/jbc.270.22.12990			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768890	hybrid			2022-12-27	WOS:A1995RB43900011
J	PUENTE, XS; LOPEZOTIN, C				PUENTE, XS; LOPEZOTIN, C			CLONING AND EXPRESSION ANALYSIS OF A NOVEL HUMAN SERINE HYDROLASE WITH SEQUENCE SIMILARITY TO PROKARYOTIC ENZYMES INVOLVED IN THE DEGRADATION OF AROMATIC-COMPOUNDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-HYDROXYMUCONIC SEMIALDEHYDE HYDROLASE; POLYCHLORINATED BIPHENYL DEGRADATION; SIGNAL RECOGNITION PARTICLE; PSEUDOMONAS-PUTIDA; EPOXIDE HYDROLASE; MESSENGER-RNA; 2-HYDROXY-6-OXOHEPTA-2,4-DIENOATE HYDROLASE; PROTEIN TRANSLOCATION; MOLECULAR-CLONING; ALU SEQUENCES	A full-length cDNA coding for a novel human serine hydrolase has been cloned from a breast carcinoma cDNA library. Nucleotide sequence analysis has shown that the isolated cDNA contains an open reading frame coding for a polypeptide of 274 amino acids and a complete Alu repetitive sequence within its 3'-untranslated region. The predicted amino acid sequence contains the Gly-X-Ser-X-Gly motif characteristic of serine hydrolases and displays extensive similarity to several prokaryotic hydrolases involved in the degradation of aromatic compounds. The highest degree of identities was detected with four serine hydrolases encoded by the bphD genes of different strains of Pseudomonas with the ability to degrade biphenyl derivatives. On the basis of these sequence similarities, this novel human enzyme has been tentatively called Biphenyl hydrolase-related protein (Bph-rp). The Bph-rp cDNA was expressed in Escherichia coli, and after purification, the recombinant protein was able to degrade p-nitrophenylbutyrate, a water-soluble substrate commonly used for assaying serine hydrolases. This hydrolytic activity was abolished by diisopropyl fluorophosphate, a covalent inhibitor of serine hydrolases, providing additional evidence that the isolated cDNA encodes a member of this protein superfamily. Northern blot analysis of poly(A)(+) RNAs isolated from a variety of human tissues revealed that Bph-rp is mainly expressed in liver and kidney, which was also confirmed at the protein level by Western blot analysis with antibodies raised against purified recombinant Bph-rp. According to structural characteristics, hydrolytic activity and tissue distribution of Bph-rp, a potential role of this enzyme in detoxification processes is proposed.	UNIV OVIEDO,FAC MED,DEPT BIOL FUNC,E-33006 OVIEDO,SPAIN	University of Oviedo			Puente, Xosé S./ADB-0672-2022; López-Otín, Carlos/AAB-2106-2020	Puente, Xosé S./0000-0001-9525-1483; López-Otín, Carlos/0000-0001-6964-1904				ALEXSON SEH, 1994, J BIOL CHEM, V269, P17118; ARAND M, 1994, FEBS LETT, V338, P251, DOI 10.1016/0014-5793(94)80278-5; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; CHANG DY, 1993, J BIOL CHEM, V268, P6423; CHAUDHRY GR, 1991, MICROBIOL REV, V55, P59, DOI 10.1128/MMBR.55.1.59-79.1991; CHUNG LP, 1988, P NATL ACAD SCI USA, V85, P6227, DOI 10.1073/pnas.85.17.6227; CYGLER M, 1993, PROTEIN SCI, V2, P366; DEREWENDA ZS, 1991, BIOCHEM CELL BIOL, V69, P842, DOI 10.1139/o91-125; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUGGLEBY CJ, 1986, J GEN MICROBIOL, V132, P717; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; FURUKAWA K, 1982, BIODEGRADATION DETOX, P33; GRANT DF, 1993, J BIOL CHEM, V268, P17628; GUNDELFINGER ED, 1983, NUCLEIC ACIDS RES, V11, P7363, DOI 10.1093/nar/11.21.7363; Harayama S., 1989, Genetics of bacterial diversity., P151; HAYASE N, 1990, J BACTERIOL, V172, P1160, DOI 10.1128/jb.172.2.1160-1164.1990; HEINEMANN FS, 1984, J BIOL CHEM, V259, P797; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5597, DOI 10.1073/pnas.83.15.5597; HOFER B, 1993, GENE, V130, P47, DOI 10.1016/0378-1119(93)90345-4; HORN JM, 1991, MOL MICROBIOL, V5, P2459, DOI 10.1111/j.1365-2958.1991.tb02091.x; JACK LJW, 1990, J BIOL CHEM, V265, P14481; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; KIMBARA K, 1989, J BACTERIOL, V171, P2740, DOI 10.1128/jb.171.5.2740-2747.1989; KNEHR M, 1993, J BIOL CHEM, V268, P17623; KROETZ DL, 1993, BIOCHEMISTRY-US, V32, P11606, DOI 10.1021/bi00094a018; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; LAROCCA D, 1990, CANCER RES, V50, P5925; LEE WH, 1986, P NATL ACAD SCI USA, V83, P6790, DOI 10.1073/pnas.83.18.6790; LOPEZBOADO YS, 1994, J BIOL CHEM, V269, P26871; Maniatis T., 1982, MOL CLONING; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; MENN FM, 1991, GENE, V104, P91, DOI 10.1016/0378-1119(91)90470-V; MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6; NORDLUND I, 1990, BIOCHIM BIOPHYS ACTA, V1049, P227, DOI 10.1016/0167-4781(90)90046-5; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; QUATTROCHI LC, 1986, P NATL ACAD SCI USA, V83, P6731, DOI 10.1073/pnas.83.18.6731; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SANCHEZ LM, 1992, J BIOL CHEM, V267, P24725; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Satoh T., 1987, REV BIOCHEM TOXICOL, V13, P155; SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889; SHARIEF FS, 1989, BIOCHEM BIOPH RES CO, V160, P79, DOI 10.1016/0006-291X(89)91623-9; SHIBATA F, 1993, GENOMICS, V17, P76, DOI 10.1006/geno.1993.1285; SHIRAI K, 1982, J BIOL CHEM, V257, P1253; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; TIMMIS KN, 1994, ANNU REV MICROBIOL, V48, P525, DOI 10.1146/annurev.mi.48.100194.002521; URIA JA, 1994, CANCER RES, V54, P2091; Vaitukaitis J L, 1981, Methods Enzymol, V73, P46; VELASCO G, 1994, J BIOL CHEM, V269, P27136; VERNET C, 1993, J MOL EVOL, V37, P600; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WANG CS, 1991, BIOCHEM J, V279, P297, DOI 10.1042/bj2790297; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	53	31	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12926	12932		10.1074/jbc.270.21.12926	http://dx.doi.org/10.1074/jbc.270.21.12926			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759552	hybrid			2022-12-27	WOS:A1995QZ71100090
J	YADA, Y; HIGUCHI, K; IMOKAWA, G				YADA, Y; HIGUCHI, K; IMOKAWA, G			PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF MEMBRANE-BOUND EPIDERMAL CERAMIDASES FROM GUINEA-PIG SKIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GROWTH-FACTOR RECEPTOR; LEUKEMIA HL-60 CELLS; LONG-CHAIN BASES; SIGNAL TRANSDUCTION; PORCINE EPIDERMIS; BETA-GLUCOSIDASE; GAUCHER DISEASE; PHORBOL ESTERS; SPHINGOSINE	Ceramidase (CDase) catalyzes the hydrolysis of ceramides to yield sphingosine and fatty acid, In this paper, two forms of membrane bound alkaline ceramidase, have been, for the first time, purified from guinea pig epidermis by chromatography on DEAE-cellulose, phenyl-Superose, HCA-hyroxyapatite, isoelectric focusing, Mono Q, and TSK-3000SW column, One species (CDase-I) migrated upon SDS-polyacrylamide gel electrophoresis as a single band with an apparent molecular mass of 60 kDa; the other (CDase-II) was only partially purified with apparent M(r) of about 148,000 estimated by gel filtration. The specific activities of the two species increased by 1.130- (for CDase-I) and 400-fold (for CDase-II) over the original tissue extract. The activity of both enzymes for ceramide species decreased in the order of linoleoyl > oleoyl > palmitoylsphingosine. The optimal pH for enzyme activity was approximately 7.0-9.0 for CDase-I and 7.5-8.5 for CDase-II, Interestingly, both enzymes were inhibited by the reaction product sphingosine with a concentration for half-maximal inhibition (ID50) of 100-130 mu M, compared to the apparent kinetic parameters with CDase-I (K-m = 90 mu M, V-max = 0.62 unit) and CDase-II (K-m = 140 mu M, V-max = 0.50 units). Some lipids, such as phosphatidylcholine and sphingomyelin, are also inhibitory with IC50 values of 50-250 mu M, suggesting well controlled CDase activity by sphingolipid metabolites. These studies begin to elucidate a regulatory mechanism for the balance of the ratio of ceramide/sphingosine which can serve as an intracellular effector molecule in epidermis.	KAO CORP,INST FUNDAMENTAL RES,HAGO,TOCHIGI 32134,JAPAN	KAO Corporation								AL BJM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P245, DOI 10.1016/0005-2760(89)90274-9; ANDERSON DS, 1951, BRIT J DERMATOL, V63, P283, DOI 10.1111/j.1365-2133.1951.tb13728.x; BALLOU LR, 1992, IMMUNOL TODAY, V13, P339, DOI 10.1016/0167-5699(92)90167-6; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; BLANK IRVIN H., 1939, JOUR INVEST DERMAL, V2, P231; BREMER EG, 1986, J BIOL CHEM, V261, P2434; DOLE VPJ, 1956, CLIN INVESTIGATOR, V35, P350; ELIAS PM, 1975, J CELL BIOL, V65, P180, DOI 10.1083/jcb.65.1.180; ELTOUNY S, 1990, J BIOL CHEM, V265, P16437; GATT S, 1966, J BIOL CHEM, V241, P3724; GOLDKORN T, 1991, J BIOL CHEM, V266, P16092; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; IMOKAWA G, 1986, J INVEST DERMATOL, V87, P758, DOI 10.1111/1523-1747.ep12456950; IMOKAWA G, 1985, J INVEST DERMATOL, V83, P282; KOLESNICK RN, 1990, J BIOL CHEM, V265, P18803; KOLESNICK RN, 1991, PROG LIPID RES, V30, P1, DOI 10.1016/0163-7827(91)90005-P; KOVAL M, 1991, BIOCHIM BIOPHYS ACTA, V1082, P113, DOI 10.1016/0005-2760(91)90184-J; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARET A, 1983, FEBS LETT, V160, P93, DOI 10.1016/0014-5793(83)80943-0; MARET A, 1984, BIOCHIM BIOPHYS ACTA, V799, P91, DOI 10.1016/0304-4165(84)90330-1; MELTON JL, 1987, BIOCHIM BIOPHYS ACTA, V921, P191, DOI 10.1016/0005-2760(87)90018-X; MERRILL AH, 1992, NUTR REV, V50, P78; MERRILL AH, 1991, J BIOENERG BIOMEMBR, V23, P83; MERRILL AH, 1989, BIOCHIM BIOPHYS ACTA, V1010, P131, DOI 10.1016/0167-4889(89)90152-3; MERRILL AH, 1986, J BIOL CHEM, V261, P2610; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V176, P339, DOI 10.1016/0005-2760(69)90192-1; NUTTER LM, 1987, CANCER RES, V47, P4407; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OISHI K, 1988, J BIOL CHEM, V263, P6865; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; ROSENWALD AG, 1993, J BIOL CHEM, V268, P4577; SHAPIRO D, 1961, J AM CHEM SOC, V83, P3327, DOI 10.1021/ja01476a033; STEVENS VL, 1989, CANCER RES, V49, P3229; SUGITA M, 1975, BIOCHIM BIOPHYS ACTA, V398, P125, DOI 10.1016/0005-2760(75)90176-9; WERTZ PW, 1990, FEBS LETT, V268, P110, DOI 10.1016/0014-5793(90)80985-R; WERTZ PW, 1987, J INVEST DERMATOL, V89, P419, DOI 10.1111/1523-1747.ep12471781; WERTZ PW, 1989, BIOCHIM BIOPHYS ACTA, V1002, P213, DOI 10.1016/0005-2760(89)90289-0; WERTZ PW, 1990, J INVEST DERMATOL, V94, P159, DOI 10.1111/1523-1747.ep12874122; WILSON E, 1986, J BIOL CHEM, V261, P2616; YADA Y, 1991, BIOCHEM J, V279, P665, DOI 10.1042/bj2790665; YAVIN E, 1969, BIOCHEMISTRY-US, V8, P1692, DOI 10.1021/bi00832a052	43	56	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12677	12684		10.1074/jbc.270.21.12677	http://dx.doi.org/10.1074/jbc.270.21.12677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759519	hybrid			2022-12-27	WOS:A1995QZ71100055
J	SILBERG, DG; WANG, W; MOSELEY, RH; TRABER, PG				SILBERG, DG; WANG, W; MOSELEY, RH; TRABER, PG			THE DOWN-REGULATED IN ADENOMA (DRA) GENE ENCODES AN INTESTINE-SPECIFIC MEMBRANE SULFATE TRANSPORT PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; SUCRASE-ISOMALTASE; BASOLATERAL MEMBRANE; HUMAN-COLON; COLORECTAL TUMORIGENESIS; RABBIT ILEUM; VESICLES; EXPRESSION; EXCHANGE; MUCOSA	A gene has been described, Down Regulated in. Adenoma (dra), which is expressed in normal colon but is absent in the majority of colon adenomas and adenocarcinomas, However, the function of this protein is unknown. Because of sequence similarity to a recently cloned membrane sulfate transporter in rat liver, the transport function of Bra was examined. We established that dra encodes for a Na+-independent transporter for both sulfate and oxalate using microinjected Xenopus oocytes as an assay system. Sulfate transport was sensitive to the anion exchange inhibitor BIBS (4,4'-diisothiocyano-2,2'disulfonic acid stilbene). Using an RNase protection assay, we found that dra mRNA expression is limited to the small intestine and colon in mouse, there fore identifying Dra as an intestine specific sulfate transporter, dra also had a unique pattern of expression during intestinal development. Northern blot analysis revealed a low level of expression in colon at birth with a marked increase in the first 2 postnatal weeks. In contrast, there was a lower, constant level of expression in small intestine in the postnatal period. Caco-2 cells, a colon carcinoma cell line that differentiates over time in culture, demonstrated a marked induction of dra mRNA as cells progressed from the preconfluent (undifferentiated) to the postconfluent (differentiated) state. These results show that Dra is an intestine-specific Na+-inde pendent sulfate transporter that has differential expression during colonic development. This functional characterization provides the foundation for investigation of the role of Dra in intestinal sulfate transport and in the malignant phenotype.	UNIV PENN,DEPT MED & GENET,PHILADELPHIA,PA 19104; UNIV MICHIGAN,DEPT MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,VET AFFAIRS MED CTR,ANN ARBOR,MI 48109	University of Pennsylvania; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066, R01DK046704] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07066, R01 DK46704] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHEARN GA, 1984, J MEMBRANE BIOL, V78, P177, DOI 10.1007/BF01925966; BATT ER, 1969, AM J PHYSIOL, V217, P1101, DOI 10.1152/ajplegacy.1969.217.4.1101; BEAULIEU JF, 1990, GASTROENTEROLOGY, V98, P1467, DOI 10.1016/0016-5085(90)91077-J; BISSIG M, 1994, J BIOL CHEM, V269, P3017; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CZERNICHOW B, 1989, INT J CANCER, V44, P238, DOI 10.1002/ijc.2910440209; DOBBINS JW, 1977, NEW ENGL J MED, V296, P298, DOI 10.1056/NEJM197702102960602; ELGAVISH A, 1991, AM J PHYSIOL, V260, pL450, DOI 10.1152/ajplung.1991.260.6.L450; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FILIPE MI, 1969, GUT, V10, P577, DOI 10.1136/gut.10.7.577; FILIPE MI, 1974, CANCER-AM CANCER SOC, V34, P282, DOI 10.1002/1097-0142(197408)34:2<282::AID-CNCR2820340211>3.0.CO;2-W; HAGENBUCH B, 1985, PFLUG ARCH EUR J PHY, V405, P202, DOI 10.1007/BF00582561; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HEDRICK L, 1994, GENE DEV, V8, P1174, DOI 10.1101/gad.8.10.1174; KNICKELBEIN RG, 1985, J MEMBRANE BIOL, V88, P199, DOI 10.1007/BF01868433; KNICKELBEIN RG, 1990, AM J PHYSIOL, V259, pG807, DOI 10.1152/ajpgi.1990.259.5.G807; KUO SM, 1988, J BIOL CHEM, V263, P9710; LANGRIDGESMITH JE, 1983, J MEMBRANE BIOL, V72, P131, DOI 10.1007/BF01870320; LAPIS K, 1990, Tokai Journal of Experimental and Clinical Medicine, V15, P155; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MARKOVICH D, 1994, J BIOL CHEM, V269, P3022; MARKOVICH D, 1993, P NATL ACAD SCI USA, V90, P8073, DOI 10.1073/pnas.90.17.8073; MARKOWITZ AJ, 1993, AM J PHYSIOL, V265, pG526, DOI 10.1152/ajpgi.1993.265.3.G526; MEIER PJ, 1987, AM J PHYSIOL, V253, pG461, DOI 10.1152/ajpgi.1987.253.4.G461; NATAMURA N, 1981, CANCER RES, V41, P278; PALACIN M, 1990, J BIOL CHEM, V265, P7142; PINTO M, 1983, BIOL CELL, V47, P323; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; PRITCHARD JB, 1983, P NATL ACAD SCI-BIOL, V80, P2603, DOI 10.1073/pnas.80.9.2603; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SANDAL NN, 1994, TRENDS BIOCHEM SCI, V19, P19, DOI 10.1016/0968-0004(94)90168-6; SCHRON CM, 1987, AM J PHYSIOL, V253, pG404, DOI 10.1152/ajpgi.1987.253.3.G404; SCHRON CM, 1985, AM J PHYSIOL, V249, pG607, DOI 10.1152/ajpgi.1985.249.5.G607; SCHRON CM, 1985, AM J PHYSIOL, V249, pG614, DOI 10.1152/ajpgi.1985.249.5.G614; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; SHAMSUDDIN AKM, 1981, J NATL CANCER I, V66, P413; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; TRABER PG, 1992, AM J PHYSIOL, V262, pG123, DOI 10.1152/ajpgi.1992.262.1.G123; TRIADOU N, 1985, PEDIATR RES, V19, P136, DOI 10.1203/00006450-198501000-00035; VIRCA GD, 1990, BIOTECHNIQUES, V8, P370; VONDIPPE P, 1982, J BIOL CHEM, V257, P4381; WILTZ O, 1991, GASTROENTEROLOGY, V100, P1266; WILTZ O, 1990, SURGERY, V108, P269; YAMORI T, 1987, CANCER RES, V47, P2741; ZWEIBAUM A, 1983, INT J CANCER, V32, P407, DOI 10.1002/ijc.2910320403	47	125	131	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11897	11902		10.1074/jbc.270.20.11897	http://dx.doi.org/10.1074/jbc.270.20.11897			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744840	hybrid			2022-12-27	WOS:A1995QY73600036
J	LALA, AK; RAJA, SM				LALA, AK; RAJA, SM			PHOTOLABELING OF A PORE-FORMING TOXIN WITH THE HYDROPHOBIC PROBE 2-[H-3]DIAZOFLUORENE - IDENTIFICATION OF MEMBRANE-INSERTED SEGMENTS OF STAPHYLOCOCCUS-AUREUS ALPHA-TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LIPOSOME MEMBRANE; 3-DIMENSIONAL STRUCTURE; CHANNEL; PROTEINS; HEMOLYSIN; PURIFICATION; PENETRATION; RESOLUTION; PHOTOLYSIS	The identification of membrane-inserted segments of pore-forming soluble proteins is crucial to understanding the action of these proteins at the molecular level. A distinct member of this class of proteins is alpha-toxin, a 293-amino acid long 33-kDa hemolytic toxin secreted by Staphylococcus aureus that can form pores in both artificial and natural membranes, We have studied the interaction of alpha-toxin with single bilayer vesicles prepared from asolectin using a hydrophobic photoactivable reagent, 2-[H-3]diazofluorene ([H-3]DAF) (Pradhan, D., and Lala, A. K. (1987) J, Biol, Chem, 262, 8242-8251), This reagent readily partitions into the membrane hydrophobic core and on photolysis labels the lipid and protein segments that penetrate the membrane. Current models on the mode of action of alpha-toxin indicate that, on interaction with membranes, alpha-toxin forms an oligomer, which represents the active pore. Ln keeping with these models, we observe that [H-3]DAF photolabels the membrane-bound alpha-toxin oligomer. Cyanogen bromide fragmentation of [H-3]DAF-labeled alpha-toxin gave several fragments, which were subjected to Edman degradation, We could thus sequence residues 1-19, 35-60, 114-139, 198-231, and 235-258, Radioactive analysis and phenylthiohydantoin-derivative analysis during sequencing permitted analysis of DAF insertion sites, The results obtained indicated that the N and C termini (residues 235-258) have been extensively labeled. The putative pore-forming glycine-rich central hinge region was poorly labeled, indicating that the apposing side of the lumen of the pore does not form the lipid-protein interface, The DAF labeling pattern indicated that the major structural motif in membrane-bound alpha-toxin was largely beta-sheet.	INDIAN INST TECHNOL, DEPT CHEM, BIOMEMBRANE LAB, BOMBAY 400076, MAHARASHTRA, INDIA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay								ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; AMES BN, 1960, J BIOL CHEM, V235, P769; ANJANEYULU PSR, 1984, P INDIAN AS-CHEM SCI, V93, P1229; ANJANEYULU PSR, 1984, INDIAN J CHEM B, V23, P802; BHAKDI S, 1981, P NATL ACAD SCI-BIOL, V78, P5475, DOI 10.1073/pnas.78.9.5475; BHAKDI S, 1989, INFECT IMMUN, V57, P3512, DOI 10.1128/IAI.57.11.3512-3519.1989; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; BRUNNER J, 1989, FEBS LETT, V257, P369, DOI 10.1016/0014-5793(89)81574-1; BRUNNER J, 1989, METHOD ENZYMOL, V172, P628; BRUNNER J, 1981, TRENDS BIOCHEM SCI, V6, P44, DOI 10.1016/0968-0004(81)90017-7; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; BUCKELEW AR, 1971, BIOCHIM BIOPHYS ACTA, V233, P7, DOI 10.1016/0005-2736(71)90352-X; CEUNEBROECK JCV, 1986, BIOCHEM BIOPH RES CO, V138, P604; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DUMONT ME, 1988, J BIOL CHEM, V263, P2087; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; FREER JH, 1968, J BACTERIOL, V95, P1153, DOI 10.1128/JB.95.3.1153-1168.1968; FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; GRASSE PB, 1983, J AM CHEM SOC, V105, P6833, DOI 10.1021/ja00361a014; GRAY GS, 1984, INFECT IMMUN, V46, P615, DOI 10.1128/IAI.46.2.615-618.1984; GROSS E, 1962, J BIOL CHEM, V237, P1856; HARSHMAN S, 1989, J BIOL CHEM, V264, P14978; HARSHMAN S, 1988, METHOD ENZYMOL, V165, P3; IKIGAI H, 1987, J BIOL CHEM, V262, P2150; IKIGAI H, 1985, BIOCHEM BIOPH RES CO, V130, P175, DOI 10.1016/0006-291X(85)90398-5; JAP BK, 1991, NATURE, V350, P167, DOI 10.1038/350167a0; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KEHOE M, 1983, INFECT IMMUN, V41, P1105, DOI 10.1128/IAI.41.3.1105-1111.1983; KOCHI SK, 1994, BIOCHEMISTRY-US, V33, P2604, DOI 10.1021/bi00175a032; KREBS J, 1984, BIOCHEMISTRY-US, V23, P400, DOI 10.1021/bi00298a002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALA AK, 1990, BIOTECHNOL APPL BIOC, V12, P586; LALA AK, 1990, PURE APPL CHEM, V62, P1453, DOI 10.1351/pac199062071453; LALA AK, 1992, J BIOL CHEM, V267, P19914; LEAR JD, 1987, J BIOL CHEM, V262, P6500; LIND I, 1987, ANAL BIOCHEM, V164, P84, DOI 10.1016/0003-2697(87)90371-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MENESTRINA G, 1986, J MEMBRANE BIOL, V90, P177, DOI 10.1007/BF01869935; Montecucco C., 1988, METHOD ENZYMOL, V165, P347; MOZDZANOWSKI J, 1992, ANAL BIOCHEM, V207, P11, DOI 10.1016/0003-2697(92)90492-P; OLOFSSON A, 1990, J MOL BIOL, V214, P299, DOI 10.1016/0022-2836(90)90162-F; OLOFSSON A, 1988, J ULTRA MOL STRUCT R, V100, P194, DOI 10.1016/0889-1605(88)90026-2; PALMER M, 1993, J BIOL CHEM, V268, P11959; PALMER M, 1993, J BIOL CHEM, V268, P11963; PRADHAN D, 1987, J BIOL CHEM, V262, P8242; RUZICKA J, 1992, J AM CHEM SOC, V114, P897, DOI 10.1021/ja00029a016; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; THELESTAM M, 1988, TOXICON, V26, P51, DOI 10.1016/0041-0101(88)90137-7; THELESTAM M, 1983, BIOCHEM BIOPH RES CO, V111, P444, DOI 10.1016/0006-291X(83)90326-1; TOBKES N, 1985, BIOCHEMISTRY-US, V24, P1915, DOI 10.1021/bi00329a017; TOMITA T, 1992, BIOCHIM BIOPHYS ACTA, V1104, P325, DOI 10.1016/0005-2736(92)90047-P; TOMITA T, 1993, BIOCHIM BIOPHYS ACTA, V1145, P51, DOI 10.1016/0005-2736(93)90380-I; TOMITA T, 1992, J BIOL CHEM, V267, P13391; WALKER B, 1993, J BIOL CHEM, V268, P5285; WALKER B, 1992, J BIOL CHEM, V267, P10902; WALKER B, 1992, J BIOL CHEM, V267, P21782; WALKER B, 1994, PROTEIN ENG, V7, P655, DOI 10.1093/protein/7.5.655; WARD RJ, 1994, BIOCHEMISTRY-US, V33, P7477, DOI 10.1021/bi00189a056; WATANABE M, 1987, BIOCHIM BIOPHYS ACTA, V898, P257, DOI 10.1016/0005-2736(87)90065-4; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009	63	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11348	11357		10.1074/jbc.270.19.11348	http://dx.doi.org/10.1074/jbc.270.19.11348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744772	hybrid			2022-12-27	WOS:A1995QX86500049
J	SALEEM, A; KHARBANDA, S; YUAN, ZM; KUFE, D				SALEEM, A; KHARBANDA, S; YUAN, ZM; KUFE, D			MONOCYTE COLONY-STIMULATING FACTOR STIMULATES BINDING OF PHOSPHATIDYLINOSITOL 3-KINASE TO GRB2-CENTER-DOT-SOS COMPLEXES IN HUMAN MONOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GUANINE-NUCLEOTIDE EXCHANGE; RECEPTOR TYROSINE KINASES; FMS PROTO-ONCOGENE; SIGNAL-TRANSDUCTION; CSF-1 RECEPTOR; FACTOR-I; INSULIN STIMULATION; GROWTH-FACTOR; SH3 DOMAIN; RAS	Monocyte colony-stimulating factor (M-CSF) is required for the proliferation of mononuclear phagocytes. The activated M-CSF receptor associates with phosphatidylinositol 3-kinase (PI 3-kinase). In the present studies, we demonstrate that M-CSF also induces direct interaction of PI 3-kinase (p85 alpha subunit) with the SH2/SH3 adaptor protein Grb2. Tyrosine-phosphorylated PI 3-kinase interacts with the SH2 domain of Grb2. A pYRNE (pY408) site in PI 3-kinase is potentially involved in this interaction. The results also demonstrate that the PI 3-kinase . Grb2 complex associates with the guanine nucleotide exchange protein Sos. Since Sos binds to the SH3 domains of Grb2 and thereby associates with Pas at the cell membrane, formation of the PI 3-kinase . Grb2 . Sos complex provides a potential mechanism for growth factor-induced interactions of PI 3-kinase and Pas.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CANC PHARMACOL,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School					NCI NIH HHS [CA42802] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042802] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; KARNITZ LM, 1994, J EXP MED, V179, P1799, DOI 10.1084/jem.179.6.1799; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; NAKAMURA T, 1992, EMBO J, V11, P4917, DOI 10.1002/j.1460-2075.1992.tb05598.x; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SARIBAN E, 1985, NATURE, V316, P64, DOI 10.1038/316064a0; SHERR CJ, 1991, TRENDS GENET, V7, P398, DOI 10.1016/0168-9525(91)90263-P; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; SJOLANDER A, 1991, P NATL ACAD SCI USA, V88, P7908, DOI 10.1073/pnas.88.18.7908; SJOLANDER A, 1992, BIOCHEM BIOPH RES CO, V169, P1503; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SUNG CK, 1994, J BIOL CHEM, V269, P12503; SUSA M, 1992, J BIOL CHEM, V267, P6905; VANDERGEER P, 1991, MOL CELL BIOL, V11, P4698, DOI 10.1128/MCB.11.9.4698; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; VANDERGEER P, 1990, MOL CELL BIOL, V10, P2991, DOI 10.1128/MCB.10.6.2991; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; YAMAUCHI K, 1993, J BIOL CHEM, V268, P14597	32	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10380	10383		10.1074/jbc.270.18.10380	http://dx.doi.org/10.1074/jbc.270.18.10380			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737969				2022-12-27	WOS:A1995QW60100006
J	MASSON, L; MAZZA, A; BROUSSEAU, R; TABASHNIK, B				MASSON, L; MAZZA, A; BROUSSEAU, R; TABASHNIK, B			KINETICS OF BACILLUS-THURINGIENSIS TOXIN BINDING WITH BRUSH-BORDER MEMBRANE-VESICLES FROM SUSCEPTIBLE AND RESISTANT LARVAE OF PLUTELLA-XYLOSTELLA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; PLANAR LIPID BILAYERS; DELTA-ENDOTOXINS; HELIOTHIS-VIRESCENS; SELECTIVE CHANNELS; INSECT RESISTANCE; MIDGUT; SPECIFICITY; MECHANISM; PROTEINS	An optical biosensor technology based on surface plasmon resonance was used to determine the kinetic rate constants for interactions between the CryIA(c) toxin from Bacillus thuringiensis and brush border membrane vesicles purified from susceptible and resistant larvae of diamondback moth (Plutella xylostella). CryIA(c) association and dissociation rate constants for vesicles from susceptible larvae were determined to be 4.5 x 10(3) M(-1) s(-1) and 3.2 x 10(-5) s(-1), respectively, resulting in a calculated affinity constant of 7 nM. CryIE toxin did not kill susceptible or resistant larvae and did not bind to brush border vesicles. Contrary to expectations based on previous studies of binding in resistant P. xylostella, the binding kinetics for CryIA(c) did not differ significantly between susceptible larvae and those that were resistant to CryIA(c). Determination of the number of CryIA(c) receptors revealed an approximately 3-fold decrease in total CryIA(c) receptor numbers for resistant vesicles. These results suggest that factors other than binding may be altered in our resistant diamond-back moth strain. They also support the view that binding is not sufficient for toxicity.	UNIV HAWAII, DEPT ENTOMOL, HONOLULU, HI 96822 USA	University of Hawaii System	MASSON, L (corresponding author), NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, 6100 ROYALMOUNT AVE, MONTREAL, PQ H4P 2R2, CANADA.							Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; [Anonymous], PATHOGENSIS INVERTEB; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BIBER J, 1981, BIOCHIM BIOPHYS ACTA, V647, P169, DOI 10.1016/0005-2736(81)90243-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAVO A, 1992, J INVERTEBR PATHOL, V60, P237, DOI 10.1016/0022-2011(92)90004-N; Entwistle P., 1993, BACILLUS THURINGIENS; FEITELSON JS, 1992, BIO-TECHNOL, V10, P271, DOI 10.1038/nbt0392-271; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; GARCZYNSKI SF, 1991, APPL ENVIRON MICROB, V57, P2816, DOI 10.1128/AEM.57.10.2816-2820.1991; GARCZYNSKI SF, 1995, IN PRESS INSECT BIOC; GOULD F, 1992, P NATL ACAD SCI USA, V89, P7986, DOI 10.1073/pnas.89.17.7986; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; LAMBERT B, 1992, BIOSCIENCE, V42, P112, DOI 10.2307/1311652; LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526; MACINTOSH SC, 1991, P NATL ACAD SCI USA, V88, P8930, DOI 10.1073/pnas.88.20.8930; MASSON L, 1990, BIOCHEM J, V269, P507, DOI 10.1042/bj2690507; MASSON L, 1994, ANAL BIOCHEM, V218, P405, DOI 10.1006/abio.1994.1199; MCGAUGHEY WH, 1992, SCIENCE, V258, P1451, DOI 10.1126/science.258.5087.1451; OPPERT B, 1994, BIOCHEM BIOPH RES CO, V198, P940, DOI 10.1006/bbrc.1994.1134; RODGERS PB, 1993, PESTIC SCI, V39, P117, DOI 10.1002/ps.2780390205; RYERSE JS, 1990, J INVERTEBR PATHOL, V56, P86, DOI 10.1016/0022-2011(90)90148-Y; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53, DOI 10.1007/BF00233051; SCHWARTZ JL, 1991, BIOCHIM BIOPHYS ACTA, V1065, P250, DOI 10.1016/0005-2736(91)90237-3; SLATIN SL, 1990, BIOCHEM BIOPH RES CO, V169, P765, DOI 10.1016/0006-291X(90)90397-6; TABASHNIK BE, 1993, APPL ENVIRON MICROB, V59, P1332, DOI 10.1128/AEM.59.5.1332-1335.1993; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P49, DOI 10.1093/jee/84.1.49; TABASHNIK BE, 1995, J ECON ENTOMOL, V88, P219, DOI 10.1093/jee/88.2.219; TABASHNIK BE, 1994, APPL ENVIRON MICROB, V60, P4627, DOI 10.1128/AEM.60.12.4627-4629.1994; TUPPY HANS, 1962, ZEIT PHYSIOL CHEM, V329, P278; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; WALTERS FS, 1993, BIOCHEM BIOPH RES CO, V196, P921, DOI 10.1006/bbrc.1993.2337; WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; WOLFERSBERGER MG, 1990, EXPERIENTIA, V46, P475, DOI 10.1007/BF01954236	45	64	69	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11887	11896		10.1074/jbc.270.20.11887	http://dx.doi.org/10.1074/jbc.270.20.11887			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744839	hybrid			2022-12-27	WOS:A1995QY73600035
J	OKAMOTO, S; NAKAMURA, K; NIHIRA, T; YAMADA, Y				OKAMOTO, S; NAKAMURA, K; NIHIRA, T; YAMADA, Y			VIRGINIAE BUTANOLIDE BINDING-PROTEIN FROM STREPTOMYCES-VIRGINIAE - EVIDENCE THAT VBRA IS NOT THE VIRGINIAE BUTANOLIDE BINDING-PROTEIN AND REIDENTIFICATION OF THE TRUE BINDING-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-FACTOR; ANTHRACYCLINE BIOSYNTHESIS; CLONED GENES; IDENTIFICATION; PURIFICATION; GRISEUS; INDUCER; CLONING; VECTORS; STREPTOMYCES-COELICOLOR-A3(2)	Virginiae butanolides (VBs) A-E are butyrolactone autoregulators that control virginiamycin production in Streptomyces virginiae. We have previously reported the purification and molecular cloning of VbrA, a putative VB binding protein (Okamoto, S., Nihira, T., Kataoka, H., Suzuki, A., and Yamada, Y. (1992) J. Biol. Chem. 267, 1093-1098). However, VbrA protein overexpressed in Escherichia coli did not show any detectable VB binding activity nor did the immunoprecipitation of native VbrA from a cell-free extract of S. virginiae cause any decrease in such activity, indicating that VbrA is not the true VB binding protein. This finding prompted us to seek the true VB binding protein by repurification. After successive purification by anion exchange, gel filtration, heparin, and hydrophobic interaction chromatography, a 26-kDa protein (p26k) was identified as the true VB binding protein. Partial amino acid sequences of p26k were determined, and the gene (barA) that encodes this protein was isolated and cloned using degenerate oligonucleotide probes. When the barA gene was expressed in Streptomyces lividans and E. coli, strong VB binding activity appeared, demonstrating unambiguously that the S. virginiae p26k protein is the true VB binding protein.	OSAKA UNIV,FAC ENGN,DEPT BIOTECHNOL,SUITA,OSAKA 565,JAPAN	Osaka University			岡本, 晋/O-8583-2015	岡本, 晋/0000-0001-5225-2689				AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; CHATER KF, 1989, REGULATION OF PROCARYOTIC DEVELOPMENT, P277; GRAFE U, 1983, BIOTECHNOL LETT, V5, P591, DOI 10.1007/BF00130838; GRAFE U, 1982, J ANTIBIOT, V35, P1722, DOI 10.7164/antibiotics.35.1722; HARA O, 1982, J ANTIBIOT, V35, P349, DOI 10.7164/antibiotics.35.349; HARA O, 1983, J GEN MICROBIOL, V129, P2939; HOPWOOD DA, 1988, PROC R SOC SER B-BIO, V235, P121, DOI 10.1098/rspb.1988.0067; HOPWOOD DA, 1985, GENETIC MANIPULATION, P70; HORINOUCHI S, 1983, J BACTERIOL, V155, P1238, DOI 10.1128/JB.155.3.1238-1248.1983; HORINOUCHI S, 1992, ANNU REV MICROBIOL, V46, P377, DOI 10.1146/annurev.micro.46.1.377; Khokhlov A. S., 1980, FRONTIERS BIOORGANIC, P201; KIM HS, 1990, J ANTIBIOT, V43, P692, DOI 10.7164/antibiotics.43.692; KIM HS, 1989, J ANTIBIOT, V42, P769, DOI 10.7164/antibiotics.42.769; KONDO K, 1989, J ANTIBIOT, V42, P1873, DOI 10.7164/antibiotics.42.1873; MIYAKE K, 1989, J BACTERIOL, V171, P4298, DOI 10.1128/JB.171.8.4298-4302.1989; MIZUNO K, 1994, TETRAHEDRON, V50, P10849, DOI 10.1016/S0040-4020(01)85697-0; MORI K, 1983, TETRAHEDRON, V39, P3107, DOI 10.1016/S0040-4020(01)91552-2; NIHIRA T, 1988, J ANTIBIOT, V41, P1828, DOI 10.7164/antibiotics.41.1828; OKAMOTO S, 1992, J BIOL CHEM, V267, P1093; PUTTIKHUNT C, 1993, FEMS MICROBIOL LETT, V110, P243, DOI 10.1111/j.1574-6968.1993.tb06327.x; RAO RN, 1987, METHOD ENZYMOL, V153, P166; RUENGJITCHATCHA.M, 1995, J BACTERIOL, V177, P551; SAKUDA S, 1991, TETRAHEDRON LETT, V32, P1817, DOI 10.1016/S0040-4039(00)74338-3; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO K, 1992, J FERMENT BIOENG, V68, P170; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; WARD JM, 1986, MOL GEN GENET, V203, P468, DOI 10.1007/BF00422072; YAMADA Y, 1987, J ANTIBIOT, V40, P496, DOI 10.7164/antibiotics.40.496; YAMADA Y, 1992, ACTINOMYCETOLOGICA, V6, P1	32	61	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12319	12326		10.1074/jbc.270.20.12319	http://dx.doi.org/10.1074/jbc.270.20.12319			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744885	hybrid			2022-12-27	WOS:A1995QY73600090
J	BOURBON, HM; MARTINBLANCO, E; ROSEN, D; KORNBERG, TB				BOURBON, HM; MARTINBLANCO, E; ROSEN, D; KORNBERG, TB			PHOSPHORYLATION OF THE DROSOPHILA ENGRAILED PROTEIN AT A SITE OUTSIDE ITS HOMEODOMAIN ENHANCES DNA-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; GLYCOGEN-SYNTHASE KINASE-3; ANTENNAPEDIA HOMEODOMAIN; INVITRO TRANSCRIPTION; MOLECULAR MECHANISM; RNA-POLYMERASE; GENE; EXPRESSION; MELANOGASTER; ACTIVATION	The engrailed gene encodes a homeodomain-containing phosphoprotein that binds DNA. Here, we show that engrailed protein is posttranslationally modified in embryos and in embryo derived cultured cells but is essentially unmodified when expressed in Escherichia coli, Engrailed protein produced by bacteria can be phosphorylated in nuclear extracts prepared from Drosophila embryos, and phosphotryptic peptides from this modified protein partly reproduce two-dimensional maps of phosphotryptic fragments obtained from metabolically labeled engrailed protein. The primary embryonic protein kinase modifying engrailed protein is casein kinase II (CK-II), Analysis of mutant proteins revealed that the in vitro phosphoacceptors are mainly clustered in a region outside the engrailed homeodomain and identified serines 394, 397, 401, and 402 as the targets for CK-II phosphorylation. CK-II-dependent phosphorylation of an N-truncated derivative of engrailed protein purified from bacteria increased its DNA binding 2-4-fold.	UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco			Martin-Blanco, Enrique/ABH-1280-2020	Martin-Blanco, Enrique/0000-0002-6926-910X				AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; BIGGIN MD, 1989, CELL, V58, P433, DOI 10.1016/0092-8674(89)90424-8; BOUROUIS M, 1990, EMBO J, V9, P2877, DOI 10.1002/j.1460-2075.1990.tb07477.x; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DAHMUS GK, 1984, J BIOL CHEM, V259, P9001; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; EKKER SC, 1991, EMBO J, V10, P1179, DOI 10.1002/j.1460-2075.1991.tb08058.x; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; GAVIS ER, 1991, DEVELOPMENT, V112, P1077; GAY NJ, 1988, EMBO J, V7, P4291, DOI 10.1002/j.1460-2075.1988.tb03327.x; GAY NJ, 1988, NUCLEIC ACIDS RES, V16, P6637, DOI 10.1093/nar/16.14.6637; GLOVER CVC, 1983, J BIOL CHEM, V258, P3258; GOUTTE C, 1993, J MOL BIOL, V233, P359, DOI 10.1006/jmbi.1993.1517; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; HU ED, 1990, J BIOL CHEM, V265, P5072; ISSINGER OG, 1993, PHARMACOL THERAPEUT, V59, P1, DOI 10.1016/0163-7258(93)90039-G; JOHNSON FB, 1990, GENE DEV, V4, P1044, DOI 10.1101/gad.4.6.1044; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KORNBERG T, 1981, DEV BIOL, V86, P363, DOI 10.1016/0012-1606(81)90194-9; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; KRAUSE HM, 1989, EMBO J, V8, P1197, DOI 10.1002/j.1460-2075.1989.tb03492.x; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; Lawrence P., 1992, MAKING FLY GENETICS; LAWRENCE PA, 1976, DEV BIOL, V50, P321, DOI 10.1016/0012-1606(76)90155-X; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LOPEZ AJ, 1991, P NATL ACAD SCI USA, V88, P9924, DOI 10.1073/pnas.88.22.9924; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MANAK JR, 1990, GENE DEV, V4, P955, DOI 10.1101/gad.4.6.955; MARCHIORI F, 1988, BIOCHIM BIOPHYS ACTA, V971, P332; MEGGIO F, 1989, EUR J BIOCHEM, V186, P459, DOI 10.1111/j.1432-1033.1989.tb15229.x; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; ODENWALD WF, 1989, GENE DEV, V3, P158, DOI 10.1101/gad.3.2.158; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OHKUMA Y, 1990, CELL, V61, P475, DOI 10.1016/0092-8674(90)90529-N; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; POOLE SJ, 1988, MECHANISMS SEGMENTAT, P85; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SCHIER AF, 1992, NATURE, V356, P804, DOI 10.1038/356804a0; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; STARK MR, 1994, NATURE, V371, P429, DOI 10.1038/371429a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; THEROND P, 1993, MECH DEVELOP, V44, P65, DOI 10.1016/0925-4773(93)90017-R; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; WARD G, 1990, CELL, V81, P561; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	61	53	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11130	11139		10.1074/jbc.270.19.11130	http://dx.doi.org/10.1074/jbc.270.19.11130			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744743	hybrid			2022-12-27	WOS:A1995QX86500019
J	BRUNN, GJ; FALLS, EL; NILSON, AE; ABRAHAM, RT				BRUNN, GJ; FALLS, EL; NILSON, AE; ABRAHAM, RT			PROTEIN-TYROSINE KINASE-DEPENDENT ACTIVATION OF STAT TRANSCRIPTION FACTORS IN INTERLEUKIN-2-STIMULATED OR INTERLEUKIN-4-STIMULATED T-LYMPHOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; RECEPTOR GAMMA-CHAIN; DNA-BINDING PROTEINS; MUTANT-CELL LINE; INTERFERON-GAMMA; GROWTH-FACTOR; IL-2 RECEPTOR; PHOSPHORYLATION; ALPHA/BETA; JAK2	The proliferation of activated T lymphocytes is critically dependent on the binding of the T-cell growth factors, interleukin (IL)-2 and IL-4, to distinct but evolutionarily related cell surface receptors. Previous results suggest that the IL-2 receptor (IL-2R) and IL-4R are coupled to both overlapping and distinct intracellular signaling pathways in T lymphocytes. In this study, we demonstrate that activation of Janus tyrosine kinases (JAKs) and STAT transcription factors is rapidly induced by exposure of factor-dependent murine T cell lines to IL-2 or IL-4, Both IL-2 and IL-4 stimulated the rapid activation of JAK1 and JAK3, whereas JAK2 activity was unaffected by either cytokine. These responses were accompanied by the appearance in cell nuclei of 3 DNA binding activities that recognized a high-affinity binding site for STAT factors, In transient transfection assays, this STAT factor target sequence conferred IL-2 and IL-4 inducibility on a synthetic luciferase reporter gene, Antibody supershifting experiments indicated that IL-2 induces the formation of STAT dimers containing STATE and STAT1 alpha. Although IL-4 also activated STAT1 alpha, the major IL4-induced STAT factor is not STAT3 and remains undefined, Pretreatment of the T-cells with the protein-tyrosine kinase inhibitor herbimycin A blocked both the nuclear translocation of STAT factors and STAT-dependent reporter gene transcription, Immunoblot analyses confirmed that cytoplasmic STAT3 was heavily phosphorylated on tyrosine in IL-a-stimulated cells, and that phosphorylated STAT3 appeared in the nuclei of these cells, These results indicate that identical JAKs and partially overlapping sets of STATs are activated by IL-2 and IL-4 in T lymphocytes.	MAYO CLIN & MAYO FDN,DEPT PHARMACOL,ROCHESTER,MN 55905	Mayo Clinic	BRUNN, GJ (corresponding author), MAYO CLIN & MAYO FDN,DEPT IMMUNOL,RM 342B GUGGENHEIM BLDG,ROCHESTER,MN 55905, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034577, U19AI034577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047286] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34577] Funding Source: Medline; NIGMS NIH HHS [GM47286] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM RT, 1986, J TISSUE CULTURE MET, V10, P93; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; AUGUSTINE JA, 1990, BIOCHIM BIOPHYS ACTA, V1052, P313, DOI 10.1016/0167-4889(90)90227-5; BOULAY JL, 1992, J BIOL CHEM, V267, P20525; BURNS LA, 1993, J BIOL CHEM, V268, P17659; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DURONIO V, 1992, P NATL ACAD SCI USA, V89, P1587, DOI 10.1073/pnas.89.5.1587; FARRAR WL, 1989, J BIOL CHEM, V264, P12562; FERNANDEZBOTRAN R, 1986, J EXP MED, V164, P580, DOI 10.1084/jem.164.2.580; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Howard Maureen C., 1993, P763; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; IZQUIERDO M, 1993, EUR J IMMUNOL, V23, P131, DOI 10.1002/eji.1830230121; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; KOBAYASHI N, 1993, P NATL ACAD SCI USA, V90, P4201, DOI 10.1073/pnas.90.9.4201; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Kono T, 1993, Semin Immunol, V5, P299, DOI 10.1006/smim.1993.1036; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; RAZ R, 1994, J BIOL CHEM, V269, P24391; ROTHMAN P, 1994, IMMUNITY, V1, P457, DOI 10.1016/1074-7613(94)90088-4; RUEGEMER JJ, 1990, J IMMUNOL, V144, P1767; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SALTZMAN EM, 1988, J BIOL CHEM, V263, P6956; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SILVENNOINEN O, 1993, SCIENCE, V261, P1736, DOI 10.1126/science.8378775; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; YIN TG, 1994, J BIOL CHEM, V269, P26614; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806	54	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11628	11635		10.1074/jbc.270.19.11628	http://dx.doi.org/10.1074/jbc.270.19.11628			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744803	hybrid			2022-12-27	WOS:A1995QX86500085
J	SEKIGUCHI, J; SHUMAN, S				SEKIGUCHI, J; SHUMAN, S			PROTEOLYTIC FOOTPRINTING OF VACCINIA TOPOISOMERASE BOUND TO DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC INTERACTION; ESCHERICHIA-COLI; DUPLEX DNA; BINDING; TYROSINE; CLEAVAGE; PROTEIN	Vaccinia DNA topoisomerase, a member of the eukaryotic type I enzyme family, binds duplex DNA and forms a covalent protein . DNA complex at sites containing a conserved sequence element 5'-CCCTT down arrow. The structure of the enzyme in the free and DNA-bound states was probed by limited proteolysis. The free topoisomerase (a 314-amino acid polypeptide) consists of protease-resistant amino- and carboxyl-terminal structural domains flanking a protease sensitive ''hinge.'' The hinge region, located between residues 135 and 142, is defined by accessibility to three different proteases, The amino-terminal region is punctuated by a trypsin sensitive ''bridge'' at Arg-80, suggesting at least a tripartite domain structure overall, A specific subset of residues accessible to proteases in the free enzyme becomes resistant to proteolysis in the DNA-bound state, The trypsin-sensitive site at Arg-80 is protected almost completely in the covalent complex, Within the hinge region, Lys-135, Tyr-136, and Glu-139 are protected from trypsin, chymotrypsin, and V8, respectively, Acquisition of altered protease sensitivity upon DNA binding occurs prior to covalent adduct formation, The 20-kDa carboxyl domain by itself binds noncovalently to duplex DNA, albeit without the sequence specificity characteristic of the full-sized topoisomerase.	SLOAN KETTERING INST,PROGRAM MOLEC BIOL,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center				Sekiguchi, JoAnn/0000-0002-7178-4258	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046330, R01GM046330] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46330] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cozzarelli N.R., 1990, DNA TOPOLOGY ITS BIO; HANAI R, 1994, P NATL ACAD SCI USA, V91, P11904, DOI 10.1073/pnas.91.25.11904; KEIL B, 1992, SPECIFICITY PROTEOLY, P94; LINDSLEY JE, 1993, NATURE, V361, P749, DOI 10.1038/361749a0; LINDSLEY JE, 1991, P NATL ACAD SCI USA, V88, P10485, DOI 10.1073/pnas.88.23.10485; LYNN RM, 1989, P NATL ACAD SCI USA, V86, P3559, DOI 10.1073/pnas.86.10.3559; MORHAM SG, 1992, J BIOL CHEM, V267, P15984; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; SEKIGUCHI J, 1994, NUCLEIC ACIDS RES, V22, P5360, DOI 10.1093/nar/22.24.5360; SEKIGUCHI J, 1994, J BIOL CHEM, V269, P31731; SHARMA A, 1994, STRUCTURE, V2, P767, DOI 10.1016/S0969-2126(94)00077-8; SHUMAN S, 1991, J BIOL CHEM, V266, P11372; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; SHUMAN S, 1990, J BIOL CHEM, V265, P17826; SHUMAN S, 1993, J BIOL CHEM, V268, P18943; SHUMAN S, 1987, P NATL ACAD SCI USA, V84, P7478, DOI 10.1073/pnas.84.21.7478; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P9793, DOI 10.1073/pnas.86.24.9793; TEMPST P, 1989, ANAL BIOCHEM, V183, P290, DOI 10.1016/0003-2697(89)90482-X; WITTSCHIEBEN J, 1994, J BIOL CHEM, V269, P29978	20	43	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11636	11645		10.1074/jbc.270.19.11636	http://dx.doi.org/10.1074/jbc.270.19.11636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744804	hybrid			2022-12-27	WOS:A1995QX86500086
J	LI, L; MATTHEWS, KS				LI, L; MATTHEWS, KS			CHARACTERIZATION OF MUTANTS AFFECTING THE KRK SEQUENCE IN THE CARBOXYL-TERMINAL DOMAIN OF LAC REPRESSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; OPERATOR DNA COMPLEX; LACTOSE REPRESSOR; PHENOTYPIC SELECTION; PROTEIN; BINDING; MUTATIONS; CLONING	The lac repressor carboxyl-terminal region is required for tetramer assembly and protein stability. To further investigate this region, especially the unusual sequence KRK, four deletion mutants eliminating the carboxyl-terminal 34, 35, 36, and 39 amino acids and five substitution mutants at the position of Arg-326, R326K, R326A, R326E, R326L, and R326W, were constructed using site specific mutagenesis. The -34-amino-acid (aa) mutant, missing the most carboxyl-proximal lysine from the KRK sequence, exhibited lower affinity for both operator and inducer and lower protein stability than dimeric proteins studied previously. The -35-aa mutant with RK missing, as well as -36 aa and -39 aa, for which the entire KRK sequence was deleted, yielded inactive polypeptides that could be detected only by monoclonal antibody for lac repressor. In the Arg-326 mutant proteins, operator binding affinity was decreased by similar to 6-fold, the shift in inducer binding at elevated pH was diminished, and protein stability was decreased. Dramatic decreases in protein expression and stability occurred with substitution at position 326 by glutamate, leucine, or tryptophan. These results suggest that Arg 326 plays an important role in the formation of the proper tertiary structure necessary for inducer and operator affinity and for protein stability.	RICE UNIV,DEPT BIOCHEM & CELL BIOL,HOUSTON,TX 77251	Rice University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM22441] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER K, 1972, NATURE, V237, P322, DOI 10.1038/237322a0; ALBERTI S, 1993, EMBO J, V12, P3227, DOI 10.1002/j.1460-2075.1993.tb05992.x; ALBERTI S, 1991, NEW BIOL, V3, P57; BARKLEY MD, 1975, BIOCHEMISTRY-US, V14, P1700, DOI 10.1021/bi00679a024; BATTEIGER B, 1982, J IMMUNOL METHODS, V55, P297, DOI 10.1016/0022-1759(82)90089-8; BETZ JL, 1986, GENE, V42, P283, DOI 10.1016/0378-1119(86)90232-5; BOURGEOIS S, 1971, METHODS ENZYMOLOGY D, V21, P491; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENOWITZ M, 1991, J BIOL CHEM, V266, P1281; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P1371; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P22206; CHANG WI, 1994, BIOCHEMISTRY-US, V33, P3607, DOI 10.1021/bi00178a018; CHANG WI, 1993, J BIOL CHEM, V268, P17613; CHEN J, 1994, J BIOL CHEM, V269, P12482; CHEN J, 1992, J BIOL CHEM, V267, P13843; CHEN J, 1994, BIOCHEMISTRY-US, V33, P1234, DOI 10.1021/bi00171a025; CHEN J, 1994, BIOCHEMISTRY-US, V33, P8728, DOI 10.1021/bi00195a014; CHEN J, 1993, THESIS RICE U; CULARD F, 1981, NUCLEIC ACIDS RES, V9, P5175, DOI 10.1093/nar/9.19.5175; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5474, DOI 10.1021/bi00367a019; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; HAMADA F, 1973, J BIOCHEM, V73, P1299, DOI 10.1093/oxfordjournals.jbchem.a130204; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JOBE A, 1972, J MOL BIOL, V72, P139, DOI 10.1016/0022-2836(72)90075-7; KISTERSWOIKE B, 1991, EUR J BIOCHEM, V198, P411, DOI 10.1111/j.1432-1033.1991.tb16030.x; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEHMING N, 1990, EMBO J, V9, P615, DOI 10.1002/j.1460-2075.1990.tb08153.x; LEHMING N, 1988, P NATL ACAD SCI USA, V85, P9747; LIN SY, 1975, BIOCHEM BIOPH RES CO, V62, P704, DOI 10.1016/0006-291X(75)90456-8; MATTHEWS KS, 1979, J BIOL CHEM, V254, P3348; MATTHEWS KS, 1987, DNA PROTEIN INTERACT, P13; Miller J. H., 1980, OPERON; MILLER JH, 1979, J MOL BIOL, V131, P249, DOI 10.1016/0022-2836(79)90075-5; MILLER JH, 1979, J MOL BIOL, V131, P191, DOI 10.1016/0022-2836(79)90073-1; Muller-Hill B, 1975, Prog Biophys Mol Biol, V30, P227; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; OGATA RT, 1978, P NATL ACAD SCI USA, V75, P5851, DOI 10.1073/pnas.75.12.5851; OGORMAN RB, 1980, J BIOL CHEM, V255, P107; OGORMAN RB, 1980, J BIOL CHEM, V255, P100; PLATT T, 1973, J BIOL CHEM, V248, P110; RIGGS AD, 1968, J MOL BIOL, V34, P361, DOI 10.1016/0022-2836(68)90260-X; ROYER CA, 1990, BIOCHEMISTRY-US, V29, P4959, DOI 10.1021/bi00472a028; SAMS CF, 1985, J BIOL CHEM, V260, P1185; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCHMITZ A, 1976, J BIOL CHEM, V251, P3359; SCHUMACHER MA, 1993, J BIOL CHEM, V268, P12282; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; WHITSON PA, 1986, BIOCHEMISTRY-US, V25, P3845, DOI 10.1021/bi00361a016; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428	51	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10640	10649		10.1074/jbc.270.18.10640	http://dx.doi.org/10.1074/jbc.270.18.10640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738001	hybrid			2022-12-27	WOS:A1995QW60100044
J	CHAUVAUX, S; SOUCHON, H; ALZARI, PM; CHARIOT, P; BEGUIN, P				CHAUVAUX, S; SOUCHON, H; ALZARI, PM; CHARIOT, P; BEGUIN, P			STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE METAL-BINDING SITES OF CLOSTRIDIUM-THERMOCELLUM ENDOGLUCANASE CELD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUPLICATED SEGMENT; ESCHERICHIA-COLI; CELLULASE; SEQUENCES; FAMILIES; RESIDUES; PROTEINS; DOMAINS	Crystallographic analysis indicated that Clostridium thermocellum endoglucanase CelD contained three Ca2+-binding sites, termed A, B, and C, and one Zn2+ binding site, The protein contributed five, six, and three of the coordinating oxygen atoms present at sites A, B, and C, respectively, Proteins altered by mutation in site A (CelD(D246A)), B (CelD(D361A)), or C (CelD(D523A)) were compared with wild type CelD, The Ca2+-binding isotherm of wad type CelD was compatible with two high affinity sites (K-alpha = 2 x 10(6) M(-1)) and one low affinity site (K alpha < 10(5) M(-1)), The Ca2+-binding isotherms of the mutated proteins showed that sites A and B were the two high affinity sites and that site C was the low affinity site, Atomic absorption spectrometry confirmed the presence of one tightly bound Zn2+ atom per CelD molecule, The inactivation rate of CelD at 75 degrees C was decreased 1.9-fold upon increasing the Ca2+ concentration from 2 x 10(-5) to 10(-3) M. The K-m of CelD was decreased 1.8-fold upon increasing the Ca2+ concentration from 5 x 10(-6) to 10(-4) M. Over similar ranges of concentration, Ca2+ did not affect the thermostability nor the kinetic properties of Cell)D-523A. These findings suggest that Ca2+ binding to site C stabilizes the active conformation of CelD in agreement with the close vicinity of site C to the catalytic center.	INST PASTEUR,UNITE PHYSIOL CELLULAIRE,F-75724 PARIS 15,FRANCE; INST PASTEUR,DEPT BIOTECHNOL,CNRS,URA 1300,F-75724 PARIS 15,FRANCE; INST PASTEUR,UNITE IMMUNOL STRUCT,F-75724 PARIS 15,FRANCE; INST PASTEUR,DEPT IMMUNOL,CNRS,URA 359,F-75724 PARIS 15,FRANCE; HOP HENRI MONDOR,PHARMACOL & TOXICOL SERV,F-94010 CRETEIL,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP			Chariot, Patrick/H-6384-2019	Chariot, Patrick/0000-0001-5556-8814; Beguin, Pierre/0000-0002-5372-6281; Alzari, Pedro/0000-0002-4233-1903				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAUVAUX S, 1992, J BIOL CHEM, V267, P4472; CHAUVAUX S, 1990, BIOCHEM J, V265, P261, DOI 10.1042/bj2650261; Gibson T., 1984, STUDIES EPSTEIN BARR; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; HENRISSAT B, 1993, GENE, V125, P199, DOI 10.1016/0378-1119(93)90329-2; JOLIFF G, 1986, BIO-TECHNOL, V4, P896, DOI 10.1038/nbt1086-896; JUY M, 1992, NATURE, V357, P89, DOI 10.1038/357089a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Lamed R, 1983, BIOTECHNOL BIOENG S, V13, P163; Maniatis T., 1982, MOL CLONING; MERET S, 1971, CLIN CHEM, V17, P369; TOKATLIDIS K, 1991, FEBS LETT, V291, P185, DOI 10.1016/0014-5793(91)81279-H; TOKATLIDIS K, 1991, FEBS LETT, V282, P205, DOI 10.1016/0014-5793(91)80478-L; TOKATLIDIS K, 1993, PROTEIN ENG, V6, P947, DOI 10.1093/protein/6.8.947; TOMME P, 1991, J BIOL CHEM, V266, P10313; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	21	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9757	9762		10.1074/jbc.270.17.9757	http://dx.doi.org/10.1074/jbc.270.17.9757			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730353	Green Published, hybrid			2022-12-27	WOS:A1995QV41700012
J	LU, S; SAYDAK, M; GENTILE, V; STEIN, JP; DAVIES, PJA				LU, S; SAYDAK, M; GENTILE, V; STEIN, JP; DAVIES, PJA			ISOLATION AND CHARACTERIZATION OF THE HUMAN TISSUE TRANSGLUTAMINASE GENE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG LIVER TRANSGLUTAMINASE; BLOOD-COAGULATION FACTOR; CROSS-LINKED ENVELOPE; AMINO-ACID SEQUENCE; HUMAN FACTOR-XIII; KERATINOCYTE TRANSGLUTAMINASE; TERMINAL DIFFERENTIATION; EXPRESSION; LINKING; SUBUNIT	Tissue transglutaminase belongs to a family of calcium-dependent enzymes, the transglutaminases that catalyze the covalent cross-linking of specific proteins by the formation of epsilon(gamma-glutamyl)lysine isopeptide bonds, The goal of this study has been the isolation and characterization of the human tissue transglutaminase gene promoter, Genomic DNA clones, spanning the 5' region of the gene, were isolated and the structure of the 5'-end of the human tissue transglutaminase gene was deter mined, 1.74 kilobases of flanking DNA were sequenced and were found to contain a TATA box element (TATAA), a CAAT box element (GGACAAT), a series of potential transcription factor-binding sites (AP1, SP1, interleukin-6 response element), and a glucocorticoid response elements, Transient transfection experiments showed that this DNA fragment included a functional promoter, which is constitutively active in multiple cell types.	UNIV TEXAS,SCH MED,DEPT PHARMACOL,HOUSTON,TX 77225; SYRACUSE UNIV,DEPT PHARMACOL,SYRACUSE,NY 13210	University of Texas System; Syracuse University			Gentile, Vittorio/A-3045-2008; Gentile, Vittorio/N-1685-2019	Gentile, Vittorio/0000-0001-7792-8294; Gentile, Vittorio/0000-0001-7792-8294	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027078] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK27078] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; BOWNESS JM, 1987, J BIOL CHEM, V262, P1022; CHANG TC, 1990, J BIOL CHEM, V265, P8176; CHIOCCA EA, 1988, J BIOL CHEM, V263, P11584; FESUS L, 1992, IMMUNOL TODAY, V13, pA16, DOI 10.1016/0167-5699(92)90059-G; Fesus L, 1988, Adv Exp Med Biol, V231, P119; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463; GENTILE V, 1991, J BIOL CHEM, V266, P478; GEORGE MD, 1990, J BIOL CHEM, V265, P11098; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; GRUNDMANN U, 1986, P NATL ACAD SCI USA, V83, P8024, DOI 10.1073/pnas.83.21.8024; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P6900, DOI 10.1021/bi00370a025; ICHINOSE A, 1988, P NATL ACAD SCI USA, V85, P5829, DOI 10.1073/pnas.85.16.5829; ICHINOSE A, 1990, J BIOL CHEM, V265, P13411; IKURA K, 1988, BIOCHEMISTRY-US, V27, P2898, DOI 10.1021/bi00408a035; KINSELLA MG, 1990, J BIOL CHEM, V265, P17891; KORSGREN C, 1991, P NATL ACAD SCI USA, V88, P4840, DOI 10.1073/pnas.88.11.4840; MARTINEZ J, 1989, J BIOL CHEM, V264, P20502; MOORE WT, 1984, J BIOL CHEM, V259, P2794; MURTAUGH MP, 1984, J EXP MED, V159, P114, DOI 10.1084/jem.159.1.114; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; PHILLIPS MA, 1990, P NATL ACAD SCI USA, V87, P9333, DOI 10.1073/pnas.87.23.9333; PHILLIPS MA, 1993, BIOCHEMISTRY-US, V32, P11057, DOI 10.1021/bi00092a015; PHILLIPS MA, 1992, J BIOL CHEM, V267, P2282; RICE RH, 1978, J CELL BIOL, V76, P705, DOI 10.1083/jcb.76.3.705; Sambrook J., 1989, MOL CLONING; SLIFE CW, 1986, J BIOL CHEM, V261, P3452; SUNG LPA, 1992, BLOOD, V79, P2763; SUTO N, 1993, J BIOL CHEM, V268, P7469; SUTO N, 1993, BIOCHIM BIOPHYS ACTA, V1172, P319, DOI 10.1016/0167-4781(93)90221-X; TAKAHASHI N, 1986, P NATL ACAD SCI USA, V83, P8019, DOI 10.1073/pnas.83.21.8019; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; YAMANISHI K, 1992, J BIOL CHEM, V267, P17858	36	88	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9748	9756		10.1074/jbc.270.17.9748	http://dx.doi.org/10.1074/jbc.270.17.9748			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730352	hybrid			2022-12-27	WOS:A1995QV41700011
J	MUROPASTOR, AM; MALOY, S				MUROPASTOR, AM; MALOY, S			PROLINE DEHYDROGENASE-ACTIVITY OF THE TRANSCRIPTIONAL REPRESSOR PUTA IS REQUIRED FOR INDUCTION OF THE PUT OPERON BY PROLINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; MEMBRANE ASSOCIATION; ESCHERICHIA-COLI; PROTEIN; GENE; SEQUENCES; EXPRESSION; INVITRO; ACID; LAC)	The proline utilization (put) operon from Salmonella typhimurium consists of the putP gene, encoding a proline transporter, and the putA gene, encoding an enzyme with both proline dehydrogenase and 1-pyrroline-5-carboxylate dehydrogenase activities. In addition to these two enzymatic activities, the PutA protein is a transcriptional repressor that regulates the expression of putP and putA in response to the availability of proline, We report the isolation of super-repressor mutants of PutA that decrease expression from the putA promoter in the presence or absence of proline. None of the mutants exhibited increased affinity for the DNA in the put regulatory region in vitro, Although DNA binding by wildtype PutA was prevented by the addition of proline and an artificial electron acceptor, DNA binding by the two strongest super-repressors was not prevented under identical conditions. The proline dehydrogenase activity of the purified mutant proteins showed altered kinetic properties (increased K-m(Pro), reduced V-max, or a completely null phenotype). The observation that these mutations simultaneously affect induction by proline and proline dehydrogenase activity suggests that a single proline-binding site is involved in both proline dehydrogenase activity and induction of the expression of the put operon. Furthermore, the results indicate that the proline dehydrogenase activity of PutA is essential for induction of the put operon by proline.	UNIV ILLINOIS,DEPT MICROBIOL,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign			Muro-Pastor, Alicia M/Q-3157-2019; Maloy, Stanley/AAA-7095-2019; Muro-Pastor, Alicia M/A-4445-2015	Muro-Pastor, Alicia M/0000-0003-2503-6336; Maloy, Stanley/0000-0001-9900-4367; Muro-Pastor, Alicia M/0000-0003-2503-6336	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034715] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34715] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMSON JLA, 1983, EUR J BIOCHEM, V134, P77, DOI 10.1111/j.1432-1033.1983.tb07533.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN ED, 1992, J BIOL CHEM, V267, P13086; BROWN ED, 1993, J BIOL CHEM, V268, P8972; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; DESPICER PO, 1993, P NATL ACAD SCI USA, V90, P4295, DOI 10.1073/pnas.90.9.4295; DESPICER PO, 1991, J BACTERIOL, V173, P211, DOI 10.1128/jb.173.1.211-219.1991; EKENA K, 1990, MOL GEN GENET, V220, P492, DOI 10.1007/BF00391761; GAY P, 1983, J BACTERIOL, V153, P1424, DOI 10.1128/JB.153.3.1424-1431.1983; GRAHAM SB, 1984, J BIOL CHEM, V259, P2656; GUTTERSON NI, 1983, P NATL ACAD SCI-BIOL, V80, P4894, DOI 10.1073/pnas.80.16.4894; HAHN DR, 1988, MOL GEN GENET, V213, P125, DOI 10.1007/BF00333408; HUGHES KT, 1985, GENETICS, V109, P263; LEE EC, 1990, J BACTERIOL, V172, P1529, DOI 10.1128/jb.172.3.1529-1538.1990; LING MF, 1994, J MOL BIOL, V243, P950, DOI 10.1006/jmbi.1994.1696; MALOY S, 1993, J BACTERIOL, V175, P307, DOI 10.1128/JB.175.2.307-316.1993; MALOY S, 1989, EXPT TECHNIQUES BACT; MALOY SR, 1983, J BACTERIOL, V154, P561, DOI 10.1128/JB.154.2.561-568.1983; MALOY SR, 1987, ESCHERICHIA COLI SAL, V2, P1513; MENZEL R, 1981, J BIOL CHEM, V256, P9755; MENZEL R, 1981, J BIOL CHEM, V256, P9762; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; MUROPASTOR AM, 1995, BIOTECHNIQUES, V18, P386; RATZKIN B, 1978, J BACTERIOL, V133, P744, DOI 10.1128/JB.133.2.744-754.1978; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STRECKER HJ, 1957, J BIOL CHEM, V225, P825; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WHITFIELD HJ, 1973, J BACTERIOL, V116, P54, DOI 10.1128/JB.116.1.54-58.1973	31	40	42	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9819	9827		10.1074/jbc.270.17.9819	http://dx.doi.org/10.1074/jbc.270.17.9819			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730362	hybrid			2022-12-27	WOS:A1995QV41700021
J	TRON, T; YANG, MJ; DICK, FA; SCHMITT, ME; TRUMPOWER, BL				TRON, T; YANG, MJ; DICK, FA; SCHMITT, ME; TRUMPOWER, BL			QSR1, AN ESSENTIAL YEAST GENE WITH A GENETIC-RELATIONSHIP TO A SUBUNIT OF THE MITOCHONDRIAL CYTOCHROME BC(1) COMPLEX, IS HOMOLOGOUS TO A GENE IMPLICATED IN EUKARYOTIC CELL-DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BC1 COMPLEX; NUCLEOTIDE-SEQUENCE; ELECTRON-TRANSFER; PROTEIN; BINDING; SUPPRESSOR; REDUCTASE; MUTANTS; SITES	Subunit 6 of the mitochondrial cytochrome bc(1) complex regulates the activity of the bc(1) complex in Saccharomyces cerevisiae but is not essential for respiration. To test whether QCR6, the nuclear gene which encodes subunit 6, might be functionally redundant with any other gene(s), we screened for mutations in yeast genes which are essential when the otherwise non-essential QCR6 is deleted from the yeast chromosome. We obtained such quinol-cytochrome c reductase subunit-requiring mutants in two complementation groups, which we named qsr1 and qsr2. The qsr mutants require QCR6 for viability on fermentable and non-fermentable carbon sources, indication that QCR6 is covering lethal mutations in qsr1 and qsr2, even when the yeast do not require respiration. QSR1 was cloned by rescuing the synthetic lethality of a qsr1-1 mutant. QSR1 encodes a 25.4-kDa protein which is 65% identical to a protein encoded by QM, a highly conserved human gene which has been implicated in tumorigenesis. In mammals QM is down-regulated during adipocyte, kidney, and heart differentiation, and in Nicotiana the homolog of QM is also down-regulated during differentiation. When one chromosomal copy of QSR1 was deleted in a diploid yeast strain, haploid spores derived therefrom and carrying the deletion were unable to grow on fermentable or non-fermentable carbon sources. Although QCR6 allows the qsr1-1 mutant to grow, it will not substitute for QSR1, since the deletion of QSR1 is lethal even if QCR6 is present. These results indicate a novel genetic relationship between a subunit of the mitochondrial respiratory chain and an essential gene in yeast which is homologous to a gene implicated in differentiation in other eukaryotes.	DARTMOUTH COLL, SCH MED, DEPT BIOCHEM, HANOVER, NH 03755 USA	Dartmouth College					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020379, R01GM020379] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 20379] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLINDER D, 1989, CELL, V56, P479, DOI 10.1016/0092-8674(89)90250-X; BROWN TA, 1995, J BACTERIOL, V177, P1380, DOI 10.1128/jb.177.5.1380-1382.1995; CRIVELLONE MD, 1988, J BIOL CHEM, V263, P14323; CVRCKOVA F, 1993, EMBO J, V12, P5277, DOI 10.1002/j.1460-2075.1993.tb06223.x; DOWDY SF, 1991, NUCLEIC ACIDS RES, V19, P5763, DOI 10.1093/nar/19.20.5763; EISINGER DP, 1993, BIOCHEM BIOPH RES CO, V196, P1227, DOI 10.1006/bbrc.1993.2383; FARMER AA, 1994, HUM MOL GENET, V3, P723, DOI 10.1093/hmg/3.5.723; Hanahan D., 1985, DNA CLONING; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; KIM CH, 1990, FEBS LETT, V266, P78, DOI 10.1016/0014-5793(90)81511-L; KIM CH, 1987, J BIOL CHEM, V262, P8103; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; KRIAUCIUNAS A, 1989, BIOCHIM BIOPHYS ACTA, V976, P70, DOI 10.1016/S0005-2728(89)80190-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE CW, 1991, METHOD ENZYMOL, V194, P273; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; MARTY I, 1993, PLANT J, V4, P265, DOI 10.1046/j.1365-313X.1993.04020265.x; MONTECLARO FS, 1993, P NATL ACAD SCI USA, V90, P6726, DOI 10.1073/pnas.90.14.6726; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; RIVERAMADRID R, 1993, PLANT PHYSIOL, V102, P329, DOI 10.1104/pp.102.1.329; ROBERTSON DE, 1993, BIOCHEMISTRY-US, V32, P1310, DOI 10.1021/bi00056a016; SAKAI A, 1990, MOL CELL BIOL, V10, P4130, DOI 10.1128/MCB.10.8.4130; SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224; SCHMITT ME, 1990, J BIOL CHEM, V265, P17005; SCHMITT ME, 1990, THESIS DARTMOUTH COL; SCHOPPINK PJ, 1988, EUR J BIOCHEM, V173, P115, DOI 10.1111/j.1432-1033.1988.tb13974.x; SCHULTE U, 1989, NATURE, V339, P147, DOI 10.1038/339147a0; SIEDOW JN, 1978, J BIOL CHEM, V253, P2392; STABEN C, 1986, J BIOL CHEM, V261, P4629; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; VANLOON APGM, 1984, EMBO J, V3, P1039, DOI 10.1002/j.1460-2075.1984.tb01924.x; YANG MJ, 1994, J BIOL CHEM, V269, P1270; YANG XH, 1986, J BIOL CHEM, V261, P2282; 1991, PROGRAM MANUAL GCG P	40	43	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9961	9970		10.1074/jbc.270.17.9961	http://dx.doi.org/10.1074/jbc.270.17.9961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730379	hybrid			2022-12-27	WOS:A1995QV41700041
J	HUANG, T; CAMPBELL, JL				HUANG, T; CAMPBELL, JL			AMPLIFICATION OF A CIRCULAR EPISOME CARRYING AN INVERTED REPEAT OF THE DFR1 LOCUS AND ADJACENT AUTONOMOUSLY REPLICATING SEQUENCE ELEMENT OF SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE GENE; LINEARIZED PLASMID DNA; WILD-TYPE P53; CELL-CYCLE; MOLECULAR DISSECTION; COPPER RESISTANCE; MAMMALIAN-CELLS; DIMER PLASMIDS; DOUBLE MINUTES; YEAST	Lack of suitable amplification markers has hindered the use of the yeast system for investigating the mechanism of gene amplification in a eukaryote with a simple genome and well defined genetic system. Recently, methotrexate has been used to select for Saccharomyces cerevisiae mutants with de novo amplification of the dihydrofolate reductase gene (DFR1) (Huang, T. (1993) In Vivo Disruption and de Novo Amplification of the DFR1 Gene Encoding Dihydrofolate Reductase in Saccharomyces cerevisiae. Ph. D. thesis, University of Alberta, Edmonton, Canada). We report here the detailed structure of a DFR1 episome amplified in methotrexate-resistant strain 25-1. The extrachromosomal DNA is found predominantly as a single 11-kilobase circular molecule. It consists of a 5.5-kilobase inverted duplication that contains the DFR1 locus and adjacent ARS (autonomously replicating sequence) element. This molecular configuration mimics the inferred structure of double minute chromosomes observed in a number of mammalian amplification systems and suggests that mechanisms that generate amplified DNAs are conserved from yeast to mammals.	CALTECH,BRAUN LABS,PASADENA,CA 91125	California Institute of Technology					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047281, R01GM025508] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 25508, GM 47281] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALADJEM MI, 1992, MUTAT RES, V276, P339, DOI 10.1016/0165-1110(92)90020-A; BARCLAY BJ, 1988, GENE, V63, P175, DOI 10.1016/0378-1119(88)90523-9; BURHANS WC, 1986, P NATL ACAD SCI USA, V83, P7790, DOI 10.1073/pnas.83.20.7790; CARROLL SM, 1993, MOL CELL BIOL, V13, P2971, DOI 10.1128/MCB.13.5.2971; COWELL JK, 1982, ANNU REV GENET, V16, P21, DOI 10.1146/annurev.ge.16.120182.000321; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; DORSEY M, 1992, GENETICS, V132, P943; DORSEY MJ, 1993, CURR GENET, V23, P392, DOI 10.1007/BF00312624; FAKHARZADEH SS, 1993, GENOMICS, V15, P283, DOI 10.1006/geno.1993.1058; FLING ME, 1988, GENE, V63, P165, DOI 10.1016/0378-1119(88)90522-7; FOGEL S, 1982, P NATL ACAD SCI-BIOL, V79, P5342, DOI 10.1073/pnas.79.17.5342; FOGEL S, 1983, CURR GENET, V7, P347, DOI 10.1007/BF00445874; FRIED M, 1991, BIOCHIM BIOPHYS ACTA, V1090, P143, DOI 10.1016/0167-4781(91)90095-4; HAMLIN JL, 1992, MUTAT RES, V276, P179, DOI 10.1016/0165-1110(92)90007-V; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HEINTZ NH, 1983, NATURE, V302, P439, DOI 10.1038/302439a0; HUANG T, 1992, GENE, V121, P167, DOI 10.1016/0378-1119(92)90177-Q; HUANG T, 1993, THESIS U ALBERTA EMO; HYRIEN O, 1988, EMBO J, V7, P407, DOI 10.1002/j.1460-2075.1988.tb02828.x; KUNES S, 1990, GENETICS, V124, P67; KUNES S, 1984, COLD SPRING HARB SYM, V49, P617, DOI 10.1101/SQB.1984.049.01.070; KUNES S, 1985, J MOL BIOL, V184, P375, DOI 10.1016/0022-2836(85)90288-8; LAGOSKY PA, 1987, NUCLEIC ACIDS RES, V15, P10355, DOI 10.1093/nar/15.24.10355; LAVI S, 1981, P NATL ACAD SCI-BIOL, V78, P6144, DOI 10.1073/pnas.78.10.6144; LEE FJS, 1992, BIOTECHNIQUES, V12, P677; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Maniatis T., 1982, MOL CLONING; Morelle G, 1989, FOCUS, V11, P7; NATH K, 1984, CURR GENET, V8, P265, DOI 10.1007/BF00419723; NONET GH, 1993, GENOMICS, V15, P543, DOI 10.1006/geno.1993.1107; PASSANANTI C, 1987, EMBO J, V6, P1697, DOI 10.1002/j.1460-2075.1987.tb02420.x; PELLEGRINI S, 1984, CELL, V36, P943, DOI 10.1016/0092-8674(84)90044-8; SCHIMKE RT, 1986, CANCER, V57, P1912, DOI 10.1002/1097-0142(19860515)57:10<1912::AID-CNCR2820571004>3.0.CO;2-O; Sherman F., 1986, METHODS YEAST GENETI; SIEDE W, 1993, P NATL ACAD SCI USA, V90, P7985, DOI 10.1073/pnas.90.17.7985; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; TLSTY TD, 1990, P NATL ACAD SCI USA, V87, P3132, DOI 10.1073/pnas.87.8.3132; TLSTY TD, 1989, P NATL ACAD SCI USA, V86, P9441, DOI 10.1073/pnas.86.23.9441; WAHL GM, 1989, CANCER RES, V49, P21; WALTON JD, 1986, CELL, V46, P857, DOI 10.1016/0092-8674(86)90067-X; WINDLE BE, 1992, MUTAT RES, V276, P199, DOI 10.1016/0165-1110(92)90009-X; WRIGHT JA, 1990, P NATL ACAD SCI USA, V87, P1791, DOI 10.1073/pnas.87.5.1791; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	44	20	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9607	9614		10.1074/jbc.270.16.9607	http://dx.doi.org/10.1074/jbc.270.16.9607			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721892	hybrid			2022-12-27	WOS:A1995QU08900081
J	ARNONE, MI; ZANNINI, M; DILAURO, R				ARNONE, MI; ZANNINI, M; DILAURO, R			THE DNA-BINDING ACTIVITY AND THE DIMERIZATION ABILITY OF THE THYROID TRANSCRIPTION FACTOR-I ARE REDOX REGULATED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVITY INVITRO; POU-DOMAIN; YEAST A1; HOMEODOMAIN; PROTEIN; SPECIFICITY; EXPRESSION; OXIDATION; ALPHA-2	The DNA binding activity of the thyroid transcription factor-1 (TTF-1), a homeodomain-containing protein implicated in the control of thyroid- and lung-specific transcription, is controlled, in vitro, by the redox potential, Oxidation decreases TTF-1 DNA binding activity, which is fully restored upon exposure to reducing agents. The decrease in DNA binding activity is due to the formation of disulfide bond(s), formed between two specific cysteine residues located outside the TTF-1 homeodomain; hence, oxidation does not appear to directly hinder TTF-1/DNA contacts, Disulfide bond formation seems to stabilize preexisting, loosely associated, TTF-1 dimers, which, upon oxidation, proceed in the formation of specific, higher order oligomers.	Staz Zool Anton Dohrn, I-81021 NAPLES, ITALY	Stazione Zoologica Anton Dohrn di Napoli			Di Lauro, Roberto/A-2746-2012; Zannini, Mariastella/I-1735-2012	Di Lauro, Roberto/0000-0001-9493-3036; ARNONE, Maria Immacolata/0000-0002-9012-7624				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; ALLEN JF, 1993, FEBS LETT, V332, P203, DOI 10.1016/0014-5793(93)80631-4; AVVEDIMENTO VE, 1985, EUR J BIOCHEM, V149, P467, DOI 10.1111/j.1432-1033.1985.tb08948.x; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; BOHINSKI RJ, 1993, J BIOL CHEM, V268, P11160; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; CAPPEL RE, 1988, J BIOL CHEM, V263, P12204; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; DAMANTE G, 1994, BBA-GENE STRUCT EXPR, V1218, P255, DOI 10.1016/0167-4781(94)90176-7; DAMANTE G, 1991, P NATL ACAD SCI USA, V88, P5388, DOI 10.1073/pnas.88.12.5388; DRANGINIS AM, 1990, NATURE, V347, P682, DOI 10.1038/347682a0; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P5793, DOI 10.1128/MCB.12.12.5793; GALANG CK, 1993, MOL CELL BIOL, V13, P4609, DOI 10.1128/MCB.13.8.4609; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P478; GOUNARI F, 1990, EMBO J, V9, P559, DOI 10.1002/j.1460-2075.1990.tb08143.x; GOUTTE C, 1993, J MOL BIOL, V233, P359, DOI 10.1006/jmbi.1993.1517; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; HO CY, 1994, EMBO J, V13, P1403, DOI 10.1002/j.1460-2075.1994.tb06394.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; KIENY MP, 1984, NATURE, V312, P163, DOI 10.1038/312163a0; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; MCBRIDE AA, 1992, P NATL ACAD SCI USA, V89, P7531, DOI 10.1073/pnas.89.16.7531; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; NICOSIA A, 1990, CELL, V61, P1225, DOI 10.1016/0092-8674(90)90687-A; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; POGNONEC P, 1992, J BIOL CHEM, V267, P24563; RIGONI P, 1993, BIOCHIM BIOPHYS ACTA, V1173, P141, DOI 10.1016/0167-4781(93)90174-C; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; TOMEI L, 1992, EMBO J, V11, P4119, DOI 10.1002/j.1460-2075.1992.tb05505.x; VERRIJZER CP, 1992, EMBO J, V11, P4993, DOI 10.1002/j.1460-2075.1992.tb05606.x; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; ZANNINI S, 1994, DEV ENDOCRINOL, V6, P79; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732	48	84	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12048	12055		10.1074/jbc.270.20.12048	http://dx.doi.org/10.1074/jbc.270.20.12048			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744853	hybrid			2022-12-27	WOS:A1995QY73600055
J	HAMAWY, MM; MINOGUCHI, K; SWAIM, WD; MERGENHAGEN, SE; SIRAGANIAN, RP				HAMAWY, MM; MINOGUCHI, K; SWAIM, WD; MERGENHAGEN, SE; SIRAGANIAN, RP			A 77-KDA PROTEIN ASSOCIATES WITH PP125(FAK) IN MAST-CELLS AND BECOMES TYROSINE-PHOSPHORYLATED BY HIGH-AFFINITY IGE RECEPTOR AGGREGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA RBL-2H3 CELLS; FOCAL ADHESION KINASE; IMMUNOGLOBULIN-E; HISTAMINE-RELEASE; FIBRONECTIN; ADHERENCE; PP125FAK; IDENTIFICATION; STIMULATION; ACTIVATION	The focal adhesion kinase, pp125(FAK), is a novel nonreceptor protein tyrosine kinase expressed in different cells including mast cells. Here we report that a 77-kDa protein associates with pp125(FAK) in the mast cell analog, rat basophilic leukemia (RBL-2H3) cells. When pp125(FAK) immunoprecipitates were subjected to an in vitro kinase assay, there was prominent phosphorylation on tyrosine of pp125(FAK) and of a 77-kDa protein. By V8 protease digestion mapping and by immunoblotting with two different anti-pp125(FAK) antibodies, the 77-kDa protein was distinct from pp125(FAK). This Fak Associated Protein or FAP was detected in RBL-2H3 cells but not in fibroblasts. The aggregation of the high affinity IgE receptor, Fc epsilon RI, induced the in vivo tyrosine phosphorylation of FAP. However, there was a marked decrease in the in vitro phosphorylation of FAP in the immunoprecipitates from Fc epsilon RI aggregated cells. Both of these Fc epsilon RI-mediated effects were enhanced by cell adhesion. There was strong association of FAP with non-tyrosine-phosphorylated pp125(FAK). Thus this interaction does not appear to be mediated by the Src homology 2 domain. Together the data indicate that FAP associates with pp125(FAK) and suggest that FAP may play a role in Fc epsilon RI signaling.			HAMAWY, MM (corresponding author), NIDR,IMMUNOL LAB,BLDG 10,RM 1N106,BETHESDA,MD 20892, USA.							BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BENHAMOU M, 1992, J BIOL CHEM, V267, P7310; BENHAMOU M, 1992, IMMUNOL TODAY, V13, P195, DOI 10.1016/0167-5699(92)90152-W; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; CHAN PY, 1994, J BIOL CHEM, V269, P20567; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; EISEMAN E, 1992, NATURE, V355, P78; FUKAMACHI H, 1994, J IMMUNOL, V152, P642; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HAMAWY MM, 1992, J IMMUNOL, V149, P615; HAMAWY MM, 1994, IMMUNOL TODAY, V15, P62, DOI 10.1016/0167-5699(94)90135-X; HAMAWY MM, 1994, J IMMUNOL, V153, P4655; HAMAWY MM, 1993, J BIOL CHEM, V268, P6851; HAMAWY MM, 1994, MOLECULAR PATHOGENESIS OF PERIODONTAL DISEASE, P235; HAMAWY MM, 1993, J BIOL CHEM, V268, P5227; HAMAWY MM, 1995, IN PRESS CELL SIGNAL; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; HATAI M, 1994, FEBS LETT, V350, P113, DOI 10.1016/0014-5793(94)00745-4; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HUTCHCROFT JE, 1992, P NATL ACAD SCI USA, V89, P9107, DOI 10.1073/pnas.89.19.9107; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; KIHARA H, 1994, J BIOL CHEM, V269, P22427; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; MINOGUCHI K, 1994, J BIOL CHEM, V269, P5249; MINOGUCHI K, 1994, MOL IMMUNOL, V31, P519; PARK DJ, 1991, J BIOL CHEM, V266, P24237; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; SIRAGANIAN RP, 1988, INFLAMMATION BASIC P, P513; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SWAIM WD, 1994, J BIOL CHEM, V269, P19466; SWIETER M, 1993, J IMMUNOL, V150, P617; TANIGUCHI T, 1994, ONCOGENE, V9, P861; TURNER CE, 1993, J CELL SCI, V105, P637; TURNER CE, 1994, J CELL SCI, V107, P1583; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413	47	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12305	12309		10.1074/jbc.270.20.12305	http://dx.doi.org/10.1074/jbc.270.20.12305			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744883	hybrid			2022-12-27	WOS:A1995QY73600088
J	PENCO, S; PASTORINO, S; BIANCHISCARRA, G; GARRE, C				PENCO, S; PASTORINO, S; BIANCHISCARRA, G; GARRE, C			LACTOFERRIN DOWN-MODULATES THE ACTIVITY OF THE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PROMOTER IN INTERLEUKIN-1-BETA-STIMULATED CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CSF MESSENGER-RNA; GM-CSF; POSTTRANSCRIPTIONAL REGULATION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; MAMMALIAN-CELLS; INTERLEUKIN-1; PROTEINS; DNA; PURIFICATION	The human neutrophil lactoferrin (Lf), a cationic iron-binding glycoprotein, has an inhibitor role on granulocyte macrophage colony-stimulating factor (GM-CSF) production via interleukin-1 (IL-1). The nuclear localization of Lf suggests that it may be involved in the transcriptional regulation of GM-CSF gene expression. To explore this possibility, the effect of Lf on GM-CSF gene expression was investigated in various cell lines and in primary cultures of fibroblasts. Down-regulation of GM-CSF mRNA level was observed in Lf-transfected embryonic fibroblasts induced to produce GM-CSF by IL-1 beta. In 5637 cell-line and in embryonic fibroblasts, co-transfection experiments, in which an Lf expression vector was used together with a vector carrying a reporter gene linked to the GM-CSF promoter, revealed that Lf reduces the activity of the GM-CSF promoter. This effect is marked in IL-1 beta-stimulated cells. These findings suggest that Lf plays a negative role in GM-CSF expression at the transcriptional level, perhaps through the mediation of IL-1 beta.	UNIV GENOA,INST BIOL & GENET,I-16132 GENOA,ITALY	University of Genoa			Scarrà, Giovanna Bianchi/G-8933-2014	Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Penco, Silvana/0000-0003-1050-095X				CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELILLO A, 1992, FEBS LETT, V298, P195, DOI 10.1016/0014-5793(92)80055-L; FALKENBURG JHF, 1991, BLOOD, V78, P658; GARRE C, 1992, J CELL PHYSIOL, V153, P477, DOI 10.1002/jcp.1041530306; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Gramigni C., 1992, Acta Medica Romana, V30, P248; HE JL, 1995, NATURE, V373, P721, DOI 10.1038/373721a0; HUTCHENS TW, 1991, PEDIATR RES, V29, P243, DOI 10.1203/00006450-199103000-00005; KAUSHANSKY K, 1989, J IMMUNOL, V143, P2525; KUCZEK ES, 1991, J IMMUNOL, V146, P2426; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPREAVE F, 1990, INT J BIOL MACROMOL, V12, P2, DOI 10.1016/0141-8130(90)90073-J; LOMAX KJ, 1989, J CLIN INVEST, V83, P514, DOI 10.1172/JCI113912; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; MOCHIZUKI DY, 1987, P NATL ACAD SCI USA, V84, P5267, DOI 10.1073/pnas.84.15.5267; MUEGGE K, 1993, P NATL ACAD SCI USA, V90, P7054, DOI 10.1073/pnas.90.15.7054; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; NIMER SD, 1989, J IMMUNOL, V143, P2374; PALACIOS R, 1982, EUR J IMMUNOL, V12, P895, DOI 10.1002/eji.1830121018; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; RAMBALDI A, 1987, BLOOD, V69, P1409; RODRIGUEZCIMADE.JC, 1990, BLOOD, V76, P1481; ROSS HJ, 1991, BLOOD, V77, P1787; SANCHEZ L, 1992, ARCH DIS CHILD, V67, P657, DOI 10.1136/adc.67.5.657; SEELENTAG WK, 1987, EMBO J, V6, P2261, DOI 10.1002/j.1460-2075.1987.tb02499.x; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG CY, 1994, MOL CELL BIOL, V14, P1153, DOI 10.1128/MCB.14.2.1153; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623; ZUCALI JR, 1989, BLOOD, V74, P1531	36	48	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12263	12268		10.1074/jbc.270.20.12263	http://dx.doi.org/10.1074/jbc.270.20.12263			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744878	hybrid			2022-12-27	WOS:A1995QY73600083
J	ZHEN, L; RUSINIAK, ME; SWANK, RT				ZHEN, L; RUSINIAK, ME; SWANK, RT			THE BETA-GLUCURONIDASE PROPEPTIDE CONTAINS A SERPIN-RELATED OCTAMER NECESSARY FOR COMPLEX-FORMATION WITH EGASYN ESTERASE AND FOR RETENTION WITHIN THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL-ENZYMES; RAT-LIVER; KDEL RECEPTOR; REACTIVE SITE; PROTEIN; SEQUENCE; CALCIUM; COMPARTMENTALIZATION; PHOSPHORYLATION; INVOLVEMENT	beta-Glucuronidase is retained within the endoplasmic reticulum (ER) via complex formation with esterase-22 (egasyn), which in turn has a COOH-terminal HTEL ER retention sequence. To identify the regions of glucuronidase that interact with egasyn, complex formation was assayed in COS cells cotransfected with egasyn cDNA and with either deletion constructs of glucuronidase or with constructs containing specific glucuronidase propeptide sequences appended to the carboxyl terminus of a rat secretory protein alpha 1-acid glycoprotein. The region of glucuronidase essential for complex formation is a linear octamer sequence at the COOH terminus of the propeptide. A portion of this octamer is similar to a sequence near the reactive site of serpins. This and associated data indicate that an interaction related to that between serine proteinases and their serpin inhibitors retains beta-glucuronidase within the ER. Further, attachment of this octamer sequence provides an alternative method of targeting proteins to the ER lumen of any cell that contains egasyn. These and related results demonstrate that complex formation with esterases/proteinases within the ER is important in the subcellular targeting and/or processing of certain proteins.	ROSWELL PK CANC INST, DEPT MOLEC & CELLULAR BIOL, BUFFALO, NY 14263 USA	Roswell Park Cancer Institute					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033559] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33559] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARBER S, 1992, J CELL BIOL, V116, P113, DOI 10.1083/jcb.116.1.113; BELINSKY SA, 1984, J BIOL CHEM, V259, P7705; BROWN J, 1987, J CELL BIOL, V105, P1571, DOI 10.1083/jcb.105.4.1571; BROWN JA, 1983, J BIOL CHEM, V258, P5323; BRUNELLE FM, 1993, BIOCHEM PHARMACOL, V46, P1953, DOI 10.1016/0006-2952(93)90636-B; COLAU B, 1984, DNA-J MOLEC CELL BIO, V3, P327, DOI 10.1089/dna.1.1984.3.327; ERICKSON AH, 1983, BIOCHEMISTRY-US, V22, P5201, DOI 10.1021/bi00291a021; GABEL CA, 1982, J CELL BIOL, V95, P536, DOI 10.1083/jcb.95.2.536; GALLAGHER P M, 1988, Genomics, V2, P215, DOI 10.1016/0888-7543(88)90005-5; HEYMANN E, 1980, ENZYMATIC BASIS DETO, V2, P291; HSU VW, 1992, CELL, V69, P625, DOI 10.1016/0092-8674(92)90226-3; ISLAM MR, 1993, J BIOL CHEM, V268, P22627; JOSLIN G, 1991, J BIOL CHEM, V266, P11282; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORZA G, 1988, J BIOL CHEM, V263, P3486; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; LEWIS MJ, 1992, J MOL BIOL, V226, P913, DOI 10.1016/0022-2836(92)91039-R; LI H, 1990, J BIOL CHEM, V265, P14732; LUSIS AJ, 1976, J BIOL CHEM, V251, P7753; LUSIS AJ, 1977, CURRENT TOPICS BIOL, P63; MACINTYRE S, 1994, J BIOL CHEM, V269, P24496; MACINTYRE SS, 1992, J CELL BIOL, V118, P253, DOI 10.1083/jcb.118.2.253; MACINTYRE SS, 1992, MOL BIOL CELL, V3, pA120; MEDDA S, 1986, BIOCHEM GENET, V24, P229, DOI 10.1007/BF00502791; MEDDA S, 1985, J BIOL CHEM, V260, P5802; MEDDA S, 1989, J BIOL CHEM, V264, P15824; MEDDA S, 1987, CELL, V50, P301, DOI 10.1016/0092-8674(87)90225-X; MENTLEIN R, 1984, ARCH BIOCHEM BIOPHYS, V228, P230, DOI 10.1016/0003-9861(84)90064-X; MORREAU H, 1992, J BIOL CHEM, V267, P17949; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MYERS M, 1988, MOL BIOL EVOL, V5, P113; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; NOVAK EK, 1991, J BIOL CHEM, V266, P6377; OZOLS J, 1989, J BIOL CHEM, V264, P12533; PATSTON PA, 1994, THROMB HAEMOSTASIS, V72, P166; PELHAM HRB, 1991, CURR OPIN CELL BIOL, V3, P589; PRUITT SC, 1988, GENE, V66, P121, DOI 10.1016/0378-1119(88)90230-2; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; SHIEH BH, 1987, J BIOL CHEM, V262, P6055; SKUDLAREK MD, 1981, J BIOL CHEM, V256, P137; SKUDLAREK MD, 1979, J BIOL CHEM, V254, P9939; SOKOLOVE PM, 1984, BIOCHEM BIOPH RES CO, V121, P987, DOI 10.1016/0006-291X(84)90774-5; SWANK RT, 1994, HDB EXPT PHARM, P131; TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325; TOMINO S, 1975, J BIOL CHEM, V250, P1146; VANSTAPEL F, 1988, ARCH BIOCHEM BIOPHYS, V263, P216, DOI 10.1016/0003-9861(88)90630-3; WEI AZ, 1994, NAT STRUCT BIOL, V1, P251, DOI 10.1038/nsb0494-251; WEITZ G, 1992, J BIOL CHEM, V267, P10039; WHITING JF, 1993, J BIOL CHEM, V268, P23197; WHITTAKER M, 1985, CANCER LETT, V26, P145, DOI 10.1016/0304-3835(85)90020-5; ZHEN LD, 1993, ARCH BIOCHEM BIOPHYS, V304, P402, DOI 10.1006/abbi.1993.1368; ZHU Y, 1994, J BIOL CHEM, V269, P3846	52	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11912	11920		10.1074/jbc.270.20.11912	http://dx.doi.org/10.1074/jbc.270.20.11912			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744842	hybrid			2022-12-27	WOS:A1995QY73600038
J	BOUVERET, E; DEROUICHE, R; RIGAL, A; LLOUBES, R; LAZDUNSKI, C; BENEDETTI, H				BOUVERET, E; DEROUICHE, R; RIGAL, A; LLOUBES, R; LAZDUNSKI, C; BENEDETTI, H			PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN-TOLB INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; CELL-ENVELOPE INTEGRITY; MEMBRANE TOPOLOGY; OUTER-MEMBRANE; TONB PROTEIN; SALMONELLA-TYPHIMURIUM; PERIPLASMIC PROTEINS; ENERGY TRANSDUCTION; CROSS-LINKING; GROUP-A	TolA, B, -Q, and -R proteins are involved in maintaining the cell envelope integrity of Escherichia coli; they have been parasitized by the group A colicins and the single strand DNA of some filamentous bacteriophages to permit them to enter the cells, TolA and TolR are anchored to the inner membrane by a single transmembrane domain, TolQ is an integral membrane protein with three transmembrane segments, and TolB has re cently been found to be periplasmic although it is partially membrane-associated The latter result suggests that TolB might interact with membrane proteins, Other lines of evidence favor the existence of a Tol complex, To further characterize this complex, we investigated which proteins interact with TolB, For this purpose, two different methods were used, First, we took advantage of the existence of a tagged TolB (TolBep) to perform immunoprecipitation under native conditions in order to preserve the putative associations of TolBep with other proteins, Secondly, in vivo cross-linking experiments with formaldehyde were performed, These two approaches led to the same result and demonstrated for the first time that a component of the Tol system, TolB, interacts with a protein located in the outer membrane, the peptidoglycan-associated lipoprotein.	CNRS,INGN & DYNAM SYST MEMBRANAIRES LAB,F-13402 MARSEILLE 20,FRANCE	Centre National de la Recherche Scientifique (CNRS)				LLOUBES, Roland/0000-0002-9520-1053; Bouveret, Emmanuelle/0000-0001-5511-6375				BENEDETTI H, 1991, EMBO J, V10, P1989, DOI 10.1002/j.1460-2075.1991.tb07728.x; BENEDETTI H, 1992, EMBO J, V11, P441, DOI 10.1002/j.1460-2075.1992.tb05073.x; BOURDINEAUD JP, 1989, J BACTERIOL, V171, P2458, DOI 10.1128/jb.171.5.2458-2465.1989; BRAUN V, 1989, J BACTERIOL, V171, P6387, DOI 10.1128/jb.171.11.6387-6390.1989; BRAUN V, 1991, BIOL MET, V4, P14, DOI 10.1007/BF01135552; CHEN R, 1987, EUR J BIOCHEM, V163, P73, DOI 10.1111/j.1432-1033.1987.tb10738.x; DAVIES JK, 1975, J BACTERIOL, V123, P102, DOI 10.1128/JB.123.1.102-117.1975; DEICH RA, 1988, J BACTERIOL, V170, P489, DOI 10.1128/jb.170.2.489-498.1988; DEROUICHE R, 1995, J BIOL CHEM, V270, P11078, DOI 10.1074/jbc.270.19.11078; EICKHELMERICH K, 1989, J BACTERIOL, V171, P5117, DOI 10.1128/jb.171.9.5117-5126.1989; FISCHER E, 1989, J BACTERIOL, V171, P5129; FOGNINILEFEBVRE N, 1987, MOL GEN GENET, V209, P391, DOI 10.1007/BF00329670; GELI V, 1993, FEMS MICROBIOL LETT, V109, P335; GORVEL JP, 1985, CELL TISSUE RES, V239, P241, DOI 10.1007/BF00214925; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; HANNAVY K, 1990, J MOL BIOL, V216, P897, DOI 10.1016/S0022-2836(99)80009-6; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; ISNARD M, 1994, J BACTERIOL, V176, P6392, DOI 10.1128/jb.176.20.6392-6396.1994; JASKULA JC, 1994, J BACTERIOL, V175, P2326; KADNER RJ, 1990, MOL MICROBIOL, V4, P2027, DOI 10.1111/j.1365-2958.1990.tb00562.x; KAMPFENKEL K, 1993, J BACTERIOL, V175, P4485, DOI 10.1128/JB.175.14.4485-4491.1993; KAMPFENKEL K, 1992, J BACTERIOL, V174, P5485, DOI 10.1128/JB.174.16.5485-5487.1992; KAMPFENKEL K, 1992, J BIOL CHEM, V268, P6050; KARLSSON M, 1993, MOL MICROBIOL, V8, P379, DOI 10.1111/j.1365-2958.1993.tb01581.x; KLEBBA PE, 1993, J BIOENERG BIOMEMBR, V25, P603; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN RA, 1994, MOL MICROBIOL, V13, P627, DOI 10.1111/j.1365-2958.1994.tb00457.x; LAZZARONI JC, 1981, J BACTERIOL, V145, P1351, DOI 10.1128/JB.145.3.1351-1358.1981; LAZZARONI JC, 1995, J MOL BIOL, V246, P1, DOI 10.1006/jmbi.1994.0058; LAZZARONI JC, 1992, MOL MICROBIOL, V6, P735, DOI 10.1111/j.1365-2958.1992.tb01523.x; LAZZARONI JC, 1989, MOL GEN GENET, V218, P460, DOI 10.1007/BF00332410; LEDUC M, 1992, J BACTERIOL, V174, P7982, DOI 10.1128/JB.174.24.7982-7988.1992; Maniatis T, 1989, DECONTAMINATION DILU; MILLER JH, 1992, LABORATORY MANUAL HD; MIZUNC T, 1981, J BIOCHEM-TOKYO, V175, P6059; MIZUNO T, 1979, J BIOCHEM-TOKYO, V86, P991, DOI 10.1093/oxfordjournals.jbchem.a132631; MULLER MM, 1993, J BACTERIOL, V175, P6059, DOI 10.1128/JB.175.18.6059-6061.1993; PAKULA AA, 1992, P NATL ACAD SCI USA, V89, P4144, DOI 10.1073/pnas.89.9.4144; POSTLE K, 1988, J BIOL CHEM, V263, P11000; POSTLE K, 1993, J BIOENERG BIOMEMBR, V25, P591; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; ROOF SK, 1991, J BACTERIOL, V173, P5554, DOI 10.1128/jb.173.17.5554-5557.1991; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SKARE JT, 1991, MOL MICROBIOL, V5, P2883, DOI 10.1111/j.1365-2958.1991.tb01848.x; SKARE JT, 1993, J BIOL CHEM, V268, P16302; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIANNEY A, 1994, J BACTERIOL, V176, P822, DOI 10.1128/jb.176.3.822-829.1994; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x	50	110	112	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11071	11077		10.1074/jbc.270.19.11071	http://dx.doi.org/10.1074/jbc.270.19.11071			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744736	hybrid			2022-12-27	WOS:A1995QX86500011
J	BROCKMANN, D; BURY, C; KRONER, G; KIRCH, HC; ESCHE, H				BROCKMANN, D; BURY, C; KRONER, G; KIRCH, HC; ESCHE, H			REPRESSION OF THE C-JUN TRANSACTIVATION FUNCTION BY THE ADENOVIRUS-TYPE-12 E1A 52R PROTEIN CORRELATES WITH THE INHIBITION OF PHOSPHORYLATION OF THE C-JUN ACTIVATION DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; MESSENGER-RNAS; GENE-PRODUCT; NEGATIVE REGULATOR; LEUCINE ZIPPERS; ACTING FACTOR; AP-1 ACTIVITY; PRIMARY-CELLS; 5 DNA; FOS	The early region 1A 52R polypeptide, a protein expressed exclusively by the in vivo oncogenic adenovirus subtype 12, represses the trans-activating function of the cellular transcription factor complex AP-1 consisting of c-Jun-c-Jun homodimers. In this report we demonstrate that the repression in vivo correlates with a direct physical interaction of the adenovirus protein with c-Jun in vitro. Interestingly, the 52R protein binds to the bZIP domain of c-Jun essential for dimerization and DNA binding but not to the c-dun activation domain. This interaction does not prevent the promoter binding of c-Jun/AP-1. Moreover, the physical association between c-Jun and the TATA box-binding protein TBP is not disturbed by the 52R polypeptide. In fact, we show evidence that down-regulation of c-Jun activity by the adenoviral protein is due to the inhibition of phosphorylation of the c-Jun trans-activation domain. In vivo phosphorylation of the c-Jun activation domain is necessary for the interaction of c-Jun with specific cofactors such as CBP and therefore a prerequisite for the activation of target genes. Due to these results we propose a model in which the 52R protein represses the trans-activating function of c-Jun by preventing its phosphorylation through a specific kinase necessary for the activation of the cellular transcription factor.			BROCKMANN, D (corresponding author), UNIV ESSEN GESAMTHSCH, INST MOLEC BIOL CANC RES, HUFELANDSTR 55, D-45122 ESSEN, GERMANY.							Abate C, 1990, Semin Cancer Biol, V1, P19; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BALDWIN AS, 1987, MOL CELL BIOL, V7, P305, DOI 10.1128/MCB.7.1.305; BERK AJ, 1979, CELL, V17, P935, DOI 10.1016/0092-8674(79)90333-7; BERNARDS R, 1983, NATURE, V305, P776, DOI 10.1038/305776a0; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCKMANN D, 1994, VIROLOGY, V198, P717, DOI 10.1006/viro.1994.1085; BROCKMANN D, 1990, VIROLOGY, V179, P585, DOI 10.1016/0042-6822(90)90125-B; BROCKMANN D, 1993, LIFE SCI ADV, V12, P13; BYRD PJ, 1988, ONCOGENE, V2, P477; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAGMEYER BM, 1993, EMBO J, V12, P3559, DOI 10.1002/j.1460-2075.1993.tb06030.x; HARLOW E, 1988, ANTIBODIES LABORATOR; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HOUWELING A, 1980, VIROLOGY, V105, P537, DOI 10.1016/0042-6822(80)90054-9; HUEBNER RJ, 1962, P NATL ACAD SCI USA, V48, P2051, DOI 10.1073/pnas.48.12.2051; ISRAEL A, 1987, P NATL ACAD SCI USA, V84, P2653, DOI 10.1073/pnas.84.9.2653; JELINEK T, 1994, J VIROL, V68, P888, DOI 10.1128/JVI.68.2.888-896.1994; JELSMA TN, 1989, VIROLOGY, V171, P120, DOI 10.1016/0042-6822(89)90518-7; JOCHEMSEN H, 1982, VIROLOGY, V122, P15, DOI 10.1016/0042-6822(82)90373-7; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; KARIN M, 1991, HORMONAL CONTROL REG, P235; KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LILLIE JW, 1987, CELL, V50, P1091, DOI 10.1016/0092-8674(87)90175-9; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; Maniatis T., 1982, MOL CLONING; MEIJER I, 1992, CELL IMMUNOL, V145, P56, DOI 10.1016/0008-8749(92)90312-D; MUKAI N, 1972, AM J PATHOL, V69, P331; MURPHY M, 1987, VIROLOGY, V159, P49, DOI 10.1016/0042-6822(87)90346-1; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NEVINS JR, 1981, CELL, V26, P213, DOI 10.1016/0092-8674(81)90304-4; OFFRINGA R, 1990, CELL, V62, P527, DOI 10.1016/0092-8674(90)90017-9; OPALKA B, 1992, INTERVIROLOGY, V33, P211, DOI 10.1159/000150253; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; PERRICAUDET M, 1980, NATURE, V288, P174, DOI 10.1038/288174a0; POPE JH, 1964, J EXP MED, V120, P577, DOI 10.1084/jem.120.4.577; Ransone Lynn J., 1993, Gene Expression, V3, P37; ROCHETTEEGLY C, 1990, GENE DEV, V4, P137, DOI 10.1101/gad.4.1.137; RON D, 1992, BIOTECHNIQUES, V13, P866; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SAMBUCETTI LC, 1986, GENE, V43, P69, DOI 10.1016/0378-1119(86)90009-0; SAWADA Y, 1980, J VIROL, V36, P639, DOI 10.1128/JVI.36.3.639-651.1980; SCHNEIDER JF, 1987, EMBO J, V6, P2053, DOI 10.1002/j.1460-2075.1987.tb02470.x; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHENK T, 1991, ADV CANCER RES, V57, P47; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; STEIN RW, 1990, J VIROL, V64, P4421, DOI 10.1128/JVI.64.9.4421-4427.1990; TELLING GC, 1994, J VIROL, V68, P877, DOI 10.1128/JVI.68.2.877-887.1994; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; YAMITHEZI A, 1994, ONCOGENE, V9, P1065; ZERLER B, 1986, MOL CELL BIOL, V6, P887, DOI 10.1128/MCB.6.3.887	69	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10754	10763		10.1074/jbc.270.18.10754	http://dx.doi.org/10.1074/jbc.270.18.10754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738014	hybrid			2022-12-27	WOS:A1995QW60100058
J	DISEPIO, D; JONES, A; LONGLEY, MA; BUNDMAN, D; ROTHNAGEL, JA; ROOP, DR				DISEPIO, D; JONES, A; LONGLEY, MA; BUNDMAN, D; ROTHNAGEL, JA; ROOP, DR			THE PROXIMAL PROMOTER OF THE MOUSE LORICRIN GENE CONTAINS A FUNCTIONAL AP-1 ELEMENT AND DIRECTS KERATINOCYTE-SPECIFIC BUT NOT DIFFERENTIATION-SPECIFIC EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PAPILLOMAVIRUS TYPE-18; CULTURED EPIDERMAL-CELLS; PROTEIN-KINASE-C; TRANSCRIPTION FACTOR; TRANSGENIC MICE; TERMINAL DIFFERENTIATION; CORNIFIED CELL; RETINOIC ACID; CALCIUM; IDENTIFICATION	Loricrin gene expression is limited to terminally differentiating keratinocytes of stratified squamous epithelia. To define the regulatory elements that mediate the expression of the loricrin gene, we replaced the loricrin coding sequences from a 6.5-kilobase genomic fragment with the chloramphenicol acetyltransferase gene and transfected this construct into cultured mouse keratinocytes. High expression levels were observed in both undifferentiated as well as differentiating cells. Transgenic mice bearing a similar construct, but with beta-galactosidase as the reporter gene, corroborated these in vitro findings and showed tissue and cell type-specific, but not differentiation-specific expression. Deletion analysis of the promoter region determined that sequences up to -60 base pairs from the start of transcription could be removed without significant loss of promoter activity. Within these proximal 60 base pairs is an evolutionarily conserved AP-1 element that is recognized by both purified c-Jun and AP-1 factors from keratinocytes in vitro. Mutation of this AP-1 site abolished the activity of the loricrin promoter. These studies show that elements directing expression of the loricrin gene to the stratified squamous epithelia are contained within a 6.5-kilobase genomic fragment, and those elements required to restrict expression to differentiated keratinocytes lie outside this region.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT DERMATOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine			Rothnagel, Joe/A-4874-2010	Rothnagel, Joe/0000-0002-6710-3165	NIAMS NIH HHS [AR40240] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040240] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSEN B, 1993, SCIENCE, V260, P78, DOI 10.1126/science.7682011; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; CASATORRES J, 1994, J BIOL CHEM, V269, P20489; Chung Su Y., 1994, Molecular and Cellular Differentiation, V2, P61; CRIPE T P, 1990, New Biologist, V2, P450; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; ECKERT RL, 1989, PHYSIOL REV, V69, P1316, DOI 10.1152/physrev.1989.69.4.1316; FAUS I, 1994, MOL CELL BIOL, V14, P3263, DOI 10.1128/MCB.14.5.3263; FISHER C, 1991, DEVELOPMENT, V111, P253; FLECKMAN P, 1989, J INVEST DERMATOL, V92, pA428; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HARPER JR, 1988, J INVEST DERMATOL, V91, P150, DOI 10.1111/1523-1747.ep12464396; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HOGAN B, 1986, MANIPULATING MOUSE E; HOHL D, 1990, DERMATOLOGICA, V180, P201, DOI 10.1159/000248031; HOHL D, 1991, J INVEST DERMATOL, V96, P414, DOI 10.1111/1523-1747.ep12469779; HOHL D, 1991, J BIOL CHEM, V266, P6626; HUFF CA, 1993, J BIOL CHEM, V268, P377; KOPAN R, 1987, J CELL BIOL, V105, P427, DOI 10.1083/jcb.105.1.427; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; LEASK A, 1990, GENE DEV, V4, P1985, DOI 10.1101/gad.4.11.1985; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LIAMINS LA, 1982, P NATL ACAD SCI USA, V79, P6453; LIEW FM, 1992, EXP CELL RES, V202, P310, DOI 10.1016/0014-4827(92)90080-R; LU B, 1994, J BIOL CHEM, V269, P7443; MACK DH, 1991, P NATL ACAD SCI USA, V88, P9102, DOI 10.1073/pnas.88.20.9102; MAGNALDO T, 1993, DNA CELL BIOL, V12, P911, DOI 10.1089/dna.1993.12.911; Magnaldo Thierry, 1993, Gene Expression, V3, P307; MALMQVIST KG, 1984, NUCL INSTRUM METH B, V3, P611, DOI 10.1016/0168-583X(84)90447-6; MEHREL T, 1990, CELL, V61, P1103, DOI 10.1016/0092-8674(90)90073-N; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; OFFORD EA, 1990, J VIROL, V64, P4792, DOI 10.1128/JVI.64.10.4792-4798.1990; OSHIMA RG, 1990, GENE DEV, V4, P835, DOI 10.1101/gad.4.5.835; ROOP DR, 1987, DIFFERENTIATION, V35, P143, DOI 10.1111/j.1432-0436.1987.tb00162.x; ROOP DR, 1983, P NATL ACAD SCI-BIOL, V80, P716, DOI 10.1073/pnas.80.3.716; ROTHNAGEL JA, 1994, GENOMICS, V23, P450, DOI 10.1006/geno.1994.1522; ROTHNAGEL JA, 1993, J INVEST DERMATOL, V101, P506, DOI 10.1111/1523-1747.ep12365886; ROTHNAGEL JA, 1987, J BIOL CHEM, V262, P15643; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; STEVEN AC, 1990, J STRUCT BIOL, V104, P150, DOI 10.1016/1047-8477(90)90071-J; TAKAHASHI H, 1993, J INVEST DERMATOL, V100, P10, DOI 10.1111/1523-1747.ep12349867; TAMAI Y, 1991, GENE, V104, P169, DOI 10.1016/0378-1119(91)90247-9; THIERRY F, 1992, J VIROL, V66, P3740, DOI 10.1128/JVI.66.6.3740-3748.1992; TSENG H, 1994, J CELL BIOL, V126, P495, DOI 10.1083/jcb.126.2.495; TSENG H, 1992, P NATL ACAD SCI USA, V89, P10311, DOI 10.1073/pnas.89.21.10311; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; WOODCOCKMITCHEL.J, 1982, J CELL BIOL, V95, P580; YONEDA K, 1993, P NATL ACAD SCI USA, V90, P10754, DOI 10.1073/pnas.90.22.10754; YUKAWA K, 1993, GENE, V133, P163; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	54	99	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10792	10799		10.1074/jbc.270.18.10792	http://dx.doi.org/10.1074/jbc.270.18.10792			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738016	hybrid			2022-12-27	WOS:A1995QW60100063
J	DUBOIS, CM; LAPRISE, MH; BLANCHETTE, F; GENTRY, LE; LEDUC, R				DUBOIS, CM; LAPRISE, MH; BLANCHETTE, F; GENTRY, LE; LEDUC, R			PROCESSING OF TRANSFORMING GROWTH-FACTOR-BETA-1 PRECURSOR BY HUMAN FURIN CONVERTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY DISEASE; BINDING-PROTEIN; HUMAN-PLATELETS; CELL-LINES; FACTOR-BETA-1; EXPRESSION; ACTIVATION; PROLIFERATION; ENDOPROTEASE; INHIBITION	Proteolytic processing of the transforming growth factor beta precursor (pro-TGF beta) is an essential step in the formation of the biologically active TGF beta homodimeric protein (TGF beta). The 361-amino-acid precursor pro-TGF beta 1 has within its primary structure the R-H-R-R processing signal found in many constitutively secreted precursor proteins and potentially recognized by members of the mammalian convertase family of endoproteases. To determine whether cleavage of pro-TGF beta 1 can be achieved by the furin convertase in vitro, purified precursor was incubated in the presence of a truncated/secreted form of the enzyme. Immunoblots showed that the 55-kDa pro-TGF beta 1 was converted into the 44 and 12.5 kDa bands corresponding to the proregion and the mature monomer, respectively. Treatment of pro-TGF beta 1 with furin resulted in a 5-fold increase in the production of biologically active TGF beta 1. Furthermore, when expressed in the furin-deficient LoVo cells, no processing of pro-TGF beta 1 was observed. In contrast, efficient processing was oberved when pro-TGF beta 1 was coexpressed with the furin convertase. Collectively, these results provide evidence that in our experimental systems the TGF beta 1 precursor is efficiently and correctly processed by human furin thus permitting release of the biologically active peptide.	MED COLL OHIO, DEPT BIOCHEM, TOLEDO, OH 43699 USA		DUBOIS, CM (corresponding author), UNIV SHERBROOKE, FAC MED, DEPT PEDIAT, DIV IMMUNOL, 3001 N 12TH AVE, SHERBROOKE, PQ J1H 5N4, CANADA.				PHS HHS [A60848] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGARD DA, 1993, SCIENCE, V260, P1903, DOI 10.1126/science.8100365; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; ASSOIAN RK, 1978, J BIOL CHEM, V235, P1357; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BRESLIN MB, 1993, J BIOL CHEM, V268, P27084; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; Brownh PD, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037500; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; CHAN SJ, 1992, P NATL ACAD SCI USA, V89, P6678, DOI 10.1073/pnas.89.15.6678; CHILDS CB, 1982, P NATL ACAD SCI-BIOL, V79, P5312, DOI 10.1073/pnas.79.17.5312; CREEMERS JWM, 1993, FEBS LETT, V336, P65, DOI 10.1016/0014-5793(93)81610-C; CZARNIECKI CW, 1988, J IMMUNOL, V140, P4217; DERYNCK R, 1986, J BIOL CHEM, V261, P4377; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; DUBOIS CM, 1990, J EXP MED, V172, P737, DOI 10.1084/jem.172.3.737; EBERT EC, 1987, J IMMUNOL, V138, P2161; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; GOEY H, 1989, J IMMUNOL, V143, P877; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Hruby D E, 1986, Methods Enzymol, V124, P295; JACOBSEN SEW, 1991, BLOOD, V77, P1706; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; KELLER JR, 1988, J EXP MED, V168, P737, DOI 10.1084/jem.168.2.737; KELLER JR, 1989, J CELL BIOCHEM, V39, P175, DOI 10.1002/jcb.240390209; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; KONDAIAH P, 1990, J BIOL CHEM, V265, P1089; KULKARNI AB, 1993, AM J PATHOL, V143, P3; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LAWRENCE D, 1985, BIOCHEM BIOPH RES CO, V133, P1026, DOI 10.1016/0006-291X(85)91239-2; LEDUC R, 1992, J BIOL CHEM, V267, P14304; LEDUC R, 1990, J CELL BIOL, V11, P338; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MIYAZONO K, 1992, J BIOL CHEM, V267, P5668; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MOSES HL, 1985, CANCER CELL, V3, P65; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; PIRCHER R, 1986, BIOCHEM BIOPH RES CO, V136, P30, DOI 10.1016/0006-291X(86)90872-7; RAPP UR, 1983, J CELL BIOCHEM, V21, P29, DOI 10.1002/jcb.240210105; REHEMTULLA A, 1993, BIOCHEMISTRY-US, V32, P11586, DOI 10.1021/bi00094a015; RISTOW HJ, 1986, P NATL ACAD SCI USA, V83, P5531, DOI 10.1073/pnas.83.15.5531; ROBERTS AB, 1983, FED PROC, V42, P2621; Roberts AB, 1990, PEPTIDE GROWTH FACTO, P419; ROBERTSON BJ, 1993, J BIOL CHEM, V268, P24274; ROOK AH, 1986, J IMMUNOL, V136, P3916; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; SCHWARZ LC, 1990, ANN NY ACAD SCI, V593, P315, DOI 10.1111/j.1749-6632.1990.tb16129.x; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; SEYEDIN SM, 1987, J BIOL CHEM, V262, P1946; SHA X, 1989, MOL ENDOCRINOL, V3, P1090, DOI 10.1210/mend-3-7-1090; SHARPLES K, 1987, DNA-J MOLEC CELL BIO, V6, P239, DOI 10.1089/dna.1987.6.239; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SOSSIN WS, 1989, NEURON, V2, P1407, DOI 10.1016/0896-6273(89)90186-4; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STRASSMANN G, 1988, J IMMUNOL, V140, P2645; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; THOMAS G, 1988, SCIENCE, V241, P226, DOI 10.1126/science.3291117; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; TUCKER RF, 1984, P NATL ACAD SCI-BIOL, V81, P6757, DOI 10.1073/pnas.81.21.6757; TURNER M, 1991, EUR J IMMUNOL, V21, P1635, DOI 10.1002/eji.1830210708; VANDEVEN WJM, 1993, CRIT REV ONCOGENESIS, V4, P115; WAHL SM, 1988, J IMMUNOL, V140, P3026; WAHL SM, 1988, J EXP MED, V168, P1403, DOI 10.1084/jem.168.4.1403; WALKER JA, 1994, J VIROL, V68, P1213, DOI 10.1128/JVI.68.2.1213-1218.1994	74	328	344	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10618	10624		10.1074/jbc.270.18.10618	http://dx.doi.org/10.1074/jbc.270.18.10618			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737999	hybrid			2022-12-27	WOS:A1995QW60100041
J	ENDO, T; OHTA, K; HARAGUCHI, K; ONAYA, T				ENDO, T; OHTA, K; HARAGUCHI, K; ONAYA, T			CLONING AND FUNCTIONAL EXPRESSION OF A THYROTROPIN RECEPTOR CDNA FROM RAT FAT-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRO-ORBITAL TISSUE; GRAVES-DISEASE; MOLECULAR-CLONING; EUKARYOTIC CELLS; AUTOANTIBODIES; LIPOLYSIS; BINDING; PROTEIN; GENE	Thyrotropin receptor (TSH-R) has been thought to be thyroid-specific, but, by Northern blot analysis, we found that rat adipose tissue expressed TSH-R mRNAs in amounts approaching those in the thyroid, To investigate the function of TSH-R from adipose tissue, we screened a rat fat cell lambda gt11 cDNA library for TSH-R sequences using a P-32-labeled rat thyroid TSH-R cDNA as a probe, Among 10(6) plaques, we obtained four positive clones, Sequencing of these cDNAs has revealed that two of them (F alpha and F beta) contained both initiation and termination codons, Comparison of F alpha with the thyroid TSH-R cDNA sequence revealed that F alpha was almost identical to the thyroid TSH-R, except that nucleotides 1041 and 1277 were changed from A to G and from C to T, respectively, In contrast, we found that F beta contained 21 novel nucleotides between nucleotides 467 and 468 of the thyroid TSH-R cDNA, encoding an additional 7 amino acids, However, when we prepared mRNA from adipose tissue and transcribed it into cDNA, we failed to amplify the F beta type of TSH-R cDNA by polymerase chain reaction, suggesting that F beta mRNAs are rare in the tissue, We then ligated F cDNAs into pSG5 and transfected them with pSV(2)-neo into Chinese hamster ovary (CHO)-K1 cells. TSH stimulated cAMP formation in CHO-F alpha cells in a manner similar to that in CHO cells transfected with thyroid TSH-R cDNA, In contrast, no increase of cAMP was observed in CHO-F beta cells, IgG from patients with Graves' disease (n = 4) showed thyroid stimulating antibody activity only in CHO-F alpha cells (1288-4582%), In addition, CHO-F alpha cells and CHO cells transfected with thyroid TSH-R showed similar I-125-TSH binding activity, These results indicate that the fat cell expresses high levels of a TSH-R whose function is indistinguishable from that in the thyroid and suggest that the TSH-R autoantibody plays an important role in the pathogenesis of the extrathyroidal manifestations of Graves' disease.	UNIV YAMANASHI,SCH MED,DEPT INTERNAL MED 3,TAMAHO,YAMANASHI 40938,JAPAN	University of Yamanashi								AKAMIZU T, 1990, P NATL ACAD SCI USA, V87, P5677, DOI 10.1073/pnas.87.15.5677; BIRNBAUMER L, 1969, J BIOL CHEM, V244, P3477; BOLONKIN D, 1975, J BIOL CHEM, V250, P6516; CHABAUD O, 1977, MOL CELL ENDOCRINOL, V7, P79, DOI 10.1016/0303-7207(77)90077-6; CHAZENBALK GD, 1990, ENDOCRINOLOGY, V127, P1240, DOI 10.1210/endo-127-3-1240; COLBEREGARAPIN F, 1981, J MOL BIOL, V150, P1, DOI 10.1016/0022-2836(81)90321-1; DAVIES TF, 1978, MOL CELL ENDOCRINOL, V9, P303, DOI 10.1016/0303-7207(78)90072-2; EKHOLM R, 1989, ADV EXPT MED BIOL, V261, P1; ENDO T, 1992, BIOCHEM BIOPH RES CO, V186, P1391, DOI 10.1016/S0006-291X(05)81560-8; ENDO T, 1993, BIOCHEM BIOPH RES CO, V190, P774, DOI 10.1006/bbrc.1993.1116; FAIN JN, 1975, J BIOL CHEM, V250, P6586; FARMER SW, 1972, J CLIN INVEST, V82, P1793; FARMER SW, 1972, ENDOCRINOLOGY, V91, P534; FELICIELLO A, 1993, LANCET, V342, P337, DOI 10.1016/0140-6736(93)91475-2; Francis T, 1991, Thyroid, V1, P223, DOI 10.1089/thy.1991.1.223; FRAZIER AL, 1990, MOL ENDOCRINOL, V4, P1264, DOI 10.1210/mend-4-8-1264; GILL DL, 1978, MOL CELL ENDOCRINOL, V10, P89, DOI 10.1016/0303-7207(78)90062-X; GILL DL, 1978, MOL CELL ENDOCRINOL, V12, P41, DOI 10.1016/0303-7207(78)90100-4; GLIEMANN J, 1972, BIOCHIM BIOPHYS ACTA, V286, P1, DOI 10.1016/0304-4165(72)90082-7; GROSS B, 1991, BIOCHEM BIOPH RES CO, V177, P679, DOI 10.1016/0006-291X(91)91842-Z; GUPTA KC, 1991, INT J MICROWAVE MILL, V1, P1, DOI 10.1002/mmce.4570010102; HARAGUCHI K, 1993, J ENDOCRINOL, V139, P425, DOI 10.1677/joe.0.1390425; HART IR, 1971, ENDOCRINOLOGY, V88, P26, DOI 10.1210/endo-88-1-26; HEUFELDER AE, 1993, THYROID, V3, P297, DOI 10.1089/thy.1993.3.297; HONNOR RC, 1985, J BIOL CHEM, V260, P5122; KOHN LD, 1975, J BIOL CHEM, V250, P6504; LOEFFLER M, 1983, J CLIN ENDOCR METAB, V57, P603, DOI 10.1210/jcem-57-3-603; MANIATIS T, 1982, MOL CLONING LABORATO, P187; MARCUS C, 1988, J CLIN INVEST, V82, P1793, DOI 10.1172/JCI113793; MULLIN BR, 1976, BIOCHEM BIOPH RES CO, V69, P55, DOI 10.1016/S0006-291X(76)80271-9; NAGAYAMA Y, 1992, MOL ENDOCRINOL, V6, P145, DOI 10.1210/me.6.2.145; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; SALVI M, 1988, FEBS LETT, V232, P135, DOI 10.1016/0014-5793(88)80402-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMURA H, 1993, J BIOL CHEM, V268, P24125; Smith B R, 1981, Methods Enzymol, V74 Pt C, P405; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106; TENG CS, 1975, BIOCHEM BIOPH RES CO, V66, P836, DOI 10.1016/0006-291X(75)90585-9; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649; WINAND RJ, 1972, P NATL ACAD SCI USA, V69, P1711, DOI 10.1073/pnas.69.7.1711	40	108	113	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10833	10837		10.1074/jbc.270.18.10833	http://dx.doi.org/10.1074/jbc.270.18.10833			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738021	hybrid			2022-12-27	WOS:A1995QW60100069
J	ZIEGELHOFFER, T; LOPEZBUESA, P; CRAIG, EA				ZIEGELHOFFER, T; LOPEZBUESA, P; CRAIG, EA			THE DISSOCIATION OF ATP FROM HSP70 OF SACCHAROMYCES-CEREVISIAE IS STIMULATED BY BOTH YDJ1P AND PEPTIDE-SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; BINDING-SPECIFICITY; UNFOLDED PROTEINS; DNAJ; AFFINITY; GROEL; GRPE; TRANSLOCATION; POLYPEPTIDES; CHAPERONES	hsp70 proteins of both eukaryotes and prokaryotes possess both ATPase and peptide binding activities, These two activities are crucial for the chaperone activity of hsp70 proteins, The activity of DnaK, the primary hsp70 of Escherichia coli, is modulated by the GrpE and DnaJ proteins, In the yeast Saccharomyces cerevisiae, the predominant cytosolic hsp70, Ssa1p, interacts with a DnaJ homologue, Ydj1p, In order to better understand the function of the Ssa1p/Ydj1p chaperone, the effects of polypeptide substrates and Ydj1p on Ssa1p ATPase activity were assessed using a combination of steady-state kinetic analysis and single turnover substrate hydrolysis experiments, Polypeptide substrates and Ydj1p both serve to stimulate ATPase activity of Ssa1p, The two types of effector are biochemically distinct, each conferring a characteristic K+ dependence on Ssa1p ATPase activity, However, in single turnover ATP hydrolysis experiments, both polypeptide substrates and Ydj1p destabilized the ATP . Ssa1p complex through a combination of accelerated hydrolysis of bound ATP and accelerated release of ATP from Ssa1p, The acceleration of ATP release by Ydj1p is a previously unidentified function of a DnaJ homologue, In the case of Ydj1p-stimulated Ssa1p, steady-state ATPase activity is increased less than g-fold at physiological K+ concentrations, despite a 15-fold increase in the hydrolysis of bound ATP, The primary effect of Ydj1p appears to be to disfavor an ATP form of Ssa1p, On the other hand, peptide stimulation of Ssa1p ATPase activity was enhanced at physiological K+ concentrations, supporting the idea that cycles of ATP hydrolysis play an important role in the interaction of hsp70 with polypeptide substrates, The enhanced ATP dissociation caused by both polypeptide substrates and Ydj1p may play a role in the regulation of Ssa1p chaperone activity by altering the relative abundance of ATP- and ADP-bound forms.	UNIV WISCONSIN,DEPT BIOMOLEC CHEM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison					NIGMS NIH HHS [5 R01 GM31107, 5 F32 GM14394] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM014394, R01GM031107] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATKINSON DE, 1965, J BIOL CHEM, V240, P757; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CEGIELSKA A, 1989, J BIOL CHEM, V264, P21122; CHAPMAN C, 1969, BIOCHEM J, V111, P609, DOI 10.1042/bj1110609; CYR DM, 1992, J BIOL CHEM, V267, P20927; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; CYR DM, 1994, J BIOL CHEM, V269, P9798; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; FINDLY RC, 1983, SCIENCE, V219, P1223, DOI 10.1126/science.6828852; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; GRECO WR, 1982, COMPUT BIOMED RES, V15, P39, DOI 10.1016/0010-4809(82)90051-9; HANEY SA, 1994, J BIOL CHEM, V269, P16541; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HENDRICK JP, 1993, P NATL ACAD SCI USA, V90, P10216, DOI 10.1073/pnas.90.21.10216; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1993, P NATL ACAD SCI USA, V90, P11019, DOI 10.1073/pnas.90.23.11019; MCKAY DB, 1993, ADV PROTEIN CHEM, V44, P67, DOI 10.1016/S0065-3233(08)60564-1; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT, P1; MUKAI H, 1993, GENE, V132, P57; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; PRASAD K, 1994, J BIOL CHEM, V269, P6931; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SHIRAYAMA M, 1993, MOL GEN GENET, V240, P323, DOI 10.1007/BF00280382; STONE DE, 1990, MOL CELL BIOL, V10, P1622, DOI 10.1128/MCB.10.4.1622; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; WANG TF, 1993, J BIOL CHEM, V268, P26049; WETZSTEIN M, 1992, J BACTERIOL, V174, P3300, DOI 10.1128/jb.174.10.3300-3310.1992; WICKNER S, 1991, NATURE, V350, P165, DOI 10.1038/350165a0; [No title captured]	43	80	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10412	10419		10.1074/jbc.270.18.10412	http://dx.doi.org/10.1074/jbc.270.18.10412			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737974	hybrid			2022-12-27	WOS:A1995QW60100012
J	HSU, K; CHANG, DY; MARAIA, RJ				HSU, K; CHANG, DY; MARAIA, RJ			HUMAN SIGNAL RECOGNITION PARTICLE (SRP) ALU-ASSOCIATED PROTEIN ALSO BINDS ALU INTERSPERSED REPEAT SEQUENCE RNAS - CHARACTERIZATION OF HUMAN SRP9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							7SL RNA; SECONDARY STRUCTURE; MESSENGER-RNA; REPETITIVE SEQUENCES; 7SL-RNA COMPONENT; CYTOPLASMIC RNAS; HUMAN GENOME; GENE; EXPRESSION; ELEMENTS	Nearly 1 million interspersed Alu elements reside in the human genome. Alu retrotransposition is presumably mediated by full-length Alu transcripts synthesized by RNA polymerase III, while some polymerase III-synthesized Alu transcripts undergo 3'-processing and accumulate as small cytoplasmic (sc) RNAs of unknown function. Interspersed Alu sequences also reside in the untranslated regions of some mRNAs. The Alu sequence is related to a portion of the 7SL RNA component of signal recognition particle (SRP), This region of 7SL RNA together with 9- and 14-kDa polypeptides (SRP9/14) regulates translational elongation of ribosomes engaged by SRP. Here we characterize human (h) SRP9 and show that it, together with hSRP14 (SRP9/14), forms the activity previously identified as Alu RNA-binding protein (REP), The primate-specific C-terminal tail of hSRP14 does not appreciably affect binding to scAlu RNA. K-d values for three Alu-homologous scRNAs were determined using Alu REP (SRP9/14) purified from HeLa cells. The Alu region of 7SL, scAlu, and scB1 RNAs exhibited K-d values of 203 pM, 318 pM, and 1.8 nM, respectively, Finally, Alu REP can bind with high affinity to synthetic mRNAs that contain interspersed Alus in their untranslated regions.	NICHHD,MOLEC GROWTH REGULAT LAB,BETHESDA,MD 20892; NIH,HOWARD HUGHES MED INST,RES SCHOLARS PROGRAM,HHMI,BETHESDA,MD 20817	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA			Maraia, Richard/ABC-1442-2020	Maraia, Richard/0000-0002-5209-0066				ADENIYIJONES S, 1985, NATURE, V317, P81, DOI 10.1038/317081a0; ANNWEILER A, 1991, NUCLEIC ACIDS RES, V19, P3750, DOI 10.1093/nar/19.13.3750; BOVIA F, 1994, NUCLEIC ACIDS RES, V22, P2028, DOI 10.1093/nar/22.11.2028; CHANG DY, 1993, J BIOL CHEM, V268, P6423; CHANG DY, 1994, MOL CELL BIOL, V14, P3949, DOI 10.1128/MCB.14.6.3949; CHANG DY, 1995, MOL CELL BIOL, P2109; DEININGER PL, 1993, EVOL BIOL, V27, P157; ECONOMOUPACHNIS A, 1985, NUCLEIC ACIDS RES, V13, P8379, DOI 10.1093/nar/13.23.8379; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; GIORDANO T, 1990, NUCLEIC ACIDS RES, V18, P4627, DOI 10.1093/nar/18.15.4627; GUNDELFINGER ED, 1983, NUCLEIC ACIDS RES, V11, P7363, DOI 10.1093/nar/11.21.7363; GUNDELFINGER ED, 1984, EMBO J, V3, P2325, DOI 10.1002/j.1460-2075.1984.tb02134.x; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; JAGADEESWARAN P, 1981, CELL, V26, P141, DOI 10.1016/0092-8674(81)90296-8; JANIAK F, 1992, BIOCHEMISTRY-US, V31, P5830, DOI 10.1021/bi00140a019; JELINEK WR, 1982, ANNU REV BIOCHEM, V51, P813, DOI 10.1146/annurev.bi.51.070182.004121; KRAMEROV DA, 1979, NUCLEIC ACIDS RES, V6, P697, DOI 10.1093/nar/6.2.697; KRAMEROV DA, 1982, NUCLEIC ACIDS RES, V10, P7477, DOI 10.1093/nar/10.23.7477; LABUDA D, 1991, J MOL EVOL, V32, P405, DOI 10.1007/BF02101280; LARSEN N, 1991, NUCLEIC ACIDS RES, V19, P209, DOI 10.1093/nar/19.2.209; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LOWREY DM, 1989, P NATL ACAD SCI USA, V86, P247, DOI 10.1073/pnas.86.1.247; MARAIA R, 1988, MOL CELL BIOL, V8, P4433, DOI 10.1128/MCB.8.10.4433; MARAIA RJ, 1993, MOL CELL BIOL, V13, P4233, DOI 10.1128/MCB.13.7.4233; MARAIA RJ, 1991, NUCLEIC ACIDS RES, V19, P5695, DOI 10.1093/nar/19.20.5695; MATERA AG, 1990, MOL CELL BIOL, V10, P5424, DOI 10.1128/MCB.10.10.5424; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; MURATANI K, 1991, P NATL ACAD SCI USA, V88, P11315, DOI 10.1073/pnas.88.24.11315; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; PAN J, 1981, NUCLEIC ACIDS RES, V9, P1151; PANACCIO M, 1987, P NATL ACAD SCI USA, V84, P6874, DOI 10.1073/pnas.84.19.6874; PANNING B, 1993, MOL CELL BIOL, V13, P3231, DOI 10.1128/MCB.13.6.3231; PANNING B, 1994, VIROLOGY, V202, P408, DOI 10.1006/viro.1994.1357; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; Schmid C, 1992, CURR OPIN GENET DEV, V2, P874, DOI 10.1016/S0959-437X(05)80110-8; SCHMID CW, 1990, CHROMOSOMES EUKARYOT, P3; SCHMID CW, 1985, MOL EVOLUTIONARY GEN, P323; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1988, TRENDS BIOCHEM SCI, V13, P314, DOI 10.1016/0968-0004(88)90127-2; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; SINGER MF, 1982, CELL, V28, P433, DOI 10.1016/0092-8674(82)90194-5; SINNETT D, 1991, J BIOL CHEM, V266, P8675; SRIVASTAVA R, 1987, P NATL ACAD SCI USA, V84, P4224, DOI 10.1073/pnas.84.12.4224; STOPPALYONNET D, 1990, P NATL ACAD SCI USA, V87, P1551, DOI 10.1073/pnas.87.4.1551; STRUB K, 1990, MOL CELL BIOL, V10, P777, DOI 10.1128/MCB.10.2.777; STRUB K, 1989, P NATL ACAD SCI USA, V86, P9747, DOI 10.1073/pnas.86.24.9747; STRUB K, 1991, MOL CELL BIOL, V11, P3949, DOI 10.1128/MCB.11.8.3949; STRUB K, 1993, TRANSLATIONAL APPARATUS, P635; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; ULLU E, 1984, EMBO J, V3, P3303, DOI 10.1002/j.1460-2075.1984.tb02294.x; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; VANARSDELL SW, 1981, CELL, V26, P11, DOI 10.1016/0092-8674(81)90028-3; VIDAL F, 1993, P NATL ACAD SCI USA, V90, P208, DOI 10.1073/pnas.90.1.208; VIDAUD D, 1989, EUR J HUM GENET, V1, P30; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WALTER P, 1983, CELL, V34, P525, DOI 10.1016/0092-8674(83)90385-9; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WEINER AM, 1980, CELL, V22, P209, DOI 10.1016/0092-8674(80)90169-5; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; ZWIEB C, 1985, NUCLEIC ACIDS RES, V13, P6105, DOI 10.1093/nar/13.17.6105	63	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10179	10186		10.1074/jbc.270.17.10179	http://dx.doi.org/10.1074/jbc.270.17.10179			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730321	hybrid			2022-12-27	WOS:A1995QV41700068
J	KOMISSAROV, AA; ROMANOVA, DV; DEBABOV, VG				KOMISSAROV, AA; ROMANOVA, DV; DEBABOV, VG			COMPLETE INACTIVATION OF ESCHERICHIA-COLI URIDINE PHOSPHORYLASE BY MODIFICATION OF ASP(5) WITH WOODWARDS REAGENT-K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; MOLECULAR-PROPERTIES; CARBOXYL GROUPS; ACTIVE-SITE; ENZYME; CRYSTALLIZATION; QUANTITATION; RESOLUTION; PROTEINS; SEQUENCE	Woodward's reagent K (WRK) completely inactivated Escherichia coli uridine phosphorylase by reversible binding in the active site (K-i = 0.07 mM) with subsequent modification of a carboxyl (k(2) = 1.2 min(-1)). Neither substrate alone protected uridine phosphorylase from inactivation. The presence of phosphate did not affect the K-i and k(2) values. The addition of uracil or uridine led to a significant increase of both K-i (to 2.5 or 2.1 mM, respectively) and k(2) (to 6.1 or 4.8 min(-1), respectively) values. Thus, WRK could react in accordance with slow (high affinity) and fast (low affinity) mechanisms. Combined addition of phosphate and uracil completely protected uridine phosphorylase. Tryptic digestion yielded a single modified peptide (Ser(4)-Asp(WRK)-Val-Phe-His-Leu-Gly-Leu-Thr-Lys(13)). Treatment of the modified enzyme with hydroxylamine led to removal of the bulky WRK residue and replacement of the Asp(5) carboxyl by a hydroxamic group. The enzyme thus obtained recovered about 10% of initial specific activity, whereas its substrate binding ability changed only moderately; the K-m values for phosphate and uridine were changed from 5.1 and 0.19 mM (or 7.3 and 0.14 mM according to Leer et al. (Leer, J. C., Hammer-Jespersen, K., and M. Schwartz (1977) Eur. J. Biochem. 75, 217-224)) to 22.6 and 0.12 mM, respectively. The hydroxamic enzyme had higher thermostability than the native enzyme. The results obtained demonstrated the importance of the carboxyl at position 5. The loss of activity after selective group replacement is due to impaired stabilization of the transition state rather than to a decline in substrate affinity or change of the active site structure.	RUSSIAN FEDERAT GNII GENET,STATE SCI CTR,MOSCOW 113545,RUSSIA									BOSE R, 1974, BIOCHEMISTRY-US, V13, P2051, DOI 10.1021/bi00707a008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAKE AJ, 1974, J BIOL CHEM, V249, P5452; BRYKUN IA, 1989, GENETIKA+, V25, P1717; COOK WJ, 1987, J BIOL CHEM, V262, P2852; DRABIKOWSKA AK, 1990, BIOCHEM J, V270, P319, DOI 10.1042/bj2700319; EALICK SE, 1990, J BIOL CHEM, V265, P1812; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; IIGO M, 1990, BIOCHEM PHARMACOL, V39, P1247; KOMISSAROV AA, 1994, BBA-PROTEIN STRUCT M, V1205, P54, DOI 10.1016/0167-4838(94)90091-4; KOMISSAROV AA, 1994, FEBS LETT, V355, P192, DOI 10.1016/0014-5793(94)01204-0; KOMISSAROV AA, 1993, PHARM WORLD SCI F, V15, P20; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEER JC, 1977, EUR J BIOCHEM, V75, P217, DOI 10.1111/j.1432-1033.1977.tb11520.x; Magni G, 1978, Methods Enzymol, V51, P290; MIKHAILOV AM, 1992, BIOCHEM INT, V26, P607; MOOSER G, 1991, J BIOL CHEM, V266, P8916; NAGUIB FNM, 1987, BIOCHEM PHARMACOL, V36, P2195, DOI 10.1016/0006-2952(87)90150-X; PETRA PH, 1971, BIOCHEMISTRY-US, V10, P3163, DOI 10.1021/bi00793a001; Raznikov A V, 1992, Biokhimiia, V57, P1902; SCHWARTZ PM, 1985, BIOCHEM PHARMACOL, V34, P3585, DOI 10.1016/0006-2952(85)90737-3; SINHA U, 1985, ANAL BIOCHEM, V151, P327, DOI 10.1016/0003-2697(85)90183-6; TISHKOV VI, 1983, BIOORG KHIM+, V9, P1341; TSUPRUN V L, 1991, Biokhimiya, V56, P930; VERES Z, 1988, EUR J BIOCHEM, V178, P173, DOI 10.1111/j.1432-1033.1988.tb14441.x; VITA A, 1986, INT J BIOCHEM, V18, P431, DOI 10.1016/0020-711X(86)90185-0; WALTER MR, 1990, J BIOL CHEM, V265, P14016; WALTON L, 1989, NUCLEIC ACIDS RES, V17, P6741, DOI 10.1093/nar/17.16.6741	28	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10050	10055		10.1074/jbc.270.17.10050	http://dx.doi.org/10.1074/jbc.270.17.10050			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730307	hybrid			2022-12-27	WOS:A1995QV41700052
J	POSAS, F; CAMPS, M; ARINO, JQ				POSAS, F; CAMPS, M; ARINO, JQ			THE PPZ PROTEIN PHOSPHATASES ARE IMPORTANT DETERMINANTS OF SALT TOLERANCE IN YEAST-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; KINASE GENE; ATPASE; DOWNSTREAM; TRANSPORT; MUTATIONS; HOMOLOGS; PATHWAY; TRK1; PAIR	Protein phosphatases PPZ1 and PPZ2 represent a novel form of Ser/Thr phosphatases structurally related to type 1 phosphatases and characterized by an unusual amino-terminal region. We have found that the deletion of PPZ1 gene results in increased tolerance to Na+ and Li+ cations. Simultaneous deletion of PPZ2 gene results in an additional increase in salt tolerance. After exposure to high concentration of Li+, the intracellular content of the cation was markedly decreased in ppz1 Delta ppz2 Delta mutants when compared to wild type cells. No significant differences were observed between both strains when the Li+ influx was measured, but ppz1 Delta ppz2 Delta mutants eliminated Li+ more efficiently than wild type cells. This can be explained by the fact that expression of the ENA1 gene, which encodes the major component of the efflux system for these cations, is strongly increased in ppz1 Delta ppz2 Delta cells. As expected, the disruption of the PPZ genes did not complement the characteristic hypersensitivity for Na+ and Li+ of a ena1 Delta strain. The lack of protein phosphatase 2B (calcineurin) has been found to decrease salt resistance by reducing the expression of the ENA1 gene. We have observed that the disruption of the PPZ genes substantially enhances the resistance of the hypersensitive calcineurin-deficient mutants. Since PPZ phosphatases have been found to be functionally related to the protein kinase C/mitogen-activated kinase pathway, we have tested bck1 or mpk1/slt2 deletion mutants and found that they do not display altered salt sensitivity. However, disruption of PPZ1 fails to increase salt resistance in a mpk1/slt2 background. In conclusion, we postulate the existence in yeast of a novel PPZ-mediated pathway involved in salt homeostasis that is opposite to and independent of the recently described calcineurin-mediated pathway.	UNIV AUTONOMA BARCELONA,FAC VET,DEPT BIOQUIM & BIOL MOLEC,E-08193 BARCELONA,SPAIN	Autonomous University of Barcelona			Arino, Joaquin/D-3756-2011; Posas, Francesc/K-1364-2013; Zhang, Ning/F-1387-2014	Arino, Joaquin/0000-0002-6774-2987; Posas, Francesc/0000-0002-4164-7076; Arino Carmona, Joaquin/0000-0002-0390-4270				COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; GABER RF, 1988, MOL CELL BIOL, V8, P2848, DOI 10.1128/MCB.8.7.2848; GALLWITZ D, 1980, P NATL ACAD SCI-BIOL, V77, P2546, DOI 10.1073/pnas.77.5.2546; GARCIADEBLAS B, 1993, MOL GEN GENET, V236, P363, DOI 10.1007/BF00277134; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; GAXIOLA R, 1992, EMBO J, V11, P3157, DOI 10.1002/j.1460-2075.1992.tb05392.x; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; HARO R, 1993, PHYSIOL PLANTARUM, V89, P868, DOI 10.1111/j.1399-3054.1993.tb05298.x; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; HUGHERS V, 1993, EUR J BIOCHEM, V216, P2669; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; LEE KS, 1993, MOL CELL BIOL, V13, P5843, DOI 10.1128/MCB.13.9.5843; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; LEVIN DE, 1993, J NIH RES, V5, P49; MARTINEZ R, 1991, MOL GEN GENET, V227, P149, DOI 10.1007/BF00260720; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; MURGUIA JR, 1995, SCIENCE, V267, P232; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; POSAS F, 1993, FEBS LETT, V318, P282, DOI 10.1016/0014-5793(93)80529-4; POSAS F, 1992, J BIOL CHEM, V267, P11734; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; RODRIGUEZNAVARRO A, 1981, BIOCHIM BIOPHYS ACTA, V640, P352, DOI 10.1016/0005-2736(81)90558-7; RODRIGUEZNAVARRO A, 1994, BBA-BIOENERGETICS, V1187, P203, DOI 10.1016/0005-2728(94)90111-2; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Sherman F., 1986, METHODS YEAST GENETI; SKALA J, 1991, YEAST, V7, P651, DOI 10.1002/yea.320070614; TORRES L, 1991, MOL MICROBIOL, V5, P2845, DOI 10.1111/j.1365-2958.1991.tb01993.x; TRECO DA, 1989, CURRENT PROTOCOLS MO, V2; WARD MP, 1994, MOL CELL BIOL, V14, P5619, DOI 10.1128/MCB.14.9.5619; WELIHINDA AA, 1994, BBA-BIOMEMBRANES, V1193, P107, DOI 10.1016/0005-2736(94)90339-5	34	122	123	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13036	13041		10.1074/jbc.270.22.13036	http://dx.doi.org/10.1074/jbc.270.22.13036			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768897	hybrid			2022-12-27	WOS:A1995RB43900018
J	CHANG, PY; GOODYEAR, LJ; BENECKE, H; MARKUNS, JS; MOLLER, DE				CHANG, PY; GOODYEAR, LJ; BENECKE, H; MARKUNS, JS; MOLLER, DE			IMPAIRED INSULIN SIGNALING IN SKELETAL-MUSCLES FROM TRANSGENIC MICE EXPRESSING KINASE-DEFICIENT INSULIN-RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; TYROSINE KINASE; MONOCLONAL-ANTIBODIES; SUBSTRATE PHOSPHORYLATION; TRANSFECTED CELLS; OBESE MICE; STIMULATION; PROTEIN; RAT	Transgenic mice which overexpress kinase-deficient human insulin receptors in muscle were used to study the relationship between insulin receptor tyrosine kinase and the in vivo activation of several downstream signaling pathways. Intravenous insulin stimulated insulin receptor tyrosine kinase activity by 7-fold in control muscle versus less than or equal to 1.5-fold in muscle from transgenic mice. Similarly, insulin failed to stimulate tyrosyl phosphorylation of receptor beta-subunits or insulin receptor substrate 1 (IRS-1) in transgenic muscle, Insulin substantially stimulated IRS-1 associated phosphatidylinositol (PI) 3-kinase in control versus absent stimulation in transgenic muscles. In contrast, insulin-like growth factor 1 modestly stimulated PI 3-kinase in both control and transgenic muscle, The effects of insulin to stimulate p42 mitogen activated protein kinase and c-fos mRNA expression were also markedly impaired in transgenic muscle. Specific immunoprecipitation of human receptors followed by measurement of residual insulin receptors suggested the presence of hybrid mouse-human heterodimers, In contrast, negligible hybrid formation involving insulin-like growth factor 1 receptors was evident, We conclude that (i) transgenic expression of kinase-defective insulin receptors exerts dominant-negative effects at the level of receptor autophosphorylation and kinase activation; (ii) insulin receptor tyrosine kinase activity is required for in vivo insulin-stimulated IRS-1 phosphorylation, IRS-1-associated PI 3-kinase activation, phosphorylation of mitogen-activated protein kinase, and c-fos gene induction in skeletal muscle; (iii) hybrid receptor formation is likely to contribute to the in vivo dominant-negative effects of kinase-defective receptor expression.	BETH ISRAEL HOSP, DEPT MED, CHARLES A DANA RES INST, BOSTON, MA 02215 USA; BETH ISRAEL HOSP, DEPT MED, HARVARD THORNDIKE LAB, BOSTON, MA 02215 USA; JOSLIN DIABET CTR, DIV RES, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School				Markuns, Jeffrey/0000-0002-8044-2575	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR042238] Funding Source: NIH RePORTER; NIAMS NIH HHS [R29-AR42238] Funding Source: Medline; PHS HHS [R01 45874-01] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BACKER JM, 1992, J BIOL CHEM, V267, P1367; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; CHANG PY, 1994, J BIOL CHEM, V269, P16034; CHIN JE, 1991, J BIOL CHEM, V266, P15587; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEBANT A, 1988, P NATL ACAD SCI USA, V85, P8032, DOI 10.1073/pnas.85.21.8032; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; ELDREDGE ER, 1994, MOL CELL BIOL, V14, P7527, DOI 10.1128/MCB.14.11.7527; FOLLI F, 1992, J BIOL CHEM, V267, P22171; GIORGINO F, 1992, ENDOCRINOLOGY, V130, P1433, DOI 10.1210/en.130.3.1433; GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424; GOTTSCHALK WK, 1991, J BIOL CHEM, V266, P8814; GRAKO KA, 1994, MOL ENDOCRINOL, V8, P682, DOI 10.1210/me.8.6.682; GRIGORESCU F, 1984, J BIOL CHEM, V259, P5003; HARING H, 1989, DIABETES METAB REV, V5, P431; HAWLEY DM, 1989, J BIOL CHEM, V264, P2438; HEI YJ, 1993, J BIOL CHEM, V268, P13203; HEYDRICK SJ, 1993, J CLIN INVEST, V91, P1358, DOI 10.1172/JCI116337; JACOB R, 1989, J CLIN INVEST, V83, P1717, DOI 10.1172/JCI114072; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KLEIN HH, 1993, DIABETES, V42, P883, DOI 10.2337/diabetes.42.6.883; LEE CH, 1993, P NATL ACAD SCI USA, V90, P11713, DOI 10.1073/pnas.90.24.11713; LEMARCHANDBRUST.Y, 1982, AM J PHYSIOL, V243, pE74; LEMARCHANDBRUSTEL Y, 1985, NATURE, V315, P676, DOI 10.1038/315676a0; LEVYTOLEDANO R, 1994, EMBO J, V13, P835, DOI 10.1002/j.1460-2075.1994.tb06326.x; MAEGAWA H, 1988, J BIOL CHEM, V263, P12629; MCCLAIN DA, 1990, J BIOL CHEM, V265, P1678; MOLLER DE, 1990, J BIOL CHEM, V265, P14979; MOLLER DE, 1991, J BIOL CHEM, V266, P10995; MOUNTJOY KG, 1990, BIOCHEM BIOPH RES CO, V169, P978, DOI 10.1016/0006-291X(90)91990-A; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; OLSON AL, 1994, ENDOCRINOLOGY, V134, P271, DOI 10.1210/en.134.1.271; OSTEROP APRM, 1992, J BIOL CHEM, V267, P14647; PANG L, 1993, BIOCHEM BIOPH RES CO, V196, P301, DOI 10.1006/bbrc.1993.2249; PRICE DJ, 1990, P NATL ACAD SCI USA, V87, P7944, DOI 10.1073/pnas.87.20.7944; RAFAELOFF R, 1991, BIOCHEM BIOPH RES CO, V179, P912, DOI 10.1016/0006-291X(91)91905-R; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; SELVA E, 1993, J BIOL CHEM, V268, P2250; SOOS MA, 1989, P NATL ACAD SCI USA, V86, P5217, DOI 10.1073/pnas.86.14.5217; STEELEPERKINS G, 1990, J BIOL CHEM, V265, P9458; STUMPO DJ, 1988, J BIOL CHEM, V263, P1611; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TAUB R, 1987, J BIOL CHEM, V262, P10893; Taylor Simeon I., 1993, P83; TOLLEFSEN SE, 1989, J BIOL CHEM, V264, P13810; TREADWAY JL, 1991, P NATL ACAD SCI USA, V88, P214, DOI 10.1073/pnas.88.1.214; UENO H, 1993, J BIOL CHEM, V268, P22814; UENO H, 1992, J BIOL CHEM, V267, P1470; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WHITE MF, 1994, INSULIN RESISTANCE, P9; WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358; WILDEN PA, 1994, MOL ENDOCRINOL, V8, P558, DOI 10.1210/me.8.5.558; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; YONEZAWA K, 1991, MOL ENDOCRINOL, V5, P194, DOI 10.1210/mend-5-2-194; ZHOU GX, 1993, BIOCHEM BIOPH RES CO, V197, P578, DOI 10.1006/bbrc.1993.2518	58	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12593	12600		10.1074/jbc.270.21.12593	http://dx.doi.org/10.1074/jbc.270.21.12593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759507	hybrid			2022-12-27	WOS:A1995QZ71100042
J	GE, LM; LUPAS, A; PERALDIROUX, S; SPADA, S; PLUCKTHUN, A				GE, LM; LUPAS, A; PERALDIROUX, S; SPADA, S; PLUCKTHUN, A			A MOUSE IG-KAPPA DOMAIN OF VERY UNUSUAL FRAMEWORK STRUCTURE LOSES FUNCTION WHEN CONVERTED TO THE CONSENSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI TRYPTOPHAN SYNTHASE; CRYSTAL-STRUCTURE; V(H) SEGMENTS; SOLUBLE FORM; PROTEIN; LAMBDA; REPERTOIRE; SEQUENCES; GENERATION; RESOLUTION	Antibody gene sequences, particularly those of kappa light chains, are very well conserved in the framework region, and the variability is concentrated in the complementar ity-determining regions (CDR). We now found that the murine antibody 93-6 (Djavadi-Ohaniance, L., Friguet, B., and Goldberg, M. (1984) Biochemistry 23, 97-104) whose F-ab fragment binds the beta-subunit of Escherichia coli tryptophan synthase with high affinity (K-d of 6.7.10(-9) M) has a highly unusual kappa light chain framework, which is crucial for the function of this antibody. It carries an insertion of 8 amino acids in a conserved framework loop that faces the antigen, and its framework region 2 (FR2) which precedes CDR2 is shortened by one amino acid, normally leucine and part of an absolutely conserved beta-bulge preceding CDR2. Removal of the insertion to restore the consensus sequence reduced the binding affinity of 93-6 by a factor 3, while insertion of the missing leucine into FR2 completely abolished binding.	UNIV ZURICH, INST BIOCHEM, CH-8057 ZURICH, SWITZERLAND; MAX PLANCK INST BIOCHEM, PROT ENGN GRP, D-82152 MARTINSRIED, GERMANY	University of Zurich; Max Planck Society			Plückthun, Andreas/C-2746-2009	Plückthun, Andreas/0000-0003-4191-5306				BRELIER AM, 1990, J BIOL CHEM, V265, P7987; CHEN BL, 1974, BIOCHEMISTRY-US, V13, P1295, DOI 10.1021/bi00703a037; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; COX JPL, 1994, EUR J IMMUNOL, V24, P827, DOI 10.1002/eji.1830240409; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; DJAVADIOHANIANCE L, 1984, BIOCHEMISTRY-US, V23, P97, DOI 10.1021/bi00296a016; FRIGUET B, 1989, RES IMMUNOL, V140, P355, DOI 10.1016/0923-2494(89)90142-9; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; FRIGUET B, 1993, J IMMUNOL METHODS, V158, P243, DOI 10.1016/0022-1759(93)90220-2; GE L, 1995, EXPRESSING ANTIBODIE, P229; GLOCKSHUBER R, 1990, BIOCHEMISTRY-US, V29, P1362, DOI 10.1021/bi00458a002; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; Kabat EA, 1991, SEQUENCES PROTEINS I; KNAPPIK A, 1994, BIOTECHNIQUES, V17, P754; LAUTNERRIESKE A, 1993, GENOMICS, V16, P497, DOI 10.1006/geno.1993.1216; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; Lindner Peter, 1992, Methods (Orlando), V4, P41, DOI 10.1016/1046-2023(92)90055-D; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; PRESS EM, 1970, BIOCHEM J, V117, P641, DOI 10.1042/bj1170641; REES AR, 1994, TRENDS BIOTECHNOL, V12, P199, DOI 10.1016/0167-7799(94)90083-3; SANCHEZ P, 1990, J IMMUNOL, V144, P2816; SELSING E, 1982, P NATL ACAD SCI-BIOL, V79, P4681, DOI 10.1073/pnas.79.15.4681; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; SIMON T, 1992, PROTEIN ENG, V5, P229, DOI 10.1093/protein/5.3.229; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; WANG AC, 1973, BIOCHEMISTRY-US, V12, P528, DOI 10.1021/bi00727a027; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WEICHHOLD GM, 1993, GENOMICS, V16, P503, DOI 10.1006/geno.1993.1217; WILLIAMS SC, 1993, EUR J IMMUNOL, V23, P1456, DOI 10.1002/eji.1830230709	34	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12446	12451		10.1074/jbc.270.21.12446	http://dx.doi.org/10.1074/jbc.270.21.12446			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759486	hybrid			2022-12-27	WOS:A1995QZ71100019
J	ROSSMANITH, W; TULLO, A; POTUSCHAK, T; KARWAN, R; SBISA, E				ROSSMANITH, W; TULLO, A; POTUSCHAK, T; KARWAN, R; SBISA, E			HUMAN MITOCHONDRIAL TRANSFER-RNA PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA GENES; RIBONUCLEASE-P; DNA; GENOME; MRP; TRANSCRIPTION; PRECURSORS; SEQUENCE; REPLICATION; NUCLEASES	tRNA processing is a central event in mammalian mitochondrial gene expression. We have identified key enzymatic activities (ribonuclease P, precursor tRNA 3'-endonuclease, and ATP(CTP)-tRNA-specific nucleotidyltransferase) that are involved in HeLa cell mitochondrial tRNA maturation. Different mitochondrial tRNA precursors are cleaved precisely at the tRNA 5'- and 3'-ends in a homologous mitochondrial in vitro processing system, The cleavage at the 5'-end precedes that at the 3'-end, and the tRNAs are substrates for the specific CCA addition in the same in vitro system, Using a comparative enzymatic approach as well as biochemical and immunological techniques, we furthermore demonstrate that human cells contain two distinct enzymes that remove 5'-extensions from tRNA precursors, the previously characterized nuclear and the newly identified mitochondrial ribonuclease P. These two cellular isoenzymes have different substrate specificities that seem to be well adapted to their structurally disparate mitochondrial and nuclear tRNA substrates. This kind of approach may also help to understand the structural diversities and commonalities of tRNAs.	UNIV VIENNA, INST TUMORBIOL KREBSFORSCH, A-1010 VIENNA, AUSTRIA; CNR, CTR STUDIO MITOCONDRI & METAB ENERGET, I-70126 BARI, ITALY	University of Vienna; Consiglio Nazionale delle Ricerche (CNR)			Sbisa', Elisabetta/AAW-9727-2020; Tullo, Apollonia/AAX-1079-2020; Rossmanith, Walter/F-3662-2010	Tullo, Apollonia/0000-0002-5081-4745; Rossmanith, Walter/0000-0003-2337-2248; Potuschak, Thomas/0000-0002-2632-4981				ALTMAN S, 1971, NATURE-NEW BIOL, V233, P35, DOI 10.1038/newbio233035a0; ALTMAN S, 1993, FASEB J, V7, P7, DOI 10.1096/fasebj.7.1.7916700; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Attardi Giuseppe, 1993, P9; BARTKIEWICZ M, 1989, GENE DEV, V3, P488, DOI 10.1101/gad.3.4.488; BECKLER GS, 1992, PROMEGA NOTES, V39, P12; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; CHEN JY, 1988, J BIOL CHEM, V263, P13677; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; England T E, 1980, Methods Enzymol, V65, P65; FRONTALI L, 1982, NUCLEIC ACIDS RES, V10, P7283, DOI 10.1093/nar/10.22.7283; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GOLD HA, 1988, P NATL ACAD SCI USA, V85, P5483, DOI 10.1073/pnas.85.15.5483; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HANICJOYCE PJ, 1990, J BIOL CHEM, V265, P13782; Hopper AK, 1992, MOL CELLULAR BIOL YE, P99; KARWAN R, 1991, GENE DEV, V5, P1264, DOI 10.1101/gad.5.7.1264; KARWAN R, 1993, FEBS LETT, V319, P1, DOI 10.1016/0014-5793(93)80025-P; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; KISS T, 1992, CELL, V70, P11, DOI 10.1016/0092-8674(92)90528-K; KOSKI RA, 1976, CELL, V9, P101, DOI 10.1016/0092-8674(76)90056-8; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; MANAM S, 1987, J BIOL CHEM, V262, P10272; MARTIN NC, 1985, J BIOL CHEM, V260, P1479; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; MUKERJI SK, 1972, J BIOL CHEM, V247, P481; NARDELLI M, 1994, FEBS LETT, V344, P10, DOI 10.1016/0014-5793(94)00342-4; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; OOMMEN A, 1992, MOL CELL BIOL, V12, P865, DOI 10.1128/MCB.12.2.865; PALLESCHI C, 1984, EMBO J, V3, P1389, DOI 10.1002/j.1460-2075.1984.tb01982.x; POTUSCHAK T, 1993, NUCLEIC ACIDS RES, V21, P3239, DOI 10.1093/nar/21.14.3239; ROBERTSON HD, 1972, J BIOL CHEM, V247, P5243; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; ROSSMANITH W, 1993, MOL BIOL REP, V18, P29, DOI 10.1007/BF01006892; SACCONE C, 1994, PRINCIPLES MED BIO B, V1, P39; Sambrook J, 1989, MOL CLONING LABORATO; SBISA E, 1992, FEBS LETT, V296, P311, DOI 10.1016/0014-5793(92)80311-4; SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100; STAHL DA, 1989, NUCLEIC ACIDS SEQUEN, P137; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; TAPPER DP, 1983, METHOD ENZYMOL, V97, P426; TULLO A, 1995, EUR J BIOCHEM, V227, P657, DOI 10.1111/j.1432-1033.1995.tb20185.x	47	127	127	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12885	12891		10.1074/jbc.270.21.12885	http://dx.doi.org/10.1074/jbc.270.21.12885			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759547	hybrid			2022-12-27	WOS:A1995QZ71100084
J	THOLANIKUNNEL, BG; GRANNEMAN, JG; MALBON, CC				THOLANIKUNNEL, BG; GRANNEMAN, JG; MALBON, CC			THE M(R)-35,000 BETA-ADRENERGIC-RECEPTOR MESSENGER-RNA-BINDING PROTEIN BINDS TRANSCRIPTS OF G-PROTEIN-LINKED RECEPTORS WHICH UNDERGO AGONIST-INDUCED DESTABILIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; 3' UNTRANSLATED REGION; CELL-FREE SYSTEM; MOLECULAR-CLONING; BETA-3-ADRENERGIC RECEPTOR; GENE-EXPRESSION; DOWN-REGULATION; RICH DOMAINS; TURNOVER	The M(r) 35,000 beta-adrenergic receptor mRNA-binding protein, termed beta-ARB protein, is induced by beta-adrenergic agonists and binds to beta(2)-receptor mRNAs that display agonist-induced destabilization. Recently a cognate sequence in the mRNA was identified that provides for recognition by beta-ARE protein. In the present work we test the ability of the beta-ARB to discriminate among G-protein-linked receptor mRNAs that either do or do not display agonist-induced destabilization and test the predictive value of the presence of the cognate sequence to identify receptors displaying post-transcriptional regulation. Transcripts of beta(2)-, but not rat beta(1)-, rat beta(3)-, or human beta(3)-adrenergic receptors bind beta-ARB protein, linking agonist-induced destabilization of mRNA to transcripts with the cognate sequence. Scanning GeneBank for G-protein-linked receptor transcripts with the cognate sequence revealed several candidates, including the thrombin receptor. We demonstrate that the thrombin receptor mRNA is recognized by beta-ARB protein and like the beta(2)-receptor is regulated post-transcriptionally by agonist and cAMP. Thus, the domain of regulation by beta-ARB protein includes transcripts of G-protein-linked receptors other than beta(2)-adrenergic receptors.	SUNY STONY BROOK, UNIV MED CTR, DEPT PHARMACOL, DIABET & METAB DIS RES PROGRAM, STONY BROOK, NY 11794 USA; WAYNE STATE UNIV, DEPT PSYCHIAT, DETROIT, MI 48201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Wayne State University			malbon, craig/ABF-3604-2020		NIDDK NIH HHS [DK25410] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025410] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERTA JA, 1994, J BIOL CHEM, V269, P4532; BAHOU WF, 1991, J CLIN INVESTI, V91, P1405; BAHOUTH SW, 1992, MOL PHARMACOL, V42, P971; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; BRASS LF, 1991, J BIOL CHEM, V266, P958; BRASS LF, 1992, J BIOL CHEM, V267, P6044; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BRAWERMAN G, 1987, CELL, V48, P5, DOI 10.1016/0092-8674(87)90346-1; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; CHEN CYA, 1994, MOL CELL BIOL, V14, P416, DOI 10.1128/MCB.14.1.416; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEVELAND DW, 1988, TRENDS BIOCHEM SCI, V13, P339, DOI 10.1016/0968-0004(88)90103-X; COLLINS S, 1988, J BIOL CHEM, V263, P9067; COLLINS S, 1991, ANNU REV PHYSIOL, V53, P497, DOI 10.1146/annurev.physiol.53.1.497; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DREYFUSS G, 1986, ANNU REV CELL BIOL, V2, P459, DOI 10.1146/annurev.cellbio.2.1.459; GRANNEMAN JG, 1994, ENDOCRINOLOGY, V135, P1025, DOI 10.1210/en.135.3.1025; GRANNEMAN JG, 1992, ENDOCRINOLOGY, V130, P109, DOI 10.1210/en.130.1.109; GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895; GRANNEMAN JG, 1995, IN PRESS J AM PHYSL; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P5021, DOI 10.1073/pnas.85.14.5021; HADCOCK JR, 1989, J BIOL CHEM, V264, P13956; HADCOCK JR, 1989, J BIOL CHEM, V264, P19928; HADCOCK JR, 1991, TRENDS NEUROSCI, V14, P242, DOI 10.1016/0166-2236(91)90124-D; HADCOCK JR, 1993, J NEUROCHEM, V60, P1, DOI 10.1111/j.1471-4159.1993.tb05816.x; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; HOUGH C, 1990, BIOCHEM BIOPH RES CO, V170, P46, DOI 10.1016/0006-291X(90)91238-N; HUANG LY, 1993, J BIOL CHEM, V268, P25769; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LELIAS JM, 1993, FEBS LETT, V324, P127, DOI 10.1016/0014-5793(93)81377-C; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; PEI R, 1988, MOL CELL BIOL, V8, P2860, DOI 10.1128/MCB.8.7.2860; PELTZ SW, 1991, CRIT REV EUKAR GENE, V1, P99; PORT JD, 1992, J BIOL CHEM, V267, P24103; RAGHOW R, 1987, TRENDS BIOCHEM SCI, V12, P358, DOI 10.1016/0968-0004(87)90165-4; ROSS J, 1988, MOL BIOL MED, V5, P1; SCARPACE PJ, 1985, MOL PHARMACOL, V28, P495; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; STEITZ JA, 1982, COLD SPRING HARB SYM, V47, P893, DOI 10.1101/SQB.1983.047.01.103; STOLLE CA, 1988, GENE, V62, P65, DOI 10.1016/0378-1119(88)90580-X; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; VAKALOPOULOU E, 1991, MOL CELL BIOL, V11, P3355, DOI 10.1128/MCB.11.6.3355; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WILUSZ J, 1990, MOL CELL BIOL, V10, P6397, DOI 10.1128/MCB.10.12.6397; WILUSZ J, 1988, CELL, V52, P221, DOI 10.1016/0092-8674(88)90510-7; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; WRESCHNER DH, 1988, EUR J BIOCHEM, V172, P333, DOI 10.1111/j.1432-1033.1988.tb13891.x	57	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12787	12793		10.1074/jbc.270.21.12787	http://dx.doi.org/10.1074/jbc.270.21.12787			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759533	hybrid			2022-12-27	WOS:A1995QZ71100070
J	KAPAZOGLOU, A; SAGLIOCCO, F; DURE, L				KAPAZOGLOU, A; SAGLIOCCO, F; DURE, L			PSII-T, A NEW NUCLEAR-ENCODED LUMENAL PROTEIN FROM PHOTOSYSTEM-II - TARGETING AND PROCESSING IN ISOLATED-CHLOROPLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYLAKOID PROTEIN; IMPORT; TRANSPORT; PEPTIDES; COMPLEX	An intronless nuclear gene, psbT, isolated from cotton, encodes a putative 11-kDa protein (PSII-T) highly homologous in its C terminus to the N terminus of the partially sequenced PSII-T protein from spinach photosystem II. Analysis of the deduced amino acid sequence of cotton PSII-T revealed the presence of potential chloroplast stroma and thylakoid targeting domains and a putative mature PSII protein of 3.0 kDa, composed of only 28 amino acid residues. The cotton PSII-T 11-kDa precursor was synthesized in vitro in a wheat germ extract translation system, and the translation product was used in assays for protein imports into isolated pea chloroplasts. It was shown that the cotton PSII-T precursor was imported into the chloroplasts, processed to a mature form of approximately 3.0 kDa, agreeing with the predicted size from amino acid sequence analysis, and localized to the lumenal side of the thylakoid membrane, thus defining a new nuclear encoded lumenal protein and the smallest polypeptide of PSII reported to date. Processing of the PSII-T precursor occurred in two steps and involved the formation of a stromal intermediate of approximately 7.5 kDa, as predicted from primary structure analysis.	UNIV GEORGIA,DEPT BIOCHEM & MOLEC BIOL,ATHENS,GA 30602	University System of Georgia; University of Georgia			Kapazoglou, Aliki/AAV-6723-2021	Kapazoglou, Aliki/0000-0002-7584-5994				ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1989, J BIOL CHEM, V264, P14225; CLINE K, 1986, J BIOL CHEM, V261, P4804; DEBOER AD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P221, DOI 10.1016/0304-4157(91)90015-O; GAVEL Y, 1990, FEBS LETT, V261, P455, DOI 10.1016/0014-5793(90)80614-O; GILMARTIN PM, 1990, PLANT CELL, V2, P369, DOI 10.1105/tpc.2.5.369; IKEUCHI M, 1989, FEBS LETT, V242, P263, DOI 10.1016/0014-5793(89)80482-X; IKEUCHI M, 1992, BOT MAG TOKYO, V105, P327, DOI 10.1007/BF02489425; IKEUCHI M, 1988, FEBS LETT, V241, P99, DOI 10.1016/0014-5793(88)81039-1; JAMES HE, 1989, J BIOL CHEM, V264, P19573; KIRWIN PM, 1987, J BIOL CHEM, V262, P16386; LJUNGBERG U, 1986, BIOCHIM BIOPHYS ACTA, V849, P112, DOI 10.1016/0005-2728(86)90102-7; MURATA N, 1987, PROGR PHOTOSYNTHESIS, V1, P701; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; REED JE, 1990, EUR J BIOCHEM, V194, P33, DOI 10.1111/j.1432-1033.1990.tb19423.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SMEEKENS S, 1990, TRENDS BIOCHEM SCI, P73; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535	20	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12197	12202		10.1074/jbc.270.20.12197	http://dx.doi.org/10.1074/jbc.270.20.12197			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744870	hybrid			2022-12-27	WOS:A1995QY73600074
J	NAKAOKA, T; KOJIMA, N; OGITA, T; TSUJI, S				NAKAOKA, T; KOJIMA, N; OGITA, T; TSUJI, S			CHARACTERIZATION OF THE PHOSPHATIDYLSERINE-BINDING REGION OF RAT MARCKS (MYRISTOYLATED, ALANINE-RICH PROTEIN-KINASE-C SUBSTRATE) - ITS REGULATION THROUGH PHOSPHORYLATION OF SERINE-152	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-V; TRANSLOCATION; ASSOCIATION; CALMODULIN; MEMBRANE; CHICKEN; DOMAIN	We reported previously that recombinant myristoylated, alanine-rich protein kinase C substrate (MARCKS) expressed in Escherichia coli as well as MARCKS purified from rat brain specifically bound to phosphatidylserine (PS) in a calcium-independent manner and that the binding was regulated through phosphorylation of MARCKS (Nakaoka, T., Kojima, N., Hamamoto, T., Kurosawa, N., Lee, Y. C,, Kawasaki, H., Suzuki, K., and Tsuji, S. (1993) J. Biochem. (Tokyo) 114, 449-452), In this study, to identify the minimum PS-binding region of MARCKS and the regulatory phosphorylation site, the binding of MARCKS to PS was examined in deletion mutants producing glutathione S-transferase (GST) fusion proteins, The mutant proteins GST-6-180 and GST-127-160 had almost the same ability to bind to immobilized PS as MARCKS purified from rat brain, whereas GST-127-152 did not bind to it, In addition, the binding of GST-6-156 to immobilized PS was 62% of that of GST-6-180, but that of GST-6-152 was only 8% and that of GST-6-135 was not detected, The effect of phosphorylation by protein kinase C was examined in several mutants of GST-6-180 whose serine residues were substituted with alanine, After phosphorylation, the mutants GST-6-180[S156A and S163A], GST-6-180[S156A], and GST-6-180[S163A] did not bind to immobilized PS like native MARCKS and GST-6-180, However, even after phosphorylation, GST-6-180[S152A] and GST-6-180[S152A and S156A] could bind to immobilized PS. These results strongly suggest that MARCKS binds to PS molecules in the inner leaflet of the plasma membrane through residues 127-156, with residues 153-156 (FKKS) being particularly important in the binding of MARCKS to PS, and that the binding is regulated through the protein kinase C-catalyzed phosphorylation of the serine at residue 152.	INST PHYS & CHEM RES,FRONTIER RES PROGRAM,MOLEC GLYCOBIOL LAB,WAKO,SAITAMA 35101,JAPAN; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,BUNKYO KU,TOKYO 112,JAPAN	RIKEN; University of Tokyo								ADEREM AA, 1988, NATURE, V332, P362, DOI 10.1038/332362a0; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BYERS DM, 1993, J NEUROCHEM, V60, P1414, DOI 10.1111/j.1471-4159.1993.tb03303.x; COUCSSENS L, 1986, SCIENCE, V233, P859; ELUSALIMSKY JD, 1991, J BIOL CHEM, V266, P7073; GRAFF JM, 1989, J BIOL CHEM, V264, P11912; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; JAMES G, 1990, BIOCHEMISTRY-US, V29, P2623, DOI 10.1021/bi00463a001; KALAFATIS M, 1992, J BIOL CHEM, V267, P21580; KIM JY, 1994, J BIOL CHEM, V269, P28214; MANENTI S, 1994, J BIOL CHEM, V269, P8309; MAYER LD, 1983, BIOCHEMISTRY-US, V22, P6226, DOI 10.1021/bi00295a029; MCILROY BK, 1991, J BIOL CHEM, V266, P4959; NAKAOKA T, 1993, J BIOCHEM-TOKYO, V114, P449, DOI 10.1093/oxfordjournals.jbchem.a124196; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; OKAMURAIKEDA K, 1992, J BIOL CHEM, V267, P18284; ORTEL TL, 1992, J BIOL CHEM, V267, P4189; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; TANIGUCHI H, 1993, J BIOL CHEM, V268, P9960; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; YU FX, 1992, J BIOL CHEM, V267, P14616	22	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12147	12151		10.1074/jbc.270.20.12147	http://dx.doi.org/10.1074/jbc.270.20.12147			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744864	hybrid			2022-12-27	WOS:A1995QY73600067
J	PAANANEN, K; SAARINEN, J; ANNILA, A; KOVANEN, PT				PAANANEN, K; SAARINEN, J; ANNILA, A; KOVANEN, PT			PROTEOLYSIS AND FUSION OF LOW-DENSITY-LIPOPROTEIN PARTICLES STRENGTHEN THEIR BINDING TO HUMAN AORTIC PROTEOGLYCANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE RECEPTORS; PLASMA-LIPOPROTEINS; APOLIPOPROTEIN-B; CHOLESTEROL; GLYCOSAMINOGLYCANS; ATHEROSCLEROSIS; ACCUMULATION; FIBROBLASTS; INHIBITION; RESIDUES	Lipid droplets resembling those seen in the extracellular space of the arterial intima were generated in vitro when granule proteases of rat serosal mast cells degraded the apolipoprotein B-100 (apoB-100) component of granule bound low density lipoprotein (LDL), and the particles fused on the granule surface (Paananen, K., and Kovanen, P. T. (1994) J. Biol. Chem. 269, 2023-2031). Moreover, the binding of the fused particles to the heparin proteoglycan component of the granules was found to be strengthened. We have now treated LDL particles with alpha-chymotrypsin and examined the strength with which the proteolytically modified LDL binds to human aortic proteoglycans on an affinity column. We found that chymotryptic degradation of the LDL particles triggered particle fusion. The higher the degree of proteolytic degradation, the higher were the degree of fusion and the strength of binding to the aortic proteoglycans. Separation of the proteolyzed particles by size exclusion chromatography into two fractions, unfused and fused particles, and analysis of their binding strengths revealed that not only the fused but also the unfused proteolyzed particles bound more tightly to the proteoglycans than did the native LDL particles. To investigate the mechanism underlying this increase in binding strength, we attached [C-13]dimethyl groups to the lysines and used NMR spectroscopy to quantify the active lysine residues of apoB-100, which are thought to be located in basic areas of apoB-100 and involved in binding of LDL to proteoglycans. Analysis of the C-13-labeled particles showed that, despite loss of apoB-100 fragments from the particles, the number of active lysine residues in the unfused proteolyzed particles had not decreased. In the fused proteolyzed particles, the number of active lysine residues was markedly increased. Thus, proteolytic fusion appears to increase the number of basic domains of apoB-100, which would explain the observed increase in the strength of binding of the modified LDL particles to arterial proteoglycans. Since the fused particles resemble the small lipid droplets found in the atherosclerotic arterial intima, this LDL modification offers a plausible mechanism for the focal accumulation of lipid droplets in the extracellular proteoglycan matrix during atherogenesis.	WIHURI RES INST, SF-00140 HELSINKI, FINLAND; STATE TECH RES CTR FINLAND, SF-02044 ESPOO, FINLAND	Wihuri Research Institute			Oorni, Katariina/G-2484-2011	Oorni, Katariina/0000-0002-9525-0250				BARTOLD PM, 1985, ANAL BIOCHEM, V150, P320, DOI 10.1016/0003-2697(85)90517-2; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; CAMEJO G, 1993, J BIOL CHEM, V268, P14131; CAMEJO G, 1988, ARTERIOSCLEROSIS, V8, P368, DOI 10.1161/01.ATV.8.4.368; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHANG JY, 1983, METHOD ENZYMOL, V91, P41, DOI 10.1016/S0076-6879(83)91009-1; Forte T, 1972, Adv Lipid Res, V10, P1; FRANK JS, 1989, J LIPID RES, V30, P967; GUYTON JR, 1990, EUR HEART J, V11, P20, DOI 10.1093/eurheartj/11.suppl_E.20; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HURTCAMEJO E, 1990, J LIPID RES, V31, P1387; IVERIUS PH, 1972, J BIOL CHEM, V247, P2607; JENTOFT N, 1983, METHOD ENZYMOL, V91, P570; KAARTINEN M, 1994, ARTERIOSCLER THROMB, V14, P966, DOI 10.1161/01.ATV.14.6.966; KAARTINEN M, 1994, CIRCULATION, V90, P1669, DOI 10.1161/01.CIR.90.4.1669; KOVANEN PT, 1991, J BIOL CHEM, V266, P4430; KRITHARIDES L, 1993, ANAL BIOCHEM, V213, P79, DOI 10.1006/abio.1993.1389; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDKATZ S, 1988, J BIOL CHEM, V263, P13831; MACEK J, 1987, J CHROMATOGR-BIOMED, V414, P156, DOI 10.1016/0378-4347(87)80034-8; MAHLEY RW, 1979, BIOCHIM BIOPHYS ACTA, V575, P81, DOI 10.1016/0005-2760(79)90133-4; MAHLEY RW, 1977, J BIOL CHEM, V252, P7279; NIEVELSTEIN PFEM, 1991, ARTERIOSCLER THROMB, V11, P1795, DOI 10.1161/01.ATV.11.6.1795; PAANANEN K, 1994, J BIOL CHEM, V269, P2023; PASQUINELLI G, 1989, SCANNING MICROSCOPY, V3, P1151; PLANE F, 1993, ATHEROSCLEROSIS, V103, P73, DOI 10.1016/0021-9150(93)90041-R; RADDING CM, 1960, J CLIN INVEST, V39, P1560, DOI 10.1172/JCI104177; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Smith E B, 1974, Adv Lipid Res, V12, P1; VIJAYAGOPAL P, 1992, ARTERIOSCLER THROMB, V12, P237, DOI 10.1161/01.ATV.12.2.237; WAGNER WD, 1986, ARTERIOSCLEROSIS, V6, P407, DOI 10.1161/01.ATV.6.4.407; WEISGRABER KH, 1987, J BIOL CHEM, V262, P11097	33	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12257	12262		10.1074/jbc.270.20.12257	http://dx.doi.org/10.1074/jbc.270.20.12257			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744877	hybrid			2022-12-27	WOS:A1995QY73600082
J	WALDRON, RT; SHORT, AD; GILL, DL				WALDRON, RT; SHORT, AD; GILL, DL			THAPSIGARGIN-RESISTANT INTRACELLULAR CALCIUM PUMPS - ROLE IN CALCIUM POOL FUNCTION AND GROWTH OF THAPSIGARGIN-RESISTANT CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; REGULATORY MECHANISM; ACINAR-CELLS; CA2+; INHIBITION; GTP; RELEASE; ATPASE; TRANSPORT; PROTEINS	Exposure of cells to the intracellular Ca2+ pump blocker, thapsigargin (TG), results in emptying of Ca2+ pools and termination of cell proliferation (Short, A. D., Bian, J., Ghosh, T. K., Waldron, R. T., Rybak, S. L., and Gill, D. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4986-4990). DC-3F Chinese hamster lung cells were made resistant to TG by long-term stepwise exposure to increasing TG concentrations in culture (Gutheil, J. C., Hart, S. R., Belani, C. P., Melera, P. W., and Hussain, A. (1994) J. Biol. Chem. 269, 7976-7981). Since these cells (DC-3F/TG2) grow in the presence of TG, it was important to ascertain what Ca2+ pool function they retain. TG-resistant DC-3F/TG2 cells cultured with 2 mu M TG had a doubling time (24 h) not significantly different from the parent DC-3F cells without TG. Analysis of TG-induced inhibition of Ca-45(2+) uptake into permeabilized parent DC-3F cells revealed two distinct Ca2+ pump activities with 20,000-fold different sensitivities to TG; the IC50 values for TG were 200 pM and 4 mu M, representing 80% and 20% of total pumping activity, respectively. Total pump activity in parent DC-3F and resistant DC-3F/TG2 cells was similar (0.23 +/- 0.10 and 0.18 +/- 0.08 nmol of Ca2+/10(6) cells, respectively). In DC-3F/TG2 cells, up to 100 nM TG had no effect on Ca2+ pumping; however, almost all pumping was blocked at higher TG concentrations with an IC50 of 5 mu M. In both cell types, each Ca2+ pump activity (regardless of TG sensitivity) had high Ca2+ affinity (K-m values similar or equal to 0.1 mu M) and similar ATP dependence and vanadate sensitivity. In DC-3F cells, the TG-sensitive Ca2+ pool was releasable with inositol 1,4,5-trisphosphate (InsP(3)) or GTP and was oxalate-permeable; the TG-insensitive pool in these cells was not InsP(3)-releasable. GTP induced Ca2+ uptake in the presence of oxalate indicated Ca2+ transfer between distinct pools in the DC-SF cells. In resistant DC-3F/TG2 cells, almost 50% of total TG-insensitive Ca2+ accumulation was releasable with InsP(3); unlike the parent cells, this pool was not oxalate-permeable, and GTP induced no Ca2+ transfer between pools in the presence of oxalate. Thus, whereas InsP(3) releases Ca2+ only from the high TG sensitivity Ca2+ pumping pool in parent DC-SF cells, in resistant DC-3F/TG2 cells the TG-resistant Ca2+ pumping pool now contains functional InsP(3) receptors. It is concluded that the ability of TG-resistant DC-3F/TG2 TG2 cells to grow in the presence of 2 mu M TG results from expression of a distinct TG-resistant Ca2+ pump which serves to accumulate Ca2+ within an InsP(3),-releasable Ca2+ pool; this provides further evidence for the essential role of functional Ca2+ pools in progression of cells through the cell cycle and cell division.	UNIV MARYLAND,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore			Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019304] Funding Source: NIH RePORTER; NINDS NIH HHS [NS19304] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIAN JH, 1991, J BIOL CHEM, V266, P8801; CHUEH SH, 1987, J BIOL CHEM, V262, P13857; CHUEH SH, 1985, J BIOL CHEM, V261, P13883; DEHLINGERKREMER M, 1991, J MEMBRANE BIOL, V119, P85, DOI 10.1007/BF01868543; FURUYA Y, 1994, CANCER RES, V54, P6167; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; GHOSH TK, 1991, J BIOL CHEM, V266, P24690; GILL DL, 1986, NATURE, V320, P461, DOI 10.1038/320461a0; GILL DL, 1993, HDB EXPT PHARM GTPAS, V108, P625; Gill Donald L., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P265; GRYNKIEWICZ G, 1985, J BIOL CHEM, V261, P3440; GUTHEIL JC, 1994, J BIOL CHEM, V269, P7976; HAJNOCZKY G, 1994, J BIOL CHEM, V269, P10280; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; KOVACS T, 1994, J BIOL CHEM, V269, P6177; KUZNETSOV G, 1992, J BIOL CHEM, V267, P3932; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MACLENNAN DH, 1992, ANN NY ACAD SCI, V671, P1, DOI 10.1111/j.1749-6632.1992.tb43779.x; MARTONOSI A, 1982, CALCIUM CELL FUNCTIO, V3, P37; MILNER RE, 1992, MOL CELL BIOCHEM, V112, P1; MISSIAEN L, 1994, J BIOL CHEM, V269, P5817; MULLANEY JM, 1987, J BIOL CHEM, V262, P13865; MULLANEY JM, 1988, P NATL ACAD SCI USA, V85, P2499, DOI 10.1073/pnas.85.8.2499; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; PAPP B, 1991, J BIOL CHEM, V266, P14593; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; ROSSIER MF, 1991, TRENDS NEUROSCI, V14, P311; RYSSIKORA KE, 1994, J BIOL CHEM, V269, P31607; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; SHORT AD, 1993, J BIOL CHEM, V268, P25887; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; TAO JG, 1992, J BIOL CHEM, V267, P24972; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THEVENOD F, 1989, J MEMBRANE BIOL, V109, P173, DOI 10.1007/BF01870856; THEVENOD F, 1989, J MEMBRANE BIOL, V109, P263; WALDRON RT, 1994, J BIOL CHEM, V269, P11927	41	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11955	11961		10.1074/jbc.270.20.11955	http://dx.doi.org/10.1074/jbc.270.20.11955			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744845	hybrid			2022-12-27	WOS:A1995QY73600044
J	JARIELENCONTRE, I; PARIAT, M; MARTIN, F; CARILLO, S; SALVAT, C; PIECHACZYK, M				JARIELENCONTRE, I; PARIAT, M; MARTIN, F; CARILLO, S; SALVAT, C; PIECHACZYK, M			UBIQUITINYLATION IS NOT AN ABSOLUTE REQUIREMENT FOR DEGRADATION OF C-JUN PROTEIN BY THE 26-S PROTEASOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; ORNITHINE DECARBOXYLASE; FOS; FIBROBLASTS; COMPLEXES; ONCOGENE; CALPAIN; GROWTH; SYSTEM; TRANSFORMATION	Degradation of rapidly turned over cellular proteins is commonly thought to be energy dependent, to require tagging of protein substrates by multi-ubiquitin chains, and to involve the 26 S proteasome, which is the major neutral proteolytic activity in both the cytosol and the nucleus, The c-Jun oncoprotein is very unstable in vivo, Using cell-free degradation assays, we show that ubiquitinylation, along with other types of tagging, is not an absolute prerequisite for ATP dependent degradation of c-Jun by the 26 S proteasome. This indicates that a protein may bear intrinsic structural determinants allowing its selective recognition and breakdown by the 26 S proteasome. Moreover, taken together with observations by different groups, our data point to the notion of the existence of multiple degradation pathways operating on c-Jun.	INSERM, U249, INST MOLEC GENET, CNRS, UMR 9942, F-34033 MONTPELLIER 01, FRANCE; INSERM, U249, CTR RECH BIOCHIM MACROMOLEC, CNRS, UMR 9008, F-34033 MONTPELLIER 01, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier			PIECHACZYK, Marc/E-7896-2013	PIECHACZYK, Marc/0000-0003-1367-2597				ABATE C, 1990, CELL GROWTH DIFFER, V1, P455; Angel P. E., 1994, FOS JUN FAMILIES TRA; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; BOS TJ, 1990, GENE DEV, V4, P1677, DOI 10.1101/gad.4.10.1677; CARILLO S, 1994, ONCOGENE, V9, P1679; CHANG LMS, 1982, J BIOL CHEM, V257, P5700; CIECHANOVER A, 1994, J BIOL CHEM, V269, P9582; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DESA MFG, 1988, J CELL SCI, V89, P151; GROPPER R, 1991, J BIOL CHEM, V266, P3602; HARLOW E, 1988, ANTIBODIES; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; MAKI M, 1989, J BIOL CHEM, V264, P18866; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; MORGAN IM, 1993, ONCOGENE, V8, P1135; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PETERS JM, 1994, TRENDS BIOCHEM SCI, V19, P377, DOI 10.1016/0968-0004(94)90115-5; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; RIVETT AJ, 1993, BIOCHEM J, V291, P1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SAWADA H, 1993, FEBS LETT, V335, P207, DOI 10.1016/0014-5793(93)80731-9; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; TANAKA K, 1988, J BIOL CHEM, V263, P16209; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; UGAI S, 1993, J BIOCHEM, V113, P754, DOI 10.1093/oxfordjournals.jbchem.a124116; WATT F, 1993, NUCLEIC ACIDS RES, V21, P5092, DOI 10.1093/nar/21.22.5092	40	131	132	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11623	11627		10.1074/jbc.270.19.11623	http://dx.doi.org/10.1074/jbc.270.19.11623			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744802	Green Published, hybrid			2022-12-27	WOS:A1995QX86500084
J	HO, V; ACQUAVIVA, A; DUH, E; BUNN, HF				HO, V; ACQUAVIVA, A; DUH, E; BUNN, HF			USE OF A MARKED ERYTHROPOIETIN GENE FOR INVESTIGATION OF ITS CIS-ACTING ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE CHAIN-REACTION; MESSENGER-RNA LEVELS; BINDING-PROTEIN; TRANSCRIPTIONAL ENHANCER; HYPOXIA; EXPRESSION; CLONING; DEGRADATION; SEQUENCES; HOMOLOGY	To examine the function of conserved noncoding regions in the erythropoietin (Epo) gene, we have prepared clones and pools of Hep3B cells stably transfected with a marked 4.1-kilobase Epo gene and deletions thereof, The marked transcripts had single base substitutions at three sites in the coding portion of Exon 5, enabling them to be distinguished from endogenous Epo mRNA by ribonuclease protection and competitive polymerase chain reaction. The basal expression and hypoxic induction of the marked Epo gene that had no deletions were indistinguishable from that of the endogenous Epo gene. Likewise, deletion of conserved intervening sequence 1 had minimal effect on hypoxic induction, In contrast, a 3'-deletion that included the conserved S'-enhancer element resulted in a substantial, but not complete, suppression of hypoxic induction while a 3' deletion downstream of the enhancer resulted in enhancement, A 188-base pair deletion of a conserved 3'-untranslated region in Exon 5 had minimal effect on hypoxic induction, However, the truncated Epo mRNA had a markedly prolonged half life (15 h) in comparison to the endogenous Epo mRNA (2.0 h) or the marked full-length Epo mRNA (2.1 h), Further deletions in the 3'-UTR showed that a relatively small region of approximately 50 bases is responsible for the relatively rapid turnover of Epo mRNA. These experiments provide information on cis-acting elements of the Epo gene that cannot be obtained from conventional reporter gene transfection experiments.	BRIGHAM & WOMENS HOSP, DEPT MED, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041234] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK41234] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECK I, 1993, BLOOD, V82, P704; BECK I, 1991, J BIOL CHEM, V266, P15563; BERU N, 1986, MOL CELL BIOL, V6, P2571, DOI 10.1128/MCB.6.7.2571; BLANCHARD KL, 1992, MOL CELL BIOL, V12, P5373, DOI 10.1128/MCB.12.12.5373; BONDURANT MC, 1986, MOL CELL BIOL, V6, P2731, DOI 10.1128/MCB.6.7.2731; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CLEVELAND DW, 1985, ANNU REV BIOCHEM, V54, P331, DOI 10.1146/annurev.bi.54.070185.001555; CZYZYKKRZESKA MF, 1994, J BIOL CHEM, V269, P760; CZYZYKRZESKA MF, 1994, J BIOL CHEM, V269, P9940; FANDREY J, 1993, BLOOD, V81, P617; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; GALSON DL, 1993, BLOOD, V82, P3321; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; GOLDBERG MA, 1991, BLOOD, V77, P271; GOLDBERG MA, 1987, P NATL ACAD SCI USA, V84, P7972, DOI 10.1073/pnas.84.22.7972; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; IMAGAWA S, 1991, BLOOD, V77, P278; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; MADAN A, 1993, P NATL ACAD SCI USA, V90, P3928, DOI 10.1073/pnas.90.9.3928; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MCDONALD JD, 1986, MOL CELL BIOL, V6, P842, DOI 10.1128/MCB.6.3.842; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; RONDON IJ, 1991, J BIOL CHEM, V266, P16594; SCHUSTER SJ, 1989, BLOOD, V73, P13; SCHUSTER SJ, 1987, BLOOD, V70, P316; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHOEMAKER CB, 1986, MOL CELL BIOL, V6, P849, DOI 10.1128/MCB.6.3.849; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230	33	23	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10084	10090		10.1074/jbc.270.17.10084	http://dx.doi.org/10.1074/jbc.270.17.10084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730312	hybrid			2022-12-27	WOS:A1995QV41700057
J	ICHINOSE, H; OHYE, T; MATSUDA, Y; HORI, T; BLAU, N; BURLINA, A; ROUSE, B; MATALON, R; FUJITA, K; NAGATSU, T				ICHINOSE, H; OHYE, T; MATSUDA, Y; HORI, T; BLAU, N; BURLINA, A; ROUSE, B; MATALON, R; FUJITA, K; NAGATSU, T			CHARACTERIZATION OF MOUSE AND HUMAN GTP CYCLOHYDROLASE-I GENES - MUTATIONS IN PATIENTS WITH GTP CYCLOHYDROLASE-I DEFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TETRAHYDROBIOPTERIN; CELLS; HYPERPHENYLALANINEMIA; COFACTOR; MUTANT; GAMMA; HPH-1; BIOSYNTHESIS; MACROPHAGES	GTP cyclohydrolase I is the first and rate-limiting enzyme for the biosynthesis of tetrahydrobiopterin in mammals. Previously, we reported three species of human GTP cyclohydrolase I cDNA in a human liver cDNA library (Togari, A., Ichinose, H., Matsumoto, S., Fujita, IC., and Nagatsu, T. (1992) Biochem. Biophys. Res. Commun. 187, 359-365). Furthermore, very recently, we found that the GTP cyclohydrolase I gene is causative for hereditary progressive dystonia with marked diurnal fluctuation, also known as DOPA-responsive dystonia (Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K., and Nagatsu, T. (1994) Nature Genetics 8, 236-242). To clarify the mechanisms that regulate transcription of the GTP cyclohydrolase I gene and to generate multiple species of mRNA, we isolated genomic DNA clones for the human and mouse GTP cyclohydrolase I genes. Structural analysis of the isolated clones revealed that the GTP cyclohydrolase I gene is encoded by a single copy gene and is composed of six exons spanning similar to 30 kilobases. We sequenced all exon/intron boundaries of the human and mouse genes. Structural analysis also demonstrated that the heterogeneity of GTP cyclohydrolase I mRNA is caused by an alternative usage of the splicing acceptor site at the sixth exon. The transcription start site of the mouse GTP cyclohydrolase I gene and the 5'-flanking sequences of the mouse and human genes were deter mined. We performed regional mapping of the mouse gene by fluorescence in situ hybridization, and the mouse GTP cyclohydrolase I gene was assigned to region C2-3 of mouse chromosome 14. We identified missense mutations in patients with GTP cyclohydrolase I deficiency and expressed mutated enzymes in Escherichia coli to confirm alterations in the enzyme activity.	FUJITA HLTH UNIV,INST COMPREHENS MED SCI,TOYOAKE,AICHI 47011,JAPAN; NATL INST RADIOL SCI,DIV GENET,CHIBA 263,JAPAN; UNIV ZURICH,DEPT PEDIAT,DIV CLIN CHEM,CH-8032 ZURICH,SWITZERLAND; UNIV PADUA,DEPT PEDIAT,I-35128 PADUA,ITALY; MIAMI CHILDRENS HOSP,RES INST,MIAMI,FL 33155; UNIV TEXAS,MED BRANCH,DEPT PEDIAT,GALVESTON,TX 77550	Fujita Health University; National Institutes for Quantum Science & Technology; University of Zurich; University of Padua; University of Texas System; University of Texas Medical Branch Galveston			Ichinose, Hiroshi/D-8986-2015	Ichinose, Hiroshi/0000-0001-6008-6860; Blau, Nenad/0000-0003-4347-3230				BLANAR MA, 1989, EMBO J, V8, P1139, DOI 10.1002/j.1460-2075.1989.tb03484.x; BLAU N, 1985, CLIN CHIM ACTA, V148, P47, DOI 10.1016/0009-8981(85)90299-2; BLAU N, 1995, IN PRESS J PEDIATR; BODE VC, 1988, GENETICS, V118, P299; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; DALTON S, 1988, EMBO J, V7, P49, DOI 10.1002/j.1460-2075.1988.tb02782.x; DHONDT JL, 1985, J PEDIATR-US, V106, P954, DOI 10.1016/S0022-3476(85)80251-1; GUTLICH M, 1992, BIOCHIM BIOPHYS ACTA, V1171, P133, DOI 10.1016/0167-4781(92)90112-D; GUTLICH M, 1994, BIOCHEM J, V302, P215, DOI 10.1042/bj3020215; HATAKEYAMA K, 1991, J BIOL CHEM, V266, P765; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; JONES KA, 1988, GENE DEV, V2, P1101, DOI 10.1101/gad.2.9.1101; KAUFMAN S, 1959, J BIOL CHEM, V234, P2677; KWON NS, 1989, J BIOL CHEM, V264, P20496; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; MATALON R, 1984, Pediatric Research, V18, p223A, DOI 10.1203/00006450-198404001-00781; MATSUDA Y, 1992, CYTOGENET CELL GENET, V61, P282, DOI 10.1159/000133423; MCDONALD JD, 1988, PEDIATR RES, V23, P63, DOI 10.1203/00006450-198801000-00014; MCDONALD JD, 1988, J NEUROCHEM, V50, P655, DOI 10.1111/j.1471-4159.1988.tb02961.x; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; NAYLOR EW, 1987, PEDIATRICS, V79, P374; NICHOL CA, 1985, ANNU REV BIOCHEM, V54, P729, DOI 10.1146/annurev.biochem.54.1.729; NIEDERWIESER A, 1984, EUR J PEDIATR, V141, P203; NOMURA T, 1993, BIOCHEM BIOPH RES CO, V191, P523, DOI 10.1006/bbrc.1993.1249; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOEDON G, 1987, EUR J BIOCHEM, V166, P303, DOI 10.1111/j.1432-1033.1987.tb13515.x; TANAKA K, 1989, P NATL ACAD SCI USA, V86, P5864, DOI 10.1073/pnas.86.15.5864; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; TOGARI A, 1992, BIOCHEM BIOPH RES CO, V187, P359, DOI 10.1016/S0006-291X(05)81501-3; WERNER ER, 1990, J BIOL CHEM, V265, P3189; WERNERFELMAYER G, 1993, FEBS LETT, V322, P223, DOI 10.1016/0014-5793(93)81574-J; XIAO JH, 1987, EMBO J, V6, P3005, DOI 10.1002/j.1460-2075.1987.tb02606.x; ZIEGLER I, 1993, J BIOL CHEM, V268, P12544	36	136	142	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10062	10071		10.1074/jbc.270.17.10062	http://dx.doi.org/10.1074/jbc.270.17.10062			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730309	hybrid			2022-12-27	WOS:A1995QV41700054
J	SUNDARAM, SK; FAN, JH; LEV, M				SUNDARAM, SK; FAN, JH; LEV, M			A NEUTRAL GALACTOCEREBROSIDE SULFATE SULFATIDASE FROM MOUSE-BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFOTRANSFERASE ACTIVITY; VITAMIN-K; RAT-BRAIN; 3-KETODIHYDROSPHINGOSINE SYNTHETASE; BACTEROIDES-MELANINOGENICUS; PARTIAL-PURIFICATION; CERAMIDE; SPHINGOMYELINASE; LIVER	We have described an enzyme in brain that catabolizes galactocerebroside sulfatide with a pH optimum of 7.2. To our knowledge, this is the first description of a catabolic enzyme for sulfatide at a neutral pH, Activity at a neutral pH implies a non-lysosomal location for this sulfatidase. Galactocerebroside sulfate sulfatidase (n-sulfatidase) activity was not apparent in crude microsomal extracts acid was detected following partial purification of the enzyme, This enzyme, n-sulfatidase, differs from other arylsulfatases in its M(r), inability to bind to concanavalin A, and substrate specificity; n-sulfatidase was unable to hydrolyze p-nitrocatechol sulfate or estrone sulfate, The molecular mass of n-sulfatidase obtained by Sephacryl S-200 chromatography was 72 kDa, and the active fraction from this procedure was purified >600-fold by isoelectric focusing. Following SDS polyacrylamide gel electrophoresis, two bands were obtained with apparent molecular masses of 58 and 66 kDa, Enzyme activity was regenerated from both of these bands, with the 66-kDa band showing greater activity, The K-m of the sulfatidase was determined as 5.8 x 10(-5) M. The pI of n-sulfatidase was 7.7 in contrast to the pI of 4.9 for the sulfotransferase. No requirement was found for Mg2+ or ATP for sulfatidase activity; vitamin K-1 enhanced sulfatidase activity approximately 3.3-fold. Therefore, this enzyme may have a role in the pathogenesis of metachromatic leukodystrophy in which sulfatides accumulate in the nervous and other tissues and in myelination since sulfatides are an important component of myelin.	CUNY,SCH MED,SOPHIE DAVIES SCH BIOMED EDUC,DEPT MICROBIOL,NEW YORK,NY 10031	City University of New York (CUNY) System					NCRR NIH HHS [RR03060] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; BETTS JC, 1994, J BIOL CHEM, V269, P8455; BRATTAIN MG, 1977, BIOCHEM J, V163, P247, DOI 10.1042/bj1630247; CHATTERJEE S, 1993, ADV LIPID RES, V26, P25; CUMAR FA, 1968, J BIOL CHEM, V243, P3807; DYER CA, 1990, J CELL BIOL, V111, P625, DOI 10.1083/jcb.111.2.625; DYER CA, 1991, J NEUROSCI RES, V711, P699; FARRELL DF, 1971, J BIOL CHEM, V246, P4694; GOLDKORN T, 1991, J BIOL CHEM, V266, P16092; HANNUN YA, 1993, ADV LIPID RES, V25, P27; IWAMORI M, 1976, ARCH BIOCHEM BIOPHYS, V174, P199, DOI 10.1016/0003-9861(76)90339-8; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; LEV M, 1973, ARCH BIOCHEM BIOPHYS, V157, P500, DOI 10.1016/0003-9861(73)90668-1; LEV M, 1981, ARCH BIOCHEM BIOPHYS, V212, P424, DOI 10.1016/0003-9861(81)90384-2; LEV M, 1972, J LIPID RES, V13, P364; LEV M, 1993, T AM SOC NEUROCHEM, V24, P185; LISTER MD, 1993, BIOCHIM BIOPHYS ACTA, V1165, P314, DOI 10.1016/0005-2760(93)90142-V; MCALARNEY T, 1994, J NEUROSCI RES, V37, P453, DOI 10.1002/jnr.490370404; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; OLIVERA A, 1992, J BIOL CHEM, V267, P26121; PHILLIPS NC, 1976, BIOCHEM J, V153, P579, DOI 10.1042/bj1530579; RAGHAVAN SS, 1981, J NEUROCHEM, V36, P724, DOI 10.1111/j.1471-4159.1981.tb01648.x; SHAPIRO LJ, 1989, METABOLIC BASIS INHE, P1965; SUNDARAM KS, 1992, J BIOL CHEM, V267, P24041; SUNDARAM KS, 1990, ARCH BIOCHEM BIOPHYS, V277, P109, DOI 10.1016/0003-9861(90)90557-F; SUNDARAM KS, 1990, BIOCHEM BIOPH RES CO, V169, P927, DOI 10.1016/0006-291X(90)91982-X; SUNDARAM KS, 1988, J LIPID RES, V29, P1475; TAYLOR T, 1987, BIOCHIM BIOPHYS ACTA, V913, P131, DOI 10.1016/0167-4838(87)90321-9; TENNEKOON G, 1978, J NEUROCHEM, V31, P329, DOI 10.1111/j.1471-4159.1978.tb12466.x; VOS JP, 1994, BBA-LIPID LIPID MET, V1211, P125, DOI 10.1016/0005-2760(94)90262-3	32	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10187	10192		10.1074/jbc.270.17.10187	http://dx.doi.org/10.1074/jbc.270.17.10187			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730322	hybrid			2022-12-27	WOS:A1995QV41700069
J	WEDLER, FC; LEY, BW; LEE, BH; OLEARY, MH; KANTROWITZ, ER				WEDLER, FC; LEY, BW; LEE, BH; OLEARY, MH; KANTROWITZ, ER			L-ASPARTATE ASSOCIATION CONTRIBUTES TO RATE LIMITATION AND INDUCTION OF THE T-]R TRANSITION IN ESCHERICHIA-COLI ASPARTATE TRANSCARBAMOYLASE - EQUILIBRIUM EXCHANGES AND KINETIC ISOTOPE EFFECTS WITH A V-MAX-ENHANCED MUTANT, ASP-236-]ALA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTATION; HETEROTROPIC INTERACTIONS; CATALYTIC SUBUNITS; RESIDUES 230-245; CARBAMOYLTRANSFERASE; MECHANISM; ENZYME; CHAIN; C-13; CTP	Equilibrium isotope exchange kinetics (EIEK) and kinetic isotope effects have been used to determine the mechanistic basis for the altered kinetic characteristics of a mutant version of Escherichia coli aspartate trans carbamoylase in which Asp-236 of the catalytic chain is replaced by alanine (Asp 236 --> Ale), The [C-14]Asp reversible arrow N-carbamyl-L-aspartate (CAsp) and [C-14]CP reversible arrow CAsp exchange rates, observed as a function of various reactant-product pairs, exhibited dramatic increases in maximal rates, along with decreases in substrate half-saturation values and cooperativity, The carbon kinetic isotope effect, C-13 versus C-12 at the carbonyl group of carbamoyl phosphate, for the Asp-236 --> Ala enzyme decreased toward unity as [Asp] increased, as observed for the wildtype enzyme, Both the kinetic isotope effects and EIEK results indicate that the Asp-236 --> Ala enzyme operates by the same ordered kinetic mechanism as the wild-type enzyme, Although activation effects by ATP and N-phosphonacetyl-L-aspartate are lost, inhibition by CTP was apparent in equilibrium exchanges, Simulation of the EIEK data indicated that the best fit to the observed changes in saturation curves was obtained by preferentially increasing the rate of the T --> R transition, k(T-->R), thereby destabilizing the T-state and increasing the equilibrium constant for the T reversible arrow R transition, A multistep model for Asp binding to aspartate transcarbamoylase is proposed, in which Asp induces the initial conformational changes that in turn trigger the T --> R transition, followed by stepwise filling of the remaining active sites.	BOSTON COLL, MERKERT CHEM CTR, DEPT CHEM, CHESTNUT HILL, MA 02167 USA; PENN STATE UNIV, DEPT BIOCHEM & MOLEC BIOL, ALTHOUSE LAB, UNIVERSITY PK, PA 16802 USA; UNIV NEBRASKA, DEPT BIOCHEM, LINCOLN, NE 68583 USA	Boston College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Nebraska System; University of Nebraska Lincoln					NIGMS NIH HHS [GM43043, GM26237] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043043, R01GM026237] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN CM, 1964, BIOCHEMISTRY-US, V3, P1238, DOI 10.1021/bi00897a010; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BOYER PD, 1978, ACCOUNTS CHEM RES, V11, P218, DOI 10.1021/ar50125a007; FOOTE J, 1985, J MOL BIOL, V186, P175, DOI 10.1016/0022-2836(85)90267-0; GERHART JC, 1967, J BIOL CHEM, V242, P2886; GERHART JC, 1962, J BIOL CHEM, V237, P891; GOUAUX JE, 1990, BIOCHEMISTRY-US, V29, P7702, DOI 10.1021/bi00485a020; GOUAUX JE, 1988, P NATL ACAD SCI USA, V85, P4205, DOI 10.1073/pnas.85.12.4205; HSUANYU Y, 1989, BIOCHIM BIOPHYS ACTA, V995, P54, DOI 10.1016/0167-4838(89)90232-X; HSUANYU Y, 1987, ARCH BIOCHEM BIOPHYS, V259, P316, DOI 10.1016/0003-9861(87)90498-X; HSUANYU Y, 1988, BIOCHIM BIOPHYS ACTA, V957, P455, DOI 10.1016/0167-4838(88)90236-1; HSUANYU YC, 1989, J BIOL CHEM, V264, P17259; JACOBSON GR, 1973, ENZYMES, V9, P225; KANTROWITZ ER, 1988, SCIENCE, V241, P669, DOI 10.1126/science.3041592; KANTROWITZ ER, 1990, TRENDS BIOCHEM SCI, V15, P53, DOI 10.1016/0968-0004(90)90176-C; KE HM, 1988, J MOL BIOL, V204, P725, DOI 10.1016/0022-2836(88)90365-8; KIM KH, 1987, J MOL BIOL, V196, P853, DOI 10.1016/0022-2836(87)90410-4; KNOWLES JR, 1977, ACCOUNTS CHEM RES, V10, P105, DOI 10.1021/ar50112a001; KRAUSE KL, 1987, J MOL BIOL, V193, P527, DOI 10.1016/0022-2836(87)90265-8; LADJIMI MM, 1985, J MOL BIOL, V186, P715, DOI 10.1016/0022-2836(85)90391-2; LIPSCOMB WN, 1994, ADV ENZYMOL RAMB, V68, P67; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIDDLETON SA, 1986, P NATL ACAD SCI USA, V83, P5866, DOI 10.1073/pnas.83.16.5866; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NEWTON CJ, 1990, P NATL ACAD SCI USA, V87, P2309, DOI 10.1073/pnas.87.6.2309; Northrop D. B., 1977, ISOTOPE EFFECTS ENZY, P122; NOWLAN SF, 1985, J BIOL CHEM, V260, P4712; PARMENTIER LE, 1992, BIOCHEMISTRY-US, V31, P6577, DOI 10.1021/bi00143a030; PARMENTIER LE, 1992, BIOCHEMISTRY-US, V31, P6598, DOI 10.1021/bi00143a033; PARMENTIER LE, 1992, BIOCHEMISTRY-US, V31, P6570, DOI 10.1021/bi00143a029; PASTRALANDIS SC, 1978, J BIOL CHEM, V253, P4624; PORTER RW, 1969, J BIOL CHEM, V244, P1846; PURICH DL, 1980, METHOD ENZYMOL, V64, P3; RAY WJ, 1983, BIOCHEMISTRY-US, V22, P4625, DOI 10.1021/bi00289a003; STEVENS RC, 1991, PROTEIN ENG, V4, P391, DOI 10.1093/protein/4.4.391; TAUC P, 1982, J MOL BIOL, V155, P155, DOI 10.1016/0022-2836(82)90442-9; WALDROP GL, 1992, BIOCHEMISTRY-US, V31, P6585, DOI 10.1021/bi00143a031; WALDROP GL, 1992, BIOCHEMISTRY-US, V31, P6592, DOI 10.1021/bi00143a032; WEDLER FC, 1994, ANAL BIOCHEM, V218, P449, DOI 10.1006/abio.1994.1205; WEDLER FC, 1989, J BIOL CHEM, V264, P17266; WEDLER FC, 1995, IN PRESS METHODS ENZ; WILD JR, 1989, P NATL ACAD SCI USA, V86, P46, DOI 10.1073/pnas.86.1.46	42	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9725	9733		10.1074/jbc.270.17.9725	http://dx.doi.org/10.1074/jbc.270.17.9725			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730350	hybrid			2022-12-27	WOS:A1995QV41700008
J	NEYA, S; KAKU, T; FUNASAKI, N; SHIRO, Y; IIZUKA, T; IMAI, K; HORI, H				NEYA, S; KAKU, T; FUNASAKI, N; SHIRO, Y; IIZUKA, T; IMAI, K; HORI, H			NOVEL LIGAND-BINDING PROPERTIES OF THE MYOGLOBIN SUBSTITUTED WITH MONOAZAHEMIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL HISTIDINE; PROSTHETIC GROUP; HEME; COMPLEXES; OXYGEN; AUTOOXIDATION; METMYOGLOBIN; FORMYLATION; HEMOGLOBIN; REDUCTION	The iron complex of alpha-azamesoporphyrin XIII was combined with apomyoglobin to investigate influence of the meso nitrogen on ligand binding properties in the reconstituted protein. Stoichiometric complex formation between the two components was confirmed, and conservation of the native coordination structures in the resultant myoglobin was established with spectroscopic criteria and apparently normal ligand binding. The visible absorption spectra of various ferric and ferrous derivatives are characteristic with less intense Soret peaks and enhanced visible bands. The electron paramagnetic resonance spectrum with g = 5.2 suggests an anomalous intermediate spin (S = 3/2) character for the aquomet protein. The oxygen affinity of reduced azaheme myoglobin, 0.010 mm Hg, is 50 times larger than that of the native myoglobin. In addition, azaheme myoglobin forms stable complexes with imidazole, pyridine, or cyanide in ferrous state. All of these new properties were consistently explained in terms of stronger equatorial Ligand field of the heme iron in a narrower coordination cavity. Similarities of azaheme to verdoheme were also pointed out.	INST PHYS & CHEM RES,WAKO,SAITAMA 35101,JAPAN; OSAKA UNIV,SCH MED,DEPT PHYSICOCHEM PHYSIOL,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,FAC ENGN SCI,DEPT BIOPHYS ENGN,TOYONAKA,OSAKA 560,JAPAN	RIKEN; Osaka University; Osaka University	NEYA, S (corresponding author), KYOTO PHARMACEUT UNIV,DEPT PHYS CHEM,KYOTO 607,JAPAN.							ADLER AD, 1970, J INORG NUCL CHEM, V32, P2443, DOI 10.1016/0022-1902(70)80535-8; ASAKURA T, 1978, METHOD ENZYMOL, V52, P445; BALCH AL, 1993, J AM CHEM SOC, V115, P1422, DOI 10.1021/ja00057a027; BALCH AL, 1993, INORG CHEM, V32, P291, DOI 10.1021/ic00055a011; BELLELLI A, 1990, J BIOL CHEM, V365, P18898; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; BRAULT D, 1974, BIOCHEMISTRY-US, V13, P4591, DOI 10.1021/bi00719a019; ENGEL J, 1978, J CHEM SOC PERK T 1, P871, DOI 10.1039/p19780000871; ERCOLANI C, 1991, J CHEM SOC DALTON, P1309, DOI 10.1039/dt9910001309; Fischer H, 1936, LIEBIGS ANN CHEM, V523, P154; FUHRHOP JH, 1975, PORPHYRINS METALLOPO, P757; FUJII H, 1990, THESIS KYOTO U KYOTO; GRIGG R, 1978, J CHEM SOC P2, P407; Hambright P., 1975, PORPHYRINS METALLOPO, P234; HARRIS RLN, 1966, J CHEM SOC C, P22, DOI 10.1039/j39660000022; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; HOFFMAN BM, 1983, ACCOUNTS CHEM RES, V16, P15, DOI 10.1021/ar00085a003; HORI H, 1990, J BIOL CHEM, V265, P15028; Imai K, 1981, Methods Enzymol, V76, P438; Jackson A. H., 1978, PORPHYRINS, VI, P365; KEILIN D, 1955, BIOCHEM J, V61, P153, DOI 10.1042/bj0610153; KENNEDY BJ, 1986, INORG CHEM, V25, P2539, DOI 10.1021/ic00235a011; KOENIG DF, 1965, ACTA CRYSTALLOGR, V18, P663, DOI 10.1107/S0365110X65001536; LAMAR GN, 1977, BIOCHEM BIOPH RES CO, V77, P104, DOI 10.1016/S0006-291X(77)80170-8; Lever ABP, 1993, PHTHALOCYANINES PROP, V3, P1; MALTEMPO MM, 1979, BIOCHEMISTRY-US, V18, P2935, DOI 10.1021/bi00581a003; MAXWELL JC, 1976, BIOCHEMISTRY-US, V15, P388, DOI 10.1021/bi00647a023; NEYA S, 1989, BIOCHIM BIOPHYS ACTA, V996, P226, DOI 10.1016/0167-4838(89)90251-3; NEYA S, 1994, BBA-PROTEIN STRUCT M, V1208, P31, DOI 10.1016/0167-4838(94)90156-2; NEYA S, 1988, J BIOL CHEM, V263, P8810; NEYA S, 1993, J BIOL CHEM, V268, P8935; OLIVAS E, 1977, J BIOL CHEM, V252, P4038; PADLAN EA, 1975, J BIOL CHEM, V250, P7069; PALMER SM, 1985, INORG CHEM, V24, P2040, DOI 10.1021/ic00207a017; Rothgeb T M, 1978, Methods Enzymol, V52, P473; SAITO S, 1986, J CHEM SOC PERK T 1, P1, DOI 10.1039/p19860000001; SCHEIDT WR, 1989, ACTA CRYSTALLOGR C, V45, P1214, DOI 10.1107/S0108270189000715; Scheidt WR, 1983, IRON PORPHYRINS 1, P89; SCHONBAUM GR, 1976, ENZYMES, V13, P303; SEYBERT DW, 1977, J MOL BIOL, V113, P419, DOI 10.1016/0022-2836(77)90150-4; SHRIVER DF, 1994, INORG CHEM, P667; Siedel W, 1933, H-S Z PHYSIOL CHEM, V214, P145, DOI 10.1515/bchm2.1933.214.3-4.145; SONO M, 1982, J BIOL CHEM, V257, P5496; SONO M, 1976, J BIOL CHEM, V251, P2664; SONO M, 1975, J BIOL CHEM, V250, P5227; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; SUN J, 1993, BIOCHEMISTRY-US, V32, P14151, DOI 10.1021/bi00214a012; TAKAHASHI S, 1994, J BIOL CHEM, V269, P1010; TAKAHASHI S, 1994, BIOCHEMISTRY-US, V33, P5531, DOI 10.1021/bi00184a023; TAMURA M, 1973, BIOCHIM BIOPHYS ACTA, V295, P467, DOI 10.1016/0005-2795(73)90042-1; TAMURA M, 1973, BIOCHIM BIOPHYS ACTA, V317, P34, DOI 10.1016/0005-2795(73)90197-9; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; THOMPSON JA, 1993, INORG CHEM, V24, P2040; WEBER PC, 1982, BIOCHEMISTRY-US, V21, P5116, DOI 10.1021/bi00264a001	54	27	27	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13118	13123		10.1074/jbc.270.22.13118	http://dx.doi.org/10.1074/jbc.270.22.13118			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768907	hybrid			2022-12-27	WOS:A1995RB43900029
J	POOLMAN, B; KNOL, J; LOLKEMA, JS				POOLMAN, B; KNOL, J; LOLKEMA, JS			KINETIC-ANALYSIS OF LACTOSE AND PROTON COUPLING IN GLU(379) MUTANTS OF THE LACTOSE TRANSPORT PROTEIN OF STREPTOCOCCUS-THERMOPHILUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTANTS; ESCHERICHIA-COLI; LAC PERMEASE; HISTIDINE-RESIDUES; CARRIER PROTEIN; SYSTEM; ARGININE-302; MECHANISM; MEMBRANE; TYROSINE	The role of Glu(379) in the lactose-H+ symport protein (LacS) of Streptococcus thermophilus was studied by analyzing the kinetic mechanism of transport of wild-type and Ala(379), Asp(379), and Gln(379) mutant proteins. Glu(379) forms part of the sequence motif Lys-X-X-His-X-X-Glu that is present in a number of sugar transport proteins, including LacY of Escherichia coli. The E379A and E379Q mutants were defective in the uptake of lactose against a concentration gradient and lactose dependent proton uptake, but catalyzed facilitated influx of lactose down a concentration gradient and equilibrium exchange with rates similar to that of the wild-type enzyme. The E879D mutant was partially defective in the coupled transport of lactose and protons. These results suggest that an acidic residue at position 379 is required for the coupled uptake of lactose and protons and are consistent with a mechanism in which lactose transport in the E379A and E379Q mutants occurs by uniport rather than proton symport. Lactose efflux down a concentration gradient in wild-type LacS and LacS-E379D increased with pH with apparent pK (pK(alpha)) values of greater than or equal to 8.5 and 8.0, respectively, whereas efflux in the E379Q mutant increased sigmoidally with a pK(alpha) of about 6.0. Imposition of an artificial membrane potential (inside negative) in membrane vesicles bearing wild-type LacS or LacS-E379Q not only inhibited the lactose efflux mediated by wild-type but also that of the mutant enzyme. To associate the role of Glu(379) with specific step(s) in the translocation cycle of LacS, the properties of wild-type LacS and the Glu(379) mutants have been evaluated by numerical analysis of simple kinetic schemes for translocation catalysis by solute H+ symport proteins. The properties of the wild-type enzyme are consistent with a mechanism in which the order of ligand binding on the inside is substrate first and proton last, whereas the order is random (or proton first, substrate last) at the outer surface of the membrane. The wild-type enzyme is asymmetric with regard to proton binding; the pK for proton binding on the outside is at least 4 units higher than the pK on the inside. The properties of the Glu(379) mutants correspond with a lowering of the pK on the outside (pK(OUT) similar to pK(IN)), and the induction of a leak pathway in which the binary enzyme-substrate complex becomes mobile.			POOLMAN, B (corresponding author), UNIV GRONINGEN,GRONINGEN BIOMOLEC SCI & BIOTECHNOL INST,DEPT MICROBIOL,KERKLAAN 30,9751 NN HAREN,NETHERLANDS.		Knol, Jan/A-2178-2010; Knol, Jan/AAL-6487-2020	Knol, Jan/0000-0002-2103-5961; Knol, Jan/0000-0002-2103-5961				CALAMIA J, 1992, J MOL BIOL, V224, P539, DOI 10.1016/0022-2836(92)90542-R; CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; CARRASCO N, 1989, BIOCHEMISTRY-US, V28, P2533, DOI 10.1021/bi00432a028; CARRASCO N, 1986, BIOCHEMISTRY-US, V25, P4486, DOI 10.1021/bi00364a004; FOUCAUD C, 1992, J BIOL CHEM, V267, P22087; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; FRANCO PJ, 1991, J BIOL CHEM, V266, P6693; HARLOW E, 1988, ANTIBODIES LABORATOR; HENDERSON PJF, 1986, METHOD ENZYMOL, V125, P387; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; KING SC, 1989, J BIOL CHEM, V264, P7390; KING SC, 1990, J BIOL CHEM, V265, P3153; KING SC, 1989, BIOCHIM BIOPHYS ACTA, V982, P253, DOI 10.1016/0005-2736(89)90062-X; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE JA, 1989, BIOCHEMISTRY-US, V28, P2540, DOI 10.1021/bi00432a029; LEE JI, 1993, J BIOL CHEM, V268, P20007; LIANG WS, 1992, THESIS U CAMBRIDGE; LOLKEMA JS, 1993, J BIOL CHEM, V268, P17850; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P1284, DOI 10.1021/bi00219a018; LOLKEMA JS, 1995, J BIOL CHEM, V270, P12670, DOI 10.1074/jbc.270.21.12670; MATZKE EA, 1992, J BIOL CHEM, V267, P19095; MENICK DR, 1987, BIOCHEMISTRY-US, V26, P6638, DOI 10.1021/bi00395a012; POOLMAN B, 1992, J BIOL CHEM, V267, P9150; POOLMAN B, 1989, J BACTERIOL, V171, P244, DOI 10.1128/jb.171.1.244-253.1989; POOLMAN B, 1995, P NATL ACAD SCI USA, V92, P778, DOI 10.1073/pnas.92.3.778; POOLMAN B, 1983, EUR J BIOCHEM, V135, P41, DOI 10.1111/j.1432-1033.1983.tb07615.x; POOLMAN B, 1990, MOL MICROBIOL, V4, P1629, DOI 10.1111/j.1365-2958.1990.tb00539.x; POOLMAN B, 1993, BIOCHIM BIOPHYS ACTA, V1183, P5, DOI 10.1016/0005-2728(93)90003-X; PUTTNER IB, 1986, BIOCHEMISTRY-US, V25, P4483; PUTTNER IB, 1989, BIOCHEMISTRY-US, V28, P2525, DOI 10.1021/bi00432a027; ROEPE PD, 1990, PROG CELL R, V1, P213; RUSSELL AJ, 1987, NATURE, V328, P496, DOI 10.1038/328496a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VIITANEN P, 1983, BIOCHEMISTRY-US, V22, P2531, DOI 10.1021/bi00279a034; WALZ D, 1988, CELL BIOPHYS, V12, P13, DOI 10.1007/BF02918348	37	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12995	13003		10.1074/jbc.270.22.12995	http://dx.doi.org/10.1074/jbc.270.22.12995			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768891	hybrid, Green Submitted			2022-12-27	WOS:A1995RB43900012
J	RYLE, MJ; LANZILOTTA, WN; MORTENSON, LE; WATT, GD; SEEFELDT, LC				RYLE, MJ; LANZILOTTA, WN; MORTENSON, LE; WATT, GD; SEEFELDT, LC			EVIDENCE FOR A CENTRAL ROLE OF LYSINE-15 OF AZOTOBACTER-VINELANDII NITROGENASE IRON PROTEIN IN NUCLEOTIDE BINDING AND PROTEIN CONFORMATIONAL-CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNESIUM ADENOSINE 5'-TRIPHOSPHATE; ELECTRON-PARAMAGNETIC-RESONANCE; CLOSTRIDIUM-PASTEURIANUM; MOFE PROTEIN; FE PROTEIN; BINDING; MGATP; METALLOCLUSTERS; AZOFERREDOXIN; COMPONENT	Biological nitrogen fixation catalyzed by purified nitrogenase requires the hydrolysis of a minimum of 16 MgATP for each N-2 reduced. In the present study, we demonstrate a central function for Lys-1B of Azotobacter vinelandii nitrogenase iron protein (FeP) in the interaction of nucleotides with nitrogenase. Changing Lys-1B of the FeP to Arg resulted in an FeP with a dramatically reduced affinity for both MgATP and MgADP. From equilibrium column binding experiments at different nucleotide concentrations, apparent dissociation constants (K-d) for wild type FeP binding of MgADP (143 mu M) and MgATP (571 mu M) were determined. Over the same nucleotide concentration ranges, the K15R FeP showed no significant affinity for either nucleotide. This contrasts sharply with previous results with an FeP in which Lys-1B was changed to Gln (K15Q) where it was found that the K15Q FeP bound MgADP with the same affinity as wild type FeP and MgATP with a slightly reduced affinity. Analysis of K15R FeP by EPR, circular dichroism (CD), and microcoulometry revealed that the [4Fe-4S] cluster was unaffected by the amino acid change and that addition of either MgADP or MgATP did not result in the protein conformational changes normally detected by these techniques. These results are integrated into a model for how MgATP and MgADP bind and induce conformational changes within the FeP.	UTAH STATE UNIV,DEPT CHEM & BIOCHEM,LOGAN,UT 84322; UNIV GEORGIA,DEPT BIOCHEM,ATHENS,GA 30602; BRIGHAM YOUNG UNIV,DEPT CHEM & BIOCHEM,PROVO,UT 84602	Utah System of Higher Education; Utah State University; University System of Georgia; University of Georgia; Brigham Young University				Seefeldt, Lance/0000-0002-6457-9504				ANDERSON GL, 1984, BIOCHEMISTRY-US, V23, P2118, DOI 10.1021/bi00305a002; BOLIN JT, 1993, P NATL ACAD SCI USA, V90, P1078, DOI 10.1073/pnas.90.3.1078; BURRIS RH, 1991, J BIOL CHEM, V266, P9339; CHEN L, 1994, J BIOL CHEM, V269, P3290; CHROMY V, 1974, CLIN CHEM, V20, P1362; CORDEWENER J, 1983, EUR J BIOCHEM, V132, P47, DOI 10.1111/j.1432-1033.1983.tb07323.x; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HAGEMAN RV, 1980, BIOCHEMISTRY-US, V19, P2333, DOI 10.1021/bi00552a009; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; KIM J, 1994, BIOCHEMISTRY-US, V33, P389, DOI 10.1021/bi00168a001; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; LJONES T, 1978, BIOCHEMISTRY-US, V17, P1866, DOI 10.1021/bi00603a010; LOWE DJ, 1993, BIOCHEM J, V292, P93, DOI 10.1042/bj2920093; MEYER J, 1988, BIOCHEMISTRY-US, V27, P6150, DOI 10.1021/bi00416a048; MORTENSON LE, 1993, ADV ENZYMOL RAMB, V67, P299; NORMAND P, 1989, J MOL EVOL, V29, P436, DOI 10.1007/BF02602914; ORMEJOHNSON WH, 1992, SCIENCE, V257, P1639, DOI 10.1126/science.1529351; ORMEJOHNSON WH, 1972, P NATL ACAD SCI USA, V69, P3142, DOI 10.1073/pnas.69.11.3142; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SEEFELDT LC, 1994, PROTEIN SCI, V3, P2073, DOI 10.1002/pro.5560031120; SEEFELDT LC, 1992, J BIOL CHEM, V267, P6680; SEEFELDT LC, 1993, PROTEIN SCI, V2, P93; SMITH BE, 1992, EUR J BIOCHEM, V205, P1, DOI 10.1111/j.1432-1033.1992.tb16746.x; STEPHENS PJ, 1979, P NATL ACAD SCI USA, V76, P2585, DOI 10.1073/pnas.76.6.2585; WALKER GA, 1974, BIOCHEMISTRY-US, V13, P2382, DOI 10.1021/bi00708a023; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALKER MN, 1974, J BIOL CHEM, V249, P6356; WATT GD, 1977, BIOCHEMISTRY-US, V16, P264, DOI 10.1021/bi00621a017; WATT GD, 1986, BIOCHEMISTRY-US, V25, P8156, DOI 10.1021/bi00373a005; WATT GD, 1979, ANAL BIOCHEM, V99, P399, DOI 10.1016/S0003-2697(79)80024-X; WOLLE D, 1992, SCIENCE, V258, P992, DOI 10.1126/science.1359643; YATES MG, 1991, BIOL NITROGEN FIXATI, P685; ZUMFT WG, 1974, EUR J BIOCHEM, V46, P525, DOI 10.1111/j.1432-1033.1974.tb03646.x; ZUMFT WG, 1972, BIOCHEM BIOPH RES CO, V48, P1525, DOI 10.1016/0006-291X(72)90887-X	37	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13112	13117		10.1074/jbc.270.22.13112	http://dx.doi.org/10.1074/jbc.270.22.13112			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768906	hybrid			2022-12-27	WOS:A1995RB43900028
J	TORTI, M; RAMASCHI, G; MONTSARRAT, N; SINIGAGLIA, F; BALDUINI, C; PLANTAVID, M; BRETON, M; CHAP, H; MAUCO, G				TORTI, M; RAMASCHI, G; MONTSARRAT, N; SINIGAGLIA, F; BALDUINI, C; PLANTAVID, M; BRETON, M; CHAP, H; MAUCO, G			EVIDENCE FOR A GLYCOPROTEIN-IIB-IIIA-INDEPENDENT AND AGGREGATION-INDEPENDENT MECHANISM OF PHOSPHATIDYLINOSITOL 3',4'-BISPHOSPHATE SYNTHESIS IN HUMAN PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-STIMULATED PLATELETS; CONCANAVALIN-A; PHOSPHOLIPASE-C; TYROSINE PHOSPHORYLATION; ACTIVATED PLATELETS; COMPLEX; THROMBOSPONDIN; CYTOSKELETON; PROTEINS; BINDING	The synthesis of phosphatidylinositol 3',4'-bisphosphate (PtdIns(3,4)P-2) in P-32-labeled human platelets induced by the tetrameric lectin concanavalin A and the physiological agonist thrombin were compared. Like thrombin, concanavalin A stimulated a time dependent accumulation of PtdIns(3,4)P-2, which reached maximal levels after 5 min of stimulation. However, while synthesis of PtdIns(3,4)P-2 induced by thrombin was dependent on platelet aggregation, the production of PtdIns(3,4)P-2 induced by concanavalin A was unchanged when aggregation was prevented by the omission of stirring or when fibrinogen binding to platelets was inhibited by the tetrapeptide RGDS. Accumulation of PtdIns(SP)P, was not observed in platelets stimulated with succinyl-concanavalin A, a dimeric derivative of the lectin that binds to the same receptors on the platelet surface but does not promote clustering of membrane glycoproteins. The synthesis of PtdIns(3,4)P-2 induced by concanavalin A was also independent of the membrane glycoprotein IIb-IIIa, as normal accumulation of this Lipid was observed in platelets from two patients affected by Glanzmann thrombasthenia. In contrast, thrombin showed a strongly reduced ability to stimulate PtdIns(3,4)P-2 production in thrombasthenic platelets. Although concanavalin A was able to induce association of the regulatory subunit of the phosphatidylinositol 3-kinase with tyrosine-phosphorylated proteins, the tyrosine kinase inhibitor tyrphostin AG-213 did not inhibit the lectin-induced synthesis of PtdIns(3,4)P-2. These results demonstrate the existence of a novel mechanism of PtdIns(3,4)P-2 synthesis in human platelets, which is independent of glycoprotein IIb-IIIa and aggregation, but requires clustering of membrane glycoproteins. As clustering events occur during platelet aggregation promoted by physiological agonists, this new mechanism may also be involved in the aggregation-dependent production of PtdIns(3,4)P-2 in thrombin-stimulated platelets.	UNIV GENOA,INST BIOL CHEM,I-31059 GENOA,ITALY; HOP PURPAN,INSERM,U326,F-31059 TOULOUSE,FRANCE	University of Genoa; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	TORTI, M (corresponding author), UNIV PAVIA,DEPT BIOCHEM,VIA BASSI 21,I-27100 PAVIA,ITALY.		Mauco, Gerard/A-3164-2016	Mauco, Gerard/0000-0003-2998-2397				BANGA HS, 1986, P NATL ACAD SCI USA, V83, P9197, DOI 10.1073/pnas.83.23.9197; BILLAH MM, 1982, J BIOL CHEM, V257, P2705; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; FITZGERALD LA, 1985, ANAL BIOCHEM, V151, P169, DOI 10.1016/0003-2697(85)90067-3; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; GUINEBAULT C, 1993, BIOCHEM J, V292, P851, DOI 10.1042/bj2920851; GUINEBAULT C, 1995, IN PRESS J CELL BIOL; GUNTHER GR, 1973, P NATL ACAD SCI USA, V70, P1012, DOI 10.1073/pnas.70.4.1012; GUTKIND JS, 1990, MOL CELL BIOL, V10, P3806, DOI 10.1128/MCB.10.7.3806; HORVATH AR, 1992, EMBO J, V11, P855, DOI 10.1002/j.1460-2075.1992.tb05123.x; ISENBERG WM, 1987, J CELL BIOL, V104, P1655, DOI 10.1083/jcb.104.6.1655; KAKAIYA RM, 1988, THROMB HAEMOSTASIS, V59, P281; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; LAWLER J, 1986, BLOOD, V67, P1197; LEUNG LLK, 1984, J CLIN INVEST, V74, P1764, DOI 10.1172/JCI111595; MOROI M, 1984, BIOCHIM BIOPHYS ACTA, V798, P295, DOI 10.1016/0304-4165(84)90101-6; NEWMAN PJ, 1992, J CELL BIOL, V119, P239, DOI 10.1083/jcb.119.1.239; NOLAN RD, 1990, J BIOL CHEM, V265, P2441; PHILLIPS DR, 1980, J CELL BIOL, V86, P77, DOI 10.1083/jcb.86.1.77; PHILLIPS DR, 1988, BLOOD, V71, P831; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; RAMASCHI G, 1993, CELL BIOCHEM FUNCT, V11, P241, DOI 10.1002/cbf.290110404; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; SILVERSTEIN RL, 1989, J CLIN INVEST, V84, P546, DOI 10.1172/JCI114197; SINIGAGLIA F, 1988, BIOCHEM BIOPH RES CO, V154, P258, DOI 10.1016/0006-291X(88)90678-X; SORISKY A, 1992, BIOCHEM J, V286, P581, DOI 10.1042/bj2860581; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; SULTAN C, 1991, J BIOL CHEM, V266, P23554; SULTAN C, 1990, BIOCHEM J, V269, P831, DOI 10.1042/bj2690831; THOMASON PA, 1994, J BIOL CHEM, V269, P16525; TORTI M, 1992, CELL BIOCHEM FUNCT, V10, P53, DOI 10.1002/cbf.290100109; TORTI M, 1995, J CELL BIOCHEM, V57, P30, DOI 10.1002/jcb.240570105; TORTI M, 1992, J BIOL CHEM, V267, P8293; TORTI M, 1994, P NATL ACAD SCI USA, V91, P4239, DOI 10.1073/pnas.91.10.4239; WHEELER ME, 1985, J CELL BIOL, V101, P993, DOI 10.1083/jcb.101.3.993; ZHANG J, 1992, J BIOL CHEM, V267, P4686; ZHANG J, 1994, J BIOL CHEM, V268, P2251	41	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13179	13185		10.1074/jbc.270.22.13179	http://dx.doi.org/10.1074/jbc.270.22.13179			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768914	hybrid			2022-12-27	WOS:A1995RB43900037
J	TRIGON, S; MORANGE, M				TRIGON, S; MORANGE, M			DIFFERENT CARBOXYL-TERMINAL DOMAIN KINASE-ACTIVITIES ARE INDUCED BY HEAT-SHOCK AND ARSENITE - CHARACTERIZATION OF THEIR SUBSTRATE-SPECIFICITY, SEPARATION BY MONO-Q CHROMATOGRAPHY, AND COMPARISON WITH THE MITOGEN-ACTIVATED PROTEIN-KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; GROWTH-FACTOR RECEPTOR; LARGEST SUBUNIT; REPEAT DOMAIN; MAP KINASES; PHOSPHORYLATION; TRANSCRIPTION; INITIATION; PURIFICATION; IDENTIFICATION	In response to heat-shock and chemical treatments, cells undergo profound biochemical changes such as modifications in protein phosphorylation in order to resist the new, unfavorable growth conditions. We have previously shown that in HeLa cells a protein kinase (HS-CTD kinase) activity is induced rapidly after a heat or sodium arsenite shock. This kinase activity is able to phosphorylate a synthetic peptide composed of four repeats of the motif Ser-Pro Thr-Ser-Pro-Ser-Tyr, a motif highly repeated in the carboxyl-terminal domain (CTD) of the largest subunit of eukaryotic RNA polymerase II. In this paper, we designed a new experimental procedure to characterize the substrate specificity of this kinase activity. We show that HS-CTD kinase activity phosphorylates a consensus sequence (-P-X-S/T-P-) which is similar to the sequence phosphorylated by extracellular regulated protein kinases (also called mitogen-activated protein kinases). However, there is a slight but reproducible difference between these kinases in their use of serine or threonine as the phosphate acceptor. Mono Q chromatography allows the separation of five stress-induced CTD kinase activities, two of which coelute with active mitogen-activated protein kinase forms revealed by Western blotting with anti ERK1-ERK2 antibodies. The other three CTD kinase activities induced after a stress are distinct from ERK1 and ERK2 and have different enzymatic properties. The molecular nature of these HS-CTD kinases and the physiological significance of their activation during stress remain to be determined.			TRIGON, S (corresponding author), ECOLE NORMALE SUPER, UNITE GENET MOLEC, 46 RUE ULM, F-75230 PARIS 05, FRANCE.							ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ARIAS JA, 1991, J BIOL CHEM, V266, P8055; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; BIRD TA, 1991, J BIOL CHEM, V266, P22661; CISEK LJ, 1989, NATURE, V339, P679, DOI 10.1038/339679a0; CISEK LJ, 1991, METHOD ENZYMOL, V200, P301; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; COHEN P, 1993, BIOCHEM SOC T, V21, P555, DOI 10.1042/bst0210555; DAHMUS ME, 1983, J BIOL CHEM, V258, P2303; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DUBOIS MF, 1991, CR ACAD SCI III-VIE, V313, P165; DUBOIS MF, 1993, FEBS LETT, V324, P191, DOI 10.1016/0014-5793(93)81391-C; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1991, J BIOL CHEM, V266, P2789; LAYBOURN PJ, 1989, J BIOL CHEM, V264, P6693; LEE JM, 1989, P NATL ACAD SCI USA, V86, P3624, DOI 10.1073/pnas.86.10.3624; LEGAGNEUX V, 1990, EUR J BIOCHEM, V193, P121, DOI 10.1111/j.1432-1033.1990.tb19312.x; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; MING Z, 1993, J BIOL CHEM, V268, P35; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; PAYNE JM, 1993, J BIOL CHEM, V268, P80; PEKKALA D, 1984, MOL CELL BIOL, V4, P1198, DOI 10.1128/MCB.4.7.1198; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SANGHERA JS, 1990, J BIOL CHEM, V265, P52; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; STONE N, 1992, J BIOL CHEM, V267, P6353; TRIGON S, 1993, REV ROUM BIOCHIM, V3, P185; WEBER K, 1969, J BIOL CHEM, V244, P4406; ZEHRING WA, 1988, P NATL ACAD SCI USA, V85, P3698, DOI 10.1073/pnas.85.11.3698	42	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13091	13098		10.1074/jbc.270.22.13091	http://dx.doi.org/10.1074/jbc.270.22.13091			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768904	hybrid			2022-12-27	WOS:A1995RB43900025
J	BEJA, O; BIBI, E				BEJA, O; BIBI, E			MULTIDRUG-RESISTANCE PROTEIN (MDR)-ALKALINE PHOSPHATASE HYBRIDS IN ESCHERICHIA-COLI SUGGEST A MAJOR REVISION IN THE TOPOLOGY OF THE C-TERMINAL HALF OF MDR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							P-GLYCOPROTEIN; BACTERIAL TRANSPORT; MEMBRANE-PROTEIN; STRUCTURAL MODEL; CYSTIC-FIBROSIS; GENE; SEQUENCE; ORIENTATION; ANTIBODIES; EXPORT	Recent studies reveal that the organization of the multidrug resistance protein (Mdr) in the membrane is probably not exactly as predicted from hydropathy profiling, When expressed in Escherichia coli, phoA gene fusions can be utilized to study the membrane topology of Mdr. Using this approach, it was proposed recently that the N-terminal hydrophobic domain of Mdr spans the membrane six times, in a different fashion from that predicted by hydropathy analysis (Bibi, E. and Beja, O. (1994) J. Biol. Chem. 269, 19910-19915). In this study, we analyze mdr-phoA fusions constructed in the C-terminal half of Mdr. Overall, the results presented here lead to a significant revision in the membrane topology model of the C-terminal half of Mdr. The new topology is discussed with regard to the hydropathy profiles of the well characterized ABC proteins MalG and MalF, which are strikingly similar to those of the N- and C-terminal halves of Mdr, respectively.	WEIZMANN INST SCI,DEPT BIOCHEM,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science				Bibi, Eitan/0000-0003-3700-2707				BIBI E, 1994, J BIOL CHEM, V269, P19910; BIBI E, 1993, P NATL ACAD SCI USA, V90, P9209, DOI 10.1073/pnas.90.19.9209; BOYD D, 1993, J BACTERIOL, V175, P553, DOI 10.1128/JB.175.2.553-556.1993; CIANFRIGLIA M, 1994, INT J CANCER, V56, P153; EHRMANN M, 1990, P NATL ACAD SCI USA, V87, P7574, DOI 10.1073/pnas.87.19.7574; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; GEORGES E, 1993, J BIOL CHEM, V268, P1792; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gros P, 1993, Int Rev Cytol, V137C, P169; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JACHEZ B, 1994, ANTI-CANCER DRUG, V5, P655, DOI 10.1097/00001813-199412000-00008; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOO TW, 1994, J BIOL CHEM, V269, P28683; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; MIMURA CS, 1991, P NATL ACAD SCI USA, V88, P84, DOI 10.1073/pnas.88.1.84; NIKAIDO H, 1994, FEBS LETT, V346, P55, DOI 10.1016/0014-5793(94)00315-7; PRINZ WA, 1994, J BACTERIOL, V176, P6410, DOI 10.1128/jb.176.20.6410-6413.1994; RIORDAN JR, 1989, SCIENCE, V245, P1066; SKACH WR, 1993, J BIOL CHEM, V268, P6903; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Theorell H, 1967, Harvey Lect, V61, P17; TRAXLER B, 1993, J MEMBRANE BIOL, V132, P1; YOSHIMURA A, 1989, J BIOL CHEM, V264, P16282; ZHANG JT, 1991, J BIOL CHEM, V266, P18224; ZHANG JT, 1993, J BIOL CHEM, V268, P15101	31	42	43	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12351	12354						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759475				2022-12-27	WOS:A1995QZ71100007
J	GARRETT, JE; CAPUANO, IV; HAMMERLAND, LG; HUNG, BCP; BROWN, EM; HEBERT, SC; NEMETH, EF; FULLER, F				GARRETT, JE; CAPUANO, IV; HAMMERLAND, LG; HUNG, BCP; BROWN, EM; HEBERT, SC; NEMETH, EF; FULLER, F			MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF HUMAN PARATHYROID CALCIUM RECEPTOR CDNAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; EXTRACELLULAR DIVALENT-CATIONS; PROTEIN-KINASE-C; INTRACELLULAR CALCIUM; CYTOSOLIC CALCIUM; CELLS; CA-2+; HYPERPARATHYROIDISM; ACCUMULATION; MESSENGERS	Parathyroid cells express a cell surface receptor, coupled to the mobilization of intracellular Ca2+, that is activated by increases in the concentration of extracellular Ca2+ and by a variety of other cations, This ''Ca2+ receptor'' (CaR) serves as the primary physiological regulator of parathyroid hormone secretion, Alterations in the CaR have been proposed to underlie the increases in Ca2+ set-point seen in primary hyperparathyroidism due to parathyroid adenoma, We have isolated human CaR cDNAs from an adenomatous parathyroid gland, The cloned receptor, expressed in Xenopus oocytes, responds to extracellular application of physiologically relevant concentrations of Ca2+ and other CaR agonists, The rank order of potency of CaR agonists displayed by the native receptor (Gd3+ > neomycin B > Ca2+ > Mg2+) is maintained by the expressed receptor, The nucleotide sequence of the human CaR cDNA predicts a protein of 1078 amino acids with high sequence similarity to a bovine CaR, and displays seven putative membrane-spanning regions common to G protein-coupled receptors. The deduced protein sequence shows potential sites for N-linked glycosylation and phosphorylation by protein kinase C and has a low level of sequence similarity to the metabotropic glutamate receptors, Comparison of the cDNA sequence to that of the normal human CaR gene showed no alteration in the coding region sequence of the CaR in this particular instance of parathyroid adenoma, Human cDNA clones with differing 5'-untranslated regions were isolated, suggesting alternative splicing of the parathyroid CaR mRNA, A rare variant cDNA clone representing a 10 amino acid insertion into the extracellular domain was also isolated. Northern blot analysis of normal and adenomatous parathyroid gland mRNA identified a predominant transcript of similar to 5.4 kilobases, and less abundant transcripts of similar to 10, 4.8 and 4.2 kilobases in RNA from the adenoma. While there is no evidence for alteration of the primary amino acid sequence of the CaR in this adenoma, modulation of CaR biosynthesis through alternative RNA processing may play a role in set-point alterations.	NPS PHARMACEUT, DEPT PHARMACOL, SALT LAKE CITY, UT 84108 USA; BRIGHAM & WOMENS HOSP, DIV ENDOCRINE HYPERTENS, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT MED, DIV RENAL, MOLEC PHYSIOL & BIOPHYS LAB, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	GARRETT, JE (corresponding author), NPS PHARMACEUT, DEPT BIOL MOLEC, 420 CHIPETA WAY, SALT LAKE CITY, UT 84108 USA.		Centeno, Patricia Pacios/O-8368-2016					BROWN E, 1987, FEBS LETT, V218, P113, DOI 10.1016/0014-5793(87)81029-3; BROWN EM, 1991, ENDOCRINOLOGY, V128, P3047, DOI 10.1210/endo-128-6-3047; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; BROWN EM, 1986, PROGR SURGERY, V18, P13; CHEN CJ, 1989, ENDOCRINOLOGY, V124, P233, DOI 10.1210/endo-124-1-233; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EL-HAJJ FULEIHAN G, 1991, ENDOCRINOLOGY, V128, P2931, DOI 10.1210/endo-128-6-2931; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FLIEGEL L, 1987, P NATL ACAD SCI USA, V84, P1167, DOI 10.1073/pnas.84.5.1167; FOX J, 1993, J BONE MINER RES, V8, pS181; FRIED RM, 1986, J BIOL CHEM, V261, P7669; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; KHOSLA S, 1993, J CLIN ENDOCR METAB, V76, P715, DOI 10.1210/jc.76.3.715; KIFOR O, 1988, ENDOCRINOLOGY, V123, P2723, DOI 10.1210/endo-123-6-2723; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KURTZ A, 1989, P NATL ACAD SCI USA, V86, P3423, DOI 10.1073/pnas.86.9.3423; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NEMETH EF, 1987, J BIOL CHEM, V262, P5188; NEMETH EF, 1990, CELL CALCIUM, V11, P323, DOI 10.1016/0143-4160(90)90033-Q; NEMETH EF, 1994, NEWS PHYSL, V10, P1; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; POLLAK MR, 1994, J CLIN INVEST, V93, P1108, DOI 10.1172/JCI117062; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P141, DOI 10.1113/jphysiol.1993.sp019764; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P163, DOI 10.1113/jphysiol.1993.sp019765; RACKE FK, 1993, FEBS LETT, V333, P132, DOI 10.1016/0014-5793(93)80390-G; SAMBROOK J, 1989, MOL CHANGE LABORATOR; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SMITH VL, 1990, CELL REGUL, V1, P165, DOI 10.1091/mbc.1.2.165; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341	35	419	452	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12919	12925		10.1074/jbc.270.21.12919	http://dx.doi.org/10.1074/jbc.270.21.12919			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759551	hybrid			2022-12-27	WOS:A1995QZ71100089
J	LEZOUALCH, F; SEUGNET, I; MONNIER, AL; GHYSDAEL, J; BEHR, JP; DEMENEIX, BA				LEZOUALCH, F; SEUGNET, I; MONNIER, AL; GHYSDAEL, J; BEHR, JP; DEMENEIX, BA			INHIBITION OF NEUROGENIC PRECURSOR PROLIFERATION BY ANTISENSE ALPHA-THYROID HORMONE-RECEPTOR OLIGONUCLEOTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA RESPONSE ELEMENTS; CHICK OPTIC TECTUM; RETINOIC ACID; DIFFERENTIAL EXPRESSION; CELL-PROLIFERATION; BRAIN-DEVELOPMENT; GENE; PROTEIN; BINDING; BETA	Thyroid hormone 3,5,3'-triiodo-L-thyronine (T-3) is required for normal brain development in vertebrates. T-3 acts through two classes of nuclear receptors (TR alpha and TR beta) that have distinct developmental spatial and temporal distributions suggesting different functions during neuronal development. One possibility is that TR alpha, which is expressed early in embryogenesis, is involved in neuroblast proliferation. To test this hypothesis we used the embryonic chick optic lobe, as we found that T-3 stimulates [H-3]thymidine incorporation in this tissue both in vivo and in vitro during embryonic days 6-9. We applied oligonucleotides (ODNs) against TR alpha and TR beta to primary cultures of chick optic lobes. By employing a cationic lipid vector we could use very low ODN concentrations (< 150 nM). Antisense ODNs against TR alpha significantly inhibited [H-3]thymidine incorporation, whereas antisense TR beta had no significant effect, However, both ODNs inhibited expression of TRs, as they blocked transcription from a T-3-activated reporter gene. Random ODNs used as controls had no significant effect on [H-3]thymidine incorporation or on T-3-dependent transcription. These observations suggest that TR alpha is implicated in neuroblast proliferation and add credence to the hypothesis that the multiplicity of nuclear receptors allows for specific actions of T-3 during development.	NATL MUSEUM NAT HIST, PHYSIOL GEN & COMPAREE LAB, CNRS, URA 90, F-75005 PARIS, FRANCE; INST CURIE, ONCOGENESE RETROVIRALE & MOLEC LAB, CNRS, URA 1443, F-91405 ORSAY, FRANCE; UNIV STRASBOURG 1, CHIM GENET LAB, CNRS, URA 1386, F-67401 STRASBOURG, FRANCE	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Lezoualc'h, Frank/E-5031-2016; GHYSDAEL, Jacques/F-3377-2013					ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; Baffoni G. M., 1960, Rendiconti Accad Lincei (8), V28, P102; BALAZS R, 1968, J NEUROCHEM, V15, P1335, DOI 10.1111/j.1471-4159.1968.tb05913.x; BEHR JP, 1989, P NATL ACAD SCI USA, V86, P6982, DOI 10.1073/pnas.86.18.6982; BETRAM J, 1994, BIOCHEM BIOPH RES CO, V200, P661; BRADLEY DJ, 1989, P NATL ACAD SCI USA, V86, P7250, DOI 10.1073/pnas.86.18.7250; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; CAPACCIOLI S, 1993, BIOCHEM BIOPH RES CO, V197, P818, DOI 10.1006/bbrc.1993.2552; DELUZE A, 1993, P NATL ACAD SCI USA, V90, P7322, DOI 10.1073/pnas.90.15.7322; DUSSAULT JH, 1987, ANNU REV PHYSIOL, V49, P321, DOI 10.1146/annurev.ph.49.030187.001541; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; FORREST D, 1991, EMBO J, V10, P269, DOI 10.1002/j.1460-2075.1991.tb07947.x; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GLINEUR C, 1990, GENE DEV, V4, P1663, DOI 10.1101/gad.4.10.1663; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; HARRINGTON EA, 1994, CURR OPIN GENET DEV, V4, P120, DOI 10.1016/0959-437X(94)90100-7; HIRST MA, 1992, P NATL ACAD SCI USA, V89, P5527, DOI 10.1073/pnas.89.12.5527; JACOBSON M, 1991, DEV NEUROBIOL, P282; KAWAHARA A, 1991, DEVELOPMENT, V112, P933; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; LAVAIL JH, 1971, BRAIN RES, V28, P421; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; LEZOUALCH F, 1992, MOL ENDOCRINOL, V6, P1797, DOI 10.1210/me.6.11.1797; LOUIS JC, 1981, EXP BRAIN RES, V42, P63; NICHOLSO.JL, 1972, BRAIN RES, V44, P13, DOI 10.1016/0006-8993(72)90362-9; Oppenheimer J H, 1976, Recent Prog Horm Res, V32, P529; PRATI M, 1992, ENDOCRINOLOGY, V130, P2651, DOI 10.1210/en.130.5.2651; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; STRAIT KA, 1990, J BIOL CHEM, V265, P10514; STRAIT KA, 1991, P NATL ACAD SCI USA, V88, P3887, DOI 10.1073/pnas.88.9.3887; STRAIT KA, 1992, MOL ENDOCRINOL, V6, P1874, DOI 10.1210/me.6.11.1874; STUNNENBERG HG, 1993, BIOESSAYS, V15, P309, DOI 10.1002/bies.950150504; Thommes R C, 1987, J Exp Zool Suppl, V1, P273; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WICKSTROM EL, 1988, P NATL ACAD SCI USA, V85, P1028, DOI 10.1073/pnas.85.4.1028; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; YEN PM, 1992, J BIOL CHEM, V267, P3565	41	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12100	12108		10.1074/jbc.270.20.12100	http://dx.doi.org/10.1074/jbc.270.20.12100			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744858	hybrid			2022-12-27	WOS:A1995QY73600061
J	LOSCH, A; KOCHBRANDT, C				LOSCH, A; KOCHBRANDT, C			DITHIOTHREITOL TREATMENT OF MADIN-DARBY CANINE KIDNEY-CELLS REVERSIBLY BLOCKS EXPORT FROM THE ENDOPLASMIC-RETICULUM BUT DOES NOT AFFECT VECTORIAL TARGETING OF SECRETORY PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; VIRUS-G-PROTEIN; GLYCOPROTEIN COMPLEX; BINDING; PATHWAY; OLIGOMERIZATION; HEMAGGLUTININ; BIOSYNTHESIS; POLYPEPTIDE; DEGRADATION	Addition of dithiothreitol (DTT) to the culture me medium of Madin-Darby canine kidney (MDCK) cells blocks transport of newly synthesized gp80 (clusterin, apolipoprotein J), a soluble marker protein for apical exocytosis in this epithelial cell line, In cells treated with DTT during pulse labeling, gp80 is retained in the endoplasmic reticulum, After removal of the reducing agent, gp80 is posttranslationally oxidized and secreted at the apical surface of MDCK cell monolayers, This demonstrates that when folded and oxidized posttranslationally, gp80 can acquire a conformation that exhibits sorting signals for vectorial targeting, In the continuous presence of DTT, the transepithelial electrical resistance of filter grown monolayers is maintained for several hours, indicating the presence of functionally intact tight junctions. Under the same conditions, transport competent forms of gp80 mature within the Golgi complex and are secreted predominantly at the apical surface of MDCK monolayers, Furthermore, another secretory protein, the osteopontin derived 20-kDa polypeptide, is targeted to the apical plasma membrane domain in the continuous presence of DTT, These re suits suggest that the apical sorting machinery in MDCK cells functions independent of the redox state of the secretory pathway.	UNIV MAINZ, INST BIOCHEM, D-55099 MAINZ, GERMANY	Johannes Gutenberg University of Mainz								BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; CHANAT E, 1993, EMBO J, V12, P2159, DOI 10.1002/j.1460-2075.1993.tb05864.x; CHOIMIURA NH, 1992, J BIOCHEM, V112, P557, DOI 10.1093/oxfordjournals.jbchem.a123938; CLAUDE P, 1978, J MEMBRANE BIOL, V39, P219, DOI 10.1007/BF01870332; DESILVA A, 1993, J CELL BIOL, V120, P647, DOI 10.1083/jcb.120.3.647; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; GOTTLIEB TA, 1986, P NATL ACAD SCI USA, V83, P2100, DOI 10.1073/pnas.83.7.2100; HARTMANN K, 1991, J BIOL CHEM, V266, P9924; HOBMAN TC, 1992, J CELL BIOL, V118, P795, DOI 10.1083/jcb.118.4.795; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; JENNE DE, 1992, TRENDS BIOCHEM SCI, V16, P27; KIRSZBAUM L, 1992, FEBS LETT, V297, P70, DOI 10.1016/0014-5793(92)80330-J; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KONDORKOCH C, 1985, CELL, V43, P297, DOI 10.1016/0092-8674(85)90035-2; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LODISH HF, 1993, J BIOL CHEM, V268, P20598; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; MACHAMER CE, 1990, J BIOL CHEM, V265, P6879; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; NOIVA R, 1992, J BIOL CHEM, V267, P3553; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PETERS T, 1982, J BIOL CHEM, V257, P8847; PICCIONI R, 1982, METHODS CHLOROPLAST, P985; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SEGAL MS, 1992, J CELL BIOL, V118, P227, DOI 10.1083/jcb.118.2.227; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; ULLRICH O, 1991, J BIOL CHEM, V266, P3518; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; WADA I, 1994, J BIOL CHEM, V269, P7464	41	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11543	11548		10.1074/jbc.270.19.11543	http://dx.doi.org/10.1074/jbc.270.19.11543			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744793	hybrid			2022-12-27	WOS:A1995QX86500073
J	SHIBATA, H; SUZUKI, Y; OMATA, W; TANAKA, S; KOJIMA, I				SHIBATA, H; SUZUKI, Y; OMATA, W; TANAKA, S; KOJIMA, I			DISSECTION OF GLUT4 RECYCLING PATHWAY INTO EXOCYTOSIS AND ENDOCYTOSIS IN RAT ADIPOCYTES - EVIDENCE THAT GTP-BINDING PROTEINS ARE INVOLVED IN BOTH PROCESSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORT ACTIVITY; INSULIN ACTION; ADIPOSE-CELLS; KINASE-C; TRANSLOCATION; INTERNALIZATION; LOCALIZATION; STIMULATION; MECHANISM; FAMILY	The effects of guanine nucleotides on either exocytosis or endocytosis of GLUT4 were examined in electrically permeabilized rat adipocytes by using D-k-(62-85), a major histocompatibility complex class I-derived peptide, Reversal of glucose transport activity that had been stimulated with insulin was completely blocked by D-k-(62-85), Likewise, endocytosis of the trypsin-cleaved 35-kDa fragment of GLUT4 was almost completely inhibited by the peptide, Insulin-stimulated glucose transport activity was enhanced about 50% by D-k-(62-85), whereas the basal transport activity was stimulated only slightly, Although guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) augmented glucose transport to the same extent as insulin in the absence of the peptide, glucose transport stimulated by GTP gamma S was only 60% of the insulin effect in the presence of the peptide; the effect of insulin was markedly enhanced by D-k-(62-85), whereas GTP gamma S-induced glucose transport was not affected, suggesting that GTP gamma S has an effect similar to that of the peptide, In fact, endocytosis of the 35-kDa fragment of GLUT4 was markedly inhibited by GTP gamma S, Additionally, GLUT4 endocytosis was accelerated by GTP but was inhibited by guanosine 5'-O-(2-thiodiphosphate), These results indicate that GTP gamma S induces translocation of GLUT4 by both stimulating exocytosis and inhibiting endocytosis, With respect to the dependence on GTP hydrolysis, distinct types of GTP-binding proteins are involved in exocytosis and endocytosis of GLUT4.			SHIBATA, H (corresponding author), GUNMA UNIV,INST MOLEC & CELLULAR REGULAT,DEPT CELL BIOL,MAEBASHI,GUMMA 371,JAPAN.							BALDINI G, 1991, J BIOL CHEM, V266, P4037; CZECH MP, 1993, J BIOL CHEM, V268, P9187; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; James David E., 1994, Trends in Cell Biology, V4, P120, DOI 10.1016/0962-8924(94)90066-3; JHUN BH, 1992, J BIOL CHEM, V267, P17710; KONO T, 1982, J BIOL CHEM, V257, P942; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; RODBELL M, 1964, J BIOL CHEM, V239, P375; SALTIS J, 1991, J BIOL CHEM, V266, P261; SHIBATA H, 1991, ARCH BIOCHEM BIOPHYS, V285, P97, DOI 10.1016/0003-9861(91)90333-E; SHIBATA Y, 1987, BIOCHIM BIOPHYS ACTA, V902, P154, DOI 10.1016/0005-2736(87)90147-7; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; STAGSTED J, 1993, J BIOL CHEM, V268, P22809; STAGSTED J, 1990, CELL, V62, P297, DOI 10.1016/0092-8674(90)90367-N; SUZUKI Y, 1992, BIOCHEM BIOPH RES CO, V189, P572, DOI 10.1016/0006-291X(92)91596-I; YANG J, 1993, J BIOL CHEM, V268, P4600; YANO Y, 1993, BIOCHIM BIOPHYS ACTA, V1176, P327, DOI 10.1016/0167-4889(93)90062-T	20	46	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11489	11495		10.1074/jbc.270.19.11489	http://dx.doi.org/10.1074/jbc.270.19.11489			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744788	hybrid			2022-12-27	WOS:A1995QX86500067
J	ALMUSTAFA, J; SYKORA, M; KINCAID, JR				ALMUSTAFA, J; SYKORA, M; KINCAID, JR			RESONANCE RAMAN INVESTIGATION OF CYANIDE LIGATED BEEF-LIVER AND ASPERGILLUS-NIGER CATALASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; IRON-CARBON BOND; HORSERADISH-PEROXIDASE; 3-DIMENSIONAL STRUCTURE; LIGAND VIBRATIONS; SPECTRA; SPECTROSCOPY; RESOLUTION; NADPH; MOLECULES	Resonance Raman spectroscopy has been used to investigate the properties of cyanide-bound beef liver catalase (BLC) and Aspergillus niger catalase (ANC) in the pH range 4.9-11.5. Evidence has been obtained for the binding of cyanide to both BLC and ANC in two binding geometries. The first conformer, exhibiting the nu[Fe-CN] stretching mode at a higher frequency than the delta[Fe-C-N] bending mode, exists as an essentially linear Fe-C-N linkage. For both BLC-CN and ANC-CN, the nu[Fe-CN] and delta[Fe-C-N] frequencies of this conformer were practically identical and observed at similar to 434 and similar to 413 cm(-1), respectively. The second conformer exhibits a nu[Fe-CN] mode at lower frequency than the delta[Fe-C-N] mode, and is thus characteristic of a bent Fe-C-N linkage. The nu[Fe-CN] and delta[Fe-C-N] modes were identified at 349 and 445 cm(-1), respectively, for BLC-CN, and at 350 and 456 cm(-1), respectively, for ANC-CN. The two conformers persist in the pH range 4.9-11.5. Furthermore, upon raising the pH to 11.5, the nu[Fe-CN] mode of the linear conformer of BLC-CN downshifts to 429 cm(-1) while that of the bent conformer remains unchanged. The observed pH-dependent shift is attributed to the deprotonation of a distal-side amino acid residue, probably a distal histidine, The Fe-C-N axial vibrations of the two conformers identified for ANC-CN did not show any significant pH-dependent shifts, indicating a more stable hydrogen bonding interaction relative to BLC-CN.			ALMUSTAFA, J (corresponding author), MARQUETTE UNIV,DEPT CHEM,MILWAUKEE,WI 53233, USA.		Sykora, Milan/N-5743-2019	Sykora, Milan/0000-0002-1747-0709	NIDDK NIH HHS [DK 35153] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035153] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALMUSTAFA J, 1994, BIOCHEMISTRY-US, V33, P2191, DOI 10.1021/bi00174a028; BANCI L, 1991, INORG CHEM, V30, P4510, DOI 10.1021/ic00024a010; BELAL R, 1989, NEW J CHEM, V13, P853; BROWETT WR, 1979, BIOCHIM BIOPHYS ACTA, V577, P291, DOI 10.1016/0005-2795(79)90033-3; CHANCE B, 1952, J BIOL CHEM, V194, P483; CHUANG WJ, 1988, J INORG BIOCHEM, V34, P201, DOI 10.1016/0162-0134(88)85030-X; CHUANG WJ, 1992, J BIOL CHEM, V267, P13293; CHUANG WJ, 1989, J BIOL CHEM, V264, P14209; EGLINTON DG, 1983, BIOCHIM BIOPHYS ACTA, V742, P648, DOI 10.1016/0167-4838(83)90284-4; EVANGELISTAKIRK.R, 1986, BIOCHEMISTRY-US, V25, P4420; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; FITA I, 1985, P NATL ACAD SCI USA, V82, P1604, DOI 10.1073/pnas.82.6.1604; FITA I, 1985, J MOL BIOL, V185, P21, DOI 10.1016/0022-2836(85)90180-9; GALSTON AW, 1957, ACTA CHEM SCAND, V5, P781; HAN SW, 1989, BIOCHEMISTRY-US, V28, P5477, DOI 10.1021/bi00439a024; HERBERT D, 1948, BIOCHEM J, V43, P193, DOI 10.1042/bj0430193; HU SH, 1992, FEBS LETT, V314, P293, DOI 10.1016/0014-5793(92)81492-5; HU SZ, 1993, BIOCHEMISTRY-US, V32, P10125, DOI 10.1021/bi00089a031; KERR EA, 1984, FEBS LETT, V178, P31, DOI 10.1016/0014-5793(84)81233-8; KIKUCHITORII K, 1982, J BIOCHEM, V92, P1449, DOI 10.1093/oxfordjournals.jbchem.a134069; KIRKMAN HN, 1984, P NATL ACAD SCI-BIOL, V81, P4343, DOI 10.1073/pnas.81.14.4343; KIRKMAN HN, 1987, J BIOL CHEM, V262, P660; LI XY, 1988, J AM CHEM SOC, V110, P6024, DOI 10.1021/ja00226a017; LOPEZGARRIGA JJ, 1990, BIOCHEMISTRY-US, V29, P9387, DOI 10.1021/bi00492a012; MARGOLIASH E, 1971, BIOCHEM J, V74, P339; MURSHUDOV GN, 1992, FEBS LETT, V312, P127, DOI 10.1016/0014-5793(92)80919-8; MURTHY MRN, 1981, J MOL BIOL, V152, P465, DOI 10.1016/0022-2836(81)90254-0; NAGAI M, 1989, BIOCHEMISTRY-US, V28, P2418, DOI 10.1021/bi00432a012; POULOS TL, 1987, ADV INORG BIOCHEM, V7, P1; RAJANI C, 1995, IN PRESS J RAMAN SPE; ROBERT A, 1991, INORG CHEM, V30, P706, DOI 10.1021/ic00004a021; SAKURADA J, 1986, J BIOL CHEM, V261, P9657; SCHONBAUM GR, 1976, ENZYMES, V13, P263; SCOTT DON, 1960, ENZYMOLOGIA, V22, P229; SHARMA KD, 1989, J BIOL CHEM, V264, P12772; Spiro, 1988, BIOL APPL RAMAN SPEC, P1; Sumner JB, 1937, J BIOL CHEM, V121, P417; TANAKA T, 1987, BIOPHYS J, V52, P801, DOI 10.1016/S0006-3495(87)83274-5; TEROAKA J, 1981, J BIOL CHEM, V256, P3969; THANABAL V, 1988, J AM CHEM SOC, V110, P3027, DOI 10.1021/ja00218a005; UNO T, 1988, INORG CHEM, V27, P3215, DOI 10.1021/ic00291a035; UNO T, 1987, J BIOL CHEM, V262, P4549; VAINSHTEIN BK, 1986, J MOL BIOL, V188, P49, DOI 10.1016/0022-2836(86)90479-1; YU NT, 1984, P NATL ACAD SCI-BIOL, V81, P5106, DOI 10.1073/pnas.81.16.5106; YU NT, 1988, BIOL APPLICATIONS RA, P39	45	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10449	10460		10.1074/jbc.270.18.10449	http://dx.doi.org/10.1074/jbc.270.18.10449			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737979	hybrid			2022-12-27	WOS:A1995QW60100017
J	BIDWAI, AP; REED, JC; GLOVER, CVC				BIDWAI, AP; REED, JC; GLOVER, CVC			CLONING AND DISRUPTION OF CKB1, THE GENE ENCODING THE 38-KDA BETA-SUBUNIT OF SACCHAROMYCES-CEREVISIAE CASEIN KINASE-II (CKII) - DELETION OF CKII REGULATORY SUBUNITS ELICITS A SALT-SENSITIVE PHENOTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; CELLULAR-REGULATION; ESCHERICHIA-COLI; SHUTTLE VECTORS; PROTEIN-KINASE; YEAST; CALMODULIN; PHOSPHORYLATION	Saccharomyces cerevisiae casein kinase II (CKII) contains two distinct catalytic (alpha and alpha') and regulatory (beta and beta') subunits, We report here the isolation and disruption of the gene, CKB1, encoding the 38-kDa beta subunit. The predicted Ckb1 sequence includes the N-terminal autophosphorylation site, internal acidic domain, and potential metal binding motif (CPX(3)C-X(22)-CPXC) present in other beta subunits but is unique in that it contains two additional autophosphorylation sites as well as a 30-amino-acid acidic insert. CKB1 is located on the left arm of chromosome VII, approximately 33 kilobases from the centromere and does not correspond to any previously characterized genetic locus. Haploid and diploid strains lacking either or both beta subunit genes are viable, demonstrating that the regulatory subunit of CKII is dispensable in S. cerevisiae. Such strains exhibit wild type behavior with regard to growth on both fermentable and nonfermentable carbon sources, mating, sporulation, spore germination, and resistance to heatshock and nitrogen starvation, but are salt sensitive. Salt sensitivity is specific for NaCl and LiCl and is not observed with KCI or agents which increase osmotic pressure alone, These data suggest a role for CKII in ion homeostasis in S. cerevisiae.	UNIV GEORGIA, DEPT BIOCHEM & MOLEC BIOL, ATHENS, GA 30602 USA	University System of Georgia; University of Georgia				Bidwai, Ashok/0000-0002-4297-5629	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033237] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33237] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BIDWAI AP, 1994, ARCH BIOCHEM BIOPHYS, V309, P348, DOI 10.1006/abbi.1994.1123; BIDWAI AP, 1993, ARCH BIOCHEM BIOPHYS, V300, P265, DOI 10.1006/abbi.1993.1037; BOLDYREFF B, 1993, EUR J BIOCHEM, V218, P515, DOI 10.1111/j.1432-1033.1993.tb18404.x; BOLDYREFF B, 1993, BIOCHEMISTRY-US, V32, P12672, DOI 10.1021/bi00210a016; BOLDYREFF B, 1994, J BIOL CHEM, V269, P4827; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COLLINGE MA, 1994, PLANT MOL BIOL, V25, P649, DOI 10.1007/BF00029603; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; FELSENSTEIN J, 1982, Q REV BIOL, V57, P379, DOI 10.1086/412935; GLOVER CVC, 1983, J BIOL CHEM, V258, P3258; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P77; HANNA DE, 1991, THESIS U GEORGIA ATH; HU E, 1990, J BIOL CHEM, V265, P20609; HU ED, 1990, J BIOL CHEM, V265, P5072; ISSINGER OG, 1993, PHARMACOL THERAPEUT, V59, P1, DOI 10.1016/0163-7258(93)90039-G; ISSINGER OG, 1992, BIOCHEMISTRY-US, V31, P6098, DOI 10.1021/bi00141a020; LIN WJ, 1991, J BIOL CHEM, V266, P5664; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; LIVAK KJ, 1990, GENETICS, V124, P303; MEGGIO F, 1992, EUR J BIOCHEM, V205, P939, DOI 10.1111/j.1432-1033.1992.tb16860.x; MEGGIO F, 1992, EUR J BIOCHEM, V204, P293, DOI 10.1111/j.1432-1033.1992.tb16636.x; MEGGIO F, 1983, FEBS LETT, V162, P235, DOI 10.1016/0014-5793(83)80762-5; MEGGIO F, 1987, FEBS LETT, V215, P241, DOI 10.1016/0014-5793(87)80154-0; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; MORTIMER RK, 1992, YEAST, V8, P817, DOI 10.1002/yea.320081002; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; REED JC, 1994, J BIOL CHEM, V269, P18192; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; ROUSSOU I, 1994, MOL CELL BIOL, V14, P576, DOI 10.1128/MCB.14.1.576; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SKALA J, 1991, YEAST, V7, P651, DOI 10.1002/yea.320070614; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; TEITZ T, 1990, MUTAT RES, V236, P85, DOI 10.1016/0921-8777(90)90036-5; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WELCH MD, 1993, GENETICS, V135, P265; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359; ZALKIN H, 1982, J BIOL CHEM, V257, P1491	47	75	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10395	10404		10.1074/jbc.270.18.10395	http://dx.doi.org/10.1074/jbc.270.18.10395			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737972				2022-12-27	WOS:A1995QW60100010
J	FARABAUGH, PJ				FARABAUGH, PJ			POSTTRANSCRIPTIONAL REGULATION OF TRANSPOSITION BY TY RETROTRANSPOSONS OF SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							VIRUS-LIKE PARTICLES; TRANSPOSABLE ELEMENT COPIA; STRANDED-RNA VIRUS; POL FUSION PROTEIN; GENE-EXPRESSION; NUCLEOTIDE-SEQUENCE; TRANSLATIONAL SUPPRESSION; REVERSE-TRANSCRIPTASE; RETROVIRAL PROTEINS; YEAST				FARABAUGH, PJ (corresponding author), UNIV MARYLAND, DEPT BIOL SCI, CATONSVILLE, MD 21228 USA.			Farabaugh, Philip/0000-0002-5658-7141				ADAMS SE, 1987, CELL, V49, P111, DOI 10.1016/0092-8674(87)90761-6; ATKINS JF, 1990, CELL, V62, P413, DOI 10.1016/0092-8674(90)90007-2; BALASUNDARAM D, 1994, J BACTERIOL, V176, P7126, DOI 10.1128/JB.176.22.7126-7128.1994; BALASUNDARAM D, 1994, P NATL ACAD SCI USA, V91, P172, DOI 10.1073/pnas.91.1.172; BELCOURT MF, 1990, CELL, V62, P339, DOI 10.1016/0092-8674(90)90371-K; Boeke J.D., 1991, MOL CELLULAR BIOL YE, V1, P193; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; CLARE J, 1985, P NATL ACAD SCI USA, V82, P2829, DOI 10.1073/pnas.82.9.2829; CLARE JJ, 1988, P NATL ACAD SCI USA, V85, P6816, DOI 10.1073/pnas.85.18.6816; CURCIO MJ, 1990, MOL GEN GENET, V220, P213; CURCIO MJ, 1988, MOL CELL BIOL, V8, P3571, DOI 10.1128/MCB.8.9.3571; CURCIO MJ, 1994, GENETICS, V136, P1245; CURCIO MJ, 1992, MOL CELL BIOL, V12, P2813, DOI 10.1128/MCB.12.6.2813; CURRAN JF, 1993, NUCLEIC ACIDS RES, V21, P1837, DOI 10.1093/nar/21.8.1837; DICKSON C, 1984, RNA TUMOR VIRUSES MO, P513; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; DOBSON MJ, 1984, EMBO J, V3, P1115, DOI 10.1002/j.1460-2075.1984.tb01938.x; EICHINGER DJ, 1988, CELL, V54, P955, DOI 10.1016/0092-8674(88)90110-9; FARABAUGH PJ, 1993, CELL, V74, P591, DOI 10.1016/0092-8674(93)90507-M; FARABAUGH PJ, 1993, CELL, V74, P93, DOI 10.1016/0092-8674(93)90297-4; FARABAUGH PJ, 1980, NATURE, V286, P352, DOI 10.1038/286352a0; FELSENSTEIN KM, 1988, J VIROL, V62, P2179, DOI 10.1128/JVI.62.6.2179-2182.1988; GARFINKEL DJ, 1991, J VIROL, V65, P4573, DOI 10.1128/JVI.65.9.4573-4581.1991; GARFINKEL DJ, 1985, CELL, V42, P507, DOI 10.1016/0092-8674(85)90108-4; GARFINKEL DJ, 1992, RETROVIRIDAE, V1, P107; HANSEN LJ, 1992, J VIROL, V66, P1414, DOI 10.1128/JVI.66.3.1414-1424.1992; HANSEN LJ, 1988, MOL CELL BIOL, V8, P5245, DOI 10.1128/MCB.8.12.5245; HANSEN LJ, 1990, J VIROL, V64, P2599, DOI 10.1128/JVI.64.6.2599-2607.1990; HATFIELD DL, 1992, ADV VIRUS RES, V41, P193, DOI 10.1016/S0065-3527(08)60037-8; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACKS T, 1990, CURR TOP MICROBIOL, V157, P93; JANETZKY B, 1992, J BIOL CHEM, V267, P19798; KAWAKAMI K, 1993, GENETICS, V135, P309; KAWAKAMI K, 1992, GENETICS, V131, P821; KIRCHNER J, 1993, J VIROL, V67, P19, DOI 10.1128/JVI.67.1.19-28.1993; KIRCHNER J, 1992, J VIROL, V66, P6081, DOI 10.1128/JVI.66.10.6081-6092.1992; LEVIN HL, 1990, MOL CELL BIOL, V10, P6791, DOI 10.1128/MCB.10.12.6791; LINIAL ML, 1990, CURR TOP MICROBIOL, V157, P125; MELLOR J, 1985, NATURE, V318, P583, DOI 10.1038/318583a0; MELLOR J, 1985, NUCLEIC ACIDS RES, V13, P6249, DOI 10.1093/nar/13.17.6249; MELLOR J, 1985, NATURE, V313, P243, DOI 10.1038/313243a0; MOUNT SM, 1985, MOL CELL BIOL, V5, P1630, DOI 10.1128/MCB.5.7.1630; MULLER F, 1987, MOL GEN GENET, V207, P421, DOI 10.1007/BF00331610; ORLINSKY KJ, 1994, J VIROL, V68, P4152, DOI 10.1128/JVI.68.7.4152-4166.1994; OROSZLAN S, 1990, CURR TOP MICROBIOL, V157, P153; PANDE S, 1995, MOL CELL BIOL, V15, P298, DOI 10.1128/MCB.15.1.298; PARK J, 1992, J VIROL, V65, P5111; Sandmeyer SB, 1992, CURR OPIN GENET DEV, V2, P705, DOI 10.1016/S0959-437X(05)80130-3; STUCKA R, 1992, GENE, V122, P119, DOI 10.1016/0378-1119(92)90039-R; VIMALADITHAN A, 1994, MOL CELL BIOL, V14, P8107, DOI 10.1128/MCB.14.12.8107; VOYTAS DF, 1992, NATURE, V358, P717, DOI 10.1038/358717a0; WARMINGTON JR, 1985, NUCLEIC ACIDS RES, V13, P6679, DOI 10.1093/nar/13.18.6679; WICKNER RB, 1989, FASEB J, V3, P2257, DOI 10.1096/fasebj.3.11.2550303; WILSON W, 1986, NUCLEIC ACIDS RES, V14, P7001, DOI 10.1093/nar/14.17.7001; XU H, 1991, MOL CELL BIOL, V11, P2736, DOI 10.1128/MCB.11.5.2736; XU H, 1990, Proceedings of the National Academy of Sciences of the United States of America, V87, P8360, DOI 10.1073/pnas.87.21.8360; YOSHIOKA K, 1991, GENE, V103, P179; YOUNGREN SD, 1988, MOL CELL BIOL, V8, P1421, DOI 10.1128/MCB.8.4.1421	59	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10361	10364		10.1074/jbc.270.18.10361	http://dx.doi.org/10.1074/jbc.270.18.10361			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737964	hybrid			2022-12-27	WOS:A1995QW60100001
J	LEE, GJ; POKALA, N; VIERLING, E				LEE, GJ; POKALA, N; VIERLING, E			STRUCTURE AND IN-VITRO MOLECULAR CHAPERONE ACTIVITY OF CYTOSOLIC SMALL HEAT-SHOCK PROTEINS FROM PEA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CRYSTALLIN; CITRATE SYNTHASE; EXPRESSION; PHOSPHORYLATION; RESISTANCE; PLANTS; FAMILY; TOMATO; HSP27; GENES	Plants synthesize several classes of small heat shock proteins ranging in size from 15 to 30 kDa. Two conserved classes, designated class I and class II, are localized to the cytosol. Recombinant HSP18.1 and HSP17.7, representing class I and class II proteins from pea, respectively, were expressed in Escherichia coli and purified. Non-denaturing polyacrylamide gel electrophoresis and electron microscopy demonstrated that the purified proteins formed discretely sized, high molecular weight complexes. Sedimentation equilibrium analytical ultracentrifugation revealed that the HSP18.1 and HSP17.7 complexes were composed of approximately 12 subunits. Both proteins were able to enhance the refolding of chemically denatured citrate synthase and lactate dehydrogenase at stoichiometric levels in an ATP-independent manner. Furthermore, HSP18.1 and HSP17.7 prevented aggregation of citrate synthase at 45 degrees C and irreversible inactivation of citrate synthase at 38 degrees C. HSP18.1 also suppressed aggregation of lactate dehydrogenase at 55 degrees C. These findings demonstrate that HSP18.1 and HSP17.7 can function as molecular chaperones in vitro.	WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	LEE, GJ (corresponding author), UNIV ARIZONA, DEPT BIOCHEM, LIFE SCI S, TUCSON, AZ 85721 USA.		Pokala, Navin/AAH-5719-2019	Pokala, Navin/0000-0003-2323-6190; Vierling, Elizabeth/0000-0002-0066-4881				ANDERSSON LO, 1972, FEBS LETT, V20, P199, DOI 10.1016/0014-5793(72)80793-2; ARRIGO AP, 1987, J BIOL CHEM, V262, P15359; Arrigo AP, 1994, BIOL HEAT SHOCK PROT, P335; BEHLKE J, 1991, FEBS LETT, V288, P119, DOI 10.1016/0014-5793(91)81016-2; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BERGER EM, 1983, EXP CELL RES, V147, P437, DOI 10.1016/0014-4827(83)90225-2; BLOXHAM DP, 1980, BIOCHEMISTRY-US, V19, P3979, DOI 10.1021/bi00558a014; BOUCHARD RA, 1990, GENOME, V33, P68, DOI 10.1139/g90-012; CHEN Q, 1994, J BIOL CHEM, V269, P13216; CLOS J, 1994, PROTEIN EXPRES PURIF, V5, P133, DOI 10.1006/prep.1994.1020; DEROCHER AE, 1994, PLANT J, V5, P93, DOI 10.1046/j.1365-313X.1994.5010093.x; DEROCHER AE, 1991, PLANT PHYSIOL, V96, P1038, DOI 10.1104/pp.96.4.1038; DIETRICH PS, 1991, PLANT PHYSIOL, V96, P1268, DOI 10.1104/pp.96.4.1268; FRAY RG, 1990, NUCLEIC ACIDS RES, V18, P7148, DOI 10.1093/nar/18.23.7148; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; HELM KW, 1993, MOL CELL BIOL, V13, P238, DOI 10.1128/MCB.13.1.238; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HERNANDEZ LD, 1993, PLANT PHYSIOL, V101, P1209, DOI 10.1104/pp.101.4.1209; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Jaenicke R, 1989, PROTEIN STRUCTURE PR, P191; JAKOB U, 1993, J BIOL CHEM, V268, P1517; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KANDROR O, 1994, J BIOL CHEM, V269, P23575; KATO K, 1994, J BIOL CHEM, V269, P11274; KORNBERG A, 1955, METHOD ENZYMOL, V1, P441, DOI 10.1016/0076-6879(55)01072-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRY J, 1992, J BIOL CHEM, V267, P794; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LAUZON LM, 1990, NUCLEIC ACIDS RES, V18, P4274, DOI 10.1093/nar/18.14.4274; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LENNE C, 1994, PLANT PHYSIOL, V105, P1255, DOI 10.1104/pp.105.4.1255; MANSFIELD MA, 1987, PLANT PHYSIOL, V84, P1007, DOI 10.1104/pp.84.4.1007; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; NOVER L, 1984, EUR J BIOCHEM, V139, P303, DOI 10.1111/j.1432-1033.1984.tb08008.x; OCHOA S, 1957, BIOCHEM PREP, V5, P19; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PLESOFSKYVIG N, 1992, J MOL EVOL, V35, P537, DOI 10.1007/BF00160214; ROLLET E, 1992, BIOCHEM BIOPH RES CO, V185, P116, DOI 10.1016/S0006-291X(05)80963-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TARDIEU A, 1986, J MOL BIOL, V192, P711, DOI 10.1016/0022-2836(86)90023-9; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; WANG Z, 1992, PROTEIN SCI, V1, P522	47	266	287	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10432	10438		10.1074/jbc.270.18.10432	http://dx.doi.org/10.1074/jbc.270.18.10432			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737977	hybrid			2022-12-27	WOS:A1995QW60100015
J	PROSSNITZ, ER; SCHREIBER, RE; BOKOCH, GM; YE, RD				PROSSNITZ, ER; SCHREIBER, RE; BOKOCH, GM; YE, RD			BINDING OF LOW-AFFINITY N-FORMYL PEPTIDE RECEPTORS TO G-PROTEIN - CHARACTERIZATION OF A NOVEL INACTIVE RECEPTOR INTERMEDIATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERLEUKIN-8 RECEPTOR; ADENYLATE-CYCLASE; RECONSTITUTION; FLUORESCENCE; COMPLEX; LIGAND; CDNA	G protein-coupled seven-transmembrane-containing receptors, such as the N-formyl peptide receptor (FPR) of neutrophils, likely undergo a conformational change upon binding of ligand, which enables the receptor to transmit a signal to G proteins. We have examined the functional significance of numerous conserved charged amino acid residues proposed to be located within or near the transmembrane domains. Whereas the wild type FPR exhibits a K-d for an agonist of 1-3 nM, which is reduced to similar to 40 nM in the presence of guanosine 5'-3-O-(thio)triphosphate (GTP gamma S)) substitution of either Asp(71) or Arg(123) resulted in mutant receptors that bound ligand with only low affinity (K-d = 30-50 niM) independent of GTP gamma S. In contrast, substitution of Arg(163), predicted to be located at a similar depth within the membrane as Asp(71), had no effect on ligand binding. Replacement of residues Arg(309)-Glu(310)-Arg(311) resulted in an FPR with intermediate ligand binding characteristics. Functional analysis of the mutant receptors revealed that substitution of either Asp(71) or Arg(123) resulted in a mutant receptor that was unable to mediate calcium mobilization, whereas replacement of residues Arg(309)-Glu(310)-Arg(311) yielded a receptor with an EC(50) of 50 nM, compared with 0.5 nM for the wild type FPR. In order to determine the point of the defect in signal transduction, we performed reconstitution of the solubilized receptors with purified G proteins. The wild type FPR displayed a K-d for G protein of similar to 0.6 mu M compared with the Arg(309)/Glu(310)/Arg(311) mutant with a K-d of approximately 30 mu M. A Significant physical interaction between the Asp(71) or Arg(123) mutants and G protein was not observed. The implications of these findings for signal transduction mechanisms are discussed.	Scripps Res Inst, DEPT CELL BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute	PROSSNITZ, ER (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, IMM12, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.		Ye, Richard/O-5223-2016; Prossnitz, Eric R./B-4543-2008; Ye, Richard/ABF-2413-2020	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; Prossnitz, Eric/0000-0001-9190-8302	NIAID NIH HHS [AI33503, AI36357] Funding Source: Medline; NIGMS NIH HHS [GM46572] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033503, R01AI036357, R29AI036357, R56AI033503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046572] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN RA, 1986, BIOCHIM BIOPHYS ACTA, V882, P271, DOI 10.1016/0304-4165(86)90248-5; ALLEN RA, 1987, PHARMACOL THERAPEUT, V33, P333, DOI 10.1016/0163-7258(87)90070-2; BOMMAKANTI RK, 1992, J BIOL CHEM, V267, P7576; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; COBBOLD PH, 1987, BIOCHEM J, V248, P313, DOI 10.1042/bj2480313; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; DELEAN A, 1980, J BIOL CHEM, V255, P7108; FAY SP, 1991, BIOCHEMISTRY-US, V30, P5066, DOI 10.1021/bi00234a033; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; POSNER RG, 1994, MOL PHARMACOL, V45, P65; PROBST WC, 1992, DNA CELL BIOL, P11; PROSSNITZ ER, 1991, BIOCHEM BIOPH RES CO, V179, P471, DOI 10.1016/0006-291X(91)91394-R; PROSSNITZ ER, 1993, BIOCHEM J, V294, P581, DOI 10.1042/bj2940581; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; SAMAMA P, 1993, J BIOL CHEM, V268, P5066; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SCHREIBER RE, 1993, J LEUKOCYTE BIOL, V53, P470, DOI 10.1002/jlb.53.4.470; SCHREIBER RE, 1994, J BIOL CHEM, V269, P326; STERNWEIS PC, 1981, J BIOL CHEM, V256, P1517; YE RD, 1991, BIOCHEM BIOPH RES CO, V180, P105, DOI 10.1016/S0006-291X(05)81261-6	24	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10686	10694		10.1074/jbc.270.18.10686	http://dx.doi.org/10.1074/jbc.270.18.10686			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738006	hybrid			2022-12-27	WOS:A1995QW60100050
J	TONG, GX; TANEN, MR; BAGCHI, MK				TONG, GX; TANEN, MR; BAGCHI, MK			LIGAND MODULATES THE INTERACTION OF THYROID-HORMONE RECEPTOR-BETA WITH THE BASAL TRANSCRIPTION MACHINERY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; RETINOIC ACID RECEPTORS; RESPONSE ELEMENTS; X-RECEPTOR; PROGESTERONE-RECEPTOR; PREINITIATION COMPLEX; NUCLEAR RECEPTORS; ENHANCES BINDING; ONCOGENE PRODUCT; GENE-EXPRESSION	We investigated the molecular mechanisms underlying the transcriptional silencing and the hormone-induced activation of target genes by thyroid hormone receptor beta (TR-beta). We developed a cell-free transcription system containing HeLa cell nuclear extracts in which unliganded human TR-beta represses basal transcription from a promoter bearing thyroid hormone response elements. Binding of hormonal ligand to the receptor reverses this transcriptional silencing. Specific binding of TR-beta to the thyroid hormone response element at the target promoter is crucial for silencing. Studies employing TR-beta mutants indicate that the silencing activity is located within the C-terminal rather than the N-terminal domain of the receptor. Our studies reveal further that unliganded TR-beta inhibits the assembly of a functional transcription preinitiation complex (PIC) at the target promoter. We postulate that interaction with TR-beta impairs the function(s) of one or more assembling transcriptional complexes during the multistep assembly of a PIC. Consistent with this hypothesis, we observe that, in the absence of thyroid hormone, TR-beta or a heterodimer of TR-beta and retinoid-X-receptor undergoes direct protein-protein interactions with the transcription factor IIB-TATA binding protein complex, an early intermediate during PIC assembly. Binding of hormone to TR-beta dramatically reduces the interaction between the receptor and the transcription factor IIB-TATA binding protein complex. We propose that the role of ligand is to facilitate the assembly of functional PICs at the target promoter by reducing nonproductive interactions between TR-beta and the initiation factors.	POPULAT COUNCIL,NEW YORK,NY 10021; UNIV ROCHESTER,NEW YORK,NY 10021	Population Council; University of Rochester								AUFLIEGNER M, 1993, MOL CELL BIOL, V13, P5725, DOI 10.1128/MCB.13.9.5725; BAGCHI MK, 1990, J BIOL CHEM, V265, P5129; BANIAHMAD A, 1992, P NATL ACAD SCI USA, V89, P10633, DOI 10.1073/pnas.89.22.10633; BANIAHMAD A, 1995, MOL CELL BIOL, V15, P76, DOI 10.1128/MCB.15.1.76; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BANIAHMAD A, 1993, P NATL ACAD SCI USA, V90, P8832, DOI 10.1073/pnas.90.19.8832; BRENT G A, 1989, New Biologist, V1, P329; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; CASANOVA J, 1994, MOL CELL BIOL, V14, P5756, DOI 10.1128/MCB.14.9.5756; Chin W.W., 1991, NUCL HORMONE RECEPTO, P79; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; Drapkin R, 1993, CURR OPIN CELL BIOL, V5, P469, DOI 10.1016/0955-0674(93)90013-G; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FLORES O, 1992, J BIOL CHEM, V267, P2786; FONDELL JD, 1993, GENE DEV, V7, P1400, DOI 10.1101/gad.7.7b.1400; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; GANDRILLON O, 1989, CELL, V58, P115, DOI 10.1016/0092-8674(89)90408-X; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; HAMADA K, 1989, P NATL ACAD SCI USA, V86, P8289, DOI 10.1073/pnas.86.21.8289; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; HISATAKE K, 1993, NATURE, V363, P744, DOI 10.1038/363744a0; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOFFMANN A, 1991, NUCLEIC ACIDS RES, V19, P6337, DOI 10.1093/nar/19.22.6337; JOHNSON FB, 1992, GENE DEV, V7, P1400; KLEINHITPASS L, 1990, CELL, V60, P247, DOI 10.1016/0092-8674(90)90740-6; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; LAZAR MA, 1990, MOL ENDOCRINOL, V4, P1627, DOI 10.1210/mend-4-11-1627; LEE IJ, 1994, P NATL ACAD SCI USA, V91, P1647, DOI 10.1073/pnas.91.5.1647; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LENG XH, 1993, J STEROID BIOCHEM, V46, P643, DOI 10.1016/0960-0760(93)90306-H; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; PARVIN JD, 1992, CELL, V68, P1135, DOI 10.1016/0092-8674(92)90084-P; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; SAMUELS HH, 1988, J CLIN INVEST, V81, P957, DOI 10.1172/JCI113449; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHROEDER C, 1990, ONCOGENE, V5, P1445; SHARIF M, 1991, CELL, V66, P885, DOI 10.1016/0092-8674(91)90435-2; SUEN CS, 1993, MOL CELL BIOL, V13, P1719, DOI 10.1128/MCB.13.3.1719; TAKEDA K, 1992, J CLIN ENDOCR METAB, V74, P49, DOI 10.1210/jc.74.1.49; THOMPSON CC, 1989, P NATL ACAD SCI USA, V86, P3494, DOI 10.1073/pnas.86.10.3494; TONEY JH, 1993, BIOCHEMISTRY-US, V32, P2, DOI 10.1021/bi00052a001; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; USALA SJ, 1991, MOL ENDOCRINOL, V5, P327, DOI 10.1210/mend-5-3-327; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZAWEL L, 1992, Current Opinion in Cell Biology, V4, P488, DOI 10.1016/0955-0674(92)90016-6; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	64	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10601	10611		10.1074/jbc.270.18.10601	http://dx.doi.org/10.1074/jbc.270.18.10601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737997	hybrid			2022-12-27	WOS:A1995QW60100039
J	ZGOMBICKNIGHT, M; ANG, HL; FOGLIO, MH; DUESTER, G				ZGOMBICKNIGHT, M; ANG, HL; FOGLIO, MH; DUESTER, G			CLONING OF THE MOUSE CLASS-IV ALCOHOL-DEHYDROGENASE (RETINOL DEHYDROGENASE) CDNA AND TISSUE-SPECIFIC EXPRESSION PATTERNS OF THE MURINE ADH GENE FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT FORMALDEHYDE DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; ENZYMATIC-PROPERTIES; MOLECULAR ANALYSIS; HUMAN STOMACH; LIVER; ACID; PURIFICATION; ISOZYMES; PROTEIN	Humans possess five classes of alcohol dehydrogenase (ADH), including forms able to oxidize ethanol or formaldehyde as part of a defense mechanism, as well as forms acting as retinol dehydrogenases in the synthesis of the regulatory ligand retinoic acid. However, the mouse has previously been shown to possess only three forms of ADH. Hybridization analysis of mouse genomic DNA using cDNA probes specific for each of the five classes of human ADH has now indicated that mouse DNA cross-hybridizes to only classes I, III, and IV. With human class II or class V ADH cDNA probes, hybridization to mouse genomic DNA was very weak or undetectable, suggesting either a lack of these genes in the mouse or a high degree of mutational divergence relative to the human genes. cDNAs for murine ADH classes I and III have previously been cloned, and we now report the cloning of a full-length mouse class IV ADH cDNA In Northern blot analyses, mouse class TV ADH mRNA was abundant in the stomach, eye, skin, and ovary, thus correlating with the expression pattern for the mouse Adh-3 gene previously determined by enzyme analysis. In situ hybridization studies on mouse stomach indicated that class IV ADH transcripts were abundant in the mucosal epithelium but absent from the muscular layer. Comparison of the expression patterns for all three mouse ADH genes indicated that class III was expressed ubiquitously, whereas classes I and IV were differentially expressed in an overlapping set of tissues that all contain a large component of epithelial cells. This expression pattern is consistent with the ability of classes I and IV to oxidize retinol for the synthesis of retinoic acid known to regulate epithelial cell differentiation. The results presented here indicate that the mouse has a simpler ADH gene family than the human but has conserved class IV ADH previously shown to be a very active retinol dehydrogenase in humans.	LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037	Sanford Burnham Prebys Medical Discovery Institute					NIAAA NIH HHS [AA07261] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007261] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALGAR EM, 1983, EUR J BIOCHEM, V137, P139, DOI 10.1111/j.1432-1033.1983.tb07807.x; Ausubel F.M., 1989, CURRENT PROTOCOLS MO, V2; Blaner William S., 1994, P229; BOLEDA MD, 1993, ARCH BIOCHEM BIOPHYS, V307, P85, DOI 10.1006/abbi.1993.1564; BOLEDA MD, 1989, ARCH BIOCHEM BIOPHYS, V274, P74, DOI 10.1016/0003-9861(89)90416-5; CECI JD, 1987, GENE, V59, P171, DOI 10.1016/0378-1119(87)90325-8; CECI JD, 1986, GENE, V41, P217, DOI 10.1016/0378-1119(86)90101-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONNOR MJ, 1987, BIOCHEM J, V244, P489, DOI 10.1042/bj2440489; CONNOR MJ, 1988, CANCER RES, V48, P7038; CRABB DW, 1989, GENOMICS, V5, P906, DOI 10.1016/0888-7543(89)90133-X; DANIELSSON O, 1994, P NATL ACAD SCI USA, V91, P4980, DOI 10.1073/pnas.91.11.4980; DANIELSSON O, 1992, P NATL ACAD SCI USA, V89, P9247, DOI 10.1073/pnas.89.19.9247; DE LUCA LM, 1991, FASEB J, V5, P2924; DERR RF, 1994, BIOCHEM ARCH, V10, P59; DUESTER G, 1986, J BIOL CHEM, V261, P2027; EDENBERG HJ, 1985, P NATL ACAD SCI USA, V82, P2262, DOI 10.1073/pnas.82.8.2262; ESTONIUS M, 1993, EUR J BIOCHEM, V215, P497, DOI 10.1111/j.1432-1033.1993.tb18059.x; GIRI PR, 1989, BIOCHEM BIOPH RES CO, V164, P453, DOI 10.1016/0006-291X(89)91741-5; HOLMES RS, 1978, COMP BIOCHEM PHYS B, V61, P339, DOI 10.1016/0305-0491(78)90134-7; HOLMES RS, 1977, GENETICS, V87, P709; HOOG JO, 1987, BIOCHEMISTRY-US, V26, P1926, DOI 10.1021/bi00381a021; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; HOOG JO, 1991, ADV EXP MED BIOL, V284, P285; HOOG JO, 1995, IN PRESS ADV EXP MED; Hur M W, 1992, DNA Seq, V3, P167, DOI 10.3109/10425179209034012; HUR MW, 1992, GENE, V121, P305, DOI 10.1016/0378-1119(92)90135-C; JORNVALL H, 1987, P NATL ACAD SCI USA, V84, P2580, DOI 10.1073/pnas.84.9.2580; JULIA P, 1987, EUR J BIOCHEM, V162, P179, DOI 10.1111/j.1432-1033.1987.tb10559.x; KAISER R, 1993, P NATL ACAD SCI USA, V90, P11222, DOI 10.1073/pnas.90.23.11222; KOIVUSALO M, 1989, FEBS LETT, V257, P105, DOI 10.1016/0014-5793(89)81797-1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KREBS HA, 1970, BIOCHEM J, V118, P635, DOI 10.1042/bj1180635; LEVITT MD, 1994, AM J PHYSIOL, V267, pG452, DOI 10.1152/ajpgi.1994.267.3.G452; LIM RT, 1993, ALCOHOL CLIN EXP RES, V17, P1337, DOI 10.1111/j.1530-0277.1993.tb05250.x; MATSUO Y, 1990, AM J HUM GENET, V46, P85; MORENO A, 1991, J BIOL CHEM, V266, P1128; PARES X, 1994, P NATL ACAD SCI USA, V91, P1893, DOI 10.1073/pnas.91.5.1893; PARES X, 1992, FEBS LETT, V303, P69, DOI 10.1016/0014-5793(92)80479-Z; PARES X, 1990, FEBS LETT, V277, P115, DOI 10.1016/0014-5793(90)80822-Z; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; ROUT UK, 1991, BIOL NEONATE, V59, P93; Sambrook J, 1989, MOL CLONING LABORATO; SATRE MA, 1994, J BIOL CHEM, V269, P15606; STONE CL, 1993, ALCOHOL CLIN EXP RES, V17, P911, DOI 10.1111/j.1530-0277.1993.tb00863.x; VONBAHRLINDSTROM H, 1991, GENE, V103, P269, DOI 10.1016/0378-1119(91)90285-J; WANG B, 1992, BIOTECHNIQUES, V13, P527; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; YANG ZN, 1994, ALCOHOL CLIN EXP RES, V18, P587, DOI 10.1111/j.1530-0277.1994.tb00914.x; YASUNAMI M, 1991, P NATL ACAD SCI USA, V88, P7610, DOI 10.1073/pnas.88.17.7610; YIN SJ, 1993, ALCOHOL CLIN EXP RES, V17, P376, DOI 10.1111/j.1530-0277.1993.tb00779.x; YIN SJ, 1990, BIOCHEM INT, V22, P829; YOKOYAMA S, 1994, FEBS LETT, V351, P411, DOI 10.1016/0014-5793(94)00895-7; ZGOMBICKNIGHT M, 1995, J BIOL CHEM, V270, P4305, DOI 10.1074/jbc.270.9.4305; ZHANG K, 1987, GENE, V57, P27, DOI 10.1016/0378-1119(87)90173-9; ZHENG YW, 1993, J BIOL CHEM, V268, P24933	56	73	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10868	10877						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738026	hybrid			2022-12-27	WOS:A1995QW60100074
J	CHALOVICH, JM; CHEN, YD; DUDEK, R; LUO, H				CHALOVICH, JM; CHEN, YD; DUDEK, R; LUO, H			KINETICS OF BINDING OF CALDESMON TO ACTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; ACTOMYOSIN ATPASE ACTIVITY; CHICKEN GIZZARD CALDESMON; MYOSIN SUBFRAGMENT-1; SKELETAL-MUSCLE; THIN-FILAMENTS; TROPOMYOSIN; INHIBITION; CALMODULIN; DOMAIN	The time course of interaction of caldesmon with actin may be monitored by fluorescence changes that occur upon the binding of 12-(N-methyl-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl))-labeled caldesmon to actin or to acrylodan actin. The concentration dependence of the observed rate of caldesmon-actin binding was analyzed to a first approximation as a single-step reaction using a Monte Carlo simulation. The derived association and dissociation rates were 10(7) M(-1) S-1 and 18.2 S-1, respectively. Smooth muscle tropomyosin enhances the binding of caldesmon to actin, and this was found to be due to a reduction in the rate of dissociation to 6.3 S-1. There is no evidence from this study for a different mechanism of binding in the presence of tropomyosin. The floor escence changes that occurred with the binding of 12(N-methhyl-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl))-labeled caldesmon to actin or actin-tropomyosin were reversed by the addition of myosin subfragment 1 as predicted by a competitive binding mechanism.	E CAROLINA UNIV,SCH MED,DEPT ANAT,GREENVILLE,NC 27858; NIDDK,PHYS CHEM LAB,BETHESDA,MD 20892	University of North Carolina; East Carolina University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	CHALOVICH, JM (corresponding author), E CAROLINA UNIV,SCH MED,DEPT BIOCHEM,GREENVILLE,NC 27858, USA.			Chalovich, Joseph/0000-0002-1243-4055	NIAMS NIH HHS [R01 AR035216, AR35216, AR40540] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040540, R01AR035216] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BRENNER B, 1991, P NATL ACAD SCI USA, V88, P5739, DOI 10.1073/pnas.88.13.5739; BRETSCHER A, 1984, J BIOL CHEM, V259, P2873; CHALOVICH JM, 1987, J BIOL CHEM, V262, P5711; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; CHALOVICH JM, 1992, J BIOL CHEM, V267, P16644; CHEN YD, 1992, BIOPHYS J, V63, P1063, DOI 10.1016/S0006-3495(92)81687-9; DABROWSKA R, 1985, BIOCHIM BIOPHYS ACTA, V842, P70, DOI 10.1016/0304-4165(85)90295-8; FUJII T, 1987, J BIOL CHEM, V262, P2757; FUJII T, 1988, J BIOCHEM-TOKYO, V104, P734, DOI 10.1093/oxfordjournals.jbchem.a122542; GRACEFFA P, 1992, BIOCHIM BIOPHYS ACTA, V1120, P205, DOI 10.1016/0167-4838(92)90271-E; GRACEFFA P, 1987, FEBS LETT, V218, P139, DOI 10.1016/0014-5793(87)81034-7; Hayat MA, 1972, PRINCIPLES TECHNIQUE, V2; HEGMANN TE, 1991, CELL MOTIL CYTOSKEL, V20, P109, DOI 10.1002/cm.970200204; HEMRIC ME, 1988, J BIOL CHEM, V263, P1878; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; MARSTON SB, 1993, J BIOL CHEM, V268, P12317; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; NGAI PK, 1985, BIOCHEM J, V230, P695, DOI 10.1042/bj2300695; PFITZER G, 1993, P NATL ACAD SCI USA, V90, P5904, DOI 10.1073/pnas.90.13.5904; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; SMITH CWJ, 1987, J BIOL CHEM, V262, P116; SMITH CWJ, 1985, FEBS LETT, V184, P115, DOI 10.1016/0014-5793(85)80665-7; SOBUE K, 1985, BIOCHEM BIOPH RES CO, V132, P645, DOI 10.1016/0006-291X(85)91181-7; SZPACENKO A, 1986, FEBS LETT, V202, P182, DOI 10.1016/0014-5793(86)80683-4; TRAYER HR, 1988, BIOCHEMISTRY-US, V27, P5718, DOI 10.1021/bi00415a049; VELAZ L, 1990, J BIOL CHEM, V265, P2929; VELAZ L, 1989, J BIOL CHEM, V264, P9602; WALKER G, 1989, J BIOL CHEM, V264, P496; WATSON MH, 1990, BIOCHIM BIOPHYS ACTA, V1054, P103, DOI 10.1016/0167-4889(90)90211-U; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; WILLIAMS DL, 1984, BIOCHEMISTRY-US, V23, P4150, DOI 10.1021/bi00313a022; YAMASHIRO S, 1990, NATURE, V344, P675, DOI 10.1038/344675a0	32	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9911	9916		10.1074/jbc.270.17.9911	http://dx.doi.org/10.1074/jbc.270.17.9911			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730374	Green Submitted, Green Accepted			2022-12-27	WOS:A1995QV41700034
J	WOOLKALIS, MJ; DEMELFI, TM; BLANCHARD, N; HOXIE, JA; BRASS, LF				WOOLKALIS, MJ; DEMELFI, TM; BLANCHARD, N; HOXIE, JA; BRASS, LF			REGULATION OF THROMBIN RECEPTORS ON HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTACYCLIN PRODUCTION; PHOSPHOINOSITIDE HYDROLYSIS; HOMOLOGOUS DESENSITIZATION; PROTEOLYTIC MECHANISM; CALCIUM-CONCENTRATION; MOBILIZATION; ACTIVATION; PLATELETS; CLONING	Activated thrombin receptors on human umbilical vein endothelial cells rapidly undergo homologous desensitization, leaving the cells unable to respond to thrombin. The present studies examine the fate of activated thrombin receptors on endothelial cells and the mechanisms that restore intact receptors to the cell surface. The results show that: 1) at biologically relevant concentrations, thrombin rapidly cleaves all of its receptors on the cell surface, 2) The cleaved receptors are cleared from the cell surface in a two-phase process, with 60% being internalized within 10 min, the remainder requiring several hours, 3) The restoration of intact, thrombin-responsive receptors on the cell surface initially occurs from an intracellular pool of receptors in a process that is independent of protein synthesis, 4) Recycling of cleaved receptors either does not occur on endothelial cells or is masked by receptor clearance, 5) Subconfluent endothelial cells re-express intact receptors on the cell surface at a slower rate than confluent cells, 6) The agonist peptide, SFLLRN, also causes receptor internalization, although at concentrations greater than those required for receptor activation and desensitization. These results are distinctly different from those observed with megakaryoblastic cell lines, where >90% of the activated thrombin receptors are internalized rapidly, up to 40% of the cleaved receptors are recycled, and no intracellular pool of intact receptors has been detected, Since the primary structure of the thrombin receptor is the same in all the cell types studied, these results demonstrate that there can be substantial differences between cell types in the mechanisms involved in the clearance of activated receptors and the re-expression on the cell surface of intact receptors capable of responding to thrombin.	UNIV PENN,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PATHOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania	WOOLKALIS, MJ (corresponding author), THOMAS JEFFERSON UNIV,DEPT PHYSIOL,1020 LOCUST ST,PHILADELPHIA,PA 19107, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049987, P01HL040387] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL40387, HL49987] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAHOU WF, 1993, J CLIN INVEST, V91, P1405, DOI 10.1172/JCI116344; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BENNETT JS, 1983, P NATL ACAD SCI-BIOL, V80, P2417, DOI 10.1073/pnas.80.9.2417; BRASS LF, 1992, J BIOL CHEM, V267, P6044; BRASS LF, 1994, J BIOL CHEM, V289, P2943; BROCK TA, 1988, J CELL PHYSIOL, V136, P54, DOI 10.1002/jcp.1041360107; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; FOSTERMANN U, 1991, P NATL ACAD SCI USA, V88, P1788; GOLIGORSKY MS, 1989, J BIOL CHEM, V264, P16771; GREEN SA, 1994, J BIOL CHEM, V269, P26215; HALLAM TJ, 1988, BIOCHEM J, V251, P243, DOI 10.1042/bj2510243; HEIN L, 1994, J BIOL CHEM, V269, P27719; HORVAT R, 1995, IN PRESS J CELL SCI; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; HUANG EM, 1987, BIOCHEM J, V242, P11, DOI 10.1042/bj2420011; HUNG DT, 1992, J CELL BIOL, V116, P827, DOI 10.1083/jcb.116.3.827; ISHII K, 1994, J BIOL CHEM, V269, P1125; ISHII K, 1993, J BIOL CHEM, V268, P9780; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JAFFE EA, 1987, J BIOL CHEM, V262, P8557; JONES LG, 1989, MOL PHARMACOL, V36, P142; NGAIZA JR, 1991, BIOCHEM BIOPH RES CO, V179, P1656, DOI 10.1016/0006-291X(91)91765-5; PARIS S, 1988, J BIOL CHEM, V263, P11250; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V	25	100	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9868	9875		10.1074/jbc.270.17.9868	http://dx.doi.org/10.1074/jbc.270.17.9868			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730369				2022-12-27	WOS:A1995QV41700028
J	GIETZ, RD; GRAHAM, KC; LITCHFIELD, DW				GIETZ, RD; GRAHAM, KC; LITCHFIELD, DW			INTERACTIONS BETWEEN THE SUBUNITS OF CASEIN KINASE-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; BETA-SUBUNIT; MOLECULAR-CLONING; CATALYTIC SUBUNIT; ESCHERICHIA-COLI; PROTEIN; PHOSPHORYLATION; EXPRESSION; YEAST; IDENTIFICATION	Casein kinase II (CKII) is a protein serine/threonine kinase known to control the activity of a variety of regulatory nuclear proteins. This enzyme has a tetrameric structure composed of two catalytic (alpha and/or alpha') subunits and two beta subunits. We have examined the subunit composition of tetrameric complexes of purified bovine CKII by immunoprecipitation using alpha, alpha', or beta subunit-specific antibodies. These experiments indicate that the enzyme can exist as homotetramers (i.e. alpha(2) beta(2) alpha(2)'beta(2)) as well as heterotetramers (i.e. alpha alpha'beta(2),). To further examine subunit interactions between the alpha, alpha', or beta subunits of CKII, we have utilized the yeast two hybrid system (Fields, S. and Song, O. (1989) Nature 340: 245-246). For these studies, each subunit of human CKII was expressed in yeast as a fusion with the DNA binding domain or with the transcriptional activation domain of the yeast GAL4 transcriptional activator. These studies demonstrate that the alpha or alpha' subunits of CKII can interact with the beta subunits of CKII, but not with other alpha or alpha' subunits. By comparison, the beta subunits of CRII can interact with alpha, alpha', or beta subunits. These results indicate that the CKII holoenzyme forms because of the ability of beta subunits to dimerize, bringing two heterodimers (alpha beta or alpha'beta) into a tetrameric complex.	UNIV MANITOBA, MANITOBA INST CELL BIOL, MANITOBA CANC TREATMENT & RES FDN, WINNIPEG, MB R3E 0V9, CANADA; UNIV MANITOBA, DEPT HUMAN GENET, WINNIPEG, MB R3E 0V9, CANADA	University of Manitoba; University of Manitoba			Litchfield, David/E-4636-2015	Litchfield, David/0000-0002-2425-6620				BIDWAI AP, 1993, ARCH BIOCHEM BIOPHYS, V300, P265, DOI 10.1006/abbi.1993.1037; BODENBACH L, 1994, EUR J BIOCHEM, V220, P263, DOI 10.1111/j.1432-1033.1994.tb18622.x; BOLDYREFF B, 1993, BIOCHEMISTRY-US, V32, P12672, DOI 10.1021/bi00210a016; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FILHOL O, 1991, BIOCHEMISTRY-US, V30, P11133, DOI 10.1021/bi00110a016; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HARPER JW, 1993, CELL, V75, P805; HELLERHARRISON RA, 1989, BIOCHEMISTRY-US, V28, P9053, DOI 10.1021/bi00449a014; HU E, 1990, J BIOL CHEM, V265, P20609; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; JAKOBI R, 1989, EUR J BIOCHEM, V183, P227, DOI 10.1111/j.1432-1033.1989.tb14917.x; JEDLICKI A, 1992, FEBS LETT, V297, P280, DOI 10.1016/0014-5793(92)80556-V; KIKKAWA U, 1992, MOL CELL BIOL, V12, P5711, DOI 10.1128/MCB.12.12.5711; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN WJ, 1991, J BIOL CHEM, V266, P5664; LITCHFIELD DW, 1992, J BIOL CHEM, V267, P13943; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; LITCHFIELD DW, 1993, MOL CELL BIOCHEM, V128, P187, DOI 10.1007/BF01076770; LITCHFIELD DW, 1991, J BIOL CHEM, V266, P20380; LOZEMAN FJ, 1990, BIOCHEMISTRY-US, V29, P8436, DOI 10.1021/bi00488a034; LUSCHER B, 1994, EUR J BIOCHEM, V220, P521, DOI 10.1111/j.1432-1033.1994.tb18651.x; MARIDOR G, 1991, J BIOL CHEM, V266, P2362; MEGGIO F, 1992, EUR J BIOCHEM, V204, P293, DOI 10.1111/j.1432-1033.1992.tb16636.x; MEISNER H, 1989, BIOCHEMISTRY-US, V28, P4072, DOI 10.1021/bi00435a066; Meisner H, 1991, CURR OPIN CELL BIOL, V3, P474, DOI 10.1016/0955-0674(91)90076-B; Miller J. H, 1972, EXPT MOL GENETICS; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; PAETKAU DW, 1994, GENE DEV, V8, P2035, DOI 10.1101/gad.8.17.2035; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; ROUSSOU I, 1994, MOL CELL BIOL, V14, P576, DOI 10.1128/MCB.14.1.576; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; WU JLC, 1988, MOL CELL BIOL, V8, P4981; YU IJ, 1991, J CELL BIOL, V114, P1217, DOI 10.1083/jcb.114.6.1217; [No title captured]	42	117	125	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13017	13021		10.1074/jbc.270.22.13017	http://dx.doi.org/10.1074/jbc.270.22.13017			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768894	hybrid			2022-12-27	WOS:A1995RB43900015
J	GUZDER, SN; HABRAKEN, Y; SUNG, P; PRAKASH, L; PRAKASH, S				GUZDER, SN; HABRAKEN, Y; SUNG, P; PRAKASH, L; PRAKASH, S			RECONSTITUTION OF YEAST NUCLEOTIDE EXCISION-REPAIR WITH PURIFIED RAD PROTEINS, REPLICATION PROTEIN-A, AND TRANSCRIPTION FACTOR TFIIH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							STRANDED-DNA ENDONUCLEASE; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; DAMAGED DNA; GENE; ENCODES; HELICASE; ATPASE	Nucleotide excision repair (NER) functions to remove DNA damage caused by ultraviolet light and by other agents that distort the DNA helix. The NER machinery has been conserved in structure and function from yeast to humans, and in humans, defective NER is the underlying cause of the cancer-prone disease xeroderma pigmentosum. Here, we reconstitute the incision reaction of NER in Saccharomyces cerevisiae using purified protein factors. The Rad14 protein, the Rad4-Rad23 complex, the Rad2 nuclease, the Rad1-Rad10 nuclease, replication protein A, and the RNA polymerase II transcription factor TFIIH were purified to near homegeneity from yeast. We show that these protein factors are both necessary and sufficient for dual incision of DNA damaged by either ultraviolet light or N-acetoxy-2-aminoacetylfluorene. Incision in the reconstituted system requires ATP, which cannot be substituted by adenosine 5'-O-(3-thiotriphosphate), suggesting that the hydrolysis of ATP is indispensable for the incision reaction. The excision DNA fragments formed as a result of dual incision are in the 24-27-nucleotide range.	UNIV TEXAS,MED BRANCH,SEALY CTR MOLEC SCI,GALVESTON,TX 77555	University of Texas System; University of Texas Medical Branch Galveston			Prakash, Satya/C-6420-2013; Prakash, Louise/C-7891-2012	Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NCI NIH HHS [CA41621, CA35035] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA035035, R37CA035035, R01CA041621] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAILLY V, 1991, P NATL ACAD SCI USA, V88, P9712, DOI 10.1073/pnas.88.21.9712; BAILLY V, 1992, P NATL ACAD SCI USA, V89, P8273, DOI 10.1073/pnas.89.17.8273; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; CLUGSTON CK, 1992, CANCER RES, V52, P6375; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; GIETZ RD, 1988, GENE, V74, P535, DOI 10.1016/0378-1119(88)90186-2; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; GUZDER SN, 1993, P NATL ACAD SCI USA, V90, P5433, DOI 10.1073/pnas.90.12.5433; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; GUZDER SN, 1995, J BIOL CHEM, V270, P8385, DOI 10.1074/jbc.270.15.8385; HABRAKEN Y, 1993, NATURE, V366, P365, DOI 10.1038/366365a0; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; QIU HF, 1993, GENE DEV, V7, P2161, DOI 10.1101/gad.7.11.2161; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; SUNG P, 1993, J BIOL CHEM, V268, P26391; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1992, NATURE, V355, P743, DOI 10.1038/355743a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; SUNG P, 1994, J BIOL CHEM, V269, P8303; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; VANVUUREN AJ, 1994, EMBO J, V13, P1645, DOI 10.1002/j.1460-2075.1994.tb06428.x; WANG ZG, 1994, NATURE, V368, P74, DOI 10.1038/368074a0; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757	28	197	198	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12973	12976		10.1074/jbc.270.22.12973	http://dx.doi.org/10.1074/jbc.270.22.12973			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768886	hybrid			2022-12-27	WOS:A1995RB43900007
J	NAKAMUTA, M; OKA, K; KRUSHKAL, J; KOBAYASHI, K; YAMAMOTO, M; LI, WH; CHAN, L				NAKAMUTA, M; OKA, K; KRUSHKAL, J; KOBAYASHI, K; YAMAMOTO, M; LI, WH; CHAN, L			ALTERNATIVE MESSENGER-RNA SPLICING AND DIFFERENTIAL PROMOTER UTILIZATION DETERMINE TISSUE-SPECIFIC EXPRESSION OF THE APOLIPOPROTEIN-B MESSENGER-RNA-EDITING PROTEIN (APOBEC1) GENE IN MICE - STRUCTURE AND EVOLUTION OF APOBEC1 AND RELATED NUCLEOSIDE NUCLEOTIDE DEAMINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; MESSENGER-RNA; TYROSINE PHOSPHATASE; RESPONSIVE ELEMENTS; PHYLOGENETIC TREES; ENHANCER ELEMENTS; SEQUENCE; INVITRO; COMPILATION; BINDING	Apolipoprotein (ape) B mRNA editing consists of a C-->U conversion involving the first base of the codon CAA, encoding Gin 2153, to UAA, a stop codon. Editing occurs in the intestine only in most mammals, and in both the liver and intestine in a few mammalian species including mouse. We have cloned the cDNA for the mouse apoB mRNA editing protein, apobec1. Expression of mouse apobec1 cDNA in HepG2 cells results in the editing of the intracellular apoB mRNA. The cDNA predicts a 229-amino acid protein showing 92, 66, and 70% identity to the rat; rabbit, and human proteins, respectively. Based on the estimated values of divergence of apobec1 sequences in terms of the numbers of synonymous and non-synonymous substitutions per site, we found that apobec1 is a fairly rapidly evolving protein. Sequence comparison among mammalian apobec1 sequences has permitted the identification of seven conserved regions that may be functionally important for editing activity. We present a phylogenetic tree relating apobec1 sequences to double-stranded RNA adenosine deaminase and other nucleotide/nucleoside deaminases. Northern blot analysis indicates that apobec1 mRNA exists in two different sizes, a similar to 2,2-kilobase (kb) form in small intestine and a similar to 2.4-kb form in liver, spleen, kidney, lung, muscle, and heart. To study the molecular basis for the different sized apobec1 mRNAs, we cloned the apobec1 gene and characterized its exon-intron organization together with the sequences expressed in the hepatic and intestinal mRNA. The mouse apobec1 gene contains 8 exons and spans similar to 25 kb, and is located in chromosome 6. The major hepatic mRNA intestinal mRNA misses the first 3 exons and its transcription is initiated in exon 4. The intestinal mRNA also contains at its 5' end a unique 102-nucleotide piece that is absent in the Liver mRNA. We also identified two alternatively spliced hepatic apobec1 mRNAs with different acceptor sites in exon 4. Transient expression studies using promoter-reporter gene constructs in HeLa, Hepa, and Caco-2 cells indicate that the 5'-flanking sequences of the liver mRNA (i.e. upstream of exon 1) have predominantly hepatic promoter activity and the 5'-flanking sequences of the major small intestine mRNA (i.e. upstream of exon 4) have preferential intestinal promoter activity. We conclude that alternative mRNA splicing and differential promoter utilization determine the tissue specific expression of the apobec1 gene in mice. Our observations provide information on unique aspects of the molecular basis of the tissue-specific expression of apobec1 mRNA and the evolutionary basis of RNA editing.	BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; UNIV TEXAS,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77225; CHILDRENS NUTR RES CTR,HOUSTON,TX 77030; NATL DEF MED COLL,DEPT BIOCHEM 2,TOKOROZAWA,SAITAMA 359,JAPAN	Baylor College of Medicine; University of Texas System; National Defense Medical College - Japan	NAKAMUTA, M (corresponding author), BAYLOR COLL MED,DEPT CELL BIOL,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.		Kobayashi, Kunihisa/V-9554-2019	Kobayashi, Kunihisa/0000-0002-7741-846X; Li, Wen-Hsiung/0000-0003-1086-1456	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL027341, P50HL027341] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL27341] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSEN RD, 1987, MOL CELL BIOL, V7, P3574, DOI 10.1128/MCB.7.10.3574; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BAIROCH A, 1993, NUCLEIC ACIDS RES, V21, P3093, DOI 10.1093/nar/21.13.3093; BARKER WC, 1993, NUCLEIC ACIDS RES, V21, P2967; BARNES C, 1993, BIOCHEM BIOPH RES CO, V197, P1410, DOI 10.1006/bbrc.1993.2634; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BENNE R, 1993, RNA; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; BERGET SM, 1984, NATURE, V309, P179, DOI 10.1038/309179a0; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; BHATTACHARYA S, 1994, TRENDS BIOCHEM SCI, V19, P105, DOI 10.1016/0968-0004(94)90200-3; BOSTROM K, 1990, J BIOL CHEM, V265, P22446; BROOKS AR, 1991, J BIOL CHEM, V266, P7848; CATTANEO R, 1991, ANNU REV GENET, V25, P71, DOI 10.1146/annurev.ge.25.120191.000443; CHAN L, 1992, J BIOL CHEM, V267, P25621; CHAN L, 1995, SCI MED, V2, P68; CHANG Z, 1991, BIOCHEMISTRY-US, V30, P2273, DOI 10.1021/bi00222a033; CHEN SH, 1990, J BIOL CHEM, V265, P6811; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; COLEMAN RD, 1989, BIOCHIM BIOPHYS ACTA, V1037, P129; DRISCOLL DM, 1994, J BIOL CHEM, V269, P19843; DRISCOLL DM, 1989, CELL, V58, P519, DOI 10.1016/0092-8674(89)90432-7; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FAISST S, 1990, CELL, V61, P497; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GREEVE J, 1993, J LIPID RES, V34, P1367; HADJIAGAPIOU C, 1994, NUCLEIC ACIDS RES, V22, P1874, DOI 10.1093/nar/22.10.1874; HARRIS SG, 1993, J BIOL CHEM, V268, P7382; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P629, DOI 10.1073/pnas.91.2.629; IMBERT J, 1989, MOL CELL BIOL, V9, P5315, DOI 10.1128/MCB.9.12.5315; JOSHI CP, 1987, NUCLEIC ACIDS RES, V15, P9627, DOI 10.1093/nar/15.23.9627; KIM U, 1994, J BIOL CHEM, V269, P13480; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kimura M., 1983, NEUTRAL THEORY MOL E; KLOCK G, 1987, NATURE, V329, P734, DOI 10.1038/329734a0; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEVYWILSON B, 1988, MOL CELL BIOL, V8, P71, DOI 10.1128/MCB.8.1.71; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; NAGALLA SR, 1994, MOL ENDOCRINOL, V8, P943, DOI 10.1210/me.8.8.943; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; RICE CM, 1993, NUCLEIC ACIDS RES, V21, P2967, DOI 10.1093/nar/21.13.2967; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAI J, 1994, J BIOL CHEM, V269, P2173; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCANU AM, 1990, LIPOPROTEIN; SCHEIDEREIT C, 1984, P NATL ACAD SCI-BIOL, V81, P3029, DOI 10.1073/pnas.81.10.3029; Scott James, 1994, Current Opinion in Lipidology, V5, P87, DOI 10.1097/00041433-199404000-00004; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; SMITH HC, 1991, P NATL ACAD SCI USA, V88, P1489, DOI 10.1073/pnas.88.4.1489; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; SOMMER A, 1991, BIOCHEMISTRY-US, V30, P11245, DOI 10.1021/bi00111a008; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; TENG BB, 1990, J BIOL CHEM, V265, P20616; TENG BB, 1994, J BIOL CHEM, V269, P29395; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; VANTHOOFT FM, 1982, P NATL ACAD SCI-BIOL, V79, P179; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; WU JH, 1990, J BIOL CHEM, V265, P12312; YAMANAKA S, 1994, J BIOL CHEM, V269, P21725; YI TL, 1992, GENOMICS, V14, P793, DOI 10.1016/S0888-7543(05)80189-2; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; ZHARKIKH AA, 1991, GENE, V101, P251, DOI 10.1016/0378-1119(91)90419-C	70	89	92	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13042	13056		10.1074/jbc.270.22.13042	http://dx.doi.org/10.1074/jbc.270.22.13042			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768898	hybrid			2022-12-27	WOS:A1995RB43900019
J	HOLEN, I; STROMHAUG, PE; GORDON, PB; FENGSRUD, M; BERG, TO; SEGLEN, PO				HOLEN, I; STROMHAUG, PE; GORDON, PB; FENGSRUD, M; BERG, TO; SEGLEN, PO			INHIBITION OF AUTOPHAGY AND MULTIPLE STEPS IN ASIALOGLYCOPROTEIN ENDOCYTOSIS BY INHIBITORS OF TYROSINE PROTEIN-KINASES (TYRPHOSTINS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; VESICLE FUSION INVITRO; RAT HEPATOCYTES; OKADAIC ACID; GROWTH-FACTOR; PHOSPHORYLATION; CELLS; LYSOSOMES; PROLIFERATION; MICROTUBULES	In isolated rat hepatocytes, several tyrosine protein kinase inhibitors (tyrphostins) reduced the autophagic sequestration of electroinjected [H-3]raffinose by 40-75% at doses that did not significantly affect cellular ATP levels or plasma membrane integrity, Tyrphostin 46 specifically inhibited autophagy, whereas tyrphostins 1, 25 and 51 also suppressed the receptor-mediated endocytic uptake of I-125-tyramine-cellobiose-asialoorosomucoid, I-125-TC-AOM, by 20-30% and its degradation by 70-90%. Tyrphostins 1 and 51, and the microtubule inhibitor vinblastine, inhibited an early endocytic step (endosome maturation/multivesiculation?), causing accumulation of endocytosed I-125-TC-AOM in a recycling compartment that corresponded to light endosomes (1.10-1.11 g/ml) in sucrose density gradients. In the electron microscope, these endosomes could be recognized as small, peripheral endocytic vesicles and tubules accumulating endocytosed AOM-gold, The serine/threonine protein phosphatase inhibitor okadaic acid inhibited an intermediate endocytic step (detachment of multivesicular endosomes from the tubulovesicular network?), causing accumulation of I-125-TC-AOM in a recycling compartment corresponding to light endosomes (1.10-1.11 g/ml), but with a multivesicular rather than a tubulovesicular morphology, Tyrphostin 25 inhibited endocytosis at a late step (endosome-lysosome fusion?), causing accumulation of I-125-TC-AOM in a non-recycling compartment corresponding to dense, multivesicular endosomes (1.14 g/ml) that had probably detached from the light endosomal network.	NORWEGIAN RADIUM HOSP,INST CANC RES,DEPT TISSUE CULTURE,N-0310 OSLO,NORWAY	University of Oslo			Brinchmann, Monica Fengsrud/C-2916-2012	Brinchmann, Monica Fengsrud/0000-0002-1222-0743; Holen, Ingunn/0000-0002-8759-6913				BERG T, 1985, EXP CELL RES, V156, P570, DOI 10.1016/0014-4827(85)90565-8; BERG T, 1985, EXP CELL RES, V161, P285, DOI 10.1016/0014-4827(85)90086-2; BRYCKAERT MC, 1992, EXP CELL RES, V199, P255, DOI 10.1016/0014-4827(92)90432-8; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; COURTOY PJ, 1993, ENDOCYTIC COMPONENTS, V19, P29; DVIR A, 1991, J CELL BIOL, V113, P857, DOI 10.1083/jcb.113.4.857; FALLON RJ, 1994, J BIOL CHEM, V269, P11011; FALLON RJ, 1994, J BIOL CHEM, V269, P26626; FALLON RJ, 1988, J BIOL CHEM, V263, P13159; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; GEFFEN I, 1993, J BIOL CHEM, V268, P20772; GOLTZ JS, 1992, P NATL ACAD SCI USA, V89, P7026, DOI 10.1073/pnas.89.15.7026; GRIFFITHS G, 1990, J CELL SCI, V95, P441; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HOLEN I, 1991, BIOMED BIOCHIM ACTA, V50, P389; HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633; HOLEN I, 1993, EUR J BIOCHEM, V215, P113, DOI 10.1111/j.1432-1033.1993.tb18013.x; HOPKINS CR, 1986, TRENDS BIOCHEM SCI, V11, P473, DOI 10.1016/0968-0004(86)90250-1; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; KINDBERG GM, 1990, J BIOL CHEM, V265, P8999; OHASHI M, 1991, EXP CELL RES, V197, P168, DOI 10.1016/0014-4827(91)90419-U; OHMICHI M, 1993, BIOCHEMISTRY-US, V32, P4650, DOI 10.1021/bi00068a024; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; RICKARD JE, 1991, J BIOL CHEM, V266, P17597; RINDRESS D, 1993, J BIOL CHEM, V268, P5139; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SEGLEN PO, 1985, EXP CELL RES, V157, P550, DOI 10.1016/0014-4827(85)90141-7; SEGLEN PO, 1978, BIOCHEM J, V174, P469, DOI 10.1042/bj1740469; SEGLEN PO, 1986, EXP CELL RES, V162, P273, DOI 10.1016/0014-4827(86)90446-5; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; WIJETUNGE S, 1992, BIOCHEM BIOPH RES CO, V189, P1620, DOI 10.1016/0006-291X(92)90262-J; WOODMAN PG, 1992, J CELL BIOL, V116, P331, DOI 10.1083/jcb.116.2.331; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; YOUNG SW, 1993, FEBS LETT, V316, P278, DOI 10.1016/0014-5793(93)81308-M	38	46	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12823	12831		10.1074/jbc.270.21.12823	http://dx.doi.org/10.1074/jbc.270.21.12823			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759538				2022-12-27	WOS:A1995QZ71100075
J	MA, Q; DONG, LQ; WHITLOCK, JP				MA, Q; DONG, LQ; WHITLOCK, JP			TRANSCRIPTIONAL ACTIVATION BY THE MOUSE AH RECEPTOR - INTERPLAY BETWEEN MULTIPLE STIMULATORY AND INHIBITORY FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIOXIN-RESPONSIVE ENHANCER; HEAT-SHOCK PROTEIN; DNA RECOGNITION; BINDING; CLONING; MECHANISM; LIGAND; CDNA; GENE; ARNT	The aromatic hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that mediates cellular responses to the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). We cloned AhR cDNA from C57BL/6 mouse liver and verified by transfection that it encodes a functional protein. Analyses of deletion mutants indicate that the carboxyl half of AhR contains several types of transactivation domain, which function independently of domains that mediate TCDD recognition, DNA binding, and heterodimerization with the Ah receptor nuclear translocator (Arnt) protein. The transactivation domains function independently of each other, display different levels of activity, and act synergistically when Linked. In addition, AhR contains an 82-amino acid domain:that inhibits transactivation. The inhibitory domain displays specificity, in that it blocks the transactivating functions of AhR and Arnt, but not that of the herpes simplex protein VP16. The inhibitory activity depends upon the cell type in which AhR is expressed, implying that a cell-specific protein mediates the effect.			MA, Q (corresponding author), STANFORD UNIV, SCH MED, DEPT MOLEC PHARMACOL, STANFORD, CA 94305 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003719] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES03719] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BAILAR JC, 1991, NEW ENGL J MED, V324, P261; BLAIR WS, 1994, MOL CELL BIOL, V14, P7226, DOI 10.1128/MCB.14.11.7226; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CARVER LA, 1994, J BIOL CHEM, V269, P30109; CHANG CY, 1993, PHARMACOGENETICS, V3, P312, DOI 10.1097/00008571-199312000-00005; CHEN HS, 1994, J BIOL CHEM, V269, P27554; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; DOLWICK KM, 1993, MOL PHARMACOL, V44, P911; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; ELFERINK CJ, 1994, RECEPTOR, V4, P157; EMA M, 1994, J BIOL CHEM, V269, P27337; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; FISHER JM, 1990, J BIOL CHEM, V265, P9676; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HAHN S, 1993, CELL, V72, P481, DOI 10.1016/0092-8674(93)90064-W; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; INGLES CJ, 1991, NATURE, V351, P588, DOI 10.1038/351588a0; JAIN S, 1994, J BIOL CHEM, V269, P31518; JOHNSON ES, 1992, CRIT REV TOXICOL, V21, P451, DOI 10.3109/10408449209089883; JONES PBC, 1986, P NATL ACAD SCI USA, V83, P2802, DOI 10.1073/pnas.83.9.2802; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LI H, 1994, J BIOL CHEM, V269, P28098; LUSSKA A, 1992, J BIOL CHEM, V267, P15146; MATSUSHITA N, 1993, J BIOL CHEM, V268, P21002; MILLER AG, 1983, J BIOL CHEM, V258, P3523; MORGAN JE, 1992, P NATL ACAD SCI USA, V89, P11622, DOI 10.1073/pnas.89.23.11622; OKEY AB, 1994, TRENDS PHARMACOL SCI, V15, P226, DOI 10.1016/0165-6147(94)90316-6; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; POLAND A, 1994, MOL PHARMACOL, V46, P915; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; REICK M, 1994, MOL CELL BIOL, V14, P5653, DOI 10.1128/MCB.14.9.5653; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SAFE SH, 1986, ANNU REV PHARMACOL, V26, P371, DOI 10.1146/annurev.pa.26.040186.002103; Sambrook J, 1989, MOL CLONING LABORATO; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; WHITELAW M, 1993, MOL CELL BIOL, V13, P2504, DOI 10.1128/MCB.13.4.2504; WHITELAW ML, 1994, MOL CELL BIOL, V14, P8343, DOI 10.1128/MCB.14.12.8343; WHITELAW ML, 1993, EMBO J, V12, P4169, DOI 10.1002/j.1460-2075.1993.tb06101.x; WHITLOCK JP, 1993, CHEM RES TOXICOL, V6, P754, DOI 10.1021/tx00036a003; WOLFFE AP, 1994, CELL, V77, P13, DOI 10.1016/0092-8674(94)90229-1; WU L, 1992, P NATL ACAD SCI USA, V89, P4811, DOI 10.1073/pnas.89.11.4811	54	78	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12697	12703		10.1074/jbc.270.21.12697	http://dx.doi.org/10.1074/jbc.270.21.12697			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759522	hybrid			2022-12-27	WOS:A1995QZ71100058
J	MATSUDA, S; KAWASAKI, H; MORIGUCHI, T; GOTOH, Y; NISHIDA, E				MATSUDA, S; KAWASAKI, H; MORIGUCHI, T; GOTOH, Y; NISHIDA, E			ACTIVATION OF PROTEIN-KINASE CASCADES BY OSMOTIC SHOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; EPIDERMAL GROWTH-FACTOR; MAP KINASE; SIGNAL-TRANSDUCTION; XENOPUS-OOCYTES; THREONINE PHOSPHORYLATION; TYROSINE; INVITRO; RAF; IDENTIFICATION	Osmotic shock induces a variety of biochemical and physiological responses in vertebrate cells. By analyzing extracts obtained from rat 3Y1 fibroblastic cells exposed to hyper-osmolar media, we have found that mitogen-activated protein kinases (MAPKs) and stress-activated protein kinases (SAPKs, also known as JNKs) are both activated in response to osmotic shock, MAPKK1 (MEK1) was also activated markedly, Furthermore, Raf-1 and MEKK were activated strikingly by the osmotic shock, Activation of Raf-1 and MEKK. in response to osmotic shock was detected also in PC12 cells, in which MEKK activation by the osmotic shock was much stronger than that by epidermal growth factor. Activation of SAPKs in PC12 cells by the osmotic shock was also more marked than that by epidermal growth factor, The activated MEKK phosphorylated not only MAPKKs but also XMEK2, which is distantly related to MAPKK, Recombinant wild-type XMEK2, but not kinase-negative XMEK2, was able to phosphorylate and activate recombinant SAPK alpha in vitro, In addition, this activity of XMEK2 was activated by the activated MEKK. These results suggest that the MAPK cascade consisting of Raf-1, MAPKK, and MAPK and the SAPK cascade consisting of MEKK, XMEK2, and SAPK are both activated in response to osmotic shock, Finally, it was found that XMEK2 is a good substrate for SAPK.	KYOTO UNIV,INST VIRUS RES,DEPT MOLEC BIOL & GENET,SAKYO KU,KYOTO 60601,JAPAN	Kyoto University			Moriguchi, Tetsuo/D-7061-2012; Kawasaki, Hiroshi/C-4404-2015; KAWASAKI, Hiroshi/L-3736-2015	Moriguchi, Tetsuo/0000-0002-9598-4991; Kawasaki, Hiroshi/0000-0002-2514-1497				ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; AMMERER G, 1994, CURR OPIN GENET DEV, V4, P90, DOI 10.1016/0959-437X(94)90096-5; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; FUKUDA M, 1994, J BIOL CHEM, V269, P33097; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; HACCARD O, 1993, SCIENCE, V267, P1262; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOSHI M, 1989, EUR J BIOCHEM, V184, P477, DOI 10.1111/j.1432-1033.1989.tb15040.x; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; KOSAKO H, 1994, J BIOL CHEM, V269, P28354; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; KOSAKO H, 1993, EMBO J, V12, P787, DOI 10.1002/j.1460-2075.1993.tb05713.x; KOSAKO H, 1992, EMBO J, V11, P2903, DOI 10.1002/j.1460-2075.1992.tb05359.x; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; KYRIAKIS JM, 1991, J BIOL CHEM, V266, P10043; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEEVERS S J, 1992, Trends in Cell Biology, V2, P283, DOI 10.1016/0962-8924(92)90105-V; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MATSUDA S, 1993, J BIOL CHEM, V268, P3277; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; MINHONG Y, 1994, NATURE, V372, P798; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; NISHIDA E, 1992, INT REV CYTOL, V138, P211, DOI 10.1016/S0074-7696(08)61589-2; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; NISHIDA E, 1987, J BIOL CHEM, V262, P16200; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; TERADA Y, 1994, J BIOL CHEM, V49, P31296; YASHAR BM, 1993, MOL CELL BIOL, V13, P5738, DOI 10.1128/MCB.13.9.5738	52	147	148	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12781	12786		10.1074/jbc.270.21.12781	http://dx.doi.org/10.1074/jbc.270.21.12781			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759532	hybrid			2022-12-27	WOS:A1995QZ71100069
J	MOSS, J; VAUGHAN, M				MOSS, J; VAUGHAN, M			STRUCTURE AND FUNCTION OF ARF PROTEINS - ACTIVATORS OF CHOLERA-TOXIN AND CRITICAL COMPONENTS OF INTRACELLULAR VESICULAR TRANSPORT PROCESSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ADP-RIBOSYLATION FACTOR; GTP-BINDING PROTEIN; BREFELDIN-A; GUANINE-NUCLEOTIDE; GOLGI MEMBRANES; VESICLES; CELLS; COATOMER; EXCHANGE; FUSION				MOSS, J (corresponding author), NHLBI,PULM CRIT CARE MED BRANCH,BETHESDA,MD 20892, USA.							AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; BALCH WE, 1992, J BIOL CHEM, V267, P13053; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BECK KA, 1991, J BIOL CHEM, V266, P4442; BOMAN AL, 1992, NATURE, V358, P512, DOI 10.1038/358512a0; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; BOTSTEIN D, 1988, COLD SPRING HARB SYM, V53, P629, DOI 10.1101/SQB.1988.053.01.072; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; Colombo M. I., 1994, Molecular Biology of the Cell, V5, p381A; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; EASTMAN SJ, 1992, BIOCHEMISTRY-US, V31, P4262, DOI 10.1021/bi00132a016; FENSOME A, 1994, FEBS LETT, V349, P34, DOI 10.1016/0014-5793(94)00634-2; Fishman P.H., 1990, ADP RIBOSYLATING TOX, P127; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HELMS JB, 1993, J CELL BIOL, V121, P751, DOI 10.1083/jcb.121.4.751; HONG JX, 1995, P NATL ACAD SCI USA, V92, P3056, DOI 10.1073/pnas.92.7.3056; HONG JX, 1994, J BIOL CHEM, V269, P9743; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1992, J BIOL CHEM, V267, P13039; LEE FJS, 1994, J BIOL CHEM, V269, P20931; LEE FJS, 1994, J BIOL CHEM, V269, P21555; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; MOSS J, 1993, CELL SIGNAL, V5, P367, DOI 10.1016/0898-6568(93)90076-X; NODA M, 1990, BIOCHIM BIOPHYS ACTA, V1034, P195, DOI 10.1016/0304-4165(90)90076-9; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; RANDAZZO PA, 1994, J BIOL CHEM, V269, P29490; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; STUTCHFIELD J, 1993, BIOCHEM J, V293, P649, DOI 10.1042/bj2930649; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; TEAL SB, 1994, J BIOL CHEM, V269, P3135; TSAI SC, 1988, J BIOL CHEM, V263, P1768; TSAI SC, 1994, P NATL ACAD SCI USA, V91, P3063, DOI 10.1073/pnas.91.8.3063; TSAI SC, 1993, J BIOL CHEM, V268, P10820; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; WEIDMAN PJ, 1994, J CELL BIOL, V127, P1815, DOI 10.1083/jcb.127.6.1815; WELSH CF, 1994, J BIOL CHEM, V269, P15583; ZEUZEM S, 1992, P NATL ACAD SCI USA, V89, P6619, DOI 10.1073/pnas.89.14.6619; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; ZHANG GF, 1995, J BIOL CHEM, V270, P21, DOI 10.1074/jbc.270.1.21	54	262	268	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12327	12330		10.1074/jbc.270.21.12327	http://dx.doi.org/10.1074/jbc.270.21.12327			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759471	hybrid			2022-12-27	WOS:A1995QZ71100001
J	DAVIDSON, GA; VARHOL, RJ				DAVIDSON, GA; VARHOL, RJ			KINETICS OF THAPSIGARGIN-CA2+-ATPASE (SARCOPLASMIC-RETICULUM) INTERACTION REVEALS A 2-STEP BINDING MECHANISM AND PICOMOLAR INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ACTIVE-SITE; CROSS-LINKING; NUCLEOTIDE BINDING; TUMOR PROMOTER; CALCIUM-PUMP; ATPASE; CA2+-ATPASE; CA-2+-ATPASE; PROTEIN; PHOSPHORYLATION	Thapsigargin is a high affinity inhibitor of sarco- and endoplasmic reticulum (SERCA) type ATPases. We have used kinetics to determine the dissociation constant of thapsigargin-sarcoplasmic reticulum Ca2+-ATPase interaction in the absence and presence of non-ionic detergent. The observed ''off'' rate constant was measured as 0.0052 s(-1) at 26 degrees C by the kinetics of inhibition of ATPase activity following transfer from an inactivated thapsigargin-ATPase complex to native ATPase. Inactive ATPase was produced by cross-linking the active site with glutaraldehyde. The observed dissociation rate constant was increased 7-fold by 0.1% Triton X-100, indicating that perturbation of the transmembrane and stalk region by detergent altered the binding parameters of the inhibitor. In addition, thapsigargin stabilized the ATPase against inactivation caused by detergent in the absence of Ca2+. The observed ''on'' rate constant of thapsigargin was measured at 26 degrees C as 25 s(-1) irrespective of thapsigargin concentration, by the kinetics of thapsigargin-induced change in intrinsic fluorescence. An Arrhenius plot showed a temperature dependence of this rate constant, indicative of a conformational change in the protein with an activation energy of 9.5 kcal/mol for thapsigargin binding. The affinity of the Ca2+-ATPase for thapsigargin was calculated to be greater than 2 PM at pH 7.0 and 26 degrees C.			DAVIDSON, GA (corresponding author), UNIV CAPE TOWN,SCH MED,DEPT CHEM PATHOL,MED RES COUNCIL BIOMEMBRANE RES UNIT,CAPE TOWN 7925,SOUTH AFRICA.							CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; CHRISTENSEN SB, 1985, TETRAHEDRON LETT, V26, P107, DOI 10.1016/S0040-4039(00)98480-6; CHRISTENSEN SB, 1993, FEBS LETT, V335, P345, DOI 10.1016/0014-5793(93)80416-R; DEAN WL, 1978, BIOCHEMISTRY-US, V17, P1683, DOI 10.1021/bi00602a016; DEJESUS F, 1993, FEBS LETT, V332, P229, DOI 10.1016/0014-5793(93)80638-B; GUILLAIN F, 1980, J BIOL CHEM, V255, P2072; HENDERSON IMJ, 1994, BIOCHEM J, V297, P625, DOI 10.1042/bj2970625; KIJIMA Y, 1991, J BIOL CHEM, V266, P22912; LACAPERE JJ, 1990, J BIOL CHEM, V265, P8583; MCINTOSH DB, 1988, J BIOL CHEM, V263, P12220; MCINTOSH DB, 1992, J BIOL CHEM, V267, P22328; MCINTOSH DB, 1985, BIOCHEMISTRY-US, V24, P1244, DOI 10.1021/bi00326a029; MCINTOSH DB, 1991, P NATL ACAD SCI USA, V88, P6437, DOI 10.1073/pnas.88.15.6437; MCINTOSH DB, 1984, BIOCHEMISTRY-US, V53, P1959; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; NORREGAARD A, 1993, FEBS LETT, V336, P248, DOI 10.1016/0014-5793(93)80813-A; ROSS DC, 1987, J BIOL CHEM, V262, P12977; ROSS DC, 1991, J BIOL CHEM, V266, P4613; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; SUMBILLA C, 1993, J BIOL CHEM, V268, P21185; TAKAYASU K, 1993, BIOL CHEM H-S, V374, P550; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VERJOVSKIALMEID.S, 1981, J BIOL CHEM, V256, P2940; WICTOME M, 1992, FEBS LETT, V304, P109, DOI 10.1016/0014-5793(92)80599-C; WICTOME M, 1992, BIOCHEM J, V283, P525, DOI 10.1042/bj2830525	28	62	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11731	11734		10.1074/jbc.270.20.11731	http://dx.doi.org/10.1074/jbc.270.20.11731			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744817	hybrid			2022-12-27	WOS:A1995QY73600008
J	WARING, JF; RADFORD, JE; BURNS, LJ; GINDER, GD				WARING, JF; RADFORD, JE; BURNS, LJ; GINDER, GD			THE HUMAN-LEUKOCYTE ANTIGEN A2 INTERFERON-STIMULATED RESPONSE ELEMENT CONSENSUS SEQUENCE BINDS A NUCLEAR FACTOR REQUIRED FOR CONSTITUTIVE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; TISSUE-SPECIFIC EXPRESSION; ENHANCER-LIKE SEQUENCES; IFN-INDUCIBLE GENES; TRANSCRIPTIONAL ACTIVATOR; DIFFERENTIAL REGULATION; LEUKEMIA-CELLS; TUMOR-CELLS; T-CELLS	Both constitutive and interferon-inducible enhancer-like elements have been identified previously in the promoter of human leukocyte antigen (HLA) class I genes. One of these sites is termed the interferon-stimulated response element (ISRE). We have tested the function of an ISRE consensus sequence in the human HLA class I gene HLA-A2 and confirmed previous studies that showed that the HLA-A2 ISRE consensus sequence does not mediate a response to interferons. However, deletion of the ISRE consensus sequence caused a severalfold reduction in the constitutive expression of the HLA-A2 gene in K562 and Jurkat cells. Mobility shift assays performed with the HLA-A2 ISRE revealed the presence of a constitutive binding protein (ISRE/CBP). This protein binds specifically to the HLA-A2 ISRE sequence, and binding is not efficiently competed by the ISRE sequences of the HLA-B7 or ISG54 genes. Substitution of the HLA-B7 or ISG54 ISRE sequences for the HLA-A2 ISRE sequence caused a severalfold reduction in the constitutive expression of the HLA-A2 gene. Mass determinations showed the ISRE/CBP to be 105 kDa, different than any previously characterized ISRE binding proteins. We propose that ISRE/CBP is a novel positive transcriptional regulatory factor for the HLA-A2 gene that may contribute to the differential expression of HLA-A versus HLA-B genes.	UNIV MINNESOTA,DEPT MED,DIV MED ONCOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; UNIV IOWA,GENET PHD PROGRAM,IOWA CITY,IA 52242	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa					NCI NIH HHS [R01-CA45634] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045634] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACKRILL AM, 1988, ONCOGENE, V3, P483; BALDWIN AS, 1990, MOL CELL BIOL, V10, P1406, DOI 10.1128/MCB.10.4.1406; BALDWIN AS, 1987, MOL CELL BIOL, V7, P305, DOI 10.1128/MCB.7.1.305; BALL ED, 1984, J IMMUNOL, V132, P2424; BASHAM TY, 1982, P NATL ACAD SCI-BIOL, V79, P3265, DOI 10.1073/pnas.79.10.3265; BURKE PA, 1989, J EXP MED, V169, P1309, DOI 10.1084/jem.169.4.1309; BURNS LJ, 1993, BLOOD, V81, P1558; CHAMBERLAIN JW, 1991, MOL CELL BIOL, V11, P3564, DOI 10.1128/MCB.11.7.3564; CHEN E, 1986, MOL CELL BIOL, V6, P1698, DOI 10.1128/MCB.6.5.1698; CLARK L, 1988, GENE DEV, V2, P991, DOI 10.1101/gad.2.8.991; DALE TC, 1989, EMBO J, V8, P831, DOI 10.1002/j.1460-2075.1989.tb03444.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEY A, 1992, MOL CELL BIOL, V12, P3590, DOI 10.1128/MCB.12.8.3590; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; GANGULY S, 1989, P NATL ACAD SCI USA, V86, P5247, DOI 10.1073/pnas.86.14.5247; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAKEM R, 1991, J IMMUNOL, V147, P2384; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HENSELING U, 1990, MOL CELL BIOL, V10, P4100, DOI 10.1128/MCB.10.8.4100; HO NS, 1989, GENE, V77, P51; HOOD L, 1983, ANNU REV IMMUNOL, V1, P529, DOI 10.1146/annurev.iy.01.040183.002525; IMAM AMA, 1990, NUCLEIC ACIDS RES, V18, P6573, DOI 10.1093/nar/18.22.6573; KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9; KOLLER BH, 1988, J IMMUNOL, V141, P897; KOLLER BH, 1985, J IMMUNOL, V134, P2727; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; MARINCOLA FM, 1994, J IMMUNOL, V153, P1225; MASCHEK U, 1989, MOL CELL BIOL, V9, P3136, DOI 10.1128/MCB.9.7.3136; Maxam A M, 1980, Methods Enzymol, V65, P499; MISKIMINS WK, 1985, P NATL ACAD SCI USA, V82, P6741, DOI 10.1073/pnas.82.20.6741; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MIYAZAKI J, 1986, P NATL ACAD SCI USA, V83, P9537, DOI 10.1073/pnas.83.24.9537; MOLLER P, 1987, INT J CANCER, V40, P32, DOI 10.1002/ijc.2910400107; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; NGUYEN C, 1985, IMMUNOGENETICS, V21, P479, DOI 10.1007/BF00430931; PARRINGTON J, 1993, EUR J BIOCHEM, V214, P617, DOI 10.1111/j.1432-1033.1993.tb17961.x; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; RADFORD JE, 1991, BLOOD, V77, P2008; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; SANDERSON AR, 1983, IMMUNOL TODAY, V4, P211, DOI 10.1016/0167-5699(83)90027-0; SCHMIDT H, 1990, IMMUNOGENETICS, V31, P245; SCHWARTZ RJ, 1992, NUCLEIC ACIDS RES, V20, P140; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; Soong T W, 1991, Semin Cancer Biol, V2, P23; TANAKA K, 1985, SCIENCE, V228, P26, DOI 10.1126/science.3975631; Travers P J, 1982, Natl Cancer Inst Monogr, V60, P175; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; WALLICH R, 1985, NATURE, V315, P301, DOI 10.1038/315301a0; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; WEDRYCHOWSKI A, 1992, J BIOL CHEM, V267, P4533; WEISZ A, 1992, J BIOL CHEM, V267, P25589; YANO O, 1987, EMBO J, V6, P3317, DOI 10.1002/j.1460-2075.1987.tb02652.x; ZACHOW KR, 1989, J IMMUNOL, V143, P3385; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	61	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12276	12285		10.1074/jbc.270.20.12276	http://dx.doi.org/10.1074/jbc.270.20.12276			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744880	hybrid			2022-12-27	WOS:A1995QY73600085
J	YAMAMORI, B; KURODA, S; SHIMIZU, K; FUKUI, K; OHTSUKA, T; TAKAI, Y				YAMAMORI, B; KURODA, S; SHIMIZU, K; FUKUI, K; OHTSUKA, T; TAKAI, Y			PURIFICATION OF A RAS-DEPENDENT MITOGEN-ACTIVATED PROTEIN-KINASE KINASE KINASE FROM BOVINE BRAIN CYTOSOL AND ITS IDENTIFICATION AS A COMPLEX OF B-RAF AND 14-13-3-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SIGNAL-TRANSDUCTION PATHWAY; MAP KINASE; XENOPUS-OOCYTES; DOWNSTREAM; DEFINITION; EXPRESSION; INVITRO; C-RAF-1; REGION; FAMILY	We previously purified a protein factor, named REKS (Ras-dependent Extracellular Signal-regulated Kinase (ERK)/mitogen-activated protein kinase Kinase (MEK) Stimulator), from Xenopus eggs by use of a cell-free assay system in which recombinant GTP gamma S (guanosine 5'-(3-O-thio)triphosphate) -Ki-Ras activates recombinant MEK. By use of this assay system, we purified here bovine REKS to near homogeneity from the cytosol fraction of bovine brain by successive chromatographies of Mono S, Mono Q, GTP gamma S-glutathione S-transferase-Ha-Ras-coupled glutathione-agarose, and Mono Q columns. It was composed of three proteins with masses of about 95, 32, and 30 kDa as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The 95-, 32-, and 30-kDa proteins were identified by immunoblot analysis to be B-Raf protein kinase, 14-3-3 protein, and 14-3-3 protein, respectively. Moreover, the REKS activity was specifically immunoprecipitated by an anti-B-Raf antibody. Bovine REKS was activated by lipid-modified GTP gamma S-Ki-Ras far more effectively than by a lipid-unmodified one. Lipid-modified GDP-Ki-Ras was inactive. Exogenous addition of 14-3-3 proteins stimulated further the REKS activity both in the presence and absence of GTP gamma S-Ki-Ras. These results indicate that at least one of the direct targets of Ras is B-Raf complexed with 14-3-3 proteins in bovine brain.	OSAKA UNIV,SCH MED,DEPT MOLEC BIOL & BIOCHEM,SUITA,OSAKA 565,JAPAN; NATL INST PHYSIOL SCI,DEPT CELL PHYSIOL,OKAZAKI,AICHI 444,JAPAN	Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)			KURODA, SHINYA/G-4961-2014					AELST LV, 1993, P NATL ACAD SCI USA, V90, P6213; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CATLING AD, 1994, J BIOL CHEM, V269, P30014; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; ITOH T, 1993, P NATL ACAD SCI USA, V90, P975, DOI 10.1073/pnas.90.3.975; ITOH T, 1993, J BIOL CHEM, V268, P3025; JAISWAL RK, 1994, MOL CELL BIOL, V14, P6944, DOI 10.1128/MCB.14.10.6944; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; KIKUCHI A, 1994, J BIOL CHEM, V269, P20054; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KURODA S, 1995, J BIOL CHEM, V270, P2460, DOI 10.1074/jbc.270.6.2460; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; MOODIE SA, 1994, MOL CELL BIOL, V14, P7153, DOI 10.1128/MCB.14.11.7153; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; SHIMIZU K, 1994, J BIOL CHEM, V269, P22917; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; STORM SM, 1990, ONCOGENE, V5, P345; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	45	97	99	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11723	11726		10.1074/jbc.270.20.11723	http://dx.doi.org/10.1074/jbc.270.20.11723			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744815	hybrid			2022-12-27	WOS:A1995QY73600006
J	LUBBEN, B; FABRIZIO, P; KASTNER, B; LUHRMANN, R				LUBBEN, B; FABRIZIO, P; KASTNER, B; LUHRMANN, R			ISOLATION AND CHARACTERIZATION OF THE SMALL NUCLEOLAR RIBONUCLEOPROTEIN PARTICLE SNR30 FROM SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; SMALL NUCLEAR-RNA; YEAST; PROTEIN; FIBRILLARIN; SNRNPS; DEPLETION; INVITRO; SNORNP; BINDS	The nucleolus of the yeast Saccharomyces cerevisiae contains the small nucleolar RNA snR30 (snoRNA), that is found associated with at least two proteins, NOP1 and GAR1. Ah three of these molecules are essential for the cell's viability and have been implicated in pre-rRNA maturation. NOP1 and GAR1 are believed to be general rRNA-processing factors or, alternatively, integral protein components of the small nucleolar ribonucleoprotein particle snR30 (snoRNP). In this paper, we describe procedures for the biochemical isolation of snR30 RNP, and we identify seven snR30 RNP proteins of molecular masses of 10, 23, 25, 38, 46, 48, and 65 kDa, including the previously reported GAR1 protein. Additional proteins, including NOP1, may also be components of snR30 RNP but are lost during our stringent isolation procedure. The 10, 23-, and 25-kDa (GAR1) and 65-kDa proteins remain tightly associated with the snR30 RNA even after isopycnic sedimentation in cesium sulfate gradients. Electron microscopy of Mono and-purified snR30 RNPs show a slightly elongated two-domain structure approximately 20 nm long and 14 nm wide.	UNIV MARBURG,INST MOLEK BIOL & TUMORFORSCH,D-35037 MARBURG,GERMANY	Philipps University Marburg								ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; BACH M, 1990, METHOD ENZYMOL, V181, P232; BALLY M, 1988, NUCLEIC ACIDS RES, V16, P5291, DOI 10.1093/nar/16.12.5291; CLARK MW, 1990, J CELL BIOL, V111, P1741, DOI 10.1083/jcb.111.5.1741; DANDEKAR T, 1993, NUCLEIC ACIDS RES, V21, P5386, DOI 10.1093/nar/21.23.5386; FABRIZIO P, 1989, GENE DEV, V3, P2137, DOI 10.1101/gad.3.12b.2137; FABRIZIO P, 1994, SCIENCE, V264, P261, DOI 10.1126/science.8146658; FILIPOWICZ W, 1993, MOL BIOL REP, V18, P149, DOI 10.1007/BF00986770; FOURNIER MJ, 1993, TRENDS BIOCHEM SCI, V18, P131, DOI 10.1016/0968-0004(93)90020-N; GIRARD JP, 1992, EMBO J, V11, P673, DOI 10.1002/j.1460-2075.1992.tb05099.x; HUGHES JMX, 1987, EMBO J, V6, P2145, DOI 10.1002/j.1460-2075.1987.tb02482.x; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; JANSEN R, 1993, EMBO J, V12, P2549, DOI 10.1002/j.1460-2075.1993.tb05910.x; JONES MH, 1990, EMBO J, V9, P2555, DOI 10.1002/j.1460-2075.1990.tb07436.x; JONG AYS, 1987, MOL CELL BIOL, V7, P2947, DOI 10.1128/MCB.7.8.2947; KASTNER B, 1989, EMBO J, V8, P277, DOI 10.1002/j.1460-2075.1989.tb03374.x; LEE WC, 1991, J CELL BIOL, V113, P1, DOI 10.1083/jcb.113.1.1; LEHMEIER T, 1990, NUCLEIC ACIDS RES, V18, P6475, DOI 10.1093/nar/18.22.6475; LI HV, 1990, MOL CELL BIOL, V10, P1145, DOI 10.1128/MCB.10.3.1145; LIN RJ, 1985, J BIOL CHEM, V260, P4780; LUBBEN B, 1993, NUCLEIC ACIDS RES, V21, P5377, DOI 10.1093/nar/21.23.5377; LUHRMANN R, 1990, MOL BIOL REP, V14, P183, DOI 10.1007/BF00360468; MORRISSEY JP, 1993, MOL CELL BIOL, V13, P2469, DOI 10.1128/MCB.13.4.2469; PARKER KA, 1987, MOL CELL BIOL, V7, P2899, DOI 10.1128/MCB.7.8.2899; RUSSELL ID, 1992, J CELL BIOL, V119, P737, DOI 10.1083/jcb.119.4.737; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; TOLLERVEY D, 1985, EMBO J, V4, P3873, DOI 10.1002/j.1460-2075.1985.tb04160.x; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; TYE K, 1989, EMBO J, V8, P3113; ZAGORSKI J, 1988, MOL CELL BIOL, V8, P3282, DOI 10.1128/MCB.8.8.3282	32	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11549	11554		10.1074/jbc.270.19.11549	http://dx.doi.org/10.1074/jbc.270.19.11549			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744794	hybrid			2022-12-27	WOS:A1995QX86500074
J	SHIN, HJ; RHO, HM				SHIN, HJ; RHO, HM			RELEASE OF THE HEPATITIS-B VIRUS-ASSOCIATED DNA-POLYMERASE FROM THE VIRAL PARTICLE BY THE PROTEOLYTIC CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PUTATIVE REVERSE-TRANSCRIPTASE; NUCLEOTIDE-SEQUENCE; READING FRAME; PROTEIN; GENE; REPLICATION; STRAND; MUTATIONS; PRIMER; GENOME	Previous efforts for biochemical study of the human hepatitis B virus (HBV) DNA polymerase have been limited by its tight association with viral nucleocapsids, We report here that the soluble DNA polymerase from HBV particles was obtained by low pH treatment of the viral particles followed by incubation with small amounts of subtilisin, By these treatments, the similar to 100-kDa band in the activity gel assay was gradually converted to similar to 70 kDa, which subsequently showed reverse transcriptase activity on several exogenous templates. The single similar to 70-kDa active band, which did not show any DNA polymerase activity in endogenous reaction, was eluted through DEAE-Sepharose chromatography, These results suggest that the similar to 100-kDa protein, most likely the product of HBV Pol open reading frame, is tightly associated with viral nucleocapsids, and the similar to 70-kDa protein, the proteolytic cleavage product of similar to 100-kDa enzyme, is solubilized from viral particles as an active enzyme on exogenous templates.	SEOUL NATL UNIV,COLL NAT SCI,DEPT MOLEC BIOL,SEOUL 151742,SOUTH KOREA; SEOUL NATL UNIV,COLL NAT SCI,CELL DIFFERENTIAT RES CTR,SEOUL 151742,SOUTH KOREA	Seoul National University (SNU); Seoul National University (SNU)								BAVAND M, 1989, J VIROL, V63, P1019, DOI 10.1128/JVI.63.2.1019-1021.1989; BAVAND MR, 1988, J VIROL, V62, P626, DOI 10.1128/JVI.62.2.626-628.1988; CHANG LJ, 1990, J VIROL, V64, P5553, DOI 10.1128/JVI.64.11.5553-5558.1990; CHANG LJ, 1989, NATURE, V337, P364, DOI 10.1038/337364a0; FARUQI AF, 1991, VIROLOGY, V183, P764, DOI 10.1016/0042-6822(91)91007-4; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; GERLICH WH, 1980, CELL, V21, P801, DOI 10.1016/0092-8674(80)90443-2; GRANDGENETT DP, 1975, J VIROL, V15, P526, DOI 10.1128/JVI.15.3.526-533.1975; Heermann KH, 1991, MOL BIOL HEPATITIS B, P109; KAPLAN PM, 1973, J VIROL, V12, P995, DOI 10.1128/JVI.12.5.995-1005.1973; KIM SH, 1992, J GEN VIROL, V73, P2421, DOI 10.1099/0022-1317-73-9-2421; KIM SK, 1994, J GEN VIROL, V75, P917, DOI 10.1099/0022-1317-75-4-917; LEE HJ, 1993, BIOTECHNOL LETT, V15, P821; LI JS, 1989, J VIROL, V63, P4965, DOI 10.1128/JVI.63.11.4965-4968.1989; LIEN JM, 1986, J VIROL, V57, P229, DOI 10.1128/JVI.57.1.229-236.1986; MACK DH, 1988, J VIROL, V62, P4786, DOI 10.1128/JVI.62.12.4786-4790.1988; MANDART E, 1984, J VIROL, V49, P782, DOI 10.1128/JVI.49.3.782-792.1984; MOLNARKIMBER KL, 1983, J VIROL, V45, P165, DOI 10.1128/JVI.45.1.165-172.1983; OBERHAUS SM, 1993, J VIROL, V67, P6558, DOI 10.1128/JVI.67.11.6558-6566.1993; OU JH, 1990, J VIROL, V64, P4578, DOI 10.1128/JVI.64.9.4578-4581.1990; RADZIWILL G, 1988, VIROLOGY, V163, P123, DOI 10.1016/0042-6822(88)90239-5; RADZIWILL G, 1990, J VIROL, V64, P613, DOI 10.1128/JVI.64.2.613-620.1990; RHO HM, 1989, NUCLEIC ACIDS RES, V17, P2124, DOI 10.1093/nar/17.5.2124; RHO HM, 1979, VIROLOGY, V99, P192, DOI 10.1016/0042-6822(79)90054-0; RHO HM, 1980, CANCER LETT, V10, P207, DOI 10.1016/0304-3835(80)90073-7; SCHLICHT HJ, 1989, CELL, V56, P85, DOI 10.1016/0092-8674(89)90986-0; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Temin H M, 1972, Adv Virus Res, V17, P129, DOI 10.1016/S0065-3527(08)60749-6; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; TOH H, 1983, NATURE, V305, P827, DOI 10.1038/305827a0; WANG GH, 1993, J VIROL, V67, P6507, DOI 10.1128/JVI.67.11.6507-6512.1993; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; WEBER M, 1994, J VIROL, V68, P2994, DOI 10.1128/JVI.68.5.2994-2999.1994; WILL H, 1986, SCIENCE, V231, P594, DOI 10.1126/science.2418501; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	35	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11047	11050		10.1074/jbc.270.19.11047	http://dx.doi.org/10.1074/jbc.270.19.11047			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744734	hybrid			2022-12-27	WOS:A1995QX86500007
J	HAMAZAKI, H				HAMAZAKI, H			CA2+-DEPENDENT BINDING OF HUMAN SERUM AMYLOID-P COMPONENT TO ALZHEIMERS BETA-AMYLOID PEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HEPARAN-SULFATE; DISEASE; PROTEIN; CDNA; LOCALIZATION; DEPOSITS; PRECURSOR; PLAQUES; GENE	Serum amyloid P component (SAP), a normal glyco protein, is universally found in amyloid deposits, including cerebrovascular amyloid of Alzheimer's disease. This paper describes the Ca2+-dependent binding of human SAP to Alzheimer's beta-amyloid peptide (A beta). I-125-SAP binds to synthetic human A beta-(1-40) immobilized on microtiter plates at a dissociation constant of 6.0 x 10(-9) M in 0.01 M Tris-HCl, 0.15 M NaCl, pH 7.5, containing 2 mM Ca2+, 1% bovine serum albumin, and 0.05% Tween 20. Binding inhibition assay has shown that soluble A beta-(1-40) and A beta-(1-28) also bind to SAP. Since SAP is resistant to proteases in the presence of calcium, the Ca2+-dependent binding of SAP to soluble A beta and to beta-amyloid fibrils would give pathological effects on fibril formation and persistence of beta-amyloid in Alzheimer's disease.			HAMAZAKI, H (corresponding author), KITASATO UNIV,SCH MED,DEPT BIOL,SAGAMIHARA,KANAGAWA 228,JAPAN.							ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; BALTZ ML, 1986, CLIN EXP IMMUNOL, V66, P691; BUSH AI, 1994, J BIOL CHEM, V269, P12152; CORIA F, 1988, LAB INVEST, V58, P454; DALFERES ER, 1967, ARCH BIOCHEM BIOPHYS, V118, P284, DOI 10.1016/0003-9861(67)90350-5; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HAMAZAKI H, 1987, J BIOL CHEM, V262, P1456; HAMAZAKI H, 1994, BIOCHEM BIOPH RES CO, V205, P1172, DOI 10.1006/bbrc.1994.2789; HAUPT H, 1972, H-S Z PHYSIOL CHEM, V353, P1841, DOI 10.1515/bchm2.1972.353.2.1841; HAWKINS PN, 1988, J EXP MED, V167, P903, DOI 10.1084/jem.167.3.903; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; ISHII T, 1984, ACTA NEUROPATHOL, V36, P296; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KINOSHITA CM, 1992, PROTEIN SCI, V1, P700, DOI 10.1002/pro.5560010602; LADROR US, 1994, J BIOL CHEM, V269, P18422; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MANTZOURANIS EC, 1985, J BIOL CHEM, V260, P7752; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; NELSON SR, 1991, LANCET, V338, P335, DOI 10.1016/0140-6736(91)90478-8; OHNISHI S, 1986, J BIOCHEM-TOKYO, V100, P849, DOI 10.1093/oxfordjournals.jbchem.a121797; PENNOCK CA, 1968, NATURE, V217, P753, DOI 10.1038/217753a0; PEPYS MB, 1977, LANCET, V1, P1029; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; PEPYS MB, 1988, Q J MED, V67, P283; PINTERIC L, 1979, CAN J BIOCHEM CELL B, V57, P727, DOI 10.1139/o79-091; PRELLI F, 1985, J BIOL CHEM, V260, P2895; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; SKINNER M, 1980, AMYLOID AMYLOIDOSIS, P384; SNOW AD, 1987, LAB INVEST, V56, P120; SNOW AD, 1988, AM J PATHOL, V133, P456; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; WOOD SP, 1988, J MOL BIOL, V202, P169, DOI 10.1016/0022-2836(88)90529-3	38	61	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10392	10394		10.1074/jbc.270.18.10392	http://dx.doi.org/10.1074/jbc.270.18.10392			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737971	hybrid			2022-12-27	WOS:A1995QW60100009
J	LEFEBVRE, P; GAUB, MP; TAHAYATO, A; ROCHETTEEGLY, C; FORMSTECHER, P				LEFEBVRE, P; GAUB, MP; TAHAYATO, A; ROCHETTEEGLY, C; FORMSTECHER, P			PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2A REGULATE THE TRANSCRIPTIONAL AND DNA-BINDING ACTIVITIES OF RETINOIC ACID RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-HORMONE RECEPTORS; THYROID-HORMONE; GENE-EXPRESSION; X-RECEPTOR; SIGNALING PATHWAYS; OKADAIC ACID; GLUCOCORTICOID RECEPTOR; RESPONSIVE ELEMENT; ESTROGEN-RECEPTOR; CATALYTIC SUBUNIT	To determine which factors may regulate the DNA binding and transcriptional properties of retinoic acid receptors (RARs and RXRs), we investigated the sensitivity of reporter genes bearing various retinoic acid response elements (RAREs) to protein phosphatases (PPases) inhibition. PPases inhibition by okadaic acid led to an increase of the reporter genes activity in a RARE-dependent and ligand-independent manner and was dependent on the type of response element used. Overexpression of protein phosphatases 2A and 1 (PP2A and PP1) decreased the inducibility of the reporter genes tested. Nuclear extracts from okadaic acid-treated COS cells displayed an 2-5-fold increased level of receptor binding to RAREs in vitro, suggesting that PPases inhibition increased the DNA binding activity of retinoid receptors. Treatment of receptors extracted from COS cells by alkaline phosphatase and partially purified PP1 and PP2A decreased their DNA binding activity, but heterodimers bound to DNA were not sensitive to phosphatase treatment. Reconstitution experiments showed that phosphorylation of both receptors increased the DNA binding activity of RXR/RAR heterodimers. Taken together, these data show that the modulation of the phosphorylation state of RARs and RXRs represents an other level of regulation of the retinoid signaling pathway.	INST GENET & BIOL MOLEC & CELLULAIRE, INSERM, U184, GENET MOLEC EUCARYOTES LAB, CNRS, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	LEFEBVRE, P (corresponding author), FAC MED LILLE 1, INSERM, BIOCHIM STRUCT LAB, CJF 92-03, 1 PL VERDUN, F-59045 LILLE, FRANCE.		Lefebvre, Philippe/F-2685-2010	Lefebvre, Philippe/0000-0002-9366-5129				ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Ausubel FM, 1991, CURRENT PROTOCOLS MO; BARETTINO D, 1993, EMBO J, V12, P1343, DOI 10.1002/j.1460-2075.1993.tb05779.x; BECK CA, 1992, MOL ENDOCRINOL, V6, P607, DOI 10.1210/me.6.4.607; BERKENSTAM A, 1992, CELL, V69, P401, DOI 10.1016/0092-8674(92)90443-G; BHAT MK, 1994, P NATL ACAD SCI USA, V91, P7927, DOI 10.1073/pnas.91.17.7927; BOURGUET W, 1992, BIOCHEM BIOPH RES CO, V187, P711, DOI 10.1016/0006-291X(92)91253-M; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN HW, 1993, MOL CELL BIOL, V13, P5970, DOI 10.1128/MCB.13.10.5970; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; DEFRANCO DB, 1991, MOL ENDOCRINOL, V5, P1215, DOI 10.1210/mend-5-9-1215; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; GAUB MP, 1992, EXP CELL RES, V201, P335, DOI 10.1016/0014-4827(92)90282-D; GLASS CK, 1991, DNA CELL BIOL, V10, P623, DOI 10.1089/dna.1991.10.623; GLINEUR C, 1990, GENE DEV, V4, P1663, DOI 10.1101/gad.4.10.1663; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; HUGGENVIK JI, 1993, MOL ENDOCRINOL, V7, P543, DOI 10.1210/me.7.4.543; HUSMANN M, 1991, MOL CELL BIOL, V11, P4097, DOI 10.1128/MCB.11.8.4097; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; KEAVENEY M, 1993, NATURE, V365, P562, DOI 10.1038/365562a0; KIM YH, 1993, J BIOL CHEM, V268, P18513; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KURET J, 1986, FEBS LETT, V203, P197, DOI 10.1016/0014-5793(86)80741-4; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; LEFEBVRE P, 1991, MOL CELL BIOL, V11, P2529, DOI 10.1128/MCB.11.5.2529; LEHMANN JM, 1993, MOL CELL BIOL, V13, P7698, DOI 10.1128/MCB.13.12.7698; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LIN KH, 1992, P NATL ACAD SCI USA, V89, P7737, DOI 10.1073/pnas.89.16.7737; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MASON SA, 1993, J BIOL CHEM, V268, P21501; MOYER ML, 1993, J BIOL CHEM, V268, P22933; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; NAGPAL S, 1992, CELL, V70, P1007, DOI 10.1016/0092-8674(92)90250-G; ORTI E, 1992, ENDOCR REV, V13, P105, DOI 10.1210/er.13.1.105; PETKOVICH M, 1992, ANNU REV NUTR, V12, P443, DOI 10.1146/annurev.nu.12.070192.002303; POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936; ROCHETTEEGLY C, 1991, J CELL BIOL, V115, P535, DOI 10.1083/jcb.115.2.535; ROCHETTEEGLY C, 1994, BIOCHEM BIOPH RES CO, V204, P525, DOI 10.1006/bbrc.1994.2491; ROCHETTEEGLY C, 1992, MOL ENDOCRINOL, V6, P2197, DOI 10.1210/me.6.12.2197; SCHONTHAL A, 1992, NEW BIOL, V4, P16; SILBERMAN SR, 1984, J BIOL CHEM, V259, P2913; SOMERS JP, 1992, MOL ENDOCRINOL, V6, P26, DOI 10.1210/me.6.1.26; SRINIVASAN M, 1994, J BIOL CHEM, V269, P12514; SUGAWARA A, 1994, J BIOL CHEM, V269, P433; TAHAYATO A, 1993, MOL ENDOCRINOL, V7, P1642, DOI 10.1210/me.7.12.1642; TAWARA I, 1993, FEBS LETT, V321, P224, DOI 10.1016/0014-5793(93)80113-9; TINI M, 1993, GENE DEV, V7, P295, DOI 10.1101/gad.7.2.295; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZHANG XK, 1993, TRENDS ENDOCRIN MET, V4, P156, DOI 10.1016/1043-2760(93)90105-N; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	62	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10806	10816		10.1074/jbc.270.18.10806	http://dx.doi.org/10.1074/jbc.270.18.10806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738017	hybrid			2022-12-27	WOS:A1995QW60100065
J	DOBI, A; DAMERON, CT; HU, S; HAMER, D; WINGE, DR				DOBI, A; DAMERON, CT; HU, S; HAMER, D; WINGE, DR			DISTINCT REGIONS OF CU(I)-CENTER-DOT-ACE1 CONTACT 2 SPATIALLY-RESOLVED DNA MAJOR GROOVE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECO RI ENDONUCLEASE; CUP2 GENE-PRODUCT; YEAST METALLOTHIONEIN; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; BINDING PROTEIN; EXPRESSION; COPPER; ACE1	The interaction between the Cu(I). ACE1 (CuACE1) transcription factor and its DNA binding site in the yeast metallothionein gene was studied by systematically altering the DNA sequence through base substitution, modification, and deletions as well as by altering the protein structure through chemical modification. We show here that CuACE1 is comprised of two distinct domains that contact DNA through minor groove interactions located between two major groove interaction sites. The minor groove interactions are shown to be critical for formation of a stable CuACE1 . DNA complex, The NH2-terminal segment of ACEI is shown to contact the 5'-most distal major groove site.	NCI, BIOCHEM LAB, BETHESDA, MD 20892 USA; UNIV UTAH, HLTH SCI CTR, SALT LAKE CITY, UT 84132 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah								BRUNELLE A, 1987, P NATL ACAD SCI USA, V84, P6673, DOI 10.1073/pnas.84.19.6673; BUCHMAN C, 1989, MOL CELL BIOL, V9, P4091, DOI 10.1128/MCB.9.9.4091; BUCHMAN C, 1990, MOL CELL BIOL, V10, P4778, DOI 10.1128/MCB.10.9.4778; CARRI MT, 1991, FEBS LETT, V278, P263, DOI 10.1016/0014-5793(91)80131-L; DAMERON CT, 1991, P NATL ACAD SCI USA, V88, P6127, DOI 10.1073/pnas.88.14.6127; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; FURST P, 1989, P NATL ACAD SCI USA, V86, P5267, DOI 10.1073/pnas.86.14.5267; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GRALLA EB, 1991, P NATL ACAD SCI USA, V88, P8558, DOI 10.1073/pnas.88.19.8558; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; HU S, 1990, New Biologist, V2, P544; HUIBREGTSE JM, 1989, P NATL ACAD SCI USA, V86, P65, DOI 10.1073/pnas.86.1.65; Imbert J, 1990, Adv Inorg Biochem, V8, P139; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; LU AL, 1981, J BIOL CHEM, V256, P3200; Maniatis T., 1982, MOL CLONING; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCCLARIN JA, 1986, SCIENCE, V234, P1526, DOI 10.1126/science.3024321; MEHRA RK, 1991, J CELL BIOCHEM, V45, P30, DOI 10.1002/jcb.240450109; NAKAGAWA KH, 1991, J AM CHEM SOC, V113, P3621, DOI 10.1021/ja00009a075; SCHEIT KH, 1967, BIOCHIM BIOPHYS ACTA, V149, P344, DOI 10.1016/0005-2787(67)90162-1; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; STARR DB, 1991, CELL, V67, P1231, DOI 10.1016/0092-8674(91)90299-E; THIELE DJ, 1992, NUCLEIC ACIDS RES, V20, P1183, DOI 10.1093/nar/20.6.1183; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; THORVALDSEN JL, 1994, BIOCHEMISTRY-US, V33, P9566, DOI 10.1021/bi00198a024; THORVALDSEN JL, 1993, J BIOL CHEM, V268, P12512; WELCH J, 1989, EMBO J, V8, P255, DOI 10.1002/j.1460-2075.1989.tb03371.x; Winge D R, 1994, Adv Inorg Biochem, V10, P1; WINGE DR, 1985, J BIOL CHEM, V260, P4464; ZHOU PB, 1992, MOL CELL BIOL, V12, P3766, DOI 10.1128/MCB.12.9.3766; ZHOU PB, 1991, P NATL ACAD SCI USA, V88, P6112, DOI 10.1073/pnas.88.14.6112	34	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10171	10178		10.1074/jbc.270.17.10171	http://dx.doi.org/10.1074/jbc.270.17.10171			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730320	hybrid			2022-12-27	WOS:A1995QV41700067
J	LEE, SL; TOURTELLOTTE, LC; WESSELSCHMIDT, RL; MILBRANDT, J				LEE, SL; TOURTELLOTTE, LC; WESSELSCHMIDT, RL; MILBRANDT, J			GROWTH AND DIFFERENTIATION PROCEEDS NORMALLY IN CELLS DEFICIENT IN THE IMMEDIATE-EARLY GENE NGFI-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR EGR-1; EMBRYONAL CARCINOMA-CELLS; FINGER-ENCODING GENE; STEM-CELLS; C-FOS; ES CELLS; EXPRESSION; PROTEIN; RAT; PROTOONCOGENE	NGFI-A (also known as EGR-1, zif/268, and Krox-24) is a zinc finger transcription factor induced in many cell types by a variety of growth and differentiation stimuli, To determine if NGFI-A plays a requisite role in these processes, we used homologous recombination to mutate both alleles of NGFI-A in embryonic stem (ES) cells and examined its effect on growth and differentiation. We find that ES cells lacking NGFI-A exhibit similar growth rates and serum-induced gene expression profiles compared to wild-type parental cells. They are capable of differentiating into neurons, cardiac myocytes, chondrocytes, and squamous epithelium, Chimeric mice were generated from targeted ES cells, and their progeny were crossed to produce homozygous mutant mice, Growth and histological analyses of mice lacking NGFI-A confirm the finding in ES cells that NGFI-A is not required for many of the processes associated with its expression and suggest that the function of NGFI-A is either more subtle in vivo or masked by redundant expression provided by other gene family members such as NGFI-C, Krox-20, or EGR3.	WASHINGTON UNIV, SCH MED, DEPT INTERNAL MED, ST LOUIS, MO 63110 USA; JEWISH HOSP ST LOUIS, DEPT MED, DIV BONE MARROW TRANSPLANTAT, ST LOUIS, MO 63110 USA; JEWISH HOSP ST LOUIS, DEPT GENET, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Barnes-Jewish Hospital; Barnes-Jewish Hospital	LEE, SL (corresponding author), WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA.			Milbrandt, Jeffrey/0000-0002-5477-7689	NCI NIH HHS [P01 CA53514] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHAVRIER P, 1988, MOL CELL BIOL, V8, P1319, DOI 10.1128/MCB.8.3.1319; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P4739, DOI 10.1073/pnas.89.10.4739; DAY ML, 1990, J BIOL CHEM, V265, P15253; EDWARDS SA, 1991, DEV BIOL, V148, P165, DOI 10.1016/0012-1606(91)90327-Y; FIELD SJ, 1992, P NATL ACAD SCI USA, V89, P9306, DOI 10.1073/pnas.89.19.9306; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GUPTA MP, 1991, J BIOL CHEM, V266, P12813; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HILBERG F, 1992, ONCOGENE, V7, P2371; IWAKI K, 1990, J BIOL CHEM, V265, P13809; KHARBANDA S, 1991, J CLIN INVEST, V88, P571, DOI 10.1172/JCI115341; KIM HS, 1988, NUCLEIC ACIDS RES, V16, P8887, DOI 10.1093/nar/16.18.8887; LANOIX J, 1991, CELL GROWTH DIFFER, V2, P391; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; LINZER DIH, 1983, P NATL ACAD SCI-BIOL, V80, P4271, DOI 10.1073/pnas.80.14.4271; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MCMAHON AP, 1990, DEVELOPMENT, V108, P281; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; PATWARDHAN S, 1991, ONCOGENE, V6, P917; PEREZCASTILLO A, 1993, J BIOL CHEM, V268, P19445; ROBBINS J, 1990, J BIOL CHEM, V265, P11905; ROBERTSON E, 1987, TERATOCARCINOMA EMBR; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; SEYFERT VL, 1989, MOL CELL BIOL, V9, P2083, DOI 10.1128/MCB.9.5.2083; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SUVA LJ, 1991, MOL CELL BIOL, V11, P2503, DOI 10.1128/MCB.11.5.2503; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; WATSON MA, 1990, DEVELOPMENT, V110, P173	38	161	163	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9971	9977		10.1074/jbc.270.17.9971	http://dx.doi.org/10.1074/jbc.270.17.9971			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730380	hybrid			2022-12-27	WOS:A1995QV41700042
J	PAPP, B; BYRN, RA				PAPP, B; BYRN, RA			STIMULATION OF HIV EXPRESSION BY INTRACELLULAR CALCIUM-PUMP INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL CLONE; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; CA2+ STORES; THYMIC LYMPHOCYTES; TUMOR PROMOTER; THAPSIGARGIN; CA-2+	We have studied the role of intracellular calcium sequestration on human immunodeficiency virus (HIV) production by latently infected T-lymphocytic cells. Inhibition of the sarco-endoplasmic reticulum-type calcium transport ATPases by thapsigargin or cyclopiazonic acid induced activation of HIV production in the GEM-derived ACH-S cells. An approximately 50% depletion of the thapsigargin-sensitive calcium pools as measured fluorimetrically of Indo-loaded cells fully activated virus production. Viral activation was manifest by increases in soluble viral core p24 production, increases in cellular immunofluorescent staining for viral antigens, and increased viral transcription as measured by HIV long terminal repeat-directed expression of the chloramphenicol acetyltransferase reporter gene. Virus induction could be blocked in a dose dependent manner by the calcium channel blocker econazole. Virus production by the Jurkat-derived HIV-l-inducible J1.1 cells was not significantly stimulated by thapsigargin. These data indicate that intracellular calcium pool function is involved in the control of the transcription of proviral HIV in a cell type-specific manner within the T-Iymphoid lineage and that AGH-2 cells represent a useful model for the study of calcium dependent activation of the transcription of proviral HIV.	HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,HEMATOL ONCOL RES LAB,BOSTON,MA 02215	Harvard University; Harvard Medical School								BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BUTERA ST, 1994, J VIROL, V68, P2726, DOI 10.1128/JVI.68.4.2726-2730.1994; COMBETTES L, 1994, SCIENCE, V265, P818; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; EMBERTSON J, 1993, P NATL ACAD SCI USA, V90, P357; EMBERTSON J, 1993, NATURE, V362, P359; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; FINCH EA, 1994, SCIENCE, V265, P813, DOI 10.1126/science.265.5173.813-a; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; GHOSH TK, 1991, J BIOL CHEM, V266, P24690; GRAZIOSI C, 1993, AIDS, V7, pS53, DOI 10.1097/00002030-199311002-00012; GRINSTEIN S, 1989, B NEW YORK ACAD MED, V65, P69; GROVER AK, 1992, CELL CALCIUM, V13, P9, DOI 10.1016/0143-4160(92)90025-N; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTHEIL JC, 1994, J BIOL CHEM, V269, P7976; HASELTINE WA, 1991, FASEB J, V5, P2349, DOI 10.1096/fasebj.5.10.1829694; HAVERSTICK DM, 1993, MOL BIOL CELL, V4, P173, DOI 10.1091/mbc.4.2.173; IINO M, 1992, NATURE, V360, P76, DOI 10.1038/360076a0; INO M, 1990, J GEN PHYSIOL, V95, P1103; KIJIMA Y, 1991, J BIOL CHEM, V266, P22912; LI WWF, 1993, J BIOL CHEM, V268, P12003; MACLENNAN DH, 1992, ANN NY ACAD SCI, V671, P1, DOI 10.1111/j.1749-6632.1992.tb43779.x; MASON MJ, 1991, J BIOL CHEM, V266, P10872; MASON MJ, 1993, AM J PHYSIOL, V264, pC654, DOI 10.1152/ajpcell.1993.264.3.C654; MASON MJ, 1991, J BIOL CHEM, V266, P20856; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; NORDSTROM T, 1992, EXP CELL RES, V202, P487, DOI 10.1016/0014-4827(92)90103-F; NYE KE, 1991, AIDS, V5, P413, DOI 10.1097/00002030-199104000-00009; NYE KE, 1990, AIDS, V4, P41, DOI 10.1097/00002030-199001000-00006; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PAPP B, 1994, AIDS RES HUM RETROV, V10, P775, DOI 10.1089/aid.1994.10.775; PAPP B, 1991, J BIOL CHEM, V266, P14593; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PARYS JB, 1992, J BIOL CHEM, V267, P18776; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; PEREZ VL, 1991, J IMMUNOL, V147, P3145; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; SARKADI B, 1991, J MEMBRANE BIOL, V123, P9, DOI 10.1007/BF01993958; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; SCHENTAL A, 1991, P NATL ACAD SCI USA, V88, P7096; SCHWARTZ O, 1988, AIDS RES HUM RETROV, V4, P441, DOI 10.1089/aid.1988.4.441; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TAO JG, 1992, J BIOL CHEM, V267, P24972; THASTRUP O, 1987, BIOCHIM BIOPHYS ACTA, V927, P65, DOI 10.1016/0167-4889(87)90066-8; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; THASTRUP O, 1987, BIOCHEM BIOPH RES CO, V142, P654, DOI 10.1016/0006-291X(87)91464-1; WALDRON RT, 1994, J BIOL CHEM, V269, P11927; ZEIRA M, 1990, AIDS RES HUM RETROV, V6, P629, DOI 10.1089/aid.1990.6.629; ZHANG BX, 1993, J BIOL CHEM, V268, P10997; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295; [No title captured]	63	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10278	10283		10.1074/jbc.270.17.10278	http://dx.doi.org/10.1074/jbc.270.17.10278			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730332	hybrid			2022-12-27	WOS:A1995QV41700081
J	TESSON, F; LIMONBOULEZ, I; URBAN, P; PUYPE, M; VANDEKERCKHOVE, J; COUPRY, I; POMPON, D; PARINI, A				TESSON, F; LIMONBOULEZ, I; URBAN, P; PUYPE, M; VANDEKERCKHOVE, J; COUPRY, I; POMPON, D; PARINI, A			LOCALIZATION OF I-2-IMIDAZOLINE BINDING-SITES ON MONOAMINE OXIDASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-3 IDAZOXAN BINDING; GUANIDINIUM-RECEPTIVE SITES; VENTROLATERAL MEDULLA; RABBIT KIDNEY; RAT-BRAIN; IMIDAZOLINE; MEMBRANES; CELLS; ALPHA-2-ADRENOCEPTORS; EXPRESSION	Imidazoline binding sites (IBS) were proposed to be responsible for some of the pharmacological and therapeutic activities of imidazoline and related compounds and have been classified into two subtypes, I1BS and I2BS, Convergent studies attribute a role in central blood pressure regulation to the I1BS. In contrast, the function of I2BS remains unknown. In the present study, by combining biochemical and molecular biology approaches, we show that 1) microsequencing of I2BS purified from rabbit kidney mitochondria allowed the recovery of four peptide sequence stretches displaying up to 85.7% similarity with human, rat, and bovine monoamine oxidases (MAO)-A and -B; 2) I2BS and MAO displayed identical biophysical characteristics as their activities, measured by [H-3]idazoxan binding and [C-14]tyramine oxidation, respectively, could not be separated using various chromatographic procedures; and 3) heterologous expression of human placenta MAO-A and human liver MAO-B in yeast, inherently devoid of I2BS and MAO activities, led to the coexpression of [H-9]idazoxan binding sites displaying ligand-recognition properties typical of I2BS. These results show definitely that I2BS is located on both MAO-A and -B. The fact that I2BS ligands inhibited MAO activity independently of the interaction with the catalytic region suggests that I2BS might be a previously unknown MAO regulatory site.	CHU RANGUEIL,INST LOUIS BUGNARD,INSERM,U388,F-31054 TOULOUSE,FRANCE; CTR GENET MOLEC,CNRS,UPR 2420,F-91198 GIF SUR YVETTE,FRANCE; STATE UNIV GHENT,PHYSIOL CHEM LAB,B-9000 GHENT,BELGIUM	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ghent University			COUPRY, Isabelle/L-4900-2014; Tesson, Frederique/A-3218-2013; Limon, Isabelle/P-2750-2017; Limon, Isabelle/AAJ-6169-2020	Limon, Isabelle/0000-0002-8773-6971; Limon, Isabelle/0000-0002-8773-6971; Parini, Angelo/0000-0002-9848-8838; Urban, Philippe/0000-0003-0557-839X				ATLAS D, 1994, SCIENCE, V266, P462, DOI 10.1126/science.7939689; BAUW G, 1987, P NATL ACAD SCI USA, V84, P4806, DOI 10.1073/pnas.84.14.4806; BAUW G, 1988, J PROTEIN CHEM, V7, P194; BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232; BRICCA G, 1994, EUR J PHARM-MOLEC PH, V266, P25, DOI 10.1016/0922-4106(94)90205-4; COUPRY I, 1987, BIOCHEM BIOPH RES CO, V147, P1055, DOI 10.1016/S0006-291X(87)80177-8; COUPRY I, 1990, J PHARMACOL EXP THER, V252, P293; DIAMANT S, 1992, BRIT J PHARMACOL, V106, P101, DOI 10.1111/j.1476-5381.1992.tb14300.x; DOXEY JC, 1983, BRIT J PHARMACOL, V78, P489, DOI 10.1111/j.1476-5381.1983.tb08809.x; ERNSBERGER P, 1990, J PHARMACOL EXP THER, V253, P408; ERNSBERGER P, 1987, EUR J PHARMACOL, V134, P1, DOI 10.1016/0014-2999(87)90125-7; GHIKA J, 1991, NEUROLOGY, V41, P986, DOI 10.1212/WNL.41.7.986; JACKSON HC, 1991, PSYCHOPHARMACOLOGY, V105, P558, DOI 10.1007/BF02244380; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; LIMON I, 1992, J BIOL CHEM, V267, P21645; MALLARD NJ, 1992, BRIT J PHARMACOL, V106, P1019, DOI 10.1111/j.1476-5381.1992.tb14450.x; MICHEL MC, 1992, TRENDS PHARMACOL SCI, V13, P369; OLMOS G, 1993, BRIT J PHARMACOL, V108, P597, DOI 10.1111/j.1476-5381.1993.tb12848.x; REGUNATHAN S, 1993, BIOCHEM PHARMACOL, V45, P1667, DOI 10.1016/0006-2952(93)90308-J; RENOUARD A, 1993, BRIT J PHARMACOL, V109, P625, DOI 10.1111/j.1476-5381.1993.tb13618.x; RILEY LA, 1991, BIOCHEM PHARMACOL, V42, P1953, DOI 10.1016/0006-2952(91)90595-V; RUIZ J, 1993, NEUROSCI LETT, V160, P109, DOI 10.1016/0304-3940(93)90925-B; SASTRE M, 1993, J NEUROCHEM, V61, P881, DOI 10.1111/j.1471-4159.1993.tb03599.x; SINGER TP, 1993, MONOAMINE OXIDASE BA, P23; TESSON F, 1992, EUR J PHARMACOL, V219, P335, DOI 10.1016/0014-2999(92)90316-V; TESSON F, 1991, J BIOL CHEM, V266, P155; TIMMERMANS PBMWM, 1982, J MED CHEM, V25, P1389, DOI 10.1021/jm00354a001; URBAN P, 1990, BIOCHIMIE, V72, P463, DOI 10.1016/0300-9084(90)90070-W; URBAN P, 1991, FEBS LETT, V286, P142, DOI 10.1016/0014-5793(91)80960-B; VENAULT P, 1993, LIFE SCI, V52, P639, DOI 10.1016/0024-3205(93)90455-C; WENDT RL, 1980, PHARM ANTIHYPERTENSI, P99; WEYLER W, 1989, PHARMACOL THERAPEUT, V47, P391	32	176	177	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9856	9861		10.1074/jbc.270.17.9856	http://dx.doi.org/10.1074/jbc.270.17.9856			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730367	hybrid			2022-12-27	WOS:A1995QV41700026
J	WANG, F; KAN, M; XU, JM; YAN, GC; MCKEEHAN, WL				WANG, F; KAN, M; XU, JM; YAN, GC; MCKEEHAN, WL			LIGAND-SPECIFIC STRUCTURAL DOMAINS IN THE FIBROBLAST GROWTH-FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE EPITHELIAL-CELLS; 3-DIMENSIONAL STRUCTURE; SIGNAL-TRANSDUCTION; BINDING; KINASE; VARIANTS; HEPARIN; REGION; GENES; SITE	Two tandem immunoglobulin-like disulfide loops (Loops II and III) linked by a short connecting sequence in the ectodomain of the fibroblast growth factor receptor kinase compose the binding sites for glycosaminoglycan and fibroblast growth factor (FGF) ligands. Alternate splicing of exons IIIb and IIIc coding for the COOH-terminal half of Loop III confers high affinity for FGF-7 or FGF-2, respectively, on the fibroblast growth factor receptor ectodomain without effect on the binding of FGF-1, Here we show that a 139-amino acid fragment composed of Loop II, the inter-loop II/III sequence, and a short segment of the NH2 terminus of Loop III is sufficient and near the minimal requirement for binding of FGF-1, FGF-2, and FGF-7, Extension of the fragment by five additional highly conserved residues (SD(P/A)QP) within a distinct constitutive structural domain (fl1) in Loop III restricts the binding of FGF-7 without effect on FGF-1 and FGF-2. Since the presence of exon IIIc in the full-length ectodomain does not change this ligand binding profile, we suggest that alternately spliced exon IIIc plays no active role in binding of the three ligands. In contrast, exon IIIb actively abrogates the restriction on the binding of FGF-7 and concurrently lowers the affinity for FGF-2.	TEXAS A&M UNIV, ALBERT B ALKEK INST BIOSCI & TECHNOL, DEPT BIOCHEM & BIOPHYS, HOUSTON, TX 77030 USA	Texas A&M University System					NCI NIH HHS [CA59971] Funding Source: Medline; NIDDK NIH HHS [DK35310, DK38639] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA059971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035310, P01DK038639] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; BOTTARO DP, 1993, J BIOL CHEM, V268, P9180; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CHEON HG, 1994, P NATL ACAD SCI USA, V91, P989, DOI 10.1073/pnas.91.3.989; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; HOU JZ, 1991, SCIENCE, V251, P665, DOI 10.1126/science.1846977; HOU JZ, 1992, J BIOL CHEM, V267, P17804; HOU JZ, 1993, PROTEIN SCI, V2, P86; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; KAN M, 1991, METHOD ENZYMOL, V198, P158; KAN M, 1992, IN VITRO CELL DEV-AN, V28A, P515; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; MATSUZAKI K, 1993, J BIOL CHEM, V268, P12719; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; SEDDON AP, 1995, BIOCHEMISTRY-US, V34, P731, DOI 10.1021/bi00003a004; SHI E, 1993, MOL CELL BIOL, V13, P3907, DOI 10.1128/MCB.13.7.3907; SPRINGER BA, 1994, J BIOL CHEM, V269, P26879; WANG F, 1995, J BIOL CHEM, V270, P10231, DOI 10.1074/jbc.270.17.10231; WERNER S, 1992, MOL CELL BIOL, V12, P82, DOI 10.1128/MCB.12.1.82; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; XU JM, 1992, J BIOL CHEM, V267, P17792; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; YAN GC, 1992, MOL ENDOCRINOL, V6, P2123, DOI 10.1210/me.6.12.2123; YAN GC, 1993, BIOCHEM BIOPH RES CO, V194, P512, DOI 10.1006/bbrc.1993.1849; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	32	88	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10222	10230		10.1074/jbc.270.17.10222	http://dx.doi.org/10.1074/jbc.270.17.10222			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730326	hybrid			2022-12-27	WOS:A1995QV41700074
J	ZHONG, JM; CHENHWANG, MC; HWANG, YW				ZHONG, JM; CHENHWANG, MC; HWANG, YW			SWITCHING NUCLEOTIDE SPECIFICITY OF HA-RAS P21 BY A SINGLE AMINO-ACID SUBSTITUTION AT ASPARTATE-119	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-TU; BINDING DOMAIN; MOLECULAR MECHANISM; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TERMINAL DOMAIN; PROTEINS; GDP; EXCHANGE; MUTANTS	We examined c-Ha-Ras harboring an aspartate to asparagine substitution at position 119 (mutation D119N). The Asp-119 is part of the conserved NKXD motif shared by members of the regulatory GTPase family, This asparagine residue has been proposed to participate in direct bonding to the guanine ring and to determine the guanine-nucleotide binding specificity, The D119N mutation was found to alter nucleotide specificity of Ha-Ras from guanine to xanthine, an observation that directly supports the essential role of hydrogen bonding between the side chain of the aspartic acid residue and the guanine ring in nucleotide binding specificity, Resides nucleotide binding specificity, the D119N mutation has little or no effect on the interaction of Ha-Ras with SDC25C, SOS1, GAP, or Raf, Neither does it affect the hydrolysis of nucleotide triphosphate. Like xanthine-nucleotide-specific EF-Tu, xanthine-nucleotide-specific Ras and related proteins will be useful tools for elucidating cellular systems containing multiple regulatory GTPases.	NEW YORK STATE INST BASIC RES DEV DISABIL,DEPT MOLEC BIOL,STATEN ISL,NY 10314; CUNY,IBR,CSI,CTR DEV NEUROSCI,NEW YORK,NY 10021; CUNY,GRAD PROGRAM BIOL,NEW YORK,NY 10021	Institute for Basic Research in Developmental Disabilities; City University of New York (CUNY) System; Institute for Basic Research in Developmental Disabilities; City University of New York (CUNY) System					NCI NIH HHS [CA53782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA053782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; Crystal R G, 1974, Methods Enzymol, V30, P101; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; FEIG LA, 1986, P NATL ACAD SCI USA, V83, P4607, DOI 10.1073/pnas.83.13.4607; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; HWANG YW, 1993, J BIOL CHEM, V268, P24692; HWANG YW, 1987, J BIOL CHEM, V262, P13081; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; KANG C, 1994, J BIOL CHEM, V269, P24046; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LACOUR TFM, 1985, EMBO J, V4, P2385, DOI 10.1002/j.1460-2075.1985.tb03943.x; LAMBRIGHT DG, 1994, NATURE, V360, P621; LIU BX, 1993, ONCOGENE, V8, P8081; MANNE V, 1984, P NATL ACAD SCI-BIOL, V81, P6953, DOI 10.1073/pnas.81.22.6953; MISTOU MY, 1992, EMBO J, V11, P2391, DOI 10.1002/j.1460-2075.1992.tb05303.x; MOODIE SA, 1993, SCIENCE, V260, P1588; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; SUNG YJ, 1995, BIOCHEMISTRY-US, V34, P3470, DOI 10.1021/bi00010a040; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WEIJLAND A, 1994, BIOCHEMISTRY-US, V33, P10711, DOI 10.1021/bi00201a019; WEIJLAND A, 1994, TRENDS BIOCHEM SCI, V19, P188, DOI 10.1016/0968-0004(94)90018-3; WEIJLAND A, 1993, SCIENCE, V259, P1311, DOI 10.1126/science.8446899; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	38	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10002	10007		10.1074/jbc.270.17.10002	http://dx.doi.org/10.1074/jbc.270.17.10002			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730301	hybrid			2022-12-27	WOS:A1995QV41700046
J	SHACKELTON, LM; MANN, DM; MILLIS, AJT				SHACKELTON, LM; MANN, DM; MILLIS, AJT			IDENTIFICATION OF A 38-KDA HEPARIN-BINDING GLYCOPROTEIN (GP38K) IN DIFFERENTIATING VASCULAR SMOOTH-MUSCLE CELLS AS A MEMBER OF A GROUP OF PROTEINS ASSOCIATED WITH TISSUE REMODELING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; BASEMENT-MEMBRANE; CAROTID-ARTERY; MESSENGER-RNA; ALPHA-ACTIN; EXPRESSION; MODULATION; PHENOTYPE; ATHEROSCLEROSIS; PROLIFERATION	Cultured aortic smooth muscle cells (SMC) exhibit morphological and phenotypic modulation characterized by a change from a substrate attached monolayer culture to a multilayered nodular cell culture in which SMC are imbedded into the extracellular matrix. Associated with nodule formation is a change in the pattern of SMC gene expression including increased expression of a well characterized marker of smooth muscle cell differentiation, SM alpha-actin, and a 38-kDa glycoprotein (gp38k). gp38k has sequence homology with proteins reported to be correlated with tissue remodeling. To characterize the gp38k mRNA we designed degenerate oligonucleotides based on partial polypeptide sequencing to select a cDNA encoding the full-length gp38k. Southern analysis indicates that porcine gp38k is present as a single copy gene. Northern analysis indicates that the increase in gp38k is correlated with an increase in the steady state level of gp38k mRNA; and is present in cultures that have initiated the formation of multilayered foci and nodules. The correlation between SMC differentiation and gp38k expression is further established by using culture conditions that facilitate SMC differentiation. Cultures seeded onto reconstituted extracellular matrix show rapid formation of nodules and increased expression of gp38k mRNA. Comparison of the gp38k and cDNA sequences with nucleotide and protein sequences available through GenBank. and SwissProt data banks revealed that molecules homologous to gp38k were present in human, mouse, bovine, and Drosophila tissues, suggesting that the gp38k may be a member of a gene family. Although a function for gp38k has not been identified, this report represents the first report of its correlation with a specific process important in phenotypic and morphological modulation of vascular SMC.	SUNY ALBANY,DEPT BIOL SCI,CTR CELL DIFFERENTIAT,ALBANY,NY 12222; AMER RED CROSS,DEPT BIOCHEM,ROCKVILLE,MD 20855	State University of New York (SUNY) System; State University of New York (SUNY) Albany; American Red Cross					NHLBI NIH HHS [HL40417] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040417] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AUSUBEL FM, 1987, CURRENT PROTOCOLS MO, V2; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; BIRUKOV KG, 1993, EXP CELL RES, V204, P46, DOI 10.1006/excr.1993.1007; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; BRENNAN MJ, 1983, DEV BIOL, V97, P391, DOI 10.1016/0012-1606(83)90095-7; BRENNAN MJ, 1982, J CELL PHYSIOL, V112, P284, DOI 10.1002/jcp.1041120219; CAMPBELL GR, 1985, EXP MOL PATHOL, V42, P139, DOI 10.1016/0014-4800(85)90023-1; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHAMLEYCAMPBELL JH, 1981, J CELL BIOL, V89, P379, DOI 10.1083/jcb.89.2.379; CHANG NCA, 1993, S27879 ACC; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; CHOMCZYNSKI P, 1993, MANUFACTURERS PROTOC; CLOWES AW, 1983, LAB INVEST, V49, P327; COLLARD MW, 1987, BIOCHEMISTRY-US, V26, P3297, DOI 10.1021/bi00386a008; CORJAY MH, 1989, J BIOL CHEM, V264, P10501; DAMORE PA, 1993, GROWTH FACTORS, V8, P61, DOI 10.3109/08977199309029135; DAVIDSON JM, 1993, J CELL PHYSIOL, V155, P149, DOI 10.1002/jcp.1041550119; DEMOULIERE A, 1992, EXP CELL RES, V201, P64; DIEMER V, 1992, J BIOL CHEM, V267, P5257; DILLEY RJ, 1987, ATHEROSCLEROSIS, V63, P99, DOI 10.1016/0021-9150(87)90109-2; DONNELLY KM, 1991, MOL ENDOCRINOL, V5, P356, DOI 10.1210/mend-5-3-356; FINGERLE J, 1989, P NATL ACAD SCI USA, V86, P8412, DOI 10.1073/pnas.86.21.8412; FRID MG, 1992, DEV BIOL, V158, P185; GIMBRONE MA, 1975, LAB INVEST, V33, P16; GLUKHOVA M, 1993, DEV BIOL, V157, P437, DOI 10.1006/dbio.1993.1147; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; HEDIN U, 1987, DIFFERENTIATION, V33, P239, DOI 10.1111/j.1432-0436.1987.tb01563.x; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; JENNE DE, 1992, TRENDS BIOCHEM SCI, V17, P154, DOI 10.1016/0968-0004(92)90325-4; JOHNSON DE, 1990, J AM COLL CARDIOL, V15, P419, DOI 10.1016/S0735-1097(10)80071-3; KIRKPATRICK RB, 1995, GENE, V153, P147, DOI 10.1016/0378-1119(94)00756-I; KOCHER O, 1991, LAB INVEST, V65, P459; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; KUNZELAMNN U, 1992, Cellular Physiology and Biochemistry, V2, P49, DOI 10.1159/000154625; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAJACK RA, 1987, J CELL BIOL, V105, P465, DOI 10.1083/jcb.105.1.465; MATSUDAIRA P, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P1; MAY JF, 1975, VIRCHOWS ARCH B, V18, P205; MILLIS AJT, 1986, J CELL PHYSIOL, V127, P366, DOI 10.1002/jcp.1041270304; MILLIS AJT, 1985, J BIOL CHEM, V260, P3754; MOSSE PRL, 1985, LAB INVEST, V53, P556; NOBUYOSHI M, 1991, J AM COLL CARDIOL, V17, P433, DOI 10.1016/S0735-1097(10)80111-1; OWENS GK, 1988, J CELL BIOL, V107, P771, DOI 10.1083/jcb.107.2.771; PAULY RR, 1992, CIRCULATION, V86, P68; RAINES EW, 1993, BRIT HEART J, V69, pS30; ROSENBERG ME, 1993, J LAB CLIN MED, V121, P205; ROSS R, 1971, J CELL BIOL, V50, P159, DOI 10.1083/jcb.50.1.159; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; ROVNER AS, 1986, J BIOL CHEM, V261, P4740; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SELL C, 1992, CELL BIOL INT REP, V16, P221, DOI 10.1016/S0309-1651(06)80124-4; SENDAI Y, 1994, BIOL REPROD, V50, P927, DOI 10.1095/biolreprod50.4.927; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; STRAUCH AR, 1992, J CELL BIOCHEM, V50, P266, DOI 10.1002/jcb.240500307; THOMASSALGAR S, 1994, J BIOL CHEM, V267, P17879; THYBERG J, 1983, DIFFERENTIATION, V25, P156; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; WADA KN, 1990, NUCLEIC ACIDS RES, V18, P2367, DOI 10.1093/nar/18.suppl.2367	60	193	210	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13076	13083		10.1074/jbc.270.22.13076	http://dx.doi.org/10.1074/jbc.270.22.13076			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768902	hybrid			2022-12-27	WOS:A1995RB43900023
J	DEER, JLR; HURLEY, JB; YARFITZ, SL				DEER, JLR; HURLEY, JB; YARFITZ, SL			G-PROTEIN CONTROL OF DROSOPHILA PHOTORECEPTOR PHOSPHOLIPASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOLIGO-FORBESI PHOTORECEPTORS; GTP-BINDING PROTEIN; ALPHA-SUBUNITS; NORPA GENE; MOLECULAR-CLONING; PH DOMAIN; MELANOGASTER; PURIFICATION; EXPRESSION; ACTIVATION	Light stimulates phosphatidylinositol bisphosphate phospholipase C (PLC) activity in Drosophila photoreceptors. We have investigated the mechanism of this reaction by assaying PLC activity in Drosophila head membranes using exogenous phospholipid substrates. PLC activation depends on the photoconversion of rhodopsin to metarhodopsin and is reduced in norpA(EE5) PLC and ninaE(P332) rhodopsin mutants. NorpA PLC is stimulated by light at free Ca2+ concentrations between 10 nM and 1 mu M. This finding is consistent with a Ca2+ mediated positive feedback mechanism that contributes to the rapid temporal response of invertebrate photoreceptor cells. The guanyl nucleotide dependence of light-stimulated PLC activity indicates that a G protein regulates NorpA. This was confirmed by the observation that light stimulation of PLC activity is deficient in mutants that lack the eye-specific G protein beta subunit G beta e. These results indicate that G beta e functions as the beta subunit of the G protein coupling rhodopsin to NorpA PLC.	UNIV WASHINGTON, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NEI NIH HHS [EY06641] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CHEN CK, 1994, INVEST OPHTH VIS SCI, V35, P1485; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; EBERHARD DA, 1988, TRENDS NEUROSCI, V11, P517, DOI 10.1016/0166-2236(88)90174-9; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; FEIN A, 1986, SCIENCE, V232, P1543, DOI 10.1126/science.3487116; FERREIRA PA, 1993, P NATL ACAD SCI USA, V90, P6042, DOI 10.1073/pnas.90.13.6042; GUILLON G, 1992, CELL SIGNAL, V4, P11, DOI 10.1016/0898-6568(92)90004-R; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; JHON DY, 1993, J BIOL CHEM, V268, P6654; JIANG YW, 1994, BIOCHEM BIOPH RES CO, V203, P1195, DOI 10.1006/bbrc.1994.2309; LEE CW, 1993, J BIOL CHEM, V268, P21318; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LOTT JS, 1992, FEBS LETT, V312, P241, DOI 10.1016/0014-5793(92)80943-B; Maniatis T., 1982, MOL CLONING; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; MINKE B, 1992, SENSORY TRANSDUCTION, P202; MINTA A, 1989, J BIOL CHEM, V264, P8171; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; NAGY K, 1991, Q REV BIOPHYS, V24, P165, DOI 10.1017/S0033583500003401; NOBES C, 1992, BIOCHEM J, V287, P545, DOI 10.1042/bj2870545; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; PARKER PJ, 1994, TRENDS BIOCHEM SCI, V19, P54, DOI 10.1016/0968-0004(94)90031-0; PAYNE R, 1986, J GEN PHYSIOL, V87, P243, DOI 10.1085/jgp.87.2.243; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; POTTINGER JDD, 1991, BIOCHEM J, V279, P323, DOI 10.1042/bj2790323; RANGANATHAN R, 1994, NEURON, V13, P837, DOI 10.1016/0896-6273(94)90250-X; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; RYBA NJ, 1993, BIOCHEM J, V292, P333, DOI 10.1042/bj2920333; SCHNEUWLY S, 1991, J BIOL CHEM, V266, P24314; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; TAYLOR SJ, 1987, BIOCHEM J, V248, P791, DOI 10.1042/bj2480791; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TOYOSHIMA S, 1990, J BIOL CHEM, V265, P14842; WOLFGANG WJ, 1990, J NEUROSCI, V10, P1014; WU DQ, 1992, J BIOL CHEM, V267, P1811; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; YARFITZ SL, 1994, J BIOL CHEM, V269, P30340; YOSHIOKA T, 1985, J BIOCHEM-TOKYO, V97, P1251, DOI 10.1093/oxfordjournals.jbchem.a135171; ZHU LQ, 1993, J BIOL CHEM, V268, P15994; ZINKL GM, 1990, VISUAL NEUROSCI, V5, P429, DOI 10.1017/S0952523800000559; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	52	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12623	12628		10.1074/jbc.270.21.12623	http://dx.doi.org/10.1074/jbc.270.21.12623			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759511	hybrid			2022-12-27	WOS:A1995QZ71100046
J	BECKER, J; MELCHIOR, F; GERKE, V; BISCHOFF, FR; PONSTINGL, H; WITTINGHOFER, A				BECKER, J; MELCHIOR, F; GERKE, V; BISCHOFF, FR; PONSTINGL, H; WITTINGHOFER, A			RNA1 ENCODES A GTPASE-ACTIVATING PROTEIN-SPECIFIC FOR GSP1P, THE RAN/TC4 HOMOLOG OF SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CHROMOSOME CONDENSATION; BINDING PROTEIN; ESCHERICHIA-COLI; YEAST MUTANT; GENE-PRODUCT; RCC1; RAS; REGULATOR; INITIATION	Ran/TC4 is a res-related GTP-binding protein predominantly located in the nucleus, Ran/TC4 is essential for nuclear transport and is involved in mitotic control, In Saccharomyces cerevisiae a gene highly homologous to Ran/TC4 has been identified and named GSP1. Like all ras-related GTP-binding proteins, Gsp1p undergoes cycles of GTP hydrolysis and GDP/GTP exchange, The switching between the two different nucleotide bound states regulates the function of these GTP-binding proteins, Here we identify the product of the yeast RNA1 gene as the GTPase-activating protein (GAP) of Gsp1p, RNA1 belongs to a group of genes which are conserved in a variety of different organisms, We have expressed and purified recombinant Gsp1p and Rna1p from Escherichia coli. The GTPase activity of Gsp1p is stimulated 10(7)-fold by Rna1p. In addition, we find that the previously identified human RanGAP1 and rna1p from Schizosaccharomyces pombe are also able to induce GTPase activity of Gsp1p, The GTP hydrolysis of Ran is induced by RanGAP1 and rna1p but not by Rna1p. Implications for the suggested functions of Ran/TC4/Gsp1p in nuclear transport and mitotic control are discussed.	UNIV MUNSTER, ZENTRUM DERMATOL, D-48149 MUNSTER, GERMANY; Scripps Res Inst, DEPT CELL BIOL, LA JOLLA, CA 92037 USA; SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA; DEUTSCH KREBSFORSCHUNGSZENTRUM, MOLEC BIOL MITOSIS PROJECT, D-69120 HEIDELBERG, GERMANY	University of Munster; Scripps Research Institute; Scripps Research Institute; Helmholtz Association; German Cancer Research Center (DKFZ)	BECKER, J (corresponding author), MAX PLANCK INST MOLEK PHYSIOL, STRUKTURELLE BIOL ABT, POB 102664, D-44026 DORTMUND, GERMANY.		Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797				AEBI M, 1990, MOL GEN GENET, V224, P72, DOI 10.1007/BF00259453; BELHUMEUR P, 1993, MOL CELL BIOL, V13, P2152, DOI 10.1128/MCB.13.4.2152; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLARKE PR, 1995, IN PRESS J CELL SCI; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; DEGREGORI J, 1994, GENE DEV, V8, P265, DOI 10.1101/gad.8.3.265; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; FEUERSTEIN J, 1987, J BIOL CHEM, V262, P8455; FLEISCHMANN M, 1991, MOL GEN GENET, V227, P417, DOI 10.1007/BF00273932; FORRESTER W, 1992, GENE DEV, V6, P1914, DOI 10.1101/gad.6.10.1914; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; HOPPER AK, 1978, CELL, V14, P211, DOI 10.1016/0092-8674(78)90108-3; HOPPER AK, 1990, J CELL BIOL, V111, P309, DOI 10.1083/jcb.111.2.309; HUTCHISON HT, 1969, J BACTERIOL, V99, P807, DOI 10.1128/JB.99.3.807-814.1969; JOHN J, 1988, J BIOL CHEM, V263, P11792; KADOWAKI T, 1993, EMBO J, V12, P2929, DOI 10.1002/j.1460-2075.1993.tb05955.x; KLEBE C, 1993, BIOCHEMISTRY-US, V32, P11923, DOI 10.1021/bi00095a023; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; KORNBLUTH S, 1994, J CELL BIOL, V125, P705, DOI 10.1083/jcb.125.4.705; LOUNSBURY KM, 1994, J BIOL CHEM, V269, P11285; MATSUMOTO T, 1991, CELL, V66, P347, DOI 10.1016/0092-8674(91)90624-8; MELCHIOR F, 1993, MOL BIOL CELL, V4, P569, DOI 10.1091/mbc.4.6.569; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MOORE MS, 1994, TRENDS BIOCHEM SCI, V19, P211, DOI 10.1016/0968-0004(94)90024-8; MOORE MS, 1992, CELL, V69, P939, DOI 10.1016/0092-8674(92)90613-H; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; PARLATO G, 1981, FEBS LETT, V125, P257, DOI 10.1016/0014-5793(81)80733-8; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; SAZER S, 1994, EMBO J, V13, P606, DOI 10.1002/j.1460-2075.1994.tb06298.x; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; SEKI T, 1992, MOL BIOL CELL, V3, P1373, DOI 10.1091/mbc.3.12.1373; SHIOKAWA K, 1974, P NATL ACAD SCI USA, V71, P2658, DOI 10.1073/pnas.71.7.2658; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TRAGLIA HM, 1989, MOL CELL BIOL, V9, P2989, DOI 10.1128/MCB.9.7.2989; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206	50	106	106	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11860	11865		10.1074/jbc.270.20.11860	http://dx.doi.org/10.1074/jbc.270.20.11860			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744835	hybrid			2022-12-27	WOS:A1995QY73600031
J	KRNACIK, MJ; LI, S; LIAO, J; ROSEN, JM				KRNACIK, MJ; LI, S; LIAO, J; ROSEN, JM			POSITION-INDEPENDENT EXPRESSION OF WHEY ACIDIC PROTEIN TRANSGENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; HIGH-LEVEL EXPRESSION; CASEIN GENE-EXPRESSION; MICE; REGION; ENHANCER; CELLS; ASSAY; TRANSCRIPTION; ORGANIZATION	The expression of a 3-kilobase genomic rat whey acidic protein (WAP) clone (-949/+2020) in transgenic mice has been demonstrated previously to be copy number dependent and independent of the site of integration (Dale, T., Krnacik, M. J., Schmidhauser, C., Yang, C. Q.-L., Bissell, M. J., and Rosen, J. M. (1992) Mol. Cell. Biol, 12, 905-914), The present study demonstrated that position-independent expression of the rat WAP -949/ +2020 transgene was dependent on transgene spacing, Position-independent expression also was inhibited by an internal replacement of 49 base pair within the conserved GC-rich 3'-untranslated region (3'-UTR) with an identically sized nonspecific DNA sequence, Using electrophoretic mobility shift assays, nuclear factors isolated from mouse and human cells were shown to associate specifically with the rWAP 3'-UTR DNA, but not with the 3'-UTR containing the internal replacement or specific point mutations, Since a single copy of the 3'UTR inserted 5' of the promoter could not rescue the 3'-UTR deletion, the 3'-UTR element does not appear to be functioning as either a classic enhancer or insulator element, However, the level of expression of rWAP transgenes was correlated with transgene association with the chromosomal scaffold in vivo.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030	Baylor College of Medicine					NCI NIH HHS [CA 16303] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016303, R37CA016303] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE M, 1990, J CELL BIOL, V111, P1197, DOI 10.1083/jcb.111.3.1197; ALTIOK S, 1994, MOL CELL BIOL, V14, P6004, DOI 10.1128/MCB.14.9.6004; ARONOW BJ, 1992, MOL CELL BIOL, V12, P4170, DOI 10.1128/MCB.12.9.4170; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; BAYNA EM, 1990, NUCLEIC ACIDS RES, V18, P2977, DOI 10.1093/nar/18.10.2977; BONIFER C, 1990, EMBO J, V9, P2843, DOI 10.1002/j.1460-2075.1990.tb07473.x; BURDON T, 1991, J BIOL CHEM, V266, P6909; CARTER KC, 1993, SCIENCE, V259, P1330, DOI 10.1126/science.8446902; CHAMBERLAIN JW, 1991, MOL CELL BIOL, V11, P3564, DOI 10.1128/MCB.11.7.3564; CHEN LH, 1989, CELL REGUL, V1, P45, DOI 10.1091/mbc.1.1.45; CHUNG JH, 1994, CELL, V74, P505; CIEJEK EM, 1984, NATURE, V306, P607; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; DALE TC, 1992, MOL CELL BIOL, V12, P905, DOI 10.1128/MCB.12.3.905; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DOPPLER W, 1991, MOL ENDOCRINOL, V5, P1624, DOI 10.1210/mend-5-11-1624; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GREENBERG NM, 1991, P NATL ACAD SCI USA, V88, P8327, DOI 10.1073/pnas.88.19.8327; GREENBERG NM, 1994, MOL ENDOCRINOL, V8, P230, DOI 10.1210/me.8.2.230; GREER P, 1990, MOL CELL BIOL, V10, P2521, DOI 10.1128/MCB.10.6.2521; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HOBBS AA, 1982, J BIOL CHEM, V257, P3598; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LEE KF, 1988, NUCLEIC ACIDS RES, V16, P1027, DOI 10.1093/nar/16.3.1027; LI S, 1995, MOL CELL BIOL, V15, P2063; LI S, 1994, J BIOL CHEM, V269, P14235; MCKENZIE RM, 1978, J DAIRY SCI, V61, P723, DOI 10.3168/jds.S0022-0302(78)83639-X; MCKNIGHT RA, 1992, P NATL ACAD SCI USA, V89, P6943, DOI 10.1073/pnas.89.15.6943; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; REITMAN M, 1993, MOL CELL BIOL, V13, P3990, DOI 10.1128/MCB.13.7.3990; ROBINSON SI, 1982, CELL, V28, P99, DOI 10.1016/0092-8674(82)90379-8; Sambrook J, 1989, MOL CLONING LABORATO; SPECTOR DL, 1993, BIOCHEM SOC T, V21, P918, DOI 10.1042/bst0210918; STIEF A, 1989, NATURE, V341, P343, DOI 10.1038/341343a0; VILOTTE JL, 1989, EUR J BIOCHEM, V186, P43, DOI 10.1111/j.1432-1033.1989.tb15175.x; WHITELAW CB, 1992, BIOCHEM J, V285, P31; XING YG, 1993, SCIENCE, V259, P1326, DOI 10.1126/science.8446901	42	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11119	11129		10.1074/jbc.270.19.11119	http://dx.doi.org/10.1074/jbc.270.19.11119			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744742	hybrid			2022-12-27	WOS:A1995QX86500018
J	TORII, S; BANNO, T; WATANABE, T; IKEHARA, Y; MURAKAMI, K; NAKAYAMA, K				TORII, S; BANNO, T; WATANABE, T; IKEHARA, Y; MURAKAMI, K; NAKAYAMA, K			CYTOTOXICITY OF BREFELDIN-A CORRELATES WITH ITS INHIBITORY EFFECT ON MEMBRANE-BINDING OF COP COAT PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; TRANS-GOLGI NETWORK; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; ORGANELLE STRUCTURE; GUANINE-NUCLEOTIDE; SECRETORY PROTEINS; RAT HEPATOCYTES; PHOSPHOLIPASE-D; CELL-SURFACE	The fungal metabolite brefeldin A (BFA) causes the inhibition of protein secretion and the disruption of the structure and function of organelles along the exocytic and endocytic pathways including the Golgi complex. Such effects of BFA have been ascribed in large part to its ability to prevent recruitment of cytosolic coat proteins onto organelle membranes. Here we show that mammalian cell lines differ from one another with respect to sensitivity to this drug. The BFA sensitivity of a given cell line appears to be dependent on the species or the order from which the cell line originates, rather than on the cell line itself. In each cell line, the dose of EFA required for inhibition of cell growth and of protein secretion correlates with the dose required for inhibition of binding of beta-COP, a coat protein of COP-coated vesicles, but not that for inhibition of binding of gamma-adaptin, a component of HA-I/AP-1 adaptor of clathrin-coated vesicles. These observations suggest that: (i) there are at least two targets for EFA that differ from each other in sensitivity to this drug, (ii) the difference in the sensitivity to BFA of the beta-COP binding is determined by the difference in the structure of a target protein for this drug, and (iii) the cytotoxicity of BFA is ascribed mainly to its inhibitory effect on the membrane binding of COP-coat proteins.	UNIV TSUKUBA,INST BIOL SCI,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,CTR GENE EXPT,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,INST BASIC MED SCI,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,INST APPL BIOCHEM,TSUKUBA,IBARAKI 305,JAPAN; FUKUOKA UNIV,SCH MED,DEPT BIOCHEM,JONAN KU,FUKUOKA 81401,JAPAN	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Fukuoka University			Nakayama, Kazuhisa/ABF-2924-2020	Watanabe, Tsuyoshi/0000-0002-6094-7728; Nakayama, Kazuhisa/0000-0001-7701-7183				AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; CHEN C, 1992, EXP CELL RES, V203, P321, DOI 10.1016/0014-4827(92)90005-S; COCKCROFT S, 1993, SCIENCE, V263, P523; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; DONALDSON JG, 1991, J CELL BIOL, V111, P2295; FISHMAN PH, 1992, FEBS LETT, V314, P371, DOI 10.1016/0014-5793(92)81508-J; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; JACKSON CL, 1994, GENETICS, V137, P423; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KAHN RA, 1993, CELL, V75, P1045, DOI 10.1016/0092-8674(93)90314-G; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KREIS TE, 1994, CURR OPIN CELL BIOL, V6, P533, DOI 10.1016/0955-0674(94)90073-6; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LIPPINCOTTSCHWA.J, 1990, CELL, V60, P821; LIPPINCOTTSCHWA.J, 1991, CELL, V67, P601; LIPPINCOTTSCHWARTZ, 1989, CELL, V56, P801; LOW SH, 1991, J BIOL CHEM, V266, P17729; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; MELLOR H, 1994, FEBS LETT, V350, P143, DOI 10.1016/0014-5793(94)00756-X; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; ODA K, 1987, FEBS LETT, V214, P135, DOI 10.1016/0014-5793(87)80028-5; ORCI L, 1991, CELL, V64, P1183; PAYNE GS, 1989, SCIENCE, V245, P1358, DOI 10.1126/science.2675311; PELHAM HRB, 1994, CELL, V79, P1125, DOI 10.1016/0092-8674(94)90002-7; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; REAVES B, 1992, J CELL BIOL, V116, P85, DOI 10.1083/jcb.116.1.85; ROBINSON M S, 1992, Trends in Cell Biology, V2, P293, DOI 10.1016/0962-8924(92)90118-7; ROBINSON MS, 1990, J CELL BIOL, V111, P2319, DOI 10.1083/jcb.111.6.2319; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; Schmid SL, 1993, CURR OPIN CELL BIOL, V5, P621, DOI 10.1016/0955-0674(93)90131-9; SCHURMANN A, 1994, J BIOL CHEM, V269, P15683; SEAMAN MNJ, 1994, CURR BIOL, V4, P926, DOI 10.1016/S0960-9822(00)00208-6; SEGUCHI T, 1992, J BIOL CHEM, V267, P11626; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; STEMNES MA, 1993, CELL, V73, P999; TAKATSUKI A, 1985, AGR BIOL CHEM TOKYO, V49, P899, DOI 10.1080/00021369.1985.10866826; TAUCHIYA M, 1991, J BIOL CHEM, V266, P2772; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; TURI TG, 1994, J BIOL CHEM, V269, P24229; WONG DH, 1992, J CELL BIOL, V117, P1171, DOI 10.1083/jcb.117.6.1171; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; YAN JP, 1994, J CELL BIOL, V126, P65, DOI 10.1083/jcb.126.1.65	56	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11574	11580		10.1074/jbc.270.19.11574	http://dx.doi.org/10.1074/jbc.270.19.11574			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744796	hybrid			2022-12-27	WOS:A1995QX86500077
J	GIARDINA, C; LIS, JT				GIARDINA, C; LIS, JT			SODIUM-SALICYLATE AND YEAST HEAT-SHOCK GENE-TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROMOTER; ASPIRIN; ACTIVATION; EXPRESSION; RESISTANCE; INVIVO; CELLS; DRUGS; ACID	The anti-inflammatory drug sodium salicylate modulates the activity of specific transcription factors in humans. Here we show that salicylate and sorbate, another organic acid, stimulate DNA binding by yeast heat shock transcription factor (HSF) in vivo. Surprisingly, salicylate inhibits heat shock gene transcription even in cells induced by a prior heat shock. This inhibition of transcription occurs at a step after HSF and transcription factor IID binding but before promoter melting by RNA polymerase. Salicylate appears to generate a tight binding but activation-impotent HSF by cytoplasmic acidification, since inhibiting proton efflux from cells triggers this same DNA binding and inhibition of heat shock gene expression.	CORNELL UNIV,BIOCHEM MOLEC & CELL BIOL SECT,ITHACA,NY 14853	Cornell University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMSON S, 1985, P NATL ACAD SCI USA, V82, P7227, DOI 10.1073/pnas.82.21.7227; ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; CHENG LL, 1994, MICROBIOL-SGM, V140, P1085, DOI 10.1099/13500872-140-5-1085; DEGITZ K, 1991, J BIOL CHEM, V266, P14024; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; FERREIRA SH, 1974, ANNU REV PHARMACOL, V14, P57, DOI 10.1146/annurev.pa.14.040174.000421; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; GRILLI M, 1993, INT REV CYTOL, V143, P1; JURIVICH DA, 1994, P NATL ACAD SCI USA, V91, P2280, DOI 10.1073/pnas.91.6.2280; JURIVICH DA, 1992, SCIENCE, V255, P1243, DOI 10.1126/science.1546322; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; KREBS HA, 1983, BIOCHEM J, V214, P657, DOI 10.1042/bj2140657; LEE MS, 1991, EMBO J, V10, P607, DOI 10.1002/j.1460-2075.1991.tb07988.x; LINDQUIST S, 1988, ANNU REV GENET, V55, P1151; MACILWAIN C, 1993, NATURE, V364, P369; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; MORIMOTO RI, 1990, BIOL HEAT SHOCK PROT, P417; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; PANARETOU B, 1990, J GEN MICROBIOL, V136, P1763, DOI 10.1099/00221287-136-9-1763; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; WEISSMANN G, 1991, SCI AM, V264, P84, DOI 10.1038/scientificamerican0191-84	26	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10369	10372		10.1074/jbc.270.18.10369	http://dx.doi.org/10.1074/jbc.270.18.10369			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737966	hybrid			2022-12-27	WOS:A1995QW60100003
J	BRENNAN, J; TAKEI, F; WONG, S; MAGER, DL				BRENNAN, J; TAKEI, F; WONG, S; MAGER, DL			CARBOHYDRATE-RECOGNITION BY A NATURAL-KILLER-CELL RECEPTOR, LY-49C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INTEGRAL MEMBRANE-PROTEINS; MAJOR HISTOCOMPATIBILITY ANTIGENS; CLASS-I; ANIMAL LECTINS; MULTIGENE FAMILY; MOUSE NKR-P1; GENE-COMPLEX; IDENTIFICATION; REJECTION; MOLECULE	Ly-49 represents a family of type II transmembrane proteins containing C-type lectin domains. At least two members of the Ly-49 family, namely Ly-49A and Ly-49C, are expressed by distinct subsets of natural killer cells and bind to class I major histocompatibility complex antigens on the surface of target cells. In this report we have established that Ly-49C mediates carbohydrate recognition. The sulfated glycans fucoidan, lambda-carrageenan, and dextran sulfate were found to be potent inhibitors of Ly-49C-mediated cell adhesion, whereas other polysaccharides of similar size, charge, or sulfate content were noninhibitory. Ah of the polysaccharides which inhibited Ly-49C adhesion also blocked the binding of the antibody 5E6 to Ly-49C-expressing COS cells, confirming the direct protein-carbohydrate interaction. The enzymatic removal of specific carbohydrates from the target cell surface has shown that Ly-49C-mediated adhesion is not sialic acid-dependent, but is significantly decreased following fucosidase treatment. These results suggest an important role for carbohydrate recognition by natural killer cell receptors.	UNIV BRITISH COLUMBIA, DEPT MED GENET, VANCOUVER, BC V5Z 1L3, CANADA; UNIV BRITISH COLUMBIA, DEPT PATHOL, VANCOUVER, BC V5Z 1L3, CANADA; UNIV OXFORD, INST GLYOBIOL, DEPT BIOCHEM, OXFORD OX1 3QU, ENGLAND	University of British Columbia; University of British Columbia; University of Oxford	BRENNAN, J (corresponding author), BRITISH COLUMBIA CANC AGCY, TERRY FOX LAB, 601 W 10TH AVE, VANCOUVER, BC V5Z 1L3, CANADA.			Takei, Fumio/0000-0002-3620-5046; Mager, Dixie/0000-0002-5955-2550				ALTINGMEES M, 1986, MOL IMMUNOL, V23, P847, DOI 10.1016/0161-5890(86)90070-2; BEZOUSKA K, 1994, J BIOL CHEM, V269, P16945; BEZOUSKA K, 1994, NATURE, V372, P150, DOI 10.1038/372150a0; BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; CHAMBERS WH, 1993, GLYCOBIOLOGY, V3, P9, DOI 10.1093/glycob/3.1.9; CHAN PY, 1989, J IMMUNOL, V142, P1727; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; DEANGELIS PL, 1987, J BIOL CHEM, V262, P13946; DOUGHERTY GJ, 1994, J BIOL CHEM, V269, P9074; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; GIORDA R, 1991, J IMMUNOL, V147, P1701; GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KIMBALL ES, 1983, CONTEMP TOP MOLEC IM, V9, P1; LANIER LL, 1986, J IMMUNOL, V137, P2735; LANIER LL, 1994, J IMMUNOL, V153, P2417; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MCCOY J P JR, 1991, Glycobiology, V1, P321, DOI 10.1093/glycob/1.4.321; MISRA DN, 1987, IMMUNOGENETICS, V26, P204, DOI 10.1007/BF00346513; PARISH CR, 1988, J IMMUNOL, V141, P3498; PATANKAR MS, 1993, J BIOL CHEM, V268, P21770; ROCHON YP, 1994, J IMMUNOL, V152, P1385; SENTMAN CL, 1994, J IMMUNOL, V153, P5482; SENTMAN CL, 1989, J EXP MED, V170, P191, DOI 10.1084/jem.170.1.191; SMITH HRC, 1994, J IMMUNOL, V153, P1068; SWIEDLER SJ, 1985, J BIOL CHEM, V260, P4046; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; WONG S, 1991, J IMMUNOL, V147, P1417; YEDNOCK TA, 1989, ADV IMMUNOL, V44, P313, DOI 10.1016/S0065-2776(08)60645-8; YEDNOCK TA, 1987, J CELL BIOL, V104, P725, DOI 10.1083/jcb.104.3.725; YOKOYAMA WM, 1990, J IMMUNOL, V145, P2353; YOKOYAMA WM, 1989, J IMMUNOL, V143, P1379; YOKOYAMA WM, 1991, J IMMUNOL, V147, P3229; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201	43	73	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9691	9694		10.1074/jbc.270.17.9691	http://dx.doi.org/10.1074/jbc.270.17.9691			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730344				2022-12-27	WOS:A1995QV41700001
J	HUSAIN, I; TOMKINSON, AE; BURKHART, WA; MOYER, MB; RAMOS, W; MACKEY, ZB; BESTERMAN, JM; CHEN, JW				HUSAIN, I; TOMKINSON, AE; BURKHART, WA; MOYER, MB; RAMOS, W; MACKEY, ZB; BESTERMAN, JM; CHEN, JW			PURIFICATION AND CHARACTERIZATION OF DNA-LIGASE-III FROM BOVINE TESTES - HOMOLOGY WITH DNA-LIGASE-II AND VACCINIA DNA-LIGASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER EMBRYOS; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; DAMAGING AGENTS; STRAIN 46BR; CALF THYMUS; CELL-CYCLE; GENE; RECOMBINATION; REPLICATION	Mammalian cell nuclei contain three biochemically distinct DNA ligases. In the present study we have found high levels of DNA ligase I and DNA ligase III activity in bovine testes and have purified DNA ligase III to near homogeneity. The high level of DNA ligase III suggests a role for this enzyme in meiotic recombination. In assays measuring the fidelity of DNA joining, we detected no significant differences between DNA ligases II and III, whereas DNA ligase I was clearly a more faithful enzyme and was particularly sensitive to 3' mismatches. Amino acid sequences of peptides derived from DNA ligase III demonstrated that this enzyme, like DNA ligase II, is highly homologous with vaccinia DNA ligase. The absence of unambiguous differences between homologous peptides from DNA ligases II and III (10 pairs of peptides, 136 identical amino acids) indicates that these enzymes are either derived from a common precursor polypeptide or are encoded from the same gene by alternative splicing. Based on similarities in amino acid sequence and biochemical properties, we suggest that DNA ligases II and III. Drosophila DNA ligase II, and the DNA ligases encoded by the pox viruses constitute a distinct family of DNA ligases that perform specific roles in DNA repair and genetic recombination.	GLAXO INC,RES INST,DEPT CELL BIOL,RES TRIANGLE PK,NC 27709; GLAXO INC,RES INST,DEPT BIOANALYT & STRUCT CHEM,RES TRIANGLE PK,NC 27709; UNIV TEXAS,HLTH SCI CTR,CTR MOLEC MED,INST BIOTECHNOL,SAN ANTONIO,TX 78245	GlaxoSmithKline; GlaxoSmithKline; University of Texas System; University of Texas Health San Antonio				Mackey, Zachary/0000-0002-4533-0973	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047251, R01GM047251] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47251] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGUADO B, 1992, J GEN VIROL, V73, P2887, DOI 10.1099/0022-1317-73-11-2887; BARKER DG, 1985, NUCLEIC ACIDS RES, V13, P8323, DOI 10.1093/nar/13.23.8323; BARKER DG, 1987, EUR J BIOCHEM, V162, P658; BARNES DE, 1990, P NATL ACAD SCI USA, V87, P6679, DOI 10.1073/pnas.87.17.6679; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKHART W, 1993, TECHNIQUES PROTEIN C, V4, P399; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; CHAN JYH, 1984, MUTAT RES, V131, P209, DOI 10.1016/0167-8817(84)90027-0; COLINAS RJ, 1990, VIROLOGY, V179, P267, DOI 10.1016/0042-6822(90)90295-3; CREISSEN D, 1982, NATURE, V296, P271, DOI 10.1038/296271a0; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; HENDERSON LM, 1985, P NATL ACAD SCI USA, V82, P2044, DOI 10.1073/pnas.82.7.2044; HIGASHITANI A, 1990, CELL STRUCT FUNCT, V15, P67, DOI 10.1247/csf.15.67; JESSBERGER R, 1993, J BIOL CHEM, V268, P15070; JOHNSTON LH, 1986, EXP CELL RES, V165, P541, DOI 10.1016/0014-4827(86)90606-3; KERR SM, 1991, EMBO J, V10, P4343, DOI 10.1002/j.1460-2075.1991.tb05012.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKO DD, 1990, J BIOL CHEM, V265, P12618; LEHMAN IR, 1974, SCIENCE, V186, P790; LEHMANN AR, 1988, CANCER RES, V48, P6343; LI CG, 1994, NUCLEIC ACIDS RES, V22, P632, DOI 10.1093/nar/22.4.632; LI J-H, 1989, Molecular Toxicology, V2, P1; LJUNGQUIST S, 1994, MUTAT RES, V314, P177, DOI 10.1016/0921-8777(94)90081-7; LONN U, 1989, CARCINOGENESIS, V10, P981, DOI 10.1093/carcin/10.6.981; MALKAS LH, 1990, BIOCHEMISTRY-US, V29, P6362, DOI 10.1021/bi00479a004; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; PARKS RJ, 1994, VIROLOGY, V202, P642, DOI 10.1006/viro.1994.1385; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; RABIN BA, 1986, J BIOL CHEM, V261, P637; RESNICK M A, 1987, P157; ROBERTS E, 1994, J BIOL CHEM, V269, P3789; SMITH GL, 1989, NUCLEIC ACIDS RES, V17, P9021; SODERHALL S, 1976, NATURE, V260, P640, DOI 10.1038/260640a0; SODERHALL S, 1975, J BIOL CHEM, V250, P8438; SODERHALL S, 1973, BIOCHEM BIOPH RES CO, V53, P910, DOI 10.1016/0006-291X(73)90178-2; SQUIRES S, 1983, CARCINOGENESIS, V4, P565, DOI 10.1093/carcin/4.5.565; TAKAHASHI M, 1987, FEBS LETT, V213, P345, DOI 10.1016/0014-5793(87)81520-X; TEO IA, 1983, MUTAT RES, V107, P371, DOI 10.1016/0027-5107(83)90177-X; TERAOKA H, 1986, J BIOL CHEM, V261, P6888; TERAOKA H, 1982, J BIOL CHEM, V257, P4758; TOMKINSON AE, 1993, NUCLEIC ACIDS RES, V21, P5425, DOI 10.1093/nar/21.23.5425; TOMKINSON AE, 1991, J BIOL CHEM, V266, P21728; TOMKINSON AE, 1990, J BIOL CHEM, V265, P12611; TOMKINSON AE, 1992, BIOCHEMISTRY-US, V31, P11762, DOI 10.1021/bi00162a013; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; WAGA S, 1994, J BIOL CHEM, V269, P10923; WANG YCJ, 1994, J BIOL CHEM, V269, P31923; YOO HY, 1992, BIOCHEM BIOPH RES CO, V186, P900, DOI 10.1016/0006-291X(92)90831-5	49	65	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9683	9690		10.1074/jbc.270.16.9683	http://dx.doi.org/10.1074/jbc.270.16.9683			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721901	hybrid			2022-12-27	WOS:A1995QU08900092
J	LOLKEMA, JS; POOLMAN, B				LOLKEMA, JS; POOLMAN, B			UNCOUPLING IN SECONDARY TRANSPORT PROTEINS - A MECHANISTIC EXPLANATION FOR MUTANTS OF LAC PERMEASE WITH AN UNCOUPLED PHENOTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI LACTOSE CARRIER; ESCHERICHIA-COLI; PROTONS; HISTIDINE-322; PHENYLALANINE; REPLACEMENT; TYROSINE; KINETICS; EFFLUX; PH	The kinetic behavior of a H+-substrate symporter has been studied in which in addition to the unloaded (E) and fully loaded states (E.S.H) of the carrier also one of the binary complexes (E.S or E.H) may reorient its binding sites. This results in two types of uncoupled mutants, the ES leak and the EH leak type, The effects of pH and substrate concentration (pS) on the coupling of transport have been analyzed, In the enzyme with the ES leak, the proton:substrate stoichiometry (v(H+)lv(S)) and the substrate accumulation levels decrease sigmoidally from fully coupled at low pH to completely uncoupled at high pH. Importantly, the coupling inferred from initial rate measurements is higher than from steady state accumulation levels. In the enzyme with the EH leak, the coupling inferred from the accumulation levels increases hom no coupling at low pH to full coupling at high pH and saturating substrate concentration, The v(H+)/v(S) increases sigmoidally with pH from <1 to >1 and is highly dependent on pS. At each pH value a substrate concentration can be found that results in apparent complete coupling between the two fluxes. The ES leak and the ER leak mutants provide a mechanism for substrate-induced and substrate-inhibited proton leakage, respectively, Furthermore, substrate efflux down a concentration gradient is inhibited by a membrane potential (inside negative) under uncoupled conditions in the case of an ES leak but not in the case of an EH leak. The properties of the mutants mimic those of various transport mutants that have been described, in particular mutants of the lactose transport protein of Escherichia coli. The analysis offers general means for targeted experimentation, which allows discrimination between various types of transport mutants.			LOLKEMA, JS (corresponding author), UNIV GRONINGEN,GRONINGEN BIOMOLEC SCI & BIOTECHNOL INST,DEPT MICROBIOL,KERKLAAN 30,9751 NN HAREN,NETHERLANDS.							BROOKER RJ, 1985, J BIOL CHEM, V260, P6181; BROOKER RJ, 1990, J BIOL CHEM, V265, P4155; BROOKER RJ, 1991, J BIOL CHEM, V266, P4131; FRANCO PJ, 1991, J BIOL CHEM, V266, P6693; GARCIA ML, 1983, BIOCHEMISTRY-US, V22, P2524, DOI 10.1021/bi00279a033; KABACK HR, 1990, BACTERIA, V12, P151; KING SC, 1989, J BIOL CHEM, V264, P7390; KING SC, 1990, J BIOL CHEM, V265, P3153; KING SC, 1990, J BIOL CHEM, V265, P9645; KRUPKA RM, 1993, BIOCHIM BIOPHYS ACTA, V1183, P105, DOI 10.1016/0005-2728(93)90009-5; LOLKEMA JS, 1993, J BIOL CHEM, V268, P17850; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; MATZKE EA, 1992, J BIOL CHEM, V267, P19095; PAGE MGP, 1987, BIOCHIM BIOPHYS ACTA, V897, P112, DOI 10.1016/0005-2736(87)90319-1; POOLMAN B, 1993, BIOCHIM BIOPHYS ACTA, V1183, P5, DOI 10.1016/0005-2728(93)90003-X; PUTTNER IB, 1989, BIOCHEMISTRY-US, V28, P2525, DOI 10.1021/bi00432a027; VIITANEN P, 1993, BIOCHEMISTRY-US, V22, P2524	17	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12670	12676		10.1074/jbc.270.21.12670	http://dx.doi.org/10.1074/jbc.270.21.12670			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759518	hybrid, Green Submitted			2022-12-27	WOS:A1995QZ71100054
J	SZYF, M; THEBERGE, J; BOZOVIC, V				SZYF, M; THEBERGE, J; BOZOVIC, V			RAS INDUCES A GENERAL DNA DEMETHYLATION ACTIVITY IN MOUSE EMBRYONAL P19 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION PATTERNS; CARCINOMA-CELLS; EXPRESSION; DIFFERENTIATION; SUBUNIT; INVIVO	We demonstrate that expression of v-Ha-ras in mouse embryonal P19 cells results in genome-wide demethylation. Analysis of the pattern of methylation of specific genes reveals that different types of genes are demethylated in the ras transfectants: skeletal muscle specific genes, a gene specifically expressed in the adrenal cortex (c21), ubiquitous genes, and exogenously introduced sequences. Transient transfection and in vitro demethylation assays reveal that the ras transfectants express high levels of a general DNA demethylation activity. This demonstrates that the general DNA demethylation activity in mouse embryonal cells is controlled by an important cellular signal transducer and that DNA demethylase is a potential downstream effector of Ras.			SZYF, M (corresponding author), MCGILL UNIV,DEPT PHARMACOL & THERAPEUT,3655 DRUMMOND ST,MONTREAL,PQ H3G 1Y6,CANADA.							Ausubel FM., 1988, CURRENT PROTOCOLS MO; BOULTER CA, 1988, ONCOGENE, V2, P207; BRANDEIS M, 1993, BIOESSAYS, V13, P709; DEGROOT RP, 1990, EMBO J, V9, P1831, DOI 10.1002/j.1460-2075.1990.tb08308.x; DRABER P, 1989, INT J DEV BIOL, V3, P369; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; FEINBERG AP, 1988, CANCER RES, V48, P1159; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; GARDNER PD, 1987, MOL BRAIN RES, V3, P69, DOI 10.1016/0169-328X(87)90046-5; JOST JP, 1993, P NATL ACAD SCI USA, V90, P4684, DOI 10.1073/pnas.90.10.4684; KAUTIAINEN TL, 1986, J BIOL CHEM, V261, P1594; NUR I, 1985, J BACTERIOL, V164, P19, DOI 10.1128/JB.164.1.19-24.1985; PAROUSH Z, 1990, CELL, V63, P1229, DOI 10.1016/0092-8674(90)90418-E; PROST E, 1986, GENE, V45, P107, DOI 10.1016/0378-1119(86)90138-1; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; RAZIN A, 1985, BIOCH BIOL DNA METHY, P239; ROULEAU J, 1995, J BIOL CHEM, V270, P1595, DOI 10.1074/jbc.270.4.1595; ROULEAU J, 1992, J BIOL CHEM, V267, P7368; RUDNICKI MA, 1989, BIOCHEM CELL BIOL, V67, P590, DOI 10.1139/o89-091; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; SALUZ HP, 1986, P NATL ACAD SCI USA, V83, P7167, DOI 10.1073/pnas.83.19.7167; SHEMER R, 1991, J BIOL CHEM, V266, P23676; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SZYF M, 1985, P NATL ACAD SCI USA, V82, P8090, DOI 10.1073/pnas.82.23.8090; SZYF M, 1990, MOL CELL BIOL, V10, P4396, DOI 10.1128/MCB.10.8.4396; SZYF M, 1991, J BIOL CHEM, V266, P10027; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; SZYF M, 1990, MOL ENDOCRINOL, V4, P1144, DOI 10.1210/mend-4-8-1144; UHLER MD, 1987, J BIOL CHEM, V262, P15202; YISRAELI J, 1985, DNA METHYLATION BIOC, P353	32	52	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12690	12696		10.1074/jbc.270.21.12690	http://dx.doi.org/10.1074/jbc.270.21.12690			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759521	hybrid			2022-12-27	WOS:A1995QZ71100057
J	WELCH, RW; WANG, YH; CROSSMAN, A; PARK, JB; KIRK, KL; LEVINE, M				WELCH, RW; WANG, YH; CROSSMAN, A; PARK, JB; KIRK, KL; LEVINE, M			ACCUMULATION OF VITAMIN-C (ASCORBATE) AND ITS OXIDIZED METABOLITE DEHYDROASCORBIC ACID OCCURS BY SEPARATE MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COULOMETRIC ELECTROCHEMICAL DETECTION; ADRENOMEDULLARY CHROMAFFIN CELLS; HUMAN-NEUTROPHILS; INSITU KINETICS; TRANSPORT; FIBROBLASTS; GLUCOSE; REDUCTASE; DISULFIDE; AFFINITY	It is unknown whether ascorbate alone (vitamin C), its oxidized metabolite dehydroascorbic acid alone, or both species are transported into human cells. This problem was addressed using specific assays for each compound, freshly synthesized pure dehydroascorbic acid, the specially synthesized analog 6-chloroascorbate, and a new assay for 6-chloroascorbate. Ascorbate and dehydroascorbic acid were transported and accumulated distinctly; neither competed with the other, Ascorbate was accumulated as ascorbate by sodium-dependent carrier-mediated active transport, Dehydroascorbic acid transport and accumulation as ascorbate was at least 10-fold faster than ascorbate transport and was sodium-independent. Once transported, dehydroascorbic acid was immediately reduced intracellularly to ascorbate. The analog 6-chloroascorbate had no effect on dehydroascorbic acid transport but was a competitive inhibitor of ascorbate transport. The K-i for 6-chloroascorbate (2.9-4.4 mu M) was similar to the K-m for ascorbate transport (9.8-12.6 mu M) 6-Chloroascorbate was itself transported and accumulated in fibroblasts by a sodium-dependent transporter. These data provide new information that ascorbate and dehydroascorbic acid are transported into human neutrophils and fibroblasts by two distinct mechanisms and that the compound available for intracellular utilization is ascorbate.	NIDDKD,CELL BIOL & GENET LAB,BETHESDA,MD 20892; NIDDK,BIOORGAN CHEM LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								BIGLEY R, 1983, DIABETES, V32, P545, DOI 10.2337/diabetes.32.6.545; BIGLEY RH, 1974, J EXP MED, V139, P1084, DOI 10.1084/jem.139.5.1084; Borsook H, 1937, J BIOL CHEM, V117, P237; Cleland W W, 1979, Methods Enzymol, V63, P103; COASSIN M, 1991, ARCH BIOCHEM BIOPHYS, V290, P458, DOI 10.1016/0003-9861(91)90566-2; DHARIWAL KR, 1991, AM J CLIN NUTR, V54, P712, DOI 10.1093/ajcn/54.4.712; DHARIWAL KR, 1989, J BIOL CHEM, V264, P15404; DILIBERTO EJ, 1983, J BIOL CHEM, V258, P2886; DYER DL, 1994, AM J PHYSIOL, V267, pC301, DOI 10.1152/ajpcell.1994.267.1.C301; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; HALLIWELL B, 1987, FEBS LETT, V213, P15, DOI 10.1016/0014-5793(87)81456-4; HENDRY JM, 1964, CLIN CHIM ACTA, V9, P498, DOI 10.1016/0009-8981(64)90089-0; KISS J, 1980, HELV CHIM ACTA, V63, P1728, DOI 10.1002/hlca.19800630642; LAM KW, 1993, OPHTHALMIC RES, V25, P100, DOI 10.1159/000267272; LEVINE M, 1994, ASIAN PAC J CLIN  S1, V2, P5; MELHORN RJ, 1991, J BIOL CHEM, V266, P2724; MENNITI FS, 1987, J BIOL CHEM, V262, P7651; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; NEALE KD, 1972, ELEMENTARY KINETICS; OKAMURA M, 1980, CLIN CHIM ACTA, V103, P259; PADH H, 1987, BIOCHIM BIOPHYS ACTA, V901, P283, DOI 10.1016/0005-2736(87)90125-8; ROSENBAUM JT, 1985, AM J PATHOL, V120, P244; STAHL RL, 1985, BIOCHIM BIOPHYS ACTA, V839, P119, DOI 10.1016/0304-4165(85)90189-8; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; WASHKO P, 1992, J BIOL CHEM, V267, P23568; WASHKO P, 1989, J BIOL CHEM, V264, P18996; WASHKO PW, 1989, ANAL BIOCHEM, V181, P276, DOI 10.1016/0003-2697(89)90243-1; WASHKO PW, 1993, J BIOL CHEM, V268, P15531; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1989, NEW ENGL J MED, V321, P329; WELCH RW, 1993, BIOCHEM J, V294, P505, DOI 10.1042/bj2940505; WELCH RW, 1993, ANAL BIOCHEM, V210, P199, DOI 10.1006/abio.1993.1173; WELLS WW, 1990, J BIOL CHEM, V265, P15361; WILSON JX, 1989, J MEMBRANE BIOL, V111, P83, DOI 10.1007/BF01869211; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; WINKLER BS, 1992, BIOCHIM BIOPHYS ACTA, V1117, P287, DOI 10.1016/0304-4165(92)90026-Q; ZHOU A, 1991, BIOCHEM J, V274, P739, DOI 10.1042/bj2740739	37	168	173	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12584	12592		10.1074/jbc.270.21.12584	http://dx.doi.org/10.1074/jbc.270.21.12584			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759506	hybrid			2022-12-27	WOS:A1995QZ71100041
J	MCPHEE, JC; RAGSDALE, DS; SCHEUER, T; CATTERALL, WA				MCPHEE, JC; RAGSDALE, DS; SCHEUER, T; CATTERALL, WA			CRITICAL ROLE FOR TRANSMEMBRANE SEGMENT IVS6 OF THE SODIUM-CHANNEL ALPHA-SUBUNIT IN FAST INACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURO-BLASTOMA CELLS; FREE MEMBRANE PATCHES; RAT-BRAIN; NA CHANNELS; FUNCTIONAL EXPRESSION; PERIODIC PARALYSIS; POTASSIUM CHANNELS; GATING PROPERTIES; PROTEIN-STRUCTURE; OPEN STATES	Fast Na+ channel inactivation is thought to occur by the binding of an intracellular inactivation gate to regions around or within the Na+ channel pore through hydrophobic interactions, Previous studies indicate that the intracellular loop between domains III and IV of the Na+ channel Lu subunit (L(III-IV)) forms the inactivation gate, A three residue hydrophobic motif (IFM) is an essential structural feature of the gate and may serve as an inactivation particle that binds within the pore, In this study, we used alanine-scanning mutagenesis to examine the functional role of amino acid residues in transmembrane segment IVS6 of the Na+ channel cu sub unit in fast inactivation, Mutant F1764A, in the center of IVS6, and mutant V1774A, near its intracellular end, exhibited substantial sustained Na+ currents at the end of 30-ms depolarizations. The double mutation F1764A/V1774A almost completely abolished fast inactivation, demonstrating a critical role for these amino acid residues in the process of inactivation, Single channel analysis of these three mutants revealed continued reopenings late in 40 ms depolarizing pulses, indicating that the stability of the inactivated state was substantially impaired compared with wild type, In addition, the cumulative first latency distribution for the V1774A mutation contained a new component arising from opening transitions from the destabilized inactivated state, Substitution of multiple amino acid residues showed that the disruption of inactivation was not correlated with the hydrophobicity of the substitution at position 1774, in contrast to the expectation if this residue interacts directly with the IFM motif, Thermodynamic cycle analysis of simultaneous mutations in the IFM motif and in IVS6 suggested that mutations in these two regions independently disrupt inactivation, consistent with the conclusion that they do not interact directly, Furthermore, a peptide containing the IFM motif (acetyl-KIFMK-amide) restored inactivation to the F1764A/V1774A IVS6 mutant, indicating that the binding site for the IFM motif remains intact in these mutants, These results suggest that the amino acid residues 1764 and 1774 in IVS6 do not directly interact with the IFM motif of the inactivation gate but instead play a novel role in fast inactivation of the Na+ channel.			MCPHEE, JC (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL SJ-30,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15751] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1987, J NEUROSCI, V7, P418; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; CAHALAN MD, 1979, BIOPHYS J, V27, P57, DOI 10.1016/S0006-3495(79)85202-9; CANNON SC, 1993, NEURON, V10, P317, DOI 10.1016/0896-6273(93)90321-H; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHANDLER WK, 1970, J PHYSIOL-LONDON, V211, P653, DOI 10.1113/jphysiol.1970.sp009298; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; CORREA AM, 1994, BIOPHYS J, V66, P1864, DOI 10.1016/S0006-3495(94)80980-4; CORREA AM, 1994, BIOPHYS J, V66, P1853, DOI 10.1016/S0006-3495(94)80979-8; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Eaholtz Galen, 1995, Biophysical Journal, V68, pA159; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; GONOI T, 1984, J NEUROSCI, V4, P2836; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HILLE B, 1992, IONIC CHANNELS EXCIT, P403; HORN R, 1984, BIOPHYS J, V45, P323, DOI 10.1016/S0006-3495(84)84158-2; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MCPHEE JC, 1994, P NATL ACAD SCI USA, V91, P12346, DOI 10.1073/pnas.91.25.12346; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MOORMAN JR, 1990, SCIENCE, V250, P688; NAGY K, 1987, J MEMBRANE BIOL, V96, P251, DOI 10.1007/BF01869307; NAGY K, 1983, PFLUG ARCH EUR J PHY, V399, P302, DOI 10.1007/BF00652757; NILIUS B, 1988, BIOPHYS J, V53, P857, DOI 10.1016/S0006-3495(88)83166-7; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PATLAK J, 1982, J GEN PHYSIOL, V79, P333, DOI 10.1085/jgp.79.3.333; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; SCANLEY BE, 1990, J GEN PHYSIOL, V95, P411, DOI 10.1085/jgp.95.3.411; SCHEUER T, 1993, BIOPHYS J, V64, pA88; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Taylor J. R., 1982, INTRO ERROR ANAL STU; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WEST JW, 1992, NEURON, V8, P59, DOI 10.1016/0896-6273(92)90108-P; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZHANG XJ, 1992, PROTEIN SCI, V1, P761, DOI 10.1002/pro.5560010608; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	59	142	143	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12025	12034		10.1074/jbc.270.20.12025	http://dx.doi.org/10.1074/jbc.270.20.12025			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744852	hybrid			2022-12-27	WOS:A1995QY73600053
J	BOGGS, KP; ROCK, CO; JACKOWSKI, S				BOGGS, KP; ROCK, CO; JACKOWSKI, S			LYSOPHOSPHATIDYLCHOLINE ATTENUATES THE CYTOTOXIC EFFECTS OF THE ANTINEOPLASTIC PHOSPHOLIPID 1-O-OCTADECYL-2-O-METHYL-RAC-GLYCERO-3-PHOSPHOCHOLINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LEUKEMIC-CELLS; STIMULATING FACTOR-I; ETHER LIPID ANALOGS; HAMSTER OVARY CELLS; PROTEIN-KINASE-C; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE TRANSLOCATION; PLATELET-ACTIVATING-FACTOR; ALKYL-LYSOPHOSPHOLIPIDS; HL-60 CELLS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS	A colony-stimulating factor 1-dependent cell line was used to determine the relationship between the inhibition of phospholipid synthesis and the cytotoxic activity of the antineoplastic ether lipid, 1-O-octadecyl-2-O- methyl-rac-glycero-3-phosphocholine (ET-18-OCH3), ET-18-OCH3 inhibited choline incorporation into phosphatidylcholine as well as total phospholipid synthesis, Exposure to ET-18-OCH3 at the G(1)/S boundary led to the accumulation of cells in G(2), whereas the addition of ET-18-OCH3 in the G(1) phase of the cell cycle prevented entry into the S phase. In both cases, ET-18-OCH, treatment triggered DNA fragmentation and morphological changes associated with apoptosis within 10 h, The addition of lysophosphatidylcholine provided an exogenous source of cellular phospholipid and prevented ET-18-OCH3-dependent accumulation of cells in G(2) and apoptosis, However, lysophosphatidylcholine did not overcome the ET-18-OCH3-dependent G(1) block, although the growth-arrested cells remained viable, These data indicate that restoring phosphatidylcholine synthesis by supplementation with lysophosphatidylcholine over rides the cytotoxic but not the cytostatic activity of ET-18-OCH3.	ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38101 USA; UNIV TENNESSEE, DEPT BIOCHEM, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center			Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045737] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM 45737] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREESEN R, 1978, CANCER RES, V38, P3894; ANDREESEN R, 1979, BLOOD, V54, P519; BERDEL WE, 1991, BRIT J CANCER, V64, P208, DOI 10.1038/bjc.1991.277; BERDEL WE, 1980, EUR J CANCER, V16, P1119; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; DANIEL LW, 1987, LIPIDS, V22, P851, DOI 10.1007/BF02535543; DANIEL LW, 1993, CANCER CHEMOTHERAPY, P146; DEAN PN, 1980, CELL TISSUE KINET, V13, P299, DOI 10.1111/j.1365-2184.1980.tb00468.x; DIOMEDE L, 1993, INT J CANCER, V53, P124, DOI 10.1002/ijc.2910530123; DOWNING JR, 1989, EMBO J, V8, P3345, DOI 10.1002/j.1460-2075.1989.tb08496.x; ESKO JD, 1982, P NATL ACAD SCI-BIOL, V79, P1698, DOI 10.1073/pnas.79.6.1698; ESKO JD, 1981, J BIOL CHEM, V256, P7388; GEILEN CC, 1994, BBA-LIPID LIPID MET, V1211, P14, DOI 10.1016/0005-2760(94)90133-3; GEILEN CC, 1992, J BIOL CHEM, V267, P6719; HAASE R, 1991, FEBS LETT, V288, P129, DOI 10.1016/0014-5793(91)81018-4; HAMILTON JA, 1989, J CELL PHYSIOL, V141, P618, DOI 10.1002/jcp.1041410321; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HEESBEEN EC, 1993, LEUKEMIA RES, V17, P143, DOI 10.1016/0145-2126(93)90059-T; HERRMANN DBJ, 1985, J NATL CANCER I, V75, P423; HOFFMAN DR, 1986, CANCER RES, V46, P5803; HOFFMAN DR, 1992, BIOCHIM BIOPHYS ACTA, V1127, P74, DOI 10.1016/0005-2760(92)90203-8; HOFMANN J, 1994, BIOCHEM BIOPH RES CO, V199, P937, DOI 10.1006/bbrc.1994.1319; IMAMURA K, 1990, EMBO J, V9, P2423, DOI 10.1002/j.1460-2075.1990.tb07418.x; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; JAMIL H, 1993, BIOCHEM J, V291, P419, DOI 10.1042/bj2910419; JAMIL H, 1990, J BIOL CHEM, V265, P4332; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; LESLIE CC, 1995, IN PRESS ADV MOL CEL; LOCK RB, 1990, CANCER RES, V50, P3761; LOCK RB, 1990, CANCER RES, V50, P3767; LOCK RB, 1992, CANCER RES, V52, P1817; MODOLELL M, 1979, CANCER RES, V39, P4681; MOLLINEDO F, 1993, BIOCHEM BIOPH RES CO, V192, P603, DOI 10.1006/bbrc.1993.1458; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Munder P. G., 1977, IMMUNOLOGY, V7, P411; MUSCHEL RJ, 1991, CANCER RES, V51, P5113; NOSEDA A, 1987, LIPIDS, V22, P878, DOI 10.1007/BF02535548; NOSEDA A, 1989, EXP MOL PATHOL, V50, P69, DOI 10.1016/0014-4800(89)90057-9; O'Connor P M, 1992, Semin Cancer Biol, V3, P409; OCONNER PM, 1993, CELL GROWTH DIFFER, V3, P43; OCONNOR PM, 1993, J BIOL CHEM, V268, P8298; PARKER J, 1987, J BIOL CHEM, V262, P5385; PAWELCZYK T, 1993, BIOCHEM PHARMACOL, V45, P493, DOI 10.1016/0006-2952(93)90087-D; POWIS G, 1992, CANCER RES, V52, P2835; ROCK CO, 1992, MOL CELL BIOL, V12, P2351, DOI 10.1128/MCB.12.5.2351; RUNGE MH, 1980, J NATL CANCER I, V64, P1301, DOI 10.1093/jnci/64.6.1301; SALARI H, 1992, BIOCHEM CELL BIOL, V70, P129, DOI 10.1139/o92-019; SALARI H, 1992, BIOCHIM BIOPHYS ACTA, V1134, P81, DOI 10.1016/0167-4889(92)90030-F; SCHWARZBAUM S, 1984, J IMMUNOL, V132, P1158; SEEWALD MJ, 1990, CANCER RES, V50, P4458; TRONCHERE H, 1991, BIOCHEM BIOPH RES CO, V176, P157, DOI 10.1016/0006-291X(91)90903-K; TSAO YP, 1992, CANCER RES, V52, P1823; TUSHINSKI RJ, 1985, J CELL PHYSIOL, V122, P221, DOI 10.1002/jcp.1041220210; VALLARI DS, 1988, BIOCHEM BIOPH RES CO, V156, P1, DOI 10.1016/S0006-291X(88)80797-6; VALLARI DS, 1990, J BIOL CHEM, V265, P4261; VALLARI DS, 1989, BIOCHIM BIOPHYS ACTA, V1006, P250, DOI 10.1016/0005-2760(89)90204-X; VANCE DE, 1989, PHOSPHATIDYLCHOLINE, P225; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Vogler W R, 1993, J Hematother, V2, P93, DOI 10.1089/scd.1.1993.2.93; VOGLER WR, 1991, LIPIDS, V26, P1418, DOI 10.1007/BF02536579; VOGLER WR, 1985, EXP HEMATOL, V13, P629; WESTPHAL O, 1987, LIPIDS, V22, P787, DOI 10.1007/BF02535532; WHETTON AD, 1986, EMBO J, V5, P3281, DOI 10.1002/j.1460-2075.1986.tb04640.x; WIEDER T, 1993, BIOCHEM J, V291, P561, DOI 10.1042/bj2910561; WORKMAN P, 1990, BIOCHEM PHARMACOL, V41, P319; XU XX, 1993, MOL CELL BIOL, V13, P1522, DOI 10.1128/MCB.13.3.1522	68	86	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11612	11618		10.1074/jbc.270.19.11612	http://dx.doi.org/10.1074/jbc.270.19.11612			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744800	hybrid			2022-12-27	WOS:A1995QX86500082
J	HERMAN, WH; SIMONSON, MS				HERMAN, WH; SIMONSON, MS			NUCLEAR SIGNALING BY ENDOTHELIN-1 - A RAS PATHWAY FOR ACTIVATION OF THE C-FOS SERUM RESPONSE ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GLOMERULAR MESANGIAL CELLS; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; 3T3 CELLS; RECEPTOR; FIBROBLASTS; DNA; TRANSCRIPTION; TRANSDUCTION	Endothelin-1 (ET-1) regulates gene expression and growth of vascular cells by triggering signals that link its cognate, G protein-coupled receptor in the plasma membrane to transcriptional activation of immediate early genes in the nucleus, To define the nature of these signals, we asked whether Ras proteins contribute to activation of the c-fos serum response element (SRE) by ET-1 in mesangial cells, a microvascular cell from the renal glomerulus, ET-1 stimulated Ras by increasing Ras GTP loading, Addition of ET-1 or transfection with a plasmid expressing v-Ha-Ras stimulated SRE dependent transcription, Activation of the c-fos SRE by ET-1 was blocked by a dominant negative Asn-17 c-Ha-Ras mutant, Expression of v-Ha-Ras reversed inhibition of ET-1-stimulated SRE transcriptional activity by Asn-17 c-Ha-Ras, ET-1 also stimulated kinase activity of c-Raf-1, a downstream effector in Ras signaling cascades, Activation of the c-fos SRE by transfection with a plasmid expressing constitutively activated Delta Raf-1 was consistent with a role for Ras-Raf-1 in ET-1 signaling, Interestingly, Ras dependent SRE activation in cells treated with ET-1 was blocked by point mutations in the SRE CArG DNA sequence, which binds the serum response factor, but not by mutations that inhibit binding of ternary complex factors (p62(TCF)) to the Ets DNA sequence of the SRE, Thus, Ras contributes to a nuclear signaling cascade linking ET-1 receptors to transcriptional activation through the CArG cis-element of the c-fos SRE.	CASE WESTERN RESERVE UNIV, SCH MED, DEPT MED, DIV NEPHROL, CLEVELAND, OH 44106 USA	Case Western Reserve University					NIDDK NIH HHS [DK-46939] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046939] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BATTISTINI B, 1993, PEPTIDES, V14, P385, DOI 10.1016/0196-9781(93)90057-N; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; BENIGNI A, 1993, KIDNEY INT, V44, P440, DOI 10.1038/ki.1993.263; CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; CAZAUBON SM, 1994, J BIOL CHEM, V269, P24805; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; CRESPO P, 1994, J BIOL CHEM, V269, P21103; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DOUGLAS SA, 1994, CIRC RES, V75, P190, DOI 10.1161/01.RES.75.1.190; FAURE M, 1994, J BIOL CHEM, V269, P7851; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FORCE T, 1991, J BIOL CHEM, V266, P6650; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GUTMAN A, 1991, MOL CELL BIOL, V11, P5381, DOI 10.1128/MCB.11.10.5381; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HIPSKIND RA, 1994, GENE DEV, V8, P1803, DOI 10.1101/gad.8.15.1803; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KONIG H, 1991, NUCLEIC ACIDS RES, V19, P3607, DOI 10.1093/nar/19.13.3607; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; LAMORTE VJ, 1993, J BIOL CHEM, V268, P19411; LUSCHER TF, 1992, HYPERTENSION, V19, P117, DOI 10.1161/01.HYP.19.2.117; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MASAKI T, 1993, ENDOCR REV, V14, P256, DOI 10.1210/er.14.3.256; MOODIE SA, 1994, TRENDS GENET, V10, P44, DOI 10.1016/0168-9525(94)90147-3; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MULDOON LL, 1989, J BIOL CHEM, V264, P8529; PRIBNOW D, 1992, MOL ENDOCRINOL, V6, P1003, DOI 10.1210/me.6.7.1003; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; RUBANYI GM, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199304000-00002; SANTORO IM, 1991, MOL CELL BIOL, V11, P6296, DOI 10.1128/MCB.11.12.6296; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIMONSON MS, 1990, METHOD ENZYMOL, V187, P544; SIMONSON MS, 1992, J BIOL CHEM, V267, P8643; SIMONSON MS, 1990, FASEB J, V4, P2989, DOI 10.1096/fasebj.4.12.2168326; SIMONSON MS, 1993, J BIOL CHEM, V268, P9347; SIMONSON MS, 1993, PHYSIOL REV, V73, P375, DOI 10.1152/physrev.1993.73.2.375; SIMONSON MS, 1994, MOL PHARMACOL, V46, P41; SIMONSON MS, 1995, IN PRESS AM J PHYSL, V265; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; TREISMAN R, 1992, TRANSCRIPTIONAL REGU, P881; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; WANG YZ, 1992, BIOCHEM J, V287, P589, DOI 10.1042/bj2870589; WEBER H, 1994, MOL ENDOCRINOL, V8, P148, DOI 10.1210/me.8.2.148; WESTWICK JK, 1994, P NATL ACAD SCI USA, V91, P6030, DOI 10.1073/pnas.91.13.6030; WINITZ S, 1993, J BIOL CHEM, V268, P19196; YAN MH, 1994, J BIOL CHEM, V269, P19067; ZACHARY I, 1991, P NATL ACAD SCI USA, V88, P4577, DOI 10.1073/pnas.88.11.4577	62	63	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11654	11661		10.1074/jbc.270.19.11654	http://dx.doi.org/10.1074/jbc.270.19.11654			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744805	hybrid			2022-12-27	WOS:A1995QX86500088
J	MAUVIEL, A; SANTRA, M; CHEN, YQ; UITTO, J; IOZZO, RV				MAUVIEL, A; SANTRA, M; CHEN, YQ; UITTO, J; IOZZO, RV			TRANSCRIPTIONAL REGULATION OF DECORIN GENE-EXPRESSION - INDUCTION BY QUIESCENCE AND REPRESSION BY TUMOR-NECROSIS-FACTOR-ALPHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESSENGER-RNA LEVELS; SMALL PROTEOGLYCAN DECORIN; HUMAN DERMAL FIBROBLASTS; EXTRACELLULAR-MATRIX; SULFATE PROTEOGLYCAN; COLLAGEN PRODUCTION; INHIBITS COLLAGEN; BINDING-PROTEINS; COLON-CARCINOMA	Decorin, a leucine-rich proteoglycan with ubiquitous tissue distribution, may play essential biological roles during inflammation and cancer growth through its ability to bind extracellular matrix constituents and growth factors. In this study, we demonstrate that decorin gene expression is greatly enhanced after normal diploid fibroblasts reach confluency and cease to proliferate. Elevation of decorin mRNA steady state levels was maintained for up to 16 days postconfluency. In vitro transcription analyses indicated enhanced transcriptional activity in quiescent fibroblasts when compared to cells harvested in their logarithmic phase of growth. This phenotypic trait was reversed by the exogenous addition of tumor necrosis factor-alpha (TNF-alpha). Furthermore, transforming growth factor-beta (TGF-beta) downregulated decorin gene expression in an additive manner with TNF-alpha. Transient cell transfection assays using plasmid constructs harboring the decorin promoter linked to the chloramphenicol acetyltransferase reporter gene demonstrated a dose-dependent transcriptional repression by TNF-alpha. These findings were further corroborated by in vitro transcription experiments using nuclear extracts from control and TNF-alpha-treated quiescent fibroblasts, In contrast, the decorin promoter constructs failed to respond to TGF-beta, thus suggesting either post-transcriptional regulation by this growth factor or lack of TGF-beta-responsive elements. Further experiments with 5' deletion constructs showed two TNF-alpha response elements, one residing within the 5'-untranslated region (exon Ib), the other one between residues - 188 and - 140 of the decorin promoter. Collectively, our results indicate that TNF-alpha, through its ability to transcriptionally inhibit decorin gene expression in growth-arrested cells, may be a key modulator of the biological functions of this proteoglycan.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT PATHOL & CELL BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON CANC INST, PHILADELPHIA, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	MAUVIEL, A (corresponding author), THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT DERMATOL, 233 S 10TH ST, BLSB RM 430, PHILADELPHIA, PA 19107 USA.		Iozzo, Renato/AAS-1980-2020; MAUVIEL, Alain/F-6251-2013	Iozzo, Renato/0000-0002-5908-5112; Mauviel, Alain/0000-0002-0438-2793	NATIONAL CANCER INSTITUTE [R01CA047282, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041439] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA39481, R01-CA47282] Funding Source: Medline; NIAMS NIH HHS [R01-AR41439] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADANY R, 1990, J BIOL CHEM, V265, P11389; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARMENDARIZBORUNDA J, 1992, J BIOL CHEM, V267, P14316; BIDANSET DJ, 1992, J CELL BIOL, V118, P1523, DOI 10.1083/jcb.118.6.1523; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; DANIELSON KG, 1993, GENOMICS, V15, P146, DOI 10.1006/geno.1993.1022; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; FISHER LW, 1989, J BIOL CHEM, V264, P4571; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; Gallagher JT, 1989, CURR OPIN CELL BIOL, V1, P1201, DOI 10.1016/S0955-0674(89)80072-9; GOLDRING MB, 1987, J BIOL CHEM, V262, P4337; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HEINO J, 1988, BIOCHEM J, V252, P309, DOI 10.1042/bj2520309; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; IOZZO RV, 1985, J BIOL CHEM, V260, P7464; KAHARI VM, 1987, BIOCHIM BIOPHYS ACTA, V929, P142, DOI 10.1016/0167-4889(87)90169-8; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; KAHARI VM, 1992, J BIOL CHEM, V267, P26134; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; KRESSE H, 1993, EXPERIENTIA, V49, P403, DOI 10.1007/BF01923585; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; LE JM, 1987, LAB INVEST, V56, P234; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LI YP, 1993, MOL CELL BIOL, V13, P3714, DOI 10.1128/MCB.13.6.3714; MAUVIEL A, 1993, CURR BIOL, V3, P822, DOI 10.1016/0960-9822(93)90216-B; MAUVIEL A, 1993, WOUNDS, V5, P137; MAUVIEL A, 1993, J BIOL CHEM, V268, P6520; MAUVIEL A, 1988, FEBS LETT, V236, P47, DOI 10.1016/0014-5793(88)80283-7; MAUVIEL A, 1991, J INVEST DERMATOL, V96, P243, DOI 10.1111/1523-1747.ep12462185; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; MAUVIEL A, 1994, J BIOL CHEM, V269, P25; MAUVIEL A, 1988, BIOCHEM J, V252, P247, DOI 10.1042/bj2520247; PULKKINEN L, 1990, J BIOL CHEM, V265, P17780; RANGES GE, 1987, J EXP MED, V166, P991, DOI 10.1084/jem.166.4.991; Sambrook J, 1989, MOL CLONING LABORATO; SANTRA M, 1994, J BIOL CHEM, V269, P579; SCHMIDT G, 1991, BIOCHEM J, V280, P411, DOI 10.1042/bj2800411; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; SOLISHERRUZO JA, 1988, J BIOL CHEM, V263, P5841; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Uitto J, 1992, Exp Dermatol, V1, P2, DOI 10.1111/j.1600-0625.1992.tb00065.x; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; VOGEL KG, 1992, EUR J CELL BIOL, V59, P304; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; WINNEMOLLER M, 1991, EUR J CELL BIOL, V54, P10; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0	52	123	125	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11692	11700		10.1074/jbc.270.19.11692	http://dx.doi.org/10.1074/jbc.270.19.11692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744809	hybrid			2022-12-27	WOS:A1995QX86500093
J	RAY, S; MUKHERJI, S; BHADURI, A				RAY, S; MUKHERJI, S; BHADURI, A			2 TRYPTOPHANS AT THE ACTIVE-SITE OF UDP-GLUCOSE 4-EPIMERASE FROM KLUYVEROMYCES-FRAGILIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; UDPGLUCOSE 4-EPIMERASE; GALACTOSE 4-EPIMERASE; FLUORESCENCE; BINDING; DEHYDROGENASE; PROTEINS; RESIDUE; KINETICS; ENERGY	Efficient fluorescence energy transfer from aromatic residues to the pyridine moiety of the bound coenzyme (NAD) of UDP-glucose 4-epimerase from Kluyveromyces fragilis had been reported earlier (Mukherji, S., and Bhaduri, A. (1992) J, Biol, Chem, 267, 11709-11713). We have employed N-bromosuccinimide (NBS) to identify tryptophan as the exclusive aromatic donor in the energy transfer. The characteristic UV absorption spectrum associated with Trp oxidation is observed during NBS modification of two of the four Trp residues of native epimerase along with concomitant inactivation of the enzyme, Excellent correlation between the observed inactivation and abolition of fluorescence energy transfer to coenzyme from Trp in epimerase upon treatment with NBS implicates the involvement of the same two tryptophans in both catalytic activity and fluorescence energy transfer, SDS-polyacrylamide gel electrophoresis and fluorescence data preclude gross structural/conformational changes in epimerase due to NBS oxidation, The susceptible tryptophans do not reside at the substrate binding site as substrates and UMP fail to protect against NBS modification, However, failure of sodium borohydride to reduce the bound NAD in the NBS-inactivated epimerase suggests that the reactive tryptophans are close to the coenzyme. Tryptophan fluorescence lifetime values of 1.9 and 3.9 ns for the native and 3.5 ns for the NBS-modified epimerase, complemented by a linear Stern-Volmer plot (effective Stern-Volmer constant = 2.85 M(-1)) of acrylamide quenching, suggest that the two key tryptophans are buried close to an intrinsic quencher, presumably NAD.	INDIAN INST CHEM BIOL,CALCUTTA 700032,W BENGAL,INDIA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)								ALMARSSON O, 1992, J AM CHEM SOC, V114, P8702, DOI 10.1021/ja00048a055; BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43; BERTLAND AU, 1968, P NATL ACAD SCI USA, V61, P629, DOI 10.1073/pnas.61.2.629; BERTLAND AU, 1970, BIOCHEMISTRY-US, V9, P4649, DOI 10.1021/bi00826a005; BHATTACHARJEE H, 1992, J BIOL CHEM, V267, P11714; BHATTACHARYYA D, 1993, BIOCHEMISTRY-US, V32, P9726, DOI 10.1021/bi00088a027; BURKE JR, 1993, BIOCHEMISTRY-US, V32, P13220, DOI 10.1021/bi00211a034; CAPUTTO R, 1949, J BIOL CHEM, V179, P497; CLERMONT S, 1993, BIOCHEMISTRY-US, V32, P10178, DOI 10.1021/bi00089a038; CREVELING CR, 1965, BIOCHEM BIOPH RES CO, V21, P624, DOI 10.1016/0006-291X(65)90532-2; DARROW RA, 1970, J BIOL CHEM, V245, P2036; DARROW RA, 1968, BIOCHEMISTRY-US, V7, P1645, DOI 10.1021/bi00845a005; DARROW RA, 1966, P NATL ACAD SCI USA, V55, P205, DOI 10.1073/pnas.55.1.205; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; EKLUND H, 1984, BIOCHEMISTRY-US, V23, P5982, DOI 10.1021/bi00320a014; Frey P. A., 1987, PYRIDINE NUCLEOTID B, V2B, P462; GABRIEL O, 1978, TRENDS BIOCHEM SCI, V3, P193, DOI 10.1016/S0968-0004(78)91666-3; GABRIEL O, 1978, INT REV BIOCHEM, V16, P1; GABRIEL O, 1975, SUBUNIT ENZYMES, P84; GRINVALD A, 1974, ANAL BIOCHEM, V59, P583, DOI 10.1016/0003-2697(74)90312-1; HELENE C, 1969, BIOCHEM BIOPH RES CO, V37, P393, DOI 10.1016/0006-291X(69)90927-9; KONOPKA JM, 1989, BIOCHEMISTRY-US, V28, P2645, DOI 10.1021/bi00432a043; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P83; Lakowicz J. R., 1983, PRINCIPLES FLUORESCE, P259; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P342; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANIATIS T, 1982, MOL CLONING LABORATO, P466; MAY JM, 1993, BIOCHEMISTRY-US, V32, P9524, DOI 10.1021/bi00088a002; MCCLURE WO, 1967, BIOCHEMISTRY-US, V6, P559, DOI 10.1021/bi00854a025; MUKHERJI S, 1986, J BIOL CHEM, V261, P4519; MUKHERJI S, 1992, J BIOL CHEM, V267, P11709; PATCHORNIK A, 1960, J AM CHEM SOC, V82, P5923, DOI 10.1021/ja01507a032; PETERMAN BF, 1979, BIOCHIM BIOPHYS ACTA, V577, P314, DOI 10.1016/0005-2795(79)90035-7; PORTER DJT, 1993, J BIOL CHEM, V268, P66; Ramachandran L.K., 1967, METHOD ENZYMOL, V11, P283; RAY M, 1980, J BIOL CHEM, V255, P777; RAY M, 1980, J BIOL CHEM, V255, P782; RAY M, 1976, EUR J BIOCHEM, V70, P319, DOI 10.1111/j.1432-1033.1976.tb11020.x; SAMANTA AK, 1983, J BIOL CHEM, V258, P1118; SHANMUGASUNDARA.T, 1988, BIOCHEMISTRY-US, V27, P6499; SIMPSON RT, 1963, BIOCHEMISTRY-US, V2, P616, DOI 10.1021/bi00903a039; Spande T.F., 1967, DETERMINATION TRYPTO, P498; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; UDENFRIEND S, 1962, FLUORESCENCE ASSAY B, V1, P249; WEBER G, 1957, NATURE, V180, P1409, DOI 10.1038/1801409a0; WIGET P, 1978, BIOPOLYMERS, V17, P167, DOI 10.1002/bip.1978.360170113	48	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11383	11390		10.1074/jbc.270.19.11383	http://dx.doi.org/10.1074/jbc.270.19.11383			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744774	hybrid			2022-12-27	WOS:A1995QX86500053
J	ZHANG, ZY				ZHANG, ZY			KINETIC AND MECHANISTIC CHARACTERIZATION OF A MAMMALIAN PROTEIN-TYROSINE-PHOSPHATASE, PTP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAVING GROUP DEPENDENCE; ESCHERICHIA-COLI; BOVINE HEART; SUBSTRATE-SPECIFICITY; ALKALINE-PHOSPHATASE; HUMAN-PLACENTA; EXPRESSION; PURIFICATION; PHOSPHORYLATION; INTERMEDIATE	The kinetic mechanism of the hydrolysis of phosphate monoesters catalyzed by a soluble form of rat protein-tyrosine phosphatase (PTPase), PTP1, was probed with a variety of steady-state and pre-steady-state kinetic techniques. Product inhibition and O-18 exchange experiments are consistent with the enzymatic reaction proceeding through two chemical steps, i.e. formation and breakdown of a covalent phosphoenzyme intermediate. The variation of k(cat)/K-m with pH indicates that three ionizable groups are involved in enzyme substrate binding and catalysis. The first group must be deprotonated and is attributed to the second ionization of the substrate. The other two groups with pK(a) values of 5.1 and 5.5 correspond to two enzyme active site residues. The k(cat)-pH profiles for both p-nitrophenyl phosphate and beta-naphthyl phosphate are bell-shaped and are superimposable, with the apparent pK(a) values derived from the acidic limb and the basic limb of the profile being 4.4 and 6.8, respectively. This suggests that the rate-limiting step corresponds to the decomposition of the phosphoenzyme intermediate at all pH values. Results from leaving group dependence of k(cat) at two different pH values support the above conclusion. Furthermore, burst kinetics have been demonstrated with PTP1 using p-nitrophenyl phosphate as a substrate. The rate constants for the formation and the breakdown of the intermediate are 241 and 12 s(-1), respectively, at pH 6.0 and 3.5 degrees C. A normal D2O solvent isotope effect (k(cat)(H)/k(cat)(D) = 1.5) is associated with the breakdown of the phosphoenzyme intermediate, indicating a solvent-derived proton in the transition state. The leaving group dependence of k(cat)/K-m suggests that there is a strong electrophilic interaction between the enzyme and the leaving group oxygen in the transition state of the phosphorylation event. These results are compared with those of the Yersinia PTPase and suggest that the mechanism for PTPase-catalyzed phosphate monoester hydrolysis is conserved from bacterial to mammals.			ZHANG, ZY (corresponding author), ALBERT EINSTEIN COLL MED,DEPT MOLEC PHARMACOL,1300 MORRIS PK AVE,BRONX,NY 10461, USA.							APPLEBUR.ML, 1970, J BIOL CHEM, V245, P4968; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BENDER ML, 1967, J CHEM EDUC, V44, P84, DOI 10.1021/ed044p84; Boyer P.D., 1990, ENZYMES, V19, P99; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; CHO HJ, 1992, J AM CHEM SOC, V114, P7296, DOI 10.1021/ja00044a052; CHO HJ, 1992, BIOCHEMISTRY-US, V31, P133, DOI 10.1021/bi00116a019; EARGLE DH, 1977, ANAL BIOCHEM, V82, P186; FALLER LD, 1989, BIOCHEMISTRY-US, V28, P6908, DOI 10.1021/bi00443a020; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HALL AD, 1986, BIOCHEMISTRY-US, V25, P4784, DOI 10.1021/bi00365a010; HERSCHLAG D, 1989, J AM CHEM SOC, V111, P7579, DOI 10.1021/ja00201a047; KIRBY AJ, 1967, J AM CHEM SOC, V89, P415, DOI 10.1021/ja00978a044; MARTIN B, 1985, J BIOL CHEM, V260, P4932; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; SKOOG MT, 1984, J AM CHEM SOC, V106, P7597, DOI 10.1021/ja00336a047; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; VANETTEN RL, 1978, P NATL ACAD SCI USA, V75, P4784; WALTON KM, 1993, ANNU REV BIOCHEM, V62, P101; WO YYP, 1992, BIOCHEMISTRY-US, V31, P1712, DOI 10.1021/bi00121a019; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; ZHANG ZY, 1992, J BIOL CHEM, V267, P23759; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; ZHANG ZY, 1994, J BIOL CHEM, V269, P8140; ZHANG ZY, 1991, BIOCHEMISTRY-US, V30, P8954, DOI 10.1021/bi00101a006; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; ZHANG ZY, 1994, ADV ENZYMOL RAMB, V68, P1; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P15266, DOI 10.1021/bi00255a007; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516	40	98	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11199	11204		10.1074/jbc.270.19.11199	http://dx.doi.org/10.1074/jbc.270.19.11199			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744751	hybrid			2022-12-27	WOS:A1995QX86500028
J	LIU, H; TAN, XQ; RUSSELL, KA; VEENHUIS, M; CREGG, JM				LIU, H; TAN, XQ; RUSSELL, KA; VEENHUIS, M; CREGG, JM			PER3, A GENE REQUIRED FOR PEROXISOME BIOGENESIS IN PICHIA-PASTORIS, ENCODES A PEROXISOMAL MEMBRANE-PROTEIN INVOLVED IN PROTEIN IMPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST HANSENULA-POLYMORPHA; RAT-LIVER PEROXISOMES; ACYL-COA OXIDASE; ZELLWEGER SYNDROME; TARGETING SIGNAL; 3-KETOACYL-COA THIOLASE; CANDIDA-TROPICALIS; SACCHAROMYCES-CEREVISIAE; FIREFLY LUCIFERASE; MOLECULAR ANALYSIS	PER genes are essential for the biogenesis of peroxisomes in the yeast Pichia pastoris. Here we describe the cloning of PER3 and functional characterization of its product Per3p. The PER3 sequence predicts that Per3p is a 713-amino acid (81-kDa) hydrophobic protein with at least three potential membrane-spanning domains. We show that Per3p is a membrane protein of the peroxisome. Methanol- or oleate-induced cells of per3-1, a mutant strain generated by chemical mutagenesis, lack normal peroxisomes but contain numerous abnormal vesicular structures. The vesicles contain thiolase, a PTS2 protein, but only a small portion of several other peroxisomal enzymes, including heterologously expressed luciferase, a PTS1 protein. These results suggest that the vesicles in per3-1 cells are peroxisomal remnants similar to those observed in cells of patients with the peroxisomal disorder Zellweger syndrome, and that the mutant is deficient in PTS1 but not PTS2 import. In a strain in which most of PER3 was deleted, peroxisomes as well as peroxisomal remnants appeared to be completely absent, and both PTS1- and PTS2-containing enzymes were located in the cytosol. We propose that Per3p is an essential component of the machinery re quired for import of all peroxisomal matrix proteins and is composed of independent domains involved in the import of specific PTS groups.	OREGON GRAD INST SCI & TECHNOL,DEPT CHEM BIOCHEM & MOLEC BIOL,PORTLAND,OR 97291; UNIV GRONINGEN,CTR BIOL,ELECTRON MICROSCOPY LAB,9751 NN HAREN,NETHERLANDS	University of Groningen					NIDDK NIH HHS [DK-43698] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043698] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALFE A, 1990, PEDIATR RES, V27, P304, DOI 10.1203/00006450-199003000-00023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUINENBERG PG, 1990, YEAST, V6, P245, DOI 10.1002/yea.320060309; BUCHEL DE, 1980, NATURE, V283, P541, DOI 10.1038/283541a0; CREGG JM, 1985, MOL CELL BIOL, V9, P3376; CREGG JM, 1989, GENETICS MOL BIOL IN, P343; DEHOOP MJ, 1992, BIOCHEM J, V286, P657, DOI 10.1042/bj2860657; DIDION T, 1992, FEBS LETT, V303, P113, DOI 10.1016/0014-5793(92)80500-G; DOMMES V, 1981, J BIOL CHEM, V256, P8259; DOUMA AC, 1985, ARCH MICROBIOL, V143, P237, DOI 10.1007/BF00411242; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; EVERS ME, 1994, MOL BIOL CELL, V5, P829, DOI 10.1091/mbc.5.8.829; FABER KN, 1995, FEBS LETT, V357, P115, DOI 10.1016/0014-5793(94)01317-T; Fahimi HD, 1987, PEROXISOMES BIOL MED; FUJIKI Y, 1984, P NATL ACAD SCI-BIOL, V81, P7127, DOI 10.1073/pnas.81.22.7127; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; GARRARD LJ, 1989, J BIOL CHEM, V264, P13929; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; GREEN S, 1992, BIOCHEM PHARMACOL, V43, P393, DOI 10.1016/0006-2952(92)90554-V; HANSEN H, 1992, MOL GEN GENET, V235, P269, DOI 10.1007/BF00279370; HEIKOOP JC, 1992, EUR J CELL BIOL, V57, P165; IMANAKA T, 1987, J CELL BIOL, V105, P2915, DOI 10.1083/jcb.105.6.2915; JANOWICZ ZA, 1985, NUCLEIC ACIDS RES, V13, P3043, DOI 10.1093/nar/13.9.3043; KAMIRYO T, 1989, AGR BIOL CHEM TOKYO, V53, P179, DOI 10.1080/00021369.1989.10869248; KAMIRYO T, 1982, J BACTERIOL, V152, P269; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; KOUTZ P, 1989, YEAST, V5, P167, DOI 10.1002/yea.320050306; KRAGLER F, 1993, J CELL BIOL, V120, P665, DOI 10.1083/jcb.120.3.665; KURIHARA T, 1992, EUR J BIOCHEM, V210, P999, DOI 10.1111/j.1432-1033.1992.tb17505.x; KURTZMAN CP, 1984, A VAN LEEUW J MICROB, V50, P209, DOI 10.1007/BF02342132; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazarow P. B., 1989, METABOLIC BASIS INHE, P1479; LEDEBOER AM, 1985, NUCLEIC ACIDS RES, V13, P3063, DOI 10.1093/nar/13.9.3063; LIU H, 1992, J BACTERIOL, V174, P4943, DOI 10.1128/JB.174.15.4943-4951.1992; MACCAMMON MT, 1994, J CELL BIOL, V124, P915; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MICHELS PAM, 1986, EMBO J, V5, P1049, DOI 10.1002/j.1460-2075.1986.tb04321.x; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; NGUYEN VT, 1988, ANAL BIOCHEM, V171, P404, DOI 10.1016/0003-2697(88)90505-2; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; RAYMOND CK, 1990, J CELL BIOL, V111, P877, DOI 10.1083/jcb.111.3.877; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOS MJ, 1988, J BIOL CHEM, V263, P10502; SANTOS MJ, 1988, SCIENCE, V239, P1536, DOI 10.1126/science.3281254; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SMALL GM, 1988, EMBO J, V7, P1167, DOI 10.1002/j.1460-2075.1988.tb02927.x; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SULTER GJ, 1993, YEAST, V9, P733, DOI 10.1002/yea.320090707; SWINKELS BW, 1992, FEBS LETT, V305, P133, DOI 10.1016/0014-5793(92)80880-P; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tolbert N E, 1974, Methods Enzymol, V31, P734; UEDA M, 1990, METHOD ENZYMOL, V188, P463; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANDERKLEI IJ, 1990, METHOD ENZYMOL, V188, P420; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VEENHUIS M, 1983, ARCH MICROBIOL, V134, P193, DOI 10.1007/BF00407757; VEENHUIS M, 1991, YEASTS, V4, P601; WANDERS RJA, 1984, BIOCHEM BIOPH RES CO, V123, P1054, DOI 10.1016/S0006-291X(84)80240-5; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737; WATERHAM HR, 1992, YEAST, V8, P961, DOI 10.1002/yea.320081106; WENDLAND M, 1993, J CELL BIOL, V120, P675, DOI 10.1083/jcb.120.3.675; WIEMER EAC, 1989, EUR J CELL BIOL, V50, P407; YAJIMA S, 1992, HUM GENET, V88, P491, DOI 10.1007/BF00219334; YAMAMOTO R, 1991, P NATL ACAD SCI USA, V88, P463, DOI 10.1073/pnas.88.2.463; ZHANG JW, 1993, MOL BIOL CELL, V4, P1351, DOI 10.1091/mbc.4.12.1351	74	86	91	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10940	10951		10.1074/jbc.270.18.10940	http://dx.doi.org/10.1074/jbc.270.18.10940			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738036	hybrid			2022-12-27	WOS:A1995QW60100084
J	MERTENS, L; VANDENBOSCH, L; VERBOOMEN, H; WUYTACK, F; DESMEDT, H; EGGERMONT, J				MERTENS, L; VANDENBOSCH, L; VERBOOMEN, H; WUYTACK, F; DESMEDT, H; EGGERMONT, J			SEQUENCE AND SPATIAL REQUIREMENTS FOR REGULATED MUSCLE-SPECIFIC PROCESSING OF THE SARCOPLASMIC ENDOPLASMIC RETICULUM CA2+-ATPASE 2 GENE TRANSCRIPT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SARCOPLASMIC-RETICULUM; SPLICE SITES; CA-2+ PUMP; CA2+ PUMP; DIFFERENTIATION; ATPASE; INTRON; EXPRESSION; DEFINITION	Expression of the muscle-specific 2a isoform of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA2) requires activation of an otherwise inefficient splicing process at the 3'-end of the primary gene transcript, The sequence and topology requirements for this regulated splicing event were studied in the BC(3)H1 myogenic cell line using a minigene containing the 3'-end of the SERCA2 gene, In undifferentiated BC(3)H1 cells, the splice process is made inefficient by the presence of a weak muscle-type 5'-donor site (5'D1) and a long terminal intron, Both optimizing the 5'D1 and decreasing the length of the muscle-specific intron, induced muscle type splicing in undifferentiated myogenic cells, Moreover, the induction of muscle-type transcripts was only observed when two competing processing sites, the polyadenylation site (pA(u)) used in non-muscle cells and the second neuronal 5'-donor site (5'D2), were weak, Indeed, making 5'D2 consensus induced neuronal-type splicing in undifferentiated myocytes and prevented the appearance of muscle-type transcripts, Similarly, replacing the polyadenylation site (pA(u)) with a strong site almost completely inhibited muscle-type splicing after myogenic differentiation. We conclude that weak processing sites and a long terminal intron are required for tissue-dependent mRNA processing of the SERCA2 transcript.			MERTENS, L (corresponding author), CATHOLIC UNIV LEUVEN,PHYSIOL LAB,CAMPUS GASTHUISBERG,B-3000 LOUVAIN,BELGIUM.		Van Den Bosch, Ludo/B-7258-2012	Mertens, Luc/0000-0001-7308-1268; Eggermont, Jan/0000-0002-8497-1159; Van Den Bosch, Ludo/0000-0003-0104-4067				ANGER M, 1994, J MOL CELL CARDIOL, V26, P539, DOI 10.1006/jmcc.1994.1064; BOBE R, 1994, J BIOL CHEM, V269, P1417; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEJAEGERE S, 1993, BIOCHIM BIOPHYS ACTA, V1173, P188, DOI 10.1016/0167-4781(93)90180-L; DELABASTIE D, 1988, FEBS LETT, V229, P45, DOI 10.1016/0014-5793(88)80794-4; DESMEDT H, 1991, J BIOL CHEM, V266, P7092; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; EGGERMONT J, 1991, BIOCHEM J, V271, P649; EGGERMONT JA, 1990, BIOCHEM J, V266, P901; EPERON IC, 1993, EMBO J, V12, P3607, DOI 10.1002/j.1460-2075.1993.tb06034.x; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HOROWITZ DS, 1994, TRENDS GENET, V10, P100, DOI 10.1016/0168-9525(94)90233-X; KORCZAK B, 1988, J BIOL CHEM, V263, P48133; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; LUKASHIN AV, 1992, NUCLEIC ACIDS RES, V20, P2511, DOI 10.1093/nar/20.10.2511; LYTTON J, 1992, J BIOL CHEM, V267, P14483; LYTTON J, 1988, J BIOL CHEM, V263, P15024; MOORMAN A, 1994, J MOL CELL CARDIOL, V26, P90; PETERSON ML, 1986, P NATL ACAD SCI USA, V83, P8883, DOI 10.1073/pnas.83.23.8883; PLESSERS L, 1991, J NEUROSCI, V11, P650; Sambrook J, 1989, MOL CLONING LABORATO; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; TIAN M, 1993, CELL, V74, P105, DOI 10.1016/0092-8674(93)90298-5; TSURUSHITA N, 1987, MOL CELL BIOL, V7, P2602, DOI 10.1128/MCB.7.7.2602; VANDENBOSCH L, 1994, BIOCHEM J, V302, P559, DOI 10.1042/bj3020559; VANOOYEN A, 1979, SCIENCE, V206, P337, DOI 10.1126/science.482942; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; WUYTACK F, 1994, J BIOL CHEM, V269, P1410; WUYTACK F, 1992, ANN NY ACAD SCI, V671, P82, DOI 10.1111/j.1749-6632.1992.tb43786.x	36	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					11004	11011		10.1074/jbc.270.18.11004	http://dx.doi.org/10.1074/jbc.270.18.11004			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738043	hybrid			2022-12-27	WOS:A1995QW60100092
J	KONIECZNY, I; MARSZALEK, J				KONIECZNY, I; MARSZALEK, J			THE REQUIREMENT FOR MOLECULAR CHAPERONES IN LAMBDA-DNA REPLICATION IS REDUCED BY THE MUTATION-PI IN LAMBDA-P GENE, WHICH WEAKENS THE INTERACTION BETWEEN LAMBDA-P PROTEIN AND DNAB HELICASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DNAB; SPECIALIZED NUCLEOPROTEIN STRUCTURES; HEAT-SHOCK PROTEINS; BACTERIOPHAGE-LAMBDA; O-PROTEIN; PHAGE-LAMBDA; INITIATION; ORIGIN; COMPLEX; INVITRO	During the initiation of lambda DNA replication, the host DnaB helicase is complexed with phage lambda P protein in order to be properly positioned near the ori lambda-lambda O initiation complex, However, the lambda P-DnaB interaction inhibits the activities of DnaB, Thus, the concerted action of bacterial heat shock proteins, DnaK, DnaJ, and GrpE, is required to activate the helicase. Wild-type phage lambda cannot grow on the E, coli dnaB, dnaK dnaJ, and grpE mutants, However, lambda phage with a mutation pi in the lambda P gene, is able to produce progeny in these mutants as well as in the wild-type bacteria, Purified mutant lambda pi protein reveals a much lower affinity to DnaB than wildtype lambda P, and the lambda pi-DnaB complex is unstable, Also, a very low concentration of DnaK protein is sufficient to activate the helicase in a replication system based on lambda dv dsDNA. In that system, the mutant DnaK756 protein, inactive in the lambda P-dependent replication, revealed its activity in the lambda pi-dependent reaction, The lambda O-lambda P-dependent replication system based on M13 ssDNA efficiently replicates DNA in the absence of any chaperone protein, unless lambda P is substituted by the lambda pi mutant protein, Data presented in this paper explain why lambda pi phage is able to grow on wild-type and dnaK756 bacteria.	UNIV GDANSK,DEPT BIOL MOLEC,PL-80222 GDANSK,POLAND	Fahrenheit Universities; University of Gdansk			Marszalek, Jaroslaw/F-5824-2011	Marszalek, Jaroslaw/0000-0002-6978-1189; Konieczny, Igor/0000-0002-1588-5601				ALFANO C, 1989, J BIOL CHEM, V260, P10699; ALFANO C, 1989, J BIOL CHEM, V260, P10709; ALLEN GC, 1991, J BIOL CHEM, V266, P22096; ARAI K, 1981, J BIOL CHEM, V256, P5247; BAKER TA, 1986, CELL, V54, P53; DODSON M, 1985, P NATL ACAD SCI USA, V82, P4678, DOI 10.1073/pnas.82.14.4678; DODSON M, 1986, P NATL ACAD SCI USA, V83, P7638, DOI 10.1073/pnas.83.20.7638; DODSON M, 1989, J BIOL CHEM, V264, P10719; DRAHOS DJ, 1982, J BACTERIOL, V149, P1050, DOI 10.1128/JB.149.3.1050-1063.1982; GEORGOPOULOS C, 1971, BACTERIOPHAGE LAMBDA, P191; HOFFMANN HJ, 1992, P NATL ACAD SCI USA, V89, P12108, DOI 10.1073/pnas.89.24.12108; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; KLEIN A, 1980, EUR J BIOCHEM, V105, P1, DOI 10.1111/j.1432-1033.1980.tb04467.x; KLINKERT J, 1978, J VIROL, V25, P730, DOI 10.1128/JVI.25.3.730-737.1978; Kornberg A., 1992, DNA REPLICATION; LEBOWITZ JH, 1985, P NATL ACAD SCI USA, V82, P3988, DOI 10.1073/pnas.82.12.3988; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; LIBEREK K, 1990, J BIOL CHEM, V265, P3022; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; MALLORY JB, 1990, J BIOL CHEM, V265, P13297; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MARSZALEK J, 1992, J BIOL CHEM, V267, P19334; MASAI H, 1990, J BIOL CHEM, V265, P15134; MENSAWILMOT K, 1989, J BIOL CHEM, V264, P2853; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; Pawlowicz Alicja, 1993, Acta Biochimica Polonica, V40, P29; REISER W, 1983, MOL GEN GENET, V192, P430, DOI 10.1007/BF00392186; ROBERTS JD, 1983, NUCLEIC ACIDS RES, V11, P7435, DOI 10.1093/nar/11.21.7435; SAITO H, 1977, J MOL BIOL, V113, P1, DOI 10.1016/0022-2836(77)90038-9; Sambrook J, 1989, MOL CLONING LABORATO; SCHNOS M, 1988, CELL, V52, P385, DOI 10.1016/S0092-8674(88)80031-X; SCHUSTER RC, 1980, MOL GEN GENET, V178, P429; SHERMAN MY, 1992, EMBO J, V11, P71; SZALEWSKA A, 1994, MOL MICROBIOL, V13, P469, DOI 10.1111/j.1365-2958.1994.tb00441.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TIPPESCHINDLER R, 1979, MOL GEN GENET, V168, P185, DOI 10.1007/BF00431444; TSURIMOTO T, 1981, MOL GEN GENET, V181, P325, DOI 10.1007/BF00425606; TSURIMOTO T, 1981, MOL GEN GENET, V187, P79; WAHLE E, 1989, J BIOL CHEM, V264, P2463; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; WICKNER SH, 1979, COLD SPRING HARB SYM, V43, P303, DOI 10.1101/SQB.1979.043.01.037; WOLD MS, 1982, P NATL ACAD SCI-BIOL, V79, P6176, DOI 10.1073/pnas.79.20.6176; YAMAMOTO T, 1987, J BIOL CHEM, V262, P7996; ZAHN K, 1985, EMBO J, V4, P3605, DOI 10.1002/j.1460-2075.1985.tb04124.x; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1993, PHILOS T ROY SOC B, V339, P271, DOI 10.1098/rstb.1993.0025; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591; ZYLICZ M, 1984, MOL GEN GENET, V196, P401, DOI 10.1007/BF00436186	49	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9792	9799		10.1074/jbc.270.17.9792	http://dx.doi.org/10.1074/jbc.270.17.9792			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730358	hybrid			2022-12-27	WOS:A1995QV41700017
J	LEHMANN, JM; MOORE, LB; SMITHOLIVER, TA; WILKISON, WO; WILLSON, TM; KLIEWER, SA				LEHMANN, JM; MOORE, LB; SMITHOLIVER, TA; WILKISON, WO; WILLSON, TM; KLIEWER, SA			AN ANTIDIABETIC THIAZOLIDINEDIONE IS A HIGH-AFFINITY LIGAND FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA(PPAR-GAMMA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ENHANCES ADIPOCYTE DIFFERENTIATION; GLUCOCORTICOID RECEPTOR; FATTY-ACIDS; SUPERFAMILY; MEMBER; IDENTIFICATION; DOMAINS; FAMILY; CELLS; AGENT	Thiazolidinedione derivatives are antidiabetic agents that increase the insulin sensitivity of target tissues in animal models of non-insulin dependent diabetes mellitus. In vitro, thiazolidinediones promote adipocyte differentiation of preadipocyte and mesenchymal stem cell lines; however, the molecular basis for this adipogenic effect has remained unclear. Here, we report that thiazolidinediones are potent and selective activators of peroxisome proliferator activated receptor gamma (PPAR gamma), a member of the nuclear receptor superfamily recently shown to function in adipogenesis. The most potent of these agents, BRL49653, binds to PPAR gamma with a K-d of approximately 40 nM. Treatment of pluripotent C3H10T1/2 stem cells with BRL49653 results in efficient differentiation to adipocytes. These data are the first demonstration of a high affinity PPAR ligand and provide strong evidence that PPAR gamma is a molecular target for the adipogenic effects of thiazolidinediones. Furthermore, these data raise the intriguing possibility that PPAR gamma is a target for the therapeutic actions of this class of compounds.	GLAXO INC,RES INST,DEPT MED CHEM,RES TRIANGLE PK,NC 27709; GLAXO INC,RES INST,DEPT BIOCHEM,RES TRIANGLE PK,NC 27709; GLAXO INC,RES INST,DEPT CELLULAR BIOCHEM,RES TRIANGLE PK,NC 27709	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline			feinstein, doug/M-9414-2019					CANTELLO BCC, 1994, J MED CHEM, V37, P3977, DOI 10.1021/jm00049a017; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; CHEN F, 1993, BIOCHEM BIOPH RES CO, V196, P671, DOI 10.1006/bbrc.1993.2302; COLCA JR, 1990, NEW ANTIDIABETIC DRU, P255; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HARRIS PKW, 1994, MOL PHARMACOL, V45, P439; HIRAGUN A, 1988, J CELL PHYSIOL, V134, P124, DOI 10.1002/jcp.1041340115; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HUSSMAN M, 1991, MOL CELL BIOL, V11, P4097; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; KELLER H, 1993, TRENDS ENDOCRIN MET, V4, P291, DOI 10.1016/1043-2760(93)90048-J; KLETZIEN RF, 1992, MOL PHARMACOL, V41, P393; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MCGARRY JD, 1994, J CELL BIOCHEM, V55, P29, DOI 10.1002/jcb.240550005; SANDOUK T, 1993, AM J PHYSIOL, V264, pC1600, DOI 10.1152/ajpcell.1993.264.6.C1600; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; SPARKS RL, 1991, J CELL PHYSIOL, V146, P101, DOI 10.1002/jcp.1041460114; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZHU YJ, 1993, J BIOL CHEM, V268, P26817	30	3292	3458	5	178	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12953	12956		10.1074/jbc.270.22.12953	http://dx.doi.org/10.1074/jbc.270.22.12953			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768881	hybrid			2022-12-27	WOS:A1995RB43900002
J	LEIDICH, SD; KOSTOVA, Z; LATEK, RR; COSTELLO, LC; DRAPP, DA; GRAY, W; FASSLER, JS; ORLEAN, P				LEIDICH, SD; KOSTOVA, Z; LATEK, RR; COSTELLO, LC; DRAPP, DA; GRAY, W; FASSLER, JS; ORLEAN, P			TEMPERATURE-SENSITIVE YEAST GPI ANCHORING MUTANTS GPI2 AND GPI3 ARE DEFECTIVE IN THE SYNTHESIS OF N-ACETYLGLUCOSAMINYL PHOSPHATIDYLINOSITOL - CLONING OF THE GP12 GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; CELL-SURFACE MOLECULES; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; PIG-A; BIOSYNTHESIS; PROTEIN; LYMPHOMA; THY-1; EXPRESSION	To identify genes required for the synthesis of glycosyl phosphatidylinositol (GPI) membrane anchors in yeast, we devised a way to isolate GPI anchoring mutants in which colonies are screened for defects in [H-3]-inositoI incorporation into protein. The gpi1 mutant, identified in this way, is temperature sensitive for growth and defective in vitro in the synthesis of GlcNAc-phosphatidylinositol, the first intermediate in GPI biosynthesis (Leidich, S. D., Drapp, D. A., and Orlean, P. (1994) J. Biol. Chem. 269, 10193-10196). We report the isolation of two more conditionally lethal mutants, gpi2 and gpi3, which, like gpi1, have a temperature-sensitive defect in the incorporation of [H-3]inositol into protein and which lack in vitro GlcNAc-phosphatidylinositol synthetic activity. Haploid Saccharomyces cerevisiae strains containing any pairwise combination of the gpi1, gpi2, and gpi3 mutations are inviable. The GPI2 gene, cloned by complementation of the gpi2 mutant's temperature sensitivity, encodes a hydrophobic 269-amino acid protein that resembles no other gene product known to participate in GPI assembly. Gene disruption experiments show that GPI2 is required for vegetative growth. Overexpression of the GPI2 gene causes partial suppression of the gpi1 mutant's temperature sensitivity, a result that suggests that the Gpi1 and Gpi2 proteins interact with one another in vivo. The gpi3 mutant is defective in the SPT14 gene, which encodes a yeast protein similar to the product of the mammalian PIG-A gene, which complements a GlcNAc-phosphatidylinositol synthesis-defective human cell line. In yeast, at least three gene products are required for the first step in GPI synthesis, as is the case in mammalian cells, and utilization of several different proteins at this stage is therefore likely to be a general characteristic of the GPI synthetic pathway.	UNIV ILLINOIS,DEPT BIOCHEM,URBANA,IL 61801; UNIV IOWA,DEPT BIOL,IOWA CITY,IA 52242	University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa			Gray, William M/F-9402-2010	Gray, William M/0000-0002-1320-290X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM040306, R01GM046220] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46220, GM40306] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARMSTRONG C, 1992, J BIOL CHEM, V267, P25347; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CONZELMANN A, 1986, EMBO J, V5, P3291, DOI 10.1002/j.1460-2075.1986.tb04642.x; COSTELLO LC, 1992, J BIOL CHEM, V267, P8599; De Nobel Hans, 1994, Trends in Cell Biology, V4, P42, DOI 10.1016/0962-8924(94)90003-5; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; FASSLER JS, 1988, GENETICS, V118, P203; FASSLER JS, 1991, MOL GEN GENET, V230, P310, DOI 10.1007/BF00290682; FATEMI SH, 1986, CELL, V46, P653, DOI 10.1016/0092-8674(86)90340-5; Henry S. A., 1982, MOL BIOL YEAST SACCH, P101; HIROSE S, 1992, J BIOL CHEM, V267, P5272; HIROSE S, 1992, P NATL ACAD SCI USA, V89, P6025, DOI 10.1073/pnas.89.13.6025; HYMAN R, 1988, TRENDS GENET, V4, P5, DOI 10.1016/0168-9525(88)90120-5; KAMITANI T, 1993, J BIOL CHEM, V268, P20733; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEIDICH SD, J BIOL CHEM, V1013, P94; LISANTI MP, 1990, TRENDS BIOCHEM SCI, V15, P113, DOI 10.1016/0968-0004(90)90195-H; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MIYATA T, 1993, SCIENCE, V259, P1318, DOI 10.1126/science.7680492; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; PUOTI A, 1991, J BIOL CHEM, V266, P21051; PUOTI A, 1991, J CELL BIOL, V113, P515, DOI 10.1083/jcb.113.3.515; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIKORSKI RS, 1989, GENETICS, V122, P19; SMITH SW, 1974, J BIOL CHEM, V249, P3395; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; STEVENS VL, 1991, J BIOL CHEM, V266, P10039; SUGIYAMA E, 1991, J BIOL CHEM, V266, P12119; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; VELOURS J, 1988, EUR J BIOCHEM, V170, P637, DOI 10.1111/j.1432-1033.1988.tb13745.x; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; YEH ETH, 1988, CELL, V52, P665, DOI 10.1016/0092-8674(88)90404-7	39	102	107	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13029	13035		10.1074/jbc.270.22.13029	http://dx.doi.org/10.1074/jbc.270.22.13029			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768896	hybrid			2022-12-27	WOS:A1995RB43900017
J	SULLI, C; SCHWARTZBACH, SD				SULLI, C; SCHWARTZBACH, SD			THE POLYPROTEIN PRECURSOR TO THE EUGLENA LIGHT-HARVESTING CHLOROPHYLL A/B-BINDING PROTEIN IS TRANSPORTED TO THE GOLGI-APPARATUS PRIOR TO CHLOROPLAST IMPORT AND POLYPROTEIN PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LHCP-II APOPROTEIN; THYLAKOID MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; TRANSIT PEPTIDE; PHOTOSYSTEM-II; SECRETORY PROTEINS; CELLS; GRACILIS; SIGNAL; LOCALIZATION	The major Euglena thylakoid protein, the light harvesting chlorophyll alb-binding protein of photosystem II (pLHCPII) is synthesized in the cytoplasm as a polyprotein precursor composed of a 141 amino acid presequence containing a signal peptide domain followed by eight mature LHCPIIs covalently Linked by a decapeptide. To determine the transport route from cytoplasm to chloroplast and the site of polyprotein processing, EugIena was pulse labeled with [S-35]sulfate, organelles separated on sucrose gradients, and pLRCPII and LHCPII immunoprecipitated and separated on SDS gels. After a 10-min pulse, the pLHCPII polyprotein was found in the endoplasmic reticulum (ER) and Golgi apparatus. LHCPII was undetectable after a 10-min pulse consistent with the 20-min half-life for pLHCPII processing. When pulse-labeled cells were chased for 20 or 40 min with unlabeled sulfate, the fraction of pLHCPII in the ER decreased, and the fraction in the Golgi apparatus increased. LHCPII appeared only in thylakoids and chloroplasts, never in the ER or Gels apparatus. Na,CO, extraction, a treatment that releases soluble but not integral membrane proteins, did not remove pLHCPII from ER and Golgi membranes. Trypsin digestion of ER and Golgi membranes produced 4 pLHCPII membrane protected fragments. The Euglena pLRCPII polyprotein is transported as an integral membrane protein from the ER to the Golgi apparatus and from the Gels apparatus to the chloroplast. Polyprotein processing appears to occur during or soon after chloroplast import of the membrane-bound precursor.	UNIV NEBRASKA, SCH BIOL SCI, LINCOLN, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln								ARION WJ, 1989, METHOD ENZYMOL, V174, P58; AUCHINCLOSS AH, 1992, J BIOL CHEM, V267, P10439; AUDIGIER Y, 1987, P NATL ACAD SCI USA, V84, P5783, DOI 10.1073/pnas.84.16.5783; BOWLES DJ, 1976, BIOCHIM BIOPHYS ACTA, V443, P360, DOI 10.1016/0005-2787(76)90500-1; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHAN RL, 1990, EMBO J, V9, P333, DOI 10.1002/j.1460-2075.1990.tb08115.x; CHIDANANDA S, 1993, MOL BIOL CELL, V4, pA105; DOCKERTY A, 1979, PLANT PHYSIOL, V63, P468, DOI 10.1104/pp.63.3.468; FELDMAN RI, 1987, J BIOL CHEM, V262, P9332; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GALBRAITH DW, 1992, PLANTA, V186, P324, DOI 10.1007/BF00195312; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; GILLOTT MA, 1980, PROTOPLASMA, V105, P45, DOI 10.1007/BF01279848; GRUNOW A, 1993, EUR J CELL BIOL, V61, P10; HAND JM, 1989, EMBO J, V8, P3195, DOI 10.1002/j.1460-2075.1989.tb08478.x; HORRUM MA, 1980, PLANTA, V149, P376, DOI 10.1007/BF00571173; HUANG LQ, 1992, PLANT PHYSIOL, V99, P247, DOI 10.1104/pp.99.1.247; JACKSON RC, 1977, P NATL ACAD SCI USA, V74, P5598, DOI 10.1073/pnas.74.12.5598; JONES EW, 1991, J BIOL CHEM, V266, P7963; KISHORE R, 1993, P NATL ACAD SCI USA, V90, P11845, DOI 10.1073/pnas.90.24.11845; KISHORE R, 1992, PLANT SCI, V85, P79, DOI 10.1016/0168-9452(92)90096-5; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KOHORN BD, 1986, J CELL BIOL, V102, P972, DOI 10.1083/jcb.102.3.972; KOHORN BD, 1991, J BIOL CHEM, V266, P12048; KUHLBRANDT W, 1991, NATURE, V350, P130, DOI 10.1038/350130a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPPA GK, 1988, J BIOL CHEM, V263, P14996; LILJESTROM P, 1991, J VIROL, V65, P147; LIN Q, 1994, J BIOL CHEM, V269, P9436; MONROY AF, 1987, PLANT SCI, V51, P61, DOI 10.1016/0168-9452(87)90221-4; MUCHHAL US, 1992, PLANT MOL BIOL, V18, P287, DOI 10.1007/BF00034956; MUCHHAL US, 1994, NUCLEIC ACIDS RES, V22, P5737, DOI 10.1093/nar/22.25.5737; OSAFUNE T, 1991, EXP CELL RES, V193, P320, DOI 10.1016/0014-4827(91)90103-2; OSAFUNE T, 1983, EXP CELL RES, V148, P530, DOI 10.1016/0014-4827(83)90176-3; OSAFUNE T, 1991, J ELECTRON MICROSC, V40, P41; OSAFUNE T, 1980, J ULTRA MOL STRUCT R, V73, P77, DOI 10.1016/0022-5320(80)90117-3; OSAFUNE T, 1990, J ELECTRON MICROSC, V39, P168; OSAFUNE T, 1980, J ULTRA MOL STRUCT R, V73, P64, DOI 10.1016/0022-5320(80)90116-1; OSAFUNE T, 1992, J STRUCT BIOL, V109, P97, DOI 10.1016/1047-8477(92)90041-8; PAYAN LA, 1991, J CELL BIOL, V112, P603, DOI 10.1083/jcb.112.4.603; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PERRY SE, 1994, PLANT CELL, V6, P93, DOI 10.1105/tpc.6.1.93; RIKIN A, 1988, P NATL ACAD SCI USA, V85, P5117, DOI 10.1073/pnas.85.14.5117; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; SAIDHA T, 1985, BIOCHEM J, V232, P357, DOI 10.1042/bj2320357; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIFF JA, 1991, J PHOTOCH PHOTOBIO B, V11, P219, DOI 10.1016/1011-1344(91)80262-G; SHARIF AL, 1989, EUR J BIOCHEM, V184, P353, DOI 10.1111/j.1432-1033.1989.tb15026.x; SHIGEMORI Y, 1994, PLANT MOL BIOL, V24, P209, DOI 10.1007/BF00040587; SHORE G, 1975, J CELL BIOL, V64, P557, DOI 10.1083/jcb.64.3.557; SMEEKENS SP, 1993, BIO-TECHNOL, V11, P182, DOI 10.1038/nbt0293-182; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; TESSIER LH, 1991, EMBO J, V10, P2621, DOI 10.1002/j.1460-2075.1991.tb07804.x; TOKUNAGA M, 1979, J PROTOZOOL, V26, P471, DOI 10.1111/j.1550-7408.1979.tb04655.x; VONHEIJNE G, 1988, BIOCHIM BIOPHYS ACTA, V947, P307, DOI 10.1016/0304-4157(88)90013-5; WAINWRIGHT IM, 1992, J PHYCOL, V28, P643, DOI 10.1111/j.0022-3646.1992.00643.x; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; XU HX, 1993, J CELL BIOL, V122, P1169, DOI 10.1083/jcb.122.6.1169	58	64	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13084	13090		10.1074/jbc.270.22.13084	http://dx.doi.org/10.1074/jbc.270.22.13084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768903	hybrid			2022-12-27	WOS:A1995RB43900024
J	BRAUWEILER, A; GARL, P; FRANKLIN, AA; GIEBLER, HA; NYBORG, JK				BRAUWEILER, A; GARL, P; FRANKLIN, AA; GIEBLER, HA; NYBORG, JK			A MOLECULAR MECHANISM FOR HUMAN T-CELL LEUKEMIA-VIRUS LATENCY AND TAX TRANSACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; TRANSCRIPTIONAL CONTROL REGION; MULTIPLE NUCLEAR FACTORS; CAMP-RESPONSIVE ELEMENT; DNA-BINDING PROTEINS; HTLV-I; ENHANCER ELEMENT; 21-BASE-PAIR ENHANCER; TRANS-ACTIVATOR; GENE-PRODUCT	The human T cell leukemia virus type I (HTLV-I) is the causative agent of an aggressive T-cell malignancy in humans. While the virus appears to maintain a state of latency in most infected cells, high level virion production is an essential step in the HTLV-I Life cycle, The virally-encoded Tax protein, a potent activator of gene expression, is believed to control the switch from latency to replication. Tax stimulation of HTLV-I transcription is mediated through cellular activating transcription factor/cAMP response element binding proteins, which bind the three al-base pair (bp) repeat viral enhancer elements, In this report, we show that viral latency may result from a highly unstable interaction between CREB and the HTLV-I 21-bp repeats, resulting in rapid dissociation of CREB from the viral promoter. In the presence Tax, the dissociation rate of CREB from a 21-bp repeat element is decreased. This stabilization is highly specific, requiring the amino-terminal region of CREB and appropriate 21-bp repeat sequences. me suggest that Tax stabilization of CREB binding to the viral promoter leads to an increase in gene expression, possibly providing the switch from latency to high level replication of the virus.	COLORADO STATE UNIV,DEPT BIOCHEM & MOLEC BIOL,FT COLLINS,CO 80523	Colorado State University					NATIONAL CANCER INSTITUTE [R55CA055035, R01CA055035] Funding Source: NIH RePORTER; NCI NIH HHS [CA-55035] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADYA N, 1994, P NATL ACAD SCI USA, V91, P5642, DOI 10.1073/pnas.91.12.5642; ALTMAN R, 1988, J VIROL, V62, P1339, DOI 10.1128/JVI.62.4.1339-1346.1988; ANDERSON MG, 1994, NUCLEIC ACIDS RES, V22, P3194, DOI 10.1093/nar/22.15.3194; ARMSTRONG AP, 1993, P NATL ACAD SCI USA, V90, P7303, DOI 10.1073/pnas.90.15.7303; BEIMLING P, 1992, ONCOGENE, V7, P257; BEIMLING P, 1988, ONCOGENE, V4, P511; BRADY J, 1987, J VIROL, V61, P2175, DOI 10.1128/JVI.61.7.2175-2181.1987; CONNOR LM, 1993, VIROLOGY, V195, P569, DOI 10.1006/viro.1993.1408; FRANKLIN AA, 1993, J BIOL CHEM, V268, P21225; Franklin Audrey A., 1995, Journal of Biomedical Science, V2, P17, DOI 10.1007/BF02257921; FUJII M, 1991, ONCOGENE, V6, P2349; FUJISAWA J, 1989, J VIROL, V63, P3234, DOI 10.1128/JVI.63.8.3234-3239.1989; FUJISAWA J, 1986, EMBO J, V5, P713, DOI 10.1002/j.1460-2075.1986.tb04272.x; FUJISAWA JI, 1991, J VIROL, V65, P4525, DOI 10.1128/JVI.65.8.4525-4528.1991; GIAM CZ, 1989, J BIOL CHEM, V264, P15236; HINUMA Y, 1982, INT J CANCER, V29, P631, DOI 10.1002/ijc.2910290606; HOEFFLER JP, 1991, MOL ENDOCRINOL, V5, P256, DOI 10.1210/mend-5-2-256; ISHIBASHI K, 1987, J IMMUNOL, V139, P1509; KAWANO F, 1985, CANCER-AM CANCER SOC, V55, P851, DOI 10.1002/1097-0142(19850215)55:4<851::AID-CNCR2820550424>3.0.CO;2-J; KINOSHITA T, 1989, P NATL ACAD SCI USA, V86, P5620, DOI 10.1073/pnas.86.14.5620; LOW KG, 1994, MOL CELL BIOL, V14, P4958, DOI 10.1128/MCB.14.7.4958; MATTHEWS MAH, 1992, MOL CELL BIOL, V12, P1986, DOI 10.1128/MCB.12.5.1986; MONTAGNE J, 1990, EMBO J, V9, P957, DOI 10.1002/j.1460-2075.1990.tb08194.x; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; NAKAMURA M, 1989, NUCLEIC ACIDS RES, V17, P5207, DOI 10.1093/nar/17.13.5207; NYBORG JK, 1990, J BIOL CHEM, V265, P8237; NYBORG JK, 1990, J BIOL CHEM, V265, P8230; NYBORG JK, 1988, P NATL ACAD SCI USA, V85, P1457, DOI 10.1073/pnas.85.5.1457; PACAUCCARALERTK.S, 1994, MOL CELL BIOL, V14, P456; PASKALIS H, 1986, P NATL ACAD SCI USA, V83, P6558, DOI 10.1073/pnas.83.17.6558; RIGGS AD, 1970, J MOL BIOL, V48, P67, DOI 10.1016/0022-2836(70)90219-6; SHIMOTOHNO K, 1986, P NATL ACAD SCI USA, V83, P8112, DOI 10.1073/pnas.83.21.8112; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; TAN TH, 1989, MOL CELL BIOL, V9, P1733, DOI 10.1128/MCB.9.4.1733; TSUCHIYA H, 1994, ONCOGENE, V9, P337; TSUJIMOTO A, 1991, J VIROL, V65, P1420, DOI 10.1128/JVI.65.3.1420-1426.1991; WAGNER S, 1993, SCIENCE, V262, P395, DOI 10.1126/science.8211160; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445; ZIFF EB, 1990, TRENDS GENET, V6, P69, DOI 10.1016/0168-9525(90)90081-G	41	80	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12814	12822		10.1074/jbc.270.21.12814	http://dx.doi.org/10.1074/jbc.270.21.12814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759537	hybrid			2022-12-27	WOS:A1995QZ71100074
J	LAW, B; ROSSIE, S				LAW, B; ROSSIE, S			THE DIMERIC AND CATALYTIC SUBUNIT FORMS OF PROTEIN PHOSPHATASE 2A FROM RAT-BRAIN ARE STIMULATED BY C-2-CERAMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; CERAMIDE; PURIFICATION; PHOSPHORYLATION; IDENTIFICATION; CALCINEURIN; TYPE-2A; GROWTH; KINASE	Protein phosphatase 2A (PP-2A) is a heterotrimeric enzyme consisting of a catalytic (C) subunit and A and B regulatory subunits, PP-2A is activated by ceramide in vitro suggesting that PP-2A may be a target of this putative second messenger in vivo (Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C., and Hannun, Y. A. (1993) J. Biol. Chem. 268, 15523-15530). In this study, sensitivity to ceramide was only observed when the B subunit was present, suggesting that the B subunit was required for ceramide activation, Here we show that dimeric PP-2A, produced from trimeric PP-2A by heparin-agarose-induced dissociation of the B subunit and isolated by preparative native electrophoresis, is activated by ceramide, The catalytic subunit of PP-2A, produced from trimeric PP-2A by freezing and thawing in the presence of 0.2 m beta-mercaptoethanol and isolated by gel filtration, is also activated by ceramide, The trimeric and catalytic subunit forms of PP-2A exhibit a similar dose dependence of activation by ceramide, and are stimulated to a similar extent at ceramide concentrations yielding maximal activation, These findings indicate that neither the A nor the B subunit is required for ceramide stimulation of PP-2A Together, these results demonstrate that the catalytic subunit contains a ceramide binding site and suggest that efforts to understand the mechanism of activation of PP-2A by ceramide should be focused on this subunit, The discovery that the catalytic subunit contains a ceramide binding site raises the possibility that other members of this serine/threonine phosphatase gene family may contain Lipid binding sites and be regulated by ceramide or other Lipid second messengers.	PURDUE UNIV,DEPT BIOCHEM 1153,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NINDS NIH HHS [NS31221] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031221, R29NS031221] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOLLAG DM, 1991, PROTEIN METHODS, P145; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHEN SC, 1989, J BIOL CHEM, V264, P7267; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1988, METHOD ENZYMOL, V159, P390; DENT P, 1990, FEBS LETT, V259, P281, DOI 10.1016/0014-5793(90)80027-G; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; FAVRE B, 1994, J BIOL CHEM, V269, P16311; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; GUO H, 1993, J BIOL CHEM, V268, P11193; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KAMIBAYASHI C, 1994, J BIOL CHEM, V269, P20139; KAMIBAYASHI C, 1991, J BIOL CHEM, V266, P13251; KIM MY, 1991, J BIOL CHEM, V266, P484; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; LEE J, 1993, J BIOL CHEM, V268, P19192; MAIZEL JV, 1971, METHOD VIROL, V51, P179; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; MUMBY MC, 1985, J BIOL CHEM, V260, P3763; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; RUEDIGER R, 1991, MOL CELL BIOL, V11, P4282, DOI 10.1128/MCB.11.8.4282; SHENG ZQ, 1993, J BIOL CHEM, V268, P4728; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; TAMURA S, 1980, EUR J BIOCHEM, V104, P347, DOI 10.1111/j.1432-1033.1980.tb04435.x; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981	34	83	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12808	12813		10.1074/jbc.270.21.12808	http://dx.doi.org/10.1074/jbc.270.21.12808			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759536	hybrid			2022-12-27	WOS:A1995QZ71100073
J	MENG, F; HOVERSTEN, MT; THOMPSON, RC; TAYLOR, L; WATSON, SJ; AKIL, H				MENG, F; HOVERSTEN, MT; THOMPSON, RC; TAYLOR, L; WATSON, SJ; AKIL, H			A CHIMERIC STUDY OF THE MOLECULAR-BASIS OF AFFINITY AND SELECTIVITY OF THE KAPPA-OPIOID AND THE DELTA-OPIOID RECEPTORS - POTENTIAL ROLE OF EXTRACELLULAR DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; FUNCTIONAL EXPRESSION; CLONING; RAT; BINDING; PEPTIDES; LIGAND; CDNA; IDENTIFICATION	Within the large family of G-protein-coupled receptors, a picture is emerging which contrasts the binding of small ligands and the binding of peptides to the seven-helix configuration of the proteins. Because of its unique richness in both peptide and non-peptide ligands, the opioid receptor family offers several advantages for achieving a better understanding of similarities and differences in ligand/receptor interactions across different classes of agonists and antagonists. Since multiple, naturally occurring, ligands interact with the multiple receptors with varying degrees of selectivity, this family is also an excellent model for examining the structural basis of selectivity. Thus, the molecular basis of binding affinity and selectivity of the kappa and the delta opioid receptors was investigated by the construction of four kappa/delta chimeric receptors. The pharmacological profiles of these chimeras as well as those of the wild type kappa and delta receptors were determined by their binding with several different categories of opioid ligands. A linear model was used to deduce the relative contribution of each corresponding pairs of kappa-delta receptor segments to the binding of a given ligand. The results show that the kappa and delta receptors bind the same opioid core differently and achieve their selectivity through different mechanisms. In addition, the interaction of a peptide ligand with a receptor appears to be different from that of a small ligand. Furthermore, these results point to a particularly important role of the second extracellular loop and the top half of transmembrane domain 4 in the binding of prodynorphin products. Together, the results suggest that these peptide receptors can be bound and activated via multiple binding pockets as a function of their own topography and the nature of the interacting ligand.			MENG, F (corresponding author), UNIV MICHIGAN,MENTAL HLTH RES INST,205 ZINA PITCHER PL,ANN ARBOR,MI 48109, USA.				NIADDK NIH HHS [P30-AM34933] Funding Source: Medline; NIDA NIH HHS [R01 DA02265] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002265] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN Y, 1993, MOL PHARMACOL, V44, P8; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FUKUDA K, 1993, FEBS LETT, V327, P311, DOI 10.1016/0014-5793(93)81011-N; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; HUGGENVIK JI, 1991, MOL ENDOCRINOL, V5, P921, DOI 10.1210/mend-5-7-921; IYENGAR S, 1986, J PHARMACOL EXP THER, V238, P429; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KONG HY, 1993, J BIOL CHEM, V268, P23055; LEANDER JD, 1985, J PHARMACOL EXP THER, V234, P463; LUTZ RA, 1992, J RECEPTOR RES, V12, P267, DOI 10.3109/10799899209074796; Mansour A., 1993, OPIOIDS, P79; MANZANARES J, 1990, NEUROENDOCRINOLOGY, V52, P200, DOI 10.1159/000125582; MENG F, 1993, P NATL ACAD SCI USA, V90, P9954, DOI 10.1073/pnas.90.21.9954; MINAMI M, 1993, FEBS LETT, V329, P291, DOI 10.1016/0014-5793(93)80240-U; MORLEY JE, 1983, PEPTIDES, V4, P797, DOI 10.1016/0196-9781(83)90069-4; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; OSTROWSKI J, 1992, ANNU REV PHARMACOL, V32, P167, DOI 10.1146/annurev.pharmtox.32.1.167; ROCHE PC, 1992, ENDOCRINOLOGY, V131, P268, DOI 10.1210/en.131.1.268; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; SCHWYZER R, 1986, BIOCHEMISTRY-US, V25, P6335, DOI 10.1021/bi00368a075; Schwyzer R, 1977, Ann N Y Acad Sci, V297, P3, DOI 10.1111/j.1749-6632.1977.tb41843.x; SIMON EJ, 1991, MED RES REV, V11, P357, DOI 10.1002/med.2610110402; SIMON EJ, 1986, ANN NY ACAD SCI, V463, P31, DOI 10.1111/j.1749-6632.1986.tb21501.x; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; SURRATT CK, 1994, J BIOL CHEM, V269, P20548; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; WANG JB, 1993, P NATL ACAD SCI USA, V90, P10230, DOI 10.1073/pnas.90.21.10230; WANG JB, 1994, J BIOL CHEM, V269, P25966; WATLING KJ, 1993, TRENDS PHARMACOL SCI, V14, P81, DOI 10.1016/0165-6147(93)90067-T; WOOD PL, 1982, NEUROPHARMACOLOGY, V21, P487, DOI 10.1016/0028-3908(82)90038-7; XIE YB, 1990, J BIOL CHEM, V265, P21411; XUE JC, 1994, J BIOL CHEM, V369, P30195; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736	37	110	111	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12730	12736		10.1074/jbc.270.21.12730	http://dx.doi.org/10.1074/jbc.270.21.12730			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759527	hybrid			2022-12-27	WOS:A1995QZ71100063
J	ZHOU, GC; BAO, ZQ; DIXON, JE				ZHOU, GC; BAO, ZQ; DIXON, JE			COMPONENTS OF A NEW HUMAN PROTEIN-KINASE SIGNAL-TRANSDUCTION PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN	We have identified two components of a new protein kinase signaling cascade, MAPK/ERK kinase 5 (MEK5) and extracellular signal-regulated kinase 5 (ERK5). The MEK5 cDNA was isolated by degenerate PCR and encodes a 444-amino acid protein, which has approximately 40% identity to known MEKs. ERK5 was identified by a specific interaction with the MEK5 mutants S311A/T315A and K195M in the yeast two-hybrid system, The proteins were found to interact in an in vitro binding assay as well. ERK5 did not interact with MEK1 or MEK2. ERK5 is predicted to contain 815 amino acids and is approximately twice the size of all known ERKs. The C terminus of ERK5 has sequences which suggest that it may be targeted to the cytoskeleton. Sequences located in the N terminus of MEK5 may be important in coupling GTPase signaling molecules to the MEK5 protein kinase cascade. Both MEK5 and ERK5 are expressed in many adult tissue and are abundant in heart and skeletal muscle. A recombinant GST-ERK5 kinase domain displays autophosphorylation on Ser/Thr and Tyr residues.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R37DK018024] Funding Source: NIH RePORTER; NIDDK NIH HHS [NIDDKD 18024] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; AMMERER G, 1994, CURR OPIN GENET DEV, V4, P90, DOI 10.1016/0959-437X(94)90096-5; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LUNDBLAD V, 1988, CURRENT PROTOCOLS MO; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MIYAMOTO S, 1987, GENE, V54, P125, DOI 10.1016/0378-1119(87)90354-4; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SEGER R, 1994, J BIOL CHEM, V269, P25699; STURGILL TW, 1986, BIOCHEM BIOPH RES CO, V134, P565, DOI 10.1016/S0006-291X(86)80457-0; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; WU J, 1993, P NATL ACAD SCI USA, V90, P173, DOI 10.1073/pnas.90.1.173; ZHENG CF, 1993, J BIOL CHEM, V268, P11435; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x; ZHENG Y, 1994, J BIOL CHEM, V269, P2369	29	523	546	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12665	12669		10.1074/jbc.270.21.12665	http://dx.doi.org/10.1074/jbc.270.21.12665			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759517	hybrid			2022-12-27	WOS:A1995QZ71100053
J	AMIN, N; PETERKOFSKY, A				AMIN, N; PETERKOFSKY, A			A DUAL MECHANISM FOR REGULATING CAMP LEVELS IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE ADENYLATE CYCLASE; PHOSPHODIESTERASE; PHOSPHATE	In Escherichia coli, inorganic orthophosphate regulates cAMP levels by acting at two separate loci. First, adenylyl cyclase activity measured in permeabilized cells of E. coli is substantially stimulated by physiological concentrations of inorganic phosphate. This stimulation does not require the presence of cAMP phosphodiesterase activity. Second, measurements of cAMP phosphodiesterase activity in permeabilized cells show a dose dependent inhibition of that activity by inorganic orthophosphate. A model is proposed in which inorganic orthophosphate serves as a multifaceted regulator of cAMP levels by both stimulating synthesis and inhibiting degradation of the nucleotide.	NHLBI,BIOCHEM GENET LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)								ALPER MD, 1975, J BACTERIOL, V122, P1081, DOI 10.1128/JB.122.3.1081-1090.1975; AMIN N, 1992, BIOCHEM BIOPH RES CO, V182, P1218, DOI 10.1016/0006-291X(92)91861-J; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; FRASER ADE, 1978, CAN J MICROBIOL, V24, P1423, DOI 10.1139/m78-228; HARWOOD JP, 1975, J BIOL CHEM, V250, P4656; IWASA Y, 1981, FEBS LETT, V124, P207, DOI 10.1016/0014-5793(81)80138-X; LIBERMAN E, 1985, J BIOL CHEM, V260, P4075; Nielsen L D, 1974, Methods Enzymol, V38, P249; NIELSEN LD, 1973, J BACTERIOL, V116, P857, DOI 10.1128/JB.116.2.857-866.1973; PETERKOFSKY A, 1993, PROG NUCLEIC ACID RE, V44, P31, DOI 10.1016/S0079-6603(08)60216-0; PETERKOFSKY A, 1977, TRENDS BIOCHEM SCI, V2, P12, DOI 10.1016/0968-0004(77)90317-6; RAO N, 1994, PHOSPHATE IN MICROORGANISMS, P22; REDDY P, 1985, GENE MANIPULATION EX, P31; ROSENBERG H, 1982, J BACTERIOL, V149, P123, DOI 10.1128/JB.149.1.123-130.1982; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X	15	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11803	11805		10.1074/jbc.270.20.11803	http://dx.doi.org/10.1074/jbc.270.20.11803			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744829	hybrid			2022-12-27	WOS:A1995QY73600023
J	CHEN, YR; HARTMANN, FC				CHEN, YR; HARTMANN, FC			A SIGNATURE OF THE OXYGENASE INTERMEDIATE IN CATALYSIS BY RIBULOSE-BISPHOSPHATE CARBOXYLASE OXYGENASE AS PROVIDED BY A SITE-DIRECTED MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							1,5-BISPHOSPHATE CARBOXYLASE; ACTIVE-SITE; RIBULOSEBISPHOSPHATE CARBOXYLASE; MECHANISM; PRODUCTS; SPINACH	An uncharacterized minor transient product, observed in our earlier studies of substrate turnover by the E48Q mutant of Rhodospirillum rubrum ribulose-bisphosphate carboxylase/oxygenase (Lee, E. H., Harpel, M. R., Chen, Y. R., and Hartman, F. C. (1993) J. Biol. Chem. 268, 26583-26591), becomes a major product when it is trapped and stabilized with berate as an additive to the reaction mixture. Chemical characterization establishes this novel product as D-glycero-2,3-pentodiulose 1,5-bisphosphate, thereby demonstrating oxidation of the C-3 hydroxyl of D- ribulose 1,5-bisphosphate to a carbonyl. As the formation of the novel oxidation product is oxygen-dependent and generates hydrogen peroxide, its precursor must be a peroxy derivative of ribulose bisphosphate. Thus, discovery of the dicarbonyl bisphosphate lends direct support to the long standing, but heretofore unproven, postulate that the normal pathway for oxidative cleavage of ribulose bisphosphate by the wild-type enzyme entails a peroxy intermediate. Our results also suggest that stabilization of the peroxy intermediate by the wild-type enzyme promotes carbon-carbon scission as opposed to elimination of hydrogen peroxide.	OAK RIDGE NATL LAB,DIV BIOL,PROT ENGN PROGRAM,OAK RIDGE,TN 37831; UNIV TENNESSEE,GRAD SCH BIOMED SCI,OAK RIDGE,TN 37831	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville								ANDERSSON I, 1989, NATURE, V337, P229, DOI 10.1038/337229a0; BRANDEN R, 1984, BIOCHEMISTRY-US, V23, P4378; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; EDMONDSON DL, 1990, FEBS LETT, V260, P62, DOI 10.1016/0014-5793(90)80066-R; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1376, DOI 10.1104/pp.93.4.1376; HARPEL MR, 1994, BIOCHEMISTRY-US, V33, P5553, DOI 10.1021/bi00184a026; HARPEL MR, 1993, ANAL BIOCHEM, V209, P367, DOI 10.1006/abio.1993.1136; HARTMAN FC, 1994, ANNU REV BIOCHEM, V63, P197, DOI 10.1146/annurev.biochem.63.1.197; JORDAN DB, 1983, ARCH BIOCHEM BIOPHYS, V227, P425, DOI 10.1016/0003-9861(83)90472-1; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; KUEHN GD, 1978, BIOCHEM J, V175, P909, DOI 10.1042/bj1750909; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; LARIMER FW, 1987, J BIOL CHEM, V262, P15327; LARSON EM, 1995, IN PRESS BIOCHEMISTR, V34; LEE EH, 1993, J BIOL CHEM, V268, P26583; LORIMER GH, 1973, BIOCHEMISTRY-US, V12, P18, DOI 10.1021/bi00725a004; MASSEY V, 1994, J BIOL CHEM, V269, P22459; SCHLOSS JV, 1982, METHOD ENZYMOL, V90, P522; SCHNEIDER G, 1992, ANNU REV BIOPH BIOM, V21, P119, DOI 10.1146/annurev.bb.21.060192.001003; YOKOTA A, 1991, PLANT CELL PHYSIOL, V32, P755; ZHU GH, 1991, PLANT PHYSIOL, V97, P1354, DOI 10.1104/pp.97.4.1354	21	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11741	11744		10.1074/jbc.270.20.11741	http://dx.doi.org/10.1074/jbc.270.20.11741			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744819	hybrid			2022-12-27	WOS:A1995QY73600011
J	CUENDA, A; NOGUES, M; HENAO, F; GUTIERREZMERINO, C				CUENDA, A; NOGUES, M; HENAO, F; GUTIERREZMERINO, C			INTERACTION BETWEEN GLYCOGEN-PHOSPHORYLASE AND SARCOPLASMIC-RETICULUM MEMBRANES AND ITS FUNCTIONAL IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; CA-2+ RELEASE; MECHANISM; ATPASE; CA2+; AMP; FLUORESCENCE; MODULATION; ACTIVATION; COMPLEX	Skeletal muscle glycogen phosphorylase b binds to sarcoplasmic reticulum (SR) membranes with a dissociation constant of 1.7 +/- 0.6 mg of phosphorylase/ml at 25 degrees C at physiological pH and ionic strength. Raising the temperature to 37 degrees C produced a 2-3-fold decrease in the dissociation constant. The SR membranes could bind up to 1.1 +/- 0.1 mg of glycogen phosphorylase b/mg of SR protein, whereas liposomes prepared with endogenous SR lipids and reconstituted Ca2+-ATPase were unable to bind glycogen phosphorylase, Binding of glycogen phosphorylase b to SR membranes is accompanied by inhibition of its activity in the presence of AMP. The V-max for glycogen phosphorylase b associated with SR membranes is 40 +/- 5% of that for purified glycogen phosphorylase and shows a decreased affinity for its allosteric activators, AMP and IMP. These kinetic effects are also observed with purified glycogen phosphorylase b when starch or cu-amylose is used as substrate instead of glycogen. Treatment of SR membranes with alpha-amylase produced dissociation of glycogen phosphorylase b from the SR membranes. Thus, linear polysaccharide fragments of glycogen bound to the SR membranes are likely mediating the binding of glycogen phosphorylase b to these membranes.	UNIV EXTREMADURA, FAC CIENCIAS, DEPT BIOQUIM & BIOL MOLEC, E-06080 BADAJOZ, SPAIN	Universidad de Extremadura			Gutierrez-Merino, Carlos/K-4574-2014; Henao, Fernando/F-6694-2016	Gutierrez-Merino, Carlos/0000-0003-3673-7007; Henao, Fernando/0000-0003-1117-8544				ANDERSEN JP, 1989, BIOCHIM BIOPHYS ACTA, V988, P47, DOI 10.1016/0304-4157(89)90003-8; BARFORD D, 1991, J MOL BIOL, V218, P233, DOI 10.1016/0022-2836(91)90887-C; BUC MH, 1971, BIOCHIMIE, V53, P283, DOI 10.1016/S0300-9084(71)80094-9; Busby S J, 1976, Curr Top Cell Regul, V10, P89; CUENDA A, 1990, EUR J BIOCHEM, V194, P663, DOI 10.1111/j.1432-1033.1990.tb15666.x; CUENDA A, 1994, BBA-BIOMEMBRANES, V1194, P35, DOI 10.1016/0005-2736(94)90200-3; CUENDA A, 1993, BIOCHEM BIOPH RES CO, V196, P1127, DOI 10.1006/bbrc.1993.2368; CUENDA A, 1991, FEBS LETT, V283, P273, DOI 10.1016/0014-5793(91)80606-4; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ENTMAN ML, 1980, J BIOL CHEM, V255, P6245; ENTMAN ML, 1976, J BIOL CHEM, V251, P3140; FERNANDEZSALGUERO P, 1990, BIOCHIM BIOPHYS ACTA, V1022, P33, DOI 10.1016/0005-2736(90)90397-7; FISCHER EH, 1978, VERSATILITY PROTEINS, P133; Fiske CH, 1925, J BIOL CHEM, V66, P375; GUTIERREZMERINO C, 1989, BIOCHEMISTRY-US, V28, P3398, DOI 10.1021/bi00434a039; GUTIERREZMERINO C, 1983, TRENDS BIOCHEM SCI, V8, P8; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LELOIR LF, 1957, METHOD ENZYMOL, V3, P840, DOI 10.1016/S0076-6879(57)03459-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; MADSEN NB, 1967, J BIOL CHEM, V242, P3301; MATA AM, 1985, BIOCHEM BIOPH RES CO, V133, P176, DOI 10.1016/0006-291X(85)91857-1; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; MERINO CG, 1987, ARCH BIOCHEM BIOPHYS, V252, P303, DOI 10.1016/0003-9861(87)90035-X; MERINO CG, 1976, FEBS LETT, V67, P9, DOI 10.1016/0014-5793(76)80859-9; MERINO CG, 1980, J BIOCHEM-TOKYO, V87, P1483, DOI 10.1093/oxfordjournals.jbchem.a132889; MEYER F, 1970, J BIOL CHEM, V245, P6642; MORANGE M, 1976, EUR J BIOCHEM, V65, P553, DOI 10.1111/j.1432-1033.1976.tb10373.x; PICKART CM, 1982, J BIOL CHEM, V257, P5319; ROSS DC, 1987, J BIOL CHEM, V262, P2042; STRAUSBAUCH PH, 1967, METHOD ENZYMOL, V11, P671; VARSANYI M, 1981, FEBS LETT, V131, P223, DOI 10.1016/0014-5793(81)80372-9; Wang J. H, 1972, ENZYMES, V7, P435; WANSON JC, 1968, J CELL BIOL, V38, P130, DOI 10.1083/jcb.38.1.130; WANSON JC, 1972, J CELL BIOL, V54, P206, DOI 10.1083/jcb.54.2.206; WARREN GB, 1974, P NATL ACAD SCI USA, V78, P795	38	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11998	12004		10.1074/jbc.270.20.11998	http://dx.doi.org/10.1074/jbc.270.20.11998			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744850	hybrid			2022-12-27	WOS:A1995QY73600050
J	PATTI, JM; HOUSEPOMPEO, K; BOLES, JO; GARZA, N; GURUSIDDAPPA, S; HOOK, M				PATTI, JM; HOUSEPOMPEO, K; BOLES, JO; GARZA, N; GURUSIDDAPPA, S; HOOK, M			CRITICAL RESIDUES IN THE LIGAND-BINDING SITE OF THE STAPHYLOCOCCUS-AUREUS COLLAGEN-BINDING ADHESIN (MSCRAMM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PROPOLYPEPTIDE; VONWILLEBRAND-FACTOR; REACTIVE ARTHRITIS; MEDIATES ADHESION; MEMBRANE-PROTEIN; LEAST-SQUARES; V COLLAGEN; YERSINIA; IDENTIFICATION; RECEPTOR	We have identified a discrete collagen-binding site within the Staphylococcus aureus collagen adhesin that is located in a region between amino acids Asp(209) and Tyr(233). Polyclonal antibodies raised against a recombinant form of the collagen adhesin inhibited the binding of collagen type II to S. aureus. When overlapping synthetic peptides mimicking segments of the adhesin fragment were tested for their ability to neutralize the inhibitory activity of the antibody only one peptide, CBD4 was found to be active. CBD4 bound directly to collagen and at high concentrations inhibited the binding of collagen to S. aureus, A synthetic peptide derivative of CBD4 lacking 2 carboxyl-terminal residues (Asn(232) Tyr(233)) had no inhibitory activity. The importance of these residues for collagen binding was confirmed by biospecific interaction analysis, Mutant adhesin proteins N-232 --> A and Y-233 --> A exhibited dramatic changes in collagen binding activity. The dominant dissociation rate for the binding of mutant adhesin protein N-232 --> A to immobilized collagen II decreased almost 10-fold, while the Y-233 --> A and the double mutant exhibited even more significant decreases in affinity and apparent binding ratio when compared to the wild type protein.			PATTI, JM (corresponding author), TEXAS A&M UNIV,CTR EXTRACELLULAR MATRIX BIOL,ALBERT B ALKEK INST BIOSCI & TECHNOL,HOUSTON,TX 77030, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624, R56AI020624] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 47313] Funding Source: Medline; NIAID NIH HHS [AI 20624] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALELJUNG P, 1994, CURR MICROBIOL, V28, P231, DOI 10.1007/BF01575966; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; EMODY L, 1989, J BACTERIOL, V171, P6674; FERNANDEZ MP, 1988, J BIOL CHEM, V263, P5921; GOLDENBERG DL, 1989, ARTHRITIS RHEUM, V32, P496, DOI 10.1002/anr.1780320422; GRANFORS K, 1989, NEW ENGL J MED, V320, P216, DOI 10.1056/NEJM198901263200404; GRANFORS K, 1980, J INFECT DIS, V141, P424, DOI 10.1093/infdis/141.4.424; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; House-Pompeo Karen, 1994, Methods (Orlando), V6, P134, DOI 10.1006/meth.1994.1016; HUNTER W, 1978, HDB EXPT IMMUNOLOGY; INGHAM KC, 1989, J BIOL CHEM, V264, P16977; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; JOHNSON ML, 1992, ANAL BIOCHEM, V206, P215, DOI 10.1016/0003-2697(92)90356-C; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; MALMQVIST M, 1993, NATURE, V361, P186, DOI 10.1038/361186a0; MERILAHTIPALO R, 1991, ANN RHEUM DIS, V50, P87, DOI 10.1136/ard.50.2.87; MIETTINEN A, 1993, KIDNEY INT, V43, P592, DOI 10.1038/ki.1993.87; MUMBY SM, 1984, J CELL BIOL, V98, P646, DOI 10.1083/jcb.98.2.646; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021; PATTI JM, 1992, J BIOL CHEM, V267, P4766; PATTI JM, 1994, INFECT IMMUN, V62, P152, DOI 10.1128/IAI.62.1.152-161.1994; RYDEN C, 1989, EUR J BIOCHEM, V184, P331, DOI 10.1111/j.1432-1033.1989.tb15023.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHULZEKOOPS H, 1992, INFECT IMMUN, V60, P2153, DOI 10.1128/IAI.60.6.2153-2159.1992; SPEZIALE P, 1987, FEMS MICROBIOL LETT, V48, P47, DOI 10.1016/0378-1097(87)90133-9; SWITALSKI LM, 1993, INFECT IMMUN, V61, P4119, DOI 10.1128/IAI.61.10.4119-4125.1993; SWITALSKI LM, 1989, J BIOL CHEM, V264, P21080; SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; TAKAGI J, 1992, BIOCHEMISTRY-US, V31, P8530, DOI 10.1021/bi00151a021; TAKAGI J, 1991, J BIOL CHEM, V266, P5575; TARKKANEN AM, 1990, MOL MICROBIOL, V4, P1353, DOI 10.1111/j.1365-2958.1990.tb00714.x; VELGE P, 1988, PARASITOLOGY, V97, P255, DOI 10.1017/S0031182000058467; VOYTEK A, 1988, BIOMATERIALS, V9, P107, DOI 10.1016/0142-9612(88)90080-4; WESTERLUND B, 1989, MOL MICROBIOL, V3, P329, DOI 10.1111/j.1365-2958.1989.tb00178.x	40	66	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12005	12011		10.1074/jbc.270.20.12005	http://dx.doi.org/10.1074/jbc.270.20.12005			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744851	hybrid			2022-12-27	WOS:A1995QY73600051
J	COGAN, JG; SUN, SQ; STOFLET, ES; SCHMIDT, LJ; GETZ, MJ; STRAUCH, AR				COGAN, JG; SUN, SQ; STOFLET, ES; SCHMIDT, LJ; GETZ, MJ; STRAUCH, AR			PLASTICITY OF VASCULAR SMOOTH-MUSCLE ALPHA-ACTIN GENE-TRANSCRIPTION - CHARACTERIZATION OF MULTIPLE, SINGLE-STRAND, AND DOUBLE-STRAND SPECIFIC DNA-BINDING PROTEINS IN MYOBLASTS AND FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-BETA GENE; STROMAL MYOFIBROBLASTS; REGULATORY ELEMENTS; PROMOTER; CELLS; EXPRESSION; SEQUENCE; CIS; INTERACTS; DIFFERENTIATION	Transcriptional activity of the mouse vascular smooth muscle (VSM) alpha-actin promoter was governed by both cell type and developmental stage-specific mechanisms, A purine-rich motif (PrM) located as -181 to -176 in the promoter was absolutely required for activation in mouse AKR-2B embryonic fibroblasts and partially contributed to activation in undifferentiated mouse BC3H1 myoblasts, Transcriptional enhancer factor 1 recognized the PrM and cooperated with other promoter binding proteins to regulate serum growth factor -dependent transcription in both myoblasts and fibroblasts, Two distinct protein factors (VAC-ssBF1 and VAC-ssBF2) also were identified that bound sequence specifically to single-stranded oligonucleotide probes that spanned both the PrM and a closely positioned negative regulatory element, VAC-ssBF1 and BF2 binding activity was detected in undifferentiated myoblasts, embryonic fibroblasts, and several smooth muscle tis sues in the mouse and human, A myoblast-specific pro tein (VAC-RF1) also was detected that bound double-stranded probes containing a CArG-like sequence that previously was shown to impart strong, cell type specific repression, The binding activity of transcription en hancer factor 1, VAC-RF1, and VAC-ssBF1 was significantly diminished when confluent BC3H1 myoblasts differentiated into myocytes and expressed VSN alpha-actin mRNA after exposure to serum-free medium, The results indicated that cell type-specific control of the VSM alpha-actin gene promoter required the participation of multiple DNA binding proteins, including two that were enriched in smooth muscle and had preferential affinity for single-stranded DNA.	OHIO STATE UNIV,COLL MED,DEPT CELL BIOL NEUROBIOL & ANAT,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL MED,BIOCHEM PROGRAM,COLUMBUS,OH 43210; MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Mayo Clinic					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043370] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 43370] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BABAEV VR, 1990, AM J PATHOL, V136, P1031; BLANK RS, 1992, J BIOL CHEM, V267, P984; BOCHATONPIALLAT ML, 1992, DIFFERENTIATION, V49, P175, DOI 10.1111/j.1432-0436.1992.tb00665.x; BOCHATONPIALLAT ML, 1993, ARTERIOSCLER THROMB, V13, P1449, DOI 10.1161/01.ATV.13.10.1449; BONDJERS G, 1991, CIRCULATION, V84, P2; CAMPBELL S, 1992, GENE DEV, V6, P367, DOI 10.1101/gad.6.3.367; Cogan J. G., 1993, Molecular Biology of the Cell, V4, p158A; DARBY I, 1990, LAB INVEST, V63, P21; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; DAVIS EC, 1993, LAB INVEST, V68, P89; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; FINOCCHIARO LME, 1991, NUCLEIC ACIDS RES, V19, P4279, DOI 10.1093/nar/19.15.4279; FLINK IL, 1992, J BIOL CHEM, V267, P9917; FOSTER DN, 1992, J BIOL CHEM, V267, P11995; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GAILLARD C, 1990, J MOL BIOL, V215, P245, DOI 10.1016/S0022-2836(05)80343-2; GRAY T A, 1990, Technique (Philadelphia), V2, P147; HOEFFLER WK, 1985, CELL, V41, P955, DOI 10.1016/S0092-8674(85)80076-3; ISHIJI T, 1992, EMBO J, V11, P2271, DOI 10.1002/j.1460-2075.1992.tb05286.x; KARIYA K, 1993, J BIOL CHEM, V268, P26658; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KOCHER O, 1991, LAB INVEST, V65, P459; KOLLURI R, 1992, NUCLEIC ACIDS RES, V20, P111, DOI 10.1093/nar/20.1.111; LAZARD D, 1993, P NATL ACAD SCI USA, V90, P999, DOI 10.1073/pnas.90.3.999; LEE SH, 1995, IN PRESS J CELL PHYS; LEE TC, 1992, P NATL ACAD SCI USA, V89, P9814, DOI 10.1073/pnas.89.20.9814; LEE TC, 1991, MOL CELL BIOL, V11, P5090, DOI 10.1128/MCB.11.10.5090; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MIN BH, 1990, J BIOL CHEM, V265, P16667; MUKHERJEE R, 1990, NUCLEIC ACIDS RES, V18, P5713, DOI 10.1093/nar/18.19.5713; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; QUINN JP, 1993, NUCLEIC ACIDS RES, V21, P1637, DOI 10.1093/nar/21.7.1637; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; SAPPINO AP, 1990, LAB INVEST, V63, P144; SCHURCH W, 1981, VIRCHOWS ARCH A, V391, P125, DOI 10.1007/BF00437591; SHIMIZU N, 1992, NUCLEIC ACIDS RES, V20, P1793, DOI 10.1093/nar/20.7.1793; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; Skalli O, 1988, MOL CELLULAR BIOL WO, P373; STOFLET ES, 1992, MOL BIOL CELL, V3, P1073, DOI 10.1091/mbc.3.10.1073; STRAUCH AR, 1991, J CELL PHYSIOL, V146, P337, DOI 10.1002/jcp.1041460302; TADA H, 1992, J VIROL, V66, P6885, DOI 10.1128/JVI.66.12.6885-6892.1992; TAYLOR MV, 1991, NUCLEIC ACIDS RES, V19, P2669, DOI 10.1093/nar/19.10.2669; WANG ZY, 1993, J BIOL CHEM, V268, P10681; WILKISON WO, 1990, J BIOL CHEM, V265, P477; WILLIAMS M, 1992, NUCLEIC ACIDS RES, V20, P4935, DOI 10.1093/nar/20.18.4935; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	51	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11310	11321		10.1074/jbc.270.19.11310	http://dx.doi.org/10.1074/jbc.270.19.11310			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744768	hybrid			2022-12-27	WOS:A1995QX86500045
J	SHIAO, YJ; LUPO, G; VANCE, JE				SHIAO, YJ; LUPO, G; VANCE, JE			EVIDENCE THAT PHOSPHATIDYLSERINE IS IMPORTED INTO MITOCHONDRIA VIA A MITOCHONDRIA-ASSOCIATED MEMBRANE AND THAT THE MAJORITY OF MITOCHONDRIAL PHOSPHATIDYLETHANOLAMINE IS DERIVED FROM DECARBOXYLATION OF PHOSPHATIDYLSERINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHETIC-ENZYMES; LIVER SUBCELLULAR MEMBRANES; ROUGH ENDOPLASMIC-RETICULUM; PERMEABILIZED ANIMAL-CELLS; HAMSTER OVARY CELLS; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; LIPOPROTEIN SECRETION; LIPID-COMPOSITION; HEPATOCYTES	Phosphatidylserine is synthesized in both the endo plasmic reticulum and a unique membrane fraction, the mitochondria-associated membrane (MAM) (Vance, J. E. (1990) J. Biol. Chem. 265, 7248-7256). In Chinese hamster ovary cells labeled with [H-3]serine or [H-3]ethanolamine, we found that the majority of mitochondrial phosphatidylethanolamine was derived from phosphatidylserine decarboxylation. Essentially no mitochondrial phosphatidylethanolamine, especially that in the inner membrane, was imported from the endoplasmic reticulum. We tested the hypothesis that phosphatidylserine made in the endoplasmic reticulum is delivered via the MAM to mitochondria for decarboxylation to phosphatidylethanolamine. Cells were pulse-labeled with [H-3]serine and subsequently incubated either in the presence of hydroxylamine (for inhibition of phosphatidylserine decarboxylation) or under conditions for which cellular ATP had been depleted (for inhibition of phosphatidylserine import into mitochondria). In hydroxylamine-treated cells, within 2 h, the amount of radiolabeled phosphatidylserine in the MAM and mito chondria, but not microsomes, was greater than in untreated cells. Moreover, in ATP-depleted, but not in control, cells the amount of radiolabeled phosphatidylserine in the MAM approximately doubled by 3 h. These observations are consistent with the hypothesis that newly synthesized phosphatidylserine normally traverses the MAM en route to mitochondria.	UNIV ALBERTA,LIPID & LIPOPROT RES GRP,EDMONTON,AB T6G 2S2,CANADA; UNIV ALBERTA,DEPT MED,EDMONTON,AB T6G 2S2,CANADA	University of Alberta; University of Alberta			Shiao, Young-Ji/AAA-9647-2022	LUPO, Gabriella/0000-0002-9291-6969				ARDAIL D, 1993, J BIOL CHEM, V268, P25985; BJERVE KS, 1985, BIOCHIM BIOPHYS ACTA, V833, P396, DOI 10.1016/0005-2760(85)90096-7; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; CUI Z, 1993, J BIOL CHEM, V268, P16655; DENNIS EA, 1972, J LIPID RES, V13, P263; FRANKE WW, 1971, PROTOPLASMA, V73, P35, DOI 10.1007/BF01286409; Hoult J.R.S., METHODS ENZYMOLOGY, P443, DOI [10.1016/0076-6879(94)34115-X, DOI 10.1016/0076-6879(94)34115-X, DOI 10.1016/0076-6879(67)10072-4]; HOVIUS R, 1992, J BIOL CHEM, V267, P16790; JELSEMA CL, 1978, J BIOL CHEM, V253, P7960; KATZ J, 1983, BIOCHEM J, V214, P795, DOI 10.1042/bj2140795; KUGE O, 1986, J BIOL CHEM, V261, P5790; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLER HR, 1955, METHOD ENZYMOL, V2, P553; MARTIN OC, 1987, J BIOL CHEM, V262, P5890; MCMURRAY WC, 1969, BIOCHEM J, V112, P91, DOI 10.1042/bj1120091; MEIER PJ, 1981, BIOCHIM BIOPHYS ACTA, V646, P283, DOI 10.1016/0005-2736(81)90335-7; PICKETT CB, 1980, EXP CELL RES, V128, P343, DOI 10.1016/0014-4827(80)90070-1; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; SHIAO YJ, 1993, J BIOL CHEM, V268, P26085; SHORE GC, 1977, J CELL BIOL, V72, P714, DOI 10.1083/jcb.72.3.714; SIMBENI R, 1990, J BIOL CHEM, V265, P281; SNELL EE, 1977, TRENDS BIOCHEM SCI, V2, P131, DOI 10.1016/0968-0004(77)90441-8; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1991, J LIPID RES, V32, P1971; VANCE JE, 1988, J BIOL CHEM, V263, P5898; VANCE JE, 1991, J BIOL CHEM, V266, P8241; VANCE JE, 1988, BIOCHIM BIOPHYS ACTA, V963, P10, DOI 10.1016/0005-2760(88)90332-3; VANCE JE, 1991, J BIOL CHEM, V266, P89; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VANGOLDE LM, 1974, BIOCHIM BIOPHYS ACTA, V360, P179, DOI 10.1016/0005-2760(74)90168-4; VANHEUSDEN GPH, 1990, J BIOL CHEM, V265, P4105; VOELKER DR, 1991, J BIOL CHEM, V266, P12185; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; VOELKER DR, 1993, J BIOL CHEM, V268, P7069; VOELKER DR, 1990, J BIOL CHEM, V265, P14340; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921; VOELKER DR, 1991, BIOCH LIPIDS LIPOPRO, P489; YAFFE MP, 1983, BIOCHEMISTRY-US, V22, P1497, DOI 10.1021/bi00275a026; ZBOROWSKI J, 1983, FEBS LETT, V157, P179, DOI 10.1016/0014-5793(83)81141-7; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	41	190	190	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11190	11198		10.1074/jbc.270.19.11190	http://dx.doi.org/10.1074/jbc.270.19.11190			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744750	hybrid			2022-12-27	WOS:A1995QX86500027
J	STEFFENSEN, B; WALLON, UM; OVERALL, CM				STEFFENSEN, B; WALLON, UM; OVERALL, CM			EXTRACELLULAR-MATRIX BINDING-PROPERTIES OF RECOMBINANT FIBRONECTIN TYPE II-LIKE MODULES OF HUMAN 72-KDA GELATINASE TYPE-IV COLLAGENASE - HIGH-AFFINITY BINDING TO NATIVE TYPE-I COLLAGEN BUT NOT NATIVE TYPE-IV COLLAGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLAST COLLAGENASE; HEPARAN-SULFATE PROTEOGLYCAN; DENSITY-LIPOPROTEIN-RECEPTOR; BASEMENT-MEMBRANE COLLAGEN; EPIDERMAL GROWTH-FACTOR; TISSUE INHIBITOR; ESCHERICHIA-COLI; BOVINE PROLACTIN; DOMAIN-STRUCTURE; CYSTEINE SWITCH	72-kDa gelatinase/type IV collagenase is an important matrix metalloproteinase in the degradation of basement membranes and denatured collagens (gelatin), These proteolytic processes are required for pathologic tissue destruction and physiologic tissue remodeling, To investigate the molecular determinants of substrate specificity of this enzyme, a 21-kDa domain of 72-kDa gelatinase, consisting of three tandem fibronectin type II-Like modules, was expressed in Escherichia coli, Similar to full-length 72-kDa gelatinase and the type II modules in fibronectin, the recombinant (r) fibronectin-like domain of this proteinase bound denatured type I collagen with an apparent K-d in the micromolar range, This domain, designated the collagen-binding domain (rCBD123), possesses at least two collagen binding sites that can each be simultaneously occupied, rCBD123 also avidly bound elastin and denatured types IV and V collagens, but neither native types IV and V collagens nor fibronectin, all of which are substrates of the enzyme, Although 72-kDa gelatinase is involved in basement membrane degradation, rCBD123 also did not bind reconstituted basement membrane, laminin, or SPARC, Native type I collagen, which is not degraded by 72-kDa gelatinase, competed with gelatin for a shared binding site on rCBD123, rCBD123 also displaced full-length 72-kDa gelatinase bound to native type I collagen, further demonstrating that the collagen binding properties of the recombinant domain closely mimicked those of the full-length enzyme, Since rCBD123 showed reduced binding to pepsin cleaved type I collagen, either or both of the collagen telopeptide ends contain recognition sites for the 72-kDa gelatinase fibronectin-like domain, This was confirmed by the avid binding of rCBD123 to the alpha 1(I) collagen cyanogen bromide fragment CB2 from the NH2-terminal telopeptide. rCBD123 also bound alpha 1(I)-CB7, which encompasses the fibronectin-binding site, and to alpha 1(I)-CB8, a fragment not bound by fibronectin, Thus, type I collagen contains multiple binding sites for rCBD123 which are partially masked by the triple helical conformation of native collagen and fully exposed upon unfolding of the triple helix, The potential of the fibronectin-like collagen binding domain of 72-kDa gelatinase to bind extracellular matrix proteins may facilitate enzyme localization in connective tissue matrices.			STEFFENSEN, B (corresponding author), UNIV BRITISH COLUMBIA,FAC DENT,VANCOUVER,BC V6T 1Z3,CANADA.							BANYAI L, 1991, FEBS LETT, V282, P23, DOI 10.1016/0014-5793(91)80436-7; BANYAI L, 1994, BIOCHEM J, V298, P403, DOI 10.1042/bj2980403; BANYAI L, 1990, EUR J BIOCHEM, V193, P801, DOI 10.1111/j.1432-1033.1990.tb19403.x; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BLUNDELL TL, 1994, NAT STRUCT BIOL, V1, P73, DOI 10.1038/nsb0294-73; CAMPBELL ID, 1990, BIOCHEM PHARMACOL, V40, P35, DOI 10.1016/0006-2952(90)90175-K; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; Creighton T. E., 1990, PROTEIN STRUCTURE PR, P155; CROUCH E, 1980, P NATL ACAD SCI-BIOL, V77, P745, DOI 10.1073/pnas.77.2.745; DEDHAR S, 1993, CLIN EXP METASTAS, V11, P391, DOI 10.1007/BF00132982; DOBELI H, 1990, MOL BIOCHEM PARASIT, V41, P259, DOI 10.1016/0166-6851(90)90189-S; DOMENICUCCI C, 1988, BIOCHEM J, V253, P139, DOI 10.1042/bj2530139; ELTIS LD, 1994, PROTEIN ENG, V7, P1145, DOI 10.1093/protein/7.9.1145; ENGVALL E, 1981, COLLAGEN REL RES, V1, P505; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; GUIDRY C, 1990, J BIOL CHEM, V265, P19230; GUILLEMETTE JG, 1991, PROTEIN ENG, V4, P585, DOI 10.1093/protein/4.5.585; HIGHBERGER JH, 1979, BIOCHEM BIOPH RES CO, V89, P202, DOI 10.1016/0006-291X(79)90964-1; HOLLECKER M, 1990, PROTEIN STRUCTURE PR, P145; HOWARD EW, 1991, J BIOL CHEM, V266, P17972; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; INGHAM KC, 1989, J BIOL CHEM, V264, P16977; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; JILEK F, 1979, H-S Z PHYSIOL CHEM, V360, P597, DOI 10.1515/bchm2.1979.360.1.597; KADERBHAI MA, 1985, EUR J BIOCHEM, V153, P167, DOI 10.1111/j.1432-1033.1985.tb09283.x; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; KLEINMAN HK, 1976, BIOCHEM BIOPH RES CO, V72, P426, DOI 10.1016/S0006-291X(76)80060-5; KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; LITVINOVICH SV, 1991, J MOL BIOL, V217, P563, DOI 10.1016/0022-2836(91)90758-X; LUCK DN, 1992, PROTEIN ENG, V5, P559, DOI 10.1093/protein/5.6.559; MANN K, 1987, FEBS LETT, V218, P167, DOI 10.1016/0014-5793(87)81040-2; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; MURPHY G, 1994, J BIOL CHEM, V269, P6632; MURPHY G, 1992, J BIOL CHEM, V267, P9612; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; MURPHY G, 1992, J BIOL CHEM, V267, P637; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; OLINS PO, 1988, GENE, V73, P227, DOI 10.1016/0378-1119(88)90329-0; OVERALL CM, 1988, BIOCHEM J, V256, P965, DOI 10.1042/bj2560965; OVERALL CM, 1989, J BIOL CHEM, V264, P1860; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; OVERALL CM, 1987, J DENT RES, V66, P1271, DOI 10.1177/00220345870660071201; OVERALL CM, 1995, IN PRESS J CELL PHYS; OVERALL CM, 1991, TRENDS GLYCOSCI GLYC, V3, P384; OVERALL CM, 1992, MATRIX METALLOPROTEI, P209; OWENS RJ, 1986, EMBO J, V5, P2825, DOI 10.1002/j.1460-2075.1986.tb04575.x; Piez KA, 1967, TREATISE COLLAGEN, P207; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; REPONEN P, 1994, J CELL BIOL, V124, P1091, DOI 10.1083/jcb.124.6.1091; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; SALONEN J, 1990, ARCH ORAL BIOL, V35, P337, DOI 10.1016/0003-9969(90)90180-I; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SELTZER JL, 1990, J BIOL CHEM, V265, P20409; SKORSTENGAARD K, 1994, FEBS LETT, V343, P47, DOI 10.1016/0014-5793(94)80604-7; SODEK J, 1992, MATRIX METALLOPROTEI, P352; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; TAKACS BJ, 1991, J IMMUNOL METHODS, V143, P231, DOI 10.1016/0022-1759(91)90048-K; TIMPL R, 1994, EUR J BIOCHEM, V84, P43; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; WASI S, 1984, CAN J BIOCHEM CELL B, V62, P470, DOI 10.1139/o84-064; WEEKS BS, 1993, J CELL PHYSIOL, V157, P644, DOI 10.1002/jcp.1041570326; WILHELM SM, 1988, J BIOL CHEM, V264, P17213; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WINDSOR LJ, 1991, BIOCHEMISTRY-US, V30, P641, DOI 10.1021/bi00217a008	72	188	189	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11555	11566		10.1074/jbc.270.19.11555	http://dx.doi.org/10.1074/jbc.270.19.11555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744795	hybrid			2022-12-27	WOS:A1995QX86500075
J	YAN, SF; TRITTO, I; PINSKY, D; LIAO, H; HUANG, J; FULLER, G; BRETT, J; MAY, L; STERN, D				YAN, SF; TRITTO, I; PINSKY, D; LIAO, H; HUANG, J; FULLER, G; BRETT, J; MAY, L; STERN, D			INDUCTION OF INTERLEUKIN-6 (IL-6) BY HYPOXIA IN VASCULAR CELLS - CENTRAL ROLE OF THE BINDING-SITE FOR NUCLEAR FACTOR-IL-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; COLONY-STIMULATING FACTORS; HUMAN-ENDOTHELIAL-CELLS; SMOOTH-MUSCLE CELLS; GRANULOCYTE-MACROPHAGE; SIGNAL TRANSDUCER; LEUCINE ZIPPER; EXPRESSION; TRANSCRIPTION; ACTIVATION	The pathologic picture in ischemic tissue injury shares features with the inflammatory response, including production of proinflammatory cytokines. Hypoxia-mediated induction of interleukin-6 (IL-6), a cytokine with anti-inflammatory properties, could set in motion mechanisms limiting inflammation in ischemia, Exposure of cultured endothelial cells (ECs) to H (pO(2) approximate to 12-16 torr) increased transcription of IL-6, elevated levels of IL-6 mRNA, and induced elaboration of IL-6 antigen in a time-dependent manner, Exposure of mice to hypoxia increased IL-6 transcripts in the lung, and immuno-staining revealed a striking increase in IL-6 antigen in pulmonary vasculature. Transfection of ECs with deletion chimeric IL-6 promoter-chloramphenicol acetyltransferase (CAT) constructs showed hypoxia-mediated 9-11-fold induction with -1200/+13, -596/+13, and -225/+13 but no induction with -111/+13. Electrophoretic mobility shift assays (EMSAs) using -225/-111 as the labeled probe demonstrated enhanced binding activity in nuclear extracts of hypoxic ECs and lung; the appearance of the gel shift band was prevented by excess unlabeled probe (-225/-111), and hypoxia-mediated enhancement of the band was blocked by a probe corresponding to the nuclear factor (NF)-IL-6 site (-158/-145). The hypoxia-enhanced band on EMSA displayed a supershift with antibody to CCAAT-enhancer-binding protein beta (C/EBP-beta), but antibody to C/EBP-alpha or -delta was without effect. Transfection of ECs with a construct comprising thymidine kinase promoter, -225/-111 in either the 5' to 3' or 3' to 5' orientation, and the reporter CAT showed this region to be an enhancer (approximate to 8-fold) under hypoxia, EMSA with the NF-IL-6 probe revealed a prominent induction of binding activity with nuclear extracts from hypoxic ECs and whole lung, Constructs with -158/-145 and the CAT reporter gene showed induction when transfected into hypoxic ECs, whereas a similar construct with the NF-IL-6 motif mutationally inactivated failed to display hypoxia-induced expression. Furthermore, the tumor necrosis factor (TNF) gene, whose product contributes to ischemic pathology and contains a putative regulatory NF-IL-6 site, demonstrated enhanced binding activity for its NF-IL-B motif and induction of TNF mRNA based on analysis of hypoxic lung, These data indicate that hypoxia induces expression of IL-6, most likely a result of hypoxic activation at the NF-IL-B site, and suggest that other genes with regulatory NF-IL-6 sites may also be induced by a similar mechanism.	COLUMBIA UNIV, COLL PHYS & SURG, DEPT PHYSIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV, COLL PHYS & SURG, DEPT MED, NEW YORK, NY 10032 USA; UNIV ALABAMA, DEPT CELL BIOL, BIRMINGHAM, AL 35294 USA; UNIV ALABAMA, DEPT ANAT, BIRMINGHAM, AL 35294 USA; NEW YORK MED COLL, DEPT MICROBIOL, VALHALLA, NY 10595 USA; NEW YORK MED COLL, DEPT IMMUNOL, VALHALLA, NY 10595 USA	Columbia University; Columbia University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; New York Medical College; New York Medical College			Tritto, Isabella/Y-8881-2019	TRITTO, Isabella/0000-0003-0026-7154; Huang, James/0000-0001-5495-3577	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL021006, R01HL042833, R01HL042507] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL21006, HL42833, HL42507] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ADERKA D, 1989, J IMMUNOL, V143, P3517; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; ANDERSON GM, 1991, MOL CELL BIOL, V11, P1935, DOI 10.1128/MCB.11.4.1935; BARTALENA L, 1992, MOL ENDOCRINOL, V6, P935, DOI 10.1210/me.6.6.935; BARTON BE, 1993, INFECT IMMUN, V61, P1496, DOI 10.1128/IAI.61.4.1496-1499.1993; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BRETT J, 1993, AM J PATHOL, V143, P1699; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; COLLETTI LM, 1990, J CLIN INVEST, V85, P1936, DOI 10.1172/JCI114656; COLUCCI WS, 1985, MOL PHARMACOL, V27, P517; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; GRENETT HE, 1991, GENE, V101, P267, DOI 10.1016/0378-1119(91)90422-8; GUMKOWSKI F, 1987, BLOOD VESSELS, V24, P11; HENSEL G, 1989, LYMPHOKINE RES, V8, P347; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IKEDA U, 1991, AM J PHYSIOL, V260, pHUMUO; KARAKURUM M, 1994, J CLIN INVEST, V93, P1564, DOI 10.1172/JCI117135; KASAHARA T, 1991, IMMUNOLOGY, V74, P60; KISHIMOTO T, 1988, ANNU REV IMMUNOL, V6, P485, DOI 10.1146/annurev.iy.06.040188.002413; KOGA S, 1992, J CLIN INVEST, V90, P1007, DOI 10.1172/JCI115913; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KOUREMBANAS S, 1990, J CLIN INVEST, V86, P670, DOI 10.1172/JCI114759; MECHAM RP, 1987, SCIENCE, V237, P423, DOI 10.1126/science.3603030; METINKO AP, 1992, J CLIN INVEST, V90, P791, DOI 10.1172/JCI115953; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; MEYRICK B, 1980, AM J PATHOL, V100, P151; MULLANE KM, 1990, PATHOPHYSIOLOGY SEVE, P239; NABATA T, 1990, BIOCHEM INT, V20, P445; OGAWA S, 1990, J CLIN INVEST, V85, P1090, DOI 10.1172/JCI114540; OHKAWA F, 1994, AM J PHYSIOL, V266, pH898, DOI 10.1152/ajpheart.1994.266.3.H898; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; POBER JS, 1988, AM J PATHOL, V133, P426; POGNONEC P, 1992, J BIOL CHEM, V267, P24563; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; RAY A, 1988, P NATL ACAD SCI USA, V85, P6701, DOI 10.1073/pnas.85.18.6701; RAY A, 1990, MOL CELL BIOL, V10, P5736, DOI 10.1128/MCB.10.11.5736; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; Sambrook J, 1989, MOL CLONING LABORATO; SCHINDLER R, 1990, BLOOD, V75, P40; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SHREENIWAS R, 1992, J CLIN INVEST, V90, P2333, DOI 10.1172/JCI116122; TAGA T, 1992, FASEB J, V6, P3387, DOI 10.1096/fasebj.6.15.1334470; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TILG H, 1994, BLOOD, V83, P113; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; ULICH TR, 1991, AM J PATHOL, V138, P1097; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; YONG K, 1991, BLOOD, V77, P1675	56	314	337	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11463	11471		10.1074/jbc.270.19.11463	http://dx.doi.org/10.1074/jbc.270.19.11463			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744784	hybrid			2022-12-27	WOS:A1995QX86500063
J	BERNSTEIN, J; SHEFLER, I; ELROYSTEIN, O				BERNSTEIN, J; SHEFLER, I; ELROYSTEIN, O			THE TRANSLATIONAL REPRESSION MEDIATED BY THE PLATELET-DERIVED GROWTH-FACTOR 2/C-SIS MESSENGER-RNA LEADER IS RELIEVED DURING MEGAKARYOCYTIC DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; C-SIS GENE; MESSENGER-RNA; VACCINIA VIRUS; INITIATION FACTOR-4E; EXPRESSION SYSTEM; FACTOR-II; 5'-NONCODING SEQUENCES; 5'-UNTRANSLATED REGION; INTERNAL INITIATION	Expression of the platelet-derived growth factor 2/c-sis gene is highly restricted and controlled at multiple levels. Its structured mRNA leader, which is unusually long (1022 nucleotides), serves as a potent translational inhibitor. One of the sites of PDGF2 synthesis is megakaryocytes, implying that PDGF2 translation efficiency is modulated during megakaryocytic differentiation. To study the role of the mRNA leader as a translational cis-modulator, the hybrid T7/vaccinia cytoplasmic expression system was used to disconnect between determinants controlling transcription, alternative splicing, and mRNA stability from those controlling translation. Chimeric transcripts in which the human PDGF2/c-sis mRNA leader positioned in frame upstream of a reporter gene were used to determine whether the mRNA leader can confer variable translational efficiencies during differentiation. It is demonstrated that there is a time window during megakaryocytic differentiation of K562 cells in which the strong translational inhibition by PDGF2/c-sis mRNA leader is relieved. The time course of the translational repression relief is similar to that of PDGF2/c-sis transcriptional induction during the differentiation process. A 179-nucleotides CG-rich fragment immediately upstream of the initiator AUG codon is necessary for coffering stringent modulation of the translational efficiency. In NIH3T3 overexpressing translation initiation factor eIF4E, the inhibitory effect of the mRNA leader of c-sis is not relieved, suggesting that the changes in the translational machinery during megakaryocytic differentiation are beyond eIF4E activity. The possible involvement of a 5'-end independent translational mechanism is discussed.	TEL AVIV UNIV, GEORGE S WISE FAC LIFE SCI, DEPT CELL RES & IMMUNOL, IL-69978 TEL AVIV, ISRAEL	Tel Aviv University				Elroy-Stein, Orna/0000-0002-3716-1540				ALITALO R, 1987, EMBO J, V6, P1213, DOI 10.1002/j.1460-2075.1987.tb02356.x; ARRICK BA, 1994, MOL CELL BIOL, V14, P619, DOI 10.1128/MCB.14.1.619; AVNI D, 1994, MOL CELL BIOL, V14, P3822, DOI 10.1128/MCB.14.6.3822; BETSHOLTZ C, 1993, BIOL PLATELET DERIVE, P11; BONTHRON DT, 1991, GENOMICS, V10, P287, DOI 10.1016/0888-7543(91)90515-G; BORMAN A, 1993, J GEN VIROL, V74, P1775, DOI 10.1099/0022-1317-74-9-1775; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLAMONICI OR, 1986, MOL CELL BIOL, V6, P1847, DOI 10.1128/MCB.6.5.1847; ELROYSTEIN O, 1990, P NATL ACAD SCI USA, V87, P6743, DOI 10.1073/pnas.87.17.6743; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; ELROYSTEIN O, 1991, CURRENT PROTOCOLS MO; FEN Z, 1991, ONCOGENE, V6, P953; FUERST TR, 1989, J MOL BIOL, V206, P333, DOI 10.1016/0022-2836(89)90483-X; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GIERMAN TM, 1992, VIROLOGY, V188, P934, DOI 10.1016/0042-6822(92)90557-6; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; IGARASHI H, 1987, ONCOGENE, V1, P79; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; JIN HM, 1993, P NATL ACAD SCI USA, V90, P7563, DOI 10.1073/pnas.90.16.7563; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; KIM SJ, 1992, J BIOL CHEM, V267, P13702; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LAROCHELLE WJ, 1993, BIOL PLATELET DERIVE, P129; LASO MRV, 1993, J BIOL CHEM, V268, P6453; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; LONING F, 1991, SCIENCE, V251, P807; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; MANZELLA JM, 1991, J BIOL CHEM, V266, P2383; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; MILLER KG, 1981, CELL, V27, P165, DOI 10.1016/0092-8674(81)90370-6; MIZOKAMI A, 1994, J BIOL CHEM, V269, P25655; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; MORLEY SJ, 1993, EUR J BIOCHEM, V218, P39, DOI 10.1111/j.1432-1033.1993.tb18349.x; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; OH SK, 1992, GENE DEV, V6, P1643, DOI 10.1101/gad.6.9.1643; PECH M, 1989, MOL CELL BIOL, V9, P396, DOI 10.1128/MCB.9.2.396; RAINES EW, 1993, BIOL PLATELET DERIVE, P74; RAO CD, 1986, P NATL ACAD SCI USA, V83, P2392, DOI 10.1073/pnas.83.8.2392; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; RAO SM, 1993, J BIOL CHEM, V268, P22164; RATNER L, 1987, NUCLEIC ACIDS RES, V15, P6017, DOI 10.1093/nar/15.15.6017; RATNER L, 1989, NUCLEIC ACIDS RES, V17, P4101, DOI 10.1093/nar/17.11.4101; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; ROMEO DS, 1993, MOL ENDOCRINOL, V7, P759, DOI 10.1210/me.7.6.759; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHNIERLE BS, 1992, VIROLOGY, V188, P931, DOI 10.1016/0042-6822(92)90556-5; SCOTTO L, 1993, MOL CELL BIOL, V13, P3588, DOI 10.1128/MCB.13.6.3588; SHAMA S, 1995, IN PRESS GENE EXPR; SHANTZ LM, 1994, CANCER RES, V54, P2313; SONENBERG N, 1988, MICROBIOL REV, V44, P173; TUAZON PT, 1990, J BIOL CHEM, V265, P10617; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; VANDENOUWELAND AMW, 1987, NUCLEIC ACIDS RES, V15, P959, DOI 10.1093/nar/15.3.959; VANDENOUWELAND MW, 1986, NUCLEIC ACIDS RES, V14, P765, DOI 10.1093/nar/14.2.765; WAGNER RE, 1990, MOL CELL BIOL, V10, P5983; WHETTER LE, 1994, J VIROL, V68, P5253, DOI 10.1128/JVI.68.8.5253-5263.1994	67	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10559	10565		10.1074/jbc.270.18.10559	http://dx.doi.org/10.1074/jbc.270.18.10559			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737991	hybrid			2022-12-27	WOS:A1995QW60100032
J	MORITA, I; SCHINDLER, M; REGIER, MK; OTTO, JC; HORI, T; DEWITT, DL; SMITH, WL				MORITA, I; SCHINDLER, M; REGIER, MK; OTTO, JC; HORI, T; DEWITT, DL; SMITH, WL			DIFFERENT INTRACELLULAR LOCATIONS FOR PROSTAGLANDIN ENDOPEROXIDE-H SYNTHASE-1 AND SYNTHASE-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SWISS 3T3 CELLS; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; INDUCIBLE CYCLOOXYGENASE; SUBCELLULAR-LOCALIZATION; ALVEOLAR MACROPHAGES; ENDOTHELIAL-CELLS; GROWTH-FACTOR; EXPRESSION	The subcellular locations of prostaglandin endoperoxide synthase-1 and -2 (PGHS-1 and -2) were determined by quantitative confocal fluorescence imaging microscopy in murine 3T3 cells and human and bovine endothelial cells using immunocytofluorescence with isozyme-specific antibodies, In all of the cell types examined, PGHS-1 immunoreactivity was found equally distributed in the endoplasmic reticulum (ER) and nuclear envelope (NE), PGHS-2 immunoreactivity was also present in the ER and NE. However, PGHS-2 staining was twice as concentrated in the NE as in the ER, A histofluorescence staining method was developed to localize cyclooxygenase/peroxidase activity. In quiescent 3T3 cells, which express only PGHS-1, histofluorescent staining was most concentrated in the perinuclear cytoplasmic region. In contrast, histochemical staining for PGHS-2 activity was about equally intense in the nucleus and in the cytoplasm, a pattern of activity staining distinct from that observed with PGHS-1, Our results indicate that there are significant differences in the subcellular locations of PGHS-1 and PGHS-2, It appears that PGHS-1 functions predominantly in the ER whereas PGHS-S may function in the ER and the NE, We speculate that PGHS-1 and PGHS-2 acting in the ER and PGHS-2 functioning in the NE represent independent prostanoid biosynthetic systems.	MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824	Michigan State University					NIDDK NIH HHS [DK22042, DK45209] Funding Source: Medline; NIGMS NIH HHS [GM40713] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK022042, R01DK022042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040713] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNETT J, 1994, BBA-PROTEIN STRUCT M, V1209, P130, DOI 10.1016/0167-4838(94)90148-1; BHATTACHARYYA DK, 1995, ARCH BIOCHEM BIOPHYS, V317, P19, DOI 10.1006/abbi.1995.1130; BRANNON TS, 1994, J CLIN INVEST, V93, P2230, DOI 10.1172/JCI117220; CRAIG S, 1988, EUR J CELL BIOL, V46, P80; DEWITT DL, 1993, ARCH BIOCHEM BIOPHYS, V306, P94, DOI 10.1006/abbi.1993.1485; EVETT GE, 1993, ARCH BIOCHEM BIOPHYS, V306, P169, DOI 10.1006/abbi.1993.1496; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; Gorman R R, 1978, Adv Cyclic Nucleotide Res, V9, P597; GRANTHAM JJ, 1968, J CLIN INVEST, V47, P1154, DOI 10.1172/JCI105804; HABENICHT AJR, 1985, J CLIN INVEST, V75, P1381, DOI 10.1172/JCI111839; HAN JW, 1990, P NATL ACAD SCI USA, V87, P3373, DOI 10.1073/pnas.87.9.3373; HERSCHMANN HR, 1991, ANN REV BIOCH, V37, P281; HSI LC, 1994, BIOCHEM BIOPH RES CO, V202, P1592, DOI 10.1006/bbrc.1994.2114; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JANSZEN FHA, 1972, ADV BIOSCI, V9, P287; JONES DA, 1993, J BIOL CHEM, V268, P9049; KRAEMER SA, 1992, ARCH BIOCHEM BIOPHYS, V293, P391, DOI 10.1016/0003-9861(92)90411-O; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1993, J BIOL CHEM, V268, P5425; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; LEE SH, 1992, J BIOL CHEM, V267, P25934; LIN AH, 1989, J BIOL CHEM, V264, P17379; MARCUS AJ, 1980, J CLIN INVEST, V66, P979, DOI 10.1172/JCI109967; MEADE EA, 1993, J BIOL CHEM, V268, P6610; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; MORITA I, 1984, BIOCHIM BIOPHYS ACTA, V792, P304; MURAKAMI M, 1994, J BIOL CHEM, V269, P22269; OHKI S, 1979, J BIOL CHEM, V254, P829; ONEILL GP, 1994, MOL PHARMACOL, V45, P245; ONEILL GP, 1993, FEBS LETT, V330, P156, DOI 10.1016/0014-5793(93)80263-T; OSULLIVAN MG, 1992, J BIOL CHEM, V267, P14547; OSULLIVAN MG, 1992, BIOCHEM BIOPH RES CO, V187, P1123, DOI 10.1016/0006-291X(92)91313-F; OTTO JC, 1993, J BIOL CHEM, V268, P18234; OTTO JC, 1994, J BIOL CHEM, V269, P19868; PATRIGNANI P, 1995, IN PRESS J PHARM EXP; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; PILBEAM CC, 1993, J BIOL CHEM, V268, P25643; RAZ A, 1988, J BIOL CHEM, V263, P3022; REDDY ST, 1994, J BIOL CHEM, V269, P15473; REGIER MK, 1993, ARCH BIOCHEM BIOPHYS, V301, P439, DOI 10.1006/abbi.1993.1168; RIESE J, 1990, J LEUKOCYTE BIOL, V55, P476; ROBBI M, 1991, J BIOL CHEM, V266, P20498; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; Simmons D.L., 1991, PROSTAGLANDINS LEUKO, P67; SMITH WL, 1994, MET IONS BIOL SYST, V30, P163; SMITH WL, 1992, AM J PHYSIOL, V263, pF181; SONNENBURG WK, 1988, J BIOL CHEM, V263, P6155; SUH KS, 1989, J CELL BIOL, V108, P811, DOI 10.1083/jcb.108.3.811; TANG BL, 1992, J BIOL CHEM, V267, P7072; TERASAKI M, 1992, J CELL SCI, V101, P315; VELASCO A, 1987, HISTOCHEM J, V19, P7, DOI 10.1007/BF01675287; WADE MH, 1993, BIOANALYTICAL INSTRU, V37, P117; [No title captured]	54	487	499	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10902	10908		10.1074/jbc.270.18.10902	http://dx.doi.org/10.1074/jbc.270.18.10902			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738031	hybrid			2022-12-27	WOS:A1995QW60100079
J	BRINI, M; MARSAULT, R; BASTIANUTTO, C; ALVAREZ, J; POZZAN, T; RIZZUTO, R				BRINI, M; MARSAULT, R; BASTIANUTTO, C; ALVAREZ, J; POZZAN, T; RIZZUTO, R			TRANSFECTED AEQUORIN IN THE MEASUREMENT OF CYTOSOLIC CA2+ CONCENTRATION ([CA2+](C)) - A CRITICAL-EVALUATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED RECOMBINANT AEQUORIN; FREE CALCIUM; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR CALCIUM; CELLS; CA-2+; CDNA; EXPRESSION; CLONING; PROTEIN	Targeted recombinant aequorins represent to date the most specific means of monitoring [Ca2+] in subcellular organelles (Rizzuto, R., Simpson, A. W. M., Brini, M., and Pozzan, T. (1992) Nature 358, 325-328; Brini, M., Murgia, M., Pasti, L., Picard, D., Pozzan, T., and Rizzuto, R. (1993) EMBO J. 12, 4813-4819; Kendall, J. Ri., Dormer, R. L., and Campbell, A. R. (1992) Biochem. Biophys. Res. Commun. 189, 1008-1016). Up until now, however, only limited attention has been paid to the use of recombinant photoproteins for measuring, in mammalian cells, the [Ca2+] in the cytoplasm, a compartment for which effective Ca2+ probes are already available. Here we describe this approach in detail, highlighting the advantages, under various experimental conditions, of using recombinant cytosolic aequorin (cytAEQ) instead of classical fluorescent indicators. We demonstrate that cytAEQ is expressed recombinantly at high levels in transiently transfected cell Lines and primary cultures as well as in stably transfected clones, and we describe a simple algorithm for converting aequorin luminescence data into [Ca2+] values. We show that although fluorescent indicators at the usual intracellular concentrations (50-100 mu M) are associated with a significant buffering of the [Ca2+](c) transients, this problem is negligible with recombinantly expressed aequorin. The large dynamic range of the photoprotein also allows an accurate estimate of the large [Ca2+](c) increases that are observed in some cell types such as neurons. Finally, cytAEQ appears to be an invaluable tool for measuring [Ca2+](c) in cotransfection experiments. In particular, we show that when cotransfected with an alpha(1)-adrenergic receptor (coupled to inositol 1,4,5-trisphosphate generation), cytAEQ faithfully monitors the subpopulation of cells expressing the receptor, whereas the signal of fura-2, at the population level, is dominated largely by that of the untransfected cells.	UNIV PADUA,DEPT BIOMED SCI,I-35121 PADUA,ITALY; UNIV PADUA,CNR,CTR STUDY MITOCHONDRIAL PHYSIOL,I-35121 PADUA,ITALY	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua			Alvarez, Javier/K-8210-2014; Brini, Marisa/K-5189-2016; Rizzuto, Rosario/B-6312-2008	Alvarez, Javier/0000-0003-0636-5521; Rizzuto, Rosario/0000-0001-7044-5097; Brini, Marisa/0000-0001-5141-0243	Telethon [495] Funding Source: Medline	Telethon(Fondazione Telethon)		ALLEN DG, 1978, NATURE, V273, P509, DOI 10.1038/273509a0; ALLEN DG, 1971, SCIENCE, V195, P996; Blinks J.R., 1978, Methods in Enzymology, V57, P292; BRINI M, 1993, EMBO J, V12, P4813, DOI 10.1002/j.1460-2075.1993.tb06170.x; BRINI M, 1994, CELL CALCIUM, V16, P259, DOI 10.1016/0143-4160(94)90089-2; BUTTON D, 1993, CELL CALCIUM, V14, P663, DOI 10.1016/0143-4160(93)90091-J; COBBOLD PH, 1980, NATURE, V285, P441, DOI 10.1038/285441a0; Cobbold PH, 1991, CELLULAR CALCIUM PRA, P55; FABIATO A, 1991, CELLULAR CALCIUM PRA, P159; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; INOUYE S, 1985, P NATL ACAD SCI USA, V82, P3154, DOI 10.1073/pnas.82.10.3154; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KENDALL JM, 1992, BIOCHEM BIOPH RES CO, V189, P1008, DOI 10.1016/0006-291X(92)92304-G; KENDALL JM, 1994, ANAL BIOCHEM, V221, P173, DOI 10.1006/abio.1994.1394; KENDALL JM, 1992, BIOCHEM BIOPH RES CO, V187, P1091, DOI 10.1016/0006-291X(92)91309-E; KNIGHT MR, 1991, FEBS LETT, V282, P405, DOI 10.1016/0014-5793(91)80524-7; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; KNIGHT MR, 1993, J CELL BIOL, V121, P83, DOI 10.1083/jcb.121.1.83; LEW PD, 1986, J CELL BIOL, V102, P2197, DOI 10.1083/jcb.102.6.2197; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; MILLER AL, 1994, METHOD CELL BIOL, V40, P305; MOISESCU DG, 1977, BIOCHIM BIOPHYS ACTA, V460, P189, DOI 10.1016/0005-2728(77)90206-7; MURGIA M, 1994, CELL CALCIUM, V16, P167, DOI 10.1016/0143-4160(94)90020-5; NAKAJIMASHIMADA J, 1991, P NATL ACAD SCI USA, V88, P6878, DOI 10.1073/pnas.88.15.6878; PRASHER D, 1985, BIOCHEM BIOPH RES CO, V126, P1259, DOI 10.1016/0006-291X(85)90321-3; RIDGWAY EB, 1967, BIOCHEM BIOPH RES CO, V29, P229, DOI 10.1016/0006-291X(67)90592-X; RIDGWAY EB, 1977, P NATL ACAD SCI USA, V74, P623, DOI 10.1073/pnas.74.2.623; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; RIZZUTO R, 1994, METHOD CELL BIOL, V40, P339; RIZZUTO R, 1995, IN PRESS METHODS ENZ; SARAN S, 1994, FEBS LETT, V337, P43, DOI 10.1016/0014-5793(94)80626-8; SHEU YA, 1993, ANAL BIOCHEM, V209, P343, DOI 10.1006/abio.1993.1132; SHIMOMURA O, 1993, CELL CALCIUM, V14, P373, DOI 10.1016/0143-4160(93)90041-4; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; VILLALBA M, 1994, J BIOL CHEM, V269, P2468; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X	40	314	323	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9896	9903		10.1074/jbc.270.17.9896	http://dx.doi.org/10.1074/jbc.270.17.9896			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730373	hybrid			2022-12-27	WOS:A1995QV41700032
J	FORTENBERRY, SC; CHIRGWIN, JM				FORTENBERRY, SC; CHIRGWIN, JM			THE PROPEPTIDE IS NONESSENTIAL FOR THE EXPRESSION OF HUMAN CATHEPSIN-D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL-ENZYME PHOSPHORYLATION; PROTEIN RECOGNITION DETERMINANTS; HAMSTER KIDNEY-CELLS; ACTIVE HUMAN RENIN; PROCATHEPSIN-D; ASPARTIC PROTEINASES; PORCINE PEPSINOGEN; TARGETING SIGNAL; CRYSTAL-STRUCTURES; SITE	When the 44-amino acid propeptide of human procathepsin D was deleted by mutagenesis in vitro, the mature protein was stably expressed and secreted from transfected mammalian cells. The secreted protein was correctly folded as judged by its binding to pepstatinyl-agarose. We were unable to detect lysosomal targeting of the propeptide-deleted protein, and targeting was not restored by the substitution of the propeptides from pepsin or renin. We conclude that its propeptide is not essential for the folding of nascent cathepsin D. Efficient lysosomal targeting in mammalian cells appears to require the precursor form of the molecule.	UNIV TEXAS, HLTH SCI CTR, DEPT MED, DIV ENDOCRINOL & METAB, SAN ANTONIO, TX 78284 USA; UNIV TEXAS, HLTH SCI CTR, DEPT BIOCHEM, SAN ANTONIO, TX 78284 USA; AUDIE L MURPHY MEM VET ADM MED CTR, RES SERV, SAN ANTONIO, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital								AHMAD F, 1978, INT J PEPT PROT RES, V12, P155; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; BARANSKI TJ, 1992, J BIOL CHEM, V267, P23342; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; CANTOR AB, 1992, J BIOL CHEM, V267, P23349; CHIDGEY MAJ, 1990, EUR J BIOCHEM, V190, P139, DOI 10.1111/j.1432-1033.1990.tb15556.x; CHU WN, 1990, MOL ENDOCRINOL, V4, P1905, DOI 10.1210/mend-4-12-1905; COCKETT MI, 1991, NUCLEIC ACIDS RES, V19, P319, DOI 10.1093/nar/19.2.319; CONNER GE, 1990, DNA CELL BIOL, V9, P1, DOI 10.1089/dna.1990.9.1; CONNER GE, 1992, J BIOL CHEM, V267, P21738; CONNER GE, 1989, BIOCHEMISTRY-US, V28, P3530, DOI 10.1021/bi00434a057; CONNER GE, 1989, BIOCHEM J, V263, P601, DOI 10.1042/bj2630601; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; DELBRUCK R, 1994, EUR J CELL BIOL, V64, P7; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FAUST PL, 1985, P NATL ACAD SCI USA, V82, P4910, DOI 10.1073/pnas.82.15.4910; FAUST PL, 1987, J CELL BIOL, V105, P1937, DOI 10.1083/jcb.105.5.1937; FOLTMANN B, 1988, BIOL CHEM H-S, V369, P311; FRA AM, 1993, EMBO J, V12, P4755, DOI 10.1002/j.1460-2075.1993.tb06164.x; FURIE B, 1991, ANN NY ACAD SCI, V614, P1; FUSEK M, 1991, FEBS LETT, V287, P160, DOI 10.1016/0014-5793(91)80040-A; GLICKMAN JN, 1993, J CELL BIOL, V123, P99, DOI 10.1083/jcb.123.1.99; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; HARLOW E, 1988, ANTIBODIES LABORATOR; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; HASILIK A, 1992, EXPERIENTIA, V48, P130, DOI 10.1007/BF01923507; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORST M, 1993, J BIOL CHEM, V268, P19690; HORST M, 1991, BIOCHEM J, V273, P355, DOI 10.1042/bj2730355; HSUEH WA, 1991, HYPERTENSION, V17, P469, DOI 10.1161/01.HYP.17.4.469; HUTCHINS C, 1991, CRIT REV BIOCHEM MOL, V26, P77, DOI 10.3109/10409239109081721; ISIDORO C, 1991, BIOCHEM J, V273, P363, DOI 10.1042/bj2730363; JAMES MNG, 1986, NATURE, V319, P33, DOI 10.1038/319033a0; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; KOELSCH G, 1994, GEBS LETT, V343, P6; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KORNFELD S, 1990, BIOCHEM SOC T, V18, P367, DOI 10.1042/bst0180367; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN XL, 1989, J BIOL CHEM, V264, P4482; LIN XL, 1993, PROTEIN SCI, V2, P1383, DOI 10.1002/pro.5560020903; METCALF P, 1993, EMBO J, V12, P1293, DOI 10.1002/j.1460-2075.1993.tb05774.x; NILSSON B, 1991, ANNU REV MICROBIOL, V45, P607; NORMAN JA, 1992, MOL PHARMACOL, V41, P53; PAIN RH, 1985, BIOCHEM SOC T, V13, P1032, DOI 10.1042/bst0131032; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; RICHO GR, 1994, J BIOL CHEM, V269, P14806; ROTHWELL V, 1993, DNA CELL BIOL, V12, P291, DOI 10.1089/dna.1993.12.291; SACHDEV D, 1991, ADV EXP MED BIOL, V309, P335; SAGHERIAN C, 1994, BIOCHEM BIOPH RES CO, V204, P135, DOI 10.1006/bbrc.1994.2436; Sambrook J, 1989, MOL CLONING LABORATO; SHINDE U, 1994, J BIOCHEM, V115, P629, DOI 10.1093/oxfordjournals.jbchem.a124386; TANG J, 1987, J CELL BIOCHEM, V33, P53, DOI 10.1002/jcb.240330106; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; TREVINO RJ, 1993, BIOTECHNIQUES, V15, P366; VALLS LA, 1990, J CELL BIOL, V111, P361, DOI 10.1083/jcb.111.2.361; VANDENHAZEL HB, 1993, J BIOL CHEM, V268, P18002	61	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9778	9782		10.1074/jbc.270.17.9778	http://dx.doi.org/10.1074/jbc.270.17.9778			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730356	hybrid			2022-12-27	WOS:A1995QV41700015
J	WATANABE, S; ITO, Y; MIYAJIMA, A; ARAI, K				WATANABE, S; ITO, Y; MIYAJIMA, A; ARAI, K			GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR-DEPENDENT REPLICATION OF POLYOMA-VIRUS REPLICON IN HEMATOPOIETIC-CELLS - ANALYSES OF RECEPTOR SIGNALS FOR REPLICATION AND TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; COMMON BETA-SUBUNIT; LARGE TUMOR-ANTIGEN; DNA-REPLICATION; ACTIVATION DOMAINS; YEAST GAL4; T-ANTIGEN; PROTEIN-A; GM-CSF; C-FOS	Granulocyte macrophage colony stimulating factor (GM-CSF) stimulates proliferation of various hemato poietic cells. Using cytoplasmic deletion mutants of the human GM-CSF receptor (hGMR) beta subunit and tyrosine kinase inhibitors, we previously showed that distinct signaling pathways of hGMR are involved in the induction of c-fos/c-jun mRNAs and of c-myc mRNA/cell proliferation. We used polyoma virus (Py) replicon to analyze the initiation of DNA replication induced by hGM-CSF in mouse BA/F3 pro-B cells expressing hGMR. hGM-CSF efficiently stimulated Py replication in the presence of Py enhancer and Py large T antigen supplied in trans. Analyses of Py enhancer mutants revealed that hGM-CSF promoted Py replication and activated transcription of the Py early promoter through the PEA3/PEBP5 region of Py enhancer. The membrane proximal region of hGMR beta subunit is required for activation of PEA3/PEBP5-dependent replication which is also required for activation of DNA synthesis in the host cells. In contrast, a more distal region which is essential for activation of c-fos and c-jun genes is required for the PEA3/PEBP5-dependent transcription of Py early promoter. These results indicate that distinct signaling pathways of hGMR are required to activate PEA3/PEBP5-dependent replication and transcription although the same enhancer is required for both activities.	UNIV TOKYO,INST MED SCI,DEPT MOLEC & DEV BIOL,MINATO KU,TOKYO 108,JAPAN; KYOTO UNIV,INST VIRUS RES,DEPT VIRAL ONCOL,SAKYO KU,KYOTO 606,JAPAN; DNAX RES INST MOLEC & CELLULAR BIOL INC,DEPT MOLEC BIOL,PALO ALTO,CA 94304	University of Tokyo; Kyoto University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.								ANDO K, 1993, P NATL ACAD SCI USA, V90, P9571, DOI 10.1073/pnas.90.20.9571; BARU M, 1991, J VIROL, V65, P3496, DOI 10.1128/JVI.65.7.3496-3503.1991; BENNETTCOOK ER, 1991, EMBO J, V10, P959, DOI 10.1002/j.1460-2075.1991.tb08030.x; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; CAMPBELL BA, 1988, MOL CELL BIOL, V8, P1993, DOI 10.1128/MCB.8.5.1993; CAMPBELL BA, 1986, MOL CELL BIOL, V6, P2068, DOI 10.1128/MCB.6.6.2068; CARROLL MP, 1990, J BIOL CHEM, V265, P19812; CEGIELSKA A, 1993, MOL CELL BIOL, V13, P1202, DOI 10.1128/MCB.13.2.1202; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; COGEN B, 1978, VIROLOGY, V85, P222, DOI 10.1016/0042-6822(78)90426-9; DEPAMPHILIS ML, 1993, ANNU REV BIOCHEM, V62, P29; DEVILLIERS J, 1984, NATURE, V312, P242, DOI 10.1038/312242a0; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; DUTTA A, 1993, CURR BIOL, V3, P709, DOI 10.1016/0960-9822(93)90076-Z; FANGMAN WL, 1992, CELL, V71, P363, DOI 10.1016/0092-8674(92)90505-7; FARMERIE WG, 1984, P NATL ACAD SCI USA, V68, P6919; FORSBURG SL, 1991, ANNU REV CELL BIOL, V7, P227, DOI 10.1146/annurev.cb.07.110191.001303; FUJIMURA FK, 1981, CELL, V23, P809, DOI 10.1016/0092-8674(81)90445-1; HASSELL JA, 1986, CANCER CELL, V4, P561; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; ISHIKAWA H, 1993, ONCOGENE, V8, P2889; KANDA T, 1994, MOL CELL BIOL, V14, P2651, DOI 10.1128/MCB.14.4.2651; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kornberg A., 1992, DNA REPLICATION; LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B; Maniatis T., 1982, MOL CLONING; MARTIN ME, 1992, MOL CELL BIOL, V12, P2213, DOI 10.1128/MCB.12.5.2213; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MIYAJIMA A, 1987, GENE, V58, P273, DOI 10.1016/0378-1119(87)90382-9; MURAKAMI Y, 1991, P NATL ACAD SCI USA, V88, P3947, DOI 10.1073/pnas.88.9.3947; MURAKAMI Y, 1990, ONCOGENE, V5, P5; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; RASSOULZADEGAN M, 1983, P NATL ACAD SCI-BIOL, V80, P4354, DOI 10.1073/pnas.80.14.4354; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; SATOH T, 1992, J BIOL CHEM, V267, P2537; TYNDALL C, 1981, NUCLEIC ACIDS RES, V9, P6231, DOI 10.1093/nar/9.23.6231; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; WANG EH, 1993, J VIROL, V67, P6788, DOI 10.1128/JVI.67.11.6788-6796.1993; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; WATANABE S, 1994, INT IMMUNOL, V6, P523, DOI 10.1093/intimm/6.4.523; WATANABE S, 1991, CURR OPIN BIOTECH, V2, P227, DOI 10.1016/0958-1669(91)90015-W; WATANABE S, 1993, MOL CELL BIOL, V13, P1440, DOI 10.1128/MCB.13.3.1440; WATANABE S, 1993, MOL BIOL CELL, V4, P983, DOI 10.1091/mbc.4.10.983; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; XIN JH, 1992, GENE DEV, V6, P481, DOI 10.1101/gad.6.3.481; YAMAGUCHI Y, 1989, J VIROL, V63, P1040, DOI 10.1128/JVI.63.3.1040-1048.1989; ZHIGANG H, 1993, CELL, V73, P1223	57	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9615	9621		10.1074/jbc.270.16.9615	http://dx.doi.org/10.1074/jbc.270.16.9615			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721893	hybrid			2022-12-27	WOS:A1995QU08900082
J	LIEVENS, PMJ; DONADY, JJ; TUFARELLI, C; NEUFELD, EJ				LIEVENS, PMJ; DONADY, JJ; TUFARELLI, C; NEUFELD, EJ			REPRESSOR ACTIVITY OF CCAAT DISPLACEMENT PROTEIN IN HL-60 MYELOID-LEUKEMIA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY ORGAN IDENTITY; GAMMA-GLOBIN GENE; DNA-BINDING; CUT LOCUS; DROSOPHILA; EXPRESSION; PROMOTER; REGION; ACTIVATION; ACID	CCAAT displacement protein (CDP)/cut is implicated in several systems as a transcriptional repressor of developmentally regulated genes. In myeloid leukemia cells, CDP/cut binding activity as assayed on the promoter of the phagocyte-specific cytochrome heavy chain gene gp91-phox varies inversely with expression of gp91-phox mRNA. We used two approaches to ascertain whether CDP/cut serves as a repressor of gp91-phox gene expression, First, we used transient transfection assays in 3T3 cells to demonstrate that the CDP/cut binding site from the gp91-phox promoter acts as a negative regulatory element in artificial promoter constructs, Second, we isolated a stable transformant of HL-60 myeloid cells constitutively expressing transfected CDP/cut cDNA, Stable transformants carrying expression vector alone or expressing CDP/cut mRNA were induced to differentiate along the macrophage lineage with phorbol ester or along the neutrophil lineage with dimethyl sulfoxide or retinoic acid/dimethylformamide, Northern blot analysis was used to assess induction of mRNAs encoding gp91-phox, and the myeloid oxidase cytosolic components, p47 and p67, In the stable transformant expressing transfected CDP/cut cDNA, gp91-phox induction was selectively reduced, whereas morphologic differentiation and induction of mRNA for myeloid oxidase components p47 and p67 were unaffected, These data provide persuasive evidence that CDP/cut acts to repress the gp91-phox gene.	CHILDRENS HOSP, DANA FARBER CANC INST, DIV PEDIAT HEMATOL ONCOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School			Tufarelli, Cristina/AAD-3265-2019; Neufeld, Ellis J./F-9331-2011	Tufarelli, Cristina/0000-0002-1053-4618; Neufeld, Ellis J./0000-0001-8092-6281	NHLBI NIH HHS [HL49196] Funding Source: Medline; NIDDK NIH HHS [DK01977] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK001977] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDRES V, 1994, GENE DEV, V8, P245, DOI 10.1101/gad.8.2.245; ANDRES V, 1992, DEVELOPMENT, V116, P321; AUFIERO B, 1994, P NATL ACAD SCI USA, V91, P7757, DOI 10.1073/pnas.91.16.7757; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BONTHRON DT, 1986, NATURE, V324, P270, DOI 10.1038/324270a0; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DUFORT D, 1994, MOL CELL BIOL, V14, P4251, DOI 10.1128/MCB.14.6.4251; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; HARADA R, 1994, J BIOL CHEM, V269, P2062; JACK JW, 1985, CELL, V42, P869, DOI 10.1016/0092-8674(85)90283-1; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LIU S, 1991, GENETICS, V127, P151; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; McDonagh K, 1991, BLOOD, V78, p255a; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; RODAWAY ARF, 1990, MOL CELL BIOL, V10, P5388, DOI 10.1128/MCB.10.10.5388; Sambrook J, 1989, MOL CLONING LABORATO; SKALNIK DG, 1991, J BIOL CHEM, V266, P16736; SKALNIK DG, 1991, P NATL ACAD SCI USA, V88, P8505, DOI 10.1073/pnas.88.19.8505; SUPERTIFURGA G, 1989, BIOCHIM BIOPHYS ACTA, V1007, P237, DOI 10.1016/0167-4781(89)90046-8; SUPERTIFURGA G, 1988, EMBO J, V7, P3099, DOI 10.1002/j.1460-2075.1988.tb03176.x; VALARCHE I, 1993, DEVELOPMENT, V119, P881; YOON SO, 1994, J BIOL CHEM, V269, P18453; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	29	100	102	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12745	12750		10.1074/jbc.270.21.12745	http://dx.doi.org/10.1074/jbc.270.21.12745			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759529	hybrid			2022-12-27	WOS:A1995QZ71100065
J	ROSS, DC; EGAN, TJ; PURVES, LR				ROSS, DC; EGAN, TJ; PURVES, LR			PERIODATE MODIFICATION OF HUMAN SERUM TRANSFERRIN FE(III)-BINDING SITES - INHIBITION OF CARBONATE INSERTION INTO FE(III)-CHELATOR-TRANSFERRIN AND CU(II)-CHELATOR-TRANSFERRIN TERNARY COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-BINDING SITE; N-TERMINAL HALF; HUMAN LACTOFERRIN; X-RAY; MOLECULAR-STRUCTURE; INORGANIC ANIONS; FERRIC IONS; OVOTRANSFERRIN; IRON(III); RELEASE	Periodate modification of human serum transferrin produces a species that binds Fe(III) weakly at pH 7.4 contrary to previous reports that Fe(III)-binding activity is completely lost, Ternary complexes of periodate-modified transferrin and either Fe(III) with nitrilotriacetate (NTA), oxalate, citrate, or EDTA, or of Cu(II) with oxalate could be formed. Peak wavelength maxima of these spectral bands are identical to those reported for native transferrin in the absence of bicarbonate. No carbonate ternary complexes of periodate-modified transferrin with Fe(III), Al(III), Cu(II), or Zn(II) could be formed. Conditional (Fe(NTA)) binding constants (log K) for C- and N-terminal modified sites are 7.33 and 7.54, respectively, The respective extinction coefficients at 470 nm are decreased 45% compared with the native protein. The electron paramagnetic resonance spectrum of the complex closely resembles that of the Fe(III) NTA ternary complex formed with native transferrin in the absence of bicarbonate. Anions, including bicarbonate, at high concentrations destabilize formation of this Fe(III)NTA ternary complex, while Fe(III) chelators readily remove the bound Fe(III), Bicarbonate, sulfate, and pyrophosphate still bind to the modified binding sites in the absence of metal although with slightly lower affinity and with lower molar difference absorptivities, Results are interpreted as an inhibition of a crucial protein conformational change by an intramolecular cross-link, preventing formation of the particularly stable metal carbonate ternary complex hom the less stable metal-chelate ternary complex, The method can be used to produce monosited transferrins.			ROSS, DC (corresponding author), UNIV CAPE TOWN,RED CROSS WAR MEM CHILDRENS HOSP,DEPT CHEM PATHOL,RONDEBOSCH 7700,SOUTH AFRICA.							AESCHBACH R, 1976, BIOCHIM BIOPHYS ACTA, V439, P292, DOI 10.1016/0005-2795(76)90064-7; AINSCOUGH EW, 1980, INORG CHEM, V19, P3655, DOI 10.1021/ic50214a018; AISEN P, 1973, ANN NY ACAD SCI, V222, P337, DOI 10.1111/j.1749-6632.1973.tb15272.x; AISEN P, 1973, BIOCHEMISTRY-US, V12, P3679, DOI 10.1021/bi00743a017; AISEN P, 1978, J BIOL CHEM, V253, P1930; AISEN P, 1967, J BIOL CHEM, V242, P2484; ANDERSON BF, 1990, NATURE, V344, P784, DOI 10.1038/344784a0; ANDERSON BF, 1987, P NATL ACAD SCI USA, V84, P1768; ANDRSEN SO, 1966, ACTA PHYSL SCAN S263, V66, P31; AZARI P, 1970, ARCH BIOCHEM BIOPHYS, V138, P32, DOI 10.1016/0003-9861(70)90280-8; Baes C.F., 1976, HYDROLYSIS CATIONS, DOI 10.1002/bbpc.19770810252; BAILEY S, 1988, BIOCHEMISTRY-US, V27, P5804, DOI 10.1021/bi00415a061; BAKER EN, 1992, J INORG BIOCHEM, V47, P147, DOI 10.1016/0162-0134(92)84061-Q; BAKER EN, 1987, TRENDS BIOCHEM SCI, V12, P350, DOI 10.1016/0968-0004(87)90163-0; BALDWIN DA, 1981, BIOCHEM BIOPH RES CO, V99, P1101, DOI 10.1016/0006-291X(81)90732-4; BALDWIN DA, 1987, S AFR J SCI, V83, P22; BALI PK, 1989, J AM CHEM SOC, V111, P4457, DOI 10.1021/ja00194a047; BATES GW, 1971, J BIOL CHEM, V246, P3679; BERTINI I, 1988, INORG CHEM, V27, P1081, DOI 10.1021/ic00279a029; BINFORD JS, 1974, J BIOL CHEM, V249, P407; CHITAMBAR CR, 1986, J CLIN INVEST, V78, P1538, DOI 10.1172/JCI112746; DAY CL, 1992, J BIOL CHEM, V267, P13857; DUBACH J, 1991, BIOPHYS J, V59, P1091, DOI 10.1016/S0006-3495(91)82324-4; EATON SS, 1990, J BIOL CHEM, V265, P7138; EATON SS, 1989, J BIOL CHEM, V264, P4776; EGAN TJ, 1992, INORG CHEM, V31, P1994, DOI 10.1021/ic00037a005; EGAN TJ, 1993, S AFR J SCI, V89, P446; EVANS RW, 1980, BIOCHEM J, V189, P541, DOI 10.1042/bj1890541; FOLEY AA, 1988, BIOCHIM BIOPHYS ACTA, V965, P154, DOI 10.1016/0304-4165(88)90051-7; FORDHUTCHINSON AW, 1971, EUR J BIOCHEM, V21, P55, DOI 10.1111/j.1432-1033.1971.tb01439.x; FRIEDEN E, 1980, TRENDS BIOCHEM SCI, V5, pR11; GABER BP, 1974, J AM CHEM SOC, V96, P6868, DOI 10.1021/ja00829a010; GEOGHEGAN KF, 1980, J BIOL CHEM, V255, P1429; GERSTEIN M, 1993, J MOL BIOL, V234, P357, DOI 10.1006/jmbi.1993.1592; GROSSMANN JG, 1992, J MOL BIOL, V225, P811, DOI 10.1016/0022-2836(92)90402-6; HARRIS WR, 1990, INORG CHEM, V29, P119, DOI 10.1021/ic00326a024; HARRIS WR, 1985, BIOCHEMISTRY-US, V24, P7412, DOI 10.1021/bi00346a057; HARRIS WR, 1990, J INORG BIOCHEM, V38, P175, DOI 10.1016/0162-0134(90)84011-D; HARRIS WR, 1991, BIOCHEMISTRY-US, V30, P6930, DOI 10.1021/bi00242a017; HARRIS WR, 1988, J INORG BIOCHEM, V33, P211, DOI 10.1016/0162-0134(88)80050-3; HSUAN JJ, 1986, BIOCHEM J, V238, P931, DOI 10.1042/bj2380931; HSUAN JJ, 1987, BIOCHEM J, V247, P467, DOI 10.1042/bj2470467; KOJIMA N, 1981, J BIOL CHEM, V256, P2034; KYSTEVA MA, 1976, BIOCHIM BIOPHYS ACTA, V453, P484; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON SM, 1980, JNCI-J NATL CANCER I, V64, P41; LEGRAND D, 1990, BIOCHEM J, V266, P575; LESTAS AN, 1976, BRIT J HAEMATOL, V32, P341, DOI 10.1111/j.1365-2141.1976.tb00937.x; LIN LN, 1993, BIOCHEMISTRY-US, V32, P9398, DOI 10.1021/bi00087a019; LIN LN, 1991, BIOCHEMISTRY-US, V30, P11660, DOI 10.1021/bi00114a008; LINDLEY PF, 1993, ACTA CRYSTALLOGR D, V49, P292, DOI 10.1107/S0907444992012101; LONNERDAL B, 1977, FEBS LETT, V75, P89, DOI 10.1016/0014-5793(77)80059-8; MAKEY DG, 1976, BIOCHIM BIOPHYS ACTA, V453, P250, DOI 10.1016/0005-2795(76)90270-1; MARQUES HM, 1991, J INORG BIOCHEM, V41, P187, DOI 10.1016/0162-0134(91)80011-6; MARTEL AE, 1974, CRITICAL STABILITY C, V3, P161; MARTELL AE, 1974, CRITICAL STABILITY C, V1, P139; MARTIN RB, 1986, J INORG BIOCHEM, V28, P181, DOI 10.1016/0162-0134(86)80081-2; MAY PM, 1988, TALANTA, V35, P933, DOI 10.1016/0039-9140(88)80224-8; MCDEVITT MR, 1990, INORG CHEM, V29, P3425, DOI 10.1021/ic00343a029; NAJARIAN RC, 1978, J BIOL CHEM, V253, P38; PATCH MG, 1981, INORG CHIM ACTA, V56, P71; PECORARO VL, 1981, BIOCHEMISTRY-US, V20, P7033, DOI 10.1021/bi00527a040; PENNER MH, 1987, ARCH BIOCHEM BIOPHYS, V252, P7, DOI 10.1016/0003-9861(87)90002-6; PENNER MH, 1983, ARCH BIOCHEM BIOPHYS, V255, P740; PRICE EM, 1972, BIOCHEM BIOPH RES CO, V46, P646; PRINCIOTTO JV, 1975, NATURE, V255, P87, DOI 10.1038/255087a0; ROGERS TB, 1977, J BIOL CHEM, V252, P8108; ROSKAMS AJ, 1990, P NATL ACAD SCI USA, V87, P9024, DOI 10.1073/pnas.87.22.9024; ROSSENEUMOTREFF MY, 1971, BIOPOLYMERS, V10, P1039, DOI 10.1002/bip.360100610; SARRA R, 1990, ACTA CRYSTALLOGR B, V46, P763, DOI 10.1107/S0108768190006450; SCHLABACH MR, 1975, J BIOL CHEM, V250, P2182; SHONGWE MS, 1992, BIOCHEMISTRY-US, V31, P4451, DOI 10.1021/bi00133a010; SMIT S, 1981, J INORG BIOCHEM, V15, P329, DOI 10.1016/S0162-0134(00)80236-6; SOLA M, 1990, INORG CHEM, V29, P1113, DOI 10.1021/ic00331a002; TAN AT, 1969, BIOCHEMISTRY-US, V8, P3711, DOI 10.1021/bi00837a033; TEUWISSEN B, 1972, EUR J BIOCHEM, V31, P239, DOI 10.1111/j.1432-1033.1972.tb02526.x; TSANG CP, 1975, BIOCHIM BIOPHYS ACTA, V386, P32, DOI 10.1016/0005-2795(75)90243-3; VERWEIJ H, 1982, BIOCHIM BIOPHYS ACTA, V701, P180, DOI 10.1016/0167-4838(82)90111-X; YOUNG JW, 1968, EUR J BIOCHEM, V4, P385, DOI 10.1111/j.1432-1033.1968.tb00223.x; ZWEIER JL, 1977, J BIOL CHEM, V252, P6090	80	9	9	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12404	12410		10.1074/jbc.270.21.12404	http://dx.doi.org/10.1074/jbc.270.21.12404			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759481	hybrid			2022-12-27	WOS:A1995QZ71100014
J	SMITH, TK; MEISTER, A				SMITH, TK; MEISTER, A			CHEMICAL MODIFICATION OF ACTIVE-SITE RESIDUES IN GAMMA-GLUTAMYL-TRANSPEPTIDASE ASPARTATE-422 AND CYSTEINE-453	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE TRANSPEPTIDASE; BINDING; IDENTIFICATION; GLUTATHIONE; SEQUENCE; SUBUNIT	gamma-Glutamyl transpeptidase, an enzyme of central significance in glutathione metabolism, is inactivated by iodoacetamide, which esterifies an active site carboxyl group identified here as that of Asp-422. Treatment of the inactivated enzyme with hydroxylamine leads to de-esterification and to restoration of enzymatic activity. N-Acetylimidazole, which also inactivates the enzyme, acetylates several amino acid residues. Acetylation exposes Cys-453, which is buried in the native enzyme, to reaction with iodoacetamide. Incubation of the acetylated enzyme with glutamine produces a stabilized gamma-glutamyl-enzyme form which is (a) located exclusively on the light subunit, (b) more labile to base than to acid, (c) destabilized by denaturation of the enzyme with guanidinium ions, and (d) reactive with hydroxylamine to form gamma-glutamylhydroxamate. Stabilization of the gamma-glutamyl-enzyme appears to be associated with acetylation of lysine residues (including Lys-99). These and other findings suggest that the alpha-amino group of the gamma-glutamyl substrate is linked electrostatically to Asp-422 so as to facilitate reaction of the gamma-carbonyl of the substrate with an enzyme hydroxyl group to form a gamma-glutamyl-enzyme.			SMITH, TK (corresponding author), CORNELL UNIV, COLL MED, DEPT BIOCHEM, NEW YORK, NY 10021 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK012034] Funding Source: NIH RePORTER; NIDDK NIH HHS [2 R37 DK12034] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLOMA J, 1986, NUCLEIC ACIDS RES, V14, P1393, DOI 10.1093/nar/14.3.1393; ELCE JS, 1980, BIOCHEM J, V185, P473, DOI 10.1042/bj1850473; GARDELL SJ, 1980, FEBS LETT, V122, P171, DOI 10.1016/0014-5793(80)80430-3; IKEDA Y, 1993, J BIOL CHEM, V268, P3980; IKEDA Y, 1995, J BIOL CHEM, V270, P12471, DOI 10.1074/jbc.270.21.12471; LAPERCHE Y, 1989, P NATL ACAD SCI USA, V86, P3159; Means G.E., 1971, CHEM MODIFICATION PR; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Meister A, 1976, ENZYMES BIOL MEMBR, Vv3, P315; Meister A, 1989, GLUTATHIONE CHEM BIO, P367; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; PAPANDRIKOPOULOU A, 1989, EUR J BIOCHEM, V183, P693, DOI 10.1111/j.1432-1033.1989.tb21100.x; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; REDDY GS, 1963, J CHEM SOC, P1414, DOI 10.1039/jr9630001414; REVEL JP, 1959, J BIOL CHEM, V234, P577; SAKAMURO D, 1988, GENE, V73, P1; STOLE E, 1994, J BIOL CHEM, V269, P21435; STOLE E, 1990, P NATL ACAD SCI USA, V87, P1706, DOI 10.1073/pnas.87.5.1706; STOLE E, 1991, J BIOL CHEM, V266, P17850; SUZUKI H, 1989, J BACTERIOL, V171, P5169, DOI 10.1128/jb.171.9.5169-5172.1989; SZEWCZUK A, 1965, BIOCHIM BIOPHYS ACTA, V105, P352, DOI 10.1016/S0926-6593(65)80159-X; Tate S.S., 1980, ENZYMATIC BASIS DETO, VII, P95; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; TATE SS, 1977, P NATL ACAD SCI USA, V74, P931, DOI 10.1073/pnas.74.3.931; TATE SS, 1985, METHOD ENZYMOL, V113, P400; THOMPSON GA, 1980, J BIOL CHEM, V255, P2109; WEBER K, 1969, J BIOL CHEM, V244, P4406	29	16	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12476	12480		10.1074/jbc.270.21.12476	http://dx.doi.org/10.1074/jbc.270.21.12476			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759491				2022-12-27	WOS:A1995QZ71100024
J	RUBIO, S; LACAZEMASMONTEIL, T; CHAILLEYHEU, B; KAHN, A; BOURBON, JR; DUCROC, R				RUBIO, S; LACAZEMASMONTEIL, T; CHAILLEYHEU, B; KAHN, A; BOURBON, JR; DUCROC, R			PULMONARY SURFACTANT PROTEIN-A (SP-A) IS EXPRESSED BY EPITHELIAL-CELLS OF SMALL AND LARGE-INTESTINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATITIS-ASSOCIATED PROTEIN; II CELLS; ALKALINE-PHOSPHATASE; RAT LUNG; SECRETION; SEQUENCE; GENE; DIFFERENTIATION; PHAGOCYTOSIS; ORGANIZATION	Surfactant protein A (SP-A) is the most abundant protein associated with phospholipids in pulmonary surfactant, There are several lines of evidence that pulmonary and gastrointestinal epithelium produce closely related surface-active materials, although the presence of SP-A in gastrointestinal tract has so far not been reported, Indirect immunofluorescence experiments using different antibodies raised against rat pulmonary SP-A showed that some jejunal and colonic but not gastric epithelial cells positively stained for SP-A. Analysis of the proteins in cell lysates from rat small intestine and colon studied by Western blot revealed several immunoreactive bands, including the characteristic triplet of 26-, 32-, and 38-kDa monomeric proteins, less strongly labeled than in lung cells, and higher molecular mass forms of 66 and 120 kDa also present in lung cells, The 66- and 120-kDa bands displayed the expected isoelectric pH of SP-A after two-dimensional electrophoresis. Alkylation induced conversion of the 120-kDa form (almost completely) and the 66-kDa form (partly) into the 26-38-kDa monomeric species, The presence of SP-A mRNA in rat stomach, small intestine, and colon was then searched for by conventional cDNA/reverse transcriptase-polymerase chain reaction, Products of appropriate size (372 base pairs) identical to that of pulmonary tissue were amplified in small intestine and colon but not in stomach or in other tissues used as controls. Cloning and sequencing of rat colon SP-A cDNA revealed the same sequence as the one reported for rat lung SP-A Furthermore, analysis of the transcriptional initiation site of SP-A gene in colon by anchored-polymerase chain reaction showed that transcription was initiated at the same site in both colon and lung. These data, which demonstrate that small intestine and colon express SP-A constitutively and that this protein is present in some epithelial cells, extend the concept of intestinal surfactant and underline its close relationships to pulmonary surfactant.	UNIV PARIS, INSERM, U319, F-75251 PARIS 05, FRANCE; HOP ANTOINE BECLERE, SERV PEDIAT & REANIMAT NEONATALE, CLAMART, FRANCE; INST COCHIN GENET MOLEC, INSERM, U129, F-75014 PARIS, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)								AMIGO L, 1992, GASTROENTEROLOGY, V102, P774; AUDIE JP, 1993, J HISTOCHEM CYTOCHEM, V41, P1479, DOI 10.1177/41.10.8245407; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTLER BD, 1983, AM J PHYSIOL, V244, pG645, DOI 10.1152/ajpgi.1983.244.6.G645; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAWFORD SW, 1986, BIOCHEM J, V240, P107, DOI 10.1042/bj2400107; DESCHRYVERKECSKEMETI K, 1989, J CLIN INVEST, V84, P1355, DOI 10.1172/JCI114306; DOYLE IR, 1994, AM J RESP CELL MOL, V11, P405, DOI 10.1165/ajrcmb.11.4.7917309; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; DUCROC R, 1992, J PEDIATR GASTR NUTR, V15, P20, DOI 10.1097/00005176-199207000-00004; DUSETTI NJ, 1993, J BIOL CHEM, V268, P14470; ELIAKIM R, 1989, J BIOL CHEM, V264, P20614; ELIAKIM R, 1991, AM J PHYSIOL, V261, pG269, DOI 10.1152/ajpgi.1991.261.2.G269; FISHER JH, 1988, BIOCHIM BIOPHYS ACTA, V950, P338, DOI 10.1016/0167-4781(88)90130-3; FISHER JH, 1995, AM J RESP CELL MOL, V12, P13, DOI 10.1165/ajrcmb.12.1.7811466; FRASLON C, 1993, AM J PHYSIOL, V264, pL504, DOI 10.1152/ajplung.1993.264.5.L504; FROH D, 1990, BIOCHIM BIOPHYS ACTA, V1052, P78, DOI 10.1016/0167-4889(90)90060-Q; HAAS C, 1991, EUR J BIOCHEM, V197, P799; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; HAWGOOD S, 1991, ANNU REV PHYSIOL, V53, P375, DOI 10.1146/annurev.ph.53.030191.002111; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; HILLS BA, 1984, ARCH OTOLARYNGOL, V110, P3; HILLS BA, 1983, AM J PHYSIOL, V244, pG561, DOI 10.1152/ajpgi.1983.244.5.G561; IOVANNA J, 1991, J BIOL CHEM, V266, P24664; ITOH K, 1989, SCAND J GASTROENTERO, V24, P23, DOI 10.3109/00365528909091116; KUROKI Y, 1988, J BIOL CHEM, V263, P3388; KUROKI Y, 1988, P NATL ACAD SCI USA, V85, P5566, DOI 10.1073/pnas.85.15.5566; KWUN SY, 1992, GASTROENTEROLOGY, V102, P104; LACAZEMASMONTEIL T, 1992, EUR J BIOCHEM, V206, P613, DOI 10.1111/j.1432-1033.1992.tb16966.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHTENBERGER LM, 1983, SCIENCE, V219, P1327, DOI 10.1126/science.6828859; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; RICHARDS RJ, 1987, LUNG, V165, P143, DOI 10.1007/BF02714430; SANDERS RL, 1975, BIOCHEMISTRY-US, V14, P835, DOI 10.1021/bi00675a030; SANO K, 1987, BIOCHEM BIOPH RES CO, V144, P367, DOI 10.1016/S0006-291X(87)80519-3; SENEGASBALAS E, 1993, GASTROENTEROLOGY, V104, pA448; SENEGASBALAS FO, 1991, J HISTOCHEM CYTOCHEM, V39, P915, DOI 10.1177/39.7.1865108; SHAPIRO LH, 1991, J BIOL CHEM, V266, P11999; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; TIETZE CC, 1992, AM J PHYSIOL, V263, pG756, DOI 10.1152/ajpgi.1992.263.5.G756; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; VANIWAARDEN JF, 1991, AM J PHYSIOL, V261, pL204, DOI 10.1152/ajplung.1991.261.2.L204; WATANABE T, 1990, J BIOL CHEM, V265, P7432; WEAVER TE, 1985, BIOCHIM BIOPHYS ACTA, V827, P260, DOI 10.1016/0167-4838(85)90210-9; WEAVER TE, 1991, BIOCHEM J, V273, P249, DOI 10.1042/bj2730249; WEISER MM, 1973, J BIOL CHEM, V248, P2536; WHITSETT JA, 1985, J BIOL CHEM, V260, P5273; WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.physiol.53.1.395	53	106	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12162	12169		10.1074/jbc.270.20.12162	http://dx.doi.org/10.1074/jbc.270.20.12162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744866	hybrid			2022-12-27	WOS:A1995QY73600069
J	STOUT, JG; STROBEL, RS; KIRLEY, TL				STOUT, JG; STROBEL, RS; KIRLEY, TL			PROPERTIES OF AND PROTEINS ASSOCIATED WITH THE EXTRACELLULAR ATPASE OF CHICKEN GIZZARD SMOOTH-MUSCLE - A MONOCLONAL-ANTIBODY STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE GLYCOPROTEIN; CELL-ADHESION MOLECULE; TRANSVERSE TUBULE; ECTO-ATPASE; MG-ATPASE; INTEGRIN; MG2+-ATPASE; EXPRESSION; CALDESMON; IDENTITY	The chicken gizzard smooth muscle extracellular ATPase (ecto ATPase) is a low abundance, high specific activity, divalent cation dependent, nonspecific nucleotide triphosphatase (NTPase). The ATPase is a 66-kDa glycoprotein with a protein core of 53 kDa (Stout, J.G. and Kirley, T.L. (1994) J. Biochem. Biophys. Methods 29, 61-75). In this study we evaluated the characteristics of a bank of monoclonal antibodies raised against a partially purified chicken gizzard ecto-ATPase. 18 monoclonal antibodies identified by an ATPase capture assay were tested for effects on ATPase activity as well as for their Western blot and immunoprecipitation potential. The five most promising monoclonal antibodies were used to immunopurify the ecto-ATPase. The one step immunoaffinity purification of solubilized chicken gizzard membranes with all five of these monoclonal antibodies isolated a 66-kDa protein whose identity was confirmed by N-terminal sequence analysis to be the ecto-ATPase. Several of these monoclonal antibodies stimulated ecto-ATPase activity similar to that observed previously with lectins. Western blot analysis revealed that three of the five monoclonal antibodies recognized a major immunoreactive band at 66 kDa (53-kDa core protein), consistent with previous purification results. The other two antibodies recognized proteins of approximately 90 and 160 kDa on Western blots. The 90-kDa co-immunopurifying (and presumably associated or re lated) protein was identified by N-terminal analysis as LEP100, a glycoprotein that shuttles between the plasma and lysosomal membranes. The approximately 160-kDa co-immunopurifying protein was identified by N-terminal analysis as integrin, a protein involved in extracellular contacts with adhesion molecules, Extended N-terminal sequence analysis of the immunopurified 66-kDa ecto-ATPase revealed some sequence homology with mouse lysosomal associated membrane protein. Tissue distribution of the ecto-ATPase showed that the highest levels of protein were expressed in muscle tissues (cardiac, skeletal, and smooth) and brain.	UNIV CINCINNATI,COLL MED,DEPT PHARMACOL & CELL BIOPHYS,CINCINNATI,OH 45267; ST JOHNS UNIV,DEPT BIOL,COLLEGEVILLE,MN 56321	University of Cincinnati; College of Saint Benedict & Saint Johns University; Saint Johns University Collegeville				Kirley, Terence/0000-0002-6211-1414	NHLBI NIH HHS [T32-HL07382] Funding Source: Medline; NIAMS NIH HHS [R01 AR38576, K04 AR01841] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K04AR001841, R01AR038576] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE M, 1990, J BIOCHEM-TOKYO, V107, P507, DOI 10.1093/oxfordjournals.jbchem.a123075; ANSORGE W, 1985, J BIOCHEM BIOPH METH, V11, P13, DOI 10.1016/0165-022X(85)90037-5; AURIVILLIUS M, 1990, FEBS LETT, V264, P267, DOI 10.1016/0014-5793(90)80264-J; BRIESEWITZ R, 1993, J BIOL CHEM, V268, P2989; CHEUNG PH, 1993, J BIOL CHEM, V268, P24303; CUNNINGHAM HB, 1993, ARCH BIOCHEM BIOPHYS, V303, P32, DOI 10.1006/abbi.1993.1252; DAMIANI E, 1987, J CELL BIOL, V104, P461, DOI 10.1083/jcb.104.3.461; DUBYAK GR, 1993, AM J PHYSIOL, V34, pC577; DZHANDZHUGAZYAN K, 1993, FEBS LETT, V336, P279, DOI 10.1016/0014-5793(93)80820-K; Fiske CH, 1925, J BIOL CHEM, V66, P375; GEFTER ML, 1977, SOMAT CELL GENET, V3, P231, DOI 10.1007/BF01551818; HEFFERNAN M, 1989, CANCER RES, V49, P6077; HORVATH E, 1989, J NEUROSCI RES, V24, P398, DOI 10.1002/jnr.490240309; IGNATIUS MJ, 1990, J CELL BIOL, V111, P709, DOI 10.1083/jcb.111.2.709; KIRLEY TL, 1991, BIOCHEM J, V278, P375, DOI 10.1042/bj2780375; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN SH, 1991, BIOCHEM J, V278, P155, DOI 10.1042/bj2780155; LIN SH, 1989, J BIOL CHEM, V264, P14408; LIN SH, 1984, J BIOL CHEM, V259, P3016; MARSTON SB, 1991, BIOCHEM J, V279, P1; MATHEWS PM, 1992, J CELL BIOL, V118, P1027, DOI 10.1083/jcb.118.5.1027; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOULTON MP, 1986, J BIOL CHEM, V261, P2244; NABI IR, 1991, J CELL BIOL, V115, P1573, DOI 10.1083/jcb.115.6.1573; NIMMO HG, 1982, ANAL BIOCHEM, V121, P17, DOI 10.1016/0003-2697(82)90551-6; OKAMOTO VR, 1985, ARCH BIOCHEM BIOPHYS, V237, P43, DOI 10.1016/0003-9861(85)90252-8; PLESNER L, 1995, INT REV CYTOL, V158, P1; STOSCHECK CM, 1990, ANAL BIOCHEM, V184, P111, DOI 10.1016/0003-2697(90)90021-Z; STOSCHECK CM, 1987, ANAL BIOCHEM, V160, P301, DOI 10.1016/0003-2697(87)90051-0; STOUT JG, 1994, J BIOCHEM BIOPH METH, V29, P61, DOI 10.1016/0165-022X(94)90057-4; STOUT JG, 1994, BIOCHEM MOL BIOL INT, V33, P1091; STOUT JG, 1994, BIOCHEM MOL BIOL INT, V32, P745; STROBEL R, 1993, ANN NY ACAD SCI, V671, P487; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SYFRIG J, 1991, EXP CELL RES, V194, P165, DOI 10.1016/0014-4827(91)90349-Y; TREUHEIT MJ, 1992, J BIOL CHEM, V267, P11777; VALENTE APC, 1990, BIOCHIM BIOPHYS ACTA, V1039, P297, DOI 10.1016/0167-4838(90)90262-E; YAGI K, 1994, BIOCHEM BIOPH RES CO, V203, P1237, DOI 10.1006/bbrc.1994.2315; YAZAKI PJ, 1993, FASEB J, V7, P11; YAZAKI PJ, 1992, BIOPHYS J, V61, P120; ZOT AS, 1990, J BIOL CHEM, V265, P20988	41	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11845	11850		10.1074/jbc.270.20.11845	http://dx.doi.org/10.1074/jbc.270.20.11845			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744834	hybrid			2022-12-27	WOS:A1995QY73600029
J	FRANCIS, MK; PHINNEY, DG; RYDER, K				FRANCIS, MK; PHINNEY, DG; RYDER, K			ANALYSIS OF THE HORMONE-DEPENDENT REGULATION OF A JUND-ESTROGEN RECEPTOR CHIMERA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTOR; G0-TO-G1 TRANSITION; CELL-PROLIFERATION; MOUSE FIBROBLASTS; BINDING DOMAINS; FOS PROTEINS; C-JUN; TRANSFORMATION; EXPRESSION; GENE	The modular ligand-binding domains of steroid receptors have been widely used to generate protein chimeras that are ligand dependent for activity, In a similar manner, we generated a series of conditionally active JunD and c-Fos proteins by fusing their carboxyl (COOH)terminal ends with a COOH-terminal fragment of the human estrogen receptor (ER) that contains the ligand-binding domain, JunD-ER (DER) and Fos-ER (FER) chimeras with an intact leucine zipper and basic region exhibit hormone-dependent activation of activator protein-1-directed transcription in transient expression as says, One of these fusions, DER, has been examined in detail to determine its mechanism of action, Results from immunoprecipitation experiments with extracts from DER and Fos transfected cells demonstrate that Fos and DER readily form heterodimer complexes, Surprisingly, the formation of Fos:DER heterodimers, and possibly DER homodimers, is estrogen-independent. However, gel shift assays clearly demonstrate that DNA binding to AP1 sites by Fos:DER heterodimers or DER homodimers is estrogen-dependent, Moreover, in the absence of estrogen, the DER protein is an effective inhibitor of Fos-mediated transactivation, and this effect is reversed by the presence of estrogen, Our results indicate that the DER protein is a direct, hormone-reversible inhibitor of Fos and that estrogen controls the conditional positive or dominant negative activities of DER at the level of DNA binding to AP1 sites, Accordingly, clonally derived fibroblast cell lines that stably express the DER protein exhibit reduced entry into the S phase of the cell cycle when quiescent cells are serum stimulated in the absence of estrogen, This is in contrast to the estrogen-treated controls, These results support the hypothesis that AP1 is important for cell cycle progression and provide a unique approach for examining the role of AP1 in this process.	FOX CHASE CANC CTR,PHILADELPHIA,PA 19111	Fox Chase Cancer Center			Phinney, Donald G/D-2155-2014	Phinney, Donald/0000-0002-8688-2619	NATIONAL CANCER INSTITUTE [P30CA006927, F32CA009219, R01CA052752] Funding Source: NIH RePORTER; NCI NIH HHS [F32CA-09219, CA-52752, CA-06927-31] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; BONTHRON DT, 1986, NATURE, V324, P270, DOI 10.1038/324270a0; BOSSYWETZEL E, 1992, GENE DEV, V6, P2340, DOI 10.1101/gad.6.12a.2340; BROWN PH, 1994, ONCOGENE, V9, P791; BROWN PH, 1993, ONCOGENE, V8, P877; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; FRIEDMAN AD, 1988, NATURE, V335, P452, DOI 10.1038/335452a0; HARLOW E, 1988, ANTIBODIES LABORATOR; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; KOVARY K, 1992, MOL CELL BIOL, V12, P5015, DOI 10.1128/MCB.12.11.5015; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; KUMAR V, 1986, EMBO J, V5, P2231, DOI 10.1002/j.1460-2075.1986.tb04489.x; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; RANSONE LJ, 1990, P NATL ACAD SCI USA, V87, P3806, DOI 10.1073/pnas.87.10.3806; ROEMER K, 1993, P NATL ACAD SCI USA, V90, P9252, DOI 10.1073/pnas.90.20.9252; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUERMANN M, 1993, ONCOGENE, V8, P2781; STANLEY ER, 1977, CELL, V10, P35; SUPERTIFURGA G, 1991, P NATL ACAD SCI USA, V88, P5114, DOI 10.1073/pnas.88.12.5114; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; VOGT PK, 1990, ADV CANCER RES, V55, P2; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7	36	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11502	11513		10.1074/jbc.270.19.11502	http://dx.doi.org/10.1074/jbc.270.19.11502			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744790	hybrid			2022-12-27	WOS:A1995QX86500069
J	KAISER, MW; BROW, DA				KAISER, MW; BROW, DA			LETHAL MUTATIONS IN A YEAST U6 RNA GENE-B BLOCK PROMOTER ELEMENT IDENTIFY ESSENTIAL CONTACTS WITH TRANSCRIPTION FACTOR-IIIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SNRNA GENE; DNA; INVITRO; BINDING; TRANSFORMATION; MUTAGENESIS; SEQUENCE	The B block promoter element is the primary binding site for the RNA polymerase III transcription initiation factor TFIIIC. It is always located within the transcript coding region, except in the Saccharomyces cerevisiae U6 RNA gene (SNR6), in which the B block lies 120 base pairs downstream of the terminator. We have exploited the unique location of the SNR6 B block to examine the sequence specificity of its interaction with TFIIIC. The in vitro and in vivo effects of all possible single base pair substitutions in the 9-base pair core of the B block were determined. Five mutant alleles are recessive lethal when present at a low copy number; these alleles identify crucial contacts between TFIIIC and the B block promoter element. Transcript analysis reveals that lethal B block substitutions reduce U6 RNA synthesis at least 10-fold in vivo and 20-fold in vitro. One viable B block mutant strain has one-third the wild type amount of U6 RNA and exhibits reduced levels of the U4-U6 RNA complex required for spliceosome assembly. The locations of lethal single and double point mutations leads us to propose that two domains of TFIIIC contact over-lapping sites on the B block element.			KAISER, MW (corresponding author), UNIV WISCONSIN, SCH MED, DEPT BIOMOLEC CHEM, MADISON, WI 53706 USA.				NIGMS NIH HHS [T32 GM07215] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON DS, 1983, CELL, V34, P655, DOI 10.1016/0092-8674(83)90398-7; BAKER RE, 1986, J BIOL CHEM, V261, P5275; BOSSI L, 1983, NUCLEIC ACIDS RES, V11, P3207, DOI 10.1093/nar/11.10.3207; BROW DA, 1987, J BIOL CHEM, V262, P13953; BROW DA, 1990, GENE DEV, V4, P1345, DOI 10.1101/gad.4.8.1345; BURNOL AF, 1993, J MOL BIOL, V233, P644, DOI 10.1006/jmbi.1993.1542; BURNOL AF, 1993, NATURE, V362, P475, DOI 10.1038/362475a0; CAMIER S, 1985, EMBO J, V4, P491, DOI 10.1002/j.1460-2075.1985.tb03655.x; CHALKER DL, 1993, P NATL ACAD SCI USA, V90, P4927, DOI 10.1073/pnas.90.11.4927; CHATTOO BB, 1979, GENETICS, V93, P51; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; ESCHENLAUER JB, 1993, MOL CELL BIOL, V13, P3015, DOI 10.1128/MCB.13.5.3015; EVANS CF, 1990, METHOD ENZYMOL, V181, P439; FOLK WR, 1982, NUCLEIC ACIDS RES, V10, P7153, DOI 10.1093/nar/10.22.7153; FORTNER DM, 1994, GENE DEV, V8, P221, DOI 10.1101/gad.8.2.221; GAETA BA, 1990, NUCLEIC ACIDS RES, V18, P1541, DOI 10.1093/nar/18.6.1541; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GEIDUSCHEK EP, 1992, TRANSCRIPTIONAL REGU, V1, P247; GERLACH VL, 1995, MOL CELL BIOL, V15, P1455; GRUISSEM W, 1982, CELL, V30, P81, DOI 10.1016/0092-8674(82)90014-9; HEITER P, 1985, CELL, V40, P381; HERNANDEZ N, 1992, TRANSCRIPTIONAL REGU, V1, P281; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOAZEIRO CAP, 1994, MOL CELL BIOL, V14, P2798, DOI 10.1128/MCB.14.4.2798; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; LEE CP, 1991, P NATL ACAD SCI USA, V88, P11378, DOI 10.1073/pnas.88.24.11378; LEE JY, 1991, P NATL ACAD SCI USA, V88, P6986, DOI 10.1073/pnas.88.16.6986; LEFEBVRE O, 1992, P NATL ACAD SCI USA, V89, P10512, DOI 10.1073/pnas.89.21.10512; LETOILE ND, 1994, P NATL ACAD SCI USA, V91, P1652, DOI 10.1073/pnas.91.5.1652; LI ZR, 1993, NUCLEIC ACIDS RES, V21, P4645, DOI 10.1093/nar/21.19.4645; MADHANI HD, 1990, GENE DEV, V4, P2264, DOI 10.1101/gad.4.12b.2264; MARGOTTIN F, 1991, SCIENCE, V251, P424, DOI 10.1126/science.1989075; MOENNE A, 1990, EMBO J, V9, P271, DOI 10.1002/j.1460-2075.1990.tb08105.x; NICHOLS M, 1989, J BIOL CHEM, V264, P17084; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Sambrook J, 1989, MOL CLONING LABORATO; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; STILLMAN DJ, 1985, CELL, V40, P311, DOI 10.1016/0092-8674(85)90145-X; TRANGUCH AJ, 1993, J BIOL CHEM, V268, P14045; TRECO DA, 1989, CURRENT PROTOCOLS MO; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; YEAN SL, 1991, MOL CELL BIOL, V11, P5571, DOI 10.1128/MCB.11.11.5571	48	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11398	11405		10.1074/jbc.270.19.11398	http://dx.doi.org/10.1074/jbc.270.19.11398			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744776	hybrid			2022-12-27	WOS:A1995QX86500055
J	WU, WI; MCDONOUGH, VM; NICKELS, JT; KO, JS; FISCHL, AS; VALES, TR; MERRILL, AH; CARMAN, GM				WU, WI; MCDONOUGH, VM; NICKELS, JT; KO, JS; FISCHL, AS; VALES, TR; MERRILL, AH; CARMAN, GM			REGULATION OF LIPID BIOSYNTHESIS IN SACCHAROMYCES-CEREVISIAE BY FUMONISIN B-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PHOSPHATIDATE PHOSPHATASE-ACTIVITY; YEAST PHOSPHATIDYLSERINE SYNTHASE; MIXED MICELLAR ANALYSIS; PHOSPHOLIPID BIOSYNTHESIS; PHOSPHATIDYLINOSITOL SYNTHASE; FUSARIUM-MONILIFORME; SPHINGOLIPID BIOSYNTHESIS; SPHINGOSINE INHIBITION; ESCHERICHIA-COLI	The regulation of lipid biosynthesis in the yeast Saccharomyces cerevisiae by fumonisin B-1 was examined. Fumonisin B-1 inhibited the growth of yeast cells. Cells supplemented with fumonisin B, accumulated free sphinganine and phytosphingosine in a dose-dependent manner. The cellular concentration of ceramide was reduced in fumonisin B-1 supplemented cells. Ceramide synthase activity was found in yeast cell membranes and was inhibited by fumonisin B-1. Fumonisin B-1 inhibited the synthesis of the inositol containing sphingolipids inositol phosphorylceramide, mannosylinositol phosphorylceramide, and mannosyldiinositol phosphorylceramide. Fumonisin B-1 also caused a decrease in the synthesis of the major phospholipids synthesized via the CDP-diacylglycerol-dependent pathway and the synthesis of neutral lipids. The effects of fumonisin B-1 and sphingoid bases on the activities of enzymes in the pathways leading to the synthesis of sphingolipids, phospholipids, and neutral lipids were also examined. Other than ceramide synthase, fumonisin B-1 did not affect the activities of any of the enzymes examined. However, sphinganine and phytosphingosine inhibited the activities of inositol phosphorylceramide synthase, phosphatidylserine synthase, and phosphatidate phosphatase. These are key enzymes responsible for the synthesis of lipids in yeast. The data reported here indicated that the biosynthesis of sphingolipids, phospholipids and neutral lipids was coordinately regulated by fumonisin B-1 through the regulation of lipid biosynthetic enzymes by sphingoid bases.	RUTGERS STATE UNIV, COOK COLL, DEPT FOOD SCI, NEW JERSEY AGR EXPT STN, NEW BRUNSWICK, NJ 08903 USA; UNIV RHODE ISL, DEPT FOOD SCI & NUTR, KINGSTON, RI 02892 USA; EMORY UNIV, SCH MED, ROLLINS RES CTR, DEPT BIOCHEM, ATLANTA, GA 30322 USA	Rutgers State University New Brunswick; University of Rhode Island; Emory University				Merrill, Alfred/0000-0002-6673-968X	NIGMS NIH HHS [GM-46368, GM-28140, GM-49214] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM046368, R01GM028140, R29GM049214] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBAS HK, 1991, WEED SCI, V39, P673, DOI 10.1017/S004317450008855X; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BAELEE M, 1990, J BIOL CHEM, V265, P7221; BAELEE MS, 1984, J BIOL CHEM, V259, P857; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; BANGHAM AD, 1972, ANNU REV BIOCHEM, V41, P753, DOI 10.1146/annurev.bi.41.070172.003541; BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; BERRIDGE MJ, 1987, BIOCHIM BIOPHYS ACTA, V907, P33, DOI 10.1016/0304-419X(87)90017-5; BEZUIDENHOUT SC, 1988, J CHEM SOC CHEM COMM, P743, DOI 10.1039/c39880000743; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUXEDA RJ, 1993, J BIOL CHEM, V268, P6248; CARMAN GM, 1992, METHOD ENZYMOL, V209, P242; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CARMAN GM, 1992, METHOD ENZYMOL, V209, P305; CARMAN GM, 1989, PHOSPHATIDYLCHOLINE, P165; CULBERTSON MR, 1976, J BACTERIOL, V126, P232, DOI 10.1128/JB.126.1.232-242.1976; CULBERTSON MR, 1975, GENETICS, V80, P23; CULLIS PR, 1991, BIOCH LIPIDS LIPOPRO, P1; EXTON JH, 1990, J BIOL CHEM, V265, P1; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; GREENBERG ML, 1982, MOL GEN GENET, V186, P157, DOI 10.1007/BF00331845; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1987, J BIOL CHEM, V262, P13620; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HANSON BA, 1980, J LIPID RES, V21, P309; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; HJELMSTAD RH, 1991, J BIOL CHEM, V266, P4357; HJELMSTAD RH, 1991, BIOCHEMISTRY-US, V30, P1731, DOI 10.1021/bi00221a001; HOLLAND KM, 1988, J BACTERIOL, V170, P828, DOI 10.1128/jb.170.2.828-833.1988; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HOSAKA K, 1989, J BIOL CHEM, V264, P2053; HOSAKA K, 1980, J BACTERIOL, V143, P176, DOI 10.1128/JB.143.1.176-181.1980; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KINNEY AJ, 1990, J BACTERIOL, V172, P1133, DOI 10.1128/jb.172.2.1133-1136.1990; KISS Z, 1990, J BIOL CHEM, V265, P7345; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KLIG LS, 1988, J BACTERIOL, V170, P1878, DOI 10.1128/jb.170.4.1878-1886.1988; KO JS, 1994, J BACTERIOL, V176, P5181, DOI 10.1128/jb.176.16.5181-5183.1994; LAVIE Y, 1990, J BIOL CHEM, V265, P3868; LAVIE Y, 1990, FEBS LETT, V277, P7, DOI 10.1016/0014-5793(90)80796-L; LESTER RL, 1993, ADV LIPID RES, V26, P253; LIN YP, 1989, J BIOL CHEM, V264, P8641; MARASAS WFO, 1988, ONDERSTEPOORT J VET, V55, P197; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; MCMASTER CR, 1994, J BIOL CHEM, V269, P28010; MERRILL AH, 1991, J BIOENERG BIOMEMBR, V23, P83; MERRILL AH, 1989, BIOCHEMISTRY-US, V28, P3138, DOI 10.1021/bi00434a004; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; MERRILL AH, 1992, METHOD ENZYMOL, V209, P427; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; MORASH SC, 1994, J BIOL CHEM, V269, P28769; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; MULLMANN TJ, 1991, J BIOL CHEM, V266, P2013; NICKELS JT, 1994, J BIOL CHEM, V269, P11018; NIKOLOFF DM, 1991, ANNU REV GENET, V25, P559; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; PREISS J, 1986, J BIOL CHEM, V261, P8597; QUINLAN JJ, 1992, J BIOL CHEM, V267, P18013; RAMGOPAL M, 1990, J LIPID RES, V31, P653; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; SMITH SW, 1974, J BIOL CHEM, V249, P3395; STEINER MR, 1972, BIOCHIM BIOPHYS ACTA, V260, P222, DOI 10.1016/0005-2760(72)90035-5; STEINER S, 1972, J BACTERIOL, V109, P81, DOI 10.1128/JB.109.1.81-88.1972; TAYLOR FR, 1978, J BACTERIOL, V136, P531, DOI 10.1128/JB.136.2.531-537.1978; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; VANVELDHOVEN PP, 1992, BIOCHEM BIOPH RES CO, V187, P209, DOI 10.1016/S0006-291X(05)81480-9; WALSH JP, 1986, J BIOL CHEM, V261, P6239; WANG E, 1991, J BIOL CHEM, V266, P14486; WELLS GB, 1983, J BIOL CHEM, V258, P200; WHITE MJ, 1991, ADV MICROB PHYSIOL, V32, P1, DOI 10.1016/S0065-2911(08)60004-1; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; ZHAO C, 1994, J BIOL CHEM, V269, P21480	81	98	99	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13171	13178		10.1074/jbc.270.22.13171	http://dx.doi.org/10.1074/jbc.270.22.13171			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768913	hybrid, Green Published			2022-12-27	WOS:A1995RB43900036
J	QABAR, A; DERICK, L; LAWLER, J; DIXIT, V				QABAR, A; DERICK, L; LAWLER, J; DIXIT, V			THROMBOSPONDIN-3 IS A PENTAMERIC MOLECULE HELD TOGETHER BY INTERCHAIN DISULFIDE LINKAGE INVOLVING 2 CYSTEINE RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; MURINE DEVELOPMENT; GENE; EXPRESSION; CARTILAGE; PEPTIDES; FAMILY	The thrombospondins (TSPs) are a family of 5 distinct gene products designated TSP1, -2, -3, -4, and COMP, for cartilage oligomeric matrix protein. TSP1, the prototypical member, is a trimeric extracellular matrix molecule implicated in cell migration and development. TSP1 trimer formation is mediated by interchain disulfide linkage involving two NH2-terminal cysteines. TSP3, a recent addition to the family, is a developmentally regulated heparin binding protein that is similar in sequence to the COOH terminus of TSP1 but has a distinct NH2 terminus. This has raised the question of the oligomeric nature of TSP3 and identification of the cysteine residues involved in oligomer formation. We demonstrate, using a combination of deletional and site-directed mutagenesis and rotary shadowing electron microscopy, that TSP3, like TSP4 and COMP, is a pentameric molecule. TSP3 is held together by interchain disulfide linkage involving just two cysteine residues, Cys-245 and Cys-248.	UNIV MICHIGAN,SCH MED,DEPT PATHOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT CELLULAR & MOLEC BIOL,ANN ARBOR,MI 48109; ST ELIZABETHS HOSP BOSTON,DEPT BIOMED RES,BOSTON,MA 02135; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02115	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School			Lawler, Jack/AAJ-1379-2020		NATIONAL CANCER INSTITUTE [R01CA058182] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045351] Funding Source: NIH RePORTER; NCI NIH HHS [CA58182] Funding Source: Medline; NHLBI NIH HHS [HL45351] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS J, 1993, CURR BIOL, V3, P188, DOI 10.1016/0960-9822(93)90270-X; BORNSTEIN P, 1993, GENOMICS, V15, P607, DOI 10.1006/geno.1993.1114; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; CORLESS CL, 1992, DEV DYNAM, V193, P346, DOI 10.1002/aja.1001930408; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; Frazier WA, 1991, CURR OPIN CELL BIOL, V3, P792, DOI 10.1016/0955-0674(91)90052-Z; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; IRUELAARISPE ML, 1993, DEV DYNAM, V197, P40, DOI 10.1002/aja.1001970105; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1995, J BIOL CHEM, V270, P2809, DOI 10.1074/jbc.270.6.2809; LAWLER J, 1992, BIOCHEMISTRY-US, V81, P1173; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; OROURKE KM, 1992, J BIOL CHEM, V267, P24921; PROCHOWNIK EV, 1989, J CELL BIOL, V109, P843, DOI 10.1083/jcb.109.2.843; QABAR AN, 1994, J BIOL CHEM, V269, P1262; SHINGU T, 1993, GENOMICS, V16, P78, DOI 10.1006/geno.1993.1143; SOTTILE J, 1991, BIOCHEMISTRY-US, V30, P6556, DOI 10.1021/bi00240a028; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; TYLER JM, 1980, J ULTRA MOL STRUCT R, V71, P95, DOI 10.1016/S0022-5320(80)90098-2; VOGEL T, 1993, J CELL BIOCHEM, V53, P74, DOI 10.1002/jcb.240530109; WOLF FW, 1990, GENOMICS, V6, P685, DOI 10.1016/0888-7543(90)90505-O	24	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12725	12729		10.1074/jbc.270.21.12725	http://dx.doi.org/10.1074/jbc.270.21.12725			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759526	hybrid, Green Submitted			2022-12-27	WOS:A1995QZ71100062
J	DEWAARD, M; WITCHER, DR; PRAGNELL, M; LIU, HY; CAMPBELL, KP				DEWAARD, M; WITCHER, DR; PRAGNELL, M; LIU, HY; CAMPBELL, KP			PROPERTIES OF THE ALPHA(1)-BETA ANCHORING SITE IN VOLTAGE-DEPENDENT CA2+ CHANNELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; BRAIN CALCIUM-CHANNEL; BETA-SUBUNIT; 1,4-DIHYDROPYRIDINE RECEPTOR; FUNCTIONAL EXPRESSION; BLOCKERS; BINDING; CLONING	In voltage-dependent Ca2+ channels, the beta subunit interacts with the alpha(1) subunit via a cytoplasmic site, A biochemical assay has been developed to quantitatively describe the interaction between both subunits, In vitro synthesized S-35-labeled beta subunits specifically bind to a glutathione S-transferase (GST) fusion protein containing the alpha(1a) interaction domain (AID(A), located between the amino-acids 383 and 400 of the cytoplasmic loop between the hydrophobic domains I and II), Kinetic analysis demonstrates that the association of S-35-labeled beta(1b) subunit to the AID(A) GST fusion protein occurs with a fast rate constant at 4 degrees C, The binding is almost irreversible as demonstrated by the absence of dissociation observed after an 8-h incubation with an 18-amino acid synthetic AID(A) peptide, The alpha(1)-beta binding site does not seem to be a target for cytoplasmic regulation, The interaction is mostly unaffected by changes in ionic strength, pH, and Ca2+ concentration or by protein kinase C phosphorylation. The specificity of subunit interaction in voltage-dependent Ca2+ channels was also followed by saturation analyses, The data obtained show that the AID(A) GST fusion protein binds to a single site on the beta(1b) with an apparent K-d of 5 nM, The affinities of AID(A) GST fusion protein for various beta subunits was measured and demonstrate that beta subunits associate with different affinities to each alpha(1) interaction domain, The rank order of AID(A) affinity for each beta subunit is as follows: beta(4) > beta(2a) > beta(1b) much greater than beta(3). The binding of the beta subunit to alpha(1) subunit can be inhibited in vitro by the AID(A) synthetic peptide with an apparent K-i of 285 nM. This interaction can also be prevented in heterologous Ca2+ channels by the injection of the AID(A) GST fusion protein into Xenopus oocytes, Our results demonstrate that the site of interaction between AID and beta subunit is responsible for anchoring the beta subunit to the alpha(1) subunit and thus allowing the beta subunit to modify Ca2+ channel activity.	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,PROGRAM NEUROSCI,IOWA CITY,IA 52242	Howard Hughes Medical Institute; University of Iowa; University of Iowa			De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Campbell, Kevin/0000-0003-2066-5889	NIAID NIH HHS [T32-AI07343] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007343] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BIRNBAUMER L, 1994, NEURON, V13, P503; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; DEWAARD M, 1995, IN PRESS J PHYSL; EPPIG JJ, 1976, IN VITRO CELL DEV B, V12, P418; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; GRABNER M, 1994, J BIOL CHEM, V269, P23668; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; JAHN H, 1988, EUR J BIOCHEM, V178, P535, DOI 10.1111/j.1432-1033.1988.tb14480.x; JORGENSEN AO, 1989, J CELL BIOL, V109, P135, DOI 10.1083/jcb.109.1.135; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LEUNG AT, 1988, J BIOL CHEM, V263, P994; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; NISHIMURA S, 1993, FEBS LETT, V324, P283, DOI 10.1016/0014-5793(93)80135-H; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PIETROBON D, 1990, EUR J BIOCHEM, V193, P599, DOI 10.1111/j.1432-1033.1990.tb19378.x; POWERS PA, 1992, J BIOL CHEM, V267, P22967; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SAKAMOTO J, 1991, J BIOL CHEM, V266, P18914; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SOONG TW, 1993, SCIENCE, V260, P1193; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; WITCHER DR, 1993, NEUROPHARMACOLOGY, V32, P1127, DOI 10.1016/0028-3908(93)90007-P	33	124	126	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12056	12064		10.1074/jbc.270.20.12056	http://dx.doi.org/10.1074/jbc.270.20.12056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744854	hybrid			2022-12-27	WOS:A1995QY73600056
J	PITCHER, JA; TOUHARA, K; PAYNE, ES; LEFKOWITZ, RJ				PITCHER, JA; TOUHARA, K; PAYNE, ES; LEFKOWITZ, RJ			PLECKSTRIN HOMOLOGY DOMAIN-MEDIATED MEMBRANE ASSOCIATION AND ACTIVATION OF THE BETA-ADRENERGIC-RECEPTOR KINASE REQUIRES COORDINATE INTERACTION WITH G(BETA-GAMMA) SUBUNITS AND LIPID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GAMMA-SUBUNITS; G-PROTEINS; SIGNALING PROTEINS; PH DOMAIN; BRAIN	The pleckstrin homology (PH) domain is an approximately 100-amino-acid region of sequence homology present in numerous proteins of diverse functions, which forms a discrete structural module. Several ligands capable of binding to PH domain containing proteins have been identified including phosphatidylinositol 4,5-bisphosphate (PIP2) and the G(beta gamma) subunits of heterotrimeric G proteins (G(beta gamma)), which bind to the amino and carboxyl termini of the PH domain, respectively. Here we report that the binding of G(beta gamma) and lipid to the PH domain of the beta-adrenergic receptor kinase (beta ARK) synergistically enhances agonist dependent receptor phosphorylation and that both PH domain-binding ligands are required for membrane association of the kinase. PIP2 and to a lesser extent phosphatidylinositol 4 phosphate, phosphatidylinositol, and phosphatidic acid were the only lipids tested capable, in the presence of G(beta gamma), of enhancing beta ARK activity. In contrast, the K-m and V-max for phosphorylation of a soluble beta ARK substrate (casein) was not altered in either the presence or absence of G(beta gamma) and/or PIP2. A fusion protein of the beta ARK containing an intact PH domain inhibits G(beta gamma)/PIP2-dependent beta ARK activity. In contrast, a mutant fusion protein in which a tryptophan residue, invariant in all PH domain sequences, is mutated to alanine shows no inhibitory activity. The requirement for the simultaneous presence of two PH domain binding ligands represents a previously unappreciated mechanism for effecting membrane localization of a protein and may have relevance to other PH domain-containing proteins.	DUKE UNIV,MED CTR,HOWARD HUGHES MED RES INST,DEPT MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,HOWARD HUGHES MED RES INST,DEPT BIOCHEM,DURHAM,NC 27710	Duke University; Duke University			Lefkowitz, Robert/AAW-2649-2021; Pitcher, Julie/ABH-2078-2020		NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARRIZA JL, 1992, J NEUROSCI, V12, P4045; BENOVIC JL, 1984, BIOCHEMISTRY-US, V23, P4510, DOI 10.1021/bi00315a002; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; CERIONE RA, 1983, NATURE, V306, P562, DOI 10.1038/306562a0; CIFUENTES ME, 1993, J BIOL CHEM, V268, P11586; DAVIS LH, 1994, J BIOL CHEM, V269, P4409; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; HAGA K, 1992, J BIOL CHEM, V267, P2222; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HASLAM RJ, 1993, NATURE, V363, P310; KIM CM, 1993, J BIOL CHEM, V268, P15412; KIM CM, 1993, RECEPTOR, V3, P39; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; PARKER PJ, 1994, TRENDS BIOCHEM SCI, V19, P54, DOI 10.1016/0968-0004(94)90031-0; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; SATOSHI T, 1994, P NATL ACAD SCI USA, V91, P11256; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0	26	332	336	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11707	11710		10.1074/jbc.270.20.11707	http://dx.doi.org/10.1074/jbc.270.20.11707			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744811	hybrid			2022-12-27	WOS:A1995QY73600002
J	SOFER, A; FUTERMAN, AH				SOFER, A; FUTERMAN, AH			CATIONIC AMPHIPHILIC DRUGS INHIBIT THE INTERNALIZATION OF CHOLERA-TOXIN TO THE GOLGI-APPARATUS AND THE SUBSEQUENT ELEVATION OF CYCLIC-AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; ENDOCYTOSIS; ENDOSOMES; BINDING; INVAGINATIONS; TRANSFERRIN	Cholera toxin (CT) consists of a pentameric B subunit which binds with high affinity to ganglioside GM(1), and an A subunit which stimulates adenylate cyclase, resulting in the elevation of cAMP. We now examine the effect of cationic amphiphilic drugs (CADs) on the internalization of rhodamine (Rh)-CT in cultured hippocampal neurons. CADs have recently been shown to inhibit receptor recycling by disrupting the assembly-disassembly of clathrin at the plasma membrane and on endosomes (Wang, L.-H., Rothberg, K. G., and Anderson, R. G. W. (1993) J. Cell Biol. 123, 1107-1117), Rh-CT was internalized by an energy- and temperature-dependent (presumably vesicular) mechanism to the Golgi apparatus. Internalization to the Golgi apparatus was completely but reversibly blocked by CADs, and the ability of CT to stimulate the elevation of cAMP was significantly reduced. In control cells, cAMP levels were elevated 2.3-fold after 20 min of incubation with CT, but in CAD-treated cells cAMP levels were only elevated 1.3-fold. The effect of CADs on CT internalization was not due to a direct effect of CADs on the Golgi apparatus. Our data demonstrate that CADs inhibit vesicular transport of CT to the Golgi apparatus and imply that the sorting of CT to the Golgi apparatus occurs in the same endosomal compartment involved in sorting recycling receptors to the plasma membrane, since both pathways are inhibited by CADs.	WEIZMANN INST SCI, DEPT MEMBRANE RES & BIOPHYS, IL-76100 REHOVOT, ISRAEL	Weizmann Institute of Science				Futerman, Anthony/0000-0003-0013-0115				ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; DIPAOLA M, 1984, J CELL PHYSIOL, V118, P193, DOI 10.1002/jcp.1041180212; FISHMAN PH, 1982, J MEMBRANE BIOL, V69, P85, DOI 10.1007/BF01872268; FISHMAN PH, 1993, ADV LIPID RES, V25, P165; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Goslin K., 1991, CULTURING NERVE CELL, P251; HANSEN SH, 1993, J CELL BIOL, V123, P89, DOI 10.1083/jcb.123.1.89; HAREL R, 1993, J BIOL CHEM, V268, P14476; HARPER JF, 1975, J CYCLIC NUCLEOTIDE, V1, P201; HUNT RC, 1986, J BIOL CHEM, V261, P3681; JANICOT M, 1991, J BIOL CHEM, V266, P12858; JOSEPH KC, 1979, J CELL BIOL, V81, P543, DOI 10.1083/jcb.81.3.543; LEDEEN RW, 1992, TRENDS GLYCOSCI GLYC, V4, P174; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; MONTESANO R, 1982, NATURE, V296, P651, DOI 10.1038/296651a0; NAMBIAR MP, 1993, J CELL PHYSIOL, V154, P222, DOI 10.1002/jcp.1041540203; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; SCHWARZ A, 1995, J BIOL CHEM, V270, P10990, DOI 10.1074/jbc.270.18.10990; SCHWARZMANN G, 1987, GANGLIOSIDES MODULAT, P217; SEAMAN MNJ, 1993, J CELL BIOL, V123, P1093, DOI 10.1083/jcb.123.5.1093; TETTAMANTI G, 1993, ADV LIPID RES, V25, P235; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; VANECHTEN G, 1993, J BIOL CHEM, V268, P5341; WANG E, 1991, J BIOL CHEM, V266, P14486; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107	31	80	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12117	12122		10.1074/jbc.270.20.12117	http://dx.doi.org/10.1074/jbc.270.20.12117			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744860	hybrid			2022-12-27	WOS:A1995QY73600063
J	CHEN, X; RUBENSTEIN, PA				CHEN, X; RUBENSTEIN, PA			A MUTATION IN AN ATP-BINDING LOOP OF SACCHAROMYCES-CEREVISIAE ACTIN (S14A) CAUSES A TEMPERATURE-SENSITIVE PHENOTYPE IN-VIVO AND IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND DIVALENT-CATION; LOW-AFFINITY SITES; MUSCLE G-ACTIN; YEAST ACTIN; F-ACTIN; MYOSIN SUBFRAGMENT-1; CELL-CYCLE; CONFORMATIONAL-CHANGES; POLYMERIZATION; PHALLOIDIN	The Ser(14) hydroxyl group of actin is one of six groups that potentially form hydrogen bonds with the gamma-phosphate of the ATP bound in the cleft separating the two domains of the protein, To understand the importance of this group in actin function, we mutated Ser(14) of Saccharomyces cerevisiae actin and studied the effects of these mutations in vivo and in vitro. Substitution of Cys or Gly resulted in cell death. Substitution of Thr for Ser resulted in an actin with wild type properties in, vivo and in vitro. Cells carrying the Ser(14) --> Ala (S14A) mutation were viable but displayed a temperature sensitive lethality at 37 degrees C preceded by delocalization of actin patches, the appearance of bar-like structures, and finally the disappearance of identifiable actin structures, The mutation caused no effect on the critical concentration of polymerization but resulted in an actin with an increased rate of polymerization, an altered protease susceptibility, and a decreased filament ATPase activity, At 37 degrees C, Mg-, but not Ca-S14A-actin irreversibly lost the ability to polymerize, These results demonstrate the importance of the ATP-Ser(14) hydroxyl hydrogen bond in regulating actin function in, vivo and in vitro and the magnification of the effects of the mutation when Mg(2+)is substituted for Ca2+ in the protein.	UNIV IOWA, COLL MED, DEPT BIOCHEM, IOWA CITY, IA 52242 USA	University of Iowa			Chen, Xin/D-2073-2010	Rubenstein, Peter/0000-0003-1225-4414	NIGMS NIH HHS [GM-33689] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; ADAMS AEM, 1991, METHOD ENZYMOL, V194, P729; BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; CARLIER MF, 1987, J BIOL CHEM, V262, P3052; CARLIER MF, 1986, J BIOL CHEM, V261, P785; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; CLARK SW, 1992, NATURE, V359, P246, DOI 10.1038/359246a0; COLUCCIO LM, 1984, J CELL BIOL, V99, P529, DOI 10.1083/jcb.99.2.529; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1993, J BIOL CHEM, V268, P2410; COOPER J A, 1992, P47; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8; DREWES G, 1993, EUR J BIOCHEM, V212, P247, DOI 10.1111/j.1432-1033.1993.tb17656.x; DREWES G, 1990, J BIOL CHEM, V265, P3017; DRUBIN DG, 1993, MOL BIOL CELL, V4, P1277, DOI 10.1091/mbc.4.12.1277; DRUBIN DG, 1991, CELL, V65, P1093, DOI 10.1016/0092-8674(91)90001-F; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; ESTES JE, 1969, ARCH BIOCHEM BIOPHYS, V132, P388, DOI 10.1016/0003-9861(69)90380-4; FIEVEZ S, 1993, FEBS LETT, V316, P186, DOI 10.1016/0014-5793(93)81212-I; FRIEDEN C, 1980, J BIOL CHEM, V255, P8991; FRIEDEN C, 1982, J BIOL CHEM, V257, P2882; GERSHMAN LC, 1984, BIOCHEMISTRY-US, V23, P2199, DOI 10.1021/bi00305a015; HEYGI G, 1986, BIOCHEMISTRY-US, V25, P5793; HIGHTOWER RC, 1986, GENETICS, V114, P315; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACOBSON GR, 1976, P NATL ACAD SCI USA, V73, P2742, DOI 10.1073/pnas.73.8.2742; JOHANNES FJ, 1991, EMBO J, V10, P3951, DOI 10.1002/j.1460-2075.1991.tb04965.x; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KASAI M, 1969, BIOCHIM BIOPHYS ACTA, V172, P300, DOI 10.1016/0005-2728(69)90072-3; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KITAZAWA T, 1982, J MUSCLE RES CELL M, V3, P437, DOI 10.1007/BF00712093; KONNO K, 1987, BIOCHEMISTRY-US, V26, P3582, DOI 10.1021/bi00386a050; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; LEESMILLER JP, 1992, NATURE, V359, P244, DOI 10.1038/359244a0; LEESMILLER JP, 1992, P NATL ACAD SCI USA, V89, P80, DOI 10.1073/pnas.89.1.80; MORNET D, 1984, P NATL ACAD SCI-BIOL, V81, P3680, DOI 10.1073/pnas.81.12.3680; NEWMAN J, 1993, BIOPHYS J, V64, P1559, DOI 10.1016/S0006-3495(93)81525-X; NOVICK P, 1985, CELL, V40, P405, DOI 10.1016/0092-8674(85)90154-0; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; SCHWOB E, 1992, NATURE, V355, P179, DOI 10.1038/355179a0; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SELDEN LA, 1983, BIOCHEM BIOPH RES CO, V116, P478, DOI 10.1016/0006-291X(83)90548-X; SHAH DM, 1983, J MOL APPL GENET, V2, P1111; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; SPUDICH JA, 1974, J BIOL CHEM, V249, P6013; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; TOBACMAN LS, 1983, J BIOL CHEM, V258, P8806; TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207; VALENTINRANC C, 1991, J BIOL CHEM, V266, P7668; VLAHERTY KM, 1991, P NATL ACAD SCI USA, V89, P7290; WEBER A, 1969, BIOCHEMISTRY-US, V8, P2266, DOI 10.1021/bi00834a005; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3	65	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11406	11414		10.1074/jbc.270.19.11406	http://dx.doi.org/10.1074/jbc.270.19.11406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744777	hybrid			2022-12-27	WOS:A1995QX86500056
J	DEPREZ, PN; INESTROSA, NC				DEPREZ, PN; INESTROSA, NC			2 HEPARIN-BINDING DOMAINS ARE PRESENT ON THE COLLAGENIC TAIL OF ASYMMETRIC ACETYLCHOLINESTERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EXTRACELLULAR-MATRIX; FORMS; MUSCLE; GLYCOSAMINOGLYCANS; ASSOCIATION; MEMBRANES; ENDPLATE; CELLS	The collagen-tailed form of acetylcholinesterase (AChE) binds to heparin and heparan sulfate proteoglycans, We have employed synthetic peptides corresponding to the central collagenic region of the tail of AChE, to identify the heparin-binding domains of the tail of asymmetric AChE. Two putative heparin-binding consensus sequences were localized in the collagenic tail. Peptides containing such sequences (P-(145-159) and P-(249-262)) were able to release asymmetric AChE bound to heparin-agarose. A triple mutation, Asn-Asp-Gly-Gly instead of Arg-His-Gly-Arg, completely abolishes the capacity of the peptide P-(145-159) to elute AChE from the heparin column. Our results suggest that the interaction between the collagen tailed AChE and proteoglycans is mediated by clusters of basic residues that form two belts around the triple helix of the collagenic tail.	PONTIFICIA UNIV CATOLICA CHILE,FAC CIENCIAS BIOL,DEPT CELLULAR & MOLEC BIOL,SANTIAGO,CHILE	Pontificia Universidad Catolica de Chile								BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BRANDAN E, 1985, J CELL BIOL, V101, P985, DOI 10.1083/jcb.101.3.985; BRANDAN E, 1984, BIOCHEM J, V221, P415, DOI 10.1042/bj2210415; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; DUDAI Y, 1973, P NATL ACAD SCI USA, V70, P2473, DOI 10.1073/pnas.70.9.2473; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; HALL ZW, 1973, J NEUROBIOL, V4, P343, DOI 10.1002/neu.480040404; HALL ZW, 1971, NATURE-NEW BIOL, V232, P62, DOI 10.1038/newbio232062a0; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; INESTROSA NC, 1990, J MEMBRANE BIOL, V118, P1, DOI 10.1007/BF01872200; INESTROSA NC, 1982, CELL, V29, P71, DOI 10.1016/0092-8674(82)90091-5; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; LWEBUGAMUKASA JS, 1976, BIOCHEMISTRY-US, V15, P1425, DOI 10.1021/bi00652a012; MCMAHAN UJ, 1978, NATURE, V271, P172, DOI 10.1038/271172a0; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; VIGNY M, 1983, J BIOL CHEM, V258, P8794; YABKOWITZ R, 1989, J BIOL CHEM, V264, P10888; YAMADA KM, 1980, J BIOL CHEM, V255, P6055; YONATH A, 1969, J MOL BIOL, V43, P461, DOI 10.1016/0022-2836(69)90352-0	24	69	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11043	11046		10.1074/jbc.270.19.11043	http://dx.doi.org/10.1074/jbc.270.19.11043			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744733	hybrid			2022-12-27	WOS:A1995QX86500006
J	KING, SM; PATELKING, RS				KING, SM; PATELKING, RS			THE M(R)=8,000 AND 11,000 OUTER ARM DYNEIN LIGHT-CHAINS FROM CHLAMYDOMONAS FLAGELLA HAVE CYTOPLASMIC HOMOLOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE CHAIN; SECONDARY STRUCTURE; PROTEIN; MOTOR; PURIFICATION; IDENTIFICATION; DICTYOSTELIUM; MICROTUBULES; AXONEMES; ELEGANS	We report here the molecular cloning of the M(r) = 8,000 and 11,000 dynein light chains (DLCs) from the outer arm of Chlamydomonas flagella, These two molecules, which are associated with the intermediate chains at the base of the soluble dynein particle, have predicted masses of 10.3 and 13.8 kDa, respectively, and are 40% identical. Southern blot analysis indicates that one gene exists for each DLC in the Chlamydomonas genome and only a single message was observed for each on Northern blots. Secondary structure predictions suggest that both molecules contain a highly amphiphilic alpha helix that is presumably involved in protein-protein interactions. Several DLC homologues were identified in the Gen-Bank(TM) databases. One, predicted from the genomic sequence of Caenorhabditis elegans, is 88.8% identical with the M(r) = 8,000 Chlanydomonas DLC. A second, from rice callus cDNA, is 47% identical with the same DLC. As neither nematodes nor higher plants have motile cilia or flagella at any stage of their life cycles, these DLC homologues presumably must function within the cytoplasm where they may represent previously unrecognized components of cytoplasmic dynein.			KING, SM (corresponding author), UNIV CONNECTICUT, CTR HLTH, DEPT BIOCHEM, FARMINGTON, CT 06032 USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARKALOW K, 1994, J CELL BIOL, V126, P727, DOI 10.1083/jcb.126.3.727; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; Chitwood, 1974, INTRO NEMATOLOGY; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dillman J. F. Iii, 1993, Molecular Biology of the Cell, V4, p160A; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOODENOUGH U, 1984, J MOL BIOL, V180, P1083, DOI 10.1016/0022-2836(84)90272-9; HARRIS EH, 1989, CHLAMYDOMONAS SOURCE, P392; HOOG C, 1991, NUCLEIC ACIDS RES, V19, P6123, DOI 10.1093/nar/19.22.6123; KAISER ET, 1984, SCIENCE, V223, P249, DOI 10.1126/science.6322295; KING SM, 1986, METHOD ENZYMOL, V134, P291; KING SM, 1990, J BIOL CHEM, V265, P19807; KING SM, 1994, J BIOL CHEM, V269, P5452; KING SM, 1991, J BIOL CHEM, V266, P8401; King SM, 1989, CELL MOVEMENT DYNEIN, V1, P61; KOONCE MP, 1992, J CELL BIOL, V119, P1597, DOI 10.1083/jcb.119.6.1597; KOONCE MP, 1990, CELL MOTIL CYTOSKEL, V15, P51, DOI 10.1002/cm.970150108; LYE RJ, 1987, CELL, V51, P309, DOI 10.1016/0092-8674(87)90157-7; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; MIKAMI A, 1993, NEURON, V10, P787, DOI 10.1016/0896-6273(93)90195-W; MITCHELL DR, 1986, CELL MOTIL CYTOSKEL, V6, P510, DOI 10.1002/cm.970060510; MITCHELL DR, 1985, J CELL BIOL, V100, P1228, DOI 10.1083/jcb.100.4.1228; MITCHELL DR, 1993, J CELL SCI, V105, P1069; NEELY MD, 1988, J CELL BIOL, V265, P8691; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; OLMSTED JB, 1986, METHOD ENZYMOL, V134, P467; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1992, J CELL BIOL, V118, P1133, DOI 10.1083/jcb.118.5.1133; PFISTER KK, 1982, CELL MOTIL CYTOSKEL, V2, P525, DOI 10.1002/cm.970020604; PIPERNO G, 1979, J BIOL CHEM, V254, P2187; PIPERNO G, 1990, J CELL BIOL, V110, P379, DOI 10.1083/jcb.110.2.379; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; PIPERNO G, 1979, J BIOL CHEM, V254, P3084; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; STEPHENS RE, 1992, J CELL SCI, V103, P999; VALLEE R, 1993, P NATL ACAD SCI USA, V90, P8769, DOI 10.1073/pnas.90.19.8769; WILKERSON CG, 1995, IN PRESS J CELL BIOL; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Witman George B., 1994, V13, P229	41	164	167	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11445	11452		10.1074/jbc.270.19.11445	http://dx.doi.org/10.1074/jbc.270.19.11445			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744782	hybrid			2022-12-27	WOS:A1995QX86500061
J	LEIBOVITZ, D; KOCH, Y; FRIDKIN, M; PITZER, F; ZWICKL, P; DANTES, A; BAUMEISTER, W; AMSTERDAM, A				LEIBOVITZ, D; KOCH, Y; FRIDKIN, M; PITZER, F; ZWICKL, P; DANTES, A; BAUMEISTER, W; AMSTERDAM, A			ARCHAEBACTERIAL AND EUKARYOTIC PROTEASOMES PREFER DIFFERENT SITES IN CLEAVING GONADOTROPIN-RELEASING-HORMONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MULTICATALYTIC PROTEINASE COMPLEXES; THERMOPLASMA-ACIDOPHILUM; CELLS; LOCALIZATION	Thermoplasma 20 S proteasomes are composed of only two different types of subunits (designated as alpha and beta) but are nearly indistinguishable in their quaternary structure from eukaryotic 20 S proteasomes consisting of 14 distinct subunits, In this study, we compared both the nature and the rate of the proteolytic activities of Thermoplasma and of granulosa cell proteasomes on the neurohormone, gonadotropin-releasing hormone (GnRH), the degradation products of which can be unequivocally identified, Both Thermoplasma and granulosa proteasome degrade the decapeptide GnRH at the Trp(3)-Ser(4), Ser(4)-Tyr(5), Tyr(5)-Gly(6), and Gly(6)-Leu(7) bonds. While the main product of Thermoplasma proteasomes was a GnRH-(1-4) fragment, the main product of granulosa cell proteasome was a GnRH-(1-5) fragment, indicating that the principal degrading activity of Thermoplasma proteasome targets Ser(4)-Tyr(5) bond, while the principal degrading activity of granulosa cell proteasome targets the Tyr(5)-Gly(6) bond of GnRH. These differences in the degradation pattern of the neurohormone were observed when proteasome activities were compared both at 60 degrees C, the optimal temperature for Thermoplasma proteasomal activity, and at 37 degrees C, the optimal temperature of granulosa proteasome proteolytic activity. Although the catalytic mechanism is probably conserved from archaebacterial to eukaryotic proteasomes, our results suggest that there are striking differences in the preferred cleavage site of GnRH. This reflects the changes in the proteasomal subunit repertoire during evolution.	WEIZMANN INST SCI,DEPT HORMONE RES,IL-76100 REHOVOT,ISRAEL; WEIZMANN INST SCI,DEPT ORGAN CHEM,IL-76100 REHOVOT,ISRAEL; MAX PLANCK INST BIOCHEM,D-82152 MARTINSRIED,GERMANY	Weizmann Institute of Science; Weizmann Institute of Science; Max Planck Society								AKIYAMA KY, 1994, SCIENCE, V265, P1231, DOI 10.1126/science.8066462; AMSTERDAM A, 1993, P NATL ACAD SCI USA, V90, P99, DOI 10.1073/pnas.90.1.99; Barany G, 1979, PEPTIDES           A, V2, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; DAHLMANN B, 1992, EUR J BIOCHEM, V208, P789, DOI 10.1111/j.1432-1033.1992.tb17249.x; DAHLMANN B, 1985, BIOCHEM J, V228, P161, DOI 10.1042/bj2280161; DAHLMANN B, 1989, FEBS LETT, V251, P125, DOI 10.1016/0014-5793(89)81441-3; ELKABES S, 1981, BIOCHEM BIOPH RES CO, V103, P240, DOI 10.1016/0006-291X(81)91685-5; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; Greenstein J. P., 1961, CHEM AMINO ACIDS, V3; GRZIWA A, 1991, FEBS LETT, V290, P186, DOI 10.1016/0014-5793(91)81256-8; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; KOCH Y, 1974, BIOCHEM BIOPH RES CO, V61, P95, DOI 10.1016/0006-291X(74)90539-7; KOPP F, 1993, J MOL BIOL, V219, P14; LEIBOVITZ D, 1994, FEBS LETT, V346, P203, DOI 10.1016/0014-5793(94)00472-2; LOWE J, 1995, IN PRESS SCIENCE; LUPAS A, 1993, ENZYME PROTEIN, V47, P252, DOI 10.1159/000468684; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; PETERS JM, 1994, TRENDS BIOCHEM SCI, V19, P377, DOI 10.1016/0968-0004(94)90115-5; PUHLER G, 1992, EMBO J, V11, P1607, DOI 10.1002/j.1460-2075.1992.tb05206.x; PUHLER G, 1994, SYST APPL MICROBIOL, V16, P734; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; RIVETT AJ, 1993, BIOCHEM J, V291, P1; SEEMULLER E, 1995, IN PRESS SCIENCE; TANAKA K, 1990, CELL STRUCT FUNCT, V15, P127, DOI 10.1247/csf.15.127; TANAKA K, 1992, NEW BIOL, V4, P173; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2; ZWICKL P, 1992, FEBS LETT, V312, P157, DOI 10.1016/0014-5793(92)80925-7; ZWICKL P, 1992, BIOCHEMISTRY-US, V31, P964, DOI 10.1021/bi00119a004	33	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11029	11032		10.1074/jbc.270.19.11029	http://dx.doi.org/10.1074/jbc.270.19.11029			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744730	hybrid			2022-12-27	WOS:A1995QX86500002
J	RAJENDRAN, VM; GEIBEL, J; BINDER, HJ				RAJENDRAN, VM; GEIBEL, J; BINDER, HJ			CHLORIDE-DEPENDENT NA-H EXCHANGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							APICAL MEMBRANE-VESICLES; RAT DISTAL COLON; MOLECULAR-CLONING; NA+/H+ EXCHANGER; GENE FAMILY; EXPRESSION	The mechanism of sodium movement across apical membrane of colonic crypt cells of rat distal colon was examined in studies of both Na-22 uptake by apical membrane vesicles (AMV) and the rate of intracellular pH (pH(i)) recovery from an acid load by the addition of lumen sodium, In the presence of chloride but not in its absence, Na-22 uptake in crypt AMV was stimulated by an outward gradient of either [H+] or [Na+], Na-22 uptake stimulated by an outward [Na+] gradient was also observed in the presence of other halides in the order of chloride > bromide > fluoride > iodide, pH(i) recovery from an acid load was both lumen sodium- and chloride-dependent, and the rate of pH(i) recovery by lumen sodium in the presence of chloride was 65-fold greater than that in the absence of chloride (dpH/dt is 655.4 and 10.2 in the presence and absence of chloride, respectively), One mM amiloride inhibited both [H+] gradient-stimulated Na-22 uptake in the presence of chloride in crypt AMV (80%) and lumen sodium- and chloride-dependent pH(i) recovery in crypt cells (96%), [H+] gradient stimulation of Na-22 uptake by crypt AMV in the presence of chloride was less sensitive to amiloride than amiloride inhibition of Na-H exchange in colonic surface AMV. These studies provide compelling evidence that a chloride dependent Na-H exchange that is relatively amiloride-resistant is present in the apical membrane of colonic crypt cells, As prior studies have not identified a chloride-dependent Na-H exchange, the molecular and functional basis of this novel transport process is not known.	YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06520; YALE UNIV,DEPT SURG,NEW HAVEN,CT 06520; YALE UNIV,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06520	Yale University; Yale University; Yale University					NIDDK NIH HHS [DK 14669-22] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK014669] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARONSON PS, 1985, ANN REV PHYSL, V47, P245; BINDER HJ, 1994, PHYSL GASTROINTESTIN, V1, P2133; BOOKSTEIN C, 1994, J CLIN INVEST, V93, P106, DOI 10.1172/JCI116933; BURG M, 1966, AM J PHYSIOL, V210, P1293, DOI 10.1152/ajplegacy.1966.210.6.1293; CHO JH, 1994, AM J PHYSIOL, V267, pC796, DOI 10.1152/ajpcell.1994.267.3.C796; COLLINS JF, 1993, P NATL ACAD SCI USA, V90, P3938, DOI 10.1073/pnas.90.9.3938; DELCASTILLO JR, 1991, AM J PHYSIOL, V261, pG1005, DOI 10.1152/ajpgi.1991.261.6.G1005; GEIBEL J, 1989, AM J PHYSIOL, V257, pF586, DOI 10.1152/ajprenal.1989.257.4.F586; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; HOOGERWERF WA, 1994, GASTROENTEROLOGY, V106, P239; KNICKELBEIN RG, 1988, J CLIN INVEST, V82, P2158, DOI 10.1172/JCI113838; LOMAX RB, 1994, AM J PHYSIOL, V266, pG71, DOI 10.1152/ajpgi.1994.266.1.G71; LOWRY OH, 1951, J BIOL CHEM, V193, P265; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; PIZZONIA J, 1994, KIDNEY INT, V5, P297; RAJENDRAN VM, 1989, J BIOL CHEM, V264, P18638; RAJENDRAN VM, 1990, J BIOL CHEM, V265, P8408; RAJENDRAN VM, 1992, J BIOL CHEM, V88, P1379; SINGH G, 1994, KIDNEY INT, V5, P262; SINGH SK, 1994, GASTROENTEROLOGY, V106, pA272; STIEGER B, 1986, J MEMBRANE BIOL, V91, P19, DOI 10.1007/BF01870211; TSE CM, 1991, EMBO J, V10, P1957, DOI 10.1002/j.1460-2075.1991.tb07725.x; TSE M, 1993, J MEMBRANE BIOL, V135, P93; WAISBREN SJ, 1994, AM J PHYSIOL, V266, pC1013, DOI 10.1152/ajpcell.1994.266.4.C1013; WELSH MJ, 1982, SCIENCE, V218, P1219, DOI 10.1126/science.6293054; YUN CHC, 1993, J BIOL CHEM, V268, P206	26	58	59	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11051	11054		10.1074/jbc.270.19.11051	http://dx.doi.org/10.1074/jbc.270.19.11051			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744735	hybrid			2022-12-27	WOS:A1995QX86500008
J	WARNE, TR; BUCHANAN, FG; ROBINSON, M				WARNE, TR; BUCHANAN, FG; ROBINSON, M			GROWTH-DEPENDENT ACCUMULATION OF MONOALKYLGLYCEROL IN MADIN-DARBY CANINE KIDNEY-CELLS - EVIDENCE FOR A ROLE IN THE REGULATION OF PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; DIACYLGLYCEROL; ACTIVATION; PROLIFERATION; SPHINGOSINE; ALKYLACYLGLYCEROL; DIRADYLGLYCEROLS; ALKYLGLYCEROLS; PHOSPHOLIPIDS; MACROPHAGES	1-O-Alkyl-sn-glycerol (alkylglycerol) forms the backbone of complex ether-linked glycerolipids, including biologically active lipids such as platelet-activating factor, Synthetic alkylglycerol itself possesses several potent pharmacological activities and has been shown to inhibit protein kinase C (PKC) in vitro, In spite of these properties, free alkylglycerol has been regarded only as a potential product of the inflammatory degradation of complex ether lipids rather than a natural cell constituent. To explore the possibility that endogenous alkylglycerol functions as a physiological regulator in normal cells, we measured its content, along with related monoglycerides and diglycerides, by high performance liquid chromatography and gas-liquid chromatography in Madin-Darby canine kidney (MDCK) cells, The content of free alkylglycerol increased up to 20-fold during the growth of MDCK cell cultures to a confluent density, The increase was greatest during the log phase of growth, in which the content of alkylglycerol rose from 6.0 +/- 1.3 nmol/10(8) cells in preconfluent cultures to 23.6 +/- 3.4 nmol/10(8) cells in confluent cultures, Analysis of the molecular species of alkylglycerol showed that the higher content in quiescent MDCK cells was due primarily to an increase in 1-O- octadecyl-sn-glycerol. In contrast, the levels of monoacylglycerol and the PKC activator diacylglycerol were lower in confluent, quiescent cultures than in preconfluent, proliferating cultures, A similar pattern of changes in the monoglyceride and diglyceride content was observed in interleukin-3 dependent CFTL-12 mast cells when cell proliferation was blocked by growth factor withdrawal, Growth of MDCK cells to a confluent density resulted in a decrease in particulate PKC enzyme activity to a level that was only 6% of that in proliferating cells. To explore whether the accumulation of cellular alkylglycerol contributes to growth-dependent changes in PKC activity, we examined the effects of adding alkylglycerol to the activity and subcellular distribution of the enzyme in MDCK cells, Treatment of cells with 1-O-dodecyl-sn-glycerol resulted in a decrease in the activity of membrane associated PKC activity and inhibited 12-0-tetradecanoylphorbol-13-acetate-stimulated translocation of PKC from the cytosol to the membrane fraction, Alkylglycerol was also shown to inhibit the activity of purified PKC in vitro when present at levels similar to that of the diacylglycerol activator, We propose that the accumulation of alkylglycerol during the growth of MDCK cells to a confluent density contributes to the decrease in PKC activity, The control of cellular alkyl-glycerol levels may be a novel mechanism for the regulation of cellular physiology.			WARNE, TR (corresponding author), E TENNESSEE STATE UNIV, JAMES H QUILLEN COLL MED, DEPT BIOCHEM, JOHNSON CITY, TN 37614 USA.				NATIONAL CANCER INSTITUTE [R15CA059981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038660] Funding Source: NIH RePORTER; NCI NIH HHS [CA59981] Funding Source: Medline; NIDDK NIH HHS [DK38660] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDO K, 1972, CANCER RES, V321, P125; BANFIC H, 1993, BIOCHEM J, V290, P633, DOI 10.1042/bj2900633; BAUMANN WJ, 1964, J ORG CHEM, V29, P3055, DOI 10.1021/jo01033a065; BLIGH EG, 1959, CAN J BIOCH PHYSL, V37, P627; BOCCKINO SB, 1989, BIOCHEM BIOPH RES CO, V164, P290, DOI 10.1016/0006-291X(89)91716-6; BROWN MA, 1987, CELL, V50, P809, DOI 10.1016/0092-8674(87)90339-4; CABOT MC, 1982, BIOCHIM BIOPHYS ACTA, V713, P16, DOI 10.1016/0005-2760(82)90161-8; FARRAR WL, 1985, NATURE, V315, P235, DOI 10.1038/315235a0; FORD DA, 1989, J BIOL CHEM, V264, P13818; GODSON C, 1990, J BIOL CHEM, V265, P8369; HALSEY DL, 1987, J BIOL CHEM, V262, P2234; HANNUN YA, 1985, J BIOL CHEM, V260, P39; IGARASHI Y, 1989, BIOCHEMISTRY-US, V28, P6796, DOI 10.1021/bi00443a002; MAVIS RD, 1972, J BIOL CHEM, V247, P2835; MCNEELY TB, 1989, BIOCHEM J, V259, P601, DOI 10.1042/bj2590601; MERRILL AH, 1989, BIOCHEMISTRY-US, V28, P3138, DOI 10.1021/bi00434a004; MILOSZEWSKA J, 1986, FEBS LETT, V206, P283, DOI 10.1016/0014-5793(86)80997-8; MYHER JJ, 1989, J CHROMATOGR, V471, P187, DOI 10.1016/S0021-9673(00)94167-0; NGWENYA BZ, 1991, P SOC EXP BIOL MED, V196, P69; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PARKER J, 1987, J BIOL CHEM, V262, P5385; ROBINSON M, 1991, BIOCHIM BIOPHYS ACTA, V1085, P63, DOI 10.1016/0005-2760(91)90232-7; ROBINSON M, 1995, IN PRESS BIOCH BIOPH; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; UBERALL F, 1991, CANCER RES, V51, P5821; VANVELDHOVEN PP, 1989, ANAL BIOCHEM, V183, P177, DOI 10.1016/0003-2697(89)90186-3; VED HS, 1991, J NEUROSCI RES, V30, P353, DOI 10.1002/jnr.490300211; WARNE TR, 1991, ANAL BIOCHEM, V198, P302, DOI 10.1016/0003-2697(91)90429-W; WARNE TR, 1990, LIPIDS, V25, P748, DOI 10.1007/BF02544045; WEINSTEIN IB, 1990, ADV SEC MESS PHOSPH, V24, P307; WEISS BA, 1989, MOL PHARMACOL, V36, P317; WHATLEY RE, 1993, J BIOL CHEM, V268, P16130; WHETTON AD, 1988, P NATL ACAD SCI USA, V85, P3284, DOI 10.1073/pnas.85.10.3284; WYKLE RL, 1970, J BIOL CHEM, V245, P3047; YAMAMOTO N, 1987, CANCER RES, V47, P2008; YAMAMOTO N, 1988, CANCER RES, V48, P6044	36	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11147	11154		10.1074/jbc.270.19.11147	http://dx.doi.org/10.1074/jbc.270.19.11147			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744745	hybrid			2022-12-27	WOS:A1995QX86500021
J	PRIGMORE, E; AHMED, S; BEST, A; KOZMA, R; MANSER, E; SEGAL, AW; LIM, L				PRIGMORE, E; AHMED, S; BEST, A; KOZMA, R; MANSER, E; SEGAL, AW; LIM, L			A 68-KDA KINASE AND NADPH OXIDASE COMPONENT P67(PHOX) ARE TARGETS FOR CDC42HS AND RAC1 IN NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING PROTEIN; BINDING; CHIMAERIN; P21RAC1	Cdc42Hs and Rad are members of the Ras superfamily of small molecular weight (p21) GTP binding proteins. Cdc42Hs induces filopodia formation in Swiss 3T3 fibroblasts while Rad induces membrane ruffling. Rad also activates superoxide production by the components (cytochrome b, p40(phox), p67(phox), and p47(phox)) Of the neutrophil oxidase. To isolate target proteins involved in these signaling pathways, we have probed proteins from neutrophil cytosol immobilized on nitrocellulose with Cdc42Hs labeled with [gamma-P-32]GTP. Cdc42Hs probe detected binding protein(s) of 66-68 kDa in neutrophil cytosol. Rad probe also detected the 66-68-kDa proteins, suggesting the possibility that p67(phox) may be a binding protein for both of these p21 proteins. Indeed, Cdc42Hs and Rad were found to bind specifically to purified recombinant p67(phox) but not the other oxidase components. A 68-kDa Cdc42Hs binding protein was purified from neutrophil cytosol and found to be related to the recently described p65(pak) kinase from brain. These results suggest that the p68 kinase and p67(phox) are targets for Cdc42Hs and Rad in neutrophils.	INST NEUROL,DEPT NEUROCHEM,LONDON WC1N 1PJ,ENGLAND; NATL UNIV SINGAPORE,INST MOLEC & CELL BIOL,GLAXO IMCB GRP,SINGAPORE,SINGAPORE; UNIV LONDON UNIV COLL,DEPT MED,LONDON WC1E 6JJ,ENGLAND	University of London; University College London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of London; University College London			Manser, Edward/ABD-2301-2020; Kozma, Robert/C-6365-2013	Kozma, Robert/0000-0001-7011-5768; Segal, Anthony/0000-0001-7602-9043	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABO A, 1992, J BIOL CHEM, V267, P16767; ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; AHMED S, 1994, J BIOL CHEM, V269, P17642; AHMED S, 1993, J BIOL CHEM, V268, P10709; AHMED S, 1991, BIOCHEM J, V280, P233, DOI 10.1042/bj2800233; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; KWONG CH, 1993, BIOCHEMISTRY-US, V32, P5711, DOI 10.1021/bi00072a029; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557; XU XM, 1993, FASEB J, V7, pA1294	22	72	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10717	10722		10.1074/jbc.270.18.10717	http://dx.doi.org/10.1074/jbc.270.18.10717			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738010	hybrid			2022-12-27	WOS:A1995QW60100054
J	YE, WL; LAFER, EM				YE, WL; LAFER, EM			CLATHRIN BINDING AND ASSEMBLY ACTIVITIES OF EXPRESSED DOMAINS OF THE SYNAPSE-SPECIFIC CLATHRIN ASSEMBLY PROTEIN AP-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COATED VESICLES; MONOCLONAL-ANTIBODIES; F1-20 PROTEIN; BOVINE BRAIN; PURIFICATION; CLONING; CHAINS; NP185; ORGANIZATION; ADAPTERS	We separately expressed the 58-kDa C-terminal, 42-kDa middle, 16-kDa C-terminal, and 33-kDa N-terminal regions of AP-3 (also called F1-20, AP180, NP185, and pp155), and determined their clathrin binding and assembly properties. The 58-kDa C-terminal region of AP-3 is able to bind to clathrin triskelia and assemble them into a homogeneous population of clathrin cages and will also bind to preassembled clathrin cages. The 42-kDa central region of AP-3 can bind to both clathrin triskelia and to clathrin cages, but cannot assemble clathrin triskelia into clathrin cages. The 16-kDa C-terminal region of AP-3 can bind to clathrin cages, but cannot bind to clathrin triskelia or assemble clathrin triskelia into clathrin cages. The clathrin binding activities of the 42-kDa central region and 16-kDa C-terminal region are weaker than the corresponding activity of either the 58-kDa C-terminal region or full-length AP-3. Previous efforts had mapped a clathrin binding site within the N-terminal 33 kDa of AP-3 (Murphy, d. E., Pleasure, I. T., Puszkin, S., Prasad, K., and Keen, J. H. (1991) J. Biol. Chem. 266, 4401-4408; Morris, S. A., Schro der, S., Plessmann, U., Weber, K., and Ungewickell, E. (1993) EMBO J. 12, 667-675). However, although the N-terminal 33 kDa of AP-3 is able to bind to clathrin triskelia (Murphy, J. E., Pleasure, I. T., Puszkin, S., Prasad, K., and Keen, J. H. (1991) J. Biol. Chem. 266, 4401-4408; Ye, W., and Lafer, E. M. (1995) J. Neurosci. Res. 41, 15-26), it does not promote their assembly into clathrin cages (Murphy, J. E., Pleasure, I. T., Puszkin, S., Prasad, K., and Keen, J. H. (1991) J. Biol. Chem. 266, 4401-4408; Ye, W., and Lafer, E. M. (1995) J. Neurosci. Res. 41, 15-26) or bind to preassembled clathrin cages (Ye, W., and Lafer, E. M. (1995) J. Neurosci. Res. 41, 15-26). It appears that the smallest functional unit that carries out all of the reported clathrin binding and assembly properties of AP-3, essentially as well as the full-length protein, is the 58-kDa C-terminal region.	UNIV TEXAS,HLTH SCI CTR,INST BIOTECHNOL,CTR MOLEC MED,SAN ANTONIO,TX 78245; UNIV PITTSBURGH,DEPT BIOL SCI,PITTSBURGH,PA 15260	University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh				Lafer, Eileen/0000-0002-0493-6522; Ye, Weilan/0000-0002-6219-3982	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS029051, R01NS029051] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29051, R01 NS029051] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; JACKSON AP, 1987, NATURE, V326, P154, DOI 10.1038/326154a0; KEEN JH, 1986, J CELL BIOL, V102, P1325, DOI 10.1083/jcb.102.4.1325; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; KIRCHHAUSEN T, 1987, SCIENCE, V236, P320, DOI 10.1126/science.3563513; KIRCHHAUSEN T, 1989, P NATL ACAD SCI USA, V86, P2612, DOI 10.1073/pnas.86.8.2612; KIRCHHAUSEN T, 1993, CURR OPIN STRUC BIOL, V3, P182, DOI 10.1016/S0959-440X(05)80150-2; KIRCHHAUSEN T, 1987, P NATL ACAD SCI USA, V84, P8805, DOI 10.1073/pnas.84.24.8805; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; KOHTZ DS, 1988, J BIOL CHEM, V263, P7418; LINDNER R, 1991, BIOCHEMISTRY-US, V30, P9097, DOI 10.1021/bi00101a027; MORRIS SA, 1990, J BIOL CHEM, V265, P3354; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; MURPHY JE, 1994, J BIOL CHEM, V269, P21346; MURPHY JE, 1991, J BIOL CHEM, V266, P4401; PEARSE BMF, 1975, J MOL BIOL, V97, P93, DOI 10.1016/S0022-2836(75)80024-6; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PERRY DG, 1991, J HISTOCHEM CYTOCHEM, V39, P1461, DOI 10.1177/39.11.1918924; PERRY DG, 1992, J NEUROSCI RES, V33, P408, DOI 10.1002/jnr.490330307; PLEY U, 1993, CRIT REV BIOCHEM MOL, V28, P431, DOI 10.3109/10409239309078441; PRASAD K, 1988, BIOCHEMISTRY-US, V27, P6098, DOI 10.1021/bi00416a040; ROBINSON MS, 1989, J CELL BIOL, V108, P833, DOI 10.1083/jcb.108.3.833; ROBINSON MS, 1990, J CELL BIOL, V111, P2319, DOI 10.1083/jcb.111.6.2319; SOUSA R, 1990, NEUROSCIENCE, V34, P403, DOI 10.1016/0306-4522(90)90149-X; SOUSA R, 1992, J NEUROSCI, V12, P2130; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; VIGERS GPA, 1986, EMBO J, V5, P2079, DOI 10.1002/j.1460-2075.1986.tb04469.x; YE W, 1995, J NEUROSCI RES, V41, P15, DOI 10.1002/jnr.490410104; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339; ZHOU SB, 1992, J NEUROSCI, V12, P2144; ZHOU SB, 1993, J BIOL CHEM, V268, P12655	36	59	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10933	10939		10.1074/jbc.270.18.10933	http://dx.doi.org/10.1074/jbc.270.18.10933			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738035	Green Accepted			2022-12-27	WOS:A1995QW60100083
J	BRTVA, TR; DRUGAN, JK; GHOSH, S; TERRELL, RS; CAMPBELLBURK, S; BELL, RM; DER, CJ				BRTVA, TR; DRUGAN, JK; GHOSH, S; TERRELL, RS; CAMPBELLBURK, S; BELL, RM; DER, CJ			2 DISTINCT RAF DOMAINS MEDIATE INTERACTION WITH RAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; REGION; CELLS; P21	A key event for Res transformation involves the direct physical association between Ras and the Raf-l kinase, This interaction promotes both Raf translocation to the plasma membrane and activation of Raf kinase activity, Although substantial experimental evidence has demonstrated that Raf residues 51-131 alone are sufficient for Ras binding, conflicting observations have suggested that the Raf cysteine-rich domain (residues 139-184) may also be important for interaction with Ras, To clarify the role of the Raf cysteine rich domain in Ras-Raf binding, we have compared the ability of two distinct Raf fragments to interact with Ras using both in vitro Ras binding and in vivo Ras inhibition assays, First, we determined that both Raf sequences 2-140 and 139-186 (designated Raf-Cys) showed preferential binding to active, GTP-bound Ras in vitro, Second, we observed that Raf-Cys antagonized oncogenic Ras(Q61L)-mediated transactivation of Ras-responsive elements and focus-forming activity in NIH 3T3 cells and insulin-induced germinal vesicle breakdown in Xenopus laevis oocytes in vivo. This inhibitory activity suggests that Raf Cys can interact with Ras in vivo, Taken together, these results suggest that Ras interaction with two distinct domains of Raf-l may be important in Ras-mediated activation of Raf kinase activity.	UNIV N CAROLINA,LINEBERGER CANC RES CTR,CURRICULUM GENET & MOLEC BIOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,LINEBERGER CANC RES CTR,DEPT PHARMACOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,LINEBERGER CANC RES CTR,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599; DUKE UNIV,CTR COMPREHENS CANC,DEPT MOLEC CANC BIOL,DURHAM,NC 27710	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University			Ghosh, Sujoy/I-3729-2017	Ghosh, Sujoy/0000-0002-7601-165X; Der, Channing/0000-0002-7751-2747; campbell, sharon/0000-0003-0311-409X	NATIONAL CANCER INSTITUTE [R01CA042978, R01CA052072, R01CA055008] Funding Source: NIH RePORTER; NCI NIH HHS [CA42978, CA52072, CA55008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; COX AD, 1994, METHOD ENZYMOL, V238, P277; COX AD, 1994, ONCOGENE, V9, P3281; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DELOSKEY RJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P72, DOI 10.1006/abbi.1994.1210; DESHPANDE AK, 1987, MOL CELL BIOL, V7, P1285, DOI 10.1128/MCB.7.3.1285; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FINNEY RE, 1983, CURR BIOL, V3, P805; GARCIA AM, 1993, J BIOL CHEM, V268, P18415; GHOSH S, 1994, J BIOL CHEM, V269, P30785; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; HAUSER CA, 1994, METHOD ENZYMOL, V238, P271; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KORN LJ, 1987, SCIENCE, V236, P840, DOI 10.1126/science.3554510; MILLER AF, 1993, BIOCHEMISTRY-US, V32, P7367, DOI 10.1021/bi00080a006; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; PUMIGLIA K, 1995, MOL CELL BIOL, V270, P398; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; WILLIAMS NG, 1994, CANCER METAST REV, V13, P105, DOI 10.1007/BF00690421; WU M, 1990, METHODS COMPANION ME, P315; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	30	194	196	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9809	9812		10.1074/jbc.270.17.9809	http://dx.doi.org/10.1074/jbc.270.17.9809			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730360	Green Published, hybrid			2022-12-27	WOS:A1995QV41700019
J	SORENSON, MM; DASILVA, ACR; GOUVEIA, CS; SOUSA, VP; OSHIMA, W; FERRO, JA; REINACH, FC				SORENSON, MM; DASILVA, ACR; GOUVEIA, CS; SOUSA, VP; OSHIMA, W; FERRO, JA; REINACH, FC			CONCERTED ACTION OF THE HIGH-AFFINITY CALCIUM-BINDING SITES IN SKELETAL-MUSCLE TROPONIN-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I INHIBITORY PEPTIDE; PROTEOLYTIC FRAGMENTS; MECHANICAL-PROPERTIES; BIOLOGICAL-ACTIVITY; STRUCTURAL-CHANGES; THIN FILAMENT; RABBIT PSOAS; FIBERS; CALMODULIN; SUBUNITS	Mutants of each of the four divalent cation binding sites of chicken skeletal muscle troponin C (TnC) were constructed using site directed mutagenesis to convert Asp to Ala at the first coordinating position in each site. With a view to evaluating the importance of site-site interactions both within and between the N- and C-terminal domains, in this study the mutants are examined for their ability to associate with other components of the troponin-tropomyosin regulatory complex and to regulate thin filaments. The functional effects of each mutation in reconstitution assays are largely confined to the domain in which it occurs, where the unmutated site is unable to compensate for the defect, Thus the mutants of sites I and II bind to the regulatory complex but are impaired in ability to regulate tension and actomyosin ATPase activity, whereas the mutants of sites III and IV regulate activity but are unable to remain bound to thin filaments unless Ca2+ is present. When all four sites are intact, free Mg2+ causes a 50-60-fold increase in TnC's affinity for the other components of the regulatory complex, allowing it to attach firmly to thin filaments. Calcium can replace Mg2+ at a concentration ratio of 1:5000, and at this ratio the Ca2 . TnC complex is more tightly bound to the filaments than the Mg2 . TnC form, In the C-terminal mutants, higher concentrations of Ca2+ (above tension threshold) are required to effect this transformation than in the recombinant wild-type protein, suggesting that the mutants reveal an attachment mediated by Ca2+ in the N-domain sites.	UNIV SAO PAULO,INST QUIM,DEPT BIOQUIM,SAO PAULO,BRAZIL; UNIV ESTADUAL PAULISTA,DEPT TECNOL,JABATOCABAL,SP,BRAZIL	Universidade de Sao Paulo; Universidade Estadual Paulista	SORENSON, MM (corresponding author), UFRJ,ICB,DEPT BIOQUIM MED,CIDADE UNIV,BR-21941590 RIO JANEIRO,BRAZIL.		de sousa, valeria/K-7180-2012; Ferro, Jesus Aparecido A/C-8251-2013	de sousa, valeria/0000-0003-1589-0846; Ferro, Jesus Aparecido A/0000-0002-3966-1303				ALLEN TS, 1992, BIOPHYS J, V61, P399, DOI 10.1016/S0006-3495(92)81846-5; BABU A, 1988, J BIOL CHEM, V263, P15485; BABU A, 1993, J BIOL CHEM, V268, P19232; BLANCUZZI Y, 1993, BIOCHEMISTRY-US, V32, P1302, DOI 10.1021/bi00056a015; BRANDT PW, 1987, J MOL BIOL, V195, P885, DOI 10.1016/0022-2836(87)90492-X; BRANDT PW, 1984, J MOL BIOL, V180, P379, DOI 10.1016/S0022-2836(84)80010-8; BRITO RMM, 1993, J BIOL CHEM, V268, P20966; CHANDRA M, 1994, BIOCHEMISTRY-US, V33, P2961, DOI 10.1021/bi00176a028; CHANDRA M, 1994, J BIOL CHEM, V269, P14988; CHEUNG HC, 1987, BIOCHEMISTRY-US, V26, P5904, DOI 10.1021/bi00392a049; COX JA, 1981, BIOCHEM J, V195, P205, DOI 10.1042/bj1950205; DASILVA ACR, 1993, EUR J BIOCHEM, V213, P599; DECLERCQ JP, 1991, J MOL BIOL, V220, P1017, DOI 10.1016/0022-2836(91)90369-H; DOTSON DG, 1993, J BIOL CHEM, V268, P24067; EASTWOOD AB, 1979, TISSUE CELL, V11, P553, DOI 10.1016/0040-8166(79)90062-4; EBASHI S, 1971, J BIOCHEM, V69, P441, DOI 10.1093/oxfordjournals.jbchem.a129486; FARAH CS, 1994, J BIOL CHEM, V269, P5230; FUJIMORI K, 1990, NATURE, V345, P182, DOI 10.1038/345182a0; GOLOSINSKA K, 1991, J BIOL CHEM, V266, P15797; GRABAREK Z, 1981, J BIOL CHEM, V256, P3121; GRABAREK Z, 1982, J MUSCLE RES CELL M, V13, P383; GREASER ML, 1973, J BIOL CHEM, V248, P1125; GULATI J, 1992, J BIOL CHEM, V267, P25073; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HITCHCOCK SE, 1981, J MOL BIOL, V147, P153, DOI 10.1016/0022-2836(81)90083-8; INGRAHAM RH, 1984, J BIOL CHEM, V259, P9544; JOHNSON JD, 1979, J BIOL CHEM, V254, P3497; KRETSINGER RH, 1980, CRC CRIT REV BIOCH, V12, P119; LEAVIS PC, 1978, J BIOL CHEM, V253, P5452; LEAVIS PC, 1984, BIOCHEMISTRY-US, V23, P4156, DOI 10.1021/bi00313a023; LEVINE BA, 1978, BIOCHIM BIOPHYS ACTA, V535, P11, DOI 10.1016/0005-2795(78)90028-4; LI MX, 1994, BIOCHEMISTRY-US, V33, P917, DOI 10.1021/bi00170a010; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; MOSS RL, 1992, CIRC RES, V70, P865, DOI 10.1161/01.RES.70.5.865; MOSS RL, 1983, J CELL BIOL, V96, P970, DOI 10.1083/jcb.96.4.970; MOSS RL, 1985, J GEN PHYSIOL, V86, P585, DOI 10.1085/jgp.86.4.585; NEGELE JC, 1992, J BIOL CHEM, V267, P825; PAN BS, 1987, J BIOL CHEM, V262, P7839; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POTTER JD, 1975, J BIOL CHEM, V250, P4628; PUTKEY JA, 1991, J BIOL CHEM, V266, P14881; REINACH FC, 1982, J CELL BIOL, V95, P78, DOI 10.1083/jcb.95.1.78; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; ROSENFELD SS, 1985, J BIOL CHEM, V260, P252; SHENG ZL, 1990, J BIOL CHEM, V265, P21554; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; SIN IL, 1978, BIOCHEM BIOPH RES CO, V82, P1132, DOI 10.1016/0006-291X(78)90304-2; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SMITH L, 1994, J BIOL CHEM, V269, P9857; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; SUTOH K, 1980, BIOCHEMISTRY-US, V19, P1977, DOI 10.1021/bi00550a038; SWENSON CA, 1992, BIOCHEMISTRY-US, V31, P3420, DOI 10.1021/bi00128a017; TREWHELLA J, 1989, BIOCHEMISTRY-US, V28, P1294, DOI 10.1021/bi00429a052; TRIGOGONZALEZ G, 1992, BIOCHEMISTRY-US, V31, P7009, DOI 10.1021/bi00146a001; TSUDA S, 1992, J BIOCHEM-TOKYO, V112, P665, DOI 10.1093/oxfordjournals.jbchem.a123956; VANEYK JE, 1987, BIOCHEM CELL BIOL, V65, P982; WANG CK, 1985, BIOPHYS J, V48, P727, DOI 10.1016/S0006-3495(85)83831-5; ZOT AS, 1987, ANN REV BIOPHYS CHEM, V16, P585; ZOT HG, 1982, J BIOL CHEM, V257, P7678	59	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9770	9777		10.1074/jbc.270.17.9770	http://dx.doi.org/10.1074/jbc.270.17.9770			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730355	hybrid			2022-12-27	WOS:A1995QV41700014
J	YOUSSOUFIAN, H; AUERBACH, AD; VERLANDER, PC; STEIMLE, V; MACH, B				YOUSSOUFIAN, H; AUERBACH, AD; VERLANDER, PC; STEIMLE, V; MACH, B			IDENTIFICATION OF CYTOSOLIC PROTEINS THAT BIND TO THE FANCONI-ANEMIA COMPLEMENTATION GROUP-C POLYPEPTIDE IN-VITRO - EVIDENCE FOR A MULTIMERIC COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; INTRACELLULAR-DISTRIBUTION; GENE; REGISTRY; CELLS; FACC; RECOMBINATION; MUTATION; CLONING	The oligomeric structure of Fanconi anemia complementation group C (FACC) was investigated in mammalian cell lysates, Using an affinity-purified polyclonal antibody, FACC was immunoprecipitated from radiolabeled cell lysates and shown to form monomers of 63 kDa, Association of FACC with heterologous proteins was investigated by co-precipitation of radiolabeled proteins with a recombinant chimeric FACC molecule fused to the constant portion of the human IgG1 heavy chain (FACC gamma 1), Expression of FACC gamma 1 in FACC-dedcient Fanconi anemia (FA) lymphoblasts corrected the hypersensitivity of these cells to mitomycin C, Binding of FACC gamma 1 to protein A-agarose and incubation with radiolabeled cell lysates identified three polypeptides with molecular masses of 65, 50, and 35 kDa that were also detected on immunoblots probed with the purified FACC gamma 1 polypeptide. FACC, as well as the three FACC-binding polypeptides, co-fractionated with cytosolic and membrane extracts, Binding was specific for the FACC moiety of FACC gamma 1 and was detected in cytosolic extracts of a number of FA and non-FA mammalian cells. These results demonstrate that FACC binds directly to a family of ubiquitous cytosolic proteins and is conserved in a wide range of mammalian cells.	ROCKEFELLER UNIV,INVEST DERMATOL LAB,NEW YORK,NY 10021; UNIV GENEVA,SCH MED,DEPT GENET & MICROBIOL,CH-1211 GENEVA 4,SWITZERLAND	Rockefeller University; University of Geneva	YOUSSOUFIAN, H (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV HEMATOL ONCOL,221 LONGWOOD AVE,LMRC 620,BOSTON,MA 02115, USA.			Auerbach, Arleen/0000-0002-6911-8379	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032987, R01HL032987] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32987] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTER BP, 1993, HEMATOLOGY INFANCY C, P216; AUER B, 1982, HUM GENET, V61, P369; AUERBACH AD, 1991, CANCER GENET CYTOGEN, V51, P1, DOI 10.1016/0165-4608(91)90002-C; AUERBACH AD, 1979, CANCER GENET CYTOGEN, V1, P21, DOI 10.1016/0165-4608(79)90006-2; AUERBACH AD, 1989, BLOOD, V73, P391; BAILLY V, 1992, P NATL ACAD SCI USA, V89, P8273, DOI 10.1073/pnas.89.17.8273; BARDWELL L, 1992, MOL CELL BIOL, V12, P3041, DOI 10.1128/MCB.12.7.3041; BERGER NA, 1982, NATURE, V299, P271, DOI 10.1038/299271a0; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; DUCKWORTHRYSIEC.G, 1985, SOMAT CELL MOLEC GEN, V11, P35; GAVISH H, 1993, HUM MOL GENET, V2, P123, DOI 10.1093/hmg/2.2.123; GIAMPIETRO PF, 1993, PEDIATRICS, V91, P1116; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; GIBSON RA, 1993, HUM MOL GENET, V2, P35, DOI 10.1093/hmg/2.1.35; HANG B, 1993, NUCLEIC ACIDS RES, V21, P4187, DOI 10.1093/nar/21.18.4187; HARLOW E, 1988, ANTIBODIES; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KLOCKER H, 1983, EMBO J, V2, P303, DOI 10.1002/j.1460-2075.1983.tb01423.x; SAKAGUCHI K, 1991, MUTAT RES, V255, P31, DOI 10.1016/0921-8777(91)90015-H; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; VERLANDER PC, 1994, AM J HUM GENET, V54, P595; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202; WUNDER E, 1981, HUM GENET, V58, P149, DOI 10.1007/BF00278700; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P6712, DOI 10.1073/pnas.91.14.6712; YOUSSOUFIAN H, 1994, P NATL ACAD SCI USA, V91, P7975, DOI 10.1073/pnas.91.17.7975; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	29	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9876	9882		10.1074/jbc.270.17.9876	http://dx.doi.org/10.1074/jbc.270.17.9876			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730370	hybrid			2022-12-27	WOS:A1995QV41700029
J	SILVER, GM; FALL, R				SILVER, GM; FALL, R			CHARACTERIZATION OF ASPEN ISOPRENE SYNTHASE, AN ENZYME RESPONSIBLE FOR LEAF ISOPRENE EMISSION TO THE ATMOSPHERE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPEARMINT MENTHA-SPICATA; MONOTERPENE CYCLASE; 4S-LIMONENE SYNTHASE; GLANDULAR TRICHOMES; X-PIPERITA; DIPHOSPHATE; BIOSYNTHESIS; EXPRESSION; GENE; PHOTOSYNTHESIS	Isoprene (2-methyl-1,3-butadiene) is a volatile hydrocarbon emitted from many plant species to the atmosphere, where it plays an important role in atmospheric chemistry. An enzyme extracted from aspen (Populus tremuloides) leaves was previously found to catalyze the Mg2+-dependent elimination of pyrophosphate from dimethylallyl diphosphate (DMAPP) to form isoprene (Silver, G. M., and Fall, R. (1991) Plant Physiol. 97, 1588-1591). This enzyme, isoprene synthase, has now been purified 4000-fold to near homogeneity. The enzyme had a native molecular mass of 98-137 kDa and isoelectric point of 4.7 and contained 58- and 62-kDa subunits, implying that it is a heterodimer. Partial amino acid sequences of the two subunits indicated they are closely related to each other and that they do not share a strong homology with any other reported proteins. The isoprene synthase reaction was dependent on Mg2+ or Mn2+, and the reaction products were shown to be isoprene and pyrophosphate with a stoichiometry close to 1:1. The K-m for DMAPP was high at 8 mM, and the K-cat of 1.7 s(-1) was low, but similar to those of other allylic diphosphate-utilizing enzymes. It is argued that the isoprene synthase reaction may be much more efficient in vivo, where it is under light-dependent control. It seems probable that this unique enzyme, rather than non-enzymatic reactions, can account for the emission of hundreds of millions of metric tons of isoprene from plants to the global atmosphere each year.	UNIV COLORADO, DEPT CHEM & BIOCHEM, BOULDER, CO 80309 USA; UNIV COLORADO, COOPERAT INST RES ENVIRONM SCI, BOULDER, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder								ALONSO WR, 1992, J BIOL CHEM, V267, P7582; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON MS, 1989, J BIOL CHEM, V264, P19176; AVRON M, 1981, BIOCH PLANTS COMPREH, P179; BAIER D, 1975, BIOCHIM BIOPHYS ACTA, V396, P141, DOI 10.1016/0005-2728(75)90197-8; BEATY JS, 1986, MOL GEN GENET, V203, P274, DOI 10.1007/BF00333966; BLACKWELL JR, 1993, PHYTOCHEMISTRY, V34, P1477, DOI 10.1016/S0031-9422(00)90831-8; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; CARTIER PH, 1974, ANAL BIOCHEM, V61, P416, DOI 10.1016/0003-2697(74)90407-2; CHEN A, 1983, J BIOL CHEM, V268, P11002; COLBY SM, 1993, J BIOL CHEM, V268, P23016; CROTEAU R, 1989, J BIOL CHEM, V264, P15309; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; DENERIS ES, 1985, J BIOL CHEM, V260, P1382; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Fehsenfeld F, 1992, GLOBAL BIOGEOCHEM CY, V6, P389, DOI 10.1029/92GB02125; GEBLER JC, 1992, J AM CHEM SOC, V114, P7354, DOI 10.1021/ja00045a004; GEGENHEIMER P, 1990, METHOD ENZYMOL, V182, P174; GOTOH T, 1988, BIOCHEM BIOPH RES CO, V156, P396, DOI 10.1016/S0006-291X(88)80854-4; GREENBERG JP, 1993, ATMOS ENVIRON A-GEN, V27, P2689, DOI 10.1016/0960-1686(93)90037-Y; HIRANO H, 1993, ELECTROPHORESIS, V14, P839, DOI 10.1002/elps.11501401134; JUSTESEN J, 1992, ANAL BIOCHEM, V207, P90, DOI 10.1016/0003-2697(92)90506-3; KUZMA J, 1993, PLANT PHYSIOL, V101, P435, DOI 10.1104/pp.101.2.435; MCCURRY SD, 1982, METHOD ENZYMOL, V90, P515; MONSON RK, 1992, PLANT PHYSIOL, V98, P1175, DOI 10.1104/pp.98.3.1175; MONSON RK, 1989, PLANT PHYSIOL, V90, P267, DOI 10.1104/pp.90.1.267; MUEHLBACHER M, 1988, BIOCHEMISTRY-US, V27, P7315, DOI 10.1021/bi00419a021; POSCH A, 1994, ELECTROPHORESIS, V15, P297, DOI 10.1002/elps.1150150150; POULTER CD, 1990, BIOCH CELL WALLS MEM, P169; POWELL GK, 1986, NUCLEIC ACIDS RES, V14, P2555, DOI 10.1093/nar/14.6.2555; RAJAONARIVONY JIM, 1992, ARCH BIOCHEM BIOPHYS, V296, P49, DOI 10.1016/0003-9861(92)90543-6; SANADZE G. A., 1966, FIZIOL RAST, V13, P458; Sanadze G. A., 1991, TRACE GAS EMISSIONS, P135; SILVER GM, 1991, PLANT PHYSIOL, V97, P1588, DOI 10.1104/pp.97.4.1588; VANKLEY H, 1977, ANAL BIOCHEM, V81, P485, DOI 10.1016/0003-2697(77)90725-4; 1993, NOVEX CATALOG, P69; [No title captured]; 1993, LIT EP008; 1992, PUBLICATION HP PEAK, P6; 1993, I350A AM INC PUBL; [No title captured]	42	114	156	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13010	13016		10.1074/jbc.270.22.13010	http://dx.doi.org/10.1074/jbc.270.22.13010			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768893	hybrid			2022-12-27	WOS:A1995RB43900014
J	HOUHOU, L; LAMOUROUX, A; BIGUET, NF; MALLET, J				HOUHOU, L; LAMOUROUX, A; BIGUET, NF; MALLET, J			EXPRESSION OF HUMAN DOPAMINE-BETA-HYDROXYLASE IN MAMMALIAN-CELLS INFECTED BY RECOMBINANT VACCINIA VIRUS - MECHANISMS FOR MEMBRANE ATTACHMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN GRANULES; PC12 PHEOCHROMOCYTOMA CELLS; UNCLEAVED SIGNAL PEPTIDE; MESSENGER-RNA; BOUND FORMS; MOLECULAR-CLONING; BOVINE; CDNA; SEQUENCE; BINDING	Dopamine beta-hydroxylase (DBH) is found in neurosecretory vesicles in both membrane-bound and soluble forms, We expressed various human DBH cDNAs in two mammalian cell lines, using the vaccinia virus expression system. The expression of a full-length DBH cDNA (DBH-f) reproduced the native DBH electrophoretic pattern and led to the synthesis of an active enzyme composed of two subunits of 77 and 73 kDa. In contrast, a truncated cDNA lacking the first ATG (DBH-t) generated a single band of 73 kDa. Analysis of mutated recombinant clones demonstrates that the two polypeptides do not result from the use of an alternative translation initiator codon. These results, combined with deglycosylation experiments, allow us to attribute the double band pattern to an optional cleavage of the signal peptide. When the NH2-terminal extremity is shortened, cleavage becomes obligatory, underlining the role of the first 14 amino acids in the regulation of the cleavage of the signal peptide, Subcellular analysis of recombinant DBH-t and DBH-f proteins indicates that DBH is anchored to the membrane by two distinct mechanisms; one of them is due to the non-removal of the signal peptide, whereas the second one is independent of the presence of the signal sequence. Moreover, quantification of the fractionation experiments suggests that the two modes of membrane attachment are additive.	CNRS,GENET MOLEC NEUROTRANSMISS & PROC NEURODEGENERATI,F-91198 GIF SUR YVETTE,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								ANTREASSIAN J, 1986, NEUROCHEM INT, V8, P98; BELPAIRE F, 1968, BIOCHEM PHARMACOL, V17, P411, DOI 10.1016/0006-2952(68)90251-7; BON S, 1991, J NEUROCHEM, V57, P1100, DOI 10.1111/j.1471-4159.1991.tb08267.x; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; FENG ZH, 1992, J BIOL CHEM, V267, P21808; FICHERCOLBRIE R, 1982, J NEUROCHEM, V38, P725; FOUCHIER F, 1988, BIOCHEM J, V256, P103, DOI 10.1042/bj2560103; FRIEDMAN S, 1965, J BIOL CHEM, V240, P4763; GIBSON KR, 1993, J BIOL CHEM, V268, P9490; HARTMAN BK, 1972, PHARMACOL REV, V24, P311; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; JOH TH, 1986, ANN NY ACAD SCI, V493, P343; KOBAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P1089, DOI 10.1093/nar/17.3.1089; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUHN LJ, 1986, J BIOL CHEM, V261, P3816; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; LEWIS EJ, 1990, J BIOL CHEM, V265, P1021; LEWIS EJ, 1992, J BIOL CHEM, V267, P494; MARGOLIS RK, 1984, ARCH BIOCHEM BIOPHYS, V228, P443, DOI 10.1016/0003-9861(84)90009-2; MCHUGH EM, 1985, J BIOL CHEM, V260, P4409; MCMAHON A, 1990, J NEUROSCI RES, V25, P395, DOI 10.1002/jnr.490250317; OYARCE AM, 1989, J MOL NEUROSCI, V1, P171, DOI 10.1007/BF02918903; POTTER LT, 1963, J PHARMACOL EXP THER, V142, P291; ROBERTSON JG, 1990, J BIOL CHEM, V265, P1029; ROISIN MP, 1984, BIOCHEM PHARMACOL, V33, P2245, DOI 10.1016/0006-2952(84)90662-2; SABBAN EL, 1987, J NEUROSCI, V7, P192; SABBAN EL, 1983, J BIOL CHEM, V258, P7812; SABBAN EL, 1987, ANN NY ACAD SCI, V493, P339; SAXENA A, 1983, J BIOL CHEM, V258, P4147; SAXENA A, 1985, J BIOL CHEM, V260, P3386; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; SKOTLAND T, 1977, BIOCHEM BIOPH RES CO, V74, P1483, DOI 10.1016/0006-291X(77)90609-X; SPEEDIE MK, 1985, J CHROMATOGR, V327, P351, DOI 10.1016/S0021-9673(01)81664-2; STEWART LC, 1988, J BIOL CHEM, V263, P12183; STEWART LC, 1988, ANNU REV BIOCHEM, V57, P551; STUNNENBERG HG, 1988, NUCLEIC ACIDS RES, V16, P2431, DOI 10.1093/nar/16.6.2431; STUNNENBERG HG, 1990, EXPRESSION RECOMBINA; TALJANIDISZ J, 1989, BIOCHEMISTRY-US, V28, P10054, DOI 10.1021/bi00452a026; TAYLOR CS, 1989, J BIOL CHEM, V264, P14; TAYLOR CS, 1989, J BIOL CHEM, V264, P15242; TAYLOR CS, 1990, THESISS GEORGETOWN U; VAYER P, 1990, NEUROSCI RES COMMUN, V6, P77; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WANG NY, 1990, BIOCHEMISTRY-US, V29, P6466, DOI 10.1021/bi00479a019; WINKLER H, 1986, NEUROSCIENCE, V18, P261, DOI 10.1016/0306-4522(86)90154-5; WU HJ, 1990, J NEUROCHEM, V55, P97, DOI 10.1111/j.1471-4159.1990.tb08826.x	47	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12601	12606		10.1074/jbc.270.21.12601	http://dx.doi.org/10.1074/jbc.270.21.12601			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759508	hybrid			2022-12-27	WOS:A1995QZ71100043
J	NILLER, HH; GLASER, G; KNUCHEL, R; WOLF, H				NILLER, HH; GLASER, G; KNUCHEL, R; WOLF, H			NUCLEOPROTEIN COMPLEXES AND DNA 5'-ENDS AT ORIP OF EPSTEIN-BARR-VIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGATION-MEDIATED PCR; RAJI CELLS; REPLICATION ORIGIN; STABLE REPLICATION; NUCLEAR ANTIGEN-1; HUMAN TELOMERES; PLASMID ORIGIN; BINDING; EBNA-1; SITES	Understanding protein-DNA interactions in vivo at origins of DNA replication throughout the cell cycle may shed further insight on the mechanisms of initiation and replication control. The Burkitt's lymphoma cell line Raji harbors multiple copies of latent Epstein-Barr virus. Once per cell cycle the origin of plasmid replication of Epstein-Barr virus provides replication function in cis for the viral DNA. Here we examined in vivo nucleoprotein complexes on the initiator element of the origin before and after DNA synthesis. For this purpose Raji cells were synchronously growth arrested in G(1) phase by mimosine and in mitosis by colchicine, respectively. The association of the initiator element with proteins was visualized by footprinting with dimethyl sulfate and Ligation mediated polymerase chain reaction. Methylation patterns indicated a novel binding activity within each element of a nonamer repeated three times at the initiator element. This activity was strongly diminished in mitotic cells. Furthermore, 5'-ends of Epstein-Barr virus DNA were mapped to the nonamers by ligation mediated polymerase chain reaction, suggesting potential initiation sites for replication from DS.	UNIV REGENSBURG,INST PATHOL,D-93053 REGENSBURG,GERMANY	University of Regensburg	NILLER, HH (corresponding author), UNIV REGENSBURG,INST MED MICROBIOL & HYG,FRANZ JOSEF STR ALLEE 11,D-93053 REGENSBURG,GERMANY.							ADAMS A, 1987, J VIROL, V61, P1743, DOI 10.1128/JVI.61.5.1743-1746.1987; ADAMS A, 1975, P NATL ACAD SCI USA, V72, P1477, DOI 10.1073/pnas.72.4.1477; AMBINDER RF, 1990, J VIROL, V64, P2369, DOI 10.1128/JVI.64.5.2369-2379.1990; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; CHITTENDEN T, 1989, J VIROL, V63, P3016, DOI 10.1128/JVI.63.7.3016-3025.1989; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; DEPAMPHILIS ML, 1988, CELL, V52, P635, DOI 10.1016/0092-8674(88)90398-4; DHAR V, 1991, MOL CELL BIOL, V11, P6268, DOI 10.1128/MCB.11.12.6268; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; FRAPPIER L, 1992, J VIROL, V66, P1786, DOI 10.1128/JVI.66.3.1786-1790.1992; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; GUSSANDER E, 1984, J VIROL, V52, P549, DOI 10.1128/JVI.52.2.549-556.1984; HAMPAR B, 1974, P NATL ACAD SCI USA, V71, P631, DOI 10.1073/pnas.71.3.631; HSIEH DJ, 1993, EMBO J, V12, P4933, DOI 10.1002/j.1460-2075.1993.tb06187.x; HUBERMAN JA, 1981, CELL, V23, P647, DOI 10.1016/0092-8674(81)90426-8; INOUE S, 1981, J CELL BIOL, V91, pS131, DOI 10.1083/jcb.91.3.131s; KIMBALL AS, 1989, MOL CELL BIOL, V9, P2738, DOI 10.1128/MCB.9.6.2738; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; LAMBROOK J, 1989, MOL CLONING LABORATO; LINDAHL T, 1976, J MOL BIOL, V102, P511, DOI 10.1016/0022-2836(76)90331-4; LUPTON S, 1985, MOL CELL BIOL, V5, P2533, DOI 10.1128/MCB.5.10.2533; MAXAM AM, 1980, METHOD ENZYMOL, V65, P497; MIDDLETON T, 1992, J VIROL, V66, P489, DOI 10.1128/JVI.66.1.489-495.1992; MOSCA PJ, 1992, MOL CELL BIOL, V12, P4375, DOI 10.1128/MCB.12.10.4375; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; NONOYAMA M, 1972, NATURE-NEW BIOL, V238, P169, DOI 10.1038/newbio238169a0; OH SJ, 1991, J VIROL, V65, P514, DOI 10.1128/JVI.65.1.514-519.1991; PLATT THK, 1993, J VIROL, V67, P1739, DOI 10.1128/JVI.67.3.1739-1745.1993; PRICE CM, 1987, GENE DEV, V1, P783, DOI 10.1101/gad.1.8.783; PRICE CM, 1989, BIOCHEMISTRY-US, V28, P769, DOI 10.1021/bi00428a053; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; REISMAN D, 1986, MOL CELL BIOL, V6, P3838, DOI 10.1128/MCB.6.11.3838; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; SALUZ HP, 1990, LABORATORY GUIDE IN; WEN LT, 1990, VIROLOGY, V178, P293, DOI 10.1016/0042-6822(90)90407-I; WYSOKENSKI DA, 1989, J VIROL, V63, P2657, DOI 10.1128/JVI.63.6.2657-2666.1989; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991	41	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12864	12868		10.1074/jbc.270.21.12864	http://dx.doi.org/10.1074/jbc.270.21.12864			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759544	hybrid			2022-12-27	WOS:A1995QZ71100081
J	SAHLIN, M; LASSMANN, G; POTSCH, S; SJOBERG, BM; GRASLUND, A				SAHLIN, M; LASSMANN, G; POTSCH, S; SJOBERG, BM; GRASLUND, A			TRANSIENT FREE-RADICALS IN IRON OXYGEN RECONSTITUTION OF MUTANT PROTEIN R2 Y122F - POSSIBLE PARTICIPANTS IN ELECTRON-TRANSFER CHAINS IN RIBONUCLEOTIDE REDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SMALL SUBUNIT; ACTIVATION; RESONANCE; MECHANISM; COFACTOR; EPR	Ferrous iron/oxygen reconstitution of the mutant R2 apoprotein Y122F leads to formation of a diferric center similar to that of the wild-type R2 protein of Escherichia coli ribonucleotide reductase. This reconstitution reac tion requires two extra electrons, supplied or transferred by the protein matrix of R2. We observed several transient free radical species using stopped flow and freeze quench EPR and stopped now UV-visible spectroscopy. Three of the radicals occur in the time window 0.1-2 s, i.e. concomitant with formation of the diferric site. They include a strongly iron-coupled radical (singlet EPR signal) observed only at less than or equal to 77 K, a singlet EPR signal observed only at room temperature, and a radical at Tyr-356 (light absorption at 410 nm), an invariant residue proposed to be part of an electron transfer chain in catalysis. Three additional transient radicals species are observed in the time window 6 s to 20 min. Two of these are conclusively identified, by specific deuteration, as tryptophan radicals. Comparing side chain geometry and distance to the iron center with EPR characteristics of the radicals, we propose certain Trp residues in R2 as likely to harbor these transient radicals.	STOCKHOLM UNIV, ARRHENIUS LABS, DEPT BIOPHYS, S-10691 STOCKHOLM, SWEDEN; MAX DELBRUCK CTR MOLEC MED, D-13125 BERLIN, GERMANY; TECH UNIV BERLIN, MAX VOLMER INST BIOPHYS & PHYS CHEM, D-10623 BERLIN, GERMANY	Stockholm University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Technical University of Berlin	SAHLIN, M (corresponding author), STOCKHOLM UNIV, ARRHENIUS LABS, DEPT MOLEC BIOL, S-10691 STOCKHOLM, SWEDEN.			Sjoberg, Britt-Marie/0000-0001-5953-3360				ABERG A, 1993, BIOCHEMISTRY-US, V26, P5541; ACHENBAC.H, 1972, CHEM BER-RECL, V105, P784, DOI 10.1002/cber.19721050307; ANDERSSON B., 1991, CURR TOP BIOENERG, V16, P1; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BACKES G, 1989, BIOCHEMISTRY-US, V28, P1923, DOI 10.1021/bi00430a074; BAUGHER JF, 1977, J PHYS CHEM-US, V81, P1349, DOI 10.1021/j100529a002; BENDER CJ, 1989, J AM CHEM SOC, V111, P8076, DOI 10.1021/ja00203a002; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; BOLLINGER JM, 1991, J AM CHEM SOC, V113, P6289, DOI 10.1021/ja00016a066; BOLLINGER JM, 1994, J AM CHEM SOC, V116, P8015, DOI 10.1021/ja00097a008; BOLLINGER JM, 1991, SCIENCE, V253, P292, DOI 10.1126/science.1650033; BOLLINGER JM, 1994, J AM CHEM SOC, V116, P8024, DOI 10.1021/ja00097a009; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; DAVYDOV R, 1994, J AM CHEM SOC, V116, P11120, DOI 10.1021/ja00103a029; EHRENBERG A, 1972, J BIOL CHEM, V247, P3485; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; FLOSSMANN W, 1978, RADIAT RES, V73, P75, DOI 10.2307/3574574; FONTECAVE M, 1990, BIOCHEM BIOPH RES CO, V168, P659, DOI 10.1016/0006-291X(90)92371-6; FRANZEN S, 1993, J PHYS CHEM-US, V97, P3040, DOI 10.1021/j100114a035; GALLI C, 1995, J AM CHEM SOC, V117, P740, DOI 10.1021/ja00107a017; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; GRASLUND A, 1985, ENVIRON HEALTH PERSP, V64, P139, DOI 10.2307/3430005; HENRIKSEN MA, 1994, J AM CHEM SOC, V116, P9773, DOI 10.1021/ja00100a062; HOFFMAN BM, 1981, J BIOL CHEM, V256, P6556; HOUSEMAN ALP, 1993, BIOCHEMISTRY-US, V32, P4330; KIM ST, 1993, P NATL ACAD SCI USA, V90, P8023, DOI 10.1073/pnas.90.17.8023; LAM KY, 1993, J CHEM SOC DALTON, P2797, DOI 10.1039/dt9930002797; LAND EJ, 1961, T FARADAY SOC, V57, P1885, DOI 10.1039/tf9615701885; LARSSON A, 1986, EMBO J, V5, P2037, DOI 10.1002/j.1460-2075.1986.tb04461.x; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; LINDSTROM B, 1974, J LABELLED COMPD, V10, P187, DOI 10.1002/jlcr.2590100202; LING JS, 1994, J BIOL CHEM, V269, P5595; LYNCH JB, 1989, J BIOL CHEM, V264, P8091; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; MORTON JR, 1964, CHEM REV, V64, P453, DOI 10.1021/cr60230a005; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; OCHIAI EI, 1990, J BIOL CHEM, V265, P15758; PETERSSON L, 1980, J BIOL CHEM, V255, P6706; PRUTZ WA, 1979, INT J RADIAT BIOL, V36, P513, DOI 10.1080/09553007914551301; RAVI N, 1994, J AM CHEM SOC, V116, P8007, DOI 10.1021/ja00097a007; REGNSTROM K, 1994, J BIOL CHEM, V269, P6355; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; SAHLIN M, 1990, BIOCHEM BIOPH RES CO, V167, P813, DOI 10.1016/0006-291X(90)92098-K; SAHLIN M, 1987, BIOCHEMISTRY-US, V26, P5541, DOI 10.1021/bi00391a049; SAHLIN M, 1986, J MAGN RESON, V67, P135, DOI 10.1016/0022-2364(86)90417-8; SAHLIN M, 1989, BIOCHEMISTRY-US, V28, P2618, DOI 10.1021/bi00432a039; SAHLIN M, 1982, J BIOL CHEM, V257, P366; SAHLIN M, 1994, J BIOL CHEM, V269, P11699; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; SJOBERG BM, 1986, J BIOL CHEM, V261, P5658; SJOBERG BM, 1994, STRUCTURE, V2, P793, DOI 10.1016/S0969-2126(94)00080-8; SJOBERG BM, 1977, J BIOL CHEM, V252, P536; STONE EW, 1962, J CHEM PHYS, V37, P1326, DOI 10.1063/1.1733281; STUBBE JA, 1980, J BIOL CHEM, V255, P8027; WANG JM, 1990, BIOCHEMISTRY-US, V29, P7160, DOI 10.1021/bi00483a003	58	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12361	12372		10.1074/jbc.270.21.12361	http://dx.doi.org/10.1074/jbc.270.21.12361			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759477	hybrid			2022-12-27	WOS:A1995QZ71100009
J	SIDHU, JS; OMIECINSKI, CJ				SIDHU, JS; OMIECINSKI, CJ			CAMP-ASSOCIATED INHIBITION OF PHENOBARBITAL-INDUCIBLE CYTOCHROME-P450 GENE-EXPRESSION IN PRIMARY RAT HEPATOCYTE CULTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TYROSINE AMINOTRANSFERASE GENE; BOVINE ADRENOCORTICAL-CELLS; CYCLIC-AMP; EXTRACELLULAR-MATRIX; TRANSCRIPTIONAL REGULATION; BASEMENT-MEMBRANE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; ADENOSINE 3',5'-MONOPHOSPHATE; INTERCELLULAR COMMUNICATION	The effects of elevated intracellular cyclic adenosine monophosphate (cAMP) in regulating phenobarbital (PB)-inducible gene expression in primary rat hepatocyte cultures were investigated. Cells were exposed to various concentrations (0.1-100 mu m) of cAMP analogs and/or activators of intracellular cAMP-dependent pathways. Effects of these treatments were assessed either using a 1-h pulse prior to PB (100 mu m) exposure or in conjunction with PB during a 24-h exposure period. PB-inducible responses were measured in hepatocytes by hybridization to cytochrome P450 (CYP) CYP2B1, CYP2B2, and CYP3A1 mRNAs. The cAMP analogs, 8-bromo-cAMP, 8-(4-chlorophenylthio)-cAMP, dibutyryl cAMP,and (S-p)-5,6-DCl-cBiMPS ((S-p)-5,6 -dichloro-1-beta-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate), and the activators of adenylate cyclase, forskolin and glucagon, dramatically inhibited PB-mediated induction of CYP2B1 and CYP2B2 in a concentration-dependent manner. A similar inhibition of PB-induced CYP3A1 mRNA levels was effected by the cAMP analogs and glucagon. The phosphodiesterase inhibitors isobutylmethylxanthine and RO 201724 potentiated the cAMP responses. Increasing the concentration of PB (0.05-1.00 mm) did not alleviate the cAMP-mediated repression. A requirement for protein kinase A (PKA) was demonstrated by the use of (S-p)-cAMPS, a highly specific activator of PKA whereas the inactive diastereoisomer, (R(p))-cAMPS, was ineffective in modulating PB induction. The response to cAMP was specific since elevated intracellular cAMP levels did not perturb beta-naphtholflavone-mediated induction of CYP1A1, CYP1A2, microsomal epoxide hydrolase, or dexamethasone-mediated induction of CYP3A1 gene expression. Nor did elevated intracellular cAMP modulate the liver-selective albumin gene expression levels. The results of the present study demonstrated striking inhibition of PB-mediated CYP gene induction by cAMP and PEA activators, indicating a negative regulatory role for the cAMP signal transduction pathway on PB gene induction.	UNIV WASHINGTON,DEPT ENVIRONM HLTH,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NIGMS NIH HHS [GM32281] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032281] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANHEGYI G, 1988, BIOCHEM PHARMACOL, V37, P849, DOI 10.1016/0006-2952(88)90171-2; BARTLOMOWICZ B, 1989, BIOCHEM BIOPH RES CO, V160, P46, DOI 10.1016/0006-291X(89)91618-5; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; BENTLEY J K, 1992, Current Opinion in Cell Biology, V4, P233; BERRY LA, 1988, BIOCHEM PHARMACOL, V37, P2411, DOI 10.1016/0006-2952(88)90368-1; BIRD IM, 1993, ENDOCRINOLOGY, V132, P932, DOI 10.1210/en.132.2.932; BISSELL DM, 1990, MOL BIOL MED, V7, P187; BJORNSSON OG, 1994, EUR J CLIN INVEST, V24, P137, DOI 10.1111/j.1365-2362.1994.tb00979.x; BLANKENSHIP J, 1974, BIOCHIM BIOPHYS ACTA, V340, P218, DOI 10.1016/0005-2787(74)90115-4; BLOUIN RA, 1993, ARCH BIOCHEM BIOPHYS, V303, P313, DOI 10.1006/abbi.1993.1289; BRAUMANN T, 1986, BIOCHIM BIOPHYS ACTA, V871, P199, DOI 10.1016/0167-4838(86)90174-3; BRUNS RF, 1986, MOL PHARMACOL, V29, P331; BYGRAVE FL, 1993, BIOCHEM J, V296, P1; BYUS CV, 1976, P NATL ACAD SCI USA, V73, P1241, DOI 10.1073/pnas.73.4.1241; CANEPA ET, 1992, BIOCHEM CELL BIOL, V70, P26, DOI 10.1139/o92-004; CANEPA ET, 1989, BIOCHEM CELL BIOL, V67, P751, DOI 10.1139/o89-113; CARON JM, 1990, MOL CELL BIOL, V10, P1239, DOI 10.1128/MCB.10.3.1239; CARRIER F, 1992, MOL CELL BIOL, V12, P1856, DOI 10.1128/MCB.12.4.1856; CHENG CY, 1992, ENDOCRINOLOGY, V130, P2883, DOI 10.1210/en.130.5.2883; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P15; CONNEY AH, 1982, CANCER RES, V42, P4875; COSTA M, 1976, MOL PHARMACOL, V12, P871; DYM M, 1991, ENDOCRINOLOGY, V128, P1167, DOI 10.1210/endo-128-2-1167; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; ELIASSON E, 1994, J BIOL CHEM, V269, P18378; ENAT R, 1984, P NATL ACAD SCI-BIOL, V81, P1411, DOI 10.1073/pnas.81.5.1411; EXTON JH, 1971, J BIOL CHEM, V246, P6166; EZAKI O, 1993, P NATL ACAD SCI USA, V90, P3348, DOI 10.1073/pnas.90.8.3348; FLORESRIVEROS JR, 1993, BIOCHEM BIOPH RES CO, V194, P1148, DOI 10.1006/bbrc.1993.1942; FOUTS JR, 1962, FED PROC, V2, P1107; GESSA GL, 1970, ROLE CYCLIC AMP CELL, P371; GIGER U, 1981, J BIOL CHEM, V256, P1182; GONZALEZ FJ, 1990, PHARMACOL THERAPEUT, V45, P1, DOI 10.1016/0163-7258(90)90006-N; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; HAHN CN, 1991, J BIOL CHEM, V266, P17031; HARDWICK JP, 1983, J BIOL CHEM, V258, P8081; HASSETT C, 1989, ARCH BIOCHEM BIOPHYS, V271, P380, DOI 10.1016/0003-9861(89)90287-7; Hutterer F, 1975, Adv Exp Med Biol, V58, P117; Ishibashi S, 1988, Adv Exp Med Biol, V236, P287; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; KATO R, 1965, J PHARMACOL EXP THER, V150, P285; KLAUNIG JE, 1990, TOXICOL APPL PHARM, V102, P553, DOI 10.1016/0041-008X(90)90050-5; KOCAREK TA, 1990, MOL PHARMACOL, V38, P440; KUO WN, 1979, EXPERIENTIA, V35, P997, DOI 10.1007/BF01949903; LARSSON PG, 1979, BRIT J CANCER, V40, P768, DOI 10.1038/bjc.1979.259; LEWIN E, 1977, EPILEPSIA, V18, P237, DOI 10.1111/j.1528-1157.1977.tb04472.x; MAGNUSON MA, 1987, J BIOL CHEM, V262, P14917; MANEN CA, 1978, BIOCHEM PHARMACOL, V27, P219, DOI 10.1016/0006-2952(78)90304-0; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; NIMS RW, 1994, J BIOCHEM TOXICOL, V9, P279, DOI 10.1002/jbt.2570090602; NISTICO G, 1977, INT J CLIN PHARM BI, V15, P19; NITSCH D, 1993, P NATL ACAD SCI USA, V90, P5479, DOI 10.1073/pnas.90.12.5479; OBRIEN RM, 1994, J BIOL CHEM, V269, P30419; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; OESCHBARTLOMOWI.B, 1990, ARCH TOXICOL, V64, P257; OESCHBARTLOMOWI.B, 1990, MUTAT RES, V232, P305; OKEY AB, 1990, PHARMACOL THERAPEUT, V45, P241, DOI 10.1016/0163-7258(90)90030-6; OMIECINSKI CJ, 1990, MOL PHARMACOL, V38, P462; ORMANDY GC, 1991, BRAIN RES, V553, P51, DOI 10.1016/0006-8993(91)90229-O; PERAINO C, 1975, CANCER RES, V35, P2884; PYERIN W, 1989, EMBO J, V8, P3003, DOI 10.1002/j.1460-2075.1989.tb08450.x; REINERS JJ, 1993, ARCH BIOCHEM BIOPHYS, V301, P449, DOI 10.1006/abbi.1993.1170; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; ROSS WE, 1973, RES COMMUN CHEM PATH, V5, P319; ROTHERMEL JD, 1984, J BIOL CHEM, V259, P8151; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; RUCH RJ, 1986, CELL BIOL TOXICOL, V2, P469, DOI 10.1007/BF00117849; SAAD B, 1994, TOXICOL APPL PHARM, V126, P372, DOI 10.1006/taap.1994.1128; SAEZ JC, 1990, EUR J BIOCHEM, V192, P263, DOI 10.1111/j.1432-1033.1990.tb19223.x; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SAEZ JC, 1989, AM J PHYSIOL, V257, pC1, DOI 10.1152/ajpcell.1989.257.1.C1; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; SCHMID E, 1987, EUR J BIOCHEM, V165, P499, DOI 10.1111/j.1432-1033.1987.tb11467.x; SCHUBART UK, 1986, ENDOCRINOLOGY, V119, P1741, DOI 10.1210/endo-119-4-1741; SCHUETZ EG, 1990, J BIOL CHEM, V265, P1188; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SHEPPARD H, 1972, ADV CYCL NUCL RES<D>, V1, P103; Sidhu J. S., 1994, In Vitro Toxicology, V7, P225; SIDHU JS, 1995, PHARMACOGENETICS, V5, P24, DOI 10.1097/00008571-199502000-00003; SIDHU JS, 1993, ARCH BIOCHEM BIOPHYS, V301, P103, DOI 10.1006/abbi.1993.1121; STAECKER JL, 1988, ARCH BIOCHEM BIOPHYS, V261, P291, DOI 10.1016/0003-9861(88)90344-X; WEINER M, 1972, RES COMMUN CHEM PATH, V4, P37; WEINER M, 1972, RES COMMUN CHEM PATH, V3, P249; YAMAZOE Y, 1987, J BIOL CHEM, V262, P7423	86	89	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12762	12773		10.1074/jbc.270.21.12762	http://dx.doi.org/10.1074/jbc.270.21.12762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759530	hybrid			2022-12-27	WOS:A1995QZ71100067
J	VARIN, L; MARSOLAIS, F; BRISSON, N				VARIN, L; MARSOLAIS, F; BRISSON, N			CHIMERIC FLAVONOL SULFOTRANSFERASES DEFINE A DOMAIN RESPONSIBLE FOR SUBSTRATE AND POSITION SPECIFICITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTIAL-PURIFICATION; SEQUENCE-ANALYSIS; HUMAN LIVER; SULFATE; CLONING; EXPRESSION; PROTEIN; BINDING; CDNA	The pFST3 and pFST4' cDNAs encode flavonol sulfotransferases (ST) that are 69% identical in amino acid sequence yet exhibit strict substrate and position specificities. To determine the domain responsible for the properties of the flavonol STs, several chimeric flavonol STs were constructed by the reciprocal exchange of DNA fragments derived from the plasmids pFST3 and pFST4' and by the expression of the corresponding chimeric proteins in Escherichia coli. The chimeric enzymes were enzymatically active even though their activities were reduced compared to the parent enzymes. The specificity of the resulting hybrid proteins indicates that an interval of the flavonol STs spanning amino acids 92-194 of the flavonol 3-ST sequence contains the determinant of the substrate and position preferences. From the comparison of the amino acid sequences between plant and animal STs, this interval can be subdivided into a highly conserved region corresponding to positions 134-152 of the flavonol 3-ST, flanked by two regions of high divergence from 98 to 110 and 153 to 170. In view of the similarities in length and hydropathic profiles as well as the presence of four conserved regions between plant and animal STs, the results of these experiments suggest that this interval is involved in the recognition of substrates and/or catalysis in all STs.	UNIV MONTREAL,DEPT BIOCHIM,MONTREAL,PQ H3C 3J7,CANADA	Universite de Montreal	VARIN, L (corresponding author), UNIV LAVAL,DEPT BIOL,PAVILLON CHARLES EUGENE MARCHAND,ST FOY,PQ G1K 7P4,CANADA.			Marsolais, Frederic/0000-0003-3914-141X				BARRON D, 1988, PHYTOCHEMISTRY, V27, P2375, DOI 10.1016/0031-9422(88)87003-1; BERNIER F, 1994, MOL CELL ENDOCRINOL, V99, P11; BORCHARDT RT, 1982, BIOCHIM BIOPHYS ACTA, V708, P280, DOI 10.1016/0167-4838(82)90438-1; BORCHARDT RT, 1977, BIOCHEM BIOPH RES CO, V78, P1067, DOI 10.1016/0006-291X(77)90529-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COMER KA, 1993, BIOCHEM J, V289, P233, DOI 10.1042/bj2890233; HARBORNE JB, 1975, PHYTOCHEMISTRY, V14, P1147, DOI 10.1016/S0031-9422(00)98585-6; HE JJ, 1991, SCIENCE, V251, P1479, DOI 10.1126/science.1900953; HIRSHEY SJ, 1992, MOL PHARMACOL, V42, P257; HOBKIRK R, 1985, CAN J BIOCHEM CELL B, V63, P1127, DOI 10.1139/o85-141; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, P199; KANYO ZF, 1991, J BIOL CHEM, V266, P4264; KONG ANT, 1992, BIOCHEM BIOPH RES CO, V187, P448, DOI 10.1016/S0006-291X(05)81514-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OGURA K, 1989, BIOCHEM BIOPH RES CO, V165, P168, DOI 10.1016/0006-291X(89)91050-4; Roy A.B., 1981, SULFATION DRUGS RELA, P83; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VARIN L, 1991, PLANT PHYSIOL, V95, P1254, DOI 10.1104/pp.95.4.1254; VARIN L, 1989, PLANT PHYSIOL, V90, P977, DOI 10.1104/pp.90.3.977; VARIN L, 1992, J BIOL CHEM, V267, P1858; VARIN L, 1987, ANAL BIOCHEM, V161, P176, DOI 10.1016/0003-2697(87)90669-5; VARIN L, 1992, P NATL ACAD SCI USA, V89, P1286, DOI 10.1073/pnas.89.4.1286; WEINSHILBOUM R, 1994, HDB EXPT PHARM CONJU, V112, P45; ZHENG YQ, 1994, J BIOL CHEM, V269, P30313; ZHU XY, 1993, BIOCHEM BIOPH RES CO, V195, P120, DOI 10.1006/bbrc.1993.2018	26	33	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12498	12502		10.1074/jbc.270.21.12498	http://dx.doi.org/10.1074/jbc.270.21.12498			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759495	hybrid			2022-12-27	WOS:A1995QZ71100028
J	WISEMAN, RW; KUSHMERICK, MJ				WISEMAN, RW; KUSHMERICK, MJ			CREATINE-KINASE EQUILIBRATION FOLLOWS SOLUTION THERMODYNAMICS IN SKELETAL-MUSCLE - P-31 NMR-STUDIES USING CREATINE ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATED BETA-GUANIDINOPROPIONATE; RAT MUSCLE; CYCLOCREATINE PHOSPHATE; ADENINE-NUCLEOTIDES; SUSTAIN ATP; PHOSPHOCREATINE; FIBERS; ISCHEMIA; COMPARTMENTATION; CONTRACTION	The hypothesis tested was whether creatine kinase (CK) equilibrates with its substrates and products in the cytosol as if in solution. We used the creatine analogs cyclocreatine (cCr) or beta-guanidopropionate (beta GPA) to test if mass action ratios (Gamma) for CK in muscle could be predicted from combined equilibrium constants (K-comb) measured in solutions mimicking the intracellular environment. Mice were fed cCr or beta GPA and their muscles assayed for substrates and products of the CK reaction by P-31 NMR spectroscopy and high performance liquid chromatography. After three weeks of feeding, Gamma was indistinguishable from K-comb in cCr-treated muscles demonstrating both PCr/Cr and phospho-analog/analog must have equilibrated with a constant and uniform cellular ATP/ADP ratio. In beta GPA-treated muscles, Gamma was smaller than K-comb due to a higher content of muscle beta GPA. Feeding beta GPA for 9-12 weeks resulted in a closer agreement between K-comb and Gamma, suggesting ATP/ADP ratios are not uniform within the muscle perhaps due to transient metabolic stress in some cells. From this analysis it follows that calculation of free ADP from the CII: equilibrium for a heterogeneous population of cells with respect to total Cr and ATP content is correct only if chemical potentials of these cells are uniform.	UNIV WASHINGTON,MED CTR,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195; UNIV WASHINGTON,MED CTR,CTR BIOENGN,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	WISEMAN, RW (corresponding author), UNIV WASHINGTON,MED CTR,DEPT RADIOL,SB-05,SEATTLE,WA 98195, USA.				NIAMS NIH HHS [AR36281, R29 AR41793, F32 AR08105] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036281, R29AR041793, F32AR008105] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ACHTEN E, 1990, J APPL PHYSIOL, V68, P644, DOI 10.1152/jappl.1990.68.2.644; ALBERTY RA, 1969, J BIOL CHEM, V244, P3290; ANNESLEY TM, 1977, BIOCHEM BIOPH RES CO, V74, P185, DOI 10.1016/0006-291X(77)91392-4; ANNESLEY TM, 1978, J BIOL CHEM, V253, P8120; ANNESLEY TM, 1980, J BIOL CHEM, V255, P3924; BURKE RE, 1971, SCIENCE, V174, P709, DOI 10.1126/science.174.4010.709; CHASE PB, 1988, BIOPHYS J, V53, P935, DOI 10.1016/S0006-3495(88)83174-6; CHASE PB, 1995, AM J PHYSIOL-CELL PH, V268, pC480, DOI 10.1152/ajpcell.1995.268.2.C480; CHEVLI R, 1979, BIOCHEM MED METAB B, V21, P162, DOI 10.1016/0006-2944(79)90068-1; CONNETT RJ, 1988, AM J PHYSIOL, V254, pR949, DOI 10.1152/ajpregu.1988.254.6.R949; DEBEER R, 1992, NMR BASIC PRINCIPLES, V26, P202; FITCH CD, 1968, J BIOL CHEM, V243, P2024; FITCH CD, 1974, J BIOL CHEM, V249, P1060; FITCH CD, 1975, AM J PHYSIOL, V228, P1123, DOI 10.1152/ajplegacy.1975.228.4.1123; FRIEDMAN DL, 1991, J BIOL CHEM, V266, P22404; GARLICK PB, 1992, AM J PHYSIOL, V263, pH497, DOI 10.1152/ajpheart.1992.263.2.H497; GELLERICH FN, 1992, FEBS LETT, V297, P55, DOI 10.1016/0014-5793(92)80326-C; GEORGE P, 1960, PROG BIOPHYS MOL BIO, V10, P1; GRIFFITHS GR, 1976, J BIOL CHEM, V251, P2049; HINTZ CS, 1982, AM J PHYSIOL, V242, pC218, DOI 10.1152/ajpcell.1982.242.3.C218; HUMPHREY SM, 1991, AM J PHYSIOL, V260, pH6, DOI 10.1152/ajpheart.1991.260.1.H6; HUTSON SM, 1989, BIOCHEMISTRY-US, V28, P4325, DOI 10.1021/bi00436a030; KUBY SA, 1954, J BIOL CHEM, V210, P65; KUSHMERICK MJ, 1985, J EXP BIOL, V115, P165; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; LOPRESTI P, 1989, BIOCHIM BIOPHYS ACTA, V998, P317, DOI 10.1016/0167-4838(89)90291-4; MAINWOOD GW, 1982, CAN J PHYSIOL PHARM, V60, P120, DOI 10.1139/y82-020; MCFARLAND EW, 1994, BIOPHYS J, V67, P1; MEYER RA, 1984, AM J PHYSIOL, V246, pC365, DOI 10.1152/ajpcell.1984.246.5.C365; MEYER RA, 1989, AM J PHYSIOL, V257, pC1149, DOI 10.1152/ajpcell.1989.257.6.C1149; MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548; MEYER RA, 1986, AM J PHYSIOL, V250, pC264, DOI 10.1152/ajpcell.1986.250.2.C264; MEYER RA, 1984, AM J PHYSIOL, V248, pC279; MOERLAND TS, 1989, AM J PHYSIOL, V257, pC810, DOI 10.1152/ajpcell.1989.257.4.C810; MURPHY E, 1988, BIOCHEMISTRY-US, V27, P526, DOI 10.1021/bi00402a003; NEMETH PA, 1993, AM J PHYSIOL, V264, pC411, DOI 10.1152/ajpcell.1993.264.2.C411; NODA L, 1954, J BIOL CHEM, V210, P83; PHILLIPS SK, 1993, J PHYSIOL-LONDON, V463, P157, DOI 10.1113/jphysiol.1993.sp019589; PHILLIPS SK, 1993, J PHYSIOL-LONDON, V462, P135, DOI 10.1113/jphysiol.1993.sp019547; ROBERTS JJ, 1982, AM J PHYSIOL, V248, pH911; ROWLEY GL, 1971, J AM CHEM SOC, V93, P5542, DOI 10.1021/ja00750a038; SAKS VA, 1985, J BIOL CHEM, V260, P7757; SHOUBRIDGE EA, 1985, BIOCHEM J, V232, P125, DOI 10.1042/bj2320125; SHOUBRIDGE EA, 1987, AM J PHYSIOL, V252, pC532, DOI 10.1152/ajpcell.1987.252.5.C532; SHOUBRIDGE EA, 1984, BIOCHIM BIOPHYS ACTA, V805, P79, DOI 10.1016/0167-4889(84)90039-9; TURNER DM, 1985, ARCH BIOCHEM BIOPHYS, V238, P642, DOI 10.1016/0003-9861(85)90210-3; TURNER DM, 1987, J BIOL CHEM, V262, P6605; UGURBIL K, 1985, J MAGN RESON, V64, P207, DOI 10.1016/0022-2364(85)90345-2; VEECH RL, 1979, J BIOL CHEM, V254, P6538; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WATTS DC, 1973, ENZYMES, P383; WISEMAN R, 1994, FASEB J, V8, pA10; WISEMAN RW, 1993, NMR BIOMED, V6, P153, DOI 10.1002/nbm.1940060208; WISEMAN RW, 1992, ANAL BIOCHEM, V204, P383, DOI 10.1016/0003-2697(92)90255-6; WOZNICKI DT, 1980, J NEUROCHEM, V34, P1247, DOI 10.1111/j.1471-4159.1980.tb09966.x; YAMASHITA K, 1991, J MUSCLE RES CELL M, V12, P37, DOI 10.1007/BF01781172	57	48	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12428	12438		10.1074/jbc.270.21.12428	http://dx.doi.org/10.1074/jbc.270.21.12428			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759484	hybrid			2022-12-27	WOS:A1995QZ71100017
J	DONKERSLOOT, JA; THOMPSON, J				DONKERSLOOT, JA; THOMPSON, J			CLONING, EXPRESSION, SEQUENCE-ANALYSIS, AND SITE-DIRECTED MUTAGENESIS OF THE TN5306-ENCODED N-5-(CARBOXYETHYL)ORNITHINE SYNTHASE FROM LACTOCOCCUS-LACTIS K1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; BACTERIOPHAGE-T7 DNA-POLYMERASE; GLUTAMATE-DEHYDROGENASE GENE; LACTATE-DEHYDROGENASE; ESCHERICHIA-COLI; PLASMID DNA; STREPTOCOCCUS-LACTIS; CONJUGATIVE TRANSPOSON; BACILLUS-SUBTILIS; BINDING SITES	The gene (ceo) encoding N-5-(carboxyethyl) ornithine synthase (EC 1.5.1.24) has been isolated from the sucrose-nisin transposon Tn5306 of Lactococcus lactis K1, sequenced, and expressed at high level in Escherichia coli. The cloned enzyme has allowed the synthesis of the novel N-omega-carboxypropyl amino acids N-5-(1-carboxypropyl)-L-ornithine and N-6-(1-carboxypropyl)-L-lysine. Comparison of the deduced amino acid sequence of N-5-(1-carboxyethyl)-L-ornithine synthase (M(r) = 35,323) to the functionally analogous octopine and nopaline synthases from crown gall tumors showed surprisingly little similarity. However, N-5-(1-carboxyethyl)-L-ornithine synthase and yeast saccharopine dehydrogenase exhibit homology at their N and C termini, which suggests that these two proteins constitute a distinct branch of the amino acid dehydrogenase superfamily. A centrally located 9-amino acid segment (GSGNVAQGA) in N-5-(1-carboxyethyl)-L-ornithine synthase is virtually identical with a sequence present in the beta alpha beta-fold of the nucleotide binding domain of several microbial NADPH-dependent glutamate dehydrogenases. A much longer sequence of similar to 80 residues has significant similarity to alanine dehydrogenase. Substitution of arginine 15 of N-5-(1-carboxyethyl)-L-ornithine synthase by lysine resulted in loss of enzyme activity.			DONKERSLOOT, JA (corresponding author), NIDR, MICROBIAL ECOL LAB, BLDG 30, RM 316, 30 CONVENT DR MSC 4350, BETHESDA, MD 20892 USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSEN AB, 1992, INFECT IMMUN, V60, P2317, DOI 10.1128/IAI.60.6.2317-2323.1992; ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; BANSAL A, 1989, J BIOL CHEM, V264, P9827; BARKER RF, 1983, PLANT MOL BIOL, V2, P335, DOI 10.1007/BF01578595; BATTEIGER B, 1982, J IMMUNOL METHODS, V55, P297, DOI 10.1016/0022-1759(82)90089-8; BEVAN M, 1983, NUCLEIC ACIDS RES, V11, P369, DOI 10.1093/nar/11.2.369; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENDEL V, 1984, NUCLEIC ACIDS RES, V12, P4411, DOI 10.1093/nar/12.10.4411; BUCHMAN GW, 1988, J BIOL CHEM, V263, P16260; CHASSY BM, 1976, BIOCHEM BIOPH RES CO, V68, P603, DOI 10.1016/0006-291X(76)91188-8; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CLARKE AR, 1989, TRENDS BIOCHEM SCI, V14, P101, DOI 10.1016/0968-0004(89)90131-X; CLARKE AR, 1986, NATURE, V324, P699, DOI 10.1038/324699a0; De Greve H, 1982, J Mol Appl Genet, V1, P499; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DEPICKER A, 1982, Journal of Molecular and Applied Genetics, V1, P561; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DODD HM, 1990, J GEN MICROBIOL, V136, P555, DOI 10.1099/00221287-136-3-555; DONKERSLOOT JA, 1990, J BACTERIOL, V172, P4122, DOI 10.1128/jb.172.7.4122-4126.1990; DOOLITTLE RF, 1981, SCIENCE, V214, P149, DOI 10.1126/science.7280687; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; FUJIOKA M, 1978, EUR J BIOCHEM, V90, P297, DOI 10.1111/j.1432-1033.1978.tb12603.x; GADE G, 1986, COMP BIOCHEM PHYS B, V83, P255, DOI 10.1016/0305-0491(86)90364-0; GIREESH T, 1992, APPL ENVIRON MICROB, V58, P1670, DOI 10.1128/AEM.58.5.1670-1676.1992; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; HEDIGER MA, 1986, BIOL CHEM H-S, V367, P891, DOI 10.1515/bchm3.1986.367.2.891; HORN N, 1991, MOL GEN GENET, V228, P129, DOI 10.1007/BF00282457; HUMPHREYS GO, 1975, BIOCHIM BIOPHYS ACTA, V383, P457, DOI 10.1016/0005-2787(75)90318-4; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KINNAIRD JH, 1983, GENE, V26, P253, DOI 10.1016/0378-1119(83)90195-6; KLAENHAMMER TR, 1978, APPL ENVIRON MICROB, V35, P592, DOI 10.1128/AEM.35.3.592-600.1978; KURODA SI, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00456a025; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; Maniatis T., 1982, MOL CLONING; MCPHERSON MJ, 1983, NUCLEIC ACIDS RES, V11, P5257, DOI 10.1093/nar/11.15.5257; MILLER SPF, 1987, J BIOL CHEM, V262, P16109; MILLER SPF, 1994, AMINO ACIDS, V6, P189, DOI 10.1007/BF00805846; MIZUSAWA S, 1986, NUCLEIC ACIDS RES, V14, P1319, DOI 10.1093/nar/14.3.1319; MOYE WS, 1985, J BIOL CHEM, V260, P8502; NAGASU T, 1985, GENE, V37, P247, DOI 10.1016/0378-1119(85)90279-3; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POLZIN KM, 1991, APPL ENVIRON MICROB, V57, P734, DOI 10.1128/AEM.57.3.734-743.1991; RAUCH PJG, 1994, APPL ENVIRON MICROB, V60, P1798, DOI 10.1128/AEM.60.6.1798-1804.1994; RAUCH PJG, 1992, J BACTERIOL, V174, P1280, DOI 10.1128/jb.174.4.1280-1287.1992; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SIRANOSIAN KJ, 1993, J BACTERIOL, V175, P6789, DOI 10.1128/jb.175.21.6789-6796.1993; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TABOR S, 1989, J BIOL CHEM, V264, P6447; TAGUCHI H, 1991, J BIOL CHEM, V266, P12588; TANSKANEN EI, 1990, APPL ENVIRON MICROB, V56, P3105, DOI 10.1128/AEM.56.10.3105-3111.1990; Tempe J, 1982, MOL BIOL PLANT TUMOR, P427, DOI [10.1016/B978-0-12-394380-4.50021-9, DOI 10.1016/B978-0-12-394380-4.50021-9]; THOMPSON J, 1991, J BIOL CHEM, V266, P14573; THOMPSON J, 1986, J BACTERIOL, V167, P522, DOI 10.1128/jb.167.2.522-529.1986; THOMPSON J, 1990, CURR MICROBIOL, V20, P239, DOI 10.1007/BF02089417; THOMPSON J, 1992, ANNU REV BIOCHEM, V61, P517; THOMPSON J, 1988, J BIOL CHEM, V263, P2064; THOMPSON J, 1991, J BIOL CHEM, V266, P22626; THOMPSON J, 1991, ADV ENZYMOL RAMB, V64, P317; THOMPSON J, 1989, J BIOL CHEM, V24, P9592; VALLE F, 1984, GENE, V27, P193, DOI 10.1016/0378-1119(84)90140-9; VANDEGUCHTE M, 1992, FEMS MICROBIOL LETT, V88, P73, DOI 10.1016/0378-1097(92)90685-H; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; XUAN JW, 1990, MOL CELL BIOL, V10, P4795, DOI 10.1128/MCB.10.9.4795; ZUCKER M, 1981, NUCLEIC ACIDS RES, V9, P133	74	15	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12226	12234		10.1074/jbc.270.20.12226	http://dx.doi.org/10.1074/jbc.270.20.12226			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744873	hybrid			2022-12-27	WOS:A1995QY73600078
J	JAMES, SR; PATERSON, A; HARDEN, TK; DOWNES, CP				JAMES, SR; PATERSON, A; HARDEN, TK; DOWNES, CP			KINETIC-ANALYSIS OF PHOSPHOLIPASE C-BETA ISOFORMS USING PHOSPHOLIPID-DETERGENT MIXED MICELLES - EVIDENCE FOR INTERFACIAL CATALYSIS INVOLVING DISTINCT MICELLE BINDING AND CATALYTIC STEPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNITS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIVATION; C-DELTA-1; STIMULATION; HYDROLYSIS; VESICLES; ENZYMES; ASSOCIATION; BRAIN	Phosphatidylinositol 4,5-bisphosphate (PtdIns (4,5)P-2) hydrolysis by three different beta-isoforms of phospholipase C (PLC) was examined to investigate the catalytic action of these extracellular signal-regulated enzymes. Depletion of phospholipase C from solution by incubation with sucrose-loaded vesicles of differing compositions followed by ultracentrifugation demonstrated stable attachment of PLC to the vesicles from which an equilibrium association constant of PLC with PtdIns (4,5)P-2 could be determined. A mixed micellar system was established to assay PLC activity using dodecyl maltoside, which behaved as an essentially inert diluent of PtdIns (4,5)P-2 with respect to PLC beta activity. Kinetic analyses were performed to test whether PLC beta activity was dependent on both bulk PtdIns (4,5)P-2 concentration and surface concentration in the micelles as has been shown for other lipid metabolising enzymes. Each of the PLC beta isoforms behaved similarly in these analyses, which indicated the involvement of at least two binding events. Interfacial Michaelis constants were calculated to be between 0.1-0.2 mol fraction for all three enzymes, and K-s (the equilibrium dissociation constant of PLC for lipid) ranged between 100-200 mu M. The apparent multiple interfacial binding events did not appear to result from lipid-induced PLC beta oligomerization implying that PLC beta monomers possess more than one lipid-binding site, Surface dilution of PLC catalyzed PtdIns (4,5)P-2 hydrolysis was assessed in the presence of increasing concentrations of various nonsubstrate phospholipids, which profoundly reduced PLC activity, suggesting that these lipids may inhibit enzyme action. The data indicate that G protein-regulated isoforms of PLC operate with separate lipid binding and catalytic steps and imply that under physiological conditions, PLC beta isoforms operate under first-order conditions. These findings may have implications for the mechanisms of regulation of PLC beta s by G protein subunits.	UNIV N CAROLINA, SCH MED, DEPT PHARMACOL, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	JAMES, SR (corresponding author), UNIV DUNDEE, INST MED SCI, DEPT BIOCHEM, DUNDEE DD1 4HN, SCOTLAND.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029536, R01GM029536] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 29536] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036; BOYER JL, 1992, J BIOL CHEM, V267, P25451; BUXEDA RJ, 1991, J BIOL CHEM, V266, P13859; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CARPENTER G, 1993, ADV SEC MESS PHOSPH, V28, P179; CIFUENTES ME, 1993, J BIOL CHEM, V268, P11586; CIFUENTES ME, 1994, J BIOL CHEM, V269, P1945; CREBA JA, 1983, BIOCHEM J, V212, P733, DOI 10.1042/bj2120733; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; Dennis EA, 1983, ENZYMES, P307; EATON BR, 1976, ARCH BIOCHEM BIOPHYS, V176, P604, DOI 10.1016/0003-9861(76)90204-6; FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J; FREMONT DH, 1993, P NATL ACAD SCI USA, V90, P342, DOI 10.1073/pnas.90.1.342; HANEL AM, 1993, BIOCHEMISTRY-US, V32, P5949, DOI 10.1021/bi00074a005; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5734; HIRASAWA K, 1981, BIOCHEM J, V193, P607, DOI 10.1042/bj1930607; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7330, DOI 10.1021/bi00243a038; JAIN MK, 1991, METHOD ENZYMOL, V197, P112; JAMES SR, 1994, BIOCHEM J, V298, P499, DOI 10.1042/bj2980499; JONES GA, 1993, J BIOL CHEM, V268, P20845; LEE KY, 1987, P NATL ACAD SCI USA, V84, P5540, DOI 10.1073/pnas.84.16.5540; LEE SB, 1993, J BIOL CHEM, V268, P25952; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; PARK DG, 1993, J BIOL CHEM, V268, P3710; PARKER PJ, 1994, TRENDS BIOCHEM SCI, V19, P54, DOI 10.1016/0968-0004(94)90031-0; PATERSON A, 1994, IN PRESS METHODS NEU, V6; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12742, DOI 10.1021/bi00166a005; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12748, DOI 10.1021/bi00166a006; REBECCHI MJ, 1993, J BIOL CHEM, V268, P1735; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEE SG, 1992, J BIOL CHEM, V267, P12393; ROBERTS MF, 1977, P NATL ACAD SCI USA, V74, P1950, DOI 10.1073/pnas.74.5.1950; SCHNABEL P, 1993, EUR J BIOCHEM, V217, P1109, DOI 10.1111/j.1432-1033.1993.tb18343.x; Segel IH, 1975, ENZYME KINETICS, P346; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; VANCE DE, 1985, BIOCH LIPIDS MEMBRAN, P242; VOLWERK JJ, 1994, BIOCHEMISTRY-US, V33, P3464, DOI 10.1021/bi00178a002; WAHL MI, 1992, J BIOL CHEM, V267, P10447; WALDO GL, 1994, METHOD ENZYMOL, V238, P195; WU DQ, 1993, J BIOL CHEM, V268, P3704	44	56	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11872	11881		10.1074/jbc.270.20.11872	http://dx.doi.org/10.1074/jbc.270.20.11872			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744837	hybrid			2022-12-27	WOS:A1995QY73600033
J	TOYODA, N; BERRY, MJ; HARNEY, JW; LARSEN, PR				TOYODA, N; BERRY, MJ; HARNEY, JW; LARSEN, PR			TOPOLOGICAL ANALYSIS OF THE INTEGRAL MEMBRANE-PROTEIN, TYPE-1 IODOTHYRONINE DEIODINASE (D1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; BOVINE 17-ALPHA-HYDROXYLASE; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; GENE-EXPRESSION; L-THYROXINE; SELENOCYSTEINE; CELLS; SEQUENCES	Type 1 iodothyronine deiodinase (D1) is a microsomal selenoenzyme which catalyzes deiodination of thyroxine to 3,5,3'-triiodothyronine. Immunoblotting showed that endogenous hepatic, renal, and transiently expressed D1 remains in microsomes after pH 11.5 treatment. In vitro translation studies using pancreatic microsomes identified a single transmembrane domain with a cytosolic carboxyl-terminal catalytic portion. The transmembrane domain is located between conserved basic amino acids at positions 11 and 12 and a group of charged residues at positions 34-39. A transiently expressed D1 protein in which residues 2-25 were deleted was inactive and not integrated into membranes. Activity was not restored by replacing these residues with transmembrane domains from a cytochrome P450 or type 3 deiodinase enzyme despite their incorporation into membranes. Elimination of the positive charges at positions 11 and 12 reduced the amount of transiently expressed protein by 70%, but the enzyme formed was catalytically normal. Similar results were found after conversion of the Lys-27 in the transmembrane domain to Met or Glu. We conclude that the amino terminus of D1 contains uncleaved signal and stop transfer sequence properties. In addition, positively charged residues at positions 11, 12, and 27 are required for optimal formation of the protein but not for catalysis.	HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV THYROID,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard Medical School					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036256] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK36256] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BERRY MJ, 1992, ENDOCRINOLOGY, V131, P1848, DOI 10.1210/en.131.4.1848; BERRY MJ, 1991, J BIOL CHEM, V266, P14155; BERRY MJ, 1994, NUCLEIC ACIDS RES, V22, P3753, DOI 10.1093/nar/22.18.3753; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; BERRY MJ, 1993, J CLIN INVEST, V92, P1517, DOI 10.1172/JCI116730; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; BERRY MJ, 1992, J BIOL CHEM, V267, P18055; BRINKE DAD, 1979, BIOCHEM J, V180, P273; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; CLARK BJ, 1992, J BIOL CHEM, V267, P24568; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FAY M, 1984, J CLIN ENDOCR METAB, V58, P280, DOI 10.1210/jcem-58-2-280; FEKKES D, 1979, BIOCHIM BIOPHYS ACTA, V587, P12, DOI 10.1016/0304-4165(79)90215-0; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GELPI C, 1992, P NATL ACAD SCI USA, V89, P9739, DOI 10.1073/pnas.89.20.9739; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HESCH RD, 1975, CLIN CHIM ACTA, V59, P209, DOI 10.1016/0009-8981(75)90031-5; KAPLAN MM, 1983, ENDOCRINOLOGY, V112, P35, DOI 10.1210/endo-112-1-35; KOHRLE J, 1990, J BIOL CHEM, V265, P6146; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSEN PR, 1981, ENDOCR REV, V2, P87, DOI 10.1210/edrv-2-1-87; LEONARD JL, 1991, J BIOL CHEM, V266, P11262; LEONARD JL, 1978, ENDOCRINOLOGY, V103, P274, DOI 10.1210/endo-103-1-274; MACIEL RMB, 1979, ENDOCRINOLOGY, V104, P365, DOI 10.1210/endo-104-2-365; MANDELL SJ, 1991, J CLIN ENDOCR METAB, V75, P1133; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; SATO T, 1990, EMBO J, V9, P2391, DOI 10.1002/j.1460-2075.1990.tb07414.x; SCHOENMAKERS CHH, 1989, BIOCHEM BIOPH RES CO, V162, P857, DOI 10.1016/0006-291X(89)92389-9; SCHWARTZ HL, 1971, J CLIN INVEST, V50, P1124, DOI 10.1172/JCI106584; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; TOYODA N, 1994, J BIOL CHEM, V269, P20329; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; YOSHIOKA H, 1986, J BIOL CHEM, V261, P4106	37	54	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12310	12318		10.1074/jbc.270.20.12310	http://dx.doi.org/10.1074/jbc.270.20.12310			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744884	hybrid			2022-12-27	WOS:A1995QY73600089
J	XIE, YH; MORIMOTO, T				XIE, YH; MORIMOTO, T			4 HYDROPHOBIC SEGMENTS IN THE NH2-TERMINAL 1/3 (H1-H4) OF NA,K-ATPASE ALPHA-SUBUNIT ALTERNATELY INITIATE AND HALT MEMBRANE TRANSLOCATION OF THE NEWLY SYNTHESIZED POLYPEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(NA+ + K+)-ATPASE; CDNA SEQUENCE; MONOCLONAL-ANTIBODY; MAMMALIAN KIDNEY; BETA-SUBUNIT; K+-ATPASE; NA+,K+-ATPASE; PROTEINS; DOMAINS; SIGNAL	Transmembrane disposition of the NH2-terminal third of the Na,K-ATPase a subunit was studied using an experimental approach that involved in vitro endoplasmic reticulum membrane insertion of chimeras, These chimeras consisted of four truncated amino-terminal segments of the a subunit linked at amino acid residues 126, 179, 313, and 439 to chloramphenicol acetyltransferase (CAT), a reporter protein, that contains a consensus sequence for N-linked glycosylation. The fusion sites were located after one of the four hydrophobic segments (H1-H4), The results showed that the chimeras in which the a subunit was truncated at positions 126 and 313 were glycosylated, and the glycosylated peptides were protected by membranes from proteolysis. However, the other two chimeras were not glycosylated and the inserted peptides were digested by protease into fragments which did not immunoprecipitate with anti-CAT. These results clearly demonstrate that hydrophobic segments H1 and H3 function as signal/anchor type II, and H2 and H4 function as halt transfer signals, Furthermore, membrane insertion of the NH2-terminal third of Na,K-ATPase alpha subunit is achieved by a series of alternate signal/anchor type II and halt transfer sequences.	NYU,SCH MED,KAPLAN CANC CTR,NEW YORK,NY 10016	New York University	XIE, YH (corresponding author), NYU,SCH MED,DEPT CELL BIOL,550 1ST AVE,NEW YORK,NY 10016, USA.				NIDDK NIH HHS [DK20277] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON DJ, 1983, METHOD ENZYMOL, V96, P111; ARYSTARKHOVA E, 1992, J BIOL CHEM, V267, P13694; BALL WJ, 1987, BIOCHIM BIOPHYS ACTA, V916, P100, DOI 10.1016/0167-4838(87)90216-0; BROTHERUS JR, 1983, BIOCHIM BIOPHYS ACTA, V731, P290, DOI 10.1016/0005-2736(83)90021-4; CAPASSO JM, 1992, J BIOL CHEM, V267, P1150; FARLEY RA, 1986, AM J PHYSIOL, V250, pC896, DOI 10.1152/ajpcell.1986.250.6.C896; FELSENFELD DP, 1988, J BIOL CHEM, V263, P10932; GLYNN IM, 1985, ENZYMES BIOL MEMBR, P35; HARA Y, 1987, J BIOCHEM-TOKYO, V102, P43, DOI 10.1093/oxfordjournals.jbchem.a122039; HOMAREDA H, 1989, MOL CELL BIOL, V9, P5742, DOI 10.1128/MCB.9.12.5742; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V694, P27, DOI 10.1016/0304-4157(82)90013-2; JORGENSEN PL, 1982, J BIOL CHEM, V257, P7435; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; KANO I, 1990, BIOCHEM CELL BIOL, V68, P1262, DOI 10.1139/o90-187; KAWAKAMI K, 1986, J BIOCHEM-TOKYO, V100, P389, DOI 10.1093/oxfordjournals.jbchem.a121726; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; LIPP J, 1986, CELL, V46, P1103, DOI 10.1016/0092-8674(86)90710-5; LIPP J, 1988, J CELL BIOL, V106, P1813, DOI 10.1083/jcb.106.6.1813; Mercer Robert W., 1993, V137C, P139; MOHRAZ M, 1994, J BIOL CHEM, V269, P2929; NICHOLAS RA, 1984, BIOCHEMISTRY-US, V23, P888, DOI 10.1021/bi00300a015; NOGUCHI S, 1986, FEBS LETT, V196, P315, DOI 10.1016/0014-5793(86)80270-8; OVCHINNIKOV YA, 1987, TRENDS BIOCHEM SCI, V12, P434, DOI 10.1016/0968-0004(87)90210-6; OVCHINNIKOV YA, 1987, FEBS LETT, V217, P269, DOI 10.1016/0014-5793(87)80676-2; SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0; SKOU JC, 1992, BIOCHIM BIOPHYS ACTA, V988, P185; VASILETS LA, 1993, BIOCHIM BIOPHYS ACTA, V154, P201; WALTER P, 1983, METHOD ENZYMOL, V96, P84	31	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11985	11991		10.1074/jbc.270.20.11985	http://dx.doi.org/10.1074/jbc.270.20.11985			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744848	hybrid			2022-12-27	WOS:A1995QY73600048
J	YAMAGUCHI, N; FUKUDA, MN				YAMAGUCHI, N; FUKUDA, MN			GOLGI RETENTION MECHANISM OF BETA-1,4-GALACTOSYLTRANSFERASE - MEMBRANE-SPANNING DOMAIN-DEPENDENT HOMODIMERIZATION AND ASSOCIATION WITH ALPHA-TUBULINS AND BETA-TUBULINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FULL-LENGTH CDNA; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; BOVINE BETA-1,4-GALACTOSYLTRANSFERASE; HUMAN GALACTOSYLTRANSFERASE; N-ACETYLGLUCOSAMINIDE; SECRETORY PATHWAY; PROTEIN; SIGNAL	Recent studies on proteins residing in the Golgi complex revealed that the membrane-spanning domain of these proteins are largely responsible for their retention in the Golgi complex. We show here that beta-1,4-galactosyltransferase (GT) forms homodimers and large oligomers in vivo, and the formation of the homodimers is dependent on cysteine and histidine residues within the transmembrane domain. Double mutations of these residues, Cys(29) --> Ser and His(32) --> Leu, abolish homodimerization and simultaneously reduce the Golgi retention. Co-immunoprecipitation of GT and various GT chimeras with anti-GT and anti-reporter molecule antibodies revealed that large aggregates of GT are associated with alpha- and beta-tubulins and also with other cellular proteins. This association between tubulins and GT suggests a supportive role of the cytoskeleton in the Golgi retention mechanism.	LA JOLLA CANC RES FDN,LA JOLLA,CA 92037	Sanford Burnham Prebys Medical Discovery Institute					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037016] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK37016] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; AOKI D, 1990, EMBO J, V9, P3171, DOI 10.1002/j.1460-2075.1990.tb07515.x; BARKER R, 1972, J BIOL CHEM, V247, P7135; BAYNA EM, 1988, CELL, V53, P145, DOI 10.1016/0092-8674(88)90496-5; BENG JM, 1990, J BIOL CHEM, V265, P6513; BEYER TA, 1982, GLYCOCONJUGATES, V3, P25; BORMANN BJ, 1989, J BIOL CHEM, V264, P4033; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; BURKE J, 1992, J BIOL CHEM, V267, P24433; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; DAGOSTARO G, 1989, EUR J BIOCHEM, V183, P211, DOI 10.1111/j.1432-1033.1989.tb14915.x; ECKSTEIN DJ, 1992, EXP CELL RES, V201, P83, DOI 10.1016/0014-4827(92)90350-H; FIDDES JC, 1979, NATURE, V281, P351, DOI 10.1038/281351a0; HO WC, 1989, EUR J CELL BIOL, V48, P250; IIDA H, 1991, J HISTOCHEM CYTOCHEM, V39, P1349, DOI 10.1177/39.10.1719068; KREIS TE, 1990, CELL MOTIL CYTOSKEL, V15, P67, DOI 10.1002/cm.970150202; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; LIPPINCOTTSCHWA.J, 1990, CELL, V60, P821; LOPEZ LC, 1985, J CELL BIOL, V101, P1501, DOI 10.1083/jcb.101.4.1501; Machamer CE, 1993, CURR OPIN CELL BIOL, V5, P606, DOI 10.1016/0955-0674(93)90129-E; MACHAMER CE, 1987, J CELL BIOL, V105, P1205, DOI 10.1083/jcb.105.3.1205; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; MASRI KA, 1988, BIOCHEM BIOPH RES CO, V157, P657, DOI 10.1016/S0006-291X(88)80300-0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NAKAZAWA K, 1988, J BIOCHEM-TOKYO, V104, P165, DOI 10.1093/oxfordjournals.jbchem.a122434; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; ROTH J, 1985, J CELL BIOL, V100, P118, DOI 10.1083/jcb.100.1.118; ROTH J, 1982, J CELL BIOL, V92, P223; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; RUSSO RN, 1992, J BIOL CHEM, V267, P9241; SCHACHTER H, 1980, BIOCH GLYCOPROTEINS, P85; SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SHAPER NL, 1988, J BIOL CHEM, V263, P10420; SLUSAREWICZ P, 1994, J CELL BIOL, V124, P405, DOI 10.1083/jcb.124.4.405; STROUS GJ, 1986, CRC CR REV BIOCH MOL, V21, P119, DOI 10.3109/10409238609113610; STROUS GJ, 1991, BIOL CELL, V71, P25, DOI 10.1016/0248-4900(91)90048-R; STROUS GJAM, 1982, J BIOL CHEM, V257, P7623; SUGANUMA T, 1991, J HISTOCHEM CYTOCHEM, V39, P299, DOI 10.1177/39.3.1899684; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; TANG BL, 1992, J BIOL CHEM, V267, P10122; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; TROWBRIDGE IS, 1981, P NATL ACAD SCI-BIOL, V78, P3039, DOI 10.1073/pnas.78.5.3039; TURNER JR, 1989, J CELL BIOL, V109, P2081, DOI 10.1083/jcb.109.5.2081; UEMURA M, 1992, CANCER RES, V52, P6153; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; ZAGOURAS P, 1991, J VIROL, V65, P1976, DOI 10.1128/JVI.65.4.1976-1984.1991	57	126	132	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12170	12176		10.1074/jbc.270.20.12170	http://dx.doi.org/10.1074/jbc.270.20.12170			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744867	hybrid			2022-12-27	WOS:A1995QY73600070
J	GIULIANI, C; SAJI, M; NAPOLITANO, G; PALMER, LA; TANIGUCHI, SI; SHONG, M; SINGER, DS; KOHN, LD				GIULIANI, C; SAJI, M; NAPOLITANO, G; PALMER, LA; TANIGUCHI, SI; SHONG, M; SINGER, DS; KOHN, LD			HORMONAL MODULATION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I GENE-EXPRESSION INVOLVES AN ENHANCER A-BINDING COMPLEX CONSISTING OF FRA-2 AND THE P50 SUBUNIT OF NF-KAPPA-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT THYROTROPIN RECEPTOR; AUTOIMMUNE THYROID-DISEASE; HLA-DR EXPRESSION; TRANSCRIPTION FACTORS; DNA-BINDING; C-JUN; GLUCOCORTICOID RECEPTOR; EPITHELIAL-CELLS; FRTL-5 CELLS; INTERFERON	Hydrocortisone decreases major histocompatibility complex (MHC) class I gene expression in rat thyroid cells and counteracts increases induced by interferons. Using FRTL-5 cells transfected with class I promoter-reporter gene chimeras, we show that hydrocortisone action is transcriptional and mediated by an element located between 180 and 170 base pairs upstream of the start of transcription. Gel shift assays reveal that hydrocortisone causes the decrease of a specific protein-DNA complex; this same complex, referred to as Mod-1, is increased by interferon. Oligonucleotide competition assays reveal that the Mod-1 complex is associated with enhancer A of the class I gene, -180 to -170 base pairs (5'-GGGGAGTCCCC-3'), immediately upstream of the interferon response element. Antibodies to fra-2, a fos family member, and to the p50, but not the p65, subunit of NF-kappa B supershift the Mod-1 complex. We suggest that hydrocortisone decreases MHC class I gene expression by reducing the formation of Mod-1, which contains both p50 and fra-2; interferon reverses the hydrocortisone effect and increases Mod-1 formation. These observations are relevant to the molecular basis of hydrocortisone therapy in autoimmune thyroid disease and to the actions of interferon to exacerbate or induce autoimmune disease.	NIDDK,BIOCHEM & METAB LAB,CELL REGULAT SECT,BETHESDA,MD 20892; NCI,EXPTL IMMUNOL BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Saji, Motoyasu/E-4007-2011; /H-7803-2012	shong, minho/0000-0002-0247-7115				AKAMIZU T, 1990, P NATL ACAD SCI USA, V87, P5677, DOI 10.1073/pnas.87.15.5677; Ambesi Impiombato FS., 1986, United States Patent, Patent No. [US 4608341, 4608341]; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; BOTTAZZO GF, 1983, LANCET, V2, P1115; BURMAN P, 1986, J CLIN ENDOCR METAB, V63, P1086, DOI 10.1210/jcem-63-5-1086; COOPER DS, 1984, NEW ENGL J MED, V311, P1353, DOI 10.1056/NEJM198411223112106; DEGROOT LJ, 1989, ENDOCR REV, V10, P537, DOI 10.1210/edrv-10-4-537; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOEBERITZ MV, 1990, EUR J IMMUNOL, V20, P35, DOI 10.1002/eji.1830200106; EHRLICH R, 1988, MOL CELL BIOL, V8, P695, DOI 10.1128/MCB.8.2.695; FEINTIMAN IS, 1988, EUR J CANCER CLIN ON, V24, P1299; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HANAFUSA T, 1983, LANCET, V2, P1111; HENNIGHAUSEN L, 1987, METHOD ENZYMOL, V152, P721; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HOKLAND M, 1986, METHOD ENZYMOL, V119, P688; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; IKUYAMA S, 1992, MOL ENDOCRINOL, V6, P1701, DOI 10.1210/me.6.10.1701; IKUYAMA S, 1992, MOL ENDOCRINOL, V6, P793, DOI 10.1210/me.6.5.793; ISOZAKI O, 1989, MOL ENDOCRINOL, V3, P1681, DOI 10.1210/mend-3-11-1681; ISRAEL A, 1986, NATURE, V322, P743, DOI 10.1038/322743a0; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; Kohn L D, 1992, Int Rev Immunol, V9, P135, DOI 10.3109/08830189209061788; KOHN LD, 1989, ADV EXP MED BIOL, V261, P151; KOHN LD, 1986, Patent No. 4609622; KONIG H, 1992, EMBO J, V11, P2241, DOI 10.1002/j.1460-2075.1992.tb05283.x; KORBER B, 1987, P NATL ACAD SCI USA, V84, P3380, DOI 10.1073/pnas.84.10.3380; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MARTIN A, 1992, THYROID, V2, P247, DOI 10.1089/thy.1992.2.247; Maxam A M, 1980, Methods Enzymol, V65, P499; MAYET WJ, 1989, HEPATOLOGY, V10, P24, DOI 10.1002/hep.1840100106; MISAKI T, 1988, ENDOCRINOLOGY, V123, P2849, DOI 10.1210/endo-123-6-2849; MOZES E, 1993, SCIENCE, V261, P91, DOI 10.1126/science.8316860; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; PLATZER M, 1987, ENDOCRINOLOGY, V121, P2087, DOI 10.1210/endo-121-6-2087; ROITT IM, 1991, ESSENTIAL IMMUNOLOGY; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SAJI M, 1992, J CLIN ENDOCR METAB, V75, P871, DOI 10.1210/jc.75.3.871; SAJI M, 1992, P NATL ACAD SCI USA, V89, P1944, DOI 10.1073/pnas.89.5.1944; SAJI M, 1990, ENDOCRINOLOGY, V127, P1867, DOI 10.1210/endo-127-4-1867; Sambrook J, 1989, MOL CLONING LABORATO; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHIRAYOSHI Y, 1988, P NATL ACAD SCI USA, V85, P5884, DOI 10.1073/pnas.85.16.5884; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; SINGER DS, 1994, J IMMUNOL, V153, P873; SINGER DS, 1993, NIH CATALYST    0815; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; TING JPY, 1993, CURR OPIN IMMUNOL, V5, P8, DOI 10.1016/0952-7915(93)90074-3; TODD I, 1985, CLIN EXP IMMUNOL, V61, P265; TODD I, 1986, ANN NY ACAD SCI, V475, P241, DOI 10.1111/j.1749-6632.1986.tb20873.x; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZAKARIJA M, 1988, MOL CELL ENDOCRINOL, V58, P329	57	45	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11453	11462		10.1074/jbc.270.19.11453	http://dx.doi.org/10.1074/jbc.270.19.11453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744783	hybrid			2022-12-27	WOS:A1995QX86500062
J	LITTLE, JB; NAGASAWA, H; KENG, PC; YU, YJ; LI, CY				LITTLE, JB; NAGASAWA, H; KENG, PC; YU, YJ; LI, CY			ABSENCE OF RADIATION-INDUCED G(1) ARREST IN 2 CLOSELY-RELATED HUMAN LYMPHOBLAST CELL-LINES THAT DIFFER IN P53 STATUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MUTATION; GENE; ASSAY	In order to examine more precisely the role of p53 in the activation of the G(1)/S checkpoint by ionizing radiation, we examined two human lymphoblast cell lines derived from the same donor. The TK6 line had a doubling time of 12.2 h and expressed wild type p53, while the WTK1 line had a doubling time of 12.7 h and expressed mutant p53, The two lines differ significantly in their susceptibility to radiation-induced cell killing and apoptosis, Cells were examined by flow cytometry at regular intervals from 0 to 12 h after irradiation with two different doses designed to yield equivalent survival levels in both cell lines. In some experiments, cells were incubated with colcemid to block them in the first postirradiation mitosis and prevent contamination of the flow cytometric profiles with second cycle cells. There was no significant difference between the two cell lines in the progression of irradiated cells out of G(1) and into the S and G(2) phases of the cell cycle, In particular, there was no evidence for a prolonged arrest in G(1) in the TK6 cell line expressing wild type p53, Furthermore, expression of the p53 downstream genes WAF1/CIP1 and RE appeared normal in TK6 cells, These results suggest that factors other than those in the p53 signal transduction pathway alone may be required to activate the G(1)/S checkpoint in irradiated human cells and that apoptosis and G(1) arrest may utilize different pathways.	UNIV ROCHESTER,SCH MED & DENT,DEPT RADIAT ONCOL,ROCHESTER,NY 14642	University of Rochester	LITTLE, JB (corresponding author), HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,665 HUNTINGTON AVE,BOSTON,MA 02115, USA.		Li, Chuan-Yuan/H-4148-2013		NATIONAL CANCER INSTITUTE [R35CA047542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER; NCI NIH HHS [CA47542] Funding Source: Medline; NIEHS NIH HHS [ES-00002] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMUNDSON SA, 1993, MUTAT RES, V286, P233, DOI 10.1016/0027-5107(93)90188-L; BENJAMIN MB, 1991, P NATL ACAD SCI USA, V88, P6652, DOI 10.1073/pnas.88.15.6652; CARRIER F, 1994, J BIOL CHEM, V51, P32672; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1994, CANCER RES, V54, P1169; FRIED J, 1976, COMPUT BIOMED RES, V9, P263, DOI 10.1016/0010-4809(76)90006-9; FURTH EE, 1981, ANAL BIOCHEM, V110, P1, DOI 10.1016/0003-2697(81)90103-2; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; KASTAN MB, 1991, CANCER RES, V51, P6304; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; LEEPER DB, 1973, RADIAT RES, V53, P326, DOI 10.2307/3573538; LEVY JA, 1968, CANCER, V22, P61; LITTLE JB, 1968, NATURE, V218, P1064, DOI 10.1038/2181064a0; MAK S, 1963, RADIAT RES, V20, P600, DOI 10.2307/3571352; MCILWRATH AJ, 1994, CANCER RES, V54, P3718; OCONNOR PM, 1993, CANCER RES, V53, P4776; OKADA S, 1970, RAD BIOCH, V1, P190; SKOPEK TR, 1978, BIOCHEM BIOPH RES CO, V84, P411, DOI 10.1016/0006-291X(78)90185-7; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; TERASIMA T, 1963, BIOPHYS J, V3, P11, DOI 10.1016/S0006-3495(63)86801-0; TOGUCHIDA J, 1992, CANCER RES, V52, P6194; XIA F, 1995, CANCER RES, V55, P12; ZHEN WN, 1995, RADIAT RES, V141, P170, DOI 10.2307/3579044	23	134	134	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11033	11036		10.1074/jbc.270.19.11033	http://dx.doi.org/10.1074/jbc.270.19.11033			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744731	hybrid			2022-12-27	WOS:A1995QX86500003
J	MORITA, K; EBERT, SN; WONG, DL				MORITA, K; EBERT, SN; WONG, DL			ROLE OF TRANSCRIPTION FACTOR EGR-1 IN PHORBOL ESTER-INDUCED PHENYLETHANOLAMINE N-METHYLTRANSFERASE GENE-EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE EARLY GENES; ZINC FINGER PROTEIN; MESSENGER-RNA EXPRESSION; NMDA RECEPTOR ACTIVATION; PARALLEL UP-REGULATION; TYROSINE-HYDROXYLASE; ADRENAL-GLAND; RAT-BRAIN; MONOCYTIC DIFFERENTIATION; GROWTH-FACTORS	Transfection of PC12-variant RS1 cells with an Egr-1 expression construct has previously been shown to stimulate phenylethanolamine N-methyltransferase (PNMT) promoter activity, thus suggesting a putative role of Egr-1 as a factor regulating PNMT gene expression. To elucidate the physiological implication of this finding, the effects of phorbol la myristate 13 acetate (PMA) on PNMT promoter activity and Egr-1 expression were ex examined. PMA stimulated luciferase expression in RS1 cells transfected with a rat PNMT promoter-luciferase reporter gene construct, and also elevated both Egr-1 mRNA and Egr-1 protein levels in the untransfected cells. Further study on the concentration dependence of PMA action showed that the stimulation of luciferase expression correlated with the elevation of Egr-1 mRNA level. Finally, the stimulatory action of PMA on luciferase expression was dramatically diminished in the cells transfected with a mutant construct in which the Egr-1 binding site in PNMT promoter was mutated. These findings suggest that PMA-stimulated PNMT gene expression requires the enhancement of Egr-1 expression, thus providing further evidence for the physiological role of Egr-1 in the regulation of PNMT gene expression in the adrenergic cell.	STANFORD UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,NANCY PRITZKER LAB DEV & MOLEC NEUROBIOL,STANFORD,CA 94305	Stanford University					NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH039437, F32MH010350] Funding Source: NIH RePORTER; NIMH NIH HHS [MH10350, MH39437] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ACKERMAN SL, 1991, P NATL ACAD SCI USA, V88, P7523, DOI 10.1073/pnas.88.17.7523; Ausubel FM, 1988, MOL REPROD DEV; BORDONARO M, 1994, BIOTECHNIQUES, V16, P428; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CARROLL JM, 1991, J MOL NEUROSCI, V3, P75, DOI 10.1007/BF02885528; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DAY ML, 1990, J BIOL CHEM, V265, P15253; DEFRANCO C, 1993, MOL ENDOCRINOL, V7, P365, DOI 10.1210/me.7.3.365; DUCHEMIN AM, 1992, MOL ENDOCRINOL, V6, P563, DOI 10.1210/me.6.4.563; EBERT SN, 1994, J BIOL CHEM, V269, P20885; EVINGER MJ, 1992, CELL MOL NEUROBIOL, V12, P193, DOI 10.1007/BF00712926; EVINGER MJ, 1994, J NEUROSCI, V14, P2106; GUPTA MP, 1991, J BIOL CHEM, V266, P12813; HASS R, 1992, BIOCHEM PHARMACOL, V44, P1569, DOI 10.1016/0006-2952(92)90474-W; IWAKI K, 1990, J BIOL CHEM, V265, P13809; JAMIESON GA, 1989, J CELL PHYSIOL, V139, P262, DOI 10.1002/jcp.1041390207; KATAYAMA N, 1993, J NEUROCHEM, V60, P902, DOI 10.1111/j.1471-4159.1993.tb03235.x; KHARBANDA S, 1991, J CLIN INVEST, V88, P571, DOI 10.1172/JCI115341; KIM KT, 1993, J NEUROCHEM, V60, P946, DOI 10.1111/j.1471-4159.1993.tb03241.x; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LI Y, 1993, J BIOL CHEM, V268, P3563; LIM RW, 1987, ONCOGENE, V1, P263; MILBRANDT J, 1988, SCIENCE, V238, P797; MOLNAR G, 1994, MOL CELL BIOL, V14, P5242, DOI 10.1128/MCB.14.8.5242; MULLER MT, 1987, J VIROL, V61, P858, DOI 10.1128/JVI.61.3.858-865.1987; OUELLETTE AJ, 1990, J CLIN INVEST, V85, P766, DOI 10.1172/JCI114502; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; SCHALLING M, 1988, P NATL ACAD SCI USA, V85, P8306, DOI 10.1073/pnas.85.21.8306; STACHOWIAK MK, 1990, BRAIN RES, V510, P277, DOI 10.1016/0006-8993(90)91378-T; STACHOWIAK MK, 1988, MOL BRAIN RES, V3, P275, DOI 10.1016/0169-328X(88)90050-2; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; THOENEN H, 1969, J PHARMACOL EXP THER, V169, P249; THOENEN H, 1970, BIOCHEM PHARMACOL, V19, P669, DOI 10.1016/0006-2952(70)90229-7; THOENEN H, 1969, NATURE, V221, P1264, DOI 10.1038/2211264a0; WAN DC, 1991, MOL BRAIN RES, V9, P103, DOI 10.1016/0169-328X(91)90135-K; WESSEL TC, 1992, MOL BRAIN RES, V15, P349, DOI 10.1016/0169-328X(92)90128-X; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WONG DL, 1992, DEV BRAIN RES, V67, P229, DOI 10.1016/0165-3806(92)90223-J; WONG DL, 1993, MOL BRAIN RES, V18, P107, DOI 10.1016/0169-328X(93)90178-R; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; WORLEY PF, 1990, PROG BRAIN RES, V86, P277; WURTMAN RJ, 1965, SCIENCE, V150, P1464, DOI 10.1126/science.150.3702.1464; WURTMAN RJ, 1966, J BIOL CHEM, V241, P2301; WURTMAN RJ, 1972, PHARMACOL REV, V24, P411	48	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11161	11167		10.1074/jbc.270.19.11161	http://dx.doi.org/10.1074/jbc.270.19.11161			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744747	hybrid			2022-12-27	WOS:A1995QX86500023
J	GRENTZMANN, G; BRECHEMIERBAEY, D; HEURGUEHAMARD, V; BUCKINGHAM, RH				GRENTZMANN, G; BRECHEMIERBAEY, D; HEURGUEHAMARD, V; BUCKINGHAM, RH			FUNCTION OF POLYPEPTIDE-CHAIN RELEASE FACTOR RF-3 IN ESCHERICHIA-COLI - RF-3 ACTION IN TERMINATION IS PREDOMINANTLY AT UGA-CONTAINING STOP SIGNALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA; FACTOR-II; PROTEIN-SYNTHESIS; CODONS; TRANSLATION; SUPPRESSION; MUTATIONS; SEQUENCE; RIBOSOME; CONTEXT	Two protein release factors (RFs) showing codon specificity, RF-1 (UAG, UAA) and RF-2 (UAA, UGA), are required for polypeptide chain termination in Escherichia coli. We recently reported the localization and characterization of the gene encoding RF-3 (prfC), a third protein component previously described as stimulating termination without codon specificity, RF-3 is a GTP-binding protein that displays much sequence similarity to elongation factor EF-G. In a termination assay in vitro, RF-3 lowers the K-m for terminator trinucleotides and is thought to act in termination signal recognition. The gene prfC was identified by transposon insertion mutagenesis leading to enhanced nonsense suppression of UGA. We report here that (i) RF-3 inactivation significantly enhances the suppression of termination in vivo only at UGA-dependent stop signals; (ii) the codon dependent contribution to the stimulation of fMet release in vitro by RF-3 is significantly greater with UGA termination triplet than UAG termination triplet; (iii) RF-3 increases dramatically the affinity of RF-2 to the UGA termination complex in vitro but not that of RF-1 to the UAG termination complex; (iv) RF-3 inactivation leads to a positive feedback on the autoregulation of RF-2 synthesis in vivo, dependent on the competition between frameshifting and termination. These findings are discussed in terms of the mechanism of involvement of RF-3 in translation termination.	INST BIOL PHYSICOCHIM,CNRS,URA 1139,F-75005 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS)				Buckingham, Richard/0000-0002-8567-4500; HEURGUE-HAMARD, VALERIE/0000-0003-1576-7231				BOSSI L, 1983, J MOL BIOL, V164, P73, DOI 10.1016/0022-2836(83)90088-8; BROWN CM, 1990, NUCLEIC ACIDS RES, V18, P2079, DOI 10.1093/nar/18.8.2079; BUCKINGHAM RH, 1990, RIBOSOME, P541; BUCKINGHAM RH, 1994, BIOCHIMIE, V76, P351, DOI 10.1016/0300-9084(94)90108-2; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; CASKEY CT, 1971, P NATL ACAD SCI USA, V68, P3163, DOI 10.1073/pnas.68.12.3163; CASKEY CT, 1977, MOL MECHANISMS PROTE, P443; CASKEY CT, 1971, METHOD ENZYMOL, V20, P367; CONNOLLY DM, 1991, J BACTERIOL, V173, P1711, DOI 10.1128/jb.173.5.1711-1721.1991; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; CURRAN JF, 1988, J MOL BIOL, V203, P75, DOI 10.1016/0022-2836(88)90092-7; GANOZA MC, 1966, COLD SPRING HARB SYM, V31, P273, DOI 10.1101/SQB.1966.031.01.035; GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; GOLDSTEIN J, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P430, DOI 10.1073/pnas.65.2.430; GOLDSTEIN JL, 1970, P NATL ACAD SCI USA, V67, P537, DOI 10.1073/pnas.67.2.537; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; HIRASHIMA A, 1972, J MOL BIOL, V65, P43, DOI 10.1016/0022-2836(72)90490-1; MARTIN R, 1988, J BACTERIOL, V170, P4714, DOI 10.1128/jb.170.10.4714-4717.1988; MCCAUGHAN KK, 1984, FEBS LETT, V175, P90, DOI 10.1016/0014-5793(84)80576-1; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MILLER JH, 1983, J MOL BIOL, V164, P59, DOI 10.1016/0022-2836(83)90087-6; MILMAN G, 1969, P NATL ACAD SCI USA, V63, P183, DOI 10.1073/pnas.63.1.183; MURGOLA EJ, 1985, ANNU REV GENET, V19, P57, DOI 10.1146/annurev.genet.19.1.57; RYOJI M, 1981, P NATL ACAD SCI-BIOL, V78, P5973, DOI 10.1073/pnas.78.10.5973; Sambrook J, 1989, MOL CLONING LABORATO; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SCOLNICK EM, 1969, P NATL ACAD SCI USA, V64, P1235, DOI 10.1073/pnas.64.4.1235; SORENSEN PM, 1990, BIOCHIMIE, V72, P873, DOI 10.1016/0300-9084(90)90005-2; TATE W, 1990, NUCLEIC ACIDS RES, V18, P6537, DOI 10.1093/nar/18.22.6537; TATE WP, 1990, EUR J BIOCHEM, V187, P543, DOI 10.1111/j.1432-1033.1990.tb15335.x; TATE WP, 1992, BIOCHEMISTRY-US, V31, P2443, DOI 10.1021/bi00124a001; TATE WP, 1974, ENZYMES, P87; TATE WP, 1990, RIBOSOMES PROTEIN SY, P81; TUCKER SD, 1989, BIOCHIMIE, V71, P721, DOI 10.1016/0300-9084(89)90088-6	35	39	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10595	10600		10.1074/jbc.270.18.10595	http://dx.doi.org/10.1074/jbc.270.18.10595			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737996	hybrid			2022-12-27	WOS:A1995QW60100038
J	GROSSMANN, ME; TINDALL, DJ				GROSSMANN, ME; TINDALL, DJ			THE ANDROGEN RECEPTOR IS TRANSCRIPTIONALLY SUPPRESSED BY PROTEINS THAT BIND SINGLE-STRANDED-DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RIBONUCLEIC-ACID; GENE-EXPRESSION; DOWN-REGULATION; SERTOLI CELLS; CLONING; LNCAP; RNA	The androgen receptor (AR) is a nuclear transcription factor that is essential for development of the male urogenital tract, In the current work, we have characterized the mouse androgen receptor suppressor (mARS). A single, 20-base pair, region (TCCCCCCACCCACCCCCCCT) was sufficient for suppression in chloramphenicol acetyltransferase assays. Northern analysis indicated that translational regulation is not necessary for the suppression. Analysis of the AR mRNA half-life indicated that the mARS does not affect AR RNA degradation, Gel mobility assays showed that the mARS is bound by multiple proteins that can recognize single-stranded DNA and RNA. In addition, differing proteins are expressed in distinct tissues. Purification of some of these proteins has shown that a doublet of 33 and 35 kDa binds to the G-rich strand and that a 52-kDa protein binds to the C-rich strand. Southwestern blots have confirmed that these proteins are indeed recognized by the mARS. The results of these experiments indicate that the AR 5'-untranslated region contains a suppressor element that can be bound by multiple proteins. The mARS appears to be acting either by altering transcription initiation or blocking transcription elongation. Characterization of this suppressor may provide insight into the physiological means by which the AR is regulated.	MAYO CLIN & MAYO FDN,DEPT UROL,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT BIOCHEM,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT MOLEC BIOL,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic; Mayo Clinic					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD009140] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P20CA058225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047592] Funding Source: NIH RePORTER; NCI NIH HHS [CA58225] Funding Source: Medline; NICHD NIH HHS [HD09140] Funding Source: Medline; NIDDK NIH HHS [DK47592] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTIOK S, 1994, MOL CELL BIOL, V14, P6004, DOI 10.1128/MCB.14.9.6004; BLOK LJ, 1992, ENDOCRINOLOGY, V131, P1343, DOI 10.1210/en.131.3.1343; BLOK LJ, 1992, MOL CELL ENDOCRINOL, V88, P153, DOI 10.1016/0303-7207(92)90020-7; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; FABER PW, 1991, BIOCHEM J, V278, P269, DOI 10.1042/bj2780269; GROSSMANN ME, 1994, BIOCHEMISTRY-US, V33, P14594, DOI 10.1021/bi00252a027; GROSSMANN ME, 1994, MOL ENDOCRINOL, V8, P448, DOI 10.1210/me.8.4.448; HE WW, 1990, BIOCHEM BIOPH RES CO, V171, P697, DOI 10.1016/0006-291X(90)91202-4; HENTTU P, 1993, CANCER RES, V53, P1051; ITO K, 1994, NUCLEIC ACIDS RES, V22, P53, DOI 10.1093/nar/22.1.53; KRONGRAD A, 1991, MOL CELL ENDOCRINOL, V76, P79, DOI 10.1016/0303-7207(91)90262-Q; KUMAR MV, 1994, NUCLEIC ACIDS RES, V22, P3693, DOI 10.1093/nar/22.18.3693; LINDZEY J, 1994, VITAM HORM, V49, P383; LINDZEY J, 1993, MOL ENDOCRINOL, V7, P1530, DOI 10.1210/me.7.12.1530; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P22, DOI 10.1210/mend-4-1-22; Sambrook J, 1989, MOL CLONING LABORATO; SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; WOLF DA, 1993, MOL ENDOCRINOL, V7, P924, DOI 10.1210/me.7.7.924; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407	23	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10968	10975		10.1074/jbc.270.18.10968	http://dx.doi.org/10.1074/jbc.270.18.10968			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738038	hybrid			2022-12-27	WOS:A1995QW60100087
J	MARTIN, DW; JESTY, J				MARTIN, DW; JESTY, J			CALCIUM STIMULATION OF PROCOAGULANT ACTIVITY IN HUMAN ERYTHROCYTES - ATP DEPENDENCE AND THE EFFECTS OF MODIFIERS OF STIMULATION AND RECOVERY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; MULTIFUNCTIONAL PROTEIN-KINASE; LIPID ASYMMETRY; PHOSPHOLIPID ASYMMETRY; TRANSBILAYER MOVEMENT; PLASMA-MEMBRANE; AMINOPHOSPHOLIPID TRANSLOCATION; BIOCHEMICAL-CHANGES; PHOSPHATIDYLSERINE; INVOLVEMENT	The human erythrocyte membrane is generally considered to have no procoagulant activity. The normal membrane is characterized as having an asymmetric distribution of phospholipid species such that negatively charged and aminophospholipids are predominantly located on the inner leaflet of the membrane bilayer. Elevation of cytoplasmic Ca2+ in erythrocytes produces an assortment of biochemical and structural responses that include diminished phospholipid asymmetry and an elevation in procoagulant activity. Maintenance of the normal asymmetric distribution of phospholipid species is believed to be largely mediated by a phospholipid translocase mechanism. We have utilized a recently developed single-step kinetic assay of procoagulant activity to investigate the mechanisms of Ca2+ stimulation of procoagulant activity and recovery from the procoagulant state upon removal of Ca2+. This study demonstrated that stimulation of procoagulant activity by elevated cytoplasmic Ca2+ is greatly diminished in ATP-depleted erythrocytes. Phospholipid translocase inhibitors failed to fully inhibit recovery from the procoagulant state after removal of Ca2+. The data indicate that recovery of endogenous lipid from a procoagulant configuration may not be entirely mediated by the phospholipid translocase. Additionally, the data are inconsistent with the phospholipid translocase mediating the Ca2+-induced elevation of procoagulant activity, although the involvement of other protein(s) is indicated.			MARTIN, DW (corresponding author), SUNY STONY BROOK, DEPT MED, DIV HEMATOL, STONY BROOK, NY 11794 USA.				NHLBI NIH HHS [HL-45955] Funding Source: Medline; NIDDK NIH HHS [DK-19185] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019185] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLAN D, 1981, BIOCHEM J, V198, P433, DOI 10.1042/bj1980433; ALLAN D, 1981, BIOCHEM J, V198, P441, DOI 10.1042/bj1980441; ALLEN DW, 1979, BIOCHIM BIOPHYS ACTA, V551, P1, DOI 10.1016/0005-2736(79)90348-1; ANDERSON DR, 1977, J BIOL CHEM, V252, P6617; BITBOL M, 1987, BIOCHIM BIOPHYS ACTA, V904, P268, DOI 10.1016/0005-2736(87)90376-2; BITBOL M, 1988, P NATL ACAD SCI USA, V85, P6783, DOI 10.1073/pnas.85.18.6783; Brown A., 1982, ATP ATPASE DETERMINA, P223; CARSON SD, 1985, COMPUT PROG BIOMED, V19, P151, DOI 10.1016/0010-468X(85)90006-6; CHANDRA R, 1987, BIOCHIM BIOPHYS ACTA, V902, P253, DOI 10.1016/0005-2736(87)90303-8; COHEN CM, 1986, J BIOL CHEM, V261, P7701; COHEN P, 1990, ADV SEC MESS PHOSPH, V24, P230; COMFURIUS P, 1990, BIOCHIM BIOPHYS ACTA, V1026, P153, DOI 10.1016/0005-2736(90)90058-V; CONNOR J, 1990, BIOCHIM BIOPHYS ACTA, V1025, P82, DOI 10.1016/0005-2736(90)90193-R; CONNOR J, 1992, J BIOL CHEM, V267, P19412; CONNOR J, 1987, BIOCHEMISTRY-US, V26, P5099, DOI 10.1021/bi00390a031; CONNOR J, 1991, BIOCHIM BIOPHYS ACTA, V1066, P37, DOI 10.1016/0005-2736(91)90247-6; CONNOR J, 1990, BIOCHEMISTRY-US, V29, P37, DOI 10.1021/bi00453a005; DALEKE DL, 1985, BIOCHEMISTRY-US, V24, P5406, DOI 10.1021/bi00341a019; DEVAUX PF, 1992, ANNU REV BIOPH BIOM, V21, P417, DOI 10.1146/annurev.bb.21.060192.002221; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; DODSON RA, 1987, BLOOD CELLS, V12, P555; FERRELL JE, 1984, J CELL BIOL, V98, P1992, DOI 10.1083/jcb.98.6.1992; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P653, DOI 10.1016/0006-3002(58)90124-0; GASCARD P, 1989, BIOCHEM J, V264, P547, DOI 10.1042/bj2640547; GORDESKY SE, 1973, BIOCHEM BIOPH RES CO, V50, P1027, DOI 10.1016/0006-291X(73)91509-X; HAEST CWM, 1978, BIOCHIM BIOPHYS ACTA, V509, P21, DOI 10.1016/0005-2736(78)90004-4; HANSELEIT U, 1990, BIOCHIM BIOPHYS ACTA, V1029, P127; Jesty J, 1976, Methods Enzymol, V45, P95; KAHLENBERG A, 1992, CAN J BIOCHEM, V52, P803; LEW VL, 1978, CURR TOP MEMBR TRANS, V10, P217; LORAND L, 1983, J BIOL CHEM, V258, P5300; MIDDELKOOP E, 1989, BIOCHIM BIOPHYS ACTA, V981, P151, DOI 10.1016/0005-2736(89)90093-X; MORRISON SA, 1984, BLOOD, V63, P1338; MORROT G, 1989, BIOCHEMISTRY-US, V28, P3456, DOI 10.1021/bi00434a046; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; PONNAPPA BC, 1980, BIOCHIM BIOPHYS ACTA, V598, P494, DOI 10.1016/0005-2736(80)90030-9; SCHICK PK, 1976, J CLIN INVEST, V57, P1221, DOI 10.1172/JCI108390; SCHROIT AJ, 1991, BIOCHIM BIOPHYS ACTA, V1071, P313, DOI 10.1016/0304-4157(91)90019-S; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; SULPICE JC, 1994, J BIOL CHEM, V269, P6347; TAKAI Y, 1979, J BIOCHEM-TOKYO, V86, P575, DOI 10.1093/oxfordjournals.jbchem.a132557; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; TANAKA Y, 1983, J BIOL CHEM, V258, P1335; VERHOVEN B, 1992, BIOCHIM BIOPHYS ACTA, V1104, P15, DOI 10.1016/0005-2736(92)90126-7; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; ZACHOWSKI A, 1986, BIOCHEMISTRY-US, V25, P2585, DOI 10.1021/bi00357a046; ZWAAL RFA, 1975, BIOCHIM BIOPHYS ACTA, V406, P83, DOI 10.1016/0005-2736(75)90044-9	47	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10468	10474		10.1074/jbc.270.18.10468	http://dx.doi.org/10.1074/jbc.270.18.10468			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737981	hybrid			2022-12-27	WOS:A1995QW60100019
J	MUELLER, SG; SCHRAW, WP; RICHMOND, A				MUELLER, SG; SCHRAW, WP; RICHMOND, A			ACTIVATION OF PROTEIN-KINASE-C ENHANCES THE PHOSPHORYLATION OF THE TYPE-B INTERLEUKIN-8 RECEPTOR AND STIMULATES ITS DEGRADATION IN NONHEMATOPOIETIC CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR; HUMAN NEUTROPHILS; PHORBOL ESTER; MOLECULAR CHARACTERIZATION; FUNCTIONAL EXPRESSION; ADRENERGIC-RECEPTOR; PLASMODIUM-VIVAX; U937 CELL; DESENSITIZATION; CLONING	We have previously characterized the stably transfected, clonally selected human placental cell line, 3ASubE P-3, which overexpresses the type B interleukin-8 receptor (IL-8RB) and responds to the chemokine melanoma growth stimulatory activity (MGSA) with enhanced phosphorylation of this receptor, In work described here, we demonstrate that the MGSA enhanced phosphorylation of this receptor is mediated via a process involving pertussis toxin-sensitive G proteins, Furthermore, treatment of the 3ASubE P-3 cells with either 12-O-tetradecanoylphorbol 13-acetate (TPA) or 1,2-dioctanoyl-sn-glycerol (diC(8)), two different activators of protein kinase C (PKC), results in a concentration-dependent increase in the phosphorylation of the IL-8RB. Inhibition of PKC, by treatment with staurosporin (50 mM for 2 h), or down-regulation of PKC, by prolonged treatment with TPA (400 nM for 40 h) suppresses the TPA-enhanced receptor phosphorylation, but has no effect on the MGSA enhanced receptor phosphorylation, These data suggest that the isoforms of PKC that are sensitive to these manipulations may not play a role in mediating the MGSA-enhanced phosphorylation of the IL-8RB. TPA treatment also results in a time-dependent decrease in I-125-MGSA binding to the 3ASubE P-3 cells, A 30-min treatment with 400 nM TPA results in approximately a 50% decrease in binding, whereas a 2-h treatment essentially eliminates specific binding of I-125-MGSA to these cells, The TPA-induced decrease in I-125-MGSA binding is accompanied by enhanced degradation of the IL-8RB, as indicated by Western blot analysis and pulse-chase experiments, suggesting a potential role for PKC as a negative regulator of the IL-8RB, MGSA treatment (50 nM for 2 h) also stimulates receptor degradation in the 3ASubE P-3 cells, indicating that this receptor is down-regulated in response to prolonged exposure to its ligand, In similar studies conducted on the promonocytic cell line, U937, MGSA treatment of the U937 cells resulted in receptor phosphorylation, whereas PKC activation failed to significantly modulate the phosphorylation state of the IL-8RB, Treatment of the U937 cells with MGSA, TPA, or diC(8) resulted in a loss of receptor protein present in these cell types. These data imply that MGSA signaling through the IL 8RB is similar in both the non hematopoietic and hematopoietic cell types, whereas activation of PKC by TPA or diC(8) elicits different responses in these two distinct cell types.	VANDERBILT UNIV, SCH MED, DEPT MED DERMATOL, NASHVILLE, TN 37232 USA; DEPT VET AFFAIRS MED CTR, NASHVILLE, TN 37232 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	MUELLER, SG (corresponding author), VANDERBILT UNIV, SCH MED, DEPT CELL BIOL, NASHVILLE, TN 37232 USA.		Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	NCI NIH HHS [CA 34590] Funding Source: Medline; PHS HHS [1 P30 A41943-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R23CA034590, R01CA034590] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BACON KB, 1990, BIOCHEM BIOPH RES CO, V169, P1099, DOI 10.1016/0006-291X(90)92008-N; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; BRUNS RF, 1991, BIOCHEM BIOPH RES CO, V176, P288, DOI 10.1016/0006-291X(91)90922-T; CERRETTI DP, 1993, GENOMICS, V18, P410, DOI 10.1006/geno.1993.1486; CERRETTI DP, 1993, MOL IMMUNOL, V30, P359; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; CHAUDHURI A, 1993, P NATL ACAD SCI USA, V90, P10793, DOI 10.1073/pnas.90.22.10793; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; EBELING JG, 1985, P NATL ACAD SCI USA, V82, P815, DOI 10.1073/pnas.82.3.815; HARADA A, 1994, GENE, V142, P297, DOI 10.1016/0378-1119(94)90278-X; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; HEBERT CA, 1993, J BIOL CHEM, V268, P18549; HEPLER JR, 1988, J BIOL CHEM, V263, P7610; HOHMANN HP, 1992, J BIOL CHEM, V267, P2065; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HORUK R, 1993, BIOCHEMISTRY-US, V32, P5733, DOI 10.1021/bi00073a002; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; JUNG TM, 1990, J IMMUNOL, V144, P3130; KELLEHER DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4316, DOI 10.1073/pnas.81.14.4316; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; KUPPER RW, 1992, BIOCHEM J, V282, P429, DOI 10.1042/bj2820429; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; LEE J, 1992, J BIOL CHEM, V267, P16283; LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; MICHEL G, 1992, FEBS LETT, V305, P241, DOI 10.1016/0014-5793(92)80677-9; MORO O, 1994, J BIOL CHEM, V269, P6651; MOSER B, 1991, J BIOL CHEM, V266, P10666; MOSER B, 1993, BIOCHEM J, V294, P285, DOI 10.1042/bj2940285; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; Mukaida N, 1992, Cytokines, V4, P41; MULLBERG J, 1992, BIOCHEM BIOPH RES CO, V189, P794, DOI 10.1016/0006-291X(92)92272-Y; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; PORTEU F, 1990, J EXP MED, V172, P599, DOI 10.1084/jem.172.2.599; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; RICHMOND A, 1986, J CELL PHYSIOL, V129, P375, DOI 10.1002/jcp.1041290316; SCHADENDORF D, 1993, J IMMUNOL, V151, P2667; SCHONDORF M, 1993, BIOCHEM BIOPH RES CO, V197, P549, DOI 10.1006/bbrc.1993.2514; SMITH RJ, 1992, J LEUKOCYTE BIOL, V52, P17, DOI 10.1002/jlb.52.1.17; STRASSHEIM D, 1994, J BIOL CHEM, V269, P14307; STRIETER RM, 1992, AM J PATHOL, V141, P1279; STURANI E, 1986, BIOCHEM BIOPH RES CO, V137, P343, DOI 10.1016/0006-291X(86)91216-7; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TUSCHIL A, 1992, J INVEST DERMATOL, V99, P294, DOI 10.1111/1523-1747.ep12616634; UNEMORI EN, 1993, J BIOL CHEM, V268, P1338; WALZ A, 1991, J LEUKOCYTE BIOL, V50, P279, DOI 10.1002/jlb.50.3.279; WAYS DK, 1987, CANCER RES, V47, P3344; WILKINSON SE, 1994, TRENDS PHARMACOL SCI, V15, P53, DOI 10.1016/0165-6147(94)90110-4; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840	54	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10439	10448		10.1074/jbc.270.18.10439	http://dx.doi.org/10.1074/jbc.270.18.10439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737978	hybrid			2022-12-27	WOS:A1995QW60100016
J	SOLDATOV, NM; BOURON, A; REUTER, H				SOLDATOV, NM; BOURON, A; REUTER, H			DIFFERENT VOLTAGE-DEPENDENT INHIBITION BY DIHYDROPYRIDINES OF HUMAN CA2+ CHANNEL SPLICE VARIANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; FUNCTIONAL EXPRESSION; MOLECULAR DIVERSITY; ALPHA-1 SUBUNIT; NITRENDIPINE; TRANSCRIPTS; BRAIN; HEART; SITE; DNA	Voltage-dependent inhibition by 1,4-dihydropyridines is a characteristic property of L-type Ca2+ channels. Six out of 50 exons of the channel alpha(1C) subunit gene are subjected to alternative splicing, thus generating channel isoform diversity. Using Xenopus oocytes as an expression system, we have found that transmembrane segment IIIS2 of human alpha(1C) subunit is involved in the control of voltage dependence of dihydropyridine action. This segment is genetically regulated through alternative splicing of exons 21/22. Site-directed mutagenesis points to two amino acids in IIIS2, which determine the difference of the splice variants in their sensitivities to dihydropyridines. This finding provides new insight into molecular mechanisms of Ca2+ channel inhibition by this important class of drugs.	UNIV BERN,DEPT PHARMACOL,CH-3010 BERN,SWITZERLAND	University of Bern				Bouron, Alexandre/0000-0003-4471-7727				BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; CATTERALL WA, 1991, SCIENCE, V253, P1499, DOI 10.1126/science.1654596; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DIEBOLD RJ, 1992, P NATL ACAD SCI USA, V89, P1497, DOI 10.1073/pnas.89.4.1497; Janis RA, 1987, ADV DRUG RES, V16, P309; KOKUBUN S, 1986, MOL PHARMACOL, V30, P571; KREIG PA, 1984, NUCLEIC ACIDS RES, V12, P7057; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; REGULLA S, 1991, EMBO J, V10, P45, DOI 10.1002/j.1460-2075.1991.tb07919.x; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; SCHUURMAN R, 1991, BIOTECHNIQUES, V10, P185; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SOLDATOV NM, 1992, P NATL ACAD SCI USA, V89, P4628, DOI 10.1073/pnas.89.10.4628; SOLDATOV NM, 1994, GENOMICS, V22, P77, DOI 10.1006/geno.1994.1347; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; WELLING A, 1993, CIRC RES, V73, P974, DOI 10.1161/01.RES.73.5.974	24	105	107	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10540	10543		10.1074/jbc.270.18.10540	http://dx.doi.org/10.1074/jbc.270.18.10540			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737988	hybrid			2022-12-27	WOS:A1995QW60100029
J	SPENCER, MJ; CROALL, DE; TIDBALL, JG				SPENCER, MJ; CROALL, DE; TIDBALL, JG			CALPAINS ARE ACTIVATED IN NECROTIC FIBERS FROM MDX DYSTROPHIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CALCIUM-DEPENDENT PROTEASE; MUSCLE-SPECIFIC CALPAIN; NEUTRAL PROTEASE; SKELETAL-MUSCLE; CA-2+-DEPENDENT PROTEASE; INTRACELLULAR CALCIUM; LIMITED AUTOLYSIS; ALPHA-ACTININ; MU-CALPAIN	Death of dystrophin-deficient muscle purportedly re suits from increases in [Ca](in) that cause the activation of calpains. We have tested whether calpains play a role in this process by assaying for changes in calpain concentration and activation in peak necrotic mdx mice (4 weeks of age) and in completely regenerated mdx mice (14 weeks of age). Biochemical fractionation and immunoblotting with epitope-specific antisera allowed measurement of the concentrations of m- and mu-calpains and the extent of autoproteolytic modification. Our findings show that total calpain concentration is elevated in both 4-week and 14-week mdx mice. This increase in concentration was shown to result primarily from a significant increase in m-calpain concentration at 4 weeks. Northern analysis demonstrated that neither m- nor mu-calpain mRNA concentrations differed between mdx and controls suggesting that the increased calpain concentration results from post-translational regulation. Immunoblotting with antibodies directed against amino-terminal peptides revealed an increase in autoproteolysis of mu-calpain, indicative of increased activation. The extent of autoproteolysis of mu-calpain returns to control levels during regeneration. This is not a consequence of increased calpastatin mRNA or protein. The findings reported here support a role for calpains in both the degenerative and regenerative aspects of mdx dystrophy.	UNIV CALIF LOS ANGELES,JERRY LEWIS NEUROMUSCULAR RES CTR,LOS ANGELES,CA 90095; UNIV MAINE,DEPT BIOCHEM,ORONO,ME 04469	University of California System; University of California Los Angeles; University of Maine System; University of Maine Orono	SPENCER, MJ (corresponding author), UNIV CALIF LOS ANGELES,DEPT PHYSIOL SCI,LOS ANGELES,CA 90095, USA.		Tidball, James/H-7970-2012	Tidball, James/0000-0003-1202-8038	NIA NIH HHS [AG-40343] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; ASHMORE CR, 1986, EXP NEUROL, V94, P585, DOI 10.1016/0014-4886(86)90239-6; BAKKER AJ, 1993, J PHYSIOL-LONDON, V460, P1; BECKERLE MC, 1986, J CELL BIOCHEM, V30, P259, DOI 10.1002/jcb.240300307; BERTORINI TE, 1988, NEUROLOGY, V38, P609, DOI 10.1212/WNL.38.4.609; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; BROWN N, 1993, FEBS LETT, V322, P65, DOI 10.1016/0014-5793(93)81112-D; BULLARD B, 1990, J MUSCLE RES CELL M, V11, P271, DOI 10.1007/BF01843580; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; BUSCH WA, 1972, J CELL BIOL, V52, P367, DOI 10.1083/jcb.52.2.367; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; CARPENTER S, 1979, BRAIN, V102, P147, DOI 10.1093/brain/102.1.147; CONG JY, 1989, J BIOL CHEM, V264, P10096; CONG JY, 1993, J BIOL CHEM, V268, P25740; COOLICAN SA, 1984, J BIOL CHEM, V259, P1627; COTTIN P, 1991, BIOCHIM BIOPHYS ACTA, V1079, P139, DOI 10.1016/0167-4838(91)90118-J; CROALL DE, 1989, BIOCHEMISTRY-US, V28, P6882, DOI 10.1021/bi00443a016; CROALL DE, 1992, BIOCHIM BIOPHYS ACTA, V1121, P47, DOI 10.1016/0167-4838(92)90335-B; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; CROALL DE, 1990, INTRACELLULAR CALCIU, P103; CULLEN MJ, 1975, J NEUROL SCI, V24, P179, DOI 10.1016/0022-510X(75)90232-4; CULLEN MJ, 1988, ACTA NEUROPATHOL, V77, P69, DOI 10.1007/BF00688245; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; DUNN JF, 1991, J NEUROL SCI, V103, P226, DOI 10.1016/0022-510X(91)90168-7; FOX JEB, 1987, BLOOD, V69, P537; FOX JEB, 1985, J BIOL CHEM, V260, P1060; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; FURUNO K, 1986, BIOCHEM J, V237, P859, DOI 10.1042/bj2370859; GLESBY MJ, 1988, MUSCLE NERVE, V11, P852, DOI 10.1002/mus.880110809; GOLL DE, 1991, J BIOL CHEM, V266, P8501; HATHAWAY DR, 1982, J BIOL CHEM, V257, P9072; IMAJOH S, 1986, J BIOCHEM-TOKYO, V100, P633, DOI 10.1093/oxfordjournals.jbchem.a121755; JACKSON MJ, 1985, CLIN CHIM ACTA, V147, P215, DOI 10.1016/0009-8981(85)90202-5; JOHNSON P, 1988, INT J BIOCHEM, V20, P1227, DOI 10.1016/0020-711X(88)90223-6; KAR NC, 1976, CLIN CHIM ACTA, V73, P293, DOI 10.1016/0009-8981(76)90175-3; KAY J, 1981, ACTA BIOL MED GER, V40, P1323; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE WJ, 1992, BIOCHIM BIOPHYS ACTA, V1129, P251, DOI 10.1016/0167-4781(92)90500-Y; LLADOS FT, 1985, EXPERIENTIA, V76, P121; MARSHALL PA, 1989, MUSCLE NERVE, V12, P528, DOI 10.1002/mus.880120703; MAUNDER-SEWRY C A, 1979, Journal of the Neurological Sciences, V42, P337, DOI 10.1016/0022-510X(79)90167-9; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; MONGINI T, 1988, NEUROLOGY, V38, P476, DOI 10.1212/WNL.38.3.476; MORANDI L, 1990, ANN NEUROL, V28, P674, DOI 10.1002/ana.410280512; OHNO S, 1987, METHOD ENZYMOL, V139, P363; RABBANI N, 1987, BIOCHEM MED METAB B, V37, P282, DOI 10.1016/0885-4505(87)90038-7; REDDY MK, 1975, J BIOL CHEM, V250, P4278; REDDY PA, 1986, CLIN CHIM ACTA, V160, P281, DOI 10.1016/0009-8981(86)90195-6; REEDY MK, 1981, J MUSCLE RES CELL M, V2, P45, DOI 10.1007/BF00712061; SAIDO TC, 1994, FEBS LETT, V346, P263, DOI 10.1016/0014-5793(94)00487-0; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; Sambrook J, 1989, MOL CLONING LABORATO; SAMIS JA, 1991, BIOCHEM J, V276, P293, DOI 10.1042/bj2760293; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; SORIMACHI H, 1993, J BIOL CHEM, V268, P19476; SORIMACHI H, 1992, BIOCHIM BIOPHYS ACTA, V1160, P55, DOI 10.1016/0167-4838(92)90037-E; SPENCER MJ, 1992, EXP CELL RES, V203, P107, DOI 10.1016/0014-4827(92)90045-A; Takahashi K, 1990, INTRACELLULAR CALCIU, P55; TURNER PR, 1993, J MEMBRANE BIOL, V133, P243; VERHALLEN PFJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P206, DOI 10.1016/0005-2736(87)90170-2; ZEMAN RJ, 1985, J BIOL CHEM, V260, P3619	61	172	172	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10909	10914		10.1074/jbc.270.18.10909	http://dx.doi.org/10.1074/jbc.270.18.10909			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738032	hybrid			2022-12-27	WOS:A1995QW60100080
J	VERNET, T; BERTI, PJ; DEMONTIGNY, C; MUSIL, R; TESSIER, DC; MENARD, R; MAGNY, MC; STORER, AC; THOMAS, DY				VERNET, T; BERTI, PJ; DEMONTIGNY, C; MUSIL, R; TESSIER, DC; MENARD, R; MAGNY, MC; STORER, AC; THOMAS, DY			PROCESSING OF THE PAPAIN PRECURSOR - THE IONIZATION STATE OF A CONSERVED AMINO-ACID MOTIF WITHIN THE PRO REGION PARTICIPATES IN THE REGULATION OF INTRAMOLECULAR PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL PAPAIN PRECURSOR; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PROTEOLYTIC-ENZYMES; CATHEPSIN-B; PROTEASE; YEAST; EXPRESSION; PROTEINASE; INHIBITION	The cysteine protease papain is synthesized as a 40-kDa inactive precursor with a 107-amino-acid N-terminal pro region. Although sequence conservation in the pro region is lower than in the mature proteases, a conserved motif (Gly-Xaa-Asn-Xaa-Phe-Xaa-Asp(-36), papain precursor numbering) was found within the pro region of cysteine proteases of the papain superfamily. To determinate the function to this conserved motif, we have mutagenized at random each of the 4 residues individually within the pro region of the papain precursor. Precursor mutants were expressed in yeast, screened according to their ability to be processed through either a cis or trans reaction, into mature active papain. Three classes of mutants were found. Non-functional propapain mutants of the first class are completely degraded by subtilisin indicating that they are not folded into a native state. Mutants of the second class were neutral with respect to cis and trans processing. The third class included mutants that mostly accumulated as mature papain in the yeast vacuole. They had mutations that had lost the negatively charged Asp(-36) residues and a mutation that probably introduces a positive charge, Phe(-38)His. The precursor of the Phe(-38)His mutant could be recovered by expression in a vph1 mutant yeast strain which has a vacuolar pH of about 7. The Phe(-38)His propapain mutant has an optimum pH of autoactivation about one pH unit higher than the wild type molecule. These results indicate that the electrostatic status of the conserved motif participates in the control of intramolecular processing of the papain precursor.	NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, MONTREAL, PQ H4P 2R2, CANADA	National Research Council Canada			Vernet, Thierry/G-1118-2012; Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X				ALJANABI J, 1972, J BIOL CHEM, V247, P4628; BAKER D, 1992, PROTEINS, V12, P339, DOI 10.1002/prot.340120406; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; Baker E.N., 1987, BIOL MACROMOL, V3, P314; BERTI PJ, 1994, BIOCHEM J, V302, P411, DOI 10.1042/bj3020411; Brocklehurst K., 1987, HYDROLYTIC ENZYMES, P39; BROMME D, 1993, J BIOL CHEM, V268, P4832; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHANG SC, 1994, J BIOL CHEM, V269, P3548; COLL M, 1991, EMBO J, V10, P1; COONER GE, 1992, BIOCHEMISTRY-US, V31, P1142; Davis R W, 1980, Methods Enzymol, V65, P404; DENIZOT F, 1989, EUR J IMMUNOL, V19, P631, DOI 10.1002/eji.1830190409; DESMAZEAUD MJ, 1972, BIOCHIMIE, V54, P1109, DOI 10.1016/S0300-9084(72)80014-2; FABRE E, 1992, J BIOL CHEM, V267, P15049; FABRE E, 1991, J BIOL CHEM, V266, P3782; FOX T, 1992, BIOCHEMISTRY-US, V31, P12571, DOI 10.1021/bi00165a005; FUKUDA R, 1994, J BIOL CHEM, V269, P9551; FUSEK M, 1991, FEBS LETT, V287, P160, DOI 10.1016/0014-5793(91)80040-A; GERMAIN D, 1992, FEBS LETT, V299, P283, DOI 10.1016/0014-5793(92)80132-Z; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P537, DOI 10.1080/00021369.1978.10863016; IKEMURA H, 1988, J BIOL CHEM, V263, P12959; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHANSEN JT, 1968, CR TRAV LAB CARLSB, V36, P265; JONES EW, 1991, METHOD ENZYMOL, V194, P428; KASSELL B, 1973, SCIENCE, V180, P1022, DOI 10.1126/science.180.4090.1022; KEPPLER D, 1988, CANCER RES, V48, P6855; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KOGA H, 1990, J BIOCHEM-TOKYO, V108, P976, DOI 10.1093/oxfordjournals.jbchem.a123324; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACH L, 1994, J BIOL CHEM, V269, P13030; MASON RW, 1987, BIOCHEM J, V248, P449, DOI 10.1042/bj2480449; MATTHEWS G, 1994, J BIOL CHEM, V269, P588; MCINTYRE GF, 1994, J BIOL CHEM, V269, P567; MELCHIORI A, 1992, CANCER RES, V52, P2353; MENARD R, 1991, BIOCHEMISTRY-US, V30, P8924, DOI 10.1021/bi00101a002; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; OHTA Y, 1991, MOL MICROBIOL, V5, P1507, DOI 10.1111/j.1365-2958.1991.tb00797.x; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANSEGUNDO B, 1982, BIOCHIM BIOPHYS ACTA, V707, P74, DOI 10.1016/0167-4838(82)90398-3; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P1353; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; VANDENHAZEL HB, 1992, EUR J BIOCHEM, V207, P277; VERNET T, 1991, J BIOL CHEM, V266, P21451; VERNET T, 1990, J BIOL CHEM, V265, P16661; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; VERNET T, 1993, PROTEIN ENG, V6, P213, DOI 10.1093/protein/6.2.213; VERNET T, 1989, GENE, V77, P229, DOI 10.1016/0378-1119(89)90071-1; WETMORE DR, 1992, MOL MICROBIOL, V6, P1593, DOI 10.1111/j.1365-2958.1992.tb00884.x; WILCOX CA, 1991, J CELL BIOL, V115, P297, DOI 10.1083/jcb.115.2.297; WINTHER JR, 1991, P NATL ACAD SCI USA, V88, P9330, DOI 10.1073/pnas.88.20.9330; WOOLFORD CA, 1993, J BIOL CHEM, V268, P8990; ZOLLER MJ, 1982, NUCLEIC ACIDS RES, V10, P6487, DOI 10.1093/nar/10.20.6487	58	137	141	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10838	10846		10.1074/jbc.270.18.10838	http://dx.doi.org/10.1074/jbc.270.18.10838			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738022	hybrid			2022-12-27	WOS:A1995QW60100070
J	MARQUETTE, KA; PITTMAN, DD; KAUFMAN, RJ				MARQUETTE, KA; PITTMAN, DD; KAUFMAN, RJ			A 110-AMINO ACID REGION WITHIN THE A1-DOMAIN OF COAGULATION-FACTOR-VIII INHIBITS SECRETION FROM MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; GLUCOSE-REGULATED PROTEINS; HAMSTER OVARY CELLS; HUMAN FACTOR-V; BINDING-PROTEIN; MESSENGER-RNA; HUMAN-LIVER; CDNA; CERULOPLASMIN; CLONING	Factor VIII is the coagulation factor deficient in the X-chromosome linked bleeding disorder hemophilia A. Factor VIII is homologous to blood coagulation factor V, both having a domain structure of A1-A2-B-A3-C1-C2. Previous transfection studies demonstrated that factor VIII is 10-fold less efficiently expressed than the homologous coagulation factor, factor V, The inefficient expression correlated with interaction of the factor VIII primary translation product with the protein chaperonin BiP in the lumen of the endoplasmic reticulum, In contrast, factor V was not detected in association with BiP and was secreted efficiently, To determine whether specific amino acid sequences within factor VIII inhibit secretion, we have studied the secretion of factor VIII deletion and factor VIII/factor V chimeric proteins upon transient transfection of COS-1 monkey cells, A chimeric factor VIII protein that contained the A1- and A2-domains of factor V was secreted with a similar efficiency as wild-type factor V, whereas the complementary chimera having the A1- and A2-domains of factor VIII was secreted with low efficiency, similar to wild-type factor WI, These results suggested that sequences within the A1- and A2-domains were responsible for the low secretion efficiency of factor VIII, Secretion of A1-domain deleted factor VIII was increased approximately 10-fold compared to wild-type factor VIII or A2-domain-deleted factor VIII, Expression of the factor VIII Al-domain alone did not yield secreted protein, whereas expression of the factor VIII A2-domain alone or the factor V A1-domain or A2-domain alone directed synthesis of secreted protein,. Secretion of a hybrid in which the carboxyl-terminal 110 amino acids of the A1-domain were replaced by homologous sequences from the factor V A1-domain was also increased 10-fold compared to wild type factor VIII, however, the secreted protein was not functional and the heavy and fight chains were not associated. These results localize a 1l0-amino acid region within the Al domain that inhibits factor VIII secretion, This region is clustered with multiple short peptide se sequences that have potential to bind BiP,	HOWARD HUGHES MED INST, ANN ARBOR, MI 48105 USA; UNIV MICHIGAN, MED CTR, DEPT BIOL CHEM, ANN ARBOR, MI 48105 USA; GENET INST INC, CAMBRIDGE, MA 02140 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053777] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL53777] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BLOUNT P, 1991, J CELL BIOL, V113, P1125, DOI 10.1083/jcb.113.5.1125; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; BURKE RL, 1986, J BIOL CHEM, V261, P2574; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRIPE LD, 1992, BIOCHEMISTRY-US, V31, P3777, DOI 10.1021/bi00130a007; DORNER AJ, 1990, METHOD ENZYMOL, V185, P577; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; DORNER AJ, 1990, P NATL ACAD SCI USA, V87, P7429, DOI 10.1073/pnas.87.19.7429; DORNER AJ, 1989, J BIOL CHEM, V264, P20602; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; DREYFUSS G, 1984, MOL CELL BIOL, V4, P415, DOI 10.1128/MCB.4.3.415; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GODDEN JW, 1991, SCIENCE, V253, P438, DOI 10.1126/science.1862344; HAAS IG, 1991, CURR TOP MICROBIOL, V167, P71; HELLSTERN P, 1986, THROMB HAEMOSTASIS, V56, P353; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; Kaufman Randal J., 1992, Transfusion Medicine Reviews, V6, P235, DOI 10.1016/S0887-7963(92)70174-6; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P1233, DOI 10.1128/MCB.9.3.1233; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; KAUFMAN RJ, 1988, J BIOL CHEM, V263, P6352; KELLY DA, 1984, BRIT J HAEMATOL, V56, P535, DOI 10.1111/j.1365-2141.1984.tb02178.x; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; LEWIS JH, 1985, NEW ENGL J MED, V312, P1189; LYNCH CM, 1993, HUM GENE THER, V4, P259, DOI 10.1089/hum.1993.4.3-259; MESSERSCHMIDT A, 1990, EUR J BIOCHEM, V187, P341, DOI 10.1111/j.1432-1033.1990.tb15311.x; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; PAN Y, 1994, BLOOD, V84, pA62; PITTMAN DD, 1994, BLOOD, V84, P4214, DOI 10.1182/blood.V84.12.4214.bloodjournal84124214; PITTMAN DD, 1992, BLOOD, V79, P389; PITTMAN DD, 1994, J BIOL CHEM, V269, P17329; PITTMAN DD, 1993, METHOD ENZYMOL, V222, P236; PROCTOR RR, 1961, AM J CLIN PATHOL, V36, P212; RICHARDSON JS, 1976, J MOL BIOL, V102, P221, DOI 10.1016/S0022-2836(76)80050-2; ROSENBERG HF, 1993, J BIOL CHEM, V268, P4499; RYDEN L, 1988, OXIDASES RELATED RED, P349; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P390, DOI 10.1073/pnas.81.2.390; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WION KL, 1985, NATURE, V317, P726, DOI 10.1038/317726a0; ZELECHOWSKA MG, 1985, NATURE, V317, P729, DOI 10.1038/317729a0	49	52	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10297	10303		10.1074/jbc.270.17.10297	http://dx.doi.org/10.1074/jbc.270.17.10297			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730335	hybrid			2022-12-27	WOS:A1995QV41700084
J	MCNEILL, RB; COLBRAN, RJ				MCNEILL, RB; COLBRAN, RJ			INTERACTION OF AUTOPHOSPHORYLATED CA2+ CALMODULIN-DEPENDENT PROTEIN-KINASE-II WITH NEURONAL CYTOSKELETAL PROTEINS - CHARACTERIZATION OF BINDING TO A 190-KDA POSTSYNAPTIC DENSITY PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RABBIT SKELETAL-MUSCLE; HIGH-AFFINITY BINDING; RAT-BRAIN; CA-2+ CALMODULIN; REGULATORY SUBUNIT; MOLECULAR-CLONING; CA-2+-INDEPENDENT ACTIVITY; DENDRITIC SPINES; MUTANT MICE	Subcellular localization of Ca2+/calmodulin-dependent protein kinase II: (CaMKII) by interaction with specific anchoring proteins may be an important mechanism contributing to the regulation of CaMKII. Proteins capable of binding CaMKII were identified by the use of a gel overlay assay with recombinant mouse CaMKII alpha (mCaMKII alpha or Xenopus CaMKII beta (xCaMKII beta) P-32-auto-phosphorylated at Thr(286/287) as a probe. Numerous [P-32]CaMKII-binding proteins were identified in various whole rat tissue extracts, but binding was most prominent to forebrain proteins of 190 kDa (p190) and 140 kDa (p140), Fractionation of forebrain extracts localized p190 and p140 to a crude particulate/cytoskeletal fraction and isolated postsynaptic densities. [P-32]mCaMKII alpha-bound to p190 with an apparent K-d of 609 nM (subunit concentration) and a B-max of 7.0 pmol of mCaMKII alpha subunit bound per mg of P2 protein, as measured using the overlay assay. Binding of 100 nM [P-32]mCaMKII alpha to p190 was competed by nonradioactive mCaMKII alpha autophosphorylated on Thr(286) (EC(50%) = 200 nM), but to a much lesser extent by nonradioactive mCaMKII alpha autophosphorylated on Thr(306) (EC(50%) > 2000 nM). In addition, nonphosphorylated mCaMKII alpha was a poor competitor for [P-32]mCaMKII alpha binding to p190. The competition data indicate that Ca2+/CaM-dependent autophosphorylation at Thr(286) promotes binding to p190, whereas, Ca2+/CaM-independent autophosphorylation at Thr(306) does not enhance binding. Therefore, CaMKII may become localized to postsynaptic densities by p190 following its activation by an increase of dendritic Ca2+ concentration.	VANDERBILT UNIV, SCH MED, DEPT MOLEC PHYSIOL & BIOPHYS, NASHVILLE, TN 37232 USA	Vanderbilt University			Colbran, Roger/AAU-7708-2021	Colbran, Roger/0000-0001-7401-8244	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047973] Funding Source: NIH RePORTER; NIDDK NIH HHS [5T32DK07563-07] Funding Source: Medline; NIGMS NIH HHS [GM 47973] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREGMAN DB, 1991, J BIOL CHEM, V266, P7207; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; CARR DW, 1992, J BIOL CHEM, V267, P13376; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; COHEN P, 1988, METHOD ENZYMOL, V159, P390; Cohen P., 1988, MOL ASPECTS CELL REG, V5; COLBRAN RJ, 1992, NEUROCHEM INT, V21, P469, DOI 10.1016/0197-0186(92)90080-B; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; CORREIA JJ, 1987, J BIOL CHEM, V262, P17278; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; GOLDENRING JR, 1984, J NEUROCHEM, V42, P1077, DOI 10.1111/j.1471-4159.1984.tb12713.x; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; ITO I, 1991, NEUROSCI LETT, V121, P119, DOI 10.1016/0304-3940(91)90663-E; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KERYER G, 1993, P NATL ACAD SCI USA, V90, P5418, DOI 10.1073/pnas.90.12.5418; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LEISER M, 1986, J BIOL CHEM, V261, P1904; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; LOU LL, 1989, J NEUROSCI, V9, P2020; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MAYER P, 1993, FEBS LETT, V333, P315, DOI 10.1016/0014-5793(93)80678-N; MAYER P, 1994, BIOCHEM J, V298, P757, DOI 10.1042/bj2980757; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MCGOWAN CH, 1988, METHOD ENZYMOL, V159, P416; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; MOCHLYROSEN D, 1991, J BIOL CHEM, V266, P14866; MUKHERJI S, 1994, J BIOL CHEM, V269, P20733; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; NGHIEM P, 1993, J BIOL CHEM, V268, P5471; OHTA Y, 1986, FEBS LETT, V208, P423, DOI 10.1016/0014-5793(86)81061-4; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; PATTON BL, 1990, J BIOL CHEM, V265, P11204; RANNELS SR, 1983, METHOD ENZYMOL, V99, P55; RICH DP, 1989, J NEUROCHEM, V53, P807, DOI 10.1111/j.1471-4159.1989.tb11777.x; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; RUNGE MS, 1981, BIOCHEMISTRY-US, V20, P175, DOI 10.1021/bi00504a029; SAHYOUN N, 1986, J BIOL CHEM, V261, P2339; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; SUMMERS MD, 1988, TEX AGR EXP STN B, V1555; SUZUKI T, 1994, J NEUROCHEM, V63, P1529, DOI 10.1046/j.1471-4159.1994.63041529.x; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; VALLANO ML, 1985, BIOCHEM BIOPH RES CO, V130, P957, DOI 10.1016/0006-291X(85)91708-5; VALLANO ML, 1985, P NATL ACAD SCI USA, V82, P3202, DOI 10.1073/pnas.82.10.3202; WILLMUND R, 1986, P NATL ACAD SCI USA, V83, P9789, DOI 10.1073/pnas.83.24.9789	72	84	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10043	10049		10.1074/jbc.270.17.10043	http://dx.doi.org/10.1074/jbc.270.17.10043			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730306	hybrid			2022-12-27	WOS:A1995QV41700051
J	VACCARO, AM; SALVIOLI, R; BARCA, A; TATTI, M; CIAFFONI, F; MARAS, B; SICILIANO, R; ZAPPACOSTA, F; AMORESANO, A; PUCCI, P				VACCARO, AM; SALVIOLI, R; BARCA, A; TATTI, M; CIAFFONI, F; MARAS, B; SICILIANO, R; ZAPPACOSTA, F; AMORESANO, A; PUCCI, P			STRUCTURAL-ANALYSIS OF SAPOSIN-C AND SAPOSIN-B - COMPLETE LOCALIZATION OF DISULFIDE BRIDGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; SPHINGOLIPID ACTIVATOR PROTEIN-1; PATHOGENIC ENTAMOEBA-HISTOLYTICA; PORE-FORMING PEPTIDE; GAUCHER DISEASE; VARIANT; PATIENT; GLUCOCEREBROSIDASE; GLUCOSYLCERAMIDASE; ASSIGNMENT	Saposins A, B, C, and D are a group of homologous glycoproteins derived from a single precursor, prosaposin, and apparently involved in the stimulation of the enzymatic degradation of sphingolipids in lysosomes, Ah saposins have six cysteine residues at similar positions, In the present study we have investigated the disulfide structure of saposins B and C using advanced mass spectrometric procedures. Electrospray analysis showed that deglycosylated saposins B and C are mainly present as 79- and 80-residue monomeric polypeptides, respectively. Fast atom bombardment mass analysis of peptide mixtures obtained by a combination of chemical and enzymatic cleavages demonstrated that the pairings of the three disulfide bridges present in each saposin are Cys(4)-Cys(77), Cys(7)-Cys(71), Cys(36)-Cys(47) for saposin B and Cys(5)-Cys(78), Cys(8)-Cys(72), Cys(36)-Cys(47) for saposin C. We have recently shown that saposin C interacts with phosphatidylserine-containing vesicles inducing destabilization of the lipid surface (Vaccaro, A. M., Tatti, M., Ciaffoni, F., Salvioli, R., Serafino, A., and Barca, A. (1994) FEBS Lett. 349, 181-186); this perturbation promotes the binding of the lysosomal enzyme glucosylceramidase to the vesicles and the reconstitution of its activity, It was presently found that the effects of saposin C on phosphatidylserine liposomes and on glucosylceramidase activity are markedly reduced when the three disulfide bonds are irreversibly disrupted, These results stress the importance of the disulfide structure for the functional properties of the saposin.	CNR,DIPARTIMENTO SCI BIOCHIM,I-00185 ROME,ITALY; CNR,CTR MOLEC BIOL,I-00185 ROME,ITALY; CNR,SERV SPETTROMETRIA MASSA,I-80131 NAPLES,ITALY; UNIV NAPLES,DIPARTIMENTO CHIM ORGAN & BIOL,I-80134 NAPLES,ITALY	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II	VACCARO, AM (corresponding author), IST SUPER SANITA,METAB & BIOCHIM PATOL LAB,VIALE REGINA ELENA 299,I-00161 ROME,ITALY.		Siciliano, Rosa Anna/G-9822-2013; Maras, Bruno/A-2020-2010; tatti, Massimo/N-1382-2017	PUCCI, Pietro/0000-0002-5885-1495; SICILIANO, ROSAANNA/0000-0002-1042-3424; AMORESANO, Angela/0000-0002-8386-655X				BAATZ JE, 1990, BIOCHEMISTRY-US, V29, P6714, DOI 10.1021/bi00480a022; BUKO AM, 1983, BIOMED MASS SPECTROM, V10, P324, DOI 10.1002/bms.1200100504; FURST W, 1990, EUR J BIOCHEM, V192, P709, DOI 10.1111/j.1432-1033.1990.tb19280.x; FURST W, 1992, BIOCHIM BIOPHYS ACTA, V1126, P1, DOI 10.1016/0005-2760(92)90210-M; GLEW RH, 1988, LAB INVEST, V58, P5; HIRAIWA M, 1993, ARCH BIOCHEM BIOPHYS, V303, P326, DOI 10.1006/abbi.1993.1291; ITO K, 1993, EUR J BIOCHEM, V215, P171, DOI 10.1111/j.1432-1033.1993.tb18020.x; JOHANSSON J, 1991, BIOCHEMISTRY-US, V30, P6917, DOI 10.1021/bi00242a015; JOHANSSON J, 1992, FEBS LETT, V301, P165, DOI 10.1016/0014-5793(92)81239-I; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; KLEINSCHMIDT T, 1987, BIOL CHEM H-S, V368, P1571, DOI 10.1515/bchm3.1987.368.2.1571; KLEINSCHMIDT T, 1988, BIOL CHEM H-S, V369, P1361, DOI 10.1515/bchm3.1988.369.2.1361; KONDOH K, 1991, BIOCHEM BIOPH RES CO, V181, P286, DOI 10.1016/S0006-291X(05)81415-9; LEIPPE M, 1992, EMBO J, V11, P3501, DOI 10.1002/j.1460-2075.1992.tb05432.x; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; MORIMOTO S, 1988, BIOCHEM BIOPH RES CO, V156, P403, DOI 10.1016/S0006-291X(88)80855-6; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; MORRIS HR, 1985, BIOCHEM BIOPH RES CO, V126, P1122, DOI 10.1016/0006-291X(85)90302-X; MORRIS HR, 1983, BIOCHEM BIOPH RES CO, V117, P299, DOI 10.1016/0006-291X(83)91575-9; MURRAY GJ, 1985, ANAL BIOCHEM, V147, P301, DOI 10.1016/0003-2697(85)90276-3; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; PATTHY L, 1991, J BIOL CHEM, V266, P6035; POTIER M, 1988, BIOCHEM BIOPH RES CO, V155, P32, DOI 10.1016/S0006-291X(88)81045-3; PUCCI P, 1988, BIOMED ENVIRON MASS, V17, P287, DOI 10.1002/bms.1200170410; PUCCI P, 1985, BIOCHEM BIOPH RES CO, V130, P84, DOI 10.1016/0006-291X(85)90385-7; QI XY, 1994, J BIOL CHEM, V269, P16746; RAFI MA, 1993, SOMAT CELL MOLEC GEN, V19, P1, DOI 10.1007/BF01233949; SANO A, 1988, J BIOL CHEM, V263, P19597; SANO A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P75, DOI 10.1016/0167-4838(92)90426-E; SCHNABEL D, 1991, FEBS LETT, V284, P57, DOI 10.1016/0014-5793(91)80760-Z; SHIFFER K, 1988, BIOCHEMISTRY-US, V27, P2689, DOI 10.1021/bi00408a008; STRAUBINGER RM, 1983, CELL, V32, P1069, DOI 10.1016/0092-8674(83)90291-X; VACCARO AM, 1993, BIOCHIM BIOPHYS ACTA, V1149, P55, DOI 10.1016/0005-2736(93)90024-T; VACCARO AM, 1994, FEBS LETT, V349, P181, DOI 10.1016/0014-5793(94)00659-8; VACCARO AM, 1993, FEBS LETT, V1, P159; VOGEL A, 1991, EUR J BIOCHEM, V200, P591, DOI 10.1111/j.1432-1033.1991.tb16222.x; WENGER DA, 1982, BIOCHIM BIOPHYS ACTA, V712, P639, DOI 10.1016/0005-2760(82)90293-4; YAMASHITA K, 1990, BIOCHEMISTRY-US, V29, P3030, DOI 10.1021/bi00464a020	40	78	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9953	9960		10.1074/jbc.270.17.9953	http://dx.doi.org/10.1074/jbc.270.17.9953			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730378				2022-12-27	WOS:A1995QV41700040
J	ZHANG, Y; WISNER, A; XIONG, YL; BON, C				ZHANG, Y; WISNER, A; XIONG, YL; BON, C			A NOVEL PLASMINOGEN-ACTIVATOR FROM SNAKE-VENOM - PURIFICATION, CHARACTERIZATION, AND MOLECULAR-CLONING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGKISTRODON-CONTORTRIX-CONTORTRIX; PROTEIN-C ACTIVATOR; AMINO-ACID-SEQUENCE; TISSUE-TYPE; MASS UROKINASE; BOTHROPS-ATROX; HUMAN-URINE; FIBRIN; IDENTIFICATION; THROMBIN	A novel plasminogen activator from Trimeresurus stejnegeri venom (TSV-PA) has been identified and purified to homogeneity. It is a single chain glycoprotein with an apparent molecular weight of 33,000 and an isoelectric point of pH 5.2. It specifically activates plasminogen through an enzymatic reaction. The activation of human native GIu-plasminogen by TSV-PA is due to a single cleavage of the molecule at the peptide bond Arg(561)-Val-(562). Purified TSV-PA, which catalyzes the hydrolysis of several tripeptide p-nitroanilide substrates, does not activate nor degrade prothrombin, factor X, or protein C and does not clot fibrinogen nor show fibrino(geno)lytic activity in the absence of plasminogen. The activity of TSV-PA was readily inhibited by phenylmethanesulfonyl fluoride and by p-nitrophenyl-p-guanidinobenzoate. Oligonucleotide primers designed on the basis of the N-terminal and the internal peptide sequences of TSV-PA were used for the amplification of cDNA fragments by polymerase chain reaction. This allowed the cloning of a full-length cDNA encoding TSV-PA from a cDNA library prepared from the venom glands. The deduced complete amino acid sequence of TSV-PA indicates that the mature TSV-PA protein is composed of 234 amino acids and contains a single potential N-gIycosylation site at Asn(1G1). The sequence of TSV-PA exhibits a high degree of sequence identity with other snake venom proteases: 66% with the protein C activator from Aghistrodon contortrix contortrix venom, 63% with batroxobin, and 60% with the factor V activator from Russell's viper venom. On the other hand, TSV-PA shows only 21-23% sequence similarity with the catalytic domains of u-PA and t-PA. Furthermore, TSV-PA lacks the sequence site that has been demonstrated to be responsible for the interaction of t-PA (KHRR) and u-PA (RRHR) with plasminogen activator inhibitor type 1.	INST PASTEUR,UNITE VENINS,F-75724 PARIS 15,FRANCE; CHINESE ACAD SCI,KUNMING INST ZOOL,KUNMING 650223,PEOPLES R CHINA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Chinese Academy of Sciences; Kunming Institute of Zoology				Zhang, Yun/0000-0002-8636-183X				AU LC, 1993, BIOCHEM J, V294, P387, DOI 10.1042/bj2940387; BENNETT WF, 1991, J BIOL CHEM, V266, P5191; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLEN D, 1988, BLOOD, V71, P216; DANO K, 1994, FIBRINOLYSIS, V8, P189, DOI 10.1016/0268-9499(94)90717-X; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DEARAUJO AL, 1987, TOXICON, V25, P1181, DOI 10.1016/0041-0101(87)90136-X; DELROSSO M, 1985, CANCER RES, V45, P630; FISCHER BE, 1990, BIOCHIM BIOPHYS ACTA, V1041, P48, DOI 10.1016/0167-4838(90)90121-U; FROHMAN MA, 1990, AMPLIFICATIONS, V5, P11; FUKUTAKE K, 1989, HEMOSTASIS ANIMAL VE, P591; GUNZLER WA, 1982, H-S Z PHYSIOL CHEM, V363, P1155, DOI 10.1515/bchm2.1982.363.2.1155; HOFMANN H, 1987, BIOCHEMISTRY-US, V26, P772, DOI 10.1021/bi00377a018; HOFMANN H, 1987, BIOCHEMISTRY-US, V26, P780, DOI 10.1021/bi00377a019; HORREVOETS AJG, 1994, J BIOL CHEM, V269, P12639; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; ISRAEL DI, 1993, NUCLEIC ACIDS RES, V21, P2627, DOI 10.1093/nar/21.11.2627; ITOH N, 1987, J BIOL CHEM, V262, P3132; KEIJER J, 1991, BLOOD, V78, P401; KISIEL W, 1987, J BIOL CHEM, V262, P12607; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDONALD RJ, 1982, J BIOL CHEM, V257, P9724; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; MADISON EL, 1994, FIBRINOLYSIS, V8, P221, DOI 10.1016/0268-9499(94)90720-X; MCMULLEN BA, 1989, BIOCHEMISTRY-US, V28, P674, DOI 10.1021/bi00428a039; NAKASHIMA K, 1993, P NATL ACAD SCI USA, V90, P5964, DOI 10.1073/pnas.90.13.5964; ORTHNER CL, 1988, BIOCHEMISTRY-US, V27, P2558, DOI 10.1021/bi00407a043; PAONI NF, 1993, PROTEIN ENG, V6, P529, DOI 10.1093/protein/6.5.529; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; STEFFENS GJ, 1982, H-S Z PHYSIOL CHEM, V363, P1043, DOI 10.1515/bchm2.1982.363.2.1043; Stocker K., 1990, P97; TOKUNAGA F, 1988, J BIOL CHEM, V263, P17471; VANSEUNINGEN I, 1992, ELECTROPHORESIS, V13, P97, DOI 10.1002/elps.1150130119; WALLEN P, 1972, BIOCHIM BIOPHYS ACTA, V257, P122, DOI 10.1016/0005-2795(72)90261-9; WEITZ JI, 1988, J CLIN INVEST, V82, P1700, DOI 10.1172/JCI113783; WEITZ JI, 1990, J CLIN INVEST, V86, P203, DOI 10.1172/JCI114685; WOHL RC, 1980, J BIOL CHEM, V255, P2005; Zhang Yun, 1993, Asiatic Herpetological Research, V5, P117	42	164	186	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10246	10255		10.1074/jbc.270.17.10246	http://dx.doi.org/10.1074/jbc.270.17.10246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730329	hybrid			2022-12-27	WOS:A1995QV41700077
J	KUNSTNER, P; GUARDIOLA, A; TAKAHASHI, Y; ROCHAIX, JD				KUNSTNER, P; GUARDIOLA, A; TAKAHASHI, Y; ROCHAIX, JD			A MUTANT STRAIN OF CHLAMYDOMONAS-REINHARDTII LACKING THE CHLOROPLAST PHOTOSYSTEM-II PSBI GENE GROWS PHOTOAUTOTROPHICALLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTION CENTER COMPLEX; COMPLETE SEQUENCE; NUCLEOTIDE-SEQUENCE; DNA; ORGANIZATION; GENOME; CYTOCHROME-B-559; TRANSFORMATION; EXPRESSION	The product of the chloroplast psbI gene is associated with the photosystem II reaction center. To gain insights into the function of this polypeptide, we have disrupted its gene in Chlamydomonas reinhardtii with an aadA expression cassette that confers resistance to spectinomycin through biolistic transformation. The transformants are still able to grow photoautotrophically in dim light, but not in high light, and they remain photosensitive when grown on acetate containing medium, The amounts of photosystem II complex and oxygen evolving activity are both reduced to 10-20% of wild-type levels in these psbI-deficient mutants. It appears that the PsbI polypeptide plays a role in the stability of photosystem II and possibly also in modulating electron transport or energy transfer in this complex.	UNIV GENEVA, DEPT PLANT BIOL, CH-1211 GENEVA 4, SWITZERLAND; OKAYAMA UNIV, DEPT BIOL, OKAYAMA 700, JAPAN	University of Geneva; Okayama University	KUNSTNER, P (corresponding author), UNIV GENEVA, DEPT MOLEC BIOL, 30 QUAI ERNEST ANSERMET, CH-1211 GENEVA 4, SWITZERLAND.		Rochaix, Jean-David/ABC-5243-2020; Takahashi, Yuichiro/B-2062-2011	Takahashi, Yuichiro/0000-0001-6410-0447				ANDERSSON B., 1991, CURR TOP BIOENERG, V16, P1; BENNOUN P, 1986, PLANT MOL BIOL, V6, P151, DOI 10.1007/BF00021484; BOUDREAU E, 1994, PLANT MOL BIOL, V24, P585, DOI 10.1007/BF00023556; CHEN JC, 1990, NUCLEIC ACIDS RES, V18, P4017, DOI 10.1093/nar/18.13.4017; ERICKSON JM, 1992, PHOTOSYSTEMS STRUCTU, P101; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; IKEUCHI M, 1988, FEBS LETT, V241, P99, DOI 10.1016/0014-5793(88)81039-1; IKEUCHI M, 1991, J BIOL CHEM, V266, P11111; KUCHKA MR, 1988, EMBO J, V7, P319, DOI 10.1002/j.1460-2075.1988.tb02815.x; LEU S, 1992, PLANT MOL BIOL, V18, P613, DOI 10.1007/BF00040681; MONOD C, 1994, EMBO J, V13, P2749; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; NICKELSEN J, 1994, EMBO J, V13, P3182, DOI 10.1002/j.1460-2075.1994.tb06617.x; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; PAKRASI HB, 1991, EMBO J, V10, P1619, DOI 10.1002/j.1460-2075.1991.tb07684.x; Rochaix J. D., 1988, PLANT MOL BIOL PRACT, P253; ROCHAIX JD, 1978, J MOL BIOL, V126, P597, DOI 10.1016/0022-2836(78)90011-6; Sambrook J, 1989, MOL CLONING LABORATO; SEXTON TB, 1990, CURR GENET, V17, P445, DOI 10.1007/BF00334526; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; TAKAHASHI Y, 1994, PLANT MOL BIOL, V24, P779, DOI 10.1007/BF00029859; TAKAHASHI Y, 1991, EMBO J, V10, P2033, DOI 10.1002/j.1460-2075.1991.tb07733.x; TELFER A, 1990, BIOCHIM BIOPHYS ACTA, V1017, P143, DOI 10.1016/0005-2728(90)90145-T; THOMPSON LK, 1988, BIOCHEMISTRY-US, V27, P6653, DOI 10.1021/bi00418a002; TOMO T, 1993, FEBS LETT, V323, P15, DOI 10.1016/0014-5793(93)81438-6; VERMAAS W, 1993, ANNU REV PLANT PHYS, V44, P457, DOI 10.1146/annurev.pp.44.060193.002325; WEBBER AN, 1989, FEBS LETT, V242, P259, DOI 10.1016/0014-5793(89)80481-8	29	48	50	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	1995	270	16					9651	9654						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QU089	7721898				2022-12-27	WOS:A1995QU08900087
J	HATA, Y; SUDHOF, TC				HATA, Y; SUDHOF, TC			A NOVEL UBIQUITOUS FORM OF MUNC-18 INTERACTS WITH MULTIPLE SYNTAXINS - USE OF THE YEAST 2-HYBRID SYSTEM TO STUDY INTERACTIONS BETWEEN PROTEINS INVOLVED IN MEMBRANE TRAFFIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION; IDENTIFICATION; SYNAPTOTAGMIN; RECEPTORS; NEUREXINS; ALPHA; GENE	Mune-18-1 is a 67-kDa neuronal protein that binds tightly 60 syntaxin 1 and functions in synaptic vesicle exocytosis (Hata, Y., Slaughter, C. A., and Sudhof, T. C. (1993a) Nature 366, 347-351). We have now characterized a new Munc-18 isoform, Munc-18-2, that exhibits 63% amino acid sequence identity with Munc-18-1. Munc-18-2 is expressed in most tissues, whereas Munc-18-1 is primarily expressed in brain. Using recombinant Munc-18-1 and Munc-18-2 produced in COS cells, we show that both forms of Munc-18 bind tightly to syntaxins 1A, 2, and 3 but not to syntaxin 4. In an independent approach 60 study the binding specificities of Munc-18-1 and Munc-18-2, we used the yeast two-hybrid system. This assay system depends on protein-protein interactions in the cell nucleus. We validated its utility for studying membrane trafficking proteins by testing well characterized interactions between cytosolic proteins that are known to be physiologically important in exocytosis. Strong interactions, such as the binding of syntaxins 1-4 with SNAP-25, were effectively detected by the yeast two-hybrid assay, but weak binding, such as the binding of syntaxins to synaptotagmin or of synaptotagmin to neurexins, was not. Studies on full-length and truncated forms of Munc-18s by the yeast two-hybrid system confirmed their interactions with syntaxins. Both the N and the C terminus of Munc-18 were essential for binding. Munc-18-1 and Munc-18-2 bind only to syntaxins 1A, 2, and 3 but not 4 and 5 by yeast-two hybrid system assays. Our studies demonstrate that neural and non-neural tissues have distinct forms of Munc-18, which may function in different types of exocytosis. The lack of specificity of the interactions between syntaxins and Munc-18s indicates that specificity of membrane trafficking reactions is not dependent on this interaction.	UNIV TEXAS,SW MED SCH,HOWARD HUGHES MED INST,DALLAS,TX 75235; UNIV TEXAS,SW MED SCH,DEPT MOLEC GENET,DALLAS,TX 75235	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PELHAM HRB, 1993, NATURE, V364, P582, DOI 10.1038/364582a0; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rose MD., 1990, METHODS YEAST GENETI; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1990, J BIOL CHEM, V265, P7849; SUDHOF TC, 1993, CELL, V75, P1; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	36	160	166	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					13022	13028		10.1074/jbc.270.22.13022	http://dx.doi.org/10.1074/jbc.270.22.13022			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768895	hybrid			2022-12-27	WOS:A1995RB43900016
J	XUE, JC; CHEN, CG; ZHU, JM; KUNAPULI, SP; DERIEL, JK; YU, L; LIUCHEN, LY				XUE, JC; CHEN, CG; ZHU, JM; KUNAPULI, SP; DERIEL, JK; YU, L; LIUCHEN, LY			THE 3RD EXTRACELLULAR LOOP OF THE MU-OPIOID RECEPTOR IS IMPORTANT FOR AGONIST SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BETA-2-ADRENERGIC RECEPTORS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; RAT-BRAIN; BINDING; LIGAND; SPECIFICITY; MOUSE; SITE; CDNA	To investigate the interaction between the mu opioid receptor and its ligands, we compared the binding of mu-selective ligands to two mu/kappa chimeric opioid receptors and to mu and kappa receptors. The two chimeras were constructed from cloned rat mu and kappa receptors in which a segment from the middle of the third intracellular loop to the C terminus was exchanged. When this portion of the kappa receptor was replaced by that of the mu receptor, affinities of mu selective agonists, DAMGO (Tyr-D-Ala-Gly-NMePhe-Gly-ol), PL017 (Tyr-Pro-NMePhe-D-Pro-NH2), sufentanil, and morphine, were greatly increased as compared to those for the kappa receptor. Conversely, when this region of the gamma receptor was substituted by that of the kappa receptor, affinities for these agonists were substantially decreased as compared with those of the mu receptor. Unlike selective agonists, the mu-selective antagonist, CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-penicillamine-Thr-NH2), displayed a low affinity for both chimeric receptors, similar to that of the kappa receptor. Thus, the region from the middle of the third intracellular loop to the C terminus of the mu receptor is important for the binding of selective agonists. Conversely, the determinants for selective binding of the antagonist CTAP reside in a more extended region of the receptor.	TEMPLE UNIV,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19104; TEMPLE UNIV,SCH MED,DEPT PHYSIOL,PHILADELPHIA,PA 19104; TEMPLE UNIV,SCH MED,FELS INST MOLEC BIOL & CANC RES,PHILADELPHIA,PA 19104; INDIANA UNIV,SCH MED,DEPT MED & MOLEC GENET,INDIANAPOLIS,IN 46202	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Indiana University System; Indiana University-Purdue University Indianapolis					NATIONAL INSTITUTE ON DRUG ABUSE [R29DA004745, R01DA004745] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 04745] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; CHANG KJ, 1983, J PHARMACOL EXP THER, V227, P403; CHEN Y, 1993, MOL PHARMACOL, V44, P8; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FRIELLE T, 1988, P NATL ACAD SCI USA, V85, P9494, DOI 10.1073/pnas.85.24.9494; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KONG HY, 1994, P NATL ACAD SCI USA, V91, P8042, DOI 10.1073/pnas.91.17.8042; KOSTERLITZ HW, 1981, BRIT J PHARMACOL, V73, pP299; KRAMER TH, 1989, J PHARMACOL EXP THER, V249, P544; LEYSEN JE, 1983, EUR J PHARMACOL, V87, P209, DOI 10.1016/0014-2999(83)90331-X; LI SX, 1993, BIOCHEM J, V295, P629, DOI 10.1042/bj2950629; LIUCHEN LY, 1991, EUR J PHARMACOL, V203, P195, DOI 10.1016/0014-2999(91)90715-3; MCPHERSON GA, 1983, COMPUT PROG BIOMED, V17, P107, DOI 10.1016/0010-468X(83)90031-4; ONOGI T, 1995, FEBS LETT, V357, P93, DOI 10.1016/0014-5793(94)01341-W; PASTERNAK GW, 1988, OPIATE RECEPTORS; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SURRATT CK, 1994, J BIOL CHEM, V269, P20548; WANG JB, 1993, P NATL ACAD SCI USA, V90, P10230, DOI 10.1073/pnas.90.21.10230; WANG JB, 1994, J BIOL CHEM, V269, P25966; WUSTER M, 1980, LIFE SCI, V27, P163, DOI 10.1016/0024-3205(80)90459-2; XUE JC, 1994, J BIOL CHEM, V269, P30195; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736; ZHU J, 1995, LIFE SCI, V56, P201	25	82	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12977	12979						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768887				2022-12-27	WOS:A1995RB43900008
J	BAKKER, AHF; WEENINGVERHOEFF, EJD; VERHEIJEN, JH				BAKKER, AHF; WEENINGVERHOEFF, EJD; VERHEIJEN, JH			THE ROLE OF THE LYSYL BINDING-SITE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN THE INTERACTION WITH A FORMING FIBRIN CLOT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRINGLE-2 DOMAIN; STRUCTURAL DOMAINS; LYSINE; ACID; RESOLUTION; KINETICS; PROTEINS; FINGER; GLU	To describe the role of the lysyl binding site in the interaction of tissue-type plasminogen activator (t-PA, FGK1K2P) with a forming fibrin clot, we performed binding experiments with domain deletion mutants GR1K2P, K2P, and the corresponding point mutants lacking the lysyl binding site in the absence and the presence of epsilon-amino caproic acid (EACA). Occupation of the lysyl binding site in the K2 domain with EACA has a pronounced effect on the binding of FGK1K2P to a fibrin clot (C-50 = 77 +/- 11 nM versus 376 +/- 45 nM with EACA). Deleting the lysyl binding site in the K2 domain (substitution D236N) also impairs fibrin binding but to a lesser extent (C-50 = 169 +/- 20 nM). Although the binding of K2P to a fibrin clot is weak (C-50 = 1163 +/- 490 nM), it still is 2 orders of magnitude stronger than the binding of EACA to K2P. Therefore it was surprising to find that deletion of the lysyl binding site in K2P completely abolishes fibrin binding. Even when both the F domain and the lysyl binding site were deleted, considerable fibrin binding is still observed (C-50 = 557 +/- 126 nM), suggesting other than F and K2-mediated interactions. The binding of FGK1K2P, FGK1K2P (D236N), GK1K2P, and GK1K2P (D236N) to fibrin could be competitively inhibited by FGK1K2P and K2P, indicating that all molecules recognize the same interaction sites on a fibrin clot. Based on these results, a new model for the interaction of t-PA with a forming fibrin clot is proposed. The fibrin binding sites in t-PA are not confined to the F and K2 domain. The main role of the lysyl binding site in the K2 domain of t-PA appears indirect rather than direct, most likely stabilizing a conformation favorable for fibrin binding.	TNO,PREVENT & HLTH,GAUBIUS LAB,2301 CE LEIDEN,NETHERLANDS	Netherlands Organization Applied Science Research								ALLEN RA, 1981, THROMB HAEMOSTASIS, V45, P43; BAKKER AHF, 1993, J BIOL CHEM, V268, P18496; BENNETT WF, 1991, J BIOL CHEM, V266, P5191; BYEON IJL, 1991, J MOL BIOL, V222, P1035, DOI 10.1016/0022-2836(91)90592-T; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; DEMUNK GAW, 1989, BIOCHEMISTRY-US, V28, P7318, DOI 10.1021/bi00444a026; DESERRANO VS, 1993, BIOCHEMISTRY-US, V32, P3540, DOI 10.1021/bi00065a004; DEVOS AM, 1992, BIOCHEMISTRY-US, V31, P270, DOI 10.1021/bi00116a037; DEVRIES C, 1989, J BIOL CHEM, V264, P12604; DEVRIES C, 1990, THESIS U AMSTERDAM; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; HASEGAWA A, 1985, Patent No. 156169; HORREVOETS AJG, 1994, J BIOL CHEM, V269, P12639; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; ICHIMURA M, 1987, Patent No. 217379; KACZMAREK E, 1993, J BIOL CHEM, V268, P2474; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARGOSSIAN SS, 1993, BIOCHIM BIOPHYS ACTA, V1163, P250, DOI 10.1016/0167-4838(93)90159-O; MARKUS G, 1978, J BIOL CHEM, V253, P733; NESHEIM M, 1990, J BIOL CHEM, V265, P21541; NIEUWENHUIZEN W, 1985, FIBRINOGEN STRUCTURA, P331; NOVOKHATNY VV, 1991, J BIOL CHEM, V266, P12994; NY T, 1984, P NATL ACAD SCI-BIOL, V81, P5355, DOI 10.1073/pnas.81.17.5355; PANNEKOEK H, 1990, THROMB HAEMOSTASIS, V64, P600; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; RADCLIFFE R, 1978, ARCH BIOCHEM BIOPHYS, V189, P185, DOI 10.1016/0003-9861(78)90131-5; RANBY M, 1982, BIOCHIM BIOPHYS ACTA, V704, P461, DOI 10.1016/0167-4838(82)90068-1; RAUBER P, 1988, ANAL BIOCHEM, V168, P259, DOI 10.1016/0003-2697(88)90316-8; RIJKEN DC, 1986, J BIOL CHEM, V261, P3098; Sambrook J, 1989, MOL CLONING LABORATO; THORSEN S, 1972, THROMB DIATH HAEMOST, V28, P65; VANZONNEVELD AJ, 1986, P NATL ACAD SCI USA, V83, P4670; VANZONNEVELD AJ, 1986, J BIOL CHEM, V261, P14214; VERHEIJEN JH, 1985, THROMB RES, V39, P281, DOI 10.1016/0049-3848(85)90223-3; VERHEIJEN JH, 1986, EMBO J, V5, P3525, DOI 10.1002/j.1460-2075.1986.tb04678.x; VERHEIJEN JH, 1982, THROMB RES, V27, P175; Wallen P., 1981, PROGR FIBRINOLYSIS, V5, P16; WEENINGVERHOEFF EJD, 1990, PROTEIN ENG, V4, P191, DOI 10.1093/protein/4.2.191	42	18	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12355	12360		10.1074/jbc.270.21.12355	http://dx.doi.org/10.1074/jbc.270.21.12355			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759476	hybrid, Green Submitted			2022-12-27	WOS:A1995QZ71100008
J	WADAKIYAMA, Y; KIYAMA, R				WADAKIYAMA, Y; KIYAMA, R			CONSERVATION AND PERIODICITY OF DNA BEND SITES IN THE HUMAN BETA-GLOBIN GENE LOCUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CURVED DNA; NUCLEOTIDE-SEQUENCES; PROTEIN-BINDING; TRANSCRIPTION; REPLICATION; RECOMBINATION; REGIONS; ORIGIN; GAMMA	A total of seven DNA bend sites were mapped in the 4.4-kilobase human beta-globin gene region by the circular permutation assay. The periodicity of these sites (except one) was about every 700 (average 685.5 +/- 267.7) base pairs. All of the sites contained the sequence feature of short poly(dA) tracts, which are typical of DNA bending. The relative positions of the sites to the cap site were identical to those in the E-globin gene region, suggesting that the bend sites were conserved during molecular evolution of the two globin genes. To explain this periodicity and conservation of the sites within the evolutionary unstable noncoding regions, we focused upon the appearance of a potential bend core sequence, A(2)N(8)A(2)N(8)A(2) (A/A/A), and its complement, T2N8T2N8T2 (T/T/T). These sequences appeared in or very close to most of the bend sites of the globin gene regions, whereas other A+T-rich sequences or candidates for DNA bending did not. The distances between any two of the core sequences in the entire beta-globin locus showed a strong bias to a length of about 700 base pairs and its multiples, suggesting that the periodicity exists throughout the locus. The data presented here strengthen the idea of sequence-directed nucleosome phasing.	UNIV TOKYO,INST MOLEC & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo	WADAKIYAMA, Y (corresponding author), NIPPON MED COLL,DEPT PHYSIOL,BUNKYO KU,TOKYO 113,JAPAN.							BODNAR JW, 1987, NUCLEIC ACIDS RES, V15, P1835, DOI 10.1093/nar/15.4.1835; BOSSI L, 1984, CELL, V39, P643, DOI 10.1016/0092-8674(84)90471-9; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; COLLINS F, 1984, PROG NUCLEIC ACID RE, V32, P315; COLLIS CM, 1989, NUCLEIC ACIDS RES, V17, P9447, DOI 10.1093/nar/17.22.9447; CONSTANZO G, 1990, J MOL BIOL, V216, P363; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FILIPSKI J, 1990, EMBO J, V9, P1319, DOI 10.1002/j.1460-2075.1990.tb08241.x; GOODMAN SD, 1989, NATURE, V341, P251, DOI 10.1038/341251a0; GROSVELD F, 1989, REGULATION HUMAN BET; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; HAGERMAN PJ, 1990, ANNU REV BIOCHEM, V59, P755, DOI 10.1146/annurev.biochem.59.1.755; HANSEN JC, 1991, J BIOL CHEM, V266, P4276; HUTCHISON N, 1985, CELL, V43, P471, DOI 10.1016/0092-8674(85)90177-1; IOSHIKHES I, 1992, J BIOMOL STRUCT DYN, V9, P1111, DOI 10.1080/07391102.1992.10507982; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; MAEDA N, 1983, P NATL ACAD SCI-BIOL, V80, P5012, DOI 10.1073/pnas.80.16.5012; MCALLISTER CF, 1988, J BIOL CHEM, V263, P11743; MUYLDERMANS S, 1994, J MOL BIOL, V235, P855, DOI 10.1006/jmbi.1994.1044; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; SCHROTH GP, 1992, J BIOL CHEM, V267, P9958; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; SNYDER M, 1986, NATURE, V326, P87; STAMATOYANNOPOU.G, 1987, MOL BASIS BLOOD DISE; STENZEL TT, 1987, CELL, V49, P709, DOI 10.1016/0092-8674(87)90547-2; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; WADAKIYAMA Y, 1994, J BIOL CHEM, V269, P22238; WALKER PR, 1986, J BIOL CHEM, V261, P7044; WILLIAMS JS, 1988, MOL CELL BIOL, V8, P2763, DOI 10.1128/MCB.8.7.2763; WOLFFE AP, 1989, P NATL ACAD SCI USA, V86, P9817, DOI 10.1073/pnas.86.24.9817; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; ZAHN K, 1987, SCIENCE, V236, P416, DOI 10.1126/science.2951850	37	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12439	12445		10.1074/jbc.270.21.12439	http://dx.doi.org/10.1074/jbc.270.21.12439			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759485	hybrid			2022-12-27	WOS:A1995QZ71100018
J	YAMAMOTO, YY; TSUJI, H; OBOKATA, J				YAMAMOTO, YY; TSUJI, H; OBOKATA, J			5'-LEADER OF A PHOTOSYSTEM-I GENE IN NICOTIANA-SYLVESTRIS, PSADB, CONTAINS A TRANSLATIONAL ENHANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-RESPONSIVE ELEMENT; FERRITIN MESSENGER-RNA; INTERNAL INITIATION; AUG CODONS; BINDING; EXPRESSION; PROTEIN; PLANTS; LEADER; SITE	Messenger RNA primary structures responsible for translational efficiency of a photosystem I gene, psaDb, of Nicotiana sylvestris were studied using a transgenic tobacco system. The entire 5'-leader (23 base pairs) with the first four amino acid codons of the protein coding region was fused in frame with the beta-glucuronidase (GUS) gene under the control of the 35 S promoter of cauliflower mosaic virus (CaMV). This construct (CaMV::psaDb-GUS') was introduced into tobacco. GUS activity and GUS mRNA levels were determined for individual transformants, revealing that the insertion of the psaDb sequence greatly enhanced the GUS activity relative to GUS mRNA abundance. The GUS activity/GUS mRNA was 14 times higher in the CaMV::psaDb-GUS' transformants than in the control CaMV::GUS' transformants. The high GUS activity/GUS mRNA of the CaMV::psaDb-GUS' transformants was reduced 20-fold when 13 bases within the psaDb leader were altered. These 13 bases are common to the leaders of an Arabidopsis ferredoxin gene and the psaDb gene of N. sylvestris. Since GUS proteins encoded by these chimeric GUS genes have identical amino acid sequences, these results indicate that the 5'-leader of the psaDb mRNA contains a translational enhancer element.	HOKKAIDO UNIV,GRAD SCH ENVIRONM EARTH SCI,DIV BIOL SCI,SAPPORO,HOKKAIDO 060,JAPAN; KOBE WOMENS UNIV,DEPT BIOL,KOBE,HYOGO 654,JAPAN	Hokkaido University			Yamamoto, Yoshiharu Y./B-6574-2011	Yamamoto, Yoshiharu Y./0000-0002-9667-0572				AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASPAR T, 1993, PLANT J, V3, P161, DOI 10.1111/j.1365-313X.1993.tb00019.x; CAUGHMAN SW, 1988, J BIOL CHEM, V263, P19048; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; GALLIE DR, 1993, ANNU REV PLANT PHYS, V44, P77, DOI 10.1146/annurev.pp.44.060193.000453; GIESE K, 1990, BIOCHEMISTRY-US, V29, P10562, DOI 10.1021/bi00498a020; GOLBECK JH, 1992, ANNU REV PLANT PHYS, V43, P293, DOI 10.1146/annurev.pp.43.060192.001453; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Horsch RB., 1988, PLANT MOL BIOL MANUA, DOI 10.1007/978-94-017-5294-7_5; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; JEFFERSON RA, 1987, EMBO J, V6, P3901; JOSHI CP, 1987, NUCLEIC ACIDS RES, V15, P6643, DOI 10.1093/nar/15.16.6643; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; OBOKATA J, 1990, PLANT PHYSIOL, V92, P273, DOI 10.1104/pp.92.1.273; OH SK, 1992, GENE DEV, V6, P1643, DOI 10.1101/gad.6.9.1643; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; TANG CK, 1992, J BIOL CHEM, V267, P24466; WAKIYAMA M, 1993, MOL GEN GENET, V238, P59, DOI 10.1007/BF00279531; WALDEN WE, 1988, P NATL ACAD SCI USA, V85, P9503, DOI 10.1073/pnas.85.24.9503; YAMAMOTO Y, 1993, PLANT MOL BIOL, V22, P985, DOI 10.1007/BF00028971	24	22	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12466	12470		10.1074/jbc.270.21.12466	http://dx.doi.org/10.1074/jbc.270.21.12466			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759489				2022-12-27	WOS:A1995QZ71100022
J	CORRINGER, PJ; GALZI, JL; EISELE, JL; BERTRAND, S; CHANGEUX, JP; BERTRAND, D				CORRINGER, PJ; GALZI, JL; EISELE, JL; BERTRAND, S; CHANGEUX, JP; BERTRAND, D			IDENTIFICATION OF A NEW COMPONENT OF THE AGONIST BINDING-SITE OF THE NICOTINIC ALPHA-7 HOMOOLIGOMERIC RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ACETYLCHOLINE-RECEPTOR; DELTA-SUBUNIT; LIGAND-BINDING; BUNGAROTOXIN; INTERFACES; CONTRIBUTE; MEMBRANES; RESIDUES	Tryptophan 54 of the alpha 7 neuronal nicotinic homooligomeric receptor is homologous to gamma-Trp-55 and delta-Trp-57 of non-alpha subunits of Torpedo receptor labeled by d-tubocurarine. This residue was mutated on the alpha 7-V201-5-hydrorrytryptamine (5HT)(3) homooligomeric chimera, which displays alpha 7 nicotinic pharmacology, and for which both equilibrium binding studies and electro physiological recordings could be carried out in parallel. Replacement of Trp-54 by a Phe, Ala, or His causes a progressive decrease both in binding affinity and in responses (EC(50) or IC50) for acetylcholine, nicotine, and dihydro-beta-erythroidine, without significant modification in alpha-Bgtx binding. Except for Gln-56, comparatively small effects are observed when the other residues of the 52-58 region are mutated into alanine. These data support the participation of Trp-54 to ligand binding, and provide evidence for a new ''complementary component'' of the alpha 7 nicotinic binding site, distinct from its three-loop ''principal component,'' and homologous to the ''non-alpha component'' present on gamma and delta subunits.	INST PASTEUR,CNRS,URA D1284,F-75724 PARIS 15,FRANCE; UNIV GENEVA,FAC MED,MED CTR,DEPT PHYSIOL,CH-1211 GENEVA 4,SWITZERLAND	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Geneva								ANAND R, 1993, FEBS LETT, V327, P241, DOI 10.1016/0014-5793(93)80177-V; Bertrand D, 1991, METHODS NEUROSCIENCE, V4, P174; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COCKCROFT VB, 1992, MOL NEUROBIOL, V4, P129; COHEN JB, 1992, J CELL BIOCH E, V16, P217; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; COUTURIER S, 1990, NEURON, V5, P845; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; GALZI JL, 1991, P NATL ACAD SCI USA, V88, P5051, DOI 10.1073/pnas.88.11.5051; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GALZI JL, 1994, CURR OPIN STRUC BIOL, V4, P554, DOI 10.1016/S0959-440X(94)90218-6; HUSSY N, 1994, J NEUROPHYSIOL, V72, P1317, DOI 10.1152/jn.1994.72.3.1317; KREIENKAMP HJ, 1995, IN PRESS NEURON; LUETJE CW, 1991, J NEUROSCI, V11, P837; NEUBIG RR, 1979, BIOCHEMISTRY-US, V18, P5464, DOI 10.1021/bi00591a032; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; OSWALD RE, 1982, FEBS LETT, V139, P225, DOI 10.1016/0014-5793(82)80857-0; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SEGUELA P, 1993, J NEUROSCI, V13, P596; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SMITH GB, 1994, J BIOL CHEM, V269, P20388; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; THOM D, 1977, BIOCHEM J, V168, P187, DOI 10.1042/bj1680187; WEBER M, 1974, MOL PHARMACOL, V10, P1; WEBER M, 1974, MOL PHARMACOL, V10, P13	31	123	124	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11749	11752		10.1074/jbc.270.20.11749	http://dx.doi.org/10.1074/jbc.270.20.11749			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744821	hybrid, Green Submitted			2022-12-27	WOS:A1995QY73600013
J	HUSSAIN, A; GARNETT, C; KLEIN, MG; TSAIWU, JJ; SCHNEIDER, MF; INESI, G				HUSSAIN, A; GARNETT, C; KLEIN, MG; TSAIWU, JJ; SCHNEIDER, MF; INESI, G			DIRECT INVOLVEMENT OF INTRACELLULAR CA2+ TRANSPORT ATPASE IN THE DEVELOPMENT OF THAPSIGARGIN RESISTANCE BY CHINESE-HAMSTER LUNG FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; INHIBITION; CELLS; CA-2+-ATPASE; CA2+-ATPASE; EXPRESSION; PUMP	Thapsigargin (TG), a specific inhibitor of intracellular Ca2+ transport ATPases (SERCA), inhibits cell proliferation when added to culture media in the nanomolar concentration range, However, long term exposure to gradually increasing concentrations of TG induces resistance to TG inhibition in both the parental Chinese hamster lung fibroblast DC-3F and a subline derived from it via transfection and stable expression of a full-length cDNA encoding avian SERCA1 ATPase (DC-3F/Ca cells), TG resistance develops in parallel with selection of cells expressing higher levels of the endogenous SERCA2 as well as of the exogenous transfected SERCA1 ATPase, whose Ca2+ transport function can be studied in situ by imaging techniques and following isolation in microsomal fractions, Microsomes isolated from resistant cells contain two functionally distinct populations of ATPases: a population that is inhibited by stoichiometric titration with TG, and a population displaying resistance to inhibition even when TG exceeds the enzyme stoichiometry, It is apparent that resistance to TG develops in parallel with (a) selection of cells expressing high levels of SERCA ATPases, and (b) selection of an ATPase that is resistant to TG.	UNIV MARYLAND,CTR CANC,SCH MED,DEPT MED,DIV ONCOL,BALTIMORE,MD; VET ADM MED CTR,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA)	HUSSAIN, A (corresponding author), UNIV MARYLAND,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21201, USA.			Garnett, Christine/0000-0002-4108-2511	NHLBI NIH HHS [HL27867] Funding Source: Medline; NINDS NIH HHS [NS33578] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL027867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033578] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIAN JH, 1991, J BIOL CHEM, V266, P8801; BIEDLER JL, 1970, CANCER RES, V30, P1174; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; Gill Donald L., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P265; GUTHEIL JC, 1994, J BIOL CHEM, V269, P7976; HUSSAIN A, 1992, ARCH BIOCHEM BIOPHYS, V296, P539, DOI 10.1016/0003-9861(92)90608-Y; INESI G, 1994, J MEMBRANE BIOL, V141, P1; JORGENSEN AO, 1988, CELL MOTIL CYTOSKEL, V9, P164, DOI 10.1002/cm.970090208; KARIN NJ, 1989, MOL CELL BIOL, V9, P1978, DOI 10.1128/MCB.9.5.1978; KIJIMA Y, 1991, J BIOL CHEM, V266, P22912; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LYTTON J, 1991, J BIOL CHEM, V266, P17067; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SHORT AD, 1993, J BIOL CHEM, V268, P25887; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; SUMBILLA C, 1993, J BIOL CHEM, V268, P21185; TAO JG, 1992, J BIOL CHEM, V267, P24972; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; WALDRON RT, 1994, FASEB J, V8, pA1416	20	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12140	12146		10.1074/jbc.270.20.12140	http://dx.doi.org/10.1074/jbc.270.20.12140			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744863	hybrid			2022-12-27	WOS:A1995QY73600066
J	KANNO, T; BROWN, K; SIEBENLIST, U				KANNO, T; BROWN, K; SIEBENLIST, U			EVIDENCE IN SUPPORT OF A ROLE FOR HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I TAX IN ACTIVATING NF-KAPPA-B VIA STIMULATION OF SIGNALING PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HTLV-I; P50	The human T-cell leukemia virus type I Tax protein activates NF-kappa B transcription factors from preformed cytoplasmic pools, including those pools that are retained by the I kappa B-alpha inhibitory protein. Degradation of I kappa B-alpha is enhanced by Tax, resulting in the liberation of some NF-kappa B, which then translocates into the nucleus. Here we have investigated the mechanism by which Tax causes degradation of I kappa B-alpha. Two I kappa B-alpha mutants defective in extracellular signal induced degradation of I kappa B-alpha also blocked Tax-mediated kappa B-dependent transactivation when cotransfected into Jurkat T cells. Cotransfected wild-type I kappa B-alpha or an irrelevant mutant did not significantly effect transactivation induced by Tax. The signal-defective I kappa B-alpha proteins are mutated at either of two closely spaced serines in the N terminus of the protein (Ser(32) and Ser(36)). In wild-type I kappa B-alpha one or both of these serines are inducibly phosphorylated with extracellular stimuli, and such phosphorylation appears necessary for subsequent degradation and thus activation of NF-kappa B. These results suggest that Tax triggers I kappa B-alpha degradation and thus NF-kappa B activation by a mechanism that converges with that induced by extracellular stimulation such as phorbol 12-myristate 13-acetate/ionomycin or tumor necrosis factor alpha. A role for Tax in activating signal transduction pathways upstream of I kappa B-alpha is implied.	NIAID,IMMUNOREGULAT LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; HIRAI H, 1994, P NATL ACAD SCI USA, V1, P3584; KANNO T, 1994, MOL CELL BIOL, V14, P6443, DOI 10.1128/MCB.14.10.6443; KANNO T, 1994, P NATL ACAD SCI USA, V91, P12634, DOI 10.1073/pnas.91.26.12634; LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552; MUNOZ E, 1994, J VIROL, V68, P8035; SCHRECK R, 1992, J VIROL, V66, P6288, DOI 10.1128/JVI.66.11.6288-6293.1992; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SMITH MR, 1991, J CLIN INVEST, V87, P761, DOI 10.1172/JCI115078; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; WATANABE M, 1993, ONCOGENE, V8, P2949	15	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					11745	11748		10.1074/jbc.270.20.11745	http://dx.doi.org/10.1074/jbc.270.20.11745			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744820	hybrid			2022-12-27	WOS:A1995QY73600012
J	SALVATI, AL; LAHM, A; PAONESSA, G; CILIBERTO, G; TONIATTI, C				SALVATI, AL; LAHM, A; PAONESSA, G; CILIBERTO, G; TONIATTI, C			INTERLEUKIN-6 (IL-6) ANTAGONISM BY SOLUBLE IL-6 RECEPTOR-ALPHA MUTATED IN THE PREDICTED GP130-BINDING INTERFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROWTH-HORMONE; SIGNAL TRANSDUCER; MOLECULAR-CLONING; ESCHERICHIA-COLI; GENERAL-METHOD; EXPRESSION; GP130; PURIFICATION; PROTEIN; PROGRAM	Interleukin-6 (IL-6) triggers the formation of a high affinity receptor complex constituted by the ligand-binding subunit IL-6 receptor alpha (IL-6R alpha) and the signal-transducing beta chain gp130. Since the cytoplasmic region of IL-6R alpha is not required for signal transduction, soluble forms of IL-6R alpha (sIL-6R alpha) show agonistic properties because they are still able to originate IL-6 . sIL-6R alpha complexes, which in turn associate with gp130. A three-dimensional model of the human IL-6 . IL-6R alpha . gp130 complex has been constructed and verified by site-directed mutagenesis of regions in shIL-6R alpha (where ''h'' is human) anticipated to contact hgp130, with the final goal of generating receptor variants with antagonistic properties. In good agreement with our structural model, substitutions at Asn-230, His-280, and Asp-281 selectively impaired the capability of shIL-6R alpha to associate with hgp130 both in vitro and on the cell surface, without affecting its affinity for hIL-6. Moreover, the multiple substitution mutant A228D/N230D/H280S/D281V expressed as a soluble protein partially antagonized hIL-6 bioactivity on hepatoma cells.	IST RIC BIOL MOLEC P ANGELETTI,DEPT BIOCOMP,I-00040 POMEZIA,ITALY		SALVATI, AL (corresponding author), IST RIC BIOL MOLEC P ANGELETTI,DEPT GENET,VIA PONTINA KM 30600,I-00040 POMEZIA,ITALY.		Ciliberto, Gennaro/J-4131-2017	Ciliberto, Gennaro/0000-0003-2851-8605				AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ARCONE R, 1991, EUR J BIOCHEM, V198, P541, DOI 10.1111/j.1432-1033.1991.tb16048.x; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BECK JT, 1994, NEW ENGL J MED, V330, P602, DOI 10.1056/NEJM199403033300904; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; DAYRINGER HE, 1986, J MOL GRAPHICS, V4, P82; DEHON FD, 1994, J EXP MED, V180, P2395, DOI 10.1084/jem.180.6.2395; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DUQUESNOY P, 1994, EMBO J, V13, P1386, DOI 10.1002/j.1460-2075.1994.tb06392.x; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FIORILLO MT, 1992, EUR J IMMUNOL, V22, P799, DOI 10.1002/eji.1830220325; FISCHMANN TO, 1991, J BIOL CHEM, V266, P12915; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; HEREMANS H, 1992, EUR J IMMUNOL, V22, P2395, DOI 10.1002/eji.1830220932; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KLEIN B, 1991, BLOOD, V78, P1198; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LEEBEEK FWG, 1992, J BIOL CHEM, V267, P14832; LEHAY DJ, 1992, SCIENCE, V258, P987; LU ZY, 1992, EUR J IMMUNOL, V22, P2819, DOI 10.1002/eji.1830221110; LUTTICKEN C, 1994, SCIENCE, V263, P86; MULLBERG J, 1993, FEBS LETT, V332, P174, DOI 10.1016/0014-5793(93)80507-Q; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, 1993, SCIENCE, V269, P1808; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; SATO N, 1994, CURR OPIN CELL BIOL, V6, P174, DOI 10.1016/0955-0674(94)90133-3; SAVINO R, 1994, EMBO J, V13, P5863, DOI 10.1002/j.1460-2075.1994.tb06931.x; SAVINO R, 1994, EMBO J, V13, P1357, DOI 10.1002/j.1460-2075.1994.tb06389.x; SAVINO R, 1992, P NATL ACAD SCI USA, V90, P4067; SCHWABE M, 1994, J BIOL CHEM, V269, P7201; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SITES WE, 1991, J MOL BIOL, V221, P7; SPORENO E, 1994, J BIOL CHEM, V269, P10991; SPORENO E, 1994, CYTOKINE, V6, P255, DOI 10.1016/1043-4666(94)90021-3; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; STOYAN T, 1993, EUR J BIOCHEM, V216, P239, DOI 10.1111/j.1432-1033.1993.tb18138.x; SUGITA T, 1990, J EXP MED, V171, P2001, DOI 10.1084/jem.171.6.2001; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WELLS JA, 1994, CURR OPIN CELL BIOL, V6, P163, DOI 10.1016/0955-0674(94)90132-5; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; YASUKAWA K, 1992, IMMUNOL LETT, V151, P2555; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	52	36	40	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12242	12249		10.1074/jbc.270.20.12242	http://dx.doi.org/10.1074/jbc.270.20.12242			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744875	hybrid			2022-12-27	WOS:A1995QY73600080
J	SVENSSON, LT; ALEXSON, SEH; HILTUNEN, JK				SVENSSON, LT; ALEXSON, SEH; HILTUNEN, JK			VERY LONG-CHAIN AND LONG-CHAIN ACYL-COA THIOESTERASES IN RAT-LIVER MITOCHONDRIA - IDENTIFICATION, PURIFICATION, CHARACTERIZATION, AND INDUCTION BY PEROXISOME PROLIFERATORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE MITOCHONDRIA; BETA-OXIDATION ENZYMES; FATTY-ACID OXIDATION; PALMITOYL-COENZYME; HYDROLASE ACTIVITY; CLOFIBRATE; PROTEIN; CARBOXYLESTERASE; FRACTIONS; CARNITINE	We have previously reported that long chain acyl-CoA thioesterase activity was induced about 10-fold in rat liver mitochondria, when treating rats with the peroxisome proliferator di(2-ehtylhexyl)phtalate (Wilcke M., and Alexson S. E. H (1994) Eur. J. Biochem. 222, 803-811). Here we have characterized two enzymes which are responsible for the majority of long chain acyl-CoA thioesterase activity in mitochondria from animals treated with peroxisome proliferators. A 40-kDa enzyme was purified and characterized as a very long chain acyl-CoA thioesterase (MTE-I). The second enzyme was partially purified and characterized as a long chain acyl-CoA thioesterase (MTE-II). MTE-I was inhibited by p-chloromercuribenzoic acid, which implicates the importance of a cysteine residue in, or close, to the active site. Antibodies against MTE-I demonstrated the presence of immunologically related acyl-CoA thioesterases in peroxisomes and cytosol, High expression of MTE-I was found in liver from peroxisome proliferator treated rats and in heart and brown fat from control and induced rats. Comparison of physical and catalytical characteristics of the enzymes studied here and previously purified acyl-CoA thioesterases suggest that MTE-I and MTE-II are novel enzymes.	KAROLINSKA INST, HUDDINGE UNIV HOSP, DEPT MED LAB SCI & TECHNOL, S-14186 HUDDINGE, SWEDEN; UNIV STOCKHOLM, WENNER GREN INST, DEPT METAB RES, ARRHENIUS LABS F3, S-10691 STOCKHOLM, SWEDEN; UNIV OULU, BIOCTR, DEPT MED BIOCHEM, SF-90220 OULU, FINLAND; KUOPIO UNIV, DEPT BIOCHEM & BIOTECHNOL, SF-70211 KUOPIO, FINLAND	Karolinska Institutet; Stockholm University; University of Oulu; University of Eastern Finland				Svensson, Thomas/0000-0002-9190-2979				ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; ALEXSON SEH, 1989, BIOCHIM BIOPHYS ACTA, V1005, P13, DOI 10.1016/0005-2760(89)90025-8; ALEXSON SEH, 1985, BIOCHIM BIOPHYS ACTA, V834, P149, DOI 10.1016/0005-2760(85)90150-X; ALEXSON SEH, 1993, EUR J BIOCHEM, V214, P719, DOI 10.1111/j.1432-1033.1993.tb17973.x; ALEXSON SEH, 1989, BIOCHEM J, V262, P41, DOI 10.1042/bj2620041; BAKKE OM, 1982, BIOCHEM PHARMACOL, V31, P3930, DOI 10.1016/0006-2952(82)90313-6; BERGE RK, 1983, INT J BIOCHEM, V15, P191, DOI 10.1016/0020-711X(83)90065-4; BERGE RK, 1979, EUR J BIOCHEM, V96, P393, DOI 10.1111/j.1432-1033.1979.tb13051.x; BERGE RK, 1979, BIOCHIM BIOPHYS ACTA, V574, P321, DOI 10.1016/0005-2760(79)90013-4; BERGE RK, 1984, EUR J BIOCHEM, V141, P637, DOI 10.1111/j.1432-1033.1984.tb08239.x; BERGE RK, 1981, FEBS LETT, V124, P43, DOI 10.1016/0014-5793(81)80050-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; COOPER HM, 1989, CURRENT PROTOCOLS MO, V2; GROSS RW, 1983, BIOCHEMISTRY-US, V22, P5641, DOI 10.1021/bi00293a028; HAKKOLA EH, 1989, J HISTOCHEM CYTOCHEM, V37, P1863, DOI 10.1177/37.12.2584694; HASHIMOTO T, 1982, ANN NY ACAD SCI, V386, P5, DOI 10.1111/j.1749-6632.1982.tb21403.x; HESS R, 1965, NATURE, V208, P856, DOI 10.1038/208856a0; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; IZAI K, 1992, J BIOL CHEM, V267, P1027; KAWASHIMA Y, 1981, J PHARMACOBIO-DYNAM, V4, P711, DOI 10.1248/bpb1978.4.711; KELLER H, 1993, ANN NY ACAD SCI, V684, P157, DOI 10.1111/j.1749-6632.1993.tb32279.x; KNAUER TE, 1979, BIOCHEM J, V179, P515, DOI 10.1042/bj1790515; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROW PB, 1977, SCIENCE, V197, P580, DOI 10.1126/science.195342; LEE KY, 1979, J BIOL CHEM, V254, P4516; LIN AY, 1984, NEUROCHEM RES, V9, P1571, DOI 10.1007/BF00964592; MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585; MANNAERTS GP, 1978, BIOCHIM BIOPHYS ACTA, V529, P201, DOI 10.1016/0005-2760(78)90063-2; MENTLEIN R, 1986, BIOCHEM PHARMACOL, V35, P2727, DOI 10.1016/0006-2952(86)90181-4; MENTLEIN R, 1985, BIOCHEM J, V232, P479, DOI 10.1042/bj2320479; MIYAZAWA S, 1981, EUR J BIOCHEM, V117, P425, DOI 10.1111/j.1432-1033.1981.tb06356.x; MOHAN PF, 1989, J NUTR, V119, P496, DOI 10.1093/jn/119.3.496; NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369; PALOSAARI PM, 1990, J BIOL CHEM, V265, P3347; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; VOLTTI H, 1979, BIOCHEM J, V182, P95, DOI 10.1042/bj1820095; WAKU K, 1992, BIOCHIM BIOPHYS ACTA, V1124, P101, DOI 10.1016/0005-2760(92)90085-A; WILCKE M, 1994, EUR J BIOCHEM, V222, P803, DOI 10.1111/j.1432-1033.1994.tb18927.x; YAMADA J, 1994, ARCH BIOCHEM BIOPHYS, V308, P118, DOI 10.1006/abbi.1994.1017	43	66	67	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12177	12183		10.1074/jbc.270.20.12177	http://dx.doi.org/10.1074/jbc.270.20.12177			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744868	hybrid			2022-12-27	WOS:A1995QY73600071
J	WARD, SG; MILLS, SJ; LIU, CS; WESTWICK, J; POTTER, BVL				WARD, SG; MILLS, SJ; LIU, CS; WESTWICK, J; POTTER, BVL			D-MYO-INOSITOL 1,4,5-TRISPHOSPHATE ANALOGS MODIFIED AT THE 3-POSITION INHIBIT PHOSPHATIDYLINOSITOL 3-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D ACTIVATION; MYOINOSITOL 1,4,5-TRISPHOSPHATE; TYROSINE KINASES; HUMAN NEUTROPHIL; RAT-BRAIN; RECEPTOR; WORTMANNIN; PURIFICATION; ENZYMES; POTENT	Several natural and unnatural inositol phosphates and analogues were analyzed for their ability to inhibit the in vitro phosphatidylinositol 3-kinase (PI 3-kinase) activity immunoprecipitated from a leukemic T cell line by a p85 monoclonal antibody. A 3-position ring-modified analogue of D-myo-inositol 1,4,5-trisphosphate (Ins(1,4,5)P-3), L-chiro-inositol 2,3,5-trisphosphate (L-chiro-Ins(2,3,5)P-3) and its phosphorothioate analogue, L-chiro-inositol 2,3,5-trisphosphorothioate, as well as the analogue benzene 1,2,4-trisphosphate induced reversible inhibition of PI 3-kinase activity, which correlated with decreased V-max but unchanged K-m values for PI 3-kinase. Other inositol phosphates, including D- and L-Ins(1,4,5)P-3, D-myo-inositol 1,3,4,5-tetrakisphosphate, the enantiomers of myo-inositol 1,3,4-trisphosphate DL-myo-inositol 1,4,6 trisphosphate (DL-Ins(1,4,6)P-3), and DL-scyllo-inositol 1,2,4-trisphosphate (DL-scyllo-Ins(1,2,4)P-3), did not inhibit PI 3-kinase activity under identical conditions. L-chiro-Ins(2,3,5)P-3 closely resembles Ins(1,4,5)P-3 and D-Ins(1,4,6)P-3 except for a difference in the orientation of a single hydroxyl group at either the equivalent 3-OH or 2-OH position of Ins(1,4,5)P-3, respectively. Similarly, L-chiro-Ins(2,3,5)P-3 resembles D-scyllo-Ins(1,2,4)P-3, but has a different orientation of both the equivalent 3-OH and 2-OH positions. Since Ins(1,4,5)P-3, DL-Ins(1,4,6)P-3, and DL-scyllo-Ins(1,2,4)P-3 did not inhibit PI 3-kinase activity, this suggests that the orientation of the two hydroxyl groups at the 2- and 3-positions plays a pivotal role in the inhibitory action of inositol phosphate analogues on PI 3-kinase activity. Thus, inositol phosphate analogues inter alia are shown for the first time to inhibit PI 3-kinase and may be useful tools for determining the function of PI 3-kinase and its substrate binding specificities.			WARD, SG (corresponding author), UNIV BATH,SCH PHARM & PHARMACOL,CLAVERTON DOWN,BATH BA2 7AY,AVON,ENGLAND.		Potter, Barry/AAX-4781-2020; Potter, Barry VL/A-1845-2012; Ward, Stephen/AAE-4341-2020	Ward, Stephen G./0000-0002-6795-6002	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALHAFIDH J, 1994, BRIT J PHARMACOL, V112, pP220; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BONSER RW, 1991, BRIT J PHARMACOL, V103, P1237, DOI 10.1111/j.1476-5381.1991.tb12330.x; BRIGGS AP, 1992, J BIOL CHEM, V53, P13; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; COMMUNI D, 1994, BIOCHEM J, V298, P669, DOI 10.1042/bj2980669; COOKE AM, 1987, BIOCHEM SOC T, V15, P904, DOI 10.1042/bst0150904; COOKE AM, 1989, FEBS LETT, V242, P373, DOI 10.1016/0014-5793(89)80504-6; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; FOSTER PS, 1994, EUR J BIOCHEM, V222, P955, DOI 10.1111/j.1432-1033.1994.tb18946.x; GELAS P, 1992, BIOCHEM J, V287, P67, DOI 10.1042/bj2870067; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; HIRATA M, 1993, J BIOL CHEM, V268, P19260; JOHANSON RA, 1988, J BIOL CHEM, V263, P7465; LAMPE D, 1993, TETRAHEDRON LETT, V34, P2365, DOI 10.1016/S0040-4039(00)77615-5; LAMPE D, 1994, J MED CHEM, V37, P907, DOI 10.1021/jm00033a007; LEE SY, 1990, J BIOL CHEM, V265, P9434; Liu C, 1994, Bioorg Med Chem, V2, P253, DOI 10.1016/S0968-0896(00)82168-9; LIU CS, 1992, BIOORG MED CHEM LETT, V2, P1523, DOI 10.1016/S0960-894X(00)80421-7; LIU CS, 1994, TETRAHEDRON LETT, V35, P8457, DOI 10.1016/S0040-4039(00)74432-7; LIU CS, 1992, CARBOHYD RES, V234, P107, DOI 10.1016/0008-6215(92)85042-X; MATTER WF, 1994, BIOCHEM BIOPH RES CO, V186, P5241; MILLS SJ, 1993, BIOORG MED CHEM LETT, V3, P1505, DOI 10.1016/S0960-894X(00)80007-4; MILLS SJ, 1993, BIOORG MED CHEM LETT, V3, P2599, DOI 10.1016/S0960-894X(01)80723-X; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; POITRAS M, 1993, EUR J PHARM-MOLEC PH, V244, P203, DOI 10.1016/0922-4106(93)90145-Y; Potter Barry V. L., 1993, P383; Price N.C., 1989, FUNDAMENTALS ENZYMOL; RHEINHOLD SL, 1990, FASEB J, V4, P208; RILEY AM, 1994, J MED CHEM, V37, P3918, DOI 10.1021/jm00049a011; SAFRANY ST, 1994, BIOCHEMISTRY-US, V33, P10763, DOI 10.1021/bi00201a025; SAFRANY ST, 1993, MOL PHARMACOL, V43, P499; SAFRANY ST, 1992, EUR J PHARM-MOLEC PH, V226, P265, DOI 10.1016/0922-4106(92)90071-3; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; TAKAZAWA K, 1990, BIOCHEM J, V261, P483; THELEN M, 1994, P NATL ACAD SCI USA, V91, P4960, DOI 10.1073/pnas.91.11.4960; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WARD SG, 1993, EUR J IMMUNOL, V23, P2572, DOI 10.1002/eji.1830231029; WARD SG, 1992, J BIOL CHEM, V267, P23862; WARD SG, 1990, J IMMUNOL, V144, P3523; WARD SG, 1994, EUR J BIOCHEM, V222, P515, DOI 10.1111/j.1432-1033.1994.tb18893.x; WHITMAN M, 1987, BIOCHEM J, V247, P165, DOI 10.1042/bj2470165; WILCOX RA, 1994, EUR J BIOCHEM, V223, P115, DOI 10.1111/j.1432-1033.1994.tb18972.x; WOSCHOLSKI R, 1994, FEBS LETT, V342, P109, DOI 10.1016/0014-5793(94)80482-6; WYMANN M, 1994, BIOCHEM J, V298, P517, DOI 10.1042/bj2980517; YAMAGUCHI K, 1988, BIOCHEM J, V251, P129, DOI 10.1042/bj2510129; YANO H, 1993, J BIOL CHEM, V268, P25846	52	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12075	12084		10.1074/jbc.270.20.12075	http://dx.doi.org/10.1074/jbc.270.20.12075			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744856	hybrid			2022-12-27	WOS:A1995QY73600058
J	COSTANZO, G; DIMAURO, E; NEGRI, R; PEREIRA, G; HOLLENBERG, C				COSTANZO, G; DIMAURO, E; NEGRI, R; PEREIRA, G; HOLLENBERG, C			MULTIPLE OVERLAPPING POSITIONS OF NUCLEOSOMES WITH SINGLE IN-VIVO ROTATIONAL SETTING IN THE HANSENULA-POLYMORPHA RNA-POLYMERASE-II MOX PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; CHROMATIN STRUCTURE; METHANOL OXIDASE; PHO5 PROMOTER; IN-VITRO; DNASE-I; YEAST; SEQUENCE; CORE	In vivo nucleotide level mapping of nucleosomes in the promoter of the methanol oxidase (MOX) gene in the yeast Hansenula polymorpha is reported. The 4 nucleosomes analyzed are organized in families; they localize in alternative positions along a unique rotational phase, and the linker regions can be occupied by alternative nucleosomes. This organization underscores a substantial freedom of choice by histone octamers when nucleating on a promoter region.	UNIV ROMA LA SAPIENZA, DIPARTIMENTO GENET & BIOL MOLEC, FDN IST PASTEUR FDN CENCI BOLOGNETTI, I-00185 ROME, ITALY; UNIV DUSSELDORF, INST MICROBIOL, D-40225 DUSSELDORF, GERMANY	Sapienza University Rome; Heinrich Heine University Dusseldorf	COSTANZO, G (corresponding author), CNR, CTR STUDIO ACIDI NUCL, I-00185 ROME, ITALY.							ADAMS CC, 1993, CELL, V72, P305, DOI 10.1016/0092-8674(93)90109-4; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; ALMER A, 1986, EMBO J, V5, P2681, DOI 10.1002/j.1460-2075.1986.tb04551.x; BLOOM KS, 1984, J CELL BIOL, V99, P1559, DOI 10.1083/jcb.99.5.1559; BUCKLE R, 1991, NUCLEIC ACIDS RES, V19, P1219, DOI 10.1093/nar/19.6.1219; BUTTINELLI M, 1993, P NATL ACAD SCI USA, V90, P9315, DOI 10.1073/pnas.90.20.9315; CARR KD, 1990, P NATL ACAD SCI USA, V87, P9300, DOI 10.1073/pnas.87.23.9300; CLARK DJ, 1992, CELL, V71, P11, DOI 10.1016/0092-8674(92)90262-B; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; COSTANZO G, 1990, J MOL BIOL, V216, P363, DOI 10.1016/S0022-2836(05)80327-4; FASCHER KD, 1990, EMBO J, V9, P2523, DOI 10.1002/j.1460-2075.1990.tb07432.x; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; FREEMAN L A, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P165; GEORGEL P, 1993, J MOL BIOL, V234, P319, DOI 10.1006/jmbi.1993.1589; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; GODECKE S, 1994, GENE, V139, P35, DOI 10.1016/0378-1119(94)90520-7; GODECKE S, 1991, THESIS U DUSSELDORF; GOTTSCHLING DE, 1984, CELL, V38, P501, DOI 10.1016/0092-8674(84)90505-1; HSIEH CH, 1988, CELL, V52, P535, DOI 10.1016/0092-8674(88)90466-7; LEDEBOER AM, 1985, NUCLEIC ACIDS RES, V13, P3063, DOI 10.1093/nar/13.9.3063; LEE MS, 1991, EMBO J, V10, P607, DOI 10.1002/j.1460-2075.1991.tb07988.x; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; LOSA R, 1987, CELL, V50, P801, DOI 10.1016/0092-8674(87)90338-2; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; NEGRI R, 1989, J MOL BIOL, V207, P615, DOI 10.1016/0022-2836(89)90469-5; NEGRI R, 1994, BIOPHYS CHEM, V50, P169, DOI 10.1016/0301-4622(94)85029-1; ODONOHUE MF, 1994, NUCLEIC ACIDS RES, V22, P937, DOI 10.1093/nar/22.6.937; ONEILL TE, 1993, P NATL ACAD SCI USA, V90, P6203, DOI 10.1073/pnas.90.13.6203; PATTERTON HG, 1993, J MOL BIOL, V229, P637, DOI 10.1006/jmbi.1993.1069; PENNINGS S, 1989, J MOL BIOL, V207, P183, DOI 10.1016/0022-2836(89)90449-X; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; PINA B, 1990, J MOL BIOL, V216, P975, DOI 10.1016/S0022-2836(99)80015-1; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; ROGGENKAMP R, 1984, MOL GEN GENET, V194, P489, DOI 10.1007/BF00425563; ROTH SY, 1990, MOL CELL BIOL, V10, P2247, DOI 10.1128/MCB.10.5.2247; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; SATCHWELL SC, 1989, EMBO J, V8, P229, DOI 10.1002/j.1460-2075.1989.tb03368.x; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; THOMA F, 1992, BIOCHIM BIOPHYS ACTA, V1130, P1, DOI 10.1016/0167-4781(92)90455-9; Travers A., 1993, DNA PROTEIN INTERACT, P1; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; TURNELL WG, 1992, METHOD ENZYMOL, V212, P387; van Holde K.E., 1988, CHROMATIN; VANHOLDE K, 1993, NATURE, V362, P111, DOI 10.1038/362111a0; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; VEENHUIS M, 1983, ADV MICROB PHYSIOL, V24, P1, DOI 10.1016/S0065-2911(08)60384-7; VENDITTI P, 1994, BBA-GENE STRUCT EXPR, V1219, P677, DOI 10.1016/0167-4781(94)90227-5; VENDITTI S, 1994, MOL GEN GENET, V242, P100, DOI 10.1007/BF00277353; WOLFFE AP, 1986, CELL, V44, P381, DOI 10.1016/0092-8674(86)90459-9; WORKMAN JL, 1991, CELL, V64, P533, DOI 10.1016/0092-8674(91)90237-S; WORKMAN JL, 1990, EMBO J, V9, P1299, DOI 10.1002/j.1460-2075.1990.tb08239.x; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; YENIDUNYA A, 1994, J MOL BIOL, V237, P401, DOI 10.1006/jmbi.1994.1243; ZIVANOVIC Y, 1988, J MOL BIOL, V200, P287	58	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11091	11097		10.1074/jbc.270.19.11091	http://dx.doi.org/10.1074/jbc.270.19.11091			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744739	hybrid			2022-12-27	WOS:A1995QX86500014
J	GRUNWALD, R; MEISSNER, G				GRUNWALD, R; MEISSNER, G			LUMENAL SITES AND C-TERMINUS ACCESSIBILITY OF THE SKELETAL-MUSCLE CALCIUM-RELEASE CHANNEL (RYANODINE RECEPTOR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL SARCOPLASMIC-RETICULUM; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CA-2+-INDUCED CA-2+ RELEASE; BIOCHEMICAL-CHARACTERIZATION; FUNCTIONAL-CHARACTERIZATION; POLYACRYLAMIDE GELS; EXPRESSION VECTORS; RABBIT BRAIN; PROTEIN; COMPLEX	The membrane topology of the skeletal muscle ryanodine receptor (RyR1) was investigated using site-directed antibodies directed against amino acid sequences 2804-2930, 4581-4640, 4860-4886, and 4941-5037, Ab(2804-2930) bound with identical affinity to either closed or permeabilized sarcoplasmic reticulum vesicles, confirming the cytoplasmic location of this segment. Ab(4581-4640) did not bind to closed vesicles but bound well to permeabilized vesicles, supporting a lumenal location for this segment. Ab(4860-4886) did not bind to closed vesicles but exhibited weak binding to the permeabilized vesicles, suggesting that a portion of the epitope may be exposed on the lumenal surface. The C-terminal antibody (Ab(4941-5037)) bound weakly to closed vesicles, and binding was not significantly enhanced by permeabilizing vesicles with low concentrations of non-denaturing detergent. However, the C-terminal antibodies bound efficiently to vesicles which were transiently incubated at alkaline pH or subjected to trypsinolysis, conditions where few of the vesicles were permeabilized. These results support a model for the membrane topology of the ryanodine receptor as proposed by Takeshima et al. (Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa, K., Minamino, N., Matsuo, H., Ueda, M., Hanaoka, M., Hirose, T., and Numa, S. (1989) Nature 339, 439-445). The results also suggest that the native conformation of the C terminus is inaccessible to antibodies.	UNIV N CAROLINA, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill					NIAMS NIH HHS [AR18687] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018687, R37AR018687] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSON K, 1989, J BIOL CHEM, V264, P1329; BRANDT NR, 1992, J MEMBRANE BIOL, V127, P35; CALLAWAY C, 1994, J BIOL CHEM, V269, P15876; CHEN SRW, 1993, J BIOL CHEM, V268, P13414; CHEN SRW, 1993, J BIOL CHEM, V268, P22642; CHOI ESH, 1990, DEV BIOL, V142, P169, DOI 10.1016/0012-1606(90)90160-K; CHU A, 1988, BIOCHEMISTRY-US, V27, P2827, DOI 10.1021/bi00408a025; CLARKE DM, 1990, J BIOL CHEM, V265, P17405; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; COSTELLO B, 1986, J CELL BIOL, V103, P741, DOI 10.1083/jcb.103.3.741; DUGGAN PF, 1970, J GEN PHYSIOL, V56, P147, DOI 10.1085/jgp.56.2.147; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; FERGUSON DG, 1984, J CELL BIOL, V99, P1735, DOI 10.1083/jcb.99.5.1735; GILCHRIST JSC, 1992, J BIOL CHEM, V267, P20857; GUO LH, 1984, GENE, V29, P251, DOI 10.1016/0378-1119(84)90186-0; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; HERRMANNFRANK A, 1991, PFLUG ARCH EUR J PHY, V418, P353, DOI 10.1007/BF00550873; HYMEL L, 1988, BIOCHEM BIOPH RES CO, V152, P308, DOI 10.1016/S0006-291X(88)80715-0; IINO M, 1992, BIOCHEM BIOPH RES CO, V185, P713, DOI 10.1016/0006-291X(92)91684-I; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; KNUDSON CM, 1993, J BIOL CHEM, V268, P12637; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; KREBS J, 1984, BIOCHEMISTRY-US, V23, P400, DOI 10.1021/bi00298a002; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1992, BIOCHEM J, V288, P553, DOI 10.1042/bj2880553; LAI FA, 1989, J BIOL CHEM, V264, P16776; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LILLIE SH, 1987, YEAST, V3, P63, DOI 10.1002/yea.320030202; MARKS AR, 1990, J BIOL CHEM, V265, P13143; MARTY I, 1994, BIOCHEM J, V298, P743, DOI 10.1042/bj2980743; MCPHERSON PS, 1993, J BIOL CHEM, V268, P19785; MCPHERSON PS, 1993, J BIOL CHEM, V268, P13765; MCPHERSON PS, 1990, J BIOL CHEM, V265, P18454; MEISSNER G, 1989, J BIOL CHEM, V264, P1715; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Mikoshiba Katsuhiko, 1994, Seminars in Cell Biology, V5, P273, DOI 10.1006/scel.1994.1033; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OTTER T, 1987, ANAL BIOCHEM, V162, P370, DOI 10.1016/0003-2697(87)90406-4; PESSAH IN, 1986, J BIOL CHEM, V261, P8643; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; RARDON DP, 1989, CIRC RES, V64, P779, DOI 10.1161/01.RES.64.4.779; SAITO A, 1989, Biophysical Journal, V55, p206A; SAITO A, 1988, J CELL BIOL, V107, P211, DOI 10.1083/jcb.107.1.211; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; SHOSHANBARMATZ V, 1988, J BIOL CHEM, V263, P16772; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TAKESHIMA H, 1994, FEBS LETT, V337, P81, DOI 10.1016/0014-5793(94)80634-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TU Q, 1994, J GEN PHYSIOL, V103, P853, DOI 10.1085/jgp.103.5.853; XU L, 1994, P NATL ACAD SCI USA, V91, P3294, DOI 10.1073/pnas.91.8.3294; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	63	49	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11338	11347		10.1074/jbc.270.19.11338	http://dx.doi.org/10.1074/jbc.270.19.11338			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744771	Green Published, hybrid			2022-12-27	WOS:A1995QX86500048
J	KAISE, M; MURAOKA, A; SEVA, C; TAKEDA, H; DICKINSON, CJ; YAMADA, T				KAISE, M; MURAOKA, A; SEVA, C; TAKEDA, H; DICKINSON, CJ; YAMADA, T			GLYCINE-EXTENDED PROGASTRIN PROCESSING INTERMEDIATES INDUCE H+,K+-ATPASE ALPHA-SUBUNIT GENE-EXPRESSION THROUGH A NOVEL RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-ACID SECRETION; CANINE PARIETAL-CELLS; SECRETAGOGUE STIMULATION; CHOLECYSTOKININ; ACCUMULATION; METABOLISM; AMIDATION; SEQUENCE; HUMANS	Biologically active amidated gastrin is synthesized by carboxyl-terminal alpha-amidation of a glycine extended progastrin post-translational processing intermediate (G-Gly). Although plasma levels of G-Gly are equivalent to those of gastrin, G-Gly has essentially no acute effect on gastric acid secretion. However, we have observed that inhibition of gastrin amidation leads to increased plasma concentrations of G-Gly and enhanced gastric acid secretion. We hypothesized, therefore, that G-Gly might have a chronic effect to increase H+,K+-ATPase expression in gastric parietal cells, In the present studies, we observed that a a-day preincubation with G-Gly significantly enhanced histamine-stimulated [C-14]aminopyrine uptake by isolated canine gastric parietal cells but acutely administered G-Gly had no effect, On Northern blot analysis, both G-Gly and gastrin dose-dependently increased H+,K+-ATPase alpha-subunit gene expression with maximal induction (225 +/- 35 and 170 +/- 29% of basal, mean +/- S.E.) achieved at concentrations of 10(-9) M G-Gly and 10(-8) M gastrin, respectively, Using an H+,K+-ATPase alpha-subunit gene-luciferase chimeric reporter construct transfected into primary cultured parietal cells, we observed that both G-Gly and gastrin increased luciferase activity in a manner similar to that obtained by Northern blot analysis, L365,260, a specific gastrin/CCKB receptor antagonist, completely reversed the stimulation of luciferase activity induced by gastrin but had no effect on G-Gly-stimulated activity, Gastrin increased [Ca2+](i), although G-Gly did not, however, genistein (a tyrosine kinase inhibitor) significantly reduced induction of luciferase activity by both G-Gly and gastrin. Specific binding of I-125-Leu(15)-G(2-17)-Gly to gastric parietal cells was dose-dependently displaced by G(2-17)-Gly but not by gastrin nor L365,260. Gastrin peptides truncated at the carboxyl-(G(1-13)) and amino terminus (G(2-17)-Gly) both induced H+,K+-ATPase alpha-subunit gene expression and inhibited I-125-Leu(15)-G(2-17)Gly binding, but were less potent than G(2-17)-Gly. These data indicate that G-Gly may have a functional role in potentiating gastric acid secretagogue action via enhanced expression of the gene responsible for Hf generation through action at a novel receptor that can be distinguished from the gastrin/CCKB receptor. Thus, both the substrate and product of the terminal progastrin processing reaction appear to have complementary functions in regulation of gastric acid secretion.	UNIV MICHIGAN,MED CTR,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT PHYSIOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			SEVA, Catherine/O-9166-2014	SEVA, Catherine/0000-0002-4265-7372	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034306, K08DK001903, P30DK034933] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK34306, P30DK34933, K08-DK-01903] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; BEALE EG, 1992, BIOTECHNIQUES, V12, P320; BOCK MG, 1989, J MED CHEM, V32, P16; CABERO JL, 1989, ACTA PHYSIOL SCAND, V136, P301, DOI 10.1111/j.1748-1716.1989.tb08670.x; CAMPBELL VW, 1989, J BIOL CHEM, V264, P11381; CHANG RSL, 1986, P NATL ACAD SCI USA, V83, P4923, DOI 10.1073/pnas.83.13.4923; CHEW CS, 1989, AM J PHYSIOL, V256, pG254, DOI 10.1152/ajpgi.1989.256.1.G254; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CICCOTOSTO GD, 1992, AM J PHYSIOL, V263, pG802, DOI 10.1152/ajpgi.1992.263.5.G802; DELVALLE J, 1989, GASTROENTEROLOGY, V97, P1159, DOI 10.1016/0016-5085(89)91685-5; DELVALLE J, 1992, AM J PHYSIOL, V262, pG420, DOI 10.1152/ajpgi.1992.262.3.G420; DICKINSON CJ, 1991, J BIOL CHEM, V266, P334; DICKINSON CJ, 1990, AM J PHYSIOL, V258, pG810, DOI 10.1152/ajpgi.1990.258.5.G810; EIPPER BA, 1988, ANNU REV PHYSIOL, V50, P333, DOI 10.1146/annurev.ph.50.030188.002001; HILSTED L, 1988, GASTROENTEROLOGY, V94, P96, DOI 10.1016/0016-5085(88)90615-4; HILSTED L, 1991, REGUL PEPTIDES, V36, P323, DOI 10.1016/0167-0115(91)90067-Q; HILSTED L, 1988, AM J PHYSIOL, V255, pG665, DOI 10.1152/ajpgi.1988.255.5.G665; Langone J J, 1980, Methods Enzymol, V70, P221; LUND PK, 1985, J BIOL CHEM, V260, P7609; MATSUMOTO M, 1987, AM J PHYSIOL, V252, pG315, DOI 10.1152/ajpgi.1987.252.3.G315; MCGUIGAN JE, 1972, GASTROENTEROLOGY, V62, P553; MORLEY JS, 1965, NATURE, V207, P1356, DOI 10.1038/2071356a0; MURAOKA A, 1994, GASTROENTEROLOGY, V106, pA145; PAUWELS S, 1985, GASTROENTEROLOGY, V89, P49, DOI 10.1016/0016-5085(85)90744-9; Sachs G, 1987, PHYSL GASTROINTESTIN, P865; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; SOLL AH, 1984, J CLIN INVEST, V73, P1434, DOI 10.1172/JCI111348; SOLL AH, 1980, AM J PHYSIOL, V238, pG366, DOI 10.1152/ajpgi.1980.238.4.G366; SOLL AH, 1978, J CLIN INVEST, V61, P370, DOI 10.1172/JCI108947; SONG I, 1993, BIOCHEM BIOPH RES CO, V196, P1240, DOI 10.1006/bbrc.1993.2385; SUGANO K, 1987, AM J PHYSIOL, V253, pG502, DOI 10.1152/ajpgi.1987.253.4.G502; SUGANO K, 1985, J BIOL CHEM, V260, P1724; TRACY HJ, 1964, NATURE, V204, P935, DOI 10.1038/204935a0; YAMADA T, 1993, GASTRIN, P151	35	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11155	11160		10.1074/jbc.270.19.11155	http://dx.doi.org/10.1074/jbc.270.19.11155			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744746	hybrid			2022-12-27	WOS:A1995QX86500022
J	SINGH, S; AGGARWAL, BB				SINGH, S; AGGARWAL, BB			PROTEIN-TYROSINE-PHOSPHATASE INHIBITORS BLOCK TUMOR NECROSIS FACTOR-DEPENDENT ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTOR NF-KAPPA-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; PHENYLARSINE OXIDE; T-CELLS; SIGNAL-TRANSDUCTION; INVITRO ACTIVATION; GAMMA-INTERFERON; TNF-ALPHA; KINASE-C; PHOSPHORYLATION; BINDING	Most of the inflammatory and proviral effects of tumor necrosis factor (TNF) are mediated through the activation of the nuclear transcription factor NF-kappa B. How TNF activates NF-kappa B, however, is not well understood. We examined the role of protein phosphatases in the TNF-dependent activation of NF-kappa B. Treatment of human myeloid ML-1a cells with TNF rapidly activated (within 30 min) NF-kappa B; this effect was abolished by treating cells with inhibitors of protein-tyrosine phosphatase (PTPase), including phenylarsine oxide (PAO), pervanadate, and diamide. The inhibition was dependent on the dose and occurred whether added before or at the same time as TNF. PAO also inhibited the activation even when added 15 min after the TNF treatment of cells. In contrast to inhibitors of PTPase, okadaic acid and calyculin A, which block serine threonine phosphatase, had no effect. The effect of PTPase inhibitors was not due to the modulation of TNF receptors. Since both dithiothreitol and dimercaptopropanol reversed the inhibitory effect of PAO, critical sulfhydryl groups in the PTPase must be involved in NF-kappa B activation by TNF. PTPase inhibitors also blocked NF-kappa B activation induced by phorbol ester, ceramide, and interleukin-1 but not that activated by okadaic acid. The degradation of I kappa B protein, a critical step in NF-kappa B activation, was also abolished by the PTPase inhibitors as revealed by immunoblotting. Thus, overall, we demonstrate that PTPase is involved either directly or indirectly in the pathway leading to the activation of NF-kappa B.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CLIN IMMUNOL & BIOL THERAPY,CYTOKINE RES LAB,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center			Aggarwal, Bharat B/G-3388-2013					AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAJPAI A, 1993, BIOCHIM BIOPHYS ACTA, V1177, P291, DOI 10.1016/0167-4889(93)90125-9; BALLOTTI R, 1991, EXP CELL RES, V197, P300, DOI 10.1016/0014-4827(91)90436-X; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BEUTLER B, 1992, TUMOR NECROSIS FACTO, P1; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; CHATURVEDI MM, 1994, LYMPHOKINE CYTOK RES, V13, P309; CHATURVEDI MM, 1994, J BIOL CHEM, V269, P14575; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; DBAIBO GS, 1993, J BIOL CHEM, V268, P17762; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; DURDEN DL, 1994, EXP CELL RES, V211, P150, DOI 10.1006/excr.1994.1071; EICHER DM, 1994, J IMMUNOL, V152, P2710; ELBERG G, 1994, J BIOL CHEM, V269, P9521; EVANS GA, 1994, J BIOL CHEM, V269, P23407; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; FLETCHER MC, 1993, J BIOL CHEM, V268, P23697; FROST SC, 1990, BIOCHEM J, V269, P589, DOI 10.1042/bj2690589; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; GENG Y, 1993, J IMMUNOL, V151, P6692; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GIBSON AE, 1989, AM J PHYSIOL, V257, pC182, DOI 10.1152/ajpcell.1989.257.2.C182; HASSANAIN HH, 1993, ANAL BIOCHEM, V213, P162, DOI 10.1006/abio.1993.1400; HIGUCHI M, 1992, ANAL BIOCHEM, V204, P53, DOI 10.1016/0003-2697(92)90138-W; HOHMANN HP, 1989, J BIOL CHEM, V264, P14927; IGARASHI K, 1993, MOL CELL BIOL, V13, P1634, DOI 10.1128/MCB.13.3.1634; IIVANAINEN AV, 1990, EUR J IMMUNOL, V20, P2509, DOI 10.1002/eji.1830201123; IMBERT V, 1994, BIOCHEM J, V297, P163, DOI 10.1042/bj2970163; IWASAKI T, 1992, FEBS LETT, V298, P240, DOI 10.1016/0014-5793(92)80067-Q; KATO Y, 1992, P NATL ACAD SCI USA, V89, P8507, DOI 10.1073/pnas.89.18.8507; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; KOONG AC, 1994, CANCER RES, V54, P1425; LI SF, 1993, P NATL ACAD SCI USA, V90, P9247, DOI 10.1073/pnas.90.20.9247; LINK E, 1992, J BIOL CHEM, V267, P239; MARAN A, 1994, SCIENCE, V265, P789, DOI 10.1126/science.7914032; MEDEMA RH, 1991, J BIOL CHEM, V266, P21186; MENON SD, 1993, J BIOL CHEM, V268, P26805; MONTEIRO HP, 1991, FEBS LETT, V295, P146, DOI 10.1016/0014-5793(91)81405-W; MOSS AL, 1991, J CELL PHYSIOL, V149, P313, DOI 10.1002/jcp.1041490219; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; OETKEN C, 1992, EUR J HAEMATOL, V49, P208; PEYRON JF, 1989, CELL SIGNAL, V1, P313, DOI 10.1016/0898-6568(89)90050-8; REDDY SAG, 1994, J BIOL CHEM, V269, P25369; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; SANTINI F, 1993, J BIOL CHEM, V268, P22716; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; THEVENIN C, 1990, New Biologist, V2, P793; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TOTPAL K, 1992, CANCER RES, V52, P2557; TROWBRIDGE IS, 1991, J BIOL CHEM, V266, P23517; Vilcek J, 1992, TUMOR NECROSIS FACTO, P1; YANAGA F, 1993, BIOCHEM J, V298, P733	57	123	127	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10631	10639		10.1074/jbc.270.18.10631	http://dx.doi.org/10.1074/jbc.270.18.10631			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738000				2022-12-27	WOS:A1995QW60100043
J	STAFFORD, WF; MABUCHI, K; TAKAHASHI, K; TAO, T				STAFFORD, WF; MABUCHI, K; TAKAHASHI, K; TAO, T			PHYSICAL CHARACTERIZATION OF CALPONIN - A CIRCULAR-DICHROISM, ANALYTICAL ULTRACENTRIFUGE, AND ELECTRON-MICROSCOPY STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CALPONIN; RAYLEIGH OPTICAL SYSTEMS; MYOSIN ATPASE ACTIVITY; THIN-FILAMENTS; MOLECULAR-WEIGHT; HEAVY-MEROMYOSIN; ACTIN; PROTEIN; PHOSPHORYLATION; TROPOMYOSIN	Calponin is a thin filament-associated smooth muscle protein that has been suggested to play a role in the regulation of smooth muscle contraction. We have used circular dichroism spectroscopy, electron microscopy, and analytical ultracentrifugation to study the physical properties of recombinant chicken gizzard alpha-calponin. The alpha-helix content of alpha-calponin was estimated from its circular dichroism spectrum to be similar to 13%. alpha-Calponin melts with a single sharp transition at similar to 57 degrees C. Rotary shadowing electron micrographs of alpha-calponin reveal diverse shapes ranging from elongated rods to collapsed coils. The lengths of the rod-shaped structures are similar to 18 nm. Analytical ultracentrifugation studies found alpha-calponin to be homogeneous with a monomer molecular mass of 31.4 kDa, and a s(20,w), value of 2.34 S. These data could be used to model alpha-calponin as a prolate ellipsoid of revolution with an axial ratio of 6.16, a length of 16.2 nn, and a diameter of 2.6 nm. Taken together, our results indicate that calponin is a flexible, elongated molecule whose contour length is sufficient to span three actin subunits along the long pitch helix of an F-actin filament.	BOSTON BIOMED RES INST, MUSCLE RES GRP, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA; CTR ADULT DIS, DEPT MED, OSAKA 537, JAPAN; TUFTS UNIV, SCH MED, DEPT BIOCHEM, BOSTON, MA 02111 USA	Boston Biomedical Research Institute; Harvard University; Harvard Medical School; Tufts University			Stafford, Walter/ABC-6553-2020		NIAMS NIH HHS [P01-AR41637] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041637] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE M, 1990, J BIOCHEM-TOKYO, V108, P835, DOI 10.1093/oxfordjournals.jbchem.a123289; ABE M, 1990, J BIOCHEM-TOKYO, V107, P507, DOI 10.1093/oxfordjournals.jbchem.a123075; ADAMS JM, 1992, ONCOGENE, V7, P611; ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; ANSEVIN AT, 1970, ANAL BIOCHEM, V34, P237, DOI 10.1016/0003-2697(70)90103-X; APPLEGATE D, 1994, J BIOL CHEM, V269, P10683; BARANY M, 1991, FEBS LETT, V279, P65, DOI 10.1016/0014-5793(91)80252-X; BARANY M, 1993, BIOCHIM BIOPHYS ACTA, V1179, P229, DOI 10.1016/0167-4889(93)90146-G; BRENNER SL, 1990, J MOL BIOL, V216, P949, DOI 10.1016/S0022-2836(99)80013-8; CHILDS TJ, 1992, BIOCHIM BIOPHYS ACTA, V1121, P41, DOI 10.1016/0167-4838(92)90334-A; DEROSIER DJ, 1972, ANAL BIOCHEM, V50, P139, DOI 10.1016/0003-2697(72)90493-9; GIMONA M, 1992, EUR J BIOCHEM, V205, P1067, DOI 10.1111/j.1432-1033.1992.tb16875.x; GIMONA M, 1990, FEBS LETT, V274, P159, DOI 10.1016/0014-5793(90)81353-P; GONG BJ, 1993, J BIOCHEM-TOKYO, V114, P453, DOI 10.1093/oxfordjournals.jbchem.a124197; GRACEFFA P, 1988, J BIOL CHEM, V263, P14196; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; HORIUCHI KY, 1991, BIOCHEM BIOPH RES CO, V176, P1487, DOI 10.1016/0006-291X(91)90455-G; INIESTA A, 1988, BIOPHYS J, V54, P269, DOI 10.1016/S0006-3495(88)82956-4; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kuntz I D Jr, 1974, Adv Protein Chem, V28, P239, DOI 10.1016/S0065-3233(08)60232-6; LEHMAN W, 1991, J MUSCLE RES CELL M, V12, P221, DOI 10.1007/BF01745110; LEHRER SS, 1990, J BIOL CHEM, V265, P1134; LIN Y, 1993, J BIOCHEM-TOKYO, V113, P643, DOI 10.1093/oxfordjournals.jbchem.a124096; LIU S, 1992, Biophysical Journal, V61, pA476; MABUCHI K, 1990, J STRUCT BIOL, V103, P249, DOI 10.1016/1047-8477(90)90043-C; MABUCHI K, 1991, J STRUCT BIOL, V107, P22, DOI 10.1016/1047-8477(91)90027-T; MABUCHI K, 1994, BIOPHYS J, V66, pA197; MAKUCH R, 1991, BIOCHEM J, V280, P33, DOI 10.1042/bj2800033; MARSTON SB, 1991, FEBS LETT, V292, P179, DOI 10.1016/0014-5793(91)80862-W; NAKA M, 1990, BIOCHEM BIOPH RES CO, V171, P933, DOI 10.1016/0006-291X(90)90773-G; NISHIDA W, 1990, FEBS LETT, V268, P165, DOI 10.1016/0014-5793(90)80999-Y; NODA S, 1992, BIOCHEM BIOPH RES CO, V185, P481, DOI 10.1016/S0006-291X(05)81010-1; NORTH AJ, 1994, J CELL SCI, V107, P437; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; PARKER CA, 1994, IN PRESS AM J PHYSL; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; RICHARDS EG, 1971, ANAL BIOCHEM, V41, P215, DOI 10.1016/0003-2697(71)90206-5; RICHARDS EG, 1971, ANAL BIOCHEM, V41, P189, DOI 10.1016/0003-2697(71)90205-3; RICHARDS EG, 1972, ANAL BIOCHEM, V46, P295, DOI 10.1016/0003-2697(72)90423-X; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STAFFORD WF, 1990, ARCH BIOCHEM BIOPHYS, V281, P66, DOI 10.1016/0003-9861(90)90413-S; STAFFORD WF, 1994, METHOD ENZYMOL, V240, P478; SZYMANSKI PT, 1993, FEBS LETT, V331, P256, DOI 10.1016/0014-5793(93)80348-X; TAKAHASHI K, 1986, BIOCHEM BIOPH RES CO, V141, P20, DOI 10.1016/S0006-291X(86)80328-X; TAKAHASHI K, 1988, HYPERTENSION, V11, P620, DOI 10.1161/01.HYP.11.6.620; TAKAHASHI K, 1988, J HYPERTENS, V6, pS40, DOI 10.1097/00004872-198812040-00008; TAKAHASHI K, 1987, LIFE SCI, V41, P291, DOI 10.1016/0024-3205(87)90151-2; TAKAHASHI K, 1991, J BIOL CHEM, V266, P13284; TAKAHASHI K, 1993, CIRCULATION, V88, P174; TAKAHASHI K, 1991, CIRCULATION S2, V84, P532; TAKEUCHI K, 1991, J BIOCHEM, V109, P311; Tanford C., 1961, PHYS CHEM MACROMOLEC; WALSH MP, 1993, AM J PHYSIOL, V265, pC1371, DOI 10.1152/ajpcell.1993.265.5.C1371; WINDER SJ, 1993, BIOCHEM J, V296, P827, DOI 10.1042/bj2960827; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; WINDER SJ, 1991, ADV EXP MED BIOL, V304, P37; Yphantis D, 1994, MODERN ANAL ULTRACEN, P209	60	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10576	10579		10.1074/jbc.270.18.10576	http://dx.doi.org/10.1074/jbc.270.18.10576			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737994	hybrid			2022-12-27	WOS:A1995QW60100035
J	OTERO, AS; YI, XB; GRAY, MC; SZABO, G; HEWLETT, EL				OTERO, AS; YI, XB; GRAY, MC; SZABO, G; HEWLETT, EL			MEMBRANE DEPOLARIZATION PREVENTS CELL INVASION BY BORDETELLA-PERTUSSIS ADENYLATE-CYCLASE TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HEMOLYTIC ACTIVITIES; BACILLUS-ANTHRACIS; VIRULENCE FACTORS; LIPID BILAYERS; ENTRY; TRANSLOCATION; RESOLUTION; INHIBITORS; GENE; CYAC	Adenylate cyclase toxin from Bordetella pertussis is a 177-kDa calmodulin activated enzyme that has the ability to enter eukaryotic cells and convert endogenous ATP into cAMP, Little is known, however, about the mechanism of cell entry, We now demonstrate that intoxication of cardiac myocytes by adenylate cyclase toxin is driven and controlled by the electrical potential across the plasma membrane. The steepness of the voltage dependence of intoxication is comparable with that previously observed for the activation of K+ and Na+ channels of excitable membranes. The voltage-sensitive process is downstream from toxin binding to the cell surface and appears to correspond to the translocation of the catalytic domain across the membrane.	UNIV VIRGINIA,SCH MED,DEPT MED,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,SCH MED,DEPT PHARMACOL,CHARLOTTESVILLE,VA 22908	University of Virginia; University of Virginia	OTERO, AS (corresponding author), UNIV VIRGINIA,SCH MED,DEPT MOLEC PHYSIOL & BIOL PHYS,JORDAN HALL,BOX 449,CHARLOTTESVILLE,VA 22908, USA.			gray, mary/0000-0003-4441-5905	NHLBI NIH HHS [HL 37127, HL 48726] Funding Source: Medline; NIAID NIH HHS [AI 18000] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL037127, R01HL037127, R01HL048726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018000] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; CHAUMONT F, 1990, J BIOL CHEM, V265, P16856; CHERRY J D, 1988, Pediatrics, V81, P939; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; CONFER DL, 1984, ADV CYCLIC NUCL PROT, V17, P183; EHRMANN IE, 1992, FEBS LETT, V304, P51, DOI 10.1016/0014-5793(92)80587-7; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; GENTILE F, 1990, J BIOL CHEM, V265, P10686; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; GORDON VM, 1989, J BIOL CHEM, V264, P14792; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hannavy K, 1993, CURR OPIN CELL BIOL, V5, P694, DOI 10.1016/0955-0674(93)90142-D; HANSKI E, 1985, J BIOL CHEM, V260, P5526; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; HEWLETT EL, 1993, J BIOL CHEM, V268, P7842; HEWLETT EL, 1994, HDB NATURAL TOXINS, V8, P425; Hille B., 1992, IONIC CHANNELS EXCIT, P23; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; HUDSON TH, 1988, J BIOL CHEM, V263, P4773; KHELEF N, 1992, MICROB PATHOGENESIS, V12, P227, DOI 10.1016/0882-4010(92)90057-U; LI YX, 1994, J GEN PHYSIOL, V104, P941, DOI 10.1085/jgp.104.5.941; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MENESTRINA G, 1990, TOXICON, V28, P477, DOI 10.1016/0041-0101(90)90292-F; OTERO AD, 1993, MOL PHARMACOL, V44, P595; PEARSON RD, 1987, J IMMUNOL, V139, P2749; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SZABO G, 1994, J BIOL CHEM, V269, P22496; TRAUTWEIN W, 1990, ANNU REV PHYSIOL, V52, P257, DOI 10.1146/annurev.ph.52.030190.001353; WEISS AA, 1984, J INFECT DIS, V150, P219, DOI 10.1093/infdis/150.2.219; WEISS AA, 1986, ANNU REV MICROBIOL, V40, P661, DOI 10.1146/annurev.micro.40.1.661	33	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9695	9697		10.1074/jbc.270.17.9695	http://dx.doi.org/10.1074/jbc.270.17.9695			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730345	hybrid			2022-12-27	WOS:A1995QV41700002
J	ROSS, SA; ZHANG, MX; SELMAN, BR				ROSS, SA; ZHANG, MX; SELMAN, BR			ROLE OF THE CHLAMYDOMONAS-REINHARDTII COUPLING FACTOR-1 GAMMA-SUBUNIT CYSTEINE BRIDGE IN THE REGULATION OF ATP SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I CF1; NUCLEAR TRANSFORMATION; NITRATE REDUCTASE; THIOL MODULATION; GENE; ACTIVATION; MUTANT; PHOTOPHOSPHORYLATION; DITHIOTHREITOL; PURIFICATION	The gamma-subunit of coupling factor 1 (CF1) contains a cysteine bridge that is thought to be involved in the redox control of enzymatic activity, In order to test the regulatory significance of this disulfide bond, genetic transformation experiments with Chlamydomonas reinhardtii were performed. C. reinhardtii strain atpC1 (nit1-305, cw 15, mt(-)), which is null for the gamma-subunit, was transformed and complemented with gamma-subunit constructs containing amino acid substitutions localized to the cysteine bridge between Cys(198) and Cys(204), Successful complementation was confirmed by phenotypic swlection, Northern blot analysis, reverse transcription polymerase chain reaction, and cDNA sequencing, CF1 ATPase activities of the soluble enzymes were measured in the presence and absence of dithiothreitol (DTT), Mutant CF1 enzymes showed no effect of DTT although increased activity was observed for the wild-type enzyme. In vitro, phenazine methosulfate dependent photophosphorylation assays revealed that wild-type CF1 exhibits a a-fold stimulation in the presence of 25 mM DTT, whereas each of the mutant enzymes has activities that are DTT independent. Growth measurements indicated that despite the absence of a regulatory disulfide/dithiol, the mutant strains grew with the same kinetics as wild type. This study provides evidence to illustrate the involvement of the gamma-subunit in the redox regulation of ATP synthesis in vivo, This work is also the first demonstration in C. reinhardtii of stable nuclear transformation using mutated genes to complement a known defect.	UNIV WISCONSIN,COLL AGR & LIFE SCI,DEPT BIOCHEM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison								DIENER DR, 1990, P NATL ACAD SCI USA, V87, P5739, DOI 10.1073/pnas.87.15.5739; FERNANDEZ E, 1989, P NATL ACAD SCI USA, V86, P6449, DOI 10.1073/pnas.86.17.6449; GABRYS H, 1994, PLANT PHYSIOL, V104, P769, DOI 10.1104/pp.104.2.769; HANGARTER RP, 1987, J BIOL CHEM, V262, P13513; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HASNAIN SE, 1985, MOL CELL BIOL, V5, P3647, DOI 10.1128/MCB.5.12.3647; JUNESCH U, 1985, BIOCHIM BIOPHYS ACTA, V809, P429, DOI 10.1016/0005-2728(85)90194-X; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; KETCHAM SR, 1984, J BIOL CHEM, V259, P7286; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; KRAMER DM, 1990, PHOTOSYNTH RES, V26, P213, DOI 10.1007/BF00033134; MCCARTY RE, 1984, ENZYMES BIOL MEMBR, P383; MERCHANT S, 1985, PHOTOSYNTH RES, V6, P3, DOI 10.1007/BF00029044; MILLS JD, 1984, BIOCHIM BIOPHYS ACTA, V764, P93, DOI 10.1016/0005-2728(84)90145-2; MITCHELL DR, 1991, J CELL BIOL, V113, P835, DOI 10.1083/jcb.113.4.835; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; NALIN CM, 1984, J BIOL CHEM, V259, P7275; NOCTOR G, 1988, BIOCHIM BIOPHYS ACTA, V935, P53, DOI 10.1016/0005-2728(88)90107-7; ORT DR, 1992, ANNU REV PLANT PHYS, V43, P269, DOI 10.1146/annurev.pp.43.060192.001413; QUINN J, 1993, J BIOL CHEM, V268, P7832; SAGER R, 1953, ANN NY ACAD SCI, V56, P831, DOI 10.1111/j.1749-6632.1953.tb30261.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELMAN BR, 1976, J BIOENERG BIOMEMBR, V8, P143, DOI 10.1007/BF00748960; SELMANREIMER S, 1981, BIOCHEMISTRY-US, V20, P5476, DOI 10.1021/bi00522a020; SELMANREIMER S, 1986, PROGR PHOTOSYNTHESIS; SHAHAK Y, 1985, J BIOL CHEM, V260, P1459; SHAVIT N, 1980, ANNU REV BIOCHEM, V49, P111, DOI 10.1146/annurev.bi.49.070180.000551; SMART EJ, 1991, MOL CELL BIOL, V11, P5053, DOI 10.1128/MCB.11.10.5053; SMART EJ, 1993, J BIOENERG BIOMEMBR, V25, P275, DOI 10.1007/BF00762588; SODEINDE OA, 1993, P NATL ACAD SCI USA, V90, P9199, DOI 10.1073/pnas.90.19.9199; STROTMANN H, 1987, FEBS LETT, V221, P265, DOI 10.1016/0014-5793(87)80938-9; WERNER S, 1990, FEBS LETT, V126, P204; YU LM, 1988, J BIOL CHEM, V263, P19342	35	33	34	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					9813	9818		10.1074/jbc.270.17.9813	http://dx.doi.org/10.1074/jbc.270.17.9813			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730361	hybrid			2022-12-27	WOS:A1995QV41700020
J	SHAROM, FJ; DIDIODATO, G; YU, XH; ASHBOURNE, KJD				SHAROM, FJ; DIDIODATO, G; YU, XH; ASHBOURNE, KJD			INTERACTION OF THE P-GLYCOPROTEIN MULTIDRUG TRANSPORTER WITH PEPTIDES AND IONOPHORES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; PREDICTED TRANSMEMBRANE DOMAIN; FUNCTIONAL CONSEQUENCES; DEPENDENT TRANSPORT; MEMBRANE-VESICLES; RESISTANCE PUMP; ATPASE ACTIVITY; GENE; MUTATIONS; RECONSTITUTION	P-glycoprotein functions as an ATP-driven active efflux pump for many cytotoxic drugs. We now show that hydrophobic peptides and ionophores also interact with the multidrug transporter. Multidrug-resistant cells are cross-resistant to several hydrophobic peptides and ionophores, but not to some other membrane-active species. Linear peptides, cyclic peptides, and ionophores stimulated the ATPase activity of P-glycoprotein in plasma membrane vesicles by up to 2.5-fold. Drugs and chemosensitizers were able to block P-glycoprotein ATPase stimulation by verapamil, however, peptides and ionophores (with the exception of cyclosporine A) were unable to do so. Peptides and ionophores also effectively inhibited ATP-dependent drug transport by P-glycoprotein in plasma membrane vesicles, The median effect analysis was used to extract quantitative parameters from the drug transport inhibition data. Unlike drug substrates and cyclic peptides, linear peptides did not inhibit photoaffinity labeling of P-glycoprotein by [H-3]azidopine, Taken together, these results indicate that certain hydrophobic peptides and ionophores are P-glycoprotein substrates, however, they affect the transporter in a different manner from drugs, Linear peptides interact with P-glycoprotein at a site distinct from those for verapamil and azidopine, whereas the interaction site for cyclic peptides and ionophores appears to be linked to these sites to varying degrees. Export of hydrophobic peptides may be an important physiological function of P-glycoprotein.			SHAROM, FJ (corresponding author), UNIV GUELPH, GUELPH WATERLOO CTR GRAD WORK CHEM, DEPT CHEM & BIOCHEM, GUELPH, ON N1G 2W1, CANADA.		Excoffon, Katherine/ABC-5037-2021; Sharom, Frances/A-1613-2010	Excoffon, Katherine/0000-0003-3945-0298; Sharom, Frances/0000-0002-9521-5367				ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; AMES GF, 1992, FASEB J, V6, P2660, DOI 10.1096/fasebj.6.9.1377140; ASSARAF YG, 1994, EUR J BIOCHEM, V222, P813, DOI 10.1111/j.1432-1033.1994.tb18928.x; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; DHIR R, 1993, BIOCHEMISTRY-US, V32, P9492, DOI 10.1021/bi00087a030; Doige C A, 1991, Protein Expr Purif, V2, P256, DOI 10.1016/1046-5928(91)90081-S; DOIGE CA, 1993, BIOCHIM BIOPHYS ACTA, V1146, P65, DOI 10.1016/0005-2736(93)90339-2; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P149, DOI 10.1016/0005-2736(92)90078-Z; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P161, DOI 10.1016/0005-2736(92)90079-2; ERTEL A, 1993, BIOPHYS J, V64, P426, DOI 10.1016/S0006-3495(93)81383-3; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS CF, 1990, J BIOENERG BIOMEMBR, V22, P571, DOI 10.1007/BF00762962; HOLLAND IB, 1990, BIOCHIMIE, V72, P131, DOI 10.1016/0300-9084(90)90138-7; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; HORIO M, 1991, BIOCHIM BIOPHYS ACTA, V1061, P106, DOI 10.1016/0005-2736(91)90274-C; KAMIMOTO Y, 1989, J BIOL CHEM, V264, P11693; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; LOE DW, 1994, BBA-BIOMEMBRANES, V1190, P72, DOI 10.1016/0005-2736(94)90035-3; LOE DW, 1993, BRIT J CANCER, V68, P342, DOI 10.1038/bjc.1993.338; LOO TW, 1993, J BIOL CHEM, V268, P3143; LOO TW, 1993, J BIOL CHEM, V268, P19965; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; SAEKI T, 1993, J BIOL CHEM, V268, P6077; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; SAFA AR, 1987, J BIOL CHEM, V262, P7884; SARKADI B, 1994, FASEB J, V8, P766, DOI 10.1096/fasebj.8.10.7914178; SARKADI B, 1992, J BIOL CHEM, V267, P4854; SHARMA RC, 1992, J BIOL CHEM, V267, P5731; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; SHAROM FJ, 1995, IN PRESS BIOCH J; SHIRAI A, 1994, BBA-MOL CELL RES, V1222, P400, DOI 10.1016/0167-4889(94)90047-7; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; TOPPMEYER DL, 1994, BIOCHEM PHARMACOL, V48, P609, DOI 10.1016/0006-2952(94)90292-5; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; ZHANG L, 1994, J BIOL CHEM, V269, P15973	44	102	104	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10334	10341		10.1074/jbc.270.17.10334	http://dx.doi.org/10.1074/jbc.270.17.10334			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730340	hybrid			2022-12-27	WOS:A1995QV41700089
J	VALGEIRSDOTTIR, S; ERIKSSON, A; NISTER, M; HELDIN, CH; WESTERMARK, B; CLAESSONWELSH, L				VALGEIRSDOTTIR, S; ERIKSSON, A; NISTER, M; HELDIN, CH; WESTERMARK, B; CLAESSONWELSH, L			COMPARTMENTALIZATION OF AUTOCRINE SIGNAL-TRANSDUCTION PATHWAYS IN SIS-TRANSFORMED NIH 3T3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN SARCOMA-VIRUS; GROWTH-FACTOR RECEPTOR; SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE; FAMILY TYROSINE KINASES; PDGF BETA-RECEPTOR; V-SIS; PHOSPHORYLATION SITES; SRC FAMILY; AUTOPHOSPHORYLATION SITES; PHOSPHOLIPASE C-GAMMA-1	The transforming protein of simian sarcoma virus is homologous to the platelet-derived growth factor (PDGF) B-chain. Fibroblasts transformed with simian sarcoma virus constitutively produce a growth factor that stimulates the endogenous tyrosine kinase of PDGF receptors in an autocrine manner, Autophosphorylation of PDGF receptors upon ligand stimulation provides binding sites for Src homology 2 domains of intracellular signaling molecules, which thereby become activated, We have characterized the PDGF receptor-mediated signal transduction in NIH 3T3 cells transformed with a PDGF B-chain cDNA (Sis 3T3 cells) in the absence and presence of suramin, a polyanionic compound that quenches PDGF-induced mitogenicity and reverts the transformed phenotype of the Sis 3T3 cells, Our data show that in the presence of suramin the general level of tyrosine phosphorylation was decreased, Nevertheless, autophosphorylated receptors complexed with substrates persisted in the cells, Suramin had no effect on activation of phosphatidylinositol 3'-kinase or an tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein of Ras. On the other hand, kinase activation of Src and Raf-1, phosphorylation of protein-tyrosine phosphatase 1D/Syp and Shc, and complex formation with Grb2 were greatly diminished by suramin. A possible explanation for our findings is that different PDGF receptor-coupled signaling pathways are active in different structural or functional compartments in the cell, Those pathways that are not affected by suramin might elicit distinct cellular responses, which are not sufficient for growth and transformation.	UNIV UPPSALA HOSP,DEPT PATHOL,S-75185 UPPSALA,SWEDEN	Uppsala University; Uppsala University Hospital	VALGEIRSDOTTIR, S (corresponding author), BIOMED CTR,LUDWIG INST CANC RES,BOX 595,S-75124 UPPSALA,SWEDEN.							AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; ANTONIADES HN, 1992, P NATL ACAD SCI USA, V89, P3942, DOI 10.1073/pnas.89.9.3942; ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; ARVIDSSON AK, 1994, MOL CELL BIOL, V14, P6715, DOI 10.1128/MCB.14.10.6715; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BETSHOLTZ C, 1986, P NATL ACAD SCI USA, V83, P6440, DOI 10.1073/pnas.83.17.6440; BOURASSA C, 1988, ANAL BIOCHEM, V169, P356, DOI 10.1016/0003-2697(88)90295-3; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CLAESSONWELSH L, 1987, P NATL ACAD SCI USA, V84, P8796, DOI 10.1073/pnas.84.24.8796; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; CLAESSONWELSH L, 1989, J BIOL CHEM, V264, P1742; CLAESSONWELSH L, 1993, BIOL PLATELET DERIVE, V5, P31; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; COOPER JA, 1981, MOL CELL BIOL, V1, P165, DOI 10.1128/MCB.1.2.165; COOPER JA, 1984, J BIOL CHEM, V259, P7835; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; DEVARE SG, 1983, P NATL ACAD SCI-BIOL, V80, P731, DOI 10.1073/pnas.80.3.731; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FLEMING TP, 1989, P NATL ACAD SCI USA, V86, P8063, DOI 10.1073/pnas.86.20.8063; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HERMANSON M, 1992, CANCER RES, V52, P3213; HUANG SS, 1988, J BIOL CHEM, V263, P12608; JOHNSSON A, 1986, EMBO J, V5, P1535, DOI 10.1002/j.1460-2075.1986.tb04394.x; JOHNSSON A, 1985, NATURE, V317, P438, DOI 10.1038/317438a0; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KASHISHIAN A, 1993, MOL BIOL CELL, V4, P49, DOI 10.1091/mbc.4.1.49; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KEATING MT, 1988, SCIENCE, V239, P914, DOI 10.1126/science.2829358; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LAROCHELLE WJ, 1993, BIOL PLATELET DERIVE, V5, P129; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; NISTER M, 1991, J BIOL CHEM, V266, P16755; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; OSTMAN A, 1988, J BIOL CHEM, V263, P16202; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Panayotou George, 1992, Trends in Cell Biology, V2, P358, DOI 10.1016/0962-8924(92)90042-L; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; RAPP UR, 1991, ONCOGENE, V6, P495; ROBBINS KC, 1983, NATURE, V305, P605, DOI 10.1038/305605a0; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; SATOH T, 1992, J BIOL CHEM, V267, P24149; SHAMAH SM, 1993, MOL CELL BIOL, V13, P7203, DOI 10.1128/MCB.13.12.7203; SMITS A, 1992, AM J PATHOL, V140, P639; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; VALIUS M, 1993, MOL CELL BIOL, V13, P183; VASSBOTN FS, 1994, J CELL PHYSIOL, V158, P381, DOI 10.1002/jcp.1041580221; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WEIMA SM, 1990, EXP CELL RES, V186, P324, DOI 10.1016/0014-4827(90)90312-X; WENNSTROM S, 1992, J BIOL CHEM, V267, P13749; WENNSTROM S, 1994, ONCOGENE, V9, P651; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	64	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10161	10170		10.1074/jbc.270.17.10161	http://dx.doi.org/10.1074/jbc.270.17.10161			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730319	hybrid			2022-12-27	WOS:A1995QV41700066
J	HAUSDORFF, SF; BENNETT, AM; NEEL, BG; BIRNBAUM, MJ				HAUSDORFF, SF; BENNETT, AM; NEEL, BG; BIRNBAUM, MJ			DIFFERENT SIGNALING ROLES OF SHPTP2 IN INSULIN-INDUCED GLUT1 EXPRESSION AND GLUT4 TRANSLOCATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE; 3T3-L1 ADIPOCYTES; TRANSPORTER GENE; CELL-SURFACE; PHOSPHORYLATION; ACTIVATION; SH-PTP2	Insulin activates hexose transport via at least two mechanisms: a p21(ras)-dependent pathway, leading to an increase in the amount of cell surface GLUT1; and a metabolic, p21(ras)-independent pathway, leading to translocation of the insulin-responsive transporter GLUT4 to the cell surface. Following insulin stimulation, SHPTP2, a non-transmembrane protein-tyrosine phosphatase, associates with insulin receptor substrate 1 via its Src homology 2 (SH2) domains. Microinjection of a glutathione S-transferase fusion protein encoding the N- and C-terminal SH2 domains of SHPTP2 (GST-NC-SH2) or anti-SHPTP2 antibodies into NIH-3T3 fibroblasts overexpressing the insulin receptor blocks insulin-induced DNA synthesis. Microinjection of either GST-NC-SH2 or anti-SHPTP2 antibodies into 3T3-L1 adipocytes inhibited the insulin-stimulated increase in expression of GLUT1. In contrast, translocation of GLUT4 to the cell surface was unaffected by either GST-NC-SH2 or anti-SHPTP2 antibodies. These data confirm a role for SHPTP2 in insulin-stimulated mitogenesis and indicate that whereas SHPTP2 is necessary for insulin-stimulated expression of GLUT1, it is not required for activation of the metabolic pathway leading to GLUT4 translocation.	HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02215; BETH ISRAEL HOSP,MOLEC MED UNIT,BOSTON,MA 02215	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center				Birnbaum, Morris/0000-0001-9972-8680; Bennett, Anton/0000-0001-5187-7599	NCI NIH HHS [CA49152] Funding Source: Medline; NIDDK NIH HHS [DK39519] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049152, R37CA049152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039519] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BIRNBAUM MJ, 1992, INT REV CYTOL, V137A, P239; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13801; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; DEHERREROS AG, 1989, J BIOL CHEM, V264, P9885; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FINGAR DC, 1994, ENDOCRINOLOGY, V134, P728, DOI 10.1210/en.134.2.728; FINGAR DC, 1993, J BIOL CHEM, V268, P3005; FINGAR DC, 1994, J BIOL CHEM, V269, P10127; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21931; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P13434; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; PLUSKEY S, 1995, J BIOL CHEM, V270, P2879; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WHITE MF, 1994, J BIOL CHEM, V269, P1; XIAO S, 1994, J BIOL CHEM, V269, P21244; YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664, DOI 10.1073/pnas.92.3.664	27	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 2	1995	270	22					12965	12968		10.1074/jbc.270.22.12965	http://dx.doi.org/10.1074/jbc.270.22.12965			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RB439	7768884	hybrid			2022-12-27	WOS:A1995RB43900005
J	BABITZKE, P; YANOFSKY, C				BABITZKE, P; YANOFSKY, C			STRUCTURAL FEATURES OF L-TRYPTOPHAN REQUIRED FOR ACTIVATION OF TRAP, THE TRP RNA-BINDING ATTENUATION PROTEIN OF BACILLUS-SUBTILIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ATTENUATION; OPERON; APOREPRESSOR; EXPRESSION; ACID; MTRB	A filter binding assay was used to determine the structural features of L-tryptophan required for activation of TRAP, the trp RNA-binding attenuation protein of Bacillus subtilis. We examined the ability of L-tryptophan and 26 of its analogs to activate TRAP. Our findings show that TRAP activation by L-tryptophan is highly cooperative. We also observed that TRAP activation is stereospecific; D-tryptophan did not activate. Our results further indicate that the alpha-amino group and the carbonyl moiety of the alpha-carboxyl group of the ligand are required for TRAP activation and that the heterocyclic amino nitrogen of L-tryptophan greatly enhances TRAP activation. We also found that changes at several positions of the indole ring of L-tryptophan resulted in reduced TRAP activation. In addition, indole and 5-methylindole were shown to be effective competitors of L-tryptophan activation of TRAP.	PENN STATE UNIV,DEPT BIOCHEM & MOLEC BIOL,UNIVERSITY PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	BABITZKE, P (corresponding author), STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305, USA.		Babitzke, Paul/AAL-3048-2020	Babitzke, Paul/0000-0003-2481-1062	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM009738, R01GM009738] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM09738] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTSON AA, 1994, J MOL BIOL, V244, P1, DOI 10.1006/jmbi.1994.1698; ARVIDSON DN, 1986, J BIOL CHEM, V261, P238; BABITZKE P, 1992, J BACTERIOL, V174, P2059, DOI 10.1128/JB.174.7.2059-2064.1992; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; BABITZKE P, 1994, J BIOL CHEM, V269, P16597; GOLLNICK P, 1994, MOL MICROBIOL, V11, P991, DOI 10.1111/j.1365-2958.1994.tb00377.x; GOLLNICK P, 1990, P NATL ACAD SCI USA, V87, P8726, DOI 10.1073/pnas.87.22.8726; HOCH SO, 1971, J BACTERIOL, V105, P38, DOI 10.1128/JB.105.1.38-45.1971; JOACHIMIAK A, 1983, P NATL ACAD SCI-BIOL, V80, P668, DOI 10.1073/pnas.80.3.668; KANE JF, 1977, J BACTERIOL, V132, P419, DOI 10.1128/JB.132.2.419-425.1977; KURODA MI, 1988, J BACTERIOL, V170, P3080, DOI 10.1128/jb.170.7.3080-3088.1988; LANE AN, 1985, EUR J BIOCHEM, V157, P405; MARMORSTEIN RQ, 1987, J BIOL CHEM, V262, P4922; MARMORSTEIN RQ, 1989, J BIOL CHEM, V264, P9149; OTRIDGE J, 1993, P NATL ACAD SCI USA, V90, P128, DOI 10.1073/pnas.90.1.128; SHIMOTSU H, 1986, J BACTERIOL, V166, P461, DOI 10.1128/jb.166.2.461-471.1986; SLOCK J, 1990, J BACTERIOL, V172, P7211, DOI 10.1128/jb.172.12.7211-7226.1990	17	35	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12452	12456		10.1074/jbc.270.21.12452	http://dx.doi.org/10.1074/jbc.270.21.12452			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759487	hybrid			2022-12-27	WOS:A1995QZ71100020
J	COLEMAN, T; SEIP, RL; GIMBLE, JM; LEE, D; MAEDA, N; SEMENKOVICH, CF				COLEMAN, T; SEIP, RL; GIMBLE, JM; LEE, D; MAEDA, N; SEMENKOVICH, CF			COOH-TERMINAL DISRUPTION OF LIPOPROTEIN-LIPASE IN MICE IS LETHAL IN HOMOZYGOTES, BUT HETEROZYGOTES HAVE ELEVATED TRIGLYCERIDES AND IMPAIRED ENZYME-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; SMOOTH-MUSCLE CELLS; TRANSGENIC MICE; MESSENGER-RNA; DEFICIENCY; EXPRESSION; GENE; MACROPHAGES; SECRETION	The role of the enzyme lipoprotein Lipase (LPL) in atherosclerosis is uncertain. To generate an animal model of LPL deficiency, we targeted the LPL gene in embryonic stem cells with a vector designed to disrupt the COOH terminus of the protein and used these cells to generate LPL-deficient mice, Germ line transmission of the disrupted LPL allele was achieved with two chimeric males, and offspring from each of these animals were phenotypically identical. Pups homozygous (-/-) for LPL deficiency died within 48 h of birth with extreme elevations of serum triglycerides (13,327 mg/dl) associated with essentially absent LPL enzyme activity in heart and carcass. Newborn heterozygous (+/-) LPL-deficient pups had lower LPL enzyme activity and higher triglycerides (370 versus 121 mg/dl) than wild type (+/+) littermates. Adult heterozygotes had higher triglycerides than mild type mice with ad libitum feeding (236 mg/dl for +/- versus 88 mg/dl for +/+) and after fasting for 4 h (98 mg/dl for +/- versus 51 for +/+) or 12 h (109 mg/dl for +/- versus 56 mg/dl for +/+), Triglycerides mere present as very low density Lipoprotein particles and chylomicrons, but high density lipoprotein cholesterol levels were not decreased in +/- animals. Plasma heparin-releasable LPL activity was 43% lower in +/- versus +/+ adult animals. LPL activity, mRNA, and protein were lower in the tissues of +/- versus +/+ mice. Homozygous LPL deficiency caused by disruption of the COOH terminus of the enzyme is lethal in mice, Heterozygous LPL deficiency caused by this mutation is associated with mild to moderate hypertriglyceridemia without affecting static HDL cholesterol levels. Heterozygous LPL-deficient mice could be useful for determining if hypertriglyceridemia, independently or in combination with other discrete defects, influences atherosclerosis.	WASHINGTON UNIV,SCH MED,DEPT MED,DIV ATHEROSCLEROSIS NUTR & LIPID RES,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT CELL BIOL & PHYSIOL,ST LOUIS,MO 63110; OKLAHOMA MED RES FDN,OKLAHOMA CITY,OK 73104; UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC 27599	Washington University (WUSTL); Washington University (WUSTL); Oklahoma Medical Research Foundation; University of North Carolina; University of North Carolina Chapel Hill				Semenkovich, Clay/0000-0003-1163-1871	NATIONAL CANCER INSTITUTE [R29CA050898, R01CA050898] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL047436, R37HL042630, R01HL042630] Funding Source: NIH RePORTER; NCI NIH HHS [CA50898] Funding Source: Medline; NHLBI NIH HHS [HL47436, HL42630] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUSTIN MA, 1992, ARTERIOSCLER THROMB, V11, P2; BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BLANCHETTEMACKI.EJ, 1986, LAB INVEST, V55, P347; BRUIN T, 1994, EUR J BIOCHEM, V221, P1019, DOI 10.1111/j.1432-1033.1994.tb18819.x; Brunzell JD, 1989, METABOLIC BASIS INHE, P1165; CHAPPELL DA, 1994, J BIOL CHEM, V269, P18001; COLE TG, 1988, BIOCOMMUNIQUE, V4, P4; CONNELLY PW, 1994, J BIOL CHEM, V269, P20554; DAVIS RC, 1990, J BIOL CHEM, V265, P17960; DESILVA HV, 1994, J BIOL CHEM, V269, P2324; HATANAKA K, 1986, BIOCHIM BIOPHYS ACTA, V878, P440, DOI 10.1016/0005-2760(86)90254-7; HUA XX, 1991, GENE, V107, P247, DOI 10.1016/0378-1119(91)90325-6; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; IZZO C, 1981, CLIN CHEM, V27, P371; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; KOZAKI K, 1993, J LIPID RES, V34, P1765; LALOUEL JM, 1992, CURR OPIN LIPIDOL, V3, P86; LEBOEUF RC, 1994, J LIPID RES, V35, P121; LIU MS, 1994, J BIOL CHEM, V269, P11417; MATTSSON L, 1993, J CLIN INVEST, V92, P1759, DOI 10.1172/JCI116764; MIESENBOCK G, 1990, J CLIN INVEST, V91, P448; MULDER M, 1993, J BIOL CHEM, V268, P9369; NISHINA PM, 1993, J LIPID RES, V34, P1413; OBRIEN KD, 1992, J CLIN INVEST, V89, P1544, DOI 10.1172/JCI115747; OLIVECRONA T, 1986, BIOCHIM BIOPHYS ACTA, V876, P243, DOI 10.1016/0005-2760(86)90280-8; PATERNITI JR, 1983, SCIENCE, V221, P167, DOI 10.1126/science.6857276; PERITZ LN, 1990, CLIN INVEST MED, V13, P259; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767, DOI 10.1161/01.ATV.14.11.1767; RENIER G, 1993, ARTERIOSCLER THROMB, V13, P190, DOI 10.1161/01.ATV.13.2.190; RUMSEY SC, 1992, J CLIN INVEST, V90, P1504, DOI 10.1172/JCI116018; RUTLEDGE JC, 1994, J LIPID RES, V35, P1152; SEIP RL, 1995, AM J PHYSIOL-ENDOC M, V268, pE229, DOI 10.1152/ajpendo.1995.268.2.E229; SEMENKOVICH CF, 1989, J LIPID RES, V30, P423; SHACHTER NS, 1994, J CLIN INVEST, V93, P1683, DOI 10.1172/JCI117151; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; SIMONET WS, 1991, J BIOL CHEM, V266, P8651; SLYPER AH, 1992, LANCET, V340, P289, DOI 10.1016/0140-6736(92)92368-P; TABAS I, 1993, J BIOL CHEM, V268, P20419; TALL AR, 1990, J CLIN INVEST, V86, P379, DOI 10.1172/JCI114722; WILLIAMS KJ, 1992, J BIOL CHEM, V267, P13284; WILLIAMS KJ, 1991, J CLIN INVEST, V88, P1300, DOI 10.1172/JCI115434; WILLIAMS SE, 1994, J BIOL CHEM, V269, P8653; WILSON DE, 1990, J CLIN INVEST, V86, P735, DOI 10.1172/JCI114770; WONG H, 1994, J BIOL CHEM, V269, P10319; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P10143, DOI 10.1073/pnas.88.22.10143; ZECHNER R, 1991, GENOMICS, V11, P62, DOI 10.1016/0888-7543(91)90102-K; ZSIGMOND E, 1994, J BIOL CHEM, V269, P18757	49	108	112	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 26	1995	270	21					12518	12525		10.1074/jbc.270.21.12518	http://dx.doi.org/10.1074/jbc.270.21.12518			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QZ711	7759497	Green Published, hybrid			2022-12-27	WOS:A1995QZ71100031
J	NILSSON, M; TOFTGARD, R; BOHM, S				NILSSON, M; TOFTGARD, R; BOHM, S			ACTIVATED HA-RAS BUT NOT TPA INDUCES TRANSCRIPTION THROUGH BINDING-SITES FOR ACTIVATING TRANSCRIPTION FACTOR 3/JUN AND A NOVEL NUCLEAR FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-FOS PROMOTER; VL30 TRANSCRIPTION; TUMOR-PROMOTER; ONCOGENE; ELEMENT; PROTEINS; ENHANCER; GENE; JUN; SEQUENCES	We report the identification of a 20-base pair sequence mediating induced transcription in response to an activated Ha-ras gene and epidermal growth factor (EGF) but not 12-O-tetradecanoylphorbol-13-acetate stimulation. This signal-specific nuclear target is present in the long terminal repeat of a mouse VL30 retrotransposon expressed in epidermis. Functional studies and in vitro binding analyses using cultured keratinocytes (Balb/MK) reveal that the response element is composed of two cooperating sequence motifs in juxtaposed position, both of which are targets for induced binding activity 1-2 h after EGF stimulation. Of many different activating transcription factor/cAMP-responsive element binding protein/activating protein 1 factors tested, one part of the sequence selectively binds endogenous proteins immunologically related to activating transcription factor 3 (ATF3) and Jun isotypes. The other sequence is a target for a nuclear factor showing binding specificity unrelated to factors known to mediate EGF- or ras-induced transcription as determined by its sequence specificity and by antibody experiments. This component has been characterized and partially purified by gel filtration chromatography and velocity centrifugation revealing a Stokes radius of 43.6 Angstrom and a sedimentation coefficient of 9.7 S in solution. Based on these parameters, a molecular mass of 178,000 Da was calculated. The results indicate that the specific binding of ATF3/Jun and a previously uncharacterized factor account for signal-specific transcription in response to EGF or an activated Ha-ras gene in a cell type in which the cooperative action of an activated Ha-ras gene and 12-O-tetradecanoylphorbol-13-acetate cause tumor growth.	KAROLINSKA INST,NOVUM,DEPT BIOSCI,S-14157 HUDDINGE,SWEDEN	Karolinska Institutet	NILSSON, M (corresponding author), KAROLINSKA INST,NOVUM,CTR NUTR & TOXICOL,S-14157 HUDDINGE,SWEDEN.							BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOHM S, 1993, J BIOL CHEM, V268, P3952; BOHM S, 1991, J BIOL CHEM, V266, P24834; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CHATTON B, 1994, ONCOGENE, V9, P375; CHEN RP, 1990, NATURE, V346, P583, DOI 10.1038/346583a0; DEUTSCH PJ, 1988, P NATL ACAD SCI USA, V85, P7922, DOI 10.1073/pnas.85.21.7922; GALIEN R, 1991, ONCOGENE, V6, P849; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; GUTMAN A, 1991, MOL CELL BIOL, V11, P5381, DOI 10.1128/MCB.11.10.5381; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; KEDAR PS, 1990, MOL CELL BIOL, V10, P3852, DOI 10.1128/MCB.10.7.3852; KOIKE M, 1993, MOL CARCINOGEN, V8, P105, DOI 10.1002/mc.2940080207; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; NILSSON M, 1994, J VIROL, V68, P276, DOI 10.1128/JVI.68.1.276-288.1994; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OWEN RD, 1990, MOL CELL BIOL, V10, P1; REDDY MA, 1992, MOL ENDOCRINOL, V6, P1051, DOI 10.1210/me.6.7.1051; RYSECK RP, 1991, ONCOGENE, V6, P533; Sherman M R, 1975, Methods Enzymol, V36, P211; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SPANDIDOS DA, 1984, NATURE, V310, P469, DOI 10.1038/310469a0; STRUHL K, 1990, CURRENT PROTOCOLS MO; TAN Y, 1994, MOL CELL BIOL, V14, P7546, DOI 10.1128/MCB.14.11.7546; TANFORD L, 1961, PHYSICAL CHEM MACROM, P34; THIERRY F, 1992, J VIROL, V66, P3740, DOI 10.1128/JVI.66.6.3740-3748.1992; VANDUUREN BL, 1969, PROG EXP TUMOR RES, V11, P31; VASSAR R, 1992, MOL CELL BIOL, V12, P4643, DOI 10.1128/MCB.12.10.4643; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WASYLYK C, 1989, EMBO J, V8, P3371, DOI 10.1002/j.1460-2075.1989.tb08500.x; YAMAGUCHI Y, 1989, J VIROL, V63, P1040, DOI 10.1128/JVI.63.3.1040-1048.1989; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	41	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 19	1995	270	20					12210	12218		10.1074/jbc.270.20.12210	http://dx.doi.org/10.1074/jbc.270.20.12210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QY736	7744871	hybrid			2022-12-27	WOS:A1995QY73600076
J	HELLEVUO, K; YOSHIMURA, M; MONS, N; HOFFMAN, PL; COOPER, DMF; TABAKOFF, B				HELLEVUO, K; YOSHIMURA, M; MONS, N; HOFFMAN, PL; COOPER, DMF; TABAKOFF, B			THE CHARACTERIZATION OF A NOVEL HUMAN ADENYLYL-CYCLASE WHICH IS PRESENT IN BRAIN AND OTHER TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; MESSENGER-RNA; INSITU HYBRIDIZATION; EXPRESSION; CLONING; CALMODULIN; PROTEIN; STIMULATION; GS; LOCALIZATION	We characterized a human cDNA clone which encodes a novel adenylyl cyclase. Data from Southern and Northern blot analysis, and analysis of sequence similarity with a recently cloned mouse adenylyl cyclase (10), indicated that the human adenylyl cyclase was a species variant of type VII adenylyl cyclase. The sequence of the novel human adenylyl cyclase indicated it was a member of the type II adenylyl cyclase family, and we compared the regulatory characteristics of the novel human enzyme with those of type II adenylyl cyclase. The human type VII and rat type II adenylyl cyclases, expressed in human embryonic kidney 293 cells, were activated by prostaglandin E(1) (PGE(1)), but only type VII was activated by isoproterenol. The stimulation of type VII adenylyl cyclase by PGE(1) and isoproterenol was attenuated by pretreatment of the cells with staurosporine. Phorbol 12,13-dibutyrate synergistically enhanced the stimulation of both type VII and type II enzyme activity by PGE, and by the constitutively active G(s) mutant G(s) (Q227L). The human type VII adenylyl cyclase activity was unresponsive to capacitatively induced changes in intracellular Ca2+. The functional characteristics of human type VII adenylyl cyclase resemble those of the rat type II enzyme, but the enzymes may respond differently to in vivo phosphorylation conditions. While the mRNA for adenylyl cyclase type II was found in several brain areas, the message for type VII adenylyl cyclase was localized primarily to the cerebellar granule cell layer.	UNIV COLORADO, HLTH SCI CTR, DEPT PHARMACOL, DENVER, CO 80262 USA; UNIV BORDEAUX 1, NEUROCYTOCHIM FONCT LAB, CNRS, URA 339, F-33405 TALENCE, FRANCE	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux			Tabakoff, Boris/AAX-1204-2021; Mons, Nicole/AAD-5541-2019		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009014] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA09014] Funding Source: Medline; PHS HHS [32483] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; CALI JJ, 1994, J BIOL CHEM, V269, P12190; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER DMF, 1994, BIOCHEM J, V297, P437, DOI 10.1042/bj2970437; DEFER N, 1994, FEBS LETT, V351, P109, DOI 10.1016/0014-5793(94)00836-1; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; HABER N, 1994, HUM GENET, V94, P69, DOI 10.1007/BF02272844; HELLEVUO K, 1993, BIOCHEM BIOPH RES CO, V192, P311, DOI 10.1006/bbrc.1993.1415; HELLEVUO K, 1995, HUM GENET, V95, P197; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; IYENGAR R, 1993, FASEB J, V7, P768, DOI 10.1096/fasebj.7.9.8330684; JACOBOWITZ O, 1993, J BIOL CHEM, V268, P3829; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; KRUPINSKI J, 1992, J BIOL CHEM, V267, P24858; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARGENT BL, 1988, P NATL ACAD SCI USA, V85, P2864, DOI 10.1073/pnas.85.8.2864; LUSTIG KD, 1993, J BIOL CHEM, V268, P13900; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; MONS N, 1994, MOL BRAIN RES, V22, P236, DOI 10.1016/0169-328X(94)90052-3; MONS N, 1993, SYNAPSE, V14, P51, DOI 10.1002/syn.890140108; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; PREMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809, DOI 10.1073/pnas.89.20.9809; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STENGEL D, 1992, HUM GENET, V90, P126; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STEVENS T, 1994, AM J PHYSIOL, V266, pH1416, DOI 10.1152/ajpheart.1994.266.4.H1416; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TANG WJ, 1991, J BIOL CHEM, V266, P8595; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; VILLACRES EC, 1993, GENOMICS, V16, P473, DOI 10.1006/geno.1993.1213; WATSON PA, 1994, J BIOL CHEM, V269, P28893; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716; YOSHIMURA M, 1993, J BIOL CHEM, V268, P4604	44	67	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	1995	270	19					11581	11589		10.1074/jbc.270.19.11581	http://dx.doi.org/10.1074/jbc.270.19.11581			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QX865	7744797	hybrid			2022-12-27	WOS:A1995QX86500078
J	DANSAPETRETSKI, M; RIBEIRO, JMC; ATELLA, GC; MASUDA, H; OLIVEIRA, PL				DANSAPETRETSKI, M; RIBEIRO, JMC; ATELLA, GC; MASUDA, H; OLIVEIRA, PL			ANTIOXIDANT ROLE OF RHODNIUS-PROLIXUS HEME-BINDING PROTEIN - PROTECTION AGAINST HEME-INDUCED LIPID-PEROXIDATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPHORIN; HEMOPEXIN; PHOSPHOLIPIDS	Heme in aqueous solutions actively promotes free radical reactions leading to degradation of biological molecules, The blood-sucking insect Rhodnius prolixus has a heme-binding protein (RHBP) in its hemolymph (Oliveira, P. L., Kawooya, J .K, Ribeiro, J. M. C., Meyer, T., Poorman, R., Alves, E, W., Walker, F., Padovan, G. J., and Masuda, H. (1994) J, Biol, Chem, 270, 10897-10901, Here we show that this protein inhibits heme-dependent peroxidation of both linolenic acid liposomes and lipophorin, the main lipoprotein of insect hemolymph, The oxidized lipophorin is functionally impaired, being defective both in its capacity to be loaded with phospholipids from the fat body as well as in its ability to deliver phospholipids to the growing oocytes, RHBP prevents the heme-induced oxidative damage to lipophorin. It is proposed that in vivo RHBP binds the heme derived from digestion of blood hemoglobin, suppressing the generation of activated oxygen species and protecting the insect against oxidative stress throughout the feeding cycle.	UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM MED,BR-21941590 RIO JANEIRO,BRAZIL; UNIV ARIZONA,DEPT ENTOMOL,TUCSON,AZ 85721	Universidade Federal do Rio de Janeiro; University of Arizona			Atella, Georgia/AAK-7897-2020; L. Oliveira, Pedro/A-9438-2010	L. Oliveira, Pedro/0000-0003-0307-354X; Ribeiro, Jose/0000-0002-9107-0818				AFT RL, 1983, J BIOL CHEM, V258, P2069; ATELLA GC, 1992, ARCH INSECT BIOCHEM, V19, P133, DOI 10.1002/arch.940190206; CHINO H, 1969, BIOCHIM BIOPHYS ACTA, V176, P1; CHINO H, 1985, COMPREHENSIVE INSECT, V10, P115; CRICHTON RR, 1987, BIOELECTROCH BIOENER, V18, P105, DOI 10.1016/0302-4598(87)85012-2; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; DIHEL P, 1982, CURRENT THEMES TROPI, P49; FRIEND WG, 1965, CAN J ZOOL, V43, P892; Garcia ES, 1975, AN ACAD BRAS CIENC, V47, P539; GONDIM KC, 1989, J INSECT PHYSIOL, V35, P19, DOI 10.1016/0022-1910(89)90032-2; GONDIM KC, 1989, INSECT BIOCHEM, V19, P153, DOI 10.1016/0020-1790(89)90086-3; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; GUTTERIDGE JMC, 1983, BIOCHEM BIOPH RES CO, V117, P901, DOI 10.1016/0006-291X(83)91681-9; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; HALLIWELL B, 1984, METHOD ENZYMOL, V105, P47; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; HEINECKE JW, 1987, FREE RADICAL BIO MED, V3, P65, DOI 10.1016/0891-5849(87)90040-2; HRKAL Z, 1971, BIOCHEMISTRY-US, V10, P1746, DOI 10.1021/bi00786a002; Kanost M.R., 1990, Advances in Insect Physiology, V22, P299, DOI 10.1016/S0065-2806(08)60008-9; KATASE H, 1982, BIOCHIM BIOPHYS ACTA, V710, P341; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEDTKE AJ, 1984, BASIC RES CARDIOL, V79, P513, DOI 10.1007/BF01910480; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADDRELL SH, 1969, J EXP BIOL, V51, P71; OHAGAN JE, 1974, EXP PARASITOL, V35, P110, DOI 10.1016/0014-4894(74)90013-7; OLIVEIRA PL, 1994, J BIOL CHEM, V270, P10897; ORJIH AU, 1981, SCIENCE, V214, P667, DOI 10.1126/science.7027441; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; TAKETANI S, 1987, J BIOL CHEM, V262, P4639; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; TIPPING E, 1979, BIOCHEM J, V180, P327, DOI 10.1042/bj1800327; VANDERHORST DJ, 1981, COMP BIOCHEM PHYS B, V70, P387, DOI 10.1016/0305-0491(81)90271-6; VANHEUSDEN MC, 1987, INSECT BIOCHEM, V17, P771, DOI 10.1016/0020-1790(87)90048-5; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; WALKER FA, 1988, J AM CHEM SOC, V110, P6234, DOI 10.1021/ja00226a045; Wigglesworth VB, 1943, PROC R SOC SER B-BIO, V131, P313, DOI 10.1098/rspb.1943.0010	37	75	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10893	10896		10.1074/jbc.270.18.10893	http://dx.doi.org/10.1074/jbc.270.18.10893			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7738029				2022-12-27	WOS:A1995QW60100077
J	DECROUYCHANEL, A; ELYAAGOUBI, A; KOHIYAMA, M; RICHARME, G				DECROUYCHANEL, A; ELYAAGOUBI, A; KOHIYAMA, M; RICHARME, G			REVERSAL BY GROES OF THE GROEL PREFERENCE FROM HYDROPHOBIC AMINO-ACIDS TOWARD HYDROPHILIC AMINO-ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PEPTIDE-BINDING; PROTEIN; SURFACE; DNAK; PURIFICATION; SPECIFICITY; CHAPERONES; PATHWAY; CYCLE	The chaperones GroEL/hsp60 are present in all prokaryotes and in mitochondria and chloroplasts of eukaryotic cells. They are involved in protein folding, protein targeting to membranes, protein renaturation, and control of protein protein interactions. They interact with many polypeptides in an ATP dependent manner and possess a peptide-dependent ATPase activity. GroEL/hsp60 cooperates with GroES/hsp10, and the productive folding of proteins by GroEL generally requires GroES, which appears to regulate the binding and release of substrate proteins by GroEL. In a recent study, we have shown that GroEL interacts preferentially with the side chains of hydrophobic amino acids (Ile, Phe, Val, Leu, and Trp) and more weakly with several polar or charged amino acids, including the strongest alpha-helix and beta-sheet formers (Glu, Gin, His, Thr, and Tyr). In this study, we show that GroES reduces the specificity of GroEL for hydrophobic amino acids and increases its specificity for hydrophilic ones. This shift by GroES of the GroEL specificity from hydrophobic amino acids toward hydrophilic ones might be of importance for its function in protein folding.	UNIV PARIS 07,INST JACQUES MONOD,F-75005 PARIS,FRANCE	UDICE-French Research Universities; Universite Paris Cite								BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; CHOU PY, 1978, ANN REV BIOCH, V44, P251; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FERSHT AR, 1993, FEBS LETT, V325, P5, DOI 10.1016/0014-5793(93)81405-O; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MENDOZA JA, 1992, J BIOL CHEM, V266, P13044; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; MORIMOTO R I, 1990, P1; PTITSYN OB, 1992, CONFORMATIONS FORCES, P155; RANDALL LL, 1992, SCIENCE, V257, P241, DOI 10.1126/science.1631545; RICHARME G, 1993, J BIOL CHEM, V268, P24074; RICHARME G, 1994, J BIOL CHEM, V269, P7095; SAIBIL H, 1991, NATURE, V353, P25, DOI 10.1038/353025b0; TILLY K, 1981, P NATL ACAD SCI-BIOL, V78, P1629, DOI 10.1073/pnas.78.3.1629; VITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665; VITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9	32	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10571	10575		10.1074/jbc.270.18.10571	http://dx.doi.org/10.1074/jbc.270.18.10571			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737993	hybrid			2022-12-27	WOS:A1995QW60100034
J	ZENG, CB; FROMM, HJ				ZENG, CB; FROMM, HJ			ACTIVE-SITE RESIDUES OF HUMAN BRAIN HEXOKINASE AS STUDIED BY SITE-SPECIFIC MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; HEXOSE BINDING-SITE; C-TERMINAL HALVES; YEAST HEXOKINASE; CLONED CDNA; MAMMALIAN HEXOKINASE; ESCHERICHIA-COLI; RAT HEXOKINASE; PURIFICATION; GLUCOSE	The truncated gene of hexokinase, mini hexokinase, starting with methionine 455 and ending at the C terminus was expressed in Escherichia coli. Mini-hexokinase lost its ability to ameliorate inhibition of glucose-6-P-inhibited mini-hexokinase in the presence of phosphate (P-i). We suggest that the P-i site either resides in the N-terminal half of hexokinase I or requires the N-terminal portion of the enzyme. Site-directed mutagenesis was performed to obtain two mutants of mini-hexokinase: C606S and C628S. Both are thought to be associated with the active site of hexokinase I. These mutants exhibited a 3-fold increase in K-m for glucose but no change in either the K-m for ATP or the k(cat). The circular dichroism (CD) spectra showed no differences among the wild-type or mutant enzymes. These results suggest that Cys(606) and Cys(628) are not involved in glucose binding directly. The putative ATP-binding site of full-length human brain hexokinase may involve Arg(539) and Gly(679), and these residues were mutated to Ile. For the mutant R539I, the k(cat) value decreased 114-fold relative to wildtype hexokinase, whereas the K-m values for ATP and glucose changed only slightly. No change was observed in the K-i value for 1,5-anhydroglucitol 6-phosphate. CD spectra showed only a slight change in secondary structure. For the mutant G679I, overexpressed hexokinase is insoluble. We suggest that Arg(539) is important for catalysis because it stablizes the transition state product ADP-hexokinase. Gly(679) is probably important for proper folding of the protein.	IOWA STATE UNIV SCI & TECHNOL, DEPT BIOCHEM & BIOPHYS, AMES, IA 50011 USA	Iowa State University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS010546, R01NS010546] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 10546] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON CM, 1978, J MOL BIOL, V123, P207, DOI 10.1016/0022-2836(78)90321-2; ANDREONE TL, 1989, J BIOL CHEM, V264, P363; ARORA KK, 1990, J BIOL CHEM, V265, P6481; ARORA KK, 1993, J BIOL CHEM, V268, P18259; BENNETT WS, 1980, J MOL BIOL, V140, P211, DOI 10.1016/0022-2836(80)90103-5; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRANE RK, 1954, J BIOL CHEM, V210, P597; DONG Q, 1990, ARCH BIOCHEM BIOPHYS, V276, P77, DOI 10.1016/0003-9861(90)90012-N; EASTERBY JS, 1973, EUR J BIOCHEM, V38, P201, DOI 10.1111/j.1432-1033.1973.tb03051.x; ELLISON WR, 1974, BIOCHEM BIOPH RES CO, V57, P1214, DOI 10.1016/0006-291X(74)90826-2; FERRARI RICHARD A., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P372, DOI 10.1016/0003-9861(59)90264-4; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FROHLICH KU, 1985, GENE, V36, P105, DOI 10.1016/0378-1119(85)90074-5; FROMM HJ, 1962, J BIOL CHEM, V237, P1661; FROMM HJ, 1981, REGULATION CARBOHYDR, P45; GERBER G, 1974, EUR J BIOCHEM, V45, P39, DOI 10.1111/j.1432-1033.1974.tb03527.x; GRIFFIN LD, 1991, GENOMICS, V11, P1014, DOI 10.1016/0888-7543(91)90027-C; HARRISON R, 1985, THESIS YALE U; HOLROYDE MJ, 1976, FEBS LETT, V62, P215, DOI 10.1016/0014-5793(76)80056-7; JARORI GK, 1990, EUR J BIOCHEM, V188, P9, DOI 10.1111/j.1432-1033.1990.tb15364.x; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KOPETZKI E, 1985, GENE, V39, P95, DOI 10.1016/0378-1119(85)90113-1; LAZO PA, 1980, J BIOL CHEM, V255, P7548; LIU F, 1991, BIOCHEM BIOPH RES CO, V177, P305, DOI 10.1016/0006-291X(91)91983-J; LOWRY OH, 1964, J BIOL CHEM, V239, P31; MAGNANI M, 1992, BIOCHEM J, V285, P193, DOI 10.1042/bj2850193; MANNING TA, 1984, BIOCHEM BIOPH RES CO, V118, P90, DOI 10.1016/0006-291X(84)91071-4; MEHTA A, 1988, J BIOL CHEM, V263, P15492; NISHI S, 1988, BIOCHEM BIOPH RES CO, V157, P937, DOI 10.1016/S0006-291X(88)80964-1; PURICH DL, 1971, J BIOL CHEM, V246, P3456; Rapoport S, 1968, Essays Biochem, V4, P69; REDKAR VD, 1975, BIOCHEMISTRY-US, V14, P4704, DOI 10.1021/bi00692a022; REDKAR VD, 1972, J BIOL CHEM, V247, P7576; ROSE IA, 1974, ARCH BIOCHEM BIOPHYS, V164, P729, DOI 10.1016/0003-9861(74)90086-1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIRCH DM, 1987, ARCH BIOCHEM BIOPHYS, V257, P1, DOI 10.1016/0003-9861(87)90536-4; SCHIRCH DM, 1987, ARCH BIOCHEM BIOPHYS, V254, P385, DOI 10.1016/0003-9861(87)90116-0; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; SCHWAB DA, 1989, P NATL ACAD SCI USA, V86, P2563, DOI 10.1073/pnas.86.8.2563; SCHWAB DA, 1991, ARCH BIOCHEM BIOPHYS, V285, P365, DOI 10.1016/0003-9861(91)90373-Q; SOLHEIM LP, 1981, ARCH BIOCHEM BIOPHYS, V211, P92, DOI 10.1016/0003-9861(81)90433-1; SOLS A, 1976, REFLECTIONS BIOCH, P199; SUBBARAO B, 1977, ARCH BIOCHEM BIOPHYS, V181, P8, DOI 10.1016/0003-9861(77)90477-5; SUBBARAO B, 1977, ARCH BIOCHEM BIOPHYS, V181, P19, DOI 10.1016/0003-9861(77)90478-7; SWARUP G, 1980, BIOCHEMISTRY-US, V19, P4058, DOI 10.1021/bi00558a024; THELEN AP, 1991, ARCH BIOCHEM BIOPHYS, V286, P645, DOI 10.1016/0003-9861(91)90094-Y; URETA T, 1982, COMP BIOCHEM PHYS B, V71, P549, DOI 10.1016/0305-0491(82)90461-8; URETA T, 1975, ISOZYMES, V3, P575; WHITE TK, 1989, ARCH BIOCHEM BIOPHYS, V274, P375, DOI 10.1016/0003-9861(89)90451-7; [No title captured]	51	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1995	270	18					10509	10513		10.1074/jbc.270.18.10509	http://dx.doi.org/10.1074/jbc.270.18.10509			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QW601	7737985				2022-12-27	WOS:A1995QW60100025
J	GLOMB, MA; MONNIER, VM				GLOMB, MA; MONNIER, VM			MECHANISM OF PROTEIN MODIFICATION BY GLYOXAL AND GLYCOLALDEHYDE, REACTIVE INTERMEDIATES OF THE MAILLARD REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-DEPENDENT ACCUMULATION; DIABETES-MELLITUS; ALPHA-DICARBONYL; LENS PROTEINS; CROSS-LINKING; AMINO-ACIDS; PRODUCTS; N-EPSILON-(CARBOXYMETHYL)LYSINE; AUTOXIDATION; PENTOSIDINE	The role of glyoxal and glycolaldehyde in protein cross-linking and N-epsilon-(carboxymethyl)lysine (CML) formation during Maillard reaction under physiological conditions was investigated, Incubation of bovine serum albumin with these reagents lead to rapid formation of C-2-imine cross-links and CML. Initial CML formation rate from glyoxal was not dependent on oxidation, suggesting an intramolecular Cannizzaro reaction. CML formation from glucose/lysine or Amadori product of both was strongly dependent on oxidation, Blocking of Amadori product by boric acid totally suppressed CML formation from Amadori product, but only by 37% in the glucose/lysine system. Trapping of glyoxal with aminoguanidine hardly suppressed CML formation from Amadori product, whereas it blocked 50% of CML production in the glucose/lysine system. While these results would support a significant role for glucose autoxidation in CML formation, the addition of lysine to a glucose/aminoguanidine incubation system catalyzed glyoxal triazine formation 7-fold, thereby strongly suggesting that glucose autoxidation is not a factor for glyoxal-mediated CML formation, Based on these results, it can be estimated that approximately 50% of the CML forming in a glucose/lysine system originates from oxidation of Amadori product, and 40-50% originates from a pre-Amadori stage largely independent from glucose autoxidation, This step may be related to the so-called Namiki pathway of the Maillard reaction.			GLOMB, MA (corresponding author), CASE WESTERN RESERVE UNIV,INST PATHOL,2085 ADELBERT RD,CLEVELAND,OH 44106, USA.		Monnier, Vincent M/B-1371-2009		NATIONAL EYE INSTITUTE [R01EY007099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005601] Funding Source: NIH RePORTER; NEI NIH HHS [EY 07099] Funding Source: Medline; NIA NIH HHS [AG 05601] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACHARYA AS, 1983, P NATL ACAD SCI-BIOL, V80, P3590, DOI 10.1073/pnas.80.12.3590; AHMED MU, 1986, J BIOL CHEM, V261, P4889; Baynes JW., 1989, PROG CLIN BIOL RES, V304, P1; BENSON JR, 1975, P NATL ACAD SCI USA, V72, P619, DOI 10.1073/pnas.72.2.619; BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6; BROWNLEE M, 1980, DIABETES, V29, P1044, DOI 10.2337/diabetes.29.12.1044; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; CHO RK, 1986, AGR BIOL CHEM TOKYO, V50, P1373, DOI 10.1080/00021369.1986.10867600; Chuyen N. V., 1973, Agricultural and Biological Chemistry, V37, P2209; DUNN JA, 1989, BIOCHEMISTRY-US, V28, P9464, DOI 10.1021/bi00450a033; DUNN JA, 1991, BIOCHEMISTRY-US, V30, P1205, DOI 10.1021/bi00219a007; DUNN JA, 1990, BIOCHEMISTRY-US, V29, P10964, DOI 10.1021/bi00501a014; ERIKSON JG, 1952, J AM CHEM SOC, V74, P4706; FU MX, 1992, DIABETES, V41, P42, DOI 10.2337/diab.41.2.S42; GLASS JD, 1978, BIOCHEM BIOPH RES CO, V81, P527, DOI 10.1016/0006-291X(78)91566-8; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; HAYASHI T, 1977, J AGR FOOD CHEM, V25, P1282, DOI 10.1021/jf60214a047; HAYASHI T, 1985, AGR BIOL CHEM TOKYO, V49, P3131, DOI 10.1080/00021369.1985.10867244; HAYASHI T, 1986, AMINO CARBONYL REACT, P29; JOHNSON RN, 1982, CLIN CHIM ACTA, V127, P87; LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; MICHEEL F, 1959, CHEM BER-RECL, V92, P2836, DOI 10.1002/cber.19590921127; MIYATA S, 1992, J CLIN INVEST, V89, P1102, DOI 10.1172/JCI115690; MORION MS, 1994, BIOCHIM BIOPHYS ACTA, V1191, P33; NEDVIDEK W, 1992, Z LEBENSM UNTERS FOR, V194, P222, DOI 10.1007/BF01198411; PORTEROOTIN M, IN PRESS BIOCH BIOPH; SCHWARTZ BA, 1977, ARCH BIOCHEM BIOPHYS, V181, P542, DOI 10.1016/0003-9861(77)90261-2; SELL DR, 1991, DIABETES METAB REV, V7, P239, DOI 10.1002/dmr.5610070404; SLIGHT SH, 1992, BIOCHIM BIOPHYS ACTA, V1117, P199, DOI 10.1016/0304-4165(92)90080-E; SMITH PR, 1993, CLIN SCI, V84, P87, DOI 10.1042/cs0840087; VELISEK J, 1989, J FOOD SCI, V54, P1544, DOI 10.1111/j.1365-2621.1989.tb05155.x; VENUTI MC, 1982, SYNTHESIS-STUTTGART, P61; WOLFF SP, 1991, FREE RADICAL BIO MED, V10, P339, DOI 10.1016/0891-5849(91)90040-A	34	500	509	0	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 28	1995	270	17					10017	10026		10.1074/jbc.270.17.10017	http://dx.doi.org/10.1074/jbc.270.17.10017			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QV417	7730303	hybrid			2022-12-27	WOS:A1995QV41700048
